Study Status,Study Results,Conditions,Interventions,Sex,Age,Phases,Enrollment,Study Type,Study Design,Start Date,Completion Date,Locations,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"CANCER,NOS",DRUG: Lirilumab|DRUG: Nivolumab|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,337,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",10/7/12,12/13/19,"Ucsf, San Francisco, California, 94115, United States|Florida Cancer Affiliates - Ocala, Ocala, Florida, 34471, United States|University Of Chicago Medical Center, Chicago, Illinois, 60637, United States|Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Lutherville, Maryland, 21093, United States|Beth Israel Deaconess Med Ctr, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Massachusetts General Hospital, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, 43210, United States|Providence Portland Med Ctr, Portland, Oregon, 97213, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|UPMC Eye and Ear Institute, Pittsburgh, Pennsylvania, 15213, United States|West Cancer Center, Germantown, Tennessee, 38138, United States|Texas Oncology-Central Austin Cancer Center, Austin, Texas, 78731, United States|University Of Texas Medical Branch Of Galveston, Galveston, Texas, 77555, United States|University Of Washington, Seattle, Washington, 98195, United States|Juravinski Cancer Center, Hamilton, Ontario, L8V 5C2, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|Local Institution, Bordeaux, 33075, France|Local Institution, Lyon, 69373, France|Local Institution, Nice, 06189, France|Local Institution, Paris, 75005, France|Institut Gustave Roussy, Villejuif, 94805, France|IRCCS Istituto Nazionale Tumori Milano, Milan, MI, 20133, Italy|Local Institution, Siena, 53100, Italy|Local Institution, Barcelona, 08035, Spain|Local Institution - 0038, Madrid, 28034, Spain|Local Institution, Madrid, 28050, Spain|Kantonsspital Graubuenden, Chur, 7000, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Tumors,DRUG: Additive classical homeopathy|DRUG: Homeopathic Placebo globules,ALL,"ADULT, OLDER_ADULT",PHASE3,150,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",2/1/12,7/31/19,"Michael Frass, Vienna, 1120, Austria",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Cancer Nos Metastatic Recurrent,GENETIC: Ad-RTS-hIL-12 and Veledimex|DRUG: Palifosfamide,ALL,"ADULT, OLDER_ADULT",PHASE2,12,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/4/13,8/7/14,"Baptist Cancer Institute, Jacksonville, Florida, 32207, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Billings Clinic, Billings, Montana, 59101, United States|Signal Point Clinical Research Center, Middletown, Ohio, 45042, United States|Greenville Hospital System, Greenville, South Carolina, 29605, United States|The Jones Clinic, PC, Germantown, Tennessee, 38138, United States|Mary Crowley Medical Research Center, Dallas, Texas, 75201, United States|Evergreen Hematology & Oncology, Spokane, Washington, 99218, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,NeuroEndocrine Tumours,DRUG: lanreotide acetate,ALL,"ADULT, OLDER_ADULT",PHASE4,50,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2014-05,2017-06,"Basingstoke & North Hampshire Hospital, Basingstoke, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|University Hospital Wales, Cardiff, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|St James's University Hospital, Leeds, United Kingdom|University Hospital Aintree, Liverpool, United Kingdom|Hammersmith Hospital, London, United Kingdom|King's College Hospital, London, United Kingdom|Royal Free Hospital, London, United Kingdom|Maidstone Hospital, Maidstone, United Kingdom|The Christie Hospital, Manchester, United Kingdom|Norfolk & Norwich Hospital, Norwich, United Kingdom|Royal Hallamshire Hospital, Sheffield, United Kingdom|Southampton University Hospital, Southampton, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Oncology,BIOLOGICAL: SUPLEXA,ALL,"ADULT, OLDER_ADULT",PHASE1,46,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/28/22,7/23/24,"Greenslopes Private Hospital/Gallipoli Medical Research Foundation, Brisbane, Queeensland, 4120, Australia|Cancer Research Sa (Crsa), Adelaide, South Australia, 5000, Australia|Southern Oncology Clinical Research Unit (SOCRU), Adelaide, South Australia, 5042, Australia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Male Genital Organs|Malignant Neoplasms of Urinary Tract,DRUG: Deep Neuromuscular Blockade (NMB)|DRUG: Moderate Neuromuscular Blockade (NMB)|DRUG: Sugammadex|DRUG: Neostigmine|BEHAVIORAL: Pain Assessment,ALL,OLDER_ADULT,PHASE4,100,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",11/17/17,10/22/20,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Liver Tumour,DRUG: ThermoDox® (LTLD)|DEVICE: Focused Ultrasound of Target Liver Tumour|DIAGNOSTIC_TEST: Pre-LTLD Biopsy of Target Liver Tumour|DIAGNOSTIC_TEST: Post-LTLD Biopsy of Target Liver Tumour|DIAGNOSTIC_TEST: Post-LTLD+FUS (Post-FUS) Biopsy of Target Liver Tumour|DEVICE: Thermometry of Target Tumour,ALL,"ADULT, OLDER_ADULT",PHASE1,10,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-07,2017-04,"Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pancreatic Tumours|Midgut Neuroendocrine Tumours,DRUG: Lanreotide autogel 120 mg,ALL,"ADULT, OLDER_ADULT",PHASE2,99,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/15/15,10/24/19,"Erasme Hospital, Brussels, 1070, Belgium|Cliniques Unversitaires Saint Luc, Brussels, 1200, Belgium|Antwerp University Hospital, Edegem, 2650, Belgium|UZ Leuven, Leuven, B-3000, Belgium|Aarhus University Hospital, Aarhus, Denmark|Rigshospitalet, Copenhagen, 2100, Denmark|Hôpital Beaujon, Clichy, 92118, France|Hôpital Edouard Herriot, Lyon, 69437, France|Institut Paoli Calmette, Marseille, 13273, France|Institut Gustave Roussy, Villejuif, 94805, France|Charité - CVK, Berlin, 13353, Germany|Universitätsklinikum Erlangen, Erlangen, 91054, Germany|Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, 69120, Germany|St Vincent's University Hospital, Dublin, D4, Ireland|IRCCS Azienda Ospedaliera Universitaria, San Martino, Genova, 16132, Italy|Azienda Ospedaliera - Universitaria Careggi, Florence, 50134, Italy|Fondacione IRCCS Istituto Nazionale Dei Tumori, Milan, 20133, Italy|Università degli Studi ""Federico II"" di Napoli, Napoli, 80131, Italy|Azienda Ospedaliera sant'Andrea, Roma, 00189, Italy|AVL/NKI Medisch Oncologie, Amsterdam, 1066, Netherlands|Academic Medical Center, Amsterdam, 1105, Netherlands|Erasmus MC, Rotterdam, 3015, Netherlands|Samodzielny Publiczny Szpital Kliniczny nr 5, Katowice, 40-952, Poland|Katedra i Klinika Endokrynologii, Poznan, 60-355, Poland|Centrum Diagnostyczno-Lecznicze ""GAMMED"", Warsaw, 02-348, Poland|Hospital Universitario Vall D'hebron, Barcelona, 08034, Spain|Hospital Universitario Ramón Y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 De Octubre, Madrid, 28041, Spain|Hospital Universitario Central de Asturias, Oviedo, 33011, Spain|Queen Elizabeth Medical Center, Birmingham, B15 2TH, United Kingdom|Royal Free Hospital, London, NW3 2QG, United Kingdom|The Christie Hospital NHS Foundation Trust, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Oncology,DRUG: Sym013,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,32,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/1/16,2019-06,"Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, 78229, United States|NEXT Oncology, San Antonio, Texas, 78240, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumours,DRUG: Lanreotide (Autogel formulation) and Temozolomide,ALL,"ADULT, OLDER_ADULT",PHASE2,40,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-07,6/18/19,"Oncologia Medica - Istituto Oncologico del Mediterraneo - IOM, Viagrande, Catania, 95029, Italy|Unità Operativa di Oncologia Azienda Ospedaliera Spedali Civili di Brescia, Brescia, 25123, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) S.r.l., IRCCS, Meldola, 47014, Italy|Unità Oncologia Medica Gastrointestinale e Tumori Neuroendocrini Istituto Europeo di Oncologia, IEO, Milan, 20141, Italy|Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica , Università degli Studi, Napoli, 80131, Italy|Dipartimento di Oncologia Università di Torino Ospedale San Luigi Gonzaga, Orbassano, 10043, Italy|S.C di Oncologia Medica, Azienda Ospedaliera Universitaria di Perugia, Perugia, 06123, Italy|U.O. Oncologia - Azienda Ospedaliero-Universitaria Pisana Ospedale S. Chiara, Pisa, 56126, Italy|Oncologia Medica - Istituto Tumori Regina Elena San Gallicano, Roma, 00144, Italy|OUC di Oncologia- Azienda Ospedaliera Universitaria Integrata - Ospedale Borgo Roma, Verona, 37134, Italy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumours,DRUG: Pazopanib,ALL,"CHILD, ADULT",PHASE2,57,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/8/14,11/5/19,"Novartis Investigative Site, Long Beach, California, 90801, United States|Novartis Investigative Site, Madera, California, 93638-8762, United States|Novartis Investigative Site, Orange, California, 92868, United States|Novartis Investigative Site, Palo Alto, California, 94304, United States|Novartis Investigative Site, San Francisco, California, United States|Novartis Investigative Site, Hartford, Connecticut, 06106, United States|Novartis Investigative Site, Orlando, Florida, 32806, United States|Novartis Investigative Site, St. Petersburg, Florida, 33701, United States|Novartis Investigative Site, Chicago, Illinois, 60611, United States|Novartis Investigative Site, Indianapolis, Indiana, 46202, United States|Novartis Investigative Site, Minneapolis, Minnesota, 55404, United States|Novartis Investigative Site, Kansas City, Missouri, 64108, United States|Novartis Investigative Site, St Louis, Missouri, 63110, United States|Novartis Investigative Site, Hackensack, New Jersey, 07601, United States|Novartis Investigative Site, New York, New York, 10032, United States|Novartis Investigative Site, Chapel Hill, North Carolina, 27599, United States|Novartis Investigative Site, Charlotte, North Carolina, 28203, United States|Novartis Investigative Site, Cincinnati, Ohio, 45229, United States|Novartis Investigative Site, Nashville, Tennessee, 37212, United States|Novartis Investigative Site, Dallas, Texas, 75235, United States|Novartis Investigative Site, Fort Worth, Texas, 76104, United States|Novartis Investigative Site, Houston, Texas, 77030, United States|Novartis Investigative Site, Norfolk, Virginia, 23507, United States|Novartis Investigative Site, Seattle, Washington, 98105, United States|Novartis Investigative Site, Toronto, Ontario, M5G 1X8, Canada|Novartis Investigative Site, Montreal, Quebec, H3T 1C5, Canada|Novartis Investigative Site, Prague, 150 05, Czechia|Novartis Investigative Site, Paris, 75248, France|Novartis Investigative Site, Budapest, 1094, Hungary|Novartis Investigative Site, Košice, 041 66, Slovakia|Novartis Investigative Site, Madrid, 28009, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Oncology,DRUG: Entospletinib,ALL,"ADULT, OLDER_ADULT",PHASE1,56,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/16/15,10/25/17,"Clinical Pharmacology of Miami, Inc. (CPMI), Miami, Florida, United States|Orlando Clinical Research Center, Orlando, Florida, United States|DaVita Clinical Research, Minneapolis, Minnesota, United States|The Texas Liver Institute, San Antonio, Texas, United States|APEX GmBH, Munich, Germany|Auckland Clinical Studies, Auckland, New Zealand",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumours,DRUG: GSK525762|DRUG: Abiraterone|DRUG: Enzalutamide|DRUG: Prednisone,MALE,"ADULT, OLDER_ADULT",PHASE1,73,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/18/17,6/22/21,"GSK Investigational Site, Los Angeles, California, 90033, United States|GSK Investigational Site, Baltimore, Maryland, 21287, United States|GSK Investigational Site, Towson, Maryland, 21204, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Detroit, Michigan, 48201, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, New York, New York, 10016, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19104, United States|GSK Investigational Site, Madison, Wisconsin, 53792, United States|GSK Investigational Site, Sydney, New South Wales, 2050, Australia|GSK Investigational Site, Clayton, Victoria, 3168, Australia|GSK Investigational Site, Melbourne, Victoria, 3000, Australia|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Barcelona, 8036, Spain|GSK Investigational Site, Madrid, 28034, Spain|GSK Investigational Site, Málaga, 3075EA, Spain|GSK Investigational Site, Sabadell (Barcelona), 08208, Spain|GSK Investigational Site, Santander, 39008, Spain|GSK Investigational Site, Sutton, London, SM2 5NG, United Kingdom|GSK Investigational Site, Glasgow, G12 OYN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematologic Malignancy|Myeloid Malignancy,DRUG: Ruxolitinib|DRUG: Mesna|DRUG: Anti-thymocyte globulin (ATG)|DRUG: Cyclosporine|DRUG: Cyclophosphamide|DRUG: Fludarabine|DRUG: Methotrexate|RADIATION: Total Body Irradiation (radiation treatment)|DRUG: Bone marrow infusion|DRUG: Busulfan|DRUG: Thiotepa,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/14/23,5/8/24,"St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Renal Malignant Tumor,DRUG: Contrast enhanced ultrasound with Lumason,ALL,"ADULT, OLDER_ADULT",PHASE4,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,7/16/19,9/21/21,"Indiana University Hospital, Indianapolis, Indiana, 46022, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumours,DRUG: RXC004|DRUG: RXC004|DRUG: RXC004|BIOLOGICAL: Denosumab|BIOLOGICAL: pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,45,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/10/21,11/30/23,"Wollongong Hospital, Wollongong, New South Wales, 2500, Australia|The Alfred Hospital - Alfred Health, Melbourne, Victoria, 3304, Australia|Cambridge University Hospital NHS Foundation Trust, Cambridge, CB2 0XY, United Kingdom|Beatson West of Scotland Cancer Care, Glasgow, G12 0YN, United Kingdom|St James University Hospital, Leeds, LS9 7TF, United Kingdom|Barts Cancer Institute - Haemato-Oncology, London, EC1M 6BQ, United Kingdom|University College Hospitals NHS Foundation Trust, London, NW1 2BU, United Kingdom|Royal Free London Foundation NHS Trust, London, NW3 2QG, United Kingdom|Imperial College Healthcare NHS Trust - Hammersmith Hospital, London, W12 0HS, United Kingdom|The Christie NHS Foundation Trust - Medical Oncology, Manchester, M20 4BX, United Kingdom|Oxford Cancer and Haematology Centre Churchill Hospital, Oxford, OX3 7LE, United Kingdom|Weston Park Hospital, Sheffield, S10 2SJ, United Kingdom|The Royal Marsden Hospital (Surrey), Sutton, SM25PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumours,DRUG: Ceralasertib,ALL,"ADULT, OLDER_ADULT",PHASE2,54,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/1/20,2/18/25,"Research Site, Duarte, California, 91010, United States|Research Site, Los Angeles, California, 90089, United States|Research Site, San Francisco, California, 94115, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Indianapolis, Indiana, 46202, United States|Research Site, Baltimore, Maryland, 21231, United States|Research Site, Ann Arbor, Michigan, 48109, United States|Research Site, Las Vegas, Nevada, 89119, United States|Research Site, New York, New York, 10065, United States|Research Site, Ephrata, Pennsylvania, 17522, United States|Research Site, Philadelphia, Pennsylvania, 19104, United States|Research Site, Myrtle Beach, South Carolina, 29572, United States|Research Site, Bordeaux, 33076, France|Research Site, Dijon, 21079, France|Research Site, Lyon, 69373, France|Research Site, Vandœuvre-lès-Nancy, 54519, France|Research Site, Barcelona, 08036, Spain|Research Site, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignant Neoplasm|Metastatic Malignant Neoplasm|Unresectable Malignant Neoplasm,DIAGNOSTIC_TEST: Laboratory Biomarker Analysis|DRUG: Muscadine Grape Skin Extract|PROCEDURE: Quality-of-Life Assessment,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2016-03,4/24/23,"Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Rare Tumours,DRUG: Durvalumab|DRUG: Tremelimumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,140,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/14/16,1/29/25,"Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia, V1Y 5L3, Canada|BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada|CancerCare Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 1V7, Canada|Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, L8V 5C2, Canada|London Regional Cancer Program, London, Ontario, N6A 5W9, Canada|Ottawa Hospital Research Institute, Ottawa, Ontario, K1H 8L6, Canada|University Health Network, Toronto, Ontario, M5G 2M9, Canada|CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, H2X 3E4, Canada|The Research Institute of the McGill University, Montreal, Quebec, H4A 3J1, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, S4T 7T1, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, S7N 4H4, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Haematological Malignancies,DRUG: AZD0466|DRUG: Voriconazole,ALL,"ADULT, OLDER_ADULT",PHASE1,46,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/11/21,8/8/23,"Research Site, Duarte, California, 91010, United States|Research Site, Jacksonville, Florida, 32224, United States|Research Site, Chicago, Illinois, 60611, United States|Research Site, Columbus, Ohio, 43210, United States|Research Site, Houston, Texas, 77030, United States|Research Site, Melbourne, 3004, Australia|Research Site, Parkville, 3050, Australia|Research Site, Pessac, 33604, France|Research Site, Aachen, 52074, Germany|Research Site, Heidelberg, 69120, Germany|Research Site, Kiel, 24105, Germany|Research Site, Bologna, 40138, Italy|Research Site, Meldola, 47014, Italy|Research Site, Rozzano, 20089, Italy|Research Site, Busan, 47392, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Small Bowel Cancers|Colorectal Cancers,BIOLOGICAL: CV301|DRUG: MSB0011359C|DRUG: N-803|DRUG: NHS-IL12,ALL,"ADULT, OLDER_ADULT",PHASE2,32,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/22/20,8/16/24,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Solid Tumour|Breast Cancer Nos Metastatic Recurrent|Neuropathy,DRUG: Eribulin|DRUG: Cyclophosphamide,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,44,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/27/12,12/31/19,"University of California, San Francisco, San Francisco, California, 94143, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Malignant Neoplasm|Fatigue|Metastatic Malignant Neoplasm|Recurrent Malignant Neoplasm|Refractory Malignant Neoplasm,DRUG: Dexamethasone|BEHAVIORAL: Exercise Intervention|OTHER: Laboratory Biomarker Analysis|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,90,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",8/13/15,12/31/26,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasms of Male Genital Organs,PROCEDURE: Caudal Nerve Block (CNB)|DRUG: Ropivacaine|DRUG: Epinephrine|DRUG: Decadron|DRUG: Clonidine|DRUG: Propofol|BEHAVIORAL: Phone Call,MALE,"ADULT, OLDER_ADULT",PHASE3,52,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE,2016-06,5/10/20,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Peritoneal Surface Malignancy,BIOLOGICAL: Talimogene Laherparepvec,ALL,"ADULT, OLDER_ADULT",PHASE1,28,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/23/19,10/13/22,"University of Illinois College of Medicine at Chicago, Chicago, Illinois, 60612, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Wake Forest University School of Medicine, Winston-Salem, North Carolina, 27013, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm,DRUG: ponatinib hydrochloride|OTHER: laboratory biomarker analysis,ALL,"ADULT, OLDER_ADULT",PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/24/15,11/17/22,"University of Michigan, Ann Arbor, Michigan, 48109, United States|Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, 43210, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Cancers,DRUG: Ilorasertib,ALL,"ADULT, OLDER_ADULT",PHASE2,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/5/16,5/12/22,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematologic Malignancy,DEVICE: ClinicMACs,ALL,"ADULT, OLDER_ADULT",PHASE2,2,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/21/20,4/26/21,"Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Myeloid Malignancies|Lymphoid Malignancies,BIOLOGICAL: NK Cell enriched-DLI only|BIOLOGICAL: NK-DLI + DUK-CPG-001,ALL,"ADULT, OLDER_ADULT",PHASE2,36,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,6/8/16,2024-10,"Duke University Health System, Durham, North Carolina, 27710, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Oncology|Solid Tumors,DRUG: M3814|DRUG: M3814|DRUG: Avelumab|RADIATION: Radiotherapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Time from first study intervention up to long term safety follow-up period (Up to 516 Days)|Part B: Best Percent Change From Baseline in Tumor Size According to RECIST v 1.1, Tumor size is derived as the best percent change from baseline in target lesions (sum of longest diameter for non-nodal lesions and short axis for nodal lesions) at each time point., Time from first study intervention up to long term safety follow-up period (Up to 513 Days)|Part FE: Best Percent Change From Baseline in Tumor Size According to RECIST v 1.1, Tumor size is derived as the best percent change from baseline in target lesions (sum of longest diameter for non-nodal lesions and short axis for nodal lesions) at each time point.," Time from first study intervention up to long term safety follow-up period (Up to 512.4 Days)""",ALL,"ADULT, OLDER_ADULT",PHASE1,57,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/27/18,8/17/22,"H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, 33612, United States|The University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Mount Sinai - PRIME (10707), Lake Success, New York, 11041, United States|UC Health Clinical Trials Office (10702), Cincinnati, Ohio, 45267-0502, United States|University of Oklahoma Health Sciences Center - Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, 15213, United States|Greenville Hospital System University Medical Center (ITOR), Greenville, South Carolina, 29605, United States|Vanderbilt-Ingram Cancer Center (8867), Nashville, Tennessee, 37212, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Malignancies|Hematologic Malignancies,DRUG: MLN0128|DRUG: paclitaxel|DRUG: trastuzumab,ALL,"ADULT, OLDER_ADULT",PHASE1,68,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/28/11,9/15/17,"Fort Myers, Florida, 33905, United States|Oklahoma City, Oklahoma, 73104, United States|Nashville, Tennessee, 37203, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Myeloid Malignancy,DRUG: APR-246|DRUG: Venetoclax|DRUG: Azacitidine,ALL,"ADULT, OLDER_ADULT",PHASE1,51,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/13/19,1/14/22,"Yale Cancer Center, New Haven, Connecticut, 06511, United States|H. Lee Moffitt CC, Tampa, Florida, 33612, United States|Northwestern Medicine, Chicago, Illinois, 60611, United States|University of Chicago Medicine, Chicago, Illinois, 60637, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Weill Cornell Cancer Center, New York, New York, 10021, United States|Memorial Sloan Kettering CC, New York, New York, 10065, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Malignant Neoplasm,DRUG: Dexamethasone|OTHER: Placebo|OTHER: Questionnaire|OTHER: Quality-of-Life Assessment|DRUG: Everolimus,ALL,"ADULT, OLDER_ADULT",PHASE3,39,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",6/3/19,8/3/22,"University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, 35233, United States|Kingman Regional Medical Center, Kingman, Arizona, 86401, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, 72903, United States|PCR Oncology, Arroyo Grande, California, 93420, United States|Epic Care-Dublin, Dublin, California, 94568, United States|Bay Area Breast Surgeons Inc, Emeryville, California, 94608, United States|Epic Care Partners in Cancer Care, Emeryville, California, 94608, United States|Contra Costa Regional Medical Center, Martinez, California, 94553-3156, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, 94609, United States|Bay Area Tumor Institute, Oakland, California, 94609, United States|Epic Care Cyberknife Center, Walnut Creek, California, 94597, United States|Holy Cross Hospital, Fort Lauderdale, Florida, 33308, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, 83706, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, 83605, United States|Kootenai Medical Center, Coeur d'Alene, Idaho, 83814, United States|Walter Knox Memorial Hospital, Emmett, Idaho, 83617, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, 83642, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, 83686, United States|Kootenai Cancer Center, Post Falls, Idaho, 83854, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, 83864, United States|Rush - Copley Medical Center, Aurora, Illinois, 60504, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, 61704, United States|Illinois CancerCare-Canton, Canton, Illinois, 61520, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, 62902, United States|SIH Cancer Institute, Carterville, Illinois, 62918, United States|Illinois CancerCare-Carthage, Carthage, Illinois, 62321, United States|Centralia Oncology Clinic, Centralia, Illinois, 62801, United States|Carle on Vermilion, Danville, Illinois, 61832, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, 62526, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Illinois CancerCare-Dixon, Dixon, Illinois, 61021, United States|Carle Physician Group-Effingham, Effingham, Illinois, 62401, United States|Crossroads Cancer Center, Effingham, Illinois, 62401, United States|Illinois CancerCare-Eureka, Eureka, Illinois, 61530, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, 61401, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, 61401, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, 61443, United States|Illinois CancerCare-Macomb, Macomb, Illinois, 61455, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, 61938, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, 62864, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, 62269, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, 61350, United States|Illinois CancerCare-Pekin, Pekin, Illinois, 61554, United States|Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States|Methodist Medical Center of Illinois, Peoria, Illinois, 61636, United States|Illinois CancerCare-Peru, Peru, Illinois, 61354, United States|Valley Radiation Oncology, Peru, Illinois, 61354, United States|Illinois CancerCare-Princeton, Princeton, Illinois, 61356, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Springfield Clinic, Springfield, Illinois, 62702, United States|Memorial Medical Center, Springfield, Illinois, 62781, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, 62226, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|The Carle Foundation Hospital, Urbana, Illinois, 61801, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, 60560, United States|Physicians' Clinic of Iowa PC, Cedar Rapids, Iowa, 52402, United States|Iowa Methodist Medical Center, Des Moines, Iowa, 50309, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, 50309, United States|Broadlawns Medical Center, Des Moines, Iowa, 50314, United States|Iowa Lutheran Hospital, Des Moines, Iowa, 50316, United States|Trinity Regional Medical Center, Fort Dodge, Iowa, 50501, United States|Methodist West Hospital, West Des Moines, Iowa, 50266-7700, United States|Ochsner LSU Health Monroe Medical Center, Monroe, Louisiana, 71202, United States|LSU Health Sciences Center at Shreveport, Shreveport, Louisiana, 71103, United States|Lafayette Family Cancer Center-EMMC, Brewer, Maine, 04412, United States|Mercy Medical Center, Springfield, Massachusetts, 01104, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, 48106, United States|Bronson Battle Creek, Battle Creek, Michigan, 49017, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, 48114, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, 48114, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, 48188, United States|Saint Joseph Mercy Canton, Canton, Michigan, 48188, United States|Caro Cancer Center, Caro, Michigan, 48723, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, 48118, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, 48118, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, 48346, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, 48346, United States|Ascension Saint John Hospital, Detroit, Michigan, 48236, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, 48054, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, 48503, United States|Genesee Hematology Oncology PC, Flint, Michigan, 48503, United States|Genesys Hurley Cancer Institute, Flint, Michigan, 48503, United States|Hurley Medical Center, Flint, Michigan, 48503, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, 49503, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, 49503, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, 49503, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, 48236, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, 48236, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, 48236, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Borgess Medical Center, Kalamazoo, Michigan, 49048, United States|Sparrow Hospital, Lansing, Michigan, 48912, United States|Hope Cancer Clinic, Livonia, Michigan, 48154, United States|Saint Mary Mercy Hospital, Livonia, Michigan, 48154, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, 48044, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, 48044, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, 48453, United States|Mercy Health Mercy Campus, Muskegon, Michigan, 49444, United States|Lakeland Hospital Niles, Niles, Michigan, 49120, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, 49444, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, 48341, United States|Hope Cancer Center, Pontiac, Michigan, 48341, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, 48341, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, 48341, United States|Huron Medical Center PC, Port Huron, Michigan, 48060, United States|Lake Huron Medical Center, Port Huron, Michigan, 48060, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, 49677, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, 48309, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, 48601, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, 48604, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, 49085, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, 49085, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, 48312, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, 48764, United States|Munson Medical Center, Traverse City, Michigan, 49684, United States|Advanced Breast Care Center PLLC, Warren, Michigan, 48088, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, 48093, United States|Macomb Hematology Oncology PC, Warren, Michigan, 48093, United States|Michigan Breast Specialists-Warren, Warren, Michigan, 48093, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, 48093, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, 48661, United States|Metro Health Hospital, Wyoming, Michigan, 49519, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, 48106, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, 48197, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, 56601, United States|Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States|Cambridge Medical Center, Cambridge, Minnesota, 55008, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Fairview Southdale Hospital, Edina, Minnesota, 55435, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, 55369, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, 55109, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, 55109, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States|Health Partners Inc, Minneapolis, Minnesota, 55454, United States|Monticello Cancer Center, Monticello, Minnesota, 55362, United States|New Ulm Medical Center, New Ulm, Minnesota, 56073, United States|Fairview Northland Medical Center, Princeton, Minnesota, 55371, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, 55422, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|United Hospital, Saint Paul, Minnesota, 55102, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States|Lakeview Hospital, Stillwater, Minnesota, 55082, United States|Sanford Thief River Falls Medical Center, Thief River Falls, Minnesota, 56701, United States|Ridgeview Medical Center, Waconia, Minnesota, 55387, United States|Rice Memorial Hospital, Willmar, Minnesota, 56201, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, 55125, United States|Sanford Cancer Center Worthington, Worthington, Minnesota, 56187, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, 55092, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, 63011, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, 63628, United States|Cox Cancer Center Branson, Branson, Missouri, 65616, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|Southeast Cancer Center, Cape Girardeau, Missouri, 63703, United States|Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, 63376, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, 63141, United States|Parkland Health Center - Farmington, Farmington, Missouri, 63640, United States|Capital Region Southwest Campus, Jefferson City, Missouri, 65109, United States|Freeman Health System, Joplin, Missouri, 64804, United States|Mercy Hospital Joplin, Joplin, Missouri, 64804, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, 65401, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, 64506, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, 63670, United States|Mercy Hospital Springfield, Springfield, Missouri, 65804, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Saint Louis Cancer and Breast Institute-South City, St Louis, Missouri, 63109, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Mercy Hospital South, St Louis, Missouri, 63128, United States|Siteman Cancer Center-South County, St Louis, Missouri, 63129, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Siteman Cancer Center at Christian Hospital, St Louis, Missouri, 63136, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, 63080, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, 63127, United States|Mercy Hospital Washington, Washington, Missouri, 63090, United States|Community Hospital of Anaconda, Anaconda, Montana, 59711, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Bozeman Deaconess Hospital, Bozeman, Montana, 59715, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Great Falls Clinic, Great Falls, Montana, 59405, United States|Saint Peter's Community Hospital, Helena, Montana, 59601, United States|Kalispell Regional Medical Center, Kalispell, Montana, 59901, United States|Community Medical Hospital, Missoula, Montana, 59804, United States|Nebraska Hematology and Oncology, Lincoln, Nebraska, 68506, United States|Southeast Nebraska Cancer Center - 68th Street Place, Lincoln, Nebraska, 68516, United States|Faith Regional Health Services Carson Cancer Center, Norfolk, Nebraska, 68701, United States|Great Plains Health Callahan Cancer Center, North Platte, Nebraska, 69101, United States|Nebraska Cancer Specialists - Omaha, Omaha, Nebraska, 68124, United States|Oncology Hematology West PC, Omaha, Nebraska, 68130, United States|Regional West Medical Center Cancer Center, Scottsbluff, Nebraska, 69361, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, 89703, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, 89052, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, 89052, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, 89052, United States|21st Century Oncology-Henderson, Henderson, Nevada, 89074, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, 89074, United States|Las Vegas Urology - Green Valley, Henderson, Nevada, 89074, United States|Las Vegas Urology - Pebble, Henderson, Nevada, 89074, United States|Urology Specialists of Nevada - Green Valley, Henderson, Nevada, 89074, United States|Las Vegas Urology - Pecos, Las Vegas, Nevada, 89074, United States|Desert West Surgery, Las Vegas, Nevada, 89102, United States|OptumCare Cancer Care at Oakey, Las Vegas, Nevada, 89102, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, 89103, United States|Cancer and Blood Specialists-Shadow, Las Vegas, Nevada, 89106, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, 89106, United States|Urology Specialists of Nevada - Central, Las Vegas, Nevada, 89106, United States|21st Century Oncology, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, 89109, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, 89113, United States|Las Vegas Prostate Cancer Center, Las Vegas, Nevada, 89113, United States|Las Vegas Urology - Sunset, Las Vegas, Nevada, 89113, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, 89119, United States|21st Century Oncology-Vegas Tenaya, Las Vegas, Nevada, 89128, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, 89128, United States|Cancer and Blood Specialists-Tenaya, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, 89128, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, 89128, United States|Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, 89128, United States|Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, 89128, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, 89128, United States|Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, 89128, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, 89135, United States|Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, 89144, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, 89144, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, 89144, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, 89148-2405, United States|21st Century Oncology-Fort Apache, Las Vegas, Nevada, 89148, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, 89148, United States|Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, 89148, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, 89149, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, 89169, United States|University Cancer Center, Las Vegas, Nevada, 89169, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, 89048, United States|Renown Regional Medical Center, Reno, Nevada, 89502, United States|Saint Mary's Regional Medical Center, Reno, Nevada, 89503, United States|Radiation Oncology Associates, Reno, Nevada, 89509, United States|New Hampshire Oncology Hematology PA-Concord, Concord, New Hampshire, 03301, United States|Solinsky Center for Cancer Care, Manchester, New Hampshire, 03103, United States|Virtua Samson Cancer Center, Moorestown, New Jersey, 08057, United States|Virtua Memorial, Mount Holly, New Jersey, 08060, United States|Virtua Voorhees, Voorhees Township, New Jersey, 08043, United States|Hematology Oncology Associates of Central New York-Auburn, Auburn, New York, 13021, United States|Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, 13057, United States|Hematology Oncology Associates of Central New York-Onondaga Hill, Syracuse, New York, 13215, United States|CaroMont Regional Medical Center, Gastonia, North Carolina, 28054, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, 58501, United States|Sanford South University Medical Center, Fargo, North Dakota, 58103, United States|Southpointe-Sanford Medical Center Fargo, Fargo, North Dakota, 58103, United States|Sanford Medical Center Fargo, Fargo, North Dakota, 58104, United States|Sanford Broadway Medical Center, Fargo, North Dakota, 58122, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, 58122, United States|Altru Cancer Center, Grand Forks, North Dakota, 58201, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, 45714, United States|Adena Regional Medical Center, Chillicothe, Ohio, 45601, United States|Mount Carmel East Hospital, Columbus, Ohio, 43213, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, 43214, United States|Riverside Methodist Hospital, Columbus, Ohio, 43214, United States|Grant Medical Center, Columbus, Ohio, 43215, United States|The Mark H Zangmeister Center, Columbus, Ohio, 43219, United States|Mount Carmel Health Center West, Columbus, Ohio, 43222, United States|Doctors Hospital, Columbus, Ohio, 43228, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, 43015, United States|Grady Memorial Hospital, Delaware, Ohio, 43015, United States|Dublin Methodist Hospital, Dublin, Ohio, 43016, United States|Central Ohio Breast and Endocrine Surgery, Gahanna, Ohio, 43230, United States|Mount Carmel Grove City Hospital, Grove City, Ohio, 43123, United States|Fairfield Medical Center, Lancaster, Ohio, 43130, United States|OhioHealth Mansfield Hospital, Mansfield, Ohio, 44903, United States|Marietta Memorial Hospital, Marietta, Ohio, 45750, United States|OhioHealth Marion General Hospital, Marion, Ohio, 43302, United States|Knox Community Hospital, Mount Vernon, Ohio, 43050, United States|Licking Memorial Hospital, Newark, Ohio, 43055, United States|Newark Radiation Oncology, Newark, Ohio, 43055, United States|Southern Ohio Medical Center, Portsmouth, Ohio, 45662, United States|Saint Ann's Hospital, Westerville, Ohio, 43081, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, 43701, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, 73120, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, 97814, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, 97030, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, 97914, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, 97210, United States|Legacy Meridian Park Hospital, Tualatin, Oregon, 97062, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, 18103, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, 18017, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania, 18301, United States|Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, 18201, United States|Self Regional Healthcare, Greenwood, South Carolina, 29646, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, 57104, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, 57117-5134, United States|Overlake Medical Center, Bellevue, Washington, 98004, United States|Valley Medical Center, Renton, Washington, 98055, United States|Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver, Washington, 98684, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, 98686, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, 54729, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, 54701, United States|Mayo Clinic Health System-Eau Claire Clinic, Eau Claire, Wisconsin, 54701, United States|Mayo Clinic Health System Eau Claire Hospital-Luther Campus, Eau Claire, Wisconsin, 54703, United States|Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, 54601, United States|Marshfield Clinic - Ladysmith Center, Ladysmith, Wisconsin, 54848, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, 54449, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, 54548, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, 54017, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, 54868, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin, 54482, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin, 54401, United States|Marshfield Clinic - Weston Center, Weston, Wisconsin, 54476, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, 54494, United States|Billings Clinic-Cody, Cody, Wyoming, 82414, United States|Welch Cancer Center, Sheridan, Wyoming, 82801, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Malignant Neoplasm|Delirium|Locally Advanced Malignant Neoplasm|Metastatic Malignant Neoplasm|Recurrent Malignant Neoplasm,DRUG: Chlorpromazine|DRUG: Haloperidol|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,70,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE",6/5/17,6/30/27,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Malignancy,DRUG: Duvelisib,ALL,"ADULT, OLDER_ADULT",PHASE2,19,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-04,5/4/20,"Denver, Colorado, 80218, United States|Sarasota, Florida, 34232, United States|Nashville, Tennessee, 37203, United States|UT MD Anderson Cancer Center, Houston, Texas, 77030, United States|Azienda Ospedaliera Santa Maria di Terni/SC Oncoematologia, Terni, Umbria, 05100, Italy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm,DRUG: Palonosetron Hydrochloride|DRUG: Ondansetron Hydrochloride|DRUG: Dexamethasone|DRUG: Fosaprepitant Dimeglumine|DRUG: Olanzapine|OTHER: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,690,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",11/20/18,5/1/23,"University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, 35233, United States|Fairbanks Memorial Hospital, Fairbanks, Alaska, 99701, United States|Kingman Regional Medical Center, Kingman, Arizona, 86401, United States|Mayo Clinic Hospital in Arizona, Phoenix, Arizona, 85054, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, 85259, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, 72903, United States|Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, 72401, United States|PCR Oncology, Arroyo Grande, California, 93420, United States|Epic Care-Dublin, Dublin, California, 94568, United States|Bay Area Breast Surgeons Inc, Emeryville, California, 94608, United States|Epic Care Partners in Cancer Care, Emeryville, California, 94608, United States|Tibor Rubin VA Medical Center, Long Beach, California, 90822, United States|Contra Costa Regional Medical Center, Martinez, California, 94553-3156, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, 94609, United States|Bay Area Tumor Institute, Oakland, California, 94609, United States|Desert Regional Medical Center, Palm Springs, California, 92262, United States|Epic Care Cyberknife Center, Walnut Creek, California, 94597, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, 80012, United States|The Medical Center of Aurora, Aurora, Colorado, 80012, United States|Boulder Community Hospital, Boulder, Colorado, 80301, United States|Boulder Community Foothills Hospital, Boulder, Colorado, 80303, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, 80304, United States|Rocky Mountain Cancer Centers - Centennial, Centennial, Colorado, 80112, United States|Cancer Center of Colorado at Sloan's Lake, Denver, Colorado, 80204, United States|Denver Health Medical Center, Denver, Colorado, 80204, United States|National Jewish Health-Main Campus, Denver, Colorado, 80206, United States|The Women's Imaging Center, Denver, Colorado, 80209, United States|Colorado Blood Cancer Institute, Denver, Colorado, 80218, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, 80218, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, 80218, United States|SCL Health Saint Joseph Hospital, Denver, Colorado, 80218, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, 80220, United States|Rose Medical Center, Denver, Colorado, 80220, United States|Western Surgical Care, Denver, Colorado, 80220, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, 80113, United States|Swedish Medical Center, Englewood, Colorado, 80113, United States|National Jewish Health-Western Hematology Oncology, Golden, Colorado, 80401, United States|Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, 81501, United States|Grand Valley Oncology, Grand Junction, Colorado, 81505, United States|North Colorado Medical Center, Greeley, Colorado, 80631, United States|Good Samaritan Medical Center, Lafayette, Colorado, 80026, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, 80120, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, 80124, United States|Sky Ridge Medical Center, Lone Tree, Colorado, 80124, United States|McKee Medical Center, Loveland, Colorado, 80539, United States|National Jewish Health-Northern Hematology Oncology, Thornton, Colorado, 80260, United States|SCL Health Lutheran Medical Center, Wheat Ridge, Colorado, 80033, United States|Middlesex Hospital, Middletown, Connecticut, 06457, United States|Holy Cross Hospital, Fort Lauderdale, Florida, 33308, United States|Mayo Clinic in Florida, Jacksonville, Florida, 32224-9980, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, 96813, United States|Island Urology, Honolulu, Hawaii, 96813, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, 96813, United States|Queen's Medical Center, Honolulu, Hawaii, 96813, United States|Straub Clinic and Hospital, Honolulu, Hawaii, 96813, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, 96813, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, 96817, United States|Hawaii Diagnostic Radiology Services LLC, Honolulu, Hawaii, 96817, United States|Kuakini Medical Center, Honolulu, Hawaii, 96817, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, 96817, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, 96817, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States|Tripler Army Medical Center, Honolulu, Hawaii, 96859, United States|Straub Medical Center - Kahului Clinic, Kahului, Hawaii, 96732, United States|Castle Medical Center, Kailua, Hawaii, 96734, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, 96766, United States|Hawaii Cancer Care - Savio, ‘Aiea, Hawaii, 96701, United States|Pali Momi Medical Center, ‘Aiea, Hawaii, 96701, United States|Queen's Cancer Center - Pearlridge, ‘Aiea, Hawaii, 96701, United States|The Cancer Center of Hawaii-Pali Momi, ‘Aiea, Hawaii, 96701, United States|The Queen's Medical Center - West Oahu, ‘Ewa Beach, Hawaii, 96706, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, 83706, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, 83605, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, 83814, United States|Walter Knox Memorial Hospital, Emmett, Idaho, 83617, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, 83642, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, 83686, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, 83854, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, 83864, United States|Saint Anthony's Health, Alton, Illinois, 62002, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, 61704, United States|Loyola Center for Health at Burr Ridge, Burr Ridge, Illinois, 60527, United States|Illinois CancerCare-Canton, Canton, Illinois, 61520, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, 62902, United States|SIH Cancer Institute, Carterville, Illinois, 62918, United States|Illinois CancerCare-Carthage, Carthage, Illinois, 62321, United States|Centralia Oncology Clinic, Centralia, Illinois, 62801, United States|Carle on Vermilion, Danville, Illinois, 61832, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, 62526, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, 60115, United States|Illinois CancerCare-Dixon, Dixon, Illinois, 61021, United States|Carle Physician Group-Effingham, Effingham, Illinois, 62401, United States|Crossroads Cancer Center, Effingham, Illinois, 62401, United States|Illinois CancerCare-Eureka, Eureka, Illinois, 61530, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, 60201, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, 61401, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, 61401, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, 60134, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, 60026, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, 60035, United States|Loyola Medicine Homer Glen, Homer Glen, Illinois, 60491, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, 61443, United States|Illinois CancerCare-Macomb, Macomb, Illinois, 61455, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, 61938, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park, Illinois, 60160, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, 62864, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, 62269, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, 61350, United States|Illinois CancerCare-Pekin, Pekin, Illinois, 61554, United States|Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States|Methodist Medical Center of Illinois, Peoria, Illinois, 61636, United States|Illinois CancerCare-Peru, Peru, Illinois, 61354, United States|Valley Radiation Oncology, Peru, Illinois, 61354, United States|Illinois CancerCare-Princeton, Princeton, Illinois, 61356, United States|OSF Saint Anthony Medical Center, Rockford, Illinois, 61108, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Springfield Clinic, Springfield, Illinois, 62702, United States|Memorial Medical Center, Springfield, Illinois, 62781, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, 62226, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|The Carle Foundation Hospital, Urbana, Illinois, 61801, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, 60555, United States|Illinois CancerCare - Washington, Washington, Illinois, 61571, United States|Saint Vincent Anderson Regional Hospital/Cancer Center, Anderson, Indiana, 46016, United States|Memorial Regional Cancer Center Day Road, Mishawaka, Indiana, 46545, United States|Baptist Health Floyd, New Albany, Indiana, 47150, United States|Reid Health, Richmond, Indiana, 47374, United States|Memorial Hospital of South Bend, South Bend, Indiana, 46601, United States|Mary Greeley Medical Center, Ames, Iowa, 50010, United States|McFarland Clinic PC - Ames, Ames, Iowa, 50010, United States|University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf, Iowa, 52722, United States|McFarland Clinic PC-Boone, Boone, Iowa, 50036, United States|Saint Anthony Regional Hospital, Carroll, Iowa, 51401, United States|Mercy Hospital, Cedar Rapids, Iowa, 52403, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, 52403, United States|Iowa Methodist Medical Center, Des Moines, Iowa, 50309, United States|Medical Oncology and Hematology Associates-Des Moines, Des Moines, Iowa, 50309, United States|Broadlawns Medical Center, Des Moines, Iowa, 50314, United States|Iowa Lutheran Hospital, Des Moines, Iowa, 50316, United States|JCHC McCreery Cancer Center, Fairfield, Iowa, 52556, United States|McFarland Clinic PC-Trinity Cancer Center, Fort Dodge, Iowa, 50501, United States|Trinity Regional Medical Center, Fort Dodge, Iowa, 50501, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|McFarland Clinic PC-Jefferson, Jefferson, Iowa, 50129, United States|McFarland Clinic PC-Marshalltown, Marshalltown, Iowa, 50158, United States|Ottumwa Regional Health Center, Ottumwa, Iowa, 52501, United States|MercyOne Waterloo Medical Center, Waterloo, Iowa, 50702, United States|Methodist West Hospital, West Des Moines, Iowa, 50266-7700, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, 66720, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, 67801, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, 67846, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, 67530, United States|Lawrence Memorial Hospital, Lawrence, Kansas, 66044, United States|Kansas Institute of Medicine Cancer and Blood Center, Lenexa, Kansas, 66219, United States|Minimally Invasive Surgery Hospital, Lenexa, Kansas, 66219, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, 67905, United States|Cancer Center of Kansas - Newton, Newton, Kansas, 67114, United States|Menorah Medical Center, Overland Park, Kansas, 66209, United States|Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka, Kansas, 66606, United States|Associates In Womens Health, Wichita, Kansas, 67208, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, 67208, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, 67214, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, 67214, United States|Baptist Health Corbin, Corbin, Kentucky, 40701, United States|Baptist Health Hardin, Elizabethtown, Kentucky, 42701, United States|Baptist Health Lexington, Lexington, Kentucky, 40503, United States|Baptist Health Louisville, Louisville, Kentucky, 40207, United States|Baptist Health Madisonville/Merle Mahr Cancer Center, Madisonville, Kentucky, 42431, United States|Saint Claire Regional Medical Center, Morehead, Kentucky, 40351, United States|Owensboro Health Mitchell Memorial Cancer Center, Owensboro, Kentucky, 42303, United States|Baptist Health Paducah, Paducah, Kentucky, 42003, United States|LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, 70805, United States|Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, 70809, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, 70809, United States|Our Lady of the Lake Physicians Group - Medical Oncology, Baton Rouge, Louisiana, 70809, United States|Medical Center of Baton Rouge, Baton Rouge, Louisiana, 70816, United States|Louisiana Hematology Oncology Associates, Baton Rouge, Louisiana, 70817, United States|Our Lady of the Lake Medical Oncology, Baton Rouge, Louisiana, 70817, United States|Woman's Hospital, Baton Rouge, Louisiana, 70817, United States|Ochsner High Grove, Baton Rouge, Louisiana, 70836, United States|Northshore Oncology Associates-Covington, Covington, Louisiana, 70433, United States|Ochsner Hematology Oncology North Shore - Covington (West Region), Covington, Louisiana, 70433, United States|Oncology Center of The South Incorporated, Houma, Louisiana, 70360, United States|Terrebonne General Medical Center, Houma, Louisiana, 70360, United States|Ochsner Medical Center Kenner, Kenner, Louisiana, 70065, United States|Ochsner LSU Health Monroe Medical Center, Monroe, Louisiana, 71202, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, 70121, United States|Ochsner LSU Health Saint Mary's Medical Center, Shreveport, Louisiana, 71101, United States|LSU Health Sciences Center at Shreveport, Shreveport, Louisiana, 71103, United States|Anne Arundel Medical Center, Annapolis, Maryland, 21401, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, 21215, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, 20889-5600, United States|Northwest Hospital Center, Randallstown, Maryland, 21133, United States|UM Saint Joseph Medical Center, Towson, Maryland, 21204, United States|William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster, Maryland, 21157, United States|Berkshire Medical Center - Cancer Center, Pittsfield, Massachusetts, 01201, United States|Mercy Medical Center, Springfield, Massachusetts, 01104, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, 48106, United States|Bronson Battle Creek, Battle Creek, Michigan, 49017, United States|IHA Hematology Oncology Consultants-Brighton, Brighton, Michigan, 48114, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, 48114, United States|IHA Hematology Oncology Consultants-Canton, Canton, Michigan, 48188, United States|Saint Joseph Mercy Canton, Canton, Michigan, 48188, United States|Caro Cancer Center, Caro, Michigan, 48723, United States|IHA Hematology Oncology Consultants-Chelsea, Chelsea, Michigan, 48118, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, 48118, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, 48346, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, 48346, United States|Ascension Saint John Hospital, Detroit, Michigan, 48236, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, 48054, United States|Green Bay Oncology - Escanaba, Escanaba, Michigan, 49829, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, 48503, United States|Genesee Hematology Oncology PC, Flint, Michigan, 48503, United States|Genesys Hurley Cancer Institute, Flint, Michigan, 48503, United States|Hurley Medical Center, Flint, Michigan, 48503, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, 49503, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, 49503, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, 49503, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, 48236, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, 48236, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, 48236, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Borgess Medical Center, Kalamazoo, Michigan, 49048, United States|Sparrow Hospital, Lansing, Michigan, 48912, United States|Hope Cancer Clinic, Livonia, Michigan, 48154, United States|Saint Mary Mercy Hospital, Livonia, Michigan, 48154, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, 48044, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, 48044, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, 48453, United States|Mercy Health Mercy Campus, Muskegon, Michigan, 49444, United States|Lakeland Hospital Niles, Niles, Michigan, 49120, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, 49444, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, 48341, United States|Hope Cancer Center, Pontiac, Michigan, 48341, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, 48341, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, 48341, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, 49677, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, 48309, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, 48601, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, 48604, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, 49085, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, 49085, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, 48312, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, 48764, United States|Munson Medical Center, Traverse City, Michigan, 49684, United States|Advanced Breast Care Center PLLC, Warren, Michigan, 48088, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, 48093, United States|Macomb Hematology Oncology PC, Warren, Michigan, 48093, United States|Michigan Breast Specialists-Warren, Warren, Michigan, 48093, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, 48093, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, 48661, United States|Metro Health Hospital, Wyoming, Michigan, 49519, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, 48106, United States|IHA Hematology Oncology Consultants-Ann Arbor, Ypsilanti, Michigan, 48197, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, 56601, United States|Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, 55337, United States|Cambridge Medical Center, Cambridge, Minnesota, 55008, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Fairview Southdale Hospital, Edina, Minnesota, 55435, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Mayo Clinic Health Systems-Mankato, Mankato, Minnesota, 56001, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, 55369, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, 55109, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, 55109, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States|Minneapolis VA Medical Center, Minneapolis, Minnesota, 55417, United States|Health Partners Inc, Minneapolis, Minnesota, 55454, United States|Monticello Cancer Center, Monticello, Minnesota, 55362, United States|New Ulm Medical Center, New Ulm, Minnesota, 56073, United States|Fairview Northland Medical Center, Princeton, Minnesota, 55371, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, 55422, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, 56303, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|United Hospital, Saint Paul, Minnesota, 55102, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States|Lakeview Hospital, Stillwater, Minnesota, 55082, United States|Sanford Thief River Falls Medical Center, Thief River Falls, Minnesota, 56701, United States|Ridgeview Medical Center, Waconia, Minnesota, 55387, United States|Rice Memorial Hospital, Willmar, Minnesota, 56201, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, 55125, United States|Sanford Cancer Center Worthington, Worthington, Minnesota, 56187, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, 55092, United States|Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus, Mississippi, 39705, United States|Baptist Cancer Center-Grenada, Grenada, Mississippi, 38901, United States|Hattiesburg Clinic - Hematology/Oncology Clinic, Hattiesburg, Mississippi, 39401, United States|Forrest General Hospital / Cancer Center, Hattiesburg, Mississippi, 39404, United States|Baptist Memorial Hospital and Cancer Center-Union County, New Albany, Mississippi, 38652, United States|Baptist Memorial Hospital and Cancer Center-Oxford, Oxford, Mississippi, 38655, United States|Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, 38671, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, 63011, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, 65613, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, 63628, United States|Cox Cancer Center Branson, Branson, Missouri, 65616, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|Southeast Cancer Center, Cape Girardeau, Missouri, 63703, United States|Saint Luke's Hospital, Chesterfield, Missouri, 63017, United States|University of Missouri - Ellis Fischel, Columbia, Missouri, 65212, United States|Parkland Health Center - Farmington, Farmington, Missouri, 63640, United States|Centerpoint Medical Center LLC, Independence, Missouri, 64057, United States|Capital Region Southwest Campus, Jefferson City, Missouri, 65109, United States|Freeman Health System, Joplin, Missouri, 64804, United States|Mercy Hospital Joplin, Joplin, Missouri, 64804, United States|Research Medical Center, Kansas City, Missouri, 64132, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, 65401, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, 64506, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, 63670, United States|Mercy Hospital Springfield, Springfield, Missouri, 65804, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Saint Louis Cancer and Breast Institute-South City, St Louis, Missouri, 63109, United States|Mercy Hospital South, St Louis, Missouri, 63128, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, 63080, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, 63127, United States|Mercy Hospital Washington, Washington, Missouri, 63090, United States|Community Hospital of Anaconda, Anaconda, Montana, 59711, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Saint Vincent Healthcare, Billings, Montana, 59101, United States|Saint Vincent Frontier Cancer Center, Billings, Montana, 59102, United States|Bozeman Deaconess Hospital, Bozeman, Montana, 59715, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, 59701, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Great Falls Clinic, Great Falls, Montana, 59405, United States|Saint Peter's Community Hospital, Helena, Montana, 59601, United States|Kalispell Regional Medical Center, Kalispell, Montana, 59901, United States|Community Medical Hospital, Missoula, Montana, 59804, United States|Nebraska Hematology and Oncology, Lincoln, Nebraska, 68506, United States|Cancer Partners of Nebraska - Pine Lake, Lincoln, Nebraska, 68516, United States|Southeast Nebraska Cancer Center - 68th Street Place, Lincoln, Nebraska, 68516, United States|Faith Regional Health Services Carson Cancer Center, Norfolk, Nebraska, 68701, United States|Great Plains Health Callahan Cancer Center, North Platte, Nebraska, 69101, United States|Nebraska Cancer Specialists - Omaha, Omaha, Nebraska, 68124, United States|Oncology Hematology West PC, Omaha, Nebraska, 68130, United States|Regional West Medical Center Cancer Center, Scottsbluff, Nebraska, 69361, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, 89703, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, 89052, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, 89052, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, 89052, United States|21st Century Oncology-Henderson, Henderson, Nevada, 89074, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, 89074, United States|Las Vegas Urology - Green Valley, Henderson, Nevada, 89074, United States|Las Vegas Urology - Pebble, Henderson, Nevada, 89074, United States|Urology Specialists of Nevada - Green Valley, Henderson, Nevada, 89074, United States|Las Vegas Urology - Pecos, Las Vegas, Nevada, 89074, United States|Desert West Surgery, Las Vegas, Nevada, 89102, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, 89102, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, 89103, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, 89106, United States|Urology Specialists of Nevada - Central, Las Vegas, Nevada, 89106, United States|21st Century Oncology, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, 89109, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, 89113, United States|Las Vegas Prostate Cancer Center, Las Vegas, Nevada, 89113, United States|Las Vegas Urology - Sunset, Las Vegas, Nevada, 89113, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, 89119, United States|21st Century Oncology-Vegas Tenaya, Las Vegas, Nevada, 89128, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, 89128, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, 89128, United States|Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada, 89128, United States|Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada, 89128, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, 89128, United States|Urology Specialists of Nevada - Northwest, Las Vegas, Nevada, 89128, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, 89135, United States|Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada, 89144, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, 89144, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, 89144, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, 89148-2405, United States|21st Century Oncology-Fort Apache, Las Vegas, Nevada, 89148, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, 89148, United States|Urology Specialists of Nevada - Southwest, Las Vegas, Nevada, 89148, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, 89149, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, 89169, United States|University Cancer Center, Las Vegas, Nevada, 89169, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, 89048, United States|Renown Regional Medical Center, Reno, Nevada, 89502, United States|Saint Mary's Regional Medical Center, Reno, Nevada, 89503, United States|Radiation Oncology Associates, Reno, Nevada, 89509, United States|Hematology Oncology Associates of Central New York-Auburn, Auburn, New York, 13021, United States|Northwell Health Imbert Cancer Center, Bay Shore, New York, 11706, United States|New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York, 11215, United States|Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, 13057, United States|Arnot Ogden Medical Center/Falck Cancer Center, Elmira, New York, 14905, United States|Glens Falls Hospital, Glens Falls, New York, 12801, United States|Northwell Health/Center for Advanced Medicine, Lake Success, New York, 11042, United States|NYP/Weill Cornell Medical Center, New York, New York, 10065, United States|Hematology Oncology Associates of Central New York-Onondaga Hill, Syracuse, New York, 13215, United States|James J Peters VA Medical Center, The Bronx, New York, 10468, United States|AdventHealth Infusion Center Asheville, Asheville, North Carolina, 28803, United States|AdventHealth Infusion Center Haywood, Clyde, North Carolina, 28721, United States|Cape Fear Valley Health System, Fayetteville, North Carolina, 28304, United States|CaroMont Regional Medical Center, Gastonia, North Carolina, 28054, United States|AdventHealth Hendersonville, Hendersonville, North Carolina, 28792, United States|CarolinaEast Medical Center, New Bern, North Carolina, 28561, United States|CarolinaEast Oncology and Hematology Associates, New Bern, North Carolina, 28562, United States|Marion L Shepard Cancer Center at Vidant Beaufort Hospital, Washington, North Carolina, 27889, United States|AdventHealth Infusion Center Weaverville, Weaverville, North Carolina, 28787, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, 58501, United States|Sanford South University Medical Center, Fargo, North Dakota, 58103, United States|Sanford Broadway Medical Center, Fargo, North Dakota, 58122, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, 58122, United States|Altru Cancer Center, Grand Forks, North Dakota, 58201, United States|Aultman Alliance Community Hospital, Alliance, Ohio, 44601, United States|Indu and Raj Soin Medical Center, Beavercreek, Ohio, 45431, United States|Saint Elizabeth Boardman Hospital, Boardman, Ohio, 44512, United States|Aultman Health Foundation, Canton, Ohio, 44710, United States|Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, 45459, United States|Miami Valley Hospital South, Centerville, Ohio, 45459, United States|Oncology",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Cincinnati, Ohio,45236, United States|Good Samaritan Hospital - Dayton,45406, United States|Miami Valley Hospital, Dayton, Ohio,45409, United States|Dayton Physician LLC-Miami Valley Hospital North, Dayton, Ohio,45415, United States|Miami Valley Hospital North, Dayton, Ohio,45415, United States|Dayton Veterans Affairs Medical Center, Dayton, Ohio,45428, United States|Armes Family Cancer Center, Findlay, Ohio,45840, United States|Blanchard Valley Hospital, Findlay, Ohio,45840, United States|Orion Cancer Care, Findlay, Ohio,45840, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, 45005-1066, United States|Dayton Physicians LLC-Atrium, Franklin, Ohio,45005, United States|Dayton Physicians LLC-Wayne, Greenville, Ohio,45331, United States|Wayne Hospital, Greenville, Ohio,45331, United States|Greater Dayton Cancer Center, Kettering, Ohio,45409, United States|First Dayton Cancer Care, Kettering, Ohio,45420, United States|Kettering Medical Center, Kettering, Ohio,45429, United States|Springfield Regional Cancer Center, Springfield, Ohio,45504, United States|Springfield Regional Medical Center, Springfield, Ohio,45505, United States|Dayton Physicians LLC-Upper Valley, Troy, Ohio,45373, United States|Upper Valley Medical Center, Troy, Ohio,45373, United States|Saint Joseph Warren Hospital, Warren, Ohio,44484, United States|Saint Elizabeth Youngstown Hospital, Youngstown, Ohio,44501, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma,73104, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma,73120, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon,97814, United States|Legacy Mount Hood Medical Center, Gresham, Oregon,97030, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon,97914, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon,97210, United States|Legacy Meridian Park Hospital, Tualatin, Oregon,97062, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania,18103, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania,18017, United States|Geisinger Medical Center, Danville, Pennsylvania,17822, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania,18301, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania,18201, United States|Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania,18201, United States|Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania,17837, United States|Lewistown Hospital, Lewistown, Pennsylvania,17044, United States|Phoenixville Hospital, Phoenixville, Pennsylvania,19460, United States|Pottstown Hospital, Pottstown, Pennsylvania,19464, United States|Geisinger Cancer Services-Pottsville, Pottsville, Pennsylvania,17901, United States|Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania,18840, United States|Community Medical Center, Scranton, Pennsylvania,18510, United States|Geisinger Medical Oncology-Selinsgrove, Selinsgrove, Pennsylvania,17870, United States|Geisinger Medical Group, State College, Pennsylvania,16801, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania,18711, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina,29316, United States|Ralph H Johnson VA Medical Center, Charleston, South Carolina,29401, United States|Prisma Health Cancer Institute - Laurens, Clinton, South Carolina,29325, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina,29640, United States|Tidelands Georgetown Memorial Hospital, Georgetown, South Carolina,29440, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina,29605, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina,29605, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina,29605, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina,29615, United States|Self Regional Healthcare, Greenwood, South Carolina,29646, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina,29650, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina,29672, United States|Rapid City Regional Hospital, Rapid City, South Dakota,57701, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota,57104, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, 57117-5134, United States|Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee,38017, United States|Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee,38120, United States|Houston Methodist San Jacinto Hospital, Baytown, Texas,77521, United States|Houston Methodist Hospital, Houston, Texas,77030, United States|Methodist Willowbrook Hospital, Houston, Texas,77070, United States|Houston Methodist West Hospital, Houston, Texas,77094, United States|Houston Methodist Saint John Hospital, Nassau Bay, Texas,77058, United States|Houston Methodist Sugar Land Hospital, Sugar Land, Texas,77479, United States|Houston Methodist The Woodlands Hospital, The Woodlands, Texas,77385, United States|American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah,84003, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah,84720, United States|Logan Regional Hospital, Logan, Utah,84321, United States|Intermountain Medical Center, Murray, Utah,84107, United States|McKay-Dee Hospital Center, Ogden, Utah,84403, United States|Utah Valley Regional Medical Center, Provo, Utah,84604, United States|Riverton Hospital, Riverton, Utah,84065, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah,84106, United States|LDS Hospital, Salt Lake City, Utah,84143, United States|Dixie Medical Center Regional Cancer Center, St. George, Utah,84770, United States|Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners, Vermont, 05602, United States|University of Vermont Medical Center, Burlington, Vermont, 05401, United States|University of Vermont and State Agricultural College, Burlington, Vermont, 05405, United States|Augusta Health Center for Cancer and Blood Disorders, Fishersville, Virginia,22939, United States|MultiCare Auburn Medical Center, Auburn, Washington,98001, United States|Overlake Medical Center, Bellevue, Washington,98004, United States|MultiCare Gig Harbor Medical Park, Gig Harbor, Washington,98335, United States|Jefferson Healthcare, Port Townsend, Washington,98368, United States|MultiCare Good Samaritan Hospital, Puyallup, Washington,98372, United States|Valley Medical Center, Renton, Washington,98055, United States|MultiCare Deaconess Cancer and Blood Specialty Center - Downtown, Spokane, Washington,99204, United States|MultiCare Deaconess Cancer and Blood Specialty Center - North, Spokane, Washington,99218, United States|MultiCare Deaconess Cancer and Blood Specialty Center - Valley, Spokane Valley, Washington,99216, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington,98405, United States|MultiCare Tacoma General Hospital, Tacoma, Washington,98405, United States|Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver, Washington,98684, United States|Legacy Salmon Creek Hospital, Vancouver, Washington,98686, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington,98902, United States|Edwards Comprehensive Cancer Center, Huntington, West Virginia,25701, United States|Saint Mary's Medical Center, Huntington, West Virginia,25702, United States|Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin,53105, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin,54729, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin,54701, United States|Mayo Clinic Health System-Eau Claire Clinic, Eau Claire, Wisconsin,54701, United States|Mayo Clinic Health System Eau Claire Hospital-Luther Campus, Eau Claire, Wisconsin,54703, United States|Aurora Health Center-Fond du Lac, Fond du Lac, Wisconsin,54937, United States|Aurora Health Care Germantown Health Center, Germantown, Wisconsin,53022, United States|Aurora Cancer Care-Grafton, Grafton, Wisconsin,53024, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin,54301, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin,54303, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin,54311, United States|Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin,53142, United States|Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin,54601, United States|Marshfield Clinic - Ladysmith Center, Ladysmith, Wisconsin,54848, United States|Holy Family Memorial Hospital, Manitowoc, Wisconsin,54221, United States|Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin,54143, United States|Saint Vincent Hospital Cancer Center at Marinette, Marinette, Wisconsin,54143, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin,54449, United States|Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin,53209, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin,53215, United States|Aurora Sinai Medical Center, Milwaukee, Wisconsin,53233, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin,54548, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin,53149, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin,54017, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin,53066, United States|Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin,54154, United States|Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin,54904, United States|Aurora Cancer Care-Racine, Racine, Wisconsin,53406, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin,54868, United States|HSHS Saint Nicholas Hospital, Sheboygan, Wisconsin,53081, United States|Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin,53081, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin,54482, United States|Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, 54235-1495, United States|Aurora Medical Center in Summit, Summit, Wisconsin,53066, United States|Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin,54241, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin,53188, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin,53188, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin,54401, United States|Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin,53226, United States|Aurora West Allis Medical Center, West Allis, Wisconsin,53227, United States|Marshfield Medical Center - Weston, Weston, Wisconsin,54476, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin,54494, United States|Cheyenne Regional Medical Center-West, Cheyenne, Wyoming,82001, United States|Billings Clinic-Cody, Cody, Wyoming,82414, United States|Welch Cancer Center, Sheridan, Wyoming,82801, United States|FHP Health Center-Guam, Tamuning,96913," Guam"""TERMINATED,YES,Advanced Cancers,DRUG: lorlatinib|DRUG: lorlatinib|DRUG: lorlatinib|DRUG: lorlatinib|DRUG: lorlatinib,ALL,"ADULT, OLDER_ADULT",PHASE1,1,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/14/20,7/8/21,"University of Colorado Denver CTO (CTRC), Aurora, Colorado, 80045, United States|University of Colorado Hospital, Anschutz Cancer Pavilion (ACP), Aurora, Colorado, 80045, United States|University of Colorado Hospital, Anschutz Inpatient Pavilion (AIP), Aurora, Colorado, 80045, United States|University of Colorado Hospital, Anschutz Outpatient Pavilion (AOP), Aurora, Colorado, 80045, United States|Emory University Hospital, Atlanta, Georgia, 30322, United States|Investigational Drug Service, Atlanta, Georgia, 30322, United States|The Emory Clinic, Atlanta, Georgia, 30322, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, 30322, United States|Mays Cancer Center, San Antonio, Texas, 78229, United States|University Health System, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm,DRUG: Netupitant|DRUG: Palonosetron Hydrochloride|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,43,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,4/27/17,3/20/20,"OHSU Knight Cancer Institute, Portland, Oregon, 97239, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Cancers,DRUG: Pembrolizumab|RADIATION: Radiotherapy,ALL,"ADULT, OLDER_ADULT",PHASE1,59,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/8/15,12/31/19,"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematological Malignancy,DRUG: Isatuximab SAR650984|DRUG: Dexamethasone|DRUG: Dexamethasone,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,351,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/11/10,7/13/23,"Mayo Clinic Site Number : 840003, Scottsdale, Arizona, 85054, United States|UCSF MS Center Site Number : 840005, San Francisco, California, 94117, United States|Emory University Site Number : 840009, Atlanta, Georgia, 30322, United States|University of Chicago Site Number : 840010, Chicago, Illinois, 60637, United States|The University Of Michigan Site Number : 840022, Ann Arbor, Michigan, 48109-0759, United States|Karmanos Cancer Center Site Number : 840027, Detroit, Michigan, 48201, United States|Mayo Clinic of Rochester Site Number : 840018, Rochester, Minnesota, 55905, United States|Washington University School of Medicine Site Number : 840013, St Louis, Missouri, 63110, United States|The Cancer Center At Hackensack University Medical Site Number : 840011, Hackensack, New Jersey, 07601, United States|Memorial Sloan-Kettering Cancer Center Site Number : 840014, New York, New York, 10021, United States|Duke University Medical College Site Number : 840016, Durham, North Carolina, 27707, United States|University of Cincinnati Site Number : 840004, Cincinnati, Ohio, 45267-0542, United States|Vanderbilt University Site Number : 840001, Nashville, Tennessee, 37232, United States|Huntsman Cancer Institute at the University of Utah Site Number : 840002, Salt Lake City, Utah, 84112-5550, United States|Fred Hutchinson Cancer Research Center Site Number : 840012, Seattle, Washington, 98109, United States|Medical College of Wisconsin Site Number : 840017, Milwaukee, Wisconsin, 53226, United States|Investigational Site Number : 032003, Capital Federal, Buenos Aires, C1425ASS, Argentina|Investigational Site Number : 032002, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1181ACH, Argentina|Investigational Site Number : 032001, Ciudad de Buenos Aires, Buenos Aires, C1426ANZ, Argentina|Investigational Site Number : 056001, Antwerp, 2060, Belgium|Hospital Mae de Deus Site Number : 076003, Porto Alegre, Rio Grande do Sul, 90110-270, Brazil|Hospital de Amor - Hospital do Cancer de Barretos - Fundacao Pio XII Site Number : 076001, Barretos, São Paulo, 14784-400, Brazil|Clínica São Germano Site Number : 076002, São Paulo, São Paulo, 04537-081, Brazil|Instituto COI de Educacao e Pesquisa Site Number : 076004, Rio de Janeiro, 22775-002, Brazil|Investigational Site Number : 152001, Temuco, La Araucanía, 4810469, Chile|Investigational Site Number : 246001, Helsinki, 00029, Finland|Investigational Site Number : 246002, Turku, 20520, Finland|Investigational Site Number : 250003, Nantes, 44093, France|Investigational Site Number : 250004, Pierre-Bénite, 69495, France|Investigational Site Number : 250001, Toulouse, 31059, France|Investigational Site Number : 300001, Athens, 11528, Greece|Investigational Site Number : 376004, Jerusalem, 91120, Israel|Investigational Site Number : 376002, Tel Litwinsky, 52621, Israel|Investigational Site Number : 380001, Bologna, 40138, Italy|Investigational Site Number : 380002, Torino, 10126, Italy|Investigational Site Number : 484003, San Luis Potosí City, San Luis Potosí, 78419, Mexico|Investigational Site Number : 484001, Monterrey, 64460, Mexico|Investigational Site Number : 604001, Arequipa, Peru|Investigational Site Number : 604002, Lima, 34, Peru|Investigational Site Number : 643002, Moscow, 125284, Russia|Investigational Site Number : 643003, Novosibirsk, 630087, Russia|Investigational Site Number : 643001, Petrozavodsk, 185019, Russia|Investigational Site Number : 643004, Saint Petersburg, 194291, Russia|Investigational Site Number : 724005, Barcelona, Barcelona [Barcelona], 08036, Spain|Investigational Site Number : 724007, Badalona, Catalunya [Cataluña], 08916, Spain|Investigational Site Number : 724002, Pamplona, Navarre, 31008, Spain|Investigational Site Number : 724006, Valencia, Valenciana, Comunidad, 46017, Spain|Investigational Site Number : 724004, Madrid, 28041, Spain|Investigational Site Number : 724001, Salamanca, 37007, Spain|Investigational Site Number : 724008, Seville, 41013, Spain|Investigational Site Number : 792002, Ankara, 06200, Turkey (Türkiye)|Investigational Site Number : 792005, Ankara, 06500, Turkey (Türkiye)|Investigational Site Number : 792001, Istanbul, Turkey (Türkiye)|Investigational Site Number : 792004, Samsun, 55139, Turkey (Türkiye)|Investigational Site Number : 804001, Kyiv, 04112, Ukraine|Investigational Site Number : 804004, Vinnytsia, 21001, Ukraine|Investigational Site Number : 804002, Zaporizhzhya, 69600, Ukraine|Investigational Site Number : 826002, Southampton, Hampshire, SO16 6YD, United Kingdom|Investigational Site Number : 826001, Nottingham, Nottinghamshire, NG5 1PB, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Cancers,DRUG: LY2606368,ALL,"ADULT, OLDER_ADULT",PHASE2,27,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/12/16,7/1/21,"Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasms of Urinary Tract|Bladder Cancer,DRUG: Rocuronium|DRUG: Sugammadex|DRUG: Neostigmine|DRUG: Glycopyrrolate,ALL,"ADULT, OLDER_ADULT",PHASE4,54,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",9/18/17,11/24/19,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Cancers,DRUG: Fentanyl Sublingual Spray (FSS)|BEHAVIORAL: Questionnaires|BEHAVIORAL: Mental Ability Tests|BEHAVIORAL: Study Diary,ALL,"ADULT, OLDER_ADULT",PHASE2,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/2/16,11/4/19,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastasis From Malignant Tumor of Prostate (Disorder),DRUG: 64Cu-PSMA I&T,MALE,"ADULT, OLDER_ADULT",PHASE2,26,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,12/5/22,5/17/23,"Yale University, New Haven, Connecticut, 06520, United States|Edward Hines, Jr. VA Hospital, Hines, Illinois, 60141, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Saint Louis University, St Louis, Missouri, 63104, United States|John J. Cochran Veterans Hospital, St Louis, Missouri, 63106, United States|Washington University, St Louis, Missouri, 63110, United States|Nebraska Cancer Specialists, Omaha, Nebraska, 68130, United States|XCancer Omaha/Urology Cancer Center, Omaha, Nebraska, 68130, United States|MD Anderson, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Malignancies,DRUG: Cyclophosphamide,ALL,"ADULT, OLDER_ADULT",PHASE2,58,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-12,2020-09,"Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Cancers,BIOLOGICAL: RENCA macrobeads,ALL,"ADULT, OLDER_ADULT",PHASE2,70,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/3/14,10/22/18,"University of Kansas Cancer Center, Westwood, Kansas, 66205, United States|Weill Cornell Medical Center / The Rogosin Institute, New York, New York, 10021, United States|Calvary Hospital, The Bronx, New York, 10461, United States|The Ohio State University; OSU Comprehensive Cancer Center, Columbus, Ohio, 43210-1228, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignancies,BIOLOGICAL: Part A|BIOLOGICAL: Part B,ALL,"ADULT, OLDER_ADULT",PHASE1,184,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/21/18,7/7/22,"Sarcoma Oncology Research Center, Santa Monica, California, 90404, United States|University of Colorado Denver, Aurora, Colorado, 80045, United States|University of Miami Hospital Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Florida Cancer Specialists, Sarasota, Florida, 34238, United States|University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, 21201, United States|Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21231, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Mayo Clinic-Rochester, Rochester, Minnesota, 55901, United States|Carolina BioOncology Institute, Huntersville, North Carolina, 28078, United States|University Hospitals Seidman Cancer Center, Cleveland, Ohio, 44101, United States|Rhode Island Hospital, Providence, Rhode Island, 02906, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignancies,DRUG: INCAGN01949|DRUG: Nivolumab|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,52,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/9/17,9/17/19,"The University of Alabama Birmingham (UAB), Birmingham, Alabama, 90025, United States|Scottsdale Healthcare Hospitals DBA HonorHealth, Scottsdale, Arizona, 85258, United States|The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|Mount Sinai Medical Center of Florida, Inc., Miami, Florida, 33140, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|John Theurer Cancer Center At Hackensack UMC, Hackensack, New Jersey, 07601, United States|Rutgers, The State University, New Brunswick, New Jersey, 08901, United States|New York University Clinical Cancer Center, New York, New York, 10016, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|Carolina BioOncology Institute, Huntersville, North Carolina, 28078, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Sarah Cannon Research Institute, LLC (SCRI), Nashville, Tennessee, 37203, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Myeloid Hematologic Malignancy|Lymphoid Hematologic Malignancy,DRUG: Ixazomib,ALL,"ADULT, OLDER_ADULT",PHASE2,20,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/10/17,9/2/21,"Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematologic Malignancies,DRUG: Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant,ALL,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/21/12,1/1/23,"UCSD Medical Center, La Jolla, California, 92093, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Human Cancers,DRUG: MOv18 IgE|DRUG: MOv18 IgE|DRUG: MOv18 IgE|DRUG: MOv18 IgE|DRUG: MOv18 IgE|DRUG: MOv18 IgE|DRUG: MOv18 IgE,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,26,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/16/16,7/30/21,"Addenbrooke's Hospital, Cambridge, Cambridge, United Kingdom|Guy's and St Thomas's Hospital, London, SE1 9RT, United Kingdom|University College London Hospital, London, United Kingdom|Royal Marsden Hospital, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor Malignancy,DRUG: Pemigatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,111,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/17/19,3/29/22,"Cancer Treatment Centers of America, Goodyear, Arizona, 85338, United States|Mayo Clinic Hospital, Phoenix, Arizona, 85054, United States|The University of Arizona Cancer Center, Tucson, Arizona, 85724, United States|Chao Family Comprehensive Cancer Center University of California, Irvine, Orange, California, 92868, United States|Stanford Cancer Center, Palo Alto, California, 94304, United States|John Wayne Cancer Institute, Santa Monica, California, 90404, United States|St. Joseph Heritage Healthcare, Santa Rosa, California, 95403, United States|Florida Cancer Specialists & Research Institute, Fort Myers, Florida, 33901, United States|Mayo Clinic Jacksonville, Jacksonville, Florida, 32224, United States|Florida Cancer Specialists, St. Petersburg, Florida, 33705, United States|Florida Cancer Specialists, Tallahassee, Florida, 32308, United States|Florida Cancer Specialists, West Palm Beach, Florida, 33401, United States|Illinois Cancer Specialists, Arlington Heights, Illinois, 60005, United States|Edward H Kaplan & Associates, Skokie, Illinois, 60076, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|Cancer Treatment Centers of America, Zion, Illinois, 60099, United States|Indiana University Health - Arnett Cancer Care, Lafayette, Indiana, 47904, United States|University of Iowa, Iowa City, Iowa, 52242, United States|University of Kansas Cancer Center, Westwood, Kansas, 66205, United States|Ochsner Clinic, New Orleans, Louisiana, 70121, United States|Central Maine Medical Center, Lewiston, Maine, 04240, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Umass Memorial Medical Center, Inc., Worcester, Massachusetts, 01655, United States|Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|Summit Medical Group, Florham Park, New Jersey, 07932, United States|Winthrop University Hospital, Mineola, New York, 11501, United States|Oncology Specialists of Charlotte, Charlotte, North Carolina, 28204, United States|Duke Cancer Center, Durham, North Carolina, 27710, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, 27157, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Southwestern Regional Medical Center, Tulsa, Oklahoma, 74133, United States|Cancer Institute of Greenville Health System, Greenville, South Carolina, 29605, United States|The West Clinic Pc, Germantown, Tennessee, 38138, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Houston Methodist Hospital, Houston, Texas, 77030, United States|Joe Arrington Cancer Center, Lubbock, Texas, 79410, United States|Virginia Cancer Specialists, Pc, Fairfax, Virginia, 22031, United States|Virginia Oncology Associates-Lake Wright, Norfolk, Virginia, 23502, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Multicare Institute For Research & Innovation, Tacoma, Washington, 98405, United States|West Virginia University Hospitals Inc, Morgantown, West Virginia, 26506, United States|University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, 53792, United States|The Finsen Centre National Hospital, Copenhagen, 02100, Denmark|Institut Bergonie, Bordeaux, 33000, France|CENTRE GEORGES FRANï¿½OIS LECLERC, Dijon, 21079, France|Centre Antoine Lacassagne, Nice, 06189, France|Hospital Saint Louis, Paris, 75010, France|A.P.H. Paris Hopital Cochin, Paris, 75014, France|Institut Universitaire Du Cancer de Toulouse Oncopole, Toulouse, 31059, France|Universitatsklinikum Koln, Cologne, 50937, Germany|University Medical Center Freiburg, Freiburg im Breisgau, 79106, Germany|University Medical Centre Hamburg-Eppendorf, Centre of Oncology, Hamburg, 20246, Germany|University Hospital Grosshadern Munich, Munich, 81377, Germany|Universitaetsklinikum in Tubingen, Tübingen, 72076, Germany|Ha Emek Medical Center, Afula, 18101, Israel|Rambam Health Care Campus, Haifa, 3525408, Israel|Hadassah Hebrew University Medical Center Ein Karem Hadassah, Jerusalem, 90000, Israel|Rabin Medical Center - Beilinson Hospital, Petah Tikva, 4841492, Israel|Assaf Harofeh Medical Center, Ẕerifin, 7030000, Israel|L AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S. ORSOLA ï¿½ MALPIGHI, Bologna, 40138, Italy|Fondazione Del Piemonte Per L Oncologia Ircc Candiolo, Candiolo, 10060, Italy|Fondazione Irccs Istituto Nazionale Dei Tumori, Milan, 20133, Italy|Istituto Nazionale Tumori Irccs Fondazione Pascale, Napoli, 80131, Italy|Istituto Nazionale Tumori Regina Elena Irccs, Roma, 00144, Italy|Centro Ricerche Cliniche Di Verona (Crc), Verona, 37134, Italy|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Kanazawa University Hospital, Ishikawa, 920-8641, Japan|Kobe University Hospital, Kobe, 650-0017, Japan|Tohoku University Hospital, Sendai, 980-8574, Japan|Keio University Hospital, Shinjuku-ku, 160-8582, Japan|Shizuoka Cancer Center, Shizuoka, 411-8777, Japan|Kanagawa Cancer Center, Yokohama, 241-8515, Japan|National Cancer Center, Goyang-si, 10408, South Korea|Seoul National University Bundang Hospital, Seongnam-si, 13620, South Korea|Severance Hospital Yonsei University Health System, Seoul, 03722, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|Hospital General Universitario Vall D Hebron, Barcelona, 08035, Spain|Hospital Clinic I Provincial, Barcelona, 08036, Spain|Centro Integral Oncologico Clara Campal (Ciocc), Madrid, 28050, Spain|Hospital Regional Universitario de Malaga, Málaga, 29010, Spain|Clinica Universidad de Navarra (Cun), Pamplona, 31008, Spain|Hospital Universitario Marques de Valdecilla, Santander, 39008, Spain|Hospital Universitario Y Politcnico de La Fe, Valencia, 46026, Spain|Inselspital - Universitaetsspital Bern, Bern, 03010, Switzerland|Universitatsspital Zurich, Zurich, 08091, Switzerland|University College London Hospitals (Uclh), London, NW1 2PG, United Kingdom|Imperial College Healthcare Nhs Trust - Hammersmith Hospital, London, W12 0HS, United Kingdom|Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematopoietic Malignancies,DRUG: Cyclophosphamide,ALL,"ADULT, OLDER_ADULT",PHASE2,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/2/17,12/18/18,"New York University School of Medicine, New York, New York, 10016, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm,DRUG: placebo administration|DRUG: EMLA|DRUG: propofol|DRUG: fentanyl citrate,ALL,"CHILD, ADULT",PHASE2,33,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",5/14/12,6/26/18,"Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Malignancy,DRUG: Tacrolimus|DRUG: Methotrexate|DRUG: Tocilizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,29,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/6/18,4/1/23,"Froedtert Hospital, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Malignant Tumor of Ill-defined Site,GENETIC: Pharmacogenomic Testing,ALL,"ADULT, OLDER_ADULT",PHASE2,75,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2015-09,2019-06,"Levine Cancer Institute, Charlotte, North Carolina, 28204, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Haematological Malignancies,DRUG: AZD4573|DRUG: Acalabrutinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,40,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/17/21,2/27/25,"Research Site, Duarte, California, 91010, United States|Research Site, La Jolla, California, 92093-0052, United States|Research Site, Houston, Texas, 77030, United States|Research Site, Salt Lake City, Utah, 84112, United States|Research Site, Clayton, 3168, Australia|Research Site, Nedlands, 6009, Australia|Research Site, Québec, Quebec, G1R 2J6, Canada|Research Site, Lille, 59037, France|Research Site, Dublin, D08 NHY1, Ireland|Research Site, Galway, H91 YR71, Ireland|Research Site, Krakow, 30-510, Poland|Research Site, Seoul, 03080, South Korea|Research Site, Seoul, 05505, South Korea|Research Site, Seoul, 06351, South Korea|Research Site, Barcelona, 08035, Spain|Research Site, Palma de Mallorca, 07120, Spain|Research Site, Plymouth, PL6 8DH, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Myeloid Malignancies,DRUG: Magrolimab|DRUG: Azacitidine|DRUG: Venetoclax|DRUG: Mitoxantrone|DRUG: Etoposide|DRUG: Cytarabine|DRUG: CC-486,ALL,"ADULT, OLDER_ADULT",PHASE2,54,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/28/21,3/4/24,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California, 91010, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, 90048, United States|Stanford Cancer Center, Palo Alto, California, 94305, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|The University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|OU Health, Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Baylor University Medical Center, Dallas, Texas, 75246, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States|Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Austin Health, Heidelberg, Victoria, 3084, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|Royal Perth Hospital, Perth, Western Australia, 6000, Australia|Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, OX3 9DU, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematological Malignancies,DRUG: Magrolimab|DRUG: Azacitidine,ALL,"ADULT, OLDER_ADULT",PHASE1,258,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/8/17,9/5/23,"City of Hope National Medical Center, Duarte, California, 91010, United States|University of California San Diego (UCSD), La Jolla, California, 92093, United States|UCLA Clinical and Translational Research Center (CTRC), Los Angeles, California, 90095, United States|Chao Family Comprehensive Cancer Center - UC Irvine Medical Center, Orange, California, 92868, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|Stanford University Medical Center, Stanford, California, 94305, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|University Of Miami - Miller School Of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|The University of Chicago, Chicago, Illinois, 60637, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute/ Boston Children's Hospital, Boston, Massachusetts, 02215, United States|Mid America Division, Inc., Kansas City, Missouri, 64132, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Weill Cornell Medical College - New York-Presbyterian Hospital, New York, New York, 10021, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Herbert Irving Comprehensive Cancer Center-Columbia University Medical Center, New York, New York, 10032, United States|Montefiore Medical Center, The Bronx, New York, 10467, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|Duke University Medical Center, Durham, North Carolina, 27705, United States|Ohio State University Medical Center, Columbus, Ohio, 43210, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Tennesssee Oncology - Centennial Clinic Location, Nashville, Tennessee, 37203, United States|Texas Oncology - Baylor Charles A. Simmons Cancer Center, Dallas, Texas, 75246, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Medical College of WI Froedtert Hospital, Milwaukee, Wisconsin, 53226, United States|Oxford Centre for Respiratory Medicine Churchill Hospital, Oxford University Hospitals NHS Trust, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Malignancies,DRUG: MBG453|DRUG: PDR001|DRUG: Decitabine,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,252,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/23/15,8/30/22,"Sidney Kimmel CCC At JH Sidney Kimmel CCC, Baltimore, Maryland, 21231, United States|Dana Farber Cancer Institute DFCI - Brookline, Boston, Massachusetts, 02215, United States|UT M.D Anderson Cancer Center, Houston, Texas, 77030, United States|Mays Cancer Ctr Uthsa Mdacc, San Antonio, Texas, 78229, United States|Novartis Investigative Site, Toronto, Ontario, M5G 2C1, Canada|Novartis Investigative Site, Milan, MI, 20141, Italy|Novartis Investigative Site, Rozzano, MI, 20089, Italy|Novartis Investigative Site, Kashiwa, Chiba, 277 8577, Japan|Novartis Investigative Site, Amsterdam, 1066 CX, Netherlands|Novartis Investigative Site, Leiden, 2300 RC, Netherlands|Novartis Investigative Site, Singapore, 168583, Singapore|Novartis Investigative Site, Seoul, 03080, South Korea|Novartis Investigative Site, Geneva, CH 1211, Switzerland|Novartis Investigative Site, Taipei, 10002, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Pituitary Tumor|ACTH-producing Pituitary Tumour,DRUG: Pasireotide LAR,ALL,"ADULT, OLDER_ADULT",PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/10/17,3/31/20,"Neuroendocrine Unit and Pituitary Center, Columbia University, New York, New York, 10032, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignancies,DRUG: AZD7648|DRUG: PLD,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/9/19,12/7/22,"Research Site, New Haven, Connecticut, 06510, United States|Research Site, Houston, Texas, 77030, United States|Research Site, London, EC1A 7BE, United Kingdom|Research Site, London, SE1 9RT, United Kingdom|Research Site, Newcastle upon Tyne, NE7 7DN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Malignancies,DRUG: Pemigatinib|DRUG: Retifanlimab|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/8/21,4/11/24,"John Wayne Cancer Institute, Santa Monica, California, 90404, United States|Oncology Specialists of Charlotte, Charlotte, North Carolina, 28207, United States|Md Anderson Cancer Center, Houston, Texas, 77030, United States|South Texas Accelerated Research Therapeutics, San Antonio, Texas, 78229, United States|Virginia Cancer Specialists, Pc, Fairfax, Virginia, 22031, United States|The Finsen Centre National Hospital, Copenhagen, 02100, Denmark|Fondazione Irccs Istituto Nazionale Dei Tumori, Milan, 20133, Italy|Istituto Nazionale Tumori Regina Elena Irccs, Rome, 00144, Italy|Azienda Ospedaliera Universitaria Senese Policlinico Santa Maria Alle Scotte, Siena, 53100, Italy|Kanagawa Cancer Center, Yokohama, 241-8515, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematological Malignancies,DRUG: Tenalisib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,17,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/28/18,3/25/23,"University of California, Hellen Diller Family Comprehensive Cancer Center, San Francisco, California, 94143, United States|Division of Hematology, University of Colorado,, Denver, Colorado, 80045, United States|Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, 44195, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Ltd. M.Zodelava Hematology Centre, Tbilisi, Georgia|Medivest - Institute of Hematology and Transfusiology, Tbilisi, Georgia|Silesian Healthy Blood Clinic Grosicki, Grosicka Sp.J., Chorzów, 41-503, Poland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Cancers,OTHER: Placebo|DRUG: Glutamine|BEHAVIORAL: Questionnaires,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,77,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",7/10/14,3/3/21,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cervical Intraepithelial Neoplasia,"BIOLOGICAL: HPV (Types 16, 18) Vaccine, Adsorbed",FEMALE,"ADULT, OLDER_ADULT",PHASE4,6051,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,8/22/18,2/28/20,"GSK Investigational Site, Jintan, Jiangsu, 213200, China|GSK Investigational Site, Lianshui, Jiangsu, 223400, China|GSK Investigational Site, Xuzhou, Jiangsu, 221006, China|GSK Investigational Site, Yancheng, Jiangsu, 224500, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Malignancies,BIOLOGICAL: Haplo HCT <55 years old|BIOLOGICAL: Haplo HCT ≥55 years old|DRUG: GVHD Prophylaxis|BIOLOGICAL: Haplo HCT ≥55 and < 65 years old|BIOLOGICAL: Haplo HCT ≥65 and ≤75 years old,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,78,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/24/17,3/24/25,"Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cervical Intraepithelial Neoplasia,BIOLOGICAL: HPV9 High formulation|BIOLOGICAL: HPV9 Medium formulation|BIOLOGICAL: HPV9 Low formulation|BIOLOGICAL: Gardasil 9,FEMALE,"CHILD, ADULT",PHASE1|PHASE2,1080,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",8/22/22,2/25/24,"GSK Investigational Site, San Diego, California, 92103-6204, United States|GSK Investigational Site, San Diego, California, 92120, United States|GSK Investigational Site, Wheat Ridge, Colorado, 80033, United States|GSK Investigational Site, Coral Gables, Florida, 33134, United States|GSK Investigational Site, Kissimmee, Florida, 34741, United States|GSK Investigational Site, Miami, Florida, 33125, United States|GSK Investigational Site, North Miami Beach, Florida, 33162, United States|GSK Investigational Site, Pompano Beach, Florida, 33060, United States|GSK Investigational Site, Sarasota, Florida, 34239, United States|GSK Investigational Site, Atlanta, Georgia, 30328, United States|GSK Investigational Site, Evansville, Indiana, 47712, United States|GSK Investigational Site, South Bend, Indiana, 46617, United States|GSK Investigational Site, Topeka, Kansas, 66606, United States|GSK Investigational Site, Wichita, Kansas, 67205, United States|GSK Investigational Site, Lexington, Kentucky, 40509, United States|GSK Investigational Site, Covington, Louisiana, 70433, United States|GSK Investigational Site, Elkridge, Maryland, 21075, United States|GSK Investigational Site, Saginaw, Michigan, 48602, United States|GSK Investigational Site, Jefferson City, Missouri, 65109, United States|GSK Investigational Site, Las Vegas, Nevada, 89102, United States|GSK Investigational Site, Albuquerque, New Mexico, 87102, United States|GSK Investigational Site, Raleigh, North Carolina, 27612, United States|GSK Investigational Site, Columbus, Ohio, 43213, United States|GSK Investigational Site, Norman, Oklahoma, 73072, United States|GSK Investigational Site, North Charleston, South Carolina, 29405, United States|GSK Investigational Site, Chattanooga, Tennessee, 37404, United States|GSK Investigational Site, Carrollton, Texas, 75010, United States|GSK Investigational Site, Corpus Christi, Texas, 78412, United States|GSK Investigational Site, Dallas, Texas, 75251, United States|GSK Investigational Site, Fort Worth, Texas, 76104, United States|GSK Investigational Site, Houston, Texas, 77065, United States|GSK Investigational Site, Humble, Texas, 77338, United States|GSK Investigational Site, Humble, Texas, 77346, United States|GSK Investigational Site, Irving, Texas, 75062, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, Tomball, Texas, 77375, United States|GSK Investigational Site, West Jordan, Utah, 84088, United States|GSK Investigational Site, Norfolk, Virginia, 23502, United States|GSK Investigational Site, Norfolk, Virginia, 68701, United States|GSK Investigational Site, Sofia, 1431, Bulgaria|GSK Investigational Site, Sofia, 1606, Bulgaria|GSK Investigational Site, Hradec Králové, CZ-500 03, Czechia|GSK Investigational Site, Olomouc, 772 00, Czechia|GSK Investigational Site, Olomouc, 779 00, Czechia|GSK Investigational Site, Prague, 160000, Czechia|GSK Investigational Site, Tallinn, 10128, Estonia|GSK Investigational Site, Tallinn, 10617, Estonia|GSK Investigational Site, Tartu, 50106, Estonia|GSK Investigational Site, Tartu, 50708, Estonia|GSK Investigational Site, Dijon, 21000, France|GSK Investigational Site, La Roche-sur-Yon, 85025, France|GSK Investigational Site, La Tronche, 38043, France|GSK Investigational Site, Nantes, 44093, France|GSK Investigational Site, Paris, 75679, France|GSK Investigational Site, Rennes, 35000, France|GSK Investigational Site, Tours, 37000, France|GSK Investigational Site, Schwerin, 19055, Germany|GSK Investigational Site, Würzburg, 97074, Germany|GSK Investigational Site, Kaunas, 49387, Lithuania|GSK Investigational Site, Kaunas, LT-48259, Lithuania|GSK Investigational Site, Kaunas, LT-49456, Lithuania|GSK Investigational Site, Kaunas, LT-50177, Lithuania|GSK Investigational Site, Vilnius, 8661, Lithuania|GSK Investigational Site, Bydgoszcz, 85-796, Poland|GSK Investigational Site, Krakow, 30-348, Poland|GSK Investigational Site, Lodz, 91-363, Poland|GSK Investigational Site, Skierniewice, 96-100, Poland|GSK Investigational Site, Warsaw, 00-215, Poland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Superficial, Palpable, Unresectable/Metastatic Solid Tumour",DRUG: AGI-134,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,38,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/30/18,12/31/23,"UCLA, Los Angeles, California, 90095, United States|AHS Hospital Corp., Morristown, New Jersey, 07960, United States|Providence Cancer Institute Franz Clinic, Portland, Oregon, 97213, United States|Emek Medical Center, Afula, 7177871, Israel|Rambam Health Care Campus, Haifa, 3109601, Israel|Hadassah Hebrew University Medical Center, Jerusalem, Israel|Sheba Medical Center, Ramat Gan, 52621, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel|University of Birmingham, Birmingham, B15 2TT, United Kingdom|Edinburgh Cancer Research Centre, Edinburgh, EH4 2XR, United Kingdom|The Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|University Collage London, London, W1T 7HA, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|Churchill Hospital, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Cancers,DRUG: Fentanyl Sublingual Spray|PROCEDURE: Shuttle Walk Test|BEHAVIORAL: Questionnaires|BEHAVIORAL: Mental Ability Tests|BEHAVIORAL: Phone Call,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,50,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",1/4/16,1/27/21,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Cancers,DRUG: Ridaforolimus Tablet|DRUG: Ridaforolimus Intravenous (IV) Infusion,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,7,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/1/09,2/4/18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Cancers,DRUG: Fentanyl Buccal Tablet|OTHER: Placebo Buccal Tablet|BEHAVIORAL: Questionnaires,ALL,"ADULT, OLDER_ADULT",PHASE2,36,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",5/27/14,12/4/19,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematological Malignancies,DRUG: Cyclophosphamide|DRUG: Thiotepa|DRUG: Fludarabine|DRUG: Melphalan|DRUG: Mesna|BIOLOGICAL: G-CSF|DRUG: Mycophenolate mofetil|DRUG: Tacrolimus|DRUG: Methylprednisolone|RADIATION: Total lymphoid irradiation|BIOLOGICAL: Lymphocyte infusions|DEVICE: CliniMACS,ALL,"CHILD, ADULT",PHASE2,24,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/11/14,5/23/17,"St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignancies,BIOLOGICAL: Cabiralizumab|BIOLOGICAL: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1,19,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/25/17,10/23/19,"Local Institution, Nagoya, Aichi-ken, 4678602, Japan|Local Institution, Kamogawa-shi, Chiba, 2968602, Japan|Local Institution, Kashiwa-shi, Chiba, 2778577, Japan|Local Institution, Chuo-ku, Tokyo, 1040045, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Cancers,DRUG: Fentanyl Pectin Nasal Spray|DRUG: Placebo Nasal Spray|OTHER: Walk Test|BEHAVIORAL: Questionnaires|BEHAVIORAL: Mental Ability Tests,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",6/11/13,11/25/19,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Cervix Cancer|Cervix Intraepithelial Neoplasia Grade 3|Cervix; Intraepithelial Neoplasia, Grade I|Cervix; Intraepithelial Neoplasia, Grade II",DRUG: Artesunate pessary|DIAGNOSTIC_TEST: blood draws for pharmacokinetics of the study drug,FEMALE,"ADULT, OLDER_ADULT",PHASE1,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/29/24,8/14/24,"Lumumba Sub-County Hospital, Kisumu, Kenya",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Nonhematologic Malignancies,DRUG: MLN2480|DRUG: MLN0128|DRUG: Alisertib|DRUG: Paclitaxel|DRUG: Cetuximab|DRUG: Irinotecan,ALL,"ADULT, OLDER_ADULT",PHASE1,81,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/14/15,7/2/18,"Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 2114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 2115, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 2115, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Institut Bergonie, Bordeaux, Gironde, 33076, France|Institut Claudius Regaud-Oncopole, Toulouse, Haute Garonne, 31059, France|Institut Gustave Roussy, Villejuif, Val De Marne, 94805, France|Hospital Universitari Vall d'Hebron, Barcelona, 8035, Spain|START Madrid. Fundacion Jimenez Diaz, Madrid, 28040, Spain|Hospital Clinico Universitario Virgen de la Victoria, Málaga, 29010, Spain|Sarah Cannon Research Institure UK, London, Greater London, W1G 6AD, United Kingdom|The Chrisie, Manchester, Greater Manchester, M20 4BX, United Kingdom|Churchill Hospital, Oxford, Oxfordshire, OX3 7LJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Nonhematologic Malignancies,DRUG: TAK-228|DRUG: TAK-117,ALL,"ADULT, OLDER_ADULT",PHASE1,101,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/28/13,4/30/18,"Boston, Massachusetts, United States|Nashville, Tennessee, United States|San Antonio, Texas, United States|Barcelona, Spain|Sutton, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor Malignancies,BIOLOGICAL: Clostridium novyi-NT spores,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-10,10/31/17,"Washington University School of Medicine, St Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10021, United States|Albert Einstein College of Medicine, The Bronx, New York, 10461, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|UT M.D. Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cervical Intraepithelial Neoplasia,PROCEDURE: Blood sampling for antibody determination,FEMALE,"CHILD, ADULT, OLDER_ADULT",PHASE3,228,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,2/28/18,6/29/18,"GSK Investigational Site, Taizhou, Jiangsu, 225300, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematological Malignancies,DRUG: Ibandronate|DRUG: Vitamin Supplements,ALL,"ADULT, OLDER_ADULT",PHASE3,78,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/9/08,4/7/17,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm of Breast,DRUG: DS-8201a,ALL,"ADULT, OLDER_ADULT",PHASE1,51,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/26/17,2/19/21,"Kanagawa Cancer Center, Yokohama, Kanagawa, 241-8515, Japan|National Cancer Center Hospital, Chuo Ku, Tokyo, 104-0045, Japan|The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Koto-Ku, Tokyo, 135-8550, Japan|Toranomon Hospital, Minato-Ku, Tokyo, 105-8470, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Social Medical Corporation Hakuaikai Sagara Hospital, Kagoshima, 892-0833, Japan|Shizuoka Cancer Center, Shizuoka, 411-8777, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Malignancies,DRUG: Tildrakizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,51,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/1/20,6/17/24,"Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cancer Malignancies,DRUG: melatonin|DRUG: placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,911,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2/6/13,4/19/17,"St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cervical Intraepithelial Neoplasia,BIOLOGICAL: PepCan|BIOLOGICAL: Candin®,FEMALE,ADULT,PHASE2,81,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",11/30/15,9/14/22,"University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Progressive Solid Malignancies|Refractory Solid Malignancies|Cancer,BIOLOGICAL: TAPA-pulsed DC vaccine|DRUG: Cyclophosphamide Pill|DRUG: Imiquimod Topical Cream,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/28/17,8/30/18,"San Antonio, Texas, 78240, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Hematologic Malignancies,DEVICE: CliniMACS® CD34 Reagent System|DRUG: Fludarabine|DRUG: Melphalan|DRUG: anti-thymocyte globulin (rabbit)|DRUG: Rituximab|RADIATION: Total Body Irradiation|DRUG: Mycophenolate Mofetil|DRUG: Tacrolimus,ALL,"ADULT, OLDER_ADULT",PHASE2,270,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/16/12,2028-04,"University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Weill Cornell Medical College, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm of Breast,DRUG: Trastuzumab plus docetaxel (for four 21-day cycles) after four 14-day cycles of Doxorubicin plus cyclophosphamide,FEMALE,"ADULT, OLDER_ADULT",PHASE3,108,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",7/9/16,8/5/18,"Shafa Hospital, Ahvāz, Iran|Sheikh Mofid Clinic, Isfahan, Iran|Javadol Aemeh Clinic, Kerman, Iran|Park clinic, Kerman, Iran|Payandeh Clinic, Kermanshah, Iran|Imam Reza Hospital, Mashhad, Iran|Tohid Hospital, Sanandaj, Iran|Shahid Faqihi Hospital, Shiraz, Iran|Baqiatallah Hospital, Tehran, Iran|Booali Hospital, Tehran, Iran|Firoozgar Hospital, Tehran, Iran|Imam Khomeini hospital, Tehran, Iran|Jahad Daneshgahi Clinic, Tehran, Iran|Masood Clinic, Tehran, Iran|Mehrad Hospital, Tehran, Iran|Rasool Akram Hospital, Tehran, Iran|Toos Hospital, Tehran, Iran|Mortazavizadeh Clinic, Yazd, Iran|Aliebne Abitaleb Hospital, Zahedan, Iran",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Dyspnea|Malignant Neoplasm,DRUG: Dexamethasone|OTHER: Placebo|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,135,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",12/4/17,12/31/25,"Lyndon B. Johnson Hospital, Houston, Texas, 77026, United States|Harris Health System Settegast Health Center, Houston, Texas, 77028, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Oropharyngeal Cancer,DRUG: Utomilumab|BIOLOGICAL: ISA101b,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/4/18,11/5/21,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor Malignancy|Hematologic Malignancy|Leukemia|Lymphoma|Multiple Myeloma,BIOLOGICAL: Messenger ribonucleic acid (mRNA)-1273 Vaccine|BIOLOGICAL: Messenger ribonucleic acid (mRNA)-1273 Vaccine Booster|DIAGNOSTIC_TEST: ECG|OTHER: Antibiotics|OTHER: Anti-viral agents|OTHER: Anti-fungal agent|OTHER: Anti-emetics,ALL,"ADULT, OLDER_ADULT",PHASE2,19,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,4/28/21,5/25/23,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Locally Advanced or Metastatic Solid Tumours,DRUG: AZD0171|DRUG: Durvalumab|DRUG: Gemcitabine|DRUG: Nab-paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE2,126,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/10/21,12/15/25,"Research Site, La Jolla, California, 92037, United States|Research Site, Los Angeles, California, 90025, United States|Research Site, Orange, California, 92868, United States|Research Site, Ventura, California, 93003, United States|Research Site, Atlanta, Georgia, 30318, United States|Research Site, Coeur d'Alene, Idaho, 83814, United States|Research Site, Boston, Massachusetts, 02114, United States|Research Site, Ann Arbor, Michigan, 48109, United States|Research Site, Grand Rapids, Michigan, 49503, United States|Research Site, Buffalo, New York, 14263, United States|Research Site, New York, New York, 10065, United States|Research Site, Portland, Oregon, 97239, United States|Research Site, San Antonio, Texas, 78229, United States|Research Site, Charlottesville, Virginia, 22908, United States|Research Site, Seattle, Washington, 98195, United States|Research Site, Madison, Wisconsin, 53792, United States|Research Site, Barrie, Ontario, L4M 6M2, Canada|Research Site, Toronto, Ontario, M4N 3M5, Canada|Research Site, Toronto, Ontario, M5G 2M9, Canada|Research Site, Seongnam-si, 13620, South Korea|Research Site, Seongnam-si, 463-712, South Korea|Research Site, Seoul, 03080, South Korea|Research Site, Seoul, 03722, South Korea|Research Site, Seoul, 05505, South Korea|Research Site, Seoul, 06351, South Korea|Research Site, Seoul, 06591, South Korea|Research Site, Badalona, 08916, Spain|Research Site, Barcelona, 08035, Spain|Research Site, Madrid, 28027, Spain|Research Site, Madrid, 28034, Spain|Research Site, Madrid, 28041, Spain|Research Site, Madrid, 28050, Spain|Research Site, Majadahonda, 28222, Spain|Research Site, Pamplona, 31008, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Cancers|Sarcoma,PROCEDURE: Hyperthermic Peritoneal Perfusion (HIPEC)|DRUG: Cisplatin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/9/11,2/16/18,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematological Malignancies,DRUG: Pasireotide,ALL,"ADULT, OLDER_ADULT",PHASE2,37,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/21/15,10/15/19,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Duke University Medical Center, Durham, North Carolina, 27705, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Gynecologic Malignancies,DRUG: Paclitaxel|DRUG: Carboplatin,FEMALE,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/20/16,1/24/19,"Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, 44195, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Lymphoid Malignancies,DRUG: Idelalisib,ALL,"ADULT, OLDER_ADULT",PHASE4,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/4/16,12/28/17,"Amsterdam, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,UNKNOWN,YES,Dyspnea|Malignant Neoplasm,PROCEDURE: Oxygen Therapy|PROCEDURE: Oxygen Therapy|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration|PROCEDURE: Respiratory Therapy|PROCEDURE: Respiratory Therapy,ALL,"ADULT, OLDER_ADULT",PHASE2,74,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",3/17/15,5/31/23,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm of Breast,DRUG: vinflunine|DRUG: Capecitabine,FEMALE,"ADULT, OLDER_ADULT",PHASE3,112,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-09,2017-07,"Beijing, China|Changchun, China|Chengdu, China|Dalian, China|Fuzhou, China|Hangzhou, China|Harbin, China|Jinan, China|Nanjing, China|Shanghai, China|Shenyang, China|Tianjin, China|Wuhan, China|NUH, Singapore, 119228, Singapore|Gleneagles Hospital, Singapore, 258500, Singapore|Kaohsiung City, Taiwan|Taichung, Taiwan|Taipei, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced BRAF Mutant Cancers,DRUG: Binimetinib|DRUG: Encorafenib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,17,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/14/19,9/2/23,"Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Cancer Center @ Suffolk (Limited protocol activity), Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Ovarian|Breast|SCLC|Gastric Cancers,DRUG: Olaparib|DRUG: MEDI4736|DRUG: Bevacizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,264,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/17/16,9/17/26,"Research Site, Newnan, Georgia, 30265, United States|Research Site, Towson, Maryland, 21204, United States|Research Site, Boston, Massachusetts, 02114, United States|Research Site, Detroit, Michigan, 48202, United States|Research Site, St Louis, Missouri, 63110, United States|Research Site, Hilliard, Ohio, 43026, United States|Research Site, Philadelphia, Pennsylvania, 19104, United States|Research Site, Bordeaux, 33076, France|Research Site, Caen, 14076, France|Research Site, Clermont-Ferrand, 63011, France|Research Site, Dijon, 21079, France|Research Site, Marseille, 13385, France|Research Site, Nantes, 44202, France|Research Site, Paris, 75014, France|Research Site, Pierre Benit Cedex, 69495, France|Research Site, Toulouse, 31059, France|Research Site, Villejuif, 94805, France|Research Site, Haifa, 91096, Israel|Research Site, Jerusalem, 91031, Israel|Research Site, Petah Tikva, 49100, Israel|Research Site, Ramat Gan, 5265601, Israel|Research Site, Tel Aviv, 6423906, Israel|Research Site, Amsterdam, 1066 CX, Netherlands|Research Site, Amsterdam, 1081 HV, Netherlands|Research Site, Maastricht, 6229 HX, Netherlands|Research Site, Nijmegen, 6525 GA, Netherlands|Research Site, Rotterdam, 3075 EA, Netherlands|Research Site, Utrecht, 3584 CX, Netherlands|Research Site, Goyang-si, 10408, South Korea|Research Site, Seongnam-si, 13620, South Korea|Research Site, Seoul, 03080, South Korea|Research Site, Seoul, 03722, South Korea|Research Site, Seoul, 05505, South Korea|Research Site, Seoul, 06273, South Korea|Research Site, Seoul, 06591, South Korea|Research Site, Seoul, 135-710, South Korea|Research Site, Chur, CH-7000, Switzerland|Research Site, Lausanne, 1011, Switzerland|Research Site, Cambridge, CB2 0QQ, United Kingdom|Research Site, Dundee, DD1 9SY, United Kingdom|Research Site, Glasgow, G12 0YN, United Kingdom|Research Site, Greater London, SW3 6JJ, United Kingdom|Research Site, London, NW1 2PG, United Kingdom|Research Site, London, SE1 9RY, United Kingdom|Research Site, Manchester, M20 4BX, United Kingdom|Research Site, Newcastle upon Tyne, NE7 7DN, United Kingdom|Research Site, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasms of Digestive Organs|Colorectal Cancer|Colon Cancer,DRUG: Durvalumab|DRUG: Trametinib,ALL,"ADULT, OLDER_ADULT",PHASE2,29,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/21/18,5/5/22,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Cancer|Tumors|Neoplasm|Malignancy,DRUG: BMS-986226|BIOLOGICAL: Nivolumab|BIOLOGICAL: Ipilimumab|BIOLOGICAL: Tetanus Vaccine,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,80,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/1/17,12/20/21,"Local Institution - 0005, Boston, Massachusetts, 02215, United States|Local Institution - 0012, St Louis, Missouri, 63110, United States|Local Institution - 0002, Hackensack, New Jersey, 07601, United States|Local Institution - 0001, Philadelphia, Pennsylvania, 19111, United States|Local Institution - 0004, Nashville, Tennessee, 37203, United States|Local Institution - 0014, Edmonton, Alberta, T6G 1Z2, Canada|Local Institution - 0006, Hamilton, Ontario, L8V 5C2, Canada|Local Institution - 0003, Toronto, Ontario, M5G 2M9, Canada|Local Institution - 0007, Madrid, 28040, Spain|Local Institution - 0008, Madrid, 28050, Spain|Local Institution - 0009, Chur, 7000, Switzerland|Local Institution - 0010, Lausanne, 1011, Switzerland|Local Institution - 0011, Zurich, 8091, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Malignant Neoplasms of Female Genital Organs|Gynecologic Cancer,DRUG: Bupivacaine|DRUG: Liposomal Bupivacaine|DRUG: Oxycodone|BEHAVIORAL: Pill Diary|BEHAVIORAL: Symptom Questionnaire,FEMALE,"ADULT, OLDER_ADULT",PHASE3,105,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,8/31/16,7/23/20,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Lymphoma|Non-Hodgkin Lymphoma|NHL|Hematologic Malignancies|Lymphoid Malignancies,"DEVICE: Vysis LSI MYC Break Apart Rearrangement Probe Kit|DRUG: Venetoclax|DRUG: VIP152|DRUG: Prednisone|DIAGNOSTIC_TEST: PET|DIAGNOSTIC_TEST: EKG|DIAGNOSTIC_TEST: ECHO|DIAGNOSTIC_TEST: CT neck chest, abdomen, and pelvis|DIAGNOSTIC_TEST: MRI|PROCEDURE: Bone marrow aspiration/Biopsy",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,8,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,4/5/23,1/31/26,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Lymphoma|Lymphoid Malignancies,DRUG: ACY-1215,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,23,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,4/2/14,5/5/19,"Moffit Cancer Center, Tampa, Florida, 33612, United States|Columbia University Medical Center, New York, New York, 10019, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Non-hematologic Malignancy,DRUG: Sapanisertib|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,61,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/26/15,5/31/18,"Scottsdale, Arizona, United States|Sarasota, Florida, United States|Oklahoma City, Oklahoma, United States|Germantown, Tennessee, United States|Nashville, Tennessee, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumours|Neuroendocrine Tumour of the Lung|Small Intestinal NET,DRUG: Surufatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,78,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/13/21,10/15/24,"University of Alabama, Birmingham (UAB), Birmingham, Alabama, 35233, United States|University of California Irvine Medical Center UCIMC - H.H. Chao Comprehensive Digestive Disease Center CDDC, Orange, California, 92868, United States|Emory University, Winship Cancer Institute, Atlanta, Georgia, 30322-1013, United States|Stony Brook Cancer Center, Stony Brook, New York, 11794, United States|Houston Methodist, Houston, Texas, 77030, United States|CHU Bordeaux, Pessac, 33604, France|Institut Gustave Roussy, Villejuif, 94800, France|Charite Universitatsmedizin Berlin, Berlin, 13353, Germany|Universitaetsklinikum Erlangen, Erlangen, 91054, Germany|Universitatsklinikum Essen, Klinik fur Endokrinologie, Essen, 45147, Germany|Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Bari, 70124, Italy|ASST-Spedali Civili di Brescia, Brescia, 25123, Italy|Universita degli Studi di Firenze - Azienda Ospedaliero Universitaria Careggi (AOUC), Florence, 50134, Italy|Istituto Europeo di Oncologia, Milan, 20141, Italy|Haukeland University Hospital, Bergen, 5021, Norway|Oslo University Hospital Rikshospitalet, Oslo, 0372, Norway|Institut Catala d'Oncologis (ICO) - Hospital Duran i Reynals, Barcelona, 8013, Spain|Hospital Vall Hebron, Barcelona, 8035, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario Virgen del Rocio, Seville, 41013, Spain|Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom|Christie Hospital, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematological Malignancies|Thrombocytopenia,DRUG: EACA|OTHER: Platelet transfusion,ALL,"ADULT, OLDER_ADULT",PHASE2,29,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/23/14,5/14/21,"Emory University Hospital, Atlanta, Georgia, 30322, United States|Atlanta VA Medical Center, Decatur, Georgia, 30033, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,B-cell Malignancies,DRUG: Zanubrutinib|DRUG: Fluconazole|DRUG: Diltiazem|DRUG: Voriconazole|DRUG: Clarithromycin,ALL,"ADULT, OLDER_ADULT",PHASE1,26,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/15/20,2/21/22,"Concord Repatriation General Hospital, Concord, New South Wales, 2139, Australia|John Flynn Private Hospital, Tugun, Queensland, 4224, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Flinders Medical Centre, Bedford PK, South Australia, 5042, Australia|Monash Health, Clayton, Victoria, 3168, Australia|Peninsula Private Hospital, Frankston, Victoria, 3199, Australia|Linear Clinical Research, Nedlands, Western Australia, 6009, Australia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,B-cell Malignancies,DRUG: Tirabrutinib|DRUG: Idelalisib|DRUG: Entospletinib|DRUG: Obinutuzumab,ALL,"ADULT, OLDER_ADULT",PHASE1,203,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/16/15,9/25/24,"Georgetown University Medical Center, Washington D.C., District of Columbia, 20007, United States|Indiana University Health Goshen Center for Cancer Care, Goshen, Indiana, 46506, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|CHRU de Lille, Hopital Claude Huriez, Lille, 59037, France|Hopital Saint Eloi, Montpellier, 34295, France|Chu Haut Leveque, Pessac, 33604, France|Centre Hospitalier de Lyon Sud, Pierre-Bénite, 69310, France|Institut Universitaire du Cancer-Oncopole I.U.C.T-O, Toulouse, 3110, France|Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB20QQ, United Kingdom|Cardiff and Vale Health Board, Clinical Research Facility, Cardiff, CF14 4XW, United Kingdom|Leeds Teaching Hosptials NHS Trust, Dept of Haematology, Leeds, LS9 7TF, United Kingdom|University Hospitals of Leicester NHS Trust, Leicester, LE1 5WW, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|Plymouth Hospitals NHS Trust, Plymouth, PL68DH, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Cancers|Pain,DRUG: Fentanyl Nasal Spray|DRUG: Hydromorphone Hydrochloride|BEHAVIORAL: Phone Call,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,84,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,9/14/15,6/21/20,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Glioblastoma Multiforme|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|DIPG|High-grade Astrocytoma NOS|CNS Primary Tumor, NOS (Malignant Glioma)",DRUG: INCB7839,ALL,"CHILD, ADULT",PHASE1,13,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/27/20,12/1/24,"Children's Hospital Los Angeles, Los Angeles, California, 90026, United States|Stanford University and Lucile Packard Children's Hospital, Palo Alto, California, 94304, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, 60614, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02245, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Cincinnati Children Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15224, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Texas Children's Hospital, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Oncology|Acute Myeloid Leukemia,DRUG: Open Label LAM-003,ALL,"ADULT, OLDER_ADULT",PHASE1,17,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/16/18,10/5/20,"Yale University, New Haven, Connecticut, 06511, United States|University of Maryland, Baltimore, Maryland, 21201, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Hackensack Meridien Health, Hackensack, New Jersey, 07601, United States|Weill Cornell Medical College, New York, New York, 10021, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,HPV-Related Malignancy,DRUG: Gardasil9,FEMALE,"CHILD, ADULT",PHASE4,195,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH,4/29/19,12/30/20,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Tumors|Solid Malignant Tumors|Osteosarcoma|Differentiated Thyroid Cancer (DTC),DRUG: Lenvatinib|DRUG: Lenvatinib|DRUG: Lenvatinib|DRUG: Lenvatinib|DRUG: Lenvatinib|DRUG: Ifosfamide|DRUG: Etoposide|DRUG: Ifosfamide|DRUG: Etoposide,ALL,"CHILD, ADULT",PHASE1|PHASE2,117,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/29/14,7/20/22,"Texas Children's Hospital, Houston, Texas, 77030, United States|CHU Strasbourg - Hopital Hautepierre, Strasbourg, Bas Rhin, France|Centre Oscar Lambret Lille, Lille, Rhone, France|Centre Leon Berard, Lyon, Rhone, France|CHU Nantes - Hopital Mere-Enfant, Nantes, France|Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris, Paris, France|Institut Gustave Roussy, Paris, France|CHU de Toulouse - Hopital des Enfants, Toulouse, France|Universitaetsklinikum Muenster, Münster, Germany|Kinderklinik des Olga hospitals, Stuttgart, Germany|Istituto Ortopedico Rizzoli, Bologna, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy|Ospedale Pediatrico Bambino Gesu, Roma, Italy|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Infantil Universitario Nino Jesus, Madrid, Spain|Hospital Universitario y Politecnico La Fe Hospital La Fe Valencia, Valencia, Spain|Birmingham Children's Hospital, Birmingham, United Kingdom|University College London Hospital, London, United Kingdom|Royal Victoria Infirmary, Newcastle, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor Malignancy,DRUG: CRLX301,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,42,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2015-04,10/4/17,"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|MD Anderson, Houston, Texas, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematologic Malignancies|Solid Tumor,DRUG: PF-0791800 (TTI-621)|DRUG: PF-07901800 (TTI-621) plus Rituximab|DRUG: PF-07901800 (TTI-621) plus Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1,249,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/28/16,11/23/22,"City of Hope National Medical Center, Duarte, California, 91010, United States|City of Hope, Duarte, California, 91010, United States|Freidenrich Center for Translational Research (CTRU), Palo Alto, California, 94304, United States|Stanford Cancer Institute, Palo Alto, California, 94304, United States|Colorado Blood Cancer Institute, Denver, Colorado, 80218, United States|Presbyterian/St.Luke's Medical Center, Denver, Colorado, 80218, United States|Mayo Clinic Jacksonville, Jacksonville, Florida, 32224, United States|Mayo Clinic, Jacksonville, Florida, 32224, United States|Moffitt Cancer Center Richard M Schulze Family Foundation Outpatient Center at McKinley Campus, Tampa, Florida, 33612, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Covance Biorepository, Greenfield, Indiana, 46140, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Hackensack Meridian Health John Theurer Cancer Center, Hackensack, New Jersey, 07601, United States|Hackensack UMC, Hackensack, New Jersey, 07601, United States|The John Theurer Cancer Center at Hackensack UMC, Hackensack, New Jersey, 07601, United States|Memorial Sloan Kettering Cancer Center- Monmouth, Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Cancer Center Westchester, Harrison, New York, 10604, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, 10016, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, 10016, United States|NYU Investigational Pharmacy, New York, New York, 10016, United States|NYU Langone Health (Tisch Hospital), New York, New York, 10016, United States|Memorial Sloan Kettering Cancer Center-Clinical Trails Office, New York, New York, 10017, United States|Columbia Univeristy, New York, New York, 10019, United States|Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care, New York, New York, 10021, United States|Memorial Sloan Kettering Cancer Center Rockefeller Outpatient Pavillion, New York, New York, 10022, United States|Columbia University Medical Center., New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Oregon Health & Science University-Research Pharmacy Services, Portland, Oregon, 97239, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Oregon Health and Sciences University, Portland, Oregon, 97239, United States|University of Pittsburgh Medical Center Presbyterian Shadyside, Pittsburgh, Pennsylvania, 15213, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15237, United States|Centennial Medical Center, Nashville, Tennessee, 37203, United States|Sarah Cannon Research Institute (Pharmacy), Nashville, Tennessee, 37203, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|Myriad RMB Inc, Austin, Texas, 78759, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Texas MD Anderson Cancer Center, Cancer Prevention Center, Houston, Texas, 77030, United States|University of Texas MD Anderson Cancer Center, Melanoma and Skin Clinic, Houston, Texas, 77030, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Washington - Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States|Fairmont Medical Building, Suite 810, Vancouver, B.C., V5Z1H7, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 1H6, Canada|Princess Margaret Cancer Center, Toronto, Ontario, M5G 2M9, Canada|University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Malignancies,DRUG: MLN0128,ALL,"ADULT, OLDER_ADULT",PHASE1,198,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/4/10,2/7/19,"Scottsdale, Arizona, United States|Los Angeles, California, United States|Miami, Florida, United States|Sarasota, Florida, United States|Indianapolis, Indiana, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Buffalo, New York, United States|New York, New York, United States|Cleveland, Ohio, United States|Oklahoma City, Oklahoma, United States|Philadelphia, Pennsylvania, United States|Nashville, Tennessee, United States|Barcelona, Spain|Valencia, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Medullary Thyroid Carcinoma|Multiple Endocrine Neoplasia Type 2A|Multiple Endocrine Neoplasia Type 2B,DRUG: Vandetanib,ALL,"CHILD, ADULT",PHASE1|PHASE2,17,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/20/07,11/1/20,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Oncology Patients Receiving Chemotherapy,DRUG: Cetirizine HCl 10 mg/mL|DRUG: Diphenhydramine 50 mg/mL|DRUG: anti-CD20 such as Rituximab or Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE2,34,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",3/25/20,12/23/20,"St.Joseph Heritage Care, Napa, California, 94558, United States|Eisenhower Medical Center, Rancho Mirage, California, 92270, United States|St. Joseph Heritage Healthcare, Santa Rosa, California, 95403, United States|Oncology Consultants, Houston, Texas, 77030, United States|Baylor, Scott, & White Medical Center, Round Rock, Texas, 78665, United States|Baylor, Scott, & White Medical Center, Temple, Texas, 76508, United States|Baylor, Scott, & White Medical Center, Waco, Texas, 76712, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Cancers|Lymphoma,DRUG: Azacitidine|DRUG: Vorinostat|DRUG: Gemcitabine|DRUG: Busulfan|DRUG: Melphalan|DRUG: Dexamethasone|OTHER: Caphosol|DRUG: Glutamine|DRUG: Pyridoxine|DRUG: Rituximab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,61,INTERVENTIONAL,Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/7/13,11/22/17,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,B-cell Malignancies,DRUG: Zanubrutinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,385,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/4/14,3/31/21,"Banner MD Anderson Cancer Centre, Gilbert, Arizona, 85234, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Mayo Clinic, Rochester, Minnesota, 55901, United States|M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|Concord Repatriation General Hospital, Concord, New South Wales, Australia|St George Hospital, Sydney, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Royal Hobart Hospital, Hobart, Tasmania, Australia|Monash Health, Clayton, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|St Vincent's Hospital, Melbourne, Victoria, Australia|Peter MacCallum Cancer Centre, East Melbourne, Parkville, Victoria, 3050, Australia|Melbourne Health, Parkville, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Policlinico S.Orsola Malpighi, AOU di Bologna, Bologna, Italy|Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, Milan, Italy|North Shore Hospital, Auckland, New Zealand|Dong-A University Medical Centre, Busan, South Korea|Inje University Busan Paik Hospital, Busan, South Korea|National Cancer Center, Goyang-si, South Korea|Samsung Medical Center, Seoul, South Korea|Derriford Hospital, Plymouth, Devon, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Malignancies,BIOLOGICAL: MEDI4736 (Durvalumab)|BIOLOGICAL: MEDI4736 (Durvalumab) + Tremelimumab,ALL,"ADULT, OLDER_ADULT",PHASE3,867,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/5/17,12/16/22,"Research Site, Santa Rosa, California, 95403, United States|Research Site, Washington D.C., District of Columbia, 20007, United States|Research Site, Tinley Park, Illinois, 60487, United States|Research Site, Omaha, Nebraska, 68130, United States|Research Site, Hackensack, New Jersey, 07601, United States|Research Site, East Setauket, New York, 11733, United States|Research Site, Greenville, South Carolina, 29607, United States|Research Site, Knoxville, Tennessee, 37920, United States|Research Site, Blacksburg, Virginia, 24060, United States|Research Site, Spokane, Washington, 99208, United States|Research Site, Moncton, New Brunswick, E1C 6Z8, Canada|Research Site, Brampton, Ontario, L6R 3J7, Canada|Research Site, Hamilton, Ontario, L8V 5C2, Canada|Research Site, Kingston, Ontario, K7L 5P9, Canada|Research Site, London, Ontario, N6A 4L6, Canada|Research Site, Newmarket, Ontario, L3Y 2P9, Canada|Research Site, Toronto, Ontario, M4N 3M5, Canada|Research Site, Toronto, Ontario, M5G 2M9, Canada|Research Site, Greenfield Park, Quebec, J4V 2H1, Canada|Research Site, Québec, Quebec, G1R 2J6, Canada|Research Site, Besançon, 25030, France|Research Site, Bordeaux, 33075, France|Research Site, Bordeaux, 33076, France|Research Site, Brest, 29609, France|Research Site, Dijon, 21034, France|Research Site, Lille, 59000, France|Research Site, Lyon, 69373, France|Research Site, Marseille, 13005, France|Research Site, Montpellier, 34298, France|Research Site, Nice, 6189, France|Research Site, Nîmes, 30029, France|Research Site, Paris, 75010, France|Research Site, Pierre-Bénite, 69495, France|Research Site, Poitiers, 86021, France|Research Site, Rouen, 76031, France|Research Site, Saint-Herblain, 44805, France|Research Site, Strasbourg, 67065, France|Research Site, Toulouse, 31059, France|Research Site, Tours, 37044, France|Research Site, Villejuif, 94805, France|Research Site, Berlin, 13585, Germany|Research Site, Bielefeld, 33611, Germany|Research Site, Dresden, 01307, Germany|Research Site, Duisburg, 47179, Germany|Research Site, Erlangen, 91054, Germany|Research Site, Essen, 45136, Germany|Research Site, Gütersloh, 33332, Germany|Research Site, Hamburg, 20246, Germany|Research Site, Jena, 07747, Germany|Research Site, Kiel, 24116, Germany|Research Site, Münster, 48149, Germany|Research Site, Stuttgart, 70174, Germany|Research Site, Würzburg, 97080, Germany|Research Site, Ancona, 60126, Italy|Research Site, Arezzo, 52100, Italy|Research Site, Avellino, 83100, Italy|Research Site, Bari, 70124, Italy|Research Site, Catania, 95126, Italy|Research Site, Lecce, 73100, Italy|Research Site, Meldola, 47014, Italy|Research Site, Milan, 20141, Italy|Research Site, Modena, 41124, Italy|Research Site, Padua, 35128, Italy|Research Site, Pisa, 56126, Italy|Research Site, Ravenna, 48100, Italy|Research Site, Roma, 00128, Italy|Research Site, Roma, 00152, Italy|Research Site, Rozzano, 20089, Italy|Research Site, Udine, 33100, Italy|Research Site, Leiden, 2333 ZA, Netherlands|Research Site, Busan, 49241, South Korea|Research Site, Goyang-si, 10408, South Korea|Research Site, Seoul, 03722, South Korea|Research Site, Seoul, 05505, South Korea|Research Site, London, EC1A 7BE, United Kingdom|Research Site, London, W1G 6AD, United Kingdom|Research Site, London, W6 8RF, United Kingdom|Research Site, Newcastle, NE7 7DN, United Kingdom|Research Site, Sheffield, S10 2SJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cervical Intraepithelial Neoplasia Grade 2/3|Cervical Squamous Cell Carcinoma In Situ|Cervical Squamous Intraepithelial Neoplasia 2|High Grade Cervical Intraepithelial Neoplasia,DRUG: Imiquimod|DRUG: Topical Fluorouracil,FEMALE,ADULT,EARLY_PHASE1,13,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/15/19,8/2/24,"UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,B-Cell Malignancies,DRUG: Parsaclisib|DRUG: Itacitinib|DRUG: Rituximab|DRUG: Ifosfamide|DRUG: Carboplatin|DRUG: Etoposide,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,88,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/22/16,4/12/21,"University of Alabama At Birmingham Comprehensive Cancer Center, Birmingham, Alabama, 35205, United States|University of Michigan Cancer Center, Ann Arbor, Michigan, 48109, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Nyu Langone Laura and Isaac Perlmutter Cancer Center, New York, New York, 10016, United States|University Hospitals Case Medical Center, Cleveland, Ohio, 44106, United States|Greenville Health System Cancer Institute, Greenville, South Carolina, 29605, United States|Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Malignancies|Metastatic Cancer,DRUG: INCAGN01876|DRUG: Epacadostat|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,10,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/21/17,7/1/20,"The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Malignancy|Solid Tumor,DRUG: Everolimus,ALL,"ADULT, OLDER_ADULT",PHASE2,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/7/15,8/15/17,"Washington University School of Medicine, St Louis, Missouri, 63110, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor|Hematologic Malignancies,DRUG: BGJ398,ALL,"ADULT, OLDER_ADULT",PHASE2,84,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/24/14,4/30/18,"Alabama Oncology St. Vincent's Birmingham, Birmingham, Alabama, 35211, United States|North County Oncology Medical Clinic Inc, Oceanside, California, 92056, United States|San Francisco General Hospital San Francisco Gen Hosp (7), San Francisco, California, 94110, United States|Rocky Mountain Cancer Centers Rocky Mountain Cancer Ctr (50), Greenwood Village, Colorado, 80304, United States|Norwalk Hospital, Norwalk, Connecticut, 06856, United States|Florida Cancer Specialists Florida Cancer Specialists 36, Fort Myers, Florida, 33901, United States|University of Miami Sylvester Comprehensive Cancer, Miami, Florida, 33136, United States|NorthWest Georgia Oncology Centers NW Georgia Oncology, Marietta, Georgia, 30060, United States|Harbin Clinic Medical Oncology Clin. Res., Rome, Georgia, 30165, United States|Illinois Cancer Specialists, Arlington Heights, Illinois, 60005, United States|Lurie Children's Hospital of Chicago Developmental Therapeutics, Chicago, Illinois, 60611, United States|Community Clinical Research Center, Anderson, Indiana, 46011, United States|Indiana University Indiana Univ. - Purdue Univ., Indianapolis, Indiana, 46202, United States|Northern Indiana Cancer Research Consortium No. Indiana Cancer Res., South Bend, Indiana, 46617, United States|University of Louisville / James Graham Brown Cancer Center SC, Louisville, Kentucky, 40202, United States|St. Agnes Hospital St. Agnes Hospital (2), Baltimore, Maryland, 21229, United States|Southcoast Centers for Cancer Care, Fairhaven, Massachusetts, 02719, United States|Cancer and Hematology Centers of West Michigan Dept. of Oncology, Grand Rapids, Michigan, 49546, United States|Minnesota Oncology Hematology, P.A. Minnesota Oncology Hem (27), Minneapolis, Minnesota, 55404, United States|Research Medical Center Research Med Center (2), Kansas City, Missouri, 64132, United States|Billings Clinic Billings Clinic (8), Billings, Montana, 59101, United States|Dartmouth Hitchcock Medical Center Dartmouth Hitchcock - Lebanon, Bedford, New Hampshire, 03110, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|New Mexico Cancer Center, Albuquerque, New Mexico, 87109, United States|Waverly Hematology Oncology, Cary, North Carolina, 27518, United States|University of N C at Chapel Hill Physician Office Building, Chapel Hill, North Carolina, 27599-7600, United States|Duke University Medical Center Seeley G. Mudd Bldg., Durham, North Carolina, 27710, United States|Wake Forest Baptist Health Hem & Onc Medical Center, Winston-Salem, North Carolina, 27157, United States|Sanford Hematology Oncology, Fargo, North Dakota, 58122, United States|Oncology Hematology Care Inc Oncology Hematology Care 2, Cincinnati, Ohio, 45242, United States|University Hospitals of Cleveland Seidman Cancer Center University Hospitals, Cleveland, Ohio, 44106, United States|Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland, Ohio, 44195, United States|Bend Memorial Clinic Bend Mem. Clinic, Bend, Oregon, 97701, United States|Northwest Cancer Specialists Northwest Cancer, Portland, Oregon, 97210, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, 18103, United States|Cancer Treatment Centers of America Eastern Regional Medical Center, Philadelphia, Pennsylvania, 19124, United States|University of Pittsburgh Cancer Institute Hillman Cancer Center (2), Pittsburgh, Pennsylvania, 15232, United States|Rhode Island Hospital Rhode Island Hosp. (2), Providence, Rhode Island, 02903, United States|Sanford University of South Dakota Medical Center Sanford Health, Sioux Falls, South Dakota, 57104, United States|Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga, Tennessee, 37404, United States|Tennessee Oncology Tennessee Oncology (3), Nashville, Tennessee, 37203, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, 76104, United States|Oncology Consultants Oncology Group, Houston, Texas, 77024, United States|Houston Methodist Cancer Center, Houston, Texas, 77030, United States|MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston, Texas, 77030, United States|Texas Oncology, McAllen, Texas, 78503, United States|Cancer Therapy & Research Center UT Health Science Center Oncology Dept., San Antonio, Texas, 78229, United States|Texas Oncology Cancer Care & Research Center Texas Oncology, Waco, Texas, 76712, United States|Deke Slayton Cancer Center Deke Slayton Cancer Center (2), Webster, Texas, 77598, United States|Intermountain Medical Center Intermountain Healthcare, Murray, Utah, 84157, United States|Northern Utah Cancer Associates Northern Utah Assoc (3), Ogden, Utah, 84403, United States|University of Utah / Huntsman Cancer Institute SC-2, Salt Lake City, Utah, 84103, United States|Utah Cancer Specialists Utah Cancer Specialists (11), Salt Lake City, Utah, 84106, United States|Virginia Cancer Specialists Fairfax Northern Virginia, Fairfax, Virginia, 22031, United States|Shenandoah Oncology Shenandoah Oncology (5), Winchester, Virginia, 22601, United States|Northwest Medical Specialties NW Medical Specialties, Tacoma, Washington, 98405, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Cancers|Solid Tumors,DRUG: Panax Ginseng|DIETARY_SUPPLEMENT: Placebo|BEHAVIORAL: Questionnaires,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,165,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",10/14/11,10/31/25,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignancies|Metastatic Cancer,DRUG: INCAGN01876|DRUG: Nivolumab|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,145,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/25/17,11/9/21,"The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|University of Florida, Gainesville, Florida, 32610, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Washington University - Siteman Cancer Center, St Louis, Missouri, 37201, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Memorial Sloan Kettering Cancer, New York, New York, 10065, United States|The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|University of Oklahoma, Sarah Cannon Research Institute, Oklahoma City, Oklahoma, 73104, United States|Providance Portland Medical Center, Portland, Oregon, 97213, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|University of Pittsburgh, UPMC Cancer Pavilion, Pittsburgh, Pennsylvania, 15232, United States|Tennessee Oncology, Sarah Cannon Research Institute, Nashville, Tennessee, 37201, United States|BUMC Mary Crowley Cancer Research Centers, Dallas, Texas, 75230, United States|MD Anderson, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Blacktown Cancer and Haematology Centre, Blacktown, New South Wales, 2148, Australia|Scientia Clinical Research, Randwick, New South Wales, 2148, Australia|Greenslopes Private Hospital, Brisbane, Queensland, 4120, Australia|Austin Hospital, Heidelberg, Victoria, 3084, Australia|Linear Clinical Research, Perth, Western Australia, 6009, Australia|CHA Centre Hospitalier de l'Ardenne, Libramont, Chevigny, 6800, Belgium|Saint Augustinus Hospital, Antwerp, 2610, Belgium|Institut Jules Bordet, Brussels, 1000, Belgium|CHU Brugmann, Brussels, 1020, Belgium|Cliniques Universitaires Saint-Luc, Brussels, 1200, Belgium|Mi Kryviy Rih Center of Dnipropetrovsk Regional Council, Charleroi, 6000, Belgium|Ghent University Hospital, Ghent, 37201, Belgium|AZ Groeninge, Kortrijk, 8500, Belgium|Hospital Clinic I Provincial, Barcelona, 08036, Spain|Hospital Clinico y Provincial de Barcelona, Barcelona, 08036, Spain|Institut Catala D'Oncologia-Badalona, Barcelona, 08916, Spain|Hospital Vall de Hebron, Barcelona, Spain|Hospital Reina Sophia, Córdoba, 14004, Spain|University Hospital Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario Doce de Octubre, Madrid, 28041, Spain|Hospital HM Sanchinarro, Madrid, 28050, Spain|Clinica Universidad De Navarra (CUN), Pamplona, 31008, Spain|Hospital Universitario Virgen Del Rocio, Seville, 41015, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cognitive Impairment|Malignant Neoplasm,DRUG: Ibuprofen|OTHER: Placebo|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,87,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",5/26/17,6/1/22,"Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, 91505, United States|Beebe Medical Center, Lewes, Delaware, 19958, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, 19713, United States|Helen F Graham Cancer Center, Newark, Delaware, 19713, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, 19713, United States|Regional Hematology and Oncology PA, Newark, Delaware, 19713, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, 19718, United States|Beebe Health Campus, Rehoboth Beach, Delaware, 19971, United States|Nanticoke Memorial Hospital, Seaford, Delaware, 19973, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, 19801, United States|Saint Luke's Mountain States Tumor Institute, Boise, Idaho, 83712, United States|Saint Luke's Mountain States Tumor Institute - Fruitland, Fruitland, Idaho, 83619, United States|Saint Luke's Mountain States Tumor Institute - Meridian, Meridian, Idaho, 83642, United States|Saint Luke's Mountain States Tumor Institute - Nampa, Nampa, Idaho, 83686, United States|Saint Luke's Mountain States Tumor Institute-Twin Falls, Twin Falls, Idaho, 83301, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, 61704, United States|Illinois CancerCare-Canton, Canton, Illinois, 61520, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, 62902, United States|SIH Cancer Institute, Carterville, Illinois, 62918, United States|Illinois CancerCare-Carthage, Carthage, Illinois, 62321, United States|Centralia Oncology Clinic, Centralia, Illinois, 62801, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, 62526, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Crossroads Cancer Center, Effingham, Illinois, 62401, United States|Illinois CancerCare-Eureka, Eureka, Illinois, 61530, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, 61401, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, 61401, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, 61443, United States|Illinois CancerCare-Macomb, Macomb, Illinois, 61455, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, 61350, United States|Illinois CancerCare-Pekin, Pekin, Illinois, 61554, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, 61554, United States|Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, 61615, United States|Methodist Medical Center of Illinois, Peoria, Illinois, 61636, United States|OSF Saint Francis Medical Center, Peoria, Illinois, 61637, United States|Illinois CancerCare-Peru, Peru, Illinois, 61354, United States|Valley Radiation Oncology, Peru, Illinois, 61354, United States|Illinois CancerCare-Princeton, Princeton, Illinois, 61356, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Springfield Clinic, Springfield, Illinois, 62702, United States|Memorial Medical Center, Springfield, Illinois, 62781, United States|Cancer Care Specialists of Illinois-Swansea, Swansea, Illinois, 62226, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, 62226, United States|Bronson Battle Creek, Battle Creek, Michigan, 49017, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, 49503, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, 49503, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Borgess Medical Center, Kalamazoo, Michigan, 49048, United States|Mercy Health Mercy Campus, Muskegon, Michigan, 49444, United States|Lakeland Hospital Niles, Niles, Michigan, 49120, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, 49677, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, 49085, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, 49085, United States|Munson Medical Center, Traverse City, Michigan, 49684, United States|Metro Health Hospital, Wyoming, Michigan, 49519, United States|Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Fairview-Southdale Hospital, Edina, Minnesota, 55435, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Fairview Maple Grove Medical Center, Maple Grove, Minnesota, 55369, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, 55109, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, 55109, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States|Health Partners Inc, Minneapolis, Minnesota, 55454, United States|Monticello Cancer Center, Monticello, Minnesota, 55362, United States|New Ulm Medical Center, New Ulm, Minnesota, 56073, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, 55422, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|United Hospital, Saint Paul, Minnesota, 55102, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States|Lakeview Hospital, Stillwater, Minnesota, 55082, United States|Ridgeview Medical Center, Waconia, Minnesota, 55387, United States|Rice Memorial Hospital, Willmar, Minnesota, 56201, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, 55125, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, 55092, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, 63628, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|Southeast Cancer Center, Cape Girardeau, Missouri, 63703, United States|Capital Region Southwest Campus, Jefferson City, Missouri, 65109, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, 63670, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, 63080, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, 63127, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, 89703, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, 89052, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, 89052, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, 89052, United States|21st Century Oncology-Henderson, Henderson, Nevada, 89074, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, 89074, United States|Desert West Surgery, Las Vegas, Nevada, 89102, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, 89103, United States|Cancer and Blood Specialists-Shadow, Las Vegas, Nevada, 89106, United States|OptumCare Cancer Care at Oakey, Las Vegas, Nevada, 89106, United States|21st Century Oncology, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, 89113, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, 89119, United States|Cancer Therapy and Integrative Medicine, Las Vegas, Nevada, 89121, United States|21st Century Oncology-Vegas Tenaya, Las Vegas, Nevada, 89128, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, 89128, United States|Cancer and Blood Specialists-Tenaya, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, 89128, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, 89128, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, 89144, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, 89144, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, 89148-2405, United States|21st Century Oncology-Fort Apache, Las Vegas, Nevada, 89148, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, 89148, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, 89149, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, 89169, United States|University Cancer Center, Las Vegas, Nevada, 89169, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, 89048, United States|Renown Regional Medical Center, Reno, Nevada, 89502, United States|Saint Mary's Regional Medical Center, Reno, Nevada, 89503, United States|Radiation Oncology Associates, Reno, Nevada, 89509, United States|Cancer Care of Western North Carolina, Asheville, North Carolina, 28801, United States|Mission Hospital Inc-Memorial Campus, Asheville, North Carolina, 28801, United States|Hope Women's Cancer Centers-Asheville, Asheville, North Carolina, 28816, United States|Marietta Memorial Hospital, Columbus, Ohio, 43215, United States|Saint Charles Health System, Bend, Oregon, 97701, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, 97015, United States|Providence Oncology and Hematology Care Southeast, Clackamas, Oregon, 97015, United States|Bay Area Hospital, Coos Bay, Oregon, 97420, United States|Providence Newberg Medical Center, Newberg, Oregon, 97132, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, 97045, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Providence Saint Vincent Medical Center, Portland, Oregon, 97225, United States|Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, 19317, United States|Greenville Health System Cancer Institute-Laurens, Clinton, South Carolina, 29325, United States|Greenville Health System Cancer Institute-Easley, Easley, South Carolina, 29640, United States|Greenville Health System Cancer Institute-Butternut, Greenville, South Carolina, 29605, United States|Greenville Health System Cancer Institute-Faris, Greenville, South Carolina, 29605, United States|Greenville Memorial Hospital, Greenville, South Carolina, 29605, United States|Greenville Health System Cancer Institute-Eastside, Greenville, South Carolina, 29615, United States|Greenville Health System Cancer Institute-Greer, Greer, South Carolina, 29650, United States|Greenville Health System Cancer Institute-Seneca, Seneca, South Carolina, 29672, United States|Greenville Health System Cancer Institute-Spartanburg, Spartanburg, South Carolina, 29307, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, 98520, United States|Cancer Care Center at Island Hospital, Anacortes, Washington, 98221, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, 98225, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, 98531, United States|Swedish Medical Center-Edmonds, Edmonds, Washington, 98026, United States|Providence Regional Cancer Partnership, Everett, Washington, 98201, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, 98029, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, 99336, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, 98503, United States|PeaceHealth Saint John Medical Center, Longview, Washington, 98632, United States|Pacific Gynecology Specialists, Seattle, Washington, 98104, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, 98107, United States|Kaiser Permanente Washington, Seattle, Washington, 98112, United States|Swedish Medical Center-First Hill, Seattle, Washington, 98122-4307, United States|Swedish Medical Center-Cherry Hill, Seattle, Washington, 98122-5711, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, 98584, United States|Rockwood Cancer Treatment Center-DHEC-Downtown, Spokane, Washington, 99204, United States|Rockwood North Cancer Treatment Center, Spokane, Washington, 99218, United States|Rockwood Clinic Cancer Treatment Center-Valley, Spokane Valley, Washington, 99216, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, 98664, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, 99362, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, 98597, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, 54017, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm|Nausea|Vomiting,DRUG: Netupitant|DRUG: Palonosetron|DRUG: Palonosetron Hydrochloride|OTHER: Placebo|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,53,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",5/3/17,2/14/22,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignancies|Metastatic Cancer,DRUG: INCAGN01876,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,100,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/20/16,12/16/19,"The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|Yale University, New Haven, Connecticut, 06511, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering at Monmouth, Middletown, New Jersey, 07748, United States|MSK Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignancies|Metastatic Cancer,DRUG: INCAGN01949,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,87,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/31/16,3/26/19,"Rutgers, The State University of New Jersey, New Brunswick, New Jersey, 08901, United States|New York University Clinical Cancer Center, New York, New York, 10016, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Vall d'Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain|University Hospital of Laussane (CHUV), Lausanne, 1011, Switzerland|University College Hospital, London, NW1 2PG, United Kingdom|University of Oxford, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasm|Skull Base Neoplasm,DRUG: 5-Aminolevulinic acid Hydrochloride,ALL,"ADULT, OLDER_ADULT",PHASE2,7,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,9/14/21,12/25/22,"Mount Sinai Union Square, New York, New York, 10003, United States|New York Eye and Ear Infirmary of Mount Sinai, New York, New York, 10003, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Malignant Neoplasm|Fatigue,DRUG: Ethyl Icosapentate|BEHAVIORAL: Exercise Intervention|BEHAVIORAL: Exercise Intervention|OTHER: Laboratory Biomarker Analysis|OTHER: Placebo|BEHAVIORAL: Quality-of-Life Assessment|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,2,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",3/16/17,11/24/20,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Tumors,DRUG: surufatinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,130,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2015-11,6/2/23,"City of Hope Comprehensive Cancer Center, Los Angeles, California, 91010, United States|Rocky Mountain Cancer Center, Denver, Colorado, 80218, United States|SCRI at HealthONE, Denver, Colorado, 80218, United States|Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Mount Sinai Hospital, New York, New York, 10029, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10072, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|Mary Crowley Cancer Research Center, Dallas, Texas, 75230, United States|Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hepatocellular Carcinoma|Malignant Neoplasm,COMBINATION_PRODUCT: TACE plus autologous Tcm immunotherapy|PROCEDURE: TACE,ALL,"ADULT, OLDER_ADULT",PHASE2,52,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/9/17,10/31/19,"Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, 100021, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignancies|Advanced Cancer,DRUG: ASP7517|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,24,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/11/21,6/21/24,"Emory University, Atlanta, Georgia, 30322, United States|University of Chicago, Chicago, Illinois, 60603, United States|University of Iowa Hospitals, Iowa City, Iowa, 52242, United States|UPCI Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors and Hematologic Malignancy,DRUG: INCB054329 Monotherapy,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,69,INTERVENTIONAL,Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,4/14/15,1/31/18,"Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States|University of California, San Francisco, Medical Center at Mount Zion, San Francisco, California, 94115, United States|Sarah Cannon Research Institute Research Center, Denver, Colorado, 80218, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|The University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Horizon Oncology Center, Lafayette, Indiana, 47905, United States|John Hopkins, Baltimore, Maryland, 21287-0013, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Washington University School of Medicine in St. Louis, St Louis, Missouri, 63110, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232-0021, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Tumors,DRUG: E7046,ALL,"ADULT, OLDER_ADULT",PHASE1,31,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/30/15,2/27/18,"Boston, Massachusetts, United States|Houston, Texas, United States|Villejuif, Cedex, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Malignant Neoplasms of Mesothelial and Soft Tissue|Gastrointestinal Stromal Tumor With Neurogenic Differentiation,DRUG: Ferric Carboxymaltose|DIETARY_SUPPLEMENT: Iron Supplements|BEHAVIORAL: Questionnaire,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,12/18/17,3/6/19,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced/Metastatic Solid Malignancies,DRUG: IBI308,ALL,"ADULT, OLDER_ADULT",PHASE1,39,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/27/18,12/7/20,"UC Irvine Medical Center, Orange, California, 92868, United States|Northside Hospital, Inc, Atlanta, Georgia, 30342, United States|Henry Ford Medical Center, Detroit, Michigan, 48202, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Mary Crowley Cancer Research, Dallas, Texas, 75230, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours",DRUG: lanreotide|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2|PHASE3,53,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-01,2020-01,"Clinique Universitaire saint-Luc, Brussels, Belgium|CHU d'Angers - Hôtel Dieu, Angers, France|CHU - Hôpital Avicenne, Bobigny, France|CHU Côte de Nacre, Caen, France|CHU Estaing, Clermont-Ferrand, France|Hôpital Beaujon, Clichy, France|CHU Le Bocage Service d'HGE, Dijon, 21079, France|CH Les Oudairies, La Roche-sur-Yon, France|Hôpital Edouard Herriot, Lyon, France|CHU La Timone, Marseille, France|Hôpital de la Source, Orléans, France|CHU Cochin, Paris, France|Hôpital Haut Lévêque Bat Magellan, Service d'hépato-gastroentérologie, Pessac, France|Hôpital de la Milétrie, Poitiers, France|Hôpital Robert Debré, Reims, France|CHU de Rennes - Hôpital Pontchaillou, Rennes, France|CHU Charles Nicolle, Rouen, France|CHU de Saint Etienne, Saint-Priest-en-Jarez, France|Hôpital Rangueil, Toulouse, France|Institut Gustave Roussy, Villejuif, France|Charite Campus Virchow Kilikum, Berlin, Germany|University Hospital Marburg, Marburg, Germany|Royal Free Hospital Neuroendocrine Tumour Unit, London, United Kingdom|Manchester Academic Health Sciences Centre (MAHSC), Manchester, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,B-cell Malignancies|Cancer,DRUG: MEDI-551|DRUG: Rituximab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,136,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/16/10,3/21/19,"Research Site, Birmingham, Alabama, 35249, United States|Research Site, La Jolla, California, 92093, United States|Research Site, Washington D.C., District of Columbia, 20007, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Chicago, Illinois, 60612, United States|Research Site, Westwood, Kansas, 66205, United States|Research Site, Rochester, Minnesota, 55905, United States|Research Site, New Brunswick, New Jersey, 08903, United States|Research Site, Lake Success, New York, 11042, United States|Research Site, Hershey, Pennsylvania, 17033, United States|Research Site, Houston, Texas, 77030, United States|Research Site, Morgantown, West Virginia, 26506, United States|Research Site, Milwaukee, Wisconsin, 53226, United States|Research Site, Ghent, 9000, Belgium|Research Site, Leuven, 3000, Belgium|Research Site, Yvoir, 5530, Belgium|Research Site, Montreal, Quebec, H3T 1E2, Canada|Research Site, Cona, 44124, Italy|Research Site, Modena, 41124, Italy|Research Site, Madrid, 28033, Spain|Research Site, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Carcinoid Tumors,DRUG: Pasireotide Long Acting Release (LAR),ALL,"ADULT, OLDER_ADULT",PHASE2,29,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/1/11,3/2/23,"Stanford Cancer Institute, Stanford, California, 94305, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasm Metastasis,DRUG: DS-8201a|DRUG: Ritonavir|DRUG: Itraconazole,ALL,"ADULT, OLDER_ADULT",PHASE1,40,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/12/18,9/11/23,"Hokkaido Cancer Center, Sapporo, Hokkaido, 003-0804, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, 060-8648, Japan|Kobe University Hospital, Kobe, Hyōgo, 650-0017, Japan|Hamamatsu University Hospital, Hamamatsu, Shizuoka, 431-3125, Japan|Shizuoka Cancer Center, Nagaizumicho, Shizuoka, 411-0934, Japan|National Cancer Center Hospital, Chuo Ku, Tokyo, 104-0045, Japan|The Cancer Institute Hospital of JFCR, Koto-Ku, Tokyo, 135-8550, Japan|Seoul National University Hospital, Seoul, 03080, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|National Taiwan University Hospital, Taipei, 100, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors and Hematologic Malignancy,DRUG: INCB059872|DRUG: all-trans retinoic acid (ATRA)|DRUG: azacitidine|DRUG: nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,116,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/5/16,4/14/22,"University of Alabama, Birmingham, Alabama, 35487, United States|Moores UCSD Cancer Center, La Jolla, California, 92093, United States|UCLA Medical Center, Los Angeles, California, 90095, United States|Northwestern University, Chicago, Illinois, 60208, United States|University of Kansas Center for Research, Inc., Kansas City, Kansas, 66045, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Columbia University, New York, New York, 10027, United States|Oregon Health Science University, Portland, Oregon, 97297, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Vanderbilt University, Nashville, Tennessee, 37240, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Institut Jules Bordet, Brussels, Belgium|Netherland Cancer Institute, Amsterdam, Netherlands|VU Medical Center, Amsterdam, Netherlands|Erasmus MC, Rotterdam, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasm,DRUG: PF-05212384 (gedatolisib)|DRUG: Docetaxel|DRUG: Cisplatin|DRUG: Dacomitinib,ALL,"ADULT, OLDER_ADULT",PHASE1,110,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,9/10/13,1/8/20,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|University of Alabama at Birmingham, Birmingham, Alabama, 35249, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, 90095, United States|UCLA Hematology Oncology, Los Angeles, California, 90095, United States|Westwood Bowyer Clinic, Los Angeles, California, 90095, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94115, United States|Santa Monica UCLA Medical Center & Orthopaedic Hospital, Santa Monica, California, 90404, United States|UCLA Hematology Oncology, Santa Monica, California, 90404, United States|University of Colorado Denver CTO (CTRC), Aurora, Colorado, 80045, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Harper Professional Building, Detroit, Michigan, 48201, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Medical University of South Carolina/ University Hospital, Charleston, South Carolina, 29425, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|MUSC SCTR Research, Charleston, South Carolina, 29425, United States|MUSC Health East Cooper, Mt. Pleasant, South Carolina, 29464, United States|MUSC Specialty Care-North, North Charleston, South Carolina, 29406, United States|British Columbia Cancer Agency - Vancouver Centre, Vancouver, British Columbia, V5Z 4E6, Canada|Princess Margaret Cancer Center, Toronto, Ontario, M5G 2M9, Canada|Istituto Europeo di Oncologia - Divisione Sviluppo di Nuovi Farmaci per Terapie Innovative, Milan, MI, 20141, Italy|Istituto Regina Elena Struttura Complessa Oncologia Medica A, Roma, RM, 00144, Italy|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|University College London Hospital, NIHR UCLH Clinical Research Facility, London, W1T 7HA, United Kingdom|Oxford Cancer Centre, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Low-Grade Gliomas|Malignant Neoplasms, Brain|Soft Tissue Neoplasms",DRUG: MEK162,ALL,"CHILD, ADULT",PHASE1|PHASE2,105,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/4/16,8/1/25,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital of Colorado, Aurora, Colorado, 80045, United States|Children's National Heath Systems, Washington D.C., District of Columbia, 20010, United States|Nicklaus Children's Hospital, Miami, Florida, 33155, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Children's Hospitals and Clinics of Minnesota-Minneapolis, Minneapolis, Minnesota, 55404, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|New York University, New York, New York, 10016, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|University of Texas Southwestern Medical, Dallas, Texas, 75390, United States|Texas Children's Hospital, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98145, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,HLA-A2 Positive Cells Present|Metastatic Malignant Neoplasm|Metastatic Malignant Neoplasm in the Brain,BIOLOGICAL: Aldesleukin|BIOLOGICAL: Anti-thyroglobulin mTCR-transduced Autologous Peripheral Blood Lymphocytes|DRUG: Cyclophosphamide|BIOLOGICAL: Filgrastim|DRUG: Fludarabine Phosphate|OTHER: Laboratory Biomarker Analysis,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/20/17,8/4/20,"Albert Einstein College of Medicine, The Bronx, New York, 10461, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Cancers|Non-Hodgkin's Lymphoma,DRUG: Fulvestrant|DRUG: GDC-0032|DRUG: Letrozole|DRUG: Midazolam,ALL,"ADULT, OLDER_ADULT",PHASE1,674,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/16/11,6/25/21,"TGen Clinical Research Srvs, Scottsdale, Arizona, 85258, United States|University of Arizona Cancer Center, Tucson, Arizona, 85719, United States|University of California Irvine Medical Center, Orange, California, 92868, United States|UC Davis; Comprehensive Cancer Center, Sacramento, California, 95817, United States|Sutter Health, San Francisco, California, 94109, United States|Yale University, New Haven, Connecticut, 06510, United States|Florida Cancer Specialists - Fort Myers (New Hampshire Ct), Fort Myers, Florida, 33901-8101, United States|Sarah Cannon Res Inst; FL, Sarasota, Florida, 34232, United States|Univ of Chicago, Chicago, Illinois, 60637, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Maine, 48201-2013, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Inst., Boston, Massachusetts, 02115, United States|Washington University; Division of Oncology, St Louis, Missouri, 63110, United States|New York Oncology Hematology, P.C., Albany, New York, 12206, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Sarah Cannon Res Inst; OK, Oklahoma City, Oklahoma, 73104, United States|West Cancer Center, Germantown, Tennessee, 38138, United States|Sarah Cannon Res Inst; TN Onc, Nashville, Tennessee, 37203, United States|Vanderbilt Breast Center; Vanderbilt Health Pharmacy, Nashville, Tennessee, 37204, United States|Vanderbilt, Nashville, Tennessee, 37232, United States|Texas Cancer Center, Abilene, Texas, 79606-5208, United States|Mary Crowley Cancer Rsch Ctr, Dallas, Texas, 75230, United States|Baylor Sammons Cancer Center, Dallas, Texas, 75246, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|USO - Tyler Cancer Ctr, Tyler, Texas, 75702, United States|Northwest Cancer Specialists - Vancouver, Vancouver, Washington, 98684, United States|Yakima Valley Memorial Hospital/North Star Lodge, Yakima, Washington, 98902, United States|University Health Network; Princess Margaret Hospital; Medical Oncology Dept, Toronto, Ontario, M5G 2M9, Canada|Institut Gustave Roussy, Villejuif, 94805, France|Hospital Univ Vall d'Hebron; Servicio de Oncologia, Sant Andreu de la Barca, Barcelona, 08740, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Thoracic Sarcomas|Thorasic Cancers|Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura|Sarcoma|Melanoma,BIOLOGICAL: H1299 cell lysates|DRUG: Cyclophosphamide|DRUG: Celecoxib|BIOLOGICAL: Iscomatrix adjuvant,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,21,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/3/14,6/15/15,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm of Breast|Breast Cancer,DRUG: Genomically Directed Monotherapy|OTHER: Observation/Standard Therapy,ALL,"ADULT, OLDER_ADULT",PHASE2,193,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT,4/3/14,9/9/22,"University of Alabama Hematology Oncology Clinic at Medical West, Birmingham, Alabama, 35294, United States|Georgetown University: Lombardi Comprehensive Cancer Center, Washington D.C., District of Columbia, 20007, United States|University of Florida: Shands Cancer Center, Gainesville, Florida, 32610, United States|Memorial Cancer Institute, Hollywood, Florida, 33021, United States|University of Miami, Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Memorial Breast Cancer Center: Memorial West, Pembroke Pines, Florida, 33028, United States|Emory University: Winship Cancer Institute, Atlanta, Georgia, 30322, United States|University of Chicago Medicine, Chicago, Illinois, 60637, United States|Community Hospital of Anderson and Madison County, Inc, Anderson, Indiana, 46011, United States|Fort Wayne Oncology & Hematology, Inc., Fort Wayne, Indiana, 46845, United States|IU Health Goshen Hospital, Goshen, Indiana, 46527, United States|Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Community Regional Cancer Center, Indianapolis, Indiana, 46256, United States|St. Vincent Hospital, Indianapolis, Indiana, 46260, United States|IU Health Arnett Cancer Center, Lafayette, Indiana, 47904, United States|Community Healthcare System: Monroe Medical Associates, Munster, Indiana, 46321, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, 46628, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, 21742, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Washington University: Siteman Cancer Center, St Louis, Missouri, 63110, United States|Nebraska Cancer Specialists, Omaha, Nebraska, 68114, United States|University of Cincinnati Cancer Institute, Cincinnati, Ohio, 45267, United States|Mercy Clinic Oncology & Hematology: McAuley, Oklahoma City, Oklahoma, 73120, United States|Pinnacle Health Cancer Center, Harrisburg, Pennsylvania, 17109, United States|Erlanger Health System, Chattanooga, Tennessee, 37403, United States|Joe Arrington Cancer Research and Treatment Center, Lubbock, Texas, 79410, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|Froedtert/Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Aurora Health Care, Wauwatosa, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasm,DRUG: BI 891065,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,12,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/26/19,5/17/23,"National Cancer Center Hospital, Tokyo, Chuo-ku, 104-0045, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Malignancy|Myeloproliferative Disorder,DRUG: Isavuconazole,ALL,"ADULT, OLDER_ADULT",PHASE2,99,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/4/17,11/8/21,"Memorial Sloan Kettering Cancer Center, New York, New York, 10021, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hepatocellular Carcinoma (HCC)|Solid Malignancies,DRUG: FGF401|BIOLOGICAL: PDR001,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,172,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/29/14,5/30/19,"University of California LA Santa Monica Location, Los Angeles, California, 90095, United States|Massachusetts General Hospital Oncology Dept, Boston, Massachusetts, 02114, United States|Uni Of TX MD Anderson Cancer Cntr, Houston, Texas, 77030, United States|Novartis Investigative Site, Shanghai, Shanghai Municipality, 200032, China|Novartis Investigative Site, Rennes, Ille Et Vilaine, 35062, France|Novartis Investigative Site, Lille, 59037, France|Novartis Investigative Site, Montpellier, 34295, France|Novartis Investigative Site, Pessac, 33604, France|Novartis Investigative Site, Toulouse, 31059, France|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Hanover, 30625, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Würzburg, 97080, Germany|Novartis Investigative Site, Hong Kong, Hong Kong|Novartis Investigative Site, Milan, MI, 20132, Italy|Novartis Investigative Site, Modena, MO, 41124, Italy|Novartis Investigative Site, Ōsaka-sayama, Osaka, 589 8511, Japan|Novartis Investigative Site, Chuo Ku, Tokyo, 104 0045, Japan|Novartis Investigative Site, Singapore, 168583, Singapore|Novartis Investigative Site, Seoul, 03080, South Korea|Novartis Investigative Site, Seoul, 05505, South Korea|Novartis Investigative Site, Seoul, 06351, South Korea|Novartis Investigative Site, Barcelona, Catalonia, 08035, Spain|Novartis Investigative Site, Barcelona, Catalonia, 08036, Spain|Novartis Investigative Site, Madrid, 28034, Spain|Novartis Investigative Site, Tainan, 70403, Taiwan|Novartis Investigative Site, Taipei, 10002, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Oral Cavity Carcinoma|Oral Intraepithelial Neoplasia,OTHER: Laboratory Biomarker Analysis|OTHER: Patient Observation|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,15,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/14/17,7/14/25,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Tumors,DRUG: Mirvetuximab soravtansine,ALL,"ADULT, OLDER_ADULT",PHASE1,206,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/28/12,3/19/18,"University of Kansas Medical Center Research Institute, Fairway, Kansas, 66205, United States|Massachusetts General Hospital, Boston, Massachusetts, 02062, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Ohio State University, Columbus, Ohio, 43210, United States|University of Oklahoma Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|CTRC at the University of Texas Health Science Center, San Antonio, Texas, 78229, United States|Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|McGill University Health Centre, Montreal, Quebec, H4A3J1, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Breast Neoplasm|Neoplasm Metastasis,DRUG: Abemaciclib|DRUG: Fulvestrant|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,368,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",3/11/22,2026-02,"St. Joseph's Hospital and Medical Center, Phoenix, Arizona, 85004, United States|Highlands Oncology Group, Springdale, Arkansas, 72762, United States|Providence Medical Foundation, Fullerton, California, 92835, United States|Cancer and Blood Specialty Clinic, Los Alamitos, California, 90720, United States|TRIO-US (Translational Research in Oncology-US), Los Angeles, California, 90024, United States|Keck School of Medicine of USC, Los Angeles, California, 90033, United States|UCLA Hematology/Oncology - Parkside, Santa Monica, California, 90404, United States|Olive View-UCLA Medical Center, Sylmar, California, 91342, United States|Torrance Memorial Physician Network / Cancer Care, Torrance, California, 90505, United States|PIH Health Hematology Medical Oncology, Whittier, California, 90602, United States|Rocky Mountain Cancer Center - Hale Parkway, Denver, Colorado, 80220, United States|Florida Cancer Specialists SOUTH/Sarah Cannon Research Institute/SCRI, Fort Myers, Florida, 33901-8101, United States|Millennium Oncology Research Clinic, Hollywood, Florida, 33024, United States|University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida, 33136, United States|Woodlands Medical Specialists, PA, Pensacola, Florida, 32503, United States|Florida Cancer Specialists SOUTH/Sarah Cannon Research Institute/SCRI, Sarasota, Florida, 34232, United States|Florida Cancer Specialists EAST/Sarah Cannon Research Institute/SCRI, West Palm Beach, Florida, 33401, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, 30322, United States|Northeast Georgia Medical Center, Gainesville, Georgia, 30501, United States|Central Georgia Cancer Care, Macon, Georgia, 31201, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States|Ingalls Memorial Hospital, Harvey, Illinois, 60426, United States|Hematology Oncology Clinic- Baton Rouge/Sarah Cannon Research Institute/SCRI, Baton Rouge, Louisiana, 70809, United States|Clinical Trials of SWLA, Lake Charles, Louisiana, 70601, United States|Central Maine Medical Center, Lewiston, Maine, 04240, United States|Mfsmc-Hjwci, Baltimore, Maryland, 21237, United States|Maryland Oncology Hematology, P.A. - Clinton, Clinton, Maryland, 20735, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|MGH Northshore Cancer Center, Danvers, Massachusetts, 01923, United States|Southcoast Centers for Cancer Care, Fairhaven, Massachusetts, 02719, United States|Dana-Farber Cancer Institute - Foxborough, Foxborough, Massachusetts, 02035, United States|Dana Farber Cancer Center Merrimack Valley, Methuen, Massachusetts, 01844, United States|Dana Farber Cancer Institute, Milford, Massachusetts, 01757, United States|Mass General Cancer Center, Newton, Massachusetts, 02462, United States|Dana Farber Cancer Institute, South Weymouth, Massachusetts, 02190, United States|Reliant Medical Group, Worcester, Massachusetts, 01606, United States|St. Vincent Frontier Cancer Center, Billings, Montana, 59102, United States|Dana Farber Cancer Center Londonderry, Londonderry, New Hampshire, 03053, United States|University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, 87106, United States|Lifespan Cancer Institute, Providence, Rhode Island, 02906, United States|Tennessee Oncology-Chattanooga /Sarah Cannon Research Institute/SCRI, Chattanooga, Tennessee, 37404, United States|Sarah Cannon Research Institute/SCRI, Nashville, Tennessee, 37203, United States|Tennessee Oncology-Nashville/Sarah Cannon Research Institute/SCRI, Nashville, Tennessee, 37203, United States|Texas Oncology - Bedford, Bedford, Texas, 76022, United States|Texas Oncology - Denton, Denton, Texas, 76201, United States|Texas Oncology, P.A., El Paso, Texas, 79902, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030-4009, United States|Texas Oncology - McKinney, McKinney, Texas, 75071, United States|Woodlands Medical Specialists, PA, McKinney, Texas, 75071, United States|Woodlands Medical Specialists, PA, Mesquite, Texas, 75150, United States|Texas Oncology - Plano East, Plano, Texas, 75075-7787, United States|Texas Oncology-Plano West, Plano, Texas, 75093, United States|Mays Cancer Center, San Antonio, Texas, 78229, United States|US Oncology, The Woodlands, Texas, 77380, United States|Texas Oncology - Tyler Cancer Center, Tyler, Texas, 75702, United States|Intermountain Medical Center, Murray, Utah, 84107, United States|Intermountain Healthcare - St. George, St. George, Utah, 84790, United States|The University of Vermont Medical Center Inc., Burlington, Vermont, 05401, United States|Shenandoah Oncology, P.C., Winchester, Virginia, 22601, United States|Fundación Cenit Para La Investigación En Neurociencias, CABA, Buenos Aires F.D., 1125, Argentina|Fundación Respirar, Buenos Aires, Buenos Air, C1426ABP, Argentina|Centro de Investigaciones Metabólicas (CINME), Ciudad Autónoma de Buenos Aire, Buenos Air, C1027AAP, Argentina|Instituto Médico Río Cuarto, Río Cuarto, Córdoba Province, 5800, Argentina|Centro Medico San Roque, San Miguel de Tucumán, Tucumán Province, 4000, Argentina|CER San Juan, San Juan, 5400, Argentina|Algemeen Ziekenhuis klina, Brasschaat, Antwerpen, 2930, Belgium|Jessa Ziekenhuis, Hasselt, Limburg, 3500, Belgium|CHU UCL Namur/Site Sainte Elisabeth, Namur, 5000, Belgium|Multiscan, Pardubice, Pardubický kraj, 53203, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Králové, 500 05, Czechia|Herlev and Gentofte Hospital, Copenhagen, Capital Region, 2730, Denmark|Regionshospitalet Gødstrup, Herning, Central Jutland, 7400, Denmark|Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, Aquitaine, 33076, France|CHRU de Brest, Brest, Finistère, 29609, France|Hôpital privé du Confluent SAS, Nantes, Loire-Atlantique, 44277, France|CHD Vendee, La Roche-sur-Yon, Vendée, 85000, France|University Hospital of Patras, Pátrai, Achaḯa, 26504, Greece|Alexandra Hospital, Athens, Attikí, 115 28, Greece|University General Hospital of Heraklion, Heraklion, Irakleío, 711 10, Greece|Euromedica General Clinic of Thessaloniki, Thessaloniki, 546 45, Greece|Bacs-Kiskun Megyei Korhaz, Kecskemét, Bács-Kiskun county, 6000, Hungary|Petz Aladar Egyetemi Oktato Korhaz, Győr, Győr-Moson-Sopron, 9024, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, 1062, Hungary|Országos Onkológiai Intézet, Budapest, 1122, Hungary|Meir Medical Center, Kfar Saba, Central District, 4428164, Israel|Rabin Medical Center, Petah Tikva, Central District, Israel|Sheba Medical Center, Ramat Gan, Central District, 5265601, Israel|Hadassah Medical Center, Jerusalem, Jerusalem, 9112001, Israel|Soroka Medical Center, Beersheba, Southern District, 8400000, Israel|Sourasky Medical Center, Tel Aviv, Tell Abīb, 6423906, Israel|Humanitas Istituto Clinico Catanese, Misterbianco, Catania, 95045, Italy|IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) ""Dino Amadori"", Meldola, Emilia-Romagna, 47014, Italy|P.O. ""S. Maria della Misericordia"" Azienda Sanitaria Universitaria Friuli Centrale, Udine, Friuli Venezia Giulia, 33100, Italy|Instituto Tumori Giovanni Paolo II, Bari, 70124, Italy|Ospedale Misericordia di Grosseto, Grosseto, 58100, Italy|Ospedale San Raffaele, Milan, 20132, Italy|ASL Viterbo Ospedale Belcolle, Viterbo, 01100, Italy|Centro de Investigacion en Artritis y Osteoporosis SC, Mexicali, Estado de Baja California, 21200, Mexico|COI Tijuana - Centro Oncológico Internacional, Tijuana, Estado de Baja California, 22010, Mexico|Centro Oncológico Internacional (COI), Guadalajara, Jalisco, 45647, Mexico|Centro Regiomontano de Investigación, Monterrey, Nuevo León, 64060, Mexico|Oncologico Potosino, S.C., San Luis Potosí City, San Luis Potosí, 78209, Mexico|Europejskie Centrum Zdrowia - Oddzial Onkologii, Otwock, Masovian Voivodeship, 05-400, Poland|Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Koszarowskiego, Opole, Opole Voivodeship, 45-060, Poland|Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do, 13620, South Korea|Korea University Anam Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 02841, South Korea|Korea University Guro Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 08308, South Korea|Kyungpook National University Chilgok Hospital, Daegu, Taegu-Kwangyǒkshi, 41404, South Korea|CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña], 15006, Spain|Hospital Universitari Son Espases, Palma, Balears [Baleares], 07120, Spain|Parc de Salut Mar - Hospital del Mar, Barcelona, Barcelona [Barcelona], 08003, Spain|Hospital Clínic de Barcelona, Barcelona, Catalunya [Cataluña], 08036, Spain|Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Región de, 30120, Spain|H.R.U Málaga - Hospital Materno-infantil, Málaga, Málaga, 29011, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarre, 31009, Spain|Hospital Universitari Sant Joan de Reus, Reus, Tarragona [Tarragona], 43204, Spain|Hospital Universitario Doctor Peset, Valencia, Valenciana, Comunitat, 46017, Spain|Hospital Infanta Cristina, Badajoz, 06006, Spain|Hospital General Universitario Gregorio Marañon, Madrid, 28009, Spain|Hospital Universitario de Toledo, Toledo, 45007, Spain|Karolinska Universitetssjukhuset Solna, Stockholm, Stockholms, 171 76, Sweden|Universitetssjukhuset Örebro, Örebro, Örebro Län [se-18], 701 85, Sweden|Chi Mei Medical Center, Tainan, Tainan, 71004, Taiwan|Kaohsiung Medical University Hospital, Kaohsiung City, 80756, Taiwan|Taipei Tzu Chi General Hospital, New Taipei City, 231, Taiwan|Mackay Memorial Hospital, Taipei, 10449, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Chang Gung Medical Foundation-Linkou Branch, Taoyuan District, 333, Taiwan|Izmir Medical Park Hospital, Cordaleo, İzmir, 009035575, Turkey (Türkiye)|Necmettin Erbakan Meram Medical Fac., Meram, Konya, 42080, Turkey (Türkiye)|Adana City Hospital, Adana, 01370, Turkey (Türkiye)|Ankara Gülhane Eitim ve Aratrma Hastanesi, Ankara, 06010, Turkey (Türkiye)|Memorial Ankara Hastanesi, Ankara, 06520, Turkey (Türkiye)|Dicle Üniversitesi, Diyarbakır, 21200, Turkey (Türkiye)|Trakya University, Edirne, 22030, Turkey (Türkiye)|TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, 34722, Turkey (Türkiye)|İnönü Üniversitesi Turgut Özal Tıp Merkezi Eğitim ve Araştırma Hastanesi, Malatya, 44280, Turkey (Türkiye)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,B-cell Lymphoid Malignancies,DRUG: Zanubrutinib|DRUG: Obinutuzumab,ALL,"ADULT, OLDER_ADULT",PHASE1,119,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/13/16,9/2/20,"Florida Cancer Specialists Fort Myers, Fort Myers, Florida, 33916, United States|Florida Cancer Specialists East, West Palm Beach, Florida, 33401, United States|Tennessee Oncology, Nashville, Tennessee, 37205, United States|St George Hospital, Kogarah, New South Wales, 2217, Australia|Brisbane Clinic For Lymphoma, Greenslopes, Queensland, 4120, Australia|Ashford Cancer Centre Research Northeast, Windsor Gardens, South Australia, 5087, Australia|St Vincents Hospital Melbourne, Fitzroy, Victoria, 3065, Australia|Barwon Health the Geelong Hospital, Geelong, Victoria, 3220, Australia|St Frances Xavier Cabrini Hospital, Malvern, Victoria, 3144, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|Royal Perth Hospital, Perth, Western Australia, 6000, Australia|Asan Medical Center, Seoul, Seoul Teugbyeolsi, 05505, South Korea|Gangnam Severance Hospital, Yonsei University Health System, Seoul, Seoul Teugbyeolsi, 06273, South Korea|Samsung Medical Center, Seoul, Seoul Teugbyeolsi, 06351, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Tumors,DRUG: Lenvatinib|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,357,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/22/15,7/11/22,"Alaska Clinical Research Center, Anchorage, Alaska, United States|Arizona Oncology Associates, Oro Valley, Arizona, United States|Arizona Oncology Associates, PC - HOPE, Site #1, Tucson, Arizona, United States|Arizona Oncology Associates, PC - HOPE, Site #2, Tucson, Arizona, United States|Arizona Oncology Associates, PC - HOPE, Site #3, Tucson, Arizona, United States|Rocky Mountain Cancer Centers, Aurora, Colorado, United States|Rocky Mountain Cancer Centers, Boulder, Colorado, United States|Rocky Mountain Cancer Centers, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers, Site #1, Denver, Colorado, United States|Rocky Mountain Cancer Centers, Site #2, Denver, Colorado, United States|Rocky Mountain Cancer Centers, Lakewood, Colorado, United States|Rocky Mountain Cancer Centers, Littleton, Colorado, United States|Rocky Mountain Cancer Centers, Lone Tree, Colorado, United States|Rocky Mountain Cancer Centers, Longmont, Colorado, United States|Rocky Mountain Cancer Centers, Parker, Colorado, United States|Rocky Mountain Cancer Centers, Pueblo, Colorado, United States|Rocky Mountain Cancer Centers, Thornton, Colorado, United States|Baptist Health Medical Group Oncology, LLC, Site #1, Miami, Florida, United States|Baptist Health Medical Group Oncology, LLC, Site #2, Miami, Florida, United States|Baptist Health Medical Group Oncology, LLC, Site #3, Miami, Florida, United States|Boca Raton Clinical Research Medical Center, Plantation, Florida, United States|Piedmont Cancer Institue, Atlanta, Georgia, United States|The University of Chicago, Chicago, Illinois, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Mass General Hospital, Boston, Massachusetts, United States|University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, United States|Comprehensive Cancer Centers of Nevada, Site #1, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada, Site #2, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada, Site #3, Henderson, Nevada, United States|Comprehensive Cancer Centers of Nevada, Site #1, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Site #2, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Site #3, Las Vegas, Nevada, United States|Comprehensive Cancer Centers of Nevada, Site #4, Las Vegas, Nevada, United States|New York Hematology Oncology (US Onc), Albany, New York, United States|Memorial Sloan Kettering at Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Texas Oncology-Bedford, Bedford, Texas, United States|Texas Oncology (US Onc), Dallas, Texas, United States|Texas Oncology, Dallas, Texas, United States|Texas Oncology-Denton South, Denton, Texas, United States|Texas Oncology-Fort Worth, Site #1, Fort Worth, Texas, United States|Texas Oncology-Grapevine, Grapevine, Texas, United States|Texas Oncology-Longview Cancer Center, Longview, Texas, United States|Texas Oncology-Plano West, Plano, Texas, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, United States|Texas Oncology-Tyler, Tyler, Texas, United States|Texas Oncology-Waco, Site #1, Waco, Texas, United States|Texas Oncology-Waco, Site #2, Waco, Texas, United States|Haukeland Univerity Hospital, Bergen, Norway|Sørlandet Hospital, Kristiansand, 4604, Norway|Akershus Universitetssykehus HF, Lørenskog, Norway|Oslo Univerity Hospital, Oslo, Norway|Sykehuset Østfold, Sarpsborg, Norway|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitario De Fuenlabrada, Fuenlabrada, Spain|Hospital La Paz, Madrid, Spain|Hospital Universitario Clinico San Carlos, Madrid, Spain|MD Anderson Cancer Center Madrid - España, Madrid, Spain|Parc Taulí Sabadell, Sabadell, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Universitari i Politécnic La Fe., Valencia, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Ovarian Neoplasms|Endometrial Neoplasms|Breast Neoplasms,DRUG: PF-07260437|DIAGNOSTIC_TEST: B7-H4 IHC,ALL,"ADULT, OLDER_ADULT",PHASE1,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/7/21,10/17/23,"City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California, 91010, United States|Moffitt Cancer Center at McKinley Campus, Tampa, Florida, 33612, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox, Illinois, 60451, United States|The University of Chicago Medicine Center of Advanced Care Orland Park, Orland Park, Illinois, 60462, United States|Montefiore Einstein Center for Cancer Care, The Bronx, New York, 10461, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Swedish Cancer Institute Edmonds Campus, Edmonds, Washington, 98026, United States|Swedish Cancer Institute, Seattle, Washington, 98104, United States|Fred Hutchinson Cancer Center, Seattle, Washington, 98109, United States|University of Washington Medical Center - Mountlake, Seattle, Washington, 98195, United States|Pan American Center for Oncology Trials, LLC, Rio Piedras, 00935, Puerto Rico|Pan American Center for Oncology Trials- Hospital Oncologico, Rio Piedras, 00935, Puerto Rico|Pan American Center for Oncology Trials, Rio Piedras, 00935, Puerto Rico",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors,DRUG: [18F]-FET-βAG-TOCA,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,56,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,5/14/14,10/17/18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Tumors,"DRUG: Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody",ALL,"ADULT, OLDER_ADULT",PHASE2,474,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/16/15,7/28/20,"Columbia University Medical Center, New York, New York, 10027, United States|Memorial Sloan Kettering, New York, New York, 10065, United States|The Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Sarah Cannon Cancer Center and Research Institute, Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie, Graz, 8036, Austria|Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Chemotherapie & Infektionskrankhei, Vienna, 1090, Austria|INCA 1- Instituto Nacional de Câncer X, Rio de Janeiro, Rio de Janeiro, 20231-050, Brazil|Hospital das Clinicas - UFRGS, Porto Alegre, Rio Grande do Sul, 90035-903, Brazil|Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, São Paulo, 01246-000, Brazil|BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada|University Health Network; Princess Margaret Hospital; Medical Oncology Dept, Toronto, Ontario, M5G 2M9, Canada|Aarhus Universitetshospital; Kræftafdelingen, Aarhus N, 8200, Denmark|Herlev Hospital; Afdeling for Kræftbehandling, Herlev, 2730, Denmark|Odense Universitetshospital, Onkologisk Afdeling, Klinisk Forsknings Enhed, Odense C, 5000, Denmark|Helsinki University Central Hospital; Dept of Oncology, Helsinki, 00029, Finland|Institut Bergonie, Bordeaux, 33076, France|Centre Leon Berard; Departement Oncologie Medicale, Lyon, 69373, France|Hopital Saint Louis, Service D Oncologie Medicale, Paris, 75475, France|Institut Gustave Roussy, Villejuif, 94805, France|Uniklinik-Eppendorf; Zentren F. Innere Medizin-Klinik U. Poliklinik, Hamburg, 20246, Germany|Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen, Heidelberg, 69120, Germany|Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie, Trier, 54290, Germany|St Vincent'S Uni Hospital; Medical Oncology, Dublin, 4, Ireland|St James' Hospital; Cancer Clinical Trials Office, Dublin, Ireland|Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Campania, 80131, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardy, 20133, Italy|Azienda Ospedaliera Universitaria Senese, U.O.C. Immunoterapia Oncologica, Siena, Tuscany, 53100, Italy|Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, 1066 CX, Netherlands|Erasmus MC, Rotterdam, 3015 GD, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, 3584 CX, Netherlands|Haukeland Universitetssjukehus; Klinisk forskningspost, Bergen, 5021, Norway|Oslo Universitetssykehus HF; Radiumhospitalet, Oslo, 0310, Norway|Centrum Onkologii w Bydgoszczy, Bydgoszcz, 85-796, Poland|Uniwersyteckie Centrum Kliniczne; Klinika Onkologii i Radioterapii, Gdansk, 80-214, Poland|Narodowy Instytut Onkologii im. M.Sklodowskiej-Curie; Klinika Now. Tkanek Miekkich,Kosci i Czer., Warsaw, 02-781, Poland|Russian Oncology Research Center n.a. N.N. Blokhin Dpt of Clinical Pharmacology and Chemotherapy, Moscow, 115478, Russia|S-Pb clinical scientific practical center of specialized kinds of medical care (oncological), Saint Petersburg, 197758, Russia|Clinica Universitaria de Navarra; Servicio de Oncologia, Pamplona, Navarre, 31008, Spain|Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona, 08035, Spain|Freiburger Spital; Onkologie, Fribourg, 1708, Switzerland|Kantonsspital St. Gallen; Onkologie/Hämatologie, Sankt Gallen, 9007, Switzerland|Trakya University Medical Faculty, Edirne, 22030, Turkey (Türkiye)|Istanbul Uni Cerrahpasa Medical Faculty Hospital; Medical Oncology, Istanbul, 34300, Turkey (Türkiye)|Prof. Dr. Cemil Tascioglu City Hospital; Med Onc, Istanbul, 34384, Turkey (Türkiye)|Hacettepe Uni Medical Faculty Hospital; Oncology Dept, Sihhiye/Ankara, 06230, Turkey (Türkiye)|Clatterbridge Cancer Centre, Bebington, CH63 4JY, United Kingdom|Southampton General Hospital; Medical Oncology, Southampton, SO16 6YD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Graft vs Host Disease|Malignancy,DRUG: Abatacept|DRUG: placebo,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,186,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION",2/1/13,3/30/24,"Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, 94609, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|University of Florida, Gainesville, Florida, 32610, United States|Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, 30322, United States|Emory University/Winship Cancer Center, Atlanta, Georgia, 30322, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Washington University, St Louis, Missouri, 63141, United States|Michael Grimley, Cincinnati, Ohio, 45229, United States|University of Utah, Salt Lake City, Utah, 84113, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98101, United States|Children's and Women's Health Center of BC, Vancouver, British Columbia, V6H 3V4, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,HER2-amplified Biliary Tract Cancers,DRUG: ZW25 (Zanidatamab),ALL,"ADULT, OLDER_ADULT",PHASE2,87,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/1/20,7/11/24,"Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|University of Arizona Cancer Center, Tucson, Arizona, 95724, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|University of California Los Angeles, Santa Monica, California, 90404, United States|The Oncology Institute of Hope and Innovation, Whittier, California, 90603, United States|Advent Health Cancer Institute, Orlando, Florida, 32804, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, 30322, United States|University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|University of Texas Southwestern Medical Center - Hospital, Dallas, Texas, 75390, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|Centro de Cáncer Nuestra Señora de la Esperanza, Santiago, 8330032, Chile|Radiomed (Clinica Alemana de Temuco), Temuco, 645, Chile|Beijing Cancer Hospital, Beijing, 100142, China|Peking Union Medical College Hospital, Beijing, 100730, China|Jilin Cancer Hospital, Changchun, 130012, China|Hunan Cancer Hospital, Changsha, 410013, China|West China Hospital, Chengdu, 610041, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China|The First Affiliated Hospital of Zhejiang University, Hangzhou, 310003, China|Zhejiang Provincial People's Hospital, Hangzhou, 310014, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, 310016, China|Zhejiang Cancer Hospital, Hangzhou, 310022, China|Affiliated Tumor Hospital of Harbin Medical University, Harbin, 150081, China|Anhui Provincial Hospital, Hefei, 230001, China|Huzhou Central Hospital, Huzhou, 313000, China|Jinhua Central Hospital, Jinhua, 321000, China|The First Hospital Of Lanzhou University, Lanzhou, 730000, China|Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China|Shandong Provincial Third Hospital, Shandong, 250031, China|Affiliated Zhongshan Hospital of Fudan University, Shanghai, 200032, China|The Third Affiliated Hospital of the Chinese PLA, Shanghai, 200081, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China|Weifang People's Hospital, Weifang, 261000, China|Hubei Cancer Hospital, Wuhan, 430079, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China|Oncologie médicale Hopital Jean Minjoz, Besançon, 25030, France|Institut de Cancerologie et d'Hematologie Hopital Morvan - CHRU de Brest, Brest, 29200, France|Hopitaux de La Timone, Marseille, 13385, France|Département Oncologie Gastro-entérologie CHRU de Poitiers La Miletrie, Poitiers, 86000, France|Département De Médecine, Villejuif, 94805, France|Fondazione del Piemonte per l'Oncologia (IRCCS), Candiolo, 10060, Italy|Istituto Clinico Humanitas, Milan, 20089, Italy|Istituto Nazionale Dei Tumori, Milan, 20133, Italy|Istituto Oncologico Veneto - I.R.C.C.S., Padua, 35128, Italy|Gyeongsang National University Hospital, Jinju, 52727, South Korea|Pusan National University Hospital, Pusan, 49241, South Korea|Seoul National University Bundang Hospital, Seongnam, 13620, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital Yonsei University Health System, Seoul, 03722, South Korea|Asan Medical Center Hospital, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, 06591, South Korea|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Universitario Germans Trias i Pujol, Barcelona, 08916, Spain|Hospital Universitario Reina Sofia, Córdoba, 14004, Spain|Hospital General Universitario Gregorio Marañón, Madrid, 28007, Spain|Hospital Universitario Doce de Octubre, Madrid, 28041, Spain|Corporacio Sanitaria Parc Tauli, Sabadell, 08208, Spain|Hospital Miguel Servet, Zaragoza, 50009, Spain|University College London Hospitals (UCLH), London, NW1 2PG, United Kingdom|Royal Free London NHS Foundation Trust, London, NW3 2QG, United Kingdom|Imperial College Healthcare NHS Trust, London, W12 0HS, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasm,DRUG: Isatuximab SAR650984|DRUG: Atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,107,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/6/18,5/11/22,"Investigational Site Number :8400004, Santa Monica, California, 90404, United States|Investigational Site Number :8400007, Boston, Massachusetts, 02115, United States|Investigational Site Number :8400002, Houston, Texas, 77030, United States|Investigational Site Number :0560001, Brussels, 1200, Belgium|Investigational Site Number :0560002, Ghent, 9000, Belgium|Investigational Site Number :1240001, Toronto, Ontario, M5G 2M9, Canada|Investigational Site Number :2030001, Brno, 65653, Czechia|Investigational Site Number :2030003, Olomouc, 77900, Czechia|Investigational Site Number :2030002, Prague, 12808, Czechia|Investigational Site Number :3800007, Meldola, Forlì-Cesena, 47014, Italy|Investigational Site Number :3800003, Rozzano, Milano, 20089, Italy|Investigational Site Number :3800009, Milan, 20141, Italy|Investigational Site Number :3800004, Padua, 35128, Italy|Investigational Site Number :5280001, Rotterdam, 3015 CE, Netherlands|Investigational Site Number :7240001, Barcelona, Barcelona [Barcelona], 08035, Spain|Investigational Site Number :7240006, Hospitalet de Llobregat, Castille and León, 08908, Spain|Investigational Site Number :7240004, Madrid, Madrid, Comunidad de, 28050, Spain|Investigational Site Number :7240003, Madrid / Madrid, Madrid, Comunidad de, 28040, Spain|Investigational Site Number :7240008, Pamplona, Navarre, 31008, Spain|Investigational Site Number :7240007, Madrid, 28041, Spain|Investigational Site Number :1580005, Kaohsiung City, 807, Taiwan|Investigational Site Number :1580002, Tainan, 704, Taiwan|Investigational Site Number :1580003, Taipei, 104, Taiwan|Investigational Site Number :1580006, Taipei, 112, Taiwan|Investigational Site Number :1580004, Taipei, 114, Taiwan|Investigational Site Number :1580001, Taipei, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cervical Intraepithelial Neoplasia|Cervical Dysplasia,DRUG: 9-valent HPV vaccine|DRUG: Imiquimod,FEMALE,"ADULT, OLDER_ADULT",PHASE2,134,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2016-07,11/22/22,"Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, 06510, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasm,DRUG: preladenant|BIOLOGICAL: pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,10,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/27/17,2/21/18,"START Midwest ( Site 0001), Grand Rapids, Michigan, 49546, United States|Princess Margaret Hospital ( Site 0010), Toronto, Ontario, H9H 4M7, Canada|Jewish General Hospital ( Site 0011), Montreal, Quebec, H9H 4M7, Canada|Rambam Health Care Campus ( Site 0020), Haifa, Israel|Tel Aviv Sourasky Medical Center ( Site 0021), Tel Aviv, Israel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms|Breast Neoplasms,DRUG: talazoparib,ALL,"ADULT, OLDER_ADULT",PHASE1,28,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/30/17,7/18/24,"Aichi Cancer Center Hospital, Nagoya, Aichi-ken, 464-8681, Japan|National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan|National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, 003-0804, Japan|Kanagawa Cancer Center, Yokohama, Kanagawa, 241-8515, Japan|Saitama Cancer Center, Kitaadachi-gun, Saitama, 362-0806, Japan|National Cancer Center Hospital, Chuo-Ku, Tokyo, 104-0045, Japan|Hakuaikai Medical Corporation Sagara Hospital, Kagoshima, 892-0833, Japan|National Hospital Organization Osaka National Hospital, Osaka, 540-0006, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Biochemical Recurrence of Malignant Neoplasm of Prostate,DRUG: 64Cu-SAR-BBN,MALE,"ADULT, OLDER_ADULT",PHASE2,53,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,9/19/22,5/13/24,"Tower Urology, Los Angeles, California, 90048, United States|Stanford University, Stanford, California, 94305, United States|Biogenix Molecular, Miami, Florida, 33165, United States|Bamf Health, Inc, Grand Rapids, Michigan, 49503, United States|St Louis University Hospital, St Louis, Missouri, 63104, United States|GU Research Network, Omaha, Nebraska, 68130, United States|Carolina Urologic Research Center, Myrtle Beach, South Carolina, 29572, United States|Urology San Antonio, San Antonio, Texas, 78258, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Biochemical Recurrence of Malignant Neoplasm of Prostate,DRUG: 64Cu-SAR-bisPSMA,MALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,52,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,4/11/22,8/8/23,"Tower Urology, Los Angeles, California, 90048, United States|GU Research Network, Omaha, Nebraska, 68130, United States|New Mexico Cancer Center, Albuquerque, New Mexico, 87109, United States|Carolina Urologic Research Center, Myrtle Beach, South Carolina, 29572, United States|Urology San Antonio, San Antonio, Texas, 78258, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasm,BIOLOGICAL: Olaratumab|DRUG: Doxorubicin,ALL,"ADULT, OLDER_ADULT",PHASE1,25,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/23/15,1/14/20,"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician., Chūōku, 104-0045, Japan|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician., Kōtoku, 135-8550, Japan|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician., Nagoya, 466-8560, Japan|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician., Suita-shi, 565-0871, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumors|Gastrointestinal Neoplasms|Carcinoid Tumors,DRUG: Lanreotide|DEVICE: Y-90 microspheres,ALL,"ADULT, OLDER_ADULT",PHASE2,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/28/17,6/10/22,"Rocky Mountain Cancer Center, Denver, Colorado, 80218, United States|Research Medical Center/HCA Midwest, Kansas City, Missouri, 64132, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor|Sars-CoV2|Hematological Malignancy,DRUG: BMS-986253,ALL,"ADULT, OLDER_ADULT",PHASE2,43,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/16/20,3/1/21,"Columbia University Irving Medical Center, New York, New York, 10032, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Cancer|Neoplasm Metastasis|Radiation Oncology|Neoplasm|Metastasis,PROCEDURE: Radiation Therapy|DRUG: ECI301,ALL,"ADULT, OLDER_ADULT",PHASE1,2,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/6/11,4/24/13,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematologic Malignancy|Acute Myeloid Leukemia,DRUG: Entospletinib|DRUG: Daunorubicin|DRUG: Cytarabine,ALL,"ADULT, OLDER_ADULT",PHASE1,9,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/19/17,2/26/19,"University of Fukui Hospital, Fukui, 910-1193, Japan|Kyushu University Hospital, Fukuoka, 812-8582, Japan|Tokai University Hospital, Kanagawa, 259-1193, Japan|Tohoku University Hospital, Miyagi, 980-8574, Japan|Kindai University Hospital, Ōsaka, 589-8511, Japan|NTT Medical Center Tokyo, Tokyo, 141-8625, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms|Breast Neoplasms,DRUG: Xentuzumab|DRUG: Abemaciclib|DRUG: Letrozole|DRUG: Anastrozole|DRUG: Fulvestrant|DRUG: Abemaciclib,ALL,"ADULT, OLDER_ADULT",PHASE1,133,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/4/17,5/16/24,"University of California Los Angeles, Santa Monica, California, 90404, United States|Yale University School of Medicine, New Haven, Connecticut, 06511, United States|University of Miami, Miami, Florida, 33136, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|Herlev and Gentofte Hospital, Herlev, 2730, Denmark|Copenhagen University Hospital, Rigshospitalet, København Ø, 2100, Denmark|Docrates Clinic, Helsinki, 00180, Finland|HUCH Comprehensive Cancer Center, building 2, Helsinki, 00290, Finland|Tampere University Hospital, Tampere, 33520, Finland|CRST - Clinical Research Services Turku, Turku, 20520, Finland|HOP Jean Minjoz, Besançon, 25030, France|INS Paoli-Calmettes, Marseille, 13273, France|INS Curie, Paris, 75005, France|Ctr Cario, Plerin Sur Mer, 22190, France|Aichi Cancer Center Hospital, Aichi, Nagoya, 464-8681, Japan|National Cancer Center Hospital East, Chiba, Kashiwa, 277-8577, Japan|Tokai University Hospital, Kanagawa, Isehara, 259-1193, Japan|National Cancer Center Hospital, Tokyo, Chuo-ku, 104-0045, Japan|National Cancer Center, Goyang, 10408, South Korea|Severance Hospital, Seoul, 03722, South Korea|Hospital Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Duran i Reynals, L'Hospitalet de Llobregat, 08907, Spain|Clínica Universidad de Navarra - Madrid, Madrid, 28027, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Fundación Jiménez Díaz, Madrid, 28040, Spain|Hospital Virgen de la Victoria, Málaga, 29010, Spain|Hospital Quirónsalud Madrid, Pozuelo de Alarcón, 28223, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors|Advanced Malignancies|Metastatic Cancer,DRUG: Azacitidine|DRUG: Pembrolizumab|DRUG: Epacadostat|DRUG: INCB057643|DRUG: Pembrolizumab|DRUG: Epacadostat|DRUG: INCB059872,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,70,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/27/17,3/2/20,"City of Hope National Medical Center, Duarte, California, 91010, United States|University of California San Diego, La Jolla, California, 92093, United States|The University of Chicago, Chicago, Illinois, 60637, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, 19014, United States|Sarah Cannon, Nashville, Tennessee, 37203, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Washington, Seattle, Washington, 98109, United States|Vall D Hebron Univ, Barcelona, 08035, Spain|Univ De Navarra, Pamplona, 31008, Spain|University College London Hospitals (Uclh), London, W1t7ha, United Kingdom|Churchill Hospital, Oxford, Ox37le, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Unresectable or Metastatic Solid Malignancy,"DRUG: Entrectinib|DRUG: Inavolisib|DRUG: Alectinib|DRUG: Ipatasertib|DRUG: Atezolizumab|DRUG: Trastuzumab Emtansine|DRUG: Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf|DRUG: Tucatinib|DRUG: Investigator's Choice of Chemotherapy|DRUG: Paclitaxel|DRUG: Tiragolumab|DRUG: Pralsetinib",ALL,"ADULT, OLDER_ADULT",PHASE2,252,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/13/21,2/27/24,"Alaska Oncology and Hematology, Anchorage, Alaska, 99508, United States|Arizona Clinical Research Ctr, Oro Valley, Arizona, 85755-6216, United States|Genesis Cancer Center, Hot Springs, Arkansas, 71913, United States|California Cancer Associates for Research and Excellence - Encinitas, Encinitas, California, 92024-1328, United States|Los Angeles Hematology Oncology Medical Group, Los Angeles, California, 90017, United States|Pacific Cancer Care - Monterey, Monterey, California, 93940, United States|Kaiser Permanente - San Francisco Medical Center, San Francisco, California, 94118, United States|Sarcoma Oncology Center, Santa Monica, California, 90403, United States|Kaiser Permanente Medical Ctr, Vallejo, California, 94589, United States|Ventura County Hematology Oncology Specialists, Ventura, California, 93003, United States|Eastern CT Hematology and Oncology Associates, Norwich, Connecticut, 06360-2740, United States|SCRI Florida Cancer Specialists South, Fort Myers, Florida, 33916, United States|Florida Cancer Specialists - NORTH - SCRI - PPDS, St. Petersburg, Florida, 33705-1400, United States|Florida Cancer Specialists - PAN - SCRI - PPDS, Tallahassee, Florida, 32308, United States|Florida Cancer Specialists - EAST - SCRI - PPDS, West Palm Beach, Florida, 33401-3406, United States|St Luke?s Cancer Institute, Boise, Idaho, 83712, United States|Hematology and Oncology Clinic, Baton Rouge, Louisiana, 70809, United States|Saint Agnes Hospital - Baltimore - Hunt - PPDS, Baltimore, Maryland, 21229-5201, United States|Ascension St. John Hospital, Detroit, Michigan, 48236, United States|Frontier Cancer Center and Blood Institute, Billings, Montana, 59102, United States|Southeast Nebraska Cancer Center, Lincoln, Nebraska, 68510-2496, United States|New Jersey Hematology Oncology Associates LLC, Brick, New Jersey, 08724-3009, United States|Astera Cancer Care East Brunswick, East Brunswick, New Jersey, 08816, United States|Central Park Hematology and Oncology, New York, New York, 10028-0506, United States|Eastchester Center for Cancer Care, The Bronx, New York, 10469, United States|New York Cancer & Blood Specialists, The Bronx, New York, 10469, United States|Messino Cancer Centers, Asheville, North Carolina, 28806, United States|Gabrail Cancer Center, Canton, Ohio, 44718, United States|Tri County Hematologyoncology, Canton, Ohio, 44718, United States|SCRI Mark H. Zangmeister Center, Columbus, Ohio, 43219, United States|Kaiser Permanente Center For Health Research, Portland, Oregon, 97227, United States|Sarah Cannon Research Institute / Tennessee Oncology, Chattanooga, Tennessee, 37404, United States|The West Clinic, PC dba West Cancer Center, Memphis, Tennessee, 38138, United States|SCRI Oncology Partners, Nashville, Tennessee, 37203, United States|The Center for Cancer and Blood Disorders - PPDS, Fort Worth, Texas, 76104-4611, United States|Mays Cancer Center at UT Health San Antonio MD Anderson Cancer, San Antonio, Texas, 78229, United States|Virginia Commonwealth University - Massey Cancer Center, Richmond, Virginia, 23219, United States|Northwest Medical Specialties B, Federal Way, Washington, 98003, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastroenteropancreatic Neuroendocrine Tumors,DRUG: arginine/lysine,ALL,"ADULT, OLDER_ADULT",PHASE4,42,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,1/25/21,11/18/23,"Istituto Europeo di Oncologia, Milan, MI, 20141, Italy|Erasmus University Medical Center, Rotterdam, Gelderland, 3015, Netherlands|Gammed-Centrum Diagnostyczno-Lecznicze, Warsaw, 02-351, Poland|University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2GW, United Kingdom|University Hospitals Coventry & Warwickshire NHS Trust, Coventry, CV2 2DX, United Kingdom|Royal Surrey Country Hospital, Guildford, GU2 7XX, United Kingdom|Liverpool Royal Hospital, Liverpool, L7 8YA, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Hematologic Malignancy|Bone Marrow Transplant,DRUG: Tocilizumab|DRUG: Fludarabine|DRUG: Melphalan|DRUG: Anti-thymocyte globulin (rabbit)|RADIATION: Total Body Irradiation,ALL,"ADULT, OLDER_ADULT",PHASE2,21,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/7/20,2027-05,"Weill Cornell Medical College, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Cancers|Advanced Solid Cancers Refractory to PD-1 and PD-L1 Therapies,DRUG: Zalifrelimab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,89,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-04,3/31/22,"City of Hope National Medical Center, Duarte, California, 91010, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Rocky Mountain Cancer Center, Denver, Colorado, 80218, United States|University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, 60611, United States|Ochsner Cancer Institute, New Orleans, Louisiana, 70121, United States|Atlantic Health System/Morristown Medical Center, Morristown, New Jersey, 07962, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Texas Oncology - Austin Midtown, Austin, Texas, 78705, United States|Texas Oncology, Tyler Texas, Tyler, Texas, 75702, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,AIDS-Related Non-Hodgkin Lymphoma|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Hepatocellular Carcinoma|HIV Infection|Kaposi Sarcoma|Locally Advanced Lung Non-Small Cell Carcinoma|Locally Advanced Malignant Solid Neoplasm|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Non-Hodgkin Lymphoma|Recurrent Classic Hodgkin Lymphoma|Recurrent Malignant Neoplasm|Refractory Classic Hodgkin Lymphoma|Refractory Malignant Neoplasm|Stage III Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Unresectable Melanoma,DRUG: Antiretroviral Therapy|PROCEDURE: Biopsy|PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|BIOLOGICAL: Pembrolizumab|PROCEDURE: Positron Emission Tomography,ALL,"ADULT, OLDER_ADULT",PHASE1,58,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/4/16,3/25/24,"University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, 35233, United States|Zuckerberg San Francisco General Hospital, San Francisco, California, 94110, United States|UCSF Medical Center-Parnassus, San Francisco, California, 94143, United States|Yale University, New Haven, Connecticut, 06520, United States|Louisiana State University Health Science Center, New Orleans, Louisiana, 70112, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, 21287, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, 10016, United States|Mount Sinai Hospital, New York, New York, 10029, United States|FHCC South Lake Union, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Carcinoid Tumors,DRUG: Ramucirumab|DRUG: Somatostatin Analog,ALL,"ADULT, OLDER_ADULT",PHASE2,43,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/14/16,12/31/23,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumors,DRUG: Telotristat (Low-Dose)|DRUG: Telotristat (High-Dose),ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/13/21,6/3/22,"Markey Cancer Center, Lexington, Kentucky, 40536, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroblastoma|Osteosarcoma|Other Solid Tumor Cancers,BIOLOGICAL: Humanized 3F8 Bispecific Antibody|OTHER: Blood draw,ALL,CHILD,PHASE1|PHASE2,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/22/19,10/20/21,"Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Urinary Bladder Neoplasm|Neoplasm Metastasis,BIOLOGICAL: Bempegaldesleukin|BIOLOGICAL: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE2,192,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/29/19,6/30/22,"San Francisco VA Medical Center - NAVREF - PPDS, San Francisco, California, 94143, United States|Innovative Clinical Research Institute, LLC, Whittier, California, 90603, United States|Rocky Mountain Cancer Centers, Aurora, Colorado, 80012, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, 30322, United States|Southeastern Regional Medical Center - CTCA - PPDS, Newnan, Georgia, 30265, United States|Investigator Site - Peoria, Peoria, Illinois, 61615, United States|Laura And Isaac Perlmutter Cancer Center, New York, New York, 10016, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Centro de Investigación Clínica - Clínica Viedma, Viedma, Río Negro Province, R8500ACE, Argentina|Instituto de Oncologia de Rosario, Rosario, Santa Fe Province, S2000DSK, Argentina|CAIPO Centro para la atención integral del paciente oncológico, San Miguel de Tucumán, Tucumán Province, 4000, Argentina|Hospital Alemán, Buenos Aires, C1118AAT, Argentina|Instituto Médico Especializado Alexander Fleming, Buenos Aires, C1426ANZ, Argentina|Centro Médico Privado CEMAIC, Córdoba, X5000HHW, Argentina|Sanatorio Privado Duarte Quirós, de Clínica Colombo S.A., Córdoba, X5002AOQ, Argentina|St Vincent's Hospital Sydney, Darlinghurst, New South Wales, 2010, Australia|Tasman Health Care, Southport, Queensland, 4215, Australia|Adelaide Cancer Centre, Kurralta Park, South Australia, 5037, Australia|Monash Health, Monash Medical Centre, Bentleigh East, Victoria, 3165, Australia|St John of God Murdoch Hospital, Nedlands, Western Australia, 6009, Australia|Algemeen Ziekenhuis Klina, Brasschaat, Antwerpen, 2930, Belgium|GasthuisZusters Antwerpen, Wilrijk, Antwerpen, 2610, Belgium|AZ Groeninge, Kortrijk, 8500, Belgium|University Health Network, Toronto, Ontario, M5G 2M9, Canada|Helsingin Yliopistollinen Keskussairaala - PPDS, Helsinki, 00290, Finland|Centre François Baclesse, Caen, Calvados, 14076, France|Hôpital Privé TOULON/HYERES Sainte Marguerite, Hyères, 83400, France|Centre Jean Bernard Clinique Victor Hugo, Le Mans, 72015, France|Hôpital Européen Georges Pompidou, Paris, 75908, France|Edog Ico - Ppds, Saint-Herblain, 44805, France|Institut Gustave Roussy, Villejuif, 94805, France|Studienpraxis Urologie, Nürtingen, Baden-Wurttemberg, 72622, Germany|Kliniken Nordoberpfalz AG, Weiden, Bavaria, 92637, Germany|Charité - Universitätsmedizin Berlin, Berlin, 10117, Germany|Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden, 01307, Germany|Alexandra Hospital, Athens, Attica, 115 28, Greece|Medical Center of Athens, Marousi, Attica, 151 25, Greece|University General Hospital of Larissa, Larissa, 41110, Greece|Euromedica - PPDS, Thessaloniki, 54645, Greece|Shamir Medical Center Assaf Harofeh, Ẕerifin, Central District, 70300, Israel|Rambam Medical Center - PPDS, Haifa, 31096, Israel|Meir Medical Center, Kfar Saba, 44281, Israel|Sheba Medical Center - PPDS, Ramat Gan, 52621, Israel|Tel Aviv Sourasky Medical Center PPDS, Tel Aviv, 52620, Israel|Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST - PPDS, Meldola, Emilia-Romagna, 47014, Italy|Centro Di Riferimento Oncologico, Aviano, Pordenone, 33081, Italy|Istituto Nazionale Dei Tumori, Milan, 20133, Italy|Health Pharma Professional Research S.A de C.V., Mexico City, Mexico City, 03810, Mexico|Phylasis Clinicas Research S. de R.L. de C.V., Cuautitlán Izcalli, 54769, Mexico|Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, 1066, Netherlands|Centro Hospitalar E Universitário de Coimbra EPE, Coimbra, 3000-075, Portugal|Regional Clinical Oncology Hospital, Yaroslavl, Yaroslavl Oblast, 150040, Russia|Federal State Institution Medical Radiology Research Center, Obninsk, 249036, Russia|Clinical Oncology Dispensary, Omsk, 644013, Russia|PMI Euromedservice, Pushkin, 196603, Russia|Railway Clinical Hospital JSC RZhD, Saint Petersburg, 195271, Russia|Hospital General Universitario de Elche, Elche, Alicante, 03203, Spain|Hospital de La Santa Creu i Sant Pau, Barcelona, Catalonia, 08025, Spain|Hospital Universitario Ramon y Cajal, Pozuelo de Alarcón, Madrid, 28223, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario HM Sanchinarro - CIOCC, Madrid, 28050, Spain|Hospital Universitario Virgen del Rocio - PPDS, Seville, 41013, Spain|Fundacion Instituto Valenciano de Oncologia, Valencia, 46009, Spain|Ankara University Medical Faculty - PPDS, Ankara, 6100, Turkey (Türkiye)|Izmir Medicalpark Hospital, Izmir, 35530, Turkey (Türkiye)|Inonu University Faculty of Medicine Turgut Ozal Medical Center, Malatya, 44280, Turkey (Türkiye)|Royal Marsden Hospital - Surrey, Sutton, Surrey, SM2 5PT, United Kingdom|Leicester Royal Infirmary, Leicester, LE1 5WW, United Kingdom|Barts Health NHS Trust, London, EC1A 7BE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors,DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,21,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/26/16,2020-03,"Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|MD Anderson Cancer Center, Houston, Texas, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Carcinoid Tumors|Neuroblastoma|Medulloblastoma,DRUG: 68Ga-DOTATOC PET/CT,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,122,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2015-09,1/20/20,"University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm|Oral Pain|Stomatitis,OTHER: Best Practice|DRUG: Methylene Blue|DRUG: Methylene Blue|DRUG: Methylene Blue,ALL,"ADULT, OLDER_ADULT",PHASE2,69,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2/28/19,2/3/22,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms|Pancreatic Neoplasms,DRUG: LMB-100|DRUG: Nab-Paclitaxel|DEVICE: Mesothelin Expression|DRUG: LMB-100,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,40,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/3/16,6/22/21,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Cancer|Breast Carcinoma|Cancer of Breast|Malignant Tumor of Breast,DRUG: Palbociclib|DRUG: Letrozole|DRUG: Fulvestrant|PROCEDURE: Optional research biopsy|DRUG: Goserelin|PROCEDURE: Research blood draw|PROCEDURE: Circulating tumor cell blood draw|PROCEDURE: Tumor biopsy (optional),FEMALE,"ADULT, OLDER_ADULT",PHASE2,55,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/15/17,3/31/23,"Washington University School of Medicine, St Louis, Missouri, 63110, United States|University of Nebraska, Lincoln, Nebraska, 68588, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Esophageal Neoplasms|Lung Neoplasms|Mesothelioma|Thymus Neoplasms|Neoplasms, Germ Cell and Embryonal",DRUG: Mithramycin,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,3,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/8/19,12/1/21,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors,DRUG: Lenvatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,123,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-10,2020-08,"Universitätsklinik für Innere Medizin, Graz, 8036, Austria|Medizinische Universität Wien, Vienna, a-1090, Austria|Spedali Civili di Brescia, Brescia, Italy|Instituto Oncologico Mediterraneo, Catania, Italy|Azienda Ospedaliero Universitaria Careggi - SC di Oncologia, Florence, 50139, Italy|IRST of Meldola, Meldola, Italy|Istituto Europeo di Oncologia - Unità di Oncologia Medica Gastrointestinale e Tumori Neuroendocrini, Milan, 20141, Italy|AOU Policlinico di Modena - DH Oncologico, Modena, 41124, Italy|IRCCS Napoli, Napoli, Italy|Hospital Universatorio de Verona, Verona, Italy|Hospital Virgen de la Victoria, Málaga, Andalusia, 29010, Spain|Hospital de Donostia, Donostia / San Sebastian, Basque Country, Spain|Hospital Marqués de Valdecilla, Santander, Cantabria, 39011, Spain|Hospital Central de Asturias, Oviedo, Principality of Asturias, 33006, Spain|Hospital Universitario Vall Hebrón, Barcelona, 08035, Spain|ICO Hospitalet, L'Hospitalet de Llobregat, 08908, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario la Paz, Madrid, 28046, Spain|Hospital Miguel Servet, Zaragoza, 50009, Spain|Beatson Oncology Centre Gartnavel General Hospital, Glasgow, G12 0YN, United Kingdom|Christie Hospital, Manchester, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pancreatic Cancer|Unresectable Biliary-pancreatic Malignancies,DEVICE: ERCP with SEMS plus radiofrequency ablation|DEVICE: ERCP with SEMS alone (standard of care),ALL,"ADULT, OLDER_ADULT",PHASE3,24,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-01,2019-11,"Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms|Lymphoma|Hematologic Neoplasms,DRUG: TAK-981,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,109,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/1/18,12/14/23,"University of California San Diego Moores Cancer Center, La Jolla, California, 92093, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|HealthPartners Cancer Care Center - Regions Hospital, Saint Paul, Minnesota, 55101, United States|University Hospitals Seidman Cancer Center, Cleveland, Ohio, 44106, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: CC-90011|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE2,92,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/14/20,12/19/23,"Local Institution - 102, Indianapolis, Indiana, 46260, United States|Local Institution - 106, New York, New York, 10021, United States|Local Institution - 105, Canton, Ohio, 44718, United States|Local Institution - 104, Cleveland, Ohio, 44106, United States|Local Institution - 109, Pittsburgh, Pennsylvania, 15232, United States|Local Institution - 107, Fort Sam Houston, Texas, 78235-8200, United States|Local Institution - 110, Houston, Texas, 77090, United States|Local Institution - 111, Fairfax, Virginia, 22031, United States|Local Institution - 156, Lyon, 69500, France|Local Institution - 153, Marseille, 13385, France|Local Institution - 154, Rennes, 35033, France|Local Institution - 151, Saint-Herblain, 44800, France|Local Institution - 152, Villejuif, 94805, France|Local Institution - 301, Aviano, 33081, Italy|Local Institution - 306, Meldola, 47014, Italy|Local Institution - 303, Milan, 20133, Italy|Local Institution - 305, Roma, 00128, Italy|Local Institution - 304, Verona, 37134, Italy|Local Institution - 451, Lodz, 90-242, Poland|Local Institution - 452, Lodz, 93-338, Poland|Local Institution - 454, Poznan, 60-693, Poland|Local Institution - 453, Warsaw, 02-781, Poland|Local Institution - 361, A Coruña, 15006, Spain|Local Institution - 351, Badalona (Barcelona), 08916, Spain|Local Institution - 355, Barcelona, 08023, Spain|Local Institution - 356, Barcelona, 08035, Spain|Local Institution - 359, Las Palmas de Gran Canaria, 35016, Spain|Local Institution - 358, Madrid, 28027, Spain|Local Institution - 353, Madrid, 28040, Spain|Local Institution - 357, Madrid, 28041, Spain|Local Institution - 360, Majadahonda, Madrid, 28222, Spain|Local Institution - 352, Pamplona, 31008, Spain|Local Institution - 362, Valencia, 46014, Spain|Local Institution - 354, Valencia, 46026, Spain|Local Institution - 254, London, SW3 6JJ, United Kingdom|Local Institution - 251, Manchester, M20 4BX, United Kingdom|Local Institution - 255, Sutton-Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors,DRUG: 68Ga-DOTATOC,ALL,"ADULT, OLDER_ADULT",PHASE3,11,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,5/16/16,2017-03,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Everolimus|DRUG: Sandostatin LAR Depot,ALL,"ADULT, OLDER_ADULT",PHASE4,34,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/14/13,8/28/20,"Hematology Oncology Services of Arkansas SC, Little Rock, Arkansas, 72205, United States|Rocky Mountain Cancer Centers SC, Greenwood Village, Colorado, United States|Stamford Hospital, Stamford, Connecticut, 06902, United States|H Lee Moffitt Cancer Center and Research Institute SC-2, Tampa, Florida, 33612, United States|Central Indiana Cancer Centers SC, Indianapolis, Indiana, 46227, United States|Crescent City Research Consortium, LLC SC-3, Metairie, Louisiana, 70006, United States|Mayo Clinic SC-2, Rochester, Minnesota, 55905, United States|Washington University School of Medicine Dept of Oncology, St Louis, Missouri, 63110, United States|Nebraska Cancer Specialists Onc Dept, Omaha, Nebraska, 68154, United States|Clinical Research Alliance, Lake Success, New York, 11042, United States|New York University Medical Center SC-4, New York, New York, 10016, United States|Oregon Health and Science University SC-8, Portland, Oregon, 97239, United States|Utah Cancer Specialists Utah Cancer (2), Salt Lake City, Utah, 84106, United States|Novartis Investigative Site, Prague, Czech Republic, 120 00, Czechia|Novartis Investigative Site, Arezzo, AR, 52100, Italy|Novartis Investigative Site, Milan, MI, 20133, Italy|Novartis Investigative Site, Milan, MI, 20141, Italy|Novartis Investigative Site, Groningen, 9713 GZ, Netherlands|Novartis Investigative Site, Leningrad Region, Russia, 188663, Russia|Novartis Investigative Site, Seoul, 03080, South Korea|Novartis Investigative Site, Seoul, 03722, South Korea|Novartis Investigative Site, Barcelona, Catalonia, 08035, Spain|Novartis Investigative Site, Bangkok, 10700, Thailand|Novartis Investigative Site, Izmir, 35040, Turkey (Türkiye)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,ALK-activated Tumors,DRUG: Ceritinib,ALL,CHILD,PHASE1,83,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/28/13,4/26/19,"Dana Farber Cancer Institute Dept of Onc, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering SC - 7, New York, New York, 10017, United States|Cincinnati Children s Hospital Medical Center Dept of Oncology, Cincinnati, Ohio, 45229-3039, United States|St Jude s Childrens Research Hospital Dept of Oncology, Memphis, Tennessee, 38105-2794, United States|Texas Children's Hospital Dept of Oncology, Houston, Texas, 77030, United States|Novartis Investigative Site, Randwick, New South Wales, 2130, Australia|Novartis Investigative Site, Parkville, Victoria, 3052, Australia|Novartis Investigative Site, Toronto, Ontario, M5G 1X8, Canada|Novartis Investigative Site, Paris, 75231, France|Novartis Investigative Site, Villejuif, 94805, France|Novartis Investigative Site, Cologne, North Rhine-Westphalia, 50937, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Milan, MI, 20133, Italy|Novartis Investigative Site, Utrecht, CS, 3584, Netherlands|Novartis Investigative Site, Amsterdam, 1105 AZ, Netherlands|Novartis Investigative Site, Rotterdam, 3015 CN, Netherlands|Novartis Investigative Site, Seoul, 03080, South Korea|Novartis Investigative Site, Barcelona, Catalonia, 08035, Spain|Novartis Investigative Site, Valencia, Valencia, 46026, Spain|Novartis Investigative Site, Madrid, 28009, Spain|Novartis Investigative Site, West Midlands, Birmingham, B4 6NH, United Kingdom|Novartis Investigative Site, Sutton, Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Carcinoid Tumors|Neuroblastoma|Medulloblastoma,DRUG: 68Ga-DOTATOC PET/CT,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,223,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2/21/12,8/27/17,"University of Iowa Health Care, Iowa City, Iowa, 52242, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Multiple Endocrine Neoplasia Type 1|Pancreatic Neuroendocrine Carcinoma,RADIATION: Computed Tomography Perfusion Imaging|OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Ziv-Aflibercept,ALL,"ADULT, OLDER_ADULT",PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/18/14,1/31/18,"Moffitt Cancer Center-International Plaza, Tampa, Florida, 33607, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumors,DRUG: ABI-009,ALL,"ADULT, OLDER_ADULT",PHASE2,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/5/18,2/26/21,"Ochsner Clinic Foundation, New Orleans, Louisiana, 70121, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors,DRUG: LEE011|DRUG: everolimus,ALL,"ADULT, OLDER_ADULT",PHASE2,21,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/27/17,1/31/24,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Md Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: MK-8353|DRUG: Selumetinib,ALL,"ADULT, OLDER_ADULT",PHASE1,30,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2/22/19,3/19/21,"Florida Cancer Specialists ( Site 7000), Sarasota, Florida, 34232, United States|Next Oncology ( Site 0001), San Antonio, Texas, 78229, United States|BC Cancer-Vancouver Center ( Site 0011), Vancouver, British Columbia, V5Z 4E6, Canada|Princess Margaret Cancer Centre ( Site 0012), Toronto, Ontario, M5G 2M9, Canada|Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 0020), Bellinzona, Canton Ticino, 6500, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors,DRUG: 64Cu-DOTATATE,ALL,"ADULT, OLDER_ADULT",PHASE3,63,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,8/23/18,8/7/19,"Excel Diagnostics and Nuclear Oncology Center, Houston, Texas, 77042, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,OTHER: Screening Platform,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,16,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,12/16/21,10/4/22,"GSK Investigational Site, Gainesville, Florida, 32608, United States|GSK Investigational Site, Waterloo, Iowa, 50701, United States|GSK Investigational Site, Springfield, Missouri, 65807, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors,DRUG: Octreotide|DRUG: LAR Lanreotide|BEHAVIORAL: Questionnaires,ALL,"ADULT, OLDER_ADULT",PHASE4,51,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/19/17,4/10/23,"Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Commack, Commack, New York, 11725, United States|Memorial Sloan Kettering West Harrison, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, 11553, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: Avelumab,ALL,"ADULT, OLDER_ADULT",PHASE1,1756,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/31/13,12/16/19,"Cancer Treatment Centers of America - Western Regional Medical Center, Goodyear, Arizona, 85338, United States|Scottsdale Healthcare Corporation, Scottsdale, Arizona, 85258-4550, United States|Pinnacle Oncology Hematology, Scottsdale, Arizona, 85258, United States|Highlands Oncology Group, Rogers, Arkansas, 72758, United States|Pacific Cancer Medical Center, Inc., Anaheim, California, 92801, United States|California Cancer Associates for Research & Excellence, Inc, Encinitas, California, 92024, United States|Healing Hands Oncology and Medical Care, Inglewood, California, 90305, United States|Scripps Health dba Scripps Clinical Research Services, La Jolla, California, 92037, United States|The Angeles Clinic and Research Institute - West LA, Los Angeles, California, 90025, United States|Cedars-Sinai Medical Center - Oncology, Los Angeles, California, 90048, United States|University of California Davis Health System, Sacramento, California, 95817, United States|Sharp Memorial Hospital, San Diego, California, 92123, United States|Georgetown University Medical Center- Research Parent, Washington D.C., District of Columbia, 20057, United States|Holy Cross Hospital, Fort Lauderdale, Florida, 33308, United States|University of Miami, Miami, Florida, 33136, United States|Hematology - Oncology Associates of Treasure Coast - Hematology-Oncology Associates of Treasure Coast, Port Saint Lucie, Florida, 34952, United States|Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Northeast Georgia Cancer Care, LLC, Athens, Georgia, 30607, United States|Peachtree Hematology-Oncology Consultants, PC, Atlanta, Georgia, 30318, United States|Augusta University - formerly Georgia Regents University, Augusta, Georgia, 30912, United States|Northwest Georgia Oncology Centers PC, Marietta, Georgia, 30060, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Horizon Oncology Research, INC, Lafayette, Indiana, 47905, United States|The Johns Hopkins Hospital, Baltimore, Maryland, 21287-7049, United States|RCCA MD LLC - Bethesda, Bethesda, Maryland, 20817, United States|National Cancer Institute, Bethesda, Maryland, 20892, United States|Maryland Oncology Hematology, P.A., Rockville, Maryland, 20850, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Henry Ford Medical Center, Detroit, Michigan, 48202, United States|Michigan State University, Lansing, Michigan, 48910, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, 55407, United States|Kansas City Research Institute, LLC - Phase I Unit, Kansas City, Missouri, 64131, United States|Washington University in St. Louis, St Louis, Missouri, 63110, United States|San Juan Oncology Associates, Farmington, New Mexico, 87401, United States|Columbia University College of Phys & Surgeons, New York, New York, 10032, United States|Montefiore Medical Center PRIME, The Bronx, New York, 10461, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27514, United States|Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville, North Carolina, 28078, United States|UC Health Clinical Trials Office, Cincinnati, Ohio, 45267-0502, United States|University Hospitals Case Medical Center - Case Comprehensive Cancer Center, Cleveland, Ohio, 44106, United States|OSU - James Comprehensive Cancer Center - Division of Hematology, Columbus, Ohio, 43210-1228, United States|Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center - d/b/a The Mark H. Zangmeister Center, Columbus, Ohio, 43219, United States|Oklahoma University Medical Center, Oklahoma City, Oklahoma, 73104, United States|Penn State Univ. Milton S. Hershey Medical Center - MSHMC Cardiology, Hershey, Pennsylvania, 17033, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Medical University of South Carolina, Charleston, South Carolina, 29245, United States|The West Clinic, Germantown, Tennessee, 38138, United States|Baptist Cancer Center, Memphis, Tennessee, 38120, United States|SCRI - Tennessee Oncology, Nashville, Tennessee, 37203, United States|Texas Oncology, P.A, Dallas, Texas, 75246, United States|Oncology Consultants, P.A., Houston, Texas, 77030, United States|Texas Oncology, P.A. - Tyler, Tyler, Texas, 75702, United States|Northwest Medical Specialties, PLLC, Lakewood, Washington, 98499-3071, United States|GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk, 2610, Belgium|Nemocnice Rudolfa a Stefanie Benesov, a.s., Benešov, 256 01, Czechia|ICO - Site Paul Papin - service d'oncologie medicale, Angers, 49055, France|Centre Léon Bérard, Lyon, 69008, France|Centre Antoine Lacassagne, Nice, 06189, France|Centre Paul Strauss - Service de Médecine Oncologique, Strasbourg, 67000, France|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz - I. Medizinische Klinik Gastroenterologie u Hepato., Mainz, 55131, Germany|Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH - Innere Medizin II Haematologie / Onkologie, Villingen-Schwenningen, 78052, Germany|Centrum Onkologii-Instytut im. M. Sklodowskiej Curie - Dept of Digestive System Oncology, Warsaw, 02-781, Poland|Seoul National University Bundang Hospital, Seongnam-si, 13620, South Korea|Korea University Anam Hospital, Seoul, 02841, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital, Yonsei University, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Gangnam Severance Hospital, Yonsei University Health System, Seoul, 06273, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, 06591, South Korea|National Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Sarah Cannon Research Institute UK, London, W1G 6AD, United Kingdom|Derriford Hospital - Dept of Oncology Clinical Trials, Plymouth, PL6 8BQ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: PF-06647020 Q3W|DRUG: fluconazole|DRUG: PF-06647020 Q2W|DRUG: PF-06647020 combined with Avelumab,ALL,"ADULT, OLDER_ADULT",PHASE1,138,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,10/17/14,11/5/19,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|University of Alabama at Birmingham, Birmingham, Alabama, 35249, United States|Scottsdale Healthcare Hospitals DBA HonorHealth, Scottsdale, Arizona, 85258, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|University of California Davis Medical Center, Sacramento, California, 95817, United States|Stanford Cancer Center, Stanford, California, 94305, United States|Stanford Hospital and Clinics, Stanford, California, 94305, United States|University of Chicago Medicine, Chicago, Illinois, 60637, United States|START Midwest, Grand Rapids, Michigan, 49503, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, 78229, United States|Inova Fairfax Hospital Woodburn GYN Infusion Center, Annandale, Virginia, 22003, United States|Mid Atlantic Gynecologic Oncology and Pelvic Surgery Associates (MAGOPSA), Annandale, Virginia, 22003, United States|Fairfax Radiological Consultants, Fairfax, Virginia, 22031, United States|Inova Schar Cancer Institute, Fairfax, Virginia, 22031, United States|Inova Loudon Hospital, Leesburg, Virginia, 20176, United States|Hospital Universitario Fundacion Jimenez Diaz, Madrid, 28040, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors|Advanced Malignancies|Metastatic Cancer,DRUG: INCB052793|DRUG: gemcitabine|DRUG: nab-paclitaxel|DRUG: dexamethasone|DRUG: Carfilzomib|DRUG: bortezomib|DRUG: lenalidomide|DRUG: azacitidine|DRUG: INCB052793|DRUG: pomalidomide|DRUG: INCB050465|DRUG: INCB039110,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,83,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/10/14,2/27/19,"Birmingham, Alabama, United States|West Hollywood, California, United States|New Haven, Connecticut, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Indianapolis, Indiana, United States|Hackensack, New Jersey, United States|New York, New York, United States|Durham, North Carolina, United States|Portland, Oregon, United States|Greenville, South Carolina, United States|Site 2, Nashville, Tennessee, United States|Nashville, Tennessee, United States|Dallas, Texas, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors|NHL,DRUG: KPT-9274|DRUG: Niacin ER|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1,60,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/8/16,1/26/21,"UCLA Health, Los Angeles, California, 90024, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Georgetown University, Lombardi Comprehensive Cancer Center, Washington D.C., District of Columbia, 20007, United States|Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States|NYU-Laura & Isaac Perlmutter Cancer Center, New York, New York, 100016, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: MSB0011359C,ALL,"ADULT, OLDER_ADULT",PHASE1,600,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/31/15,5/23/22,"Arizona Clinical Research Center, Tucson, Arizona, 85715, United States|Pacific Oncology Associates, Escondido, California, 92025, United States|University of California Davis Health System, Sacramento, California, 95817, United States|California Pacific Medical Center, San Francisco, California, 94118, United States|Innovative Clinical Research Institute, Whittier, California, 90603, United States|Rocky Mountain Cancer Centers, LLP, Denver, Colorado, 80218, United States|Eastern Connecticut Hematology/Oncology Assoc., Norwich, Connecticut, 06360, United States|Sylvester Cancer Center, Miami, Florida, 33136, United States|Hematology - Oncology Associates of Treasure Coast, Port Saint Lucie, Florida, 34952, United States|University Cancer & Blood Center, LLC, Athens, Georgia, 30607, United States|Southeastern Regional Medical Center, Newnan, Georgia, 30265, United States|Metairie Oncologists, LLC, Metairie, Louisiana, 70006, United States|National Cancer Institute, Bethesda, Maryland, 20892, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Michigan State University, Lansing, Michigan, 48910, United States|Washington University, St Louis, Missouri, 63110, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|UC Health Clinical Trials Office, Cincinnati, Ohio, 45206, United States|Case Comprehensive Cancer Center, Cleveland, Ohio, 44106, United States|Penn State University Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Greenville Hospital System University Medical Center (ITOR), Greenville, South Carolina, 29605, United States|Tennessee Cancer Specialists, Knoxville, Tennessee, 37909, United States|Texas Oncology, P.A. - Austin, Austin, Texas, 78705, United States|Mary Crowley Cancer Research Centers, Dallas, Texas, 75230, United States|Texas Oncology, P.A. - Fort Worth, Fort Worth, Texas, 76104, United States|Oncology Consultants, P.A., Houston, Texas, 77030, United States|University of Texas M. D. Anderson Cancer Center - Investigational Cancer Therapeutics, Houston, Texas, 77030, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, 78229, United States|Texas Oncology, P.A. - Tyler, Tyler, Texas, 75702, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States|Virginia Oncology Associates - Hampton, Norfolk, Virginia, 23502, United States|Compass Oncology, Vancouver, Washington, 98684, United States|Blacktown Hospital, Blacktown, New South Wales, 2148, Australia|St George Hospital, Kogarah, New South Wales, 2217, Australia|Liverpool Hospital, Liverpool, New South Wales, 2170, Australia|Port Macquarie Base Hospital, Port Macquarie, New South Wales, 2444, Australia|Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia|Calvary Mater Newcastle, Waratah, New South Wales, 2298, Australia|Gallipoli Medical Research Foundation Ltd, Greenslopes, Queensland, 4120, Australia|Tasman Oncology Research Ltd, Southport, Queensland, 4216, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia|Peter MacCallum Cancer Centre-East Melbourne, East Melbourne, Victoria, 3002, Australia|Cabrini Hospital Malvern, Malvern, Victoria, 3144, Australia|Border Medical Oncology Research Unit, Wodonga, Victoria, 3690, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, 6150, Australia|Linear Clinical Research Limited, Nedlands, Western Australia, 6009, Australia|Institut Jules Bordet, Brussels, 1000, Belgium|Cliniques Universitaires Saint-Luc, Brussels, 1200, Belgium|Grand Hôpital de Charleroi, Charleroi, 6000, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|Universitair Ziekenhuis Gent, Ghent, 9000, Belgium|Centre Hospitalier de l'Ardenne, Libramont, 6800, Belgium|C. H. U. Sart Tilman, Liège, 4000, Belgium|GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk, 2610, Belgium|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|Centre Antoine Lacassagne, Nice, Alpes Maritimes, 06189, France|Centre Paul Strauss, Strasbourg, Bas Rhin, 67000, France|Hôpital de la Timone#, Marseille, Bouches-du-Rhône, 13385, France|Centre Georges François Leclerc, Dijon, Côte-d'Or, 21079, France|CHU Bordeaux - Hôpital Saint André, Bordeaux, Gironde, 33075, France|Institut Claudius Regaud-Oncopole, Toulouse, Haute Garonne, 31059, France|CHU de Grenoble - Hôpital Nord, Grenoble, Isere, 38043, France|ICO - Site René Gauducheau, Saint-Herblain, Loire Atlantique, 44805, France|Centre Oscar Lambret, Lille, Nord, 59020, France|Institut Curie - Centre de Lutte Contre le Cancer (CLCC) de Paris, Paris, Paris, 75248, France|Hôpital Saint-Louis, Paris, Paris, 75475, France|Groupe Hospitalier Pitie-Salpetriere, Paris, Paris, 75571, France|Centre Léon Bérard, Lyon, Rhone, 69008, France|Centre Hospitalier de la Croix Rousse, Lyon, Rhone, 69317, France|Hôpital Henri Mondor, Créteil, Val De Marne, 94010, France|Institut Régional du Cancer de Montpellier, Montpellier, 34298, France|Medizinische Hochschule Hannover, Hanover, Lower Saxony, 30625, Germany|Cellex Koeln, Cologne, North Rhine-Westphalia, 50670, Germany|Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Saxony, 01307, Germany|Charite Universitaetsmedizin Berlin - Campus Charite Mitte, Berlin, 10117, Germany|Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo, Torino, 10060, Italy|Ospedale San Raffaele, Milan, 20132, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy|IEO Istituto Europeo di Oncologia, Milan, 20141, Italy|Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, 80131, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, 56126, Italy|Policlinico Universitario Agostino Gemelli, Roma, 00168, Italy|A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena, 53100, Italy|National Cancer Center Hospital East, Kashiwa-shi, Chiba, 277-8577, Japan|Kindai University Hospital, Osakasayama-shi, Osaka, 589-8511, Japan|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea|Chungbuk National University Hospital, Cheongju-si, North Chungcheong, 28644, South Korea|Pusan National University Hospital, Busan, 49241, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 135-710, South Korea|Hospital Infanta Cristina, Badajoz, 06080, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clinic i Provincial de Barcelona, Barcelona, 08036, Spain|Hospital General Universitario Gregorio Marañon, Madrid, 28007, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Centro Integral Oncologico Clara Campal, Madrid, 28050, Spain|Hospital Universitario Virgen Macarena, Seville, 41009, Spain|Hospital Universitario Virgen del Rocio, Seville, 41013, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|National Taiwan University Hospital, Taipei, 100, Taiwan|Mackay Memorial Hospital, Taipei, 104, Taiwan|Taipei Medical University Hospital, Taipei, 110, Taiwan|Guy's Hospital, London, Greater London, SE1 9RT, United Kingdom|University College London Hospitals, London, Greater London, WC1E 6AG, United Kingdom|The Christie, Manchester, Greater Manchester, M20 4BX, United Kingdom|Southampton General Hospital, Southampton, Hampshire, SO16 6YD, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, Strathclyde, G12 OYN, United Kingdom|Northern Centre for Cancer Care, Newcastle upon Tyne, Tyne & Wear, NE7 7DN, United Kingdom|Queen Elizabeth Hospital, Birmingham, West Midlands, B15 2TG, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: BI 905681,ALL,"ADULT, OLDER_ADULT",PHASE1,21,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/23/19,5/27/21,"Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: INCB057643|DRUG: Gemcitabine|DRUG: Paclitaxel|DRUG: Rucaparib|DRUG: Abiraterone|DRUG: Ruxolitinib|DRUG: Azacitidine,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,137,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/18/16,2/13/19,"University of Alabama, Birmingham, Alabama, 35294-3300, United States|University of California, La Jolla, California, 92093, United States|Sarah Cannon Research Institute at Health One, Denver, Colorado, 80218, United States|Yale University, New Haven, Connecticut, 06510, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Hematology - Oncology Associates of Treasure Coast, Port Saint Lucie, Florida, 34952, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Washington University, St Louis, Missouri, 63110, United States|University of Rochester, Wilmot Cancer Center, Rochester, New York, 14642, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, 27157, United States|Oncology Consultants, P.A., Houston, Texas, 77030, United States|The Methodist Hospital, Houston, Texas, 77030, United States|Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|MultiCare Institute for Research and Innovation, Tacoma, Washington, 98405, United States|Institut Jules Bordet, Clinical Trial Conduct Unit, Brussels, B-1000, Belgium|HÔPITAL SAINT-LOUIS, Service Hématologie Adultes, Paris, 75010, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,"DRUG: Regorafenib, (Stivarga, BAY73-4506)|DRUG: Nivolumab (Opdivo)",ALL,"ADULT, OLDER_ADULT",PHASE2,175,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/3/21,3/29/24,"City of Hope - Duarte Cancer Center, Duarte, California, 91010, United States|Rocky Mountain Cancer Centers / Aurora, CO, Aurora, Colorado, 80012, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Sarah Cannon Cancer Center, Nashville, Tennessee, 37203, United States|Baylor Charles A. Sammons Cancer Center at Dallas, Dallas, Texas, 75246, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Hôpital Erasme/Erasmus Ziekenhuis, Brussels, 1070, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|CHU de Liège, Liège, 4000, Belgium|Institut Bergonie - Unicancer Nouvelle Aquitaine, Bordeaux, 33076, France|UNICANCER - Centre Leon Berard (CLB), Lyon, 69008, France|APHP-Hopital la Pitie Salpetriere, Paris, 75651, France|Institut de Cancerologie Ouest - Saint-Herblain, Saint-Herblain, 44800, France|Institut Claudius Regaud - iUCT Oncopole, Toulouse, 31059, France|Gustave Roussy - Departement Oncologie-Radiotherapie, Villejuif, 94805, France|AUSL di Bologna_Istituto delle Scienze Neurologiche - UO Oncologia del Sistema Nervoso, Bologna, Emilia-Romagna, 40139, Italy|IRCCS Foundation Istituto Neurologico Carlo Besta, Milan, Lombardy, 20133, Italy|Humanitas Mirasole S.p.A. - Oncologia Medica ed Ematologia, Rozzano, Lombardy, 20089, Italy|Istituto Oncologico Veneto_Padova - UOC Oncologia 1, Padua, Veneto, 35128, Italy|ASST Grande Ospedale Metropolitano Niguarda - Oncologia Falck, Milan, 20162, Italy|Aichi Cancer Center Hospital, Nagoya, Aichi-ken, 464-8681, Japan|Kobe University Hospital, Kobe, Hyōgo, 650-0017, Japan|Saitama Cancer Center, Kitaadachi-gun, Saitama, 362-0806, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, 135-8550, Japan|Severance Hospital, Yonsei University Health System, Seoul, Seoul Teugbyeolsi, 03722, South Korea|Seoul National University Hospital, Seoul, Seoul Teugbyeolsi, 3080, South Korea|Chi Mei Medical Center, Taikang, Tainan, 71004, Taiwan|China Medical University Hospital, Taichung, 404327, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Royal Marsden NHS Trust (Surrey), Sutton, Surrey, SM2 5PT, United Kingdom|University Hospitals Coventry and Warwickshire NHS Trust, Coventry, West Midlands, CV2 2DX, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|The Royal Marsden NHS Foundation Trust | The Royal Marden Hospital - The Royal Marsden Clinical Trials Unit (CTU), London, SW3 6JJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Locally Advanced Malignant Neoplasm|Breast Cancer,DRUG: Propranolol|OTHER: DOT imaging|DRUG: Paclitaxel|DRUG: Nab-paclitaxel|DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Doxorubicin|DRUG: Cyclophosphamide|PROCEDURE: Surgery|DRUG: Premedication|DRUG: Anti-nausea therapy|DRUG: Pegfilgrastim,FEMALE,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,2012-10,10/16/19,"Columbia University Irving Medical Center, New York, New York, 10032, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: PF-06671008|DRUG: PF-06671008,ALL,"ADULT, OLDER_ADULT",PHASE1,28,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/28/16,3/29/19,"Memorial Sloan Kettering Cancer Center - Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center- Clinical Trials Office, New York, New York, 10017, United States|Memorial Sloan Kettering Cancer Center Rockefeller Outpatient Pavillion, New York, New York, 10022, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|The University of Texas - M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Huntsman Cancer Hospital, Salt Lake City, Utah, 84112, United States|Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Metastatic Neoplasm,DRUG: Vociprotafib|DRUG: Pembrolizumab|DRUG: Adagrasib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,65,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/9/20,4/4/24,"University of California Irvine Medical Center- Site Number : 8400002, Orange, California, 92868, United States|The University of Texas MD Anderson Cancer Center- Site Number : 8400001, Houston, Texas, 77030, United States|Investigational Site Number : 0320003, Rosario, Santa Fe Province, 2000, Argentina|Investigational Site Number : 0320001, Buenos Aires, 1019, Argentina|Investigational Site Number : 0320004, Buenos Aires, 1093, Argentina|Investigational Site Number : 0320002, Buenos Aires, 1125, Argentina|Investigational Site Number : 0360002, Sydney, New South Wales, 2031, Australia|Investigational Site Number : 0360001, Woolloongabba, Queensland, 4102, Australia|Investigational Site Number : 0360003, Melbourne, Victoria, 3084, Australia|Investigational Site Number : 1520002, Temuco, La Araucanía, 4780000, Chile|Investigational Site Number : 1520001, Santiago, Reg Metropolitana de Santiago, 8420383, Chile|Investigational Site Number : 1520003, Viña del Mar, Región de Valparaíso, 2520598, Chile|Investigational Site Number : 4100002, Seongnam-si, Gyeonggi-do, 13496, South Korea|Investigational Site Number : 4100003, Cheongju-si, North Chungcheong, 28644, South Korea|Investigational Site Number : 4100001, Seoul, Seoul-teukbyeolsi, 03722, South Korea|Investigational Site Number : 7240001, Madrid, 28040, Spain|Investigational Site Number : 7240002, Madrid, 28050, Spain|Investigational Site Number : 7240003, Valencia, 46010, Spain|Investigational Site Number : 1580002, Tainan, 704, Taiwan|Investigational Site Number : 1580001, Taipei, 100, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Thoracic Neoplasm,DRUG: Metformin,ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,18,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,5/15/18,11/30/21,"Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Solid Tumors|Treatment-Refractory Cancers,DRUG: rhIL-15|DRUG: Ipilimumab|DRUG: Nivolumab|PROCEDURE: Tumor biopsies|DIAGNOSTIC_TEST: EKG|DIAGNOSTIC_TEST: ECHO|DIAGNOSTIC_TEST: CT Scan,ALL,"ADULT, OLDER_ADULT",PHASE1,31,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/5/18,5/8/25,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: Epacadostat|DRUG: Nivolumab|DRUG: Ipilimumab|DRUG: Lirilumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,11,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/21/18,1/29/21,"University of Alabama at Birmingham, Birmingham, Alabama, 35294, United States|The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|John Wayne Cancer Institute, Santa Monica, California, 90404, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Cancers|Malignant Pleural Effusions,BEHAVIORAL: Questionnaires|DRUG: Fentanyl Patch|DRUG: Fentanyl (IV)|OTHER: Saline|DRUG: Doxycycline|BEHAVIORAL: Phone Calls,ALL,"ADULT, OLDER_ADULT",PHASE4,3,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",4/27/16,5/23/17,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: INCB001158|DRUG: Epacadostat|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,5,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/1/18,3/30/19,"University of Alabama, Birmingham, Alabama, 35294-3300, United States|The University of Chicago Medicine, Chicago, Illinois, 60637, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors,DRUG: Drug: Everolimus|DRUG: STZ-5FU,ALL,"ADULT, OLDER_ADULT",PHASE3,141,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,10/27/14,7/12/21,"Aarhus Aarhus University Hospital NET Centre (AUH-NET), Aarhus, 8000, Denmark|Rigshospitalet NET CoE, University of Copenhagen, Copenhagen, 2100, Denmark|Odense University Hospital, Odense, 5000, Denmark|Brest Hopital Augustin Morvan, Institut de Cancero-Hemato, Brest, Brest Cedex, 29609, France|Clichy Neuroendocrine Tumor (NET) Center Hôpital Beaujon, Clichy, Clichy Cedex, 92118, France|Institut Gustave-Roussy, Villejuif, Paris, France|Hôpitaux Universitaires de Strasbourg Hôpital de Hautepierre, Strasbourg, Strasbourg Cedex, 67098, France|UTTIOM Unité Transversale de Thérapeutiques Innovantes en Oncologie Médicale CHU Angers, Angers, France|University Hospital of Bordeaux Hôpital Saint-André, Bordeaux, 33075, France|Hôpital Edouard Herriot, Lyon, France|Hôpital La Timone, Marseille, France|Bad Berka ChA Klinik für Innere Medizin, Bad Berka, 99437, Germany|Berlin Charité Universitätsmedizin, Berlin, Germany|Köln Universitätsklinikum Köln (AöR), Cologne, 50937, Germany|UKM Facharzt für Innere Medizin Gastroenterologie, Onkologische Gastroenterologie (DGVS), Halle, Germany|Medizinische Klinik und Poliklinik , Universitätsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|Magdeburg Universitätsklinikum Magdeburg A. ö. R, Magdeburg, 39120, Germany|Mainz Universitätsmedizin, Mainz, Germany|Marburg Universitätsklinikum Giessen und Marburg GmbH, Marburg, 35033, Germany|Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM) at the University of Munich, München, 81377, Germany|Medizin II am Klinik und Poliklinik rechts der Isar, München, 81675, Germany|Istituto Nazionale Tumori (Fondazione G Pascale), Napoli, Naples, 80131, Italy|Istituto Europeo di Oncologia- IRCCS, Milan, Italy|Amsterdam Academic Medical Center, Amsterdam, 1105AZ, Netherlands|UMCG / University of Groningen, Groningen, Netherlands|Maastricht UMC, Maastricht, Netherlands|Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain|Instituto Catalán de Oncología de Hospitalet, L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Hospital Central de Asturias, Oviedo, Principality of Asturias, 33006, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|HCU Virgen de la Victoria, Málaga, 29010, Spain|Hospital Universitario Virgen del Rocío, Seville, 41013, Spain|University Hospital, Uppsala, 75185, Sweden|Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom|The Royal Marsden, Sutton, Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: talazoparib,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/30/20,12/14/21,"Jilin Cancer Hospital, Changchun, Jilin, 130000, China|Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: BI 905677,ALL,"ADULT, OLDER_ADULT",PHASE1,37,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/8/18,7/27/22,"University of Southern California, Los Angeles, California, 90033, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|National Cancer Center Hospital East, Chiba, Kashiwa, 277-8577, Japan|Erasmus MC Kanker Instituut, Rotterdam, 3015 CN, Netherlands|Hospital Vall d'Hebron, Barcelona, 08035, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: TSR-033|DRUG: Dostarlimab|DRUG: mFOLFOX6|DRUG: FOLFIRI|DRUG: Bevacizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,111,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/8/17,2/13/23,"GSK Investigational Site, Los Angeles, California, 90095, United States|GSK Investigational Site, Whittier, California, 90603, United States|GSK Investigational Site, Sarasota, Florida, 34232, United States|GSK Investigational Site, Tampa, Florida, 33612, United States|GSK Investigational Site, Boston, Massachusetts, 02115, United States|GSK Investigational Site, Cleveland, Ohio, 44106, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73104, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15232, United States|GSK Investigational Site, Greenville, South Carolina, 29605, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, Villejuif, 94805, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: INCB053914|DRUG: I-DAC (Intermediate dose cytarabine)|DRUG: Azacitidine|DRUG: Ruxolitinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,97,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/29/15,8/11/20,"The University of Arizona Cancer Center, Tucson, Arizona, 85719, United States|UC Davis comprehensive Cancer Center, Sacramento, California, 95817, United States|UCLA Medical Hematology & Oncology, Santa Monica, California, 90095, United States|Yale University, New Haven, Connecticut, 06511, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|Florida Cancer Specialists & Research Institute, Sarasota, Florida, 33916, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Emory University-Winship Cancer Institute, Atlanta, Georgia, 30322, United States|University of Maryland, Baltimore, Maryland, 21201, United States|Dana-Farber Cancer Center, Boston, Massachusetts, 02215, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|University of Nebraska Medical Center, Omaha, Nebraska, 69198, United States|Oncology Hematology Care Clinical Trials LLC, Cincinnati, Ohio, 45236, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Texas Oncology, Austin, Texas, 78705, United States|Texas Oncology, Tyler, Texas, 75702, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Leukemia|Lymphoid Malignancies|Metastatic Malignant Neoplasm to the Leptomeninges,DRUG: Intrathecal Rituximab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/24/13,3/23/17,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: feladilimab|DRUG: Tremelimumab|DRUG: Docetaxel|DRUG: Paclitaxel|DRUG: Cetuximab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,26,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/26/18,9/16/21,"GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, New York, New York, 10016-4744, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15232, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, Melbourne, Victoria, 3000, Australia|GSK Investigational Site, Ottawa, Ontario, K1H 8L6, Canada|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: Relacorilant with nab-paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,85,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/23/16,9/12/20,"038, Scottsdale, Arizona, 85258, United States|014, San Francisco, California, 94143, United States|001, Chicago, Illinois, 60637, United States|013, Ogden, Utah, 84403, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastroenteropancreatic Neuroendocrine Tumors,DRUG: Lanreotide|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/1/17,6/7/22,"Duke University Medical Center, Durham, North Carolina, 27710, United States|Lexington Medical Center, Columbia, South Carolina, 29169, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Lisavanbulin Phase 1 dose escalation portion|DRUG: Lisavanbulin Phase 2a expansion portion,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,72,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/20/15,11/24/22,"UZ Leuven, Leuven, 3000, Belgium|Klinikum der Goethe-Universität Frankfurt, Frankfurt, 60528, Germany|Universitätsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitätsklinikum Regensburg, Regensburg, 93053, Germany|Universitätsklinikum Tübingen, Tübingen, 72076, Germany|Universitätsspital Basel, Basel, 4031, Switzerland|Inselspital Universitätsspital Bern, Bern, 3010, Switzerland|Kantonsspital St. Gallen, Sankt Gallen, 9007, Switzerland|Universitätsspital Zürich, Zurich, 8091, Switzerland|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|University College London NHS Foundation Trust, London, NW1 2BU, United Kingdom|Sir Bobby Robson Cancer Trials Research Centre; Northern Centre for Cancer Care, Newcastle upon Tyne, NE7 7DN, United Kingdom|Royal Marsden Hospital, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: Curcumin|DRUG: Placebo,FEMALE,"ADULT, OLDER_ADULT",PHASE2,7,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,11/20/17,10/30/18,"Grady Memorial Hospital, Atlanta, Georgia, 30303, United States|Grady Hospital - Ponce De Leon Clinic, Atlanta, Georgia, 30308, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Relapsed/Refractory B-cell Malignancies,DRUG: Tirabrutinib,ALL,"ADULT, OLDER_ADULT",PHASE1,29,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/10/15,12/30/20,"CHRU de Lille, Lille, Nord, 59037, France|Hopital Saint Eloi, Montpellier, 34295, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, 69310, France|University Hospital of Wales, Cardiff, CF14 4XW, United Kingdom|Leicester Royal Infirmary, Leicester, LE1 5WW, United Kingdom|Derriford Hospital, Plymouth, PL68DH, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Brain Tumors|Spinal Cord Tumors,DRUG: Temozolomide|DRUG: Lapatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,58,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2009-01,7/31/18,"University of California, San Francisco, San Francisco, California, 94143, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, 53792, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumors,DRUG: Satoreotide tetraxetan|OTHER: Amino acid solution|OTHER: Antiemetic,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,40,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/6/17,2/22/22,"MD Anderson Cancer Center, Department of Nuclear Medicine, Houston, Texas, 77030, United States|Peter MacCallum Cancer Centre, Molecular Imaging and Targeted Therapeutics Laboratory, East Melbourne, 3002, Australia|Ramsay Hollywood Private Hospital, Department of Nuclear Medicine, Perth, 6009, Australia|University Hospital Vienna, Department of Nuclear Medicine, Vienna, 1090, Austria|CHU de Quebec - Universite Laval Research Center, Department of Radiology and Nuclear Medicine, Québec, G1R2J6, Canada|University Hospital Aarhus, Department of Hepatology and Gastroenterology, Aarhus, 8000, Denmark|CHU de Nantes, Hotel Dieu, Service de Medecine Nucleaire, Nantes, 44093, France|University Hospital Basel, Department of Nuclear Medicine, Basel, 4031, Switzerland|Royal Free Hospital, Department of Nuclear Medicine, London, NW3 2QG, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Organ Malignancies|Adenoidcystic Carcinoma|Neuroendocrine Tumors,DRUG: Lenalidomide|DRUG: Everolimus,ALL,"ADULT, OLDER_ADULT",PHASE1,44,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/9/10,11/5/20,"Grady Health System, Atlanta, Georgia, 30303, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, 30322, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: PF-04518600|DRUG: PF-04518600|DRUG: PF-04518600 plus PF-05082566|DRUG: PF-04518600 plus PF-05082566,ALL,"ADULT, OLDER_ADULT",PHASE1,174,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/23/15,11/12/20,"The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California, 90025, United States|Keck Hospital of USC, Los Angeles, California, 90033, United States|LAC+USC Medical Center, Los Angeles, California, 90033, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Ronald Regan Medical Center, Los Angeles, California, 90095, United States|UCLA Hematology & Oncology Clinic, Los Angeles, California, 90095, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, 92663, United States|Medical Imaging Center of Southern California, Inc., Santa Monica, California, 90403, United States|Santa Monica UCLA Hematology & Oncology Clinic, Santa Monica, California, 90404, United States|UConn Health, Pharmacy, Farmington, Connecticut, 06030-2205, United States|UConn Health, Neag Comprehensive Cancer Center, Farmington, Connecticut, 06030, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Massachusetts General Hospital (MGH), Boston, Massachusetts, 02114, United States|Brigham & Women's Hospital (BWH), Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center (BIDMC), Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, 02215, United States|Massachusetts General/Chelsea HealthCare Center, Chelsea, Massachusetts, 02150, United States|Mass General/North Shore Center for Outpatient Care, Danvers, Massachusetts, 01923, United States|Mass General West, Waltham, Massachusetts, 02451, United States|Columbia University Medical Center - Herbert Irving Pavilion, New York, New York, 10032, United States|Methodist Hospital-Pathology, Houston, Texas, 77030, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States|Groupe hospitalier Pitie Salpetriere, Paris, 75013, France|Institut Gustave Roussy, Villejuif, 94805, France|National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan|The Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands|Slotervaart Hospital/Antoni van Leeuwenhoek, Amsterdam, 1066 EC, Netherlands|Erasmus MC, Rotterdam, 3015 GD, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: BAY94-9343 (Anetumab ravtansine),ALL,"ADULT, OLDER_ADULT",PHASE2,9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/3/19,5/18/22,"University of Chicago, Chicago, Illinois, 60637, United States|National Cancer Institute - Maryland, Bethesda, Maryland, 20892, United States|Sarah Cannon Cancer Center, Nashville, Tennessee, 37203, United States|Mary Crowley Medical Research Center, Dallas, Texas, 75230, United States|Hôpital de la Timone - Marseille, Marseille, 13385, France|ASST Grande Ospedale Metropolitano Niguarda, Milan, Lombardy, 20162, Italy|Samodzielny Publiczny Wojewodzki Szpital Zespolony, Szczecin-Zdunowo, 70-891, Poland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasm Metastasis,DRUG: 200 mg of pembrolizumab|BIOLOGICAL: V938,ALL,"ADULT, OLDER_ADULT",PHASE1,35,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/4/19,8/24/22,"UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0002), San Francisco, California, 94158, United States|MD Anderson Cancer Center ( Site 0001), Houston, Texas, 77030, United States|Huntsman Cancer Institute ( Site 0004), Salt Lake City, Utah, 84112, United States|Princess Margaret Cancer Centre ( Site 0010), Toronto, Ontario, M5G 2M9, Canada|Rambam Health Care Campus-Oncology Division ( Site 0020), Haifa, 3109601, Israel|Chaim Sheba Medical Center ( Site 0021), Ramat Gan, 5265601, Israel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Pediatric Cancer|Solid Tumor Pediatric|Hematological Malignancies,DRUG: Durvalumab / Tremelimumab Combination Therapy,ALL,"CHILD, ADULT",PHASE1|PHASE2,50,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/7/19,12/30/24,"Research Site, Baltimore, Maryland, 21231, United States|Research Site, Boston, Massachusetts, 02115, United States|Research Site, New Hyde Park, New York, 11040, United States|Research Site, Oklahoma City, Oklahoma, 73104, United States|Research Site, Charleston, South Carolina, 29425, United States|Research Site, Lille, 59020, France|Research Site, Marseille, 13385, France|Research Site, Paris, 75248, France|Research Site, Cologne, 50924, Germany|Research Site, Genova, 16100, Italy|Research Site, Milan, 20133, Italy|Research Site, Rome, 00165, Italy|Research Site, Torino, 10126, Italy|Research Site, Utrecht, 3584 CS, Netherlands|Research Site, Barcelona, 08035, Spain|Research Site, Madrid, 28009, Spain|Research Site, Leeds, LS1 3EX, United Kingdom|Research Site, London, WC1N 3JH, United Kingdom|Research Site, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: GSK3901961|DRUG: GSK3845097|DRUG: GSK4427296|DRUG: Cyclophosphamide|DRUG: Fludarabine,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/21/20,6/8/23,"GSK Investigational Site, Jacksonville, Florida, 32224, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Westwood, Kansas, 66205, United States|GSK Investigational Site, Lexington, Kentucky, 40536, United States|GSK Investigational Site, Baltimore, Maryland, 21287, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Melbourne, Victoria, 3000, Australia|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Montreal, Quebec, H1T 2M4, Canada|GSK Investigational Site, Munich, Bavaria, 81377, Germany|GSK Investigational Site, Cologne, North Rhine-Westphalia, 50937, Germany|GSK Investigational Site, Dresden, Saxony, 01307, Germany|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Stockholm, SE-171 64, Sweden",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: 750 milligram Xentuzumab|DRUG: 1000 milligram Xentuzumab|DRUG: 1400 milligram Xentuzumab,ALL,"ADULT, OLDER_ADULT",PHASE1,21,INTERVENTIONAL,Allocation: NA|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/11/14,7/14/23,"National Cancer Center Hospital East, Chiba, Kashiwa, 277-8577, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pediatric Solid Tumor|Refractory Tumor|Recurrent Tumor|CNS Malignancies,DRUG: Ramucirumab,ALL,"CHILD, ADULT",PHASE1,29,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/11/15,7/16/19,"Childrens Hospital of Alabama, Birmingham, Alabama, 35233, United States|Children's Oncology Group, Monrovia, California, 91016, United States|Childrens Hospital of Orange County, Orange, California, 92868, United States|University of California, San Francisco, San Francisco, California, 94158, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010-2970, United States|Children's Healthcare of Atlanta at Scottish Rite, Atlanta, Georgia, 30322, United States|Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Mark O Harfield-Warren Grant Magnuson Clinical Center, Bethesda, Maryland, 20892, United States|University of Michigan Health Systems, Ann Arbor, Michigan, 48109, United States|University of Minnesota Hospital, Minneapolis, Minnesota, 55455, United States|Washington University Medical School, St Louis, Missouri, 63110, United States|Columbia University Medical Center, New York, New York, 10032, United States|Children's Hospital Medical Center, Cincinnati, Ohio, 45229-3039, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania, 15224, United States|St Jude Childrens Research Hospital, Memphis, Tennessee, 38105, United States|Texas Childrens Hospital, Houston, Texas, 77030, United States|Seattle Children's Hospital Research Foundation, Seattle, Washington, 98105, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasm Metastasis,DRUG: methotrexate|DRUG: Cyclosporin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,42,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/12/99,8/13/20,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: BI 6727,ALL,"ADULT, OLDER_ADULT",PHASE1,65,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/4/05,4/6/21,"1230.1.32002 Boehringer Ingelheim Investigational Site, Brussels, Belgium|1230.1.32001 Boehringer Ingelheim Investigational Site, Leuven, Belgium",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasm,DRUG: DS-8201a,ALL,"ADULT, OLDER_ADULT",PHASE2,86,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2/23/18,11/10/20,"City of Hope Medical Center, Duarte, California, 91010, United States|University of Southern California, Los Angeles, California, 90089, United States|UCLA Health, Santa Monica, California, 90404, United States|Mayo Clinic Jacksonville, Jacksonville, Florida, 32224-1865, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Greenville Health System Cancer Institute, Greenville, South Carolina, 29605-4255, United States|West Cancer Center, Germantown, Tennessee, 38138, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|MD Anderson Cancer Center, University of Texas, Houston, Texas, 77030-4000, United States|Università degli studi della Campania L.Vanvitelli, Napoli, Campania, 80131, Italy|Oncology Institute Veneto IOV-IRCCS, Padua, Ferrara, 35128, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milan, Lombardo, 20162, Italy|Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, 20133, Italy|Aichi Cancer Center Hospital, Nagoya, Aichi-ken, 464-8681, Japan|National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, 791-0280, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, 060-8648, Japan|Kindai University Hospital, Ōsaka-sayama, Osaka, 589-8511, Japan|The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-Ku, Tokyo, 135-8550, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Clinica Universidad de Navarra, Pamplona, Navarre, 31008, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitari Clinic de Barcelona, Barcelona, 08036, Spain|Royal Marsden Institute (Chelsea), Chelsea, London, England, SM2 5PT, United Kingdom|Royal Marsden Institute (Sutton), Sutton, Surrey, England, SW3 6JJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Tumors,DRUG: BMS-986158|BIOLOGICAL: Nivolumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,83,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/19/15,3/17/21,"City Of Hope National Medical Center, Duarte, California, 91010, United States|University Of Colorado, Aurora, Colorado, 80045, United States|Dana Farber Cancer Institute., Boston, Massachusetts, 02215, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Univ. Of Pa, Philadelphia, Pennsylvania, 19104, United States|Institute for Translational Oncology Research-ITOR, Greenville, South Carolina, 29605, United States|Nucleus Network, Melbourne, Victoria, 3004, Australia|The Ottawa Hospital Cancer Centre, Ottawa, Ontario, K1H 8L6, Canada|Local Institution, Lyon, 69373, France|Local Institution, Villejuif, 94800, France|H. Univ. Vall dHebron, Barcelona, 08035, Spain|Centro Integral Oncologico Clara Campal, Madrid, 28050, Spain|Clinica Universidad de Navarra, Pamplona, 31008, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: GSK3901961|DRUG: Cyclophosphamide|DRUG: Fludarabine,ALL,"ADULT, OLDER_ADULT",PHASE1,7,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/9/21,6/8/23,"GSK Investigational Site, New Haven, Connecticut, 06504, United States|GSK Investigational Site, Jacksonville, Florida, 32224, United States|GSK Investigational Site, Tampa, Florida, 33612, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Westwood, Kansas, 66205, United States|GSK Investigational Site, Lexington, Kentucky, 40536, United States|GSK Investigational Site, Baltimore, Maryland, 21287, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19111, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Melbourne, Victoria, 3000, Australia|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Montreal, Quebec, H1T 2M4, Canada|GSK Investigational Site, Munich, Bavaria, 81377, Germany|GSK Investigational Site, Hanover, Lower Saxony, 30625, Germany|GSK Investigational Site, Cologne, North Rhine-Westphalia, 50937, Germany|GSK Investigational Site, Dresden, Saxony, 01307, Germany|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Stockholm, SE-171 64, Sweden",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: lenvatinib|DRUG: pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/12/17,4/15/20,"Eisai Trial Site 1, Chuo-ku, Tokyo, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: DS-8201a (DP1)|DRUG: DS-8201a (DP2)|DRUG: DS-8201a (DP),ALL,"ADULT, OLDER_ADULT",PHASE1,292,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/1/15,12/22/23,"Sharp Memorial Hospital, San Diego, California, 92123, United States|Mayo Clinic, Jacksonville, Florida, 32224, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|UC Health Clinical Trials Office, Cincinnati, Ohio, 45229, United States|University of Texas M. D. Anderson Cancer Center, Houston, Texas, 77030-3721, United States|Aichi Cancer Center Hospital, Aichi, Japan|National Cancer Center Hospital East, Chiba, Japan|Social Medical Corporation Hakuaikai Sagara Hospital, Kagoshima, Japan|Kindai University Hospital, Osaka, Japan|National Cancer Center Hospital, Tokyo, Japan|The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Tokyo, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: GSK3326595|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,297,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/30/16,8/30/23,"GSK Investigational Site, Denver, Colorado, 80218, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, Edmonton, Alberta, T6G 1Z2, Canada|GSK Investigational Site, Ottawa, Ontario, K1H 8L6, Canada|GSK Investigational Site, Toronto, Ontario, M5G 1Z5, Canada|GSK Investigational Site, Bordeaux, 33076, France|GSK Investigational Site, Lyon, 69373, France|GSK Investigational Site, Villejuif, 94805, France|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Leiden, 2333 ZA, Netherlands|GSK Investigational Site, Rotterdam, 3015 GD, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: GSK3174998|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,141,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/11/15,4/29/20,"GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, New York, New York, 10016, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Villejuif, 94805, France|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Neoplasms, Ovarian",DRUG: MORAb-202|DRUG: Paclitaxel|DRUG: Pegylated Liposomal Doxorubicin (PLD)|DRUG: Topotecan,FEMALE,"ADULT, OLDER_ADULT",PHASE2,106,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/1/23,9/11/25,"Local Institution - 0065, Sacramento, California, 95817, United States|Local Institution - 0025, San Francisco, California, 94109, United States|Local Institution - 0078, Whittier, California, 90602-3171, United States|Local Institution - 0081, South Bend, Indiana, 46601-1033, United States|Local Institution - 0043, Kansas City, Kansas, 66160, United States|Local Institution - 0023, Canton, Ohio, 44710-1702, United States|Local Institution - 0061, Columbus, Ohio, 43219, United States|Local Institution - 0044, Nashville, Tennessee, 37203-1625, United States|Local Institution - 0082, Salt Lake City, Utah, 84124, United States|Local Institution - 0042, Spokane, Washington, 99204, United States|Local Institution - 0016, Sydney, New South Wales, 2065, Australia|Local Institution - 0017, Waratah, New South Wales, 2298, Australia|Local Institution - 0031, Chermside, Queensland, 4032, Australia|Local Institution - 0015, Clayton, Victoria, 3168, Australia|Local Institution - 0027, Malvern, Victoria, 3144, Australia|Local Institution - 0058, Nedlands, Western Australia, 6009, Australia|Local Institution - 0032, Leuven, VBR, 3000, Belgium|Local Institution - 0013, Namur, WNA, 5000, Belgium|Local Institution - 0012, Brussels, 1200, Belgium|Local Institution - 0045, Liège, 4000, Belgium|Local Institution - 0030, Santiago, RM, 8420323, Chile|Local Institution - 0036, Santiago, 7510032, Chile|Local Institution - 0029, Temuco, 4800827, Chile|Local Institution - 0046, Jerusaelm, JM, 9112001, Israel|Local Institution - 0054, Haifa, 31999, Israel|Local Institution - 0080, Jerusalem, 91031, Israel|Local Institution - 0055, Ramat Gan, 5265601, Israel|Local Institution - 0048, Tel Aviv, 64239, Israel|Local Institution - 0003, Bologna, BO, 40138, Italy|Local Institution - 0011, Milan, MI, 20132, Italy|Local Institution - 0009, Milan, MI, 20141, Italy|Local Institution - 0010, Roma, RM, 00168, Italy|Local Institution - 0002, Brescia, 25123, Italy|Local Institution - 0018, Akashi, Hyogo, 673-8558, Japan|Local Institution - 0019, Chūōku, 104-0045, Japan|Local Institution - 0014, Hidaka-shi, 350-1298, Japan|Local Institution - 0004, Kurume-Shi, 830-0011, Japan|Local Institution - 0037, Tokyo, 135-8550, Japan|Local Institution - 0056, Seoul, 03080, South Korea|Local Institution - 0049, Seoul, 03722, South Korea|Local Institution - 0053, Seoul, 5505, South Korea|Local Institution - 0039, Barcelona, B, 08035, Spain|Local Institution - 0005, Madrid, M, 28007, Spain|Local Institution - 0001, Madrid, M, 28041, Spain|Local Institution - 0007, Valencia, V, 46009, Spain|Local Institution - 0006, Valencia, V, 46010, Spain|Local Institution - 0021, Barcelona, 08036, Spain|Local Institution - 0020, Girona, 17007, Spain|Local Institution - 0038, Madrid, 28033, Spain|Local Institution - 0022, Madrid, 28046, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: GSK1795091|DRUG: GSK3174998|DRUG: GSK3359609|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,54,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/26/18,3/11/22,"GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Tacoma, Washington, 98405, United States|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Barcelona, 08035, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: BI 1387446 50 μg|DRUG: BI 754091|DRUG: BI 1387446 100 μg|DRUG: BI 1387446 200 μg|DRUG: BI 1387446 400 μg,ALL,"ADULT, OLDER_ADULT",PHASE1,42,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/3/20,3/21/24,"The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27514, United States|Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Hospital Vall d'Hebron, Barcelona, 08035, Spain|CIO Clara Campal, Madrid, 28050, Spain|Hospital Clínico de Valencia, Valencia, 46010, Spain|The Royal Marsden Hospital, Chelsea, London, SW3 6JJ, United Kingdom|Churchill Hospital, Oxford, OX3 7LE, United Kingdom|The Royal Marsden Hospital, Sutton, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Carcinoid Tumor|Carcinoid Tumor of GI System|Neuroendocrine Tumors,DRUG: Nivolumab|DRUG: Cabozantinib,ALL,"ADULT, OLDER_ADULT",PHASE2,19,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/26/19,1/31/24,"Boston Medical Center, Boston, Massachusetts, 02118, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasm Metastasis,BIOLOGICAL: Gebasaxturev|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,76,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/28/20,7/25/23,"John Theurer Cancer Center ( Site 0004), Hackensack, New Jersey, 07601, United States|Providence Portland Medical Center ( Site 0001), Portland, Oregon, 97213, United States|Princess Margaret Cancer Centre ( Site 0031), Toronto, Ontario, M5G 2M9, Canada|Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0032), Montreal, Quebec, H2X 3E4, Canada|Centre Hospitalier Lyon-Sud ( Site 0055), Pierre-Bénite, Auvergne-Rhône-Alpes, 69495, France|Hopital La Timone ( Site 0051), Marseille, Bouches-du-Rhone, 13005, France|Gustave Roussy ( Site 0053), Villejuif, Val-de-Marne, 94800, France|Universitaetsklinikum Heidelberg-Nationales Centrum für Tumorerkrankungen ( Site 0172), Heidelberg, Baden-Wurttemberg, 69120, Germany|Universitaetsklinikum Tuebingen ( Site 0171), Tübingen, Baden-Wurttemberg, 72076, Germany|Orszagos Onkologiai Intezet ( Site 0070), Budapest, 1122, Hungary|HaEmek Medical Center ( Site 0071), Afula, 1834111, Israel|Hadassah Medical Center. Ein Kerem ( Site 0072), Jerusalem, 9112001, Israel|Sourasky Medical Center ( Site 0073), Tel Aviv, 6423906, Israel|Istituto Europeo di Oncologia IRCCS-Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative (, Milan, 20141, Italy|National Cancer Center Hospital East ( Site 0166), Kashiwa, Chiba, 277-8577, Japan|Helse Bergen HF - Haukeland Universitetssykehus ( Site 0162), Bergen, Hordaland, 5021, Norway|Oslo Universitetssykehus Radiumhospitalet ( Site 0161), Oslo, 0379, Norway|Clinica San Gabriel ( Site 0097), Lima, 15087, Peru|Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Oddzial Badan Wczesnych Faz ( Site 0181, Warsaw, Masovian Voivodeship, 02-781, Poland|Centro Hospitalar Universitário Lisboa Norte, E.P.E. - Hospital de Santa Maria ( Site 0192), Lisbon, Lisbon District, 1649-035, Portugal|Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 0191), Porto, 4200-072, Portugal|Hospital Universitari Vall d Hebron ( Site 0121), Barcelona, 08035, Spain|Clinica Universitaria de Navarra ( Site 0122), Madrid, 28027, Spain|Chang Gung Medical Foundation - Kaohsiung ( Site 0145), Kaohsiung City, 833, Taiwan|China Medical University Hospital ( Site 0144), Taichung, 40447, Taiwan|National Cheng Kung University Hospital ( Site 0142), Tainan, 704, Taiwan|National Taiwan University Hospital ( Site 0141), Taipei, 10002, Taiwan|Mackay Memorial Hospital ( Site 0143), Taipei, 10449, Taiwan|Chang Gung Memorial Hospital - Linkou Branch ( Site 0146), Taoyuan District, 333, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: RO7296682|DRUG: Atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,49,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/4/21,1/4/24,"MD Anderson Cancer Center, Houston, Texas, 77030, United States|Peter Maccallum Cancer Institute, Melbourne, Victoria, 3000, Australia|Cliniques Universitaires St-Luc, Brussels, 1200, Belgium|BC Cancer Agency - Vancouver, Vancouver, British Columbia, V5Z 4E6, Canada|The Ottawa Hospital Cancer Centre, Ottawa, Ontario, K2H 6C2, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|Rigshospitalet, København Ø, 2100, Denmark|Clinica Universitaria de Navarra, Pamplona, Navarre, 31008, Spain|Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, 08035, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasm,DRUG: Dostarlimab|DRUG: Bevacizumab|DRUG: Niraparib,FEMALE,"ADULT, OLDER_ADULT",PHASE2,41,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/15/18,4/1/22,"GSK Investigational Site, Birmingham, Alabama, 35249, United States|GSK Investigational Site, Los Angeles, California, 90095, United States|GSK Investigational Site, Palo Alto, California, 94304, United States|GSK Investigational Site, Ventura, California, 93003, United States|GSK Investigational Site, Chicago, Illinois, 60637, United States|GSK Investigational Site, Boston, Massachusetts, 02114, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Rochester, Minnesota, 55905, United States|GSK Investigational Site, Durham, North Carolina, 27710, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73104, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms|Colorectal Neoplasms|Head and Neck Neoplasms,BIOLOGICAL: MK-1697,ALL,"ADULT, OLDER_ADULT",PHASE1,22,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/13/18,2/18/20,"Scientia Clinical Research ( Site 0100), Randwick, New South Wales, 2031, Australia|Queen Mary Hospital ( Site 0200), Hong Kong, Hong Kong",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Choroid Plexus Tumors,DRUG: Carboplatin|DRUG: Cyclophosphamide|DRUG: Etoposide|DRUG: Vincristine|RADIATION: Radiation Therapy,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,2,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/2/05,12/14/17,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Incurable Platinum Refractory Germ Cell Tumors|Tumors,DRUG: ASP1650,MALE,"ADULT, OLDER_ADULT",PHASE2,19,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/19/19,10/16/20,"Indiana University Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Abramson Cancer Center University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: Bintrafusp alfa,ALL,"ADULT, OLDER_ADULT",PHASE1,25,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/15/20,8/15/22,"GSK Investigational Site, Lake Success, New York, 11041, United States|GSK Investigational Site, Cincinnati, Ohio, 45229, United States|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Bordeaux, 33000, France|GSK Investigational Site, Poitiers, 86021, France|GSK Investigational Site, Toulouse, 31059, France|GSK Investigational Site, Villejuif, 94805, France|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Madrid, 28040, Spain|GSK Investigational Site, Madrid, 28041, Spain|GSK Investigational Site, Seville, 41013, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pancreatic Mucinous-Cystic Neoplasm,DRUG: NanoPac®,ALL,"ADULT, OLDER_ADULT",PHASE2,20,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/29/17,6/29/20,"Parkview Cancer Institute, Fort Wayne, Indiana, 46845, United States|The Ohio State University, Wexner Medical Center, Columbus, Ohio, 43210, United States|Texas Tech University Health Sciences Center, El Paso, Texas, 79905, United States|Baylor College of Medicine, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: [14C] Subasumstat|DRUG: Subasumstat,ALL,"ADULT, OLDER_ADULT",PHASE1,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/14/23,7/16/24,"Central Hospital of Northern Pest - Military Hospital, Budapest, 1062, Hungary|Pharmaceutical Research Associates Magyarorszag, Budapest, 1077, Hungary",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: GSK3368715|DRUG: GSK3368715,ALL,"ADULT, OLDER_ADULT",PHASE1,31,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/22/18,3/4/21,"GSK Investigational Site, Los Angeles, California, 90033, United States|GSK Investigational Site, Newport Beach, California, 92663, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19104-4206, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Salt Lake City, Utah, 84112, United States|GSK Investigational Site, Melbourne, Victoria, 3000, Australia|GSK Investigational Site, Toronto, Ontario, M5G 1X5, Canada|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Thyroid Neoplasm,DRUG: Valproic Acid|DRUG: Liothyronine Sodium,ALL,"ADULT, OLDER_ADULT",PHASE2,13,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/24/10,4/28/16,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: M3541|RADIATION: Palliative Radiotherapy (RT),ALL,"ADULT, OLDER_ADULT",PHASE1,15,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/6/17,4/27/20,"IU Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Washington University, St Louis, Missouri, 63110, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37212, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Lung Neoplasm,DRUG: risedronate|DRUG: Matching placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,84,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",7/12/19,3/2/22,"High Point Regional Medical Center, High Point, North Carolina, 27262, United States|Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, 27157, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumors,DRUG: Pembrolizumab Injection,ALL,"ADULT, OLDER_ADULT",PHASE2,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/4/17,3/11/19,"Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: GSK525762,ALL,"ADULT, OLDER_ADULT",PHASE2,111,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/14/14,4/30/20,"GSK Investigational Site, Little Rock, Arkansas, 72205, United States|GSK Investigational Site, Aurora, Colorado, 80045, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19104, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, East Melbourne, Victoria, 3002, Australia|GSK Investigational Site, Seoul, 03722, South Korea|GSK Investigational Site, Seoul, 06351, South Korea|GSK Investigational Site, Barcelona, 08036, Spain|GSK Investigational Site, Madrid, 28006, Spain|GSK Investigational Site, Madrid, 28040, Spain|GSK Investigational Site, Málaga, 29010, Spain|GSK Investigational Site, Salamanca, 37007, Spain|GSK Investigational Site, Cambridge, CB2 0QQ, United Kingdom|GSK Investigational Site, London, W12 0NN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Stomach Neoplasms|Esophageal Neoplasms,DRUG: Amivantamab,ALL,"ADULT, OLDER_ADULT",PHASE2,62,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/30/21,7/3/23,"National Cancer Center Hospital, Chūōku, 104 0045, Japan|National Cancer Center Hospital East, Kashiwa, 277 8577, Japan|Saitama Cancer center, Kitaadachi-gun, 362-0806, Japan|Niigata Cancer Center Hospital, Niigata, 951-8566, Japan|Hokkaido University Hospital, Sapporo, 060-8648, Japan|Tohoku University Hospital, Sendai, 980 8574, Japan|Osaka University Hospital, Suita-shi, 565-0871, Japan|Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, 113 8677, Japan|The Cancer Institute Hospital of JFCR, Tokyo, 135 8550, Japan|Yokohama City University Medical Center, Yokohama, 232 0024, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: volasertib|DRUG: itraconazole,ALL,"ADULT, OLDER_ADULT",PHASE1,28,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/4/13,4/22/21,"PRA Hungary Ltd., Phase I. Clinical Pharmacology Unit, Budapest, 1077, Hungary|National Institute of Oncology, Budapest, 1122, Hungary",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms,DRUG: Part A: Dose Escalation of Cantrixil|DRUG: Part B: Expansion Cohort of Cantrixil,FEMALE,"ADULT, OLDER_ADULT",PHASE1,32,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/5/16,3/24/20,"Peggy and Charles Stephenson Cancer Center, OU Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Lifespan Cancer Institute, Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Mary Crowley Cancer Research Center, Dallas, Texas, 75230, United States|Westmead Adults Hospital, Westmead, New South Wales, 2145, Australia|ICON Cancer Care, South Brisbane, Queensland, 4101, Australia|Flinders Medical Centre, Adelaide, South Australia, Australia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: BI 836880|DRUG: BI 754091,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,21,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/12/19,3/28/22,"Shizuoka Cancer Center, Shizuoka, Sunto-gun, 411-8777, Japan|National Cancer Center Hospital, Tokyo, Chuo-ku, 104-0045, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Cancers|Hematologic Disorder|Solid Tumors,DRUG: Dexamethasone|DRUG: Placebo|BEHAVIORAL: Questionnaires|DEVICE: Spirometer|OTHER: Phone Calls,ALL,"ADULT, OLDER_ADULT",PHASE2,52,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",2013-01,1/26/21,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,BIOLOGICAL: IMC-CS4,ALL,"ADULT, OLDER_ADULT",PHASE1,52,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/15/11,5/31/18,"The Angeles Clinic & Research Institute, Los Angeles, California, 90025, United States|Univ of California San Francisco, San Francisco, California, 94115, United States|Emory University, Atlanta, Georgia, 30322, United States|Columbia University College of Phys & Surgeons, New York, New York, 10032, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106-5055, United States|Ohio State University Medical Center, Columbus, Ohio, 43210, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Brain Tumors,"DRUG: temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid",ALL,"CHILD, ADULT",PHASE2,46,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2005-10,12/30/17,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|Emory University, Atlanta, Georgia, 30322, United States|Hawaii Pacific Health, Lihue, Hawaii, 96766, United States|Children's Memorial Hospital, Chicago, Illinois, 60614, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Children's Hospital and Clinics of Minnesota, Minneapolis, Minnesota, 55404, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Steven and Alexandra Cohen Children's Medical Center of New York- North Shore LIJ, New Hyde Park, New York, 11040, United States|NYU Hassenfeld Center, New York, New York, 10016, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Medical Univ. of South Carolina, Charleston, South Carolina, 29425, United States|Vanderbilt Univ., Nashville, Tennessee, 37240, United States|Children's Medical Center of Dallas, Dallas, Texas, 75235, United States|MD Anderson Cancer Center (MDACC), Houston, Texas, 77030, United States|Virginia Commonwealth Univ., Richmond, Virginia, 23284, United States|Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,BIOLOGICAL: ISA 101|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE2,33,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/23/15,11/30/21,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: Lete-cel|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,34,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/31/18,11/4/22,"GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, La Jolla, California, 92093-0987, United States|GSK Investigational Site, Sacramento, California, 95817, United States|GSK Investigational Site, Stanford, California, 94305, United States|GSK Investigational Site, Denver, Colorado, 80218, United States|GSK Investigational Site, Hollywood, Florida, 33021, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Chicago, Illinois, 60637, United States|GSK Investigational Site, Iowa City, Iowa, 52242, United States|GSK Investigational Site, Lexington, Kentucky, 40536, United States|GSK Investigational Site, Baltimore, Maryland, 21201, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Durham, North Carolina, 27710, United States|GSK Investigational Site, Columbus, Ohio, 43210, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19111, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15232, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Salt Lake City, Utah, 84112-5550, United States|GSK Investigational Site, Toronto, Ontario, M5G 1X6, Canada|GSK Investigational Site, Montreal, Quebec, H2X 0A9, Canada|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Groningen, 9713 GZ, Netherlands|GSK Investigational Site, Rotterdam, 3015 GD, Netherlands|GSK Investigational Site, Utrecht, 3584 CX, Netherlands|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Madrid, 28040, Spain|GSK Investigational Site, Madrid, 28050, Spain|GSK Investigational Site, London, WC1E 6AG, United Kingdom|GSK Investigational Site, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene,DRUG: Pioglitazone,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2012-04,3/31/17,"University of Colorado, Aurora, Colorado, 80045, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: MK-1775 (AZD1775),ALL,"ADULT, OLDER_ADULT",PHASE1,67,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/19/12,5/19/20,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Vemurafenib,ALL,"ADULT, OLDER_ADULT",PHASE4,215,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/19/13,2/17/20,"Highlands Oncology Group, Rogers, Arkansas, 72758, United States|UCLA Department of Medicine, Los Angeles, California, 90024, United States|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, 90502, United States|University of Chicago Medical Center; Medicine, Section of Pulmonary, Chicago, Illinois, 60637, United States|Siouxland Regional Cancer Center d/b/a June E. Nylen Cancer Center, Sioux City, Iowa, 51108, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|New York University Medical Center PRIME, New York, New York, 10016, United States|Evelyn H. Lauder Center, New York, New York, 10065, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, 19104, United States|Mary Crowley Medical Research Center; Oncology, Dallas, Texas, 75246, United States|M D Anderson Physician Network, Webster, Texas, 77598, United States|University of Washington Seattle Cancer Care Alliance, Seattle, Washington, 98195, United States|N.N. Alexandrov National Cancer Centre of Belarus, Minsk District, 223040, Belarus|Institut Jules Bordet, Brussels, 1000, Belgium|University Clinical Center of the Republic of Srpska, Banja Luka, 78000, Bosnia and Herzegovina|University Clinic Centre Sarajevo, Sarajevo, 71000, Bosnia and Herzegovina|Hospital das Clinicas - UFRGS, Porto Alegre, Rio Grande do Sul, Brazil|McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal, Quebec, H3T 1E2, Canada|Clinical Hospital Center Sestre Milosrdnice, Zagreb, 10000, Croatia|Clinical Hospital Centre Zagreb, Zagreb, 10000, Croatia|Bank of Cyprus Oncology Center, Nicosia, 2006, Cyprus|Medical Research Institute, Alexandria, 21131, Egypt|National Cancer Institute, Cairo, 11796, Egypt|Mansoura University Hospital, Dakahlia, 324, Egypt|Gharbia Cancer Society, Tanta, Egypt|Centre Léon Bérard, Lyon, 69373, France|Institut Gustave Roussy, Villejuif, 94805, France|Universitätsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz; Apotheke, Mainz, 55131, Germany|Universitätsklinikum Wurzburg, Würzburg, 97080, Germany|University General Hospital of Heraklion, Crete, 711 10, Greece|Semmelweis Egyetem, Budapest, 1083, Hungary|Orszagos Onkologiai Intezet, Budapest, 1122, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont; Fázis I-es Klinikai Farmakológiai Vizsgálóhely, Budapest, H-1077, Hungary|Debreceni Egyetem Klinikai Központ; Bőrgyógyászati Klinika, Debrecen, 4012, Hungary|Pecsi Tudomanyegyetem, Pécs, 7624, Hungary|Rambam Health Care Campus, Haifa, 3109600, Israel|Hadassah University Hospital - Ein Kerem, Jerusalem, 9112001, Israel|Chaim Sheba Medical Center; Allergy and Clinical Immunology Unit, Ramat Gan, 5266202, Israel|Tel-Aviv Sourasky Medical Center, Tel Aviv, 6423906, Israel|Azienda Socio Sanitaria Territoriale Niguarda (Ospedale Niguarda Ca' Granda), Milan, Lombardy, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Tuscany, 56100, Italy|Maastricht University Medical Center, Maastricht, 6229 HX, Netherlands|Auckland City Hospital, Auckland, 1023, New Zealand|Christchurch Clinical Studies Trust, Christchurch, 8011, New Zealand|IPO de Lisboa; Servico de Oncologia Medica, Lisbon, 1099-023, Portugal|IPO do Porto; Servico de Oncologia Medica, Porto, 4200-072, Portugal|Medisprof SRL, Cluj-Napoca, 400058, Romania|FSBSI ""Russian Oncological Scientific Center n.a. N.N. Blokhin""; Chemotherapy Departement, Moskva, Moscow Oblast, 115478, Russia|Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic, Kazan', 420029, Russia|SBIH "" Clinical Oncological Dispensary # 1""; Chemotherapy department #1 and #2, Krasnodar, 350040, Russia|Moscow city oncology hospital #62 of Moscow Healthcare Department, Moscow, 143423, Russia|St. Petersburg SHI ""City Clinical Oncology Dispensary"", Saint Petersburg, 197022, Russia|SBIH Republican Clinical Oncological Dispensary of the MoH of Republic Bashkortostan, Ufa, 450054, Russia|Institute for Oncology and Radiology of Serbia; Medical Oncology, Belgrade, 11000, Serbia|Clinical Center Bezanijska Kosa, Belgrade, 11070, Serbia|Cape Town Oncology Trials, Cape Town, 7570, South Africa|Wits Donald Gordon Clinical Trial Centre; Medical Oncology, Parktown, Johannesburg, 2193, South Africa|Cancercare Langenhoven Drive Oncology Centre, Port Elizabeth, 6045, South Africa|Kyungpook National University Chilgok Hospital, Daegu, 41404, South Korea|Samsung Medical Center, Seoul, (0)6351, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital, Yonsei University Health System, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Hospital Universitario Son Espases, Palma de Mallorca, Balearic Islands, 07010, Spain|Hospital Universitario Marques de Valdecilla; Servicio de Oncologia, Santander, Cantabria, 39008, Spain|Complejo Hospitalario Universitario A Coruña, A Coruña, LA Coruña, 15006, Spain|Hospital Regional Universitario de Malaga; Oncologia, Málaga, Malaga, 29010, Spain|Hospital General Universitario Santa Lucia, Cartagena (Murcia), Murcia, 30202, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clinic i Provincial de Barcelona, Barcelona, 08036, Spain|Hospital Universitario La Paz, Madrid, 280146, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario Clínico San Carlos; Servicio de Oncologia, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|START Madrid. Centro Integral Oncologico Clara Campal; CIOCC, Madrid, 28050, Spain|Hospital Universitario de Salamanca, Salamanca, 37007, Spain|Hospital Universitario Virgen Macarena, Seville, 41009, Spain|Instituto Valenciano Oncologia; Oncologia Medica, Valencia, 46009, Spain|Hospital General Universitario de Valencia, Valencia, 46014, Spain|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|Churchill Hospital, Oxford, OX3 7LJ, United Kingdom|Royal Marsden Hospital, Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Rogaratinib (BAY1163877) oral solution|DRUG: Rogaratinib (BAY1163877) oral tablet|DRUG: Rogaratinib (BAY1163877) 800 mg BID,ALL,"ADULT, OLDER_ADULT",PHASE1,168,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/30/13,1/9/20,"Chicago, Illinois, 60611-2908, United States|Chicago, Illinois, United States|Pittsburgh, Pennsylvania, 15232, United States|Besançon, 25030, France|Créteil, 94010, France|Dijon, 21079, France|Lille, 59020, France|Lyon, 69008, France|Heidelberg, Baden-Wurttemberg, 69120, Germany|Tübingen, Baden-Wurttemberg, 72076, Germany|Weiden, Bavaria, 92637, Germany|Würzburg, Bavaria, 97080, Germany|Cologne, North Rhine-Westphalia, 50937, Germany|Essen, North Rhine-Westphalia, 45147, Germany|Dresden, Saxony, 01307, Germany|Hamburg, 20246, Germany|Magdeburg, 39120, Germany|Singapore, 119228, Singapore|Singapore, 169610, Singapore|Seoul, 03080, South Korea|Seoul, 03722, South Korea|Seoul, 135-710, South Korea|Barcelona, 08035, Spain|Madrid, 28034, Spain|Madrid, 28041, Spain|Valencia, 46014, Spain|Sankt Gallen, Canton of St. Gallen, 9007, Switzerland|Chur, Kanton Graubünden, 7000, Switzerland|Geneva, 1205, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Carcinoid Tumor|Pancreatic Neuroendocrine Tumor,DRUG: Cabozantinib,ALL,"ADULT, OLDER_ADULT",PHASE2,61,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2012-07,2023-12,"Massachusetts General Hospital, Boston, Massachusetts, 02214, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hyperparathyroidism|Hypercalcemia|Parathyroid Neoplasm|Multiple Endocrine Neoplasia|MEN1,DRUG: 68Ga-Dotatate|DRUG: 18F-DOPA,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,1553,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC,12/15/93,12/23/20,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Colorectal Neoplasm,DRUG: Selinexor|DRUG: Oxaliplatin|DRUG: 5-FU|DRUG: Folinic Acid,ALL,"ADULT, OLDER_ADULT",PHASE1,10,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2015-03,3/9/17,"University Hospital Antwerpen, Antwerp, 1200, Belgium|University Hospital Hamburg, Hamburg, 20246, Germany",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: NC-6004|DRUG: Gemcitabine,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,119,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-05,5/6/19,"California Cancer Associates for Research and Excellence, Encinitas, California, 92024, United States|UC San Diego Moores Cancer Center, La Jolla, California, 92037, United States|Pacific Hematology Oncology Associates, San Francisco, California, 94115, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|University Hospitals Case Medical Center, Cleveland, Ohio, 44121, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Multiprofile Hospital for Active Treatment Serdika EOOD, Sofia, Sofia-Grad, 1632, Bulgaria|Complex Oncology Center - Shumen EOOD, Shumen, 9700, Bulgaria|Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST, Meldola, 47014, Italy|ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda Ca' Granda, Milan, 20162, Italy|Wojewodzki Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie, Krakow, 31826, Poland|Med-Polonia Sp. z o.o., Poznan, 60693, Poland|Fundeni Clinical Institute, Bucharest, 22328, Romania|Coltea Clinical Hospital, Bucharest, 30171, Romania|Prof Dr I Chiricuta Institute of Oncology, Cluj-Napoca, 400015, Romania|Oncology Center Sfantul Nectarie, Craiova, 200347, Romania|Euroclinic Oncology Center SRL, Iași, 700106, Romania|Institutul Regional de Oncologie Iasi, Iași, 700483, Romania",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Dostarlimab|DRUG: Belrestotug.|DRUG: Nelistotug,ALL,"ADULT, OLDER_ADULT",PHASE2,62,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/23/21,5/2/24,"GSK Investigational SIte, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Edmonton, Alberta, T6G 1Z2, Canada|GSK Investigational Site, Brampton, Ontario, L6R 3J7, Canada|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Bordeaux, 33076, France|GSK Investigational Site, Paris, 75018, France|GSK Investigational Site, Paris, 75248, France|GSK Investigational Site, Villejuif, 94805, France|GSK Investigational Site, Großhansdorf, 22927, Germany|GSK Investigational Site, Meldola FC, 47014, Italy|GSK Investigational Site, Milan, 20133, Italy|GSK Investigational Site, Siena, 53100, Italy|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Madrid, 28034, Spain|GSK Investigational Site, Málaga, 29010, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasm Metastasis,DRUG: Olaratumab|DRUG: Doxorubicin|DRUG: Vincristine|DRUG: Irinotecan|DRUG: Ifosfamide,ALL,CHILD,PHASE1,68,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/29/16,4/3/19,"Phoenix Childrens Hospital, Phoenix, Arizona, 85016, United States|Childrens Hospital of Los Angeles, Los Angeles, California, 90027, United States|University of California, San Francisco, San Francisco, California, 94158, United States|The Children's Hospital for Cancer and Blood Disorders, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010-2970, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Riley Hosptial for Children, Indianapolis, Indiana, 46202, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Minnesota Medical School, Minneapolis, Minnesota, 55455, United States|Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|Cohen Children's Medical Center, New Hyde Park, New York, 11040, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Levine Children's Hospital, Charlotte, North Carolina, 28203, United States|St Jude Childrens Research Hospital, Memphis, Tennessee, 38105, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232-6307, United States|Mary Crowley Cancer Research Center, Dallas, Texas, 75230, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75235, United States|Texas Childrens Hospital, Houston, Texas, 77030, United States|Primary Childrens Medical Center, Salt Lake City, Utah, 84132, United States|Seattle Children's Hospital Research Foundation, Seattle, Washington, 98105, United States|National Cancer Center Hospital, Chuo-Ku, Tokyo, 104-0045, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: Feladilimab|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE2,8,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/4/21,9/23/21,"GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Brampton, Ontario, L6R3J7, Canada|GSK Investigational Site, Bordeaux, 33076, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasm,DRUG: Perflutren Lipid Microsphere Intravenous Suspension,MALE,"ADULT, OLDER_ADULT",PHASE2,55,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2/1/17,9/20/18,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: BI 836880,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/4/16,7/31/19,"CTR Georges-François Leclerc, Dijon, 21079, France|Hospital Vall d'Hebron, Barcelona, 08035, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: PLX3397|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,74,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2012-05,2018-02,"University of Alabama at Birmingham, Birmingham, Alabama, 35233, United States|Univeristy of California, San Francisco, San Francisco, California, 94143, United States|University of Colorado, Anschutz Cancer Pavilion, Aurora, Colorado, 80045, United States|Sylvester Comprehensive Cancer Center/UMHC, Miami, Florida, 33136, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States|Ohio State University, Columbus, Ohio, 43210, United States|University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasms|Peritoneal Neoplasms|Fallopian Tube Neoplasms,DRUG: Trabectedin|DRUG: DOXIL|DRUG: Dexamethasone|DRUG: DOXIL,FEMALE,"ADULT, OLDER_ADULT",PHASE3,581,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/16/13,11/16/18,"Birmingham, Alabama, United States|Phoenix, Arizona, United States|Scottsdale, Arizona, United States|Sedona, Arizona, United States|Tucson, Arizona, United States|Hot Springs, Arkansas, United States|Greenbrae, California, United States|La Jolla, California, United States|Los Angeles, California, United States|Orange, California, United States|Sacramento, California, United States|Englewood, Colorado, United States|New Britain, Connecticut, United States|New Haven, Connecticut, United States|Stamford, Connecticut, United States|Fort Myers, Florida, United States|Jacksonville, Florida, United States|Miami, Florida, United States|Sarasota, Florida, United States|St. Petersburg, Florida, United States|Tampa, Florida, United States|Atlanta, Georgia, United States|Savannah, Georgia, United States|Chicago, Illinois, United States|Park Ridge, Illinois, United States|Indianapolis, Indiana, United States|Louisville, Kentucky, United States|Covington, Louisiana, United States|New Orleans, Louisiana, United States|Scarborough, Maine, United States|Worcester, Massachusetts, United States|Detroit, Michigan, United States|Lansing, Michigan, United States|Duluth, Minnesota, United States|Edina, Minnesota, United States|Columbia, Missouri, United States|Kansas City, Missouri, United States|Hackensack, New Jersey, United States|Morristown, New Jersey, United States|New Brunswick, New Jersey, United States|Summit, New Jersey, United States|Brightwaters, New York, United States|Hawthorne, New York, United States|New York, New York, United States|Pinehurst, North Carolina, United States|Akron, Ohio, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Tulsa, Oklahoma, United States|Portland, Oregon, United States|Abington, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Providence, Rhode Island, United States|Charleston, South Carolina, United States|Greenville, South Carolina, United States|Nashville, Tennessee, United States|Austin, Texas, United States|Bedford, Texas, United States|Dallas, Texas, United States|Fort Worth, Texas, United States|Houston, Texas, United States|San Antonio, Texas, United States|The Woodlands, Texas, United States|Webster, Texas, United States|Salt Lake City, Utah, United States|Annandale, Virginia, United States|Newport News, Virginia, United States|Roanoke, Virginia, United States|Spokane, Washington, United States|Vancouver, Washington, United States|Green Bay, Wisconsin, United States|Madison, Wisconsin, United States|Milwaukee, Wisconsin, United States|Wauwatosa, Wisconsin, United States|Adelaide, Australia|Ballarat, Australia|Brisbane, Australia|Gosford, Australia|Parkville, Australia|Subiaco, Australia|Toorak Gardens, Australia|Townsville, Australia|Wodonga, Australia|Woodville, Australia|Guangzhou, China|Jinan, China|Shanghai, China|Shenyang, China|Beersheba, Israel|Haifa, Israel|Holon, Israel|Jerusalem, Israel|Kfar Saba, Israel|Petah Tikva, Israel|Ramat Gan, Israel|Rehovot, Israel|Tel Aviv, Israel|Ẕerifin, Israel|Auckland, New Zealand|Wellington, New Zealand|Bydgoszcz, Poland|Gdansk, Poland|Lublin, Poland|Poznan, Poland|Warsaw, Poland|Arkhangelsk, Russia|Chelyabinsk, Russia|Ivanovo, Russia|Kirov, Russia|Krasnodar, Russia|Moscow, Russia|Nal'chik, Russia|Nizhny Novgorod, Russia|Omsk, Russia|Orenburg, Russia|Pyatigorsk, Russia|Ryazan, Russia|Saint Petersburg, Russia|Sochi, Russia|Ufa, Russia|Yaroslavl, Russia|Cape Town, South Africa|Durban, South Africa|eManzimtoti, South Africa|Johannesburg, South Africa|Port Elizabeth, South Africa|Pretoria, South Africa|Bern, Switzerland|Zurich, Switzerland|Bebington, United Kingdom|Glasgow, United Kingdom|Guildford, United Kingdom|London, United Kingdom|Maidstone, United Kingdom|Manchester, United Kingdom|Plymouth, United Kingdom|Swansea, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Breast Neoplasms|Prostate Neoplasms|Neoplasms, Squamous Cell|Melanoma|Mesothelioma|Pancreatic Neoplasms|Colorectal Neoplasms|Carcinoma, Renal Cell|Liver Neoplasms",DRUG: PF-06952229|DRUG: Enzalutamide,ALL,"ADULT, OLDER_ADULT",PHASE1,49,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/4/18,3/30/22,"HonorHealth, Scottsdale, Arizona, 85258, United States|UCLA Dept of Medicine -Hematology/Oncology,Santa Monica, Santa Monica, California, 90404, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Mass General/ North Shore Center for Outpatient Care, Danvers, Massachusetts, 01923, United States|Dana-Farber Cancer Institute - Chestnut Hill, Newton, Massachusetts, 02459, United States|OU Medical Center Presbyterian Tower, Oklahoma City, Oklahoma, 73104, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Sarah Cannon Research Institute - Pharmacy, Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The Sarah Cannon Research Institute / Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|NEXT Oncology, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: BI 836880,ALL,"ADULT, OLDER_ADULT",PHASE1,29,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/5/16,11/4/20,"INS Curie, Paris, 75248, France|Universitätsklinikum Augsburg, Augsburg, 86156, Germany|Universitätsklinikum Freiburg, Freiburg im Breisgau, 79106, Germany",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Docetaxel|DRUG: Feladilimab|DRUG: Ipilimumab|DRUG: GSK4428859A|DRUG: Dostarlimab|DRUG: GSK6097608,ALL,"ADULT, OLDER_ADULT",PHASE2,175,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/24/19,5/2/24,"GSK Investigational Site, Los Angeles, California, 90025, United States|GSK Investigational Site, St Louis, Missouri, 63110-1093, United States|GSK Investigational Site, The Bronx, New York, 10461-2375, United States|GSK Investigational Site, Pinehurst, North Carolina, 28374, United States|GSK Investigational Site, Chattanooga, Tennessee, 37404, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, Edmonton, Alberta, T6G 1Z2, Canada|GSK Investigational Site, Brampton, Ontario, L6R 3J7, Canada|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Bordeaux, 33076, France|GSK Investigational Site, Caen, 14033, France|GSK Investigational Site, Paris, 75018, France|GSK Investigational Site, Paris, 75248, France|GSK Investigational Site, Saint-Herblain, 44093, France|GSK Investigational Site, Villejuif, 94805, France|GSK Investigational Site, Berlin, 14165, Germany|GSK Investigational Site, Gauting, 82131, Germany|GSK Investigational Site, Großhansdorf, 22927, Germany|GSK Investigational Site, Heidelberg, 69126, Germany|GSK Investigational Site, Immenhausen, 34376, Germany|GSK Investigational Site, Kassel, 34125, Germany|GSK Investigational Site, Leipzig, 04357, Germany|GSK Investigational Site, Meldola FC, 47014, Italy|GSK Investigational Site, Milan, 20133, Italy|GSK Investigational Site, Napoli, 80131, Italy|GSK Investigational Site, Orbassano to, 10043, Italy|GSK Investigational Site, Ravenna, 48121, Italy|GSK Investigational Site, Siena, 53100, Italy|GSK Investigational Site, Amsterdam, 1081 HV, Netherlands|GSK Investigational Site, Maastricht, 6229 HX, Netherlands|GSK Investigational Site, Lodz, 93-513, Poland|GSK Investigational Site, Poznan, 60-569, Poland|GSK Investigational Site, Warsaw, 02-781, Poland|GSK Investigational Site, Bucharest, 020142, Romania|GSK Investigational Site, Craiova, 200347, Romania|GSK Investigational Site, Floreşti, 407280, Romania|GSK Investigational Site, Otopeni, 075100, Romania|GSK Investigational Site, Timișoara, 300166, Romania|GSK Investigational Site, Chelyabinsk, 454048, Russia|GSK Investigational Site, Saint Petersburg, 194291, Russia|GSK Investigational Site, Saint Petersburg, 197183, Russia|GSK Investigational Site, Cheongju Chungcheongbuk-do, 28644, South Korea|GSK Investigational Site, Gyeonggi-do, 10408, South Korea|GSK Investigational Site, Seongnam-si Gyeonggi-do, 13620, South Korea|GSK Investigational Site, Seoul, 05505, South Korea|GSK Investigational Site, Badajoz, 06080, Spain|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Barcelona, 08036, Spain|GSK Investigational Site, Madrid, 28027, Spain|GSK Investigational Site, Madrid, 28033, Spain|GSK Investigational Site, Madrid, 28034, Spain|GSK Investigational Site, Málaga, 29010, Spain|GSK Investigational Site, Santander, 39008, Spain|GSK Investigational Site, Seville, 41009, Spain|GSK Investigational Site, Stockholm, SE-171 64, Sweden|GSK Investigational Site, Uppsala, SE- 75 185, Sweden",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: GSK3845097|DRUG: Cyclophosphamide|DRUG: Fludarabine,ALL,"ADULT, OLDER_ADULT",PHASE1,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/21/20,10/24/22,"GSK Investigational Site, New Haven, Connecticut, 06504, United States|GSK Investigational Site, Jacksonville, Florida, 32224, United States|GSK Investigational Site, Tampa, Florida, 33612, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Westwood, Kansas, 66205, United States|GSK Investigational Site, Lexington, Kentucky, 40536, United States|GSK Investigational Site, Baltimore, Maryland, 21287, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19111, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Melbourne, Victoria, 3000, Australia|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Montreal, Quebec, H1T 2M4, Canada|GSK Investigational Site, Munich, Bavaria, 81377, Germany|GSK Investigational Site, Hanover, Lower Saxony, 30625, Germany|GSK Investigational Site, Cologne, North Rhine-Westphalia, 50937, Germany|GSK Investigational Site, Dresden, Saxony, 01307, Germany|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Stockholm, SE-171 64, Sweden",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,BIOLOGICAL: vibostolimab|BIOLOGICAL: pembrolizumab|DRUG: pemetrexed|DRUG: carboplatin|BIOLOGICAL: pembrolizumab/vibostolimab coformulation|DRUG: cisplatin|DRUG: etoposide,ALL,"ADULT, OLDER_ADULT",PHASE1,474,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/13/16,7/24/24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors|Recurrent Solid Tumors,DRUG: ONO-4538,ALL,"ADULT, OLDER_ADULT",PHASE1,18,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2014-10,2014-12,"Seongnam-si Clinical Site 105, Seongnam-si, Gyeonggi-do, South Korea|Seoul Clinical Site 101, Seoul, South Korea|Seoul Clinical Site 102, Seoul, South Korea|Seoul Clinical Site 103, Seoul, South Korea|Seoul Clinical Site 104, Seoul, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: RO7296682,ALL,"ADULT, OLDER_ADULT",PHASE1,76,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/9/19,7/21/22,"Peter MacCallum Cancer Centre; Medical Oncology, Melbourne, Victoria, 3000, Australia|Cliniques Universitaires St-Luc, Brussels, 1200, Belgium|BC Cancer Agency - Vancouver, Vancouver, British Columbia, V5Z 4E6, Canada|The Ottawa Hospital Cancer Centre, Ottawa, Ontario, K2H 6C2, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 1Z5, Canada|Rigshospitalet; Onkologisk Klinik, København Ø, 2100, Denmark|Clinica Universitaria de Navarra, Pamplona, Navarre, 31008, Spain|Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, 08035, Spain|START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, 28040, Spain|START Madrid. Centro Integral Oncologico Clara Campal; CIOCC, Madrid, 28050, Spain|Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, Valencia, 46010, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: GSK3052230|DRUG: paclitaxel|DRUG: carboplatin|DRUG: docetaxel|DRUG: pemetrexed|DRUG: cisplatin,ALL,"ADULT, OLDER_ADULT",PHASE1,65,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/9/13,10/24/17,"GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Sacramento, California, 95817, United States|GSK Investigational Site, Chicago, Illinois, 60637, United States|GSK Investigational Site, Peoria, Illinois, 61615-7822, United States|GSK Investigational Site, Detroit, Michigan, 48201, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Chapel Hill, North Carolina, 27599-7600, United States|GSK Investigational Site, Columbus, Ohio, 43210, United States|GSK Investigational Site, Charleston, South Carolina, 29425, United States|GSK Investigational Site, Leuven, 3000, Belgium|GSK Investigational Site, Koebenhavn Oe, 2100, Denmark|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Arkhangelsk, 163045, Russia|GSK Investigational Site, Ryazan, 390011, Russia|GSK Investigational Site, Saint Petersburg, 197 089, Russia|GSK Investigational Site, Saint Petersburg, 197758, Russia|GSK Investigational Site, Saint Petersburg, 198255, Russia|GSK Investigational Site, Vsevolozhsk, 188663, Russia|GSK Investigational Site, Badajoz, 06080, Spain|GSK Investigational Site, Barcelona, 08028, Spain|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Madrid, 28034, Spain|GSK Investigational Site, Madrid, 28040, Spain|GSK Investigational Site, Málaga, 29010, Spain|GSK Investigational Site, Seville, 41013, Spain|GSK Investigational Site, Leicester, Leicestershire, LE1 5WW, United Kingdom|GSK Investigational Site, London, SE1 9RT, United Kingdom|GSK Investigational Site, Nottingham, NG5 1PB, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: feladilimab (GSK3359609)|DRUG: GSK3174998|DRUG: Pembrolizumab|DRUG: Docetaxel|DRUG: Pemetrexed|DRUG: Paclitaxel plus Carboplatin|DRUG: Gemcitabine plus Carboplatin|DRUG: Fluorouracil (5-FU) plus carboplatin or cisplatin|DRUG: Dostarlimab|DRUG: Cobolimab|DRUG: Bintrafusp alfa,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Up to approximately 367 weeks|Part 1B: Receptor Occupancy of Feladilimab, Blood samples were collected to assess the cluster of differentiation 4 (CD4+) and cluster of differentiation 8 (CD8+) receptor occupancy by Feladilimab as a pharmacodynamic analysis. It was assessed using validated flow cytometry assay., Up to approximately 367 weeks|Part 2B: Receptor Occupancy of Feladilimab, Blood samples were collected to assess the cluster of differentiation 4 (CD4+) and cluster of differentiation 8 (CD8+) receptor occupancy by Feladilimab as a pharmacodynamic analysis. It was assessed using validated flow cytometry assay.,"ADULT, OLDER_ADULT",PHASE1,829,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/23/16,7/5/23,"GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Los Angeles, California, 90025, United States|GSK Investigational Site, Sarasota, Florida, 34232, United States|GSK Investigational Site, New York, New York, 10016, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73104, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19111, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Nashville, Tennessee, 37232-6307, United States|GSK Investigational Site, Heidelberg, Victoria, 3084, Australia|GSK Investigational Site, Melbourne, Victoria, 3000, Australia|GSK Investigational Site, Nedlands, Western Australia, 6009, Australia|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Shnghai, 200126, China|GSK Investigational Site, Bordeaux, 33076, France|GSK Investigational Site, Lyon, 69373, France|GSK Investigational Site, Paris, 75005, France|GSK Investigational Site, Villejuif, 94805, France|GSK Investigational Site, Siena, Tuscany, 53100, Italy|GSK Investigational Site, Chiba, 277-8577, Japan|GSK Investigational Site, Osaka, 589-8511, Japan|GSK Investigational Site, Tokyo, 104-0045, Japan|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Barcelona, 08036, Spain|GSK Investigational Site, Madrid, 28040, Spain|GSK Investigational Site, MÃ¡ga, 29010, Spain|GSK Investigational Site, Seville, 41009, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,"DRUG: DSP-0509|DRUG: DSP-0509, Pembrolizumab|DRUG: DSP-0509, Pembrolizumab",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,36,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/1/18,12/20/22,"Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 25799, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Henry-Joyce Cancer Center, Vanderbilt University, Nashville, Tennessee, 37232, United States|M.D. Anderson Cancer Center, The University of Texas, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: BMS-986156|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,295,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/14/15,12/16/19,"University Of Alabama At Birmingham, Birmingham, Alabama, 35294-3300, United States|UCSD Moores Cancer Center, La Jolla, California, 92093-0698, United States|Emory University, Atlanta, Georgia, 30322, United States|The Ohio State University, Columbus, Ohio, 43210, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|The West Clinic, P.C., Germantown, Tennessee, 38138, United States|Liverpool Cancer Therapy Center, Liverpool, New South Wales, 2170, Australia|Local Institution, Westmead, New South Wales, 2145, Australia|Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia|Linear Clinical Research Ltd, Nedlands, Western Australia, 6009, Australia|Local Institution - 0012, Ghent, 9000, Belgium|Local Institution, Edmonton, Alberta, T6G 1Z2, Canada|Local Institution, Toronto, Ontario, M5G 1Z5, Canada|Local Institution, Paris, 75248, France|Institut Claudius Regaud, Toulouse, 31059, France|Institut Gustave Roussy, Vlllejuif, 94800, France|Local Institution, Bonn, 53127, Germany|Local Institution, Freiburg im Breisgau, 79106, Germany|Local Institution, Würzburg, 97080, Germany|Local Institution - 0015, Milan, Lombardy, 20141, Italy|Local Institution - 0014, Milan, 20133, Italy|Local Institution, Amsterdam, 1066CX, Netherlands|Local Institution, Madrid, 28040, Spain|Local Institution, Madrid, 28041, Spain|Cantonal Hospital St. Gallen, Sankt Gallen, 9007, Switzerland|Local Institution, Zurich, 8091, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors|Metastatic Solid Tumors,DRUG: PF-06939999 dose escalation|DRUG: PF-06939999 monotherapy|DRUG: PF-06939999 in combination with docetaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,54,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/14/19,4/27/22,"Scottsdale Healthcare Hospitals d/b/a HonorHealth, Scottsdale, Arizona, 85258, United States|Virginia G. Piper Cancer Pharmacy, Scottsdale, Arizona, 85258, United States|Keck Hospital of USC, Los Angeles, California, 90033, United States|LAC + USC Medical Center, Los Angeles, California, 90033, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Keck Medical Center of USC Pasadena, Pasadena, California, 91105, United States|AdventHealth Celebration Infusion Center, Celebration, Florida, 34747, United States|AdventHealth Medical Group Oncology Research at Celebration, Celebration, Florida, 34747, United States|University Of Miami Hospital and Clinics/Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|AdventHealth Orlando - Investigational Drug Services, Orlando, Florida, 32804, United States|AdventHealth Orlando Infusion Center, Orlando, Florida, 32804, United States|AdventHealth Orlando, Orlando, Florida, 32804, United States|St. Joseph Mercy Hospital, Ann Arbor, Michigan, 48106, United States|St. Joseph Mercy Brighton, Brighton, Michigan, 48114, United States|Henry-Joyce Cancer Clinic, Nashville, Tennessee, 37232, United States|Oncology IDS Pharmacy, Nashville, Tennessee, 37232, United States|The University of Texas, Houston, Texas, 77030, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Inova Schar Cancer Institute, Fairfax, Virginia, 22031, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: BAL101553|DRUG: BAL101553 at MTD,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,43,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/24/16,8/7/20,"Oncology Institute of Southern Switzerland; Ospedale Regionale San Giovanni Bellinzona e Valli, Bellinzona, 6500, Switzerland|Inselspital Bern, Bern, 3010, Switzerland|Cantonal Hospital of Grisons, Department of Oncology/ Haematology, Chur, 7000, Switzerland|Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland|Cantonal Hospital of St. Gallen, Dep. Medical Oncology & Hematology, Sankt Gallen, 9007, Switzerland|UniversitaetsSpital Zürich, Zurich, 8091, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasm Metastasis,DRUG: Drug Cocktail|DRUG: Abemaciclib,ALL,"ADULT, OLDER_ADULT",PHASE1,48,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,3/8/16,1/6/21,"Sarah Cannon Research Institute at HealthOne, Denver, Colorado, 80218, United States|IU Simon Cancer Center, Indianapolis, Indiana, 46202, United States|University of Kansas Hospital, Fairway, Kansas, 66160, United States|Mary Crowley Cancer Research Center, Dallas, Texas, 75230, United States|South Texas Accelerated Research Therapeutics, LCC, San Antonio, Texas, 78229-3307, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Rivaroxaban|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,841,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION",9/11/15,8/24/18,"Phoenix, Arizona, United States|Tucson, Arizona, United States|Little Rock, Arkansas, United States|Los Angeles, California, United States|Martinez, California, United States|Santa Barbara, California, United States|Torrance, California, United States|Upland, California, United States|Denver, Colorado, United States|Norwich, Connecticut, United States|Gainesville, Florida, United States|Miami, Florida, United States|Miami Shores, Florida, United States|New Port Richey, Florida, United States|Atlanta, Georgia, United States|Evanston, Illinois, United States|Joliet, Illinois, United States|Peoria, Illinois, United States|Rockford, Illinois, United States|Skokie, Illinois, United States|Urbana, Illinois, United States|Anderson, Indiana, United States|Cedar Rapids, Iowa, United States|Brewer, Maine, United States|Baltimore, Maryland, United States|Silver Spring, Maryland, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Rochester, Minnesota, United States|Saint Cloud, Minnesota, United States|Kansas City, Missouri, United States|Grand Island, Nebraska, United States|Las Vegas, Nevada, United States|Lebanon, New Hampshire, United States|Albany, New York, United States|East Syracuse, New York, United States|New York, New York, United States|Rochester, New York, United States|The Bronx, New York, United States|Charlotte, North Carolina, United States|High Point, North Carolina, United States|Cleveland, Ohio, United States|Eugene, Oregon, United States|Portland, Oregon, United States|Erie, Pennsylvania, United States|Charleston, South Carolina, United States|Greenville, South Carolina, United States|North Charleston, South Carolina, United States|Rapid City, South Dakota, United States|Nashville, Tennessee, United States|Abilene, Texas, United States|Austin, Texas, United States|Beaumont, Texas, United States|Bedford, Texas, United States|Dallas, Texas, United States|Denton, Texas, United States|Flower Mound, Texas, United States|Garland, Texas, United States|Houston, Texas, United States|Paris, Texas, United States|San Antonio, Texas, United States|Sugar Land, Texas, United States|Temple, Texas, United States|The Woodlands, Texas, United States|Tyler, Texas, United States|Waco, Texas, United States|Roanoke, Virginia, United States|Winchester, Virginia, United States|Green Bay, Wisconsin, United States|Weston, Wisconsin, United States|Amberloup, Belgium|Bonheiden, Belgium|Brussels, Belgium|Edegem, Belgium|Laken (brussel), Belgium|Turnhout, Belgium|Wilrijk, Belgium|Barretos, Brazil|Caxias do Sul, Brazil|Curitiba, Brazil|Itajaí, Brazil|Lajeado, Brazil|Londrina, Brazil|Mogi das Cruzes, Brazil|Porto Alegre, Brazil|Porto Alegre, Rs, Brazil|Rio de Janeiro, Brazil|Santo André, Brazil|São José do Rio Preto, Brazil|São Paulo, Brazil|Sorocaba, Brazil|Plovdiv, Bulgaria|Sofia, Bulgaria|Toronto, Ontario, Canada|Saint-Jérôme, Quebec, Canada|Québec, Canada|Benešov nad Černou, Czechia|Brno, Czechia|Jindřichův Hradec, Czechia|Kladno, Czechia|Liberec, Czechia|Nový Jičín, Czechia|Olomouc, Czechia|Pardubice, Czechia|Prague, Czechia|Tábor, Czechia|Angers, France|Avignon, France|Dijon, France|Hyers, France|Le Mans, France|Paris, France|Rennes, France|Saint-Herblain, France|Valenciennes, France|Berlin, Germany|Brandenburg, Germany|Cologne, Germany|Dortmund, Germany|Dresden, Germany|Esslingen am Neckar, Germany|Gauting, Germany|Hamburg, Germany|Hanover, Germany|Herne, Germany|Kiel, Germany|Leipzig, Germany|Lübeck, Germany|Magdeburg, Germany|Merseburg, Germany|Minden, Germany|München, Germany|Paderborn, Germany|Recklinghausen, Germany|Weiden, Germany|Arkhangelsk, Russia|Chelyabinsk, Russia|Kursk, Russia|Moscow, Russia|Novosibirsk, Russia|Omsk, Russia|Saint Petersburg, Russia|Tomsk, Russia|Yaroslavi, Russia|Bournemouth, United Kingdom|Cheltenham, United Kingdom|Dundee, United Kingdom|London, United Kingdom|Manchester, United Kingdom|Plymouth, United Kingdom|Swindon, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Bevacizumab,ALL,"ADULT, OLDER_ADULT",PHASE4,95,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/13/12,9/27/19,"A.Ö. LKH; Abt. für Lungenkrankheiten, Steyr, 4400, Austria|Hospital Araujo Jorge; Departamento de Ginecologia E Mama, Goiânia, Goiás, 74605-070, Brazil|Hospital Sao Lucas - PUCRS, Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Hospital de Cancer de Barretos, Barretos, São Paulo, 14784-400, Brazil|Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, São Paulo, 01246-000, Brazil|Hospital Perola Byington, São Paulo, São Paulo, 01317-000, Brazil|Hospital A. C. Camargo; Oncologia, São Paulo, São Paulo, 01509-010, Brazil|Hospital Sao Jose, São Paulo, São Paulo, CEP 01321-001, Brazil|MBAL Serdika EOOD, Sofia, 1632, Bulgaria|University Health Network; Princess Margaret Hospital; Medical Oncology Dept, Toronto, Ontario, M5G 2M9, Canada|Fakultni nemocnice Olomouc; Onkologicka klinika, Olomouc, 779 00, Czechia|North Estonia Medical Centre Foundation; Oncology Center, Tallinn, 13419, Estonia|HOPITAL JEAN MINJOZ; Oncologie, Besançon, 25030, France|Centre Leonard De Vinci;Chimiotherapie, Dechy, 59187, France|Centre Georges François Leclerc; Service Pharmacie, Bp 77980, Dijon, 21000, France|Hopital Roger Salengro; Service de Neurologie, Lille, France|Centre Leon Berard; Departement Oncologie Medicale, Lyon, 69373, France|Centre Paul Strauss; Oncologie Medicale, Strasbourg, 67065, France|Hopital Larrey; Pneumologie, Toulouse, 31059, France|Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie, Frankfurt am Main, 60528, Germany|LungenClinic Großhansdorf GmbH, Großhansdorf, 22927, Germany|Orszagos Onkologiai Intezet; Nogyogyaszati Osztaly, Budapest, 1122, Hungary|Ospedale Antonio Perrino; Oncologia Medica, Brindisi, Apulia, 72100, Italy|A.O. Universitaria Federico II Di Napoli; Oncologia Ed Endocrinologia Clinica, Napoli, Campania, 80131, Italy|Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; Unità Operativa Oncologia Medica, Bologna, Emilia-Romagna, 40138, Italy|Azienda Ospedaliera San Camillo Forlanini; U.O.C. Pneumologia Ad Indirizzo Oncologico 1, Rome, Lazio, 00152, Italy|Fondazione IRCCS Istituto Neurologico C. Besta; Neuro-oncologia Sperimentale e Terapia Genica, Milan, Lombardy, 20133, Italy|Irccs Istituto Europeo Di Oncologia (IEO); Oncologia Medica, Milan, Lombardy, 20141, Italy|ASST DI MONZA; Oncologia Medica, Monza, Lombardy, 20900, Italy|ASST LARIANA; Oncologia, S. Fermo Della Battaglia (CO), Lombardy, 22020, Italy|Azienda Ospedaliera Le Molintte di Torino; Dipartimento Di Neurologia - Oncologia, Turin, Piedmont, 10126, Italy|Centro Catanese Di Oncologia; Oncologia Medica, Catania, Sicily, 95126, Italy|Ospedale Nuovo Della Versilia; Divisione Di Oncologia Medica, Lido di Camaiore, Tuscany, 55043, Italy|A.O. Universitaria Pisana-Ospedale Cisanello; Dipartimento Cardio Toracico-Pneumologia Ii, Pisa, Tuscany, 56124, Italy|Ospedale Misericordia E Dolce; Oncologia Medica, Prato, Tuscany, 59100, Italy|Instituto Nacional de Cancerologia; Oncology, Distrito Federal, 14080, Mexico|Fundación Rodolfo Padilla Padilla, A.C.; Oncology, León, 37000, Mexico|Oaxaca Site Management Organization, Oaxaca City, 68000, Mexico|Radboud Ziekenhuis; Urologie, 659, Nijmegen, 6525 GA, Netherlands|Leyenburg Hospital; Pulmonology, The Hague, 2504 LN, Netherlands|Prof. Dr. I. Chiricuta Institute of Oncology, Cluj-Napoca, 400015, Romania|Euroclinic Center of Oncology SRL, Iași, 700106, Romania|Altai Region Oncology Dispensory; Oncology, Barnaul, 656049, Russia|Regional Oncology Hospital; Oncology, Irkutsk, 664035, Russia|Blokhin Cancer Research Center; Combined Treatment, Moscow, 115478, Russia|Russian Research Center of Roentgenoradiology; Dept of Chemotherapy, Moscow, 117837, Russia|P.A. Gertsen Cancer Research Inst. ; Chemotherapy Dept, Moscow, 125284, Russia|City Clinical Oncology Hospital, Moscow, 143423, Russia|Medical Radiological Scientific Center; Department of Radiotherapy of Gynaecological Disease, Obninsk, Kaluzhskaya Region, 249034, Russia|Bashkirian Republican Clinical Oncology Dispensary, Ufa, 450054, Russia|Vychodoslovensky onkologicky ustav, Košice, 040 01, Slovakia|Wits Donald Gordon Clinical Trial Centre; Medical Oncology, Parktown, Johannesburg, 2193, South Africa|National Cancer Center; Medical Oncology, Gyeonggi-do, 410-769, South Korea|Severance Hospital; Internal Medicine, Seoul, 110-744, South Korea|Asan Medical Center, Uni Ulsan Collegemedicine; Dept.Internal Medicine / Divisionhematology/Oncology, Seoul, 138-736, South Korea|Hospital de Basurto; Servicio de Oncologia, Bilbao, Vizcaya, 48013, Spain|Hospital de Cruces; Servicio de Oncologia, Bilbao, Vizcaya, 48903, Spain|Complejo Hospitalario Universitario A Coruña (CHUAC, Materno Infantil), Oncología, A Coruña, 15006, Spain|Complejo Asistencial Universitario De Burgos; Servicio de Oncologia, Burgos, 09006, Spain|Hospital Reina Sofia; Medical Oncology, Córdoba, 14004, Spain|Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia, Jaén, 23007, Spain|Hospital Gregorio Marañon, Madrid, 28007, Spain|Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid, 28041, Spain|Hospital Universitario La Paz; Servicio de Oncologia, Madrid, 28046, Spain|Hospital Regional Universitario Carlos Haya; Servicio de Oncologia, Málaga, 29010, Spain|Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, Valencia, 46010, Spain|Mälarsjukhuset, Eskilstuna, Kvinnokliniken, Eskilstuna, 63188, Sweden|Universitetssjukhuset Örebro, Onkologiska kliniken, Örebro, 701 85, Sweden|Norrlands universitetssjukhus; Onkologkliniken, Umeå, Sweden|Adana City Hospital, Medical Oncology, Adana, 01060, Turkey (Türkiye)|Addenbrooke'S Hospital; Dept of Neurosurgery, Cambridge, CB2 2QQ, United Kingdom|Christie Hospital Nhs Trust; Medical Oncology, Manchester, M2O 4BX, United Kingdom|North Wales Cancer Treatment Centre, Glan Clwyd Hospital, Rhyl, LL18 5UJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms|Peritoneal Neoplasms,PROCEDURE: Adjuvant HIPEC (open/laparoscopic)|DRUG: Standard adjuvant systemic chemotherapy|PROCEDURE: Diagnostic laparoscopy,ALL,"ADULT, OLDER_ADULT",PHASE3,204,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2015-03,6/1/19,"Academic Medical Center, Amsterdam, 1105 AZ, Netherlands|Antoni van Leeuwenhoek hospital, Amsterdam, Netherlands|Free University Medical Center, Amsterdam, Netherlands|Catharina hospital, Eindhoven, Netherlands|University Medical Centre Groningen, Groningen, Netherlands|Antonius hospital, Nieuwegein, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|Erasmus Medical Center, Rotterdam, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Veliparib + VX-970 + Cisplatin,ALL,"ADULT, OLDER_ADULT",PHASE1,53,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/9/17,12/31/21,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|MD Anderson Cancer Center, Houston, Texas, 77030-4096, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroectodermal Tumors|Rhabdomyosarcoma,DRUG: afatinib,ALL,"CHILD, ADULT",PHASE1|PHASE2,56,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/29/15,8/5/20,"Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|The University of Texas Health Science Center at Houston, Houston, Texas, 77030, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Sydney Childrens Hospital, Randwick, New South Wales, 2031, Australia|AKH - Medical University of Vienna, Vienna, 1090, Austria|St. Anna Children-Hospital, Children's Cancer Research, Wien, Vienna, 1090, Austria|The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|Rigshospitalet, København, Børneonkologisk Afsnit 5002, København Ø, 2100, Denmark|HOP Toulouse, Pédiat, Toulouse, Toulouse, 31059, Faroe Islands|HOP Pellegrin, Bordeaux, 33076, France|CTR Oscar Lambret, Lille, 59020, France|CTR Leon Berard, Lyon, 69008, France|INS Curie, Paris, 75248, France|INS Gustave Roussy, Villejuif, 94805, France|Charité - Universitätsmedizin Berlin, Berlin, 13353, Germany|Universitätsklinikum Essen AöR, Essen, 45147, Germany|Universitätsklinikum Tübingen, Tübingen, 72076, Germany|Istituto G. Gaslini, Genova, 16147, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy|Azienda Ospedaliera Universitaria di Padova, Padua, 35128, Italy|Osp. Pediatrico Bambin Gesù, Roma, 00165, Italy|Erasmus MC - Sophia Kinderziekenhuis, Rotterdam, 3015 CN, Netherlands|Hospital Vall d'Hebron, Barcelona, 08035, Spain|Hospital Infantil Universitario Niño Jesus, Madrid, 28009, Spain|Birmingham Children's Hospital, Birmingham, B4 6NH, United Kingdom|Great Ormond Street Hospital, London, WC1N 3BN, United Kingdom|Royal Manchester Children's Hospital, Manchester, M13 9WL, United Kingdom|The Royal Marsden Hospital, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: GSK525762|DRUG: Placebo|DRUG: Fulvestrant,FEMALE,"ADULT, OLDER_ADULT",PHASE1,124,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/26/19,7/19/21,"GSK Investigational Site, Birmingham, Alabama, 35249, United States|GSK Investigational Site, Gilbert, Arizona, 85234, United States|GSK Investigational Site, Scottsdale, Arizona, 85259, United States|GSK Investigational Site, San Diego, California, 92123, United States|GSK Investigational Site, Plantation, Florida, 33324, United States|GSK Investigational Site, Chicago, Illinois, 60611, United States|GSK Investigational Site, New Orleans, Louisiana, 70121, United States|GSK Investigational Site, Rochester, Minnesota, 55905, United States|GSK Investigational Site, Kansas City, Missouri, 64111, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, The Bronx, New York, 10461, United States|GSK Investigational Site, White Plains, New York, 10601, United States|GSK Investigational Site, Providence, Rhode Island, 02903, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Seattle, Washington, 98101, United States|GSK Investigational Site, Port Macquarie, New South Wales, 2444, Australia|GSK Investigational Site, Bedford Park, South Australia, 5042, Australia|GSK Investigational Site, Heidelberg, Victoria, 3084, Australia|GSK Investigational Site, Ottawa, Ontario, K1H 8L6, Canada|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Montreal, Quebec, H2L 4M1, Canada|GSK Investigational Site, Montreal, Quebec, H3T 1E2, Canada|GSK Investigational Site, Québec, Quebec, G1S 4L8, Canada|GSK Investigational Site, Bordeaux, 33076, France|GSK Investigational Site, Saint-Herblain, 44805, France|GSK Investigational Site, Gyeonggi-do, 410-769, South Korea|GSK Investigational Site, Seoul, 120-752, South Korea|GSK Investigational Site, Seoul, 135-710, South Korea|GSK Investigational Site, Seoul, 138-736, South Korea|GSK Investigational Site, A Coruña, 15006, Spain|GSK Investigational Site, Barcelona, 8035, Spain|GSK Investigational Site, Lleida, 25198, Spain|GSK Investigational Site, Manchester, Lancashire, M20 4BX, United Kingdom|GSK Investigational Site, Northwood, Middlesex, HA6 2RN, United Kingdom|GSK Investigational Site, Nottingham, Nottinghamshire, NG5 1PB, United Kingdom|GSK Investigational Site, Glasgow, G12 OYN, United Kingdom|GSK Investigational Site, London, EC1M 6BQ, United Kingdom|GSK Investigational Site, London, NW1 2PG, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Stomach Neoplasms|Esophageal Neoplasms,DRUG: Irinotecan|DRUG: Trastuzumab|DRUG: Oxaliplatin|DRUG: Leucovorin|DRUG: Fluorouracil,ALL,"ADULT, OLDER_ADULT",PHASE2,67,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/8/13,10/28/19,"Washington University School of Medicine, St Louis, Missouri, 63110, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: MLN4924|DRUG: Paclitaxel|DRUG: Gemcitabine|DRUG: Docetaxel|DRUG: Carboplatin,ALL,"ADULT, OLDER_ADULT",PHASE1,64,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER,6/10/13,5/21/18,"Atlanta, Georgia, 30322, United States|St Louis, Missouri, 63110, United States|Chapel Hill, North Carolina, 27599, United States|Cleveland, Ohio, 44106-4948, United States|Philadelphia, Pennsylvania, 19104, United States|Nashville, Tennessee, 37203, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Low Anterior Resection Syndrome|Malignant Anal Neoplasm|Malignant Bladder Neoplasm|Malignant Cervical Neoplasm|Malignant Ovarian Neoplasm|Malignant Pelvic Neoplasm|Malignant Prostate Neoplasm|Malignant Uterine Neoplasm|Malignant Vaginal Neoplasm|Malignant Vulvar Neoplasm|Rectal Carcinoma,PROCEDURE: Explantation|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration|DEVICE: Sacral Nerve Stimulator|DEVICE: Sacral Nerve Stimulator Battery|PROCEDURE: Therapeutic Conventional Surgery,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,4/12/19,9/1/22,"M D Anderson Cancer Center, Houston, Texas, 77030, United States|MD Anderson in Sugar Land, Sugar Land, Texas, 77478, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: Cobimetinib|DRUG: Atezolizumab|DRUG: Atezolizumab Cohort 7,ALL,"ADULT, OLDER_ADULT",PHASE2,87,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/23/17,6/25/20,"Georgetown University Medical Center, Washington D.C., District of Columbia, 20007, United States|Kansas City - Menorah Medical Center, Kansas City, Kansas, 66209, United States|Memorial Sloan-Kettering Cancer Center, Commack, New York, 11725, United States|Memorial Sloan Kettering - Basking Ridge, New York, New York, 10065, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|AZ Groeninge, Kortrijk, 8500, Belgium|Universitatsklinik Heidelberg; Universitätshautklinik und Nationales Centrum für Tumorerkrankungen, Heidelberg, 69120, Germany|Universitätsklinikum Tübingen; Klinik für Urologie, Tübingen, 72076, Germany|Orszagos Onkologiai Intezet, Budapest, 1122, Hungary|Debreceni Egyetem Klinikai Kozpont, Debrecen, 4032, Hungary|Jósa András Oktatókórház, Nyíregyháza, 4400, Hungary|Samsung Medical Center, Seoul, (0)6351, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Yonsei Cancer Center, Seoul, 120-752, South Korea|Barts & London School of Med; Medical Oncology, London, EC1A 7BE, United Kingdom|Royal Marsden Hospital - Fulham, London, SW3 6JJ, United Kingdom|The Royal Marsden, London, SW7 3RP, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Niraparib Tablet|DRUG: Niraparib Capsule,ALL,"ADULT, OLDER_ADULT",PHASE1,236,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,12/4/17,6/15/23,"GSK Investigational Site, Encinitas, California, 92024, United States|GSK Investigational Site, Fresno, California, 93720, United States|GSK Investigational Site, Denver, Colorado, 80218, United States|GSK Investigational Site, New Haven, Connecticut, 06520, United States|GSK Investigational Site, Sarasota, Florida, 34232, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Grand Rapids, Michigan, 49546, United States|GSK Investigational Site, Jackson, Mississippi, 39216, United States|GSK Investigational Site, Cincinnati, Ohio, 45267, United States|GSK Investigational Site, Cleveland, Ohio, 44106, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73104, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, San Marcos, Texas, 92069, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breastcancer|Breast Neoplasm,BIOLOGICAL: SV-BR-1-GM|DRUG: Cyclophosphamide|BIOLOGICAL: Interferon-alpha-2b,FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,24,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/5/17,11/22/18,"St. Joseph Heritage Healthcare, Santa Rosa, California, 95403, United States|University of Miami/Sylvester at Plantation, Plantation, Florida, 33324, United States|Cancer Center of Kansas (CCK), Wichita, Kansas, 67214, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|Providence Regional Medical Center, Everett, Washington, 98201, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: BI 860585|DRUG: exemestane|DRUG: BI 860585|DRUG: BI 860585|DRUG: paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,90,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/5/13,6/22/17,"Brussels - UNIV Saint-Luc, Brussels, 1200, Belgium|UNIV UZ Gent, Ghent, 9000, Belgium|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy|Azienda Ospedaliera di Parma, Parma, 43126, Italy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: letetresgene autoleucel (GSK3377794)|DRUG: Cyclophosphamide|DRUG: Fludarabine,ALL,"ADULT, OLDER_ADULT",PHASE1,10,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/1/16,8/10/20,"GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Tampa, Florida, 33612, United States|GSK Investigational Site, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Docetaxel|DRUG: Feladilimab,ALL,"ADULT, OLDER_ADULT",PHASE2,105,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/24/19,9/23/21,"GSK Investigational Site, St Louis, Missouri, 63110-1093, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Bordeaux, 33076, France|GSK Investigational Site, Caen, 14033, France|GSK Investigational Site, Nantes, 44093, France|GSK Investigational Site, Paris, 75018, France|GSK Investigational Site, Paris, 75248, France|GSK Investigational Site, Villejuif, 94805, France|GSK Investigational Site, Gauting, Bavaria, Germany|GSK Investigational Site, Immenhausen, Hesse, 34376, Germany|GSK Investigational Site, Leipzig, Saxony, Germany|GSK Investigational Site, Großhansdorf, Schleswig-Holstein, 22927, Germany|GSK Investigational Site, Berlin, 14165, Germany|GSK Investigational Site, Meldola (FC), Emilia-Romagna, 47014, Italy|GSK Investigational Site, Ravenna, Emilia-Romagna, 48121, Italy|GSK Investigational Site, Milan, Lombardy, 20133, Italy|GSK Investigational Site, Orbassano (TO), Piedmont, 10043, Italy|GSK Investigational Site, Maastricht, 6229 HX, Netherlands|GSK Investigational Site, Lodz, 93-513, Poland|GSK Investigational Site, Poznan, 60-569, Poland|GSK Investigational Site, Warsaw, 02-781, Poland|GSK Investigational Site, Bucharest, 020142, Romania|GSK Investigational Site, Craiova, 200347, Romania|GSK Investigational Site, Floreşti, 407280, Romania|GSK Investigational Site, Otopeni, 075100, Romania|GSK Investigational Site, Timișoara, 300166, Romania|GSK Investigational Site, Chelyabinsk, 454048, Russia|GSK Investigational Site, Saint Petersburg, 194291, Russia|GSK Investigational Site, Saint Petersburg, 197183, Russia|GSK Investigational Site, Cheongju-si, 28644, South Korea|GSK Investigational Site, Gyeonggi-do, 10408, South Korea|GSK Investigational Site, Seongnam, 13620, South Korea|GSK Investigational Site, Seoul, 05505, South Korea|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Barcelona, 08036, Spain|GSK Investigational Site, Madrid, 28027, Spain|GSK Investigational Site, Madrid, 28033, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Santander, 39008, Spain|GSK Investigational Site, Seville, 41009, Spain|GSK Investigational Site, Uppsala, SE- 75 185, Sweden",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: RO7172508|DRUG: Obinutuzumab|DRUG: Tocilizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,26,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/4/18,7/22/19,"Cliniques Universitaires St-Luc, Brussels, 1200, Belgium|Princess Margaret Cancer Center, Toronto, Ontario, M5G 1Z5, Canada|Rigshospitalet; Onkologisk Klinik, København Ø, 2100, Denmark|Clinica Universitaria de Navarra, Pamplona, Navarre, 31008, Spain|Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona, 08035, Spain|START Madrid. Centro Integral Oncologico Clara Campal; CIOCC, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: LY3127804|DRUG: Ramucirumab|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,62,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/6/15,5/24/20,"SMO Sarah Cannon Research Inst., Nashville, Tennessee, 37203, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Brussels, 1000, Belgium|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Villejuif, 94805, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona, 08035, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Relapsed/Refractory Aggressive B-Cell Malignancies,BIOLOGICAL: ONCT-808|DRUG: Bridging Therapy,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,9,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/9/23,9/12/24,"City of Hope National Medical Center, Duarte, California, 91010, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Brain Tumors,DRUG: Poly ICLC,ALL,"CHILD, ADULT",PHASE2,23,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2010-08,2019-07,"RADY Children's Hospital, San Diego, California, 92123, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30342, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Urinary Bladder Neoplasms|Ureteral Neoplasms|Urethral Neoplasms,DRUG: Crizotinib,ALL,"ADULT, OLDER_ADULT",PHASE2,8,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/27/16,11/21/19,"Levine Cancer Institute, Charlotte, North Carolina, 28204, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Liver|Metastatic Malignant Neoplasm in the Lung|Metastatic Malignant Neoplasm in the Lymph Nodes|Metastatic Malignant Neoplasm in the Spine|Prognostic Stage IV Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8,RADIATION: Stereotactic Body Radiotherapy|PROCEDURE: Surgery,FEMALE,"ADULT, OLDER_ADULT",PHASE2|PHASE3,129,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/24/14,9/4/25,"University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, 35233, United States|CTCA at Western Regional Medical Center, Goodyear, Arizona, 85338, United States|Arizona Center for Cancer Care-Peoria, Peoria, Arizona, 85381, United States|Banner University Medical Center - Tucson, Tucson, Arizona, 85719, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, 94704, United States|UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States|Los Angeles General Medical Center, Los Angeles, California, 90033, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, 95678, United States|Sutter Medical Center Sacramento, Sacramento, California, 95816, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|Naval Medical Center -San Diego, San Diego, California, 92134, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, 94080, United States|Saint Joseph's Medical Center, Stockton, California, 95204, United States|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California, 96161, United States|UCHealth University of Colorado Hospital, Aurora, Colorado, 80045, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, 80907, United States|UCHealth Memorial Hospital Central, Colorado Springs, Colorado, 80909, United States|Poudre Valley Hospital, Fort Collins, Colorado, 80524, United States|McKee Medical Center, Loveland, Colorado, 80539, United States|Helen F Graham Cancer Center, Newark, Delaware, 19713, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, 32610, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, 33021, United States|Mayo Clinic in Florida, Jacksonville, Florida, 32224-9980, United States|Miami Cancer Institute, Miami, Florida, 33176, United States|Orlando Health Cancer Institute, Orlando, Florida, 32806, United States|Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Piedmont Hospital, Atlanta, Georgia, 30309, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, 30342, United States|John B Amos Cancer Center, Columbus, Georgia, 31904, United States|CTCA at Southeastern Regional Medical Center, Newnan, Georgia, 30265, United States|Lewis Hall Singletary Oncology Center, Thomasville, Georgia, 31792, United States|Queen's Medical Center, Honolulu, Hawaii, 96813, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, 96817, United States|Northwestern University, Chicago, Illinois, 60611, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|University of Illinois, Chicago, Illinois, 60612, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, 60134, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|Methodist Medical Center of Illinois, Peoria, Illinois, 61636, United States|Memorial Medical Center, Springfield, Illinois, 62781, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, 62226, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, 60555, United States|Midwestern Regional Medical Center, Zion, Illinois, 60099, United States|Ascension Saint Vincent Anderson, Anderson, Indiana, 46016, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, 46805, United States|Parkview Regional Medical Center, Fort Wayne, Indiana, 46845, United States|IU Health Ball Memorial Hospital, Muncie, Indiana, 47303, United States|Memorial Hospital of South Bend, South Bend, Indiana, 46601, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, 67214, United States|Owensboro Health Mitchell Memorial Cancer Center, Owensboro, Kentucky, 42303, United States|MaineHealth Coastal Cancer Treatment Center, Bath, Maine, 04530, United States|MaineHealth/SMHC Cancer Care and Blood Disorders-Biddeford, Biddeford, Maine, 04005, United States|Maine Medical Center-Bramhall Campus, Portland, Maine, 04102, United States|MaineHealth Cancer Care Center of York County, Sanford, Maine, 04073, United States|MaineHealth/SMHC Cancer Care and Blood Disorders-Sanford, Sanford, Maine, 04073, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, 04074, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|Greater Baltimore Medical Center, Baltimore, Maryland, 21204, United States|UM Upper Chesapeake Medical Center, Bel Air, Maryland, 21014, United States|Central Maryland Radiation Oncology in Howard County, Columbia, Maryland, 21044, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, 01805, United States|Lowell General Hospital, Lowell, Massachusetts, 01854, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, 48183, United States|Michigan Healthcare Professionals Clarkston, Clarkston, Michigan, 48346, United States|Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, 48038, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Michigan Healthcare Professionals Farmington, Farmington Hills, Michigan, 48334, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, 48341, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, 48073, United States|GenesisCare USA - Troy, Troy, Michigan, 48098, United States|Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, 48322, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Saint Luke's Hospital of Duluth, Duluth, Minnesota, 55805, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Mercy Hospital South, St Louis, Missouri, 63128, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Kalispell Regional Medical Center, Kalispell, Montana, 59901, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States|Renown Regional Medical Center, Reno, Nevada, 89502, United States|Wentworth-Douglass Hospital, Dover, New Hampshire, 03820, United States|Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, 03756, United States|Virtua Memorial, Mount Holly, New Jersey, 08060, United States|Community Medical Center, Toms River, New Jersey, 08755, United States|Virtua Voorhees, Voorhees Township, New Jersey, 08043, United States|Lovelace Medical Center-Saint Joseph Square, Albuquerque, New Mexico, 87102, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87102, United States|Lovelace Radiation Oncology, Albuquerque, New Mexico, 87109, United States|New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, 87109, United States|Christus Saint Vincent Regional Cancer Center, Santa Fe, New Mexico, 87505, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|University of Rochester, Rochester, New York, 14642, United States|Montefiore Medical Center - Moses Campus, The Bronx, New York, 10467, United States|Dickstein Cancer Treatment Center, White Plains, New York, 10601, United States|Rex Hematology Oncology Associates-Cary, Cary, North Carolina, 27518, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Rex Hematology Oncology Associates-Garner, Garner, North Carolina, 27529, United States|Rex Hematology Oncology Associates-Blue Ridge, Raleigh, North Carolina, 27607, United States|UNC Rex Healthcare, Raleigh, North Carolina, 27607, United States|UNC Rex Cancer Center of Wakefield, Raleigh, North Carolina, 27614, United States|Novant Cancer Institute Radiation Oncology - Supply, Supply, North Carolina, 28462, United States|Novant Health Cancer Institute Radiation Oncology - Wilmington, Wilmington, North Carolina, 28401, United States|Novant Health New Hanover Regional Medical Center, Wilmington, North Carolina, 28401, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, 58501, United States|Cleveland Clinic Akron General, Akron, Ohio, 44307, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|ProMedica Flower Hospital, Sylvania, Ohio, 43560, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, 97030, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, 97210, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Providence Saint Vincent Medical Center, Portland, Oregon, 97225, United States|UPMC Pinnacle Cancer Center/Community Osteopathic Campus, Harrisburg, Pennsylvania, 17109, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, 19104, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, 15212, United States|UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, 15232, United States|Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania, 18840, United States|Reading Hospital, West Reading, Pennsylvania, 19611, United States|Self Regional Healthcare, Greenwood, South Carolina, 29646, United States|Gibbs Cancer Center-Pelham, Greer, South Carolina, 29651, United States|Spartanburg Medical Center, Spartanburg, South Carolina, 29303, United States|Texas Oncology-Austin Midtown, Austin, Texas, 78705, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, 75390, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States|Ogden Regional Medical Center, Ogden, Utah, 84405, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, 84112, United States|Inova Fairfax Hospital, Falls Church, Virginia, 22042, United States|Bon Secours Saint Mary's Hospital, Richmond, Virginia, 23226, United States|Legacy Salmon Creek Hospital, Vancouver, Washington, 98686, United States|Edwards Comprehensive Cancer Center, Huntington, West Virginia, 25701, United States|West Virginia University Healthcare, Morgantown, West Virginia, 26506, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, 54301, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, 54303, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, 54601, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, 54482, United States|Froedtert West Bend Hospital/Kraemer Cancer Center, West Bend, Wisconsin, 53095, United States|Diagnostic and Treatment Center, Weston, Wisconsin, 54476, United States|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|London Regional Cancer Program, London, Ontario, N6A 4L6, Canada|Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, K1H 8L6, Canada|CHUM - Hopital Notre-Dame, Montreal, Quebec, H2L 4M1, Canada|McGill University Department of Oncology, Montreal, Quebec, H2W 1S6, Canada|CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, H2X 3E4, Canada|The Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, H3H 2R9, Canada|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia|Yonsei University Health System-Severance Hospital, Seoul, 120-752, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: Birinapant|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,34,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/4/17,2/17/20,"Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States|UCLA Dept of Medicine-Hematology/Oncology, Santa Monica, California, 90404, United States|Mid Florida Hematology and Oncology Center, Orange City, Florida, 32763, United States|The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, 21287, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Thomas Jefferson University Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, 19107, United States|Mary Crowley Cancer Research, Dallas, Texas, 75251, United States|MD Anderson Cancer Center, The University of Texas, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Niraparib|BIOLOGICAL: Pembrolizumab|BIOLOGICAL: TSR-042 (Dostarlimab),ALL,"ADULT, OLDER_ADULT",PHASE2,53,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/29/17,8/31/21,"GSK Investigational Site, Whittier, Alaska, 90603, United States|GSK Investigational Site, Port Saint Lucie, Florida, 34952, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Harvey, Illinois, 60426, United States|GSK Investigational Site, Tinley Park, Illinois, 60487, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Florham Park, New Jersey, 07932, United States|GSK Investigational Site, Buffalo, New York, 14263, United States|GSK Investigational Site, Durham, North Carolina, 27710, United States|GSK Investigational Site, Canton, Ohio, 44718, United States|GSK Investigational Site, Cleveland, Ohio, 44106, United States|GSK Investigational Site, Columbus, Ohio, 31904, United States|GSK Investigational Site, Toledo, Ohio, 43623, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Kennewick, Washington, 99336, United States|GSK Investigational Site, Tacoma, Washington, 98405, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,BIOLOGICAL: Favezelimab|BIOLOGICAL: Pembrolizumab|DRUG: Oxaliplatin|DRUG: Irinotecan|DRUG: Leucovorin (Calcium Folinate)|DRUG: Fluorouracil [5-FU]|BIOLOGICAL: Favezelimab/Pembrolizumab|DRUG: Lenvatinib,ALL,"ADULT, OLDER_ADULT",PHASE1,481,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/2/16,3/15/24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Anal Neoplasm,BIOLOGICAL: VGX-3100|DEVICE: CELLECTRA™ 5PSP,ALL,"ADULT, OLDER_ADULT",PHASE2,23,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/15/18,5/26/21,"Howard Brown Health (HBH)-Sheridan, Chicago, Illinois, 60613, United States|Laser Surgery Care, New York, New York, 10011, United States|Clinique de Recherche en Sante, Québec, Quebec, G1S2L6, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: NY-ESO-1(c259)T Cells|DRUG: Fludarabine|DRUG: Cyclophosphamide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,50,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT,9/27/12,6/18/19,"GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Tampa, Florida, 33612, United States|GSK Investigational Site, Bethesda, Maryland, 20892, United States|GSK Investigational Site, Boston, Massachusetts, 02114, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasm,DRUG: Eribulin Mesylate|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,258,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/28/15,4/6/21,"Facility #1, Duarte, California, 91010, United States|Facility #1, Santa Barbara, California, 93105, United States|Facility #1, Denver, Colorado, 80218, United States|Facility #1, Miami, Florida, 33176, United States|Facility #1, West Palm Beach, Florida, 33401, United States|Facility #1, Boston, Massachusetts, 02115, United States|Facility #2, Boston, Massachusetts, 02115, United States|Facility #1, Minneapolis, Minnesota, 55407, United States|Facility #1, St Louis, Missouri, 63110, United States|Facility #1, Lebanon, New Hampshire, 03756, United States|Facility #1, New York, New York, 10032, United States|Facility #2, New York, New York, 10065, United States|Facility #1, Chattanooga, Tennessee, 37404, United States|Facility #1, Nashville, Tennessee, 37203, United States|Facility #1, Austin, Texas, 78731, United States|Facility #1, Fort Worth, Texas, 76104, United States|Facility #1, San Antonio, Texas, 78217, United States|Facility #2, San Antonio, Texas, 78229, United States|Facility #1, Sherman, Texas, 75090, United States|Facility #1, Salem, Virginia, 24153, United States|Facility #1, Winchester, Virginia, 22601, United States|Facility #1, Madison, Wisconsin, 53792, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: GSK2636771|DRUG: Enzalutamide,MALE,"ADULT, OLDER_ADULT",PHASE1,37,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/13/14,10/3/19,"GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Los Angeles, California, 90033, United States|GSK Investigational Site, Los Angeles, California, 90095, United States|GSK Investigational Site, Washington D.C., District of Columbia, 20007, United States|GSK Investigational Site, Detroit, Michigan, 48201, United States|GSK Investigational Site, New York, New York, 10016, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, London, SE1 9RT, United Kingdom|GSK Investigational Site, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Solid Tumors,DRUG: Dexamethasone|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,132,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2/2/06,2/28/28,"Lyndon Baines Johnson Hospital, Houston, Texas, 77030, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Metastatic Malignant Neoplasm in the Brain|Primary Brain Neoplasm,PROCEDURE: 3 Tesla Magnetic Resonance Imaging|PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging|PROCEDURE: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging|DRUG: Ferumoxytol|DRUG: Gadolinium|PROCEDURE: High Field Strength Magnetic Resonance Imaging|PROCEDURE: Susceptibility Weighted Imaging,ALL,"ADULT, OLDER_ADULT",PHASE2,40,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,11/16/06,12/31/20,"OHSU Knight Cancer Institute, Portland, Oregon, 97239, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: MSB0011359C,ALL,"ADULT, OLDER_ADULT",PHASE1,114,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/11/16,2/21/22,"NHO Kyushu Cancer Center, Fukuoka, Japan|National Cancer Center East, Department of Experimental Therapeutics, Kashiwa, Japan|National Cancer Center East, Department of hepatobiliary and pancreatic oncology, Kashiwa, Japan|Saitama Cancer Center, Kitaadachi-gun, Japan|NHO Shikoku Cancer Center, Matsuyama, Japan|Aichi Cancer Center Hospital, Nagoya, Japan|Kinki University Hospital, Sayama, Japan|National Cancer Center, Department of Experimental Therapeutics, Tokyo, Japan|National Cancer Center, Department of hepatobiliary and pancreatic oncology, Tokyo, Japan|Kanagawa Cancer Center, Department of Gastroenterology, Yokohama, Japan|Kanagawa Cancer Center, Department of Gastrointestinal Surgery, Yokohama, Japan|Asan Medical Center, Seoul, South Korea|Seoul National University Hospital, Seoul, South Korea|Severance Hospital, Seoul, South Korea|National Cheng Kung University Hospital, Tainan, Taiwan|Mackay Memorial Hospital, Taipei, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Chang Gung Memorial Hospital; Linkou, Taoyuan District, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Tumor,DRUG: Sitravatinib|DRUG: Sitravatinib,MALE,ADULT,PHASE1,26,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,7/23/20,11/9/20,"Linear Clinical Research, Nedlands, Western Australia, 6009, Australia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors,DRUG: Sotatercept,ALL,"ADULT, OLDER_ADULT",PHASE2,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,6/1/10,10/29/12,"Saint Agnes Healthcare, Baltimore, Maryland, 21229, United States|Weinberg Cancer Institution at Franklin Square, Baltimore, Maryland, 21237, United States|Pennsylvania Oncology, Philadelphia, Pennsylvania, 19106, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: Cobimetinib,ALL,"CHILD, ADULT",PHASE1|PHASE2,56,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/20/16,7/21/21,"Arkansas Children'S Hospital, Little Rock, Arkansas, 72202, United States|Arnold Palmer Hosp-Children, Orlando, Florida, 32806, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|Hôpital de la Timone, Oncologie Pédiatrique, Marseille, 13385, France|Institut Curie, Oncologie Pédiatrique, Paris, 75231, France|Institut Gustave Roussy; Service Pediatrique, Villejuif, 94805, France|Universitaetsklinikum Muenster, Münster, 48149, Germany|Schneider Children's Medical Center, Petah Tikva, 49100, Israel|Fondazione IRCCS Istituto Nazionale dei Tumori; Struttura Complessa di Pediatria Oncologica, Milan, Lombardy, 20133, Italy|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Infantil Universitario Nino Jesus, Madrid, 28009, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, 46026, Spain|Alderhey Childrens Trust, Liverpool, L12 2AP, United Kingdom|Great Ormond Street Hospital; Dept. Of Pediatric Oncology, London, WC1N 3JH, United Kingdom|The Royal Victoria Infirmary; Paediatric and Adolescent Oncology Unit, Newcastle upon Tyne, NE1 4LP, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Carcinoid Tumors|Pancreatic NET,DRUG: Ibrutinib,ALL,"ADULT, OLDER_ADULT",PHASE2,20,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/9/15,11/4/19,"H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: Gemcitabine plus PM060184,ALL,"ADULT, OLDER_ADULT",PHASE1,57,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,12/12/14,7/11/19,"New York, New York, 10461, United States|Madrid, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Everolimus|DRUG: Exemestane|DRUG: BI 836845,FEMALE,"ADULT, OLDER_ADULT",PHASE1,164,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/15/14,12/14/21,"Medical University of Graz State Hospital - University Hospital Graz, Graz, 8036, Austria|Wilhelminenspital, Vienna, 1160, Austria|Brussels - UNIV UZ Brussel, Brussels, 1090, Belgium|Brussels - UNIV Saint-Luc, Brussels, 1200, Belgium|Charleroi - HOSP Grand Hôpital de Charleroi, Charleroi, 6000, Belgium|Edegem - UNIV UZ Antwerpen, Edegem, 2650, Belgium|UZ Leuven, Leuven, 3000, Belgium|Centre Hospitalier Universitaire de Liège, Liège, 4000, Belgium|Liège - HOSP St-Joseph, Liège, 4000, Belgium|CHU UCL Namur - Site De Sainte-Elisabeth, Namur, 5000, Belgium|HOP Jean Minjoz, Besançon, 25030, France|INS Paoli-Calmettes, Marseille, 13009, France|CTR Catherine de Sienne, Nantes, 44202, France|HOP Européen G. Pompidou, Paris, 75015, France|INS Curie, Paris, 75248, France|Ctr Cario, Plerin Sur Mer, 22190, France|St. Vincent's University Hospital, Dublin, D04 T6F4, Ireland|Maastricht University, Maastricht, 6229 HX, Netherlands|National Cancer Center, Goyang, 10408, South Korea|Seoul National University Hospital, Seoul, 110-744, South Korea|Asan Medical Center, Seoul, 138-736, South Korea|Hospital Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Arnau de Vilanova, Lleida, 25198, Spain|MD Anderson Cancer Center Madrid, Madrid, 28033, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Virgen del Rocío, Seville, 41013, Spain|Hospital Clínico de Valencia, Valencia, 46010, Spain|Centrummottagningen, Stockholm, 171 76, Sweden|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, 8807, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 112, Taiwan|Ninewells Hospital & Medical School, Dundee, DD1 9SY, United Kingdom|St Bartholomew's Hospital, London, EC1M 6BQ, United Kingdom|Freeman Hospital, Newcastle upon Tyne, NE7 7DN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors|Metastatic Solid Tumors,BIOLOGICAL: Mogamulizumab (KW-0761),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,17,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2014-10,2020-02,"Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Neoplasms,DRUG: Letetresgene autoleucel|DRUG: Cyclophosphamide|DRUG: Fludarabine,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,7,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/31/19,7/1/25,"City of Hope National Medical Center, Duarte, California, 91010, United States|Stanford Hospital and Clinics, Stanford, California, 94305, United States|Sarah Cannon Research Institute, Denver, Colorado, 80218, United States|Mayo Clinic Jacksonville, Jacksonville, Florida, 32224, United States|University of Chicago, Chicago, Illinois, 60637, United States|University of Iowa College of Medicine, Iowa City, Iowa, 52242-1009, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02114, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|University of Michigan Medical Center, Ann Arbor, Michigan, 48109, United States|Minnesota Oncology Hematology, Minneapolis, Minnesota, 55455, United States|Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States|Washington University, St Louis, Missouri, 63110, United States|Memorial Sloan Kettering cancer center, New York, New York, 10065, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Ohio State University-Columbus, Columbus, Ohio, 43210, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|University of Pittsburgh, Hillman Cancer centre, Pittsburgh, Pennsylvania, 15232, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|University Of Texas Southwestern Medical Center, Dallas, Texas, 75390-8565, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390-9063, United States|University of Utah, Salt Lake City, Utah, 84112, United States|Virginia Commonwealth University, Richmond, Virginia, 23298, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109-1024, United States|Froedtert Hospital, Milwaukee, Wisconsin, 53226, United States|CIUSSS de L'Est-De-Lile-De-Montreal, Montreal, Quebec, H1T 2M4, Canada|Princess Margaret Cancer Centre, Toronto, M5G 2M9, Canada|Centre Léon Bérard, Lyon, 69373, France|CHU de Bordeaux GH Sud Hôpital Haut Lévêque, Pessac, 33604, France|Fondazione IRCCS Instituto Nazionale Dei Tumori, Milan, 20133, Italy|Ircss Istituto Clinico Humanitas, Romano di Lombardia, 20089, Italy|The Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands|Hospital Santa Creu Y Sant Pau, Barcelona, 08025, Spain|Ico Duran y Reynals l'Hospitalet de Llobrega, Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, 28040, Spain|Hospital Virgen Del Rocio, Seville, 41013, Spain|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom|University College Hospital-London, London, WC1E 6AG, United Kingdom|Christie Hospital NHS Foundation Trust, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,58,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/7/16,9/27/21,"Local Institution - 0001, Guangzhou, Guangdong, 510060, China|Local Institution, Hangzhou, Zhejiang, 310016, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Carcinoid Syndrome|Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm,OTHER: Carbon C 11 Alpha-methyltryptophan|OTHER: Laboratory Biomarker Analysis|PROCEDURE: Positron Emission Tomography|DRUG: Telotristat Etiprate,ALL,"ADULT, OLDER_ADULT",PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/20/18,10/15/20,"Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, 48201, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,BIOLOGICAL: Tislelizumab|DRUG: Pamiparib,ALL,"ADULT, OLDER_ADULT",PHASE1,229,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/2/16,9/9/20,"Pinnacle Oncology Hematology, Scottsdale, Arizona, 85258, United States|Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|Rocky Mountain Cancer Centers, Denver, Colorado, 80218, United States|Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Texas Oncology, Dallas, Texas, 75246, United States|Texas Oncology, Tyler, Texas, 75702, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|The Canberra Hospital, Garran, Australian Capital Territory, 2605, Australia|Mid North Coast Cancer Institute, Coffs Harbour, New South Wales, 2450, Australia|Calvary Mater Newcastle, Newcastle, New South Wales, 2298, Australia|Westmead Hospital, Parramatta, New South Wales, Australia|Prince of Wales, Randwick, New South Wales, Australia|Northern Cancer Institute, St Leonards, New South Wales, 2065, Australia|Icon Cancer Care, Brisbane, Queensland, 4101, Australia|Monash Health, Clayton, Victoria, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|Linear Clinical Research Ltd, Nedlands, Western Australia, Australia|Institut Gustave Roussy, Paris, 94800, France|Centre Eugene Marquis, Rennes, 35042, France|Auckland City Hospital, Auckland, 1023, New Zealand|Capital and Coast District Health Board, Wellington, 6021, New Zealand|Hospital Universitario Vall d'Hebrón, Barcelona, 08035, Spain|Hospital Clínico Universitario de Valencia, Valencia, 46010, Spain|Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Stomach Neoplasm|Gastrointestinal Neoplasms|Digestive System Neoplasm|Neoplasms by Site|Neoplasms,DRUG: EO-3021|DRUG: Ramucirumab (CYRAMZA®)|DRUG: Dostarlimab,ALL,"ADULT, OLDER_ADULT",PHASE1,88,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/10/23,6/2/25,"Mayo Clinic, Phoenix, Arizona, 85054, United States|City of Hope, Duarte, California, 91010, United States|Yale - Smilow Cancer Hospital, New Haven, Connecticut, 06519, United States|Georgetown University, Washington D.C., District of Columbia, 20007, United States|Johns Hopkins University - Sibley Memorial Hospital, Washington D.C., District of Columbia, 20016, United States|Mayo Clinic, Jacksonville, Florida, 32224, United States|Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida, 32827, United States|Henry Ford Cancer, Detroit, Michigan, 48202, United States|START Midwest, Grand Rapids, Michigan, 49546, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Atrium Health/Wake Forest University, Charlotte, North Carolina, 28204, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Mary Crowley Cancer Research, Dallas, Texas, 75230, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|UW Carbone Cancer Center - Cancer Connect, Madison, Wisconsin, 53792, United States|National Cancer Center Hospital East, Kashiwa-shi, Chiba, 277-8577, Japan|National Cancer Center Hospital, Chuo Ku, Tokyo, 104-0045, Japan|Samsung Medical Center, Seoul, South Korea|Yonsei University, Seoul, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Recurrent Prostate Carcinoma|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Lymph Nodes|Oligometastasis|Prostate Adenocarcinoma|PSA Failure,RADIATION: Hypofractionated Radiation Therapy|RADIATION: Intensity-Modulated Radiation Therapy|PROCEDURE: Metastasectomy|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration|RADIATION: Stereotactic Body Radiation Therapy,MALE,"ADULT, OLDER_ADULT",PHASE2,20,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/9/19,6/30/26,"Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematopoietic Cell Transplantation Recipient|Malignant Neoplasm|Influenza,BIOLOGICAL: Trivalent Influenza Vaccine|BIOLOGICAL: Quadrivalent Influenza Vaccine|OTHER: Laboratory Biomarker Analysis,ALL,CHILD,PHASE2,170,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION",2016-09,2024-09,"UCSF Children's Hospital, San Francisco, California, 94158, United States|Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, 45229, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232, United States|Texas Children's Hospital, Houston, Texas, 77030, United States|Seattle Children's Hospital Research Institute, Seattle, Washington, 98101, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Cancer|Solid Tumors,DRUG: Vevorisertib|DRUG: Fulvestrant|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,78,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/26/16,3/10/21,"Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Charleston Hematology Oncology, Charleston, South Carolina, 29414, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Mary Crowley Cancer Research, Dallas, Texas, 75230, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: letetresgene autoleucel (GSK3377794)|DRUG: Cyclophosphamide|DRUG: Fludarabine,ALL,"ADULT, OLDER_ADULT",PHASE2,23,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/6/16,3/22/22,"GSK Investigational Site, Tampa, Florida, 33612, United States|GSK Investigational Site, Ann Arbor, Michigan, 48109, United States|GSK Investigational Site, St Louis, Missouri, 63110, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Columbus, Ohio, 43210, United States|GSK Investigational Site, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Neoplasm, Gastrointestinal",DRUG: DS-8201a|DRUG: Physician's Choice,ALL,"ADULT, OLDER_ADULT",PHASE2,233,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/2/17,12/11/20,"Aichi Cancer Center Hospital, Nagoya, Aichi-ken, 464-8681, Japan|Hirosaki University Hospital, Hirosaki, Aomori, 036-8563, Japan|National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, 791-0280, Japan|Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Fukuoka, 806-8501, Japan|Gunma Prefectural Cancer Center, Ōta, Gunma, 373-8550, Japan|Kure Medical Center, Kure, Hiroshima, 737-0023, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, 060-8648, Japan|Hyogo Cancer Center, Akashi, Hyōgo, 673-8558, Japan|Kansai Rosai Hospital, Amagasaki, Hyōgo, 660-8511, Japan|Kobe City Medical Center General Hospital, Kobe, Hyōgo, 650-0047, Japan|Ibaraki Prefectural Central Hospital, Kasama, Ibaraki, 309-1793, Japan|Kanazawa University Hospital, Kanazawa, Ishikawa-ken, 920-8641, Japan|Iwate Medical University Hospital, Shiwa-gun, Iwate, 028-3695, Japan|Kagawa University Hospital, Kita, Kagawa-ken, 761-0793, Japan|St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, 216-8511, Japan|The Kitasato Institute Kitasato University Hospital, Sagamihara, Kanagawa, 252-0375, Japan|Yokohama City University Medical Center, Yokohama, Kanagawa, 232-0024, Japan|Kanagawa Cancer Center, Yokohama, Kanagawa, 241-8515, Japan|Japanese Red Cross Kyoto Daini Hospital, Kamigyō-ku, Kyoto, 602-8026, Japan|Miyagi Cancer Center, Natori-shi, Miyagi, 981-1293, Japan|Osaki Citizen Hospital, Ōsaki, Miyagi, 989-6183, Japan|Osaka University Hospital, Suita, Osaka, 565-0871, Japan|Toyonaka Municipal Hospital, Toyonaka, Osaka, 560-8565, Japan|Tochigi Cancer Center, Utsunomiya, Tochigi, 320-0834, Japan|Tokyo Metropolitan Komagome Hospital, Bunkyō-Ku, Tokyo, 113-8677, Japan|National Cancer Center Hospital, Chuo Ku, Tokyo, 104-0045, Japan|The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-Ku, Tokyo, 135-8550, Japan|Showa University Koto Toyosu Hospital, Koto-Ku, Tokyo, 135-8577, Japan|Toranomon Hospital, Minato-Ku, Tokyo, 105-8470, Japan|Chiba Cancer Center, Chiba, 260-8717, Japan|Fukui Prefectural Hospital, Fukui, 910-8526, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Kyushu University Hospital, Fukuoka, 812-8582, Japan|Gifu University Hospital, Gifu, 501-1194, Japan|Hiroshima City Asa Citizens Hospital, Hiroshima, 731-0293, Japan|Hiroshima Prefectural Hospital, Hiroshima, 734-8530, Japan|Kochi Health Sciences Center, Kochi, 781-8555, Japan|Niigata Cancer Center Hospital, Niigata, 951-8566, Japan|Okayama University Hospital, Okayama, 700-8558, Japan|Local Incorporated Administrative Agency Osaka City Hospital Organization Osaka City General Hospital, Osaka, 534-0021, Japan|Osaka International Cancer Institute, Osaka, 541-8567, Japan|Osaka General Medical Center, Osaka, 558-8558, Japan|Kindai University Hospital, Osaka, 589-8511, Japan|Saitama Cancer Center, Saitama, 362-0806, Japan|Shizuoka Cancer Center, Shizuoka, 411-8777, Japan|Shizuoka General Hospital, Shizuoka, 420-8527, Japan|Keio University Hospital, Tokyo, 160-8582, Japan|National Cancer Center, Ilsan, Gyeonggi-do, 10408, South Korea|Chungbuk National University Hospital, Cheongju-si, North Chungcheong, 28644, South Korea|Inje University Haeundae Paik Hospital, Busan, 48108, South Korea|Dong-A University Hospital, Busan, 49201, South Korea|Kyungpook National University Chilgok Hospital, Daegu, 41404, South Korea|Chonnam National University Hwasun Hospital, Gwangju, 58128, South Korea|Gachon University Gil Medical Center, Incheon, 21565, South Korea|Chonbuk National University Hospital, Jeonju, 54907, South Korea|Seoul National University Bundang Hospital, Seongnam, 13620, South Korea|Korea University Anam Hospital, Seoul, 02841, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Yonsei Cancer Center, Severance Hospital, Yonsei University Health System, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Gangnam Severance Hospital, Seoul, 06273, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, 06591, South Korea|Chung-Ang University Hospital, Seoul, 06973, South Korea|Korea University Guro Hospital, Seoul, 08308, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: Letetresgene autoleucel|DRUG: Letetresgene autoleucel with pembrolizumab|DRUG: Fludarabine|DRUG: Cyclophosphamide|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,6,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/18/17,11/5/20,"GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Tampa, Florida, 33612-9497, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Baltimore, Maryland, 21201, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Solid Tumor, Adult|Advanced Solid Tumor|Metastatic Solid Tumor",DRUG: Etigilimab|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,76,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,3/23/21,10/30/23,"Mereo Investigator Site, Phoenix, Arizona, 85054, United States|Mereo Investigator Site, Greenbrae, California, 94904, United States|Mereo Investigator Site, Los Angeles, California, 90025, United States|Mereo Investigator Site, Jacksonville, Florida, 32224, United States|Mereo Investigator Site, Boston, Massachusetts, 02215, United States|Mereo Investigator Site, Ann Arbor, Michigan, 48109, United States|Mereo Investigator Site, Rochester, Minnesota, 55905, United States|Mereo Investigator Site, New York, New York, 10065, United States|Mereo Investigator Site, Durham, North Carolina, 27710, United States|Mereo Investigator Site, Oklahoma City, Oklahoma, 73104, United States|Mereo Investigator Site, Nashville, Tennessee, 37203, United States|Mereo Investigator Site, Houston, Texas, 77030, United States|Mereo Investigator Site, West Valley City, Utah, 84119, United States|Mereo Investigator Site, Fairfax, Virginia, 22031, United States|Royal Marsden, London, United Kingdom|Sarah Cannon UK, London, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors,DRUG: E7080|DRUG: Comparator Drug|DRUG: Comparator Drug: Sorafenib,ALL,"ADULT, OLDER_ADULT",PHASE2,40,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/16/18,12/21/23,"Harbor UCLA Medical Center, Torrance, California, 90502, United States|Northwestern University, Chicago, Illinois, 60611, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|The Alfred Hospital, Melbourne, 3004, Australia|UZ Antwerpen, Edegem, Antwerpen, 2650, Belgium|Cliniques Universitaires Saint-Luc, Brussels, Brussels Capital, 1200, Belgium|Sun Yat-sen University, Cancer Center, Guangzhou, Guangdong, China|Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China|Harbin Medical University Cancer Hospital, Haerbin, Heilongjiang, China|Henan Cancer Hospital, Zhengzhou, Henan, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, China|Hunan Cancer Hospital, Changsha, Hunan, China|Jiangsu Cancer Hospital, Nanjing, Jiangsu, China|Nanjing First Hospital, Nanjing, Jiangsu, China|The First Hospital of Jilin University, Changchun, Jilin, China|No.10 People of Shanghai, Shanghai, Shanghai Municipality, China|West China School of Medicine/West China Hospital, Sichuan University, Chengdu, Sichuan, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China|Eisai trial site 2, Essen, 45147, Germany|Eisai trial site 1, Würzburg, 97080, Germany|Azienda Ospedaliero Universitaria Pisana, Pisa, Tuscany, 56124, Italy|Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, North Holland, 1066 CX, Netherlands|Centrum Onkologii Instytut im.Marii Sklodowskiej Curie-Oddzial w Gliwicach, Gliwice, 44-101, Poland|Institutul National de Endocrinologie ""C. I. Parhon"", Bucharest, 11863, Romania|National Cancer Center, Goyang-si, Gyeonggido, 10408, South Korea|Samsung Medical Center - PPDS, Seoul, 6351, South Korea|Chulalongkorn University, Pathum Wan, Bangkok, 10330, Thailand",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Carcinoid Tumor,DRUG: Ziv-aflibercept,ALL,"ADULT, OLDER_ADULT",PHASE2,19,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/13/13,12/26/21,"Massachusetts General Hospital, Boston, Massachusetts, 02115, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Gastrointestinal Stromal Tumors,DRUG: DS-6157a,ALL,"ADULT, OLDER_ADULT",PHASE1,34,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/8/20,3/11/22,"Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Washington University of St. Louis, St Louis, Missouri, 63110, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|MD Anderson, Houston, Texas, 77030, United States|National Cancer Center Hospital East, Tokyo, 277-8577, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Recurrent Neuroendocrine Tumor|Metastatic Neuroendocrine Tumor,DRUG: ONC201,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/2/17,5/19/23,"Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, 44195, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,SUSPENDED,YES,Lymphoma|Histiocytic Sarcoma|Follicular Dendritic Cell Sarcoma|Interdigitating Dendritic Cell Sarcoma,DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,18,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/7/17,8/18/25,"Northwestern University, Chicago, Illinois, 60611, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Nebraska, Omaha, Nebraska, 68198, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Carcinoid Tumor|Metastatic Carcinoid Tumor|Neuroendocrine Neoplasm,OTHER: Laboratory Biomarker Analysis|DRUG: Nintedanib|OTHER: Pharmacological Study|OTHER: Quality-of-Life Assessment,ALL,"ADULT, OLDER_ADULT",PHASE2,32,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/15/15,8/31/22,"Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: RMC-4630|DRUG: Cobimetinib|DRUG: Drug: Osimertinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,113,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/2/19,2/8/22,"Honor Health Research Institute, Scottsdale, Arizona, 85258, United States|City of Hope, Duarte, California, 91010, United States|UC Irvine - Chao Family Comprehensive Cancer Center, Orange, California, 92868, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|UC San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94115, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, 30322, United States|Northwestern University, Chicago, Illinois, 60611, United States|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21287, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10021, United States|Ohio State University, Columbus, Ohio, 43210, United States|University of Oklahoma - Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Providence Cancer Institute, Franz Clinic, Portland, Oregon, 97213, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Sarah Cannon Research Institute - Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|Dell Seton Medical Center at University of Texas, Austin, Texas, 78712, United States|Virginia Cancer Specialists (Fairfax) - USOR, Fairfax, Virginia, 22031, United States|University of Wisconsin, Madison, Wisconsin, 53792, United States|Severance Hospital Yonsei University Health System, Seoul, Seoul Teugbyeolsi, 03722, South Korea|Seoul National University Hospital, Seoul, 110744, South Korea|Samsung Medical Center - PPDS, Seoul, 135-710, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,BIOLOGICAL: ALT-803,ALL,"ADULT, OLDER_ADULT",PHASE1,26,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-05,2017-12,"University of Minnesota, Minneapolis, Minnesota, 55455, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08901, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|University of Washington, Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: BMS-986408|BIOLOGICAL: Nivolumab|BIOLOGICAL: Ipilimumab|BIOLOGICAL: Platinum-doublet chemotherapy|DRUG: Rabeprazole,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,68,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/2/22,7/24/25,"Local Institution - 0010, Boston, Massachusetts, 02215, United States|Local Institution - 0001, Hackensack, New Jersey, 07601, United States|Local Institution - 0003, Houston, Texas, 77030, United States|Local Institution - 0007, Edmonton, Alberta, T6G 1Z2, Canada|Local Institution - 0011, Hamilton, Ontario, L8V5C2, Canada|Local Institution - 0005, Ottawa, Ontario, K1H 8L6, Canada|Local Institution - 0006, Toronto, Ontario, M5G 2M9, Canada|Local Institution - 0015, Bordeaux, Aquitaine, 33076, France|Local Institution - 0014, Villejuif, Paris, 94800, France|Local Institution - 0018, Marseille, 13385, France|Local Institution - 0019, Toulouse, 31059, France|Local Institution - 0024, Málaga, Andalusia, 29010, Spain|Local Institution - 0025, Madrid, Madrid, Comunidad de, 28009, Spain|Local Institution - 0022, Madrid, 28040, Spain|Local Institution - 0023, Madrid, 28050, Spain|Local Institution - 0021, Sankt Gallen, Canton of St. Gallen, 9007, Switzerland|Local Institution - 0012, Basel, 4031, Switzerland|Local Institution - 0020, Geneva, 1205, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Malignancies|Relapse|Graft-Versus-Host Disease,DRUG: Carfilzomib|DRUG: Tacrolimus,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,53,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-10,10/16/20,"University of Michigan Hospital, Ann Arbor, Michigan, 48109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: GSK3326595|DRUG: 5-Azacitidine,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/16/18,1/11/22,"GSK Investigational Site, Birmingham, Alabama, 35294-3300, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Boston, Massachusetts, 02114, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Milwaukee, Wisconsin, 53226, United States|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|Unresectable Malignant Solid Neoplasm,PROCEDURE: Biopsy Procedure|PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|DRUG: Copanlisib Hydrochloride|BIOLOGICAL: Durvalumab|PROCEDURE: Echocardiography Test|PROCEDURE: Magnetic Resonance Imaging|DRUG: Olaparib|PROCEDURE: X-Ray Imaging,ALL,"ADULT, OLDER_ADULT",PHASE1,39,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/21/19,9/24/26,"Keck Medicine of USC Buena Park, Buena Park, California, 90621, United States|Keck Medicine of USC Koreatown, Los Angeles, California, 90020, United States|Los Angeles General Medical Center, Los Angeles, California, 90033, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, 92663, United States|Keck Medical Center of USC Pasadena, Pasadena, California, 91105, United States|UCHealth University of Colorado Hospital, Aurora, Colorado, 80045, United States|Northwestern University, Chicago, Illinois, 60611, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, 15232, United States|University of Texas at Austin, Austin, Texas, 78712, United States|University of Texas Medical Branch, Galveston, Texas, 77555-0565, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, 53792, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Neoplasms|Cholangiocarcinoma|Pancreatic Neoplasms,DRUG: BI 905711,ALL,"ADULT, OLDER_ADULT",PHASE1,110,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/11/20,11/27/23,"Yale Cancer Center, New Haven, Connecticut, 06511, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10022, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|START South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, 78229, United States|Brussels - UNIV Saint-Luc, Brussels, 1200, Belgium|UZ Leuven, Leuven, 3000, Belgium|Beijing Cancer Hospital, Beijing, 100142, China|The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510655, China|HOP Jean Minjoz, Besançon, 25030, France|CTR Leon Berard, Lyon, 69373, France|HOP la Milétrie, Poitiers, 86021, France|CTR Eugène Marquis, Rennes, 35042, France|Universitätsklinikum Mannheim GmbH, Mannheim, 68167, Germany|National Cancer Center Hospital East, Chiba, Kashiwa, 277-8577, Japan|Korea University Anam Hospital, Seoul, 02841, South Korea|Hospital Vall d'Hebron, Barcelona, 08035, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Hospital Clínico de Valencia, Valencia, 46010, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: ginisortamab|DRUG: trifluridine/tipiracil|DRUG: mFOLFOX6,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,93,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/9/20,4/11/24,"Onc001 50414, Los Angeles, California, 90033, United States|Onc001 50470, Charleston, South Carolina, 29425, United States|Onc001 50471, Houston, Texas, 77030, United States|Onc001 40305, Glasgow, United Kingdom|Onc001 40113, London, United Kingdom|Onc001 40304, Manchester, United Kingdom|Onc001 40306, Newcastle upon Tyne, United Kingdom|Onc001 40303, Oxford, United Kingdom|Onc001 40302, Sutton, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Relapsed Solid Tumor|Refractory Solid Tumor,DRUG: Abemaciclib|DRUG: Irinotecan|DRUG: Temozolomide|DRUG: Dinutuximab|DRUG: GM-CSF,ALL,"CHILD, ADULT",PHASE1|PHASE2,47,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/9/20,8/19/25,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|The Regents of the University of California - Los Angeles (UCLA Pediatrics), Los Angeles, California, 90095-1752, United States|Kaiser Permanente Oakland, Oakland, California, 94611, United States|Kaiser Permanente Roseville, Roseville, California, 95661, United States|Kaiser Permanente Santa Clara, Santa Clara, California, 95051, United States|Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, 46202, United States|Spectrum Health, Grand Rapids, Michigan, 49503, United States|Cohen Children's Medical Center, New Hyde Park, New York, 11040, United States|Atrium Health - Carolinas Medical Center, Charlotte, North Carolina, 28203, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, 19104, United States|Lifespan Cancer Institute, Providence, Rhode Island, 02906, United States|Perth Children's Hospital, Perth, Western Australia, 6009, Australia|UZ Gent, Ghent, Oost-Vlaanderen, 9000, Belgium|Centre Leon Berard, Lyon, Rhône, 69373 CEDEX 08, France|Gustave Roussy, Villejuif, Val-de-Marne, 94800, France|Institut Curie, Paris, 75248, France|Universitaetsklinikum Heidelberg, Heidelberg, Baden-Wurttemberg, 69120, Germany|Universitaetsklinikum Essen, Essen, North Rhine-Westphalia, 45122, Germany|Charité Campus Virchow-Klinikum, Berlin, 13353, Germany|Fondazione Policlinico Universitario Agostino Gemelli, Rome, Lazio, 168, Italy|National Cancer Center Hospital, Chuo Ku, Tokyo, 104-0045, Japan|Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], 8035, Spain|Hospital Infantil Universitario Niño Jesús, Madrid, Madrid, Comunidad de, 28009, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms,DRUG: Ziv-Aflibercept|DRUG: Ganetespib,ALL,"ADULT, OLDER_ADULT",PHASE1,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/2/14,2/25/16,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Stromal Tumors,DRUG: DCC-2618,ALL,"ADULT, OLDER_ADULT",PHASE2,39,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/23/20,8/23/22,"Beijing Cancer Hospital, Beijing, Beijing Municipality, China|Chinese People's Liberation Army General Hospital, Beijing, Beijing Municipality, China|Union Medical College Hospital, Chongqing Medical University, Chongqing, Chongqing Municipality, China|Union Medical College Hospital, Fujian Medical University, Fuzhou, Fujian, China|The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|Fudan University Cancer Hospital, Shanghai, Shanghai Municipality, China|Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China|West China Hospital of Sichuan University, Chengdu, Sichuan, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Metastatic Malignant Solid Neoplasm|Refractory Malignant Solid Neoplasm|Unresectable Malignant Solid Neoplasm,DRUG: Avelumab|DRUG: Berzosertib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,23,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/17/20,12/31/25,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Locally Advanced Esophageal and Gastric Cancers (EGC),DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/17/17,11/22/23,"Duke Cancer Center, Durham, North Carolina, 27710, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Brain Neoplasm,DRUG: Injection Tramadol|OTHER: placebo,ALL,"ADULT, OLDER_ADULT",PHASE4,80,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2016-03,2018-12,"Aga Khan University, Karachi, Sindh, 74800, Pakistan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|Refractory Malignant Solid Neoplasm|Unresectable Malignant Solid Neoplasm,DRUG: Adavosertib|DRUG: Olaparib,ALL,"ADULT, OLDER_ADULT",PHASE1,13,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/30/20,9/30/26,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Malignancies|Non-small-cell Lung Cancer,DRUG: PF-06801591,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,155,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/18/20,6/9/26,"Beijing Cancer hospital, Beijing, Beijing Municipality, 100142, China|Chongqing Cancer Hospital, Chongqing, Chongqing Municipality, 400030, China|Nanjing Drum Tower Hospital, Nanjing, Jiangsu, 210008, China|Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai Municipality, 201107, China|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|Russian Research Centre for Radiology and Surgical Technologies, Saint Petersburg, Pesochny, 197758, Russia|Private Medical Institution ""Euromedservice"", Pushkin, Sankt-Peterburg, 196603, Russia|Klinika UZI 4D, LLC, Pyatigorsk, Stavropol Kray, 357502, Russia|State budgetary institution of healthcare of Yaroslavl region ""Clinical oncology hospital"", Yaroslavl, Yaroslavl Oblast, 150054, Russia|Evimed Llc, Chelyabinsk, 454048, Russia|Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine, Chelyabinsk, 454087, Russia|Ars Medika Center, LLC, Kaliningrad, 236006, Russia|GBUZ Regional Clinical Hospital of Kaliningrad region, Kaliningrad, Russia|Enlimed Llc, Kopeysk, 456620, Russia|Orenburg Regional Clinical Oncological Dispensary, Orenburg, 460021, Russia|Russian Scientific Center For Radiology and Surgical Technologies, Pesochny, 197758, Russia|LLC Medical Center ""Magnit"", Saint Petersburg, 190005, Russia|Llc ""Mss"", Saint Petersburg, 191025, Russia|North-West Medical Center, Saint Petersburg, 191119, Russia|Road clinical clinic of JSC ""RZD"", Saint Petersburg, 192007, Russia|NS HI ""Road Clinical Hospital of JSC ""Russian Railways"""", Saint Petersburg, 195271, Russia|Private Healthcare Institution ""Clinical Hospital ""RZD-Medicine"" of St. Petersburg, Saint Petersburg, 195271, Russia|LLC ""Diagnostic center ""Energo"", Saint Petersburg, 196247, Russia|Medical University REAVIZ, Samara, 443001, Russia|Medical University REAVIZ, Samara, 443011, Russia|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea|Gachon University Gil Medical Center, Incheon, 21656, South Korea|Severance Hospital, Yonsei Univ. Health System, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, 807, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Limited Liability Company ""MedX-ray International Group"", Pliuty Village, Kyiv Oblast, Ukraine|Asklepion Medical Center, Khodosovka, Kyivska Oblast, 08173, Ukraine|""Medeya Sumy"" LLC, Sumy, Sumska Oblast, 40021, Ukraine|Communal Non-profit Enterprise City Clinical Hospital #4 of Dnipro City Council, Dnipro, 49102, Ukraine|Llc ""Mdc Expert"", Dnipro, 49102, Ukraine|Municipal Non-profit Enterprise ""SubCarpathian Clinical Oncological Centre of Ivano-Frankivsk RC"", Ivano-Frankivsk, 76018, Ukraine|Private Enterprise of Private Manufacturing Company ""Acinus"", Medical and Diagnostic Center, Kirovohrad, 25006, Ukraine|Medical centre ""Verum"" Limited Liability Company, Kyiv, 03039, Ukraine|Vita Сom LLC, Kyiv, 03141, Ukraine|The State Institution ""Romodanov Neurosurgery Institute,, Kyiv, 04050, Ukraine|Llc Medical Centre, Odesa, 65006, Ukraine|Municipal Non-profit Enterprise Odesa Regional Clinical Hospital of Odesa Regional Council, Odesa, 65025, Ukraine|Llc Lidermed, Odesa, 65062, Ukraine|Municipal Non Profit enterprise of Sumy Regional Council ""Sumy Regional Clinical Oncology Center"", Sumy, 40022, Ukraine|Llc Medical Center Diamed, Uzhhorod, 88000, Ukraine|MNPE Central City Clinical Hospital of Uzhhorod City Council, Uzhhorod, 88000, Ukraine|Мunicipal non-profit enterprise ""Zhytomyr Regional Oncology Dispensary"" of Zhytomyr Regional Council, Zhytomyr, 10002, Ukraine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Metastatic Malignant Neoplasm in the Brain,OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|OTHER: Quality-of-Life Assessment|DRUG: Ropidoxuridine|RADIATION: Whole-Brain Radiotherapy,ALL,"ADULT, OLDER_ADULT",PHASE1,11,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/8/17,10/3/26,"UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, 75390, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Ben Taub General Hospital, Houston, Texas, 77030, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Cancer|Chronic Pain Due to Malignancy (Finding),DRUG: Sulfasalazine|DRUG: Placebos,FEMALE,"ADULT, OLDER_ADULT",PHASE2,7,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",5/3/21,10/9/23,"Banner University Medical Center South, Tucson, Arizona, 85713, United States|Banner University Medical Center North Campus, Tucson, Arizona, 85719, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Stromal Tumors (GIST)|Other Relapsed or Refractory Solid Tumors,DRUG: Avapritinib,ALL,"ADULT, OLDER_ADULT",PHASE1,250,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2015-08,6/3/21,"Scottsdale Healthcare Hospitals DBA HonorHealth, Scottsdale, Arizona, 85258, United States|Sarcoma Oncology Center, Santa Monica, California, 90403, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Cancer Treatment Centers of America, Atlanta, Georgia, 30256, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Leuven Cancer Institute University Hospitals Leuven, Leuven, 3000, Belgium|Centre Leon Berard, Lyon, 69008, France|Institut Gustave Roussy, Paris, 94805, France|University of Duisburg-Essen, Essen, 45122, Germany|Fondazione IRCCS - Istituto Nazinale dei Tumori, Milan, 20133, Italy|Erasmus MC Cancer Institute, Rotterdam, 3015, Netherlands|Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie w Warszawie, Warsaw, 02-781, Poland|Asan Medical Center, Seoul, 05505, South Korea|Vall d' Hebron Institute of Oncology (VHIO), Barcelona, 08305, Spain|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neoplasms|Colorectal Neoplasms|Melanoma|Pancreatic Neoplasms|Sarcoma|Ovarian Neoplasms|Brain Neoplasms|Thyroid Neoplasms|Neuroendocrine Tumors|Cholangiocarcinoma|Salivary Gland Neoplasms|Head and Neck Neoplasms|Thyroid Cancer, Papillary|Lymphoma, Large-Cell, Anaplastic|Neoplasms by Site|Respiratory Tract Neoplasms|Thoracic Neoplasms|Respiratory Tract Diseases|Carcinoma, Bronchogenic|Bronchial Neoplasms|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasms|Digestive System Diseases|Gastrointestinal Diseases|Colonic Diseases|Intestinal Diseases|Central Nervous System",DRUG: Alectinib,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/24/21,5/16/22,"Science 37, Inc, Culver City, California, 90230, United States|Science 37-Basem; Dept 004- Basem, Culver City, California, 90230, United States|Science 37-Beg; Dept 001 Dr. M. Beg, Culver City, California, 90230, United States|Science 37-Cannon; Dept 002-Cannon, Culver City, California, 90230, United States|Science 37-Kurzrock; Dept 005-Kurzrock, Culver City, California, 90230, United States|Science 37-Thomas; Dept 006-Thomas, Culver City, California, 90230, United States|Homebased Telemedicine, Los Angeles, California, 90013, United States|Homebased Telemedicine, Sacramento, California, 95814, United States|Homebased Telemedicine, San Diego, California, 92101, United States|Homebased Telemedicine, San Francisco, California, 94104, United States|Homebased Telemedicine, San Jose, California, 95110, United States|Homebased Telemedicine, Jacksonville, Florida, 32202, United States|Homebased Telemedicine, Miami, Florida, 33132, United States|Homebased Telemedicine, Orlando, Florida, 32801, United States|Homebased Telemedicine, Tampa, Florida, 33601, United States|Homebased Telemedicine, Fort Wayne, Indiana, 46802, United States|Homebased Telemedicine, Indianapolis, Indiana, 46202, United States|Homebased Telemedicine, Minneapolis, Minnesota, 55401, United States|Homebased Telemedicine, Saint Paul, Minnesota, 55155, United States|Homebased Telemedicine, St Louis, Missouri, 63103, United States|Homebased Telemedicine, Buffalo, New York, 14202, United States|Homebased Telemedicine, New York, New York, 10038, United States|Homebased Telemedicine, Philadelphia, Pennsylvania, 19103, United States|Homebased Telemedicine, Pittsburgh, Pennsylvania, 15282, United States|Homebased Telemedicine, Austin, Texas, 78701, United States|Homebased Telemedicine, Dallas, Texas, 75202, United States|Homebased Telemedicine, Houston, Texas, 77002, United States|Homebased Telemedicine, Richmond, Virginia, 23220, United States|Homebased Telemedicine, Virginia Beach, Virginia, 23451, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: Rucaparib,ALL,"ADULT, OLDER_ADULT",PHASE2,83,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/16/20,7/15/22,"UCLA Medicine Hematology and Oncology, Los Angeles, California, 90024, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94158, United States|Florida Cancer Specialists, Fort Myers, Florida, 33901, United States|Florida Cancer Specialists, St. Petersburg, Florida, 33705, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, 60611, United States|University of Iowa Hospital and Clinics, Iowa City, Iowa, 52242, United States|Beth Israel Deaconess Medical Cancer Surgical Pavilion, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Columbia University Irving Medical Center, New York, New York, 10032, United States|New York Cancer and Blood Specialists, Port Jefferson Station, New York, 11776, United States|New York Cancer And Blood Specialists, The Bronx, New York, 10469, United States|Ohio State University, Columbus, Ohio, 43210, United States|Stephenson Cancer Center - The University of Oklahoma, Oklahoma City, Oklahoma, 73104, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|SCRI/Tennessee Oncology - Chattanooga, Chattanooga, Tennessee, 37404, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|Seattle Cancer Care Alliance/University of Washington, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,DRUG: Everolimus,ALL,"ADULT, OLDER_ADULT",PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/16/14,4/25/19,"Novartis Investigative Site, Matsuyama, Ehime, 791-0280, Japan|Novartis Investigative Site, Sapporo, Hokkaido, 060 8648, Japan|Novartis Investigative Site, Osaka, Osaka, 540-0006, Japan|Novartis Investigative Site, Kitaadachi-gun, Saitama, 362-0806, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Head and Neck Neoplasms|Lung Neoplasms|Urinary Bladder Neoplasms|Breast Neoplasms,DRUG: [F-18]-5-FLUORO-2'-DEOXYCYTIDINE|DRUG: Tetrahydrouridine intravenous (IV)|DRUG: Tetrahydrouridine (oral)|DIAGNOSTIC_TEST: Positron emission tomography (PET)/Computed tomography (CT),ALL,"ADULT, OLDER_ADULT",EARLY_PHASE1,5,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC,11/1/11,1/11/19,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms,"DRUG: Sorafenib (Nexavar, BAY43-9006)",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,206,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/21/07,9/24/21,"Los Angeles, California, 90025, United States|New Haven, Connecticut, 06511-5991, United States|Philadelphia, Pennsylvania, 19104, United States|San Antonio, Texas, 78229, United States|Randwick, New South Wales, 2031, Australia|Bruxelles - Brussel, 1200, Belgium|Charleroi, 6000, Belgium|São Paulo, 01246-903, Brazil|Plovdiv, 4002, Bulgaria|Varna, 9010, Bulgaria|Calgary, Alberta, T2N 4N1, Canada|Edmonton, Alberta, T6G 1Z2, Canada|Toronto, Ontario, M5G 2C4, Canada|Toronto, Ontario, M5G 2M9, Canada|Montreal, Quebec, H3A 1A1, Canada|Montreal, Quebec, H3G 1A4, Canada|Montreal, Quebec, H3T 1E2, Canada|Guangzhou, Guangdong, 510080, China|Xi’an, Shanxi, 710032, China|Hangzhou, Zhejiang, 310022, China|Beijing, 100021, China|Shanghai, 200030, China|Floridablanca, Santander Department, Colombia|Bordeaux, 33000, France|Gauting, Bavaria, 82131, Germany|Regensburg, Bavaria, 93042, Germany|Essen, North Rhine-Westphalia, 45239, Germany|Großhansdorf, Schleswig-Holstein, 22927, Germany|Berlin, 12200, Germany|Hamburg, 20246, Germany|Hong Kong, Hong Kong|Bologna, Emilia-Romagna, 40138, Italy|Reggio Emilia, Emilia-Romagna, 42123, Italy|Milan, Lombardy, 20089, Italy|Milan, Lombardy, 20122, Italy|Milan, Lombardy, 20133, Italy|Pavia, Lombardy, 27100, Italy|Turin, Piedmont, 10043, Italy|Pisa, Tuscany, 56126, Italy|Siena, Tuscany, 53100, Italy|Perugia, Umbria, 06132, Italy|Auckland, 1023, New Zealand|Gdansk, 80-219, Poland|Poznan, 61-848, Poland|Szczecin, 70-111, Poland|Warsaw, 02-781, Poland|Warsaw, 04-141, Poland|Wroclaw, 50 - 556, Poland|Seoul, Seoul Teugbyeolsi, 03080, South Korea|Daegu, 700721, South Korea|Seoul, 03722, South Korea|Seoul, 06351, South Korea|Oviedo, Principality of Asturias, 33011, Spain|Alicante, 03010, Spain|Barcelona, 08003, Spain|Barcelona, 08035, Spain|Barcelona, 08036, Spain|Madrid, 28040, Spain|Madrid, 28041, Spain|Valencia, 46014, Spain|Kaohsiung City, 833, Taiwan|Taichung, 40447, Taiwan|Tainan, 736, Taiwan|Taipei, 10002, Taiwan|Taipei, 106, Taiwan|Taoyuan District, 33305, Taiwan|Kiev, 115, Ukraine|Southampton, Hampshire, SO16 6YD, United Kingdom|Maidstone, Kent, ME16 9QQ, United Kingdom|Cardiff, South Glamorgan, CF14 2TL, United Kingdom|Sutton, Surrey, SM2 5PT, United Kingdom|Glasgow, G12 0YN, United Kingdom|London, SE1 9RT, United Kingdom|London, SW3 6JJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Prostatic Neoplasms|Genital Neoplasms, Male|Urogenital Neoplasms|Neoplasms by Site|Neoplasms|Genital Diseases, Male|Prostatic Disease",DRUG: 18F-PSMA,MALE,"ADULT, OLDER_ADULT",PHASE2,62,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER,4/6/21,9/3/24,"Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Solid Tumors,DRUG: Monalizumab|DRUG: Durvalumab|DRUG: Cetuximab|DRUG: mFOLFOX6|DRUG: Bevacizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,383,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/22/16,9/1/25,"Research Site, Birmingham, Alabama, 35233, United States|Research Site, Scottsdale, Arizona, 85258, United States|Research Site, Duarte, California, 91010, United States|Research Site, La Jolla, California, 92093, United States|Research Site, Los Angeles, California, 90089, United States|Research Site, Sacramento, California, 95817, United States|Research Site, Santa Monica, California, 90404, United States|Research Site, Aurora, Colorado, 80045, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Chicago, Illinois, 60611, United States|Research Site, Baltimore, Maryland, 21231, United States|Research Site, Boston, Massachusetts, 02215, United States|Research Site, Detroit, Michigan, 48202, United States|Research Site, New Brunswick, New Jersey, 08903, United States|Research Site, New Hyde Park, New York, 11042, United States|Research Site, New York, New York, 10065, United States|Research Site, The Bronx, New York, 10461, United States|Research Site, Providence, Rhode Island, 02903, United States|Research Site, Nashville, Tennessee, 37203, United States|Research Site, Dallas, Texas, 75235, United States|Research Site, San Antonio, Texas, 78229, United States|Research Site, Salt Lake City, Utah, 84112, United States|Research Site, Blacktown, 2148, Australia|Research Site, Clayton, 3168, Australia|Research Site, Waratah, 2298, Australia|Research Site, Brussels, 1200, Belgium|Research Site, Edegem, 2650, Belgium|Research Site, Leuven, 3000, Belgium|Research Site, Vancouver, British Columbia, V5Z 4E6, Canada|Research Site, Toronto, Ontario, M5G 1Z5, Canada|Research Site, Marseille, 13385, France|Research Site, Nantes, 44093, France|Research Site, Debrecen, 4032, Hungary|Research Site, Milan, 20132, Italy|Research Site, Milan, 20141, Italy|Research Site, Grafton, 1023, New Zealand|Research Site, Seoul, 03080, South Korea|Research Site, Seoul, 03722, South Korea|Research Site, Seoul, 05505, South Korea|Research Site, Seoul, 06351, South Korea|Research Site, Seoul, 06591, South Korea|Research Site, Barcelona, 08035, Spain|Research Site, Madrid, 28027, Spain|Research Site, Madrid, 28034, Spain|Research Site, Málaga, 29010, Spain|Research Site, Pamplona, 31008, Spain|Research Site, Seville, 41013, Spain|Research Site, London, SW2 6JJ, United Kingdom|Research Site, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: IPN60090|DRUG: pembrolizumab|DRUG: paclitaxel|DRUG: IPN60090 single administration,ALL,"ADULT, OLDER_ADULT",PHASE1,22,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/22/19,12/21/20,"MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms|Neoplasm Metastasis,DRUG: LY3022855,ALL,"ADULT, OLDER_ADULT",PHASE1,34,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,5/1/15,11/3/17,"Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor|Advanced Solid Tumor,DRUG: M4344 10 mg BIW|DRUG: M4344 20 mg BIW|DRUG: M4344 40 mg BIW|DRUG: M4344 80 mg BIW|DRUG: M4344 160 mg BIW|DRUG: M4344 300 mg BIW|DRUG: M4344 450 mg BIW|DRUG: M4344 700 mg BIW|DRUG: M4344 1050 mg BIW|DRUG: M4344 1200 mg BIW|DRUG: M4344 100 mg BID|DRUG: M4344 150 mg QD|DRUG: M4344 250 mg QD|DRUG: M4344 350 mg QD|DRUG: M4344 400 mg|DRUG: M4344 500 mg|DRUG: Carboplatin,ALL,"ADULT, OLDER_ADULT",PHASE1,97,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/26/15,9/24/21,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109-5901, United States|Washington University in St. Louis, St Louis, Missouri, 63110, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 8903, United States|Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York, 10065, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Froedtert & The Medical College of Wisconsin, Wauwatosa, Wisconsin, 53226, United States|Erasmus Medisch Centrum, Rotterdam, 3075 EA, Netherlands|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|""Fundacion Jimenez Diaz START Madrid. Oncology Phase I"", Madrid, Spain|START Madrid. Fundacion Jimenez Diaz- Oncologia-Fase I, Madrid, Spain|""Hospital Clinico Universitario de Valencia Servicio de Hematologia y Oncologia Medica"", Valencia, Spain|Sarah Cannon Research Institute UK, London, Greater London, W1G 6AD, United Kingdom|Royal Marsden Hospital, Sutton, Surrey, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms|Neoplasm Metastasis,DRUG: LY3164530,ALL,"ADULT, OLDER_ADULT",PHASE1,29,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-08,3/7/17,"Pinnacle Oncology Hematology, Scottsdale, Arizona, 85258, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|The START Center for Cancer Care, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumors|Carcinoid Tumor,DRUG: Nivolumab|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE2,9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/9/18,11/24/21,"Johns Hopkins Medical Institution, Baltimore, Maryland, 21287, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Stromal Tumors,DRUG: sunitinib malate dose escalation|DRUG: sunitinib malate,ALL,"CHILD, ADULT",PHASE2,6,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,2012-06,2017-08,"Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital Boston, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Fakultni nemocnice Brno, Brno, 613 00, Czechia|FN Brno, Brno, 625 00, Czechia|Masarykuv onkologicky ustav, Brno, 656 33, Czechia|CHU de La Timone, Hopital enfants, Marseille, 13385, France|Hopital d'Enfants de la Timone, Marseille, 13385, France|Hopital de la Timone, Marseille, 13385, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: BDTX-189,ALL,"ADULT, OLDER_ADULT",PHASE1,91,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/19/19,9/16/22,"9250, Scottsdale, Arizona, 85258, United States|9405, Long Beach, California, 90813, United States|9474, Orange, California, 92868, United States|7141, New Haven, Connecticut, 06520, United States|4080, Lake Mary, Florida, 32746, United States|4100, Orlando, Florida, 32827, United States|9535, Plantation, Florida, 33322, United States|4060, Sarasota, Florida, 34232, United States|9035, Atlanta, Georgia, 30322, United States|9530, Rolling Meadows, Illinois, 60008, United States|9092, New Orleans, Louisiana, 70112, United States|9203, Boston, Massachusetts, 02215, United States|9209, Buffalo, New York, 14263, United States|9215, New York, New York, 10016, United States|9236, New York, New York, 10065, United States|9264, Portland, Oregon, 97213, United States|7122, Pittsburgh, Pennsylvania, 15232, United States|4107, Chattanooga, Tennessee, 37404, United States|3000, Nashville, Tennessee, 37203, United States|9003, Dallas, Texas, 75390, United States|9117, Houston, Texas, 77030, United States|9538, Webster, Texas, 77598, United States|9112, Fairfax, Virginia, 22031, United States|9173, Milwaukee, Wisconsin, 53226, United States|9500, Copenhagen, Denmark|9501, Bordeau, 33000, France|9525, Lille, 59000, France|9373, Lyon, 69008, France|9512, Poitiers, 86021, France|9476, Rennes, 44229, France|9496, Barcelona, 08028, Spain|9363, Barcelona, 08035, Spain|9508, Barcelona, 08036, Spain|9429, Madrid, 28007, Spain|9495, Madrid, 28040, Spain|9383, Madrid, 28041, Spain|9382, Madrid, 28050, Spain|9510, Valencia, 46010, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Tumors With Aberrations in ALK or ROS1,DRUG: Ceritinib,ALL,"ADULT, OLDER_ADULT",PHASE2,47,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/17/14,12/13/17,"St Joseph Heritage Healthcare St. Joseph Heritage, Santa Rosa, California, 94503, United States|Sarah Cannon Research Institute, Denver, Colorado, 80218, United States|Rocky Mountain Cancer Centers Dept of Rocky Mountain (2), Greenwood Village, Colorado, United States|Florida Cancer Specialists Florida Cancer Specialists (31, Fort Myers, Florida, 33901, United States|Northwestern University Northwestern (6), Chicago, Illinois, 60611, United States|Physicians Clinic of Iowa, Cedar Rapids, Iowa, 52403, United States|Holy Cross Hospital Holy Cross (2), Silver Spring, Maryland, 20910, United States|Southeast Nebraska Oncology, Lincoln, Nebraska, 68510, United States|Comprehensive Cancer Centers of Nevada CCC of Nevada (1), Las Vegas, Nevada, 89109, United States|Duke University Medical Center Seeley G. Mudd Bldg., Durham, North Carolina, 27710, United States|Wake Forest Baptist Health Health Sciences, Winston-Salem, North Carolina, 27157, United States|Sanford Hematology Oncology, Fargo, North Dakota, 58122, United States|Columbus Hematology and Oncology PA Columbus Hem and Onc (2), Columbus, Ohio, 39705, United States|Andrew and Patel Associates, Camp Hill, Pennsylvania, 17011, United States|Rhode Island Hospital Rhode Island Hosp. (2), Providence, Rhode Island, 02903, United States|Sanford University of South Dakota Medical Center Sanford Clinical Research, Sioux Falls, South Dakota, 57104, United States|Oncology Consultants Oncology Group, Houston, Texas, 77024, United States|MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston, Texas, 77030, United States|Utah Cancer Specialists Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Swedish Cancer Institute Swedish Cancer Institute, Seattle, Washington, 98104, United States|Aurora Research Institute, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Locally Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|Unresectable Malignant Solid Neoplasm,BIOLOGICAL: Pembrolizumab|DRUG: Pevonedistat,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,2,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/29/21,11/3/22,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Myeloproliferative Neoplasm,DRUG: Vactosertib|DRUG: Vactosertib|DRUG: Vactosertib|DRUG: Vactosertib|DRUG: Vactosertib,ALL,"ADULT, OLDER_ADULT",PHASE2,2,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/22/19,7/10/24,"Weill Medical College of Cornell University, New York, New York, 10021, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Pancreatic Ductal Adenocarcinoma|Pain, Acute|Gastrointestinal Cancers|Demoralization",DRUG: Ketamine|DRUG: Ketamine Injectable Product|BEHAVIORAL: Meaning and Purpose therapy|OTHER: Placebo|OTHER: Questionnaires,ALL,"ADULT, OLDER_ADULT",PHASE4,1,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",5/17/24,1/31/25,"University of California, San Francisco, San Francisco, California, 94143, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,BIOLOGICAL: BNT151,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,49,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/26/21,5/28/24,"Yale Cancer Center, New Haven, Connecticut, 06510, United States|Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee, 37203, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Vall d´Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain|START Madrid - HM CIOCC, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Carcinoma, Transitional Cell|Urinary Bladder Neoplasms|Urologic Neoplasms|Renal Pelvis Neoplasms|Urothelial Cancer|Ureteral Neoplasms|Urethral Neoplasms",DRUG: Enfortumab vedotin,ALL,"ADULT, OLDER_ADULT",PHASE2,219,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/8/17,7/28/23,"Alaska Urological Institute, Anchorage, Alaska, 99503, United States|Arizona Oncology Associates, PC - HAL, Goodyear, Arizona, 85395, United States|Mayo Clinic Arizona, Phoenix, Arizona, 85054, United States|Arizona Oncology Associates, PC - HOPE, Tucson, Arizona, 85710, United States|Keck Medical Center / University of Southern California, Los Angeles, California, 90033, United States|Keck Medical Center / Newport Beach, Newport Beach, California, 92663, United States|Kaiser Permanente Oakland, Oakland, California, 94611, United States|Chao Family Comprehensive Cancer Center University of California Irvine, Orange, California, 92868, United States|University of California Irvine - Newport, Orange, California, 92868, United States|Kaiser Permanente Roseville, Roseville, California, 95661, United States|University of California Davis, Sacramento, California, 95817, United States|Kaiser Permanente Sacramento, Sacramento, California, 95825, United States|Kaiser Permanente San Francisco, San Francisco, California, 94115, United States|Kaiser Permanente San Jose, San Jose, California, 95119, United States|Kaiser Permanente San Leandro, San Leandro, California, 94577, United States|Kaiser Permanente Santa Clara, Santa Clara, California, 95051, United States|Kaiser Permanente South San Francisco, South San Francisco, California, 94080, United States|Kaiser Permanente Medical Center Northern California, Vallejo, California, 94589, United States|Kaiser Permanente Walnut Creek, Walnut Creek, California, 94596, United States|Rocky Mountain Cancer Centers - Aurora, Aurora, Colorado, 80012, United States|Yale Cancer Center, New Haven, Connecticut, 06520, United States|Ocala Oncology Center, Ocala, Florida, 34474, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Augusta University, Augusta, Georgia, 30912, United States|University of Chicago Medical Center, Chicago, Illinois, 60637-1470, United States|Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky, 40207, United States|Johns Hopkins Medical Center, Baltimore, Maryland, 21231, United States|Maryland Oncology Hematology, P.A., Rockville, Maryland, 20850, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute / Wayne State University, Detroit, Michigan, 48201, United States|Washington University in St Louis, St Louis, Missouri, 63110, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|New York Oncology Hematology, P.C., Albany, New York, 12208, United States|New York University (NYU) Cancer Institute, New York, New York, 10016, United States|Mount Sinai Medical Center, New York, New York, 10029, United States|Columbia University Medical Center, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|James P. Wilmot Cancer Center / University of Rochester Medical Center, Rochester, New York, 14642, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|James Cancer Hospital / Ohio State University, Columbus, Ohio, 43210, United States|Northwest Cancer Specialists, P.C., Tigard, Oregon, 97223, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|University of Pittsburgh Medical Center (UPMC)/Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Prisma Health, Greenville, South Carolina, 29615, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37204, United States|Texas Oncology - Austin Central, Austin, Texas, 78731, United States|Texas Oncology - Baylor Sammons Cancer Center, Dallas, Texas, 75246, United States|Houston Methodist Cancer Center, Houston, Texas, 77030, United States|University of Virginia, Charlottesville, Virginia, 22903, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|Seattle Cancer Care Alliance / University of Washington, Seattle, Washington, 98109-1023, United States|Site FR33001, Villejuif-Cedex-France, France|Site DE49004, Münster, Germany|Site DE49001, Tübingen, Germany|Site IT39001, Milan, Italy|Site IT39003, Terni, Italy|Site JP81001, Hirosaki, Aomori, Japan|Site JP81004, Tsukuba, Ibaraki, Japan|Site JP81002, Morioka, Iwate, Japan|Site JP81003, Nigata, Niigata, Japan|Site JP81008, Sayama, Osaka, Japan|Site JP81006, Shinjuku-ku, Tokyo, Japan|Site JP81009, Ube, Yamaguchi, Japan|Site JP81005, Chiba, Japan|Site JP81011, Fukuoka, Japan|Site JP81012, Fukuoka, Japan|Site JP81007, Osaka, Japan|Site JP81010, Tokushima, Japan|Site NL31001, Amsterdam, Netherlands|Site KR82005, Daejeon, South Korea|Site KR82003, Seongnam-si, South Korea|Site KR82001, Seoul, South Korea|Site KR82002, Seoul, South Korea|Site KR82004, Seoul, South Korea|Site ES34002, Barcelona, Spain|Site ES34005, Barcelona, Spain|Site ES34003, Santander, Spain|Site ES34004, Seville, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Stromal Tumors,DRUG: CGT9486|DRUG: Pexidartinib|DRUG: Sunitinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,51,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/6/15,5/11/20,"Sylvester Comprehensive Cancer Center/ UMHC, Miami, Florida, 33136, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|OSU Comprehensive Cancer Center, Columbus, Ohio, 43210, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic|Chronic Lymphocytic Leukemia|Small Lymphocytic Leukemia,DRUG: Ibrutinib,ALL,"ADULT, OLDER_ADULT",PHASE2,23,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/23/18,8/2/24,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: BMS-986466|DRUG: Adagrasib|DRUG: Cetuximab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,5,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/9/23,5/13/24,"Local Institution - 0047, Los Angeles, California, 90067, United States|Local Institution - 0040, Athens, Georgia, 30607, United States|Local Institution - 0025, Hackensack, New Jersey, 07601, United States|Local Institution - 0008, Morristown, New Jersey, 07960, United States|Local Institution - 0053, Westmead, New South Wales, 2145, Australia|Local Institution - 0083, Helsinki, 00029, Finland|Local Institution - 0020, Lille, 59037, France|Local Institution - 0082, Petah Tikva, Central District, 4941492, Israel|Local Institution - 0081, Tel Aviv, Tell Abīb, 6423906, Israel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,BIOLOGICAL: haNK™ for Infusion,ALL,"ADULT, OLDER_ADULT",PHASE1,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/2/17,5/6/19,"Chan Soon-Shiong Institute for Medicine, El Segundo, California, 90245, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasm Malignant,DRUG: SAR245408|DRUG: SAR245409,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,61,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/20/12,5/23/18,"Investigational Site Number 840010, Birmingham, Alabama, 35205, United States|Investigational Site Number 840009, Los Angeles, California, 90024, United States|Investigational Site Number 840008, Los Angeles, California, 90033, United States|Investigational Site Number 840022, Denver, Colorado, 80262, United States|Investigational Site Number 840104, Fort Myers, Florida, 33919, United States|Investigational Site Number 840006, Augusta, Georgia, 30912, United States|Investigational Site Number 840004, Boston, Massachusetts, 02115, United States|Investigational Site Number 840021, St Louis, Missouri, 63110, United States|Investigational Site Number 840002, New Brunswick, New Jersey, 08903, United States|Investigational Site Number 840020, Canton, Ohio, 44718, United States|Investigational Site Number 840015, Columbus, Ohio, 43210, United States|Investigational Site Number 840017, Philadelphia, Pennsylvania, 19111, United States|Investigational Site Number 840007, Nashville, Tennessee, 37232, United States|Investigational Site Number 840003, Dallas, Texas, 75230, United States|Investigational Site Number 840005, San Antonio, Texas, 78229, United States|Investigational Site Number 840018, Morgantown, West Virginia, 26506, United States|Investigational Site Number 056001, Leuven, 3000, Belgium|Investigational Site Number 250004, Montpellier, 34295, France|Investigational Site Number 250003, Pierre-Bénite, 69495, France|Investigational Site Number 250005, Rouen, 76038, France|Investigational Site Number 724001, Barcelona, 08035, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Primary Myelofibrosis|Secondary Myelofibrosis|Myeloid Malignancies,DRUG: Imetelstat,ALL,"ADULT, OLDER_ADULT",PHASE2,80,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/29/12,5/24/18,"Rochester, Minnesota, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematopoietic and Lymphatic System Neoplasm|Metastatic Malignant Solid Neoplasm,OTHER: Counseling|DRUG: Psilocybin|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,55,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/27/23,10/17/24,"Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Metastatic Malignant Solid Neoplasm|Refractory Malignant Solid Neoplasm|Unresectable Malignant Solid Neoplasm,PROCEDURE: Biopsy Procedure|PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|PROCEDURE: Magnetic Resonance Imaging|BIOLOGICAL: Navitoclax|PROCEDURE: Positron Emission Tomography|DRUG: Trametinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,96,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/26/14,3/6/26,"Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms,DRUG: aflibercept|DRUG: LV5FU2,ALL,OLDER_ADULT,PHASE2,117,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-05,2021-06,"CH, Aix-en-Provence, France|CHU Amiens - Hôpital Nord, Amiens, 80054, France|Chu D'Angers, Angers, 49933, France|ICO, Angers, France|CH, Auxerre, France|CH de la Côte Basque, Bayonne, 64109, France|Centre D'Oncologie Et de Radiothérapie, Bayonne, France|CH, Béziers, France|Hôpital Avicenne, Bobigny, 93000, France|CHU APHP Hôpital Avicenne, Bobigny, France|CHU- Hôpital Saint André, Bordeaux, France|Polyclinique Bordeaux Nord, Bordeaux, France|CH - Hôpital Duchenne, Boulogne-sur-Mer, France|CH, Brive-la-Gaillarde, France|CHU Côte de Nacre, Caen, France|Ch, Chambéry, France|CH Public du Cotentin, Cherbourg, France|CHU Estaing, Clermont-Ferrand, France|CH Alpes Leman, Contamine-sur-Arve, France|Centre hospitalier Sud Francilien, Corbeil-Essonnes, 91106, France|Institut de cancérologie de Bourgogne - GRRECC, Dijon, 21000, France|CHU Le Bocage, Dijon, France|CH, Elbeuf, France|Chicas, Gap, France|CHD Vendée, La Roche-sur-Yon, France|CH Robert Boulin, Libourne, France|Clinique François Chénieux, Limoges, 87000, France|CHU, Limoges, France|Ch Longjumeau, Longjumeau, 91160, France|CH Hôpital du Surcoff, Lorient, France|Ch Saint Joseph - Saint Luc, Lyon, France|CHU APHM Hôpital Nord, Marseille, France|CHU APHM La Timone, Marseille, France|Hôpital Européen de Marseille, Marseille, France|CH, Meaux, France|CH, Montélimar, France|CHU - Hôtel Dieu, Nantes, France|Polyclinique de Languedoc, Narbonne, France|CHR La Source, Orléans, 45067, France|Saint-Louis CHU AP-HP Paris, Paris, 75010, France|CH, Perpignan, France|Hôpital Haut Leveque, Pessac, 33604, France|CHU Hôpital de la Milétrie, Poitiers, France|Centre Hospitalier Annecy Genevois, Pringy, France|Centre Eugène Marquis, Rennes, France|CHU, Rouen, France|CARIO - Hôpital Privé des Côte d'Armor, Saint-Brieuc, France|ICO, Saint-Herblain, France|Polyclinique Côte Basque Sud, Saint-Jean-de-Luz, France|Ch Saintonges, Saintes, France|Centre de cancérologie Paris Nord, Sarcelles, France|CH de Bigorre, Tarbes, France|Hôpitaux du Leman, Thonon-les-Bains, France|CHU Hôpital Rangueil, Toulouse, France|Hôpital Trousseau, Tours, France|CHBA, Vannes, France|Institut Gustave Roussy, Villejuif, France|Hôpital Privé de Villeneuve d'Ascq, Villeneuve-d'Ascq, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Carcinoid Syndrome|Carcinoid|Carcinoid Tumor|Carcinoid Tumor of Ileum|Carcinoid Tumor of Cecum|Carcinoid Syndrome Diarrhea|Carcinoid Intestine Tumor|Carcinoid Tumor of Liver|Carcinoid Tumor of Pancreas,DRUG: Randomized: 40 mg Paltusotine|DRUG: Randomized: 80 mg Paltusotine,ALL,"ADULT, OLDER_ADULT",PHASE2,36,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/22/22,2026-02,"Crinetics Study Site, Los Angeles, California, 90048, United States|Crinetics Study Site, Los Angeles, California, 90095, United States|Crinetics Study Site, Newport Beach, California, 92663, United States|Crinetics Study Site, Stanford, California, 94305, United States|Crinetics Study Site, Miami, Florida, 33136, United States|Crinetics Study Site, Iowa City, Iowa, 52242, United States|Crinetics Study Site, Lexington, Kentucky, 40506, United States|Crinetics Study Site, New Orleans, Louisiana, 70112, United States|Crinetics Study Site, Boston, Massachusetts, 02118, United States|Crinetics Study Site, Rochester, Minnesota, 55905, United States|Crinetics Study Site, New York, New York, 10029, United States|Crinetics Study Site, Stony Brook, New York, 11794, United States|Crinetics Study Site, Cleveland, Ohio, 44106, United States|Crinetics Study Site, Columbus, Ohio, 43210, United States|Crinetics Study Site, Houston, Texas, 77030, United States|Crinetics Study Site, CABA, Buenos Aires, C1180 AAX, Argentina|Crinetics Study Site, CABA, Buenos Aires, C1264AAA, Argentina|Crinetics Study Site, CABA, Buenos Aires, C1426ANZ, Argentina|Crinetics Study Site, CABA, C1017AAS, Argentina|Crinetics Study Site, CABA, C1425BGH, Argentina|Crinetics Study Site, Fortaleza, Ceará, 60430-275, Brazil|Crinetics Study Site, Rio de Janeiro, Rio de Janeiro, 20231-092, Brazil|Crinetics Study Site, Rio de Janeiro, Rio de Janeiro, 22281-100, Brazil|Crinetics Study Site, Criciúma, Santa Catarina, 88811508, Brazil|Crinetics Study Site, São Paulo, São Paulo, 01509-010, Brazil|Crinetics Study Site, Rio de Janeiro, 22061-080, Brazil|Crinetics Study Site, Toronto, M4N 3M5, Canada|Crinetics Study Site, Mexico City, Cuauhtemoc, 06100, Mexico|Crinetics Study Site, Querétaro City, Querétaro, 76000, Mexico|Crinetics Study Site, Querétaro City, Querétaro, 76070, Mexico|Crinetics Study Site Peru #1, Lima, 15036, Peru|Crinetics Study Site Peru #2, Lima, 15036, Peru|Crinetics Study Site, Katowice, 40-514, Poland|Crinetics Study Site, Warsaw, 02-351, Poland|Crinetics Study Site, Wroclaw, 53-413, Poland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Metastatic Solid Tumors|Locally Advanced Solid Tumors,DRUG: OBI-888|DRUG: OBI-888|DEVICE: Globo H IHC Assay,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,54,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/7/18,4/7/22,"Scripps Clinic Torrey Pines, La Jolla, California, 92037, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, 92663, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|West Cancer Center and Research Institute, Germantown, Tennessee, 38138, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|China Medical University Hospital, Taichung, 40447, Taiwan|National Cheng Kung University Hospital, Tainan, 704, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pan Tumor,BIOLOGICAL: Nivolumab|BIOLOGICAL: Ipilimumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,212,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/31/18,8/2/23,"John Wayne Cancer Center, Santa Monica, California, 90404, United States|Rocky Mountain Cancer Centers, Denver, Colorado, 80218, United States|Local Institution - 0093, Minneapolis, Minnesota, 55404, United States|Broome Oncology, Johnson City, New York, 13790, United States|Duke Cancer Institute, Durham, North Carolina, 27710, United States|Local Institution - 0079, Portland, Oregon, 97239, United States|Local Institution - 0095, Austin, Texas, 78731, United States|Local Institution - 0094, Dallas, Texas, 75231, United States|Local Institution - 0090, Houston, Texas, 77030, United States|Texas Oncology - Northeast Texas, Tyler, Texas, 75702, United States|Local Institution - 0016, Ciudad Autonoma Beunos Aires, Buenos Aires, 1431, Argentina|Local Institution - 0087, Ciudad Autónoma de Buenos Aires, Buenos Aires, 1280, Argentina|Local Institution - 0078, CABA, 1199, Argentina|Local Institution - 0015, CABA, 1426, Argentina|Local Institution - 0119, Córdoba, 5000, Argentina|Local Institution - 0118, St Leonards, New South Wales, 2065, Australia|Local Institution - 0062, Sydney, New South Wales, 2010, Australia|Local Institution - 0117, Woolloongabba, Queensland, 4102, Australia|Local Institution - 0112, Brussels, 1090, Belgium|Local Institution - 0113, Brussels, 1200, Belgium|Local Institution - 0114, Leuven, 3000, Belgium|Local Institution - 0010, Edmonton, Alberta, T6G 1Z2, Canada|Local Institution - 0060, Hamilton, Ontario, L8V 5C2, Canada|Local Institution - 0036, Montreal, Quebec, H2X 3E4, Canada|Local Institution - 0088, Montreal, Quebec, H3T 1E2, Canada|Local Institution - 0018, Santiago, Santiago Metropolitan, 8330024, Chile|Local Institution - 0082, Santiago, Santiago Metropolitan, 8420383, Chile|Local Institution - 0080, Copenhagen, 2100, Denmark|Local Institution - 0081, Herlev, 2730, Denmark|Local Institution - 0072, Lyon, 69373, France|Local Institution - 0075, Marseille, 13273, France|Local Institution - 0073, Paris, 75248, France|Local Institution - 0074, Toulouse, 31100, France|Local Institution - 0085, Villejuif, 94805, France|Local Institution - 0039, Berlin, 12200, Germany|Local Institution - 0001, Bonn, 53127, Germany|Local Institution - 0002, Dresden, 01307, Germany|Local Institution - 0086, Essen, 45147, Germany|Local Institution - 0043, Würzburg, 97080, Germany|Local Institution - 0032, Genova, 16132, Italy|IRCCS Istituto Nazionale Tumori Milano, Milan, 20133, Italy|Local Institution - 0029, Napoli, 80131, Italy|Local Institution - 0031, Siena, 53100, Italy|Local Institution - 0116, Rotterdam, South Holland, 3015 GD, Netherlands|Local Institution - 0115, Amsterdam, 1066 CX, Netherlands|Local Institution - 0076, Warsaw, Masovian Voivodeship, 02-781, Poland|Local Institution - 0077, Gdansk, 80-214, Poland|Fundacion De Investigacion, San Juan, 00927, Puerto Rico|Local Institution - 0068, Cluj-Napoca, Cluj, 400015, Romania|Local Institution - 0069, Bucharest, 022328, Romania|Local Institution - 0067, Craiova, 200542, Romania|Local Institution - 0070, Floreşti, 407280, Romania|Local Institution - 0071, Timisoara, Timis, 300239, Romania|Local Institution - 0065, Singapore, Central Singapore, 168583, Singapore|Local Institution - 0066, Singapore, 117599, Singapore|Local Institution - 0084, Barcelona, 08035, Spain|Local Institution - 0083, Madrid, 28041, Spain|Local Institution - 0110, Pamplona, 31008, Spain|Local Institution - 0106, London, Greater London, W12 OHS, United Kingdom|Local Institution - 0107, Preston, PR2 9HT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: LAG525|DRUG: PDR001,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,490,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/17/15,12/31/20,"Columbia University Medical Center SC LAG X2101C, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center SC, New York, New York, 10065, United States|Duke Clinical Research Institute SC, Durham, North Carolina, 27704, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Cancer Therapy and Research Center UT Health Science Center CTRC 2, San Antonio, Texas, 78229, United States|Huntsman Cancer Institute Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|Novartis Investigative Site, Westmead, New South Wales, 2145, Australia|Novartis Investigative Site, Heidelberg, Victoria, 3084, Australia|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Edmonton, Alberta, T6G 1Z2, Canada|Novartis Investigative Site, Toronto, Ontario, M5G 2M9, Canada|Novartis Investigative Site, Lyon, 69373, France|Novartis Investigative Site, Saint-Herblain Cédex, 44805, France|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Würzburg, 97080, Germany|Novartis Investigative Site, Hong Kong, Hong Kong|Novartis Investigative Site, Milan, MI, 20133, Italy|Novartis Investigative Site, Modena, MO, 41124, Italy|Novartis Investigative Site, Fukuoka, Fukuoka, 811-1395, Japan|Novartis Investigative Site, Singapore, 119228, Singapore|Novartis Investigative Site, Singapore, 169610, Singapore|Novartis Investigative Site, Barcelona, Catalonia, 08035, Spain|Novartis Investigative Site, Madrid, 28009, Spain|Novartis Investigative Site, Taipei, 10002, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Prostatic Neoplasms|Prostate Cancer|Neoplasm, Prostate|Neoplasm,Prostatic",DRUG: AMG 386|DRUG: Abiraterone|DRUG: Prednisone,MALE,"ADULT, OLDER_ADULT",PHASE2,36,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/8/12,7/1/18,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Neoplasms,DRUG: PF-06804103|DRUG: PF-06804103 + Palbociclib +Letrozole,ALL,"ADULT, OLDER_ADULT",PHASE1,95,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/1/17,8/31/21,"Banner-University Medical Center Tucson, Tucson, Arizona, 85719, United States|The University of Arizona Cancer Center - North Campus, Tucson, Arizona, 85719, United States|The University of Arizona Cancer Center, Tucson, Arizona, 85724, United States|Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, 90048, United States|UCLA Health (main campus), Los Angeles, California, 90095, United States|UCLA Hematology/Oncology, Los Angeles, California, 90095, United States|Santa Monica - UCLA Medical Center and Orthopaedic Hospital, Santa Monica, California, 90404, United States|UCLA Dept of Medicine - Hematology/Oncology, Santa Monica, Santa Monica, California, 90404, United States|UCLA Health, Santa Monica, Santa Monica, California, 90404, United States|Northside Hospital Inc.- GCS/Athens, Athens, Georgia, 30606, United States|Atlanta Cancer Care - Atlanta, Atlanta, Georgia, 30342, United States|Northside Hospital, Inc. - GCS/Northside, Atlanta, Georgia, 30342, United States|Northside Hospital, Atlanta, Georgia, 30342, United States|Northside Hospital,Inc.-GCS /Blairsville, Blairsville, Georgia, 30512, United States|Northside Hospital, Inc. - GCS/Canton, Canton, Georgia, 30114, United States|Atlanta Cancer Care - Cumming, Cumming, Georgia, 30041, United States|Northside Hospital, Inc.-GCS/Stemmer, Decatur, Georgia, 30033, United States|Suburban Hematology-Oncology Associates - Duluth, Duluth, Georgia, 30096, United States|Atlanta Cancer Care - Lake Spivey, Jonesboro, Georgia, 30236, United States|Suburban Hematology-Oncology Associates- Lawrenceville, Lawrenceville, Georgia, 30046, United States|Northside Hospital, Inc. - GCS/Macon, Macon, Georgia, 31217, United States|Northside Hospital, Inc. GCS/Kennestone, Marietta, Georgia, 30060, United States|Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha, Nebraska, 68130, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Utah, Huntsman Cancer Hospital, Salt Lake City, Utah, 84112, United States|University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|Macquarie University, Macquarie Park, New South Wales, 2109, Australia|Istituto Clinico Humanitas U. O. Oculistica, Milan, Lombardy, 20089, Italy|Azienda Socio-Sanitaria Territoriale Monza, Monza, MB, 20900, Italy|Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, MI, 20133, Italy|Divisione di Cardiologia - Istituto Europeo di Oncologia Divisione di Medicina Nucleare, Milan, MI, 20141, Italy|Istituto Europeo di Oncologia, Milan, MI, 20141, Italy|LLC ""Clinica UZI 4D"", Pyatigorsk, Stavropol Kray, 357502, Russia|Private Healthcare Institution ""Clinical hospital ""RZD-Medicine"" of Saint-Petersburg, Saint Petersburg, 195271, Russia|National Cancer Center, Goyang-si, Gyeonggi-do, 10408, South Korea|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea|Gachon University Gil Medical Center, Incheon, 21565, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital, Yonsei University Health System, Seoul, 03722, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|Hospital Universitario Quirón Madrid, Pozuelo de Alarcón, Madrid, 28223, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, 28040, Spain|Hospital Universitario HM Sanchinarro, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,"Neoplasms, Breast",DRUG: Niraparib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,40,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",6/28/21,12/31/25,"GSK Investigational Site, Burbank, California, 91505, United States|GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Palo Alto, California, 94304, United States|GSK Investigational Site, San Francisco, California, 94158, United States|GSK Investigational Site, Aurora, Colorado, 80045, United States|GSK Investigational Site, Highlands Ranch, Colorado, 80045, United States|GSK Investigational Site, Chicago, Illinois, 60612, United States|GSK Investigational Site, Skokie, Illinois, 60076, United States|GSK Investigational Site, Ann Arbor, Michigan, 48109, United States|GSK Investigational Site, Albuquerque, New Mexico, 87106, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, Fargo, North Dakota, 58122, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19111, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15213, United States|GSK Investigational Site, Sioux Falls, South Dakota, 57104, United States|GSK Investigational Site, Austin, Texas, 78731, United States|GSK Investigational Site, Dallas, Texas, 75231, United States|GSK Investigational Site, Dallas, Texas, 75246, United States|GSK Investigational Site, Fort Worth, Texas, 76104, United States|GSK Investigational Site, Houston, Texas, 77024, United States|GSK Investigational Site, San Antonio, Texas, 78240, United States|GSK Investigational Site, Tyler, Texas, 75702, United States|GSK Investigational Site, Norfolk, Virginia, 23502, United States|GSK Investigational Site, Everett, Washington, 98201, United States|GSK Investigational Site, Buenos Aires, C1017 AAS, Argentina|GSK Investigational Site, Buenos Aires, C1125ABD, Argentina|GSK Investigational Site, Buenos Aires, C1426ABP, Argentina|GSK Investigational Site, Capital Federal, C1426ANZ, Argentina|GSK Investigational Site, Cipoletti Rio Negro, R8324CVE, Argentina|GSK Investigational Site, Ciudad Autonoma Buenos Aires, C1430EGF, Argentina|GSK Investigational Site, Ciudad AutOnoma de Buenos Aire, C1015ABO, Argentina|GSK Investigational Site, Ciudad Autonoma de Buenos Aire, C1426AGE, Argentina|GSK Investigational Site, Ciudad de Buenos Aires, C1118AAT, Argentina|GSK Investigational Site, Entre Ríos, 2822, Argentina|GSK Investigational Site, Camperdown, New South Wales, 2050, Australia|GSK Investigational Site, Macquarie Park, New South Wales, 2109, Australia|GSK Investigational Site, North Sydney, New South Wales, 2060, Australia|GSK Investigational Site, Feldkirch, A-6830, Austria|GSK Investigational Site, Innsbruck, 6020, Austria|GSK Investigational Site, Steyr, 4400, Austria|GSK Investigational Site, Vienna, A-1090, Austria|GSK Investigational Site, Brussels, 1070, Belgium|GSK Investigational Site, Brussels, 1200, Belgium|GSK Investigational Site, Charleroi, 6000, Belgium|GSK Investigational Site, Ghent, 9000, Belgium|GSK Investigational Site, Leuven, 3000, Belgium|GSK Investigational Site, Belo Horizonte, 30130-100, Brazil|GSK Investigational Site, Florianópolis, 88034-000, Brazil|GSK Investigational Site, Porto Alegre, 90020-090, Brazil|GSK Investigational Site, Porto Alegre, 90610000, Brazil|GSK Investigational Site, Rio de Janeiro, 20560-120, Brazil|GSK Investigational Site, Rio Grande, 95070-560, Brazil|GSK Investigational Site, Salvador, 40170-110, Brazil|GSK Investigational Site, São Paulo, 01317000, Brazil|GSK Investigational Site, São Paulo, 04312903, Brazil|GSK Investigational Site, Vitória, 29043-260, Brazil|GSK Investigational Site, Calgary, Alberta, T2N 4N2, Canada|GSK Investigational Site, Toronto, Ontario, M4N 3M5, Canada|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Montreal, Quebec, H3T 1E2, Canada|GSK Investigational Site, Québec, Quebec, G1S 4L8, Canada|GSK Investigational Site, Santiago, 7500653, Chile|GSK Investigational Site, Santiago, 7500836, Chile|GSK Investigational Site, Temuco, 5360000, Chile|GSK Investigational Site, Helsinki, 00180, Finland|GSK Investigational Site, Helsinki, HUS 00029, Finland|GSK Investigational Site, Turku, 20520, Finland|GSK Investigational Site, Avignon, 84918, France|GSK Investigational Site, Bordeaux, 33076, France|GSK Investigational Site, Caen, 14000, France|GSK Investigational Site, Dijon, 21000, France|GSK Investigational Site, Marseille, 13915, France|GSK Investigational Site, Montpellier, 34070, France|GSK Investigational Site, Pierre-Bénite, 69495, France|GSK Investigational Site, Rouen, 76000, France|GSK Investigational Site, Saint-Cloud, 92210, France|GSK Investigational Site, Berlin, 13125, Germany|GSK Investigational Site, Cologne, 50935, Germany|GSK Investigational Site, Erlangen, 91054, Germany|GSK Investigational Site, Essen, 45136, Germany|GSK Investigational Site, Mannheim, 68167, Germany|GSK Investigational Site, München, 81377, Germany|GSK Investigational Site, Ulm, 89075, Germany|GSK Investigational Site, Debrecen, 4032, Hungary|GSK Investigational Site, Dublin, 8, Ireland|GSK Investigational Site, Dublin, 9, Ireland|GSK Investigational Site, Beersheba, 84101, Israel|GSK Investigational Site, Haifa, 31096, Israel|GSK Investigational Site, Jerusalem, 91031, Israel|GSK Investigational Site, Jerusalem, 91120, Israel|GSK Investigational Site, Petah Tikva, 49100, Israel|GSK Investigational Site, Rehovot, 76100, Israel|GSK Investigational Site, Tel Aviv, 64239, Israel|GSK Investigational Site, Ancona, 60126, Italy|GSK Investigational Site, Ancona, 62100, Italy|GSK Investigational Site, Bologna, 40138, Italy|GSK Investigational Site, Brindisi, 72100, Italy|GSK Investigational Site, Candiolo to, 10060, Italy|GSK Investigational Site, Catania, 95122, Italy|GSK Investigational Site, Genova, 16132, Italy|GSK Investigational Site, Meldola FC, 47014, Italy|GSK Investigational Site, Milan, 20141, Italy|GSK Investigational Site, Milan, 20157, Italy|GSK Investigational Site, Monza, 20900, Italy|GSK Investigational Site, Napoli, 80131, Italy|GSK Investigational Site, Negrar Verona, 37024, Italy|GSK Investigational Site, Padua, 35128, Italy|GSK Investigational Site, Aichi, 464-8681, Japan|GSK Investigational Site, Chiba, 277-8577, Japan|GSK Investigational Site, Ehime, 791-0280, Japan|GSK Investigational Site, Fukuoka, 811-1395, Japan|GSK Investigational Site, Hiroshima, 730-8518, Japan|GSK Investigational Site, Hokkaido, 003-0804, Japan|GSK Investigational Site, Kagoshima, 892-0833, Japan|GSK Investigational Site, Kanagawa, 216-8511, Japan|GSK Investigational Site, Kanagawa, 241-8515, Japan|GSK Investigational Site, Kanagawa, 259-1143, Japan|GSK Investigational Site, Okayama, 700-8558, Japan|GSK Investigational Site, Osaka, 541-8567, Japan|GSK Investigational Site, Osaka, 589-8511, Japan|GSK Investigational Site, Saitama, 350-1298, Japan|GSK Investigational Site, Saitama, 350-8550, Japan|GSK Investigational Site, Saitama, 362-0806, Japan|GSK Investigational Site, Tokyo, 104-0045, Japan|GSK Investigational Site, Tokyo, 113-8431, Japan|GSK Investigational Site, Tokyo, 135-8550, Japan|GSK Investigational Site, Tokyo, 142-8666, Japan|GSK Investigational Site, León, 37178, Mexico|GSK Investigational Site, Mexico City, 04980, Mexico|GSK Investigational Site, Monterrey, 64460, Mexico|GSK Investigational Site, Monterrey, 66278, Mexico|GSK Investigational Site, Alkmaar, 1815 JD, Netherlands|GSK Investigational Site, Leeuwarden, 8934 AD, Netherlands|GSK Investigational Site, Maastricht, 6229 HX, Netherlands|GSK Investigational Site, Rotterdam, 3083 AN, Netherlands|GSK Investigational Site, The Hague, 2545 AA, Netherlands|GSK Investigational Site, Zwolle, 8025 AB, Netherlands|GSK Investigational Site, Drammen, N-3004, Norway|GSK Investigational Site, Stavanger, 4011, Norway|GSK Investigational Site, Katowice, 40-514, Poland|GSK Investigational Site, Krakow, 31-115, Poland|GSK Investigational Site, Krakow, 31-501, Poland|GSK Investigational Site, Olsztyn, 10-228, Poland|GSK Investigational Site, Poznan, 61-866, Poland|GSK Investigational Site, Rzeszów, 35-021, Poland|GSK Investigational Site, Siedlce, 08-110, Poland|GSK Investigational Site, Szczecin, 70-707, Poland|GSK Investigational Site, Warsaw, 02-781, Poland|GSK Investigational Site, Wroclaw, 53-413, Poland|GSK Investigational Site, Lisbon, 1649-035, Portugal|GSK Investigational Site, Loures, 2674-514, Portugal|GSK Investigational Site, Bucharest, 011171, Romania|GSK Investigational Site, Bucharest, 020142, Romania|GSK Investigational Site, Bucharest, 021389, Romania|GSK Investigational Site, Bucharest, 022343, Romania|GSK Investigational Site, Cluj-Napoca, 400015, Romania|GSK Investigational Site, Craiova, 200347, Romania|GSK Investigational Site, Otopeni, 075100, Romania|GSK Investigational Site, Timișoara, 300239, Romania|GSK Investigational Site, Chelyabinsk, 454048, Russia|GSK Investigational Site, Moscow, 111123, Russia|GSK Investigational Site, Moscow, 121309, Russia|GSK Investigational Site, Moscow, 143422, Russia|GSK Investigational Site, Omsk, 644013, Russia|GSK Investigational Site, Pushkin, 196603, Russia|GSK Investigational Site, Saint Petersburg, 197110, Russia|GSK Investigational Site, Saint Petersburg, 197758, Russia|GSK Investigational Site, StPetersburg, 197022, Russia|GSK Investigational Site, Cape Town, 7700, South Africa|GSK Investigational Site, Port Elizabeth, 6045, South Africa|GSK Investigational Site, Pretoria, 0041, South Africa|GSK Investigational Site, Barcelona, 08003, Spain|GSK Investigational Site, Barcelona, 08028, Spain|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Cáceres, 10003, Spain|GSK Investigational Site, Córdoba, 14004, Spain|GSK Investigational Site, Granada, 18016, Spain|GSK Investigational Site, Madrid, 28034, Spain|GSK Investigational Site, Madrid, 28041, Spain|GSK Investigational Site, Madrid, 28046, Spain|GSK Investigational Site, Madrid, 28050, Spain|GSK Investigational Site, Málaga, 29010, Spain|GSK Investigational Site, Santiago de Compostela, 15706, Spain|GSK Investigational Site, Valencia, 46010, Spain|GSK Investigational Site, Zaragoza, 50009, Spain|GSK Investigational Site, Basel, 4031, Switzerland|GSK Investigational Site, Bath, BA1 3NG, United Kingdom|GSK Investigational Site, Brighton, BN2 5BE, United Kingdom|GSK Investigational Site, Cardiff, CF14 2TL, United Kingdom|GSK Investigational Site, Coventry, CV2 2DX, United Kingdom|GSK Investigational Site, Edinburgh, EH4 2XU, United Kingdom|GSK Investigational Site, Leeds, LS9 7TF, United Kingdom|GSK Investigational Site, London, SE1 9RT, United Kingdom|GSK Investigational Site, London, SW3 6JJ, United Kingdom|GSK Investigational Site, Maidstone, ME16 9QQ, United Kingdom|GSK Investigational Site, Manchester, M20 4BX, United Kingdom|GSK Investigational Site, Sutton, SM2 5PT, United Kingdom|GSK Investigational Site, Wigan, WN1 2NN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: ALKS 4230|DRUG: ALKS 4230 + pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,243,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/14/16,8/2/23,"Mural Oncology Investigational Site, Denver, Colorado, 80045, United States|Mural Oncology Investigational Site, Port Saint Lucie, Florida, 34952, United States|Mural Oncology Investigational Site, Tampa, Florida, 33610, United States|Mural Oncology Investigational Site, Lexington, Kentucky, 40536, United States|Mural Oncology Investigational Site, Boston, Massachusetts, 02215, United States|Mural Oncology Investigational Site, Detroit, Michigan, 47201, United States|Mural Oncology Investigational Site, Buffalo, New York, 14203, United States|Mural Oncology Investigational Site, New York, New York, 10016, United States|Mural Oncology Investigational Site, Cleveland, Ohio, 44106, United States|Mural Oncology Investigational Site, Dallas, Texas, 75230, United States|Mural Oncology Investigational Site, Fairfax, Virginia, 22031, United States|Mural Oncology Investigational Site, Spokane, Washington, 99208, United States|Mural Oncology Investgational Site, Albury, New South Wales, 2640, Australia|Mural Oncology Investigational Site, Waratah, New South Wales, 2298, Australia|Mural Oncology Investigational Site, Brussels, MO, 1200, Belgium|Mural Oncology Investigational Site, Kortrijk, West-Vlaanderen, 8500, Belgium|Mural Oncology Investigational Site, Edmonton, Alberta, Canada|Mural Oncology Investigational Site, Hamilton, Ontario, Canada|Alkermes Investigational Site, Toronto, Ontario, Canada|Mural Oncology Investigational Site, Montreal, Quebec, Canada|Mural Oncology Investigational Site, Québec, Quebec, G1R 2J6, Canada|Mural Oncology Investigational Site, Skorzewo, Poznan, 60-185, Poland|Mural Oncology Investigational Site, Daejeon, 35015, South Korea|Mural Oncology Investigational Site, Seoul, 02841, South Korea|Mural Oncology Investigational Site, Seoul, 03722, South Korea|Mural Oncology Investigational Site, Barcelona, 8036, Spain|Mural Oncology Investigational Site, Madrid, 28033, Spain|Mural Oncology Investigational Site, Madrid, 28040, Spain|Mural Oncology Investigational Site, Madrid, 28041, Spain|Mural Oncology Investigational Site, Madrid, 28050, Spain|Mural Oncology Investigational Site, Valencia, 46010, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Gastrointestinal Stromal Tumors,DRUG: Pembrolizumab|DRUG: Epacadostat,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/28/18,8/19/20,"U-M Comprehensive Cancer Center, Ann Arbor, Michigan, 48109-0944, United States|Columbia University Irving Medical Center, New York, New York, 10032, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Myeloproliferative Neoplasms,DRUG: SGI-110,ALL,"ADULT, OLDER_ADULT",PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/15/16,3/31/21,"Weill Cornell Medical College, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Cancer|Neoplasms,DRUG: GSK2820151,ALL,"ADULT, OLDER_ADULT",PHASE1,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/25/16,12/13/18,"GSK Investigational Site, Detroit, Michigan, 48201, United States|GSK Investigational Site, Nashville, Tennessee, 37232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumors in Lung,DRUG: Lanreotide (Autogel formulation)|DRUG: Placebo|DRUG: Best Supportive Care,ALL,"ADULT, OLDER_ADULT",PHASE3,77,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",3/6/17,2/28/20,"Arizona Oncology Associates, Tucson, Arizona, 85711, United States|VA Greater Los Angeles, Los Angeles, California, 90073, United States|Rocky Mountain Cancer Center, Denver, Colorado, 80218, United States|Ochsner Medical Center, New Orleans, Louisiana, 70112, United States|Dana-Farber Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Center, Detroit, Michigan, 48201, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Roswell Park Cancer Center, Buffalo, New York, 14263, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University of Cincinnati, Cincinnati, Ohio, 45237, United States|Oregon Health and Science Center, Portland, Oregon, 97239, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Texas Oncology, Dallas, Texas, 75246, United States|Texas Oncology-Forth Worth, Fort Worth, Texas, 76104, United States|AKH und Med. University Vienna Allg Krankenhaus Wien, Vienna, 1090, Austria|Klinikum Wels-Grieskirchen GmbH, Wels, 4600, Austria|Tom Baker Cancer Center, Calgary, Alberta, 2TN 4N2, Canada|QEII Health Sciences Centre, Halifax, Nova Scotia, B3H 1V7, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada|Saskatoon Cancer Centre, Saskatoon, S7N 4H4, Canada|Cancer Care of Manitoba, Winnipeg, R3E0V9, Canada|Aarhus University Hospital, Aarhus, 8000, Denmark|NET-Centre, Rigshospitalet, Copenhagen, 2100, Denmark|Centre Oscar Lambret, Lille, 59020, France|Hôpital Edouard Herriot, Lyon, 69437, France|CLLC, Institut Paoli Calmettes, Marseille, 13273, France|Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier, 34000, France|CHU de Rennes - Hôpital Pontchaillou, Rennes, 35033, France|Centre René Gauducheau ICO institut de Cancerologie de l'Ouest, Saint-Herblain, 44805, France|Institut Gustave Roussy, Villejuif, 94800, France|Zentralklinik Bad Berka GmbH, Bad Berka, 99437, Germany|Evangelische Lungenklinik Berlin, Berlin, 13125, Germany|Universitätsklinikum Essen (AöR), Essen, 45145, Germany|Johann Wolfgang Goethe-Universitätsklinikum Frankfurt, Frankfurt, 60590, Germany|Universita di Genova, Genova, 16132, Italy|Insituti Scientifico Romagnolo per lo Studio e la cura dei Tumori (IRST), Meldola, 47014, Italy|Azienda Ospedaliera Antonio Cardarelli, Napoli, 80131, Italy|Azienda Ospedaliera Universitaria di Perugia Santa Maria della Misericordia, Perugia, 06123, Italy|Insittuto Clinico Humanitas, Rozzano, 20089, Italy|Antoni van Leeuwenhoek, Amsterdam, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Zakladu Medycyny Nuklearne i Endokrynologii Onkologicznej, Gliwice, 44-101, Poland|University Center of Ophtalmology & Oncology, Katowice, 40-514, Poland|Szpital Uniwersytecki W, Krakow, 31-501, Poland|Szpital Kliniczny im. H. Święcickiego U.M., Poznan, 60-355, Poland|GAMMED, Warsaw, 02-348, Poland|Hospital Universitari, Vall d'Hebron, Barcelona, 8035, Spain|University Hospital Ramón y Cajal, Madrid, 28412, Spain|Hospital Universitario Marqués de Valdecilla, Santander, 39008, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Cancer Center, Beatson Oncology, Glasgow, G12 0YN, United Kingdom|Royal Surrey County Hospital, Guildford, GU2 7XX, United Kingdom|Royal Free Hospital, London, NW3 2QC, United Kingdom|King's College Hospital, London, SE5 9RS, United Kingdom|Christie Hospital, Manchester, M20 4BX, United Kingdom|Churchill Hospital, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Pancreatic Neoplasms,DRUG: TH-302 + Sunitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,17,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/11/15,1/10/20,"Institut Catalá d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, 39008, Spain|Hospital Provincial de Castellón, Castellon, Valencia, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario Virgen de las Nieves, Granada, 18014, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario Virgen de la Victoria, Málaga, 29010, Spain|Hospital Universitario Virgen del Rocío, Seville, 41013, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms Malignant,DRUG: Crizotinib,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,44,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/22/11,9/7/23,"Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States|Highlands Oncology Group, Rogers, Arkansas, 72758, United States|Highland Oncology Group, Springdale, Arkansas, 72762, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|OHSU Center for Health and Healing 2, Portland, Oregon, 97239, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Greenville Health System, Institute for Translational Oncology Research, Greenville, South Carolina, 29605, United States|Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Chaoyang District, 100021, China|SUN Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, China|Centro di Ricerca di Fase 1 ASST-Monza, Monza, 20090, Italy|PO San Gerardo, ASST Monza-U.O Ematologia, Monza, 20900, Italy|National Hospital Organization Nagoya Medical Center, Nagoya, Aichi-ken, 460-0001, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|GBOU VPO ""First Saint-Petersburg State Medical University n.a.I.P Pavlov"" Ministry of Health, Saint Petersburg, 197022, Russia|Institute of Pedriatric Oncology, Hematology and Transplantation n.a R.M Gorbacheva, Saint Petersburg, 197101, Russia|Seoul National University Hospital, Seoul, 03080, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|National Taiwan University Hospital, Department of Internal Medicine, Taipei, 100, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cancer|Neoplasms,BIOLOGICAL: GSK2849330,ALL,"ADULT, OLDER_ADULT",PHASE1,29,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/26/13,9/18/17,"GSK Investigational Site, Aurora, Colorado, 80045, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Salt Lake City, Utah, 84112, United States|GSK Investigational Site, Heidelberg, Victoria, 3084, Australia|GSK Investigational Site, Melbourne, Victoria, 3004, Australia|GSK Investigational Site, Nedlands, Western Australia, 6009, Australia|GSK Investigational Site, Amsterdam, 1066 CX, Netherlands|GSK Investigational Site, Amsterdam, 1066 C, Netherlands|GSK Investigational Site, Groningen, 9713 GZ, Netherlands|GSK Investigational Site, Groningen, 9713 G, Netherlands|GSK Investigational Site, Nijmegen, 6525 GA, Netherlands|GSK Investigational Site, Nijmegen, 6525 G, Netherlands|GSK Investigational Site, Rotterdam, 3075 EA, Netherlands|GSK Investigational Site, Rotterdam, 3075 E, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Malignant Melanoma|Carcinoma, Non-Small-Cell Lung|Brain Neoplasms, Primary|Brain Neoplasms|Malignant Neoplasms",DRUG: PF-07284890|DRUG: Binimetinib|DRUG: Midazolam,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,65,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/8/21,3/20/24,"City of Hope (City of Hope National Medical Center, City of Hope Medical Center), Duarte, California, 91010, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94143, United States|Orlando Health Cancer Institute, Orlando, Florida, 32806, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Richard M Schulze Family Foundation Outpatient Center at McKinley Campus, Tampa, Florida, 33612, United States|Northwestern Medical Group, Chicago, Illinois, 60611, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|Johns Hopkins University / Johns Hopkins Hospital, Baltimore, Maryland, 21231, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Ophthalmic Consultants of Boston Inc (OCB), Boston, Massachusetts, 02114, United States|Brigham & Women's Hospital, Boston, Massachusetts, 02115, United States|Imaging: Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Imaging: Brigham and Women's Radiology, Coolidge Corner Imaging, Brookline, Massachusetts, 02446, United States|Imaging: Brigham and Women's Ambulatory Care, Chestnut Hill, Massachusetts, 02467, United States|Imaging: Brigham and Women's Mass General Healthcare Center, Foxborough, Massachusetts, 02035, United States|Dana-Farber Cancer Institute - Chestnut Hill, Newton, Massachusetts, 02459, United States|Siteman Cancer Center - St Peters, City of Saint Peters, Missouri, 63376, United States|Siteman Cancer Center - West County, Creve Coeur, Missouri, 63141, United States|Siteman Cancer Center - North County, Florissant, Missouri, 63031, United States|Barnes-Jewish Hospital, St Louis, Missouri, 63110, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Siteman Cancer Center - South County, St Louis, Missouri, 63129, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|MSK Monmouth., Middletown, New Jersey, 07748, United States|MSK Commack, Commack, New York, 11725, United States|MSKCC-Westchester (500 Westchester Ave.), Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York, New York, 10021, United States|Rockefeller Outpatient Pavilion (53rd Street), New York, New York, 10022, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27514, United States|Duke Eye Center, Durham, North Carolina, 27705, United States|Duke University Medical Center, Investigational Chemotherapy Services, Durham, North Carolina, 27710, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Tennessee Oncology PLLC, Franklin, Tennessee, 37067, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|Rambam Health Care Campus, Haifa, ?eif?, 3109601, Israel|Rabin Medical Center, Petah Tikva, Central District, 49100, Israel|Sheba Medical Center, Ramat Gan, Central District, 5262100, Israel|Hadassah Medical Center, Jerusalem, Jerusalem, 9112001, Israel|Sourasky Medical Center, Tel Aviv, TELL ABĪB, 6423906, Israel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Epacadostat|DRUG: Pembrolizumab|DRUG: Oxaliplatin|DRUG: Leucovorin|DRUG: 5-Fluorouracil|DRUG: Gemcitabine|DRUG: nab-Paclitaxel|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Pemetrexed|DRUG: Cyclophosphamide|DRUG: Carboplatin|DRUG: Cisplatin|DRUG: 5-Fluorouracil|DRUG: Investigator's choice of platinum agent,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,70,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/2/17,7/13/20,"Mayo Clinic Arizona, Phoenix, Arizona, 85054, United States|University of California San Diego Medical Center, Moores Cancer Center, La Jolla, California, 92093, United States|The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|Mayo Clinic, Jacksonville, Florida, 32224, United States|University of Chicago, Chicago, Illinois, 60637, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Carolina Bio-Oncology Institute, PLLC, Huntersville, North Carolina, 28078, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, 19104, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15237, United States|Tennessee Oncology - Nashville; The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Vanderbilt University; Henry Joyce Cancer Clinic, Nashville, Tennessee, 37232, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms|Prostate Neoplasms|Prostate Cancer,DRUG: 5-Azacitidine|DRUG: all trans retinoic acid|DRUG: Lupron,MALE,"ADULT, OLDER_ADULT",PHASE2,14,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/20/18,7/8/22,"Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: BLZ945|DRUG: PDR001,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,192,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/21/16,12/1/22,"Dana Farber Cancer Institute Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Sarah Cannon Research Institute Sarah Cannon Research, Nashville, Tennessee, 37203, United States|UT M.D Anderson Cancer Center, Houston, Texas, 77030, United States|Mays Cancer Ctr Uthsa Mdacc, San Antonio, Texas, 78229, United States|Novartis Investigative Site, Tel Aviv, 6423906, Israel|Novartis Investigative Site, Rozzano, MI, 20089, Italy|Novartis Investigative Site, Nagoya, Aichi-ken, 466 8560, Japan|Novartis Investigative Site, Koto Ku, Tokyo, 135 8550, Japan|Novartis Investigative Site, Singapore, 168583, Singapore|Novartis Investigative Site, Barcelona, Catalonia, 08035, Spain|Novartis Investigative Site, L'Hospitalet de Llobregat, Catalonia, 08907, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Zurich, 8091, Switzerland|Novartis Investigative Site, Taipei, 10002, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Head and Neck Neoplasms|Lung Neoplasms|Urinary Bladder Neoplasms|Breast Neoplasms,DRUG: 5-Fluoro-2'-Deoxycytidine (FdCyd) + Tetrahydrouridine (THU),ALL,"ADULT, OLDER_ADULT",PHASE2,95,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/20/09,4/11/19,"University of California, Davis, Davis, California, 95616, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|City of Hope Medical Group, South Pasadena, California, 91030, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Pazopanib|DRUG: ARQ 197,ALL,"ADULT, OLDER_ADULT",PHASE1,32,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/23/12,2/11/16,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Derazantinib low dose range|DRUG: Derazantinib middle dose range|DRUG: Derazantinib high dose range|DRUG: Derazantinib at recommended phase 2 dose (RP2D),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,119,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/10/12,8/28/18,"Scottsdale Healthcare Research Institute, Scottsdale, Arizona, 85258, United States|Emory University, Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Karmanos Cancer Institute, Detroit, Detroit, Michigan, 48201, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Montefiore-Einstein Center for Cancer Care, The Bronx, New York, 10467, United States|University of Pennsylvania Hospital, Philadelphia, Pennsylvania, 19104, United States|START - South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, 78229, United States|University of Washington, Seattle, Washington, 98109, United States|Istituto Clinico Humanitas, Milan, 20089, Italy|Istituto Nazionale Tumori (National Cancer Institute), Milan, 20133, Italy|Instituto Oncologico Veneto, IRCCS, Padua, 35128, Italy|Azienda Ospedaliero-Universitaria Pisana - U.O. Oncologia Medica 2 Univ., Pisa, 56126, Italy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,MPN (Myeloproliferative Neoplasms),DRUG: Pemigatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,47,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/25/17,10/30/24,"Mayo Clinic Arizona, Phoenix, Arizona, 85054, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|Stanford Cancer Institute, Stanford, California, 94305, United States|Emory University - Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Franciscan St. Francis Health, Indianapolis, Indiana, 46237, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Weill Cornell Medical Centers, New York, New York, 10021, United States|Md Anderson Cancer Center, Houston, Texas, 77030, United States|University of Utah, Salt Lake City, Utah, 84112, United States|Ordensklinikum Krankenhaus Der Barmherzigen Schwestern Linz, Linz, 04010, Austria|Medical University of Vienna, Vienna, 01090, Austria|Iii Med. Abteilung For Hematologie and Onkologie Hanuscfhkrankenhaus, Vienna, 01140, Austria|Universitair Ziekenhuis (Uz) Leuven, Leuven, 03000, Belgium|Princess Margaret Cancer Center, Toronto, Ontario, M5G 2M9, Canada|Centre Leon Berard, Lyon, 69373, France|Chu de Nice - Hospital L Archet, Nice, 06202, France|Hospital Saint Louis, Paris, 75475, France|Universitaire Du Cancer de Toulouse Institut Claudius Regaud Iuct-Oncopole, Toulouse, 31059, France|University Medical Center Rwth Aachen, Aachen, D-52074, Germany|Universitatsklinikum Halle (Saale), Halle, 06120, Germany|Universitatsklinikum Jena, Jena, 07740, Germany|Universitatsklinikum Leipzig, Leipzig, 04103, Germany|University Hospital Mannheim, Mannheim, 68167, Germany|Johannes Wesling Klinikum Minden, Minden, 32429, Germany|Ospedale Papa Giovanni Xxiii, Bergamo, 24127, Italy|Azienda Ospedaliero-Universitaria Careggi (Aouc), Florence, 50134, Italy|Kindai University Hospital, Osaka, 589-8511, Japan|Ntt Medical Center Tokyo, Tokyo, 141-8625, Japan|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Inselspital - Universitaetsspital Bern, Bern, 03010, Switzerland|Universitatsspital Zurich, Zurich, 08091, Switzerland|Guys and St Thomas Nhs Foundation Trust, London, SE1 9RT, United Kingdom|Oxford University Hospitals Nhs Foundation Trust, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Tislelizumab|DRUG: Fruquintinib,ALL,"ADULT, OLDER_ADULT",PHASE2,84,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/19/21,2/22/24,"Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China|The First Hospital of Lanzhou University, Lanzhou, Gansu, 730000, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Shandong Cancer Hospital, Jinan, Shandong, 250117, China|Liaocheng Peoples Hospital, Liaocheng, Shandong, 252000, China|Linyi Cancer Hospital, Linyi, Shandong, 276001, China|West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, 300060, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China|National Cancer Center, Goyang-si, Gyeonggi-do, 10408, South Korea|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea|Asan Medical Center, Seoul, Seoul Teugbyeolsi, 05505, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: M4076,ALL,"ADULT, OLDER_ADULT",PHASE1,22,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/24/21,3/31/23,"MD Anderson Center, Houston, Texas, 77030, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 1Z5, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Chronic Phase Myelofibrosis|Primary Myelofibrosis|Post-essential Thrombocythemia Myelofibrosis|Polycythemia Vera,DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/14/17,5/28/20,"Harvard Medical School Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Montefiore Medical Center Division of Hematology, Department of Oncology, The Bronx, New York, 10467, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms|Melanoma,DRUG: Modakafusp Alfa|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,45,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER,12/12/19,12/20/23,"City of Hope Comprehensive Cancer Center - Duarte, Duarte, California, 91010, United States|University of California San Diego Moores Cancer Center, La Jolla, California, 92093, United States|The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles, California, 90025, United States|University of Colorado Health Memorial Hospital Central, Colorado Springs, Colorado, 80909, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Orlando Health Cancer Institute, Orlando, Florida, 32806, United States|Norris Cotton Cancer Center Lebanon, Lebanon, New Hampshire, 03756, United States|Morristown Medical Center, Morristown, New Jersey, 07960, United States|Cleveland Clinic Main Campus, Cleveland, Ohio, 44195, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15232, United States|Avera Cancer Institute, Sioux Falls, South Dakota, 57105, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|Intermountain Medical Center, Murray, Utah, 84107, United States|West Virginia University Health Sciences Campus, Morgantown, West Virginia, 26506, United States|The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia|Ballarat Regional Integrated Cancer Center, Ballarat, Victoria, 3350, Australia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Leukemia, Myelomonocytic, Chronic",DRUG: Tipifarnib,ALL,"ADULT, OLDER_ADULT",PHASE2,44,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/10/17,11/30/20,"Mayo Clinic Arizona, Scottsdale, Arizona, 85054, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|H. Lee Moffitt Cancer Center & Research Institute, Inc., Tampa, Florida, 33612, United States|Johns Hopkins University, Baltimore, Maryland, 21231, United States|Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States|Weill Cornell Medicine, New York, New York, 10065, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|University of Pennsylvania Hospital, Philadelphia, Pennsylvania, 19104, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Malignant Solid Neoplasm|Cholangiocarcinoma|Metastatic Malignant Solid Neoplasm|Refractory Malignant Solid Neoplasm,DRUG: Infigratinib,ALL,"ADULT, OLDER_ADULT",PHASE2,17,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/16/20,12/12/25,"Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Neoplasms,DRUG: Ibrutinib|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,144,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/11/15,2/9/22,"New York, New York, United States|Bedford Park, Australia|Darlinghurst, Australia|Woolloongabba, Australia|Haifa, Israel|Jeursalem, Israel|Ramat Gan, Israel|Tel Aviv, Israel|Chorzów, Poland|Gdansk, Poland|Krakow, Poland|Wroclaw, Poland|Barcelona, Spain|Madrid, Spain|Salamanca, Spain|Ankara, Turkey (Türkiye)|Istanbul, Turkey (Türkiye)|Izmir, Turkey (Türkiye)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,"DRUG: Hydroxychloroquine, 200mg twice dailiy|DRUG: Hydroxychloroquine, 400mg twice daily",ALL,"ADULT, OLDER_ADULT",PHASE1,10,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-07,12/1/18,"University of Kentucky, Markey Cancer Center, Lexington, Kentucky, 40536, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignant Solid Neoplasm|HIV Infection|Metastatic Malignant Solid Neoplasm|Recurrent Malignant Solid Neoplasm|Unresectable Solid Neoplasm,DRUG: Cabozantinib S-malate|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study,ALL,"ADULT, OLDER_ADULT",PHASE1,36,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/21/13,5/12/21,"UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States|UCLA Center for Clinical AIDS Research and Education, Los Angeles, California, 90035, United States|UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, 90095, United States|UC San Diego Medical Center - Hillcrest, San Diego, California, 92103, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, 96813, United States|Louisiana State University, Lafayette, Louisiana, 70503, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, 21287, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|Siteman Cancer Center at Washington University, St Louis, Missouri, 63110, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Montefiore Medical Center-Einstein Campus, The Bronx, New York, 10461, United States|Montefiore Medical Center-Weiler Hospital, The Bronx, New York, 10461, United States|Montefiore Medical Center - Moses Campus, The Bronx, New York, 10467, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Thomas Street Clinic, Houston, Texas, 77009, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Ben Taub General Hospital, Houston, Texas, 77030, United States|Virginia Mason Medical Center, Seattle, Washington, 98101, United States|Harborview Medical Center, Seattle, Washington, 98104, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: Leuprolide Mesylate,MALE,"ADULT, OLDER_ADULT",PHASE3,144,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/26/17,2/1/19,"Urology Centers of Alabama, Homewood, Alabama, 35209, United States|Arizona Institute of Urology, Tucson, Arizona, 85704, United States|The Urology Center of Colorado, Denver, Colorado, 80211, United States|Carolina Clinical Trials, LLC, Concord, North Carolina, 28025, United States|Urology San Antonio, P.A, San Antonio, Texas, 78229, United States|Urology of Virginia, PLLC, Virginia Beach, Virginia, 23462, United States|Fakultní nemocnice Hradec Králové, Urologická klinika, Hradec Králové, 500 05, Czechia|Uromedical Center Olomouc, Olomouc, 779 00, Czechia|Thomayerova nemocnice, Urologické oddělení, Prague, 140 59, Czechia|Hospital of Lithuanian University of Health Sciences Kauno klinikos, Kaunas, 50009, Lithuania|Klaipėda University Hospital, Klaipėda, 92288, Lithuania|National Cancer Institute, Vilnius, 08660, Lithuania|Vilnius University Hospital, Santaros klinikos, Vilnius, 08661, Lithuania|UROCENTRUM MILAB, s.r.o., Prešov, 080 01, Slovakia|Fakultná nemocnica s poliklinikou Žilina Urológia, Žilina, 012 07, Slovakia|Pusan National University Hospital, Busan, 49241, South Korea|Keimyung University Dongsan Medical Center, Daegu, 41931, South Korea|National Cancer Center, Gyeonggi-do, 10408, South Korea|Seoul National University Bundang Hosptal, Gyeonggi-do, 13620, South Korea|Hallym University Sacred Heart Hospital, Gyeonggi-do, 14068, South Korea|Korea University Anam Hospital, Seoul, 02841, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms|Malignant Solid Tumors|Colon Neoplasms|Adenocarcinoma,BIOLOGICAL: GI-6301 (Yeast Brachyury Vaccine),ALL,"ADULT, OLDER_ADULT",PHASE1,34,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/5/12,9/1/16,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: Magrolimab|DRUG: Docetaxel,ALL,"ADULT, OLDER_ADULT",PHASE2,106,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/1/21,10/1/24,"Cancer Treatment Centers of America, Goodyear, Arizona, 85338, United States|UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States|Providence Saint John's Health Center, Santa Monica, California, 90404, United States|St. Jude Hospital Yorba dba St. Joseph Heritage Healthcare, Santa Rosa, California, 95403, United States|University of Miami, Deerfield Beach, Florida, 33064, United States|Tallahassee Memorial Healthcare Cancer Center, Tallahassee, Florida, 32308, United States|University Center and Blood Center,LLC., Athens, Georgia, 30607, United States|Southeastern regional Medical Center, Newnan, Georgia, 30265, United States|Saint Alphonsus Cancer Institute Caldwell, Caldwell, Idaho, 83605, United States|Orchard Healthcare Research Inc, Skokie, Illinois, 60077, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, 52242, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Virginia Piper Cancer Center (Alliant Health), Saint Paul, Minnesota, 55102, United States|Comprehensive Cancer Centers of Nevada- Twain Office, Las Vegas, Nevada, 89169, United States|Astera Cancer Care, East Brunswick, New Jersey, 08816, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Charleston Oncology, Charleston, South Carolina, 29414, United States|Mary Crowley Cancer Research, Dallas, Texas, 75230, United States|MD Anderson Cancer Center, Dallas, Texas, 77030, United States|Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, 84112, United States|Medical Oncology Associates,PS (dba Summit Cancer Center) (includes IP Shipment), Spokane, Washington, 99208, United States|Institut Bergonie, Bordeaux, 33000, France|Centre Georges François Leclerc, Dijon, 21079, France|Centre Hospitalier Regional Universitaire de Lille, Lille, 59037, France|Centre LÃon BÃrard Centre RÃgional de Lutte Contre Le Cancer, Lyon, 69373, France|Hopital Nord AP-HM, Marseille, 13005, France|Centre de Lutte Contre le Cancer (CLCC) - Centre Antoine Lacassagne (CAL) - Site Est, Nice, 6189, France|Hôpital de la Pitié Salpétrière, Paris, 75013, France|Centre Hospitalier Lyon-Sud, Pierre-Bénite, 69310, France|Institut de Cancérologie de l'Ouest (ICO) - Saint-Herblain, Saint-Herblain, France|Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy, Bydgoszcz, 85-796, Poland|Instytut Centrum Zdrowia Matki Polki, Lodz, 93-513, Poland|Wojewodzki Szpital Specjalistyczny w Siedlcach, Siedlce, 08-110, Poland|Instituto de Investigacion Oncologica Vall de Hebron, Barcelona, 08035, Spain|Hospital del Mar, Barcelona, 8003, Spain|Hospital Quironsalud Barcelona, Barcelona, 8023, Spain|Hospital De La Santa Creu I Sant Pau, Barcelona, 8041, Spain|Hospital Universitario de Jaen, Jaén, 23007, Spain|Hospital General Universitario Gregorio Maranon, Madrid, 28007, Spain|MD Anderson Cancer Center, Madrid, 28033, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital HM Sanchinarro, Madrid, 28050, Spain|Hospital Regional Universitario de Malaga, Málaga, 29010, Spain|Clinica Universidad de Navarra, Pamplona, 31008, Spain|Hospital Universitario Virgen Macarena, Seville, 41009, Spain|Hospital Universitario Virgen del Rocio, Seville, 41013, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|Barts Health NHS Trust, London, EC1A 7BE, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: HCW9218,ALL,"ADULT, OLDER_ADULT",PHASE1,18,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/1/22,2/28/25,"Masonic Cancer Center - University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Malignant Solid Neoplasm,PROCEDURE: Biopsy Procedure|PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|DRUG: Erdafitinib|PROCEDURE: Magnetic Resonance Imaging,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/3/18,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Malignant Solid Neoplasm,PROCEDURE: Biopsy Procedure|PROCEDURE: Biospecimen Collection|DRUG: Copanlisib|PROCEDURE: Radiologic Examination,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/8/18,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Ovarian Neoplasms,DRUG: Niraparib|DRUG: Carboplatin|DRUG: Paclitaxel,FEMALE,"ADULT, OLDER_ADULT",PHASE2,36,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/14/22,3/31/25,"GSK Investigational Site, San Francisco, California, 94115, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Tampa, Florida, 33606, United States|GSK Investigational Site, Scarborough, Maine, 04074, United States|GSK Investigational Site, Boston, Massachusetts, 02114, United States|GSK Investigational Site, St Louis, Missouri, 63141, United States|GSK Investigational Site, New York, New York, 10029, United States|GSK Investigational Site, New York, New York, 77030, United States|GSK Investigational Site, Rochester, New York, 14642, United States|GSK Investigational Site, Sioux Falls, South Dakota, 57105, United States|GSK Investigational Site, Seattle, Washington, 98104, United States|GSK Investigational Site, Ottawa, Ontario, K1H 8L6, Canada|GSK Investigational Site, Montreal, Quebec, H2X 0A9, Canada|GSK Investigational Site, Montreal, Quebec, H4A 3J1, Canada|GSK Investigational Site, A Coruña, ES, 15006, Spain|GSK Investigational Site, Madrid, ES, 28027, Spain|GSK Investigational Site, Madrid, ES, 28033, Spain|GSK Investigational Site, Madrid, ES, 28050, Spain|GSK Investigational Site, Madrid, ES, 28223, Spain|GSK Investigational Site, Málaga, ES, 29001, Spain|GSK Investigational Site, Pamplona, ES, 31008, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Nonsquamous Nonsmall Cell Neoplasm of Lung,DRUG: Pemetrexed|DRUG: Carboplatin|DRUG: demcizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,82,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2015-02,4/7/17,"Desert Hematology Oncology Medical Group, Inc., Rancho Mirage, California, 92270, United States|University of California, San Francisco, San Francisco, California, . 94143-1705, United States|Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, 06510-3221, United States|Ocala Oncology Center, Ocala, Florida, 34471, United States|Edward H. Kaplan MD & Associates, Skokie, Illinois, 60076, United States|Anne Arundel Medical Center, Annapolis, Maryland, 21401, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|Karmanos Cancer Institute, Detroit, Michigan, 4820I, United States|Broome Oncology, LLC, Binghamton, New York, 13905, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Hematology Oncology Associates of Rockland, Nyack, New York, 10960, United States|Gaston Hematology & Oncology, Gastonia, North Carolina, 28054, United States|Gabrail Cancer Center Research, Canton, Ohio, 44718, United States|University Hospitals of Cleveland, Cleveland, Ohio, 44106, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|University of Texas Medical Branch at Galveston, Galveston, Texas, 77555, United States|Texas Oncology-Sherman, Sherman, Texas, 75090-0504, United States|Compass Oncology, Vancouver, Washington, 98684, United States|Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|The Kinghorn Cancer Centre, Darlinghurst, New South Wales, 2010, Australia|North Coast Cancer Institute Port Macquarie Base Hospital, Port Macquarie, New South Wales, 2444, Australia|Royall Brisbane & Women's Hospital, Herston, Queensland, 4029, Australia|Icon Cancer Foundation, Milton, Queensland, 4064, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia|Monash Health, Monash Cancer Centre-Moorabbin, Bentleigh East, Victoria, 3165, Australia|St. John of God Subiaco Hospital, Subiaco, Western Australia, 6008, Australia|Ziekenhuisnetwerk Antwerpen- Koningin Paola Kinderzickenhuis, Antwerp, 2020, Belgium|Grand Hopital de Charleroi- Site Notre-Dame, Charleroi, 6000, Belgium|Centre Hospitalier Jolimont-Lobbes, La Louvière, 7100, Belgium|CHR de Ia Citadelle, Liège, 4000, Belgium|Azienda Ospedaliera Istituti Ospitalieri, Cremona, Lombardy, 26100, Italy|Azienda Ospedaliera Città della Salute e della Scienza di Torino, Turin, Piedmont, 10126, Italy|Smilow Cancer Hospital at Yale-New Haven, Aviano, Pordenone, 33081, Italy|Azienda Ospedaliero Universitaria Pisana, Pisa, Tuscany, 56126, Italy|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, 28222, Spain|Hospital Nuestra Senora de Sonsoles, Ávila, 05004, Spain|Hospital Universitari Vall D'Hebron, Barcelona, 08035, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Institute Catalan de Oncologia (ICO L'Hospitalet), Barcelona, 08908, Spain|Hospital Universitari Germans Trias i Pujol, Barcelona, 08916, Spain|Hospital General Universitario Gregorio Marañon, Madrid, 28009, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Madrid Universitario Sanchinarro, Madrid, 28050, Spain|Hospital Universitario Virgen del Rocio, Seville, 41013, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Brain Tumor,DRUG: [18F]FLT|DRUG: [18F]Fluciclovine,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,10,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,9/24/18,8/18/23,"Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Neoplasms|Triple Negative Breast Neoplasms,DRUG: Dasatinib|PROCEDURE: Conventional Surgery|OTHER: Laboratory Biomarker Analysis,FEMALE,"ADULT, OLDER_ADULT",PHASE2,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,5/3/17,2/8/22,"University of Illinois Hospital and Health Systems (Outpatient Care Center), Chicago, Illinois, 60612, United States|University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, 53705, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Cervical Squamous Cell Carcinoma In Situ|Vulvar High Grade Squamous Intraepithelial Lesion,DRUG: Cyclophosphamide|DRUG: Indomethacin|BIOLOGICAL: IRX-2|OTHER: Laboratory Biomarker Analysis|DIETARY_SUPPLEMENT: Multivitamin|DRUG: Omeprazole|OTHER: Placebo|PROCEDURE: Therapeutic Conventional Surgery,FEMALE,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",11/8/17,3/13/24,"USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Gastrointestinal Stromal Tumors,DRUG: Ripretinib|DRUG: Sunitinib,ALL,"ADULT, OLDER_ADULT",PHASE3,453,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/8/19,2025-12,"Mayo Clinic Scottsdale, Scottsdale, Arizona, 85259, United States|University of California San Diego Medical Center, La Jolla, California, 92103, United States|UCLA Hematology Oncology Center - Main Site, Los Angeles, California, 90024, United States|Stanford Medicine, Stanford, California, 94305, United States|University of Colorado Hospital - Anschutz Cancer Pavillion, Aurora, Colorado, 80045, United States|Rocky Mountain Cancer Centers, Denver, Colorado, 80220, United States|Smilow Cancer Hospital at Yale, New Haven, Connecticut, 06511, United States|Washington Cancer Institute at MedStar Washington Hospital Center, Washington D.C., District of Columbia, 20010, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, 33176, United States|Orlando Health UF Health Cancer Center, Orlando, Florida, 32806, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Winship Cancer Institute, Atlanta, Georgia, 30332, United States|Georgia Cancer Specialists, Sandy Springs, Georgia, 30342, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|IU Simon Cancer Center, Indianapolis, Indiana, 46202, United States|University of Iowa Hospital and Clinics, Iowa City, Iowa, 52242, United States|Norton Cancer Institute, Audubon Hospital Campus, Louisville, Kentucky, 40241, United States|Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Henry Ford Health System, Detroit, Michigan, 48202, United States|University of Minnesota Medical Center-Fairview, Minneapolis, Minnesota, 55455, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, 63110, United States|Rutgers Cancer Institute, New Brunswick, New Jersey, 08901, United States|Roswell Park Cancer Institute, Buffalo, New York, 43606, United States|The Monter Cancer Center, Lake Success, New York, 11042, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Montefiore Medical Center-Montefiore Medical Park, The Bronx, New York, 10467, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute, Columbus, Ohio, 43210, United States|University of Toledo, Toledo, Ohio, 43606, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Oregon Health & Science University Center for Health and Healing, Portland, Oregon, 97239, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Henry-Joyce Cancer Clinic, Nashville, Tennessee, 37232, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, 23298, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States|Froedtert Hospital-Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Sanatorio Allende, Córdoba, Córdoba Province, X5000JHQ, Argentina|Instituto Medicao Especializado Alexander Fleming, Buenos Aires, Argentina|Border Medical Oncology Research Unit, Albury, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, 2031, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Ashford Cancer Centre Research, Kurralta Park, South Australia, 5037, Australia|Ashford Cancer Centre Research, Kurralta Park, South Australia, Australia|The Alfred Hospital, Melbourne, Victoria, 3004, Australia|Princess Alexandara Hospital, Woolloongabba, Australia|Institut Jules Bordet, Brussels, Belgium|UZ Leuven, Leuven, Belgium|Cross Cancer Institute, Edmonton, Alberta, Canada|CancerCare Manitoba, Winnipeg, Manitoba, Canada|Juravinski Cancer Centre, Hamilton, Ontario, Canada|The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2C1, Canada|Hopital Maisonneuve-Rosemont, Québec, Canada|Clinica San Carlos de Apoquindo Red Salud UC Christs, Santiago, Chile|Fakultni nemocnice v Motole, Prague, Czechia|Institut Bergonnié, Bordeaux, France|Centre Georges François Leclerc, Dijon, France|Centre Oscar Lambret, Lille, France|Centre Léon Bérard, Lyon, France|Hopital La Timone, Marseille, France|IPC, Marseille, France|IGR, Paris, France|CHU Poitiers-Hopital la Miletrie, Poitiers, France|ICO - Site René Gauducheau, Saint-Herblain, France|HELIOS Klinikum Berlin-Buch, Berlin, Germany|Technische Universitat Dresden, Dresden, Germany|West German Cancer Center, Essen, Germany|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, Hungary|Debreceni Egyetem, Debrecen, Hungary|Shamir Medical Center (Assaf Harofeh), Be’er Ya‘aqov, Israel|Rabin Medical Cente, Petah Tikva, Israel|Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel|Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Italy|stituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy|IOV - Istituto Oncologico Veneto IRCCS, Padua, Italy|Universita degli Studi di Palermo, Palermo, Italy|Università Campus Bio-Medico di Roma, Rome, Italy|Antoni van Leeuwenhoek, Amsterdam, Netherlands|The Netherlands Cancer Institute, Amsterdam, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Centre, Leiden, Netherlands|Oslo University Hospital, Oslo, Norway|Centrum Onkologii-Instytut im. M. Sklodowskiej Curie, Warsaw, Poland|National Cancer Centre, Singapore, 169610, Singapore|Asan Medical Center, Seoul, South Korea|Samsung Medical Center, Seoul, South Korea|Seoul National University Hospital, Seoul, South Korea|Ajou University Hospital, Suwon, South Korea|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital de Basurto, Bilbao, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Clinico San Carlos, Madrid, Spain|Hospital Universitario HM Madrid Sanchinarro, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Clinico Universitario Virgen de la Victoria, Málaga, Spain|Hospital Universitario Virgen del Rocio, Seville, Spain|Instituto Valenciano de Oncología,, Valencia, Spain|Complejo Hospitalario Universitario de Vigo, Vigo, Spain|Karolinska universitetssjukhuset, Solna, Sweden|Centre Hospitalier Universitaire Vaudois, Fondation du Centre Pluridisciplinaire d'Oncologi, Lausanne, Switzerland|Universitaetsspital Zuerich, Klinik fuer Onkologie, Zurich, Switzerland|Chang Gung Memorial Hospital, Linkou District, Taoyuan County, Taiwan|Kaohsiung Chang Gung Memorial Hospital,, Kaohsiung City, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Chen Kung University Hospital, Tainan, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|St James's University Hospital, Leeds, United Kingdom|Royal Marsden Hospital - Fulham, London, United Kingdom|University College London Hospitals, London, United Kingdom|Weston Park Hospital, Sheffield, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: LY2510924|DRUG: Durvalumab,ALL,"ADULT, OLDER_ADULT",PHASE1,9,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2016-09,9/25/17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,"Uterine Neoplasms|Uterine Cervical Neoplasms|Biliary Tract Neoplasms|Urologic Neoplasms|Carcinoma, Non-Small-Cell Lung|HER2 Mutations Breast Neoplasms",DRUG: tucatinib|DRUG: trastuzumab|DRUG: fulvestrant,ALL,"ADULT, OLDER_ADULT",PHASE2,217,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/11/21,4/30/26,"HonorHealth, Phoenix, Arizona, 85016, United States|HonorHealth, Tempe, Arizona, 85284, United States|The University of Arizona Cancer Center-North Campus, Tucson, Arizona, 85719, United States|City of Hope at Huntington Beach, Huntington Beach, California, 92648, United States|City of Hope at Irvine Sand Canyon, Irvine, California, 92618, United States|Koman Family Outpatient Pavilion, La Jolla, California, 92037, United States|UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion), La Jolla, California, 92037, United States|UC San Diego Moores Cancer Center- Investigational Drug Services, La Jolla, California, 92037, United States|UC San Diego Moores Cancer Center, La Jolla, California, 92037, United States|City of Hope at Long Beach Worsham, Long Beach, California, 90808, United States|City of Hope at Long Beach Elm, Long Beach, California, 90813, United States|City of Hope at Newport Beach Lido, Newport Beach, California, 92663, United States|City of Hope Torrance, Torrance, California, 90505, United States|Rocky Mountain Cancer Centers, Aurora, Colorado, 80012, United States|Rocky Mountain Cancer Centers, Boulder, Colorado, 80303, United States|Rocky Mountain Cancer Centers, Thornton, Colorado, 80260, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Minnesota Oncology Hematology, PA, Coon Rapids, Minnesota, 55433, United States|Metro Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park, Minnesota, 55426, United States|Washington University School of Medicine - Obstetrics & Gynecology [Academic Offices), St Louis, Missouri, 63108, United States|Barnes-Jewish Hospital Investigational Drug Pharmacy (IDS), St Louis, Missouri, 63110, United States|Washington University School of Medicine - Obstetrics & Gynecology, St Louis, Missouri, 63110, United States|Washington University School of Medicine [Patient Clinics], St Louis, Missouri, 63110, United States|Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha, Nebraska, 68114, United States|Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha, Nebraska, 68130, United States|Perlmutter Cancer Center at NYU Langone GYN Oncology Associates, Mineola, New York, 11501, United States|Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York, 11501, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, 10016, United States|NYU Langone Medical Center, New York, New York, 10016, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Duke University Medical Center/Duke Cancer Center, Durham, North Carolina, 27710, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|OSU Wexner Medical Center, CarePoint East, Columbus, Ohio, 43203, United States|OSU Wexner Medical Center, Ohio State University Hospital East, Columbus, Ohio, 43203, United States|OSU Wexner Medical Center, Arther G. James Cancer Hospital, and Solove Research Institute, Columbus, Ohio, 43210, United States|OSU Wexner Medical Center, Investigational Drug Services(IP Ship to), Columbus, Ohio, 43210, United States|Osu Wexner Medical Center, The Ohio State University Hospital, Columbus, Ohio, 43210, United States|OSU Wexner Medical Center, Stefanie Spieman Comprehensive Breast Center, Columbus, Ohio, 43212, United States|OSU Wexner Medical Center, Martha Morehouse Medical Plaza, Columbus, Ohio, 43221, United States|OSU Wexner Medical Center, OutPatient Care Upper Arlington, Columbus, Ohio, 43221, United States|OSU Wexner Medical Center, CarePoint Gahanna, Gahanna, Ohio, 43230, United States|OSU Wexner Medical Center, Gynecologic Oncology at Mill Run, Hilliard, Ohio, 43026, United States|OSU Wexner Medical Center, Outpatient Care Lewis Center, Lewis Center, Ohio, 43035, United States|UH Minoff Health Center at Chagrin Highlands, Orange, Ohio, 44122, United States|OSU Wexner Medical Center, Outpatient Care New Albany, Westerville, Ohio, 43081, United States|Northwest Cancer Specialists, P.C., Portland, Oregon, 97213, United States|Northwest Cancer Specialists, P.C., Portland, Oregon, 97227, United States|Northwest Cancer Specialists, P.C., Tigard, Oregon, 97223, United States|UPMC Hillman Cancer Center - Washington, Washington, Pennsylvania, 15301, United States|Prisma Health Cancer Institute, Boiling Springs, South Carolina, 29316, United States|Prisma Health Cancer Institute, Easley, South Carolina, 29640, United States|Prisma Health Cancer Institute, Greenville, South Carolina, 29605, United States|Prisma Health Cancer Institute, Greenville, South Carolina, 29615, United States|Prisma Health Cancer Institute, Greer, South Carolina, 29650, United States|Prisma Health Cancer Institute, Seneca, South Carolina, 29672, United States|Tennessee Oncology, PLLC, Gallatin, Tennessee, 37066, United States|Tennessee Oncology, PLLC, Hendersonville, Tennessee, 37075, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Shelbyville, Tennessee, 37160, United States|Texas oncology-West Texas, Abilene, Texas, 79606, United States|US Oncology Investigational Product Center (IPC), Irving, Texas, 75063, United States|US Oncology Investigational Products Center (IPC), Irving, Texas, 75063, United States|US Oncology lnvestigational Products Center (IPC), Irving, Texas, 75063, United States|Texas Oncology - Central South, Waco, Texas, 76712, United States|Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, 84112, United States|Virginia Cancer Specialists, PC, Alexandria, Virginia, 22304, United States|Virginia Cancer Specialists, PC, Arlington, Virginia, 22205, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States|Virginia Cancer Specialists, PC, Gainesville, Virginia, 20155, United States|Fred Hutchinson Cancer Center, Seattle, Washington, 98109, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States|Northwest Cancer Specialists, P.C., Vancouver, Washington, 98684, United States|1 S Park St Medical Center, Madison, Wisconsin, 53715, United States|University of Wisconsin Clinical Science Center, Madison, Wisconsin, 53792, United States|Grand Hopital de Charleroi, Charleroi, Hainaut, B- 6060, Belgium|Cliniques Universitaires Saint-Luc, Brussels, 1200, Belgium|Universitair Ziekenhuis Antwerpen, Edegem, 2650, Belgium|AZ Groeninge, Kortrijk, 8500, Belgium|CHU de Liege, Liège, 4000, Belgium|AZ Sint-Maarten, Mechelen, 2800, Belgium|Charite Universitatsmedizin Berlin, Berlin, 12200, Germany|Charite Universitatsmedizin Berlin, Berlin, 13353, Germany|Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative lstituto Europeo di Oncologia, Milan, Milan, 20141, Italy|Aichi Cancer Center Hospital, Nagoya, Aichi-ken, 464-8681, Japan|National Cancer Center Hospital East, Kashiwa-shi, Chiba, 277-8577, Japan|St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, 216-8511, Japan|Kindai University Hospital, Osakasayama-shi, Osaka, 589-8511, Japan|National Cancer Center Hospital, Cho-ku, Tokyo, 104-0045, Japan|The Cancer Institute Hospital of JFCR, Tokyo, 135-8550, Japan|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea|Severance Hospital Yonsei University Health System, Seoul, Other, 03722, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|Institut Catala d'Oncologia Hospitalet, L'Hospitalet de Llobregat, Other, 8908, Spain|Cetir Centre Medic, Barcelona, 08029, Spain|Hospital Clínico Universitario de Valencia. Fundación Investigación Clínico de Valencia., Valencia, 46010, Spain|Ascires Eresa Campanar, Valencia, 46015, Spain|Hospital Vithas Valencia 9 de Octubre, Valencia, 46015, Spain|Sarah Cannon Research Institute UK, London, Budapest, W1G 6AD, United Kingdom|Diagnostic Centre, London, Others, W1G 7AF, United Kingdom|The Royal Marsden NHS Foundation Trust, Sutton, Surrey, SM2 5PT, United Kingdom|Guy's Hospital, London, SE1 9RT, United Kingdom|Jonathan Poon, London, SE1 9RT, United Kingdom|The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom|The Harley Street Clinic, London, W1G 8BJ, United Kingdom|Radiology, London, W1G 8PP, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Colorectal Neoplasms,DRUG: 5 FLUOROURACYL|DRUG: acide folinique|DRUG: irinotecan|DRUG: Oxaliplatin|DRUG: capécitabine|DRUG: bevacizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,21,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2016-09,2020-10,"Hopital Pierre Oudot - Service de Gastroenterologie, Bourgoin, 38300, France|Ch de Cholet - Service Maladies de L4Appareil Digestif Du Dr Kaasis, Cholet, 49325, France|Chd Vendee - Service D'Hge, La Roche-sur-Yon, 85925, France|Ch Annecy Genevois - Service Hge, Pringy, 74374, France|CH - Annecy Genevois, Pringy, France|Chu Robert Debre - Medecine Ambulatoire-Cancerologie, Reims, 51092, France|CHU Robert DEBRE, Reims, France|Chu Charles Nicolle - Service D'Hge, Rouen, 76031, France|Hopital Prive Saint Gregoire - Service de Radiotherapie, Saint-Grégoire, 35768, France|Chu de Saint Etienne-Hopital Nord - Service Hge, Saint-Priest-en-Jarez, 42270, France|Centre Hospitalier de St Malo - Service Hepato-Gastro-Enterologie, St-Malo, 35403, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Gestational Trophoblastic Neoplasia|Choriocarcinoma|Placental Site Trophoblastic Tumor|Epithelioid Trophoblastic Tumor,DRUG: TRC105|DRUG: Bevacizumab,FEMALE,"CHILD, ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-03,2018-11,"Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Ohio State University, Columbus, Ohio, 43210, United States|UT Southwestern, Dallas, Texas, 75390, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Neoplasms,DRUG: Doxorubicin|BIOLOGICAL: Trastuzumab|DRUG: Cyclophosphamide|DRUG: Paclitaxel|DRUG: Epirubicin|DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Fluorouracil,FEMALE,"ADULT, OLDER_ADULT",PHASE2,7,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/19/13,9/1/21,"Washington University School of Medicine, St Louis, Missouri, 63110, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Foregut Neuroendocrine Tumor|Hindgut Neuroendocrine Tumor|Metastatic Digestive System Neuroendocrine Tumor G1|Metastatic Neuroendocrine Tumor|Midgut Neuroendocrine Tumor G1|Neuroendocrine Tumor G2|Recurrent Digestive System Neuroendocrine Tumor G1|Regional Digestive System Neuroendocrine Tumor G1,PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|PROCEDURE: Echocardiography Test|OTHER: Laboratory Biomarker Analysis|PROCEDURE: Magnetic Resonance Imaging|PROCEDURE: Multigated Acquisition Scan|DRUG: Pazopanib Hydrochloride|OTHER: Placebo Administration|OTHER: Quality-of-Life Assessment|PROCEDURE: X-Ray Imaging,ALL,"ADULT, OLDER_ADULT",PHASE2,171,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",9/20/13,9/10/26,"Alaska Breast Care and Surgery LLC, Anchorage, Alaska, 99508, United States|Alaska Women's Cancer Care, Anchorage, Alaska, 99508, United States|Anchorage Oncology Centre, Anchorage, Alaska, 99508, United States|Katmai Oncology Group, Anchorage, Alaska, 99508, United States|Providence Alaska Medical Center, Anchorage, Alaska, 99508, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, 85259, United States|Kaiser Permanente-Anaheim, Anaheim, California, 92806, United States|Kaiser Permanente-Baldwin Park, Baldwin Park, California, 91706, United States|Kaiser Permanente-Fontana, Fontana, California, 92335, United States|Kaiser Permanente South Bay, Harbor City, California, 90710, United States|Kaiser Permanente-Irvine, Irvine, California, 92618, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, 90027, United States|Los Angeles General Medical Center, Los Angeles, California, 90033, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Kaiser Permanente West Los Angeles, Los Angeles, California, 90034, United States|Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, 94301, United States|Stanford Cancer Institute Palo Alto, Palo Alto, California, 94304, United States|Kaiser Permanente - Panorama City, Panorama City, California, 91402, United States|Kaiser Permanente-Riverside, Riverside, California, 92505, United States|Kaiser Permanente-San Diego Mission, San Diego, California, 92108, United States|Kaiser Permanente-San Diego Zion, San Diego, California, 92120, United States|UCSF Medical Center-Mount Zion, San Francisco, California, 94115, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Kaiser Permanente-San Marcos, San Marcos, California, 92078, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, 95065, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, 94086, United States|Kaiser Permanente-Woodland Hills, Woodland Hills, California, 91367, United States|The Medical Center of Aurora, Aurora, Colorado, 80012, United States|Boulder Community Foothills Hospital, Boulder, Colorado, 80303, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, 80304, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, 80907, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, 80907, United States|AdventHealth Porter, Denver, Colorado, 80210, United States|Colorado Blood Cancer Institute, Denver, Colorado, 80218, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, 80218, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, 80218, United States|Saint Joseph Hospital - Cancer Centers of Colorado, Denver, Colorado, 80218, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, 80220, United States|Rose Medical Center, Denver, Colorado, 80220, United States|Western States Cancer Research NCORP, Denver, Colorado, 80222, United States|Mercy Medical Center, Durango, Colorado, 81301, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, 80113, United States|Swedish Medical Center, Englewood, Colorado, 80113, United States|Poudre Valley Hospital, Fort Collins, Colorado, 80524, United States|Mountain Blue Cancer Care Center, Golden, Colorado, 80401, United States|Banner North Colorado Medical Center, Greeley, Colorado, 80631, United States|Rocky Mountain Cancer Centers-Greenwood Village, Greenwood Village, Colorado, 80111, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, 80228, United States|Saint Anthony Hospital, Lakewood, Colorado, 80228, United States|AdventHealth Littleton, Littleton, Colorado, 80122, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, 80124, United States|Sky Ridge Medical Center, Lone Tree, Colorado, 80124, United States|Longmont United Hospital, Longmont, Colorado, 80501, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, 80501, United States|Banner North Colorado Medical Center - Loveland Campus, Loveland, Colorado, 80539, United States|AdventHealth Parker, Parker, Colorado, 80138, United States|Rocky Mountain Cancer Centers-Parker, Parker, Colorado, 80138, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, 81004, United States|Rocky Mountain Cancer Centers - Pueblo, Pueblo, Colorado, 81008, United States|Intermountain Health Lutheran Hospital, Wheat Ridge, Colorado, 80401, United States|Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, 06105, United States|Beebe Medical Center, Lewes, Delaware, 19958, United States|Delaware Clinical and Laboratory Physicians PA, Newark, Delaware, 19713, United States|Helen F Graham Cancer Center, Newark, Delaware, 19713, United States|Medical Oncology Hematology Consultants PA, Newark, Delaware, 19713, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, 19718, United States|Beebe Health Campus, Rehoboth Beach, Delaware, 19971, United States|TidalHealth Nanticoke / Allen Cancer Center, Seaford, Delaware, 19973, United States|Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware, 19801, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|John B Amos Cancer Center, Columbus, Georgia, 31904, United States|Memorial Health University Medical Center, Savannah, Georgia, 31404, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, 96813, United States|Queen's Medical Center, Honolulu, Hawaii, 96813, United States|Straub Clinic and Hospital, Honolulu, Hawaii, 96813, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, 96813, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, 96817, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, 96817, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States|Castle Medical Center, Kailua, Hawaii, 96734, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, 96766, United States|Pali Momi Medical Center, ‘Aiea, Hawaii, 96701, United States|Queen's Cancer Center - Pearlridge, ‘Aiea, Hawaii, 96701, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, 83706, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, 83854, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, 61704, United States|Illinois CancerCare-Canton, Canton, Illinois, 61520, United States|Illinois CancerCare-Carthage, Carthage, Illinois, 62321, United States|Northwestern University, Chicago, Illinois, 60611, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, 62526, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Illinois CancerCare-Eureka, Eureka, Illinois, 61530, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, 61401, United States|Ingalls Memorial Hospital, Harvey, Illinois, 60426, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, 61443, United States|Illinois CancerCare-Macomb, Macomb, Illinois, 61455, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|SSM Health Good Samaritan, Mount Vernon, Illinois, 62864, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, 61350, United States|Illinois CancerCare-Pekin, Pekin, Illinois, 61554, United States|Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States|Illinois CancerCare-Peru, Peru, Illinois, 61354, United States|Illinois CancerCare-Princeton, Princeton, Illinois, 61356, United States|Elkhart Clinic, Elkhart, Indiana, 46514-2098, United States|Michiana Hematology Oncology PC-Elkhart, Elkhart, Indiana, 46514, United States|Elkhart General Hospital, Elkhart, Indiana, 46515, United States|Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Community Howard Regional Health, Kokomo, Indiana, 46904, United States|IU Health La Porte Hospital, La Porte, Indiana, 46350, United States|Michiana Hematology Oncology PC-Mishawaka, Mishawaka, Indiana, 46545, United States|Saint Joseph Regional Medical Center-Mishawaka, Mishawaka, Indiana, 46545, United States|Michiana Hematology Oncology PC-Plymouth, Plymouth, Indiana, 46563, United States|Reid Health, Richmond, Indiana, 47374, United States|Memorial Hospital of South Bend, South Bend, Indiana, 46601, United States|South Bend Clinic, South Bend, Indiana, 46617, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, 46628, United States|Michiana Hematology Oncology PC-Westville, Westville, Indiana, 46391, United States|Mary Greeley Medical Center, Ames, Iowa, 50010, United States|McFarland Clinic - Ames, Ames, Iowa, 50010, United States|University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf, Iowa, 52722, United States|McFarland Clinic - Boone, Boone, Iowa, 50036, United States|Mercy Hospital, Cedar Rapids, Iowa, 52403, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, 52403, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, 50325, United States|UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, 50325, United States|Iowa Methodist Medical Center, Des Moines, Iowa, 50309, United States|Iowa-Wide Oncology Research Coalition NCORP, Des Moines, Iowa, 50309, United States|UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, 50309, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, 50314, United States|UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, 50314, United States|Iowa Lutheran Hospital, Des Moines, Iowa, 50316, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|McFarland Clinic - Jefferson, Jefferson, Iowa, 50129, United States|McFarland Clinic - Marshalltown, Marshalltown, Iowa, 50158, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, 51101, United States|Mercy Medical Center-Sioux City, Sioux City, Iowa, 51102, United States|Saint Luke's Regional Medical Center, Sioux City, Iowa, 51104, United States|Methodist West Hospital, West Des Moines, Iowa, 50266-7700, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, 50266, United States|Newman Regional Health, Emporia, Kansas, 66801, United States|Saint Catherine Hospital, Garden City, Kansas, 67846, United States|Saint Rose Ambulatory and Surgery Center, Great Bend, Kansas, 67530, United States|HaysMed, Hays, Kansas, 67601, United States|University of Kansas Cancer Center-West, Kansas City, Kansas, 66112, United States|University of Kansas Cancer Center, Kansas City, Kansas, 66160, United States|The University of Kansas Cancer Center - Olathe, Olathe, Kansas, 66061, United States|Menorah Medical Center, Overland Park, Kansas, 66209, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, 66210, United States|Saint Luke's South Hospital, Overland Park, Kansas, 66213, United States|Mercy Hospital Pittsburg, Pittsburg, Kansas, 66762, United States|Kansas City NCI Community Oncology Research Program, Prairie Village, Kansas, 66208, United States|Salina Regional Health Center, Salina, Kansas, 67401, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, 66606, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, 67214, United States|Oncology Hematology Care Inc-Crestview, Crestview Hills, Kentucky, 41017, United States|Baptist Health Hardin, Elizabethtown, Kentucky, 42701, United States|Baptist Health Lexington, Lexington, Kentucky, 40503, United States|Ochsner Health Center-Summa, Baton Rouge, Louisiana, 70809, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, 70121, United States|Bixby Medical Center, Adrian, Michigan, 49221, United States|Hickman Cancer Center, Adrian, Michigan, 49221, United States|Michigan Cancer Research Consortium NCORP, Ann Arbor, Michigan, 48106, United States|Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, 48106, United States|Bronson Battle Creek, Battle Creek, Michigan, 49017, United States|Corewell Health Dearborn Hospital, Dearborn, Michigan, 48124, United States|Henry Ford Health Saint John Hospital, Detroit, Michigan, 48236, United States|OSF Saint Francis Hospital and Medical Group, Escanaba, Michigan, 49829, United States|Genesys Hurley Cancer Institute, Flint, Michigan, 48503, United States|Hurley Medical Center, Flint, Michigan, 48503, United States|Cancer Research Consortium of West Michigan NCORP, Grand Rapids, Michigan, 49503, United States|Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan, 49503, United States|Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, 49503, United States|Allegiance Health, Jackson, Michigan, 49201, United States|University of Michigan Health - Sparrow Lansing, Lansing, Michigan, 48912, United States|Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, 48154, United States|Mercy Memorial Hospital, Monroe, Michigan, 48162, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, 48162, United States|Trinity Health Muskegon Hospital, Muskegon, Michigan, 49444, United States|Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan, 49120, United States|Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, 48341, United States|Lake Huron Medical Center, Port Huron, Michigan, 48060, United States|Corewell Health Reed City Hospital, Reed City, Michigan, 49677, United States|MyMichigan Medical Center Saginaw, Saginaw, Michigan, 48601, United States|Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan, 49085, United States|Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan, 49085, United States|Munson Medical Center, Traverse City, Michigan, 49684, United States|Henry Ford Health Warren Hospital, Warren, Michigan, 48093, United States|Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Essentia Health Cancer Center, Duluth, Minnesota, 55805, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, 55805, United States|Miller-Dwan Hospital, Duluth, Minnesota, 55805, United States|Fairview Southdale Hospital, Edina, Minnesota, 55435, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, 55350, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, 55109, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, 55109, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States|Health Partners Inc, Minneapolis, Minnesota, 55454, United States|New Ulm Medical Center, New Ulm, Minnesota, 56073, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, 55422, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, 55416, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|United Hospital, Saint Paul, Minnesota, 55102, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States|Lakeview Hospital, Stillwater, Minnesota, 55082, United States|Ridgeview Medical Center, Waconia, Minnesota, 55387, United States|Rice Memorial Hospital, Willmar, Minnesota, 56201, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, 55125, United States|Cox Cancer Center Branson, Branson, Missouri, 65616, United States|Mercy Cancer Center - Cape Girardeau, Cape Girardeau, Missouri, 63703, United States|MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia, Missouri, 65212, United States|Centerpoint Medical Center LLC, Independence, Missouri, 64057, United States|MU Health Care Goldschmidt Cancer Center, Jefferson City, Missouri, 65109, United States|Mercy Hospital Joplin, Joplin, Missouri, 64804, United States|University Health Truman Medical Center, Kansas City, Missouri, 64108, United States|Saint Luke's Hospital of Kansas City, Kansas City, Missouri, 64111, United States|Heartland Hematology and Oncology Associates Incorporated, Kansas City, Missouri, 64118, United States|The University of Kansas Cancer Center-South, Kansas City, Missouri, 64131, United States|Research Medical Center, Kansas City, Missouri, 64132, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, 64154, United States|University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, 64064, United States|Saint Luke's East - Lee's Summit, Lee's Summit, Missouri, 64086, United States|Liberty Hospital, Liberty, Missouri, 64068, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States|Phelps Health Delbert Day Cancer Institute, Rolla, Missouri, 65401, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, 64506, United States|Cancer Research for the Ozarks NCORP, Springfield, Missouri, 65804, United States|Mercy Hospital Springfield, Springfield, Missouri, 65804, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Mercy Infusion Center - Chippewa, St Louis, Missouri, 63109, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Saint Vincent Healthcare, Billings, Montana, 59101, United States|Montana Cancer Consortium NCORP, Billings, Montana, 59102, United States|Bozeman Health Deaconess Hospital, Bozeman, Montana, 59715, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, 59701, United States|Benefis Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Saint Peter's Community Hospital, Helena, Montana, 59601, United States|Logan Health Medical Center, Kalispell, Montana, 59901, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, 59802, United States|Nebraska Cancer Research Center, Lincoln, Nebraska, 68510, United States|Missouri Valley Cancer Consortium, Omaha, Nebraska, 68106, United States|Nebraska Methodist Hospital, Omaha, Nebraska, 68114, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, 68122, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, 68124, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, 68130, United States|Creighton University Medical Center, Omaha, Nebraska, 68131, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, 89052, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, 89074, United States|Oncology Las Vegas - Henderson, Henderson, Nevada, 89074, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Cancer and Blood Specialists-Shadow, Las Vegas, Nevada, 89106, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, 89106, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, 89113, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, 89119, United States|Nevada Cancer Research Foundation NCORP, Las Vegas, Nevada, 89120, United States|Cancer Therapy and Integrative Medicine, Las Vegas, Nevada, 89121, United States|Cancer and Blood Specialists-Tenaya, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, 89128, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, 89128, United States|Oncology Las Vegas - Tenaya, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, 89144, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, 89148-2405, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, 89148, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, 89149, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, 89169, United States|Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, 03756, United States|Cooper Hospital University Medical Center, Camden, New Jersey, 08103, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87106, United States|Memorial Medical Center-Las Cruces, Las Cruces, New Mexico, 88011, United States|Glens Falls Hospital, Glens Falls, New York, 12801, United States|University of Rochester, Rochester, New York, 14642, United States|Syracuse Veterans Administration Medical Center, Syracuse, New York, 13210, United States|Montefiore Medical Center-Einstein Campus, The Bronx, New York, 10461, United States|Montefiore Medical Center - Moses Campus, The Bronx, New York, 10467, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, 27534, United States|Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina, 28791, United States|ECU Health Oncology Kinston, Kinston, North Carolina, 28501, United States|Iredell Memorial Hospital, Statesville, North Carolina, 28677, United States|Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, 58103, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, 45714, United States|Toledo Clinic Cancer Centers-Bowling Green, Bowling Green, Ohio, 43402, United States|Adena Regional Medical Center, Chillicothe, Ohio, 45601, United States|Oncology Hematology Care Inc-Eden Park, Cincinnati, Ohio, 45202, United States|Oncology Hematology Care Inc-Mercy West, Cincinnati, Ohio, 45211, United States|Oncology Hematology Care Inc-Anderson, Cincinnati, Ohio, 45230, United States|Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio, 45236, United States|Oncology Hematology Care Inc-Blue Ash, Cincinnati, Ohio, 45242, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, 43214, United States|Riverside Methodist Hospital, Columbus, Ohio, 43214, United States|Columbus NCI Community Oncology Research Program, Columbus, Ohio, 43215, United States|Grant Medical Center, Columbus, Ohio, 43215, United States|The Mark H Zangmeister Center, Columbus, Ohio, 43219, United States|Mount Carmel Health Center West, Columbus, Ohio, 43222, United States|Doctors Hospital, Columbus, Ohio, 43228, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, 45406, United States|Miami Valley Hospital, Dayton, Ohio, 45409, United States|Miami Valley Hospital North, Dayton, Ohio, 45415, United States|Dayton NCI Community Oncology Research Program, Dayton, Ohio, 45459, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, 43015, United States|Delaware Radiation Oncology, Delaware, Ohio, 43015, United States|Grady Memorial Hospital, Delaware, Ohio, 43015, United States|Oncology Hematology Care Inc-Healthplex, Fairfield, Ohio, 45014, United States|Blanchard Valley Hospital, Findlay, Ohio, 45840, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, 45005-1066, United States|Wayne Hospital, Greenville, Ohio, 45331, United States|Kettering Medical Center, Kettering, Ohio, 45429, United States|Fairfield Medical Center, Lancaster, Ohio, 43130, United States|Lancaster Radiation Oncology, Lancaster, Ohio, 43130, United States|Lima Memorial Hospital, Lima, Ohio, 45804, United States|Marietta Memorial Hospital, Marietta, Ohio, 45750, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, 43537, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, 43537, United States|Knox Community Hospital, Mount Vernon, Ohio, 43050, United States|Licking Memorial Hospital, Newark, Ohio, 43055, United States|Newark Radiation Oncology, Newark, Ohio, 43055, United States|Saint Charles Hospital, Oregon, Ohio, 43616, United States|Toledo Clinic Cancer Centers-Oregon, Oregon, Ohio, 43616, United States|Southern Ohio Medical Center, Portsmouth, Ohio, 45662, United States|Springfield Regional Medical Center, Springfield, Ohio, 45504, United States|ProMedica Flower Hospital, Sylvania, Ohio, 43560, United States|Mercy Hospital of Tiffin, Tiffin, Ohio, 44883, United States|Mercy Health - Saint Vincent Hospital, Toledo, Ohio, 43608, United States|University of Toledo, Toledo, Ohio, 43614, United States|Toledo Community Hospital Oncology Program CCOP, Toledo, Ohio, 43617, United States|Mercy Health - Saint Anne Hospital, Toledo, Ohio, 43623, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, 43623, United States|Upper Valley Medical Center, Troy, Ohio, 45373, United States|Fulton County Health Center, Wauseon, Ohio, 43567, United States|Saint Ann's Hospital, Westerville, Ohio, 43081, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, 43701, United States|Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, 73505, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, 74146, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, 97015, United States|Providence Milwaukie Hospital, Milwaukie, Oregon, 97222, United States|Providence Newberg Medical Center, Newberg, Oregon, 97132, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, 97045, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Providence Saint Vincent Medical Center, Portland, Oregon, 97225, United States|Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania, 18015, United States|Geisinger Medical Center, Danville, Pennsylvania, 17822, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, 18201, United States|Guthrie Medical Group PC-Robert Packer Hospital, Sayre, Pennsylvania, 18840, United States|Geisinger Medical Group, State College, Pennsylvania, 16801, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, 18711, United States|UPMC Susquehanna, Williamsport, Pennsylvania, 17701, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, 29316, United States|McLeod Regional Medical Center, Florence, South Carolina, 29506, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, 29605, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, 29605, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, 29605, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, 29615, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, 29650, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, 29672, United States|Rapid City Regional Hospital, Rapid City, South Dakota, 57701, United States|Baylor University Medical Center, Dallas, Texas, 75246, United States|Houston Methodist Hospital, Houston, Texas, 77030, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork, Utah, 84003, United States|Sandra L Maxwell Cancer Center, Cedar City, Utah, 84720, United States|Logan Regional Hospital, Logan, Utah, 84321, United States|Intermountain Medical Center, Murray, Utah, 84107, United States|McKay-Dee Hospital Center, Ogden, Utah, 84403, United States|Utah Valley Regional Medical Center, Provo, Utah, 84604, United States|Utah Cancer Specialists-Salt Lake City, Salt Lake City, Utah, 84106, United States|LDS Hospital, Salt Lake City, Utah, 84143, United States|Saint George Regional Medical Center, St. George, Utah, 84770, United States|Southwestern Vermont Medical Center, Bennington, Vermont, 05201, United States|Fredericksburg Oncology Inc, Fredericksburg, Virginia, 22401, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, 98664, United States|Compass Oncology Vancouver, Vancouver, Washington, 98684, United States|Edwards Comprehensive Cancer Center, Huntington, West Virginia, 25701, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, 54729, United States|HSHS Sacred Heart Hospital, Eau Claire, Wisconsin, 54701, United States|Marshfield Clinic Cancer Center at Sacred Heart, Eau Claire, Wisconsin, 54701, United States|Green Bay Oncology at Saint Vincent Hospital, Green Bay, Wisconsin, 54301-3526, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, 54301, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, 54303, United States|University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, 53792, United States|Holy Family Memorial Hospital, Manitowoc, Wisconsin, 54221, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, 54449, United States|Marshfield Medical Center, Marshfield, Wisconsin, 54449, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, 54548, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, 54017, United States|Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, 54154, United States|Aspirus Cancer Care - James Beck Cancer Center, Rhinelander, Wisconsin, 54501, United States|Saint Mary's Hospital, Rhinelander, Wisconsin, 54501, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, 54868, United States|HSHS Saint Nicholas Hospital, Sheboygan, Wisconsin, 53081, United States|Aspirus Cancer Care - Stevens Point, Stevens Point, Wisconsin, 54481, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin, 54401, United States|Marshfield Medical Center - Weston, Weston, Wisconsin, 54476, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, 54494, United States|Rocky Mountain Oncology, Casper, Wyoming, 82609, United States|Welch Cancer Center, Sheridan, Wyoming, 82801, United States|Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta, T2N 5G2, Canada|BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada|The Vitalite Health Network - Dr Leon Richard Oncology Centre, Moncton, New Brunswick, E1C 8X3, Canada|QEII Health Sciences Centre/Nova Scotia Health Authority, Halifax, Nova Scotia, B3H 2Y9, Canada|Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, L8V 5C2, Canada|Waterloo Regional Health Network, Kitchener, Ontario, N2G 1G3, Canada|Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, K1H 8L6, Canada|University Health Network-Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, H2X 3E4, Canada|Allan Blair Cance",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Regina, Saskatchewan, S4T 7T1, Canada|Saskatoon Cancer Centre, S7N 4H4," Canada""",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Pexidartinib,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2016-06,5/28/21,"Taipei, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Brain Neoplasms,DRUG: [18F] FLT,ALL,"CHILD, ADULT",PHASE2,50,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC,2010-10,2/5/23,"Children's Hospital, Boston, Boston, Massachusetts, 02115, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Prostate Cancer|Prostate Neoplasms|Neoplasms, Prostatic",BIOLOGICAL: PROSTVAC-V|BIOLOGICAL: PROSTVAC-F|DRUG: Docetaxel,MALE,"ADULT, OLDER_ADULT",PHASE2,74,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/19/16,12/5/23,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cancer|Solid Tumor,DRUG: RXC004|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1,46,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/18/19,9/29/23,"Royal Marsden Hospital, Institute of Cancer Research, Sutton, Surrey, SM2 5PT, United Kingdom|Guys Hospital, London, SE1 9RT, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|Sir Bobby Robson Cancer Trials Research Centre, Newcastle, NE77DN, United Kingdom|Department of Oncology, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Brain Neoplasms,DRUG: Tumor fluorescence,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,33,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2011-03,2021-02,"Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies",DRUG: TAK-164|DRUG: 89Zr-TAK-164,ALL,"ADULT, OLDER_ADULT",PHASE1,31,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER,4/23/18,2/27/20,"University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114-2621, United States|SCRI - Tennessee Oncology Nashville - Southern Hills Clinic, Nashville, Tennessee, 37205, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Urothelial Carcinoma|Urethral Neoplasms|Urinary Bladder Neoplasms|Kidney Neoplasms,DRUG: Cabozantinib,ALL,"ADULT, OLDER_ADULT",PHASE2,69,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/11/12,9/14/20,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Malignant Solid Neoplasm,PROCEDURE: Biopsy Procedure|PROCEDURE: Biospecimen Collection|PROCEDURE: Echocardiography Test|BIOLOGICAL: Pertuzumab|PROCEDURE: Radiologic Examination|BIOLOGICAL: Trastuzumab,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/23/17,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Malignant Liver Neoplasm,PROCEDURE: Ablation Therapy|PROCEDURE: Image-Guided Therapy|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,107,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/10/20,10/31/26,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Cancer|Neoplasms,DRUG: GSK2816126,ALL,"ADULT, OLDER_ADULT",PHASE1,41,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,4/24/14,6/20/17,"GSK Investigational Site, Chicago, Illinois, 60611, United States|GSK Investigational Site, New York, New York, 10021, United States|GSK Investigational Site, Villejuif, 94805, France|GSK Investigational Site, Sutton, Surrey, SM2 5PT, United Kingdom|GSK Investigational Site, Southampton, SO16 6YD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,BIOLOGICAL: FPT155|BIOLOGICAL: pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,80,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/18/18,8/10/21,"Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|St Vincent's Hospital Sydney, Darlinghurst, New South Wales, 2010, Australia|Scientia Clinical Research, Randwick, New South Wales, 2031, Australia|ICON, Auchenflower, Queensland, 4066, Australia|Olivia Newton-John Cancer Center, Heidelberg, Victoria, 3084, Australia|Cabrini Hospital, Malvern, Victoria, 3144, Australia|Linear Clinical Research, Nedlands, Western Australia, 6009, Australia|National Cancer Center, Goyang-si, Gyeonggi-do, 10408, South Korea|St Vincent Hospital of the Catholic University of Korea, Suwon, Gyeonggi-do, 16247, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital, Yonsei University Health System, Seoul, 03722, South Korea|Samsung Medical Center, Seoul, 06351, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Stromal Tumors,DRUG: DCC-2618|DRUG: Placebo Oral Tablet,ALL,"ADULT, OLDER_ADULT",PHASE3,129,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2/27/18,5/11/22,"HonorHealth, Scottsdale, Arizona, 85260, United States|University of Southern California - Norris, Los Angeles, California, 90033, United States|UCLA, Los Angeles, California, 90095, United States|Stanford, Stanford, California, 94305, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, 32224, United States|Georgia Cancer Specialists, Atlanta, Georgia, 30341, United States|University of Chicago, Chicago, Illinois, 60637, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Columbia, New York, New York, 10027, United States|MSKCC, New York, New York, 10065, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Alfred University, Melbourne, Australia|University Hospital Leuven, Leuven, Belgium|Cross Cancer Center, Edmonton, Alberta, Canada|Princess Margaret Hospital, Toronto, Canada|Helsinki University Central Hospital, Helsinki, Finland|Institut Bergonié, Bordeaux, France|Le Centre Léon Bérard, Lyon, France|Gustave-Roussy, Villejuif, France|Sarcoma Center Brandenburg, Brandenburg, Germany|University Hospital Essen, Essen, Germany|Universitätsmedizin Mannheim, Mannheim, Germany|Istituto Nazionale dei Tumori, Milan, Italy|Università Campus Bio-Medico di Roma, Rome, Italy|Leiden University Medical Center, Leiden, Netherlands|Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland|NCC, Singapore, 169610, Singapore|Vall d'Hebron, Barcelona, Spain|Hospitalario Universitario Virgen del Rocío, Seville, Spain|Royal Marsden, London, United Kingdom|University of Sheffield, Sheffield, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Lymphoma, Non-Hodgkin|Neoplasms",DRUG: CC-90011|DRUG: Rifampicin|DRUG: Itraconazole,ALL,"ADULT, OLDER_ADULT",PHASE1,75,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/31/16,3/25/24,"Local Institution - 101, Dijon, 21079, France|Local Institution - 102, Marseille, 13273, France|Local Institution - 100, Villejuif, 94805, France|Local Institution - 200, Bologna, 40123, Italy|Local Institution - 201, Milan, 20133, Italy|Local Institution - 202, Milan, 20141, Italy|Local Institution - 501, Chuo-ku, Tokyo, 104-0045, Japan|Local Institution - 502, Koto-Ku, Tokyo, 135-8550, Japan|Local Institution - 500, Kashiwa, 277-8577, Japan|Local Institution - 400, Barcelona, 08035, Spain|Local Institution - 402, Madrid, 28040, Spain|Local Institution - 404, Madrid, 28041, Spain|Local Institution - 401, Santander, 39008, Spain|Local Institution - 300, London, SW3 6JJ, United Kingdom|Local Institution - 301, Newcastle upon Tyne, NE7 7DN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Prostatic Neoplasms,"DRUG: Darolutamide (Nubeqa, BAY1841788)|DRUG: Placebo|OTHER: Androgen deprivation therapy (ADT)",MALE,"ADULT, OLDER_ADULT",PHASE3,669,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2/23/21,1/30/26,"Nepean Hospital, Kingswood, New South Wales, 2747, Australia|Northern Cancer Institute, St Leonards, New South Wales, 2065, Australia|Macquarie University Hospital - Oncology Department, Sydney, New South Wales, 2109, Australia|Cancer Research South Australia, Adelaide, South Australia, 5000, Australia|Peninsula Oncology Centre, Frankston, Victoria, 3199, Australia|Austin Health, Heidelberg, Victoria, 3084, Australia|Assistência Multidisciplinar em Oncologia (AMO), Salvador, Estado de Bahia, 41950-640, Brazil|Hosp. Araujo Jorge da Associação de Combate ao Câncer, Goiânia, Goiás, 74605-070, Brazil|Hospital da Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, 30130-100, Brazil|Cetus Oncologia Hospital Dia, Belo Horizonte, Minas Gerais, 30150-270, Brazil|Liga Paranaense de Combate ao Cancer-Hosp Erasto Gaertner, Curitiba, Paraná, 81520-060, Brazil|Liga Norte Riograndense Contra o Cancer | Centro de Pesquisa Clínica, Natal, Rio Grande do Norte, 59040-000, Brazil|Unidade de Pesquisas Clinicas em Oncologia, Pelotas, Rio Grande do Sul, 96020-080, Brazil|Santa Casa de Porto Alegre | Hospital Sao Francisco - Centro Medico Pesquisa Clinica Cardiologia, Porto Alegre, Rio Grande do Sul, 90020-090, Brazil|Hospital Mae de Deus, Porto Alegre, Rio Grande do Sul, 90850-170, Brazil|FZ Pesquisa e Servicos em Cardiologia | Porto Alegre, Brazil, Porto Alegre, Rio Grande do Sul, 91350-280, Brazil|Fundacao Pio XII - Hospital de Cancer de Barretos, Barretos/SP, São Paulo, 14784-400, Brazil|Hospital de Base | Funfarme - Centro Integrado de Pesquisa - Cardiologia, São José do Rio Preto, São Paulo, 15090-000, Brazil|Urobrasil, São Paulo, São Paulo, 01243-020, Brazil|IBCC - Instituto Brasileiro de Controle do Cancer, São Paulo, São Paulo, 03102-002, Brazil|Inst. de Assistência Médica ao Sérvidor Público Estadual, São Paulo, São Paulo, 04039-004, Brazil|Instituto COI de Educação e Pesquisa, Rio de Janeiro, 22793-080, Brazil|G. Kenneth Jansz Medicine Professional Corporation, Burlington, Ontario, L7N 3V2, Canada|Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM), Montreal, Quebec, H2X 0A9, Canada|Centro de Investigación Clínica del Sur, Temuco, Región de la Araucanía, 4781156, Chile|OncoCentro, Viña del Mar, Región de Valparaíso, 2520598, Chile|Centro de Estudios Clínicos SAGA SpA, Providencia, Santiago Metropolitan, 7500653, Chile|Fundación Arturo López Perez, Santiago, 7500921, Chile|Oncovida, Santiago, 7510032, Chile|Hospital Clínico de la Pontificia Univ. Católica de Chile, Santiago, TBC, Chile|UROMED, Santiago, Chile|Anhui Provincial Hospital, Hefei City, Anhui Province, Anhui, 230031, China|Beijing Hospital, Beijing, Beijing Municipality, 100730, China|Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510000, China|Guangzhou First People Hospital, Guangzhou, Guangdong, 510180, China|Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen, Guangdong, 518172, China|Tongji Hosp. of Tongji Med Coll, Huazhong Uni of Sci & Tech., Wuhan, Hubei, 430030, China|Zhongnan hospital ,Wuhan University, Wuhan, Hubei, 430071, China|Hubei Cancer Hospital, Wuhan, Hubei, 430079, China|Hunan Cancer Hospital - Oncology Department, Changsha, Hunan, 410013, China|NJ Drum Tower Hospital, the Affil Hos of NJ Univ Med School, Nanjing, Jiangsu, 210008, China|Nantong tumor hospital, Nantong, Jiangsu, 226361, China|The 2nd Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215004, China|1st Hospital of Jilin University, Changchun, Jilin, 130021, China|Liaoning Cancer Hospital and Institute, Shengyang, Liaoning, 110042, China|Yantai Yuhuangding Hospital, Yantai, Shandong, 264000, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, 710061, China|SichuanAcademyofMedicalSciences&SichuanProvincialPeople'sHos, Chengdu, Sichuan, 610072, China|Sichuan University West China Hospital, Chengdu, Sichuan, MISSING, China|The 1st Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310000, China|ZheJiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China|Ningbo First Hospital, Ningbo, Zhejiang, 315010, China|The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, China|Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100000, China|Peking University Third Hospital, Beijing, 100083, China|Beijing Cancer Hospital, Beijing, 100142, China|Mahatma Gandhi Cancer Hospital & Research Institute, Visakhapatnam, Andhra Pradesh, 530017, India|The Gujarat Cancer & Research Institute, Ahmedabad, Gujarat, 380016, India|HCG Cancer Centre - Ahmedabad, Ahmedabad, Gujarat, 380060, India|Cancer Care Clinic - Vadodara, Vadodara, Gujarat, 390007, India|K.L.E.S. Dr. Prabhakar Kore Hospital & Medical Research Centre, Belagavi, Karnataka, 590010, India|Healthcare Global Enterprises Ltd, Bengaluru, Karnataka, 560027, India|Amrita Institute of Medical Sciences, Kochi, Kerala, 682 041, India|Regional Cancer Centre - Thiruvananthapuram, Thiruvananthapuram, Kerala, 695011, India|Marathwada Regional Cancer Centre and Research Institute, Aurangabad, Maharashtra, 431001, India|Jaslok Hospital and Research Centre, Mumbai, Maharashtra, 400026, India|Curie Manavata Cancer Centre, Nashik, Maharashtra, 422004, India|Jehangir Hospital, Pune, Maharashtra, 411001, India|Sparsh Hospital & Critical Care, Bhubaneswar, Odisha, 751007, India|All India Institute of Medical Sciences, Bhubaneswar, Odisha, 751019, India|Jawaharlal Institute Of Postgraduate Medical Education and R, Gorimedu, Puducherry, 605006, India|Christian Medical Center & Hospital, Ludhiana, Punjab, 141008, India|Sawami Man Singh (SMS) Medical College & Attached Hospitals, Jaipur, Rajasthan, 302017, India|Apollo Speciality Hospitals, Madurai, Tamil Nadu, 625020, India|Meenakshi Mission Hospital & Research Centre, Madurai, Tamil Nadu, 625107, India|Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India|Tata Medical Center, Kolkata, 700156, India|Apex Wellness Hospital, Nashik, 422009, India|Rajiv Gandhi Cancer Institute & Research Centre, New Delhi, 110 085, India|Daugavpils Regional Hospital, Daugavpils, LV-5417, Latvia|RAKUS Hospital Gailezers, Riga, 1038, Latvia|URO Ltd., Riga, LV-1001, Latvia|P. Stradins Clinical University Hospital, Riga, LV-1002, Latvia|Vidzemes Hospital, Valmiera, LV-4201, Latvia|The Hospital of Lithuanian University of Health SciencesLUHS, Kaunas, LT-50009, Lithuania|PI Klaipedos University Hospital, Klaipėda, LT-92288, Lithuania|National Cancer Institute, Vilnius, LT-08660, Lithuania|Vilnius University Hospital Santaros Klinikos, Vilnius, LT-08661, Lithuania|Canterbury Urology Research Trust, Christchurch, Canterbury, 8013, New Zealand|Waikato Hospital, Hamilton, 3240, New Zealand|Tauranga Urology Research Limited, Tauranga, 3112, New Zealand|Aliada, San Isidro, Lima region, 15036, Peru|Hospital Guillermo Almenara Irigoyen, Santiago de Surco, Lima region, 15033, Peru|Hospital Militar Luis Arias Schreiber, Lima, LIMA 11, Peru|Clínica El Golf, Lima, LIMA 27, Peru|Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, 163045, Russia|Ltd ""EVIMED"", Chelyabinsk, 454048, Russia|Chelyabinsk Regional Oncology Dispensary, Chelyabinsk, 454087, Russia|Ivanovo Regional Oncology Dispensary, Ivanovo, 153040, Russia|Republican Clinical Oncology Dispensary Kazan, Kazan', 420029, Russia|Research Centre of X-ray and Radiology, Moscow, 117997, Russia|Volga District Med Center FMBA, Nizhny Novgorod, 603109, Russia|LLC Reafan, Novosibirsk, 630099, Russia|Medical Center ""Avicenna"", Novosibirsk, 630099, Russia|Clinical Oncological Dispensary of Omsk Region, Omsk, 644013, Russia|AV Medical Group, Saint Petersburg, 196006, Russia|Russian Scientific Radiology and Surgery Technologies Center, Saint Petersburg, 197758, Russia|Scientific Research Instutute of Oncology n.a. N.N. Petrov, Saint Petersburg, 197758, Russia|Multi-Field Clinical Medical Center ""Medical City"", Tyumen, 625041, Russia|Republican Clinical Oncology Dispensary, Ufa, 450054, Russia|Vologda Regional Hospital, Vologda, 160022, Russia|Sverdlovsk Regional Clinical Hospital #1, Yekaterinburg, 620102, Russia|Cancercare Langenhoven, Port Elizabeth, Eastern Cape, 6045, South Africa|East Rand Medical Research Unit, Johannesburg, Gauteng, 1475, South Africa|University of Pretoria, Clinical Research Unit, Pretoria, Gauteng, 2, South Africa|Cape Town Oncology Trials, Cape Town, 7570, South Africa|Parc Tauli Hospital Universitari - Oncologia, Sabadell, Barcelona, 08208, Spain|Hospital Universitario Fundacion Alcorcon - Urologia, Alcorcón, Madrid, 28922, Spain|Hospital Universitario Virgen De La Victoria - Urologia, Málaga, Málaga, 20910, Spain|Fundacio Puigvert - Urologia, Barcelona, 8025, Spain|Hospital San Pedro de Alcántara - Oncologia, Cáceres, 10003, Spain|Hospital Universitario Virgen Del Rocio S.L. - Urologia, Seville, 41013, Spain|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City, Kaohsiung, 807377, Taiwan|Changhua Christian Hospital, Changhua, 50006, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Cheng Kung University Hospital, Tainan, 704, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|CNE ""Clinical Center of Oncology, Hematology, Transplantology and Palliative Care of the Cherkasy Regional Council"", Cherkasy, 18009, Ukraine|City Dnipropetrovsk Multi- field Clinical Hosp. 4 DSMA, Dnipro, 49102, Ukraine|Kyiv City Hospital #3 - Department of Urology, Kyiv, 02660, Ukraine|Kyiv Regional Oncological Dispensary, Kyiv, 4107, Ukraine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: MK-4621,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,15,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/25/17,5/18/18,"Universitätsklinikum Carl Gustav Carus - Phase I Unit, Dresden, Germany|Universitätsklinikum Essen, Essen, Germany|National Center for Tumor Diseases, Heidelberg, Germany|START - Fundación Jiménez Díaz - Phase I Unit, Madrid, Spain|START - Hospital Universitario HM Sanchinarro - Phase I Unit, Madrid, Spain|University of Oxford Department of Oncology, Churchill Hospital, Oxford, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neoplasms, Pancreatic",DRUG: GSK3145095|DRUG: Pembrolizumab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Blood samples were to be collected at indicated timepoints for analysis of time invariance. Time invariance was to be calculated as AUC(0-tau) at Day 15 divided by AUC(0-infinity) at Day 1 for pembrolizumab., Day 1: pre-dose, 0.5 hour (within 30 minutes after end of infusion)," 24 hours after end of infusion; Day 15 (anytime during visit)""",PHASE2,8,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/16/18,8/13/19,"GSK Investigational Site, Indianapolis, Indiana, 46202, United States|GSK Investigational Site, New York, New York, 10016, United States|GSK Investigational Site, New York, New York, 10032, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19111, United States|GSK Investigational Site, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Non-small Cell Lung Cancer|EGFR-mutant Lung Cancers,DRUG: osimertinib|DRUG: Bevacizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,49,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/29/16,3/1/22,"Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering commack, Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, 11553, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors|Ovarian Cancer,DRUG: ALM201,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,20,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/27/15,3/13/17,"Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, County Antrim, BT9 7AB, United Kingdom|Dept Medical Oncology, The Christie NHS Foundation Trust, Manchester, Lancashire, M20 4BX, United Kingdom|Freeman Hospital, Northern Centre for Cancer Care, Sir Bobby Robson Cancer Trial research Centre, Newcastle, Northumberland, NE7 7DN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: MK-1088|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,27,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/7/22,9/7/23,"University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0103), Miami, Florida, 33136, United States|Laura and Isaac Perlmutter Cancer Center ( Site 0102), New York, New York, 10016, United States|South Texas Accelerated Research Therapeutics (START) ( Site 0101), San Antonio, Texas, 78229, United States|Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0201), Toronto, Ontario, M5G 2M9, Canada|Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Québec, Quebec, G1J 1Z4, Canada|Rigshospitalet ( Site 0500), Copenhagen, Capital Region, 2100, Denmark|Herlev and Gentofte Hospital ( Site 0501), Copenhagen, Capital Region, 2730, Denmark|Odense Universitetshospital ( Site 0502), Odense, Region Syddanmark, 5000, Denmark|Rambam Health Care Campus-Oncology Division ( Site 0300), Haifa, 3109601, Israel|Hadassah Medical Center ( Site 0302), Jerusalem, 9112001, Israel|Cantonal Hospital St.Gallen ( Site 0403), Sankt Gallen, Canton of St. Gallen, 9007, Switzerland|Ospedale Regionale Bellinzona e Valli ( Site 0400), Bellinzona, Canton Ticino, 6500, Switzerland|Kantonsspital Graubünden-Medizin ( Site 0402), Chur, Kanton Graubünden, 7000, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Malignant Solid Neoplasm|Recurrent Malignant Solid Neoplasm,BIOLOGICAL: Pembrolizumab|DRUG: Talabostat Mesylate,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,31,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/19/20,3/11/25,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: Debio 1347,ALL,"ADULT, OLDER_ADULT",PHASE2,63,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/22/19,1/4/22,"Ironwood Cancer & Research Centers - Scottsdale, Scottsdale, Arizona, 85260, United States|University of Arizona Cancer Center, Tucson, Arizona, 85721, United States|Moores UCSD Cancer Center, La Jolla, California, 92093, United States|University of California San Francisco, San Francisco, California, 94115, United States|Sarcoma Oncology Center, Santa Monica, California, 90403, United States|H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, 33612, United States|James Graham Brown Cancer Center, Louisville, Kentucky, 10202, United States|Tulane University Cancer Center, New Orleans, Louisiana, 70122, United States|The John Hopkins Hospital, Baltimore, Maryland, 21231, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Memorial Sloan Kettering Cancer Center, Middletown, New Jersey, 07748, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08901, United States|Memorial Sloan Kettering Cancer Center, Harrison, New York, 10604, United States|Memorial Sloan-Kettering Hospital, New York, New York, 10065, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599, United States|UC Health, LLC., Cincinnati, Ohio, 45229, United States|The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus, Ohio, 43210, United States|CTCA Cancer Treatment Centers, Tulsa, Oklahoma, 74133, United States|West Penn - Allegheny Oncology Network, Pittsburgh, Pennsylvania, 15224, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Utah Hospitals & Clinics, Salt Lake City, Utah, 84108, United States|Fred Hutchinson/Seattle Care Alliance, Seattle, Washington, 98109, United States|University of Wisconsin, Madison, Wisconsin, 53706, United States|Southern Highlands Private Hospital, Bowral, NSW 2576, Australia|Peninsula and Southeast Oncology (PASO), Frankston, 3199, Australia|Linear Clinical Research, B Block Sir Charles Gairdner Hospital, Nedlands, 6009, Australia|John Flynn Private Hospital, Tugun, 4224, Australia|LKH - Universitätsklinikum der PMU Salzburg, Salzburg, 5020, Austria|Landesklinikum Wiener Neustadt, Wiener Neustadt, 2700, Austria|Hospital de Caridade de Ijuí, Avenida David J Martins, Ijuí, 98700-000, Brazil|Hospital de Clínicas de Porto Alegre, Rio Grande, 90035-903, Brazil|CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia, Santo André, 09060-870, Brazil|ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira, Avenida Doutor Arnaldo, São Paulo, 01246-000, Brazil|MHAT - Dobrich, Dobrich, 9300, Bulgaria|Complex Oncological Center - Plovdiv, EOOD, Plovdiv, 4004, Bulgaria|MHAT ""Serdika"", EOOD, Sofia, 1632, Bulgaria|General Hospital Varazdin, Varaždin, 42000, Croatia|University Hospital Centre, Sestre Milosrdnice, Zagreb, 10000, Croatia|Fakultni nemocnice u sv. Anny v Brne, Brno, 656 91, Czechia|Fakultni nemocnice Hradec Kralove, Hradec Králové, 50005, Czechia|Fakultni nemocnice Olomouc, Olomouc, 775 20, Czechia|Fakultni nemocnice Kralovske Vinohrady, Prague, 100 34, Czechia|Thomayerova nemocnice, Prague, 14000, Czechia|Ålborg Universitets Hospital, Aalborg, 9100, Denmark|Herlev Hospital, Herlev, 2730, Denmark|Odense Universitetshospital, Odense, 5000, Denmark|Docrates Syöpäsairaala, Helsinki, 00180, Finland|Helsinki University Hospital, Helsinki, 00290, Finland|ICO - Site Paul Papin, Angers, 49055, France|CHU Bordeaux - Hôpital Saint André, Groupe Hospitalier Sud - Hôpital Haut-Lévêque, Bordeaux, 33075, France|Centre Oscar Lambret, Lille, 59020, France|Groupe Hospitalier Sud - Hôpital Haut Lévêque, Pessac, 33604, France|ICO - Site René Gauducheau, Saint-Herblain, 44805, France|Institut Gustave Roussy, Villejuif, 94805, France|General Hospital of Athens Laiko, Athens, 11527, Greece|General Hospital of Athens of Chest Diseases ""SOTIRIA"", Athens, 11527, Greece|General Hospital of Athens ""Alexandra"", Athens, 11528, Greece|University General Hospital of Ioannina, Ioannina, 45500, Greece|VU Medisch Centrum, Amsterdam, 1081 HV, Netherlands|Haga Ziekenhuis, The Hague, 2545 AA, Netherlands|Akershus University Hospital, Lørenskog, 1478, Norway|Radiumhospitalet, Montebello, Oslo, 0310, Norway|Cebu Doctors' University Hospital (CDUH), Research Office, Cebu City, 6000, Philippines|Philippine General Hospital, Clinical Trial Unit Room 5, Medical Research Laboratory, Ermita, 1000, Philippines|St. Luke's Medical Center, Human Cancer Biobank Research Center, Quezon City, 1112, Philippines|Szpital Kliniczny im.Heliodora Swiecickiego Uniwersytetu Medycznego im.K. Marcinkowskiego w Poznaniu, Poznan, 60-355, Poland|MTZ Clinical Research, Warsaw, 02-106, Poland|Centrum Onkologii-Instytut im.M.Sklodowskiej Curie, Warsaw, 02-781, Poland|S.C Delta Health Care S.R.L, Bucharest, 014142, Romania|S.C Medisprof S.R.L., Cluj-Napoca, 400641, Romania|S.C Centrul de Oncologie Sf. Nectarie S.R.L., Craiova, 200347, Romania|S.C Oncocenter Oncologie Clinica S.R.L., Timișoara, 300166, Romania|SBIH of Arkhangelsk region ""Arkhangelsk Clinical Oncological Dispensary"", Arkhangelsk, 163045, Russia|TSBHI ""Altai Territorial oncological dispensary"", Barnaul, 656049, Russia|LLC Evimed, Chelyabinsk, 454048, Russia|FSBSI ""Russian Oncological Scientific Center n.a. N.N. Blokhin"", Moscow, 115478, Russia|BHI of Omsk region ""Clinical Oncology Dispensary"", Omsk, 644013, Russia|Tomsk Research Instutite of Oncology, Tomsk, 634028, Russia|Singapore National Cancer Center (SNCC), Singapore, 169610, Singapore|Tan Tock Seng Hospital, Communicable Disease Centre, Singapore, 308440, Singapore|Seoul National University Bundang Hospital, Department of Oncology Medical office, Gyeonggi-do, 13605, South Korea|The Catholic University of Korea, St. Vincent's Hospital, CRC Room, 3F, Gyeonggi-do, South Korea|Gachon University Gil Medical Center, CRC Room, 18F, Artificial intelligence hospital, Incheon, 21565, South Korea|Korea University Anam Hospital, Seoul, 02841, South Korea|Seoul National University Hospital (SNUH), Seoul, 03080, South Korea|Ajou University Hospital, CRC room, Clinical Trial Center, Suwon, 16499, South Korea|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Centro Integral Oncologico Clara Campal, Madrid, 28050, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Shuang Ho Hospital, New Taipei City, 23561, Taiwan|Taichung Veterans General Hospital, The Radiation Oncology Department, Taichung, 40705, Taiwan|National Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei, 10048, Taiwan|Taipei Medical University Hospital (TMUH), Taipei, 11031, Taiwan|Taipei Veterans General Hospital, Medical Science & Technology Building, Taipei, 11217, Taiwan|Linkou Chang-Gung Memorial Hospital, Taoyuan District, 33305, Taiwan|CI Dnipropetrovsk CMCH #4 of Dnipropetrovsk RC Dept of Chemotherapy SI Dnipropetrovsk MA of MOHU, Dnipro, 49102, Ukraine|SI V.T. Zaycev Institute of general & urgent surgery of National academy medical sciences of Ukraine, Department of purulent surgery, Kharkiv, 61018, Ukraine|Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv, 61070, Ukraine|Ninewells Hospital, Dundee, DD1 9SY, United Kingdom|Guy's Hospital, London, SE1 9RY, United Kingdom|Hammersmith Hospital, London, W12 0HS, United Kingdom|The Christie, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Stromal Tumors,DRUG: nilotinib,ALL,"ADULT, OLDER_ADULT",PHASE2,15,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/25/13,10/2/23,"Novartis Investigative Site, Nagoya, Aichi-ken, 464 8681, Japan|Novartis Investigative Site, Kashiwa, Chiba, 277 8577, Japan|Novartis Investigative Site, Gifu, Gifu, 501-1194, Japan|Novartis Investigative Site, Sapporo, Hokkaido, 060 8648, Japan|Novartis Investigative Site, Yokohama, Kanagawa, 241-8515, Japan|Novartis Investigative Site, Kumamoto, Kumamoto, 860-8556, Japan|Novartis Investigative Site, Sendai, Miyagi, 980 8574, Japan|Novartis Investigative Site, Kurashiki, Okayama-ken, 701-0192, Japan|Novartis Investigative Site, Osaka, Osaka, 540-0006, Japan|Novartis Investigative Site, Suita, Osaka, 565 0871, Japan|Novartis Investigative Site, Chuo Ku, Tokyo, 104 0045, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neoplasms, Advanced",BIOLOGICAL: MK-1966|DRUG: SD-101,ALL,"ADULT, OLDER_ADULT",PHASE1,14,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/22/16,1/8/18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Lurbinectedin alone|DRUG: Lurbinectedin+Itraconazole co-administration,ALL,"ADULT, OLDER_ADULT",PHASE1,14,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,10/7/20,4/21/22,"Fundacion Jimenez Diaz, Madrid, 28040, Spain|Hospital HM Sanchinarro, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: Niraparib,MALE,"ADULT, OLDER_ADULT",PHASE2,289,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/31/16,8/16/23,"Tucson, Arizona, United States|Los Angeles, California, United States|Riverside, California, United States|Sacramento, California, United States|Aurora, Colorado, United States|Denver, Colorado, United States|Evanston, Illinois, United States|Danville, Kentucky, United States|Louisville, Kentucky, United States|New Orleans, Louisiana, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Omaha, Nebraska, United States|New York, New York, United States|Durham, North Carolina, United States|Lancaster, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Myrtle Beach, South Carolina, United States|Houston, Texas, United States|Charlottesville, Virginia, United States|Fairfax, Virginia, United States|Seattle, Washington, United States|Madison, Wisconsin, United States|Camperdown, Australia|Darlinghurst, Australia|East Albury, Australia|Kurralta Park, Australia|Macquarie University, Australia|Melbourne, Australia|Murdoch, Australia|Port Macquarie, Australia|Randwick, Australia|Wahroonga, Australia|Aalst, Belgium|Brussels, Belgium|Charleroi, Belgium|Ghent, Belgium|Haine-Saint-Paul, Belgium|Hasselt, Belgium|Kortrijk, Belgium|Liège, Belgium|Namur, Belgium|Ottignies, Belgium|Wilrijk, Belgium|Barretos, Brazil|Belo Horizonte, Brazil|Curitiba, Brazil|Fortaleza, Brazil|Ijuí, Brazil|Itajaí, Brazil|Joinville, Brazil|Natal, Brazil|Salvador, Brazil|São Paulo, Brazil|Vancouver, British Columbia, Canada|Oshawa, Ontario, Canada|Toronto, Ontario, Canada|Montreal, Quebec, Canada|Québec, Quebec, Canada|Aarhus N, Denmark|Copenhagen N, Denmark|Herlev, Denmark|Odense C, Denmark|Avignon, France|Besançon, France|Caen, France|Lyon, France|Nice, France|Paris, France|Reims, France|Strasbourg, France|Villejuif, France|Beersheba, Israel|Haifa, Israel|Kfar Saba, Israel|Ramat Gan, Israel|Zrifin, Israel|Alkmaar, Netherlands|Amsterdam, Netherlands|Groningen, Netherlands|Maastricht, Netherlands|Rotterdam, Netherlands|Moscow, Russia|Omsk, Russia|Tomsk, Russia|Seoul, South Korea|Barcelona, Spain|Córdoba, Spain|Madrid, Spain|Málaga, Spain|Pozuelo de Alarcón, Spain|Santander, Spain|Santiago de Compostela, Spain|Seville, Spain|Valencia, Spain|Gothenburg, Sweden|Lund, Sweden|Stockholm, Sweden|Umeå, Sweden|Kaohsiung City, Taiwan|Taichung, Taiwan|Tainan, Taiwan|Taipei, Taiwan|Taoyuan, Taiwan|Blackburn, United Kingdom|Bristol, United Kingdom|Cardiff, United Kingdom|Exeter, United Kingdom|London, United Kingdom|Preston, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Progressive Desmoids Tumors,DRUG: PAZOPANIB treatment|DRUG: Active Comparator: Vinblastine and Methotrexate,ALL,"ADULT, OLDER_ADULT",PHASE2,72,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,9/18/12,2019-09,"Institut Bergonié, Bordeaux, Aquitaine, 33000, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Solid Tumors, KRAS Mutation",DRUG: BI 3011441,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/15/21,10/20/22,"National Cancer Center Hospital East, Chiba, Kashiwa, 277-8577, Japan|National Cancer Center Hospital, Tokyo, Chuo-ku, 104-0045, Japan|Japanese Foundation for Cancer Research, Tokyo, Koto-ku, 135-8550, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Non CNS Tumors,DRUG: Talimogene Laherparepvec,ALL,"CHILD, ADULT",PHASE1,15,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/16/17,11/29/22,"AI Dupont Hospital for Children, Wilmington, Delaware, 19803, United States|Nemours du Pont Hospital in Florida, Jacksonville, Florida, 32207, United States|Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Childrens Hospital of Michigan, Detroit, Michigan, 48201, United States|Columbia University Medical Center, New York, New York, 10032, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Nationwide Childrens Hospital, Columbus, Ohio, 43205, United States|Childrens Hospital of Philidelphia, Philadelphia, Pennsylvania, 19104, United States|Universitair Ziekenhuis Gent, Ghent, 9000, Belgium|Centre Hospitalier Universitaire Sainte Justine, Montreal, Quebec, H3T 1C5, Canada|Institut Hematologie et Oncologie Pediatrique, Lyon, 69373, France|Centre Hospitalier Universitaire de Marseille - Hopital de la Timone, Marseille, 13385, France|Institut Curie, Paris, 75005, France|IRCCS Ospedale Pediatrico Bambino, Roma, 00165, Italy|Hospital Universitario Virgen del Rocio, Seville, Andalusia, 41013, Spain|Hospital Universitari Vall d Hebron, Barcelona, Catalonia, 08035, Spain|Hospital Sant Joan de Deu, Esplugues de Llobregat, Catalonia, 08950, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Valencia, 46026, Spain|Hospital Universitario Infantil Niño Jesus, Madrid, 28009, Spain|Universitaets-Kinderspital beider Basel, Basel, 4031, Switzerland|Universitaets-Kinderspital, Zurich, 8032, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Oropharyngeal Neoplasms,RADIATION: Intensity-modulated radiation therapy (IMRT)|DRUG: Cisplatin,ALL,"ADULT, OLDER_ADULT",PHASE3,42,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/10/13,10/18/19,"Mayo Clinic Scottsdale, Scottsdale, Arizona, 85259-5499, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: PF-05082566|DRUG: MK-3475,ALL,"ADULT, OLDER_ADULT",PHASE1,23,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,2014-08,2017-02,"Research Administration Office, Los Angeles, California, 90095, United States|Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles, California, 90095, United States|UCLA Hematology-Oncology Clinic, Los Angeles, California, 90095, United States|UCLA Oncology Center, Los Angeles, California, 90095, United States|Smilow Cancer Center at Yale-New Haven Hospital, New Haven, Connecticut, 06510, United States|Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, 06510, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, 78229, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: LY3415244,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/22/18,10/9/19,"Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Institut Jules Bordet, Brussels, 1000, Belgium|Universitair Ziekenhuis Gent, Ghent, 9000, Belgium|National Cancer Center Hospital East, Kashiwa, Chiba, 277 8577, Japan|National Cancer Center Hospital, Chuo-Ku, Tokyo, 104-0045, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Childhood Solid Neoplasm|Recurrent Malignant Solid Neoplasm|Recurrent Primary Central Nervous System Neoplasm|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm,OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacokinetic (PK) study|DRUG: Prexasertib,ALL,"CHILD, ADULT",PHASE1,30,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/27/17,3/31/21,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Phoenix Childrens Hospital, Phoenix, Arizona, 85016, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, 30322, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Neoplasms,DRUG: Enasidenib,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Plasma enasidenib was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6, Plasma enasidenib was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6,8, and 24 hours post-dose.|Phase 2: Apparent Terminal Phase Half-life (t1/2) of Enasidenib After Single and Multiple Oral Doses, Plasma enasidenib was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6,8, and 24 hours post-dose.|Phase 1: AUC From Time Zero to 8 Hours Postdose (AUC0-8) of AGI-16903 After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to hour 8 post-dose (AUC 0-8) was calculated using the linear trapezoidal rule., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6, and 8 hours post-dose.|Phase 1: AUC From Time Zero to 10 Hours Postdose (AUC0-10) of AGI-16903 After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 10 hours post-dose (AUC0-10) was calculated using the linear trapezoidal rule., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 1: AUC From Time Zero to 24 Hours Postdose (AUC0-24) of AGI-16903 After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 24 hours post-dose (AUC0-24) was calculated using the linear trapezoidal rule., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8,10, and 24 hours post-dose.|Phase 1: AUC From Time Zero to 72 Hours Postdose (AUC0-72) of AGI-16903 After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 72 hours post-dose (AUC0-72) was calculated using the linear trapezoidal rule., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose.|Phase 1: AUC From Time Zero to the Last Quantifiable Concentration (AUC0-t) of AGI-16903 After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to the time of the last quantifiable concentration (AUC0-t) was calculated using the linear trapezoidal rule., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose.|Phase 1: Maximum Concentration of AGI-16903 After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose.|Phase 1: Time to Maximum Concentration (Tmax) of AGI-16903 After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose.|Phase 1: Apparent Terminal Phase Half-life (t½) of AGI-16903 After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. t1/2 was not calculated when the terminal elimination rate constant (λz) was not estimable., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose.|Phase 1: AUC From Time Zero to 8 Hours Postdose (AUC0-8) of AGI-16903 After Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 8 hours post-dose (AUC0-8) was calculated using the linear trapezoidal rule., Cycle 2 Day 1 at predose and 0.5,1,2,3,4,6, and 8 hours post-dose.|Phase 1: AUC From Time Zero to 10 Hours Postdose (AUC0-10) of AGI-16903 After Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 10 hours post-dose (AUC0-10) was calculated using the linear trapezoidal rule., Cycle 2 Day 1 at predose and 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 1: AUC From Time Zero to the Last Quantifiable Concentration (AUC0-t) of AGI-16903 After Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to the last quantifiable concentration (AUC0-t) was calculated using the linear trapezoidal rule., Cycle 2 Day 1 at predose and 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 1: Maximum Concentration (Cmax) of AGI-16903 After Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Cycle 2 Day 1 at predose and 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 1: Time to Maximum Concentration (Tmax) of AGI-16903 After Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Cycle 2 Day 1 at predose and 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 2: AUC From Time Zero to 8 Hours Postdose (AUC0-8) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 8 hours post-dose (AUC0-8) was calculated using the linear trapezoidal rule., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6, and 8 hours post-dose.|Phase 2: AUC From Time Zero to 24 Hours Postdose (AUC0-24) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 24 hours post-dose (AUC0-24) was calculated using the linear trapezoidal rule., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6,8, and 24 hours post-dose.|Phase 2: AUC From Time Zero to the Last Quantifiable Concentration (AUC0-t) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to the last quantifiable concentration (AUC0-t) was calculated using the linear trapezoidal rule., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6,8, and 24 hours post-dose.|Phase 2: Maximum Concentration (Cmax) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6,8, and 24 hours post-dose.|Phase 2: Time to Maximum Concentration (Tmax) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6,8, and 24 hours post-dose.|Phase 2: Apparent Terminal Phase Half-life (t1/2) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib, AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Cycle 1 Day 1 and Cycle 2 Day 1 at predose and 2,4,6,8, and 24 hours post-dose.|Phase 1 and 2: AUC From Time Zero to 8 Hours Postdose (AUC0-8) After Single and Multiple Oral Doses of Enasidenib 100 mg QD, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3) for single dose PK analysis, and underwent PK assessments on Cycle 2, Day 1 for multiple dose (steady-state) PK analysis. Participants in Phase 2 underwent PK assessments on Cycle 1, Day 1 for single dose analysis and on Cycle 2, Day 1 for multiple dose (steady-state) analysis. Plasma enasidenib was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 8 hours post-dose (AUC0-8) was calculated using the linear trapezoidal rule., Day -3 (Phase 1 only) predose and at 0.5,1,2,3,4,6, and 8 hours post-dose or Cycle 1 Day 1 (Phase 2) and Cycle 2 Day 1 (Phase 1 & 2) at predose and 2,4,6, and 8 hours post-dose.|Phase 1 and 2: AUC From Time Zero to 24 Hours Postdose (AUC0-24) After Single and Multiple Oral Doses of Enasidenib 100 mg QD, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3) for single dose PK analysis, and underwent PK assessments on Cycle 2, Day 1 for multiple dose (steady-state) PK analysis. Participants in Phase 2 underwent PK assessments on Cycle 1, Day 1 for single dose analysis and on Cycle 2, Day 1 for multiple dose (steady-state) analysis. Plasma enasidenib was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 24 hours post-dose (AUC0-24) was calculated using the linear trapezoidal rule., Day -3 (Phase 1 only) predose and at 0.5,1,2,3,4,6,8,10, and 24 hours post-dose or Cycle 1 Day 1 (Phase 2) and Cycle 2 Day 1 (Phase 1 & 2) at predose and 2,4,6,8, and 24 hours post-dose.|Phase 1 and 2: Maximum Concentration (Cmax) After Single and Multiple Oral Doses of Enasidenib 100 mg QD, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3) for single dose PK analysis, and underwent PK assessments on Cycle 2, Day 1 for multiple dose (steady-state) PK analysis. Participants in Phase 2 underwent PK assessments on Cycle 1, Day 1 for single dose analysis and on Cycle 2, Day 1 for multiple dose (steady-state) analysis. Plasma enasidenib was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Day -3 (Phase 1 only) predose and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose or Cycle 1 Day 1 (Phase 2) and Cycle 2 Day 1 (Phase 1 & 2) at predose and 2,4,6,8, and 24 hours post-dose.|Phase 1 and 2: Time to Maximum Concentration (Tmax) After Single and Multiple Oral Doses of Enasidenib 100 mg QD, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3) for single dose PK analysis, and underwent PK assessments on Cycle 2, Day 1 for multiple dose (steady-state) PK analysis. Participants in Phase 2 underwent PK assessments on Cycle 1, Day 1 for single dose analysis and on Cycle 2, Day 1 for multiple dose (steady-state) analysis. Plasma enasidenib was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Day -3 (Phase 1 only) predose and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose or Cycle 1 Day 1 (Phase 2) and Cycle 2 Day 1 (Phase 1 & 2) at predose and 2,4,6,8, and 24 hours post-dose.|Phase 1 and 2: AUC From Time Zero to 8 Hours Postdose (AUC0-8) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib 100 mg QD, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3) for single dose PK analysis, and underwent PK assessments on Cycle 2, Day 1 for multiple dose (steady-state) PK analysis. Participants in Phase 2 underwent PK assessments on Cycle 1, Day 1 for single dose analysis and on Cycle 2, Day 1 for multiple dose (steady-state) analysis. AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 8 hours post-dose (AUC0-8) was calculated using the linear trapezoidal rule., Day -3 (Phase 1 only) predose and at 0.5,1,2,3,4,6, and 8 hours post-dose or Cycle 1 Day 1 (Phase 2) and Cycle 2 Day 1 (Phase 1 & 2) at predose and 2,4,6, and 8 hours post-dose.|Phase 1 and 2: AUC From Time Zero to 24 Hours Postdose (AUC0-24) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib 100 mg QD, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3) for single dose PK analysis, and underwent PK assessments on Cycle 2, Day 1 for multiple dose (steady-state) PK analysis. Participants in Phase 2 underwent PK assessments on Cycle 1, Day 1 for single dose analysis and on Cycle 2, Day 1 for multiple dose (steady-state) analysis. AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL. Area under the plasma concentration-time curve from time 0 to 24 hours post-dose (AUC0-24) was calculated using the linear trapezoidal rule., Day -3 (Phase 1 only) predose and at 0.5,1,2,3,4,6,8,10, and 24 hours post-dose or Cycle 1 Day 1 (Phase 2) and Cycle 2 Day 1 (Phase 1 & 2) at predose and 2,4,6,8, and 24 hours post-dose.|Phase 1 and 2: Maximum Concentration (Cmax) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib 100 mg QD, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3) for single dose PK analysis, and underwent PK assessments on Cycle 2, Day 1 for multiple dose (steady-state) PK analysis. Participants in Phase 2 underwent PK assessments on Cycle 1, Day 1 for single dose analysis and on Cycle 2, Day 1 for multiple dose (steady-state) analysis. AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Day -3 (Phase 1 only) predose and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose or Cycle 1 Day 1 (Phase 2) and Cycle 2 Day 1 (Phase 1 & 2) at predose and 2,4,6,8, and 24 hours post-dose.|Phase 1 and 2: Time to Maximum Concentration (Tmax) of AGI-16903 After Single and Multiple Oral Doses of Enasidenib 100 mg QD, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3) for single dose PK analysis, and underwent PK assessments on Cycle 2, Day 1 for multiple dose (steady-state) PK analysis. Participants in Phase 2 underwent PK assessments on Cycle 1, Day 1 for single dose analysis and on Cycle 2, Day 1 for multiple dose (steady-state) analysis. AGI-16903 is a primary metabolite of enasidenib. Plasma AGI-16903 was measured using validated liquid chromatography-mass spectrometry methods (LC-MS/MS). The lower limit of quantification (LLOQ) in plasma was 1.00 ng/mL., Day -3 (Phase 1 only) predose and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose or Cycle 1 Day 1 (Phase 2) and Cycle 2 Day 1 (Phase 1 & 2) at predose and 2,4,6,8, and 24 hours post-dose.|Phase 1: Percent Change From Baseline for Area Under the Effect Concentration Time Curve From Time 0 to 10 Hours Postdose (%BAUEC0-10) of 2-hydroxyglutarate (2-HG) on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). Plasma 2-HG was measured using qualified LC-MS/MS in order to characterize the pharmacodynamic (PD) effects of enasidenib; the LLOQ was 30.0 ng/mL. Area under the effect concentration time curve from time point zero (predose) up to 10 hours postdose (AUEC0-10) was calculated using the linear trapezoid rule. Percent change from Baseline for AUEC0-10 was calculated as (AUEC0-10 minus \[Baseline\*Tlast\]) / (Baseline\*Tlast) \* 100, where Tlast corresponded to 10 hours and Baseline was equal to the average of the Screening and Day -3 (predose) 2-HG values. Data reported are the arithmetic mean and relative standard deviation expressed as a percentage., Screening visit, Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 1: Minimum Percent Change From Baseline Response Value Post-dose Over 10 Hours (%BRmin) for 2-HG After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). Plasma 2-HG was measured using qualified LC-MS/MS in order to characterize the pharmacodynamic (PD) effects of enasidenib; the LLOQ was 30.0 ng/mL. Minimum percent change from Baseline response value post-dose over 10 hours was calculated as: (minimum observed concentration post-dose over 10 hours \[Rmin\] - Baseline) / Baseline \* 100. Baseline was equal to the average of the Screening and Day -3 (predose) 2-HG values. Data reported are the arithmetic mean and relative standard deviation expressed as a percentage., Screening visit, Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 1: Time of Minimum Observed Concentration Over 72 Hours Postdose (Tmin) of 2-HG After a Single Oral Dose of Enasidenib on Day -3, The first 3 participants enrolled in each cohort of the dose escalation phase and the first 15 participants enrolled in each arm of Phase 1 Expansion received a single dose of enasidenib three days prior to starting the 28-day dosing regimen (Day -3). Plasma 2-HG was measured using qualified LC-MS/MS, the LLOQ was 30.0 ng/mL., Day -3 prior to the single dose of enasidenib and at 0.5,1,2,3,4,6,8,10,24,48, and 72 hours post-dose.|Phase 1: Percent Change From Baseline for Area Under the Effect Concentration Time Curve From Time 0 to 10 Hours Postdose of 2-HG After Multiple Oral Doses of Enasidenib, Plasma 2-HG was measured using qualified LC-MS/MS, the LLOQ was 30.0 ng/mL. Area under the effect concentration time curve from time point zero (predose) up to 10 hours postdose (AUEC0-10) was calculated using the linear trapezoid rule. Percent change from baseline for AUEC0-10 was calculated as: (AUEC0-10 minus \[Baseline\*Tlast\]) / (Baseline\*Tlast) \* 100, where Tlast corresponded to 10 hours and Baseline was equal to the average of the Screening and Day -3 (predose) 2-HG values. Data reported are the arithmetic mean and relative standard deviation expressed as a percentage., Cycle 1, Day 15 and Cycle 2, Day 1 at predose and 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 1: Minimum Percent Change From Baseline Response Value Post-dose Over 10 Hours (%BRmin) for 2-HG After Multiple Oral Doses of Enasidenib, Plasma 2-HG was measured using qualified LC-MS/MS, the LLOQ was 30.0 ng/mL. Minimum percent change from Baseline response value post-dose over 10 hours was calculated as: (minimum observed concentration post-dose over 10 hours \[Rmin\] - Baseline) / Baseline \* 100. Baseline was equal to the average of the Screening and Day -3 (predose) 2-HG values. Data reported are the arithmetic mean and relative standard deviation expressed as a percentage., Cycle 1, Day 15 and Cycle 2, Day 1 at predose and 0.5,1,2,3,4,6,8, and 10 hours post-dose.|Phase 1: Time of Minimum Observed Concentration Over 10 Hours Postdose (Tmin) of 2-HG After Multiple Oral Doses of Enasidenib, Plasma 2-HG was measured using qualified LC-MS/MS, the LLOQ was 30.0 ng/mL., Cycle 1, Day 15 and Cycle 2, Day 1 at predose and 0.5,1,2,3,4,6,8," and 10 hours post-dose.""",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,345,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/27/13,10/31/23,"City Of Hope, Duarte, California, 91010-301, United States|Stanford Cancer Center, Stanford, California, 94305, United States|University Of Colorado Cancer Center, Aurora, Colorado, 80045, United States|University of Miami Sylvester Cancer Center, Miami, Florida, 33136, United States|Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Northwestern University, Chicago, Illinois, 60611-3008, United States|Massachusetts General Hospital, Boston, Massachusetts, 02117, United States|Dana-Farber/Mass General Brigham Cancer Care, Inc, Boston, Massachusetts, 02215, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Washington University, St Louis, Missouri, 63110, United States|Cornell University Weill Medical College, New York, New York, 10065, United States|Memorial Sloan-Kettering Cancer Center - NYC, New York, New York, 10065, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Ohio State University, Gahanna, Ohio, 43230, United States|Oregon Health and Science University OHSU, Portland, Oregon, 97239, United States|Sarah Cannon Research Institute Drug Development Unit, Nashville, Tennessee, 37203, United States|Ut Southwestern Medical Center At Dallas, Dallas, Texas, 75390-85520, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Local Institution - 202, Bordeaux, 33076, France|Local Institution - 204, Paris, 75010, France|Local Institution - 203, Pessac, 33604, France|Local Institution - 205, Toulouse, 31059, France|Local Institution - 201, Villejuif, 94805, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Transitional Cell Carcinoma of Bladder|Urethra Cancer|Ureter Cancer|Malignant Tumor of Renal Pelvis,DRUG: Cisplatin|DRUG: Gemcitabine|BIOLOGICAL: ALT-801,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,68,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/6/11,4/11/16,"The University of Arizona Cancer Center, Tucson, Arizona, 85724, United States|UF Health Center at Orlando Health, Orlando, Florida, 32806, United States|Martin Health System, Stuart, Florida, 34994, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States|Emory University, Atlanta, Georgia, 30322, United States|Robert Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, 60611, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States|University of Kansas Cancer Center, Fairway, Kansas, 66205, United States|Karmanos Cancer Center, Detroit, Michigan, 48201, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Washington University, St Louis, Missouri, 63110, United States|Levine Cancer Institute, Charlotte, North Carolina, 28203, United States|University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, United States|St. Luke's Hospital and Health Network, Easton, Pennsylvania, 18045, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|UPMC Cancer Center, Pittsburgh, Pennsylvania, 15232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Anus Neoplasms,RADIATION: Proton therapy|DRUG: Chemotherapy,ALL,"ADULT, OLDER_ADULT",PHASE2,14,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/4/17,7/1/25,"UC Health, Cincinnati, Ohio, 45044, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: GS-3583|DRUG: Zimberelimab|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: 5-Fluorouracil|DRUG: Docetaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,13,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/25/21,11/7/22,"START Midwest, Grand Rapids, Michigan, 49546, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|NEXT oncology, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors|Lymphoma,DRUG: LMP744|OTHER: Ondansetron|OTHER: Olanzapine|OTHER: Lorazepam|OTHER: Diphenoxylate hydrocholoride (HCL) + Atropine Sulfate|OTHER: Loperamide|OTHER: Diphenhydramine|OTHER: Steroid|OTHER: Epinephrine,ALL,"ADULT, OLDER_ADULT",PHASE1,36,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/27/17,10/12/23,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, 15260, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: Nivolumab|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE2,4,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/11/19,2/9/22,"Columbia University Medical Center, New York, New York, 10032, United States|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada|Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, L8V 5C2, Canada|Ottawa Hospital Research Institute, Ottawa, Ontario, K1H 8L6, Canada|University Health Network, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pancreatic Neoplasms,DRUG: nab-Paclitaxel|DRUG: Gemcitabine|DRUG: Chemoradiation|DRUG: Capecitabine|PROCEDURE: Surgery,ALL,"ADULT, OLDER_ADULT",PHASE2,107,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/21/15,4/26/18,"Mayo Clinic - Arizona, Scottsdale, Arizona, 85259, United States|UC Davis Cancer Center, Sacramento, California, 95817, United States|Scripps Clinic Torrey Pines, San Diego, California, 92037, United States|Smilow Cancer Hospital At Yale-New Haven, New Haven, Connecticut, 06510, United States|Georgetown University Medical Center Lombardi Cancer Center, Washington D.C., District of Columbia, 20007, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|Piedmont Cancer Institute PC, Atlanta, Georgia, 30318, United States|Cancer Treatment Centers of America - Southeastern Regional Medical Center, Newnan, Georgia, 30265, United States|ME Center for Cancer Medicine, Scarborough, Maine, 04074, United States|Tufts - New England Medical Center, Boston, Massachusetts, 02111, United States|University of Massachusetts, Worcester, Massachusetts, 01655, United States|Saint Joseph Mercy Ann Arbor Hospital, Ann Arbor, Michigan, 48106, United States|Karmanos Cancer Center Wayne State University, Detroit, Michigan, 48201, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|Regional Cancer Care Associates LLC, Morristown, New Jersey, 07962, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Clinical Research Alliance, Lake Success, New York, 11042, United States|State University of New York Upstate Medical Center, Syracuse, New York, 13215, United States|Montefiore Einstein Cancer Center, The Bronx, New York, 10461, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|Mark H Zangmeister Center, Columbus, Ohio, 43219, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232-5505, United States|Houston Methodist Cancer Center, Houston, Texas, 77030, United States|Tom Baker Cancer Center, Calgary, Alberta, T2N 4N2, Canada|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, V5Z 4E6, Canada|CHUM Hôpital Saint-Luc, Montreal, Quebec, H2L 4M1, Canada|McGill University, Montreal, Quebec, H2W 1S6, Canada|Centre Regional de lutte contre le cancer Paul Papin, Angers, 49933, France|CHRU Besancon, Besançon, 25000, France|Centre Hospitalier Belfort Montbeliard, Besançon, France|Hopital Beaujon, Clichy, France|Hopital Saint Antoine, Paris, 75012, France|Hopital Haut Leveque, Pessac, 33604, France|Ospedale Sacro Cuore di Gesu FatebeneFratelli, Benevento, 82100, Italy|Azienda Ospedaliera Universitaria San Martino, Genova, 16132, Italy|Policlinico Universitario Campus Biomedico Di Roma, Roma, 128, Italy|Hospital Universitario a Coruna, A Coruña, 15006, Spain|ICO-Hospital Germans Trias i Pujol, Barcelona, 08916, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario Marques de Valdecilla, Santander, 39008, Spain|Hospital Miguel Servet, Zaragoza, 50009, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: ARRY-382|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,82,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/1/16,10/24/19,"Ronald Reagan UCLA Medical Center, Los Angeles, California, 90095, United States|UCLA Hematology/Oncology, Los Angeles, California, 90095, United States|UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, 90404, United States|University of Colorado Denver, Aurora, Colorado, 80045, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|Hem-Onc Associates of Treasure Coast, Port Saint Lucie, Florida, 34952, United States|Parkview Cancer Institute, Fort Wayne, Indiana, 46845, United States|Parkview Regional Medical Center, Fort Wayne, Indiana, 46845, United States|Parkview Research Center, Fort Wayne, Indiana, 46845, United States|PPG, Fort Wayne, Indiana, 46845, United States|Horizon Oncology Research, Inc., Lafayette, Indiana, 47905, United States|Hall-Perrine Cancer Center Laboratory, Cedar Rapids, Iowa, 52403, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Mayo Clinic Labs - Rochester Superior, Rochester, Minnesota, 55901, United States|Regions Cancer Care Center, Saint Paul, Minnesota, 55101, United States|Regions Hospital Pharmacy, Saint Paul, Minnesota, 55101, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|HealthPartners Neurosciences Center, Saint Paul, Minnesota, 55130, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|UT Health Cancer Center, San Antonio, Texas, 78229, United States|UTAH Cancer Specialists, Salt Lake City, Utah, 84106, United States|ARUP Laboratories, Inc., Salt Lake City, Utah, 84108-1221, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22903, United States|UVA Health System, Charlottesville, Virginia, 22908, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Stromal Tumors,DRUG: Avapritinib,ALL,"ADULT, OLDER_ADULT",PHASE4,2,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/21/21,11/23/23,"Gustave Roussy Cancer Campus Grand Paris Institut de Cancerologie Gustave-Roussy, Villejuif, Val-de-Marne, 94800, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Prostatic Neoplasms,DRUG: 177Lu-PSMA-617|DRUG: 68Ga-PSMA-11|DRUG: ARDT,MALE,"ADULT, OLDER_ADULT",PHASE3,469,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/15/21,9/30/26,"Rocky Mountain Cancer Centers, Denver, Colorado, 80218, United States|University of Florida, Gainesville, Florida, 32610, United States|Tulane Uni Health Sciences Center, New Orleans, Louisiana, 70112, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Med Ctr, Boston, Massachusetts, 02215, United States|WA Uni School Of Med, St Louis, Missouri, 63110, United States|Urology Cancer Center PC, Omaha, Nebraska, 68130, United States|Nebraska Cancer Specialists, Omaha, Nebraska, 68154, United States|NYU Laura and Isaac Perlmutter Cancer Center, New York, New York, 10016, United States|Memorial Sloan Kettering Cancer Ctr, New York, New York, 10017, United States|Mount Sinai Hosp Med School, New York, New York, 10029, United States|Duke Univ Medical Center, Durham, North Carolina, 27710, United States|The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43221, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Uni Of TX MD Anderson Cancer Cntr, Houston, Texas, 77030, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|Onco Hemato Asso of SE Virginia, Roanoke, Virginia, 24014, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Medical College Of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Novartis Investigative Site, Innsbruck, Tyrol, 6020, Austria|Novartis Investigative Site, Linz, 4020, Austria|Novartis Investigative Site, Vienna, 1090, Austria|Novartis Investigative Site, Roeselare, West-Vlaanderen, 8800, Belgium|Novartis Investigative Site, Brussels, 1200, Belgium|Novartis Investigative Site, Ghent, 9000, Belgium|Novartis Investigative Site, Liège, 4000, Belgium|Novartis Investigative Site, Vancouver, British Columbia, V5Z 4E6, Canada|Novartis Investigative Site, Montreal, Quebec, H2W 1T8, Canada|Novartis Investigative Site, Montreal, Quebec, H3T 1E2, Canada|Novartis Investigative Site, Olomouc, 779 00, Czechia|Novartis Investigative Site, Angers, 49055, France|Novartis Investigative Site, Bordeaux, 33076, France|Novartis Investigative Site, Clermont-Ferrand, 63011, France|Novartis Investigative Site, Lyon, 69373, France|Novartis Investigative Site, Paris, 75970, France|Novartis Investigative Site, Villejuif, 94800, France|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, München, 80377, Germany|Novartis Investigative Site, Nijmegen, Gelderland, 6500HB, Netherlands|Novartis Investigative Site, Maastricht, Limburg, 6229 HX, Netherlands|Novartis Investigative Site, Utrecht, 3584 CX, Netherlands|Novartis Investigative Site, Gliwice, Silesian Voivodeship, 44-101, Poland|Novartis Investigative Site, Bratislava, 83310, Slovakia|Novartis Investigative Site, Santiago Compostela, A Coruna, 15706, Spain|Novartis Investigative Site, L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Novartis Investigative Site, Barcelona, Catalonia, 08035, Spain|Novartis Investigative Site, Majadahonda, Madrid, 28222, Spain|Novartis Investigative Site, El Palmar, Murcia, 30120, Spain|Novartis Investigative Site, Pamplona, Navarre, 31008, Spain|Novartis Investigative Site, Valencia, Valencia, 46009, Spain|Novartis Investigative Site, Barcelona, 08036, Spain|Novartis Investigative Site, Barcelona, 08041, Spain|Novartis Investigative Site, Madrid, 28009, Spain|Novartis Investigative Site, Madrid, 28040, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Málaga, 29010, Spain|Novartis Investigative Site, Seville, 41013, Spain|Novartis Investigative Site, Valencia, 46026, Spain|Novartis Investigative Site, Gothenburg, 413 45, Sweden|Novartis Investigative Site, Lund, 221 85, Sweden|Novartis Investigative Site, Stockholm, 17176, Sweden|Novartis Investigative Site, Baden, 5404, Switzerland|Novartis Investigative Site, Lausanne, 1011, Switzerland|Novartis Investigative Site, Zurich, 8091, Switzerland|Novartis Investigative Site, Guildford, Surrey, GU2 7XX, United Kingdom|Novartis Investigative Site, Sutton, Surrey, SM2 5PT, United Kingdom|Novartis Investigative Site, Coventry, CV2 2DX, United Kingdom|Novartis Investigative Site, London, EC1A 7BE, United Kingdom|Novartis Investigative Site, London, NW1 2BU, United Kingdom|Novartis Investigative Site, London, NW3 2QG, United Kingdom|Novartis Investigative Site, Middlesbrough, TS4 3BW, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: AMG 404,ALL,"ADULT, OLDER_ADULT",PHASE1,171,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/5/19,11/2/23,"Sarcoma Oncology Research Center LLC, Santa Monica, California, 90403, United States|Sarah Cannon Research Institute at HealthONE, Denver, Colorado, 80218, United States|University of Louisville James Graham Brown Cancer Center, Louisville, Kentucky, 40202, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Chris OBrien Lifehouse, Camperdown, New South Wales, 2050, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, 5011, Australia|Universitair Ziekenhuis Antwerpen, Edegem, 2650, Belgium|Nucleo de Oncologia da Bahia, Salvador, Estado de Bahia, 40170-110, Brazil|Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto, São Paulo, 15090-000, Brazil|Sociedade Beneficente de Senhoras Hospital Sirio Libanes, São Paulo, São Paulo, 01308-050, Brazil|Instituto Coi, Rio de Janeiro, 22793-080, Brazil|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|National Cancer Center Hospital East, Kashiwa-shi, Chiba, 277-8577, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, 791-0280, Japan|Wakayama Medical University Hospital, Wakayama, Wakayama, 641-8510, Japan|Uniwersyteckie Centrum Kliniczne, Gdansk, 80-214, Poland|Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw, 02-781, Poland|National University Hospital, Singapore, 119074, Singapore|National Cancer Centre Singapore, Singapore, 169610, Singapore|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital Yonsei University Health System, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|The Catholic University of Korea Seoul St Marys Hospital, Seoul, 06591, South Korea|Hospital Universitari Vall d Hebron, Barcelona, Catalonia, 08035, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation, Taoyuan District, 33305, Taiwan|Doktor Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara, 06200, Turkey (Türkiye)|Koc Universitesi Hastanesi, Istanbul, 34010, Turkey (Türkiye)|Ege Universitesi Ilac Gelistirme ve Farmakokinetik Arastirma Uygulama Merkezi (ARGEFAR), Izmir, 35100, Turkey (Türkiye)|Sarah Cannon Research Institute UK, London, W1G 6AD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Prostatic Neoplasms,DRUG: Apalutamide|DRUG: Placebo,MALE,"ADULT, OLDER_ADULT",PHASE3,1207,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",10/14/13,12/31/27,"Birmingham, Alabama, United States|Anchorage, Alaska, United States|Chandler, Arizona, United States|Tucson, Arizona, United States|Duarte, California, United States|Fullerton, California, United States|Laguna Woods, California, United States|Los Angeles, California, United States|Orange, California, United States|Roseville, California, United States|Sacramento, California, United States|San Bernardino, California, United States|San Diego, California, United States|San Francisco, California, United States|Santa Monica, California, United States|Sherman Oaks, California, United States|Stanford, California, United States|Tarzana, California, United States|Torrance, California, United States|Denver, Colorado, United States|Englewood, Colorado, United States|Glenwood Springs, Colorado, United States|Grand Junction, Colorado, United States|Washington D.C., District of Columbia, United States|Aventura, Florida, United States|Boca Raton, Florida, United States|Bradenton, Florida, United States|Daytona Beach, Florida, United States|Fort Myers, Florida, United States|Hialeah, Florida, United States|Jacksonville, Florida, United States|Miami, Florida, United States|New Port Richey, Florida, United States|Orlando, Florida, United States|Sarasota, Florida, United States|St. Petersburg, Florida, United States|Wellington, Florida, United States|Meridian, Idaho, United States|Chicago, Illinois, United States|Decatur, Illinois, United States|Maywood, Illinois, United States|Melrose Park, Illinois, United States|Carmel, Indiana, United States|Jeffersonville, Indiana, United States|Muncie, Indiana, United States|West Des Moines, Iowa, United States|Westwood, Kansas, United States|Wichita, Kansas, United States|Metairie, Louisiana, United States|New Orleans, Louisiana, United States|Annapolis, Maryland, United States|Baltimore, Maryland, United States|Rockville, Maryland, United States|Towson, Maryland, United States|Boston, Massachusetts, United States|Detroit, Michigan, United States|Lansing, Michigan, United States|Minneapolis, Michigan, United States|Royal Oak, Michigan, United States|Duluth, Minnesota, United States|Bay Saint Louis, Mississippi, United States|Southaven, Mississippi, United States|Kansas City, Missouri, United States|Missoula, Montana, United States|Omaha, Nebraska, United States|Las Vegas, Nevada, United States|Hooksett, New Hampshire, United States|Hackensack, New Jersey, United States|Lawrenceville, New Jersey, United States|Morristown, New Jersey, United States|Mount Laurel, New Jersey, United States|New Brunswick, New Jersey, United States|Voorhees Township, New Jersey, United States|Albuquerque, New Mexico, United States|Albany, New York, United States|Mineola, New York, United States|New York, New York, United States|Oneida, New York, United States|Poughkeepsie, New York, United States|Syracuse, New York, United States|The Bronx, New York, United States|Concord, North Carolina, United States|Greensboro, North Carolina, United States|Greenville, North Carolina, United States|Salisbury, North Carolina, United States|Winston-Salem, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Middleburg Heights, Ohio, United States|Middletown, Ohio, United States|Bend, Oregon, United States|Portland, Oregon, United States|Tualatin, Oregon, United States|Bala-Cynwyd, Pennsylvania, United States|Bryn Mawr, Pennsylvania, United States|Lancaster, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Warwick, Rhode Island, United States|Charleston, South Carolina, United States|Greenville, South Carolina, United States|Myrtle Beach, South Carolina, United States|West Columbia, South Carolina, United States|Memphis, Tennessee, United States|Nashville, Tennessee, United States|Abilene, Texas, United States|Amarillo, Texas, United States|Dallas, Texas, United States|Fort Sam Houston, Texas, United States|Houston, Texas, United States|McAllen, Texas, United States|San Antonio, Texas, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Virginia Beach, Virginia, United States|Burien, Washington, United States|Edmonds, Washington, United States|Seattle, Washington, United States|Tacoma, Washington, United States|Green Bay, Wisconsin, United States|Madison, Wisconsin, United States|Milwaukee, Wisconsin, United States|Adelaide, Australia|Box Hill, Australia|Camperdown, Australia|Darlinghurst, Australia|Geelong, Australia|Gosford, Australia|Hobart, Australia|Kogarah, Australia|Liverpool, Australia|Melbourne, Australia|Nedlands, Australia|Parkville, Australia|South Woodville, Australia|Southport, Australia|Sydney, Australia|Tweed Heads, Australia|Wollongong, Australia|Graz, Austria|Innsbruck, Austria|Linz, Austria|Vienna, Austria|Brussels, Belgium|Ghent, Belgium|Kortrijk, Belgium|Leuven, Belgium|Liège, Belgium|Ottignies, Belgium|Calgary, Alberta, Canada|Edmonton, Alberta, Canada|Abbotsford, British Columbia, Canada|Kelowna, British Columbia, Canada|Vancouver, British Columbia, Canada|Victoria, British Columbia, Canada|Moncton, New Brunswick, Canada|Saint John, New Brunswick, Canada|Halifax, Nova Scotia, Canada|Barrie, Ontario, Canada|Brampton, Ontario, Canada|Brantford, Ontario, Canada|Hamilton, Ontario, Canada|London, Ontario, Canada|North York, Ontario, Canada|Oakville, Ontario, Canada|Ottawa, Ontario, Canada|Owen Sound, Ontario, Canada|Toronto, Ontario, Canada|Gatineau, Quebec, Canada|Granby, Quebec, Canada|Greenfield Park, Quebec, Canada|Laval, Quebec, Canada|Montreal, Quebec, Canada|Pointe-Claire, Quebec, Canada|Québec, Quebec, Canada|Sherbrooke, Quebec, Canada|Liberec, Czechia|Olomouc, Czechia|Opava, Czechia|Pilsen, Czechia|Prague, Czechia|Aalborg C, Denmark|Copenhagen, Denmark|Odense, Denmark|Roskilde, Denmark|Helsinki, Finland|Oulu, Finland|Seinäjoki, Finland|Tampere, Finland|Turku, Finland|Angers, France|Besançon, France|Bordeaux, France|Caen Cédex 05, France|Clermont-Ferrand, France|Hyers, France|La Roche-sur-Yon, France|Le Mans, France|Lille Cedex N/a, France|Lyon, France|Marseille, France|Nice, France|Nîmes, France|Paris, France|Reims, France|Rennes, France|Rouen, France|Saint-Grégoire, France|Saint-Herblain, France|Strasbourg, France|Suresnes, France|Tours, France|Vandœuvre-lès-Nancy, France|Aachen, Germany|Bergisch Gladbach, Germany|Berlin, Germany|Braunschweig, Germany|Cologne, Germany|Duisburg, Germany|Emmendingen, Germany|Frankfurt am Main, Germany|Göttingen, Germany|Greifswald, Germany|Hamburg, Germany|Hanover, Germany|Heidelberg, Germany|Heinsberg, Germany|Homburg/Saar, Germany|Jena, Germany|Kiel, Germany|Kirchheim unter Teck, Germany|Magdeburg, Germany|Mainz, Germany|Mannheim, Germany|Marburg, Germany|Mettmann, Germany|Müllheim, Germany|Münster, Germany|Nürtingen, Germany|Regensburg, Germany|Rostock, Germany|Tübingen, Germany|Weiden, Germany|Wilhelmshaven, Germany|Wuppertan, Germany|Zirndorf, Germany|Budapest, Hungary|Miskolc, Hungary|Nyíregyhá, Hungary|Sopron, Hungary|Szentes, Hungary|Haifa, Israel|Jeruselem, Israel|Kfar Saba, Israel|Petah Tikva, Israel|Ramat Gan, Israel|Tel Aviv, Israel|Ẕerifin, Israel|Akita, Japan|Fukuoka, Japan|Gifu, Japan|Hakodate, Japan|Hiroshima, Japan|Hokkaido, Japan|Kanazawa, Japan|Kashiwa, Japan|Kita-Gun, Japan|Kobe, Japan|Koshigaya, Japan|Kumamoto, Japan|Kurume, Japan|Matsuyama, Japan|Nagano, Japan|Nagasaki, Japan|Nagoya, Japan|Niigata, Japan|Osaka, Japan|Ōsaka-sayama, Japan|Sagamihara, Japan|Sakura, Japan|Sapporo, Japan|Shinjuku-Ku, Japan|Tokushima, Japan|Tokyo, Japan|Ube, Japan|Wakayama, Japan|Yokohama, Japan|Alkmaar, Netherlands|Eindhoven, Netherlands|Hoofddorp, Netherlands|Leidschendam, Netherlands|Nijmegen, Netherlands|Rotterdam, Netherlands|Auckland, New Zealand|Christchurch, New Zealand|Hamilton, New Zealand|Nelson, New Zealand|Tauranga, New Zealand|Whangarei, New Zealand|Nordbyhagen, Norway|Bialystok, Poland|Bydgoszcz, Poland|Gdansk, Poland|Kutno, Poland|Lodz, Poland|Poznan, Poland|Szczecin, Poland|Torun, Poland|Warsaw, Poland|Wroclaw, Poland|Baia Mare, Romania|Brasov, Romania|Bucharest, Romania|Cluj-Napoca, Romania|Târgu Mureş, Romania|Barnaul, Russia|Ivanovo, Russia|Moscow, Russia|Obninsk, Russia|Omsk, Russia|Ryazan, Russia|Saint Petersburg, Russia|Ufa, Russia|Yaroslavl, Russia|Yekaterinburg, Russia|Banská Bystrica, Slovakia|Bratislava, Slovakia|Martin, Slovakia|Nitra, Slovakia|Trenčín, Slovakia|Daegu, South Korea|Gwangju, South Korea|Pusan, South Korea|Seongnam, South Korea|Seoul, South Korea|A Coruña, Spain|Badalona, Spain|Barcelona, Spain|Castellon, Spain|Girona, Spain|Guadalajara, Spain|Jerez de la Frontera, Spain|Las Palmas de Gran Canaria, Spain|Madrid, Spain|Málaga, Spain|Murcia, Spain|Palma de Mallorca, Spain|Pamplona, Spain|Sabadell, Spain|Salamanca, Spain|San Sebastián de los Reyes, Spain|Santander, Spain|Seville, Spain|Valencia, Spain|Gothenburg, Sweden|Örebro, Sweden|Stockholm, Sweden|Umeå, Sweden|Uppsala, Sweden|Kaohsiung City, Taiwan|Taichung, Taiwan|Taipei, Taiwan|Taoyuan, Taiwan|Blackburn, United Kingdom|Cambridge, United Kingdom|Cardiff, United Kingdom|Dundee, United Kingdom|Glasgow, United Kingdom|Guildford, United Kingdom|Leeds, United Kingdom|London, United Kingdom|Maidstone, United Kingdom|Metropolitan Borough of Wirral, United Kingdom|Nottingham, United Kingdom|Plymouth, United Kingdom|Southampton, United Kingdom|Surrey, United Kingdom|Swansea, United Kingdom|Wolverhampton, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematological Malignancies|Leukemia|Lymphoma|Multiple Myeloma|Hodgkin's Disease,DEVICE: Matched Sibling Allogeneic Transplantation,ALL,"ADULT, OLDER_ADULT",PHASE2,47,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/10/08,8/29/19,"Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Palbociclib|DRUG: Letrozole|DRUG: Placebo|DRUG: Letrozole,FEMALE,"ADULT, OLDER_ADULT",PHASE3,340,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",3/23/15,2/24/25,"The First Affiliated Hospital of Bengbu Medical College/Medical Oncology Department, Bengbu, Anhui, 233004, China|The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China|Fujian Medical University Union Hospital/Medical Oncology Department, Fuzhou, Fujian, 350001, China|Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, 510060, China|Zhongshan Ophthalmic Center,Sun Yat-Sen University, Guangzhou, Guangdong, 510060, China|Guangdong Provincial People's Hospital, Guangzhou, Guangdong, 510080, China|Breast Tumor Center, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, 510120, China|Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050011, China|Harbin Medical University Cancer Hospital/Oncology Department, Harbin, Heilongjiang, 150081, China|Henan Cancer Hospital, Zhengzhou, Henan, 450008, China|Hubei Cancer Hospital, Wuhan, Hubei, 430079, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China|Hunan Provincial Tumor Hospital/Breast Internal Medicine Department, Changsha, Hunan, 410013, China|Jiangsu Cancer Hospital, Nanjing, Jiangsu, 210009, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|Jilin Provincial Cancer Hospital, Changchun, Jilin, 130103, China|The First Hospital of China Medical University/Oncology Department, Shenyang, Liaoning, 110001, China|Liaoning Province Cancer Hospital, Shenyang, Liaoning, 110042, China|Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, 200025, China|West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China|Tianjin Cancer Hospital/Breast cancer department, Tianjin, Tianjin Municipality, 300060, China|The Tumor Hospital of Yunnan Province, Kunming, Yunnan, 650118, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Sir Run Run Shaw Hospital of College of Medicine of Zhejiang University, Center for Oncology, Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China|307 Hospital of PLA, Beijing, 100071, China|Beijing Cancer Hospital, Beijing, 100142, China|Peking University Third Hospital/Department of Oncology, Beijing, 100191, China|Chinese PLA General Hospital/Oncology, Beijing, 100853, China|Oncology Department, the Second Affiliated Hospital of Third Military Medical University, PLA, Chongqing, 400037, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|Department of Clinical Oncology, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Raffles Cancer Centre, Singapore, 188770, Singapore|Parkway Cancer Centre, Singapore, 258500, Singapore|Tan Tock Seng Hospital, Singapore, 308433, Singapore|Tan Tock Seng Hospital, Singapore, 308442, Singapore|China Medical University Hospital, Taichung, 40447, Taiwan|National Cheng Kung University Hospital / Internal Medicine, Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Mackay Memorial Hospital, Taipei, 10449, Taiwan|Taipei Medical University Hospital/ Department of Surgery, Taipei, 110, Taiwan|Taipei Veterans General Hospital/Surgery Department, Taipei, 11217, Taiwan|Koo Foundation, Sun Yat-Sen Cancer Center, Taipei, 11259, Taiwan|Taipei Municipal Wanfang Hospital (Managed by Taipei Medical University ), Taipei, 116, Taiwan|King Chulalongkorn Memorial Hospital, Pathumwan, Bangkok, 10330, Thailand|Chula Clinical Research Center (Chula CRC), Patumwan, Bangkok, 10330, Thailand|Department of Medicine, Faculty of Medicine, Naresuan University, Muang, Changwat Phitsanulok, 65000, Thailand|Division of Therapeutic Radiology and Oncology, Department of Radiology, Muang, Chiang Mai, 50200, Thailand|Ramathibodi Hospital, Mahidol University, Bangkok, Ratchathevi, 10400, Thailand|Oncology Unit, Department of Internal Medicine, Phramongkutklao Hospital, Bangkok, 10400, Thailand|Division of Medical Oncology, Department of Medicine,, Bangkok, 10700, Thailand",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: PD-0332991|DRUG: Letrozole|DRUG: Placebo|DRUG: Letrozole,FEMALE,"ADULT, OLDER_ADULT",PHASE3,666,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",2/22/13,11/9/23,"Southern California Permanente Medical Group, Bellflower, California, 90706, United States|Beverly Hills Cancer Center, Beverly Hills, California, 90211, United States|St. Joseph Heritage Healthcare, Fullerton, California, 92835, United States|Los Angeles Hematology/Oncology Medical Group, Glendale, California, 91206, United States|UCLA Hematology/ Oncology- Irvine, Irvine, California, 92604, United States|UCLA Hematology Oncology- Laguna Hills, Laguna Hills, California, 92653, United States|Los Angeles Hematology/Oncology Medical Group, Los Angeles, California, 90017, United States|Southern California Permanente Medical Group, Los Angeles, California, 90027, United States|Translational Research Management, Los Angeles, California, 90045, United States|Drug Management Only: UCLA West Medical Pharmacy, Attn: Steven L Wong, Pharm.D., Los Angeles, California, 90095-1772, United States|UCLA West Medical Pharmacy, Attn: Steven L. Wong, Los Angeles, California, 90095-7349, United States|UCLA West Medical Pharmacy: Drug Management Only, Los Angeles, California, 90095-7349, United States|UCLA West Medical Pharmacy; Drug Management Only, Los Angeles, California, 90095-7349, United States|UCLA West Medical Pharmacy, Los Angeles, California, 90095-7349, United States|Administrative Address: UCLA Hematology/Oncology, Los Angeles, California, 90095, United States|Drug Management Only: TRIO-US Pharmacy UCLA Medical Plaza, Attn: Steven L Wong, Pharm.D., Los Angeles, California, 90095, United States|Regulatory Management Only: TRIO-US Central Administration, Los Angeles, California, 90095, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, 90095, United States|TRIO-US Central Administration: Regulatory Management Only, Los Angeles, California, 90095, United States|TRIO-US Central Administration, Los Angeles, California, 90095, United States|UCLA Hematology Oncology, Los Angeles, California, 90095, United States|UCLA Hematology/Oncology, Los Angeles, California, 90095, United States|UCLA Hematology/ Oncology- Pasadena, Pasadena, California, 91105, United States|Torrance Health Association, DBa Torrance Memorial Physician Network, Redondo Beach, California, 90277, United States|Southern California Permanente Medical Group, San Diego, California, 92108, United States|University of California, San Francisco, San Francisco, California, 94115, United States|University of California San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94158, United States|San Luis Obispo Oncology and Hematology Health Center/ Pacific Central Coast Health Centers, San Luis Obispo, California, 93401, United States|Central Coast Medical Oncology Corporation, Santa Maria, California, 93454, United States|UCLA Santa Monica Medical Center and Orthopaedic Hospital, Santa Monica, California, 90404, United States|Stanford Women's Cancer Center, Stanford, California, 94304-5826, United States|Wellness Oncology & Hematology, West Hills, California, 91307, United States|UCLA Hematology/Oncology- Westlake, Westlake Village, California, 91361, United States|St. Mary's Hospital Regional Cancer Center, Grand Junction, Colorado, 81501, United States|Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, 06510, United States|Whittingham Cancer Center @ Norwalk Hospital, Norwalk, Connecticut, 06856, United States|MedStar Georgetown University Hospital, Washington D.C., District of Columbia, 20007, United States|Sylvester at Deerfield Beach, Deerfield Beach, Florida, 33442, United States|Memorial Breast Cancer Center at Memorial Regional Hospital, Hollywood, Florida, 33021, United States|Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, 33021, United States|Memorial Regional Hospital, Hollywood, Florida, 33021, United States|Cancer Specialist of North Florida, Pharmacy, Jacksonville, Florida, 32256, United States|Cancer Specialists of North Florida-Southpoint, Jacksonville, Florida, 32256, United States|Orlando Health, Inc., Orlando, Florida, 32806, United States|Memorial Breast Cancer Center at Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|Memorial Cancer Institute at Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|Sylvester Comprehensive Cancer Center Plantation, Plantation, Florida, 33324, United States|Cancer Specialists of North Florida - St. Augustine, Saint Augustine, Florida, 32086, United States|Grady Health System, Atlanta, Georgia, 30303, United States|Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Emory University Hospital, Atlanta, Georgia, 30322, United States|The Emory Clinic, Atlanta, Georgia, 30322, United States|Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Northwest Georgia Oncology Centers, PC, Marietta, Georgia, 30060, United States|Kootenai Clinic Cancer Services, Coeur d'Alene, Idaho, 83814, United States|Kootenai Clinic Cancer Services, Post Falls, Idaho, 83854, United States|The Mark M. Connolly Center for Cancer and Specialty Care, Chicago, Illinois, 60657, United States|Carle Foundation Hospital DBA Carle Cancer Center, Danville, Illinois, 61832, United States|Carle Foundation Hospital DBA Carle Cancer Center, Effingham, Illinois, 62401, United States|Presence Infusion Care- Evanston, Evanston, Illinois, 60202, United States|Carle Foundation Hospital DBA Carle Cancer Center, Mattoon, Illinois, 61938, United States|Presence Infusion Care- Skokie, Skokie, Illinois, 60077, United States|Carle Foundation Hospital DBA Carle Cancer Center, Urbana, Illinois, 61801, United States|James Graham Brown Cancer Center and University Hospital, Louisville, Kentucky, 40202, United States|James Graham Brown Cancer Center, Louisville, Kentucky, 40202, United States|University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, 20889-5600, United States|University of Michigan Health System, Ann Arbor, Michigan, 48109, United States|Park Nicollet Frauenshuh Cancer Center, Saint Louis Park, Minnesota, 55426, United States|The West Clinic, PC, Corinth, Mississippi, 38834, United States|The West Clinic, PC dba West Cancer Centre, Southaven, Mississippi, 38671, United States|Mercy Clinic St. Louis Cancer and Breast Institute, Ballwin, Missouri, 63011, United States|Mercy Clinic St. Louis Cancer and Breast Institute, St Louis, Missouri, 63109, United States|Mercy Hospital St. Louis - David C. Pratt Cancer Center, St Louis, Missouri, 63141, United States|Mercy Hospital St. Louis, St Louis, Missouri, 63141, United States|Saint Francis Medical Center, Grand Island, Nebraska, 68802, United States|Saint Francis Medical Center, Saint Francis Cancer Treatment Center, Grand Island, Nebraska, 68803, United States|Saint Francis Medical Center, Hastings, Nebraska, 68901, United States|Comprehensive Cancer Centers of Nevada, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada, Henderson, Nevada, 89074-8195, United States|Regulatory Office: Comprehensive Cancer Centers of Nevada Research Department, Las Vegas, Nevada, 89119, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|CareMount Medical, Brewster, New York, 10509, United States|CareMount Medical, Mount Kisco, New York, 10549, United States|Northern Westchester Hospital, Mount Kisco, New York, 10549, United States|Columbia University Medical Center, New York, New York, 10032, United States|Stony Brook University- Cancer Center, Stony Brook, New York, 11794-9447, United States|Northwest Cancer Specialists, PC, Portland, Oregon, 97213, United States|Kaiser Permanente Northwest Region, Portland, Oregon, 97227, United States|Northwest Cancer Specialists, P.C., Portland, Oregon, 97227, United States|OHSU Center for Health and Healing 2, Portland, Oregon, 97239, United States|OHSU Center for Health and Healing, Portland, Oregon, 97239, United States|OHSU Research Pharmacy Services, Portland, Oregon, 97239, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Tennessee Oncology, PLLC, Dickson, Tennessee, 37055, United States|Tennessee Oncology PLLC, Franklin, Tennessee, 37067, United States|Tennessee Oncology, PLLC, Gallatin, Tennessee, 37066, United States|The West Clinic, PC dba West Cancer Centre, Germantown, Tennessee, 38138, United States|Tennessee Oncology PLLC, Hermitage, Tennessee, 37076, United States|Tennessee Oncology, PLLC, Lebanon, Tennessee, 37090, United States|The West Clinic, PC dba West Cancer Centre, Memphis, Tennessee, 38104, United States|Tennessee Oncology PLLC, Murfreesboro, Tennessee, 37129, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37205, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37207, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37211, United States|Tennessee Oncology, PLLC, Shelbyville, Tennessee, 37160, United States|Tennessee Oncology PLLC, Smyrna, Tennessee, 37167, United States|Texas Oncology-Dallas Presbyterian Hospital, Dallas, Texas, 75231, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|Texas oncology-west Texas, El Paso, Texas, 79902, United States|Texas oncology-West Texas, El Paso, Texas, 79915, United States|Texas Oncology-west Texas, El Paso, Texas, 79938, United States|Investigational Products Center (IPC), Fort Worth, Texas, 76177, United States|The University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, Texas, 77030, United States|The University of Texas MD Anderson Cancer Center., Houston, Texas, 77030, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|US Oncology Investigational Products Center, Irving, Texas, 75063, United States|Oncology & Hematology Associates of Southwest Virginia, INC., D.B.A. Blue Rigde Cancer Care, Blacksburg, Virginia, 24060, United States|Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care, Low Moor, Virginia, 24457, United States|Virginia Oncology Associates, Newport News, Virginia, 23606, United States|Virginia oncology Associates, Norfolk, Virginia, 23502, United States|Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care, Roanoke, Virginia, 24014, United States|Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care, Salem, Virginia, 24153, United States|Virginia Oncology Associates, Virginia Beach, Virginia, 23456, United States|Shenandoah Oncology PC, Winchester, Virginia, 22601, United States|Oncology & Hematology Associates of Southwest Virginia, INC., D.B.A. Blue Rigde Cancer Care, Wytheville, Virginia, 24382, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Northwest Cancer Specialists, P.C., Vancouver, Washington, 98683, United States|Northwest Cancer Specialists P.C., Vancouver, Washington, 98684, United States|WVU Medicine, Morgantown, West Virginia, 26506, United States|University of Wisconsin, Madison, Wisconsin, 53792-6164, United States|St Vincent's Hospital Sydney, Darlinghurst, New South Wales, 2010, Australia|Laverty Pathology, Port Macquarie, New South Wales, 2444, Australia|Mid North Coast Diagnostic Imaging, Port Macquarie, New South Wales, 2444, Australia|Calvary Mater Newcastle, Waratah, New South Wales, 2298, Australia|Icon Cancer Care, Auchenflower, Queensland, 4066, Australia|Sunshine Coast University Hospital, Birtinya, Queensland, 4575, Australia|Icon Cancer Care Corporate Office, South Brisbane, Queensland, 4101, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, 4102, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Bendigo Health Care Group, The Bendigo Hospital Campus, Bendigo, Victoria, 3550, Australia|Northern Hospital, Epping, Victoria, 3076, Australia|Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia|Epworth Healthcare, Richmond, Victoria, 3121, Australia|Maroondah Hospital, Ringwood East, Victoria, 3135, Australia|Goulburn Valley Health, Shepparton, Victoria, 3630, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, 6150, Australia|Gasthuis Zusters Antwerpen - Campus Sint- Augustinus, Wilrijk, Antwerpen, 2610, Belgium|Institut Jules Bordet, Brussels, 1000, Belgium|UZ Brussel, Brussels, 1090, Belgium|Oncologie, Brussels, 1200, Belgium|Grand Hopital de Charleroi / Service d'Hematologie et Oncologie, Charleroi, 6000, Belgium|Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, 3000, Belgium|CHU Start Tilman, Liège, 4000, Belgium|CHR East Belgium - Verviers, Verviers, 4800, Belgium|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|BC Cancer Agency-Fraser Valley Centre, Surrey, British Columbia, V3V 1Z2, Canada|British Columbia Cancer Agency-Vancouver Centre, Vancouver, British Columbia, V5Z 4E6, Canada|QEII Health Sciences Centre, Victoria General Site, Halifax, Nova Scotia, B3H 2Y9, Canada|London Regional Cancer Program, London, Ontario, N6A 4L6, Canada|Southlake Regional Health Centre- Stronach Regional Cancer Centre, Newmarket, Ontario, L3Y2P9, Canada|Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada|St. Michaels Hospital, Toronto, Ontario, M5B 1W8, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|McGill University Health Centre (MUHC), Glen Site, Cedars Cancer Centre, Montreal, Quebec, H4A 3J1, Canada|Hopital du Sacre-Coeur, Montreal, Quebec, H4J 1C5, Canada|Center Hospitalier Affilie Universitaire de Quebec, Universite Laval, Hopital du Saint Sacrement, Québec, Quebec, G1S 4L8, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, S4T 7T1, Canada|Fakultni nemocnice Hradec Kralove, Klinika onkologie a radiologie, Hradec Králové, 500 05, Czechia|Institut de Cancerologie de l'Ouest- Paul Papin, Anger Cedex 02, 49055, France|Centre François Baclesse, Caen, 14076, France|Centre Georges François Leclerc, Dijon, 21079, France|CHD Vendée, La Roche-sur-Yon, 85295, France|Centre Val d'Aurelle,, Montpellier, 34298, France|Centre Antoine Lacassagne, Nice, 06189, France|Institut Curie, Departement d'Oncologie Medicale, Paris, 75248, France|Centre Eugene Marquis, Rennes, 35042, France|Hopital Rene Huguenin/Institut Curie, Saint-Cloud, 92210, France|Institut de Cancérologie de l'Ouest-Rene Gauducheau, Saint-Herblain, 44805, France|Institut Claudius Regaud- Cancer Comprehensive Center- IUCT-O-Medical Oncology Department, Toulouse Cedex-9, 31059, France|Institut Gustave Roussy, Villejuif, 94805, France|IOZ- Munchen, PGM- Studien GmbH, Munich, Bavaria, 80336, Germany|Klinikverbund Sudwest - Kliniken Sidelfingen-Boblingen, Böblingen, 71032, Germany|University Hospital Carl Gustav Carus - Department for Obstetrics and Gynecology., Dresden, 01307, Germany|Universitatsklinikum Erlangen, Frauenklinik, Erlangen, 91054, Germany|Universitaetsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|Universitatsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Gynakologie und Geburtshilfe, Kiel, 24105, Germany|Universitaetsklinikum Magdeburg AOR Universitaetsfrauenklinik, Magdeburg, 39108, Germany|Katholisches Klinikum Mainz, Mainz, 55131, Germany|Rotkreuzklinikum Munchen, Frauenklinik,, Munich, 80637, Germany|Breast Cancer, University of Munich, Grosshadern Hospital, Munich, 81377, Germany|Frauenklinik und Poliklinik Klinikum rechts der Isar, Technische Universitaet Muenchen, München, 81675, Germany|Klinikum Mutterhaus, Trier, 54290, Germany|Szent Margit Korhaz, Budapest, 1032, Hungary|Affidea Diagnosztika Kft., Budapest, 1054, Hungary|Orszagos Onkologiai Intezet ,, Budapest, 1122, Hungary|Országos Onkológiai Intézet ""B"" Belgyogyaszati osztaly, Budapest, H-1122, Hungary|Országos Onkológiai Intézet, Nuklearis Medicina Osztaly, Budapest, H-1122, Hungary|Országos Onkológiai Intézet, Radiologiai Diagnosztikai Osztily, Budapest, H-1122, Hungary|Petz Aladar Megyei Oktato Korhaz, Onkoradiologiai Osztaly, Győr, 9024, Hungary|Josa Andras Teaching Hospital,, Nyíregyháza, 4400, Hungary|Szegedi Tudomanyegyetem Altalanos Orvosi Kar, Patologia Intezet, Szeged, 6720, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Altalanos Orvostudomanyi Kar, Szeged, 6720, Hungary|Diagnoscan Magyarorszag Kft., Szeged, 6725, Hungary|Bon Secours Hospital, Cork, Ireland|St. James Hospital, Dublin, 8, Ireland|Beaumont Hospital, Dublin, 9, Ireland|Mater Misericordiae University Hospital, Dublin, Dublin 7, Ireland|St Vincents University Hospital, Dublin, Ireland|Department of Medical Oncology, Galway, Ireland|Mid Western Regional Hospital, Limerick, Ireland|Waterford Regional Hospital, Waterford, Ireland|Azienda Ospedaliero-Universitaria di Bologna, Policlinico Sant'Orsola-Malpighi, Bologna, BO, 40138, Italy|Irccs Irst, Meldola, FC, 47014, Italy|IRCCS - Istituto Europeo di Oncologia, Milan, Milan, 20141, Italy|Azienda Ospedaliera San Giuseppe Moscati, Avellino, 83100, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, 56126, Italy|Istituti Fisioterapici Ospitalieri, Roma, 00128, Italy|Ospedale SS Trinita, Sora (FR), 03039, Italy|Aichi Cancer Center Hospital, Nagoya, Aichi-ken, 464-8681, Japan|National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, 791-0280, Japan|National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, 003-0804, Japan|Kumamoto City Hospital, Kumamoto, Kumamoto, 862-8505, Japan|Saitama Cancer Center, Kita-adachi-gun, Saitama, 362-0806, Japan|National Cancer Center Hospital, Chuo-Ku, Tokyo, 104-0045, Japan|Chiba Cancer Center, Chiba, 260-8717, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Hiroshima City Hiroshima Citizens Hospital, Hiroshima, 730-8518, Japan|Hakuaikai Medical Corporation Sagara Hospital, Kagoshima, 892-0833, Japan|Kumamoto University Hospital, Kumamoto, 860-8556, Japan|Niigata Cancer Center Hospital 2-15-3, Niigata, 951-8566, Japan|Iwate Medical University Hospital, Numakunai, 020-8505, Japan|National Hospital Organization Osaka National Hospital, Osaka, 540-0006, Japan|Europejskie Centrum Zdrowia Otwock, Otwock, Masovian Voivodeship, 05-400, Poland|Oncology and Radiotherapy Clinic, Gdansk, 80-214, Poland|Niepubliczny Zakład Opieki Zdrowotnej ""Onko-Dent"" SP.P. G.L. Słomian, Żory, 44-240, Poland|Regional Budgetary Healthcare Institution Kursk Regional Clinical, Kursk, Kursk Oblast, 305524, Russia|State Budget Healthcate Institution ""Leningrad Region Oncology Dispensary"", Kuzmolovo, Leningradskaya Oblast', 188663, Russia|GUZ Republic Clinical Oncology Dispensary of Ministry of Health of Republic of Tatarstan, Kazan', 420029, Russia|Federal State Budget Institution, Moscow, 115478, Russia|State Budget Healthcare Institution Moscow City Oncology Hospital, Moscow Area, 143423, Russia|Budget Institution of Healthcare, Omsk, 644013, Russia|Budget Institution of Healthcare, Omsk, 644046, Russia|Ryazan Regional Clinical Oncology Dispensary, Ryazan, 390011, Russia|Non-State Health Care agency ""Road Clinical Hospital of PLC"" Russian Railways, Saint Petersburg, 195271, Russia|Saint-Petersburg State Budget Healthcare Institution (SBHCI), Saint Petersburg, 198255, Russia|Republican Clinical Hospital n.a. G.G. Kuvatov, Ufa, 450005, Russia|State Budget Medical Institution Republican Clinical Oncology, Ufa, 450054, Russia|SBHI of Republic of Bashkortostan Emergency Hospital, Ufa, 450106, Russia|National Cancer Center, Center for Breast Cancer, Goyang-si, Gyeonggi-do, 10408, South Korea|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea|Severance Hospital, Yonsei University Health System, Seodaemun-gu, Seoul, 03722, South Korea|Seoul National University Hospital / Department of Internal Medicine, Seoul, 03080, South Korea|Asan Medical Center, Division of Oncology, Department of Internal Medicine, Seoul, 05505, South Korea|Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Seoul, 06351, South Korea|Hospital Universitari Son Espases, Palma de Mallorca, Balearic Islands, 07010, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Consorci Sanitari de Terrassa, Terrassa, Barcelona, 08227, Spain|Hospital Universitario Fundacion de Alcorcon, Alcorcón, Madrid, 28922, Spain|Hospital Universitario de Canarias, San Cristóbal de La Laguna, Santa CRUZ DE Tenerife, 38320, Spain|Centro Oncologico de Galicia, A Coruña, 15009, Spain|Hospital Universitario Infanta Cristina, Badajoz, 06080, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clinic I Provincial, Barcelona, 08036, Spain|Hospital de Donostia, Donostia / San Sebastian, 20014, Spain|Complejo Hospitalario de Jaen, Jaén, 23007, Spain|Instituto Catalan de Oncologia L'Hospitalet, L'Hospitalet de Llobregat (Barcelona), 08908, Spain|Hospital Universitario Arnau de Vilanova de Lleida, Lleida, 25198, Spain|Hospital General Universitario Gregorio Marañon, Madrid, 28007, Spain|Centro Oncologico MD Anderson Internacional España, Madrid, 28033, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|HOSPITAL Universitario 12 DE OCTUBRE, Madrid, 28041, Spain|Hospital Madrid Universitario Sanchinarro, Madrid, 28050, Spain|Hospital Universitario Virgen Macarena, Seville, 41009, Spain|Hospital Universitario Virgen del Rocio, Seville, 41013, Spain|Instituto Valenciano de Oncologia, Valencia, 46009, Spain|National Taiwan University Hospital, Taipei, 10002, Taiwan|Mackay Memory Hospital, Taipei, 10449, Taiwan|Veterans General Hospital-Taipei, Taipei, 11217, Taiwan|MI ""Dnipropetrovsk City Multidisciplinary Clinical Hospital No.4"" of the Dnipropetrovsk City Council, Dnipro, 49102, Ukraine|State Institution Dnipropetrovsk Medical Academy at the Ministry of Health of Ukraine, Dnipro, 49102, Ukraine|Municipal Non-profit Enterprise ""Regional Centre of Oncology"", Kharkiv, 61070, Ukraine|Lviv State Oncologic Regional Treatment and Diagnostic Center, Chemotherapy Department, Lviv, 79031, Ukraine|Municipal Medical Institution ""Makiivka City Hospital No.2 of Donetsk Region"", Makiivka, 86120, Ukraine|Regional Municipal Establishment ""Sumy Regional Clinical Oncology Dispensary"", Thoracic Department, Sumy, 40005, Ukraine|City Oncology Centre of Central Municipal Clinical Hospital, Uzhhorod, 88000, Ukraine|Institute of Postgraduate education and preuniversity preparing of Uzhgorod National Univ., Uzhhorod, 88000, Ukraine|MI ""Zaporizhzhia Regional Clinical Oncology Dispensary"" Zaporizhzhia Regional Assembly,, Zaporizhzhia, 69040, Ukraine|State institution ""Zaporizhzhia Medical Academy of Postgraduate Education MOH Ukraine"",, Zaporizhzhya, 69040, Ukraine|Kent Oncology Center, Maidstone, KENT, ME16 9QQ, United Kingdom|Edinburgh Cancer Centre, Western General Hospital, Edinburgh, Scotland, EH4 2XU, United Kingdom|Beatson Institute for Cancer Research, Glasgow, Scotland, G12 0YN, United Kingdom|Guys Hospital, London, SE1 9RT, United Kingdom|The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom|Charing Cross Hospital, London, W6 8RF, United Kingdom|Christie Hospital NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|The Research And Development Office, The Christie NHS Foundation Trust, Manchester, M204BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: Dalutrafusp alfa|DRUG: mFOLFOX6 Regimen|DRUG: Dalutrafusp alfa,ALL,"ADULT, OLDER_ADULT",PHASE1,22,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/3/19,4/15/21,"Scottsdale Healthcare Hospitals d/b/a HonorHealth, Scottsdale, Arizona, 85258, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Mary Crowley Cancer Research, Dallas, Texas, 75230, United States|NEXT Oncology, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms|Lymphomas,DRUG: Belinostat,ALL,"ADULT, OLDER_ADULT",PHASE1,72,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/10/11,10/25/17,"University of California, Davis, Davis, California, 95616, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|USC Norris Cancer Center, Los Angeles, California, 90033, United States|Emory University, Atlanta, Georgia, 30322-1102, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Albert Einstein College of Medicine, The Bronx, New York, 10461, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Solid Tumors,DRUG: Sacituzumab Govitecan-hiy,ALL,"ADULT, OLDER_ADULT",PHASE4,25,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/4/20,10/18/24,"University of California San Francisco, San Francisco, California, 94143, United States|Rocky Mountain Cancer Center, Aurora, Colorado, 80012, United States|Christiana Care Health Services, Christiana Hospital, Newark, Delaware, 19718, United States|Florida Cancer Specialists & Research Institute, Fort Myers, Florida, 33905, United States|Baptist Health - Miami Cancer Institute, Miami, Florida, 33176, United States|Illinois Cancer Specialists, Arlington Heights, Illinois, 60005, United States|University of Chicago, Chicago, Illinois, 60637, United States|University of MD Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, 21201, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|New York Cancer & Blood Specialists - Setauket Medical Oncology, Port Jefferson, New York, 11776, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15213, United States|Next Oncology, Austin, Texas, 78758, United States|Oncology Consultants,P.A., Houston, Texas, 77024, United States|The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Institut Jules Bordet, Brussels, 1000, Belgium|CHU UCL NAMUR - Sainte Elisabeth, Namur, 5000, Belgium|Institut Bergonie, Bordeaux, 33076, France|Centre Leon Berard, Lyon, 69373, France|Institut Claudius Regaud, Toulouse, 31059, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Breast Neoplasms,DRUG: vepdegestrant,ALL,"ADULT, OLDER_ADULT",PHASE1,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/16/22,3/31/25,"Aichi Cancer Center Hospital, Nagoya, Aichi-ken, 464-8681, Japan|National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: LY3405105,ALL,"ADULT, OLDER_ADULT",PHASE1,54,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/31/19,2/4/21,"Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States|Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, 06511, United States|Columbia University Medical Center, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|University of Pennsylvania Hospital, Philadelphia, Pennsylvania, 19104, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Princess Margaret Hospital, Toronto, Ontario, M5TY 2M9, Canada|Institut Bergonie, Bordeaux, 33076, France|Institut Curie, Paris, 75248, France|Gustave Roussy, Villejuif, 94805, France|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Madrid Norte Sanchinarro, Madrid, 28050, Spain|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Cheng-Kung Uni. Hosp., Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei, 10048, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Desmoid Tumor,DRUG: Sirolimus,ALL,"CHILD, ADULT",PHASE1|PHASE2,9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-02,12/22/21,"UCLA Medical Center, Los Angeles, California, 90095, United States|Rady Children's Hospital, San Diego, California, 92123, United States|University of Florida College of Medicine, Gainesville, Florida, 32611, United States|Maine Medical Center, Portland, Maine, 04102, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|Children's Mercy Hospital, Kansas City, Missouri, 64108, United States|Seattle Children's Hospital, Seattle, Washington, 98101, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Childhood Solid Neoplasm|Recurrent Malignant Solid Neoplasm|Recurrent Primary Central Nervous System Neoplasm|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm,DRUG: Irinotecan Hydrochloride|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|DRUG: Sirolimus Albumin-bound Nanoparticles|DRUG: Temozolomide,ALL,"CHILD, ADULT",PHASE1,33,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/15/17,12/31/24,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, 30329, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Prisma Health Richland Hospital, Columbia, South Carolina, 29203, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Niraparib,ALL,"ADULT, OLDER_ADULT",PHASE1,9,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER,4/5/18,2/10/20,"National Cancer Center Hospital, Chuo-ku, Tokyo, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cognitive Impairment|Metastatic Malignant Neoplasm in the Brain|Solid Neoplasm,RADIATION: Whole brain radiation therapy with hippocampal avoidance|DRUG: Memantine|RADIATION: Whole brain radiation therapy,ALL,"ADULT, OLDER_ADULT",PHASE3,518,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2015-07,8/26/19,"Lewis and Faye Manderson Cancer Center, Tuscaloosa, Alabama, 35401, United States|Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Banner University Medical Center - Tucson, Tucson, Arizona, 85719, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, 91505, United States|Mercy San Juan Medical Center, Carmichael, California, 95608, United States|City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States|UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, 90027, United States|Los Angeles County-USC Medical Center, Los Angeles, California, 90033, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, 94611, United States|Stanford Cancer Institute Palo Alto, Palo Alto, California, 94304, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, 95670, United States|Rohnert Park Cancer Center, Rohnert Park, California, 94928, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, 95661, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, 95678, United States|Mercy Cancer Center - Sacramento, Sacramento, California, 95816, United States|Sutter Medical Center Sacramento, Sacramento, California, 95816, United States|University of California San Diego, San Diego, California, 92103, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, 94115, United States|Stanford Cancer Center South Bay, San Jose, California, 95124, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, 95051, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, 94080, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, 94589, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, 80304, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, 80907, United States|UCHealth Memorial Hospital Central, Colorado Springs, Colorado, 80909, United States|Swedish Medical Center, Englewood, Colorado, 80113, United States|Saint Vincent's Medical Center, Bridgeport, Connecticut, 06606, United States|Helen F Graham Cancer Center, Newark, Delaware, 19713, United States|Christiana Care Health System-Christiana Hospital, Newark, Delaware, 19718, United States|Boca Raton Regional Hospital, Boca Raton, Florida, 33486, United States|UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, 33146, United States|UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, 33442, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, 33136, United States|UF Cancer Center at Orlando Health, Orlando, Florida, 32806, United States|Cleveland Clinic-Weston, Weston, Florida, 33331, United States|Grady Health System, Atlanta, Georgia, 30303, United States|Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Piedmont Hospital, Atlanta, Georgia, 30309, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, 30342, United States|Memorial Health University Medical Center, Savannah, Georgia, 31404, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, 31405, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, 83706, United States|Saint Luke's Mountain States Tumor Institute, Boise, Idaho, 83712, United States|Saint Luke's Mountain States Tumor Institute - Meridian, Meridian, Idaho, 83642, United States|Saint Luke's Mountain States Tumor Institute - Nampa, Nampa, Idaho, 83686, United States|Saint Luke's Mountain States Tumor Institute-Twin Falls, Twin Falls, Idaho, 83301, United States|SIH Cancer Institute, Carterville, Illinois, 62918, United States|Northwestern University, Chicago, Illinois, 60611, United States|John H Stroger Jr Hospital of Cook County, Chicago, Illinois, 60612, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Crossroads Cancer Center, Effingham, Illinois, 62401, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, 60134, United States|Edward Hines Jr VA Hospital, Hines, Illinois, 60141, United States|Condell Memorial Hospital, Libertyville, Illinois, 60048, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|Methodist Medical Center of Illinois, Peoria, Illinois, 61636, United States|OSF Saint Francis Medical Center, Peoria, Illinois, 61637, United States|Memorial Medical Center, Springfield, Illinois, 62781, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, 60555, United States|Parkview Hospital Randallia, Fort Wayne, Indiana, 46805, United States|Community Cancer Center East, Indianapolis, Indiana, 46219, United States|Community Cancer Center South, Indianapolis, Indiana, 46227, United States|Community Cancer Center North, Indianapolis, Indiana, 46256, United States|Saint Luke's Hospital, Cedar Rapids, Iowa, 52402, United States|University of Kansas Cancer Center, Kansas City, Kansas, 66160, United States|Lawrence Memorial Hospital, Lawrence, Kansas, 66044, United States|University of Kansas Cancer Center-Overland Park, Overland Park, Kansas, 66210, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, 67214, United States|Wesley Medical Center, Wichita, Kansas, 67214, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, 40536, United States|Tulane University Health Sciences Center, New Orleans, Louisiana, 70112, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|MedStar Union Memorial Hospital, Baltimore, Maryland, 21218, United States|UM Upper Chesapeake Medical Center, Bel Air, Maryland, 21014, United States|Central Maryland Radiation Oncology in Howard County, Columbia, Maryland, 21044, United States|UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie, Maryland, 21061, United States|UM Saint Joseph Medical Center, Towson, Maryland, 21204, United States|Tufts Medical Center, Boston, Massachusetts, 02111, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, 01805, United States|Lowell General Hospital, Lowell, Massachusetts, 01854, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, 48106, United States|McLaren Cancer Institute-Bay City, Bay City, Michigan, 48706, United States|Henry Ford Cancer Institute-Downriver, Brownstown, Michigan, 48183, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, 48118, United States|21st Century Oncology MHP - Clarkston, Clarkston, Michigan, 48346, United States|McLaren Cancer Institute-Clarkston, Clarkston, Michigan, 48346, United States|Henry Ford Macomb Hospital-Clinton Township, Clinton Township, Michigan, 48038, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|21st Century Oncology MHP - Farmington, Farmington Hills, Michigan, 48334, United States|Genesys Hurley Cancer Institute, Flint, Michigan, 48503, United States|McLaren Cancer Institute-Flint, Flint, Michigan, 48532, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, 49503, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|McLaren Cancer Institute-Lapeer Region, Lapeer, Michigan, 48446, United States|Saint Mary Mercy Hospital, Livonia, Michigan, 48154, United States|McLaren Cancer Institute-Macomb, Mount Clemens, Michigan, 48043, United States|McLaren Cancer Institute-Central Michigan, Mount Pleasant, Michigan, 48858, United States|Mercy Health Mercy Campus, Muskegon, Michigan, 49444, United States|McLaren Cancer Institute-Owosso, Owosso, Michigan, 48867, United States|McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, 49770, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, 48341, United States|McLaren-Port Huron, Port Huron, Michigan, 48060, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, 49085, United States|21st Century Oncology MHP - Troy, Troy, Michigan, 48098, United States|Henry Ford West Bloomfield Hospital, West Bloomfield, Michigan, 48322, United States|Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, 56007, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Mayo Clinic Health Systems-Mankato, Mankato, Minnesota, 56001, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Mayo Clinic Radiation Therapy-Northfield, Northfield, Minnesota, 55057, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, 63376, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, 63141, United States|North Kansas City Hospital, Kansas City, Missouri, 64116, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Siteman Cancer Center-South County, St Louis, Missouri, 63129, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Community Medical Hospital, Missoula, Montana, 59804, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States|Renown Regional Medical Center, Reno, Nevada, 89502, United States|Wentworth-Douglass Hospital, Dover, New Hampshire, 03820, United States|Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, 03756, United States|New York-Presbyterian/Brooklyn Methodist Hospital, Brooklyn, New York, 11215, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|University of Rochester, Rochester, New York, 14642, United States|Montefiore Medical Center - Moses Campus, The Bronx, New York, 10467, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States|NHRMC Radiation Oncology - 16th Street, Wilmington, North Carolina, 28401, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, 58501, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, 58122, United States|Summa Akron City Hospital/Cooper Cancer Center, Akron, Ohio, 44304, United States|Cleveland Clinic Akron General, Akron, Ohio, 44307, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, 44111, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Cleveland Clinic Cancer Center Independence, Independence, Ohio, 44131, United States|UH Seidman Cancer Center at Southwest General Hospital, Middleburg Heights, Ohio, 44130, United States|University Hospitals Parma Medical Center, Parma, Ohio, 44129, United States|Cleveland Clinic Cancer Center Strongsville, Strongsville, Ohio, 44136, United States|UHHS-Westlake Medical Center, Westlake, Ohio, 44145, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Legacy Mount Hood Medical Center, Gresham, Oregon, 97030, United States|Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, 97210, United States|Abington Memorial Hospital, Abington, Pennsylvania, 19001, United States|Crozer-Keystone Regional Cancer Center at Broomall, Broomall, Pennsylvania, 19008, United States|Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, 19010, United States|Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania, 19317, United States|Geisinger Medical Center, Danville, Pennsylvania, 17822, United States|Northeast Radiation Oncology Center, Dunmore, Pennsylvania, 18512, United States|Crozer Regional Cancer Center at Brinton Lake, Glen Mills, Pennsylvania, 19342, United States|Riddle Memorial Hospital, Media, Pennsylvania, 19063, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Aria Health-Torresdale Campus, Philadelphia, Pennsylvania, 19114, United States|Temple University Hospital, Philadelphia, Pennsylvania, 19140, United States|Reading Hospital, West Reading, Pennsylvania, 19611, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, 18711, United States|Lankenau Medical Center, Wynnewood, Pennsylvania, 19096, United States|Greenville Health System Cancer Institute-Faris, Greenville, South Carolina, 29605, United States|Greenville Health System Cancer Institute-Eastside, Greenville, South Carolina, 29615, United States|Self Regional Healthcare, Greenwood, South Carolina, 29646, United States|The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island, South Carolina, 29926, United States|Greenville Health System Cancer Institute-Spartanburg, Spartanburg, South Carolina, 29307, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, 57117-5134, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, 37232, United States|University of Texas Medical Branch, Galveston, Texas, 77555-0565, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States|UTMB Cancer Center at Victory Lakes, League City, Texas, 77573, United States|Ogden Regional Medical Center, Ogden, Utah, 84405, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, 84112, United States|Norris Cotton Cancer Center-North, Saint Johnsbury, Vermont, 05819, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, 23298, United States|Virginia Mason Medical Center, Seattle, Washington, 98101, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, 98902, United States|West Virginia University Healthcare, Morgantown, West Virginia, 26506, United States|Wheeling Hospital/Schiffler Cancer Center, Wheeling, West Virginia, 26003, United States|Langlade Hospital and Cancer Center, Antigo, Wisconsin, 54409, United States|Mayo Clinic Health System-Eau Claire Clinic, Eau Claire, Wisconsin, 54701, United States|Aurora Cancer Care-Grafton, Grafton, Wisconsin, 53024, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, 54311, United States|UW Cancer Center Johnson Creek, Johnson Creek, Wisconsin, 53038, United States|Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, 53142, United States|Gundersen Lutheran Medical Center, La Crosse, Wisconsin, 54601, United States|Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, 54601, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, 53792, United States|Community Memorial Hospital, Menomonee Falls, Wisconsin, 53051, United States|Ascension Columbia Saint Mary's Water Tower Medical Commons, Milwaukee, Wisconsin, 53211, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, 53215, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Aurora Sinai Medical Center, Milwaukee, Wisconsin, 53233, United States|Zablocki Veterans Administration Medical Center, Milwaukee, Wisconsin, 53295, United States|Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, 54904, United States|Marshfield Clinic Stevens Point Center, Stevens Point, Wisconsin, 54482, United States|Aurora Medical Center in Summit, Summit, Wisconsin, 53066, United States|Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, 54241, United States|Aspirus Regional Cancer Center, Wausau, Wisconsin, 54401, United States|Aurora West Allis Medical Center, West Allis, Wisconsin, 53227, United States|Diagnostic and Treatment Center, Weston, Wisconsin, 54476, United States|Aspirus UW Cancer Center, Wisconsin Rapids, Wisconsin, 54494, United States|CHUM - Hopital Notre-Dame, Montreal, Quebec, H2L 4M1, Canada|McGill University Department of Oncology, Montreal, Quebec, H2W 1S6, Canada|CHUM - Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, H2X 3E4, Canada|The Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, H3H 2R9, Canada|CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ), Québec, Quebec, G1R 2J6, Canada|Centre Hospitalier Universitaire de Sherbrooke-Fleurimont, Sherbrooke, Quebec, J1H 5N4, Canada|Allan Blair Cancer Centre, Regina, Saskatchewan, S4T 7T1, Canada|Saskatoon Cancer Centre, Saskatoon, Saskatchewan, S7N 4H4, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neoplasms|Carcinoma, Non-Small-Cell Lung|Pancreatic Neoplasms|Colorectal Neoplasms",BIOLOGICAL: V941|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,70,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/26/19,8/25/22,"Banner MD Anderson Cancer Center ( Site 1008), Gilbert, Arizona, 85234, United States|City of Hope ( Site 1002), Duarte, California, 91010, United States|University of California at San Francisco ( Site 1006), San Francisco, California, 30322, United States|Smilow Cancer Hospital at Yale New Haven ( Site 1005), New Haven, Connecticut, 06510, United States|Dana-Farber Cancer Institute (Boston) ( Site 1007), Boston, Massachusetts, 02215, United States|Comprehensive Cancer Centers of Nevada ( Site 1012), Las Vegas, Nevada, 89169, United States|Tennessee Oncology Nashville Drug Development Unit ( Site 7000), Nashville, Tennessee, 37203, United States|START San Antonio ( Site 1004), San Antonio, Texas, 78229, United States|Baylor Scott & White Medical Center - Temple ( Site 1009), Temple, Texas, 76508, United States|Northwest Medical Specialties, PLLC ( Site 1001), Tacoma, Washington, 98405, United States|Kinghorn Cancer Centre ( Site 6000), Darlinghurst, New South Wales, 2010, Australia|Southern Oncology Clinical Research Unit SOCRU ( Site 6002), Bedford Park, South Australia, 5042, Australia|Monash Health-Monash Medical Centre ( Site 6001), Clayton, Victoria, 3168, Australia|Prince of Wales Hospital ( Site 2002), Hong Kong, Hong Kong|Queen Mary Hospital ( Site 2001), Hong Kong, Hong Kong|New Zealand Clinical Research (Christchurch) ( Site 6501), Christchurch, Canterbury, 8011, New Zealand|Auckland City Hospital ( Site 6500), Auckland, 1023, New Zealand|National University Hospital ( Site 3006), Singapore, Central Singapore, 119074, Singapore|National Cancer Centre Singapore ( Site 3005), Singapore, Central Singapore, 169610, Singapore|Tan Tock Seng Hospital ( Site 3007), Singapore, Central Singapore, 398442, Singapore|Asan Medical Center ( Site 0802), Songpagu, Seoul, 05505, South Korea|Seoul National University Hospital ( Site 0801), Seoul, 03080, South Korea|Severance Hospital ( Site 0800), Seoul, 03722, South Korea|National Cheng Kung University Hospital ( Site 4002), Tainan, 704, Taiwan|National Taiwan University Hospital ( Site 4000), Taipei, 10002, Taiwan|Taipei Veterans General Hospital ( Site 4001), Taipei, 11217, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Talazoparib,ALL,"ADULT, OLDER_ADULT",PHASE1,6,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2016-09,2017-06,"PRA Magyarorszag Kft, Fazis I-es Klinikai Farmakologiai Vizsgalohely, Budapest, 1077, Hungary",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cervical Intraepithelial Neoplasia Grade 2/3|High-risk HPV (Any Strain),DRUG: Artesunate Suppositories,FEMALE,"ADULT, OLDER_ADULT",PHASE1,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-02,11/6/18,"Johns Hopkins Outpatient Center, Baltimore, Maryland, 21205, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, 21231-2410, United States|Greater Baltimore Medical Center, Towson, Maryland, 21204, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Prostate Cancer|Prostatic Neoplasms|Neoplasms, Prostate",BIOLOGICAL: PROSTVAC-V/TRICOM|BIOLOGICAL: PROSTVAC-F/TRICOM,MALE,"ADULT, OLDER_ADULT",PHASE2,27,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/31/14,1/16/18,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: AMG 994|DRUG: AMG 404,ALL,"ADULT, OLDER_ADULT",PHASE1,11,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,4/29/21,6/5/23,"City of Hope National Medical Center, Duarte, California, 91010, United States|Henry Ford Hospital, Henry Ford Health Systems, Detroit, Michigan, 48202, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Monash Medical Centre, Clayton, Victoria, 3168, Australia|Linear Clinical Research Limited, Nedlands, Western Australia, 6009, Australia|Universitair Ziekenhuis Gent, Ghent, 9000, Belgium|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|Centre Leon Berard, Lyon, 69008, France|Universitatsklinikum Ulm, Ulm, 89081, Germany|Universitätsklinikum Würzburg, Würzburg, 97078, Germany|National Cancer Center Hospital East, Kashiwa-shi, Chiba, 277-8577, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, 791-0280, Japan|Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw, 02-781, Poland|Hospital Universitari Vall d Hebron, Barcelona, Catalonia, 08035, Spain|University College London Hospital, London, W1T 7HA, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pancreas Neoplasm Malignant Resectable,DRUG: Folfox6|DRUG: Gemcitabine|RADIATION: Radiation Therapy|PROCEDURE: Pancreaticoduodenectomy with retroperitoneal lymphadenectomy,ALL,"ADULT, OLDER_ADULT",PHASE2,24,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-02,1/14/20,"Henry Ford Health System, Detroit, Michigan, 48202, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Neoplasms,DRUG: Abemaciclib|DRUG: Standard Adjuvant ET|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,111,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",5/10/21,6/26/24,"Palo Verde Cancer Specialists, Glendale, Arizona, 85304, United States|TRIO-US (Translational Research in Oncology-US), Los Angeles, California, 90024, United States|Millennium Oncology - Hollywood, Hollywood, Florida, 33024, United States|Florida Cancer Specialists - North, St. Petersburg, Florida, 33705, United States|Mt. Sinai Hospital PRiSMS, Chicago, Illinois, 60608, United States|Cornell-Beshore Cancer Institute, Joplin, Missouri, 64804, United States|The Valley Hospital, Ridgewood, New Jersey, 07450, United States|Sarah Cannon Research Institute SCRI, Nashville, Tennessee, 37203, United States|Texas Oncology - Medical City Dallas, Dallas, Texas, 75230, United States|Northwest Cancer Specialists PC, The Woodlands, Texas, 77380, United States|Texas Oncology - Medical City Dallas, The Woodlands, Texas, 77380, United States|US Oncology, The Woodlands, Texas, 77380, United States|USO-Southern Cancer Center, P.C., The Woodlands, Texas, 77380, United States|Instituto de Investigaciones Clínicas Mar del Plata, Mar del Plata, Buenos Aires, 7600, Argentina|Fundación Cenit Para La Investigación En Neurociencias, CABA, Buenos Aires F.D., 1125, Argentina|Centro Medico Privado CEMAIC, Capital, Córdoba Province, X5008HHW, Argentina|Centro Medico San Roque, San Miguel de Tucumán, Tucumán Province, 4000, Argentina|Fundación CORI para la Investigación y Prevención del Cáncer, La Rioja, F5300COE, Argentina|Sanatorio Parque, Salta, 4400, Argentina|CER San Juan, San Juan, 5400, Argentina|Calvary Mater Newcastle, Waratah, New South Wales, 2298, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia|Ordensklinikum Linz, Linz, Upper Austria, 4020, Austria|Medizinische Universität Wien, Vienna, Vienna, 1090, Austria|AZ Maria Middelares, Ghent, Oost-Vlaanderen, 9000, Belgium|Clinique Saint Pierre, Ottignies, Wallonne, Région, 1340, Belgium|Jan Yperman ziekenhuis, Ieper, West-Vlaanderen, 8900, Belgium|AZ Groeninge Campus Kennedylaan, Kortrijk, West-Vlaanderen, 8500, Belgium|Instituto de Educação, Pesquisa e Gestão em Saúde, Rio de Janeiro, 22775-001, Brazil|NotreDame Intermedica Saude S.A, São Paulo, 01229-010, Brazil|Núcleo de Pesquisa Clínica da Rede São Camilo, São Paulo, 04014-002, Brazil|Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, 04543-000, Brazil|Instituto de Ensino e Pesquisa São Lucas, São Paulo, 1236030, Brazil|Afflilated Hospital of Bengbu Medical College, Bengbu, Anhui, 233004, China|Peking University People's Hospital, Beijing, Beijing Municipality, 100034, China|Beijing Cancer hospital, Beijing, Beijing Municipality, 100142, China|Fujian Medical University Union Hospital-1 Bingfanglou, Fuzhou Fujian, Fujian, 350001, China|Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510120, China|Hainan Cancer Hospital, Haikou, Hainan, 570000, China|Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China|Hubei Cancer Hospital, Wuhan, Hubei, 430079, China|Xiangya Hospital Central South University, Changsha, Hunan, 410008, China|Hunan Cancer Hospital, Changsha, Hunan, 410013, China|Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210000, China|The Third Hospital of Nanchang, Nanchang, Jiangxi, 330009, China|The Second Hospital of Jilin University, Changchun, Jilin, China|LinYi Cancer Hospital, Linyi, Shandong, 276000, China|Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, 200032, China|West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China|Sichuan Cancer hospital, Chengdu, Sichuan, 610042, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, China|Xinjiang Medical University Cancer Hospital - Urumqi, Ürümqi, Xinjiang, 830011, China|The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, 310003, China|The First People's Hospital of Hangzhou, Hangzhou, Zhejiang, 310006, China|CHU Besançon, Besançon, Doubs, 25000, France|Institut de Cancérologie de Lorraine Alexis Vautrin, Vandœuvre-lès-Nancy, Meurthe-et-Moselle, 54519, France|Centre Oscar Lambret, Lille, Nord, 59020, France|Clinique Victor Hugo Le Mans, Le Mans, Pays de la Loire Region, 72000, France|Klinikum Ludwigsburg, Ludwigsburg, Baden-Wurttemberg, 71640, Germany|Universitätsmedizin Mannheim, Mannheim, Baden-Wurttemberg, 68135, Germany|Universitaetsklinikum Ulm, Ulm, Baden-Wurttemberg, 89075, Germany|St. Vincenz-Krankenhaus Frauen- und Kinderklinik, Paderborn, North Rhine-Westphalia, 33098, Germany|Alexandra Hospital, Athens, Attikí, 115 28, Greece|General Oncology Hospital of Kifissia ""Agioi Anargiroi"", Nea Kifissia, Attikí, 14564, Greece|Euromedica General Clinic of Thessaloniki, Thessaloniki, Thessaloníki, 546 45, Greece|European Interbalkan Medical Center, Thessaloniki, 570 01, Greece|Petz Aladar Egyetemi Oktato Korhaz, Győr, Győr-Moson-Sopron, 9024, Hungary|Sourasky Medical Center, Tel Aviv, Tell Abīb, 6423906, Israel|Ospedale San Giovanni Moscati, Statte, Taranto, 74100, Italy|Ospedale Mater Salutis, Legnago, Verona, 37045, Italy|Ospedale Generale Provinciale Macerata, Macerata, 62100, Italy|Nagoya City University Hospital, Nagoya, Aichi-ken, 467-8602, Japan|Chiba cancer center, Chiba, Chiba, 260-8717, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, 791-0280, Japan|Gunma Prefectural Cancer Center, Ōta, Gunma, 373-0828, Japan|Tsukuba University Hospital, Tsukuba, Ibaraki, 305-8576, Japan|Ishikawa Prefectural Central Hospital, Kanazawa, Ishikawa-ken, 920-8201, Japan|St. Marianna University Hospital, Kawasaki, Kanagawa, 216-8511, Japan|Juntendo University Hospital, Bunkyo-ku, Tokyo, 113-8431, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|Japanese Foundation for Cancer Research, Koto, Tokyo, 135-8550, Japan|Showa University Hospital, Shinagawa, Tokyo, 142-8555, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Hiroshima University Hospital, Hiroshima, 734-8551, Japan|Sagara Hospital, Kagoshima, 892-0833, Japan|Kumamoto Shinto General Hospital, Kumamoto, 862-8655, Japan|National Hospital Organization Osaka Medical Center, Osaka, 540-0006, Japan|Osaka International Cancer Institute, Osaka, 541-8567, Japan|Shizuoka General Hospital, Shizuoka, 420-8527, Japan|St. Luke's International Hospital, Tokyo, 104-8560, Japan|Centro Oncológico Internacional (COI), Guadalajara, Jalisco, 45647, Mexico|Grupo Medico Camino Sc, Mexico City, Mexico City, 3310, Mexico|Inha University Hospital, Incheon, Incheon-gwangyeoksi [Incheon], 22332, South Korea|Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do, 13620, South Korea|CHA Bundang Medical Center, CHA University, Seongnam-si, Kyǒnggi-do, 13496, South Korea|Korea University Anam Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 2841, South Korea|Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul], 3722, South Korea|CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña], 15006, Spain|Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad de, 28041, Spain|H.R.U Málaga - Hospital Materno-infantil, Málaga, Málaga, 29011, Spain|Hospital Universitario de Canarias, San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Quirónsalud Valencia, Valencia, 46010, Spain|Brustzentrum Ostschweiz, Sankt Gallen, Canton of St. Gallen, 9016, Switzerland|Kantonsspital Winterthur, Winterthur, Canton of Zurich, 8401, Switzerland|National Taiwan University Hospital, Taipei, 10002, Taiwan|Koo Foundation Sun Yat-Sen Cancer Center, Taipei, 112, Taiwan|Chang Gung Medical Foundation-Linkou Branch, Taoyuan District, 333, Taiwan|Bristol Haematology and Oncology Centre, Bristol, Bristol, City of, BS2 8ED, United Kingdom|Colchester General Hospital, Colchester, Essex, CO4 5JL, United Kingdom|Charing Cross Hospital, London, Hammersmith and Fulham, W6 8RF, United Kingdom|Royal Marsden Hospital, Chelsea, London, SW3 6JJ, United Kingdom|Ipswich Hospital, Ipswich, Suffolk, IP4 5PD, United Kingdom|Royal Marsden Hospital (Sutton), London, Sutton, SM2 5PT, United Kingdom|The Christie, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: Evixapodlin,ALL,"ADULT, OLDER_ADULT",PHASE1,18,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/26/19,3/30/21,"California Care Associates for Research and Excellence Inc, Encinitas, California, 92024, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Northwest Medical Specialties, PLLC, Tacoma, Washington, 98405, United States|Auckland City Hospital, Auckland, 1023, New Zealand|Christchurch Clinical Studies Trust, LLC, Christchurch, 8011, New Zealand|Auckland Clinical Studies Ltd, Grafton, Auckland, 1010, New Zealand",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Laryngeal Neoplasms,RADIATION: IMRT Radiation,ALL,"ADULT, OLDER_ADULT",PHASE2,2,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/16/15,2018-05,"Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Ovarian Neoplasms,DRUG: Niraparib|DRUG: Dostarlimab,FEMALE,"ADULT, OLDER_ADULT",PHASE2,41,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/3/19,1/12/22,"GSK Investigational Site, Scottsdale, Arizona, 85258, United States|GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Newport Beach, California, 92663, United States|GSK Investigational Site, Orange, California, 92868, United States|GSK Investigational Site, Solvang, California, 93463, United States|GSK Investigational Site, Deerfield Beach, Florida, 33442, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Orlando, Florida, 32804, United States|GSK Investigational Site, Tampa, Florida, 33612, United States|GSK Investigational Site, Iowa City, Iowa, 52242-1009, United States|GSK Investigational Site, Boston, Massachusetts, 02114, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Burlington, Massachusetts, 01805, United States|GSK Investigational Site, Minneapolis, Minnesota, 55404, United States|GSK Investigational Site, Jackson, Mississippi, 39216, United States|GSK Investigational Site, New York, New York, 10022, United States|GSK Investigational Site, Durham, North Carolina, 27710, United States|GSK Investigational Site, Cleveland, Ohio, 44106, United States|GSK Investigational Site, Cleveland, Ohio, 44124, United States|GSK Investigational Site, Eugene, Oregon, 97401, United States|GSK Investigational Site, Providence, Rhode Island, 02905, United States|GSK Investigational Site, Chattanooga, Tennessee, 37403, United States|GSK Investigational Site, Germantown, Tennessee, 38138, United States|GSK Investigational Site, Austin, Texas, 78731, United States|GSK Investigational Site, Fort Worth, Texas, 76104, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, Charlottesville, Virginia, 22903, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasms,DRUG: Niraparib|BIOLOGICAL: Bevacizumab,FEMALE,"ADULT, OLDER_ADULT",PHASE2,105,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/12/17,7/12/24,"GSK Investigational Site, Mobile, Alabama, 36604, United States|GSK Investigational Site, Anchorage, Alaska, 99508, United States|GSK Investigational Site, Mesa, Arizona, 85284, United States|GSK Investigational Site, Burbank, California, 91505, United States|GSK Investigational Site, Los Angeles, California, 90095, United States|GSK Investigational Site, Fort Myers, Florida, 33908, United States|GSK Investigational Site, St. Petersburg, Florida, 33705, United States|GSK Investigational Site, Kansas City, Kansas, 66205, United States|GSK Investigational Site, Detroit, Michigan, 48201, United States|GSK Investigational Site, Detroit, Michigan, 48202, United States|GSK Investigational Site, Jackson, Mississippi, 39216, United States|GSK Investigational Site, Columbia, Missouri, 65212, United States|GSK Investigational Site, Kansas City, Missouri, 64132, United States|GSK Investigational Site, Lebanon, New Hampshire, 03756, United States|GSK Investigational Site, Englewood, New Jersey, 07631, United States|GSK Investigational Site, Morristown, New Jersey, 07962-1956, United States|GSK Investigational Site, Summit, New Jersey, 07962-1956, United States|GSK Investigational Site, Albany, New York, 12208, United States|GSK Investigational Site, Rochester, New York, 14642, United States|GSK Investigational Site, Asheville, North Carolina, 28816, United States|GSK Investigational Site, Columbus, Ohio, 43214, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73104, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15224, United States|GSK Investigational Site, Providence, Rhode Island, 02905, United States|GSK Investigational Site, Chattanooga, Tennessee, 37403, United States|GSK Investigational Site, Kingsport, Tennessee, 37660, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Fort Worth, Texas, 76104, United States|GSK Investigational Site, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms,DRUG: combined TAS-102 and TAS-OX,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,41,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/31/16,6/2/20,"Yale Cancer Center, New Haven, Connecticut, 06510, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasms,DRUG: Niraparib|BIOLOGICAL: TSR-042|BIOLOGICAL: Bevacizumab|DRUG: Carboplatin|DRUG: Paclitaxel,FEMALE,"ADULT, OLDER_ADULT",PHASE2,77,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/15/18,3/31/25,"GSK Investigational Site, Birmingham, Alabama, 35249, United States|GSK Investigational Site, Los Angeles, California, 90095, United States|GSK Investigational Site, San Francisco, California, 94109, United States|GSK Investigational Site, Stanford, California, 94304, United States|GSK Investigational Site, Ventura, California, 93003, United States|GSK Investigational Site, Tampa, Florida, 33606, United States|GSK Investigational Site, Chicago, Illinois, 60637, United States|GSK Investigational Site, Scarborough, Maine, 04074, United States|GSK Investigational Site, Baltimore, Maryland, 27710, United States|GSK Investigational Site, Boston, Massachusetts, 02114, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Rochester, Minnesota, 55905, United States|GSK Investigational Site, St Louis, Missouri, 63141, United States|GSK Investigational Site, New York, New York, 10029, United States|GSK Investigational Site, Rochester, New York, 14642, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73104, United States|GSK Investigational Site, Sioux Falls, South Dakota, 57105, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Seattle, Washington, 98104, United States|GSK Investigational Site, Ottawa, Ontario, K1H 8L6, Canada|GSK Investigational Site, Montreal, Quebec, H2X 3E4, Canada|GSK Investigational Site, Montreal, Quebec, H4A 3J1, Canada|GSK Investigational Site, A Coruña, 15006, Spain|GSK Investigational Site, Madrid, 28027, Spain|GSK Investigational Site, Madrid, 28033, Spain|GSK Investigational Site, Madrid, 28050, Spain|GSK Investigational Site, Málaga, 29011, Spain|GSK Investigational Site, Pamplona, 31008, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Nasopharyngeal Neoplasms,DRUG: CC-486,ALL,"ADULT, OLDER_ADULT",PHASE2,36,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/13/15,4/20/17,"Winship Cancer Institute of Emory University, Atlanta, Georgia, 30322, United States|University of Chicago, Chicago, Illinois, 60637, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Columbia Comprehensive Cancer Care Clinic, Jefferson City, Missouri, 65101, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|McGill University, Montreal, Quebec, H2W 1S6, Canada|Institut Hospitalier Franco-Britannique, Levallois-Perret, 92300, France|Institut Curie, Paris, 75005, France|Institut Gustave Roussy, Villejuif, 94805, France|University General Hospital of Heraklion, Heraklion, 71110, Greece|Thermi Clinic, Thessaloniki, 56429, Greece|Istituto Nazionale Dei Tumori, Milan, 20133, Italy|National Cancer Center, Singapore, 169-610, Singapore|Singapore Oncology Consultants, Singapore, 258500, Singapore|Johns Hopkins Singapore International Medical Centre, Singapore, 308433, Singapore|Instituto Catalan de Oncologia-Hospital Duran, Barcelona, 08907, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, 28050, Spain|Hospital Universitario de Salamanca, Salamanca, 37007, Spain|Chang Gung Medical Foundation, Kaohsiung Memorial Hospital, Niao-Sung Hsiang Kaohsiung County, 83301, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|Hopital Abderrahman Mami de Pneumo-Phtisiologie de l'Ariana, Aryanah, 2080, Tunisia|Institut Salah Azaiez, Bab Saadoun, 1006, Tunisia|Hospital Habib Bourguiba, Sfax, 3029, Tunisia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Sitravatinib|DRUG: Tislelizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,216,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/1/18,1/5/23,"Blacktown Cancer and Haematology Centre, Blacktown, New South Wales, 2148, Australia|Icon Cancer Foundation, South Brisbane, Queensland, 4101, Australia|Monash Health, Clayton, Victoria, 3168, Australia|Austin Health, Heidelberg, Victoria, 3084, Australia|Nucleus Network, Melbourne, Victoria, 3004, Australia|Linear Clinical Research, Nedlands, Western Australia, 6009, Australia|Beijing Cancer Hospital, Beijing, Beijing Municipality, 100142, China|The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, 361003, China|Guangdong Provincial Peoples Hospital, Guangzhou, Guangdong, 510080, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China|Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, 210008, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|The First Hospital of China Medical University, Shenyang, Liaoning, 110001, China|Jinan Central Hospital, Jinan, Shandong, 250013, China|Shandong Cancer Hospital, Jinan, Shandong, 250117, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, 300060, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor|Lymphoma,DRUG: TTX-030|DRUG: Pembrolizumab|DRUG: Gemcitabine|DRUG: nab paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,56,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,4/10/19,9/29/23,"UC Irvine Cancer Center, Orange, California, 92868, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|University of California, San Francisco, San Francisco, California, 94143, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Norton Cancer Institute, Louisville, Kentucky, 40202, United States|Nebraska Cancer Center Oncology Hematology West P.C., Omaha, Nebraska, 68130, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|Columbia University Irving Medical Center, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Montefiore Medical Center, The Bronx, New York, 10461, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44122, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|West Cancer Center and Research Institute, Germantown, Tennessee, 38138, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Huntsman Cancer Intitute, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Talazoparib,ALL,"ADULT, OLDER_ADULT",PHASE1,38,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/13/16,6/22/17,"CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield, California, 93309, United States|UCLA Hematology/Oncology - Burbank, Burbank, California, 91505, United States|St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare, Fullerton, California, 92835, United States|UCLA West Medical Pharmacy, Attn: Steven L. Wong, Pharm.D., Los Angeles, California, 90095-7349, United States|Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles, California, 90095, United States|TRIO-US Central Administration, Los Angeles, California, 90095, United States|UCLA Hematology/Oncology, Los Angeles, California, 90095, United States|UCLA West Medical Pharmacy. Attn: Steven L. Wong, Pharm.D., Los Angeles, California, 90095, United States|UCLA Hematology/Oncology - Pasadena, Pasadena, California, 91105, United States|UCLA Hematology/Oncology - Porter Ranch, Porter Ranch, California, 91326, United States|Torrance Health Association, DBA Torrance Memorial Physician Network/Cancer Care Associates, Redondo Beach, California, 90277, United States|UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, 90404, United States|UCLA Hematology/Oncology - Santa Clarita, Valencia, California, 91355, United States|Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, 33021, United States|Memorial Regional Hospital, Hollywood, Florida, 33021, United States|Orlando Health, Inc., Orlando, Florida, 32806, United States|Memorial Hospital West, Pembroke Pines, Florida, 33028, United States|Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, 46804, United States|Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, 46845, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Prostatic Neoplasms,DRUG: Doxorubicin|DRUG: Ketoconazole|DRUG: Docetaxel|DRUG: Estramustine|DRUG: Degarelix,MALE,"ADULT, OLDER_ADULT",PHASE2,19,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2015-11,9/14/17,"UTHealth Memorial Hermann Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: Abiraterone acetate|DRUG: Prednisone|DRUG: Androgen deprivation therapy (ADT),MALE,"ADULT, OLDER_ADULT",PHASE2,46,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/23/14,10/26/18,"Porto Alegre, Brazil|Rio de Janeiro, Brazil|Santo André, Brazil|São Paulo, Brazil",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Prostatic Neoplasms,DRUG: Apalutamide|DRUG: Placebo|DRUG: Androgen-deprivation Therapy (ADT),MALE,"ADULT, OLDER_ADULT",PHASE4,75,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",12/17/19,6/5/26,"Cancer Hospital Chinese Academy of Medical Sciences, Beijing, 100021, China|Peking University First Hospital, Beijing, 100034, China|Peking University People s Hospital, Beijing, 100044, China|Beijing Friendship Hospital, Beijing, 100050, China|Peking University Third Hospital, Beijing, 100191, China|Beijing Hospital, Beijing, 100730, China|Hunan Cancer hospital, Changsha, 410013, China|Sichuan Provincial Peoples Hospital, Chengdu, 610072, China|Chongqing University Cancer Hospital, Chongqing, 400030, China|Fujian Medical University Union Hospital, Fuzhou, 350001, China|Sun Yat-Sen Memorial Hospital Sun Yat-sen University, Guangzhou, 510120, China|Guangzhou First Municipal People's Hospital, Guangzhou, 510180, China|Zhejiang Provincial People's Hospital, Hangzhou, 310000, China|The First Affiliated Hospital Zhejiang University College of Medicine, Hangzhou, 310003, China|Zhejiang Cancer Hospital, Hangzhou, 310022, China|Nanjing Drum Tower Hospital, Nanjing, 210008, China|The First Affiliated Hospital of Ningbo University, Ningbo, 315010, China|Cancer Hospital, FuDan University, Shanghai, 200032, China|Shanghai Zhongshan Hospital, Shanghai, 200032, China|Huashan Hospital Fudan University, Shanghai, 200040, China|Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200240, China|The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, 200240, China|Huadong Hospital Affiliated to Fudan University, Shanghai, 200400, China|First Affiliated Hospital SooChow University, Suzhou, 215006, China|TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology, Wuhan, 430030, China|Wuxi People s Hospital, Wuxi, 214023, China|The First Affiliated Hospital of Xian Jiaotong University, Xi'an, 710061, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Cirmtuzumab + Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,23,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/15/18,2/26/24,"University of California, San Diego, La Jolla, California, 92093, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: lurbinectedin (PM01183),ALL,"ADULT, OLDER_ADULT",PHASE2,345,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/25/15,9/18/20,"Sarcoma Oncology Research Center, LLC, Santa Monica, California, 90403, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Massachussets General Hospital, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Centre, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Institute for Drug Development, Cancer Therapy & Research Center at University of Texas Health Science Center, San Antonio, Texas, 78229, United States|Institut Jules Bordet, Brussels, 1000, Belgium|Hôpital Cochin, Paris, 75014, France|Institut Claudius Regaud, Toulouse, 31059, France|Institut Gustave Roussy, Villejuif, 94805, France|Charité Universitätsmedizin Berlin - Campus Benjamin Franklin - Comprehensive Cancer Center, Berlin, 12200, Germany|Charité - Universitätsmedizin Berlin, Berlin, 13353, Germany|Istituto Clinico Humanitas, Rozzano, Milan, 20089, Italy|Istituto Ortopedico Rizzoli, Bologna, Italy|lstituto Europeo di Oncologia, Milan, 20141, Italy|ASST Monza - Ospedale San Gerardo di Monza Struttura Complessa di Oncologia Medica, Monza, 20090, Italy|AUSL Romagna - Ospedale Santa Maria delle Croci, Ravenna, 48121, Italy|Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, A Coruña, 15706, Spain|Hopsital Universitario Donostia - Donostia Unibertsitate Ospitalea, San Sebastián, Guipúzcoa, 20014, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, 28222, Spain|Complejo Hospitalario De Navarra, Pamplona, Navarre, 31008, Spain|Hospital Universitario Álvaro Cunqueiro, Vigo, Pontevedra, 36312, Spain|Hospital Universitario Central de Asturias, Oviedo, Principality of Asturias, 33011, Spain|Hospital de Basurto, Bilbao, Vizcaya, 48013, Spain|Complexo Hospitalario Universitario A Coruña, A Coruña, 15006, Spain|Hospital Universitari Vall D' Hebron, Barcelona, 08035, Spain|Complejo Hospitalario Regional Reina Sofía, Córdoba, 14004, Spain|Hospital Universitario Virgen de las Nieves, Granada, 18014, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario Madrid Sanchinarro, Madrid, 28050, Spain|Complejo Hospitalario de Especialidades Virgen de la Victoria, Málaga, 29010, Spain|Hospital Universitari i Polotècnic la Fe, Valencia, 46026, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain|Skane University Hospital, Lund, 22185, Sweden|Centre Hospitalier Universitaire Vaudois, Lausanne, Canton of Vaud, 1011, Switzerland|Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona, 6500, Switzerland|UCL Cancer Institute, London, WC1E 6DD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: Docetaxel|DRUG: Thalidomide|DRUG: Prednisone|BIOLOGICAL: bevacizumab|GENETIC: polymorphism analysis|OTHER: immunoenzyme technique|OTHER: laboratory biomarker analysis|OTHER: pharmacological study,MALE,"ADULT, OLDER_ADULT",PHASE2,73,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/19/05,1/9/18,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,BIOLOGICAL: MK-4621|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/18/18,3/2/21,"Institut Bergonie ( Site 3303), Bordeaux, 33076, France|CHU La Timone ( Site 3304), Marseille, 13005, France|Institut Curie ( Site 3302), Paris, 75005, France|Institut Gustave Roussy ( Site 3301), Villejuif, 94800, France|Charite Campus Benjamin Franklin ( Site 4903), Berlin, 10117, Germany|Universitaetsklinikum Carl Gustav Carus der TU Dresden ( Site 4901), Dresden, 01307, Germany|Hospital Universitario Fundacion Jimenez Diaz ( Site 3401), Madrid, 28040, Spain|Centro Integral Oncologico Clara Campal START Madrid ( Site 3402), Madrid, 28050, Spain|Oxford University Hospital NHS Foundation Trust ( Site 4401), Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors|Lymphoma,DRUG: Ulevostinag|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,156,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/3/17,4/21/22,"University of Alabama ( Site 0009), Birmingham, Alabama, 35294, United States|University of California San Francisco ( Site 0007), San Francisco, California, 94143, United States|UCSF ( Site 0015), San Francisco, California, 94158, United States|UCLA Medical Center ( Site 0005), Santa Monica, California, 90404, United States|Henry Ford Health System ( Site 0014), Detroit, Michigan, 48202, United States|Mount Sinai Hospital ( Site 0002), New York, New York, 10029, United States|Columbia University ( Site 0003), New York, New York, 10032, United States|UPMC Hillman Cancer Center ( Site 0013), Pittsburgh, Pennsylvania, 15232, United States|Mary Crowley Cancer Research Center ( Site 0001), Dallas, Texas, 75230, United States|Huntsman Cancer Institute ( Site 0004), Salt Lake City, Utah, 84112, United States|Institut Claudius Regaud ( Site 0051), Toulouse, Haute-Garonne, 31059, France|Institut Gustave Roussy ( Site 0049), Villejuif, Val-de-Marne, 94805, France|Institut Curie ( Site 0050), Paris, 75005, France|Rambam Medical Center ( Site 0041), Haifa, 3109601, Israel|Sheba Medical Center ( Site 0040), Ramat Gan, 5265601, Israel|Severance Hospital ( Site 0103), Seoul, 03722, South Korea|Asan Medical Center ( Site 0104), Seoul, 05505, South Korea|The Royal Marsden Foundation Trust ( Site 0031), London, London, City of, SW3 6JJ, United Kingdom|The Royal Marsden NHS Foundation Trust. ( Site 0032), Sutton, Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Neoplasms, Breast",DRUG: Niraparib,ALL,"ADULT, OLDER_ADULT",PHASE1,21,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/12/18,3/31/20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: BVD-523,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,136,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-03,2018-09,"UCLA Med-Hematology & Oncology, Los Angeles, California, 90095, United States|Yale Cancer Center, New Haven, Connecticut, 06520, United States|Florida Cancer Specialists and Research Group (Sarah Cannon Research Institute), Sarasota, Florida, 34232, United States|Massachusetts General Hospital (MGH), Boston, Massachusetts, 02114, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Sarah Cannon Research Institute Hospital at Vanderbilt, Nashville, Tennessee, 37203, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37212, United States|UT M.D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,BIOLOGICAL: Quavonlimab|BIOLOGICAL: Pembrolizumab|DRUG: Pembrolizumab/Quavonlimab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,415,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/2/17,4/8/24,"Banner MD Anderson Cancer Center ( Site 0013), Gilbert, Arizona, 85234, United States|John Theurer Cancer Center at Hackensack University Medical Center ( Site 0005), Hackensack, New Jersey, 07601, United States|Tennessee Oncology Nashville ( Site 0004), Nashville, Tennessee, 37203, United States|South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001), San Antonio, Texas, 78229, United States|Inova Schar Cancer Institute ( Site 1001), Fairfax, Virginia, 22031-4867, United States|Blacktown Hospital. Western Sydney local health district ( Site 0009), Blacktown, New South Wales, 2148, Australia|Calvary Mater Newcastle ( Site 0025), Waratah, New South Wales, 2298, Australia|Melanoma Institute Australia ( Site 0017), Wollstonecraft, New South Wales, 2065, Australia|Gallipoli Medical Research Foundation-GMRF CTU ( Site 0019), Brisbane, Queensland, 4120, Australia|Cairns and Hinterland Hospital and Health Service ( Site 0020), Cairns, Queensland, 4870, Australia|Ashford Cancer Centre Research ( Site 0012), Kurralta Park, South Australia, 5037, Australia|Ballarat Health Services ( Site 0022), Ballarat, Victoria, 3350, Australia|Alfred Health ( Site 0018), Melbourne, Victoria, 3004, Australia|Sunnybrook Research Institute ( Site 1103), Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Cancer Centre ( Site 1104), Toronto, Ontario, M5G 2M9, Canada|Centre Hospitalier de l Universite de Montreal - CHUM ( Site 1102), Montreal, Quebec, H2X 0A9, Canada|Jewish General Hospital ( Site 1105), Montreal, Quebec, H3T 1E2, Canada|McGill University Health Centre ( Site 1101), Montreal, Quebec, H4A 3J1, Canada|Fundacion Arturo Lopez Perez ( Site 5601), Santiago, Region M. de Santiago, 7500921, Chile|Beijing Cancer hospital-Digestive Oncology ( Site 5001), Beijing, Beijing Municipality, 100142, China|Chongqing Cancer Hospital-Phase 1 Unite ( Site 5004), Chongqing, Chongqing Municipality, 400030, China|Sir Run Run Shaw Hospital-Medical Oncology ( Site 5003), Hangzhou, Zhejiang, 310016, China|Hopital La Timone ( Site 3303), Marseille, Bouches-du-Rhone, 13005, France|Institut Bergonie ( Site 3306), Bordeaux, Gironde, 33076, France|CHRU Lille - Hopital Claude Huriez ( Site 3302), Lille, Nord, 59037, France|CH Lyon Sud Hospices Civils de Lyon ( Site 3307), Pierre-Bénite, Rhone, 69495, France|Gustave Roussy ( Site 3305), Villejuif, Val-de-Marne, 94800, France|Regional General Hospital of Athens ""Laiko"" ( Site 3001), Athens, Attica, 115 27, Greece|Rambam Medical Center ( Site 0003), Haifa, 3109601, Israel|Hadassah Ein Karem Hebrew University Medical Center ( Site 0021), Jerusalem, 9112001, Israel|Sheba Medical Center - Cancer Center ( Site 0002), Ramat Gan, 52621, Israel|Istituto Nazionale Tumori Fondazione Pascale ( Site 3903), Napoli, 80131, Italy|IRCCS Istituto Oncologico Veneto ( Site 3905), Padua, 35128, Italy|Policlinico Le Scotte - A.O. Senese ( Site 3907), Siena, 53100, Italy|National Cancer Center Hospital East ( Site 0014), Kashiwa, Chiba, 277-8577, Japan|Hyogo Cancer Center ( Site 0015), Akashi, Hyōgo, 673-8558, Japan|Canterbury District Health Board ( Site 0023), Christchurch, Canterbury, 8011, New Zealand|Auckland City Hospital ( Site 0016), Auckland, 1023, New Zealand|Szpital Kliniczny im. Heliodora Swiecickiego Uniwers Medyczn ( Site 4803), Poznan, Greater Poland Voivodeship, 60-780, Poland|Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Oddzial Badan Wczesnych Faz ( Site 4801, Warsaw, Masovian Voivodeship, 02-781, Poland|Sandton Oncology Medical Group PTY LTD ( Site 2701), Johannesburg, Gauteng, 2196, South Africa|Cape Town Oncology Trials Pty Ltd ( Site 2704), Kraaifontein, Western Cape, 7570, South Africa|Cancercare Rondebosch Oncology ( Site 2706), Rondebosch, Western Cape, 7700, South Africa|Asan Medical Center ( Site 0006), Seoul, Seoul, 05505, South Korea|Seoul National University Hospital ( Site 0007), Seoul, 03080, South Korea|Severance Hospital Yonsei University Health System ( Site 0008), Seoul, 03722, South Korea|Samsung Medical Center ( Site 0010), Seoul, 06351, South Korea|Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 3403), L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Onkologikoa - Instituto Oncologico de San Sebastian ( Site 3405), Donostia / San Sebastian, Gipuzkoa, 20014, Spain|Hospital General Universitario de Valencia ( Site 3404), Valencia, Valenciana, Comunitat, 46014, Spain|Hospital Clinic i Provincial de Barcelona ( Site 3401), Barcelona, 08036, Spain|Hospital Universitario Virgen de la Macarena ( Site 3402), Seville, 41009, Spain|Skanes Universitetssjukhus Lund. ( Site 4601), Lund, Skåne County, 221 85, Sweden",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,GVHD|Hematologic Neoplasms,DRUG: Cyclophosphamide|DRUG: abatacept|DRUG: Methotrexate|DRUG: Tacrolimus,ALL,"ADULT, OLDER_ADULT",PHASE2,43,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/26/19,6/15/23,"UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: LY3022855|DRUG: Durvalumab|DRUG: Tremelimumab,ALL,"ADULT, OLDER_ADULT",PHASE1,72,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/16/16,12/14/18,"Sarah Cannon Research Institute at HealthOne, Denver, Colorado, 80218, United States|Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Winship Cancer Center Emory University, Atlanta, Georgia, 30322, United States|New York University Medical Center, New York, New York, 10016, United States|Columbia University College of Phys & Surgeons, New York, New York, 10032, United States|Sarah Cannon Cancer Center, Nashville, Tennessee, 37203, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States|Universitair Ziekenhuis Antwerpen, Edegem, 2650, Belgium|Universitair Ziekenhuis Gent, Ghent, 9000, Belgium|GZA St Augustinus, Wilrijk, 2610, Belgium|Masarykuv Onkology Institute, Brno, Czech Republic, 656 53, Czechia|Rambam Medical Center, Haifa, 3109601, Israel|Hadassah Medical Center, Jerusalem, 9112001, Israel|Sheba Medical Center, Ramat Gan, 5262000, Israel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,RADIATION: Stereotactic radiotherapy|OTHER: Biological: humanized anti-PD-1 monoclonal antibody|OTHER: Biological: humanized anti-PD-L1 monoclonal antibody,ALL,"ADULT, OLDER_ADULT",PHASE2,5,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/10/17,9/22/21,"Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, 23298, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: CPX-POM - 30 mg/m^2|DRUG: CPX-POM - 60 mg/m^2|DRUG: CPX-POM - 120 mg/m^2|DRUG: CPX-POM - 240 mg/m^2|DRUG: CPX-POM - 360 mg/m^2|DRUG: CPX-POM - 600 mg/m^2|DRUG: CPX-POM - 900 mg/m^2|DRUG: CPX-POM - 1200 mg/m^2,ALL,"ADULT, OLDER_ADULT",PHASE1,19,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/15/18,5/31/20,"Sarah Cannon Research Institute, Denver, Colorado, 80218, United States|Florida Cancer Specialists & Research Institute, Sarasota, Florida, 34232, United States|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,477,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/17/14,4/30/21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Neoplasms,BIOLOGICAL: BMS-986016|BIOLOGICAL: BMS-936558,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,106,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/13/14,2/16/22,"Local Institution - 0007, Baltimore, Maryland, 21205, United States|Local Institution - 0004, Boston, Massachusetts, 02215, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Local Institution - 0010, St Louis, Missouri, 63110, United States|Weill Cornell Medical College, New York, New York, 10021, United States|Local Institution - 0002, Portland, Oregon, 97239, United States|Local Institution - 0006, Houston, Texas, 77030, United States|Local Institution - 0001, Seattle, Washington, 98109, United States|Local Institution - 0011, Vancouver, British Columbia, V5Z 4E6, Canada|Local Institution - 0012, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: BGB-A333|DRUG: BGB-A317,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,39,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/27/17,9/8/20,"Monash Health, Clayton, Victoria, 3168, Australia|Peter Maccallum Cancer Centre, Melbourne, Victoria, 3000, Australia|Nucleus Network, Melbourne, Victoria, 3004, Australia|Linear Clinical Research, Nedlands, Western Australia, 6009, Australia|Auckland City Hospital, Auckland, 1023, New Zealand|Institut Catala Doncologia, Barcelona, 08908, Spain|Start Madrid Fundacion Jimenez Diaz, Madrid, 28040, Spain|Centro Integral Oncologico Clara Campal, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Nivolumab|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,37,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/2/17,1/5/24,"Local Institution - 0015, Beijing, Beijing Municipality, 100021, China|Local Institution - 0001, Beijing, Beijing Municipality, 100142, China|Local Institution, Guangzhou, Guangdong, 510080, China|Local Institution - 0012, Guangzhou, Guangdong, 510655, China|Local Institution - 0011, Harbin, Heilongjiang, 155040, China|Local Institution, Zhengzhou, Henan, 450052, China|Local Institution - 0021, Wuhan, Hubei, 430030, China|Local Institution - 0020, Xi'an, Shan1xi, 710061, China|Local Institution - 0016, Shanghai, Shanghai Municipality, 200025, China|Local Institution - 0018, Chengdu, Sichuan, 610041, China|Local Institution - 0004, Tianjin, Tianjin Municipality, 300222, China|Local Institution - 0013, Hangzhou, Zhejiang, 310009, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Gynecological Cancers|Ovarian Cancer|Cervical Cancer|Uterine Cancer,BIOLOGICAL: Vigil|DRUG: Atezolizumab,FEMALE,"ADULT, OLDER_ADULT",PHASE2,25,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/31/17,5/18/22,"University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, 36604, United States|Georgia Cancer Center at Augusta University, Augusta, Georgia, 30912, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Billings Clinic, Billings, Montana, 59101, United States|Dartmouth-Hitchcock Medical Center/ Norris Cotton Cancer Center, Lebanon, New Hampshire, 03756, United States|Prisma Health Cancer Institute, Greenville, South Carolina, 29605, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,BIOLOGICAL: MK-4166|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,116,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/27/14,7/31/19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: axitinib|DRUG: crizotinib|DRUG: axitinib|DRUG: crizotinib|DRUG: axitinib|DRUG: crizotinib,ALL,"ADULT, OLDER_ADULT",PHASE1,50,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,2/26/14,9/5/19,"University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Investigational Drug Services IUHSCC, Indianapolis, Indiana, 46202, United States|IU Health University Hospital, Indianapolis, Indiana, 46202, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Wayne State University, Dept. of Oncology, Detroit, Michigan, 48201, United States|University of Minnesota Health Clinics and Surgery Center, Minneapolis, Minnesota, 55455, United States|University of Minnesota Medical Center, Fairview IDS Pharmacy, Minneapolis, Minnesota, 55455, United States|University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota, 55455, United States|University of Minnesota Physicians Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland, Ohio, 44106, United States|Huntsman Cancer Hospital, Salt Lake City, Utah, 84112, United States|Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|John A Moran Eye Center, Salt Lake City, Utah, 84132, United States|University Station Ophthalmology Clinic, Madison, Wisconsin, 53705, United States|University of Wisconsin Hospital and Clinics, Madison, Wisconsin, 53792, United States|St Bartholomew's Hospital - Barts Health NHS Trust, London, EC1A 7BE, United Kingdom|The Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, London, SW3 6JJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms,DRUG: pembrolizumab|DRUG: lenvatinib|DRUG: regorafenib|DRUG: TAS-102 (trifluridine and tipiracil),ALL,"ADULT, OLDER_ADULT",PHASE3,563,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/29/21,9/27/24,"Pacific Cancer Care ( Site 0031), Monterey, California, 93940, United States|Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0021), Marietta, Georgia, 30060, United States|University of Chicago Medical Center-Medicine - Section of Hematology/Oncology - Gastrointestinal P, Chicago, Illinois, 60637, United States|MFSMC-HJWCI-Oncology Research ( Site 0012), Baltimore, Maryland, 21237, United States|MedStar Good Samaritan Hospital-Oncology Research ( Site 0038), Baltimore, Maryland, 21239, United States|Henry Ford Hospital ( Site 0024), Detroit, Michigan, 48202, United States|St. Vincent Frontier Cancer Center ( Site 0005), Billings, Montana, 59102, United States|Providence Portland Medical Center ( Site 0019), Portland, Oregon, 97213, United States|Thomas Jefferson University - Clinical Trials Office ( Site 0027), Philadelphia, Pennsylvania, 19107, United States|Inova Schar Cancer Institute ( Site 0022), Fairfax, Virginia, 22031, United States|Blue Ridge Cancer Care ( Site 0036), Roanoke, Virginia, 24014, United States|Northwest Medical Specialties, PLLC ( Site 0033), Tacoma, Washington, 98405, United States|Hospital Británico de Buenos Aires-Oncology ( Site 0308), Ciudad Autónoma de Buenos Aires, Buenos Aires, C1280AEB, Argentina|Fundación favaloro para la Docencia e Investigación Médica-Oncología ( Site 0301), Buenos Aires, Buenos Aires F.D., C1096AAS, Argentina|Instituto de Oncología de Rosario ( Site 0305), Rosario, Santa Fe Province, S2000KZE, Argentina|Centro de Educación Médica e Investigaciones Clínicas (CEMIC)-Medical Oncology ( Site 0303), Buenos Aires, 1431, Argentina|IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas ( Site 0300), Buenos Aires, C1012AAR, Argentina|Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Si, Brisbane, Queensland, 4029, Australia|Gallipoli Medical Research Foundation-GMRF CTU ( Site 1500), Greenslopes, Queensland, 4120, Australia|The Queen Elizabeth Hospital-Cancer Clinical Trials ( Site 1503), Woodville, South Australia, 5011, Australia|Epworth Freemasons ( Site 1506), Melbourne, Victoria, 3002, Australia|Western Health-Sunshine & Footscray Hospitals ( Site 1501), St Albans, Victoria, 3021, Australia|Hollywood Private Hospital-Medical Oncology ( Site 1507), Perth, Western Australia, 6009, Australia|Cross Cancer Institute-Department of Medical Oncology ( Site 0207), Edmonton, Alberta, T6G 1Z2, Canada|NSHA-QEII Health Sciences Centre-Dickson Bldg-Dept. of Medical Oncology ( Site 0200), Halifax, Nova Scotia, B3H 2Y9, Canada|Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205), Hamilton, Ontario, L8V 4X2, Canada|North York General Hospital ( Site 0206), Toronto, Ontario, M2K1E1, Canada|CIUSSS de l'Est-de-l'Île-de-Montréal ( Site 0211), Montreal, Quebec, H1T 2M4, Canada|CHU de Quebec - Université Laval - Hotel Dieu de Quebec-Hemato-Dermato-Gyneco-Oncology ( Site 0203), Québec, Quebec, G1R 3S1, Canada|The First People's Hospital of Foshan-Gastrointestinal oncology ( Site 1604), Foshan, Guangdong, 528041, China|SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 1600), Guangzhou, Guangdong, 510060, China|Sir Run Run Shaw Hospital-Medical Oncology ( Site 1606), Hangzhou, Zhejiang, 310016, China|Rigshospitalet ( Site 0702), Copenhagen, Capital Region, 2100, Denmark|Herlev and Gentofte Hospital-Department of Oncology ( Site 0704), Copenhagen, Capital Region, 2730, Denmark|Odense Universitetshospital ( Site 0700), Odense, Region Syddanmark, 5000, Denmark|Vejle Sygehus-Department of Oncology ( Site 0701), Vejle, Region Syddanmark, DK-7100, Denmark|Klinikum am Steinenberg-Kreiskliniken Reutlingen GmbH ( Site 0908), Reutlingen, Baden-Wurttemberg, 72764, Germany|klinikum rechts der isar der technischen universität münchen-Klinik und Poliklinik für Innere Mediz, Munich, Bavaria, 81675, Germany|Onkodok GmbH ( Site 0907), Gütersloh, North Rhine-Westphalia, 33332, Germany|Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0901), Berlin, 10117, Germany|Asklepios Altona-Oncology ( Site 0903), Hamburg, 22763, Germany|Rambam Health Care Campus-Oncology ( Site 0800), Haifa, 3109601, Israel|Shaare Zedek Medical Center-Oncology ( Site 0804), Jerusalem, 9013102, Israel|Hadassah Medical Center-Oncology ( Site 0802), Jerusalem, 9112001, Israel|Sheba Medical Center ( Site 0803), Ramat Gan, 5262100, Israel|Sourasky Medical Center-Oncology ( Site 0801), Tel Aviv, 6423906, Israel|Aichi Cancer Center Hospital ( Site 1701), Nagoya, Aichi-ken, 4648681, Japan|National Cancer Center Hospital East ( Site 1700), Kashiwa, Chiba, 277-8577, Japan|Kobe City Medical Center General Hospital ( Site 1707), Kobe, Hyōgo, 650-0047, Japan|Kagawa University Hospital ( Site 1708), Kita, Kagawa-ken, 761-0701, Japan|Kanagawa cancer center ( Site 1705), Yokohama, Kanagawa, 2418515, Japan|Kindai University Hospital- Osakasayama Campus-Medical Oncology ( Site 1704), Sayama, Osaka, 589-8511, Japan|Saitama Prefectural Cancer Center ( Site 1703), Ina-machi, Saitama, 362-0806, Japan|Shizuoka Cancer Center ( Site 1706), Nakatogari, Shizuoka, 411-8777, Japan|National Hospital Organization Kyushu Cancer Center ( Site 1709), Fukuoka, 811-1395, Japan|National Cancer Center Hospital ( Site 1702), Tokyo, 104-0045, Japan|Japanese Foundation for Cancer Research-GI Oncology ( Site 1710), Tokyo, 135-8550, Japan|GBUZ Republican Clinical Oncological Dispensary-Antitumor drug therapy department ( Site 1109), Ufa, Baskortostan, Respublika, 450054, Russia|Saint-Petersburg City Clinical Oncology Dispensary-Department of chemotherapy ( Site 1100), Saint Petersburg, Leningradskaya Oblast', 198255, Russia|The National Medico-Surgical Center N.I. Pirogov ( Site 1102), Moscow, Moscow, 105203, Russia|Fed State Budgetary Inst N.N. Blokhin Med Center of Oncology MHRF ( Site 1107), Moscow, Moscow, 115478, Russia|First Moscow State Medical University I.M. Sechenov-Interhospital Institution """"Health Management (, Moscow, Moscow, 119991, Russia|SVERDLOVSK REGIONAL ONCOLOGY DISPENSARY ( Site 1108), Yekaterinburg, Sverdlovsk Oblast, 620905, Russia|SHBI Leningrad Regional Clinical Oncology Dispensary-Clinical Trials Department ( Site 1111), Saint Petersburg, 188663, Russia|Korea University Anam Hospital ( Site 1806), Seoul, 02841, South Korea|Seoul National University Hospital-Internal Medicine ( Site 1800), Seoul, 03080, South Korea|Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1801), Seoul, 03722, South Korea|Asan Medical Center ( Site 1803), Seoul, 05505, South Korea|Samsung Medical Center-Division of Hematology/Oncology ( Site 1804), Seoul, 06351, South Korea|The Catholic Univ. of Korea Seoul St. Mary's Hospital ( Site 1802), Seoul, 06591, South Korea|Hospital Universitario Marqués de Valdecilla ( Site 1201), Santander, Cantabria, 39008, Spain|Hospital Universitario Central de Asturias-Digestive ( Site 1200), Oviedo, Principality of Asturias, 33011, Spain|Hospital Universitari Vall d'Hebron-Oncology ( Site 1204), Barcelona, 08035, Spain|HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON ( Site 1205), Madrid, 28007, Spain|Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 1207), Seville, 41014, Spain|China Medical University Hospital-Surgical Department ( Site 1903), Taichung, 40447, Taiwan|NATIONAL CHENG-KUNG UNI. HOSP. ( Site 1904), Tainan, 704, Taiwan|National Taiwan University Hospital ( Site 1900), Taipei, 10002, Taiwan|Taipei Veterans General Hospital-Oncology ( Site 1901), Taipei, 11217, Taiwan|Chang Gung Medical Foundation.Linkou Branch ( Site 1902), Taoyuan District, 333, Taiwan|Hacettepe Universitesi-oncology hospital ( Site 1302), Ankara, 06230, Turkey (Türkiye)|Memorial Ankara Hastanesi-Medical Oncology ( Site 1304), Ankara, 06520, Turkey (Türkiye)|Trakya University-Oncology ( Site 1303), Edirne, 22030, Turkey (Türkiye)|Acıbadem Maslak Hastanesi ( Site 1307), Istanbul, 34457, Turkey (Türkiye)|Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1300), Istanbul, 34668, Turkey (Türkiye)|TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1301), Istanbul, 34722, Turkey (Türkiye)|Ege University Medicine of Faculty-Medical Oncology ( Site 1305), Izmir, 35100, Turkey (Türkiye)|İnönü Üniversitesi Turgut Özal Tıp Merkezi ( Site 1306), Malatya, 44280, Turkey (Türkiye)|Addenbrooke's Hospital ( Site 1407), Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom|UCLH-Cancer Clinical Trials Unit ( Site 1400), London, Essex, NW1 2PG, United Kingdom|Guy's & St Thomas' NHS Foundation Trust ( Site 1404), London, London, City of, SE1 9RT, United Kingdom|ROYAL MARSDEN HOSPITAL (CHELSEA) ( Site 1403), London, London, City of, SW3 6JJ, United Kingdom|Western General Hospital ( Site 1401), Edinburgh, Midlothian, EH4 2XU, United Kingdom|Royal Marsden Hospital (Sutton) ( Site 1409), London, Surrey, SM3 5PT, United Kingdom|The Christie-Medical Oncology ( Site 1411), Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasms,DRUG: Paclitaxel|DRUG: Cediranib|DRUG: Olaparib,FEMALE,"ADULT, OLDER_ADULT",PHASE2,123,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/12/17,4/1/21,"Spedali Civili di Brescia, Brescia, BS, 25123, Italy|Ospedale San Gerardo - ASST Monza, Monza, MB, 20900, Italy|Istituto Oncologico Veneto (IOV), Padua, PD, 35128, Italy|Arcispedale Santa Maria Nuova, Reggio Emilia, RE, 42123, Italy|Policlinico Umberto I - Università La Sapienza, Rome, RM, 00161, Italy|Istituto Eurpeo di Oncologia (IEO), Milan, 20141, Italy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Prostatic Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Docetaxel|DRUG: Prednisone|DRUG: Placebo|DRUG: Dexamethasone,MALE,"ADULT, OLDER_ADULT",PHASE3,81,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",9/23/20,7/18/23,"Second Affiliated hospital of Anhui Medical University-Urology (Site 1339), Hefei, Anhui, 230601, China|Peking University First Hospital ( Site 1303), Beijing, Beijing Municipality, 100034, China|The Fifth Medical Center of PLA General Hospital ( Site 1307), Beijing, Beijing Municipality, 100071, China|Peking University Third Hospital (Site 1304), Beijing, Beijing Municipality, 100089, China|Beijing Cancer Hospital ( Site 1305), Beijing, Beijing Municipality, 100142, China|The First Affiliated Hospital of Xiamen University ( Site 1319), Xiamen, Fujian, 361000, China|Sun Yat Sen Memorial Hospital ( Site 1323), Guangzhou, Guangdong, 510220, China|The First Affiliated Hospital of Guangzhou Medical University ( Site 1330), Guangzhou, Guangdong, 510230, China|Sun Yat-Sen University Cancer Center (Site 1334), Guangzhou, Guangdong, 510663, China|Harbin Medical University Cancer Hospital (Site 1326), Harbin, Heilongjiang, 150081, China|Henan Cancer Hospital ( Site 1321), Zhengzhou, Henan, 450008, China|Hubei Cancer Hospital ( Site 1329), Wuhan, Hubei, 430079, China|Hunan Cancer Hospital ( Site 1320), Changsha, Hunan, 410013, China|Nanjing Drum Tower Hospital ( Site 1312), Nanjing, Jiangsu, 210008, China|Zhongshan Hospital Fudan University ( Site 1301), Shanghai, Shanghai Municipality, 200032, China|Renji Hospital Shanghai Jiao Tong University School of Medicine (Site 1335), Shanghai, Shanghai Municipality, 200127, China|Fudan University Shanghai Cancer Center ( Site 1300), Shanghai, Shanghai Municipality, 201321, China|The First Affiliated Hospital of Xi an Jiaotong University (Site 1315), Xian, Shanxi, 710061, China|The Second Affiliated Hospital of Zhejiang University School of Medicine ( Site 1309), Hangzhou, Zhejiang, 310009, China|Zhejiang Provincial People's Hospital ( Site 1310), Hangzhou, Zhejiang, 310014, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: MEDI4736,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,68,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2015-11,8/2/21,"Yale School of Medicine, New Haven, Connecticut, 06511, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms by Site,BIOLOGICAL: nivolumab|DRUG: rHuPH20|BIOLOGICAL: nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,139,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/29/18,9/12/24,"Winship Cancer Institute., Atlanta, Georgia, 30322, United States|Local Institution - 0024, Rockville, Maryland, 20850, United States|Local Institution - 0020, Detroit, Michigan, 48201-2014, United States|Local Institution - 0001, Charlotte, North Carolina, 28204, United States|Local Institution - 0012, Eugene, Oregon, 97401, United States|Greenville Health System, Greenville, South Carolina, 29605, United States|Local Institution - 0010, Austin, Texas, 78705, United States|Local Institution - 0009, Beaumont, Texas, 77702-1449, United States|Local Institution - 0007, Dallas, Texas, 75246, United States|Local Institution - 0011, Tyler, Texas, 75702, United States|Local Institution - 0035, CABA, 1199, Argentina|Local Institution - 0025, CABA, 1426, Argentina|Local Institution - 0038, Porto Alegre, Rio Grande do Sul, 90610000, Brazil|Local Institution - 0037, São Paulo, 05651-901, Brazil|Local Institution - 0005, Santiago, 0, Chile|Local Institution - 0022, Saint-Herblain, 44805, France|Local Institution - 0021, Villejuif, 94805, France|Local Institution - 0003, Rozzano, MI, 20089, Italy|Local Institution - 0004, Padua, 35128, Italy|Local Institution - 0050, Mexico City, Mexico City, 03100, Mexico|Local Institution - 0048, Mexico City, Mexico City, 14080, Mexico|Local Institution - 0046, Monterrey, Nuevo León, 64710, Mexico|Local Institution - 0047, Monterrey, Nuevo León, 66460, Mexico|Local Institution - 0049, Puebla City, 72424, Mexico|Local Institution - 0045, Querétaro, 76000, Mexico|Local Institution - 0026, Amsterdam, North Holland, 1066 CX, Netherlands|Local Institution - 0039, Maastricht, 6229 HX, Netherlands|Local Institution - 0040, Rotorua, Bay of Plenty, 3046, New Zealand|Local Institution - 0018, Newtown, Wellington Region, 6021, New Zealand|Local Institution - 0014, Dunedin, 9012, New Zealand|Local Institution - 0015, Tauranga, 3112, New Zealand|Local Institution - 0019, Warsaw, Masovian Voivodeship, 02-781, Poland|Local Institution - 0017, Madrid, 28007, Spain|Local Institution - 0016, Málaga, 29010, Spain|Local Institution - 0033, Cardiff, Glamorgan, CF14 2TL, United Kingdom|Local Institution - 0031, Liverpool, L7 8YA, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Prostatic Neoplasms,DRUG: Apalutamide|DRUG: Abiraterone acetate|DRUG: Prednisone|DRUG: Placebo,MALE,"ADULT, OLDER_ADULT",PHASE3,982,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",11/26/14,12/31/27,"Phoenix, Arizona, United States|La Mesa, California, United States|Los Angeles, California, United States|Modesto, California, United States|San Diego, California, United States|San Francisco, California, United States|Santa Barbara, California, United States|Aurora, Colorado, United States|Denver, Colorado, United States|Jensen Beach, Florida, United States|Lakeland, Florida, United States|New Port Richey, Florida, United States|Ocala, Florida, United States|Atlanta, Georgia, United States|Melrose, Illinois, United States|Niles, Illinois, United States|Marrero, Louisiana, United States|New Orleans, Louisiana, United States|Shreveport, Louisiana, United States|Auburn, Maine, United States|Baltimore, Maryland, United States|St Louis, Missouri, United States|Omaha, Nebraska, United States|Las Vegas, Nevada, United States|Albany, New York, United States|Johnson City, New York, United States|New York, New York, United States|Poughkeepsie, New York, United States|Syracuse, New York, United States|The Bronx, New York, United States|Columbus, Ohio, United States|Tualatin, Oregon, United States|Lancaster, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Charleston, South Carolina, United States|Myrtle Beach, South Carolina, United States|Nashville, Tennessee, United States|Austin, Texas, United States|Houston, Texas, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Auburn, Washington, United States|Seattle, Washington, United States|Spokane, Washington, United States|Wenatchee, Washington, United States|Madison, Wisconsin, United States|Ciudad Automoma Buenos Aires, Argentina|Ciudad de Buenos Aires, Argentina|Córdoba, Argentina|La Rioja, Argentina|Mendoza, Argentina|Rosario, Argentina|Adelaide, Australia|Ashford, Australia|Camperdown, Australia|Herston, Australia|Liverpool, Australia|Malvern, Australia|Melbourne, Australia|Southport, Australia|Wahroonga, Australia|West Heidelberg, Australia|Woolloongabba, Australia|Antwerp, Belgium|Brussels, Belgium|Ghent, Belgium|Gosselies, Belgium|Leuven, Belgium|Liège, Belgium|Namur, Belgium|Ottignies, Belgium|Roeselare, Belgium|Sint-Niklaas, Belgium|Barretos, Brazil|Ijuí, Brazil|Natal, Brazil|Porto Alegre, Brazil|São José do Rio Preto, Brazil|São Paulo, Brazil|Abbotsford, British Columbia, Canada|Kelowna, British Columbia, Canada|Vancouver, British Columbia, Canada|Halifax, Nova Scotia, Canada|Barrie, Ontario, Canada|London, Ontario, Canada|Oakville, Ontario, Canada|Toronto, Ontario, Canada|Weston, Ontario, Canada|Montreal, Quebec, Canada|Québec, Quebec, Canada|Sherbrooke, Quebec, Canada|Angers, France|Caen, France|Dijon, France|Le Mans, France|Lyon, France|Montpellier, France|Paris, France|Saint-Herblain, France|Toulouse, France|Berlin, Germany|Dresden, Germany|Freiburg im Breisgau, Germany|Hamburg, Germany|Heidelberg, Germany|Münster, Germany|Nürtingen, Germany|Wuppertal, Germany|Fukuoka, Japan|Kanazawa, Japan|Kashiwa, Japan|Kita-Gun, Japan|Kumamoto, Japan|Kurume, Japan|Matsuyama, Japan|Miyazaki, Japan|Nagasaki, Japan|Osaka, Japan|Ōsaka-sayama, Japan|Sakura, Japan|Sapporo, Japan|Ube, Japan|Yokohama, Japan|Chihuahua City, Mexico|Cuernavaca, Mexico|Culiacán, Mexico|México, Mexico|Oaxaca City, Mexico|Zapopan, Mexico|Amsterdam, Netherlands|Amsterdam-Zuidoost, Netherlands|Blaricum, Netherlands|Dordrecht, Netherlands|Groningen, Netherlands|Heerlen, Netherlands|Nieuwegein, Netherlands|Nijmegen, Netherlands|Rotterdam, Netherlands|The Hague, Netherlands|Kursk, Russia|Moscow, Russia|Omsk, Russia|Pyatigorsk, Russia|Rostov-on-Don, Russia|Saint Petersburg, Russia|Ufa, Russia|Bloemfontein, South Africa|Cape Town, South Africa|Johannesburg, South Africa|Pretoria, South Africa|Goyang-si, South Korea|Seongnam, South Korea|Seoul, South Korea|Alcorcón, Spain|Barcelona, Spain|Cadiz, Spain|Córdoba, Spain|Madrid, Spain|San Sebastián de los Reyes, Spain|Valencia, Spain|Ayr, United Kingdom|Belfast, United Kingdom|Birmingham, United Kingdom|Edinburgh, United Kingdom|Glasgow, United Kingdom|London, United Kingdom|Manchester, United Kingdom|Metropolitan Borough of Wirral, United Kingdom|Plymouth, United Kingdom|Preston, United Kingdom|Stevenage, United Kingdom|Sutton, United Kingdom|Westcliff-on-Sea, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: Ulocuplumab|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,61,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER,7/13/15,1/27/17,"University Of Colorado Hosp, Aurora, Colorado, 80045, United States|Indiana University Health, Indianapolis, Indiana, 46202, United States|Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore, Maryland, 21287, United States|Columbia University Medical Center (Cumc), New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|Local Institution, Helsinki, 00029, Finland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Tumor Lysis Syndrome,DRUG: Febuxostat,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2/27/17,7/25/18,"University Hospital Tsaritsa Yoanna, Sofia, 1527, Bulgaria|Semmelweis Egyetem (paediatric), Budapest, 1083, Hungary|Semmelweis Egyetem, Budapest, 1085, Hungary|Debreceni Egyetem Klinikai Központ, Debrecen, 4032, Hungary|SOC Oncologia Medica A - Centro di Riferimento Oncologico, Aviano, Pordenone, 33081, Italy|Policlinico S. Orsola Malpighi, Bologna, 40138, Italy|A.O.U.C. Azienda Ospedaliero - Universitaria Careggi, Florence, 50134, Italy|Azienda Ospedaliero Universitaria Meyer, Florence, 50139, Italy|Istituto G Gaslini Ospedale Pediatrico IRCCS, Genova, 16147, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, 56126, Italy|IRCCS Ospedale Pediatrico Bambino Gesù, Rome, 00165, Italy|Ospedale Infantile Regina Margherita, Torino, 10126, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, 37126, Italy|Hospital de San Pedro de Alcantara, Cáceres, 10002, Spain|Hospital General Universitario Gregorio Maranon, Madrid, 28007, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitari i Politècnic La Fe, Valencia, 46026, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Sapanisertib,ALL,"ADULT, OLDER_ADULT",PHASE1,44,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/15/14,2/28/19,"Sarasota, Florida, United States|St Louis, Missouri, United States|The Bronx, New York, United States|Oklahoma City, Oklahoma, United States|Dallas, Texas, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: [14C]-pamiparib,ALL,"ADULT, OLDER_ADULT",PHASE1,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE,5/29/19,8/5/20,"The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, CH63 4JY, United Kingdom|Royal Liverpool University Hospital Clinical Research Unit, Liverpool, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: Apalutamide|DRUG: ADT|DRUG: Relugolix,MALE,"ADULT, OLDER_ADULT",PHASE2,108,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/19/20,10/25/23,"Arizona Urology Specialists, Tucson, Arizona, 85704, United States|Arizona Urology Specialists, Tucson, Arizona, 85741, United States|Arkansas Urology, Little Rock, Arkansas, 72211, United States|Skyline Urology, Sherman Oaks, California, 91411, United States|Genesis Research, Torrance, California, 90505, United States|The Urology Center of Colorado, Denver, Colorado, 80211, United States|Foothills Urology - Golden Off, Lakewood, Colorado, 80228, United States|Urological Research Network, Hialeah, Florida, 33016, United States|Idaho Urologic Institute, Meridian, Idaho, 83642, United States|First Urology, PSC, Jeffersonville, Indiana, 47130, United States|The Iowa Clinic, West Des Moines, Iowa, 50266, United States|Wichita Urology Group, Wichita, Kansas, 67226, United States|Ochsner LSU Health Shreveport - Regional Urology, Shreveport, Louisiana, 71106, United States|Michigan Institute of Urology, PC, Troy, Michigan, 48084, United States|Adult Pediatric Urology & Urogynecology, P.C, Omaha, Nebraska, 68114, United States|New Jersey Urology LLC, Voorhees Township, New Jersey, 08043, United States|Great Lakes Physician PC d/b/a Western New York Urology Associates, Cheektowaga, New York, 14225, United States|Associated Medical Professionals, Syracuse, New York, 13210, United States|Associated Urologists of North Carolina, Raleigh, North Carolina, 27612, United States|The Urology Group, Cincinnati, Ohio, 45212, United States|Oregon Urology Institute, Springfield, Oregon, 97477, United States|MidLantic Urology, Bala-Cynwyd, Pennsylvania, 19004, United States|Lancaster Urology, Lancaster, Pennsylvania, 17604, United States|Carolina Urologic Research Center, Myrtle Beach, South Carolina, 29572, United States|Lexington Urology, West Columbia, South Carolina, 20169, United States|Urology Associates, Nashville, Tennessee, 37209, United States|Urology Austin, Austin, Texas, 78745, United States|Houston Metro Urology, Houston, Texas, 77027, United States|Urology San Antonio Research, San Antonio, Texas, 78229, United States|Virginia Urology, Richmond, Virginia, 23235, United States|Urology Of Virginia, Pllc, Virginia Beach, Virginia, 23462, United States|Spokane Urology, Spokane, Washington, 99202, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Lymphoid Leukemia, Acute|Myeloid Malignancy|Plasma Cell Tumor",BIOLOGICAL: T-cell Receptor α/β Depleted Donor Lymphocyte Infusions,ALL,"ADULT, OLDER_ADULT",PHASE1,11,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/5/22,9/18/23,"Miami Cancer Institute at Baptist Health, Inc, Miami, Florida, 33176, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cancer|Neoplasms,DRUG: GSK1795091|DRUG: Placebo,ALL,ADULT,PHASE1,42,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",1/10/17,10/13/17,"GSK Investigational Site, Berlin, 14050, Germany",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,"DRUG: Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody|DRUG: Bevacizumab|DRUG: Entinostat|DRUG: Exemestane|DRUG: Fulvestrant|DRUG: Ipatasertib|DRUG: Tamoxifen|DRUG: Abemaciclib",FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,144,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/22/17,9/26/24,"University of Alabama at Birmingham, Birmingham, Alabama, 35249, United States|UCSF Helen Diller Family CCC, San Francisco, California, 94158, United States|Stanford Cancer Institute, Stanford, California, 94305-5456, United States|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, 90502, United States|Wellness Oncology and Hematology - Main Office, West Hills, California, 91307, United States|Northwest Georgia Oncology Centers PC - Marietta, Marietta, Georgia, 30060, United States|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21231, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|Providence Cancer Center, Portland, Oregon, 97231, United States|UPMC Pinnacle Health System, Harrisburg, Pennsylvania, 17102, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|Univ of Pittsburgh Sch of Med, Pittsburgh, Pennsylvania, 15213, United States|Sarah Cannon Research Institute / Tennessee Oncology, Nashville, Tennessee, 37203, United States|Rambam Medical Center, Haifa, 3109601, Israel|Shaare Zedek Medical Center, Jerusalem, 9103102, Israel|Rabin Medical Center-Beilinson Campus, Petah Tikva, 4941492, Israel|Sheba Medical Center, Ramat Gan, 5262100, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel|National Cancer Center, Gyeonggi-do, 10408, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|University of Ulsan College of Medicine - Asan Medical Center, Seoul, 05505, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Solid Tumors,DRUG: Avelumab 3 mg/kg Q2W|DRUG: Avelumab 10 mg/kg Q2W|DRUG: Avelumab 20 mg/kg Q2W|DRUG: Avelumab 10 mg/kg QW,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,4/24/18,2/8/21,"Research site, Guangzhou, Guangzhou, China|Research site, Changchun, Jilin, China|Research site, Hangzhou, Zhejiang, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: General anesthesia and opioids|DRUG: Regional analgesia and propofol,FEMALE,"ADULT, OLDER_ADULT",PHASE3,2108,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2007-01,2019-12,"Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Medical University of Vienna, Vienna, Austria|Peking Union Medical College Hospital, Beijing, China|University of Düsseldorf, Düsseldorf, 40225, Germany|Mater Misericordiae Hospital, Dublin, 7, Ireland|Tan Tock Seng Hospital, Singapore, Singapore",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Gastrointestinal Stromal Tumors (GIST)|Neoplasms, Connective Tissue|Neoplasms, Connective and Soft Tissue|Neoplasms by Histologic Type|Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasm|Digestive System Disease|Gastrointestinal Diseases",DRUG: THE-630,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,32,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/3/22,2/2/24,"HonorHealth Research Institute, Scottsdale, Arizona, 85258, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,DRUG: Carvedilol|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacogenomic Study|OTHER: Pharmacological Study|OTHER: Placebo Administration|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,196,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION",4/4/16,3/31/25,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Phoenix Childrens Hospital, Phoenix, Arizona, 85016, United States|Arkansas Children's Hospital, Little Rock, Arkansas, 72202-3591, United States|Kaiser Permanente Downey Medical Center, Downey, California, 90242, United States|City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States|Miller Children's and Women's Hospital Long Beach, Long Beach, California, 90806, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Kaiser Permanente-Oakland, Oakland, California, 94611, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|Rady Children's Hospital - San Diego, San Diego, California, 92123, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, 90502, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, 80218, United States|Yale University, New Haven, Connecticut, 06520, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, 19803, United States|MedStar Georgetown University Hospital, Washington D.C., District of Columbia, 20007, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, 33908, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, 32610, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, 32207, United States|AdventHealth Orlando, Orlando, Florida, 32803, United States|Nemours Children's Hospital, Orlando, Florida, 32827, United States|Nemours Children's Clinic - Pensacola, Pensacola, Florida, 32504, United States|Johns Hopkins All Children's Hospital, St. Petersburg, Florida, 33701, United States|Tampa General Hospital, Tampa, Florida, 33606, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, 33607, United States|Saint Mary's Medical Center, West Palm Beach, Florida, 33407, United States|Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, 30329, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|University of Illinois, Chicago, Illinois, 60612, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois, 60453, United States|Advocate Children's Hospital-Park Ridge, Park Ridge, Illinois, 60068, United States|Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana, 46260, United States|Blank Children's Hospital, Des Moines, Iowa, 50309, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|Norton Children's Hospital, Louisville, Kentucky, 40202, United States|Children's Hospital New Orleans, New Orleans, Louisiana, 70118, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, 70121, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, 21215, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, 55404, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, 64108, United States|Cardinal Glennon Children's Medical Center, St Louis, Missouri, 63104, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, 68114, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, 89109, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, 89135, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, 89144, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Saint Joseph's Regional Medical Center, Paterson, New Jersey, 07503, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|NYU Langone Hospital - Long Island, Mineola, New York, 11501, United States|The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, 11040, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University of Rochester, Rochester, New York, 14642, United States|Stony Brook University Medical Center, Stony Brook, New York, 11794, United States|Mission Hospital, Asheville, North Carolina, 28801, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, 44308, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Legacy Emanuel Children's Hospital, Portland, Oregon, 97227, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, 29605, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, 37232, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, 78723, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, 75390, United States|El Paso Children's Hospital, El Paso, Texas, 79905, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Methodist Children's Hospital of South Texas, San Antonio, Texas, 78229, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22908, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, 23298, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, 99204, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington, 98405, United States|Princess Margaret Hospital for Children, Perth, Western Australia, 6008, Australia|Perth Children's Hospital, Perth, Western Australia, 6009, Australia|IWK Health Centre, Halifax, Nova Scotia, B3K 6R8, Canada|Starship Children's Hospital, Grafton, Auckland, 1145, New Zealand|Christchurch Hospital, Christchurch, 8011, New Zealand",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Talazoparib|DRUG: Itraconazole|DRUG: Rifampin,ALL,"ADULT, OLDER_ADULT",PHASE1,36,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,11/7/16,1/20/18,"PRA Magyarorszag Kft, Fazis I-es Klinikai Farmakologiai Vizsgalohely, Budapest, 1077, Hungary|ARENSIA Exploratory Medicine Phase I Unit, PMSI Institute of Oncology, Chisinau, MD2025, Moldova|Szpital LUX MED, Warsaw, 02-801, Poland|I.M. Sechenov First Moscow State Medical University, Moscow, 119435, Russia|I.M. Sechenov First Moscow State Medical University, Moscow, 119991, Russia|""BioEq"" LLC, Saint Petersburg, 197342, Russia|State budget healthcare institution of Yaroslavl region ""Regional clinical oncology hospital"", Yaroslavl, 150054, Russia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Neoplasm,DRUG: Pevonedistat|DRUG: Rifampin|DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,20,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER,8/13/18,2/28/21,"Emory University, Atlanta, Georgia, 30308, United States|Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, 60611, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201-2013, United States|Greenville Health System - Institute for Translational Oncology Research, Greenville, South Carolina, 29605, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: HM30181 methanesulfonate monohydrate plus oral paclitaxel capsules,ALL,"ADULT, OLDER_ADULT",PHASE1,42,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,8/1/15,3/27/19,"Monash Medical Centre, Melbourne, Australia|Auckland City Hospital, Auckland, New Zealand|Dunedin Hospital, Dunedin, 9016, New Zealand|Wellington Regional Hospital, Wellington, New Zealand|Shuang Ho hospital, New Taipei City, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Lotung Poh-Ai Hospital, Yilan, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Brain Neoplasms,DRUG: Nivolumab|DRUG: Temozolomide|RADIATION: Radiotherapy|OTHER: Nivolumab Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,716,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT",5/9/16,4/9/24,"Local Institution - 0023, Birmingham, Alabama, 35294-3410, United States|Local Institution - 0003, Phoenix, Arizona, 85013, United States|Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|Local Institution - 0010, Los Angeles, California, 90095-1769, United States|Local Institution - 0128, Sacramento, California, 95816, United States|Local Institution - 0029, San Diego, California, 92123, United States|Local Institution - 0006, San Francisco, California, 94143-0372, United States|Local Institution - 0004, New Haven, Connecticut, 06520, United States|Local Institution - 0031, Washington D.C., District of Columbia, 20007, United States|Local Institution - 0087, Miami, Florida, 33136, United States|Local Institution - 0030, Tampa, Florida, 33612, United States|Local Institution - 0022, Chicago, Illinois, 60637, United States|Local Institution - 0060, Westwood, Kansas, 66205, United States|Local Institution - 0018, Louisville, Kentucky, 40202, United States|Local Institution - 0020, Baltimore, Maryland, 21287, United States|Local Institution - 0011, Boston, Massachusetts, 02215, United States|Local Institution - 0028, Boston, Massachusetts, 02215, United States|Local Institution - 0035, Detroit, Michigan, 48202, United States|Local Institution - 0002, St Louis, Missouri, 63110, United States|Local Institution - 0017, Edison, New Jersey, 08820, United States|Local Institution - 0012, Hackensack, New Jersey, 07601, United States|Local Institution - 0015, New York, New York, 10032, United States|Local Institution - 0024, New York, New York, 10065, United States|Local Institution - 0032, Charlotte, North Carolina, 28204, United States|Preston Robert Tisch Brain Tumor Center at Duke University, Durham, North Carolina, 27710, United States|Local Institution - 0001, Cleveland, Ohio, 44195, United States|Local Institution - 0027, Columbus, Ohio, 43210, United States|Local Institution - 0098, Allentown, Pennsylvania, 18103, United States|Local Institution - 0016, Philadelphia, Pennsylvania, 19107, United States|Local Institution - 0021, Charleston, South Carolina, 29425, United States|Erlanger Oncology & Hematology - Univ. of TN, Chattanooga, Tennessee, 37403, United States|Local Institution - 0008, Nashville, Tennessee, 37232, United States|Local Institution - 0025, Dallas, Texas, 75390-8575, United States|Local Institution - 0009, Salt Lake City, Utah, 84112, United States|Local Institution - 0005, Seattle, Washington, 98122, United States|Local Institution - 0049, Liverpool, New South Wales, 2170, Australia|Local Institution - 0052, St Leonards, New South Wales, 2065, Australia|Local Institution - 0050, Heidelberg, Victoria, 3084, Australia|Local Institution - 0051, Prahran, Victoria, 3181, Australia|Local Institution - 0122, Nedlands, Western Australia, 6009, Australia|Local Institution - 0062, Linz, 4020, Austria|Local Institution - 0061, Vienna, 1090, Austria|Local Institution - 0070, Brussels, 1090, Belgium|Local Institution - 0069, Brussels, 1200, Belgium|Local Institution - 0071, Leuven, 3000, Belgium|Local Institution - 0046, Vancouver, British Columbia, V5Z 4E6, Canada|Local Institution - 0048, Toronto, Ontario, M5G 2M9, Canada|Local Institution - 0047, Montreal, Quebec, H3A 2B4, Canada|Local Institution - 0084, Copenhagen, 2100, Denmark|Local Institution - 0085, Odense, 5000, Denmark|Local Institution - 0043, Lille, 59037, France|Local Institution - 0041, Lyon, 69394, France|Local Institution - 0040, Marseille, 13385, France|Local Institution - 0042, Nancy, 54035, France|Local Institution - 0038, Paris, 75010, France|Local Institution - 0039, Paris, 75651, France|Local Institution - 0044, Rennes, 35042, France|Local Institution - 0045, Toulouse, 31100, France|Local Institution - 0055, Bonn, 53127, Germany|Local Institution - 0131, Cologne, 50937, Germany|Local Institution - 0123, Erlangen, 91054, Germany|Local Institution - 0053, Frankfurt am Main, 60528, Germany|Local Institution - 0124, Freiburg im Breisgau, 79106, Germany|Local Institution - 0057, Hamburg, 20246, Germany|Local Institution - 0056, Heidelberg, 69120, Germany|Local Institution - 0130, Munich, 81675, Germany|Local Institution - 0054, Münster, 48149, Germany|Local Institution - 0058, Regensburg, 93053, Germany|Local Institution - 0059, Tübingen, 72076, Germany|Local Institution - 0094, Petah Tikva, 49100, Israel|Local Institution - 0093, Tel Aviv, 64239, Israel|Local Institution - 0088, Bologna, 40139, Italy|Local Institution - 0089, Milan, 20133, Italy|Local Institution - 0092, Padua, 35128, Italy|Local Institution - 0127, Rozzano (milano), 20089, Italy|Local Institution - 0090, Siena, 53100, Italy|Local Institution - 0091, Torino, 10126, Italy|Local Institution - 0110, Nagoya, Aichi-ken, 4668560, Japan|Local Institution - 0099, Chiba, Chiba, 2608677, Japan|Local Institution - 0100, Hiroshima, Hiroshima, 7348551, Japan|Local Institution - 0101, Sapporo, Hokkaido, 0608648, Japan|Local Institution - 0105, Kobe, Hyōgo, 650-0017, Japan|Local Institution - 0116, Tsukuba, Ibaraki, 3058576, Japan|Local Institution - 0103, Kanazawa, Ishikawa-ken, 9200934, Japan|Local Institution - 0102, Kagoshima, Kagoshima-ken, 8908520, Japan|Local Institution - 0118, Sagamihara-shi, Kanagawa, 2520375, Japan|Local Institution - 0106, Kumamoto, Kumamoto, 8608556, Japan|Local Institution - 0120, Okayama, Okayama-ken, 7008558, Japan|Local Institution - 0104, Hirakata-shi, Osaka, 5731191, Japan|Local Institution - 0112, Suita, Osaka, 5650871, Japan|Local Institution - 0121, Hidaka-shi, Saitama, 3501298, Japan|Local Institution - 0114, Bunkyo-ku, Tokyo, 1138655, Japan|Local Institution - 0111, Chuo-ku, Tokyo, 1040045, Japan|Local Institution - 0107, Mitaka-shi, Tokyo, 181-8611, Japan|Local Institution - 0115, Shinjuku-ku, Tokyo, 1628666, Japan|Local Institution - 0117, Yamagata, Yamagata, 9909585, Japan|Local Institution - 0109, Kyoto, 6068507, Japan|Local Institution - 0108, Kyoto, 612-8555, Japan|Local Institution - 0073, Rotterdam, South Holland, 3015 GD, Netherlands|Local Institution - 0075, Amsterdam, 1066 CX, Netherlands|Local Institution - 0074, Groningen, 9713 AP, Netherlands|Local Institution - 0072, Utrecht, 3584 CX, Netherlands|Local Institution - 0083, Oslo, 0424, Norway|Local Institution - 0086, Gdansk, 80-214, Poland|Local Institution - 0132, Warsaw, 02-781, Poland|Local Institution - 0095, Moscow, 105229, Russia|Local Institution - 0097, Moscow, 115478, Russia|Local Institution - 0126, Badalona-barcelona, 08916, Spain|Local Institution - 0078, Barcelona, 08035, Spain|Local Institution - 0125, Barcelona, 08036, Spain|Local Institution - 0077, Madrid, 28009, Spain|Local Institution - 0076, Madrid, 28041, Spain|Local Institution - 0080, Santiago Compostela, 15706, Spain|Local Institution - 0079, Valencia, 46014, Spain|Local Institution - 0081, Lund, 221 85, Sweden|Local Institution - 0082, Solna, 171 64, Sweden|Local Institution - 0065, Geneva, 1211, Switzerland|Local Institution - 0064, Lausanne, 1011, Switzerland|Local Institution - 0063, Zurich, 8091, Switzerland|Local Institution - 0066, Manchester, Greater Manchester, M20 4BX, United Kingdom|Local Institution - 0119, Sutton, Surrey, SM2 5PT, United Kingdom|Local Institution - 0068, Glasgow, G12 0YN, United Kingdom|Local Institution - 0067, London, NW1 2BU, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: Pembrolizumab|DRUG: SD-101|DRUG: Leuprolide acetate|DRUG: Abiraterone Acetate|DRUG: Prednisone|RADIATION: Stereotactic Body Radiation Therapy,ALL,"ADULT, OLDER_ADULT",PHASE2,23,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/17/17,3/31/25,"University of California San Francisco, San Francisco, California, 94143, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Neratinib|DRUG: Fulvestrant|DRUG: Trastuzumab|PROCEDURE: Tumor biopsy|PROCEDURE: Research blood sample,ALL,"ADULT, OLDER_ADULT",PHASE2,56,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/11/12,3/11/21,"University of Alabama Cancer Center, Birmingham, Alabama, 35294, United States|Mayo Clinic, Phoenix, Arizona, 85054, United States|University of Southern California Keck School of Medicine, Los Angeles, California, 90033, United States|Stanford Medicine Cancer Institute, Stanford, California, 94305, United States|University of Miami Hospital and Clinics, Miami, Florida, 33136, United States|Northwestern University - Feinberg School of Medicine, Chicago, Illinois, 60611, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Dana-Farber Cancer Institute, Harvard University, Boston, Massachusetts, 02215, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|St. Luke's Cancer Institute, Kansas City, Missouri, 64111, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|University of North Carolina at Chapel Hill (Lineberger Comprehensive Cancer Center), Chapel Hill, North Carolina, 27514, United States|Duke Cancer Institute at Duke University Medical Center, Durham, North Carolina, 27710, United States|Avera Cancer Institute, Sioux Falls, South Dakota, 57105, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|BC Cancer Agency, Vancouver, British Columbia, V5Z 1L3, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Colorectal Neoplasms,DRUG: Tepotinib|BIOLOGICAL: Cetuximab,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/28/21,3/31/22,"Mayo Clinic, Phoenix, Arizona, 85054, United States|Moores Cancer Center, La Jolla, California, 92093, United States|University of California, Los Angeles (UCLA), Santa Monica, California, 90404, United States|Georgetown Lombardi Comprehensive Cancer Center, Washington D.C., District of Columbia, 20007, United States|Mayo Clinic Hospital, Jacksonville, Florida, 322224-1865, United States|Cancer Center of Kansas, Wichita, Kansas, 67214-3728, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|North Shore-LIJ Monter Cancer Center, Lake Success, New York, 11042, United States|Allegheny-Singer Research Institute, Pittsburgh, Pennsylvania, 15212, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Scott & White Vasicek Cancer Treatment Center, Temple, Texas, 76508-0001, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109-1023, United States|Aurora Cancer Care - Milwaukee West, Wauwatosa, Wisconsin, 53226, United States|Antwerp University Hospital, Antwerp, Belgium|UZ Leuven, Leuven, Belgium|Universtity Hospital Brno, Brno, Czechia|University Hospital Olomouc, Olomouc, Czechia|Dept. of Oncology Faculty Hospital Motol, Prague, Czechia|Hospital Na Bulovce, Prague, Czechia|CHU Besançon Hôpital Jean Minjoz, Besançon, France|University Hospital of Besançon, Besançon, France|CHU Estaing, Clermont-Ferrand, France|CHU Hôpital Henri Mondor, Créteil, France|Clinique Victor Hugo, Le Mans, France|CHU de Poitiers, Poitiers, France|Curie Institute, Saint-Cloud, France|Institut Curie - René-Huguenin Hospital, Saint-Cloud, France|Istituto Scientifico Romagnolo per lo Studio e la Cura die Tumori, Meldona, Italy|Fondazione IRCCS - Istituto Tumori Milano, Milan, Italy|Grande Ospedale Metropolitano Niguarda, Milan, Italy|Istituto Europeo di Oncologia, Milan, Italy|Istituto Nazionale Tumori, Fondazione G. Pascale Napoli, Napoli, Italy|UOC Oncoematologia AOU Vanvitelli, Napoli, Italy|Istituto Oncologico Veneto IRCCS, Padua, Italy|Azienda Ospedaliero Universitaria Pisana-Ospedale Santa Chiara, Pisa, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy|Foundation IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo FG, Italy|Arkangelsk Clinical Oncological Dyspensary, Arkhangelsk, Russia|Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine, Chelyabinsk, Russia|Kursk Regional Clinical Oncology Dispensary, Kislino, Russia|FSBI ""National Medical Research Center of Oncology n.a. N.N. Blokhina"" of the MoH of the RF, Moscow, Russia|Limited Liability Company Medicine 24/7, Moscow, Russia|Russian Cancer research center n.a. N.N. Blokhin, Moscow, Russia|Omsk Regional Oncology Dispensary, Omsk, Russia|LLC Clinica UZI 4D, Pyatigorsk, Russia|Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia|Tomsk National Research Medical Center, Tomsk, Russia|MKMC Medical City, Tyumen, Russia|SAHI Republican Clinical Oncology Dispensary, Ufa, Russia|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|VHIO Valle de Hebron Instituto de Oncologia, Barcelona, Spain|H.U. Ramon y Cajal, Madrid, Spain|HM-CIOCC, Madrid, Spain|Hospital de Madrid Norte Sanchinarro, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital UNiversitario La Paz, Madrid, Spain|H.U.Marqués de Valdecilla, Santander, Spain|HUVirgen del Rocio, Seville, Spain|Consorcio Hospital General Universitario de Valencia, Valencia, Spain|Bristol Oncology Centre, Bristol, United Kingdom|Beatson WJSCC, Glasgow, United Kingdom|Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom|The Royal Marsden Hospital, London, United Kingdom|The Royal Marsden Hospital, Sutton, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Nonhematological Neoplasms,DRUG: TAK-228,ALL,"ADULT, OLDER_ADULT",PHASE1,28,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER,1/17/18,8/28/19,"National Cancer Center Hospital East, Kashiwa-shi, Chiba, 277-8577, Japan|National Cancer Center Hospital, Chūōku, Tokyo-To, 104-0045, Japan|Asan Medical Center, Seoul, 05505, South Korea|National Taiwan-University Hospital, Taipei, 100, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Prostatic Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Enzalutamide|DRUG: Placebo,MALE,"ADULT, OLDER_ADULT",PHASE3,1244,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",7/28/19,5/29/26,"University of South Alabama, Mitchell Cancer Institute ( Site 0065), Mobile, Alabama, 36604, United States|Providence Medical Foundation-Oncology ( Site 0069), Fullerton, California, 92835, United States|UCLA Hematology/Oncology - Santa Monica ( Site 0081), Los Angeles, California, 90404, United States|University of Colorado Cancer Center ( Site 0022), Aurora, Colorado, 80045, United States|Smilow Cancer Hospital at Yale New Haven ( Site 0038), New Haven, Connecticut, 06513, United States|Moffitt Cancer Center ( Site 0080), Tampa, Florida, 33612, United States|Georgia Cancer Center at Augusta University ( Site 0026), Augusta, Georgia, 30912, United States|Mount Sinai Hospital ( Site 0042), Chicago, Illinois, 60608, United States|Methodist Hospitals. ( Site 0008), Merrillville, Indiana, 46410, United States|Tulane Cancer Center ( Site 0066), New Orleans, Louisiana, 70112, United States|University of Massachusetts Worcester ( Site 0053), Worcester, Massachusetts, 01655, United States|Cancer & Hematology Centers of Western Michigan ( Site 0013), Grand Rapids, Michigan, 49503, United States|Munson Medical Center ( Site 0030), Traverse City, Michigan, 49684, United States|St. Vincent Frontier Cancer Center ( Site 0016), Billings, Montana, 59102, United States|Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0034), Omaha, Nebraska, 68130, United States|Comprehensive Cancer Centers of Nevada ( Site 0092), Las Vegas, Nevada, 89169, United States|John Theurer Cancer Center at Hackensack University Medical Center ( Site 0004), Hackensack, New Jersey, 07601, United States|Associated Medical Professionals of NY ( Site 0060), Syracuse, New York, 13210, United States|W. G. Bill Hefner VA Medical Center ( Site 0029), Salisbury, North Carolina, 28144, United States|Gabrail Cancer Center-Research ( Site 0096), Canton, Ohio, 44718, United States|Tri-State Urologic Services PSC, Inc. ( Site 0094), Cincinnati, Ohio, 45212, United States|University Hospitals Cleveland Medical Center ( Site 0036), Cleveland, Ohio, 44106, United States|Oregon Health Science University ( Site 0031), Portland, Oregon, 97239, United States|Carolina Urologic Research Center ( Site 0070), Myrtle Beach, South Carolina, 29572, United States|Inova Schar Cancer Institute ( Site 0006), Fairfax, Virginia, 22031, United States|Virginia Cancer Institute ( Site 0052), Richmond, Virginia, 23230, United States|Blue Ridge Cancer Care ( Site 0086), Roanoke, Virginia, 24014, United States|Froedtert Hospital & the Medical College of Wisconsin ( Site 0045), Milwaukee, Wisconsin, 53226, United States|Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 1013), Berazategui, Buenos Aires, B1884BBF, Argentina|Organizacion Medica de Investigacion ( Site 1019), CABA, Buenos Aires, C1015ABO, Argentina|Instituto Medico Alexander Fleming ( Site 1010), Ciudad Autonoma de Buenos Aires., Buenos Aires, C1426ANZ, Argentina|Instituto de Investigaciones Clinicas ( Site 1000), Mar del Plata, Buenos Aires, B7600FZO, Argentina|Centro de Diagnostico Urologico ( Site 1008), Buenos Aires, Buenos Aires F.D., C1120AAT, Argentina|Sanatorio Parque ( Site 1002), Rosario, Santa Fe Province, S2000DSV, Argentina|Instituto de Oncologia de Rosario ( Site 1015), Rosario, Santa Fe Province, S2000KZE, Argentina|Instituto de Investigaciones Metabolicas [Buenos Aires, Argentina] ( Site 1011), Buenos Aires, C1012AAR, Argentina|Hospital Aleman ( Site 1004), Buenos Aires, C1118AAT, Argentina|Centro Medico Dra De Salvo ( Site 1018), Buenos Aires, C1426ABP, Argentina|CEMAIC ( Site 1014), Córdoba, X5008HHW, Argentina|Centro Oncologico Riojano Integral ( Site 1005), La Rioja, F5300COE, Argentina|Centro Oncologico de Integracion Regional. COIR ( Site 1007), Mendoza, M5500AYB, Argentina|St. Vincent's Hospital ( Site 0158), Darlinghurst, New South Wales, 2010, Australia|St George Hospital ( Site 0157), Kogarah, New South Wales, 2217, Australia|Macquarie University ( Site 0151), Macquarie University, New South Wales, 2109, Australia|Port Macquarie Base Hospital ( Site 0153), Port Macquarie, New South Wales, 2444, Australia|Calvary Mater Newcastle ( Site 0148), Waratah, New South Wales, 2298, Australia|Gallipoli Medical Research Ltd ( Site 0149), Greenslopes, Queensland, 4120, Australia|Gold Coast University Hospital ( Site 0150), Southport, Queensland, 4215, Australia|Royal Adelaide Hospital ( Site 0154), Adelaide, South Australia, 5000, Australia|Monash Medical Centre ( Site 0147), Clayton, Victoria, 3168, Australia|Fiona Stanley Hospital ( Site 0162), Perth, Western Australia, 6150, Australia|Ordensklinikum Linz GmbH Elisabethinen ( Site 0373), Linz, Upper Austria, 4020, Austria|Medizinische Universität Wien ( Site 0375), Vienna, 1090, Austria|Hospital Erasto Gaertner-CEPEP - Pesquisa Clínica ( Site 1036), Curitiba, Paraná, 81520-060, Brazil|Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 1032), Natal, Rio Grande do Norte, 59075-740, Brazil|ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 1038), Ijuí, Rio Grande do Sul, 98700-000, Brazil|Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 1021), Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 1035), Itajaí, Santa Catarina, 88301-215, Brazil|Hospital de Base de Sao Jose de Rio Preto ( Site 1022), São José do Rio Preto, São Paulo, 15090-000, Brazil|A.C. Camargo Cancer Center ( Site 1026), São Paulo, 01509-900, Brazil|Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 1040), São Paulo, 04014-002, Brazil|MHAT Serdika-Second Department of Medical Oncology ( Site 0505), Sofia, Sofia (stolitsa), 1301, Bulgaria|MHAT Central Hospital ( Site 0503), Plovdiv, 4000, Bulgaria|Complex Cancer Center Plovdiv-First Medical Oncology Department ( Site 0507), Plovdiv, 4004, Bulgaria|BC Cancer Victoria-Clinical Trials Unit ( Site 0111), Victoria, British Columbia, V8R 6V5, Canada|Health Sciences North ( Site 0122), Greater Sudbury, Ontario, P3E 5J1, Canada|Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0116), Hamilton, Ontario, L8V 5C2, Canada|Grand River Hospital ( Site 0120), Kitchener, Ontario, N2G 1G3, Canada|Lakeridge Health ( Site 0117), Oshawa, Ontario, L1G 2B9, Canada|Sunnybrook Research Institute ( Site 0108), Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Cancer Centre ( Site 0107), Toronto, Ontario, M5G 2M9, Canada|CISSS de la Monteregie-Centre ( Site 0119), Greenfield Park, Quebec, J4V 2H1, Canada|Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0106), Montreal, Quebec, H2X 3E4, Canada|Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0103), Québec, Quebec, G1J 1Z4, Canada|CIUSSS du Bas Saint Laurent - Hopital Regional de Rimouski ( Site 0102), Rimouski, Quebec, G5L 5T1, Canada|CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0105), Sherbrooke, Quebec, J1H 5N4, Canada|Fundacion Arturo Lopez Perez ( Site 1049), Santiago, Region M. de Santiago, 7500921, Chile|Pontificia Universidad Catolica de Chile ( Site 1047), Santiago, Region M. de Santiago, 8330024, Chile|Bradfordhill ( Site 1044), Santiago, Region M. de Santiago, 8420383, Chile|Centro Investigación del Cáncer James Lind ( Site 1041), Temuco, Región de la Araucanía, 4800827, Chile|Rey y Oreilly Limitada ( Site 1048), Temuco, Región de la Araucanía, 4810148, Chile|Oncocentro ( Site 1045), Viña del Mar, Región de Valparaíso, 2520598, Chile|Hospital Pablo Tobon Uribe ( Site 1066), Medellín, Antioquia, 050034, Colombia|Biomelab S A S ( Site 1067), Barranquilla, Atlántico, 080001, Colombia|Clinica de la Costa S.A.S. ( Site 1073), Barranquilla, Atlántico, 080020, Colombia|Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 1062), Bogotá, Bogota D.C., 110311, Colombia|Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 1068), Valledupar, Cesar Department, 200001, Colombia|Oncomédica S.A.S ( Site 1057), Montería, Departamento de Córdoba, 230002, Colombia|Clínica Imbanaco S.A.S ( Site 1064), Cali, Valle del Cauca Department, 760042, Colombia|Hemato Oncologos S.A. ( Site 1065), Cali, Valle del Cauca Department, 760042, Colombia|Fakultni Nemocnice u sv. Anny v Brne-Onkologicko-chirurgicke oddeleni ( Site 1303), Brno, Brno-mesto, 656 91, Czechia|Nemocnice AGEL Novy Jicin a.s. ( Site 1304), Nový Jičín, Novy Jicin, 741 01, Czechia|Fakultni nemocnice Olomouc ( Site 1301), Olomouc, Olomoucký kraj, 779 00, Czechia|C.H. de Saint Quentin ( Site 0481), Saint-Quentin, Aisne, 02321, France|Centre Jean Perrin ( Site 0434), Clermont-Ferrand, Auvergne, 63011, France|Clinique Sainte Anne ( Site 0431), Strasbourg, Bas-Rhin, 67000, France|CHU de Brest -Site Hopital Morvan ( Site 0441), Brest, Brittany Region, 29200, France|CHU Jean Minjoz ( Site 0423), Besançon, Doubs, 25000, France|Institut Bergonie ( Site 0421), Bordeaux, Gironde, 33076, France|Institut Claudius Regaud IUCT Oncopole ( Site 0418), Toulouse, Haute-Garonne, 31059, France|Hopital Foch ( Site 0428), Suresnes, Hauts-de-Seine, 92150, France|Institut Regional du Cancer de Montpellier - ICM ( Site 0443), Montpellier, Herault, 34298, France|Institut De Cancerologie De L Ouest ( Site 0448), Saint-Herblain, Loire-Atlantique, 44805, France|Centre Hospitalier Regional du Orleans ( Site 0430), Orléans, Loiret, 45100, France|Centre D Oncologie de Gentilly ( Site 0432), Nancy, Meurthe-et-Moselle, 54000, France|Centre Hospitalier de Valenciennes ( Site 0439), Valenciennes, Nord, 59300, France|C.H.U. Lyon Sud ( Site 0436), Pierre-Bénite, Rhone, 69310, France|CHU Amiens Picardie Site Sud Amiens ( Site 0438), Amiens, Somme, 80000, France|Institut Gustave Roussy ( Site 0416), Villejuif, Val-de-Marne, 94800, France|Institut Sainte Catherine ( Site 0447), Avignon, Vaucluse, 84918, France|Institut Mutualiste Montsouris ( Site 0446), Paris, 75014, France|Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304), Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany|Studienpraxis Urologie ( Site 0309), Nürtingen, Baden-Wurttemberg, 72622, Germany|Universitaetsklinik fuer Urologie ( Site 0307), Tübingen, Baden-Wurttemberg, 72076, Germany|Klinikum Rechts der Isar ( Site 0300), Munich, Bavaria, 81675, Germany|Universitaetsklinik der Paracelsus Medizinischen Privatuniversitaet ( Site 0318), Nuremberg, Bavaria, 90419, Germany|Universitaetsklinikum Goettingen ( Site 0345), Göttingen, Lower Saxony, 37075, Germany|Uniklinik RWTH Aachen ( Site 0308), Aachen, North Rhine-Westphalia, 52074, Germany|Universitaetsklinikum Muenster ( Site 0320), Münster, North Rhine-Westphalia, 48149, Germany|Krankenhaus der Barmherzigen Brueder Trier ( Site 0310), Trier, Rhineland-Palatinate, 54292, Germany|Universitaetsklinikum des Saarlandes ( Site 0348), Homburg, Saarland, 66421, Germany|Universitaetsklinikum Schleswig Holstein. ( Site 0346), Lübeck, Schleswig-Holstein, 23538, Germany|Universitaetsklinikum Jena ( Site 0305), Jena, Thuringia, 07747, Germany|Charite Universitaetsmedizin Berlin ( Site 0301), Berlin, 10117, Germany|Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1321), Kecskemét, Bács-Kiskun county, 6000, Hungary|Petz Aladár Megyei Oktató Kórház-Onkológiai Osztály ( Site 1324), Győr, Győr-Moson-Sopron, 9024, Hungary|Országos Onkológiai Intézet-Urogenital Tumors Department and Clinical Pharmacology ( Site 1325), Budapest, Pest County, 1122, Hungary|Magyar Honvedseg Egeszsegugyi Kozpont-Onkologiai Osztaly ( Site 1326), Budapest, 1062, Hungary|Beaumont Hospital ( Site 0726), Dublin, D09 V2N0, Ireland|Tallaght University Hospital ( Site 0730), Dublin, D24 NROA, Ireland|Mid Western Cancer Centre ( Site 0728), Limerick, V98F858, Ireland|HaEmek Medical Center ( Site 0548), Afula, 1834111, Israel|Assuta Ashdod Medical Center ( Site 0550), Ashdod, 7747629, Israel|Soroka Medical Center ( Site 0549), Beersheba, 8410101, Israel|Rambam Health Care Campus-Oncology Division ( Site 0543), Haifa, 3109601, Israel|Hadassah Ein Kerem Medical Center ( Site 0546), Jerusalem, 9112001, Israel|Meir Medical Center ( Site 0544), Kfar Saba, 4428164, Israel|Rabin Medical Center ( Site 0545), Petah Tikva, 4941492, Israel|Chaim Sheba Medical Center ( Site 0541), Ramat Gan, 5262000, Israel|Sourasky Medical Center ( Site 0542), Tel Aviv, 6423906, Israel|Yitzhak Shamir Medical Center. ( Site 0547), Ẕerifin, 70300, Israel|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Oncologia Medica ( Site 0464), Meldola, Emilia-Romagna, 47014, Italy|A.O. Universitaria di Modena ( Site 0454), Modena, Emilia-Romagna, 41124, Italy|Istituto Clinico Humanitas Research Hospital ( Site 0452), Rozzano, Lombardy, 20089, Italy|Presidio Ospedaliero S. Maria Delle Grazie-U.O.C. ONCOLOGIA ( Site 0802), Pozzuoli, Napoli, 80078, Italy|Centro Di Riferimento Oncologico ( Site 0800), Aviano, Pordenone, 33081, Italy|Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Roma-Oncology Unit ( Site 0465), Verona, Veneto, 37134, Italy|Medical Oncology Ospedale San Donato ( Site 0461), Arezzo, 52100, Italy|Ospedale Policlinico S. Orsola-Malpighi ( Site 0453), Bologna, 40138, Italy|Azienda Ospedaliera Cannizzaro ( Site 0458), Catania, 95126, Italy|Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 0462), Napoli, 80131, Italy|Azienda Ospedaliera San Camillo Forlanini ( Site 0455), Roma, 00152, Italy|Fondazione Policlinico Universitario Agostino Gemelli ( Site 0801), Roma, 00168, Italy|Azienda Ospedaliera Santa Maria Terni ( Site 0456), Terni, 05100, Italy|Az. Osp. Univ. Sta Maria della Misericordia di Udine ( Site 0460), Udine, 33100, Italy|National Cancer Center Hospital East ( Site 0702), Kashiwa, Chiba, 2778577, Japan|Toho University Sakura Medical Center ( Site 0703), Sakura, Chiba, 285-8741, Japan|National Hospital Organization Shikoku Cancer Center ( Site 0716), Matsuyama, Ehime, 791-0280, Japan|Iizuka Hospital ( Site 0744), Iizuka, Fukuoka, 820-8505, Japan|Hakodate Goryoukaku Hospital ( Site 0739), Hakodate, Hokkaido, 040-8611, Japan|Kanazawa University Hospital ( Site 0701), Kanazawa, Ishikawa-ken, 920-8641, Japan|Kitasato University Hospital ( Site 0705), Sagamihara, Kanagawa, 252-0375, Japan|Yokohama City University Medical Center ( Site 0706), Yokohama, Kanagawa, 232-0024, Japan|Miyagi Cancer Center ( Site 0747), Natori-shi, Miyagi, 981-1293, Japan|Nara Medical University Hospital ( Site 0715), Kashihara, Nara, 634-8522, Japan|Kindai University Hospital ( Site 0714), Sayama, Osaka, 589-8511, Japan|The University of Osaka Hospital ( Site 0713), Suita, Osaka, 565-0871, Japan|Saitama Medical University International Medical Center ( Site 0708), Hidaka, Saitama, 350-1298, Japan|Saitama Medical Center ( Site 0743), Kawagoe, Saitama, 350-8550, Japan|Dokkyo Medical University Saitama Medical Center ( Site 0707), Koshigaya, Saitama, 343-8555, Japan|Hamamatsu University Hospital ( Site 0720), Hamamatsu, Shizuoka, 431-3192, Japan|Yamaguchi University Hospital ( Site 0717), Ube, Yamaguchi, 755-8505, Japan|Chiba Cancer Center ( Site 0704), Chiba, 260-8717, Japan|Kyushu University Hospital ( Site 0718), Fukuoka, 812-8582, Japan|Hiroshima Prefectural Hospital ( Site 0748), Hiroshima, 734-8530, Japan|University of Miyazaki Hospital ( Site 0721), Miyazaki, 889-1692, Japan|Nagasaki University Hospital ( Site 0719), Nagasaki, 852-8510, Japan|Toranomon Hospital ( Site 0711), Tokyo, 105-8470, Japan|Nippon Medical School Hospital ( Site 0709), Tokyo, 113-8603, Japan|Keio University Hospital ( Site 0710), Tokyo, 160-8582, Japan|Radboud University Medical Center ( Site 0470), Nijmegen, Gelderland, 6525 GA, Netherlands|Maastricht University Medical Centre ( Site 0467), Maastricht, Limburg, 6229 HX, Netherlands|Amphia Hospital Location Molengracht ( Site 0474), Breda, North Brabant, 4818 CK, Netherlands|Catharina Ziekenhuis ( Site 0472), Eindhoven, North Brabant, 5623 EJ, Netherlands|Noordwest Ziekenhuisgroep NWZ ( Site 0468), Alkmaar, North Holland, 1815 JD, Netherlands|Vrije Universiteit Medisch Centrum ( Site 0479), Amsterdam, North Holland, 1081 HV, Netherlands|Tergooiziekenhuizen ( Site 0466), Hilversum, North Holland, 1213 XZ, Netherlands|Spaarne Ziekenhuis ( Site 0473), Hoofddorp, North Holland, 2134TM, Netherlands|Ziekenhuisgroep Twente ( Site 0469), Hengelo, Overijssel, 7555 DL, Netherlands|Haaglanden MC - locatie Antoniushove ( Site 0471), Leidschendam, South Holland, 2501 ck, Netherlands|Franciscus Gasthuis en Vlietland ( Site 0489), Schiedam, South Holland, 3118 JH, Netherlands|Tauranga Hospital ( Site 0215), Tauranga, Bay of Plenty, 3112, New Zealand|Canterbury Regional Cancer & Blood Service ( Site 0195), Christchurch, Canterbury, 8011, New Zealand|Auckland City Hospital ( Site 0193), Auckland, 1023, New Zealand|Przychodnia Lekarska Komed ( Site 0628), Konin, Greater Poland Voivodeship, 62-500, Poland|Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 0636), Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-796, Poland|Clinical Best Solutions ( Site 0622), Warsaw, Masovian Voivodeship, 02-793, Poland|Szpital Wojewodzki im. Mikolaja Kopernika ( Site 0624), Koszalin, West Pomeranian Voivodeship, 75-581, Poland|Salve Medica SP ( Site 0686), Lodz, Łódź Voivodeship, 91-211, Poland|Provita Prolife Centrum Medyczne ( Site 0630), Tomaszów Mazowiecki, Łódź Voivodeship, 97-200, Poland|Puerto Rico Medical Research Center LLC ( Site 1122), San Juan, 00918, Puerto Rico|FDI Clinical Research ( Site 1121), San Juan, 00927, Puerto Rico|Chelyabinsk Regional Clinical Oncological Dispensary ( Site 0565), Chelyabinsk, Chelyabinsk Oblast, 454087, Russia|Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 0585), Krasnoyarsk, Krasnoyarsk Krai, 660133, Russia|State Budgetary Healthcare Institution ""Leningrad Regional Clinical Hospital"" ( Site 0588), Gatchina, Leningradskaya Oblast', 188300, Russia|Russian Scientific Center of Roentgenoradiology ( Site 0559), Moscow, Moscow, 117485, Russia|Central Clinical Hospital with Polyclinic ( Site 0562), Moscow, Moscow, 121359, Russia|Omsk Clinical Oncology Dispensary ( Site 0568), Omsk, Omsk Oblast, 644013, Russia|SBHI Samara Regional Clinical Oncology Dispensary ( Site 0576), Samara, Samara Oblast, 443031, Russia|Clinical Research Center of specialized types medical care-Oncology ( Site 0570), Saint Petersburg, Sankt-Peterburg, 197758, Russia|Russian Scientific Center of Radiology and Surgical Technologies ( Site 0567), Saint Petersburg, Sankt-Peterburg, 197758, Russia|Tomsk National Scientific Medical Center of Russian Academy of Science ( Site 0579), Tomsk, Tomsk Oblast, 634050, Russia|National Cancer Center ( Site 0174), Goyang-si, Kyonggi-do, 10408, South Korea|Seoul National University Bundang Hospital ( Site 0175), Seongnam-si, Kyonggi-do, 13620, South Korea|Asan Medical Center ( Site 0176), Songpagu, Seoul, 05505, South Korea|Seoul National University Hospital ( Site 0171), Seoul, 03080, South Korea|Samsung Medical Center ( Site 0172), Seoul, 06351, South Korea|Instituto Catalan de Oncologia - ICO ( Site 0330), L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Hospital Parc Tauli ( Site 0335), Sabadell, Barcelona, 08208, Spain|Institut Català d'Oncologia (ICO) - Girona ( Site 0321), Girona, Gerona, 17007, Spain|Instituto Valenciano de Oncologia ( Site 0331), Valencia, Valenciana, Comunitat, 46009, Spain|Hospital del Mar ( Site 0333), Barcelona, 08003, Spain|Hospital Provincial San Pedro Alcantara ( Site 0326), Cáceres, 10003, Spain|Hospital Universitario Gregorio Maranon ( Site 0327), Madrid, 28007, Spain|MD Anderson Cancer Center Madrid ( Site 0332), Madrid, 28033, Spain|Hospital Clinico San Carlos ( Site 0324), Madrid, 28040, Spain|Hospital Universitario HM Sanchinarro ( Site 0322), Madrid, 28050, Spain|Hospital Quiron Madrid ( Site 0325), Madrid, 28223, Spain|Hospital Universitario Virgen de la Victoria ( Site 0337), Málaga, 29016, Spain|Hospital Virgen del Rocio ( Site 0329), Seville, 41013, Spain|National Cheng Kung University Hospital ( Site 0134), Tainen, Tainan, 704, Taiwan|China Medical University Hospital ( Site 0132), Taichung, 40447, Taiwan|Taichung Veterans General Hospital ( Site 0133), Taichung, 407, Taiwan|National Taiwan University Hospital ( Site 0131), Taipei, 10048, Taiwan|Taipei Veterans General Hospital ( Site 0135), Taipei, 11217, Taiwan|Ege University Medicine of Faculty ( Site 0661), Bornova, İzmir, 35100, Turkey (Türkiye)|Baskent University Dr. Turgut Noyan Research and Training Center-ONCCOLOGY ( Site 0618), Adana, 01250, Turkey (Türkiye)|Ankara University Hospital Cebeci ( Site 0613), Ankara, 06100, Turkey (Türkiye)|Hacettepe Universitesi-oncology hospital ( Site 0615), Ankara, 06230, Turkey (Türkiye)|Ankara City Hospital-Medical Oncology ( Site 0616), Ankara, 06800, Turkey (Türkiye)|T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Baki-Istanbul Bakirkoy Sadi Konuk Training ( Site 0620), Istanbul, 34440, Turkey (Türkiye)|Acıbadem Maslak Hastanesi ( Site 0660), Istanbul, 34457, Turkey (Türkiye)|TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 0619), Istanbul, 34722, Turkey (Türkiye)|Cherkasy Regional Oncology Dispensary ( Site 1203), Cherkassy, Cherkasy Oblast, 18009, Ukraine|Dnepropetrovsk Regional Clinical Hospital Mechnikov-Department of urology ( Site 1205), Dnipro, Dnipropetrovsk Oblast, 49005, Ukraine|Dnepropetrovsk Regional Clinical Oncology Hospital-Clinical oncological dispensary ( Site 1201), Dnipropetrovsk, Dnipropetrovsk Oblast, 49055, Ukraine|Ivano-Frankivsk Regional Hospital-Urology department ( Site 1208), Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76008, Ukraine|Communal Non-Commercial Enterprise """"Prykarpatski Clinical Oncological Center"""" of Ivano-Frankivsk R ( Site 1209), Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine|CNPE Regional Center of Oncology-oncourology department ( Site 1202), Kharkiv, Kharkivs’ka Oblast’, 61070, Ukraine|LISOD - Israeli Oncological Hospital """"MedX-ray Internationa-Department of Clinical and Scientific ( Site 1207), Kiev, Kyivska Oblast, 08720, Ukraine|Municipal non-profit enterprise Kyiv City Clinical Oncology -Oncourology department ( Site 1204), Kyiv, Kyivska Oblast, 03115, Ukraine|University Hospitals Bristol NHS Foundation Trust ( Site 0530), Bristol, Bristol, City of, BS2 8ED, United Kingdom|Cambridge University Hospitals NHS Trust ( Site 0540), Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom|Torbay Hospital ( Site 0532), Torquay, Devon, TQ2 7AA, United Kingdom|University College London Hospitals NHS Foundation Trust ( Site 0482), London, London, City of, NW1 2PG, United Kingdom|Western General Hospital ( Site 0531), Edinburgh, Midlothian, EH4 2XU, United Kingdom|Royal Marsden Hospital (Sutton) ( Site 0526), London, Surrey, SM3 5PT, United Kingdom|Musgrove Park Hospital ( Site 0537), Taunton, Worcestershire, TA1 5DA, United Kingdom|Mount Vernon Cancer Centre ( Site 0536), Northwood, HA6 2RN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms,DRUG: Vicriviroc|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,41,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/24/18,6/8/21,"Honor Health ( Site 0103), Scottsdale, Arizona, 85258, United States|California Cancer Associates for Research & Excellence ( Site 0100), Encinitas, California, 92024, United States|California Cancer Associates for Research & Excellence ( Site 0102), Fresno, California, 93720, United States|Florida Cancer Specialists (South Region) - Research Office ( Site 7001), Fort Myers, Florida, 33901-8101, United States|Tennessee Oncology, PLLC/The Sarah Cannon Research Institute ( Site 7000), Nashville, Tennessee, 37203, United States|Baylor Scott & White Medical Center - Temple ( Site 0104), Temple, Texas, 76508, United States|Cross Cancer Institute ( Site 0201), Edmonton, Alberta, T6G 1Z2, Canada|CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0204), Montreal, Quebec, H1T 2M4, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Onartuzumab|DRUG: Bevacizumab|DRUG: Erlotinib,ALL,"ADULT, OLDER_ADULT",PHASE3,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/27/15,6/29/18,"Hopital Roger Salengro, Lille, 59037, France|Azienda Ospedaliero Universitaria San Giovanni Battista Di Torino, Turin, Piedmont, 10126, Italy|National Hospital Organization Shikoku Cancer Center, Ehime, 791-0280, Japan|Rigas Austrumu Kliniska Universitates slimnica, Latvijas Onkologijas centrs, Riga, LV 1079, Latvia|Ivanovo Regional Oncology Dispensary, Ivanovo, 153040, Russia|Clin Hospital Center - Kragujevac; Pulmonary Diseases, Kragujevac, 34000, Serbia|University of the Witwatersrand Research, Johannesburg, 2193, South Africa|Sandton Oncology Medical Group, Sandton, 2196, South Africa|Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona, 08035, Spain|HOSPITAL DE MADRID NORTE SANCHINARRO- CENTRO INTEGRAL ONCOLOGICO CLARA CAMPAL; Servicio de Oncologia, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Prostatic Neoplasms,BIOLOGICAL: PROSTVAC V/F|DRUG: Ipilimumab,MALE,"ADULT, OLDER_ADULT",PHASE2,15,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/6/16,4/22/20,"University of California, San Francisco, San Francisco, California, 94143, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Endometrial Neoplasms,DRUG: Pembrolizumab|DRUG: Lenvatinib|DRUG: Paclitaxel|DRUG: Doxorubicin,FEMALE,"ADULT, OLDER_ADULT",PHASE3,827,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/11/18,2/26/25,"Arizona Oncology Associates, PC- HAL, Phoenix, Arizona, 85016, United States|University of California San Francisco, San Francisco, California, 94158, United States|University of California Los Angeles, Santa Monica, California, 90095, United States|Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, 06510, United States|University of Miami Health System, Miami, Florida, 33136, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|Georgia Cancer Center at Augusta University, Augusta, Georgia, 30912, United States|North Shore University Health System, Evanston, Illinois, 60201, United States|University Medical Center New Orleans, New Orleans, Louisiana, 70112, United States|Greater Baltimore Medical Center, Baltimore, Maryland, 21204, United States|Maryland Oncology Hematology, P.A., Wheaton, Maryland, 20902, United States|John Theurer Cancer Center at Hackensack University Med Ctr, Hackensack, New Jersey, 07601, United States|Holy Name Medical Center, Teaneck, New Jersey, 07666, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10022, United States|University of Rochester, Rochester, New York, 14642, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Willamette Valley Cancer Institute and Research Center, Eugene, Oregon, 97401, United States|Sanford Gynecology Oncology, Sioux Falls, South Dakota, 57104, United States|UT West Cancer Center, Germantown, Tennessee, 38138, United States|Texas Oncology-South Austin, Austin, Texas, 78745, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75390-9032, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Texas Oncology-San Antonio Medical Center, San Antonio, Texas, 78240, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Centro de Oncologia e Investigacion Buenos Aires COIBA, Berazategui, Buenos Aires, B1884BBF, Argentina|Hospital Privado de la Comunidad, Mar del Plata, Buenos Aires, B7602CBM, Argentina|Instituto de Investigaciones Metabolicas, Buenos Aires, C1012AAR, Argentina|Hospital Aleman, Buenos Aires, C1118AAT, Argentina|Instituto de Oncologia Angel H. Roffo, Buenos Aires, C1417DTB, Argentina|Instituto Medico Especializado Alexander Fleming, Buenos Aires, C1426ANZ, Argentina|Centro Oncologico Riojano Integral, La Rioja, F5300COE, Argentina|Royal North Shore Hospital, Sydney, New South Wales, 2065, Australia|Royal Brisbane and Women s Hospital, Herston, Queensland, 4029, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia|St John of God, Subiaco, Western Australia, 6008, Australia|Hospital Araujo Jorge, Goiânia, Goiás, 74175-120, Brazil|Instituto Nacional do Cancer II, Rio de Janeiro, Rio de Janeiro, 20220-410, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, 90035-903, Brazil|Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs, Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Fundacao Dr Amaral Carvalho, Jaú, São Paulo, 17210-080, Brazil|Instituto do Cancer de Sao Paulo - ICESP, São Paulo, São Paulo, 01246-000, Brazil|Clinica de Pesquisas e Ctro de Estudos Onc. Ginecol. e Mamaria Ltda, São Paulo, São Paulo, 01317-000, Brazil|Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte, 30130-100, Brazil|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|Cancer Care Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada|London Health Sciences Centre, London, Ontario, N6A 5W9, Canada|Ottawa General Hospital, Ottawa, Ontario, K1H 8L6, Canada|Sunnybrook Health Science Centre, Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont, Montreal, Quebec, H1T 2M4, Canada|Centre Hospitalier de l Universite de Montreal - CHUM, Montreal, Quebec, H2X 3E4, Canada|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|CIUSSS de l'Estrie-CHUS, Sherbrooke, Quebec, J1H 5N4, Canada|CHU de Quebec-Universite Laval-Hotel Dieu de Quebec, Québec, G1R 2J6, Canada|Clinica del Country, Bogota, Cundinamarca, 110221, Colombia|Fundacion Valle del Lili, Cali, Valle del Cauca Department, 760032, Colombia|Biomelab S A S, Barranquilla, 08002, Colombia|Clinica Colsanitas S.A. - Sede Clinica Universitaria Colombia, Bogotá, 111321, Colombia|Rodrigo Botero SAS, Medellín, 50015, Colombia|Fundacion Colombiana de Cancerologia Clinica Vida, Medellín, 50032, Colombia|Oncomedica S.A., Montería, 230002, Colombia|Institut Bergonie, Bordeaux, 33076, France|Centre de Lutte Contre le Cancer Francois Baclesse, Caen, 14076, France|Centre Oscar Lambret, Lille, 59020, France|Centre Leon Berard, Lyon, 69008, France|Institut Regional du Cancer de Montpellier - ICM, Montpellier, 34298, France|Hopital prive du Confluent, Nantes, 44277, France|Groupe Hospitalier Broca Cochin Hotel Dieu, Paris, 75014, France|Hopital Diaconesses Croix Saint Simon, Paris, 75020, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, 69310, France|Centre Armoricain de Radiotherapie Imagerie medicale et Oncologie, Plérin, 22190, France|Centre Eugene Marquis, Rennes, 35042, France|Institut Gustave Roussy, Villejuif, 94800, France|EISAI Trial Site 4, Berlin, Germany|EISAI Trial Site 2, Dresden, Germany|EISAI Trial Site 1, Erlangen, Germany|EISAI Trial Site 6, Hamburg, Germany|EISAI Trial Site 3, Rostock, Germany|EISAI Trial Site 5, Tübingen, Germany|Mater Misericordiae University Hospital, Dublin, D07 R2WY, Ireland|Soroka Medical Center, Beersheba, 84101, Israel|Rambam Medical Center, Haifa, 3525408, Israel|Edith Wolfson Medical Center, Holon, 5822012, Israel|Hadassah Medical Center. Ein Kerem, Jerusalem, 9112001, Israel|Rabin Medical Center, Petah Tikva, 4941492, Israel|Chaim Sheba Medical Center, Ramat Gan, 5262000, Israel|Azienda Ospedaliera per l Emergenza Cannizzaro, Catania, 95126, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, 47014, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy|Ospedale San Raffaele, Milan, 20132, Italy|Istituto Europeo di Oncologia, Milan, 20141, Italy|Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, 80131, Italy|Policlinico Universitario Agostino Gemelli, Roma, 168, Italy|EISAI Trial Site 9, Nagoya, Aichi-ken, Japan|EISAI Trial Site 18, Kashiwa, Chiba, Japan|EISAI Trial Site 7, Matsuyama, Ehime, Japan|EISAI Trial Site 15, Tōon, Ehime, Japan|EISAI Trial Site 5, Kurume, Fukoka, Japan|EISAI Trial Site 11, Sapporo, Hokkaido, Japan|EISAI Trial Site 8, Akashi, Hyōgo, Japan|EISAI Trial Site 17, Tsukuba, Ibaraki, Japan|EISAI Trial Site 4, Morioka, Iwate, Japan|EISAI Trial Site 19, Isehara, Kanagawa, Japan|EISAI Trial Site 14, Sendai, Miyagi, Japan|EISAI Trial Site 1, Hidaka, Saitama, Japan|EISAI Trial Site 2, Sunto-gun, Shizuoka, Japan|EISAI Trial Site 16, Kagoshima, Japan|EISAI Trial Site 3, Niigata, Japan|EISAI Trial Site 10, Tokyo, Japan|EISAI Trial Site 12, Tokyo, Japan|EISAI Trial Site 13, Tokyo, Japan|EISAI Trial Site 6, Tokyo, Japan|Investigacion Onco Farmaceutica S de RL de CV, La Paz, Estado de Baja California, 23040, Mexico|Alivia Clinica de Alta Especialidad S.A. de C.V., Monterrey, Nuevo León, 64060, Mexico|Grupo Medico Camino SC, Mexico City, 3310, Mexico|Centro Hemato Oncologico Privado, Toluca, 50080, Mexico|Faicic S de RL de CV, Veracruz, 91900, Mexico|Auckland City Hospital, Auckland, 1023, New Zealand|Centrum Onkologii Instytut im. Marii Sklodowskiej Curie, Krakow, Lesser Poland Voivodeship, 31-115, Poland|Centrum Onkologii. Instytut im. Marii Sklodowskiej-Curie, Warsaw, Masovian Voivodeship, 02-781, Poland|Beskidzkie Centrum Onkologii im. Jana Pawla II, Bielsko-Biala, 43-300, Poland|Szpital Morski im. PCK Szpitale Wojewodzkie w Gdyni Sp. z o.o., Gdynia, 81-159, Poland|Centrum Onkologii Instytut im. Marii Sklodowskiej Curie, Gliwice, 44-101, Poland|Instytut Centrum Zdrowia Matki Polki, Lodz, 93-338, Poland|Pomorski Uniwersytet Medyczny w Szczecinie, Szczecin, 70-111, Poland|Szpital Kliniczny im Ks Anny Mazowieckiej, Warsaw, 00-315, Poland|Altay Regional Oncology Dispensary, Barnaul, 656049, Russia|Republican Clinical Oncology Dispensary of Tatarstan MoH, Kazan', 420029, Russia|FSBI National Medical Oncology Research Center n.a. N.N. Blokhina, Moscow, 115478, Russia|FSBI-FRCC of Special Types Med. Care & Technologies FMBA of Russia, Moscow, 115682, Russia|Leningrad Regional Oncology Center, Saint Petersburg, 191014, Russia|SPb SBHI City Clinical Oncological Dispensary, Saint Petersburg, 198255, Russia|Mordovia Republican Oncological Dispensary, Saransk, 430032, Russia|Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, 624028, Russia|Republican Clinical Oncology Dispensary of Republic of Bashkortostan, Ufa, 450054, Russia|National Cancer Center, Goyang-si, Gyeonggi-do, 10408, South Korea|Seoul National University Hospital, Seoul, 3080, South Korea|Asan Medical Center, Seoul, 5505, South Korea|Samsung Medical Center, Seoul, 6351, South Korea|Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, 8908, Spain|Hospital General Universitari Vall d Hebron, Barcelona, 8035, Spain|Hospital Universitario Gregorio Maranon, Madrid, 28007, Spain|Clinica Universitaria Navarra - Madrid, Madrid, 28027, Spain|Hospital Ramon y Cajal, Madrid, 28034, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario y Politecnico La Fe de Valencia, Valencia, 46026, Spain|Taipei Veterans General Hospital, Taipei, Beitou, 11217, Taiwan|Kaohsiung Veterans General Hospital, Kaohsiung City, 813, Taiwan|Kaohsiung Chang Gung Memorial Hospital of the C.G.M.F., Kaohsiung City, 833, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Chang Gung Medical Foundation. Linkou Branch, Taoyuan District, 33305, Taiwan|Basken Adana Dr.Turgut Noyan Uygulama ve Arastirma Merkezi, Adana, 01250, Turkey (Türkiye)|Hacettepe University Medical Faculty, Ankara, 06000, Turkey (Türkiye)|Baskent Universitesi Ankara Hastanesi, Ankara, 06490, Turkey (Türkiye)|Acibadem Bursa Hastanesi, Bursa, 16110, Turkey (Türkiye)|Acibadem Universitesi Atakent Hastanesi, Istanbul, 34303, Turkey (Türkiye)|Florence Nightingale Gayrettepe Hastanesi, Istanbul, 34349, Turkey (Türkiye)|Ege Universitesi Tip Fakultesi, Izmir, 35040, Turkey (Türkiye)|Royal Sussex County Hospital, Brighton, BN2 5BE, United Kingdom|Addenbrookes Hospital, Cambridge, CB2 0QQ, United Kingdom|Barts Health NHS Trust - St Bartholomew s Hospital, London, EC1A 7BE, United Kingdom|Guy s & St Thomas NHS Foundation Trust, London, SE1 9RT, United Kingdom|The Royal Marsden Foundation Trust, London, SM2 5PT, United Kingdom|The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom|Imperial College Healthcare NHS Trust, London, W12 0HS, United Kingdom|University College Hospital, London, WC1E 6AG, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Ovarian Neoplasms,DRUG: Niraparib|DRUG: Placebo,FEMALE,"ADULT, OLDER_ADULT",PHASE3,733,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",7/11/16,1/30/26,"GSK Investigational Site, Tempe, Arizona, 85284, United States|GSK Investigational Site, Tucson, Arizona, 85710, United States|GSK Investigational Site, Tucson, Arizona, 85724, United States|GSK Investigational Site, Los Angeles, California, 90095, United States|GSK Investigational Site, San Francisco, California, 94115, United States|GSK Investigational Site, San Francisco, California, 94118, United States|GSK Investigational Site, Santa Rosa, California, 95403, United States|GSK Investigational Site, Hartford, Connecticut, 06102, United States|GSK Investigational Site, New Haven, Connecticut, 06510, United States|GSK Investigational Site, Hollywood, Florida, 33323, United States|GSK Investigational Site, Jacksonville, Florida, 32224, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Atlanta, Georgia, 30342, United States|GSK Investigational Site, Augusta, Georgia, 30912, United States|GSK Investigational Site, Savannah, Georgia, 31404, United States|GSK Investigational Site, Chicago, Illinois, 60612, United States|GSK Investigational Site, Geneva, Illinois, 60555, United States|GSK Investigational Site, Hinsdale, Illinois, 60521, United States|GSK Investigational Site, Warrenville, Illinois, 60555, United States|GSK Investigational Site, Indianapolis, Indiana, 46237, United States|GSK Investigational Site, Indianapolis, Indiana, 46260, United States|GSK Investigational Site, Iowa City, Iowa, 52242, United States|GSK Investigational Site, Baton Rouge, Louisiana, 70817, United States|GSK Investigational Site, Covington, Louisiana, 70433, United States|GSK Investigational Site, New Orleans, Louisiana, 70121, United States|GSK Investigational Site, Baltimore, Maryland, 21215-5271, United States|GSK Investigational Site, Rockville, Maryland, 20910, United States|GSK Investigational Site, Burlington, Massachusetts, 01805, United States|GSK Investigational Site, Springfield, Massachusetts, 01199, United States|GSK Investigational Site, Grand Rapids, Michigan, 49503, United States|GSK Investigational Site, Minneapolis, Minnesota, 55433, United States|GSK Investigational Site, Springfield, Missouri, 65807, United States|GSK Investigational Site, Springfield, Missouri, 97477, United States|GSK Investigational Site, Middletown, New Jersey, 07748, United States|GSK Investigational Site, Neptune City, New Jersey, 07753, United States|GSK Investigational Site, Teaneck, New Jersey, 07666, United States|GSK Investigational Site, Buffalo, New York, 14263, United States|GSK Investigational Site, Harrison, New York, 10604, United States|GSK Investigational Site, Mineola, New York, 11501, United States|GSK Investigational Site, New York, New York, 10016, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Rochester, New York, 14620, United States|GSK Investigational Site, Chapel Hill, North Carolina, 27599-7570, United States|GSK Investigational Site, Wilmington, North Carolina, 28401, United States|GSK Investigational Site, Cleveland, Ohio, 44111, United States|GSK Investigational Site, Cleveland, Ohio, 44124, United States|GSK Investigational Site, Columbus, Ohio, 43210, United States|GSK Investigational Site, Mayfield Hts, Ohio, 44124, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73104, United States|GSK Investigational Site, Tulsa, Oklahoma, 74146, United States|GSK Investigational Site, Portland, Oregon, 97210, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19104, United States|GSK Investigational Site, Willow Grove, Pennsylvania, 19090, United States|GSK Investigational Site, Providence, Rhode Island, 02905, United States|GSK Investigational Site, Charleston, South Carolina, 29425, United States|GSK Investigational Site, Sioux Falls, South Dakota, 57105, United States|GSK Investigational Site, Austin, Texas, 78731, United States|GSK Investigational Site, Fort Worth, Texas, 76104, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, The Woodlands, Texas, 77380, United States|GSK Investigational Site, Tyler, Texas, 75701, United States|GSK Investigational Site, Salt Lake City, Utah, 84112, United States|GSK Investigational Site, Kennewick, Washington, 99336, United States|GSK Investigational Site, Seattle, Washington, 98104, United States|GSK Investigational Site, Spokane, Washington, 99202, United States|GSK Investigational Site, Morgantown, West Virginia, 26505, United States|GSK Investigational Site, Milwaukee, Wisconsin, 53226, United States|GSK Investigational Site, Bonheiden, 2820, Belgium|GSK Investigational Site, Brussels, 1000, Belgium|GSK Investigational Site, Brussels, 1200, Belgium|GSK Investigational Site, Charleroi, 6000, Belgium|GSK Investigational Site, Ghent, 9000, Belgium|GSK Investigational Site, Hasselt, 3500, Belgium|GSK Investigational Site, Leuven, 3000, Belgium|GSK Investigational Site, Libramont, 6800, Belgium|GSK Investigational Site, Namur, 5000, Belgium|GSK Investigational Site, Sint-Niklaas, 9100, Belgium|GSK Investigational Site, Calgary, Alberta, T2N 4N2, Canada|GSK Investigational Site, Kelowna, British Columbia, V1Y 5L3, Canada|GSK Investigational Site, Surrey, British Columbia, V3V 1Z2, Canada|GSK Investigational Site, Vancouver, British Columbia, V5Z 4E6, Canada|GSK Investigational Site, Barrie, Ontario, L4M 6M2, Canada|GSK Investigational Site, London, Ontario, N6A 4L6, Canada|GSK Investigational Site, Ottawa, Ontario, K1Y 4E9, Canada|GSK Investigational Site, Toronto, Ontario, M4N 3M5, Canada|GSK Investigational Site, Toronto, Ontario, M5G 1X6, Canada|GSK Investigational Site, Montreal, Quebec, H2X 0A9, Canada|GSK Investigational Site, Montreal, Quebec, H3T 1E2, Canada|GSK Investigational Site, Montreal, Quebec, H4A 3J1, Canada|GSK Investigational Site, Ostrava, 708 52, Czechia|GSK Investigational Site, Pilsen, 30460, Czechia|GSK Investigational Site, Prague, 10034, Czechia|GSK Investigational Site, Prague, 128 51, Czechia|GSK Investigational Site, Aalborg, 9000, Denmark|GSK Investigational Site, Copenhagen, 2100, Denmark|GSK Investigational Site, Herlev, 2730, Denmark|GSK Investigational Site, Odense C, 5000, Denmark|GSK Investigational Site, Kuopio, 70210, Finland|GSK Investigational Site, Oulu, 90029, Finland|GSK Investigational Site, Tampere, 33521, Finland|GSK Investigational Site, Turku, 20520, Finland|GSK Investigational Site, Angers, 49000, France|GSK Investigational Site, Caen, 14076, France|GSK Investigational Site, Montpellier, 34298, France|GSK Investigational Site, Nice, 06189, France|GSK Investigational Site, Paris, 75020, France|GSK Investigational Site, Paris, 75908, France|GSK Investigational Site, Pierre-Bénite, 69495, France|GSK Investigational Site, Rennes, 35042, France|GSK Investigational Site, Saint-Herblain, 44805, France|GSK Investigational Site, Aachen, 52074, Germany|GSK Investigational Site, Berlin, 13353, Germany|GSK Investigational Site, Dresden, 01307, Germany|GSK Investigational Site, Essen, 45136, Germany|GSK Investigational Site, Fürth, 90766, Germany|GSK Investigational Site, Göttingen, 37075, Germany|GSK Investigational Site, Hamburg, 20246, Germany|GSK Investigational Site, Heidelberg, 69120, Germany|GSK Investigational Site, Hildesheim, 31134, Germany|GSK Investigational Site, Mannheim, 68167, Germany|GSK Investigational Site, München, 81377, Germany|GSK Investigational Site, München, 81737, Germany|GSK Investigational Site, Debrecen, 4032, Hungary|GSK Investigational Site, Győr, 9024, Hungary|GSK Investigational Site, Dublin, 8, Ireland|GSK Investigational Site, Dunmore RoadWaterford, Ireland|GSK Investigational Site, Galway, H91 YR71, Ireland|GSK Investigational Site, Beersheba, 84101, Israel|GSK Investigational Site, Haifa, 3109601, Israel|GSK Investigational Site, Haifa, 38100, Israel|GSK Investigational Site, Holon, 58100, Israel|GSK Investigational Site, Petah Tikva, 49100, Israel|GSK Investigational Site, Ramat Gan, 52621, Israel|GSK Investigational Site, Tel Aviv, 64239, Israel|GSK Investigational Site, Candiolo, 10060, Italy|GSK Investigational Site, Lecce, 73100, Italy|GSK Investigational Site, Milan, 20132, Italy|GSK Investigational Site, Milan, 20133, Italy|GSK Investigational Site, Mirano VE, 30035, Italy|GSK Investigational Site, Modena, 41100, Italy|GSK Investigational Site, Napoli, 80131, Italy|GSK Investigational Site, Oslo, 0310, Norway|GSK Investigational Site, Lublin, 20-090, Poland|GSK Investigational Site, Olsztyn, 10-561, Poland|GSK Investigational Site, Poznan, 60-569, Poland|GSK Investigational Site, Arkhangelsk, 163045, Russia|GSK Investigational Site, Chelyabinsk, 454048, Russia|GSK Investigational Site, Irkutsk, 664035, Russia|GSK Investigational Site, Ivanovo, 153040, Russia|GSK Investigational Site, Kazan', 420029, Russia|GSK Investigational Site, Krasnoyarsk, 660133, Russia|GSK Investigational Site, Orenburg, 460021, Russia|GSK Investigational Site, Pyatigorsk, 357502, Russia|GSK Investigational Site, Saint Petersburg, 191104, Russia|GSK Investigational Site, Saint Petersburg, 194017, Russia|GSK Investigational Site, Saint Petersburg, 197758, Russia|GSK Investigational Site, Samara, 443011, Russia|GSK Investigational Site, Badalona, 08916, Spain|GSK Investigational Site, Barcelona, 08003, Spain|GSK Investigational Site, Barcelona, 08036, Spain|GSK Investigational Site, Barcelona, 08907, Spain|GSK Investigational Site, Barcelona, 8035, Spain|GSK Investigational Site, Córdoba, 14004, Spain|GSK Investigational Site, Donostia / San Sebastian, 20014, Spain|GSK Investigational Site, Elche Alicante, 03203, Spain|GSK Investigational Site, Girona, 17007, Spain|GSK Investigational Site, Madrid, 28033, Spain|GSK Investigational Site, Madrid, 28034, Spain|GSK Investigational Site, Madrid, 28041, Spain|GSK Investigational Site, Madrid, 28046, Spain|GSK Investigational Site, Seville, 41013, Spain|GSK Investigational Site, Seville, 41014, Spain|GSK Investigational Site, Valencia, 46009, Spain|GSK Investigational Site, Valencia, 46010, Spain|GSK Investigational Site, Zaragoza, 50009, Spain|GSK Investigational Site, Stockholm, SE-171 76, Sweden|GSK Investigational Site, Uppsala, SE-751 85, Sweden|GSK Investigational Site, Basel, 4031, Switzerland|GSK Investigational Site, Bern, 3010, Switzerland|GSK Investigational Site, Frauenfeld, 8501, Switzerland|GSK Investigational Site, Zurich, 8091, Switzerland|GSK Investigational Site, Dnipropetrovsk, 49100, Ukraine|GSK Investigational Site, Dnipropetrovsk, 49102, Ukraine|GSK Investigational Site, Ivano-Frankivsk, 76000, Ukraine|GSK Investigational Site, Kharkiv, 61070, Ukraine|GSK Investigational Site, Kherson, 73000, Ukraine|GSK Investigational Site, Kryvyi Rih, 50048, Ukraine|GSK Investigational Site, Kyiv, 03022, Ukraine|GSK Investigational Site, Vinnytsia, 21029, Ukraine|GSK Investigational Site, Zaporizhzhia, 69040, Ukraine|GSK Investigational Site, Bath, BA1 3NG, United Kingdom|GSK Investigational Site, Blackburn, BB2 3HH, United Kingdom|GSK Investigational Site, Edinburgh, G12 0YN, United Kingdom|GSK Investigational Site, Exeter, EX2 5DW, United Kingdom|GSK Investigational Site, Glasgow, G12 0YN, United Kingdom|GSK Investigational Site, London, W12 0HS, United Kingdom|GSK Investigational Site, Portsmouth, PO6 3LY, United Kingdom|GSK Investigational Site, Sheffield, S10 2SJ, United Kingdom|GSK Investigational Site, Staffordshire, ST4 6QG, United Kingdom|GSK Investigational Site, Truro, TR1 3LJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms,DEVICE: SIR-Spheres|DRUG: Regorafenib,ALL,"ADULT, OLDER_ADULT",PHASE2,26,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-07,6/4/17,"Florida Cancer Specialists - North, St. Petersburg, Florida, 33705, United States|Research Medical Center, Kansas City, Missouri, 64132, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Neoplasms,"DRUG: Radium-223 dichloride (Xofigo, BAY88-8223)|DRUG: Placebo (saline)|OTHER: Background hormonal therapy",FEMALE,"ADULT, OLDER_ADULT",PHASE2,99,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",3/2/15,8/13/19,"Bakersfield, California, 93309, United States|La Jolla, California, 92093, United States|Aurora, Colorado, 80045, United States|New Haven, Connecticut, 06520, United States|Cedar Rapids, Iowa, 52403, United States|Annapolis, Maryland, 21401, United States|Ann Arbor, Michigan, 48109, United States|Pontiac, Michigan, 48341, United States|St Louis, Missouri, 63110, United States|Pittsburgh, Pennsylvania, 15213-3180, United States|Houston, Texas, 77230, United States|Linz, Upper Austria, 4020, Austria|Innsbruck, 6020, Austria|Winnipeg, Manitoba, R3E 0V9, Canada|London, Ontario, N6A 4L6, Canada|Newmarket, Ontario, L3Y 2P9, Canada|Toronto, Ontario, M5G 2M9, Canada|Ostrava, 708 52, Czechia|Prague, 12808, Czechia|Copenhagen, 2100, Denmark|Herlev, 2730, Denmark|Helsinki, 00290, Finland|Tampere, FIN-33520, Finland|Angers, 49055, France|Saint-Cloud, 92210, France|Tübingen, Baden-Wurttemberg, 72076, Germany|Bonn, North Rhine-Westphalia, 53105, Germany|Essen, North Rhine-Westphalia, 45147, Germany|Kowloon, Hong Kong|Cork, Ireland|Dublin, 7, Ireland|Afula, 1834111, Israel|Haifa, 3109601, Israel|Jerusalem, 9103102, Israel|Jerusalem, 9112001, Israel|Kfar Saba, 4428164, Israel|Ramat Gan, 5262000, Israel|Tel Aviv, 64239, Israel|Ẕerifin, 7030000, Israel|Nieuwegein, 3435 CM, Netherlands|Zwolle, 8025 AB, Netherlands|Oslo, 0424, Norway|Bialystok, 15-027, Poland|Gdynia, 81-519, Poland|Warsaw, 02-781, Poland|Singapore, 119074, Singapore|Busan, 49241, South Korea|Daegu, 42601, South Korea|Incheon, South Korea|Seoul, 03080, South Korea|Seoul, 05505, South Korea|Seoul, 120-752, South Korea|L'Hospitalet de Llobregat, Barcelona, 08907, Spain|A Coruña, 15009, Spain|Barcelona, 08025, Spain|Barcelona, 08036, Spain|Madrid, 28033, Spain|Madrid, 28040, Spain|Madrid, 28041, Spain|Málaga, 29010, Spain|Seville, 41071, Spain|Zaragoza, 50009, Spain|Aarau, Canton of Aargau, 5001, Switzerland|Taipei, 11217, Taiwan|Plymouth, Devon, PL6 8DH, United Kingdom|Merseyside, Merseyside, CH63 4JY, United Kingdom|Northwood, Middlesex, HA6 2RN, United Kingdom|Nottingham, Nottinghamshire, NG5 1PB, United Kingdom|Taunton, Somerset, TA1 5DA, United Kingdom|Cottingham, HU16 5JQ, United Kingdom|Sheffield, S10 2SJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Aromasin (exemestane),FEMALE,"ADULT, OLDER_ADULT",PHASE4,564,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: ,2/9/11,11/30/18,"The First Affiliated Hospital of Bengbu Medical College/Medical Oncology Department, Bengbu, Anhui, 233004, China|The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China|Second Affiliated hospital of Anhui Medical University, Hefei, Anhui, 230601, China|The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, 400016, China|The First hospital of LanZhou university, Lanzhou, Gansu, 730000, China|Breast Surgery of The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510260, China|SUN YAT-SEN Memorial Hospital , SUN YAT-SEN University, Guangzhou, Guangdong, 510260, China|Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, 515041, China|Thyroid and breast surgery, Shenzhen, Guangdong, 518035, China|Affiliated hospital of Guangdong medical college, Zhanjiang, Guangdong, 524001, China|Hainan General Hospital, Haikou, Hainan, 570311, China|Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050011, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, China|The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan, 453100, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Henan provincial people's hospital, Zhengzhou, Henan, 450000, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, China|Jingzhou Hospital Tongji Medical College Huazhong university of science and Technology, Jingzhou, Hubei, 434020, China|Breast and thyroid surgery of the Central Hospital of WuHan, Wuhan, Hubei, 430014, China|Hunan Provincial People's Hospital, Changsha, Hunan, 410005, China|Xiangya Hospital Central South University /Department of Breast, Changsha, Hunan, 410008, China|The Affiliated Hospital of inner Mongolia medical university, Hohhot, Inner Mongolia, 010021, China|Changzhou No.2 People's Hospital, Changzhou, Jiangsu, 213004, China|Jiangsu Cancer Hospital/ Surgery Department, Nanjing, Jiangsu, 210000, China|Jinling Hospital, Nanjing, Jiangsu, 210002, China|Jiangsu Province Hospital/ Surgery Department, Nanjing, Jiangsu, 210029, China|Nanjing Maternity and Child Health Care Hospital/Department of Breast Surgery, Nanjing, Jiangsu, China|Suzhou Municipal Hospital, Suzhou, Jiangsu, 215002, China|The first hospital of jilin university, Changchun, Jilin, 130021, China|The Fourth Affiliated Hospital Of China Medical University, Shenyang, Liaoning, 110032, China|The First Affiliated Hospital of The Fourth Military Medical University, Xi'an, Shaanxi, 710032, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China|Linyi People's Hospital, Linyi, Shandong, 276000, China|The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266061, China|Qingdao municipal Hospital, Qingdao, Shandong, 266072, China|Breast Surgery of The Weifang People's Hospital, Weifang, Shandong, 261041, China|Breast Surgery of YanTai Yu Huang Ding Hospital, Yantai, Shandong, 264000, China|Breast and thyroid surgery of Central Hospital of Zibo, Zibo, Shandong, 255036, China|West China Hospital, Sichuan University/ Oncology Department, Chengdu, Sichuan, 610041, China|Sichuan Provincial People's Hospital, Chengdu, Sichuan, 610072, China|Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, China|Tianjin Cancer Hospital/Breast cancer department, Tianjin, Tianjin Municipality, 300060, China|Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, 830000, China|Yunnan Cancer Hospital, Kunming, Yunnan, 650118, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|Cancer Hospital Chinese Academy of medical sciences, Beijing, 100021, China|Fifth Medical Center of the PLA General Hospital, Beijing, 100071, China|Beijing Cancer Hospital, Beijing, 100142, China|Peking University Third Hospital/Department of Oncology, Beijing, 100191, China|China-Japan Friendship Hospital, Beijing, China|Fudan University Shanghai Cancer center/Department of Breast Surgery, Shanghai, 200032, China|Yangpu District Central Hospital, Shanghai, 200090, China|Xinhua Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, 200092, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Prostatic Neoplasms|Prostatic Neoplasms, Castration-Resistant",DRUG: Ga-68 PSMA-HBED-CC PET,MALE,"ADULT, OLDER_ADULT",PHASE2|PHASE3,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,3/1/19,3/30/21,"The University of Iowa Hospitals & Clinics, Iowa City, Iowa, 52242, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Tivantinib|DRUG: Anti-Cancer Combination Therapy,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,60,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/31/10,1/14/19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms,DRUG: BI 695502|DRUG: Avastin,ALL,"ADULT, OLDER_ADULT",PHASE3,123,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/8/16,10/3/18,"Mayo Clinic-Arizona, Phoenix, Arizona, 85054, United States|Pacific Cancer Medical Center, Inc., Anaheim, California, 92801, United States|The Oncology Institute of Hope and Innovation, Anaheim, California, 92801, United States|Rocky Mountain Cancer Centers, Denver, Colorado, 80218, United States|Ashland Bellefonte Cancer Center, Ashland, Kentucky, 41101, United States|University of Michigan Health System, Ann Arbor, Michigan, 48109, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Aultman Hospital, Canton, Ohio, 44710, United States|Oncology Hematology Care, Cincinnati, Ohio, 45242, United States|Northwest Cancer Specialists PC, Portland, Oregon, 97225, United States|Willamette Valley Cancer Institute and Research Center, Springfield, Oregon, 97477, United States|Texas Oncology, P.A., Abilene, Texas, 79606, United States|Texas Oncology, PA,, Amarillo, Texas, 79106, United States|Texas Oncology, P.A., Austin, Texas, 78705, United States|Texas Oncology, P.A., Flower Mound, Texas, 75028, United States|Texas Oncology, P.A., Garland, Texas, 75042-5788, United States|Oncology Consultants, P.A., Houston, Texas, 77030, United States|Texas Oncology, P.A., McAllen, Texas, 78503-1298, United States|Texas Oncology, PA, Mesquite, Texas, 75150, United States|Texas Oncology-San Antonio Northeast, San Antonio, Texas, 78217, United States|Texas Oncology San Antonio Medical Center, San Antonio, Texas, 78229, United States|Tyler Hematology-Oncology, PA, Tyler, Texas, 75701, United States|Texas Oncology, P.A., Tyler, Texas, 75702, United States|Texas Oncology, P.A., Deke Slayton Cancer Center, Webster, Texas, 77598, United States|Virginia Cancer Institute, Richmond, Virginia, 23226, United States|Chiba Cancer Center, Chiba, Chiba, 260-8717, Japan|National Hospital Organization Shikoku Cancer Center, Ehime, Matsuyama, 791-0280, Japan|Hokkaido University Hospital, Hokkaido, Sapporo, 060-8648, Japan|Japan Organization of Occupational Health and Safety Kansai Rosai Hospital, Hyogo, Amagasaki, 660-8511, Japan|Kagawa University Hospital, Kagawa, Kita-gun, 761-0793, Japan|Osaka University Hospital, Osaka, Suita, 565-0871, Japan|Jananese Foundation for Cancer Research, Tokyo, Koto-ku, 135-8550, Japan|Hospital Vall d'Hebron, Barcelona, 08035, Spain|Hospital Duran i Reynals, L'Hospitalet de Llobregat, 08907, Spain|Hospital Clínico de Valencia, Valencia, 46010, Spain|CI Chernivtsi RC Oncological Dispensary Bukovinian SMU, Chernivtsi, 58013, Ukraine|Munic.Instit.""City Clin.Hosp.#4"" of Dnipro City Council, Dnipropetrovsk, 49102, Ukraine|Regional Clinical Oncological Dispensary, Ivano-Frankivsk, Ivano-Frankivsk, 76018, Ukraine|CI of PH Kharkiv CCH #2, Kharkiv, 61037, Ukraine|Treatment-Diagnostic CTR of Private Enterprise, Kirovohrad, Kirovohrad, 25006, Ukraine|CI Kryvyi Rih Oncological Dispensary of DRC, Kryvyi Rih, Dnipropetrovsk, 50048, Ukraine|National Institute of Cancer, Kyiv, 03022, Ukraine|CI of LRC Lviv Onco.Reg.Treat.&Diag.Cent., Lviv, 79031, Ukraine|Poltava Regional Clinical Oncological Dispensary, Poltava, Poltava, 38011, Ukraine|Sumy Regional Oncology Center, Sumy, 40022, Ukraine|Vinnytsia Regional Clinical Oncological Dispensary, Vinnytsia, 21029, Ukraine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: LMIS 50 mg,MALE,"ADULT, OLDER_ADULT",PHASE3,30,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-02,12/19/17,"Urology Centers of Alabama, Homewood, Alabama, 35209, United States|Genesis Research, LLC, San Diego, California, 92123, United States|Idaho Urologic Institute - Meridian, Meridian, Idaho, 83642, United States|AdvanceMed Research, Lawrenceville, New Jersey, 08648, United States|Carolina Clinical Trials, LLC, Concord, North Carolina, 28025, United States|Carolina Urologic Research Center, Myrtle Beach, South Carolina, 29572, United States|Seattle Urology Research Center, Burien, Washington, 98166, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,"DRUG: Radium-223 dichloride (Xofigo, BAY88-8223)|DRUG: Placebo (saline)|DRUG: Exemestane|DRUG: Everolimus",FEMALE,"ADULT, OLDER_ADULT",PHASE2,283,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",6/4/15,10/28/22,"La Jolla, California, 92093, United States|Los Angeles, California, 90033, United States|New Haven, Connecticut, 6510, United States|Hollywood, Florida, 33021, United States|Ashland, Kentucky, 41101, United States|Rockville, Maryland, 20850, United States|Ann Arbor, Michigan, 48109, United States|Detroit, Michigan, 48202, United States|Pontiac, Michigan, 48341, United States|Rochester, Minnesota, 55905, United States|St Louis, Missouri, 63110, United States|Newark, New Jersey, 07103, United States|Jamaica, New York, 11432, United States|Watertown, South Dakota, 57201, United States|Spokane, Washington, 99208-1129, United States|Innsbruck, 6020, Austria|Brussels, 1070, Belgium|Edegem, 2650, Belgium|Kortrijk, 8500, Belgium|Leuven, 3000, Belgium|Angers, 49055, France|Nantes, 44805, France|Nîmes, 30029, France|Saint-Cloud, 92210, France|Tours, 37044, France|Herne, North Rhine-Westphalia, 44625, Germany|Chai Wan, Hong Kong|Hong Kong, Hong Kong|Kowloon, Hong Kong|Afula, 1834111, Israel|Beersheba, 8410101, Israel|Haifa, 3109601, Israel|Holon, 5822012, Israel|Jerusalem, 9103102, Israel|Jerusalem, 9112001, Israel|Ramat Gan, 5262000, Israel|Tel Aviv, 64239, Israel|Zrifin, 7030000, Israel|Bari, Apulia, 70124, Italy|Bologna, Emilia-Romagna, 40138, Italy|Forlì Cesena, Emilia-Romagna, 47014, Italy|Modena, Emilia-Romagna, 41124, Italy|Rome, Lazio, 00149, Italy|Rome, Lazio, 00161, Italy|Genoa, Liguria, 16128, Italy|Cremona, Lombardy, 26100, Italy|Milan, Lombardy, 20132, Italy|Pisa, Tuscany, 56126, Italy|Nagoya, Aichi-ken, 464-8681, Japan|Sapporo, Hokkaido, 060-8648, Japan|Sayama, Osaka, 589-8511, Japan|Hidaka, Saitama, 350-1298, Japan|Kita-Adachigun, Saitama, 362-0806, Japan|Koto-ku, Tokyo, 135-8550, Japan|Kagoshima, 892-0833, Japan|Osaka, 540-0006, Japan|Oslo, 0424, Norway|Bialystok, 15-027, Poland|Gdansk, 80-952, Poland|Gdynia, 81-519, Poland|Poznan, 61-485, Poland|Warsaw, 02-781, Poland|Singapore, 119074, Singapore|Singapore, 168583, Singapore|Singapore, 258499, Singapore|Suwon, Gyeonggido, 442-723, South Korea|Seoul, Seoul Teugbyeolsi, 03080, South Korea|Busan, 49241, South Korea|Daegu, 42601, South Korea|Incheon, South Korea|Seoul, 05505, South Korea|Palma de Mallorca, Illes Baleares, 07120, Spain|Barcelona, 08023, Spain|Barcelona, 08041, Spain|Barcelona, 8036, Spain|Madrid, 28033, Spain|Madrid, 28041, Spain|Madrid, 28046, Spain|Madrid, 28050, Spain|Pamplona, 31008, Spain|Seville, 41013, Spain|Seville, 41071, Spain|Aarau, Canton of Aargau, 5001, Switzerland|Kaohsiung City, 813414, Taiwan|Taichung, 40705, Taiwan|Taipei, 114, Taiwan|Taipei, Taiwan|Truro, Cornwall, TR1 3LJ, United Kingdom|Plymouth, Devon, PL6 8DH, United Kingdom|Nottingham, Nottinghamshire, NG5 1PB, United Kingdom|Taunton, Somerset, TA1 5DA, United Kingdom|Bristol, BS2 8ED, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: FACBC PET-CT Scan|PROCEDURE: Three-dimensional ultrasound-guided biopsy|PROCEDURE: Standard transrectal ultrasound (TRUS) guided biopsy,MALE,"ADULT, OLDER_ADULT",PHASE2,21,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC,2015-11,3/31/18,"Emory University Hospital, Atlanta, Georgia, 30322, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, 30322, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Neoplasm,DRUG: Pevonedistat|DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,68,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER,11/15/17,6/21/21,"Sarcoma Oncology Center, Santa Monica, California, 90403, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Montefiore Medical Center, The Bronx, New York, 10467, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 23801, United States|Mary Crowley Medical Research, Dallas, Texas, 75231, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Xentuzumab|DRUG: Placebo|DRUG: Everolimus|DRUG: Exemestane,FEMALE,"ADULT, OLDER_ADULT",PHASE2,103,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",11/28/18,5/11/22,"Ironwood Cancer and Research Centers, Chandler, Arizona, 85224, United States|Cancer Treatment Centers of America at Western Regional Medical Center, Goodyear, Arizona, 85338, United States|Beverly Hills Cancer Center, Beverly Hills, California, 90211, United States|University of California San Francisco, San Francisco, California, 94158, United States|Yale Cancer Center, New Haven, Connecticut, 06510, United States|Florida Cancer Specialists, Fort Myers, Florida, 33901, United States|University Cancer and Blood Center, Athens, Georgia, 30607, United States|Hematology Oncology of Indiana, Indianapolis, Indiana, 46260, United States|University of Minnesota, Minneapolis, Minnesota, 55455, United States|HCA MidAmerica Division, Inc., Kansas City, Missouri, 64132, United States|Hematology Oncology Associates of Rockland, Nyack, New York, 10960, United States|Southwestern Regional Medical Center, Tulsa, Oklahoma, 74133, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, 76104, United States|Utah Cancer Specialists Cancer Center, Salt Lake City, Utah, 84106, United States|Northwest Medical Specialties, PLLC, Tacoma, Washington, 98405, United States|The Tweed Hospital, Tweed Heads, New South Wales, 2485, Australia|Peninsula Haematology & Oncology, Frankston, Victoria, 3199, Australia|Brussels - UNIV Saint-Luc, Brussels, 1200, Belgium|Brussels - UNIV UZ Brussel, Jette, 1090, Belgium|Kortrijk - HOSP AZ Groeninge Kennedylaan, Kortrijk, 8500, Belgium|UZ Leuven, Leuven, 3000, Belgium|CHU de Quebec-Universite Laval Research Centre, Québec, G1S 4L8, Canada|INS Sainte Catherine, Avignon, 84000, France|HOP Victor Hugo, Le Mans, 72000, France|INS Paoli-Calmettes, Marseille, 13009, France|INS Curie, Paris, 75248, France|HOP Européen G. Pompidou, Paris, 75908, France|HOP Lyon Sud, Pierre-Bénite, 69495, France|INS Claudius Regaud IUCT-Oncopole, Toulouse, 31059, France|Universitätsklinikum Erlangen, Erlangen, 91054, Germany|Vincentius-Diakonissen-Kliniken gAG, Karlsruhe, 76135, Germany|General Hospital of Athens ""Alexandra"", Athens, 11528, Greece|University General Hospital of Heraklion, Heraklion, 71110, Greece|University Hospital of Larisa, Oncology Clinic, Larissa, 41334, Greece|Metropolitan Hospital, Oncology Clinic, Neo Faliro, Athens, 18547, Greece|Euromedica Kyanous Stavros General Hospital, Thessaloniki, 54645, Greece|Istituto Nazionale IRCCS Tumori Fondazione Pascale, Napoli, 80131, Italy|Iov, Irccs, Padua, 35128, Italy|Azienda Ospedaliera Sant'Andrea-Università di Roma La Sapienza, Roma, 00189, Italy|Fundação Champalimaud,, Lisbon, 1400-038, Portugal|Hospital Beatriz Ângelo, Loures, 2674-514, Portugal|Centro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, 4434-502, Portugal|Hospital Teresa Herrera, A Coruña, 15006, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Arnau de Vilanova, Lleida, 25198, Spain|Hospital General Universitario Gregorio Marañón, Madrid, 28007, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital Regional Universitario de Málaga, Málaga, 29010, Spain|Instituto Valenciano de Oncología, Valencia, 46009, Spain|Clínica Quirón de Valencia, Valencia, 46010, Spain|Hospital Clínico de Valencia, Valencia, 46010, Spain|St Bartholomew's Hospital, London, EC1A 7BE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neoplasms, Breast",DRUG: Lapatinib|BIOLOGICAL: Trastuzumab|DRUG: Aromatase Inhibitors (AIs),FEMALE,"ADULT, OLDER_ADULT",PHASE2,42,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/24/14,6/4/20,"Novartis Investigative Site, Mobile, Alabama, 36608, United States|Novartis Investigative Site, Boston, Massachusetts, 02114, United States|Novartis Investigative Site, Houston, Texas, 77030, United States|Novartis Investigative Site, Berazategui, Buenos Aires, B1880BBF, Argentina|Novartis Investigative Site, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1125ABD, Argentina|Novartis Investigative Site, Viedma, Río Negro Province, R8500ACE, Argentina|Novartis Investigative Site, Rosario, Santa Fe Province, S2000KZE, Argentina|Novartis Investigative Site, Buenos Aires, C1025ABI, Argentina|Novartis Investigative Site, Córdoba, X5004FHP, Argentina|Novartis Investigative Site, La Rioja, F5300COE, Argentina|Novartis Investigative Site, San Miguel de Tucumán, T4000IAK, Argentina|Novartis Investigative Site, Salzburg, A-5020, Austria|Novartis Investigative Site, Vienna, 1090, Austria|Novartis Investigative Site, Salvador, Estado de Bahia, 41825-010, Brazil|Novartis Investigative Site, Belo Horizonte, Minas Gerais, 30130-090, Brazil|Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, 90430-090, Brazil|Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, 90470-340, Brazil|Novartis Investigative Site, Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Novartis Investigative Site, Itajaí, Santa Catarina, 88301220, Brazil|Novartis Investigative Site, Barretos, São Paulo, 14784-400, Brazil|Novartis Investigative Site, São Paulo, São Paulo, 01236030, Brazil|Novartis Investigative Site, São Paulo, São Paulo, 01317-001, Brazil|Novartis Investigative Site, São José do Rio Preto, 15090-000, Brazil|Novartis Investigative Site, Pok Fu Lam, Hong Kong|Novartis Investigative Site, Pokfulam, Hong Kong|Novartis Investigative Site, Milan, Lombardy, 20133, Italy|Novartis Investigative Site, Milan, Lombardy, 20141, Italy|Novartis Investigative Site, México, 06760, Mexico|Novartis Investigative Site, Arequipa, Peru|Novartis Investigative Site, Lima, Lima 34, Peru|Novartis Investigative Site, Cebu, 6000, Philippines|Novartis Investigative Site, Manila, 1000, Philippines|Novartis Investigative Site, Kazan', 420029, Russia|Novartis Investigative Site, Moscow, 115 478, Russia|Novartis Investigative Site, Ryazan, 390011, Russia|Novartis Investigative Site, Saint Petersburg, 197022, Russia|Novartis Investigative Site, Saint Petersburg, 197758, Russia|Novartis Investigative Site, Volzhskiy, 404130, Russia|Novartis Investigative Site, Barcelona, 08035, Spain|Novartis Investigative Site, Barcelona, 08036, Spain|Novartis Investigative Site, Donostia / San Sebastian, 20014, Spain|Novartis Investigative Site, Madrid, 28034, Spain|Novartis Investigative Site, Madrid, 28040, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Málaga, 29010, Spain|Novartis Investigative Site, Seville, 41013, Spain|Novartis Investigative Site, Valencia, 46010, Spain|Novartis Investigative Site, Valencia, 46015, Spain|Novartis Investigative Site, Bangkok, 10330, Thailand|Novartis Investigative Site, Chiang Mai, 50200, Thailand|Novartis Investigative Site, Phitsanulok, 65000, Thailand",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Solid Tumor|Solid Tumor, Childhood|Solid Carcinoma",DRUG: Romiplostim,ALL,"CHILD, ADULT",PHASE2,2,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/10/20,3/29/23,"Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, 11553, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Relapsed/Refractory Solid Tumor Malignancies or Lymphoma|Ovarian Cancer,BIOLOGICAL: mRNA-2416|BIOLOGICAL: Durvalumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,79,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/15/17,8/18/21,"University of Colorado Hospital, Aurora, Colorado, 80045, United States|Smilow Cancer Hospital, New Haven, Connecticut, 06520, United States|Northwestern Memorial Hospital, Indianapolis, Indiana, 46202, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Minnesota Medical Center, Minneapolis, Minnesota, 55455, United States|University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Women & Infants Hospital, Providence, Rhode Island, 02905, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Docetaxel|DRUG: Prednisone|DRUG: Placebo|DRUG: Dexamethasone,MALE,"ADULT, OLDER_ADULT",PHASE3,1030,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",5/2/19,7/18/23,"University of South Alabama, Mitchell Cancer Institute ( Site 0065), Mobile, Alabama, 36604, United States|St. Joseph Heritage Healthcare ( Site 0069), Fullerton, California, 92835, United States|University of Southern California Norris Comprehensive Cancer Center ( Site 0061), Los Angeles, California, 90033, United States|USC Norris Oncology Hematology Newport Beach ( Site 0093), Newport Beach, California, 92663, United States|University of California San Francisco ( Site 0023), San Francisco, California, 94158, United States|University of Colorado Cancer Center ( Site 0022), Aurora, Colorado, 80045, United States|Yale Cancer Center ( Site 0038), New Haven, Connecticut, 06510, United States|Moffitt Cancer Center ( Site 0080), Tampa, Florida, 33612, United States|Georgia Cancer Center at Augusta University ( Site 0026), Augusta, Georgia, 30912, United States|Mount Sinai Hospital Medical Center ( Site 0042), Chicago, Illinois, 60608, United States|Methodist Hospital- Merriillville ( Site 0008), Merrillville, Indiana, 46410, United States|Karmanos Cancer Institute ( Site 0077), Detroit, Michigan, 48201, United States|Henry Ford Health System ( Site 0039), Detroit, Michigan, 48202-2608, United States|Cancer & Hematology Centers of Western Michigan ( Site 0013), Grand Rapids, Michigan, 49503, United States|Washington University School of Medicine ( Site 0057), St Louis, Missouri, 63110, United States|St. Vincent Frontier Cancer Center ( Site 0016), Billings, Montana, 59102, United States|Nebraska Cancer Specialists ( Site 0034), Omaha, Nebraska, 68130, United States|Comprehensive Cancer Centers of Nevada ( Site 0092), Las Vegas, Nevada, 89169, United States|John Theurer Cancer Center at Hackensack University Medical Center ( Site 0004), Hackensack, New Jersey, 07601, United States|Associated Medical Professionals of NY ( Site 0060), Syracuse, New York, 13210, United States|Duke Cancer Center ( Site 0010), Durham, North Carolina, 27710, United States|W. G. Bill Hefner VA Medical Center ( Site 0029), Salisbury, North Carolina, 28144, United States|University Hospitals Cleveland Medical Center ( Site 0036), Cleveland, Ohio, 44106, United States|Oregon Health Sciences University ( Site 0031), Portland, Oregon, 97239, United States|Carolina Urologic Research Center ( Site 0070), Myrtle Beach, South Carolina, 29572, United States|Inova Schar Cancer Institute ( Site 0006), Fairfax, Virginia, 22031-4867, United States|Virginia Cancer Institute ( Site 0052), Richmond, Virginia, 23230, United States|Blue Ridge Cancer Care ( Site 0086), Roanoke, Virginia, 24014, United States|Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 1013), Berazategui, Buenos Aires, B1884BBF, Argentina|Instituto de Investigaciones Clinicas ( Site 1000), Mar del Plata, Buenos Aires, B7600FZN, Argentina|Centro de Diagnostico Urologico ( Site 1008), Buenos Aires, Buenos Aires F.D., C1120AAT, Argentina|Hospital Britanico de Buenos Aires ( Site 1006), Buenos Aires, Buenos Aires F.D., C1280AEB, Argentina|Sanatorio Parque ( Site 1002), Rosario, Santa Fe Province, S2000DSV, Argentina|Instituto de Investigaciones Metabolicas [Buenos Aires, Argentina] ( Site 1011), Buenos Aires, C1012AAR, Argentina|Hospital Aleman ( Site 1004), Buenos Aires, C1118AAT, Argentina|Instituto Medico Alexander Fleming ( Site 1010), Buenos Aires, C1426ANZ, Argentina|CEMAIC ( Site 1014), Córdoba, X5008HHW, Argentina|St George Hospital ( Site 0157), Kogarah, New South Wales, 2217, Australia|Macquarie University ( Site 0151), Macquarie University, New South Wales, 2109, Australia|Port Macquarie Base Hospital ( Site 0153), Port Macquarie, New South Wales, 2444, Australia|Calvary Mater Newcastle ( Site 0148), Waratah, New South Wales, 2298, Australia|Redcliffe Hospital ( Site 0161), Redcliffe, Queensland, 4020, Australia|John Flynn Hospital & Medical Centre ( Site 0164), Tugun, Queensland, 4224, Australia|Hollywood Private Hospital ( Site 0163), Nedlands, Western Australia, 6009, Australia|Medizinische Universitat Graz ( Site 0374), Graz, Styria, 8036, Austria|Ordensklinikum Linz GmbH Elisabethinen ( Site 0373), Linz, Upper Austria, 4020, Austria|SCRI-CCCIT GesmbH ( Site 0371), Salzburg, 5020, Austria|Medizinische Universitaet Wien ( Site 0375), Vienna, 1090, Austria|Hospital de Caridade de Ijui ( Site 1038), Ijuí, Rio Grande do Sul, 98700-000, Brazil|Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 1021), Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 1035), Itajaí, Santa Catarina, 88301-215, Brazil|Hospital de Base de Sao Jose de Rio Preto ( Site 1022), São José do Rio Preto, São Paulo, 15090-000, Brazil|A.C. Camargo Cancer Center ( Site 1026), São Paulo, 01509-900, Brazil|Nova Scotia Health Authority QEII-HSC ( Site 0114), Halifax, Nova Scotia, B3H 2Y9, Canada|Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0116), Hamilton, Ontario, L8V5C2, Canada|Grand River Hospital ( Site 0120), Kitchener, Ontario, N2G 1G3, Canada|Lakeridge Health ( Site 0117), Oshawa, Ontario, L1G 2B9, Canada|Sunnybrook Research Institute ( Site 0108), Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Cancer Centre ( Site 0107), Toronto, Ontario, M5G 2M9, Canada|CHU de Quebec-Universite Laval-Hotel Dieu de Quebec ( Site 0103), Québec, Quebec, G1R 2J6, Canada|CIUSSS du Bas Saint Laurent - Hopital Regional de Rimouski ( Site 0102), Rimouski, Quebec, G5L 5T1, Canada|CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0105), Sherbrooke, Quebec, J1H 5N4, Canada|Fundacion Arturo Lopez Perez ( Site 1049), Santiago, Region M. de Santiago, 7500921, Chile|Pontificia Universidad Catolica de Chile ( Site 1047), Santiago, Region M. de Santiago, 8330032, Chile|Bradford Hill Centro de Investigaciones Clinicas ( Site 1044), Santiago, Region M. de Santiago, 8420383, Chile|Centro Investigación del Cáncer James Lind ( Site 1041), Temuco, Región de la Araucanía, 4780000, Chile|Rey y Oreilly Limitada ( Site 1048), Temuco, Región de la Araucanía, 4810148, Chile|Centro de Investigaciones Clinicas Vina del Mar ( Site 1042), Viña del Mar, Región de Valparaíso, 2540488, Chile|Peking University First Hospital ( Site 1303), Beijing, Beijing Municipality, 100034, China|The Fifth Medical Center of PLA General Hospital ( Site 1307), Beijing, Beijing Municipality, 100071, China|Beijing Cancer Hospital ( Site 1305), Beijing, Beijing Municipality, 100142, China|The First Affiliated Hospital of Xiamen University ( Site 1319), Xiamen, Fujian, 361003, China|Sun Yat Sen Memorial Hospital ( Site 1323), Guangzhou, Guangdong, 510220, China|The First Affiliated Hospital of Guangzhou Medical University ( Site 1330), Guangzhou, Guangdong, 510230, China|Harbin Medical University Cancer Hospital ( Site 1326), Harbin, Heilongjiang, 150081, China|Henan Cancer Hospital ( Site 1321), Zhengzhou, Henan, 450008, China|Hubei Cancer Hospital ( Site 1329), Wuhan, Hubei, 430079, China|Hunan Cancer Hospital ( Site 1320), Changsha, Hunan, 410013, China|Nanjing Drum Tower Hospital ( Site 1312), Nanjing, Jiangsu, 210008, China|Fudan University Shanghai Cancer Center ( Site 1300), Shanghai, Shanghai Municipality, 200032, China|Zhongshan Hospital Fudan University ( Site 1301), Shanghai, Shanghai Municipality, 200032, China|The Second Affiliated Hospital of Zhejiang University School of Medicine ( Site 1309), Hangzhou, Zhejiang, 310009, China|Zhejiang Provincial People's Hospital ( Site 1310), Hangzhou, Zhejiang, 310014, China|Hospital Pablo Tobon Uribe ( Site 1066), Medellín, Antioquia, 050034, Colombia|Biomelab S A S ( Site 1067), Barranquilla, Atlántico, 080002, Colombia|Clinica de la Costa Ltda. ( Site 1073), Barranquilla, Atlántico, 080020, Colombia|Instituto Nacional de Cancerologia E.S.E ( Site 1061), Bogotá, Bogota D.C., 110321, Colombia|Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 1062), Bogotá, Bogota D.C., 111321, Colombia|Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 1068), Valledupar, Cesar Department, 200001, Colombia|Oncomedica S.A. ( Site 1057), Montería, Departamento de Córdoba, 230002, Colombia|Oncologos del Occidente S.A. ( Site 1072), Pereira, Risaralda Department, 660001, Colombia|Centro Medico Imbanaco de Cali S.A ( Site 1064), Cali, Valle del Cauca Department, 760042, Colombia|Hemato Oncologos S.A. ( Site 1065), Cali, Valle del Cauca Department, 760042, Colombia|C.H. de Saint Quentin ( Site 0481), Saint-Quentin, Aisne, 02321, France|Clinique Sainte Anne ( Site 0431), Strasbourg, Alsace, 67000, France|Centre Jean Perrin ( Site 0434), Clermont-Ferrand, Auvergne, 63011, France|Centre Leon Berard ( Site 0422), Lyon, Auvergne, 69373, France|Institut Paoli Calmettes. ( Site 0419), Marseille, Bouches-du-Rhone, 13009, France|CHU Jean Minjoz ( Site 0423), Besançon, Doubs, 25000, France|CHU de Brest -Site Hopital Morvan ( Site 0441), Brest, Finistere, 29200, France|Institut Bergonie ( Site 0421), Bordeaux, Gironde, 33076, France|Institut Claudius Regaud IUCT Oncopole ( Site 0418), Toulouse, Haute-Garonne, 31059, France|Hopital Foch ( Site 0428), Suresnes, Hauts-de-Seine, 92151, France|Institut De Cancerologie De L Ouest ( Site 0448), Saint-Herblain, Loire-Atlantique, 44805, France|Centre Hospitalier Regional du Orleans ( Site 0430), Orléans, Loiret, 45100, France|Centre D Oncologie de Gentilly ( Site 0432), Nancy, Meurthe-et-Moselle, 54100, France|C.H.U. Lyon Sud ( Site 0436), Pierre-Bénite, Rhone, 69310, France|CHU Amiens Picardie Site Sud Amiens ( Site 0438), Amiens, Somme, 80000, France|Institut Gustave Roussy ( Site 0416), Villejuif, Val-de-Marne, 94800, France|Institut Sainte Catherine ( Site 0447), Avignon, Vaucluse, 84000, France|Institut Mutualiste Montsouris ( Site 0446), Paris, 75014, France|Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304), Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany|Universitaetsklinikum in Mannheim ( Site 0314), Mannheim, Baden-Wurttemberg, 68167, Germany|Studienpraxis Urologie ( Site 0309), Nürtingen, Baden-Wurttemberg, 72622, Germany|Universitaetsklinik fuer Urologie ( Site 0307), Tübingen, Baden-Wurttemberg, 72076, Germany|Klinikum Rechts der Isar ( Site 0300), Munich, Bavaria, 81675, Germany|Universitaetsklinik der Paracelsus Medizinischen Privatuniversitaet ( Site 0318), Nuremberg, Bavaria, 90419, Germany|Universitaetsklinikum Wuerzburg ( Site 0302), Würzburg, Bavaria, 97080, Germany|Universitaetsklinikum Goettingen ( Site 0345), Göttingen, Lower Saxony, 37075, Germany|Uniklinik RWTH Aachen ( Site 0308), Aachen, North Rhine-Westphalia, 52074, Germany|Universitaetsklinikum des Saarlandes ( Site 0348), Homburg, Saarland, 66421, Germany|Universitaetsklinikum Jena ( Site 0305), Jena, Thuringia, 07747, Germany|Charite Universitaetsmedizin Berlin ( Site 0301), Berlin, 10117, Germany|Cork University Hospital ( Site 0727), Cork, T12 YE02, Ireland|Tallaght University Hospital ( Site 0730), Dublin, D24 NROA, Ireland|Mid Western Cancer Centre ( Site 0728), Limerick, Ireland|Assaf Harofeh MC ( Site 0547), Beer Yaakov-Zerifin, 7030001, Israel|Soroka Medical Center ( Site 0548), Beersheba, 8410101, Israel|Rambam Medical Center ( Site 0543), Haifa, 3109601, Israel|Hadassah Ein Kerem Medical Center ( Site 0546), Jerusalem, 9112001, Israel|Meir Medical Center ( Site 0544), Kfar Saba, 4428164, Israel|Rabin Medical Center ( Site 0545), Petah Tikva, 4941492, Israel|Chaim Sheba Medical Center ( Site 0541), Ramat Gan, 5262000, Israel|Sourasky Medical Center ( Site 0542), Tel Aviv, 6423906, Israel|Istituto Clinico Humanitas Research Hospital ( Site 0452), Rozzano, Milano, 20089, Italy|Azienda Ospedaliera Cannizzaro ( Site 0458), Catania, 95126, Italy|A.O. Universitaria di Modena ( Site 0454), Modena, 41100, Italy|Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 0457), Napoli, 80131, Italy|Azienda Ospedaliera San Camillo Forlanini ( Site 0455), Roma, 00152, Italy|Azienda Ospedaliera Santa Maria Terni ( Site 0456), Terni, 05100, Italy|Presidio Ospedaliero Santa Chiara ( Site 0451), Trento, 38122, Italy|National Cancer Center Hospital East ( Site 0702), Kashiwa, Chiba, 277-8577, Japan|Toho University Sakura Medical Center ( Site 0703), Sakura, Chiba, 285-8741, Japan|National Hospital Organization Shikoku Cancer Center ( Site 0716), Matsuyama, Ehime, 791-0280, Japan|Kanazawa University Hospital ( Site 0701), Kanazawa, Ishikawa-ken, 920-8641, Japan|Kitasato University Hospital ( Site 0705), Sagamihara, Kanagawa, 252-0375, Japan|Yokohama City University Medical Center ( Site 0706), Yokohama, Kanagawa, 232-0024, Japan|Nara Medical University Hospital ( Site 0715), Kashihara, Nara, 634-8522, Japan|Kindai University Hospital ( Site 0714), Sayama, Osaka, 589-8511, Japan|Osaka University Hospital ( Site 0713), Suita, Osaka, 565-0871, Japan|Saitama Medical University International Medical Center ( Site 0708), Hidaka, Saitama, 1932, Japan|Dokkyo Medical University Saitama Medical Center ( Site 0707), Koshigaya, Saitama, 343-8555, Japan|Hamamatsu University Hospital ( Site 0720), Hamamatsu, Shizuoka, 431-3192, Japan|Yamaguchi University Hospital ( Site 0717), Ube, Yamaguchi, 755-8505, Japan|Chiba Cancer Center ( Site 0704), Chiba, 260-8717, Japan|Kyushu University Hospital ( Site 0718), Fukuoka, 812-8582, Japan|University of Miyazaki Hospital ( Site 0721), Miyazaki, 889-1692, Japan|Nagasaki University Hospital ( Site 0719), Nagasaki, 852-8501, Japan|Toranomon Hospital ( Site 0711), Tokyo, 105-8470, Japan|Nippon Medical School Hospital ( Site 0709), Tokyo, 113-8603, Japan|Keio University Hospital ( Site 0710), Tokyo, 160-8582, Japan|Ziekenhuis Gelderse Vallei ( Site 0485), Ede, Gelderland, 6746 RP, Netherlands|Radboud University Medical Center ( Site 0470), Nijmegen, Gelderland, 6525 GA, Netherlands|VieCuri Medisch Centrum ( Site 0487), Venlo, Limburg, 5912 BL, Netherlands|Jeroen Bosch Ziekenhuis ( Site 1200), 's-Hertogenbosch, North Brabant, 5223 GZ, Netherlands|Catharina Ziekenhuis ( Site 0472), Eindhoven, North Brabant, 5623 EJ, Netherlands|Antoni van Leeuwenhoek Ziekenhuis ( Site 0480), Amsterdam, North Holland, 1066 CX, Netherlands|Ziekenhuis Hilversum ( Site 0466), Hilversum, North Holland, 1213 XZ, Netherlands|Ziekenhuisgroep Twente ( Site 0469), Hengelo, Overijssel, 7555 DL, Netherlands|Medisch Centrum Leeuwarden ( Site 0477), Leeuwarden, Provincie Friesland, 8934 AD, Netherlands|Reinier de Graaf Groep ( Site 0484), Delft, South Holland, 2625 AD, Netherlands|Hagaziekenhuis ( Site 1201), The Hague, South Holland, 2545 AA, Netherlands|Chelyabinsk Regional Clinical Oncological Dispensary ( Site 0565), Chelyabinsk, Chelyabinsk Oblast, 454087, Russia|Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 0585), Krasnoyarsk, Krasnoyarsk Krai, 660133, Russia|SBIH City clinical hospital named after D.D. Pletniov ( Site 0575), Moscow, Moscow, 105077, Russia|Russian Scientific Center of Radiology ( Site 0559), Moscow, Moscow, 117485, Russia|Central Clinical Hospital with Polyclinic ( Site 0562), Moscow, Moscow, 121359, Russia|National Medical Research Radiological Center ( Site 0556), Moscow, Moscow, 125284, Russia|Volga District Medical Center Federal Medical and Biological Agency ( Site 0572), Nizhny Novgorod, Nizhny Novgorod Oblast, 603074, Russia|Omsk Clinical Oncology Dispensary ( Site 0568), Omsk, Omsk Oblast, 644013, Russia|SBHI Samara Regional Clinical Oncology Dispensary ( Site 0576), Samara, Samara Oblast, 443031, Russia|Leningrad Regional Oncology Center ( Site 0588), Saint Petersburg, Sankt-Peterburg, 188663, Russia|Clinical Research Center of specialized types medical care-Oncology ( Site 0570), Saint Petersburg, Sankt-Peterburg, 197758, Russia|Russian Scientific Center of Radiology and Surgical Technologies ( Site 0567), Saint Petersburg, Sankt-Peterburg, 197758, Russia|SPb SBHI City Clinical Oncological Dispensary ( Site 0571), Saint Petersburg, Sankt-Peterburg, 198255, Russia|Tomsk National Research Medical Center of Russian Academy of Sciences ( Site 0579), Tomsk, Tomsk Oblast, 634050, Russia|National Cancer Center ( Site 0174), Goyang-si, Kyonggi-do, 10408, South Korea|Seoul National University Bundang Hospital ( Site 0175), Seongnam-si, Kyonggi-do, 13620, South Korea|Seoul National University Hospital ( Site 0171), Seoul, 03080, South Korea|Asan Medical Center ( Site 0176), Seoul, 05505, South Korea|Samsung Medical Center ( Site 0172), Seoul, 06351, South Korea|Instituto Catalan de Oncologia - ICO ( Site 0330), L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Hospital Consorci Sanitari Parc Tauli ( Site 0335), Sabadell, Barcelona, 08208, Spain|Hospital Universitario Marques de Valdecilla ( Site 0336), Santander, Cantabria, 39008, Spain|Hospital Josep Trueta ( Site 0321), Girona, Gerona, 17007, Spain|Hospital del Mar ( Site 0333), Barcelona, 08003, Spain|Hospital Clinic ( Site 0323), Barcelona, 08036, Spain|Hospital Universitario Ramon y Cajal ( Site 0328), Madrid, 28034, Spain|Hospital Clinico San Carlos ( Site 0324), Madrid, 28040, Spain|Hospital Universitario HM Sanchinarro ( Site 0322), Madrid, 28050, Spain|Hospital Universitario Virgen de la Victoria ( Site 0337), Málaga, 29016, Spain|Hospital Virgen del Rocio ( Site 0329), Seville, 41013, Spain|National Cheng Kung University Hospital ( Site 0134), Tainen, Tainan, 704, Taiwan|China Medical University Hospital ( Site 0132), Taichung, 40447, Taiwan|Taichung Veterans General Hospital ( Site 0133), Taichung, 40705, Taiwan|National Taiwan University Hospital ( Site 0131), Taipei, 10048, Taiwan|Taipei Veterans General Hospital ( Site 0135), Taipei, 11217, Taiwan|University Hospitals Bristol NHS Foundation Trust ( Site 0530), Bristol, Bristol, City of, BS2 8ED, United Kingdom|Cambridge University Hospitals NHS Trust ( Site 0540), Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom|Torbay Hospital ( Site 0532), Torquay, Devon, TQ2 7AA, United Kingdom|Weston Park Hospital ( Site 0539), Sheffield, England, S10 2SJ, United Kingdom|Royal Marsden Hospital ( Site 0526), Sutton, England, SM2 5PT, United Kingdom|Mount Vernon Cancer Centre ( Site 0536), Northwood, Hertfordshire, HA6 2RN, United Kingdom|Barts Cancer Institute ( Site 0483), London, London, City of, EC1A 7BE, United Kingdom|University of North Midlands NHS Foundation Trust ( Site 0527), Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: pamiparib 60 mg|DRUG: pamiparib 20 mg|DRUG: itraconazole|DRUG: rifampin|DRUG: pamiparib,ALL,"ADULT, OLDER_ADULT",PHASE1,25,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,5/29/19,8/6/21,"Arensia Exploratory Medicine Llc, Tbilisi, 0112, Georgia|Republican Clinical Hospital, Oncology Department, Chiinu, 2025, Moldova|Szpital Luxmed, Warsaw, 02-801, Poland|Summit Clinical Research, Sro, Bratislava, 83101, Slovakia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Olaparib|DRUG: Abiraterone acetate|DRUG: Prednisone|DRUG: Enzalutamide|DRUG: Prednisolone,MALE,"ADULT, OLDER_ADULT",PHASE3,793,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/2/19,1/27/24,"St. Joseph Heritage Healthcare ( Site 0069), Fullerton, California, 92835, United States|UCLA Hematology/Oncology - Santa Monica ( Site 0081), Los Angeles, California, 90404, United States|Sibley Memorial Hospital ( Site 0096), Washington D.C., District of Columbia, 20016, United States|Georgia Cancer Center at Augusta University ( Site 0026), Augusta, Georgia, 30912, United States|Quincy Medical Group ( Site 0021), Quincy, Illinois, 62301, United States|Tulane Cancer Center ( Site 0066), New Orleans, Louisiana, 70112, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0005), Baltimore, Maryland, 21287, United States|Chesapeake Urology Research Associates ( Site 0076), Towson, Maryland, 21204, United States|Beth Israel Deaconess Medical Ctr. ( Site 0093), Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute ( Site 0033), Boston, Massachusetts, 02215, United States|UMass Memorial Medical Center ( Site 0053), Worcester, Massachusetts, 01655, United States|Barbara Ann Karmanos Cancer Institute ( Site 0077), Detroit, Michigan, 48201, United States|Henry Ford Health System ( Site 0039), Detroit, Michigan, 48202, United States|St. Vincent Frontier Cancer Center ( Site 0016), Billings, Montana, 59102, United States|Nebraska Cancer Specialists ( Site 0034), Omaha, Nebraska, 68130, United States|Comprehensive Cancer Centers of Nevada ( Site 0092), Las Vegas, Nevada, 89169, United States|University of New Mexico Cancer Center ( Site 0048), Albuquerque, New Mexico, 87131, United States|Memorial Medical Center ( Site 0095), Las Cruces, New Mexico, 88011, United States|Associated Medical Professionals of NY ( Site 0060), Syracuse, New York, 13210, United States|Duke Cancer Center Cary ( Site 0010), Cary, North Carolina, 27511, United States|Gabrail Cancer Center-Research ( Site 0097), Canton, Ohio, 44718, United States|The Urology Group- Cincinnati ( Site 0094), Cincinnati, Ohio, 45212, United States|University Hospitals of Cleveland Seidman Cancer Center ( Site 0036), Cleveland, Ohio, 44106, United States|Carolina Urologic Research Center ( Site 0070), Myrtle Beach, South Carolina, 29572, United States|Huntsman Cancer Institute ( Site 0002), Salt Lake City, Utah, 84112, United States|Virginia Cancer Institute ( Site 0052), Richmond, Virginia, 23230, United States|Blue Ridge Cancer Care ( Site 0086), Roanoke, Virginia, 24014, United States|Seattle Cancer Care Alliance ( Site 0079), Seattle, Washington, 98109, United States|Froedtert and Medical College of Wisconsin ( Site 0045), Milwaukee, Wisconsin, 53226, United States|Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 1013), Berazategui, Buenos Aires, B1884BBF, Argentina|Centro de Diagnostico Urologico ( Site 1008), Buenos Aires, Buenos Aires F.D., C1120AAT, Argentina|Hospital Britanico de Buenos Aires ( Site 1006), Buenos Aires, Buenos Aires F.D., C1280AEB, Argentina|Sanatorio Parque ( Site 1002), Rosario, Santa Fe Province, S2000DSV, Argentina|Instituto de Investigaciones Metabolicas ( Site 1011), Buenos Aires, C1012AAR, Argentina|Hospital Aleman ( Site 1004), Buenos Aires, C1118AAT, Argentina|Instituto Medico Alexander Fleming ( Site 1010), Buenos Aires, C1426ANZ, Argentina|CEMAIC ( Site 1014), Córdoba, X5008HHW, Argentina|St. Vincent's Hospital ( Site 0158), Darlinghurst, New South Wales, 2010, Australia|Macquarie University ( Site 0151), Macquarie University, New South Wales, 2109, Australia|Port Macquarie Base Hospital ( Site 0153), Port Macquarie, New South Wales, 2444, Australia|Calvary Mater Newcastle ( Site 0148), Waratah, New South Wales, 2298, Australia|Southern Medical Day Care Centre ( Site 0160), Wollongong, New South Wales, 2500, Australia|Royal Brisbane and Women s Hospital ( Site 0155), Herston, Queensland, 4029, Australia|John Flynn Hospital & Medical Centre ( Site 0164), Tugun, Queensland, 4224, Australia|Box Hill Hospital ( Site 0146), Box Hill, Victoria, 3128, Australia|Peter MacCallum Cancer Centre ( Site 0152), Melbourne, Victoria, 3000, Australia|Fiona Stanley Hospital ( Site 0162), Murdoch, Western Australia, 6150, Australia|Medizinische Universitat Graz ( Site 0374), Graz, Styria, 8036, Austria|Ordensklinikum Linz GmbH Elisabethinen ( Site 0373), Linz, Upper Austria, 4020, Austria|SCRI-CCCIT GesmbH ( Site 0371), Salzburg, 5020, Austria|Medizinische Universitaet Wien ( Site 0375), Vienna, 1090, Austria|Hospital de Caridade de Ijui ( Site 1038), Ijuí, Rio Grande do Sul, 98700-000, Brazil|Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 1021), Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral ( Site 1035), Itajaí, Santa Catarina, 88301-215, Brazil|Hospital de Base de Sao Jose de Rio Preto ( Site 1022), São José do Rio Preto, São Paulo, 15090-000, Brazil|IBCC - Instituto Brasileiro de Controle do Câncer ( Site 1040), São Paulo, São Paulo, 04014-002, Brazil|A.C. Camargo Cancer Center ( Site 1026), São Paulo, 01509-900, Brazil|Cross Cancer Institute ( Site 0110), Edmonton, Alberta, T6G 1Z2, Canada|BC Cancer-Kelowna - Sindi Ahluwalia Hawkins Centre ( Site 0113), Kelowna, British Columbia, V1Y 5L3, Canada|BC Cancer-Vancouver Center ( Site 0112), Vancouver, British Columbia, V5Z 4E6, Canada|Nova Scotia Health Authority QEII-HSC ( Site 0114), Halifax, Nova Scotia, B3H 2Y9, Canada|William Osler Health System (Brampton Civic Hospital) ( Site 0121), Brampton, Ontario, L6R 3J7, Canada|Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0116), Hamilton, Ontario, L8V 5C2, Canada|Princess Margaret Cancer Centre ( Site 0107), Toronto, Ontario, M5G 2M9, Canada|CHUQ-Univ Laval-Hotel Dieu de Quebec ( Site 0103), Québec, Quebec, G1R 2J6, Canada|CIUSSS du Bas Saint Laurent - Hopital Regional de Rimouski ( Site 0102), Rimouski, Quebec, G5L 5T1, Canada|CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0105), Sherbrooke, Quebec, J1H 5N4, Canada|Fundacion Arturo Lopez Perez ( Site 1049), Santiago, Region M. de Santiago, 7500921, Chile|Pontificia Universidad Catolica de Chile ( Site 1047), Santiago, Region M. de Santiago, 8330032, Chile|Bradford Hill Centro de Investigaciones Clinicas ( Site 1044), Santiago, Region M. de Santiago, 8420383, Chile|Centro Investigación del Cáncer James Lind ( Site 1041), Temuco, Región de la Araucanía, 4780000, Chile|Rey y Oreilly Limitada ( Site 1048), Temuco, Región de la Araucanía, 4810148, Chile|C.H. de Saint Quentin ( Site 0481), Saint-Quentin, Aisne, 02321, France|Clinique Sainte Anne ( Site 0431), Strasbourg, Alsace, 67000, France|Centre Jean Perrin ( Site 0434), Clermont-Ferrand, Auvergne, 63011, France|Institut Paoli Calmettes ( Site 0419), Marseille, Bouches-du-Rhone, 13009, France|CHU de Brest -Site Hopital Morvan ( Site 0441), Brest, Brittany Region, 29200, France|CHU Jean Minjoz ( Site 0423), Besançon, Doubs, 25000, France|Institut Bergonie ( Site 0421), Bordeaux, Gironde, 33076, France|Institut Claudius Regaud IUCT Oncopole ( Site 0418), Toulouse, Haute-Garonne, 31059, France|Hopital Foch ( Site 0428), Suresnes, Hauts-de-Seine, 92150, France|Institut Regional du Cancer de Montpellier - ICM ( Site 0443), Montpellier, Herault, 34298, France|Institut De Cancerologie De L Ouest ( Site 0448), Saint-Herblain, Loire-Atlantique, 44805, France|Centre Hospitalier Regional du Orleans ( Site 0430), Orléans, Loiret, 45100, France|Centre D Oncologie de Gentilly ( Site 0432), Nancy, Meurthe-et-Moselle, 54100, France|Centre Leon Berard ( Site 0422), Lyon, Rhone, 69373, France|C.H.U. Lyon Sud ( Site 0436), Pierre-Bénite, Rhone, 69310, France|CHU Amiens Picardie Site Sud Amiens ( Site 0438), Amiens, Somme, 80000, France|Institut Gustave Roussy ( Site 0416), Villejuif, Val-de-Marne, 94800, France|Institut Sainte Catherine ( Site 0447), Avignon, Vaucluse, 84000, France|Institut Mutualiste Montsouris ( Site 0446), Paris, 75014, France|Universitaetsklinikum Freiburg - Medizinische Klinik ( Site 0304), Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany|Universitaetsklinikum in Mannheim ( Site 0314), Mannheim, Baden-Wurttemberg, 68167, Germany|Studienpraxis Urologie ( Site 0309), Nürtingen, Baden-Wurttemberg, 72622, Germany|Universitaetsklinik fuer Urologie ( Site 0307), Tübingen, Baden-Wurttemberg, 72076, Germany|Universitaetsklinikum Erlangen ( Site 0303), Erlangen, Bavaria, 91054, Germany|Klinikum Rechts der Isar ( Site 0300), Munich, Bavaria, 81675, Germany|Universitaetsklinik der Paracelsus Medizinischen Privatuniversitaet ( Site 0318), Nuremberg, Bavaria, 90419, Germany|Universitaetsklinikum Duesseldorf ( Site 0306), Düsseldorf, North Rhine-Westphalia, 40225, Germany|Krankenhaus der Barmherzigen Brueder Trier ( Site 0310), Trier, Rhineland-Palatinate, 54292, Germany|Universitaetsklinikum Jena ( Site 0305), Jena, Thuringia, 07747, Germany|Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0301), Berlin, 10117, Germany|Tallaght University Hospital ( Site 0730), Dublin, D24 NROA, Ireland|Mid Western Cancer Centre ( Site 0728), Limerick, Ireland|Ha Emek Medical Center ( Site 0548), Afula, 1834111, Israel|Soroka Medical Center ( Site 0549), Beersheba, 8410101, Israel|Assaf Harofe ( Site 0547), Be’er Ya‘aqov, 7030001, Israel|Rambam Medical Center ( Site 0543), Haifa, 3109601, Israel|Hadassah Ein Kerem Medical Center ( Site 0546), Jerusalem, 9112001, Israel|Meir Medical Center ( Site 0544), Kfar Saba, 4428164, Israel|Rabin Medical Center ( Site 0545), Petah Tikva, 4941492, Israel|Chaim Sheba Medical Center ( Site 0541), Ramat Gan, 5262000, Israel|Sourasky Medical Center ( Site 0542), Tel Aviv, 6423906, Israel|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 0462), Meldola, Emilia-Romagna, 47014, Italy|Istituto Clinico Humanitas Research Hospital ( Site 0452), Rozzano, Lombardy, 20089, Italy|Medical Oncology Ospedale San Donato ( Site 0461), Arezzo, 52100, Italy|Policlinico S.Orsola-Malpighi ( Site 0453), Bologna, 40138, Italy|Azienda Ospedaliera Cannizzaro ( Site 0458), Catania, 95126, Italy|Azienda Ospedaliera San Camillo Forlanini ( Site 0455), Roma, 00152, Italy|Fondazione Policlinico Universitario A. Gemelli ( Site 0463), Roma, 00168, Italy|Azienda Ospedaliera Santa Maria Terni ( Site 0456), Terni, 05100, Italy|Presidio Ospedaliero Santa Chiara ( Site 0451), Trento, 38122, Italy|Fujita Health University Hospital ( Site 0724), Toyoake, Aichi-ken, 470-1192, Japan|National Cancer Center Hospital East ( Site 0702), Kashiwa, Chiba, 277-8577, Japan|Toho University Sakura Medical Center ( Site 0703), Sakura, Chiba, 285-8741, Japan|National Hospital Organization Shikoku Cancer Center ( Site 0716), Matsuyama, Ehime, 791-0280, Japan|Kobe City Medical Center General Hospital ( Site 0726), Kobe, Hyōgo, 650-0047, Japan|Kanazawa University Hospital ( Site 0701), Kanazawa, Ishikawa-ken, 920-8641, Japan|Kitasato University Hospital ( Site 0705), Sagamihara, Kanagawa, 252-0375, Japan|Yokohama City University Medical Center ( Site 0706), Yokohama, Kanagawa, 232-0024, Japan|Nara Medical University Hospital ( Site 0715), Kashihara, Nara, 634-8522, Japan|Kindai University Hospital ( Site 0714), Sayama, Osaka, 589-8511, Japan|Osaka University Hospital ( Site 0713), Suita, Osaka, 565-0871, Japan|Saitama Medical University International Medical Center ( Site 0708), Hidaka, Saitama, 350-1298, Japan|Dokkyo Medical University Saitama Medical Center ( Site 0707), Koshigaya, Saitama, 343-8555, Japan|Fuji City General Hospital ( Site 0725), Fuji, Shizuoka, 417-8567, Japan|Hamamatsu University Hospital ( Site 0720), Hamamatsu, Shizuoka, 431-3192, Japan|Yamaguchi University Hospital ( Site 0717), Ube, Yamaguchi, 755-8505, Japan|Chiba Cancer Center ( Site 0704), Chiba, 260-8717, Japan|Kyushu University Hospital ( Site 0718), Fukuoka, 812-8582, Japan|University of Miyazaki Hospital ( Site 0721), Miyazaki, 889-1692, Japan|Nagano Municipal Hospital ( Site 0723), Nagano, 381-8551, Japan|Nagasaki University Hospital ( Site 0719), Nagasaki, 852-8501, Japan|Osaka International Cancer Institute ( Site 0722), Osaka, 541-8567, Japan|Toranomon Hospital ( Site 0711), Tokyo, 105-8470, Japan|Nippon Medical School Hospital ( Site 0709), Tokyo, 113-8603, Japan|Keio University Hospital ( Site 0710), Tokyo, 160-8582, Japan|Radboud University Medical Center ( Site 0470), Nijmegen, Gelderland, 6525 GA, Netherlands|Antoni van Leeuwenhoek Ziekenhuis ( Site 0480), Amsterdam, North Holland, 1066 CX, Netherlands|Vrije Universiteit Medisch Centrum ( Site 0479), Amsterdam, North Holland, 1081 HV, Netherlands|Spaarne Ziekenhuis ( Site 0473), Hoofddorp, North Holland, 2134 TM, Netherlands|Ziekenhuisgroep Twente ( Site 0469), Hengelo, Overijssel, 7555 DL, Netherlands|Medisch Centrum Leeuwarden ( Site 0477), Leeuwarden, Provincie Friesland, 8934 AD, Netherlands|Haaglanden MC - locatie Antoniushove ( Site 0471), Leidschendam, South Holland, 2262 BA, Netherlands|Erasmus MC ( Site 0475), Rotterdam, South Holland, 3015 GD, Netherlands|Franciscus Gasthuis en Vlietland ( Site 0489), Schiedam, South Holland, 3118 JH, Netherlands|Auckland City Hospital ( Site 0193), Auckland, 1023, New Zealand|Chelyabinsk Regional Clinical Oncological Dispensary ( Site 0565), Chelyabinsk, Chelyabinsk Oblast, 454087, Russia|Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 0585), Krasnoyarsk, Krasnoyarsk Krai, 660133, Russia|Russian Scientific Center of Roentgenoradiology ( Site 0559), Moscow, Moscow, 117997, Russia|Central Clinical Hospital with Polyclinic ( Site 0562), Moscow, Moscow, 121359, Russia|Omsk Clinical Oncology Dispensary ( Site 0568), Omsk, Omsk Oblast, 644013, Russia|SBHI Samara Regional Clinical Oncology Dispensary ( Site 0576), Samara, Samara Oblast, 443031, Russia|SBHI Leningrad Regional Oncology Dispensary ( Site 0588), Saint Petersburg, Sankt-Peterburg, 191104, Russia|Clinical Research Center of specialized types medical care-Oncology ( Site 0570), Saint Petersburg, Sankt-Peterburg, 197758, Russia|Russian Scientific Center of Radiology and Surgical Technologies ( Site 0567), Saint Petersburg, Sankt-Peterburg, 197758, Russia|Tomsk National Scientific Medical Center of Russian Academy of Science ( Site 0579), Tomsk, Tomsk Oblast, 634028, Russia|Chonnam National University Hwasun Hospital ( Site 0174), Hwasun Gun, Jeonranamdo, 58128, South Korea|National Cancer Center ( Site 0176), Goyang-si, Kyonggi-do, 10408, South Korea|Asan Medical Center ( Site 0171), Songpagu, Seoul, 05505, South Korea|Severance Hospital Yonsei University Health System ( Site 0173), Seoul, 03722, South Korea|Samsung Medical Center ( Site 0172), Seoul, 06351, South Korea|Instituto Catalan de Oncologia - ICO ( Site 0330), L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Hospital Parc Tauli ( Site 0335), Sabadell, Barcelona, 08208, Spain|Hospital San Pedro de Alcantara ( Site 0326), Cáceres, Extremadura, 10003, Spain|Hospital Josep Trueta ( Site 0321), Girona, Gerona, 17007, Spain|Hospital Quiron Madrid ( Site 0325), Pozuelo de Alarcón, Madrid, 28223, Spain|Hospital del Mar ( Site 0333), Barcelona, 08003, Spain|Hospital General Universitari Vall d Hebron ( Site 0334), Barcelona, 08035, Spain|Hospital Clinic ( Site 0323), Barcelona, 08036, Spain|Hospital Universitario Virgen de la Victoria ( Site 0337), Málaga, 29016, Spain|National Cheng Kung University Hospital ( Site 0134), Tainen, Tainan, 704, Taiwan|China Medical University Hospital ( Site 0132), Taichung, 40447, Taiwan|Taichung Veterans General Hospital ( Site 0133), Taichung, 407, Taiwan|National Taiwan University Hospital ( Site 0131), Taipei, 10048, Taiwan|Taipei Veterans General Hospital ( Site 0135), Taipei, 11217, Taiwan|University Hospitals Bristol NHS Foundation Trust ( Site 0530), Bristol, Bristol, City of, BS2 8ED, United Kingdom|Cambridge University Hospitals NHS Trust ( Site 0540), Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom|Torbay Hospital ( Site 0532), Torquay, Devon, TQ2 7AA, United Kingdom|Royal Marsden Hospital ( Site 0526), Sutton, England, SM2 5PT, United Kingdom|Musgrove Park Hospital ( Site 0537), Taunton, England, TA1 5DA, United Kingdom|University of North Midlands NHS Foundation Trust ( Site 0527), Stoke-on-Trent, Staffordshire, ST4 6QG, United Kingdom|Mount Vernon Cancer Centre ( Site 0536), Northwood, HA6 2RN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Prostatic Neoplasms,BIOLOGICAL: PF-06755992|BIOLOGICAL: PF-06755990|DEVICE: TDS-IM Electroporation Device|BIOLOGICAL: Tremelimumab|BIOLOGICAL: PF-06801591|BIOLOGICAL: PF-06753512,MALE,"ADULT, OLDER_ADULT",PHASE1,91,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/30/15,2/23/21,"Banner-University Medical Center Tucson, Tucson, Arizona, 85719, United States|The University of Arizona Cancer Center-North Campus, Tucson, Arizona, 85719, United States|Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, 06510, United States|Smilow Cancer Hospital Phase 1 Unit, New Haven, Connecticut, 06511, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States|GU Research Network, Omaha, Nebraska, 68130, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Garden State Urology, Morristown, New Jersey, 07960, United States|Morristown Medical Center, Morristown, New Jersey, 07960, United States|Garden State Urology, Rockaway, New Jersey, 07866, United States|Garden State Urology, Whippany, New Jersey, 07981, United States|Northwell Health, Lake Success, New York, 11042, United States|Memorial Sloan-Kettering Cancer Center 53rd Street, New York, New York, 10022, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center, New York, New York, 10065, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Washington Medical Center, Seattle, Washington, 98195, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: PLX3397,ALL,"ADULT, OLDER_ADULT",PHASE1,132,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/1/09,10/25/18,"HonorHealth, Scottsdale, Arizona, 85258, United States|UCLA, Los Angeles, California, 90404, United States|Rocky Mountain Cancer Centers, Denver, Colorado, 80218, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York, 10065, United States|Pennsylvania Oncology Hematology Associates, Philadelphia, Pennsylvania, 19106, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Vanderbilt-Ingram Medical Center, Nashville, Tennessee, 37232, United States|Texas Oncology, PA (North), Dallas, Texas, 75246, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|Evergreen Hematology & Oncology, Spokane, Washington, 99218, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Solid Tumor, Adult","COMBINATION_PRODUCT: TTX-030, budigalimab and mFOLFOX6|COMBINATION_PRODUCT: TTX-030, budigalimab and docetaxel|COMBINATION_PRODUCT: TTX-030 and mFOLFOX6|COMBINATION_PRODUCT: TTX-030 and budigalimab|COMBINATION_PRODUCT: TTX-030, budigalimab, nab-paclitaxel and gemcitabine|COMBINATION_PRODUCT: TTX-030 and pembrolizumab|COMBINATION_PRODUCT: TTX-030, nab-paclitaxel and gemcitabine|COMBINATION_PRODUCT: Budigalimab and mFOLFOX6",ALL,"ADULT, OLDER_ADULT",PHASE1,185,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/30/20,3/27/24,"HonorHealth Research Institute, Scottsdale, Arizona, 85258, United States|City of Hope Medical Center Clinical Trials Office, Duarte, California, 91010, United States|University of Southern California, Los Angeles, California, 90007, United States|Cedars-Sinai Medical Center, Los Angeles, California, 90048, United States|UCLA Hematology/Oncology, Los Angeles, California, 90404, United States|Chao Family Comprehensive CC, UCI, Orange, California, 92868, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|Ocala Oncology Center PL, Ocala, Florida, 34474, United States|Orlando Health UF Health Cancer Center, Orlando, Florida, 32835, United States|IACT Health - John B. Amos Cancer Center, Columbus, Georgia, 31904, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Norton Cancer Institute, Louisville, Kentucky, 40202, United States|Ochsner Medical Center, New Orleans, Louisiana, 70121, United States|Nebraska Cancer Center Oncology Hematology West P.C., Omaha, Nebraska, 68130, United States|Montefiore Medical Center, The Bronx, New York, 10461, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44122, United States|University of Toledo, Toledo, Ohio, 43614, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Prisma-Health Cancer Institute, Greenville, South Carolina, 29605, United States|West Cancer Center and Research Institute, Germantown, Tennessee, 38138, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|NEXT Oncology, San Antonio, Texas, 78229, United States|Hunstman Cancer Intitute, Salt Lake City, Utah, 84112, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|Froedtert Hospital & Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|National Cancer Center, Seogu, Busan, 49201, South Korea|National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10408, South Korea|Seoul National University, Seongnam-si Bundan-gu, Gyeonggi-do, 13620, South Korea|Samsung Medical Center, Gangnam-gu, Seoul, 06351, South Korea|Severance Hospital Yonsei University, Seodaemun-gu, Seoul, 03722, South Korea|Asan Medical Center, Songpa-gu, Seoul, 05505, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors,DRUG: Avelumab|DRUG: M9241|DRUG: Avelumab (Once weekly)|DRUG: M9241 (MTD)|DRUG: Avelumab (Expansion cohort),ALL,"ADULT, OLDER_ADULT",PHASE1,52,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/31/17,10/8/20,"California Cancer Associates for Research & Excellence, Inc., San Diego, California, 92111, United States|Sharp Memorial Hospital, San Diego, California, 92123, United States|St Joseph Heritage Healthcare, Santa Rosa, California, 95403, United States|Yale University Institutional Review Board, New Haven, Connecticut, 06520, United States|Holy Cross Hospital Inc., Fort Lauderdale, Florida, 33308, United States|Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie, Florida, 34952, United States|Metairie Oncologists, LLC, Metairie, Louisiana, 70006, United States|National Cancer Institute, Bethesda, Maryland, 20892, United States|Virginia Piper Cancer Institute, Minneapolis, Minnesota, 55407, United States|Washington University, St Louis, Missouri, 63110, United States|UC Health, LLC., Cincinnati, Ohio, 45229, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Cedar Sinai Medical Center, Ashland, Oregon, 97520, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Mary Crowley Cancer Research Centers, Dallas, Texas, 75251, United States|University of Vermont Medical Center, Burlington, Vermont, 05405, United States|Northwest Medical Specialties, PLLC, Tacoma, Washington, 98405, United States|Centre Hospitalier de l'Ardenne - Pharmacie, Libramont, Belgium|GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk, Belgium|CHU Bordeaux - Hôpital Saint André, Bordeaux, France|Centre Georges François Leclerc, Dijon, France|Centre Oscar Lambret, Lille, France|Hôpital de la Timone# - CPCEM CIC - Bat F 1er étage, Marseille, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Centre Paul Strauss, Strasbourg, France|Orszagos Onkologiai Intezet, Budapest, Hungary|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy|IOV - Istituto Oncologico Veneto IRCCS, Padua, Italy|A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena, Italy|Amsterdam UMC, Locatie VUMC, Amsterdam, Netherlands|Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Hospital Universitario Virgen del Rocio, Seville, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: M3814 100 mg|DRUG: M3814 200 mg|DRUG: M3814 300 mg|DRUG: M3814 400 mg|DRUG: M3814 50 mg|RADIATION: Fractionated RT|DRUG: Cisplatin,ALL,"ADULT, OLDER_ADULT",PHASE1,52,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/15/15,11/19/21,"Research site, Fresno, California, 93720, United States|Holy Cross Hospital Inc., Fort Lauderdale, Florida, 33308, United States|University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|Research site, Billings, Montana, 59101, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Montefiore Medical Center PRIME, The Bronx, New York, 10461, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|Research site, Houston, Texas, 77030, United States|Research site, Tacoma, Washington, 98405, United States|Research site, Leuven, Belgium|Rigshospitalet - PARENT, Copenhagen, Denmark|Herlev Hospital - PARENT, Herlev, Denmark|Research site, Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany|Charite Research Organisation GmbH - Phase - I Unit of Hematology and Oncology, Berlin, Germany|Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Germany|Universitaetsklinikum Essen - Westdeutsches Tumorzentrum, Essen, Germany|Universitaetsklinikum Heidelberg - RadioOnkologie und Strahlentherapie, Heidelberg, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Kiel - Klinik für diagnostische Radiologie, Kiel, Germany|Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz - Klinik und Poliklinik fuer Radiologie, Mainz, Germany|Klinikum Mannheim GmbH Universitaetsklinikum - Parent, Mannheim, Germany|Universitaetsklinikum Tuebingen - Medizinische Klinik I, Tübingen, Germany|Research site, Amsterdam, 1066 CX, Netherlands|Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands|Research site, Oslo, Norway|Karolinska universitetssjukhuset - Solna - Radiumhemmet (onkologi), Solna, Sweden|Universitaetsspital Zuerich - Parent, Zurich, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms,DRUG: RRx-001|DRUG: Regorafenib|DRUG: Irinotecan,ALL,"ADULT, OLDER_ADULT",PHASE2,62,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-05,10/8/20,"UCSD Moores Cancer Center, La Jolla, California, 92093, United States|Stanford University, Stanford, California, 94305, United States|Kaiser Permanete, Honolulu, Hawaii, 96819, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, 20889, United States|Aquilino Cancer Center, Maryland Oncology and Hematology PA, Rockville, Maryland, 20850, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Adult Solid Neoplasm|Childhood Solid Neoplasm|Recurrent Childhood Central Nervous System Neoplasm|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Malignant Solid Neoplasm|Refractory Central Nervous System Neoplasm,OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|DRUG: Talazoparib|DRUG: Temozolomide,ALL,"CHILD, ADULT",PHASE1|PHASE2,40,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/16/14,12/31/18,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center-Parnassus, San Francisco, California, 94143, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, 30322, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Kidney Neoplasms,BIOLOGICAL: Nivolumab|BIOLOGICAL: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE4,101,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/17/20,1/4/24,"Local Institution - 0005, Ahmedabad, Gujarat, 380054, India|Local Institution - 0011, Trivandrum, Kerala, 695011, India|Local Institution - 0013, Mumbai, Maharashtra, 400 057, India|Local Institution - 0001, Mumbai, Maharashtra, 400012, India|Local Institution - 0007, New Delhi, National Capital Territory of Delhi, 110029, India|Local Institution - 0006, Bangalore, 560017, India|Local Institution - 0017, Delhi, 110085, India|Local Institution - 0002, Karnataka, 560027, India|Local Institution - 0019, Kolkata, 711103, India|Local Institution - 0016, Mumbai, 400053, India|Local Institution - 0012, Pune, 411001, India",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: Cabozantinib|DRUG: Docetaxel|DRUG: Prednisone,MALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,49,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/7/12,1/16/19,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Ovarian Cancer|NSCLC|ESCC|Solid Tumors,DRUG: ASP0739,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,16,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/23/21,6/1/23,"City of Hope, Duarte, California, 91010, United States|University of Miami, Miami, Florida, 33136, United States|Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, 60611, United States|The University of Chicago Medicine, Chicago, Illinois, 60637, United States|NYU Perlmutter Cancer Center, New York, New York, 10016, United States|Brown University, Providence, Rhode Island, 02903, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Fulvestrant|DRUG: Sapanisertib,FEMALE,"ADULT, OLDER_ADULT",PHASE2,141,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/28/16,11/25/19,"Southern Cancer Center, PC, Mobile, Alabama, 36608, United States|CBCC Global Research 6501 Truxtun Avenue Bakersfield, CA, Bakersfield, California, 93309, United States|St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare, Fullerton, California, 92835, United States|UCSD Moores Cancer Center, La Jolla, California, 92037, United States|UCLA Hematology/Oncology David Geffen School of Medicine, Los Angeles, California, 90095-7077, United States|North County Oncology, Oceanside, California, 92056, United States|Torrance Health Association, Redondo Beach, California, 90277, United States|PHC-SLO Oncology and Hematology, San Luis Obispo, California, 93401, United States|Cancer Center of Santa Barbara With Sansum Clinic, Santa Barbara, California, 93105, United States|University of Colorado Cancer Center-Anschutz Cancer Pavilion (ACP), Aurora, Colorado, 80045, United States|St. Mary'S Hospital Regional Cancer Center, Grand Junction, Colorado, 81501, United States|Rocky mountain cancer centers LLP, Lakewood, Colorado, 80228, United States|Holy Cross Hospital- Bienes Cancer Center, Fort Lauderdale, Florida, 33308, United States|Memorial Healthcare System, Hollywood, Florida, 33021, United States|Orlando Health Inc., Orlando, Florida, 33806, United States|Ft. Wayne Medical Oncology and Hematology, Inc, Fort Wayne, Indiana, 46804, United States|New England Cancer Specialists, Scarborough, Maine, 04074, United States|Health Partners Institute Park Nicollet Frauenshuh Cancer Center, Saint Louis Park, Minnesota, 55426, United States|Comprehensive Cancer Centers of Nevada, Henderson, Nevada, 89074, United States|New Jersey Hematology & Oncology Associates, Brick, New Jersey, 8724, United States|Northern Westchester Hospital Cancer Treatment & Wellness Center, Mount Kisco, New York, 10549, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Texas Oncology, P.A., Austin, Texas, 78745, United States|Texas Oncology - Presbyterian Hospital, Dallas, Texas, 75231, United States|Texas Oncology, P.A., Dallas, Texas, 75246, United States|Texas Oncology- South Second Street, McAllen, Texas, 78503, United States|Cancer Care Centers of South Texas, San Antonio, Texas, 78217, United States|Texas Oncology,PA. Tyler TX, 75702, Tyler, Texas, 75702, United States|Virginia Cancer Specialist PC, Leesburg, Virginia, 20176, United States|West Virginia University School of Medicine, Morgantown, West Virginia, 26505, United States|Hospital Universitari Son Espases, Palma de Mallorca, Balearic Islands, 07120, Spain|Hospital Son Llatzer, Palma de Mallorca, Balearic Islands, 07198, Spain|Consorci Sanitari de Terrassa, Terrassa, Barcelona, 08827, Spain|Onkologikoa, Donostia / San Sebastian, Guipuzcoa, 20014, Spain|Hospital Universitario Puerta del Hierro, Majadahonda, Madrid, 28220, Spain|Clinica Universidad de Navarra, Pamplona, Navarre, 31008, Spain|Hospital Universitario Sant Joan de Reus, Reus, Tarragona, 43204, Spain|Complejo Hospitalario Universitario A Coruna, A Coruña, 15006, Spain|Centro Oncologico de Galicia, A Coruña, 15009, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clinic i Provincial, Barcelona, 08036, Spain|Hospital De la Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital San Pedro de Alcantara, Cáceres, 10003, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, 25198, Spain|Hospital General Universitario Gregorio Maranon, Madrid, 28009, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital General Universitario Morales Messeguer, Murcia, 30008, Spain|Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, 30120, Spain|Hospital Universitario Virgen de la Macarena, Seville, 41009, Spain|Fundacion Instituto Valenciano de Oncologia, Valencia, 46009, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Neoplasms,DRUG: MK-7162|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,33,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/6/17,10/19/20,"UCLA Medical Center ( Site 0002), Santa Monica, California, 90404, United States|START Midwest ( Site 0007), Grand Rapids, Michigan, 49546, United States|Laura and Isaac Perlmutter Cancer Center ( Site 0001), New York, New York, 10016, United States|Princess Margaret Hospital.. ( Site 0130), Toronto, Ontario, M5G 2M9, Canada|Chaim Sheba Medical Center. ( Site 0301), Ramat Gan, 5265601, Israel|Severance Hospital Yonsei University Health System ( Site 0103), Seoul, 03722, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor,DRUG: Atezolizumab,ALL,"CHILD, ADULT",PHASE1|PHASE2,87,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/30/15,6/6/19,"Arkansas Children'S Hospital, Little Rock, Arkansas, 72202, United States|Stanford University/Lucile Packard Children's Hospital, Palo Alto, California, 94304, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|Alberta Children'S Hospital, Calgary, Alberta, T3B 6A8, Canada|Rigshospitalet; BØRNEUNGEKLINIKKEN, Ambulatoriet for kræft- og Blodsygdomme hos børn og unge, København Ø, 2100, Denmark|Centre Léon Bérard, Institut d'Hémato-Oncologie Pédiatrique, Lyon, 69373, France|Institut Curie, Oncologie Pédiatrique, Paris, 75231, France|Institut Gustave Roussy; Service Pediatrique, Villejuif, 94805, France|Klinik Johann Wolfgang von Goethe Uni, Frankfurt, 60590, Germany|Schneider Children's Medical Center, Petah Tikva, 49100, Israel|Ospedale Pediatrico Bambino Gesù - IRCCS; Dipartimento di Onco-Ematologia Pediatrica, Rome, Lazio, 00165, Italy|IRCCS Istituto Giannina Gaslini; Unità Operativa Oncologica Pediatrica, Genoa, Liguria, 16147, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori; Struttura Complessa di Pediatria Oncologica, Milan, Lombardy, 20133, Italy|Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Piedmont, 10126, Italy|Azienda Ospedaliera di Padova; Clinica di Onco-ematologia pediatrica, Padua, Veneto, 35128, Italy|Erasmus MC / location Sophia Kinderziekenhuis, Rotterdam, 3015 GJ, Netherlands|Hospital Sant Joan De Deu, Esplugues de Llobregas, Barcelona, 08950, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital Infantil Universitario Nino Jesus, Madrid, 28009, Spain|Hospital Universitari i Politecnic La Fe de Valencia, Valencia, 46026, Spain|Universitäts-Kinderspital; Abteilung für Onkologie, Zurich, 8032, Switzerland|Birmingham Children's Hospital, Birmingham, B4 6NH, United Kingdom|Bristol Royal Hospital For Children, Bristol, BS2 8BJ, United Kingdom|Leeds General Infirmary; Paediatric Oncology & Haematology, Leeds, LS1 3EX, United Kingdom|The Royal Victoria Infirmary; Paediatric and Adolescent Oncology Unit, Newcastle upon Tyne, NE1 4LP, United Kingdom|Royal Marsden Hospital; Pediatric Unit, Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms|Neoplasm Metastasis,DRUG: Abemaciclib|DRUG: Nonsteroidal Aromatase Inhibitor (NSAI)|DRUG: Fulvestrant,FEMALE,"ADULT, OLDER_ADULT",PHASE4,200,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/22/21,1/9/23,"MNJ Institute of Oncology, Hyderabad, Andhra Pradesh, 500004, India|Indira Gandhi Institute of Medical Sciences, Patna, Bihar, 800014, India|Nirmal Hospital Pvt Ltd., Surat, Gujarat, 395002, India|Unique Hospital Multispecialty & Research Institute, Surat, Gujarat, 395002, India|Kailash Cancer Hospital & Research Centre (KCHRC), Waghodia, Gujarat, 391760, India|HCG Cancer Centre, Kalinga Rao Road, Bengaluru, Karnataka, 560020, India|Regional Cancer Centre, Trivandrum, Kerala, 695011, India|SRJ-CBCC Cancer Hospital, Indore, Madhya Pradesh, 452001, India|Kingsway Hospital, Nagpur, Maharashtra, 440001, India|Meditrina Institute of Medical Sciences, Nagpur, Maharashtra, 440012, India|HCG Manavata Cancer Centre, Nashik, Maharashtra, 422001, India|Ruby Hall Clinic and Grant Medical Foundation, Pune, Maharashtra, 411001, India|Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, National Capital Territory of Delhi, 110085, India|Apollo Gleneagles Hospitals Kolkata, Kolkata, West Bengal, 700054, India|Max Superspeciality Hospital, Chandigarh, 160055, India",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Nasopharyngeal Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Capecitabine|DRUG: Gemcitabine|DRUG: Docetaxel,ALL,"ADULT, OLDER_ADULT",PHASE3,233,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/18/16,9/30/22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,DRUG: Imipenem/Cilastatin/Relebactam|DRUG: Cefepime|DRUG: Meropenem|DRUG: Piperacillin-Tazobactam|DRUG: Vancomycin|DRUG: Daptomycin|DRUG: Linezolid,ALL,"ADULT, OLDER_ADULT",PHASE2,100,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/14/21,10/6/23,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,"DRUG: Radium-223 dichloride (Xofigo, BAY88-8223)|DRUG: Matching placebo (normal saline)|DRUG: Abiraterone|DRUG: Prednisone/Prednisolone",MALE,"ADULT, OLDER_ADULT",PHASE3,806,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",3/30/14,2/8/24,"Anchorage, Alaska, 99503, United States|Tucson, Arizona, 85718, United States|Oceanside, California, 92056, United States|Denver, Colorado, 80211, United States|Washington D.C., District of Columbia, 20007-2113, United States|Fort Myers, Florida, 33901, United States|Atlanta, Georgia, 30322, United States|Jeffersonville, Indiana, 47130, United States|New Orleans, Louisiana, 70112, United States|Baltimore, Maryland, 21201, United States|Rockville, Maryland, 20850, United States|Towson, Maryland, 21204, United States|Boston, Massachusetts, 02114-2696, United States|Burlington, Massachusetts, 1805, United States|Detroit, Michigan, 48202, United States|Traverse City, Michigan, 49684, United States|St Louis, Missouri, 63110, United States|Omaha, Nebraska, 68130, United States|Las Vegas, Nevada, 89169, United States|Hackensack, New Jersey, 7601, United States|Poughkeepsie, New York, 12601, United States|Syracuse, New York, 13210, United States|Bala-Cynwyd, Pennsylvania, 19004, United States|Pittsburgh, Pennsylvania, 15215, United States|Pittsburgh, Pennsylvania, 15240, United States|Norfolk, Virginia, 23502, United States|Seattle, Washington, 98109-1023, United States|Spokane, Washington, 99208-1129, United States|Wheeling, West Virginia, 26003, United States|St Leonards, New South Wales, 2065, Australia|Sydney, New South Wales, 2010, Australia|Adelaide, South Australia, 5000, Australia|East Bentleigh, Victoria, 3165, Australia|Fitzroy, Victoria, 3065, Australia|Heidelberg, Victoria, 3084, Australia|East Melbourne, 3002, Australia|Randwick, 2031, Australia|Brussels, 1070, Belgium|Bruxelles - Brussel, 1200, Belgium|Edegem, 2650, Belgium|Ghent, 9000, Belgium|Belo Horizonte, Minas Gerais, 30130-090, Brazil|Porto Alegre, Rio Grande do Sul, 90020-090, Brazil|Barretos/SP, São Paulo, 14784-400, Brazil|São Paulo, São Paulo, 01246-000, Brazil|São Paulo, 01409-000, Brazil|Calgary, Alberta, T2N 4N2, Canada|Vancouver, British Columbia, V5Z 4E6, Canada|Winnipeg, Manitoba, R3A 1R9, Canada|Hamilton, Ontario, L8V 5C2, Canada|Ottawa, Ontario, K1H 8L6, Canada|Toronto, Ontario, M4N 3M5, Canada|Montreal, Quebec, H2L 4M1, Canada|Québec, Quebec, G1R 2J6, Canada|Helsinki, FIN-00260, Finland|Kuopio, FIN- 70029, Finland|Seinäjoki, 60220, Finland|Tampere, 33520, Finland|Besançon, 25030, France|Bordeaux, 33076, France|Paris, 75005, France|Paris, 75010, France|Poitiers, 86021, France|Saint-Herblain, 44800, France|Toulouse, 31059, France|Ulm, Baden-Wurttemberg, 89075, Germany|München, Bavaria, 81675, Germany|Marburg, Hesse, 35033, Germany|Münster, North Rhine-Westphalia, 48149, Germany|Dresden, Saxony, 1307, Germany|Jena, Thuringia, 7747, Germany|Berlin, 12203, Germany|Afula, 1834111, Israel|Beersheba, 8410101, Israel|Haifa, 3109601, Israel|Jerusalem, 9112001, Israel|Kfar Saba, 4428164, Israel|Petah Tikva, 4941492, Israel|Ramat Gan, 5262000, Israel|Tel Aviv, 6423906, Israel|Ẕerifin, 7030000, Israel|Modena, Emilia-Romagna, 41100, Italy|Rome, Lazio, 152, Italy|Rome, Lazio, 189, Italy|Genoa, Liguria, 16128, Italy|Milan, Lombardy, 20133, Italy|Milan, Lombardy, 20141, Italy|Cagliari, Sardinia, 9125, Italy|Trento, Trentino-Alto Adige, 38100, Italy|Cortona, Tuscany, 52040, Italy|Nagoya, Aichi-ken, 466-8560, Japan|Hirosaki, Aomori, 036-8563, Japan|Chiba, Chiba, 260-8677, Japan|Kashiwa, Chiba, 277-8577, Japan|Matsuyama, Ehime, 791-0280, Japan|Sapporo, Hokkaido, 003-0804, Japan|Kobe, Hyōgo, 650-0047, Japan|Tsukuba, Ibaraki, 305-8576, Japan|Kanazawa, Ishikawa-ken, 920-8641, Japan|Kita-gun, Kagawa-ken, 761-0793, Japan|Yokohama, Kanagawa, 236-0004, Japan|Yokohama, Kanagawa, 241-8515, Japan|Sendai, Miyagi, 980-8574, Japan|Matsumoto, Nagano, 390-8621, Japan|Kurashiki, Okayama-ken, 701-0192, Japan|Okayama, Okayama-ken, 700-8558, Japan|Sayama, Osaka, 589-8511, Japan|Hamamatsu, Shizuoka, 431-3192, Japan|Bunkyo-Ku, Tokyo, 113-0022, Japan|Bunkyo-ku, Tokyo, 113-8431, Japan|Koto-ku, Tokyo, 135-8550, Japan|Shinjuku-ku, Tokyo, 160-8582, Japan|Ube, Yamaguchi, 755-8505, Japan|Chiba, 260-8717, Japan|Fukuoka, 811-1395, Japan|Fukuoka, 812-8582, Japan|Kumamoto, 860-0008, Japan|Miyazaki, 889-1692, Japan|Nagasaki, 852-8501, Japan|Amsterdam, 1105 AZ, Netherlands|Nijmegen, 6525 GA, Netherlands|Zwolle, 8025 AB, Netherlands|Bodø, 8092, Norway|Lørenskog, 1478, Norway|Oslo, 450, Norway|Gdansk, 80-214, Poland|Gdynia, 81-519, Poland|Gliwice, 44-101, Poland|Poznan, 61-485, Poland|Moscow, 115478, Russia|Obninsk, 249036, Russia|Singapore, 119074, Singapore|Singapore, 168583, Singapore|Singapore, 258499, Singapore|Badalona, Barcelona, 8916, Spain|L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Málaga, Málaga, 29010, Spain|Oviedo, Principality of Asturias, 33011, Spain|Barcelona, 08035, Spain|Barcelona, 8036, Spain|Madrid, 28009, Spain|Madrid, 28033, Spain|Madrid, 28034, Spain|Madrid, 28046, Spain|Madrid, 28050, Spain|Pamplona, 31008, Spain|Seville, 41071, Spain|Linköping, 581 85, Sweden|Stockholm, 171 76, Sweden|Sundsvall, 851 86, Sweden|Umeå, 901 85, Sweden|Vaxjo, 351 85, Sweden|Edinburgh, Lothian, EH4 2XU, United Kingdom|Bebington, Merseyside, CH63 4JY, United Kingdom|Northwood, Middlesex, HA6 2VR, United Kingdom|Guildford, Surrey, GU2 7XX, United Kingdom|Sutton, Surrey, SM2 5PT, United Kingdom|Newcastle upon Tyne, Tyne and Wear, NE4 6BE, United Kingdom|Coventry, West Midlands, CV2 2DX, United Kingdom|Belfast, BT9 7AB, United Kingdom|Leeds, LS9 7TF, United Kingdom|London, NW3 2QG, United Kingdom|Romford, RM7 0AG, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Endometrial Neoplasms,DRUG: Paclitaxel|DRUG: Sapanisertib|DRUG: MLN1117,FEMALE,"ADULT, OLDER_ADULT",PHASE2,241,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/1/16,10/30/20,"University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, 35294-3300, United States|University of Arizona Cancer Center, Phoenix, Arizona, 85013, United States|Marin Cancer Care, Greenbrae, California, 94904, United States|University of California San Diego Medical Center, La Jolla, California, 92093-1503, United States|University of California at San Francisco (PARENT), San Francisco, California, 94115, United States|Stanford School of Medicine, Stanford, California, 94305, United States|H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, 33612-9416, United States|Florida Cancer Specialists, West Palm Beach, Florida, 33401, United States|Augusta University, Augusta, Georgia, 30912, United States|Franciscan St. Francis Health, Indianapolis, Indiana, 46237, United States|University of Kansas Medical Center Research Institute, Inc., Westwood, Kansas, 66205, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|Washington University, St Louis, Missouri, 63108, United States|NYU Langone Medical Center Clinic, New York, New York, 10016, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065-6094, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|University of Pittsburgh Medical Center Cancer Center at Magee-Womens Hospital, Pittsburgh, Pennsylvania, 15232, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|St George Hospital, Kogarah, New South Wales, 2217, Australia|Westmead Hospital, Westmead, New South Wales, 2145, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, 4029, Australia|Monash Medical Centre Clayton, Clayton, Victoria, 3168, Australia|Sunshine Hospital, Footscray, Victoria, 3011, Australia|Cabrini Hospital Malvern, Malvern, Victoria, 3144, Australia|Peter MacCallum Cancer Centre-East Melbourne, Melbourne, Victoria, 3000, Australia|UZ Antwerpen, Edegem, Antwerpen, 2650, Belgium|Cliniques Universitaires Saint-Luc, Brussels, 1200, Belgium|UZ Leuven, Leuven, 3000, Belgium|Centre Hospitalier Universitaire de Liege Site Sart Tilman, Liège, 4000, Belgium|GasthuisZusters Antwerpen Sint-Augustinus, Wilrijk, 2610, Belgium|Tom Baker Cancer Centre, Calgary, Alberta, T2N 4N2, Canada|Juravinski Cancer Clinic, Hamilton, Ontario, L8V 5C2, Canada|LHSC - Victoria Hospital, London, Ontario, N6A 4L6, Canada|Ottawa Hospital Cancer Centre, Ottawa, Ontario, K1H 8L6, Canada|University Health Network - Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|CHUM Hopital Notre-Dame, Montreal, Quebec, H2X 3E4, Canada|Medizinische Hochschule Hannover, Hanover, Lower Saxony, 30625, Germany|Universitaetsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, 17489, Germany|Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden, Saxony, 01307, Germany|Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Lübeck, Schleswig-Holstein, 23538, Germany|Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum, Berlin, 13353, Germany|Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori, Meldola, Forli - Cesena, 47014, Italy|Spedali Civili di Brescia, Brescia, 25123, Italy|Ente Ospedaliero Ospedali Galliera, Genova, 16128, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy|IEO Istituto Europeo di Oncologia, Milan, 20141, Italy|Istituto Tumori Napoli Fondazione G. Pascale, Napoli, 80131, Italy|Azienda Unita Sanitaria Locale di Ravenna, Ravenna, 48121, Italy|Istituto Nationale Tumori Regina Elena, Roma, 00144, Italy|Universita degli Studi di Roma ""La Sapienza"" - Umberto I Policlinico di Roma, Roma, 00161, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, 00168, Italy|Maastricht Universitair Medisch Centrum, Maastricht, Limburg, 6229 HX, Netherlands|Academisch Medisch Centrum, Amsterdam, North Holland, 1105 AZ, Netherlands|Erasmus Medisch Centrum Daniel den Hoed, Rotterdam, South Holland, 3015 GD, Netherlands|Universitair Medisch Centrum Groningen, Groningen, 9700 RB, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, 3584 CX, Netherlands|Haukeland universitetssykehus, Kvinneklinikken, Bergen, 5021, Norway|Radiumhospitalet, Oslo, 0310, Norway|Stavanger University Hospital, Stavanger, 4011, Norway|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|MD Anderson Cancer Centre, Madrid, 28033, Spain|Hospital Universitario Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Centro Integral Oncologico Clara Campal, Madrid, 28050, Spain|Instituto Valenciano de Oncologia IVO, Valencia, 46009, Spain|Bristol Haematology and Oncology Centre, Bristol, Avon, BS2 8ED, United Kingdom|Royal Devon and Exeter Hospital (Wonford), Exeter, Devon, EX2 5DW, United Kingdom|University College London Hospitals, London, Greater London, NW1 2BU, United Kingdom|Royal Marsden Hospital, London, Greater London, SW3 6JJ, United Kingdom|Hammersmith Hospital, London, Greater London, W12 0HS, United Kingdom|The Christie, Manchester, Greater Manchester, M20 4BX, United Kingdom|Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, United Kingdom|University Hospital Coventry, Coventry, CV2 2DX, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: MEDI4736,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,1022,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/5/12,2/28/20,"Research Site, Scottsdale, Arizona, 85258, United States|Research Site, Burbank, California, 91505, United States|Research Site, Gilroy, California, 95020, United States|Research Site, Los Angeles, California, 90025, United States|Research Site, Los Angeles, California, 90095, United States|Research Site, Orange, California, 92868, United States|Research Site, Palo Alto, California, 94304-5826, United States|Research Site, San Francisco, California, 94115, United States|Research Site, Whittier, California, 90603, United States|Research Site, New Haven, Connecticut, 06520, United States|Research Site, Washington D.C., District of Columbia, 20007, United States|Research Site, Jacksonville, Florida, 32224, United States|Research Site, Miami Beach, Florida, 33140, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Athens, Georgia, 30607, United States|Research Site, Augusta, Georgia, 30912, United States|Research Site, Chicago, Illinois, 60637, United States|Research Site, Baltimore, Maryland, 21201, United States|Research Site, Baltimore, Maryland, 21231, United States|Research Site, Boston, Massachusetts, 02215, United States|Research Site, Ann Arbor, Michigan, 48109, United States|Research Site, Detroit, Michigan, 48201, United States|Research Site, Minneapolis, Minnesota, 55407, United States|Research Site, Saint Louis Park, Minnesota, 55416, United States|Research Site, Billings, Montana, 59101, United States|Research Site, Las Vegas, Nevada, 89169, United States|Research Site, Hackensack, New Jersey, 07601, United States|Research Site, Paterson, New Jersey, 07503, United States|Research Site, New York, New York, 10065, United States|Research Site, The Bronx, New York, 10461, United States|Research Site, Chapel Hill, North Carolina, 27599, United States|Research Site, Huntersville, North Carolina, 28078, United States|Research Site, Cleveland, Ohio, 44106, United States|Research Site, Columbus, Ohio, 43210, United States|Research Site, Portland, Oregon, 97213, United States|Research Site, Philadelphia, Pennsylvania, 19107-5097, United States|Research Site, Pittsburgh, Pennsylvania, 15212, United States|Research Site, Greenville, South Carolina, 29605, United States|Research Site, Nashville, Tennessee, 37203, United States|Research Site, Dallas, Texas, 75201, United States|Research Site, Houston, Texas, 77030, United States|Research Site, Houston, Texas, 77090, United States|Research Site, San Antonio, Texas, 78229, United States|Research Site, Salt Lake City, Utah, 84403, United States|Research Site, Blacksburg, Virginia, 24060, United States|Research Site, Fairfax, Virginia, 22031, United States|Research Site, Seattle, Washington, 98104, United States|Research Site, Ghent, 9000, Belgium|Research Site, Leuven, 3000, Belgium|Research Site, Liège, B-4000, Belgium|Research Site, Namur, 5000, Belgium|Research Site, Ottawa, Ontario, K1H 8L6, Canada|Research Site, Toronto, Ontario, M5G 2M9, Canada|Research Site, Montreal, Quebec, H2X 3E4, Canada|Research Site, Paris, 75475, France|Research Site, Villejuif, 94800, France|Research Site, Berlin, 12200, Germany|Research Site, Gauting, 82131, Germany|Research Site, Heidelberg, 69120, Germany|Research Site, Jena, 07747, Germany|Research Site, Minden, 32429, Germany|Research Site, Lecce, 73100, Italy|Research Site, Milan, 20141, Italy|Research Site, Milan, 20132, Italy|Research Site, Napoli, 80131, Italy|Research Site, Siena, 53100, Italy|Research Site, Gwangju, 61469, South Korea|Research Site, Seogu, 49241, South Korea|Research Site, Seongnam-si, 13620, South Korea|Research Site, Seoul, 03080, South Korea|Research Site, Seoul, 05505, South Korea|Research Site, Seoul, 06351, South Korea|Research Site, Tainan, 70403, Taiwan|Research Site, Taipei, 10002, Taiwan|Research Site, London, EC1A 7BE, United Kingdom|Research Site, London, SW2 6JJ, United Kingdom|Research Site, London, W1G 6AD, United Kingdom|Research Site, Oxford, OX3 7LE, United Kingdom|Research Site, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasms,BIOLOGICAL: Pembrolizumab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Up to ~43 months (through database cut-off date of 18-September-2019)|DCR Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, DCR was defined as the percentage of participants in the analysis population who have a CR (Disappearance of all target lesions) or PR (≥30% decrease in SOD of target lesions) or SD (Neither sufficient shrinkage for PR nor sufficient increase for PD \[at ≥20% increase in target lesion SOD and absolute SOD increase of ≥5 mm. Appearance of ≥1 new lesion is also PD\]) or NN (does not qualify for CR or PD) for ≥24 weeks per RECIST 1.1 based on BICR. Per protocol the percentage of participants who experienced CR, PR, SD or NN per RECIST 1.1 by BICR is reported as the DCR, Up to ~43 months (through database cut-off date of 18-September-2019)|DCR Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, DCR was defined as the percentage of participants in the analysis population who have a CR (Disappearance of all target lesions) or PR (≥30% decrease in SOD of target lesions) or SD (Neither sufficient shrinkage to for PR nor sufficient increase for PD \[at ≥20% increase in target lesion SOD and absolute SOD increase of ≥5 mm. Appearance of ≥1 new lesion is also PD\]) or NN (does not qualify for CR or PD) for ≥24 weeks per RECIST 1.1 based on BICR. Per protocol the percentage of participants who experienced CR, PR, SD or NN per RECIST 1.1 by BICR is reported as the DCR, analyzed by test of binomial parameter, for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of DCR per RECIST 1.1 by BICR was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|PFS Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 based on BICR, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. PFS was analyzed by KM method. Per protocol PFS per RECIST 1.1 by BICR is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of PFS per RECIST 1.1 by BICR was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|Percentage of Participants With PFS (PFS Rate) at Month 6 Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 based on BICR, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 6 per RECIST 1.1 by BICR is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of PFS rate at Month 6 per RECIST 1.1 by BICR was not planned or executed in Cohort B., Month 6|Percentage of Participants With PFS (PFS Rate) at Month 12 Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 based on BICR, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 12 per RECIST 1.1 by BICR is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of PFS rate at Month 12 per RECIST 1.1 by BICR was not planned or executed in Cohort B., Month 12|Percentage of Participants With PFS (PFS Rate) at Month 18 Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 based on BICR, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 18 per RECIST 1.1 by BICR is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of PFS rate at Month 18 per RECIST 1.1 by BICR was not planned or conducted in Cohort B., Month 18|PFS Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 based on BICR, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. PFS was analyzed by KM method. Per protocol PFS per RECIST 1.1 by BICR is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of PFS per RECIST 1.1 by BICR was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|Percentage of Participants With PFS (PFS Rate) at Month 6 Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 based on BICR, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 6 per RECIST 1.1 by BICR is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of PFS rate at Month 6 per RECIST 1.1 by BICR was not planned or executed in Cohort B., Month 6|Percentage of Participants With PFS (PFS Rate) at Month 12 Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 based on BICR, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 12 per RECIST 1.1 by BICR is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of PFS rate at Month 12 per RECIST 1.1 by BICR was not planned or executed in Cohort B., Month 12|Percentage of Participants With PFS (PFS Rate) at Month 18 Per RECIST 1.1 by BICR in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 based on BICR, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 18 per RECIST 1.1 by BICR is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of PFS rate at Month 18 per RECIST 1.1 by BICR was not planned or executed in Cohort B., Month 18|ORR Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/ TFI ≥3-6 Months, ORR was defined as the percentage of participants in the analysis population who had a CR (Disappearance of all target lesions) or a PR (≥30% decrease in SOD of target lesions) using RECIST 1.1 based on investigator assessment. ORR was analyzed by test of binomial parameter. Per protocol the percentage of participants who experienced CR or PR per RECIST 1.1 by investigator is reported as the ORR for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of ORR per RECIST 1.1 by investigator was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|ORR Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/ TFI >6-12 Months, ORR was defined as the percentage of participants in the analysis population who had a CR (Disappearance of all target lesions) or a PR (≥30% decrease in SOD of target lesions) using RECIST 1.1 based on investigator assessment. ORR was analyzed by test of binomial parameter. Per protocol the percentage of participants who experienced CR or PR per RECIST 1.1 by investigator is reported as the ORR for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of ORR per RECIST 1.1 by investigator was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|DOR Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, For participants who demonstrated a confirmed CR (disappearance of all target lesions) or PR (≥30% decrease in SOD of target lesions) per RECIST 1.1 by investigator assessment, DOR was defined as time from first documented CR or PR until PD or death, whichever occurs first. DOR for participants who didn't progress or die at time of analysis was censored at last tumor assessment. Per RECIST 1.1 PD is ≥20% increase in target lesion SOD and absolute SOD increase of ≥5 mm. Appearance of ≥1 new lesion is also PD. Per protocol DOR analyzed by KM method is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months who had a CR or PR per RECIST 1.1 by investigator. Per protocol PFI/TFI ≥3-6 months subgroup analysis of DOR per RECIST 1.1 by investigator was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|DOR Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, For participants who demonstrated confirmed CR (disappearance of all target lesions) or PR (≥30% decrease in SOD of target lesions) per RECIST 1.1 by investigator assessment, DOR was defined as time from first documented CR or PR until PD or death, whichever occurs first. DOR for participants who didn't progress or die at time of analysis was censored at last tumor assessment. Per RECIST 1.1 PD is ≥20% increase in target lesion SOD and absolute SOD increase of ≥5 mm. Appearance of ≥1 new lesion is also PD. Per protocol DOR analyzed by KM method is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months who had a CR or PR per RECIST 1.1 by investigator. Per protocol PFI/TFI \>6-12 months subgroup analysis of DOR per RECIST 1.1 by investigator was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|DCR Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, DCR was defined as the percentage of participants in the analysis population who have CR (Disappearance of all target lesions) or PR (≥30% decrease in SOD of target lesions) or SD (Neither sufficient shrinkage for PR nor sufficient increase for PD \[at ≥20% increase in target lesion SOD and absolute SOD increase of ≥5 mm. Appearance of ≥1 new lesion is also PD\]) or NN (doesn't qualify for CR or PD) for ≥24 weeks per RECIST 1.1 by investigator assessment. Per protocol percentage of participants who experienced CR, PR, SD or NN per RECIST 1.1 by investigator is reported as DCR, analyzed by test of binomial parameter, for subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of DCR per RECIST 1.1 by investigator was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|DCR Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, DCR was defined as the percentage of participants in the analysis population who have CR (Disappearance of all target lesions) or PR (≥30% decrease in SOD of target lesions) or SD (Neither sufficient shrinkage for PR nor sufficient increase for PD \[at ≥20% increase in target lesion SOD and absolute SOD increase of ≥5 mm. Appearance of ≥1 new lesion is also PD\]) or NN (doesn't qualify for CR or PD) for ≥24 weeks per RECIST 1.1 by investigator assessment. Per protocol percentage of participants who experienced CR, PR, SD or NN per RECIST 1.1 by investigator is reported as DCR, analyzed by test of binomial parameter, for subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI\>6-12 months subgroup analysis of DCR per RECIST 1.1 by investigator was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|PFS Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 by investigator assessment, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. PFS was analyzed by KM method. Per protocol PFS per RECIST 1.1 by investigator is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of PFS per RECIST 1.1 by investigator was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|Percentage of Participants With PFS (PFS Rate) at Month 6 Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 by investigator assessment, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 6 per RECIST 1.1 by investigator is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of PFS rate at Month 6 per RECIST 1.1 by investigator was not planned or executed in Cohort B., Month 6|Percentage of Participants With PFS (PFS Rate) at Month 12 Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 by investigator assessment, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 12 per RECIST 1.1 by investigator is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of PFS rate at Month 12 per RECIST 1.1 by investigator was not planned or executed in Cohort B., Month 12|Percentage of Participants With PFS (PFS Rate) at Month 18 Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 by investigator assessment, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 18 per RECIST 1.1 by investigator is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of PFS rate at Month 18 per RECIST 1.1 by investigator was not planned or executed in Cohort B., Month 18|PFS Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 by investigator assessment, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. PFS was analyzed by KM method. Per protocol PFS per RECIST 1.1 by investigator is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of PFS per RECIST 1.1 by investigator was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|Percentage of Participants With PFS (PFS Rate) at Month 6 Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 by investigator assessment, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 6 per RECIST 1.1 by investigator is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of PFS rate at Month 6 per RECIST 1.1 by investigator was not planned or executed in Cohort B., Month 6|Percentage of Participants With PFS (PFS Rate) at Month 12 Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 by investigator assessment, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 12 per RECIST 1.1 by investigator is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of PFS rate at Month 12 per RECIST 1.1 by investigator was not planned or executed in Cohort B., Month 12|Percentage of Participants With PFS (PFS Rate) at Month 18 Per RECIST 1.1 by Investigator in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, PFS was defined as the time from first dose of study treatment to the first documented PD per RECIST 1.1 by investigator assessment, or death due to any cause, whichever occurred first. Per RECIST 1.1 PD was defined as ≥20% increase in SOD of target lesions and an absolute SOD increase of ≥5 mm. The appearance of ≥1 new lesion is also PD. Per protocol the percentage of participants with PFS (PFS rate) at Month 18 per RECIST 1.1 by investigator is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of PFS rate at Month 18 per RECIST 1.1 by investigator was not planned or executed in Cohort B., Month 18|Overall Survival (OS) in All Cohort A and Cohort B Participants, OS was defined as the time from the first dose of study drug to death due to any cause. OS analyzed by KM method is reported for all participants in Cohort A and Cohort B., Up to ~58.8 months (through database cut-off date of 18-March-2021)|Percentage of Participants With OS (OS Rate) at Month 6 in All Cohort A and Cohort B Participants, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 6 is reported for all participants in Cohort A and Cohort B., Month 6|Percentage of Participants With OS (OS Rate) at Month 12 in All Cohort A and Cohort B Participants, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 12 is reported for all participants in Cohort A and Cohort B., Month 12|Percentage of Participants With OS (OS Rate) at Month 18 in All Cohort A and Cohort B Participants, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 18 is reported for all participants in Cohort A and Cohort B., Month 18|Percentage of Participants With OS (OS Rate) at Month 24 in All Cohort A and Cohort B Participants, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 24 is reported for all participants in Cohort A and Cohort B., Month 24|OS in Subgroup of Cohort A and Cohort B Participants With PD-L1 CPS ≥10, OS was defined as the time from the first dose of study drug to death due to any cause. OS analyzed by KM method is reported for the subgroup of participants in Cohort A and Cohort B who had a PD-L1 biomarker positive expression defined by IHC as CPS ≥10., Up to ~43 months (through database cut-off date of 18-September-2019)|Percentage of Participants With OS (OS Rate) at Month 6 in Subgroup of Cohort A and Cohort B Participants With PD-L1 CPS ≥10, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 6 is reported for the subgroup of participants in Cohort A and Cohort B who had a PD-L1 biomarker positive expression defined by IHC as CPS ≥10., Month 6|Percentage of Participants With OS (OS Rate) at Month 12 in Subgroup of Cohort A and Cohort B Participants With PD-L1 CPS ≥10, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 12 is reported for the subgroup of participants in Cohort A and Cohort B who had a PD-L1 biomarker positive expression defined by IHC as CPS ≥10., Month 12|Percentage of Participants With OS (OS Rate) at Month 18 in Subgroup of Cohort A and Cohort B Participants With PD-L1 CPS ≥10, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 18 is reported for the subgroup of participants in Cohort A and Cohort B who had a PD-L1 biomarker positive expression defined by IHC as CPS ≥10., Month 18|OS in Subgroup of Cohort A and Cohort B Participants With PD-L1 CPS ≥1, OS was defined as the time from the first dose of study drug to death due to any cause. OS analyzed by KM method is reported for the subgroup of participants in Cohort A and Cohort B who had a PD-L1 biomarker positive expression defined by IHC as CPS ≥1., Up to ~43 months (through database cut-off date of 18-September-2019)|Percentage of Participants With OS (OS Rate) at Month 6 in Subgroup of Cohort A and Cohort B Participants With PD-L1 CPS ≥1, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 6 is reported for the subgroup of participants in Cohort A and Cohort B who had a PD-L1 biomarker positive expression defined by IHC as CPS ≥1., Month 6|Percentage of Participants With OS (OS Rate) at Month 12 in Subgroup of Cohort A and Cohort B Participants With PD-L1 CPS ≥1, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 12 is reported for the subgroup of participants in Cohort A and Cohort B who had a PD-L1 biomarker positive expression defined by IHC as CPS ≥1., Month 12|Percentage of Participants With OS (OS Rate) at Month 18 in Subgroup of Cohort A and Cohort B Participants With PD-L1 CPS ≥1, OS was defined as the time from the first dose of study drug to death due to any cause. The percentage of participants with OS (OS rate) at Month 18 is reported for the subgroup of participants in Cohort A and Cohort B who had a PD-L1 biomarker positive expression defined by IHC as CPS ≥1., Month 18|OS in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, OS was defined as the time from the first dose of study drug to death due to any cause. Per protocol OS analyzed by KM method is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of OS was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|Percentage of Participants With OS (OS Rate) at Month 6 in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, OS was defined as the time from the first dose of study drug to death due to any cause. Per protocol the percentage of participants with OS (OS rate) at Month 6 is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of OS rate at Month 6 was not planned or executed in Cohort B., Month 6|Percentage of Participants With OS (OS Rate) at Month 12 in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, OS was defined as the time from the first dose of study drug to death due to any cause. Per protocol the percentage of participants with OS (OS rate) at Month 12 is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of OS rate at Month 12 was not planned or executed in Cohort B., Month 12|Percentage of Participants With OS (OS Rate) at Month 18 in Subgroup of Cohort A Participants With PFI/TFI ≥3-6 Months, OS was defined as the time from the first dose of study drug to death due to any cause. Per protocol the percentage of participants with OS (OS rate) at Month 18 is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) ≥3-6 months. Per protocol PFI/TFI ≥3-6 months subgroup analysis of OS rate at Month 18 was not planned or executed in Cohort B., Month 18|OS in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, OS was defined as the time from the first dose of study drug to death due to any cause. Per protocol OS analyzed by KM method is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of OS was not planned or executed in Cohort B., Up to ~43 months (through database cut-off date of 18-September-2019)|Percentage of Participants With OS (OS Rate) at Month 6 in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, OS was defined as the time from the first dose of study drug to death due to any cause. Per protocol the percentage of participants with OS (OS rate) at Month 6 is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of OS rate at Month 6 was not planned or executed in Cohort B., Month 6|Percentage of Participants With OS (OS Rate) at Month 12 in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, OS was defined as the time from the first dose of study drug to death due to any cause. Per protocol the percentage of participants with OS (OS rate) at Month 12 is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of OS rate at Month 12 was not planned or executed in Cohort B., Month 12|Percentage of Participants With OS (OS Rate) at Month 18 in Subgroup of Cohort A Participants With PFI/TFI >6-12 Months, OS was defined as the time from the first dose of study drug to death due to any cause. Per protocol the percentage of participants with OS (OS rate) at Month 18 is reported for the subgroup of Cohort A participants with PFI/TFI (duration from end of treatment to disease recurrence) \>6-12 months. Per protocol PFI/TFI \>6-12 months subgroup analysis of OS rate at Month 18 was not planned or executed in Cohort B., Month 18|Number of Participants Who Experienced an Adverse Event (AE), An AE was defined as any untoward medical occurrence in a pharmaceutical product which does not necessarily have to have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a pre-existing condition that was temporally associated with the use of the Sponsor's product was also an AE. As specified by the protocol, the number of participants who experienced at least one AE is reported here for all participants in Cohort A and Cohort B., Up to ~58.8 months (through database cut-off date of 18-March-2021)|Number of Participants Who Discontinued Study Treatment Due to an AE, An AE was defined as any untoward medical occurrence in a pharmaceutical product which does not necessarily have to have a causal relationship with this treatment. An AE could therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal product or protocol-specified procedure, whether or not considered related to the medicinal product or protocol-specified procedure. Any worsening of a pre-existing condition that was temporally associated with the use of the Sponsor's product was also an AE. As specified by the protocol, the number of participants who discontinued study treatment due to an AE is reported here for all participants in Cohort A and Cohort B.," Up to ~58.8 months (through database cut-off date of 18-March-2021)""",FEMALE,"ADULT, OLDER_ADULT",PHASE2,376,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/25/16,3/18/21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,DRUG: Zolpidem|DIAGNOSTIC_TEST: ECG,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,1/22/19,1/30/24,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Nonhematologic Neoplasms, Advanced",DRUG: TAK-931,ALL,"ADULT, OLDER_ADULT",PHASE1,80,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,3/24/16,12/21/19,"Kashiwa, Chiba, Japan|Chuo-ku, Tokyo, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Cancer|Solid Tumors,DRUG: SX-682|DRUG: M7824|BIOLOGICAL: MVA-BN-CV301|BIOLOGICAL: recombinant fowlpox viral (FPV)-CV301,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,12,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/24/20,5/19/23,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Neoplasms,PROCEDURE: Stem cell transplantation|DRUG: Fludarabine|DRUG: Cyclophosphamide|DRUG: Etoposide|DRUG: Doxorubicin|DRUG: Vincristine|DRUG: Prednisone|DRUG: Methotrexate|DRUG: Cyclosporine|PROCEDURE: Apheresis,ALL,"ADULT, OLDER_ADULT",PHASE2,62,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/3/03,9/25/14,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Breast Neoplasms|Neoplasm Metastasis,DRUG: Imlunestrant|DRUG: Exemestane|DRUG: Fulvestrant|DRUG: Abemaciclib,ALL,"ADULT, OLDER_ADULT",PHASE3,874,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/4/21,2027-08,"Ironwood Cancer & Research Centers, Chandler, Arizona, 85224, United States|Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Marin Cancer Care, Greenbrae, California, 94904, United States|University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento, California, 95817, United States|Sharp Memorial Hospital, San Diego, California, 92123, United States|Banner MD Anderson Cancer Center at McKee Medical Center, Loveland, Colorado, 80538, United States|Clermont Oncology Center, Clermont, Florida, 34711, United States|University of Florida College of Medicine, Gainesville, Florida, 32610, United States|Mid Florida Hematology and Oncology Center, Orange City, Florida, 32763, United States|Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Florida Cancer Specialists, St. Petersburg, Florida, 33705, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, 96819, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|NorthShore University HealthSystem - Evanston Hospital, Evanston, Illinois, 60201, United States|IU Health Ball Memorial Hospital, Inc., Muncie, Indiana, 47303, United States|The University of Louisville, James Graham Brown Cancer Center, Louisville, Kentucky, 40202, United States|Jackson Oncology Associates, PLLC, Jackson, Mississippi, 39202, United States|Care Access - Clifton, Clifton, New Jersey, 07013, United States|Memorial Sloan Kettering - Bergen, Montvale, New Jersey, 07645, United States|Columbia University Medical Center, New York, New York, 10032, United States|University of North Carolina Medical Center, Chapel Hill, North Carolina, 27599, United States|Aultman Hospital, Canton, Ohio, 44710, United States|Mercy Health - St. Vincent Medical Center, Toledo, Ohio, 43608, United States|Avera Cancer Institute Sioux Falls, Sioux Falls, South Dakota, 57105, United States|Florida Cancer Specialists, Nashville, Tennessee, 37203, United States|The Mark H Zangmeister Cancer Center, Nashville, Tennessee, 37203, United States|USO - Texas Oncology - Allen, Allen, Texas, 75013, United States|Texas Oncology - Dallas Presbyterian Hospital, Dallas, Texas, 75231, United States|Willamette Valley Cancer Institute & Research Ctr., Houston, Texas, 77070, United States|Texas Oncology - Carrollton, Lewisville, Texas, 75056, United States|Texas Oncology - Denison, The Woodlands, Texas, 75020, United States|Texas Oncology - Paris, The Woodlands, Texas, 75460, United States|Blue Ridge Cancer Care, The Woodlands, Texas, 77380, United States|Broome Oncology, The Woodlands, Texas, 77380, United States|Minnesota Oncology/Hematology PA, The Woodlands, Texas, 77380, United States|Texas Oncology - Carrollton, The Woodlands, Texas, 77380, United States|Texas Oncology - McKinney, The Woodlands, Texas, 77380, United States|Texas Oncology - Medical City Dallas, The Woodlands, Texas, 77380, United States|Texas Oncology - Methodist Charlton Cancer Center, The Woodlands, Texas, 77380, United States|Texas Oncology - San Antonio Medical Center, The Woodlands, Texas, 77380, United States|Texas Oncology - The Woodlands, The Woodlands, Texas, 77380, United States|Texas Oncology - Willowbrook, The Woodlands, Texas, 77380, United States|Texas Oncology Fort Worth, The Woodlands, Texas, 77380, United States|Texas Oncology-Baylor Charles A. Sammons Cancer Center, The Woodlands, Texas, 77380, United States|USO-Rocky Mountain Cancer Center, The Woodlands, Texas, 77380, United States|Texas Oncology - Austin Central, The Woodlands, Texas, 78731, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|The University of Vermont Medical Center Inc., Burlington, Vermont, 05401, United States|Instituto de Investigaciones Clínicas Mar del Plata, Mar del Plata, Buenos Aires, B7600FZO, Argentina|CIPREC, Buenos Aires, Buenos Aires F.D., C1061AAS, Argentina|Fundación Cenit Para La Investigación En Neurociencias, CABA, Buenos Aires F.D., 1125, Argentina|Centro Medico Privado CEMAIC, Capital, Córdoba Province, X5008HHW, Argentina|Clinica Viedma, Viedma, Río Negro Province, 8500, Argentina|Instituto Argentino de Diagnóstico y Tratamiento (IADT), Buenos Aires, 1122, Argentina|Instituto San Marcos, San Juan, 5400, Argentina|Sanatorio Norte, Santiago del Estero, 4200, Argentina|St Vincent's Hospital, Darlinghurst, New South Wales, 2010, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, 4102, Australia|Ashford Cancer Centre Research, Kurralta Park, South Australia, 5037, Australia|Box Hill Hospital, Box Hill, Victoria, 3128, Australia|Maroondah Hospital, Melbourne, Victoria, 3135, Australia|Medizinische Universität Graz, Graz, Styria, 8036, Austria|Universitaetsklinikum Allgemeines Krankenhaus Wien, Vienna, Vienna, 1090, Austria|Uniklinikum Salzburg, Salzburg, 5020, Austria|Imelda General Hospital, Bonheiden, Antwerpen, 2820, Belgium|Institut Jules Bordet, Brussels, Bruxelles-Capitale, Région de, 1000, Belgium|UZ Brussel, Brussels, Bruxelles-Capitale, Région de, 1090, Belgium|UZ Gent, Ghent, Oost-Vlaanderen, 9000, Belgium|AZ Nikolaas, Sint-Niklaas, Oost-Vlaanderen, B-9100, Belgium|UZ Leuven, Leuven, Vlaams-Brabant, 3000, Belgium|AZ Groeninge Campus Kennedylaan, Kortrijk, West-Vlaanderen, 8500, Belgium|CHU UCL Namur/Site Sainte Elisabeth, Namur, 5000, Belgium|Hospital de Cancer de Londrina, Londrina, Paraná, 86015-520, Brazil|Faculdade de Medicina do ABC, Santo André, São Paulo, 09060-650, Brazil|Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo, 01246-000, Brazil|Clínica de Pesquisa e Centro de Estudos em Ginecologia Oncológica e Mamária LTDA, São Paulo, 01317-001, Brazil|Núcleo de Pesquisa Clínica da Rede São Camilo, São Paulo, 04014-002, Brazil|Afflilated Hospital of Bengbu Medical College, Bengbu, Anhui, 233004, China|Beijing Hospital, Beijing, Beijing Municipality, 100005, China|Fifth Medical Center of PLA General Hospital, Beijing, Beijing Municipality, 100039, China|Fujian Provincial Cancer Hospital, Fuzhou, Fujian, 350014, China|Sun Yat-Sen University Cancer Centre, Guangzhou, Guangdong, 511400, China|Jiangmen Center Hospital, Jiangmen, Guangdong, China|Shenzhen Second People's Hospital, Shenzhen, Guangdong, 518035, China|Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, 524001, China|Zhongshan Peoples Hospital, Zhongshan, Guangdong, 528403, China|The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, 519000, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, China|The First Affiliated Hospital of Henan University of Science &Technology, Luoyang, Henan, 471003, China|Nanyang Second General Hospital, Nanyang, Henan, 473000, China|Tongji Hospital Tongji Medical,Science & Technology, Wuhan, Hubei, 430030, China|Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, China|Hubei Cancer Hospital, Wuhan, Hubei, 430079, China|The First People's Hospital of Changde City, Changde, Hunan, 415003, China|Xiangya Hospital Central South University, Changsha, Hunan, 410008, China|Hunan Cancer Hospital, Changsha, Hunan, 421000, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The Third Hospital of Nanchang, Nanchang, Jiangxi, 330009, China|The Second Hospital of Jilin University, Changchun, Jilin, China|The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China|Jinan Central Hospital, Jinan, Shandong, 250013, China|Sichuan Cancer hospital, Chengdu, Sichuan, 610042, China|The Second People's Hospital of Neijiang, Neijiang, Sichuan, 641000, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality, 300060, China|Sir Run Run Shaw Hospital, Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China|Hwa Mei Hospital University of Chinese Academy of Sciences, Ningbo, Zhejiang, 315010, China|Ningbo Medical Center, Ningbo, Zhejiang, 315048, China|Nemocnice Horovice, Hořovice, Beroun, 268 31, Czechia|Fakultni nemocnice Kralovske Vinohrady, Prague, Praha 10, 10034, Czechia|Fakultni Thomayerova nemocnice, Prague, Praha 4, 14059, Czechia|Nemocnice Na Bulovce, Prague, Praha 8, 180 81, Czechia|Oblastni nemocnice Pribram, Příbram, Příbram, 261 01, Czechia|Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, Alsace, 67033, France|Polyclinique De Blois, La Chaussée-Saint-Victor, Centre-Val de Loire, 41260, France|CHU Besançon, Besançon, Doubs, 25000, France|Hôpital René Huguenin, Saint-Cloud, Hauts-de-Seine, 92210, France|Centre de Cancérologie du Grand Montpellier, Montpellier, Languedoc-Roussillon, 34070, France|Clinique Victor Hugo Le Mans, Le Mans, Pays de la Loire Region, 72000, France|Centre Hospitalier de la Côte Basque, Bayonne, Pyrénées-Atlantiques, 64109, France|Institut Curie, Paris, 75248, France|Institut de Cancérologie de Lorraine Alexis Vautrin, Vandœuvre-lès-Nancy, 54519, France|Klinikum Ludwigsburg, Ludwigsburg, Baden-Wurttemberg, 71640, Germany|Onkologiezentrum Donauwörth, Donauwörth, Bavaria, 86609, Germany|Universitaetsklinikum Erlangen, Erlangen, Bavaria, 91054, Germany|Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München, Bavaria, 80336, Germany|Agaplesion Markus Krankenhaus, Frankfurt am Main, Hesse, 60431, Germany|Gynäkologisch-Onkologische Praxis am Pelikanplatz, Hanover, Lower Saxony, 30177, Germany|Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung, Essen, North Rhine-Westphalia, 45136, Germany|Evangelisches Krankenhaus Bethesda Mönchengladbach, Mönchengladbach, North Rhine-Westphalia, 41061, Germany|Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, 24105, Germany|Agios Savvas Regional Cancer Hospital, Athens, Attikí, 115 22, Greece|Alexandra Hospital, Athens, Attikí, 115 28, Greece|General Oncology Hospital of Kifissia ""Agioi Anargiroi"", Nea Kifissia, Attikí, 14564, Greece|University General Hospital of Heraklion, Heraklion, Irakleío, 711 10, Greece|Euromedica General Clinic of Thessaloniki, Thessaloniki, Thessaloníki, 546 45, Greece|Papageorgiou General Hospital of Thessaloniki, Thessaloniki, Thessaloníki, 564 29, Greece|European Interbalkan Medical Center, Thessaloniki, Thessaloníki, 570 01, Greece|University General Hospital of Larissa, Larissa, Thessalía, 41110, Greece|Medstar Speciality Hospital, Bangalore, Karnataka, 560092, India|Regional Cancer Centre - Thiruvananthapuram, Thiruvananthapuram, Kerala, 695011, India|HCG Cancer Centre, Mumbai, Maharashtra, 400092, India|Government Medical College And Hospital - Nagpur, Nagpur, Maharashtra, 440003, India|Rashtrasant Tukdoji Regional Cancer Hospital, Nagpur, Maharashtra, 440027, India|HCG Manavata Cancer Centre, Nashik, Maharashtra, 422002, India|Deenanath Mangeshkar Hospital & Research Centre, Pune, Maharashtra, 411004, India|Lifepoint Multispeciality Hospital, Pune, Maharashtra, 411057, India|Yashoda Hospitals, Hyderabad, Telangana, 500082, India|University of Naples Federico II, Naples, Campania, 80100, Italy|Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, 80131, Italy|Cro-Irccs, Aviano, Friuli Venezia Giulia, 33081, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Rome, Lazio, 00168, Italy|Ospedale San Martino, Genoa, Liguria, 16132, Italy|Azienda Ospedaliera Universitaria Careggi, Florence, Tuscany, 50134, Italy|Istituto Oncologico Veneto IRCCS, Padua, 35128, Italy|Nagoya University Hospital, Nagoya, Aichi-ken, 466-8560, Japan|Chiba cancer center, Chiba, Chiba, 260-8717, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, 791-0280, Japan|Kurume General Hospital, Kurume, Fukuoka, 830-0013, Japan|Gunma Prefectural Cancer Center, Otashi, Gunma, 373-8550, Japan|National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, 003-0804, Japan|Hyogo Cancer Center, Akashi, Hyōgo, 673-8558, Japan|Shinko Hospital, Kobe, Hyōgo, 651-0072, Japan|Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, 300-0028, Japan|Tsukuba University Hospital, Tsukuba, Ibaraki, 305-8576, Japan|St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, 216-8511, Japan|Kanagawa cancer center, Yokohama, Kanagawa, 2418515, Japan|Nagano Municipal Hospital, Tomitake, Nagano, 381-8551, Japan|Niigata Cancer Center Hospital, Niigata, Niigata, 951-8566, Japan|Showa University Hospital, Shinagawa, Tokyo, 142-8555, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Hiroshima City Hospital, Hiroshima, 730-8518, Japan|Sagara Hospital, Kagoshima, 892-0833, Japan|Kumamoto Shinto General Hospital, Kumamoto, 862-8655, Japan|Osaka International Cancer Institute, Osaka, 541-8567, Japan|Shizuoka General Hospital, Shizuoka, 420-8527, Japan|Juntendo University Hospital, Tokyo, 113-8431, Japan|Centro de Investigación Clínica de Alta Especialidad, Torreón, Coahuila, 27010, Mexico|COI Centro Oncologico Internacional S.A.P.I. de C.V., Álvaro Obregón, Mexico City, 01330, Mexico|Grupo Medico Camino Sc, Mexico City, Mexico City, 03310, Mexico|Private Practice - Dr. Joaquin Reinoso, Monterrey, Nuevo León, 64320, Mexico|Filios Alta Medicina, Monterrey, Nuevo León, 64460, Mexico|Centro Medico Zambrano Hellion, San Pedro Garza García, Nuevo León, 66278, Mexico|Unidad de Investigación en Salud, Chihuahua City, 31203, Mexico|Oaxaca Site Management Organization, Oaxaca City, 68000, Mexico|Unidad Médica Onco-hematológica, Puebla City, 72424, Mexico|Maastricht UMC+, Maastricht, Limburg, 6229 HX, Netherlands|Medische Centrum Leeuwarden, Leeuwarden, Provincie Friesland, 8934 AD, Netherlands|Haga Ziekenhuis locatie Leyweg, The Hague, South Holland, 2545 AA, Netherlands|Kaluga Regional Clinical Oncology Center, Kaluga, Kalužskaja Oblast', 248007, Russia|Volgograd Regional Clinical Cancer Clinic No.1, Volgograd, Volgograd Oblast, 400138, Russia|N.N.Petrov Research Institute of Oncology, Saint Petersburg, 197758, Russia|Soon Chun Hyang University Cheonan Hospital, Cheonan-si, Chungcheongnam-do [Chungnam], 31151, South Korea|Gachon University Gil Medical Center, Namdong-gu, Incheon-gwangyeoksi [Incheon], 21565, South Korea|Ajou University Hospital, Suwon, Kyǒnggi-do, 16499, South Korea|Yeungnam Univeristy Medical Center, Daegu, Kyǒngsangbuk-do, 42415, South Korea|Dong-A University Hospital, Busan, Pusan-Kwangyǒkshi, 49201, South Korea|Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 03080, South Korea|Kangbuk Samsung Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 03181, South Korea|Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul], 03722, South Korea|Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 05505, South Korea|Gangnam Severance Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 06273, South Korea|Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 06351, South Korea|Kyungpook National University Chilgok Hospital, Daegu, Taegu-Kwangyǒkshi, 41404, South Korea|Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], 08035, Spain|Hospital Universitari Dexeusa, Barcelona, Catalunya [Cataluña], 08028, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya [Cataluña], 08041, Spain|Hospital San Pedro de Alcántara, Cáceres, Extremadura, 10003, Spain|Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Lleida [Lérida], 25198, Spain|Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad de, 28034, Spain|Hospital Universitario de Canarias, San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain|Hospital Clinico de Valencia, Valencia, Valenciana, Comunitat, 46010, Spain|Hospital Quirónsalud Valencia, Valencia, València, 46010, Spain|Hospital Universitario San Cecilio, Granada, 18016, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Hospital Universitario Virgen Macarena, Seville, 41009, Spain|Hospital Universitario Virgen Del Rocio, Seville, 41013, Spain|Chi Mei Hospital - Liouying Branch, Tainan, Tainan, 73657, Taiwan|Taichung Veterans General Hospital, Taichung, 407, Taiwan|National Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Koo Foundation Sun Yat-Sen Cancer Center, Taipei, 112, Taiwan|Medipol University Medical Faculty, Stanbul, Istanbul, 34214, Turkey (Türkiye)|Acibadem Altunizade Hospital, Üsküdar / Stanbul, Istanbul, Turkey (Türkiye)|Baskent University Dr. Turgut Noyan Research and Training Center, Adana, 01250, Turkey (Türkiye)|University of Health Sciences,Gulhane School of Medicine, Ankara, 06010, Turkey (Türkiye)|Abdurrahman Yurtaslan Ankara Oncology, education and Research Hospital, Ankara, 06200, Turkey (Türkiye)|Hacettepe Universitesi, Ankara, 06230, Turkey (Türkiye)|Memorial Ankara Hastanesi, Ankara, 06520, Turkey (Türkiye)|Ankara Bilkent Şehir Hastanesi, Ankara, 06800, Turkey (Türkiye)|Akdeniz Universitesi Hastanesi, Antalya, 07059, Turkey (Türkiye)|Dicle Üniversitesi, Diyarbakır, 21200, Turkey (Türkiye)|Trakya University, Edirne, 22030, Turkey (Türkiye)|Acıbadem Maslak Hastanesi, Istanbul, 34457, Turkey (Türkiye)|TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, Istanbul, 34722, Turkey (Türkiye)|Ege Universitesi Hastanesi, Izmir, 35100, Turkey (Türkiye)|İnönü Üniversitesi Turgut Özal Tıp Merkezi, Malatya, 44280, Turkey (Türkiye)|Mersin University, Mersin, 33343, Turkey (Türkiye)|Communal Enterprise 'Kryvyi Rih Oncology Dispensary' of the Dnipropetrovsk Regional Council, Kryvyi Rih, Dnipropetrovsk Oblast, 50048, Ukraine|CNPE ""Regional Center of Oncology"", Kharkiv, Kharkivs’ka Oblast’, 61070, Ukraine|Municipal non-profit enterprise'Odesa Regional Clinical Hospital'of Odesa Regional Council, Odesa, Odesa Oblast, 65025, Ukraine|Municipal Enterprise ""Volyn Regional Medical Oncology Centre"" of the Volyn Regional Council, Lutsk, Volyn Oblast, 43018, Ukraine|Uzhgorod Central City Clinical Hospital, Uzhhorod, Zakarpattia Oblast, 88000, Ukraine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: MLN4924|DRUG: Fluconazole|DRUG: Itraconazole|DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,51,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/1/14,6/5/17,"Winship Cancer Institute at Emory University, Atlanta, Georgia, 30322, United States|Siteman Cancer Center - South County, St Louis, Missouri, 63110, United States|Sarah Cannon Cancer Center, Nashville, Tennessee, 37203, United States|Mary Crowley Medical Research Center, Dallas, Texas, 75230, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Breast Neoplasm|Breast Neoplasm, Male|Triple Negative Breast Cancer",DRUG: Cyclophosphamide|DRUG: Indomethacin|DRUG: Omeprazole|DIETARY_SUPPLEMENT: Multivitamin,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,16,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/9/17,9/25/25,"Providence Portland Medical Center, Portland, Oregon, 97213, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Neoplasms,DRUG: Letrozole|DRUG: Afatinib,FEMALE,"ADULT, OLDER_ADULT",PHASE2,44,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2014-07,2018-11,"St. Jude Heritage Healthcare, Fullerton, California, 92835, United States|University of California Los Angeles Hematology Oncology, Los Angeles, California, 90095, United States|West Valley Hematology Oncology Medical Group, Northridge, California, 91328, United States|DBA Torrance Memorial Physician Network/Cancer Care Associates, Redondo Beach, California, 90277, United States|Coastal Integrative Cancer Care, San Luis Obispo, California, 93401, United States|Central Coast Medical Oncology Corporation, Santa Maria, California, 93454, United States|Orlando Health, Inc., Orlando, Florida, 32806, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Hope Women's Cancer Centers, Asheville, North Carolina, 28806, United States|University Hospital Clinical Center Banja Luka, Oncology Clinic, Banja Luka, 78000, Bosnia and Herzegovina|Clinical Center of University in Sarajevo, Clinic for Oncology, Sarajevo, 71000, Bosnia and Herzegovina|University Clinical Center Tuzla Clinic for Oncology, Hematology and Radiotherapy, Tuzla, 75000, Bosnia and Herzegovina|Filantropia Clinical Hospital, Bucharest, Romania|County Emergency Clinical Hospital Cluj-Napoca Oncology Department, Cluj-Napoca, 400006, Romania|SC Medisprof SRL, Cluj-Napoca, 400058, Romania|County Hospital Ploiesti, Ploieşti, 100337, Romania|County Emergency Hospital ""Sf Ioan cel Nou"", Suceava, 720237, Romania|Oncomed SRL Timisoara, Timișoara, Romania|Complexo Hospitalario Universitario A Coruña, A Coruña, 15006, Spain|Complejo Hospitalario Universitario de Albacete, Albacete, 02006, Spain|Hospital General Universitario de Alicante, Alicante, 03010, Spain|Hospital de Especialidades de Jerez de La Frontera, Jerez de la Frontera, 11408, Spain|Hospital Clínico Universitario Virgen de La Arrixaca, Murcia, 30120, Spain|Hospital Son Llatzer, Palma de Mallorca, 07198, Spain|Hospital Universitari de Sant Joan de Reus, Reus, 43204, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignant Solid Neoplasm|Fibrolamellar Carcinoma|Metastatic Malignant Solid Neoplasm|Ovarian Carcinoma|Pancreatic Neuroendocrine Tumor|Recurrent Malignant Solid Neoplasm|Refractory Malignant Solid Neoplasm|Unresectable Solid Neoplasm,DRUG: Sapanisertib|BIOLOGICAL: Ziv-Aflibercept,ALL,"ADULT, OLDER_ADULT",PHASE1,83,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/18/14,1/29/24,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Neuroendocrine Neoplasm of Lung,DRUG: Durvalumab|DRUG: Tremelimumab,ALL,"ADULT, OLDER_ADULT",PHASE2,126,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/11/17,5/23/22,"Instituto Catalán de Oncología Badalona, Badalona, Barcelona, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarre, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Principality of Asturias, Spain|Hospital Duran i Reynals/ICO L'Hospitalet, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Universitario Donostia, Donostia / San Sebastian, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Virgen de la Victoria, Málaga, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain|Hospital Universitario Virgen del Rocío, Seville, Spain|Hospital Universitario y Politécnico La Fe, Valencia, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Durvalumab,ALL,"ADULT, OLDER_ADULT",PHASE4,163,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/5/19,10/31/24,"Research Site, Fullerton, California, 92835, United States|Research Site, Washington D.C., District of Columbia, 20007, United States|Research Site, Augusta, Georgia, 30912, United States|Research Site, Baltimore, Maryland, 21201, United States|Research Site, Minneapolis, Minnesota, 55407, United States|Research Site, St Louis, Missouri, 63110, United States|Research Site, Mineola, New York, 11501, United States|Research Site, Chapel Hill, North Carolina, 27514, United States|Research Site, Huntersville, North Carolina, 28078, United States|Research Site, Greenville, South Carolina, 29605, United States|Research Site, Nashville, Tennessee, 37203, United States|Research Site, Dallas, Texas, 75251, United States|Research Site, Rosario, S2000KZE, Argentina|Research Site, Box Hill, 3128, Australia|Research Site, Melbourne, 3000, Australia|Research Site, Brussels, 1090, Belgium|Research Site, Kortrijk, 8500, Belgium|Research Site, Leuven, 3000, Belgium|Research Site, Florianópolis, 88034-000, Brazil|Research Site, Ijuí, 98700-000, Brazil|Research Site, Porto Alegre, 90035-903, Brazil|Research Site, São José do Rio Preto, 15090-000, Brazil|Research Site, Sofia, 1612, Bulgaria|Research Site, Calgary, Alberta, T2N 4N2, Canada|Research Site, Toronto, CA, M5G 2M9, Canada|Research Site, Greater Sudbury, Ontario, P3E 5J1, Canada|Research Site, Newmarket, Ontario, L3Y 2P9, Canada|Research Site, Santiago, 7500000, Chile|Research Site, Olomouc, 775 20, Czechia|Research Site, Brest, 29609, France|Research Site, Lille, 59037, France|Research Site, Lyon, 69373, France|Research Site, Dresden, 1307, Germany|Research Site, Hanover, 30625, Germany|Research Site, Holargos, Athens, 155 62, Greece|Research Site, Budapest, 1121, Hungary|Research Site, Miskolc, 3526, Hungary|Research Site, Chennai, 600006, India|Research Site, Haifa, 91096, Israel|Research Site, Bunkyō City, 113-8677, Japan|Research Site, Fukushima, 960-1295, Japan|Research Site, Isehara-shi, 259-1193, Japan|Research Site, Izumi-shi, 594-0073, Japan|Research Site, Kishiwada-shi, 596-8501, Japan|Research Site, Kōtoku, 135-8550, Japan|Research Site, Nagaoka-shi, 940-2085, Japan|Research Site, Nagoya, 466-8560, Japan|Research Site, Natori-shi, 981-1293, Japan|Research Site, Okayama, 700-8558, Japan|Research Site, Osaka, 541-8567, Japan|Research Site, Saga, 840-8571, Japan|Research Site, Suita-shi, 565-0871, Japan|Research Site, Sunto-gun, 411-8777, Japan|Research Site, Tokushima, 770-8503, Japan|Research Site, Yokohama, 241-8515, Japan|Research Site, Kuching, 93586, Malaysia|Research Site, Amsterdam, 1066 CX, Netherlands|Research Site, Arnhem, 6815 AD, Netherlands|Research Site, Lodz, 90-302, Poland|Research Site, Lodz, 93-509, Poland|Research Site, Olsztyn, 10-357, Poland|Research Site, Craiova, 200347, Romania|Research Site, Suceava, 720237, Romania|Research Site, Arkhangelsk, 163045, Russia|Research Site, Moscow, 111123, Russia|Research Site, Moscow, 115280, Russia|Research Site, Omsk, 644013, Russia|Research Site, pos.Pesochnyi, 197758, Russia|Research Site, Saint Petersburg, 197022, Russia|Research Site, Saint Petersburg, 197758, Russia|Research Site, Kamenitz, 21204, Serbia|Research Site, Daegu, 41931, South Korea|Research Site, Gwangju, 61469, South Korea|Research Site, Gyeongsangnam-do, 52727, South Korea|Research Site, Seogu, 49241, South Korea|Research Site, Seongnam-si, 13620, South Korea|Research Site, Seoul, 03080, South Korea|Research Site, Seoul, 03722, South Korea|Research Site, Seoul, 06351, South Korea|Research Site, Badalona, 08916, Spain|Research Site, Barcelona, 08028, Spain|Research Site, Barcelona, 08035, Spain|Research Site, Barcelona, 08041, Spain|Research Site, Girona, 17007, Spain|Research Site, Jaén, 23007, Spain|Research Site, Madrid, 28041, Spain|Research Site, Madrid, 28046, Spain|Research Site, Marbella, 29600, Spain|Research Site, Málaga, 29010, Spain|Research Site, Valencia, 46026, Spain|Research Site, Bellinzona, CH-6500, Switzerland|Research Site, Lausanne, 1011, Switzerland|Research Site, New Taipei City, 23561, Taiwan|Research Site, Taichung, 40447, Taiwan|Research Site, Taichung, 40705, Taiwan|Research Site, Tainan, 704, Taiwan|Research Site, Taipei, 11217, Taiwan|Research Site, Bangkok, 10330, Thailand|Research Site, Songkhla, 90110, Thailand|Research Site, Adana, 01120, Turkey (Türkiye)|Research Site, Istanbul, 34098, Turkey (Türkiye)|Research Site, Chernivtsі, 58013, Ukraine|Research Site, Ivano-Frankivsk, 76018, Ukraine|Research Site, Kharkiv, 61070, Ukraine|Research Site, Kirovohrad, 25006, Ukraine|Research Site, Kryvyi Rih, 50048, Ukraine|Research Site, Kyiv, 03022, Ukraine|Research Site, Kyiv, 03115, Ukraine|Research Site, Kyiv, 8112, Ukraine|Research Site, Sumy, 40005, Ukraine|Research Site, Uzhhorod, 88014, Ukraine|Research Site, Vinnytsia, 21029, Ukraine|Research Site, London, EC1A 7BE, United Kingdom|Research Site, London, WC1N 3BG, United Kingdom|Research Site, Manchester, M20 4BX, United Kingdom|Research Site, Hanoi, 100000, Vietnam",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Breast Neoplasms,DRUG: Abemaciclib|DRUG: Fulvestrant|DRUG: Placebo,FEMALE,"ADULT, OLDER_ADULT",PHASE3,669,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",7/22/14,2027-12,"St. Bernards Medical Center, Jonesboro, Arkansas, 72401, United States|Highlands Oncology Group, Springdale, Arkansas, 72762, United States|University of California - San Diego, La Jolla, California, 92037-0845, United States|Kaiser Permanente, Riverside, California, 92505, United States|Univ of California San Francisco, San Francisco, California, 94115, United States|Stanford University Clinic, Stanford, California, 94305, United States|Palm Beach Cancer Institue, Atlantis, Florida, 33462, United States|Holy Cross Hospital, Fort Lauderdale, Florida, 33308, United States|Florida Cancer Specialists - South, Fort Myers, Florida, 33901, United States|Palm Beach Cancer Institue, Palm Beach Gardens, Florida, 33410, United States|Florida Cancer Specialists - North, St. Petersburg, Florida, 33705, United States|Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center, Tampa, Florida, 33612, United States|Palm Beach Cancer Institue, Wellington, Florida, 33414, United States|Palm Beach Cancer Institue, West Palm Beach, Florida, 33401, United States|University Cancer & Blood Center, LLC, Athens, Georgia, 30607, United States|Harbin Clinic, Rome, Georgia, 30165, United States|Quincy Medical Group, Quincy, Illinois, 62301, United States|Pharmasite Research, Inc., Baltimore, Maryland, 21208, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Breslin Cancer Center, Lansing, Michigan, 48910, United States|Minnesota Oncology/Hematology PA, Minneapolis, Minnesota, 55404, United States|Washington University Medical School, City of Saint Peters, Missouri, 63376, United States|Washington University Medical School, Creve Coeur, Missouri, 63141, United States|Freeman Cancer Institute, Joplin, Missouri, 64804, United States|St Lukes Hospital, Kansas City, Missouri, 64111, United States|Washington University Medical School, St Louis, Missouri, 63110, United States|Washington University Medical School, St Louis, Missouri, 63129, United States|Billings Clinic, Billings, Montana, 59101, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, 03756-0001, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Columbia University Medical Center, New York, New York, 10032, United States|Rochester General Hospital, Rochester, New York, 14621, United States|Rochester General Hospital, Rochester, New York, 14625, United States|Novant Health, Oncology Research Institute, Winston-Salem, North Carolina, 27103, United States|Oklahoma Cancer Specialists & Research Institute, LLC, Tulsa, Oklahoma, 74146, United States|Sanford Research/USD, Sioux Falls, South Dakota, 57104, United States|The Boston Baskin Cancer Group, Memphis, Tennessee, 38120, United States|SMO Sarah Cannon Research Inst., Nashville, Tennessee, 37203, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|Oncology Consultants P.A., Houston, Texas, 77030, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Kadlec Clinic Hematology and Oncology, Kennewick, Washington, 99336, United States|St Mary Regional Cancer Center, Walla Walla, Washington, 99362, United States|Icon Cancer Centre South Brisbane, South Brisbane, Queensland, 4101, Australia|Gold Coast University Hospital, Southport, Queensland, 4215, Australia|Ashford Cancer Centre Research, Kurralta Park, South Australia, 5037, Australia|Monash Cancer Centre, East Bentleigh, Victoria, 3165, Australia|St. John of God Subiaco Hospital, Subiaco, Western Australia, 6008, Australia|Antwerp University Hospital, Edegem, Antwerpen, 2650, Belgium|UZ Brussel, Brussels, Bruxelles-Capitale, Région de, 1090, Belgium|UZ Leuven, Leuven, Vlaams-Brabant, 3000, Belgium|Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège, 4000, Belgium|Tom Baker Cancer Center, Calgary, Alberta, T2N 4N2, Canada|London Regional Cancer Program, London, Ontario, N6A 5W9, Canada|Humber River Hospital, Toronto, Ontario, M3M 0B2, Canada|Unity Health Toronto, St. Michael's Hospital, Toronto, Ontario, M5B 1W8, Canada|Herlev and Gentofte Hospital, Copenhagen, Capital Region, 2730, Denmark|Aalborg Universitets hospital, Aalborg, 9000, Denmark|Roskilde Sygehus, Roskilde, 4000, Denmark|Tampereen yliopistollinen sairaala, Tampere, Pirkanmaa, 33520, Finland|Helsinki University Hospital - Comprehensive Cancer Center (HYKS - Syöpäkeskus), Helsinki, Uusimaa, 00029, Finland|Turun Yliopistollinen Keskussairaala, Turku, 20520, Finland|CHU Besançon, Besançon, Doubs, 25000, France|Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne, Clermont-Ferrand, Puy-de-Dôme, 63011, France|Polyclinique De Blois, La Chaussée-Saint-Victor, 41260, France|Clinique Victor Hugo - Centre Jean Bernard, Le Mans, 72000, France|Klinikum Ludwigsburg, Ludwigsburg, Baden-Wurttemberg, 71640, Germany|Universitaetsklinikum Tuebingen, Tübingen, Baden-Wurttemberg, 72076, Germany|Gemeinschaftspraxis hop-augsburg, Augsburg, Bavaria, 86150, Germany|Klinikum der Ludwig-Maximilians-Universitaet Muenchen, München, Bavaria, 80336, Germany|Facharztzentrum Eppendorf, Hamburg, 20249, Germany|University Hospital of Patras, Pátrai, Achaḯa, 26504, Greece|Agios Savvas Regional Cancer Hospital, Athens, Attikí, 11522, Greece|University General Hospital of Heraklion, Heraklion, Krítí, 71110, Greece|Chania General Hospital 'Agios Georgios', Chania, 73300, Greece|Azienda Ospedaliero Universitaria S.Anna, Cona, Emilia-Romagna, 44124, Italy|Istituto Nazionale Tumori Regina Elena, Rome, Roma, 00144, Italy|Ospedale Bellaria - Azienda USL di Bologna, Bologna, 40139, Italy|Istituto Oncologico Veneto IRCCS, Padua, 35128, Italy|Aichi Cancer Center Hospital, Nagoya, Aichi-ken, 464-8681, Japan|Chiba cancer center, Chiba, Chiba, 260-8717, Japan|National Cancer Center Hospital East, Kashiwa, Chiba, 277-8577, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, 791-0280, Japan|Kurume General Hospital, Kurume, Fukuoka, 830-0013, Japan|National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, 003-0804, Japan|Hyogo College of Medicine, Nishinomiya, Hyōgo, 663-8501, Japan|St. Marianna University School of Medicine Hospital, Kawasaki, Kanagawa, 216-8511, Japan|Niigata Cancer Center Hospital, Niigata, Niigata, 951-8566, Japan|Saitama Prefectural Cancer Center, Ina-machi, Saitama, 362-0806, Japan|Jichi Medical University Hospital, Shimotsuke, Tochigi, 329- 0498, Japan|Tokyo Met Cancer & Infectious Diseases Center Komagome Hp, Bunkyo-ku, Tokyo, 113-8677, Japan|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|Japanese Foundation for Cancer Research, Koto, Tokyo, 135-8550, Japan|National Hospital Organization Kyushu Cancer Center, Fukuoka, 811-1395, Japan|Sagara Hospital, Kagoshima, 892-0833, Japan|Kyoto University Hospital, Kyoto, 606-8507, Japan|National Hospital Organization Osaka Medical Center, Osaka, 540-0006, Japan|Osaka International Cancer Institute, Osaka, 541-8567, Japan|Hospital Angeles, Tijuana, Estado de Baja California, 22010, Mexico|Preparaciones Oncológicas S.C., León, Guanajuato, 37178, Mexico|Centro Oncológico Internacional (COI), Guadalajara, Jalisco, 45647, Mexico|Grupo Medico Camino Sc, Mexico City, Mexico City, 03310, Mexico|Instituto Nacional de Cancerologia, Mexico City, Mexico City, 14070, Mexico|OCA Hospital, Monterrey, Nuevo León, 64000, Mexico|Tecnologico de Monterrey, Monterrey, Nuevo León, 64710, Mexico|Uniwersyteckie Centrum Kliniczne, Gdansk, Pomeranian Voivodeship, 80-214, Poland|Bialostockie Centrum Onkologii, Oddzial Onkologii Klinicznej, Bialystok, 15-027, Poland|Centrum Terapii Wspolczesnej J. M. Jasnorzewska Spolka Komandytowo-Akcyjna, Lodz, Łódź Voivodeship, Poland|Puerto Rico Hematology/Oncology Group, Bayamón, PR, 00959, Puerto Rico|S.C. MedisProf SRL, Cluj-Napoca, Cluj, 400058, Romania|Centrul de Oncologie ""Sfântul Nectarie"", Craiova, Dolj, 200347, Romania|Ianuli Med Consult SRL, Bucharest, 010976, Romania|Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk, Arkhangelskaya oblast, 163045, Russia|Regional Budgetary Healthcare Institution 'Ivanovo Regional Oncology Dispensary', Ivanovo, Ivanovo Oblast, 153040, Russia|Fed State Budgetary Inst ""N.N. Blokhin Med Center of Oncology"" MHRF, Moscow, Moscow, 115478, Russia|Kursk Regional Oncology Dispensary, Kursk, Russian Federation, 305035, Russia|N.N.Petrov Research Institute of Oncology, Saint Petersburg, Sankt-Peterburg, 197758, Russia|Saint-Petersburg City Clinical Oncology Dispensary, Saint Petersburg, Sankt-Peterburg, 198255, Russia|Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk], 28644, South Korea|Inha University Hospital, Incheon, Incheon-gwangyeoksi [Incheon], 22332, South Korea|Gachon University Gil Medical Center, Namdong-gu, Incheon-gwangyeoksi [Incheon], 21565, South Korea|Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do, 13620, South Korea|Seoul National University Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 3080, South Korea|Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul], 3722, South Korea|Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 5505, South Korea|Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul], 6351, South Korea|The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul, Seoul-teukbyeolsi [Seoul], 6591, South Korea|Ulsan University Hospital, Ulsan, Ulsan-Kwangyǒkshi, 44033, South Korea|Hospital General Universitario de Elche, Elche, Alicante, 03202, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], 08035, Spain|Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Lleida [Lérida], 25198, Spain|Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad de, 28041, Spain|Hospital General Universitario Morales Meseguer, Murcia, Murcia, Región de, 30008, Spain|Hospital Quirónsalud Valencia, Valencia, València, 46010, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Universitätsspital Basel, Basel, Canton of Basel-City, 4031, Switzerland|Spital Thun, Thun, Canton of Bern, 3600, Switzerland|HUG-Hôpitaux Universitaires de Genève, Geneva, 1211, Switzerland|Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist, Kaohsiung, 83301, Taiwan|Kaohsiung Medical University Hospital, Kaohsiung City, 80756, Taiwan|Kaohsiung Veterans General Hospital, Kaohsiung City, 81362, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|Taichung Veterans General Hospital, Taichung, 407, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Chang Gung Medical Foundation-Linkou Branch, Taoyuan District, 333, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Tislelizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,300,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/28/16,5/31/20,"Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, 100021, China|Beijing Cancer Hospital, Beijing, Beijing Municipality, 100142, China|Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North), Guangzhou, Guangdong, 510000, China|Guangdong Provincial Peoples Hospital, Guangzhou, Guangdong, 510080, China|The Fifth Affiliated Hospital Sun Yat Sen University, Zhuhai, Guangdong, 519000, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi, 330006, China|Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, 200000, China|Affiliated Zhongshan Hospital of Fudan University, Shanghai, Shanghai Municipality, 200032, China|Zhejiang University College of Medicine Second Affiliated Hospital, Hangzhou, Zhejiang, 310009, China|Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Cancer|Breast Carcinoma|Breast Tumors|Malignant Neoplasm of Breast,DRUG: Paclitaxel|DRUG: Alisertib,FEMALE,"ADULT, OLDER_ADULT",PHASE2,169,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/12/15,8/1/24,"22 Sites, Including Dallas and Austin, Texas, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Lung Neoplasms,DRUG: Sintilimab|DRUG: Pemetrexed|DRUG: Platinum|DRUG: Placebos,ALL,"ADULT, OLDER_ADULT",PHASE3,397,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",8/23/18,2/13/23,"Sun Yat-Sen University Cancer Center, Guangzhou, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Cutaneous T-Cell Lymphoma|Mature T-cell Malignancies|Peripheral T-Cell Lymphoma|Relapsed/ Refractory T-cell Malignancies,DRUG: Romidepsin|DRUG: Lenalidomide|DRUG: CC-486 (5-azacitidine)|DRUG: Dexamethasone|DIAGNOSTIC_TEST: EKG|PROCEDURE: Bone Marrow Aspiration/Biopsy|DIAGNOSTIC_TEST: MRI|PROCEDURE: Lumbar Puncture|DIAGNOSTIC_TEST: TTE,ALL,"ADULT, OLDER_ADULT",PHASE1,26,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/17/20,5/15/26,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,"Solid Tumor|Solid Carcinoma|Solid Tumor, Adult|Hematologic Malignancy",DRUG: Benralizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,51,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/16/20,3/16/26,"Memorial Sloan Kettering Cancer Center, Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center Suffolk - Hauppauge (Limited Protocol Activities), Hauppauge, New York, 11788, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Breast Neoplasms,DRUG: PD0332991|DRUG: Anastrozole|DRUG: Goserelin|PROCEDURE: Surgery (standard of care)|PROCEDURE: Tumor biopsy,FEMALE,"ADULT, OLDER_ADULT",PHASE2,84,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/10/13,8/24/26,"University of Alabama, Birmingham, Alabama, 35233, United States|Mayo Clinic - Scottsdale, Scottsdale, Arizona, 85259, United States|Mayo Clinic - Rochester, Rochester, Minnesota, 55905, United States|Washington University School of Medicine, St Louis, Missouri, 63122, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Debio 1143|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,46,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,4/26/19,4/6/22,"University of Florida, Gainesville, Florida, 32611, United States|H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612-9497, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana-Farber/Partners Cancer Care, Boston, Massachusetts, 02215, United States|Washington University, St Louis, Missouri, 63110, United States|Montefiore Medical Center PRIME, The Bronx, New York, 10461, United States|UC Health, LLC., Cincinnati, Ohio, 45229, United States|St. Luke's University Health Network, Bethlehem, Pennsylvania, 18015, United States|Methodist Hospital, Houston Methodist Cancer Center, Houston, Texas, 77030, United States|Georgetown University - Lombardi Comprehensive Cancer Center, Northwest, Washington, 20007, United States|Centre Leon Berard, Lyon, 69008, France|Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, 31100, France|Institut Gustave Roussy, Villejuif, 94800, France|Hospital Vall d'Hebron, Barcelona, 08035, Spain|START Madrid, Fundacion Jimenez Diaz, Madrid, 28040, Spain|START Madrid, H.U. Sanchinarro, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Endometrial Neoplasms,DRUG: Lenvatinib|BIOLOGICAL: Pembrolizumab|DRUG: Paclitaxel|DRUG: Carboplatin,FEMALE,"ADULT, OLDER_ADULT",PHASE3,130,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/22/19,1/14/25,"Anhui Cancer Hospital-Gynecological Oncology ( Site 2509), Hefei, Anhui, 230031, China|Beijing Obstetrics and Gynecology Hospital Capital Medical University ( Site 2505), Beijing, Beijing Municipality, 100032, China|Peking Union Medical College Hospital ( Site 2501), Beijing, Beijing Municipality, 100032, China|Beijing Cancer Hospital ( Site 2504), Beijing, Beijing Municipality, 100142, China|Chongqing Cancer Hospital ( Site 2513), Chongqing, Chongqing Municipality, 400030, China|The First Affiliated hospital of Xiamen University-Obstetrics and gynecology department ( Site 2522), Xiamen, Fujian, 361003, China|The First Affiliated Hospital.Sun Yat-sen University ( Site 2507), Guangzhou, Guangdong, 510080, China|Guang Xi Tumour Hospital, Department of Chemotherapy ( Site 2517), Nanning, Guangxi, 530021, China|Harbin Medical University Cancer Hospital ( Site 2520), Harbin, Heilongjiang, 150081, China|Hubei Cancer Hospital ( Site 2510), Wuhan, Hubei, 430079, China|Xiangya Hospital Central-South University ( Site 2512), Changsha, Hunan, 410008, China|Hunan Cancer Hospital ( Site 2523), Changsha, Hunan, 410013, China|Nanjing Maternity and Child Health Care Hospital ( Site 2508), Nanjing, Jiangsu, 210011, China|Jiangxi Maternal and Child Health Hospital ( Site 2519), Nanchang, Jiangxi, 530021, China|The First Hospital Of Jilin University ( Site 2518), Changchun, Jilin, 130012, China|The first affiliated Hospital of Xi an Jiaotong University ( Site 2502), Xi'an, Shaanxi, 710061, China|Fudan University Shanghai Cancer Center ( Site 2500), Shanghai, Shanghai Municipality, 200032, China|Obstetrics and Gynecology Hosp. Fudan University ( Site 2503), Shanghai, Shanghai Municipality, 200090, China|Shanghai First Maternity and Infant Hospital ( Site 2524), Shanghai, Shanghai Municipality, 201204, China|The First Affiliated Hospital of Xinjiang Medical University ( Site 2515), Ürümqi, Xinjiang, 830054, China|Women s Hospital School of Medicine Zhejiang University ( Site 2511), Hangzhou, Zhejiang, 310006, China|Zhejiang Cancer Hospital ( Site 2506), Hangzhou, Zhejiang, 310022, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms,"DRUG: Radium-223 dichloride (Xofigo, BAY88-8223)",MALE,"ADULT, OLDER_ADULT",PHASE2,391,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/10/14,8/9/18,"Scottsdale, Arizona, 85260, United States|New Haven, Connecticut, 06520, United States|Fort Myers, Florida, 33907, United States|Bethesda, Maryland, 20889, United States|Rockville, Maryland, 20850, United States|Ann Arbor, Michigan, 48109-0330, United States|Detroit, Michigan, 48201, United States|St Louis, Missouri, 63110, United States|Omaha, Nebraska, 68130, United States|East Setauket, New York, 11733, United States|Portland, Oregon, 97239, United States|Pittsburgh, Pennsylvania, 15215, United States|Adelaide, South Australia, 5000, Australia|Melbourne, Victoria, 3052, Australia|Box Hill, 3128, Australia|Darlinghurst, 2010, Australia|Westmead, 2145, Australia|Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande do Sul, 90470 340, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil|Instituto do Câncer do Estado de São Paulo, São Paulo, São Paulo, 01246-000, Brazil|IBCC - Instituto Brasileiro de Controle do Cancer, São Paulo, São Paulo, 03102 002, Brazil|Hospital Israelita Albert Einstein, São Paulo, São Paulo, 05651-901, Brazil|London, Ontario, N6A 4L6, Canada|Ottawa, Ontario, K1H 8L6, Canada|Toronto, Ontario, M4N 3M5, Canada|Toronto, Ontario, M5G 2M9, Canada|Montreal, Quebec, H2L 4M1, Canada|Santiago, 7500921, Chile|Chomutov, 430 12, Czechia|Prague, 150 06, Czechia|Nantes, 44805, France|Vandœuvre-lès-Nancy, 54500, France|Villejuif, 94805, France|Tübingen, Baden-Wurttemberg, 72076, Germany|München, Bavaria, 81675, Germany|Dresden, Saxony, 01307, Germany|Beersheba, 8410101, Israel|Haifa, 3109601, Israel|Jerusalem, 9112001, Israel|Kfar Saba, 4428164, Israel|Petah Tikva, 4941492, Israel|Ramat Gan, 5262000, Israel|Meldola, Emilia-Romagna, 47014, Italy|Rome, Lazio, 00152, Italy|Turin, Piedmont, 10043, Italy|Arezzo, Tuscany, 52100, Italy|Busan, Busan Gwang''yeogsi, 49241, South Korea|Seoul, Seoul Teugbyeolsi, 06273, South Korea|Seoul, 05505, South Korea|Seoul, 06591, South Korea|Seoul, 120-752, South Korea|L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Palma de Mallorca, Illes Baleares, 07120, Spain|Barcelona, 08025, Spain|Madrid, 28041, Spain|Pamplona, 31008, Spain|Gothenburg, 413 45, Sweden|Karlstad, 652 30, Sweden|Sundsvalls, 851 86, Sweden|Umeå, 901 85, Sweden|Taipei City, Taipei, 112, Taiwan|Guishan Township, Taoyuan, 333, Taiwan|Kaohsiung City, 81362, Taiwan|Taichung, 40705, Taiwan|Taipei, 100, Taiwan|Bebington, Merseyside, CH63 4JY, United Kingdom|Taunton, Somerset, TA1 5DA, United Kingdom|Northwood, HA6 2RN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostate Cancer,BIOLOGICAL: RV001V,MALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/30/17,3/29/19,"Rigshospitalet, Copenhagen, 2400, Denmark",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Melanoma|Solid Tumors,BIOLOGICAL: Pembrolizumab|DRUG: Dabrafenib|DRUG: Trametinib|DRUG: Placebo,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Blood samples were to be collected at pre-specified time points for analysis of the Vc of dabrafenib, defined as the theoretical volume that would be necessary to contain the total amount of administered dabrafenib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 22: predose, postdose, defined as the theoretical volume that would be necessary to contain the total amount of administered dabrafenib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 22: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Dabrafenib Following Administration of 150 mg Dabrafenib in Combination With Placebo and 2 mg Trametinib in Participants From Part 3, Blood samples were to be collected at pre-specified time points for analysis of the Vc of dabrafenib, defined as the theoretical volume that would be necessary to contain the total amount of administered dabrafenib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 22: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Trametinib Following Administration of 2 mg Trametinib in Combination With 2 mg/kg Pembrolizumab and 150 mg Dabrafenib in Participants Pooled From Parts 1 and 2, Blood samples were to be collected at pre-specified time points for analysis of the Vc of trametinib, defined as the theoretical volume that would be necessary to contain the total amount of administered trametinib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 22: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Trametinib Following Administration of 1.5 mg Trametinib in Combination With 2 mg/kg Pembrolizumab in Participants Pooled From Parts 1 and 2, Blood samples were to be collected at pre-specified time points for analysis of the Vc of trametinib, defined as the theoretical volume that would be necessary to contain the total amount of administered trametinib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 22: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Trametinib Following Administration of 2 mg Trametinib in Combination With 2 mg/kg Pembrolizumab and 150 mg Dabrafenib in Participants From Part 3, Blood samples were to be collected at pre-specified time points for analysis of the Vc of trametinib, defined as the theoretical volume that would be necessary to contain the total amount of administered trametinib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 22: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Trametinib Following Administration of 2 mg Trametinib in Combination With Placebo and 150 mg Dabrafenib in Participants From Part 3, Blood samples were to be collected at pre-specified time points for analysis of the Vc of trametinib, defined as the theoretical volume that would be necessary to contain the total amount of administered trametinib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 22: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Trametinib Following Administration of 2 mg Trametinib in Combination With 200 mg Pembrolizumab in Participants From Part 4, Blood samples were to be collected at pre-specified time points for analysis of the Vc of trametinib, defined as the theoretical volume that would be necessary to contain the total amount of administered trametinib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 36: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Trametinib Following Administration of 1.5 mg Trametinib in Combination With 200 mg Pembrolizumab in Participants From Part 4, Blood samples were to be collected at pre-specified time points for analysis of the Vc of trametinib, defined as the theoretical volume that would be necessary to contain the total amount of administered trametinib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 36: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Trametinib Following Administration of 2 mg of Trametinib in Combination With 200 mg Pembrolizumab in Participants From Part 5, Blood samples were to be collected at pre-specified time points for analysis of the Vc of trametinib, defined as the theoretical volume that would be necessary to contain the total amount of administered trametinib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 36: predose, postdose, 4 - 6 hrs postdose. Each cycle is a 21-day cycle.|Volume of Distribution (Vc) of Trametinib Following Administration of 1.5 mg of Trametinib in Combination With 200 mg Pembrolizumab in Participants From Part 5, Blood samples were to be collected at pre-specified time points for analysis of the Vc of trametinib, defined as the theoretical volume that would be necessary to contain the total amount of administered trametinib at the same concentration that it is observed in the blood plasma. This analysis was not performed., Cycle 1 Day 36: predose, postdose," 4 - 6 hrs postdose. Each cycle is a 21-day cycle.""",ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,184,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",5/29/14,7/14/21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Docetaxel|DRUG: Nab-paclitaxel|DRUG: Paclitaxel|DRUG: Pertuzumab|DRUG: Trastuzumab,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Baseline, every 3 cycles (1 cycle is 3 weeks) during treatment period, and 28 days post-treatment safety follow-up. The median (full range) duration of exposure to any study treatment was 16.2 (0.0-86.4) months.|Change From Baseline in FACT-B Questionnaire Breast Cancer Subscale Score Over the Course of the Study, The FACT-B questionnaire (version 4) was administered only to female participants to assess quality of life in five subscales: physical, and functional well-being, and breast cancer. For the breast cancer subscale, participants were given a series of 10 statements and were asked to rate how true each statement was for them during the past 7 days on a 5-point scale ranging from 0 (not at all) to 4 (very much). The calculated FACT-B breast cancer subscale score, ranging from 0 to 40, was the sum of the scores for each statement only if at least 50% of items had been answered; the higher the score, the better the quality of life. Baseline was defined as the last non-missing measurement taken prior to first dose of study treatment (including unscheduled assessments). Post-baseline values were summarized for planned visits only., Baseline, every 3 cycles (1 cycle is 3 weeks) during treatment period," and 28 days post-treatment safety follow-up. The median (full range) duration of exposure to any study treatment was 16.2 (0.0-86.4) months.""",ALL,"ADULT, OLDER_ADULT",PHASE3,1436,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/1/12,9/20/19,"CPMC; Service d'Oncologie Médicale, Algiers, 16000, Algeria|Centro Oncologico Riojano Integral (CORI), La Rioja, F5300COE, Argentina|Instituto de Oncología de Rosario, Rosario, S2000KZE, Argentina|Canberra Hospital; Medical Oncology, Canberra, Australian Capital Territory, 2606, Australia|Royal Prince Alfred Hospital; Medical Oncology, Camperdown, New South Wales, 2050, Australia|HOCA Chermside, Chermside, Queensland, 4032, Australia|Mater Hospital; Cancer Services, South Brisbane, Queensland, 4101, Australia|Austin and Repatriation Medical Centre; Cancer Services, Melbourne, Victoria, 3084, Australia|Royal Melbourne Hospital; Hematology and Medical Oncology, Parkville, Victoria, 3052, Australia|Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie, Graz, 8036, Austria|LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie, Graz, 8036, Austria|Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie, Innsbruck, 6020, Austria|Ordensklinikum Linz Barmherzige Schwestern; Abt. fur Innere Medizin 1, Linz, 4010, Austria|Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt., Salzburg, 5020, Austria|A.Ö. Lhk; Ii. Medizinische Abt. Mit Schwerpunkt Gaströnter. & Onkologie, Steyr, 4400, Austria|Medizinische Universität Wien; Univ.Klinik für Frauenheilkunde - Klinik für Gynäkologie, Vienna, 1090, Austria|Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Abt. für Onkologie, Vienna, 1090, Austria|UZ Brussel, Brussels, 1090, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|UZ Gent, Ghent, 9000, Belgium|UZ Leuven Gasthuisberg, Leuven, 3000, Belgium|CHU Sart-Tilman, Liège, 4000, Belgium|Oncologistas Associados, Rio de Janeiro, Rio de Janeiro, 22271-110, Brazil|Hospital Sao Lucas - PUCRS, Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Hospital Amaral Carvalho, Jaú, São Paulo, 17210-120, Brazil|Hospital Sirio Libanes; Centro de Oncologia, São Paulo, São Paulo, 01308-050, Brazil|Hospital Perola Byington, São Paulo, São Paulo, 01317-000, Brazil|Hospital das Clinicas - FMUSP, São Paulo, São Paulo, 05403-000, Brazil|Hospital Sao Jose, São Paulo, São Paulo, CEP 01321-001, Brazil|Cross Cancer Institute ; Dept of Medical Oncology, Edmonton, Alberta, T6G 1Z2, Canada|Lions Gate Hospital, North Vancouver, British Columbia, V7L 2L7, Canada|Bcca - Vancouver Island Cancer Centre; Oncology, Victoria, British Columbia, V8R 6V5, Canada|Queen Elizabeth II Health Sciences Centre; Oncology, Halifax, Nova Scotia, B3H 2Y9, Canada|William Osler Health System Brampton Civic Hospital, Brampton, Ontario, L6R 3J7, Canada|Grand River Hospital, Kitchener, Ontario, N2G 1G3, Canada|Sunnybrook Odette Cancer Centre, Toronto, Ontario, M4N 3M5, Canada|CSSS champlain - Charles-Le Moyne, Greenfield Park, Quebec, J4V 2H1, Canada|Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, H2X 0C2, Canada|McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology, Montreal, Quebec, H3T 1E2, Canada|Beijing Cancer Hospital, Beijing, 100142, China|Southwest Hospital , Third Military Medical University, Chongqing, 400038, China|Sun Yet-sen University Cancer Center, Guangzhou, 510060, China|Heilongjiang Provincial Tumor Hospital, Harbin, 150040, China|Jiangsu Cancer Hospital, Nanjing, 210009, China|Fudan University Shanghai Cancer Center, Shanghai, 200120, China|Tianjin Cancer Hospital, Tianjin, 300060, China|The First Affiliated Hospital of The Fourth Military Medical University (Xijing Hospital), Xi'an, 710032, China|First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, 710061, China|Hospital Solca Portoviejo; Oncologia, Portoviejo, EC130104, Ecuador|Hospital Solca Quito; Oncologia, Quito, EC170124, Ecuador|Manial Specialized Hospital; Oncology, Cairo, 11555, Egypt|El Mokatam HIO Hospital, Cairo, 11654, Egypt|Nci; Oncology Dept, Cairo, 11796, Egypt|North Estonia Medical Centre Foundation; Oncology Center, Tallinn, 13419, Estonia|Tartu University Hospital; Clinic of Hematology and Oncology, Tartu, 50406, Estonia|Helsinki University Central Hospital; Oncology Clinics, Helsinki, 00029, Finland|Satakunta Central Hospital; Oncology, Pori, 28500, Finland|Tampere University Hospital; Dept of Oncology, Tampere, 33520, Finland|Turku Uni Central Hospital; Oncology Clinics, Turku, 20520, Finland|Clinique De L Europe; Radiotherapie Chimiotherapie, Amiens, 80090, France|ICO Paul Papin; Oncologie Medicale., Angers, 49055, France|Polyclinique Bordeaux Nord Aquitaine; Chimiotherapie Radiotherapie, Bordeaux, 33077, France|Centre Hospitalier Fleyriat; Oncologie/Hematologie, Bourg-en-Bresse, 01012, France|Centre Leonard De Vinci;Chimiotherapie, Dechy, 59187, France|Fondation Clement Drevon; Oncology, Dijon, 21000, France|Centre Georges Francois Leclerc; Oncologie 3, Dijon, 21079, France|Clinique Sainte Marguerite; Oncologie Medicale, Hyères, 83400, France|Polyclinique de Blois; Chimiotherapie Ambulatoire, La Chaussée-Saint-Victor, 41260, France|Clinique Victor Hugo, LeMans, 72000, France|Polyclinique Du Bois; Centre Bourgogne, Lille, 59000, France|Clinique Chenieux; Oncology, Limoges, 87039, France|Centre Leon Berard; Departement Oncologie Medicale, Lyon, 69373, France|Institut Paoli Calmettes; Oncologie Medicale, Marseille, 13273, France|Centre Azureen De Cancerologie; Cons externes, Mougins, 06250, France|Hopital Cochin; Unite Fonctionnelle D Oncologie, Paris, 75014, France|Hopital Hotel Dieu; Oncologie Medicale, Paris, 75181, France|Institut Curie; Oncologie Medicale, Paris, 75231, France|Hopital Saint Louis; Service Onco Thoracique, Paris, 75475, France|Centre Catalan D' Oncologie, Perpignan, 66000, France|Polyclinique De Courlancy; Centre Radiotherapie Oncologie, Reims, 51057, France|Centre Eugene Marquis; Unite Huguenin, Rennes, 35042, France|Centre Rene Huguenin; ONCOLOGIE GENETIQUE, Saint-Cloud, 92210, France|Chp Saint Gregoire; Cancerologie Radiotherapie, Saint-Grégoire, 35768, France|Ico Rene Gauducheau; Oncologie, Saint-Herblain, 44805, France|Institut D Oncologie Medical, Strasbourg, 67000, France|Institut Claudius Regaud; Departement Oncologie Medicale, Toulouse, 31059, France|Hopital Prive Drome Ardeche; Hopital De Jour, Valence, 26000, France|Clinique Onco Des Dentellieres; Chimiotherapie Radiotherapie, Valenciennes, 59300, France|Klinikum am Bruderwald; Frauenklinik, Bamberg, 96049, Germany|Gynaekologicum Bremen; Prof. Dr. Willibald Schröder, Bremen, 28211, Germany|Universitätsklinikum Erlangen; Frauenklinik, Erlangen, 91054, Germany|Universitätsklinikum Essen; Zentrum Für Frauenheilkunde, Essen, 45122, Germany|Klinikum Esslingen; Klinik für Frauenheilkunde und Geburtshilfe, Esslingen am Neckar, 73730, Germany|AGAPLESION Markus-Krankenhaus, Frankfurt, 60431, Germany|SRH Wald-Klinikum Gera; Klinik für Frauenheilkunde und Geburtshilfe, Gera, 07548, Germany|Universitätsklinikum Hamburg-Eppendorf; Frauenklinik, Hamburg, 20246, Germany|Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding, Hanover, 30177, Germany|Nationales Centrum für Tumorerkrankungen (NCT) ; Gyn. Onk. Frauenklinik; Uniklinikum Heidelberg, Heidelberg, 69120, Germany|Universitätsklinikum des Saarlandes; Klinik f. Frauenheilkunden und Geburtshilfe, Homburg/Saar, 66424, Germany|St.-Vincenz-Krankenhaus; Frauenklinik, Limburg, 65549, Germany|Universitätsklinikum Schleswig-Holstein / Campus Lübeck; Klinik für Frauenheilkunde und Geburtshilfe, Lübeck, 23538, Germany|Brustzentrum Rhein-Ruhr Servicegesellschaft mbH, Mönchengladbach, 41061, Germany|Klinikum rechts der Isar der TU München; Klinik und Poliklinik für Frauenheilkunde, München, 81675, Germany|Ruppiner Kliniken, Klinik fuer Gynaekologie und Geburtshilfe, Neuruppin, 16816, Germany|Agaplesion Diakonieklinikum Rotenburg, Rotenburg (Wümme), 27356, Germany|Praxis Dr. Wagner, Saarbrücken, 66113, Germany|Kreiskrankenhaus Torgau; Abt.Gynäkologie und Geburtshilfe, Torgau, 04860, Germany|Universitätsklinik Tübingen; Frauenklinik, Tübingen, 72076, Germany|Anticancer Hospital Ag. Savas ; 2Nd Dept. of Oncology - Internal Medicine, Athens, 115 22, Greece|Hippokratio Hospital; 2Nd Internal Medicine, Athens, 115 27, Greece|University General Hospital of Heraklion, Crete, 711 10, Greece|University Hospital of Larissa; Oncology, Larissa, 413 35, Greece|University Hospital of Patras Medical Oncology, Pátrai, 265 04, Greece|Euromedical General Clinic of Thessaloniki; Oncology Department, Thessaloniki, 546 45, Greece|Papageorgiou General Hospital; Medical Oncology, Thessaloniki, 564 29, Greece|Queen Elizabeth Hospital; Clinical Oncology, Hong Kong, Hong Kong|Szent Margit Hospital; Dept. of Oncology, Budapest, 1032, Hungary|Fovarosi Szent Laszlo Korhaz-Rendelointezet; Onkologiai Osztaly X, Budapest, 1097, Hungary|Orszagos Onkologial Intezet; Onkologiai Osztaly X, Budapest, 1122, Hungary|Debreceni Egyetem Klinikai Kozpont ; Department of Oncology, Debrecen, 4032, Hungary|Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly, Miskolc, 3501, Hungary|Szegedi Tudomanyegyetem, AOK, Szent-Gyorgyi Albert Klinikai Kozpont, Onkoterapias Klinika, Szeged, 6720, Hungary|Soroka Medical Center; Oncology Dept, Beersheba, 8410100, Israel|Rambam Medical Center; Oncology, Haifa, 3109601, Israel|Wolfson Hospital; Oncology, Holon, 5822012, Israel|Shaare Zedek Medical Center; Oncology Dept, Jerusalem, 9103102, Israel|Hadassah Ein Karem Hospital; Oncology Dept, Jerusalem, 9112000, Israel|Nahariya Hospital; Oncology, Nahariya, 22100, Israel|Rabin Medical Center; Oncology Dept, Petah Tikva, 4941492, Israel|Chaim Sheba Medical Center; Oncology Dept, Ramat Gan, 5262100, Israel|Kaplan Medical Center; Oncology Inst., Rehovot, 7610001, Israel|Sourasky / Ichilov Hospital; Dept. of Oncology, Tel Aviv, 6423906, Israel|Assuta Medical Centre; Oncology, Tel Aviv, Israel|Assaf Harofeh; Oncology, Ẕerifin, 6093000, Israel|Azienda Ospedaliera San Giuseppe Moscati, Avellino, Campania, 83100, Italy|Az. Osp. Ospedale Civile; U.O. Di Oncologia Medica Ed Ematologia, Piacenza, Emilia-Romagna, 29100, Italy|Azienda USL di Ravenna; Unità Operativa di Oncologia Medica, Ravenna, Emilia-Romagna, 48100, Italy|Azienda Ospedaliero-Universitaria Dipartimento Interaziendale Di Oncologia, Udine, Friuli Venezia Giulia, 33100, Italy|Ospedale Belcolle Di Viterbo; Oncologia, Viterbo, Lazio, 01100, Italy|Ente Ospedaliero Ospedali Galliera; S.C. Oncologia Medica, Genoa, Liguria, 16128, Italy|Asst Papa Giovanni XXIII; Oncologia Medica, Bergamo, Lombardy, 24127, Italy|Ospedale Mater Salutis; Dept of Oncology, Legnago, Lombardy, 37045, Italy|Irccs Ospedale San Raffaele;Oncologia Medica, Milan, Lombardy, 20132, Italy|Istituto Europeo Di Oncologia, Milan, Lombardy, 20141, Italy|Irccs Policlinico S. Matteo - Uni Pavia; Clinica Medica I Div. Med. Int. Onc. Medica E Gastroent., Pavia, Lombardy, 27100, Italy|Ospedale Maggiore Della Carita; Oncologia Medica, Novara, Piedmont, 28100, Italy|Ospedale Degli Infermi Di Biella; Reparto Oncologia Medica, Ponderano (BI), Piedmont, 13875, Italy|Fondazione Del Piemonte; Medical Oncology, Turin, Piedmont, 70060, Italy|Ospedale S. Vincenzo; Oncologia Medica, Taormina, Sicily, 98030, Italy|Ospedali Riuniti Di Ancona; Oncology, Ancona, The Marches, 60121, Italy|Ospedale Di Macerata; Oncologia, Macerata, The Marches, 62100, Italy|Azienda Ospedaliero-Universitaria Careggi;S.C. Oncologia Medica 1, Florence, Tuscany, 50139, Italy|Arcispedale S.Anna; Oncologia Medica, Cona (Ferrara), Veneto, 44124, Italy|American University of Beirut - Medical Center, Beirut, 1107 2020, Lebanon|Hotel Dieu de France; Oncology, Beirut, 2063 1111, Lebanon|Hospital of Lithuanian University of Health. Sciences Kaunas Clinics, Kaunas, 50009, Lithuania|Uni Oncology Inst. ; Chemo - Radiation Dept, Vilnius, 08660, Lithuania|Iem-Fucam, D.F., 04980, Mexico|Medica Sur Centro Oncologico Integral, D.F., 14050, Mexico|Instituto Nacional de Cancerologia; Oncology, Distrito Federal, 14080, Mexico|Consultorio de Medicina Especializada; Dentro de Condominio San Francisco, Mexico City, 03100, Mexico|Centro Medico Nacional Siglo Xxi - Imss; Hospital de Oncologia, Mexico City, 06720, Mexico|Hospital General de México; Unidad de Oncologia, Mexico City, 06726, Mexico|Instituto Nacional de Ciencias Médicas Y de La Nutricion Zubirán, Mexico City, Tlalpan 14000, Mexico|Cancerologia de Queretaro; Oncologia, Queretaro, Queretaro, 76090, Mexico|Institut National D'oncologie Sidi Mohammed Ben Abdellah; Anatomopathologie, Rabat, 10000, Morocco|Medisch Centrum Alkmaar, Alkmaar, 1815 JD, Netherlands|Albert Schweitzer Ziekenhuis, Dordrecht, 3318 AT, Netherlands|Catharina ZKHS; Inwendige Geneeskunde Afd., Eindhoven, 5623 EJ, Netherlands|Martini Ziekenhuis; Dept of Internal Medicine, Groningen, 9728 NT, Netherlands|Mc Haaglanden, Locatie Antoniushove; Interne Geneeskunde, Leidschendam, 2262 BA, Netherlands|Ikazia Ziekenhuis; Interne Oncologie, Rotterdam, 3083 AN, Netherlands|Twee Steden Ziekenhuis - Locatie Tilburg; Interne Geneesekunde, Tilburg, 5042 AD, Netherlands|Vie Curie, Venlo, 5912 BL, Netherlands|Shifa International Hospital; Department of Oncology, Islamabad, 44000, Pakistan|Shaukat Khanum Memorial Cancer Hospital; Department of Oncology, Lahore, 54000, Pakistan|Hameed Latif Hospital; Department of Oncology, Lahore, 54600, Pakistan|Instituto;Oncologico Miraflores, Lima, 18, Peru|Clinica Internacional, Sede San Borja; Unidad de Investigacion de Clínica Internacional, Lima, Lima 41, Peru|Hospital Nacional LNS dela Policia Nacional del Perú. Unidad Onco; Deapartamento de Oncología, Lima, Lima11, Peru|Bialostockie Centrum Onkologii; Oddzial Onkologii Klinicznej, Bialystok, 15-027, Poland|Świętokrzyskie Centrum Onkologii; Dział Chemioterapii, Kielce, 25-734, Poland|Szpital Uniwersytecki w Krakowie, Oddział Kliniczny Kliniki Onkologii, Krakow, 30-688, Poland|Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii; Poradnia Chemioterapii, Lodz, 93-513, Poland|Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii, Otwock, 05-400, Poland|Cent.Onkologii-Instytut im. M. S-Curie, Klinika Now. Piersi i Chirurgii Rekon, Warsaw, 02-781, Poland|IPO de Coimbra; Servico de Oncologia Medica, Coimbra, 3000-075, Portugal|Hospital do Espirito Santo; Servico de Oncologia Medica, Evora, 7000-811, Portugal|Centro Clinico Champalimaud; Oncologia Medica, Lisbon, 1400-038, Portugal|Hospital da Luz; Departamento de Oncologia Medica, Lisbon, 1500-650, Portugal|Hospital de Santa Maria; Servico de Oncologia Medica, Lisbon, 1649-035, Portugal|Hospital Beatriz Angelo; Departamento de Oncologia, Loures, 2674-514, Portugal|IPO do Porto; Servico de Oncologia Medica, Porto, 4200-072, Portugal|Hospital de Sao Joao; Servico de Oncologia, Porto, 4200-319, Portugal|King Faisal Specialist Hospital & Research Centre; Oncology, Riyadh, 11211, Saudi Arabia|King Abdul Aziz Medical City, King Fahd National Guard; Oncology, Riyadh, 22490, Saudi Arabia|Institute for Onc/Rad Serbia, Belgrade, 11000, Serbia|Oncology Institute of Vojvodina, Kamenitz, 21204, Serbia|Institute of Oncology Ljubljana, Ljubljana, 1000, Slovenia|Hospital Virgen de los Lirios; Servicio de Oncologia, Alcoy, Alicante, 03804, Spain|Hospital General de Elda; Servicio de Oncologia, Elda, Alicante, 03600, Spain|Hospital Universitario Son Espases, Palma de Mallorca, Balearic Islands, 07014, Spain|Corporacio Sanitaria Parc Tauli; Servicio de Oncologia, Sabadell, Barcelona, 08208, Spain|Hospital de Jerez de la Frontera; Servicio de Oncologia, Jerez de la Frontera, Cadiz, 11407, Spain|Hospital Provincial de Castellon; Servicio de Oncologia, Castellon, Castellon, 12002, Spain|Hospital de Barbastro; Servicio de Oncologia, Barbastro, Huesca, 22300, Spain|Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia, Santiago de Compostela, LA Coruña, 15706, Spain|Complejo Hospitalario San Millan - San Pedro; Servicio de Oncologia, Logroño, La Rioja, 26006, Spain|Hospital Universitario Materno Infantil de Gran Canaria; Servicio de Oncologia, Las Palmas de Gran Canaria, LAS Palmas, 35016, Spain|Hospital de Gran Canaria Dr. Negrin; Servicio de Oncologia, Las Palmas de Gran Canaria, LAS Palmas, 35020, Spain|Fundacion Hospital de Alcorcon; Servicio de Oncologia, Alcorcón, Madrid, 28922, Spain|Hospital Severo Ochoa; Servicio de Oncologia, Leganés, Madrid, 28911, Spain|Hospital de Navarra; Servicio de Oncologia, Navarra, Navarre, 31008, Spain|Clinica Universitaria de Navarra; Servicio de Oncologia, Pamplona, Navarre, 31008, Spain|Hospital de Cabueñes; Servicio de Oncologia, Gijón, Principality of Asturias, 33394, Spain|Hospital Universitari Sant Joan de Reus; Servicio de Oncologia, Reus, Tarragona, 43204, Spain|Complejo Hospitalario Nuestra Señora de la Candelaria; Servicio de Oncologia, Santa Cruz de Tenerife, Tenerife, 38010, Spain|Hospital de Sagunto; Servicio de Oncologia, Sagunto, Valencia, 46520, Spain|Hospital de Basurto; Servicio de Oncologia, Bilbao, Vizcaya, 48013, Spain|Hospital Quiron Barcelona; Servicio de Oncologia, Barcelona, 08024, Spain|Hospital Clínic i Provincial; Servicio de Hematología y Oncología, Barcelona, 08036, Spain|Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia, Barcelona, 08041, Spain|Complejo Asistencial Universitario De Burgos; Servicio de Oncologia, Burgos, 09006, Spain|Hospital San Pedro De Alcantara; Servicio de Oncologia, Cáceres, 10003, Spain|Hospital Universitari de Girona Dr. Josep Trueta; Servicio de Oncologia, Girona, 17007, Spain|Hospital Universitario Virgen de las Nieves; Servicio de Oncologia, Granada, 18014, Spain|Hospital General Universitario de Guadalajara; Servicio de Oncologia, Guadalajara, 19002, Spain|Complejo Asistencial Universitario de Leon; Servicio de Oncologia, León, 24071, Spain|Centro Oncologico MD Anderson Internacional; Servicio de Oncologia, Madrid, 28033, Spain|Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, 28034, Spain|Fundacion Jimenez Diaz; Servicio de Oncologia, Madrid, 28040, Spain|Hospital Universitario Clínico San Carlos; Servicio de Oncologia, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid, 28041, Spain|Hospital Universitario La Paz; Servicio de Oncologia, Madrid, 28046, Spain|HOSPITAL DE MADRID NORTE SANCHINARRO- CENTRO INTEGRAL ONCOLOGICO CLARA CAMPAL; Servicio de Oncologia, Madrid, 28050, Spain|Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia, Málaga, 29010, Spain|Hospital General Universitario J.M Morales Meseguer; Servicio de Oncologia, Murcia, 30008, Spain|Hospital Universitario Virgen de Arrixaca; Servicio de Oncologia, Murcia, 30120, Spain|Complejo Hospitalario de Orense; Servicio de Oncologia, Ourense, 32005, Spain|Hospital Clinico Universitario de Salamanca; Servicio de Oncologia, Salamanca, 37007, Spain|Hospital Universitario Virgen Macarena; Servicio de Oncologia, Seville, 41009, Spain|Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia, Valencia, 46015, Spain|Hospital Universitario Dr. Peset, Valencia, 46017, Spain|Hospital Clinico Universitario de Valladolid; Servicio de Oncologia, Valladolid, 47005, Spain|Hospital de Rio Hortega; Servicio de Oncologia, Valladolid, 47010, Spain|Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia, Zaragoza, 50009, Spain|Hospital Universitario Miguel Servet; Servicio Oncologia, Zaragoza, 50009, Spain|Gävle Sjukhus; Onkologiska Kliniken, Gävle, 80187, Sweden|Sahlgrenska Universitetssjukhuset; Jubileumskliniken, Gothenburg, 413 45, Sweden|Centralsjukhuset Karlstad, Onkologkliniken, Karlstad, 65185, Sweden|Skånes University Hospital, Skånes Department of Onclology, Lund, 221 85, Sweden|Centrallasarettet Växjö, Onkologkliniken, Vaxjo, 35185, Sweden|Västmanlands sjukhus Västerås, Onkologkliniken, Västerås, 72189, Sweden|Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology, Adana, 01250, Turkey (Türkiye)|Akdeniz University Medical Faculty; Medical Oncology Department, Antalya, 07070, Turkey (Türkiye)|Ege University Medical Faculty; Medical Oncology Department, Bornova, İ̇zmi̇r, 35100, Turkey (Türkiye)|Trakya University Medical Faculty Research And Practice Hospital Medical Oncology Department, Edirne, 22770, Turkey (Türkiye)|Hacettepe Uni Medical Faculty Hospital; Oncology Dept, Sihhiye/Ankara, 06230, Turkey (Türkiye)|Mun. Multifield Clin.Hosp.#4,Dept. of Chemotherapy, DSMU; Chair of Oncology and Medical Radiology, Dnipropetrovsk, 49102, Ukraine|Kyiv City Clinical Oncological Center; Chemotherapy Department, Kiev, 03115, Ukraine|State Oncology Regional Treatment-Diagnostic Center; Chemotherapy Department, Lviv, 79031, Ukraine|Zaporozhye Regional Oncology Hospital; Dept of Oncology, Zaporizhzhya, 69104, Ukraine|Tawam Hospital, Al Ain City, 15258, United Arab Emirates|Royal United Hospital; Oncology Department, Bath, BA1 3NG, United Kingdom|City Hospital NHS Trust, Birmingham, B18 7QH, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, BS2 8ED, United Kingdom|Addenbrookes Hospital; Dept of Oncology, Cambridge, CB2 2QQ, United Kingdom|Velindre Hospital, Cardiff, CF14 2TL, United Kingdom|Walsgrave Hospital, Coventry, CV2 2DX, United Kingdom|Royal Derby Hospital, Derby, DE22 3NE, United Kingdom|University Hospital of North Durham, Durham, DH15TW, United Kingdom|Hairmyres Hospital; Oncology Dept, East Kilbride, G75 8RG, United Kingdom|Eastbourne District Hospital; Department of Pharmacy, Eastbourne, BN21 2UD, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|Diana Princess of Wales Hosp., Grimsby, DN33 2BA, United Kingdom|Royal Surrey County Hospital, Guildford, GU2 7XX, United Kingdom|Leeds Teaching Hosp NHS Trust;St James's Institute of Onc, Leeds, LS9 7TF, United Kingdom|Huddersfield Royal Infirmary - Pharmacy department, Lindley, HD3 3EA, United Kingdom|Barts and the London NHS Trust., London, EC1A 7BE, United Kingdom|Royal Free Hospital; Dept of Oncology, London, NW3 2QG, United Kingdom|Kings College Hospital NHS Foundation Trust, London, SE5 9RS, United Kingdom|Royal Marsden Hospital - London, London, SW3 6JJ, United Kingdom|Macclesfield District General Hospital, Macclesfield, SK10 3BL, United Kingdom|Christie Hospital; Breast Cancer Research Office, Manchester, M20 4QL, United Kingdom|James Cook Uni Hospital, Middlesbrough, TS4 3BW, United Kingdom|Freeman Hospital; Northern Centre For Cancer Care, New Castle Upon Tyne, NE7 7DN, United Kingdom|Mount Vernon Cancer Centre, Northwood, HA6 2RN, United Kingdom|Churchill Hospital, Oxford, OX3 7LJ, United Kingdom|Peterborough City Hospital, Peterborough, PE3 9GZ, United Kingdom|Derriford Hospital; Plymouth Oncology Centre, Plymouth, PL6 8DH, United Kingdom|Musgrove Park Hospital, Somerset, TA1 5DA, United Kingdom|The Royal Marsden Hospital, Sutton, SM2 5PT, United Kingdom|Royal Cornwall Hospital, Truro, TR1 3LQ, United Kingdom|Wishaw General Hospital, Wishaw, ML2 0DP, United Kingdom|Grupo Oncológico Cooperativo Uruguayo; Hospital de Clínicas - Dpto. de Oncología, Montevideo, 11400, Uruguay|Hospital Central De Las FF.AA.; Servicio De Oncologia, Montevideo, 11600, Uruguay|Hospital Pereira Rossell; Oncology Department, Montevideo, 11600, Uruguay|Centro Integral de Oncología, Caracas, 1060, Venezuela|Centro Médico Docente La Trinidad; Servicio de Gastroenterología, Caracas, 1080, Venezuela",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumors|Pancreatic Cancer|CRC,BIOLOGICAL: OMO-103,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/28/21,1/11/23,"University Hospital Vall d´Hebron, Barcelona, 08035, Spain|Hospital Fundación Jiménez Díaz, Madrid, 28050, Spain|Hospital Universitario HM Sanchinarro, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Hepatobiliary Neoplasm,OTHER: Laboratory Biomarker Analysis|DRUG: Ponatinib Hydrochloride|OTHER: Quality-of-Life Assessment,ALL,"ADULT, OLDER_ADULT",PHASE2,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-12,6/14/19,"Mayo Clinic in Arizona, Scottsdale, Arizona, 85259, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Herceptin,ALL,"ADULT, OLDER_ADULT",PHASE3,2577,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/17/12,2/19/20,"University ""Mother Theresa"" Hospital Center; Oncology Department, Tirana, 1000, Albania|CPMC; Service d'Oncologie Médicale, Algiers, 16000, Algeria|Fundación CENIT para la Investigación en Neurociencias, Buenos Aires, C1125ABD, Argentina|Hospital Britanico; Oncologia, Buenos Aires, C1280AEB, Argentina|Instituto De Investigaciones Clinicas Zarate, Zárate, 2800, Argentina|Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|St George Hospital; Cancer Care Centre, Kogarah, New South Wales, 2217, Australia|Prince of Wales Hospital; Oncology, Randwick, New South Wales, 2031, Australia|Princess Alexandra Hospital; Division of Cancer Services, Woolloongabba, Queensland, 4102, Australia|Queen Elizabeth Hospital; Medical Oncology, Woodville South, South Australia, 5011, Australia|Western Hospital, Footscray, Victoria, 3011, Australia|Peninsula and South Eastern Haematology and Oncology Group, Frankston, Victoria, 3199, Australia|Cabrini Medical Centre; Oncology, Malvern, Victoria, 3144, Australia|Royal Perth Hospital; Department of Medical Oncology, Perth, Western Australia, 6000, Australia|University Clinical Center of the Republic of Srpska, Banja Luka, 78000, Bosnia and Herzegovina|Clinic of Oncology, University Clinical Center Sarajevo, Sarajevo, 7100, Bosnia and Herzegovina|Hospital Sao Rafael - HSR, Salvador, Estado de Bahia, 41253-190, Brazil|Centro de Oncologia da Bahia - CENOB, Salvador, Estado de Bahia, 41820-021, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, 90035-001, Brazil|Hospital Amaral Carvalho, Jaú, São Paulo, 17210-120, Brazil|Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, São Paulo, 01246-000, Brazil|Hospital Perola Byington, São Paulo, São Paulo, 01317-000, Brazil|Complex Oncology Center - Plovdiv First Internal Chemotherapy Department, Plovdiv, 4004, Bulgaria|MHAT Serdika; Department of medical oncology, Sofia, 1303, Bulgaria|SHATOD - Sofia, Sofia, 1784, Bulgaria|Cross Cancer Institute ; Dept of Medical Oncology, Edmonton, Alberta, T6G 1Z2, Canada|British Columbia Cancer Agency (Bcca) - Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada|The Moncton Hospital, Moncton, New Brunswick, E1C 6Z8, Canada|Lakeridge Health Oshawa; Oncology, Oshawa, Ontario, L1G 2B9, Canada|St. Michael'S Hospital, Toronto, Ontario, M5B 1W8, Canada|Windsor Regional Cancer Centre, Windsor, Ontario, N8W 2X3, Canada|CSSS champlain - Charles-Le Moyne, Greenfield Park, Quebec, J4V 2H1, Canada|Mcgill University - Royal Victoria Hospital; Oncology, Montreal, Quebec, H3A 1A1, Canada|Centro Oncológico Antofagasta, Antofagasta, 1240000, Chile|Instituto Nacional del Cancer, Santiago, 8380000, Chile|Sociedad de Investigaciones Medicas Ltda (SIM), Temuco, 4800827, Chile|Hospital Carlos Van Buren, Servicio de Oncologia, Valparaíso, 2341391, Chile|Clinica del Country, Bogotá, 11001, Colombia|Clínica Imbanaco; Oncology, Cali, Colombia|Clinical Hospital Osijek; Dept For Oncology & Radiotherapy, Osijek, 31000, Croatia|Clinical Hospital Centre Zagreb, Zagreb, 10000, Croatia|Masarykův onkologický ústav; Klinika komplexní onkologické péče, Brno, 656 53, Czechia|Fakultní nemocnice Olomouc, Olomouc, 775 20, Czechia|Fakultní Nemocnice V Motole; Radioterapeuticko-Onkologicke Oddeleni, Prague, 150 06, Czechia|Hospital Metropolitano de Santiago, Santiago de los Caballeros, 51000, Dominican Republic|Instituto de Cáncer SOLCA Cuenca; Oncología, Cuenca, EC010107, Ecuador|Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology, Guayaquil, EC090112, Ecuador|Hospital Solca Quito; Oncologia, Quito, EC170124, Ecuador|Alexandria Uni ; Medical Oncology, Alexandria, 11737, Egypt|Manial Specialized Hospital; Oncology, Cairo, 11555, Egypt|Nci; Oncology Dept, Cairo, 11796, Egypt|Hospital Oncologia; Oncology, San Salvador, 01101, El Salvador|HOPITAL JEAN MINJOZ; Oncologie, Besançon, 25030, France|Clinique Tivoli; Sce Radiotherapie, Bordeaux, 33000, France|Polyclinique Bordeaux Nord Aquitaine; Chimiotherapie Radiotherapie, Bordeaux, 33077, France|Ch De Fleyriat; Pneumologie 1, Bourg-en-Bresse, 01012, France|Hopital Augustin Morvan; Federation De Cancerologie, Brest, 29200, France|Ch De Brive La Gaillarde; Radiotherapie Oncologie, Brive-la-Gaillarde, 19312, France|Clinique Sainte Marie; Chimiotherapie, Chalon-sur-Saône, 71100, France|Fondation Clement Drevon; Oncology, Dijon, 21000, France|Centre Georges-François Lecler; Ctr de Lutte Contre le Canc, Dijon, 21034, France|Ch De La Dracenie; Hopital De Jour, Draguignan, 83007, France|Hopital Prive Drome Ardeche; Chir 2A 2B, Guilherand-Granges, 07500, France|Clinique Sainte Marguerite; Oncologie Medicale, Hyères, 83400, France|CHD Les Oudairies, La Roche-sur-Yon, 85925, France|Hopital Albert Michallon; Oncologie, La Tronche, 38700, France|Ch Du Mans; Medecine Hematologie Oncologie, Le Mans, 72037, France|Clinique Victor Hugo, LeMans, 72000, France|Centre Hartmann, Levallois-Perret, 92300, France|Polyclinique Du Bois; Centre Bourgogne, Lille, 59000, France|Hopital Claude Huriez; Medecine Interne Oncologie, Lille, 59037, France|Ch Bretagne Sud Site Scorff; Oncologie Medicale, Lorient, 56100, France|CH Bretagne Sud Site Bodelio; Oncologie Radiotherapie, Lorient, 56322, France|Ctre Consultations La Sauvegarde, Lyon, 69338, France|Hôpital Saint Joseph; Oncologie Medicale, Marseille, 13285, France|Hopital Clinique Claude Bernard; Oncologie Medicale, Metz, 57000, France|CHRA;Hematologie, Metz-Tessy, 74370, France|Clinique Clementville; Hopital De Jour, Montpellier, 34070, France|Centre Azureen De Cancerologie; Cons externes, Mougins, 06250, France|Centre Antoine Lacassagne; B3 Medecine Conventionnelle, Nice, 06189, France|Hopital Cochin; Unite Fonctionnelle D Oncologie, Paris, 75014, France|Hopital Hotel Dieu; Oncologie Medicale, Paris, 75181, France|HOPITAL TENON; Cancerologie Medicale, Paris, 75970, France|Ch Francois Mitterrand; Medecine Oncologie, Pau, 64046, France|Ch Lyon Sud; Onco Secteur Jules Courmont, Pierre-Bénite, 69495, France|Chp Saint Gregoire; Cancerologie Radiotherapie, Saint-Grégoire, 35768, France|Ico Rene Gauducheau; Oncologie, Saint-Herblain, 44805, France|Clinique de L'Union; Oncologie, Saint-Jean, 31240, France|CMCO De La Cote D Opale; Auberge De Jour, Saint-Martin-Boulogne, 62280, France|Institut de Cancerologie de La Loire; Pneumologie, Saint-Priest-en-Jarez, 42270, France|Ch De Saint Quentin; Medecine B10, Saint-Quentin, 02321, France|Centre Paul Strauss; Oncologie Medicale, Strasbourg, 67065, France|Hopitaux Du Leman Site Thonon; Maternite Gynecologie, Thonon-les-Bains, 74203, France|Institut Claudius Regaud; Departement Oncologie Medicale, Toulouse, 31059, France|Clinique Pasteur; Pneumologie, Toulouse, 31076, France|Clinique Radio Des Dentellieres; Chimiotherapie Radiotherapie, Valenciennes, 59326, France|Centre-Alexis Vautrin, Vandœuvre-lès-Nancy, 54511, France|Klinikum Augsburg; Frauenklinik, Augsburg, 86156, Germany|Internist; Praxis Für Haemotologie & Onkologie, Bad Soden, 65812, Germany|Praxis Dres. Schilling & Till, Berlin, 10317, Germany|Vivantes Klinikum Am Urban; Zentrum für Brusterkrankungen, Berlin, 10967, Germany|Katholische Hospitalvereinigung Ostwestfalen gGmbH, Bielefeld, 33615, Germany|Gemeinschaftspraxis Dr. Bueckner und Dr. Nueckel, Bochum, 44787, Germany|Praxis Dr.med. Katja Ziegler-Löhr, Cologne, 50679, Germany|St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe, Cologne, 50935, Germany|Kliniken der Stadt Köln gGmbH Krankenhaus Holweide; Brustzentrum, Cologne, 51067, Germany|DONAU ISAR Klinikum Deggendorf; Frauenklinik, Deggendorf, 94469, Germany|Universitätsklinikum Essen; Zentrum Für Frauenheilkunde, Essen, 45122, Germany|Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH; Klinik für Senologie / Brustzentrum, Essen, 45136, Germany|Universitätsklinikum Freiburg; Frauenklinik, Freiburg im Breisgau, 79106, Germany|Klinikum St. Georg GmbH; Franziskus-Hospital Harderberg; Klinik für Gynaekologie und Geburtshilfe, Georgsmarienhütte, 49124, Germany|Krankenhaus St. Elisabeth und St. Barbara, Klinik für Frauenheilkunde und Geburtshilfe, Halle, 06110, Germany|Universitätsklinikum Hamburg-Eppendorf; Zentrum für operative Medizin Klinik für Gynäkologie, Hamburg, 20246, Germany|Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem, Hamburg, 20357, Germany|Gynaekologisch-Onkologische Schwerpunktpraxis Prof. Dr. med. Lueck, Dr. Schrader und Dr. Noeding, Hanover, 30177, Germany|Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe, Hanover, 30625, Germany|Nationales Centrum für Tumorerkrankungen (NCT) ; Gyn. Onk. Frauenklinik; Uniklinikum Heidelberg, Heidelberg, 69120, Germany|Universitätsklinikum Jena; Klinik und Poliklinik für Frauenheilkunde und Fortpflanzungsmedizin, Jena, 07747, Germany|Elisabeth-Krankenhaus Brustzentrum, Kassel, 34117, Germany|Klinikum Kulmbach; Frauenklinik, Kulmbach, 95326, Germany|Dres. Andreas Köhler und Roswitha Fuchs, Langen, 63225, Germany|Klinikum Leverkusen; Med. Klinik III / Onkologie, Leverkusen, 51375, Germany|Klinikum Ludwigsburg; Klinik für Frauenheilkunde und Geburtshilfe, Ludwigsburg, 71640, Germany|Universitätsklinikum Schleswig-Holstein / Campus Lübeck; Klinik für Frauenheilkunde und Geburtshilfe, Lübeck, 23538, Germany|Onkologische Schwerpunktpraxis Lübeck, Lübeck, 23562, Germany|Universitätsmedizin Mainz; Klinik u. Poliklinik f. Geburtshilfe u. Frauenheilkunde, Mainz, 55131, Germany|Gemeinschaftspraxis Fr. Dr. med. Balser & Hr. Dr. med. Weidenbach, Marburg, 35037, Germany|Klinikum Meiningen Klinik f.Gynäkologie und Geburtshilfe, Meiningen, 98617, Germany|Klinikum Memmingen; Abt.Gynäkologie, Memmingen, 87700, Germany|Mühlenkreiskliniken; Johannes Wesling Klinikum Minden; Klinik für Frauenheilkunde und Geburtshilfe, Minden, 32429, Germany|Praxis Dr.med. Steffi Busch, Mühlhausen, 99974, Germany|Gemeinschaftspraxis Prof. Dr.med. Christoph Salat und Dr.med. Oliver J. Stötzer, München, 80638, Germany|Praxis Dr. Prechtl & Dr. Kowolik; Frauenklinik, München, 81925, Germany|Universitätsklinikum Münster; Klinik für Frauenheilkunde und Geburtshilfe, Münster, 48149, Germany|Ruppiner Kliniken, Klinik fuer Gynaekologie und Geburtshilfe, Neuruppin, 16816, Germany|Klinikum Nord Frauenklinik, Nuremberg, 90419, Germany|Sana Klinikum Offenbach GmbH; Klinik für Gynäkologie & Geburtshilfe, Offenbach, 63069, Germany|medius KLINIK OSTFILDERN-RUIT; Brustzentrum, Ostfildern, 73760, Germany|Oncologianova GmbH, Recklinghausen, 45659, Germany|Agaplesion Diakonieklinikum Rotenburg, Rotenburg (Wümme), 27356, Germany|Caritas Klinik St. Theresia -Frauenklinik Brustzentrum, Saarbrücken, 66113, Germany|Leopoldina Krankenhaus der Stadt Schweinfurt GmbH, Schweinfurt, 97422, Germany|HELIOS Klinikum Schwerin; Frauenklinik, Schwerin, 19049, Germany|Johanniter-Krankenhaus Genthin-Stendal; Klinik Für Frauenheilkunde & Geburtshilfe, Stendal, 39576, Germany|Kreiskrankenhaus Torgau; Abt.Gynäkologie und Geburtshilfe, Torgau, 04860, Germany|Universitätsklinik Tübingen; Frauenklinik, Tübingen, 72076, Germany|Katharinen-Hospital gGmbH, Unna, 59423, Germany|GRN-Klinik Weinheim; Abt.Gynäkologie und Geburtshilfe, Weinheim, 69469, Germany|ASKLEPIOS KREISKRANKENHÄUSER WEIßENFELS-HOHENMÖLSEN GMBH, Weißenfels, 06667, Germany|Lahn-Dill Kliniken GmbH Klinikum Wetzlar Gynäkologie/Geburtshilfe, Wetzlar, 35578, Germany|Gesellschaft für Medizinische Studien Würselen, Würselen, 52146, Germany|Uni Hospital of Alexandroupoli; Dept. of Oncology - Duth, Alexandroupoli, 681 00, Greece|Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine, Athens, 115 22, Greece|Laiko General Hospital; 1St Pathological Clinic, Athens, 115 27, Greece|Alexandras General Hospital of Athens; Oncology Department, Athens, 115 28, Greece|Periph. University General Hospital of Heraklion Crete; Oncology Department, Heraklion, 711 10, Greece|Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept., Kifissia, 145 64, Greece|University Hospital of Larissa; Oncology, Larissa, 413 35, Greece|Euromedical General Clinic of Thessaloniki; Oncology Department, Thessaloniki, 546450, Greece|Papageorgiou General Hospital; Medical Oncology, Thessaloniki, 564 29, Greece|Centro Oncológico Sixtino / Centro Oncológico SA, Guatemala City, 01010, Guatemala|Grupo Angeles, Guatemala City, 01015, Guatemala|Queen Elizabeth Hospital; Clinical Oncology, Hong Kong, Hong Kong|Prince of Wales Hosp; Dept. Of Clinical Onc, Shatin, Hong Kong|Szent Margit Hospital; Dept. of Oncology, Budapest, 1032, Hungary|Szent Imre Hospital; Dept. of Oncology, Budapest, 1115, Hungary|Orszagos Onkologiai Intezet, Budapest, 1122, Hungary|Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika, Budapest, 1125, Hungary|Debreceni Egyetem Klinikai Kozpont ; Department of Oncology, Debrecen, 4032, Hungary|Josa Andras Korhaz; Dept of Oncoradiology, Nyíregyháza, 4400, Hungary|Pécsi Tudományegyetem; Klinikai Központ Onkoterápiás Intézet, Pécs, 7623, Hungary|Markusovszky Hospital, Szombathely, 9700, Hungary|Hasan Sadikin Hospital; Internal Medicine, Bandung, 40161, Indonesia|CiptoMangunkusumo Hospital; Internal Medicine, Central Jakarta, 10430, Indonesia|Soetomo Hospital; Surgery, East Java, 60286, Indonesia|Dharmais National Cancer Center, Jakarta, 11420, Indonesia|Sardjito Hospital; Instalasi Kanker Tulip, Yogyakarta, 55284, Indonesia|Mater Misericordiae Uni Hospital; Oncology, Dublin, 7, Ireland|Mater Private Hospital, Dublin, 7, Ireland|Beaumont Hospital; Cancer Clinical Trials Unit, Dublin, 9, Ireland|University Hospital Limerick, Limerick, Ireland|Sligo General Hospital; Oncology, Sligo, Ireland|Waterford Regional Hospital; Department Of Medical Oncology, Waterford, Ireland|Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica, Bari, Apulia, 70124, Italy|Ospedale Vito Fazzi; Div. Oncoematologia, Lecce, Apulia, 73100, Italy|IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia, San Giovanni Rotondo, Apulia, 71013, Italy|Ospedale Oncologico Regionale; U.O. Oncologia Medica Ed Ematologia, Rionero in Vulture, Basilicate, 85028, Italy|Azienda Ospedaliera A. Cardarelli, Napoli, Campania, 80131, Italy|Istituto Nazionale Tumori Irccs Fondazione g. PASCALE;U.O.C. Oncologia Medica Senologica, Napoli, Campania, 80131, Italy|Università degli Studi Federico II; Clinica di Oncologia Medica, Napoli, Campania, 80131, Italy|IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola; Oncologia Medica, Meldola, Emilia-Romagna, 47014, Italy|Ospedale Regionale Di Parma; Divisione Di Oncologia Medica, Parma, Emilia-Romagna, 43100, Italy|Az. Osp. Ospedale Civile; U.O. Di Oncologia Medica Ed Ematologia, Piacenza, Emilia-Romagna, 29100, Italy|Azienda USL di Ravenna; Unità Operativa di Oncologia Medica, Ravenna, Emilia-Romagna, 48100, Italy|Ausl Frosinone - Ospedale Umberto I; Divisione Di Oncologia, Frosinone, Lazio, 03100, Italy|IFO - Istituto Regina Elena; Oncologia Medica, Rome, Lazio, 00144, Italy|Policlinico Umberto i di Roma; dip. Scienze Radiologiche, Oncologiche, Anatomopatologiche, Rome, Lazio, 00161, Italy|Azienda Ospedaliera Sant'Andrea, Rome, Lazio, 00189, Italy|Ospedale Belcolle Di Viterbo; Oncologia, Viterbo, Lazio, 01100, Italy|Asst Papa Giovanni XXIII; Oncologia Medica, Bergamo, Lombardy, 24127, Italy|ASST DI CREMONA; Unità di Patologia Mammaria Senologia e Breast Unit, Cremona, Lombardy, 26100, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori; S. C. Oncologia Medica 2, Milan, Lombardy, 20133, Italy|ASST DI MONZA; Oncologia Medica, Monza, Lombardy, 20900, Italy|IRRCCS San Matteo; Dip Oncoematologico ; Divisione Oncologia, Pavia, Lombardy, 27100, Italy|IRCCS Istituto Clinico Humanitas; Oncologia, Rozzano, Lombardy, 20089, Italy|A.O. Città della Salute e della Scienza - Presidio Molinette; divisione oncologia medica, Turin, Piedmont, 10126, Italy|Ospedale Oncologico A.Businco; Div. Oncologia Medica II, Cagliari, Sardinia, 09121, Italy|Ospedale Civile SS Annunziata; oncologia medica, Sassari, Sardinia, 07100, Italy|Ospedale Garibaldi Nesima; Biomedicina Clinica e Molecolare, Catania, Sicily, 95100, Italy|Azienda Ospedaliero-Universitaria Careggi;S.C. Oncologia Medica 1, Florence, Tuscany, 50139, Italy|Azlenda Ospendaliero-Universitaria Pisana; C.O. Oncologia 2, Pisa, Tuscany, 56100, Italy|Azienda usl 5 Di Pisa-Ospedale Di Pontedera;U.O. Oncologia, Pontedera, Tuscany, 56025, Italy|Ospedale Civile; Oncologia Medica, Camposampiero, Veneto, 35012, Italy|Arcispedale S.Anna; Oncologia Medica, Cona (Ferrara), Veneto, 44124, Italy|Hospital of Lithuanian University of Health. Sciences Kaunas Clinics, Kaunas, 50009, Lithuania|Klaipeda University Hospital, Klaipėda, 92288, Lithuania|Hospital Wanita dan Kanak-Kanak Sabah, Sabah, Sabah, 88996, Malaysia|Sarawak General Hospital; Department of Radiotherapy, Oncology and Palliative care, Sarawak, Sarawak, 93586, Malaysia|Hospital Pulau Pinang; Jabatan Radioterapi & Onkologi, George Town, 10990, Malaysia|University Malaya Medical Centre; Clinical Oncology Unit,, Kuala Lumpur, 59100, Malaysia|Centro Estatal de Oncología de Campeche, Campeche, 24096, Mexico|Centro Estatal de Cancerología, Chihuahua City, 31000, Mexico|Instituto Nacional de Cancerologia; Oncology, Distrito Federal, 14080, Mexico|Consultorio de Medicina Especializada; Dentro de Condominio San Francisco, Mexico City, 03100, Mexico|Oaxaca Site Management Organization, Oaxaca City, 68000, Mexico|Cancerologia de Queretaro; Oncologia, Queretaro, Queretaro, 76090, Mexico|Centro Estatal de Cancerologia de Nayarit, Tepic, 63170, Mexico|Institut National D'oncologie Sidi Med Benabdellah, Rabat, 6213, Morocco|Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, 5223 GZ, Netherlands|Onze Lieve Vrouwe Gasthuis, AC Amsterdam, 1091, Netherlands|Gelre Ziekenhuis Apeldoorn, Lokatie Lukas; Afdeling Interne Geneeskunde, Apeldoorn, 7334 DZ, Netherlands|Rijnstate Ziekenhuis; Inwendige Geneeskunde, Arnhem, 6815 AD, Netherlands|Albert Schweitzer Ziekenhuis - loc Dordrecht, Dordrecht, 3318 AT, Netherlands|Ziekenhuis Gelderse Vallei; Inwendige Geneeskunde, Ede, 6716 RP, Netherlands|Catharina Ziekenhuis; Dept of Internal Medicin, Eindhoven, 5623 EJ, Netherlands|Maxima Medisch Centrum; Inwendige Geneeskunde, Eindhoven, 5631 BM, Netherlands|Martini Ziekenhuis; Dept of Internal Medicine, Groningen, 9728 NT, Netherlands|Atrium Medisch Centrum Parkstad, Heerlen, Heerlen, 6419 PC, Netherlands|Spaarne Ziekenhuis; Inwendige Geneeskunde, Hoofddorp, 2134 TM, Netherlands|St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, 3435 CM, Netherlands|Franciscus Ziekenhuis, Roosendaal, 4708 AE, Netherlands|Maasstad ziekenhuis; Afdeling oncologie hematologie, Rotterdam, 3079 DZ, Netherlands|Ikazia Ziekenhuis, Rotterdam, 3083 AN, Netherlands|Vlietland Ziekenhuis, Locatie Schiedam; Interne Geneeskunde, Schiedam, 3100 AE, Netherlands|Zuyderland ziekenhuis locatie Geleen, Sittard-Geleen, 6162 BG, Netherlands|Diakonessenhuis Utrecht: ziekenhuisapotheek, Utrecht, 3582 KE, Netherlands|Ziekenhuis VieCurie Vitaal, Venlo, 5912 BL, Netherlands|Zaans Medisch Centrum, Zaandam, 1502 DV, Netherlands|Tauranga Hospital, Clinical Trials Unit; BOP Clinical School, Tauranga, 3112, New Zealand|Sørlandet Sykehus Kristiansand, Kristiansand, 4604, Norway|Oslo universitetssykehus HF, Ullevål, Kreftsenteret, Oslo, 0450, Norway|Helse Stavanger HF, Stavanger Universitetssjukehus; Klinikk for Blod og kreftsykdommer, Stavanger, 4011, Norway|Shifa International Hospital; Department of Oncology, Islamabad, 44000, Pakistan|Aga Khan University; Department of Oncology, Karachi, 74800, Pakistan|Shaukat Khanum Memorial Cancer Hospital; Department of Oncology, Lahore, 54000, Pakistan|Hameed Latif Hospital; Department of Oncology, Lahore, 54600, Pakistan|Centro Hemato Oncologico Panama, Panama City, 0832, Panama|Centro Medico Monte Carmelo, Arequipa, 04001, Peru|Instituto Nacional de Enfermedades Neoplasicas, Lima, Lima 34, Peru|Clinica de Especialidades Medicas, Lima, Lima 41, Peru|Clinica Internacional, Sede San Borja; Unidad de Investigacion de Clínica Internacional, Lima, Lima 41, Peru|Instituto Oncologico de Lima, Lima, Lima27, Peru|Philippine General Hospital; Section Of Medical Oncology, Manila, 1000, Philippines|East Avenue Medical Center, Quezon City, 1100, Philippines|Poradnia Onkologiczna oraz Oddzial Kliniczny Onkologii SPZOZ Szpital Uniwersytecki, Krakow, 30-688, Poland|Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii, Otwock, 05-400, Poland|Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu, Poznan, 60-569, Poland|Wielkopolskie Centrum Onkologi, Poznan, 61-866, Poland|MRUKMED Lekarz Beata Madej-Mruk i Partner Spolka Partnerska Oddzial nr 1 w Rzeszowie, Rzeszów, 35-021, Poland|Wojewodzki Szpital Zespolony, Torun, 87-100, Poland|NZOZ Onko-Dent SP. P. G. L. Slomian, Poradnia Onkologiczna, Żory, 44-240, Poland|Centro Clinico Champalimaud; Oncologia Medica, Lisbon, 1400-038, Portugal|Hospital da Luz; Departamento de Oncologia Medica, Lisbon, 1500-650, Portugal|IPO do Porto; Servico de Oncologia Medica, Porto, 4200-072, Portugal|Hospital de Sao Joao; Servico de Oncologia, Porto, 4200-319, Portugal|Policlinica Sfanta Maria - Oncology; Medical Oncology, Baia Mare, 430241, Romania|Institut of Oncology Al. Trestioreanu Bucharest; Oncology Department, Bucharest, 022328, Romania|Emergency University Bucharest Hospital; Oncology Department, Bucharest, 050098, Romania|Cluj Clinical County Hospital; Oncology Dept, Cluj-Napoca, 400006, Romania|Prof. Dr. I. Chiricuta Institute of Oncology, Cluj-Napoca, 400015, Romania|SC Oncolab SRL, Craiova, 200385, Romania|Clinical Hospital 1 Craiova; Medical Oncology, Craiova, 200642, Romania|S.C. Life Search S.R.L; Medical Oncology Clinic, Timișoara, 300167, Romania|ONCOMED - Medical Centre, Timișoara, 300239, Romania|Regional Oncology Hospital, Irkutsk, 664035, Russia|City Oncological Hospital, Izhevsk, 426009, Russia|Russian Oncology Research Center n.a. N.N. Blokhin Dpt of Clinical Pharmacology and Chemotherapy, Moscow, 115478, Russia|City Clinical Oncology Hospital, Moscow, 143423, Russia|State Inst. Of Healthcare Orenburg Regional Clinical Oncology Dis, Orenburg, 460021, Russia|City Clinical Oncology Dispensary, SPb SBIH CCOD, Saint Petersburg, 198255, Russia|Bashkirian Republican Clinical Oncology Dispensary, Ufa, 450054, Russia|King Faisal Specialist Hospital & Research Centre, Jeddah, 21499, Saudi Arabia|King Abdul Aziz Medical City, King Fahd National Guard; Oncology, Riyadh, 22490, Saudi Arabia|Clinical Hospital Center Bezanijska kosa; Clinic for Oncology, Belgrade, 11000, Serbia|Institute for Onc/Rad Serbia, Belgrade, 11000, Serbia|Oncology Institute of Vojvodina, Kamenitz, 21204, Serbia|Clinical Center Kragujevac, Kragujevac, 34000, Serbia|Clinical Centre Nis, Clinic for Oncology, Niš, 18000, Serbia|National Cancer Centre; Medical Oncology, Singapore, 169610, Singapore|Mammacentrum sv. Agáty, Banská Bystrica, 974 01, Slovakia|National Cancer Institute - Comenius University; Dept. Clinical Oncology, Bratislava, 811 05, Slovakia|Vychodoslovensky onkologicky ustav, Košice, 040 01, Slovakia|Fakultna nemocnica s poliklinikou J.A. Reimana Presov, Prešov, 081 81, Slovakia|Fakultna nemocnica Trencín; Onkologicke odd., Trenčín, 911 71, Slovakia|University Medical Centre Maribor; Depart. of Gynecology & Breast Oncology, Maribor, 2000, Slovenia|Westridge Medical Center, Durban, 4058, South Africa|Donald Gordon Medical Centre, Johannesburg, 2193, South Africa|Steve Biko Academic Hospital; Oncology, Pretoria, 0002, South Africa|National Cancer Center, Goyang-si, 10408, South Korea|Samsung Medical Center, Seoul, (0)6351, South Korea|Korea University Guro Hospital, Seoul, 08308, South Korea|Yonsei University Severance Hospital; Medical Oncology, Seoul, 120-752, South Korea|Asan Medical Center., Seoul, 138-736, South Korea|Hospital General de Elda; Servicio de Oncologia, Elda, Alicante, 03600, Spain|Hospital Universitario Son Espases, Palma de Mallorca, Balearic Islands, 07014, Spain|Hospital Universitari Germans Trias i Pujol; Servicio de Oncologia, Badalona, Barcelona, 08916, Spain|Corporacio Sanitaria Parc Tauli; Servicio de Oncologia, Sabadell, Barcelona, 8208, Spain|Hospital Universitario Marques de Valdecilla; Servicio de Oncologia, Santander, Cantabria, 39008, Spain|IInstituto Oncologico de San Sebastian, Oncologikoa; Servicio de Oncologia, Donostia / San Sebastian, Guipuzcoa, 20014, Spain|Hospital Universitario Materno Infantil de Gran Canaria; Servicio de Oncologia, Las Palmas de Gran Canaria, LAS Palmas, 35016, Spain|Hospital de Gran Canaria Dr. Negrin; Servicio de Oncologia, Las Palmas de Gran Canaria, LAS Palmas, 35020, Spain|Hospital Quiron de Madrid; Servicio de Oncologia, Pozuelo de Alarcón, Madrid, 28223, Spain|Hospital de Navarra; Servicio de Oncologia, Navarra, Navarre, 31008, Spain|Hospital Do Meixoeiro; Servicio de Oncologia, Vigo, Pontevedra, 36214, Spain|Hospital de Cabueñes; Servicio de Oncologia, Gijón, Principality of Asturias, 33394, Spain|Hospital Universitario de Canarias;servicio de Oncologia, San Cristóbal de La Laguna, Tenerife, 38320, Spain|Complejo Hospitalario Nuestra Señora de la Candelaria; Servicio de Oncologia, Santa Cruz de Tenerife, Tenerife, 38010, Spain|Hospital Lluis Alcanys; Servicio de Oncologia, Xàtiva, Valencia, 46800, Spain|Hospital de Basurto; Servicio de Oncologia, Bilbao, Vizcaya, 48013, Spain|Complejo Hospitalario Universitario de Albacete; Servicio de Oncologia, Albacete, 02006, Spain|Hospital General Univ. de Alicante; Servicio de Oncologia, Alicante, 3010, Spain|Hospital del Mar; Servicio de Oncologia, Barcelona, 08003, Spain|Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia, Barcelona, 08041, Spain|Hospital Duran i Reynals; Oncologia, Barcelona, 08907, Spain|Complejo Asistencial Universitario De Burgos; Servicio de Oncologia, Burgos, 09006, Spain|Hospital San Pedro De Alcantara; Servicio de Oncologia, Cáceres, 10003, Spain|Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia, Jaén, 23007, Spain|Complejo Asistencial Universitario de Leon; Servicio de Oncologia, León, 24071, Spain|Hospital Universitari Arnau de Vilanova de Lleida; Servicio de Oncologia, Lleida, 25198, Spain|Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, 28034, Spain|Hospital Universitario Clínico San Carlos; Servicio de Oncologia, Madrid, 28040, Spain|HOSPITAL DE MADRID NORTE SANCHINARRO- CENTRO INTEGRAL ONCOLOGICO CLARA CAMPAL; Servicio de Oncologia, Madrid, 28050, Spain|Hospital Universitario Virgen de Arrixaca; Servicio de Oncologia, Murcia, 30120, Spain|Complejo Hospitalario de Toledo- H. Virgen de la Salud; Servicio de Oncologia, Toledo, 45004, Spain|Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia, Valencia, 46015, Spain|Hospital Clinico Universitario Lozano Blesa; Servicio de Oncologia, Zaragoza, 50009, Spain|Skånes University Hospital, Skånes Department of Onclology, Lund, 221 85, Sweden|Skaraborgs sjukhus Skoevde, Dept of surgery, Skövde, 54185, Sweden|Hirslanden Medical Center, Tumorzentrum, Aarau, 5000, Switzerland|Kantonsspital Baden; Frauenklinik, Baden, 5405, Switzerland|Ospedale San Giovanni; Oncologia, Bellinzona, 6500, Switzerland|Inselspital Bern; Universitätsklinik für medizinische Onkologie, Bern, 3010, Switzerland|Kantonsspital Frauenfeld, Frauenklinik Thurgau, Frauenfeld, 8501, Switzerland|CHUV; Departement d'Oncologie, Lausanne, 1011, Switzerland|Spital Thun; Medizinische Klinik, Thun, 3600, Switzerland|Kantonsspital Winterthur; Medizinische Onkologie, Winterthur, 8401, Switzerland|Stadtspital Triemli; Frauenklinik, Zurich, 8063, Switzerland|China Medical University Hospital; Surgery, Taichung, 404, Taiwan|National Cheng Kung Uni Hospital; Surgery, Tainan, 704, Taiwan|National Taiwan Uni Hospital; General Surgery, Taipei, 100, Taiwan|Tri-Service General Hospital, Division of General Surgery, Taipei, 114, Taiwan|Department of Surgery, King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand|Pramongkutklao Hospital; Medicine - Medical Oncology Unit, Bangkok, 10400, Thailand|Rajvithi Hospital, Bangkok, 10400, Thailand|Ramathibodi Hospital; Medicine/Oncology, Bangkok, 10400, Thailand|Maharaj Nakorn Chiang Mai Hospital; Department of Surgery/Head Neck and Breast Unit; Clinical Trial, Chiang Mai, 50200, Thailand|Oncology Unit, Faculty of Medicine, Vajira Hospital; Department of Medicine, Dusit, 10300, Thailand|Ankara Uni School of Medicine; Medical Oncology, Ankara, 06590, Turkey (Türkiye)|Akdeniz University Medical Faculty; Medical Oncology Department, Antalya, 07070, Turkey (Türkiye)|Dicle University Faculty of Medicine, Diyarbakır, 21280, Turkey (Türkiye)|Gaziantep Univ. Med. Fac., Gaziantep, 27310, Turkey (Türkiye)|Istanbul Uni of Medicine Faculty; Oncology Dept, Istanbul, 34390, Turkey (Türkiye)|Marmara Uni Faculty of Medicine; Medical Oncology, Istanbul, 34890, Turkey (Türkiye)|Kocaeli University Faculty of Medicine; Medical oncology, İzmit, 31380, Turkey (Türkiye)|Mersin University Medical Faculty, Mersin, 33169, Turkey (Türkiye)|19 Mayis University Medical Faculty; Medical Oncology Department, Samsun, 55139, Turkey (Türkiye)|Hacettepe Uni Medical Faculty Hospital; Oncology Dept, Sihhiye/Ankara, 06230, Turkey (Türkiye)|Kyiv City Clinical Oncological Center; Chemotherapy Department, Kiev, 03115, Ukraine|State Oncology Regional Treatment-Diagnostic Center; Chemotherapy Department, Lviv, 79031, Ukraine|Tawam Hospital, Al Ain City, 15258, United Arab Emirates|Nevill Hall Hospital, Abergavenny, NP7 7EG, United Kingdom|Bedford Hospital; Oncology, Bedford, MK42 9DJ, United Kingdom|Wexham Park Hospital; Oncology, Berkshire, SL2 4HL, United Kingdom|University Hospital Birmingham Queen Elizabeth Hospital, Birmingham, B17 0NH, United Kingdom|Heartlands Hospital; Department Of Medicine, Birmingham, B9 5SS, United Kingdom|Royal Bournemouth Hospital; Oncology, Bournemouth, BH7 7DW, United Kingdom|Kent & Canterbury Hospital, Canterbury, CT1 3NG, United Kingdom|Broomfield Hospital; Oncology, Chelmsford, CM1 7ET, United Kingdom|Glan Clwyd Distr Gen Hospital;Nth Wales Cancer Treatment Ctr, Denbighshire, LL18 5UJ, United Kingdom|Royal Derby Hospital, Derby, DE22 3NE, United Kingdom|North Devon District Hospital, Devon, EX31 4JB, United Kingdom|Russells Hall Hospital; Oncology, Dudley, DY1 2HQ, United Kingdom|University Hospital of North Durham, Durham, DH15TW, United Kingdom|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|Inverclyde Hospital, Greenock, PA16 0XN, United Kingdom|Diana Princess of Wales Hosp., Grimsby, DN33 2BA, United Kingdom|Royal Surrey County Hospital, Guildford, GU2 7XX, United Kingdom|Princess Alexandra Hospital; Oncology Department, Harlow, CM20 1QX, United Kingdom|Huddersfield Royal Infirmary, Huddersfield, HD3 3EA, United Kingdom|Ipswich Hospital, Ipswich, IP4 5PD, United Kingdom|Crosshouse Hospital; Dept of Oncology, Kilmarnock, KA2 0BE, United Kingdom|Forth Valley Royal Hospital ; Oncology Department, Larbert, FK5 4QE, United Kingdom|Leicester Royal Infirmary, Leicester, LE1 5WW, United Kingdom|St John's Hospital, Livingston, EH54 6PP, United Kingdom|Guys and St Thomas NHS Foundation Trust, Guys Hospital, London, SE1 9RT, United Kingdom|Queen Elizabeth Hospital, London, SE18 4QH, United Kingdom|St George's Hospital, London, SW17 0QT, United Kingdom|Macclesfield District General Hospital, Macclesfield, SK10 3BL, United Kingdom|Christie Hospital; Breast Cancer Research Office, Manchester, M20 4QL, United Kingdom|The Clatterbridge Cancer Ctr For Oncolgy, Metropolitan Borough of Wirral, CH63 4JY, United Kingdom|Freeman Hospital; Northern Centre For Cancer Care, New Castle Upon Tyne, NE7 7DN, United Kingdom|Royal Gwent Hospital, Newport, NP20 2UB, United Kingdom|North Tyneside General Hospital, North Shields, NE29 8NH, United Kingdom|Northampton General Hospital NHS Trust, Northampton, NN1 5BD, United Kingdom|Derriford Hospital; Plymouth Oncology Centre, Plymouth, PL6 8DH, United Kingdom|Poole General Hospital, Poole, BH15 2JB, United Kingdom|Queen Alexandra Hospital, Portsmouth, Portsmouth, PO6 3LY, United Kingdom|Royal Preston Hospital, Preston, PR2 9HT, United Kingdom|Queens Hospital; R&D, Romford, RM7 0AE, United Kingdom|Scarborough General Hospital, Scarborough, YO12 6QL, United Kingdom|Royal Shrewsbury Hospital; Pharmacy Department, Shrewsbury, SY3 8XQ, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|Sunderland Royal Hospital, Sunderland, SR4 7TP, United Kingdom|Singleton Hospital; Pharmacy Department, Swansea, SA2 8QA, United Kingdom|Great ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Swindon Cancer Research Unit; Osprey Unit Level 3, Swindon, SN3 6BB, United Kingdom|Royal Cornwall Hospital, United Kingdom|Royal Hampshire County Hospital; Winchester & Andover Breast Unit, Winchester, SO22 5DG, United Kingdom|The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, WV10 0QP, United Kingdom|Airedale General Hospital; Oncology, York, BD20 6TD, United Kingdom|York District Hospital, York, YO31 8HE, United Kingdom|Grupo Oncológico Cooperativo Uruguayo; Hospital de Clínicas - Dpto. de Oncología, Montevideo,11400, Uruguay|Hospital Militar; Oncologia, Montevideo,11600, Uruguay|Hospital Pereira Rossell; Oncology Department, Montevideo,11600, Uruguay|Instituto Oncológico Luis Razetti, Caracas,1010, Venezuela|Centro Integral de Oncología, Caracas,1060, Venezuela|Centro Médico Docente La Trinidad; Unidad de Protocolos Clínicos, Caracas,1080, Venezuela|K hospital, Hanoi,100000," Vietnam""",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Talazoparib,ALL,"ADULT, OLDER_ADULT",PHASE1,38,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/30/16,2/12/20,"UCLA Hematology/Oncology - Alhambra, Alhambra, California, 91801, United States|CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield, California, 93309, United States|St. Joseph Heritage Healthcare, Fullerton, California, 92835, United States|St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare, Fullerton, California, 92835, United States|UCLA Hematology/Oncology, Los Angeles, California, 90095, United States|UCLA Hematology/Oncology - Porter Ranch, Porter Ranch, California, 91326, United States|UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, 90404, United States|UCLA Torrance Oncology, Torrance, California, 90505, United States|UCLA Hematology/Oncology - Santa Clarita, Valencia, California, 91355, United States|Orlando Health, Inc., Orlando, Florida, 32806, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors,DRUG: Talazoparib,ALL,"ADULT, OLDER_ADULT",PHASE1,34,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/21/17,1/30/19,"Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, 46804, United States|Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne, Indiana, 46845, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Karmanos Cancer Institute Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, 08901, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|Juravinski Cancer Centre, Hamilton, Ontario, L8V 5C2, Canada|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematologic Neoplasms,DRUG: Panobinostat,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/24/13,11/19/18,"City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1), Duarte, California, 91010 3000, United States|Georgia Regents University SC-2, Augusta, Georgia, 30912, United States|Dana Farber Cancer Institute Reg. Ped, Boston, Massachusetts, 02215, United States|University of Utah / Huntsman Cancer Institute SC-2, Salt Lake City, Utah, 84103, United States|Novartis Investigative Site, Jerusalem, 91120, Israel|Novartis Investigative Site, Leiden, 2300 RC, Netherlands|Novartis Investigative Site, Salamanca, Castille and León, 37007, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Neoplasms,DRUG: Tamoxifen|DRUG: Vorinostat|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,38,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/4/15,6/8/19,"University of California, San Francisco Medical Center, San Francisco, California, 94115, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Plasma Cell Neoplasm,BIOLOGICAL: Pneumococcal 13-valent Conjugate Vaccine|BIOLOGICAL: Trivalent Influenza Vaccine,ALL,"ADULT, OLDER_ADULT",PHASE4,165,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,10/18/19,12/15/22,"Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, 30322, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Tumors With CDK4/6 Pathway Activation,DRUG: LEE011,ALL,"ADULT, OLDER_ADULT",PHASE2,106,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/25/14,1/17/18,"University of Alabama at Birmingham, Birmingham, Alabama, 35249, United States|Alaska Clinical Research, Anchorage, Alaska, 99503, United States|Arizona Oncology Associates Dept. Of Onc., Phoenix, Arizona, United States|University of Arkansas/ Arkansas Cancer Research Center UA Medical Sciences, Little Rock, Arkansas, 72205, United States|PCR Oncology, Pismo Beach, California, 93449, United States|University of California Davis Cancer Center UC Davis Cancer (3), Sacramento, California, 95817, United States|Sarah Cannon Research Institute, Denver, Colorado, 80218, United States|Danbury Hospital, Danbury, Connecticut, 06810, United States|Yale University School of Medicine Smilow Cancer Hospital, New Haven, Connecticut, 06520, United States|Whittingham Cancer Center Norwalk Hospital, Norwalk, Connecticut, 06856, United States|Stamford Hospital Med. Oncology Hematology Res., Stamford, Connecticut, 06902, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|NorthWest Georgia Oncology Centers NW Georgia Oncology, Marietta, Georgia, 30060, United States|Harbin Clinic Medical Oncology Clin. Res., Rome, Georgia, 30165, United States|Queen's Medical Center Queens Cancer Center, Honolulu, Hawaii, 96817, United States|Northwestern Medicine Developmental Therapeutics Institute, Chicago, Illinois, 60611, United States|Indiana University Indiana Univ. - Purdue Univ., Indianapolis, Indiana, 46202, United States|Northern Indiana Cancer Research Consortium No. Indiana Cancer Res., South Bend, Indiana, 46617, United States|University of Iowa Hospitals & Clinics Regulatory Contact 2, Iowa City, Iowa, 52242, United States|New England Cancer Specialists, Scarborough, Maine, 04074, United States|St. Agnes Hospital St. Agnes Hospital (2), Baltimore, Maryland, 21229, United States|Michigan Medicine University of Michigan Int. Medicine Oncology, Ann Arbor, Michigan, 48109 5271, United States|Cancer and Hematology Centers of West Michigan Dept. of Oncology, Grand Rapids, Michigan, 49546, United States|Saint Luke's Hospital/Marion Bloch Neuroscience Institute St. Luke's Hospital (4), Kansas City, Missouri, 64111, United States|Research Medical Center Research Med Center (2), Kansas City, Missouri, 64132, United States|Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2), Las Vegas, Nevada, 89109, United States|Cooper Health System Cooper Health System (5), Camden, New Jersey, 08103, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|New Mexico Cancer Care Alliance, Albuquerque, New Mexico, 87106, United States|Cancer Center at Presbyterian, Albuquerque, New Mexico, United States|Broome Oncology Broome Oncology (2), Johnson City, New York, 13790, United States|University of N C at Chapel Hill Physician Office Building, Chapel Hill, North Carolina, 27599-7600, United States|Carolina Oncology Specialists, PC, Hickory, North Carolina, 28602, United States|Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, 27157, United States|Oncology Hematology Care Inc Oncology Hematology Care 2, Cincinnati, Ohio, 45242, United States|Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland, Ohio, 44195, United States|Ohio State University Medical Center Comprehensive Cancer Center, Columbus, Ohio, 43221, United States|Oregon Health and Science University Oregon Health & Science U (56), Portland, Oregon, 97239, United States|Salem Health, Salem, Oregon, 97309, United States|Fox Chase Cancer Center Dept of Medical Oncology, Philadelphia, Pennsylvania, 19111, United States|Rhode Island Hospital Rhode Island Hosp. (2), Providence, Rhode Island, 02903, United States|Greenville Health System ITOR - Cancer Institute, Greenville, South Carolina, 29615, United States|Sanford University of South Dakota Medical Center Sanford Health, Sioux Falls, South Dakota, 57104, United States|Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology, Chattanooga, Tennessee, 37404, United States|The West Clinic Dept. of the West Clinic, Memphis, Tennessee, 38120, United States|Tennessee Oncology Tennessee Oncology (3), Nashville, Tennessee, 37203, United States|Coastal Bend Cancer Center, Corpus Christi, Texas, 78404, United States|Oncology Consultants Oncology Group, Houston, Texas, 77024, United States|MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3), Houston, Texas, 77030, United States|University of Texas Health Science Center at San Antonio Cancer Therapy & Research Ctr., San Antonio, Texas, 78229, United States|Intermountain Medical Center Intermountain Healthcare, Murray, Utah, 84157, United States|Utah Cancer Specialists Utah Cancer Specialists (11), Salt Lake City, Utah, 84106, United States|Shenandoah Oncology Shenadoah Oncology (2), Winchester, Virginia, 22601, United States|Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc, Kennewick, Washington, 99336, United States|Vista Oncology Inc. PS, Olympia, Washington, 98502, United States|Multicare Research Institute, Tacoma, Washington, 98405, United States|Northwest Medical Specialties Rainier Physicians, PC, Tacoma, Washington, 98405, United States|Providence St. Mary Regional Cancer Center, Walla Walla, Washington, 98057, United States|Wenatchee Valley Medical Center Wenatchee Valley, Wenatchee, Washington, 98801, United States|Aurora Research Institute Aurora Health Care, Milwaukee, Wisconsin, 53226, United States|Medical College of Wisconsin Cancer Center, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastro-Enteropancreatic Neuroendocrine Tumor,DRUG: Satoreotide trizoxetan 5-20μg|DRUG: Satoreotide trizoxetan 30-45μg,ALL,"ADULT, OLDER_ADULT",PHASE2,29,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC,9/26/17,8/5/19,"UCLA Medical Center, Los Angeles, California, 90095, United States|Medical University of Innsbruck, Innsbruck, A-6020, Austria|University Clinic for Radiology and Nuclear Medicine, Vienna, A-1090, Austria|Aarhus University Hospital, Aarhus, DK-8000, Denmark|Rigshospitalet, University of Copenhagen, Copenhagen, DK-2100, Denmark",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Neoplasms, Brain",DRUG: Dabrafenib,ALL,CHILD,PHASE1|PHASE2,85,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/23/13,12/4/20,"Novartis Investigative Site, Phoenix, Arizona, 85016-7710, United States|Novartis Investigative Site, Orange, California, 92868, United States|Novartis Investigative Site, Baltimore, Maryland, 21287, United States|Novartis Investigative Site, Boston, Massachusetts, 02215, United States|Novartis Investigative Site, New York, New York, 10065, United States|Novartis Investigative Site, Cincinnati, Ohio, 45229, United States|Novartis Investigative Site, Memphis, Tennessee, 38105-3678, United States|Novartis Investigative Site, Seattle, Washington, 98105, United States|Novartis Investigative Site, Parkville, Victoria, 3052, Australia|Novartis Investigative Site, Toronto, Ontario, M5G 1X8, Canada|Novartis Investigative Site, Copenhagen, DK-2100, Denmark|Novartis Investigative Site, Marseille, 13385, France|Novartis Investigative Site, Paris, 75248, France|Novartis Investigative Site, Paris, 75571, France|Novartis Investigative Site, Toulouse, 31059, France|Novartis Investigative Site, Villejuif, 94805, France|Novartis Investigative Site, Heidelberg, Baden-Wurttemberg, 69120, Germany|Novartis Investigative Site, Regensburg, Bavaria, 93053, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Jerusalem, 91120, Israel|Novartis Investigative Site, Ramat Gan, 52621, Israel|Novartis Investigative Site, Milan, 20133, Italy|Novartis Investigative Site, Esplugues de Llobregat. Barcelona, 08950, Spain|Novartis Investigative Site, Madrid, 28009, Spain|Novartis Investigative Site, Sutton, Surrey, SM2 5PT, United Kingdom|Novartis Investigative Site, London, WC1N 3JH, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Solid Tumor, Adult",DRUG: ASTX029|DRUG: ASTX029,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,192,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/7/18,3/3/25,"City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States|University of Southern California Norris Comprehensive Cancer Center Site#114, Los Angeles, California, 90033, United States|Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Site# 107, Los Angeles, California, 90048, United States|Hoag Memorial Hospital Site#115, Newport Beach, California, 92658, United States|University of California Davis Medical Center Site #121, Sacramento, California, 95817, United States|California Pacific Medical Center - Sutter Pacific Medical Center Site#117, San Francisco, California, 94115-2378, United States|Smilow Cancer Hospital at Yale New Haven Site#105, New Haven, Connecticut, 06510, United States|Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|The Sidney Kimmel Comprehensive Cancer Center Site#106, Baltimore, Maryland, 21231, United States|Massachusetts General Hospital Site#103, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute Site#104, Boston, Massachusetts, 02215, United States|University of Michigan Rogel Cancer Center Site #113, Ann Arbor, Michigan, 48109, United States|Columbia University Irving Medical Center - Herbert Irving Pavilion Site#112, New York, New York, 10032, United States|Providence Portland Medical Center Site #118, Portland, Oregon, 97223, United States|Oregon Health and Science University Site #122, Portland, Oregon, 97239, United States|University of Pennsylvania-Abramson Cancer Center, Philadelphia, Pennsylvania, 19104, United States|The University of Texas MD Anderson Cancer Center Site#111, Houston, Texas, 77030, United States|START - South Texas Accelerated Research Therapeutics, LLC Site# 101, San Antonio, Texas, 78229, United States|Virginia Cancer Specialists Site#102, Fairfax, Virginia, 22031, United States|Centre Léon Bérard Service d'Oncologie Médicale Site#202, Lyon, Auvergne-Rhône-Alpes, 69373, France|Hôpital de la Timone Site #201, Marseille, 13005, France|Institut Català d'Oncologia Badalona Site#240, Barcelona, 08028, Spain|Hospital Universitari Vall d'Hebrón Servicio de Oncología, Sala coordinación UITM Site#243, Barcelona, 08035, Spain|Hospital Universitari Germans Trias i Pujol, Barcelona, 08916, Spain|Hospital Universitario Dexeus Site#241, Barcelona, 8028, Spain|Clinica Universidad de Navarra Madrid Site #242, Madrid, 28027, Spain|Clínica Universidad de Navarra Site#242, Madrid, 28027, Spain|The Christie NHS Foundation Trust Site#220, Manchester, England, M20 4BX, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust Site #221, Newcastle upon Tyne, NE7 7DN, United Kingdom|Churchill Hospital Site #224, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Endometrial Neoplasms,DRUG: Lenvatinib|BIOLOGICAL: Pembrolizumab|DRUG: Paclitaxel|DRUG: Carboplatin,FEMALE,"ADULT, OLDER_ADULT",PHASE3,842,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/11/19,2/5/25,"University of South Alabama, Mitchell Cancer Institute ( Site 0245), Mobile, Alabama, 36604, United States|Arizona Oncology Associates PC- HOPE ( Site 8005), Tucson, Arizona, 85711, United States|UCLA Hematology and Oncology Clinic (Westwood) ( Site 0233), Los Angeles, California, 90095, United States|University of Colorado Cancer Center ( Site 0204), Aurora, Colorado, 80045, United States|Smilow Cancer Hospital at Yale New Haven ( Site 0202), New Haven, Connecticut, 06511, United States|University of Miami Health System ( Site 0249), Miami, Florida, 33136, United States|Georgia Cancer Center at Augusta University ( Site 0222), Augusta, Georgia, 30912, United States|Women's Cancer Care ( Site 0208), Covington, Louisiana, 70433, United States|Maine Medical Partners ( Site 0217), Scarborough, Maine, 04074, United States|Minnesota Oncology Hematology, PA ( Site 8003), Minneapolis, Minnesota, 55404, United States|Memorial Sloan-Kettering Cancer Center At Basking Ridge ( Site 0268), Basking Ridge, New Jersey, 07920, United States|John Theurer Cancer Center at Hackensack University Med Ctr ( Site 0226), Hackensack, New Jersey, 07601, United States|Memorial Sloan Kettering Cancer Center- Monmouth ( Site 0273), Middletown, New Jersey, 07748, United States|MSKCC-Bergen ( Site 0276), Montvale, New Jersey, 07645, United States|Holy Name Medical Center ( Site 0235), Teaneck, New Jersey, 07666, United States|Memorial Sloan-Kettering Cancer Center at Commack ( Site 0267), Commack, New York, 11725, United States|Memorial Sloan Kettering Cancer Center - West Harrison ( Site 0274), Harrison, New York, 10604, United States|The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0206), New York, New York, 10011, United States|Memorial Sloan Kettering Cancer Center ( Site 0246), New York, New York, 10022, United States|University of Rochester ( Site 0238), Rochester, New York, 14642, United States|Memorial Sloan Kettering Cancer Center - Nassau ( Site 0275), Uniondale, New York, 11553, United States|University of North Carolina- Chapel Hill ( Site 0254), Chapel Hill, North Carolina, 27599, United States|Roger Maris Cancer Center ( Site 0277), Fargo, North Dakota, 58102, United States|Willamette Valley Cancer Institute and Research Center ( Site 8004), Eugene, Oregon, 97401, United States|Sanford Cancer Center Oncology Clinic ( Site 0205), Sioux Falls, South Dakota, 57104, United States|Parkland Health & Hospital System ( Site 0272), Dallas, Texas, 75235, United States|University of Texas Southwestern Medical Center ( Site 0264), Dallas, Texas, 75390-9015, United States|Texas Oncology-The Woodlands ( Site 8000), The Woodlands, Texas, 77380, United States|Legacy Salmon Creek Medical Center ( Site 0253), Vancouver, Washington, 98686, United States|IDIM Instituto de Diagnostico e Investigaciones Metabolicas ( Site 2607), Caba, Buenos Aires, C1012AAR, Argentina|Hospital Italiano de La Plata ( Site 2601), La Plata, Buenos Aires, B1900AXI, Argentina|Instituto de Investigaciones Clinicas Mar del Plata ( Site 2606), Mar del Plata, Buenos Aires, B7600FZO, Argentina|Hospital Aleman ( Site 2600), Buenos Aires, C1118AAT, Argentina|Hospital Italiano de Buenos Aires ( Site 2603), Buenos Aires, C1199ABB, Argentina|Centro Oncologico Riojano Integral ( Site 2605), La Rioja, 5300, Argentina|Chris OBrien Lifehouse ( Site 1605), Camperdown, New South Wales, 2050, Australia|Prince of Wales Hospital [Australia] ( Site 1603), Randwick, New South Wales, 2031, Australia|Royal North Shore Hospital ( Site 1600), St Leonards, New South Wales, 2065, Australia|The Crown Princess Mary Cancer Centre - Westmead Hospital ( Site 1602), Westmead, New South Wales, 2145, Australia|Mater Misericordiae Ltd ( Site 1608), South Brisbane, Queensland, 4101, Australia|Monash Health ( Site 1606), Clayton, Victoria, 3168, Australia|Epworth Freemasons Hospital ( Site 1609), Melbourne, Victoria, 3002, Australia|Sir Charles Gairdner Hospital ( Site 1604), Nedlands, Western Australia, 6009, Australia|Universitatsklinik fuer Frauenheilkunde und Geburtshilfe ( Site 3301), Graz, Styria, 8036, Austria|Medizinische Universitat Innsbruck ( Site 3302), Innsbruck, Tyrol, 6020, Austria|Medizinische Universitat Wien ( Site 3300), Vienna, Vienna, 1090, Austria|UZA University Hospital Antwerp ( Site 3204), Edegem, Antwerpen, 2650, Belgium|UZ Leuven ( Site 3200), Leuven, Antwerpen, 3000, Belgium|Cliniques Universitaires Saint-Luc ( Site 3203), Brussels, Bruxelles-Capitale, Region de, 1200, Belgium|AZ Maria Middelares Gent ( Site 3202), Ghent, Oost-Vlaanderen, 9000, Belgium|AZ Delta ( Site 3206), Roeselare, West-Vlaanderen, 8800, Belgium|Instituto do Cancer do Ceara ( Site 2703), Fortaleza, Ceará, 60430-230, Brazil|Hospital Araujo Jorge Associacao de Combate ao Cancer de Goias ( Site 2702), Goiânia, Goiás, 74605-070, Brazil|Faculdade de Medicina da Universidade Federal de Minas Gerais ( Site 2708), Belo Horizonte, Minas Gerais, 30130-100, Brazil|Hospital de Caridade de Ijui ( Site 2712), Ijuí, Rio Grande do Sul, 98700-000, Brazil|Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 2701), Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Hospital de Base de Sao Jose de Rio Preto ( Site 2704), São José do Rio Preto, São Paulo, 15090-000, Brazil|Instituto Nacional do Cancer II ( Site 2707), Rio de Janeiro, 20220-410, Brazil|Clinica de Pesquisas e Ctro de Estudos Onc. Ginecol. e Mamaria Ltda ( Site 2706), São Paulo, 01317-001, Brazil|Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 2713), São Paulo, 01321-001, Brazil|A.C. Camargo Cancer Center ( Site 2705), São Paulo, 01509-900, Brazil|Cross Cancer Institute ( Site 0408), Edmonton, Alberta, T6G 1Z2, Canada|BC Cancer-Kelowna - Sindi Ahluwalia Hawkins Centre ( Site 0402), Kelowna, British Columbia, V1Y 5L3, Canada|BC Cancer-Vancouver Center ( Site 0412), Vancouver, British Columbia, V5Z 4E6, Canada|Juravinski Cancer Centre ( Site 0406), Hamilton, Ontario, L8V 1C3, Canada|Kingston Health Sciences Centre ( Site 0401), Kingston, Ontario, K7L 2V7, Canada|The Credit Valley Hospital ( Site 0403), Mississauga, Ontario, L5M 2N1, Canada|Sunnybrook Research Institute ( Site 0410), Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Cancer Centre ( Site 0409), Toronto, Ontario, M5G 2M9, Canada|CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 0414), Montreal, Quebec, H1T 2M4, Canada|Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0411), Montreal, Quebec, H2X 3E4, Canada|McGill University Health Centre ( Site 0404), Montreal, Quebec, H4A 3J1, Canada|CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 0417), Sherbrooke, Quebec, J1H 5N4, Canada|Anhui Provincial Cancer Hospital ( Site 2509), Hefei, Anhui, 230001, China|Beijing Obstetrics and Gynecology Hospital Capital Medical University ( Site 2505), Beijing, Beijing Municipality, 100032, China|Peking Union Medical College Hospital ( Site 2501), Beijing, Beijing Municipality, 100032, China|Beijing Cancer Hospital ( Site 2504), Beijing, Beijing Municipality, 100142, China|Chongqing Cancer Hospital ( Site 2513), Chongqing, Chongqing Municipality, 400030, China|The First Affiliated Hospital.Sun Yat-sen University ( Site 2507), Guangzhou, Guangdong, 510080, China|Guang Xi Tumour Hospital, Department of Chemotherapy ( Site 2517), Nanning, Guangxi, 530021, China|Hubei Cancer Hospital ( Site 2510), Wuhan, Hubei, 430079, China|Xiangya Hospital Central-South University ( Site 2512), Changsha, Hunan, 410008, China|Nanjing Maternity and Child Health Care Hospital ( Site 2508), Nanjing, Jiangsu, 210011, China|The first affiliated Hospital of Xi an Jiaotong University ( Site 2502), Xi'an, Shaanxi, 710061, China|Fudan University Shanghai Cancer Center ( Site 2500), Shanghai, Shanghai Municipality, 200032, China|Obstetrics and Gynecology Hosp. Fudan University ( Site 2503), Shanghai, Shanghai Municipality, 200090, China|The First Affiliated Hospital of Xinjiang Medical University ( Site 2515), Ürümqi, Xinjiang, 830054, China|Women s Hospital School of Medicine Zhejiang University ( Site 2511), Hangzhou, Zhejiang, 310006, China|Zhejiang Cancer Hospital ( Site 2506), Hangzhou, Zhejiang, 310022, China|Universitaetsmedizin Mannheim. Klinik fuer Kinder und Jugendmedizin ( Site 0622), Mannheim, Baden-Wurttemberg, 68167, Germany|Universitaetsklinikum Muenster ( Site 0615), Münster, Baden-Wurttemberg, 48149, Germany|Caritas-Krankenhaus St. Josef Regensburg ( Site 0613), Regensburg, Bavaria, 93053, Germany|HELIOS Dr. Horst Schmidt Kliniken Wiesbaden ( Site 0623), Wiesbaden, Hesse, 65199, Germany|Universitaetsklinikum Essen ( Site 0616), Essen, North Rhine-Westphalia, 45147, Germany|Universitaetsklinikum Jena ( Site 0612), Jena, Thuringia, 07747, Germany|Charite Universitaetsmedizin Berlin ( Site 0609), Berlin, 13353, Germany|Cork University Hospital ( Site 1400), Cork, T12 YE02, Ireland|St James Hospital ( Site 1401), Dublin, Dublin 8, Ireland|Meir Medical Center ( Site 0702), Kfar Saba, Central District, 4428132, Israel|Edith Wolfson Medical Center ( Site 0703), Holon, Tell Abib, 5822012, Israel|Rambam Medical Center ( Site 0700), Haifa, 3525408, Israel|Chaim Sheba Medical Center ( Site 0707), Ramat Gan, 5262000, Israel|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 0800), Meldola, Emilia-Romagna, 47014, Italy|Policlinico Universitario Agostino Gemelli ( Site 0805), Rome, Roma, 00168, Italy|Ospedale dell Angelo ( Site 0810), Mestre, Venezia, 30174, Italy|Medical Oncology Ospedale San Donato ( Site 0812), Arezzo, 52100, Italy|IRCCS Giovanni Paolo II. Ospedale Oncologico ( Site 0801), Bari, 70124, Italy|Ospedale Policlinico S. Orsola-Malpighi ( Site 0803), Bologna, 40138, Italy|Ospedale Antonio Perrino ( Site 0806), Brindisi, 72100, Italy|Azienda Ospedaliera per l Emergenza Cannizzaro ( Site 0807), Catania, 95126, Italy|Istituto Nazionale Tumori Fondazione Pascale ( Site 0808), Napoli, 80131, Italy|Ehime University Hospital ( Site 2413), Tōon, Ehime, 791-0295, Japan|Kurume University Hospital ( Site 2403), Kurume, Fukuoka, 830-0011, Japan|Gunma Prefectural Cancer Center ( Site 2404), Ōta, Gunma, 373-8550, Japan|National Hospital Organization Hokkaido Cancer Center ( Site 2408), Sapporo, Hokkaido, 003-0804, Japan|Hyogo Cancer Center ( Site 2414), Akashi, Hyōgo, 673-8558, Japan|Nippon Medical School Musashi Kosugi Hospital ( Site 2417), Kawasaki, Kanagawa, 211-8533, Japan|St. Marianna University School of Medicine Hospital ( Site 2416), Kawasaki, Kanagawa, 216-8511, Japan|University of the Ryukyus Hospital ( Site 2412), Nakagami-gun, Okinawa, 903-0215, Japan|Saitama Medical University International Medical Center ( Site 2410), Hidaka, Saitama, 350-1298, Japan|Saitama Cancer Center ( Site 2406), Kitaadachi-gun, Saitama, 362-0806, Japan|National Defense Medical College Hospital ( Site 2418), Tokorozawa, Saitama, 359-8513, Japan|Kyorin University Hospital ( Site 2402), Mitaka, Tokyo, 181-8611, Japan|National Hospital Organization Kyushu Cancer Center ( Site 2405), Fukuoka, 811-1395, Japan|Niigata Cancer Center Hospital ( Site 2415), Niigata, 951-8566, Japan|Osaka International Cancer Institute ( Site 2409), Osaka, 541-8567, Japan|The Cancer Institute Hospital of JFCR ( Site 2401), Tokyo, 135-8550, Japan|Showa University Hospital ( Site 2419), Tokyo, 142-8666, Japan|Keio University Hospital ( Site 2411), Tokyo, 160-8582, Japan|Hospital San Lucas Cardiologica del Sureste ( Site 3103), Tuxtla Gutiérrez, Chiapas, 29090, Mexico|I CAN Oncology SA de SV ( Site 3102), Monterrey, Nuevo León, 64710, Mexico|Centro Estatal de Cancerologia de Chihuahua ( Site 3101), Chihuahua City, 31000, Mexico|Centro de Investigacion Clinica Gramel ( Site 3107), Mexico City, 03720, Mexico|Centro Oncologico Internacional. SEDNA ( Site 3106), Mexico City, 04700, Mexico|Consultorio Dentro de la Torre Medica Dalinde Oncologia Medica ( Site 3108), Mexico City, 06760, Mexico|Wielkopolskie Centrum Onkologii im.M.Sklodowskiej-Curie ( Site 1004), Poznan, Greater Poland Voivodeship, 61-866, Poland|Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 1019), Krakow, Lesser Poland Voivodeship, 31-826, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie ( Site 1008), Lublin, Lower Silesian Voivodeship, 20-081, Poland|Szpital Kliniczny im Ks Anny Mazowieckiej ( Site 1011), Warsaw, Masovian Voivodeship, 00-315, Poland|Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 1009), Warsaw, Masovian Voivodeship, 02-781, Poland|Bialostockie Centrum Onkologii ( Site 1005), Bialystok, Podlaskie Voivodeship, 15-027, Poland|Centrum Onkologii Instytut im. MSC Oddział w Gliwicach ( Site 1017), Gliwice, Silesian Voivodeship, 44-102, Poland|Instytut Centrum Zdrowia Matki Polki ( Site 1020), Lodz, Łódź Voivodeship, 93-338, Poland|Krasnoyarsk Regional Clinical oncology dispensary ( Site 1118), Krasnoyarsk, Krasnoyarsk Krai, 660133, Russia|Russian Oncological Research Center n.a. N.N.Blokhin of MoH ( Site 1100), Moscow, Moscow, 115478, Russia|FSBI-FRCC of Special Types Med. Care and Technologies FMBA of Russia ( Site 1102), Moscow, Moscow, 115682, Russia|Medical Rehabilitation Center ( Site 1101), Moscow, Moscow, 125367, Russia|Samara Regional Clinical Oncology Center ( Site 1117), Samara, Samara Oblast, 443031, Russia|St.Petersburg Clinical Hospital RAS ( Site 1124), Saint Petersburg, Sankt-Peterburg, 194017, Russia|Railway Hospital of OJSC ( Site 1122), Saint Petersburg, Sankt-Peterburg, 195271, Russia|National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1103), Saint Petersburg, Sankt-Peterburg, 197758, Russia|SPb SBHI City Clinical Oncological Dispensary ( Site 1104), Saint Petersburg, Sankt-Peterburg, 198255, Russia|Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1108), Kazan', Tatarstan, Respublika, 420029, Russia|Siberian State Medical University ( Site 1121), Tomsk, Tomsk Oblast, 634028, Russia|Seoul National University Bundang Hospital ( Site 1802), Seongnam-si, Kyonggi-do, 13620, South Korea|Seoul National University Hospital ( Site 1801), Seoul, 03080, South Korea|Severance Hospital Yonsei University Health System ( Site 1804), Seoul, 03722, South Korea|Asan Medical Center ( Site 1800), Seoul, 05505, South Korea|Samsung Medical Center ( Site 1803), Seoul, 06351, South Korea|Institut Catala d Oncologia Badalona ( Site 1201), Badalona, Barcelona, 08916, Spain|Complejo Hospitalario Universitario A Coruna. CHUAC ( Site 1202), A Coruña, La Coruna, 15006, Spain|Instituto Valenciano de Oncologia - IVO ( Site 1205), Valencia, Valenciana, Comunitat, 46009, Spain|Hospital General Universitario de Valencia ( Site 1203), Valencia, Valenciana, Comunitat, 46014, Spain|Parc de Salut Mar ( Site 1200), Barcelona, 08003, Spain|Hospital Universitario Reina Sofia ( Site 1207), Córdoba, 14004, Spain|Hospital Clinico San Carlos ( Site 1209), Madrid, 28040, Spain|Hospital Materno Infantil [Malaga, Spain] ( Site 1208), Málaga, 29011, Spain|China Medical University Hospital ( Site 1903), Taichung, 404, Taiwan|Taichung Veterans General Hospital ( Site 1902), Taichung, 40705, Taiwan|National Taiwan University Hospital ( Site 1904), Taipei, 10002, Taiwan|Taipei Veterans General Hospital ( Site 1900), Taipei, 11217, Taiwan|Linkou Chang Gung Memorial Hospital ( Site 1901), Taoyuan District, 333, Taiwan|Baskent Universitesi Adana Uygulama ve Arastirma Hastanesi ( Site 1303), Adana, 01120, Turkey (Türkiye)|Cukurova Uni. Tip Fakultesi ( Site 1302), Adana, 01330, Turkey (Türkiye)|Gazi Universitesi Tip Fakultesi ( Site 1308), Ankara, 05600, Turkey (Türkiye)|Baskent Universitesi Ankara Hastanesi ( Site 1300), Ankara, 06490, Turkey (Türkiye)|Akdeniz Universitesi Tıp Fakultesi ( Site 1301), Antalya, 07070, Turkey (Türkiye)|Uludag Universitesi Tip Fakultesi ( Site 1307), Bursa, 16059, Turkey (Türkiye)|Clinical oncology dispensary of Dnipro ( Site 1512), Dnipro, Dnipropetrovsk Oblast, 49055, Ukraine|City Clinical Hosp.4 of DCC ( Site 1501), Dnipro, Dnipropetrovsk Oblast, 49102, Ukraine|MI Precarpathian Clinical Oncology Center ( Site 1503), Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine|Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 1511), Kharkiv, Kharkivs’ka Oblast’, 61024, Ukraine|Communal non profit enterprise Regional Clinical Oncology Center ( Site 1509), Kharkiv, Kharkivs’ka Oblast’, 61070, Ukraine|Khmelnitskiy Regional Onkology Dispensary ( Site 1513), Khmelnitskiy, Khmelnytskyi Oblast, 29009, Ukraine|Medical Center Asklepion LLC ( Site 1514), Khodosovka, Kyivska Oblast, 08173, Ukraine|National Cancer Institute of the MoH of Ukraine ( Site 1510), Kyiv, Kyivska Oblast, 03022, Ukraine|Medical and Diagnostic Centre LLC Dobryi Prognoz ( Site 1507), Kyiv, Kyivska Oblast, 03126, Ukraine|MI Odessa Regional Oncological Centre ( Site 1504), Odesa, Odesa Oblast, 65055, Ukraine|Kyiv City Clinical Oncology Centre ( Site 1505), Kyiv, 03115, Ukraine|Western General Hospital ( Site 1411), Edinburgh, Edinburgh, City of, EH4 2XU, United Kingdom|UCLH NHS Foundation Trust ( Site 1405), London, London, City of, NW1 2PG, United Kingdom|Mount Vernon Cancer Centre ( Site 1409), Northwood, London, City of, HA6 2RN, United Kingdom|Churchill Hospital ( Site 1406), Oxford, Oxfordshire, OX3 7LE, United Kingdom|The James Cook University Hospital ( Site 1403), Middlesbrough, TS4 3BW, United Kingdom|Northern Centre for Cancer Care ( Site 1408), Newcastle upon Tyne, NE7 7DN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasms|Neoplasms|Solid Tumor|Hepatic Impairment,DRUG: Niraparib,ALL,"ADULT, OLDER_ADULT",PHASE1,17,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,2/20/18,6/24/20,"GSK Investigational Site, Los Angeles, California, 90033, United States|GSK Investigational Site, Newport Beach, California, 92663, United States|GSK Investigational Site, Aurora, Colorado, 80045, United States|GSK Investigational Site, Atlanta, Georgia, 30322, United States|GSK Investigational Site, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pancreatic Neuroendocrine Tumors,DRUG: everolimus,ALL,"ADULT, OLDER_ADULT",PHASE4,61,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/14/16,2/22/24,"Novartis Investigative Site, Shanghai, Shanghai Municipality, 200032, China|Novartis Investigative Site, Beijing, 100039, China|Novartis Investigative Site, Beijing, 100730, China|Novartis Investigative Site, Guangzhou, 510060, China|Novartis Investigative Site, Shanghai, 200032, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Desmoid Tumors|Aggressive Fibromatosis,DRUG: PF-03084014,ALL,"ADULT, OLDER_ADULT",PHASE2,17,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/31/13,12/1/23,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Leiomyosarcoma|Uterine Neoplasm,DRUG: Letrozole,FEMALE,"ADULT, OLDER_ADULT",PHASE2,9,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/19/06,7/13/17,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignant Solid Neoplasm|Refractory Malignant Solid Neoplasm,DRUG: Adavosertib,ALL,"ADULT, OLDER_ADULT",PHASE2,31,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/16/19,10/31/22,"City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|MedStar Georgetown University Hospital, Washington D.C., District of Columbia, 20007, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, 32610, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, 40536, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, 15232, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms|Breast Cancer,DRUG: PF-06650808|DRUG: PF-06650808,ALL,"ADULT, OLDER_ADULT",PHASE1,40,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,2014-06,2017-07,"Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles, California, 90095, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, 90095, United States|UCLA Hematology/Oncology, Los Angeles, California, 90095, United States|Westwood Bowyer Clinic, Los Angeles, California, 90095, United States|Santa Monica - UCLA Medical Center & Orthopaedic Hospital, Santa Monica, California, 90404, United States|UCLA Hematology/Oncology - Santa Monica, Santa Monica, California, 90404, United States|The Ohio State University James Cancer Hospital, Columbus, Ohio, 43210, United States|The OSU Investigational Drug Services, Columbus, Ohio, 43210, United States|The OSU Stephanie Spielman Comprehensive Breast Center, Columbus, Ohio, 43212, United States|The Ohio State University Martha Morehouse Medical Plaza, Columbus, Ohio, 43221, United States|South Texas Accelerated Research Therapeutics, LLC (START), San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Stomach Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Cisplatin|DRUG: 5-fluorouracil|DRUG: oxaliplatin|DRUG: capecitabine|DRUG: Placebo for Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE3,1579,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",11/8/18,3/3/25,"UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) ( Site 0124), Los Angeles, California, 90095, United States|UC Irvine Health/Division of Hematology Oncology, Dept of Medicine ( Site 0128), Orange, California, 92868, United States|University of Miami, Sylvester Comprehensive Cancer Center ( Site 0113), Miami, Florida, 33136, United States|Greater Baltimore Medical Center ( Site 0102), Baltimore, Maryland, 21204, United States|Minnesota Oncology Hematology, PA ( Site 8000), Minneapolis, Minnesota, 55404, United States|University of Rochester ( Site 0122), Rochester, New York, 14642, United States|Cancer Treatment Centers of America - Philadelphia ( Site 0112), Philadelphia, Pennsylvania, 19124, United States|Allegheny General Hospital ( Site 0118), Pittsburgh, Pennsylvania, 15212, United States|Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 8001), Roanoke, Virginia, 24014, United States|Wenatchee Valley Clinic [Wenatchee, WA] ( Site 0116), Wenatchee, Washington, 98801, United States|Instituto Medico Alexander Fleming ( Site 0307), Buenos Aires, Buenos Aires F.D., C1426ANZ, Argentina|Instituto de Investigaciones Metabolicas ( Site 0312), Buenos Aires, C1012AAR, Argentina|Fundacion Favaloro - Hospital Universitario ( Site 0302), Buenos Aires, C1093AAS, Argentina|Centro Oncologico Riojano Integral ( Site 0313), La Rioja, F5300COE, Argentina|Instituto San Marcos ( Site 0311), San Juan, J5400EBB, Argentina|Liverpool Hospital ( Site 2301), Liverpool, New South Wales, 2170, Australia|Southern Medical Day Care Centre ( Site 2303), Wollongong, New South Wales, 2500, Australia|Box Hill Hospital ( Site 2300), Box Hill, Victoria, 3128, Australia|Instituto do Cancer do Ceara ( Site 0407), Fortaleza, Ceará, 60430-230, Brazil|CIONC - Centro Integrado de Oncologia de Curitiba ( Site 0405), Curitiba, Paraná, 80810-050, Brazil|Hospital de Caridade de Ijui ( Site 0402), Ijuí, Rio Grande do Sul, 98700 000, Brazil|Hospital Nossa Senhora da Conceicao ( Site 0403), Porto Alegre, Rio Grande do Sul, 91350-200, Brazil|CEPON - Centro de Pesquisas Oncologicas ( Site 0400), Florianópolis, Santa Catarina, 88034-000, Brazil|Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0401), Rio de Janeiro, 20231-050, Brazil|IBCC - Instituto Brasileiro de Controle do Cancer ( Site 0404), São Paulo, 03102-002, Brazil|BC Cancer - Abbotsford ( Site 0206), Abbotsford, British Columbia, V2S 0C2, Canada|Sunnybrook Research Institute ( Site 0202), Toronto, Ontario, M4N 3M5, Canada|Princess Margaret Cancer Centre ( Site 0203), Toronto, Ontario, M5G 2M9, Canada|McGill University Health Centre ( Site 0208), Montreal, Quebec, H4A 3J1, Canada|Fundacion Arturo Lopez Perez FALP ( Site 0501), Santiago, Region M. de Santiago, 7500921, Chile|Sociedad Oncovida S.A. ( Site 0508), Santiago, Region M. de Santiago, 7510032, Chile|Pontificia Universidad Catolica de Chile ( Site 0502), Santiago, Region M. de Santiago, 7620002, Chile|Instituto Clinico Oncologico del Sur ( Site 0500), Temuco, Región de la Araucanía, 4810469, Chile|Cancer Hospital Chinese Academy of Medical Sciences ( Site 2421), Beijing, Beijing Municipality, 100021, China|Peking Union Medical College Hospital ( Site 2425), Beijing, Beijing Municipality, 100730, China|Fujian Medical University Union Hospital ( Site 2410), Fuzhou, Fujian, 350001, China|Fujian Provincial Cancer Hospital ( Site 2414), Fuzhou, Fujian, 350014, China|900 Hospital of the Joint ( Site 2418), Fuzhou, Fujian, 350025, China|The First Affiliated Hospital of Xiamen University ( Site 2430), Xiamen, Fujian, 361003, China|Zhongshan Hospital Xiamen University ( Site 2447), Xiamen, Fujian, 361004, China|Guangdong General Hospital ( Site 2431), Guangzhou, Guangdong, 510080, China|Peking University Shenzhen Hospital ( Site 2442), Shenzhen, Guangdong, 518036, China|Fourth Hospital Of Hebei Medical University ( Site 2436), Shijiazhuang, Hebei, 050011, China|Harbin Medical University Cancer Hospital ( Site 2401), Harbin, Heilongjiang, 150081, China|Henan Cancer Hospital ( Site 2415), Zhengzhou, Henan, 450008, China|Hubei Cancer Hospital ( Site 2434), Wuhan, Hubei, 430079, China|Xiangya Hospital Central-South University ( Site 2419), Changsha, Hunan, 410008, China|Hunan Cancer Hospital ( Site 2439), Changsha, Hunan, 410013, China|Changzhou Cancer Hospital-Changzhou Fourth Peoples Hospital ( Site 2441), Changzhou, Jiangsu, 213032, China|The 81st Hospital of PLA ( Site 2413), Nanjing, Jiangsu, 210002, China|Jiangsu Cancer Hospital ( Site 2432), Nanjing, Jiangsu, 210009, China|Yancheng First People s Hospital ( Site 2426), Yancheng, Jiangsu, 224000, China|The First Affiliated Hospital of Nanchang University ( Site 2440), Nanchang, Jiangxi, 330006, China|The First Hospital of Jilin University ( Site 2416), Changchun, Jilin, 130021, China|The Affiliated Hospital of Qingdao University ( Site 2405), Qingdao, Shandong, 266061, China|Shanghai East Hospital ( Site 2403), Shanghai, Shanghai Municipality, 200120, China|Zhongshan Hospital affiliated to Fudan University ( Site 2407), Shanghai, Shanghai Municipality, 210000, China|1st Affil hosp of Med College of Xi'an Jiaotong University ( Site 2428), XiAn, Shanxi, 710061, China|Cancer Hospital Affiliated to Xinjiang Medical University ( Site 2420), Ürümqi, Xinjiang, 830001, China|Zhejiang Provincial People's Hospital ( Site 2446), Hangzhou, Zhejiang, 310014, China|Sir Run Run Show Hospital ( Site 2427), Hangzhou, Zhejiang, 310016, China|Zhejiang Cancer Hospital ( Site 2417), Hangzhou, Zhejiang, 310022, China|Instituto Nacional de Cancerologia E.S.E ( Site 0605), Bogotá, Bogota D.C., 110321, Colombia|Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0608), Valledupar, Cesar Department, 200001, Colombia|Oncomedica S.A. ( Site 0606), Montería, Departamento de Córdoba, 230002, Colombia|Centro Medico Imbanaco de Cali S.A ( Site 0604), Cali, Valle del Cauca Department, 760042, Colombia|CIMCA Centro de Investigacion y Manejo del Cancer ( Site 3001), San José, 10103, Costa Rica|Policlinico San Bosco ( Site 3002), San José, 10103, Costa Rica|ICIMED - Instituto de Investigacion en Ciencias Medicas ( Site 3000), San José, 10108, Costa Rica|FN Ostrava ( Site 3105), Ostrava, Moravskoslezský kraj, 708 52, Czechia|Fakultni nemocnice Plzen ( Site 3102), Pilsen, Plzeň Region, 304 60, Czechia|Masarykuv onkologicky ustav ( Site 3103), Brno, South Moravian, 65653, Czechia|Nemocnice AGEL Novy Jicin a.s. ( Site 3104), Nový Jičín, 74101, Czechia|Fakultni nemocnice Olomouc ( Site 3100), Olomouc, 779 00, Czechia|Fakultni Thomayerova nemocnice ( Site 3101), Prague, 140 59, Czechia|Rigshospitalet ( Site 3202), Copenhagen, Capital Region, 2100, Denmark|Aalborg University Hospital ( Site 3204), Aalborg, North Denmark, 9000, Denmark|Odense Universitets Hospital ( Site 3201), Odense, Region Syddanmark, 5000, Denmark|CHU de Rouen ( Site 1006), Rouen, Ain, 76000, France|CHU-Jean Minjoz ( Site 1002), Besançon, Doubs, 25030, France|C.H.R.U. de Brest - Hopital Morvan ( Site 1007), Brest, Finistere, 29200, France|Centre Oscar Lambret ( Site 1003), Lille, Nord, 59000, France|Institut de Cancerologie de l Ouest Centre Rene Gauducheau ( Site 1004), Saint-Herblain, Val-de-Marne, 44805, France|Institut Gustave Roussy ( Site 1000), Villejuif, Val-de-Marne, 94805, France|CHU Hopital Saint Antoine ( Site 1001), Paris, 75012, France|SLK-Kliniken Heilbronn ( Site 1104), Heilbronn, Baden-Wurttemberg, 74078, Germany|Universitaetsklinikum Leipzig ( Site 1114), Leipzig, Saxony, 04103, Germany|Charite Universitaetsmedizin Berlin ( Site 1101), Berlin, 13353, Germany|Facharztzentrum Eppendorf ( Site 1121), Hamburg, 20249, Germany|Asklepios Klinik Altona ( Site 1100), Hamburg, 22763, Germany|Celan SA ( Site 0705), Guatemala City, 01010, Guatemala|Oncomedica ( Site 0702), Guatemala City, 01010, Guatemala|Grupo Angeles SA ( Site 0701), Guatemala City, 01015, Guatemala|MEDI-K CAYALA ( Site 0704), Guatemala City, 01016, Guatemala|Centro Regional de Sub Especialidades Medicas SA ( Site 0703), Quetzaltenango, 09001, Guatemala|Prince of Wales Hospital ( Site 2503), Hong Kong, Hong Kong|Princess Margaret Hospital. ( Site 2502), Hong Kong, Hong Kong|Queen Mary Hospital ( Site 2501), Hong Kong, Hong Kong|Bacs-Kiskun Megyei Korhaz ( Site 3306), Kecskemét, Bács-Kiskun county, 6000, Hungary|Jasz-Nagykun-Szolnok Megyei Hetenyi Gyula Korhaz-Rendelointezet ( Site 3302), Szolnok, Jász-Nagykun-Szolnok, 5004, Hungary|Semmelweis Egyetem.. ( Site 3305), Budapest, 1083, Hungary|Orszagos Onkologiai Intezet ( Site 3303), Budapest, 1122, Hungary|University of Debrecen Medical Center Clinic of Oncology ( Site 3300), Debrecen, 4032, Hungary|St. James s Hospital ( Site 1200), Dublin, D08 W9RT, Ireland|Beaumont Hospital ( Site 2101), Dublin, D09V2N0, Ireland|Tallaght University Hospital ( Site 1202), Dublin, D24 NR0A, Ireland|Hadassah Ein Karem Jerusalem ( Site 1301), Jerusalem, Jerusalem, 9112001, Israel|Chaim Sheba Medical Center ( Site 1304), Ramat Gan, Tel Aviv, 5266202, Israel|Edith Wolfson Medical Center ( Site 1307), Holon, Tell Abib, 5822012, Israel|Sourasky Medical Center ( Site 1306), Tel Aviv, Tell Abib, 6423906, Israel|Soroka University Medical Center ( Site 1305), Beersheba, 8410101, Israel|Rambam Medical Center ( Site 1303), Haifa, 3109601, Israel|Meir Medical Center ( Site 1308), Kfar Saba, 4428164, Israel|Rabin Medical Center ( Site 1302), Petah Tikva, 4941492, Israel|Istituto Europeo di Oncologia ( Site 1411), Milan, Lombardy, 20141, Italy|Istituto Nazionale dei Tumori Fondazione IRCSS ( Site 1402), Milan, 20133, Italy|Istituto Oncologico Veneto ( Site 1412), Padua, 35128, Italy|Azienda Ospedaliera San Camillo Forlanini ( Site 1413), Roma, 00152, Italy|Aichi Cancer Center Hospital ( Site 2619), Nagoya, Aichi-ken, 464-8681, Japan|National Cancer Center Hospital East ( Site 2617), Kashiwa, Chiba, 277-8577, Japan|Hyogo Cancer Center ( Site 2604), Akashi, Hyōgo, 673-8558, Japan|Kobe City Medical Center General Hospital ( Site 2603), Kobe, Hyōgo, 650-0047, Japan|Ibaraki Prefectural Central Hospital ( Site 2610), Kasama, Ibaraki, 309-1793, Japan|Kagawa University Hospital ( Site 2615), Kita-gun, Kagawa-ken, 761-0793, Japan|Kitasato University Hospital ( Site 2618), Sagamihara, Kanagawa, 252-0375, Japan|Kanagawa Cancer Center ( Site 2614), Yokohama, Kanagawa, 241-8515, Japan|Kansai Medical University Hospital ( Site 2608), Hirakata, Osaka, 573-1191, Japan|Kindai University Hospital ( Site 2616), Sayama, Osaka, 589-8511, Japan|Osaka University Hospital ( Site 2600), Suita, Osaka, 565-0871, Japan|Saitama Cancer Center ( Site 2601), Kitaadachi-gun, Saitama, 362-0806, Japan|National Hospital Organization Kyushu Cancer Center ( Site 2612), Fukuoka, 811-1395, Japan|Hiroshima City Hiroshima Citizens Hospital ( Site 2611), Hiroshima, 730-8518, Japan|Kumamoto University Hospital ( Site 2602), Kumamoto, 860-8556, Japan|Niigata Cancer Center Hospital ( Site 2613), Niigata, 951-8566, Japan|Osaka International Cancer Institute ( Site 2607), Osaka, 541-8567, Japan|National Cancer Center Hospital ( Site 2606), Tokyo, 104-0045, Japan|Tokyo Metropolitan Komagome Hospital ( Site 2605), Tokyo, 113-8677, Japan|The Cancer Institute Hospital of JFCR ( Site 2609), Tokyo, 135-8550, Japan|Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0808), Guadalajara, Jalisco, 44280, Mexico|Christus Muguerza Clinica Vidriera ( Site 0802), Monterrey, Nuevo León, 64570, Mexico|Instituto Nacional de Cancerologia. ( Site 0804), Mexico City, 14080, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0806), Mexico City, 14080, Mexico|Medical Care and Research S.A. de C.V. ( Site 0809), Mérida, 97070, Mexico|Auckland City Hospital ( Site 2700), Auckland, Northland, 1023, New Zealand|Clinica Ricardo Palma Instituto de Oncologia y Radioterapia ( Site 0908), Lima, 15036, Peru|Instituto Nacional de Enfermedades Neoplasicas ( Site 0901), Lima, 15038, Peru|Hospital Nacional Arzobispo Loayza ( Site 0902), Lima, 15082, Peru|Clinica San Gabriel ( Site 0907), Lima, 15088, Peru|Przychodnia Lekarska Komed ( Site 1514), Konin, Greater Poland Voivodeship, 62-500, Poland|Szpital Uniwersytecki w Krakowie ( Site 1503), Krakow, Lesser Poland Voivodeship, 31-501, Poland|Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego ( Site 1506), Wroclaw, Lower Silesian Voivodeship, 50-556, Poland|Dolnoslaskie Centrum Onkologii we Wroclawiu ( Site 1504), Wroclaw, Lower Silesian Voivodeship, 53-413, Poland|Magodent Szpital Elblaska ( Site 1509), Warsaw, Masovian Voivodeship, 01-748, Poland|Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warsaw, Masovian Voivodeship, 02-781, Poland|Regionalny Szpital Specjalistyczny im Wl. Bieganskiego w Grudziadzu ( Site 1505), Grudziądz, 86-300, Poland|Chelyabinsk Regional Clinical Oncology Dispensary-Chemotherapy ( Site 1608), Chelyabinsk, Chelyabinsk Oblast, 454087, Russia|SBHI Leningrad Regional Clinical Hospital ( Site 1616), Saint Petersburg, Leningradskaya Oblast', 194291, Russia|Blokhin National Medical Oncology ( Site 1604), Moscow, Moscow, 115478, Russia|Central Clinical Hospital with Polyclinic ( Site 1614), Moscow, Moscow, 121359, Russia|SBHI Samara Regional Clinical Oncology Dispensary ( Site 1609), Samara, Samara Oblast, 443031, Russia|City Clinical Oncology Center ( Site 1603), Saint Petersburg, Sankt-Peterburg, 198255, Russia|Cancer Care Langenhoven Drive Oncology Centre ( Site 1708), Port Elizabeth, Eastern Cape, 6045, South Africa|Universitas Annex National Hospital ( Site 1701), Bloemfontein, Free State, 9301, South Africa|Sandton Oncology Medical Group PTY LTD ( Site 1700), Johannesburg, Gauteng, 2196, South Africa|Wits Clinical Research ( Site 1707), Parktown-Johannesburg, Gauteng, 2193, South Africa|Tshwane District Hospital ( Site 1702), Pretoria, Gauteng, 0002, South Africa|The Oncology Centre Overport and Umhlanga ( Site 1705), Durban, KwaZulu-Natal, 4091, South Africa|Cancercare Rondebosch Oncology ( Site 1709), Cape Town, Western Cape, 7700, South Africa|Groote Schuur Hospital ( Site 1706), Cape Town, Western Cape, 7925, South Africa|Outeniqua Cancercare Oncology Unit ( Site 1704), George, Western Cape, 6530, South Africa|Cape Town Oncology Trials Pty Ltd ( Site 1703), Kraaifontein, Western Cape, 7570, South Africa|Seoul National University Hospital ( Site 2803), Seoul, 03080, South Korea|Severance Hospital Yonsei University Health System ( Site 2800), Seoul, 03722, South Korea|Asan Medical Center ( Site 2802), Seoul, 05505, South Korea|Samsung Medical Center ( Site 2801), Seoul, 06351, South Korea|Hospital General Universitario de Elche ( Site 1803), Elche, Alicante, 03203, Spain|Institut Catala d Oncologia Hospital Germans Trias i Pujol ( Site 1806), Badalona, Barcelona, 08916, Spain|Hospital Universitario Marques de Valdecilla ( Site 1804), Santander, Cantabria, 39008, Spain|HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 1805), Pozuelo de Alarcón, Madrid, 28223, Spain|Hospital Universitario General de Asturias ( Site 1802), Oviedo, Principality of Asturias, 33011, Spain|Hospital General Universitari Vall d Hebron ( Site 1801), Barcelona, 08035, Spain|Universitaetsspital Basel ( Site 1900), Basel, Canton of Basel-City, 4056, Switzerland|Hopitaux Universitaires de Geneve HUG ( Site 1907), Geneva, Canton of Geneva, 1211, Switzerland|Kantonsspital St. Gallen ( Site 1901), Sankt Gallen, Canton of St. Gallen, 9007, Switzerland|Universitaetsspital Zuerich ( Site 1902), Zurich, Canton of Zurich, 8091, Switzerland|Istituto Oncologica della Svizzera Italiana (IOSI) ( Site 1905), Bellinzona, Canton Ticino, 6500, Switzerland|Kantonsspital Graubuenden ( Site 1903), Chur, Kanton Graubünden, 7000, Switzerland|Luzern Kantonsspital ( Site 1904), Lucerne, 6000, Switzerland|Chang Gung Medical Foundation. Kaohsiung Branch ( Site 2902), Kaohsiung City, 83301, Taiwan|National Cheng Kung University Hospital ( Site 2901), Tainan, 70457, Taiwan|National Taiwan University Hospital ( Site 2900), Taipei, 100225, Taiwan|Mackay Memorial Hospital ( Site 2903), Taipei, 104, Taiwan|Adana Sehir Hastanesi ( Site 2002), Adana, 01370, Turkey (Türkiye)|Hacettepe University Medical Faculty ( Site 2017), Ankara, 06100, Turkey (Türkiye)|Abdurrahman Yurtaslan Onkoloji Egitim ve Arastirma Hastanesi ( Site 2006), Ankara, 06200, Turkey (Türkiye)|Trakya Universitesi Tip Fakultesi ( Site 2015), Edirne, 22030, Turkey (Türkiye)|Ataturk Universitesi Tip Fakultesi Hastanesi ( Site 2000), Erzurum, 25240, Turkey (Türkiye)|Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 2001), Istanbul, 34098, Turkey (Türkiye)|Dokuz Eylul Universitesi Tip Fakultesi Hastanesi ( Site 2011), Izmir, 35340, Turkey (Türkiye)|Malatya Inonu Universitesi Tip Fakultesi Hastanesi ( Site 2009), Malatya, 44280, Turkey (Türkiye)|Sakarya Universitesi Egitim ve Arastirma Hastanesi ( Site 2012), Sakarya, 54000, Turkey (Türkiye)|City Clinical Hosp.4 of DCC ( Site 2201), Dnipro, Dnipropetrovsk Oblast, 49102, Ukraine|MI Kryviy Rih Center of Dnipropetrovsk Regional Council ( Site 2200), Kryviy Rih, Dnipropetrovsk Oblast, 50048, Ukraine|MI Precarpathian Clinical Oncology Center ( Site 2204), Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine|Communal non profit enterprise Regional Clinical Oncology Center ( Site 2208), Kharkiv, Kharkivs’ka Oblast’, 61070, Ukraine|Clinic of National Cancer Institute ( Site 2203), Kyiv, Kyivska Oblast, 03022, Ukraine|Medical and Diagnostic Centre LLC Dobryi Prognoz ( Site 2205), Kyiv, Kyivska Oblast, 03126, Ukraine|Lviv State Oncology Regional Treatment and Diagnostic Center ( Site 2210), Lviv, Lviv Oblast, 79031, Ukraine|MI Odessa Regional Oncological Centre ( Site 2212), Odesa, Odesa Oblast, 65055, Ukraine|Medical Centre LLC Oncolife ( Site 2202), Zaporizhzhya, Zaporizhzhia Oblast, 69104, Ukraine|Kyiv City Clinical Oncology Centre ( Site 2213), Kyiv, 03115, Ukraine|South Devon Healthcare Foundation Trust. Torbay Hospital ( Site 1205), Torquay, Devon, TQ2 7AA, United Kingdom|Castle Hill Hospital ( Site 1201), Cottingham, East Riding Of Yorkshire, HU16 5JQ, United Kingdom|University College London Hospital ( Site 1211), London, London, City of, NW1 2PG, United Kingdom|St. Georges University Hospital NHS Foundation Trust ( Site 1204), London, London, City of, SW17 0QT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Lymphoma|Advanced Solid Tumors,DRUG: E7766,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2/24/20,7/26/22,"Yale New Haven Hospital, New Haven, Connecticut, 06510, United States|University of Miami Hospital Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Pittsburgh Medical Center and Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Institut Gustave Roussy, Villejuif, 94805, France|Samsung Medical Center, Seoul, 06351, South Korea|Hospital Universitario Vall d'Hebrón, Barcelona, 08035, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|START Madrid, Madrid, 28050, Spain|INCLIVA Hospital Clínico Universitario de Valencia, Valencia, 46010, Spain|Imperial College Healthcare NHS Trust, London, W12 0HS, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Metastatic Ewing Sarcoma|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Bone Marrow|Metastatic Malignant Neoplasm in the Lung|Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone|Peripheral Primitive Neuroectodermal Tumor of Soft Tissues,DRUG: Cyclophosphamide|DRUG: Doxorubicin|DRUG: Doxorubicin Hydrochloride|DRUG: Etoposide|DRUG: Etoposide Phosphate|RADIATION: External Beam Radiation Therapy|BIOLOGICAL: Ganitumab|DRUG: Ifosfamide|RADIATION: Stereotactic Radiosurgery|PROCEDURE: Therapeutic Surgical Procedure|DRUG: Vincristine|DRUG: Vincristine Sulfate,ALL,"CHILD, ADULT",PHASE3,312,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/12/14,9/17/26,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|USA Health Strada Patient Care Center, Mobile, Alabama, 36604, United States|Providence Alaska Medical Center, Anchorage, Alaska, 99508, United States|Banner Children's at Desert, Mesa, Arizona, 85202, United States|Phoenix Childrens Hospital, Phoenix, Arizona, 85016, United States|Banner University Medical Center - Tucson, Tucson, Arizona, 85719, United States|Onvida Health Yuma Medical Center, Yuma, Arizona, 85364, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, 71913, United States|Arkansas Children's Hospital, Little Rock, Arkansas, 72202-3591, United States|Kaiser Permanente Downey Medical Center, Downey, California, 90242, United States|City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States|Loma Linda University Medical Center, Loma Linda, California, 92354, United States|Miller Children's and Women's Hospital Long Beach, Long Beach, California, 90806, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Valley Children's Hospital, Madera, California, 93636, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, 94609, United States|Kaiser Permanente-Oakland, Oakland, California, 94611, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, 94304, United States|Sutter Medical Center Sacramento, Sacramento, California, 95816, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|Rady Children's Hospital - San Diego, San Diego, California, 92123, United States|UCSF Medical Center-Parnassus, San Francisco, California, 94143, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, 90502, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, 80907, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, 80907, United States|AdventHealth Porter, Denver, Colorado, 80210, United States|Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, 80218, United States|CommonSpirit Cancer Center Mercy, Durango, Colorado, 81301, United States|Mercy Medical Center, Durango, Colorado, 81301, United States|Mountain Blue Cancer Care Center, Golden, Colorado, 80401, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, 80228, United States|Saint Anthony Hospital, Lakewood, Colorado, 80228, United States|AdventHealth Littleton, Littleton, Colorado, 80122, United States|Longmont United Hospital, Longmont, Colorado, 80501, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, 80501, United States|AdventHealth Parker, Parker, Colorado, 80138, United States|Rocky Mountain Cancer Centers-Parker, Parker, Colorado, 80138, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, 81004, United States|Rocky Mountain Cancer Centers - Pueblo, Pueblo, Colorado, 81008, United States|Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado, 80260, United States|Connecticut Children's Medical Center, Hartford, Connecticut, 06106, United States|Yale University, New Haven, Connecticut, 06520, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, 19803, United States|MedStar Georgetown University Hospital, Washington D.C., District of Columbia, 20007, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, 33908, United States|UF Health Cancer Institute - Gainesville, Gainesville, Florida, 32610, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, 33021, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, 32207, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, 33136, United States|Nicklaus Children's Hospital, Miami, Florida, 33155, United States|AdventHealth Orlando, Orlando, Florida, 32803, United States|Arnold Palmer Hospital for Children, Orlando, Florida, 32806, United States|Nemours Children's Hospital, Orlando, Florida, 32827, United States|Nemours Children's Clinic - Pensacola, Pensacola, Florida, 32504, United States|Johns Hopkins All Children's Hospital, St. Petersburg, Florida, 33701, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, 33607, United States|Saint Mary's Medical Center, West Palm Beach, Florida, 33407, United States|Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, 30329, United States|Augusta University Medical Center, Augusta, Georgia, 30912, United States|Memorial Health University Medical Center, Savannah, Georgia, 31404, United States|Straub Clinic and Hospital, Honolulu, Hawaii, 96813, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, 96819, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, 83712, United States|Rush-Copley Medical Center, Aurora, Illinois, 60504, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|University of Illinois, Chicago, Illinois, 60612, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Carle at The Riverfront, Danville, Illinois, 61832, United States|Carle Physician Group-Effingham, Effingham, Illinois, 62401, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, 61938, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|SSM Health Good Samaritan, Mount Vernon, Illinois, 62864, United States|Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois, 60453, United States|Advocate Children's Hospital-Park Ridge, Park Ridge, Illinois, 60068, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, 61637, United States|Saint John's Hospital, Springfield, Illinois, 62702, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Springfield Memorial Hospital, Springfield, Illinois, 62781, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|The Carle Foundation Hospital, Urbana, Illinois, 61801, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, 60560, United States|Deaconess Clinic Downtown, Evansville, Indiana, 47713, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana, 46260, United States|Franciscan Saint Anthony Health-Michigan City, Michigan City, Indiana, 46360, United States|Woodland Cancer Care Center, Michigan City, Indiana, 46360, United States|Chancellor Center for Oncology, Newburgh, Indiana, 47630, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, 50325, United States|UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, 50325, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, 51503, United States|Greater Regional Medical Center, Creston, Iowa, 50801, United States|Blank Children's Hospital, Des Moines, Iowa, 50309, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, 50314, United States|UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, 50314, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, 50266, United States|Flaget Memorial Hospital, Bardstown, Kentucky, 40004, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, 40701, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, 40504, United States|Saint Joseph Hospital East, Lexington, Kentucky, 40509, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, 40536, United States|Saint Joseph London, London, Kentucky, 40741, United States|Jewish Hospital, Louisville, Kentucky, 40202, United States|Norton Children's Hospital, Louisville, Kentucky, 40202, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, 40215, United States|UofL Health Medical Center Northeast, Louisville, Kentucky, 40245, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, 40165, United States|Children's Hospital New Orleans, New Orleans, Louisiana, 70118, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, 70121, United States|Eastern Maine Medical Center, Bangor, Maine, 04401, United States|Maine Children's Cancer Program, Scarborough, Maine, 04074, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, 21215, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, 21287, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, 20889-5600, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Baystate Medical Center, Springfield, Massachusetts, 01199, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, 01655, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Bronson Battle Creek, Battle Creek, Michigan, 49017, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Henry Ford Health Saint John Hospital, Detroit, Michigan, 48236, United States|Hurley Medical Center, Flint, Michigan, 48503, United States|Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan, 49503, United States|Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan, 49503, United States|Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, 49503, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Beacon Kalamazoo, Kalamazoo, Michigan, 49048, United States|Trinity Health Muskegon Hospital, Muskegon, Michigan, 49444, United States|Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan, 49120, United States|Huron Medical Center PC, Port Huron, Michigan, 48060, United States|Lake Huron Medical Center, Port Huron, Michigan, 48060, United States|Corewell Health Reed City Hospital, Reed City, Michigan, 49677, United States|Corewell Health Children's, Royal Oak, Michigan, 48073, United States|Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan, 49085, United States|Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan, 49085, United States|Munson Medical Center, Traverse City, Michigan, 49684, United States|Essentia Health Cancer Center, Duluth, Minnesota, 55805, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, 55404, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, 65613, United States|Cox Cancer Center Branson, Branson, Missouri, 65616, United States|University of Missouri Children's Hospital, Columbia, Missouri, 65212, United States|Freeman Health System, Joplin, Missouri, 64804, United States|Mercy Hospital Joplin, Joplin, Missouri, 64804, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, 64108, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States|Phelps Health Delbert Day Cancer Institute, Rolla, Missouri, 65401, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, 64506, United States|Mercy Hospital Springfield, Springfield, Missouri, 65804, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Cardinal Glennon Children's Medical Center, St Louis, Missouri, 63104, United States|Mercy Infusion Center - Chippewa, St Louis, Missouri, 63109, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Nebraska Medicine-Bellevue, Bellevue, Nebraska, 68123, United States|Nebraska Cancer Specialists/Oncology Hematology West PC, Grand Island, Nebraska, 68803, United States|Fred and Pamela Buffett Cancer Center - Kearney, Kearney, Nebraska, 68845, United States|CHI Health Good Samaritan, Kearney, Nebraska, 68847, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, 68510, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, 68114, United States|Nebraska Medicine-Village Pointe, Omaha, Nebraska, 68118, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, 68122, United States|Hematology and Oncology Consultants PC, Omaha, Nebraska, 68122, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, 68124, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, 68130, United States|Creighton University Medical Center, Omaha, Nebraska, 68131, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States|Midlands Community Hospital, Papillion, Nebraska, 68046, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, 89703, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, 89052, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, 89109, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, 89128, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, 89135, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, 89144, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, 89048, United States|Renown Regional Medical Center, Reno, Nevada, 89502, United States|Saint Mary's Regional Medical Center, Reno, Nevada, 89503, United States|Radiation Oncology Associates, Reno, Nevada, 89509, United States|Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, 03756, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Morristown Medical Center, Morristown, New Jersey, 07960, United States|Saint Peter's University Hospital, New Brunswick, New Jersey, 08901, United States|Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, 08903, United States|Newark Beth Israel Medical Center, Newark, New Jersey, 07112, United States|Saint Joseph's Regional Medical Center, Paterson, New Jersey, 07503, United States|Albany Medical Center, Albany, New York, 12208, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Glens Falls Hospital, Glens Falls, New York, 12801, United States|NYU Langone Hospital - Long Island, Mineola, New York, 11501, United States|The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, 11040, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, 10016, United States|Mount Sinai Hospital, New York, New York, 10029, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|University of Rochester, Rochester, New York, 14642, United States|Stony Brook University Medical Center, Stony Brook, New York, 11794, United States|State University of New York Upstate Medical University, Syracuse, New York, 13210, United States|Montefiore Medical Center-Einstein Campus, The Bronx, New York, 10461, United States|Montefiore Medical Center-Weiler Hospital, The Bronx, New York, 10461, United States|Children's Hospital at Montefiore, The Bronx, New York, 10467, United States|Montefiore Medical Center - Moses Campus, The Bronx, New York, 10467, United States|New York Medical College, Valhalla, New York, 10595, United States|Mission Hospital, Asheville, North Carolina, 28801, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, 28203, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Sanford Broadway Medical Center, Fargo, North Dakota, 58122, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, 44308, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, 45220, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Bethesda North Hospital, Cincinnati, Ohio, 45242, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, 45247, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, 45255, United States|Rainbow Babies and Childrens Hospital, Cleveland, Ohio, 44106, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Dayton Children's Hospital, Dayton, Ohio, 45404, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, 43606, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, 73120, United States|Legacy Emanuel Children's Hospital, Portland, Oregon, 97227, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, 18103, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, 18017, United States|Geisinger Medical Center, Danville, Pennsylvania, 17822, United States|Penn State Children's Hospital, Hershey, Pennsylvania, 17033, United States|Drexel University School of Medicine, Philadelphia, Pennsylvania, 19102, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania, 19134, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Rhode Island Hospital, Providence, Rhode Island, 02903, United States|Medical University of South Carolina, Charleston, South Carolina, 29425, United States|Prisma Health Richland Hospital, Columbia, South Carolina, 29203, United States|Saint Francis Hospital, Greenville, South Carolina, 29601, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, 29605, United States|Saint Francis Cancer Center, Greenville, South Carolina, 29607, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, 57117-5134, United States|T C Thompson Children's Hospital, Chattanooga, Tennessee, 37403, United States|Memorial Hospital, Chattanooga, Tennessee, 37404, United States|Pulmonary Medicine Center of Chattanooga-Hixson, Hixson, Tennessee, 37343, United States|East Tennessee Childrens Hospital, Knoxville, Tennessee, 37916, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|The Children's Hospital at TriStar Centennial, Nashville, Tennessee, 37203, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, 37232, United States|Memorial GYN Plus, Ooltewah, Tennessee, 37363, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, 78723, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, 77802, United States|Driscoll Children's Hospital, Corpus Christi, Texas, 78411, United States|Medical City Dallas Hospital, Dallas, Texas, 75230, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, 75390, United States|El Paso Children's Hospital, El Paso, Texas, 79905, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States|Covenant Children's Hospital, Lubbock, Texas, 79410, United States|UMC Cancer Center / UMC Health System, Lubbock, Texas, 79415, United States|Texas Tech University Health Sciences Center-Lubbock, Lubbock, Texas, 79430, United States|Children's Hospital of San Antonio, San Antonio, Texas, 78207, United States|Methodist Children's Hospital of South Texas, San Antonio, Texas, 78229, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|Scott and White Memorial Hospital, Temple, Texas, 76508, United States|Primary Children's Hospital, Salt Lake City, Utah, 84113, United States|Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners, Vermont, 05602, United States|University of Vermont Medical Center, Burlington, Vermont, 05401, United States|University of Vermont and State Agricultural College, Burlington, Vermont, 05405, United States|Inova Fairfax Hospital, Falls Church, Virginia, 22042, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, 23507, United States|Naval Medical Center - Portsmouth, Portsmouth, Virginia, 23708-2197, United States|VCU Massey Comprehensive Cancer Center, Richmond, Virginia, 23298, United States|Carilion Children's, Roanoke, Virginia, 24014, United States|Highline Medical Center-Main Campus, Burien, Washington, 98166, United States|Saint Elizabeth Hospital, Enumclaw, Washington, 98022, United States|Saint Francis Hospital, Federal Way, Washington, 98003, United States|Saint Clare Hospital, Lakewood, Washington, 98499, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, 98370, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|Saint Michael Cancer Center, Silverdale, Washington, 98383, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, 99204, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, 98405, United States|Mary Bridge Children's Hospital and Health Center, Tacoma, Washington, 98405, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, 98405, United States|Madigan Army Medical Center, Tacoma, Washington, 98431, United States|West Virginia University Healthcare, Morgantown, West Virginia, 26506, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, 54301, United States|Saint Vincent Hospital Cancer Center at Marinette, Marinette, Wisconsin, 54143, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, 54449, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Alberta Children's Hospital, Calgary, Alberta, T3B 6A8, Canada|University of Alberta Hospital, Edmonton, Alberta, T6G 2B7, Canada|British Columbia Children's Hospital, Vancouver, British Columbia, V6H 3V4, Canada|CancerCare Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada|Janeway Child Health Centre, St. John's, Newfoundland and Labrador, A1B 3V6, Canada|IWK Health Centre, Halifax, Nova Scotia, B3K 6R8, Canada|McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario, L8N 3Z5, Canada|Kingston Health Sciences Centre, Kingston, Ontario, K7L 2V7, Canada|Children's Hospital, London, Ontario, N6A 5W9, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, K1H 8L1, Canada|Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|The Montreal Children's Hospital of the MUHC, Montreal, Quebec, H3H 1P3, Canada|Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, H3T 1C5, Canada|CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL), Québec, G1V 4G2, Canada|San Jorge Children's Hospital, San Juan, 00912, Puerto Rico|University Pediatric Hospital, San Juan, 00926, Puerto Rico",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Medulloblastoma|Neuroectodermal Tumor,BIOLOGICAL: TTRNA-xALT|BIOLOGICAL: TTRNA-DCs,ALL,"CHILD, ADULT",PHASE2,26,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/7/10,3/28/25,"Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|University of Florida, Gainesville, Florida, 32610, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor,DRUG: Entrectinib 600 mg (T1)|DRUG: Entrectinib 600 mg (T2)|DRUG: Entrectinib 200 mg (R)|DRUG: Entrectinib 200 mg (T),ALL,ADULT,PHASE1,31,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,6/6/19,8/9/19,"Quotient Clinical Ltd, Clinical Research Unit, Nottingham, NG11 6JS, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Gastroenteropancreatic Neuroendocrine Tumors|Pheochromocytoma|Paraganglioma,DRUG: Lutetium [177Lu] oxodotreotide/dotatate,ALL,CHILD,PHASE2,11,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/31/22,5/7/34,"University of Kentucky, Lexington, Kentucky, 40536, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, 45229-3039, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Centre Léon Berard, Lyon, France|Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland|Hospital Universitari Vall d'Hebron, Barcelona, Spain|University College Hospital of London, London, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms,DRUG: Vinorelbine 25 mg/m2 weekly|DRUG: Afatinib 40mg once daily (OD)|DRUG: Paclitaxel 80 mg/m2 weekly,FEMALE,"ADULT, OLDER_ADULT",PHASE2,74,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/24/11,3/13/17,"Queen Mary Hospital, Hong Kong, Hong Kong|Prince of Wales Hospital, Shatin, Hong Kong|Sujan Surgical Cancer Hospital, Amravati, 444606, India|Tata Memorial Hospital, Maharashtra, 400 012, India|Curie Manavata Cancer Centre, Maharashtra, 422 004, India|Central India Cancer Research Institute, Nagpur, 440010, India|Ruby Hall Clinic, Pune, 411001, India|Regional Cancer Center, Thiruvananthapuram, 695 011, India|University Clinical Center, Gdansk, Gdansk, 80-211, Poland|St.Auton.Heal.Inst.""Rep.Clin.Onc.Disp.of MoH of Rep. Tatarstan"", Kazan', 420029, Russia|Clinical Oncology Dispensary No. 1, Dept. Chemotherapy, Krasnodar, 350040, Russia|N.A. Semashko Central Clinical Hospital, Moscow, Moscow, 129128, Russia|SBIH of Stavropol territory ""Pyatigorsk Oncol. Dispensary"", Pyatigorsk, 357502, Russia|SBIH ""Samara Regional Clinical Oncol. Dispensary"", Samara, Samara, 443 031, Russia|GUZ ""Oncological Dispesary #2"", Sochi, 354057, Russia|Stavropol Regional Clin. Oncology Dispensary Dept. Oncology, Stavropol, 355 047, Russia|Yaroslavl Regional Clinical Oncology Hosp. Dept.Chemotherapy, Yaroslavl, 150 040, Russia|China Medical University Hospital, Taichung, 404, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Mackay Memorial Hospital, Taipei, 10449, Taiwan|Koo Foundation Sun Yet-Sen Cancer Center, Taipei, 112, Taiwan|Taipe Veterans General Hospital, Taipei, 112, Taiwan|North Devon District Hospital, Barnstaple, EX31 4JB, United Kingdom|Royal Bournemouth and Christchurch Hospital, Bournemouth, BH7 7DW, United Kingdom|Royal Devon and Exeter Hospital, Exeter, EX2 5DW, United Kingdom|Charing Cross Hospital, London, W6 8RF, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Esophageal Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Placebo|DRUG: Cisplatin|DRUG: 5-FU,ALL,"ADULT, OLDER_ADULT",PHASE3,749,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",7/25/17,7/10/23,"Kaiser Permanente Southern California ( Site 0003), West Los Angeles, California, 90034, United States|The University of Chicago Medical Center ( Site 0001), Chicago, Illinois, 60637, United States|University of Kansas ( Site 0029), Westwood, Kansas, 66205, United States|University of Maryland Medical Center ( Site 0013), Baltimore, Maryland, 21201, United States|Dana Farber Cancer Center ( Site 0009), Boston, Massachusetts, 02215, United States|Henry Ford Cancer Center ( Site 0018), Detroit, Michigan, 48202, United States|Washington University School of Medicine ( Site 0031), St Louis, Missouri, 63110, United States|Roswell Park Cancer Institute ( Site 0004), Buffalo, New York, 14263, United States|Weill Cornell Medical College ( Site 0024), New York, New York, 10065, United States|University Hospitals Cleveland Medical Center ( Site 0002), Cleveland, Ohio, 44106, United States|UPMC Cancer Center/Hillman Cancer Center ( Site 0015), Pittsburgh, Pennsylvania, 15232, United States|University of Tennessee Medical Center Knoxville ( Site 0017), Knoxville, Tennessee, 37920, United States|Centro de Investigaciones Clinicas - Clinica Viedma ( Site 0603), Viedma, Río Negro Province, R8500ACE, Argentina|Hospital Aleman ( Site 0605), Buenos Aires, C1118AAT, Argentina|Hospital Municipal de Gastroenterologia Dr. Bonorino Udaondo ( Site 0602), Buenos Aires, C1264AAA, Argentina|Sanatorio Allende - Cordoba ( Site 0604), Córdoba, X5000JHQ, Argentina|Hospital Privado Centro Medico Cordoba ( Site 0601), Córdoba, X5016KEH, Argentina|Blacktown Hospital ( Site 2000), Blacktown, New South Wales, 2148, Australia|Liverpool Hospital. ( Site 2001), Liverpool, New South Wales, 2170, Australia|Princess Alexandra Hospital ( Site 2005), Woolloongabba, Queensland, 4102, Australia|Eastern Health ( Site 2002), Box Hill, Victoria, 3128, Australia|Peter MacCallum Cancer Centre ( Site 2003), Melbourne, Victoria, 3000, Australia|CETUS Hospital Dia Oncologia ( Site 0208), Belo Horizonte, Minas Gerais, 30110-022, Brazil|Inst de Medicina Integral Professor Fernando Figueira- IMIP ( Site 0210), Recife, Pernambuco, 50070-550, Brazil|Instituto Nacional do Cancer Jose Alencar Gomes da Silva INCA ( Site 0209), Rio de Janeiro, Rio de Janeiro, 20231-050, Brazil|Hospital Sao Vicente de Paulo ( Site 0204), Passo Fundo, Rio Grande do Sul, 99010-080, Brazil|Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs ( Site 0201), Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Clinica de Hematologia e Oncologia Viver Ltda ( Site 0211), Santa Maria, Rio Grande do Sul, 97015-513, Brazil|Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto. ( Site 0203), São José do Rio Preto, São Paulo, 15090-000, Brazil|Hospital Alemao Oswaldo Cruz ( Site 0207), São Paulo, São Paulo, 01323-903, Brazil|Hospital de Clinicas de Porto Alegre ( Site 0200), Porto Alegre, 90035-903, Brazil|Instituto do Cancer de Sao Paulo - ICESP ( Site 0206), São Paulo, 01246-000, Brazil|Tom Baker Cancer Centre ( Site 0503), Calgary, Alberta, T2N 4N2, Canada|Cross Cancer Institute ( Site 0502), Edmonton, Alberta, T6G 1Z2, Canada|CancerCare Manitoba ( Site 0500), Winnipeg, Manitoba, R3E 0V9, Canada|Juravinski Cancer Center ( Site 0508), Hamilton, Ontario, L8V 5C2, Canada|The Ottawa Hospital - Cancer Care ( Site 0501), Ottawa, Ontario, K1H 8L6, Canada|Princess Margaret Cancer Centre ( Site 0505), Toronto, Ontario, M5G 2M9, Canada|CISSS de la Monteregie-Centre ( Site 0504), Greenfield Park, Quebec, J4V 2H1, Canada|Jewish General Hospital ( Site 0507), Montreal, Quebec, H3T 1E2, Canada|Hospital Regional de Concepcion Dr. Guillermo Grant Benavente ( Site 1003), Concepción, 4070038, Chile|Pontificia Universidad Catolica de Chile ( Site 1001), Santiago, 7620002, Chile|Hospital Clinico Universidad de Chile ( Site 1002), Santiago, 8380456, Chile|Clinica Alemana de Temuco ( Site 1006), Temuco, 4810297, Chile|Anhui Provincial Hospital ( Site 0106), Hefei, Anhui, 230036, China|The First Affiliated Hospital of Anhui Medical University ( Site 0112), Hefei, Anhui, 230088, China|Peking Union Medical College Hospital ( Site 0123), Beijing, Beijing Municipality, 100032, China|The First Affiliated Hospital of Xiamen University ( Site 0119), Xiamen, Fujian, 361000, China|Guangdong General Hospital ( Site 0103), Guangzhou, Guangdong, 510120, China|The Affiliated Tumour Hospital of Harbin Medical University ( Site 0102), Harbin, Heilongjiang, 150081, China|Tongji Medical College Huazhong University of Science and Technology ( Site 0109), Wuhan, Hubei, 430030, China|Hunan Cancer Hospital ( Site 0105), Changsha, Hunan, 410013, China|PLA Cancer Centre of Nanjing Bayi Hospital ( Site 0110), Nanjing, Jiangsu, 210002, China|Zhongda Hospital Southeast University ( Site 0125), Nanjing, Jiangsu, 210009, China|Jilin Cancer Hospital ( Site 0101), Changchun, Jilin, 130012, China|The First Affiliated Hospital of Xi an Jiaotong University ( Site 0120), Xi'an, Shannxi, 710061, China|Zhejiang Cancer Hospital ( Site 0116), Hangzhou, Zhejiang, 310022, China|Beijing Cancer Hospital ( Site 0100), Beijing, 100142, China|Fujian Provincial Cancer Hospital ( Site 0104), Fuzhou, 350014, China|Shanghai Chest Hospital ( Site 0111), Shanghai, 200030, China|Fudan University Shanghai Cancer Center ( Site 0108), Shanghai, 200032, China|Renji Hospital Shanghai Jiaotong University School of Medicine ( Site 0114), Shanghai, 200127, China|Henan Cancer Hospital ( Site 0107), Zhengzhou, 450008, China|Rodrigo Botero SAS ( Site 2703), Medellín, Antioquia, 050030, Colombia|Oncomedica S.A. ( Site 2701), Montería, Departamento de Córdoba, 230018, Colombia|CIMCA Centro de Investigacion y Manejo del Cancer ( Site 2600), San José, 10103, Costa Rica|Policlinico San Bosco ( Site 2602), San José, 10103, Costa Rica|ICIMED - Instituto de Investigacion en Ciencias Medicas ( Site 2601), San José, 10108, Costa Rica|Rigshospitalet ( Site 2301), Copenhagen, 2100, Denmark|Odense Universitetshospital ( Site 2300), Odense, 5000, Denmark|Centre Leon Berard ( Site 0307), Lyon, Cedex 8, 69373, France|CHU Brest - Institut de Cancerologie et d Hematologie ( Site 0305), Brest, 29200, France|Centre Francois Baclesse ( Site 0310), Caen, 14076, France|Centre Oscar Lambret ( Site 0304), Lille, 59020, France|Institut du Cancer de Montpellier ( Site 0306), Montpellier, 34298, France|CHU de Nantes - Hotel Dieu ( Site 0303), Nantes, 44093, France|Institut Mutualiste Montsouris ( Site 0300), Paris, 75014, France|CHU de Saint Etienne Hopital Nord ( Site 0309), Saint-Etienne, 42055, France|Staedtisches Klinikum Dresden ( Site 1507), Dresden, 01067, Germany|Haematologisch-Onkologische Praxis Eppendorf Facharztzentrum Eppendorf - Hope ( Site 1502), Hamburg, 20249, Germany|Universitaetsklinikum Leipzig ( Site 1501), Leipzig, 04103, Germany|Klinikum Ludwigsburg ( Site 1509), Ludwigsburg, 71640, Germany|Universitatsklinikum Mannheim GmbH ( Site 1504), Mannheim, 68167, Germany|Klinik fuer Haematologie. Onkologie und Gastroenterologie ( Site 1508), Mönchengladbach, 41063, Germany|III. Medizinische Klinik Klinikum rechts der Isar ( Site 1506), München, 81675, Germany|Centro de Investigacion Oncologica ( Site 1402), Guatemala City, 01010, Guatemala|Oncomedica ( Site 1400), Guatemala City, 01010, Guatemala|Grupo Medico Angeles ( Site 1401), Guatemala City, 01015, Guatemala|Medi-K Cayala ( Site 1404), Guatemala City, 01016, Guatemala|Centro Regional de Sub Especialidades Medicas SA ( Site 1403), Quetzaltenango, 09001, Guatemala|Humanity Health Research Centre ( Site 1603), Hong Kong, Hong Kong|Pamela Youde Nethersole Eastern Hospital ( Site 1601), Hong Kong, Hong Kong|Princess Margaret Hospital. ( Site 1602), Hong Kong, Hong Kong|Queen Mary Hospital ( Site 1600), Hong Kong, Hong Kong|Aichi Cancer Center Hospital ( Site 0902), Nagoya, Aichi-ken, 464-8681, Japan|National Cancer Center Hospital East ( Site 0908), Kashiwa, Chiba, 277-8577, Japan|National Hospital Organization Shikoku Cancer Center ( Site 0901), Matsuyama, Ehime, 791-0280, Japan|Hokkaido University Hospital ( Site 0916), Sapporo, Hokkaido, 060-8648, Japan|Hyogo Cancer Center ( Site 0913), Akashi, Hyōgo, 673-8558, Japan|Kobe City Medical Center General Hospital ( Site 0929), Kobe, Hyōgo, 650-0047, Japan|Ibaraki Prefectural Central Hospital ( Site 0918), Kasama, Ibaraki, 309-1793, Japan|University of Tsukuba Hospital ( Site 0910), Tsukuba, Ibaraki, 305-8576, Japan|Kagawa University Hospital ( Site 0915), Kita-gun, Kagawa-ken, 761-0793, Japan|St. Marianna University School of Medicine Hospital ( Site 0903), Kawasaki, Kanagawa, 216-8511, Japan|Kanagawa Cancer Center ( Site 0921), Yokohama, Kanagawa, 241-8515, Japan|Oita University Hospital ( Site 0930), Yufu, Oita Prefecture, 879-5593, Japan|Kansai Medical University Hospital ( Site 0931), Hirakata, Osaka, 573-1191, Japan|Kindai University Hospital ( Site 0917), Sayama, Osaka, 589-8511, Japan|Osaka University Hospital ( Site 0911), Suita, Osaka, 565-0871, Japan|Osaka Medical College Hospital ( Site 0925), Takatsuki, Osaka, 569-8686, Japan|Saitama Cancer Center ( Site 0926), Kitaadachi-gun, Saitama, 362-0806, Japan|Shizuoka Cancer Center Hospital and Research Institute ( Site 0914), Sunto-gun, Shizuoka, 411-8777, Japan|Kyorin University Hospital ( Site 0905), Mitaka, Tokyo, 181-8611, Japan|Chiba University Hospital ( Site 0909), Chiba, 260-8677, Japan|Chiba Cancer Center ( Site 0900), Chiba, 260-8717, Japan|National Hospital Organization Kyushu Cancer Center ( Site 0906), Fukuoka, 811-1395, Japan|Kyushu University Hospital ( Site 0922), Fukuoka, 812-8582, Japan|Gifu University Hospital ( Site 0920), Gifu, 501-1194, Japan|Kumamoto University Hospital ( Site 0919), Kumamoto, 860-8556, Japan|Niigata Cancer Center Hospital ( Site 0924), Niigata, 951-8566, Japan|Osaka International Cancer Institute ( Site 0923), Osaka, 541-8567, Japan|Osaka General Medical Center ( Site 0912), Osaka, 558-8558, Japan|National Cancer Center Hospital ( Site 0907), Tokyo, 104-0045, Japan|The Cancer Institute Hospital of JFCR ( Site 0904), Tokyo, 135-8550, Japan|Keio University Hospital ( Site 0927), Tokyo, 160-8582, Japan|Beacon International Specialist Centre ( Site 1803), Petaling Jaya, Selangor, 46050, Malaysia|Hospital Kuala Lumpur ( Site 1805), Kuala Lumpur, 50586, Malaysia|University Malaya Medical Centre ( Site 1802), Kuala Lumpur, 59100, Malaysia|Instituto Regional de Enfermedades Neoplasicas del Sur IRENSUR ( Site 1702), Arequipa, 04000, Peru|Hospital Nacional Guillermo Almenara Irigoyen ( Site 1701), Lima, 15033, Peru|Instituto Nacional de Enfermedades Neoplasicas ( Site 1705), Lima, 15038, Peru|S C Pelican Impex SRL ( Site 2403), Oradea, Bihor County, 410469, Romania|S.C. Radiotherapy Center Cluj S.R.L ( Site 2407), Comuna Floresti, Cluj, 407280, Romania|S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 2404), Craiova, Dolj, 200347, Romania|S.C.Focus Lab Plus S.R.L ( Site 2401), Bucharest, Sector 2, 021389, Romania|S C Oncocenter Oncologie Medicala S R L ( Site 2405), Timișoara, Timiș County, 300166, Romania|S.C.Gral Medical S.R.L ( Site 2406), Bucharest, 031422, Romania|Spitalul Clinic Judetean De Urgenta Constanta ( Site 2402), Constanța, 900591, Romania|SBHCI RCOD of MHC RB ( Site 0407), Ufa, Bashkortostan Republic, 450054, Russia|Leningrad Regional Oncology Center ( Site 0405), Saint Petersburg, Vsevolzhsk District, 188663, Russia|National Medical and Surgical Center n.a. N.I.Pirogov ( Site 0402), Moscow, 105203, Russia|N.N. Blokhin NMRCO ( Site 0401), Moscow, 115478, Russia|Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 0406), Saint Petersburg, 197758, Russia|St Petersburg City Clinical Oncology Dispensary ( Site 0409), Saint Petersburg, 198255, Russia|Tomsk Scientific Research Institute of Oncology ( Site 0403), Tomsk, 634028, Russia|Cancer Care Langenhoven Drive Oncology Centre ( Site 2501), Port Elizabeth, Eastern Cape, 6045, South Africa|The Medical Oncology Centre of Rosebank ( Site 2506), Johannesburg, Gauteng, 2196, South Africa|WITS Clinical Research CMJAH Clinical Trial Site ( Site 2500), Parktown, Gauteng, 2193, South Africa|The Oncology Centre ( Site 2502), Durban, KwaZulu-Natal, 4091, South Africa|Cape Town Oncology Trials Pty Ltd ( Site 2508), Cape Town, Western Cape, 7570, South Africa|Outeniqua Cancercare Oncology Unit ( Site 2504), George, Western Cape, 6530, South Africa|Clinton Oncology Centre ( Site 2505), Alberton, 1448, South Africa|National Cancer Center ( Site 1304), Goyang-si, Gyeonggi-do, 10408, South Korea|Chonnam National University Hwasun Hospital ( Site 1305), Hwasun Gun, Jeollanam-do, 58128, South Korea|Seoul National University Cancer Hospital ( Site 1301), Seoul, 03080, South Korea|Severance Hospital Yonsei University Health System ( Site 1302), Seoul, 03722, South Korea|Asan Medical Center ( Site 1303), Seoul, 05505, South Korea|Samsung Medical Center ( Site 1300), Seoul, 06351, South Korea|Hosp. Gral. Universitari Germans Trias i Pujol ( Site 0701), Badalona, Barcelona, 08916, Spain|Hospital Universitario Central de Asturias ( Site 0708), Oviedo, Principality of Asturias, 33011, Spain|Hospital Universitari Vall d Hebron ( Site 0702), Barcelona, 08035, Spain|Hospital Universitario Reina Sofia ( Site 0706), Córdoba, 14004, Spain|Hospital Ramon y Cajal ( Site 0703), Madrid, 28034, Spain|Hospital Universitario La Paz ( Site 0700), Madrid, 28046, Spain|Complejo Hospitalario Virgen De La Victoria ( Site 0705), Málaga, 29010, Spain|Chang Gung Med Foundation. Kaohsiung Branch ( Site 1906), Kaohsiung City, 833, Taiwan|Taipei Medical University Shuang Ho Hospital ( Site 1908), New Taipei City, 235, Taiwan|China Medical University Hospital ( Site 1904), Taichung, 404, Taiwan|Kuang Tien General Hospital ( Site 1909), Taichung, 43303, Taiwan|National Cheng Kung University Hospital ( Site 1905), Tainan, 704, Taiwan|Chi Mei Medical Center Liuying ( Site 1907), Tainan, 736, Taiwan|National Taiwan University Hospital ( Site 1900), Taipei, 10002, Taiwan|Koo Foundation Sun Yat-Sen Cancer Center ( Site 1902), Taipei, 11259, Taiwan|Chang Gung Medical Foundation. Linkou ( Site 1903), Taoyuan District, 333, Taiwan|Bumrungrad International Hospital ( Site 2203), Bangkok, 10110, Thailand|Chulalongkorn Hospital ( Site 2201), Bangkok, 10330, Thailand|Ramathibodi Hospital. ( Site 2202), Bangkok, 10330, Thailand|Phramongkutklao Hospital ( Site 2205), Bangkok, 10400, Thailand|Songklanagarind Hospital ( Site 2204), Songkhla, 90110, Thailand|Adana Sehir Hastanesi ( Site 0802), Adana, 01370, Turkey (Türkiye)|Ankara Sehir Hastanesi ( Site 0808), Ankara, 06800, Turkey (Türkiye)|Istanbul Medeniyet Universitesi Goztepe EAH ( Site 0807), Istanbul, 34093, Turkey (Türkiye)|Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0804), Istanbul, 34098, Turkey (Türkiye)|Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi ( Site 0801), Istanbul, 34899, Turkey (Türkiye)|Medical Park Izmir Hastanesi ( Site 0800), Izmir, 35575, Turkey (Türkiye)|Inonu Universitesi Turgut Ozal Tip Merkezi ( Site 0803), Malatya, 44280, Turkey (Türkiye)|Lothian University Hospitals NHS Trust ( Site 1101), Edinburgh, Mid Lothian, EH4 2XU, United Kingdom|St Luke's Cancer Centre ( Site 1102), Guildford, GU2 7XX, United Kingdom|The Christie NHS Foundation Trust ( Site 1100), Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms|Colorectal Cancer,DRUG: MK-8353|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,111,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/13/17,12/2/22,"Call for Information (Investigational Site 0002), Grand Rapids, Michigan, 49546, United States|Call for Information (Investigational Site 0001), Nashville, Tennessee, 37203, United States|Merck Canada, Kirkland, Quebec, H9H 4M7, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Urologic Neoplasms,DRUG: Afatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,42,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/9/16,9/2/19,"INS Bergonié, Bordeaux, 33076, France|CTR Leon Berard, Lyon, 69373, France|INS Cancérologie du Gard, Nîmes, 30029, France|HOP Saint-Louis, Paris, 75010, France|HOP Cochin, Paris, 75014, France|HOP Européen G. Pompidou, Paris, 75015, France|HOP Foch, Suresnes, 92150, France|INS Universitaire du Cancer, Toulouse, 31059, France|INS Gustave Roussy, Villejuif, 94805, France|Ospedale San Donato di Arezzo, Arezzo, 52100, Italy|A.O. San Camillo Forlanini, Roma, 00152, Italy|Hospital Germans Trias i Pujol, Badalona, 08916, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Vall d'Hebron, Barcelona, 08038, Spain|Hospital Universitario de Elche, Elche, 03202, Spain|Hospital Universitari de Girona Doctor Josep Trueta, Girona, 17007, Spain|Hospital Duran i Reynals, L'Hospitalet de Llobregat, 08908, Spain|Hospital Universitario Lucus Augusti, Lugo, 27003, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital La Paz, Madrid, 28046, Spain|CIO Clara Campal, Madrid, 28050, Spain|Hospital Son Espases, Palma de Mallorca, 07010, Spain|CS Parc Taulí, Sabadell, 08208, Spain|Hospital Virgen Macarena, Seville, 41009, Spain|Hospital Virgen del Rocío, Seville, 41013, Spain|Instituto Valenciano de Oncología, Valencia, 46009, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Lung Neoplasms,DRUG: Anetumab Ravtansine|DEVICE: Blood test,ALL,"ADULT, OLDER_ADULT",PHASE2,2,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/19/16,7/25/18,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Gastrointestinal Stromal Tumors,DRUG: PD 0332991,ALL,"ADULT, OLDER_ADULT",PHASE2,29,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-02,2019-02,"Institut Bergonié, Bordeaux, Gironde, 33076, France|Centre Georges-Francois Leclerc, Dijon, 21079, France|Centre Oscar Lambret, Lille, 59020, France|Centre Léon Bérard, Lyon, 69373, France|Hôpital de la Timone - AP-HM, Marseille, 13385, France|Centre René Gauducheau, Nantes, 44805, France|Hôpital Saint-Antoine (AP-HP), Paris, 75571, France|CHU de REIMS - Hôpital Robert Debré, Reims, 51092, France|Institut Gustave Roussy, Villejuif, 94800, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Skin Squamous Cell Carcinoma|Appendix Adenocarcinoma|Rare Lesion|Locally Advanced Malignant Neoplasm|Locally Advanced Skin Squamous Cell Carcinoma|Metastatic Malignant Neoplasm|Metastatic Skin Squamous Cell Carcinoma|Metastatic Small Intestinal Adenocarcinoma|Rare Neoplastic Syndrome|Refractory Malignant Neoplasm|Stage IV Small Intestinal Adenocarcinoma AJCC v8|Unresectable Malignant Neoplasm,DRUG: Atezolizumab|DRUG: Cobimetinib,ALL,"ADULT, OLDER_ADULT",PHASE2,49,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/7/17,4/2/24,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Spinal Neoplasms,PROCEDURE: Stereotactic Body Radiotherapy,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,71,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/13/05,11/27/24,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cancer|Solid Tumor,DRUG: Eribulin|DRUG: Lenvatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,29,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-05,1/12/23,"Cancer Therapy and Research Center University of Texas Health Science Center San Antonio, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Cancer, Solid Tumor",DRUG: IBI308|DRUG: IBI308\Cisplatinum\Pemetrexed|DRUG: IBI308\cisplatin\gemcitabine|DRUG: IBI308\oxaliplatin\capecitabine|DRUG: IBI308\etoposide\cisplatin|DRUG: IBI308\irinotecan\5-FU,ALL,"ADULT, OLDER_ADULT",PHASE1,233,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/19/16,9/30/20,"The fifth medical center of the PLA general hospital, Beijing, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cancer|Giant Cell Tumors|Giant Cell Tumor of Bone|Benign Giant Cell Tumors,DRUG: Denosumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,535,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/9/08,5/17/18,"Research Site, Santa Monica, California, 90403, United States|Research Site, Stanford, California, 94305, United States|Research Site, Washington D.C., District of Columbia, 20010, United States|Research Site, Gainesville, Florida, 32607, United States|Research Site, Boston, Massachusetts, 02114, United States|Research Site, Boston, Massachusetts, 02215, United States|Research Site, Ann Arbor, Michigan, 48109, United States|Research Site, Minneapolis, Minnesota, 55455, United States|Research Site, New York, New York, 10003, United States|Research Site, Philadelphia, Pennsylvania, 19106, United States|Research Site, Greenville, South Carolina, 29605, United States|Research Site, Camperdown, New South Wales, 2250, Australia|Research Site, Woolloongabba, Queensland, 4102, Australia|Research Site, East Melbourne, Victoria, 3002, Australia|Research Site, Nedlands, Western Australia, 6009, Australia|Research Site, Vienna, 1090, Austria|Research Site, Toronto, Ontario, M5G 1X5, Canada|Research Site, Montreal, Quebec, H4A 3J1, Canada|Research Site, Lyon, 69373, France|Research Site, Marseille, 13385, France|Research Site, Villejuif, 94805, France|Research Site, Bad Saarow, 15526, Germany|Research Site, Stuttgart, 70174, Germany|Research Site, Bologna, 40136, Italy|Research Site, Milan, 20133, Italy|Research Site, Leiden, 2333 ZA, Netherlands|Research Site, Warsaw, 01-211, Poland|Research Site, Warsaw, 02-781, Poland|Research Site, Palma de Mallorca, Balearic Islands, 07010, Spain|Research Site, Barcelona, Catalonia, 08025, Spain|Research Site, Valencia, Valencia, 46026, Spain|Research Site, Lund, 221 85, Sweden|Research Site, Birmingham, B31 2AP, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Cancer|Breast Tumors,DRUG: Metformin|DRUG: Doxorubicin,ALL,"ADULT, OLDER_ADULT",PHASE2,30,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,2014-07,5/23/18,"Avera Cancer Institute, Sioux Falls, South Dakota, 57105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Stromal Tumor(GIST),DRUG: Ripretinib|DRUG: Sunitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,108,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/25/20,7/20/22,"Beijing Cancer Hospital, Beijing, Beijing Municipality, China|Chinese PLA General Hospital, Beijing, Beijing Municipality, China|The General Hospital of Peking University, Beijing, Beijing Municipality, China|The First Affiliated Hospital of Chongqing Medical Universty, Chongqing, Chognqing, China|Fujian Medical University Union Hospital, Fuzhou, Fujian, China|The Cancer Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The sixth Affiliated hospital of Sun Yat-sen University, Guangzhou, Guangdong, China|The 4th Hospital of Hebei Medical University, Shijiazhuang, Hebei, China|The Affiliated Hospital of Haerbin MedicalUniversity, Harbin, Heilongjiang, China|Union Hospital of HUST, Wuhan, Hubei, China|The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China|Fudan University Cancer Hospital, Shanghai, Shanghai Municipality, China|Fudan University, Zhongshan Hospital, Shanghai, Shanghai Municipality, China|Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China|West China Hospital of Sichuan University, Chengdu, Sichuan, China|The Affiliated Hospital of Xinjiang Medical University, Ürümqi, Xinjiang, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms,DRUG: Indigo carmine|PROCEDURE: water (exchange) method|PROCEDURE: water (exchange) plus dye method|PROCEDURE: air method,ALL,"ADULT, OLDER_ADULT",PHASE4,480,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,5/16/13,9/30/17,"VA Northern California Health Care System, Mather, CA, Sacramento, California, 95655, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Malignant Rhabdoid Tumors (MRT)|Neuroblastoma,DRUG: LEE011,ALL,"CHILD, ADULT",PHASE1,32,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/28/13,6/29/17,"UCSF Medical Center Dept of Pediatic Oncology, San Francisco, California, 94143, United States|Childrens Healthcare of Atlanta Dept of Oncology, Atlanta, Georgia, 30342, United States|Dana Farber Cancer Institute SC-7, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering Dept of Onc, New York, New York, 10017, United States|Cincinnati Children's Hospital Medical Center Dept of Oncology, Cincinnati, Ohio, 45229-3039, United States|St Jude s Childrens Research Hospital Dept of Oncology, Memphis, Tennessee, 38105-2794, United States|Novartis Investigative Site, Perth, Western Australia, 6840, Australia|Novartis Investigative Site, Lyon, 69373, France|Novartis Investigative Site, Paris, 75231, France|Novartis Investigative Site, Villejuif, 94805, France|Novartis Investigative Site, Cologne, North Rhine-Westphalia, 50937, Germany|Novartis Investigative Site, Augsburg, 86156, Germany|Novartis Investigative Site, Sutton, Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Anemia|Myelodysplastic/Myeloproliferative Neoplasm|Myelofibrosis,BIOLOGICAL: Sotatercept|DRUG: Ruxolitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,56,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/21/13,5/24/22,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Lymphoid Malignancies|Lymphoma|Hodgkin Lymphoma|Non-hodgkin Lymphoma,DRUG: RomiDEPsin 10 MG/M2|DRUG: Oral 5-Azacitidine 100 MG|DRUG: Romidepsin 14 MG/M2|DRUG: Oral 5-Azacitidine 200 MG|DRUG: Oral 5-Azacitidine 300 MG,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,58,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2013-11,1/6/20,"Columbia University Medical Center, New York, New York, 10019, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Solid Tumor|Breast Tumor|Colon Tumor, Malignant|Lung Tumor|Urologic Cancer|Pancreatic Cancer|Melanoma|Metastatic Cancer|Locally Advanced Solid Tumor|Esophageal Cancer|Endometrial Cancer|Head and Neck Cancer",DRUG: Niraparib,ALL,"ADULT, OLDER_ADULT",PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/15/22,8/27/24,"Yuma Regional Medical Center, Yuma, Arizona, 85364, United States|Highlands Oncology, Springdale, Arkansas, 72762, United States|Memorial Care Medical Center, Fountain Valley, California, 92708, United States|St Joseph Heritage Health - Fullerton, Fullerton, California, 92835, United States|University of California San Diego, La Jolla, California, 92093-0698, United States|MemorialCare, Long Beach, California, 90806, United States|Cancer and Blood Specialty Clinic, Los Alamitos, California, 90720, United States|Cancer and Blood Specialty, Los Alamitos, California, 90720, United States|University of California Los Angeles, Los Angeles, California, 90404, United States|St Joseph Health Medical Group - Napa, Napa, California, 94558, United States|Ventura County Hematology Oncology Specialists, Oxnard, California, 93030, United States|Sharp Healthcare, San Diego, California, 92123, United States|Ridley-Tree Cancer Center, Santa Barbara, California, 93105, United States|St Joseph Health Medical Group - Santa Rosa, Santa Rosa, California, 95403, United States|Hartford Healthcare, Hartford, Connecticut, 06102, United States|Eastern Connecticut Hematology and Oncology, Norwich, Connecticut, 06360, United States|Holy Cross, Fort Lauderdale, Florida, 33308, United States|Cancer Specialists of North Florida, Jacksonville, Florida, 32256, United States|Ocala Community Cancer Center, Ocala, Florida, 34474, United States|University Cancer & Blood Center, Athens, Georgia, 30607, United States|Hawaii Cancer Care, Honolulu, Hawaii, 96813, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Northwest Oncology & Hematology, Rolling Meadows, Illinois, 60008, United States|Fort Wayne Medical Oncology and Hematology, Fort Wayne, Indiana, 46845, United States|Goshen Health, Goshen, Indiana, 46526, United States|Community Health Network, Indianapolis, Indiana, 46250, United States|Beacon Health System, South Bend, Indiana, 46601, United States|Pontchartrain Cancer Center, Hammond, Louisiana, 70403, United States|The Center for Cancer and Blood Disorders - Maryland, Bethesda, Maryland, 20817, United States|Frederick Health, Frederick, Maryland, 21702, United States|Maryland Oncology Hematology, Rockville, Maryland, 20850, United States|Southcoast Health, Fairhaven, Massachusetts, 02719, United States|Sparrow Health, Lansing, Michigan, 48912, United States|Central Care Cancer Center, Bolivar, Missouri, 65613, United States|Mosaic Life Care, Saint Joseph, Missouri, 64507, United States|Oncology Hematology Associates, Springfield, Missouri, 65807, United States|Nebraska Cancer Specialists, Omaha, Nebraska, 68130, United States|OptumCare Cancer Care, Las Vegas, Nevada, 89102, United States|New Jersey Cancer Care and Blood Disorders, Belleville, New Jersey, 07109, United States|Englewood Health, Englewood, New Jersey, 07631, United States|Summit Medical Group, Florham Park, New Jersey, 07932, United States|Novant Health Inc. - Charlotte, Charlotte, North Carolina, 28204, United States|Southeastern Medical Oncology Center, Goldsboro, North Carolina, 27534, United States|Novant Health Inc. - Winston-Salem, Winston-Salem, North Carolina, 27103, United States|Aultman Medical Group, Canton, Ohio, 44708, United States|TriHealth, Cincinnati, Ohio, 45220, United States|University Hospitals Seidman, Cleveland, Ohio, 44106, United States|Cleveland Clinic - Taussig Cancer Center, Cleveland, Ohio, 44195, United States|OhioHealth, Columbus, Ohio, 43214, United States|The Toledo Clinic, Toledo, Ohio, 43623, United States|Oklahoma Cancer Specialists, Tulsa, Oklahoma, 74146, United States|Oregon Oncology Specialists, Salem, Oregon, 97301, United States|Gettysburg Cancer Center, Gettysburg, Pennsylvania, 17325, United States|Bon Secours - St. Francis Cancer Center, Greenville, South Carolina, 29607, United States|Avera Cancer Institute, Sioux Falls, South Dakota, 57105, United States|Sanford Health, Sioux Falls, South Dakota, 57117, United States|Baptist Cancer Center, Memphis, Tennessee, 38120, United States|Vanderbilt University, Nashville, Tennessee, 37232, United States|Texas Oncology - Austin Midtown, Austin, Texas, 78705, United States|Texas Oncology - Austin Central Pharmacy, Austin, Texas, 78731, United States|Texas Oncology - South Austin, Austin, Texas, 78745, United States|Mary Crowley Cancer Research, Dallas, Texas, 75230, United States|Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|The University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Oncology Consultants, Houston, Texas, 77030, United States|Texas Oncology - Longview Cancer Center, Longview, Texas, 75601, United States|Texas Oncology - Palestine Cancer Center, Palestine, Texas, 75801, United States|Texas Oncology - Paris Cancer Center, Paris, Texas, 75460, United States|Lumi Research, Sugar Land, Texas, 77479, United States|Texas Oncology - Tyler Pharmacy, Tyler, Texas, 75702, United States|Community Cancer Trials of Utah, Ogden, Utah, 84405, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Inova Schar Institute, Fairfax, Virginia, 22031, United States|Hematology Oncology Associates of Fredericksburg, Fredericksburg, Virginia, 22408, United States|Virginia Cancer Institute, Richmond, Virginia, 23229, United States|Virginia Cancer Institute, Richmond, Virginia, 23230, United States|PeaceHealth, Bellingham, Washington, 98225, United States|Northwest Medical Specialties, Tacoma, Washington, 98405, United States|ThedaCare, Appleton, Wisconsin, 54911, United States|SSM Health, Madison, Wisconsin, 53717, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,MPN (Myeloproliferative Neoplasms),DRUG: Parsaclisib|DRUG: Parsaclisib|DRUG: Ruxolitinib|DRUG: Parsaclisib|DRUG: Parsaclisib,ALL,"ADULT, OLDER_ADULT",PHASE2,74,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/8/17,4/29/22,"Birmingham Hematology & Oncolgy Associates Llc, Birmingham, Alabama, 35223, United States|Mayo Clinic Arizona, Scottsdale, Arizona, 85259, United States|Alta Bates Medical Center, Berkeley, California, 94704, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|California Cancer Associates For Research and Excellence, Fresno, California, 93720, United States|University of Southern California, Los Angeles, California, 90033, United States|UCLA School of Medicine, Los Angeles, California, 90095, United States|Pcr Oncology, Pismo Beach, California, 93449, United States|California Cancer Assoc. for Research and Excellence, San Marcos, California, 92069, United States|Georgetown University Hospital, Washington D.C., District of Columbia, 20007, United States|Shands Hospital, Gainesville, Florida, 32610, United States|Emory University, Atlanta, Georgia, 30322, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Indiana Blood and Marrow Transplantation, Indianapolis, Indiana, 46237, United States|McFarland Clinic, Ames, Iowa, 50010, United States|University of Kansas Cancer Center, Westwood, Kansas, 66205, United States|Norton Cancer Institute, Louisville, Kentucky, 40202, United States|Saint Agnes Hospital, Baltimore, Maryland, 21229, United States|Cancer Center For Blood Disorders, Bethesda, Maryland, 20817, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Washington University School of Medicine, St Louis, Missouri, 63130, United States|Summit Medical Group, Florham Park, New Jersey, 07932, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|New Mexico Cancer Care Alliance, Albuquerque, New Mexico, 87106, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Mount Sinai School of Medicine, New York, New York, 10029, United States|Columbia University Medical Center, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Montefiore Medical Center, The Bronx, New York, 10467, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45230, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Rush University Medical Center, Nashville, Tennessee, 37203, United States|Baylor Scott and White Research Institute, Dallas, Texas, 75246, United States|Md Anderson Cancer Center, Houston, Texas, 77030, United States|Cancer Care Centers of South Texas, San Antonio, Texas, 78217, United States|Renovatio Clinical Consultants Llc, The Woodlands, Texas, 77380, United States|Va Salt Lake City Health Care System, Salt Lake City, Utah, 84112, United States|Vista Oncology Inc Ps, Olympia, Washington, 98506, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor|Lymphoma|Multiple Myeloma|Malignant Neoplasm|Mutation Abnormality,DRUG: Investigational Agent|OTHER: Supportive Care Regimens|DIAGNOSTIC_TEST: Next Gen Sequencing Report,ALL,"ADULT, OLDER_ADULT",PHASE2,45,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/22/20,2/9/23,"Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, 27157, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cancer|Solid Tumor,BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,297,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/7/13,6/30/20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,"Cervical Cancer|HPV Cancers|Anal Cancer|Oropharyngeal Cancer|Vulvar, Vaginal, Penile, Rectal Cancer",BIOLOGICAL: PDS0101|BIOLOGICAL: M7824|BIOLOGICAL: NHS-IL12,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,51,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/9/20,7/1/26,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Rhabdoid Tumors|INI1-negative Tumors|Synovial Sarcoma|Malignant Rhabdoid Tumor of Ovary,DRUG: Tazemetostat,ALL,CHILD,PHASE1,109,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/7/16,10/22/21,"Children's Hospital of Los Angeles, Los Angeles, California, 90027, United States|University of California San Francisco - Benioff Children's Hospital, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|John Hopkins Kimmel Cancer Center, Baltimore, Maryland, 21287, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Massachusetts General Hospital - Cancer Center, Boston, Massachusetts, 02215, United States|Memorial Sloan Kettering, New York, New York, 10065, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Oregon Health & Science University (OHSU), Portland, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|St. Jude Children's Research Hospital, Inc., Memphis, Tennessee, 38105, United States|UT Southwestern Medical Center, Dallas, Texas, 75235, United States|Texas Children's Cancer and Hematology Center, Houston, Texas, 77098, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|Sydney Children's Hospital, Sydney, New South Wales, 2031, Australia|Lady Cilento/Queensland Children's Hospital, South Brisbane, Queensland, 4101, Australia|The Royal Children's Hospital, Melbourne, Victoria, 3052, Australia|The Childrens Hospital at Westmead Oncology Unit, Westmead, 2145, Australia|The Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|Rigshospitalet Department of Oncology Blegdamsvej, Copenhagen, 2100, Denmark|Institut Curie, Paris, 75248, France|Institut Gustave Roussy, Villejuif, 94800, France|Children's Hospital Augsburg Klinikum, Augsburg, 86156, Germany|Charite - Universitatsmedizin Berlin, Berlin, 13353, Germany|Universitaetsklinikum Heidelberg, Heidelberg, Germany|Westfalische Wilhelms - Universitat Munster Padiatrische, Münster, 48149, Germany|Istituto Giannina Gaslini- UOSD Centro di Neuro-Oncologia, Genova, 16147, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy|Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, Netherlands|Prinses Maxima Centrum voor Kinderoncologie, Utrecht, 3584 EA, Netherlands|Great Ormond Street Hospital for Children NHS Foundation Trust, London, WC1N 3JH, United Kingdom|Central Manchester University Hospital - Royal Manchester Children's Hospital, Manchester, M13 9WL, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Nasal Vestibulitis,DRUG: Placebo Administration|OTHER: Questionnaire Administration|DRUG: Rose Geranium in Sesame Oil Nasal Spray,ALL,"ADULT, OLDER_ADULT",PHASE3,106,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",11/13/20,12/15/22,"Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, 56007, United States|Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, 56401, United States|Essentia Health - Deer River Clinic, Deer River, Minnesota, 56636, United States|Essentia Health Saint Mary's - Detroit Lakes Clinic, Detroit Lakes, Minnesota, 56501, United States|Essentia Health Cancer Center, Duluth, Minnesota, 55805, United States|Essentia Health Ely Clinic, Ely, Minnesota, 55731, United States|Essentia Health - Fosston, Fosston, Minnesota, 56542, United States|Fairview Grand Itasca Clinic &amp; Hospital, Grand Rapids, Minnesota, 55744, United States|Essentia Health Hibbing Clinic, Hibbing, Minnesota, 55746, United States|Fairview Range Medical Center, Hibbing, Minnesota, 55746, United States|Essentia Health - International Falls Clinic, International Falls, Minnesota, 56649, United States|Mayo Clinic Health Systems-Mankato, Mankato, Minnesota, 56001, United States|Monticello Cancer Center, Monticello, Minnesota, 55362, United States|Essentia Health - Park Rapids, Park Rapids, Minnesota, 56470, United States|Fairview Northland Medical Center, Princeton, Minnesota, 55371, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|Essentia Health Sandstone, Sandstone, Minnesota, 55072, United States|Sanford Thief River Falls Medical Center, Thief River Falls, Minnesota, 56701, United States|Essentia Health Virginia Clinic, Virginia, Minnesota, 55792, United States|Sanford Cancer Center Worthington, Worthington, Minnesota, 56187, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostate Cancer|Prostatic Neoplasm,DRUG: 18F-DCFPyL|RADIATION: Tumor Irradiation|RADIATION: Prostate + tumor irradiation|RADIATION: Tumor Irradiation,MALE,"ADULT, OLDER_ADULT",PHASE1,17,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/5/18,1/30/25,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,RECRUITING,YES,Breast Neoplasm Female,DRUG: Paclitaxel,FEMALE,"ADULT, OLDER_ADULT",PHASE4,50,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/13/17,2026-06,"University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, 53792, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Cancer|Breast Neoplasm,DRUG: Pazopanib,FEMALE,"ADULT, OLDER_ADULT",PHASE2,30,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/27/12,10/2/19,"University of California, San Francisco, San Francisco, California, 94143, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Thyroid Neoplasms,DRUG: Lenalidomide,ALL,"ADULT, OLDER_ADULT",PHASE2,25,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2006-02,7/6/10,"University of Kentucky Markey Cancer Center, Lexington, Kentucky, 40536, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Hepatic Metastases|Metastases,DRUG: Everolimus|DEVICE: embolization|DRUG: Doxorubicin,ALL,"ADULT, OLDER_ADULT",PHASE2,74,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2012-12,2019-04,"CHU - Hôtel Dieu, Angers, France|Hôpital Avicenne, Bobigny, France|Hôpital Saint André, Bordeaux, France|Hôpital Côte de Nacre, Caen, France|CHU - Estaing, Clermont-Ferrand, France|Hôpital Beaujon, Clichy, France|Centre GF Leclerc, Dijon, France|CHU - Hôpital François Mitterand, Dijon, France|Hôpital Edouard Herriot, Lyon, France|CHU La Timone, Marseille, France|CHR, Orléans, France|CHU Cochin, Paris, France|Hôpital Européen Georges Pompidou, Paris, France|Hôpital Robert Debré, Reims, France|CHU, Rouen, France|Hôpital Rangueil, Toulouse, France|Hôpital Trousseau, Tours, France|Institut Gustave Roussy, Villejuif, France",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,MPN (Myeloproliferative Neoplasms),DRUG: Itacitinib|DRUG: Ruxolitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,23,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/26/18,6/1/21,"Arizona Oncology Associates, Tempe, Arizona, 85284, United States|UC Irvine Medical Center, Orange, California, 92868, United States|Anschutz Cancer Pavilion - University Of Colorado, Aurora, Colorado, 80045, United States|Rocky Mountain Cancer Center, Colorado Springs, Colorado, 80907, United States|Rocky Mountain Cancer Center, Denver, Colorado, 80218, United States|Norwalk Hospital, Norwalk, Connecticut, 06856, United States|Parkview Research Center, Fort Wayne, Indiana, 46845, United States|University of Michigan Cancer Center, Ann Arbor, Michigan, 48109, United States|Providence Cancer Center, Southfield, Michigan, 48075, United States|Nebraska Cancer Specialist, Omaha, Nebraska, 68124, United States|University Of New Mexico Cancer Center, Albuquerque, New Mexico, 87102, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Willamette Valley Cancer Institute, Eugene, Oregon, 97401, United States|Consultants in Medical Oncology and Hematology, PC, Broomall, Pennsylvania, 19008, United States|Texas Oncology - Round Rock Cancer Center, Round Rock, Texas, 78681, United States|Texas Oncology San Antonio, San Antonio, Texas, 78240, United States|Texas Oncology - Tyler, Tyler, Texas, 75702, United States|University of Virginia, Charlottesville, Virginia, 22908, United States|Ordensklinikum Linz GmbH, Servicestelle für Studien, Linz, 4020, Austria|Paracelsus Medical University Salzburg, Salzburg, A-5020, Austria|Hanusch Hospital, Vienna, 1140, Austria|VU Medical Center, Amsterdam, 1081 HV, Netherlands|Maastricht University Medical Center, Maastricht, 6202, Netherlands|Erasmus Medical Center, Rotterdam, 3015 AA, Netherlands|UMC Utrecht Department of Hematology, Utrecht, 3584, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,MPN (Myeloproliferative Neoplasms),DRUG: Ruxolitinib|DRUG: Anagrelide|DRUG: Placebo|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,12,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",11/14/17,8/3/20,"Mayo Clinic, Phoenix, Arizona, 85054, United States|Pacific Shores Medical Group, Long Beach, California, 90813, United States|University of Southern California, Los Angeles, California, 90033, United States|Ventura County Hematology-Oncology Specialists, Oxnard, California, 93030, United States|Compassionate Cancer Care Medical Group, Riverside, California, 92501, United States|Innovative Clinical Research Institute, Whittier, California, 90603, United States|Bond Clinic, PA, Winter Haven, Florida, 33880, United States|Tift Regional, Tifton, Georgia, 31794, United States|Edward Cancer Center, Naperville, Illinois, 60540, United States|North Shore Cancer Research Association-Skokie, Skokie, Illinois, 60076, United States|Southern Illinois University, Springfield, Illinois, 62702, United States|Clinical Trials of SWLA LLC, Lake Charles, Louisiana, 70601, United States|St. Agnes Hospital, Baltimore, Maryland, 21229, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Summit Medical Group, Morristown, New Jersey, 07960, United States|Columbia Weill Cornell Cancer Centers - Herbert Irving Comprehensive Cancer Center (HICCC), New York, New York, 10032, United States|Montefiore Medical Center, The Bronx, New York, 10467, United States|Waverly Hem Onc, Cary, North Carolina, 27518, United States|Vidant Medical Center, Greenville, North Carolina, 27858, United States|Gabrail Cancer Center- Canton Facility, Canton, Ohio, 44718, United States|INTEGRIS Southwest Medical Center, Oklahoma City, Oklahoma, 73109, United States|INTEGRIS Cancer Institute Proton Campus, Oklahoma City, Oklahoma, 73142, United States|Kaiser Permanente Northwest, Portland, Oregon, 97227, United States|Geisinger - Knapper Clinic, Danville, Pennsylvania, 17822, United States|Prairie Lakes Health Care System Inc., Watertown, South Dakota, 57201, United States|Renovatio Clinical, The Woodlands, Texas, 77401, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Malignant Neoplasm in the Lung|Metastatic Osteosarcoma|Recurrent Osteosarcoma,BIOLOGICAL: Dinutuximab|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|BIOLOGICAL: Sargramostim,ALL,"CHILD, ADULT",PHASE2,41,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/4/16,9/30/23,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Phoenix Childrens Hospital, Phoenix, Arizona, 85016, United States|Arkansas Children's Hospital, Little Rock, Arkansas, 72202-3591, United States|Kaiser Permanente Downey Medical Center, Downey, California, 90242, United States|Loma Linda University Medical Center, Loma Linda, California, 92354, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Valley Children's Hospital, Madera, California, 93636, United States|UCSF Benioff Children's Hospital Oakland, Oakland, California, 94609, United States|Kaiser Permanente-Oakland, Oakland, California, 94611, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|Lucile Packard Children's Hospital Stanford University, Palo Alto, California, 94304, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver, Colorado, 80218, United States|Connecticut Children's Medical Center, Hartford, Connecticut, 06106, United States|Yale University, New Haven, Connecticut, 06520, United States|Alfred I duPont Hospital for Children, Wilmington, Delaware, 19803, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|University of Florida Health Science Center - Gainesville, Gainesville, Florida, 32610, United States|Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, 32207, United States|Nicklaus Children's Hospital, Miami, Florida, 33155, United States|Arnold Palmer Hospital for Children, Orlando, Florida, 32806, United States|Nemours Children's Hospital, Orlando, Florida, 32827, United States|Nemours Children's Clinic - Pensacola, Pensacola, Florida, 32504, United States|Johns Hopkins All Children's Hospital, St. Petersburg, Florida, 33701, United States|Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida, 33607, United States|Saint Mary's Hospital, West Palm Beach, Florida, 33407, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, 30322, United States|Memorial Health University Medical Center, Savannah, Georgia, 31404, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, 83712, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|University of Illinois, Chicago, Illinois, 60612, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Saint Jude Midwest Affiliate, Peoria, Illinois, 61637, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana, 46260, United States|Blank Children's Hospital, Des Moines, Iowa, 50309, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, 40536, United States|Norton Children's Hospital, Louisville, Kentucky, 40202, United States|Ochsner Medical Center Jefferson, New Orleans, Louisiana, 70121, United States|Eastern Maine Medical Center, Bangor, Maine, 04401, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, 21215, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, 21287, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|Ascension Saint John Hospital, Detroit, Michigan, 48236, United States|Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, Michigan, 49503, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States|Beaumont Children's Hospital-Royal Oak, Royal Oak, Michigan, 48073, United States|Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota, 55404, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Children's Mercy Hospitals and Clinics, Kansas City, Missouri, 64108, United States|Cardinal Glennon Children's Medical Center, St Louis, Missouri, 63104, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Children's Hospital and Medical Center of Omaha, Omaha, Nebraska, 68114, United States|University of Nebraska Medical Center, Omaha, Nebraska, 68198, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Sunrise Hospital and Medical Center, Las Vegas, Nevada, 89109, United States|Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada, 89135, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, 89144, United States|Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, 03756, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Albany Medical Center, Albany, New York, 12208, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, 10016, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|University of Rochester, Rochester, New York, 14642, United States|State University of New York Upstate Medical University, Syracuse, New York, 13210, United States|Montefiore Medical Center - Moses Campus, The Bronx, New York, 10467, United States|New York Medical College, Valhalla, New York, 10595, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, 28203, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Sanford Broadway Medical Center, Fargo, North Dakota, 58122, United States|Children's Hospital Medical Center of Akron, Akron, Ohio, 44308, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Rainbow Babies and Childrens Hospital, Cleveland, Ohio, 44106, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Dayton Children's Hospital, Dayton, Ohio, 45404, United States|ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio, 43606, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|BI-LO Charities Children's Cancer Center, Greenville, South Carolina, 29605, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, 57117-5134, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|The Children's Hospital at TriStar Centennial, Nashville, Tennessee, 37203, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, 78723, United States|Driscoll Children's Hospital, Corpus Christi, Texas, 78411, United States|Medical City Dallas Hospital, Dallas, Texas, 75230, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, 75390, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Covenant Children's Hospital, Lubbock, Texas, 79410, United States|Children's Hospital of San Antonio, San Antonio, Texas, 78207, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|Primary Children's Hospital, Salt Lake City, Utah, 84113, United States|University of Vermont and State Agricultural College, Burlington, Vermont, 05405, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, 23507, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, 99204, United States|Madigan Army Medical Center, Tacoma, Washington, 98431, United States|West Virginia University Healthcare, Morgantown, West Virginia, 26506, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 53226, United States|John Hunter Children's Hospital, Hunter Regional Mail Centre, New South Wales, 2310, Australia|Sydney Children's Hospital, Randwick, New South Wales, 2031, Australia|The Children's Hospital at Westmead, Westmead, New South Wales, 2145, Australia|Queensland Children's Hospital, South Brisbane, Queensland, 4101, Australia|Women's and Children's Hospital-Adelaide, North Adelaide, South Australia, 5006, Australia|Monash Medical Center-Clayton Campus, Clayton, Victoria, 3168, Australia|Royal Children's Hospital, Parkville, Victoria, 3052, Australia|Princess Margaret Hospital for Children, Perth, Western Australia, 6008, Australia|Alberta Children's Hospital, Calgary, Alberta, T3B 6A8, Canada|CancerCare Manitoba, Winnipeg, Manitoba, R3E 0V9, Canada|IWK Health Centre, Halifax, Nova Scotia, B3K 6R8, Canada|Children's Hospital, London, Ontario, N6A 5W9, Canada|Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|The Montreal Children's Hospital of the MUHC, Montreal, Quebec, H3H 1P3, Canada|Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, H3T 1C5, Canada|CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL), Québec, G1V 4G2, Canada|Starship Children's Hospital, Grafton, Auckland, 1145, New Zealand|Christchurch Hospital, Christchurch, 8011, New Zealand|University Pediatric Hospital, San Juan, 00926, Puerto Rico",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: lenvatinib|DRUG: Tislelizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,58,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/18/21,7/10/24,"The Second Hospital of Anhui Medical University, Hefei, Anhui, 230601, China|Peking University First Hospital, Beijing, Beijing Municipality, 100034, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing Municipality, 100050, China|Beijing Cancer Hospital, Beijing, Beijing Municipality, 100142, China|Beijing Luhe Hospital, Capital Medical University, Beijing, Beijing Municipality, 101149, China|Chongqing Cancer Hospital, Chongqing, Chongqing Municipality, 400030, China|The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530021, China|Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China|Hunan Cancer Hospital, Changsha, Hunan, 410013, China|Jiangsu Province Cancer Hospital, Nanjing, Jiangsu, 210008, China|The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi, 330006, China|Zhejiang Provincial Peoples Hospital, Hangzhou, Zhejiang, 310014, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Cancer, Solid Tumor",BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,1260,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/4/11,12/11/18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Papillomavirus Infections|Uterine Cervical Neoplasms|Vulvar Neoplasms|Vaginal Neoplasms|Adenocarcinoma in Situ|Condylomata Acuminata,BIOLOGICAL: 9vHPV vaccine,ALL,"CHILD, ADULT",PHASE3,201,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,6/29/18,1/29/19,"National Institute of Hygiene and Epidemiology ( Site 0001), Hanoi, 100000, Vietnam",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Solid Tumors|Lymphomas,BIOLOGICAL: tTF-NGR,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/1/17,11/5/19,"University Hospital Muenster, Münster, North Rhine-Westphalia, 48149, Germany",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Oncology|MET Gene Amplification|NSCLC|MET Gene Mutation|Non Small Cell Lung Cancer,DRUG: Sym015,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,57,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2016-03,2020-12,"University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, 46202, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute/D -1251, Boston, Massachusetts, 02215, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas, 78229, United States|Rigshospitalet, Copenhagen, 2100, Denmark|Queen Mary Hospital, Hong Kong, Hong Kong|CHA Bundang Medical Center, CHA University, Seongnam-si, Gyeonggi-do, 13496, South Korea|Severance Hospital, Yonsei University Health System, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Gangnam Severance Hospital, Yonsei University Health System, Seoul, 06273, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|Korea University Guro Hospital, Seoul, 08308, South Korea|Hospital Universitario Quiron Dexeus, Barcelona, Barcelona/Cataluna, 08028, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Barcelona/Cataluna, 08035, Spain|Hospital Clinic de Barcelona, Barcelona, Barcelona/Cataluna, 08036, Spain|Centro Oncologico MD Anderson, Madrid, 28033, Spain|China Medical University Hospital, Taichung, 40447, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Cheng Kung University Hospital, Tainan, 70403, Taiwan|Taipei Medical University Hospital, Taipei, 11031, Taiwan|Tri-Service General Hospital, Taipei, 11490, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor,DRUG: RP-1664,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,29,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/14/24,8/27/25,"Participating Site 1025, San Francisco, California, 94143, United States|Participating Site 1012, New Haven, Connecticut, 06519, United States|Participating Site 1008, New York, New York, 10032, United States|Participating Site 1004, New York, New York, 10065, United States|Participating Site 4001, Copenhagen, Denmark",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Lung Cancer|Untreated Stage IV or Recurrent Squamous Cell Lung Cancers,DRUG: albumin-bound paclitaxel|DRUG: gemcitabine,ALL,"ADULT, OLDER_ADULT",PHASE2,40,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2015-08,2019-05,"Miami Cancer Institute Baptist Health South Florida, Miami, Florida, 33143, United States|Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Commack, Commack, New York, 11725, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States|Memorial Sloan Kettering Westchester, Sleepy Hollow, New York, 10591, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Metastatic Solid Neoplasm|Lymphoma,DRUG: SYNB1891|DRUG: Atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,32,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/12/19,12/9/21,"University of Colorado School of Medicine, Aurora, Colorado, 80045, United States|Hackensack University John Theurer Cancer Center, Hackensack, New Jersey, 07601, United States|Ohio State University College of Medicine, Columbus, Ohio, 43210, United States|University of Pittsburgh Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Mary Crowley Cancer Research, Dallas, Texas, 75230, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,High Tumor Mutation Burden|High TMB (Tumor Mutation Burden)|MSS (Microsatellite Stable),DRUG: MK-3475,ALL,"ADULT, OLDER_ADULT",PHASE2,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/25/18,2/5/25,"Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21231, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Ohio State University, Columbus, Ohio, 43210, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Urinary Bladder Neoplasms,DRUG: Gemcitabine|DRUG: Paclitaxel|DRUG: Cisplatin,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2015-10,9/14/17,"UTHealth Memorial Hermann Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor,DRUG: AFM24|DRUG: Atezolizumab 840 MG in 14 ML Injection,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,112,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/19/21,6/11/25,"USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Independent Public Teaching Hospital #4 in Lublin, Department of Clinical Oncology and Chemotherapy, Lublin, 20-954, Poland|European Health Center Otwock Fryderyk Chopin Hospital, Department of Clinical Oncology, Otwock, 05-400, Poland|MED-Polonia, Sp. z o.o. (LLC), Poznan, 60-693, Poland|Janusz Korczak Provincial Specialist Hospital in Slupsk Limited Liability Company, Słupsk, 76-200, Poland|Maria Sklodowska-Curie - National Research Institute of Oncology, Early Phase Research Department, Warsaw, 02-781, Poland|Seoul National University Bundang Hospital, Seongnam-si, 13620, South Korea|Severance Hospital, Yonsei University Health System, Seoul, 03722, South Korea|The Catholic University of Korea St. Vincent's Hospital, Suwon, 93, South Korea|Vall d'Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain|University Hospital Quiron Madrid, Madrid, 28223, Spain|University Clinic of Navarra - Pamplona, Pamplona, 31008, Spain|Hospital Clinic Universitario Biomedical Research institute INCLIVA, Valencia, 46010, Spain|Royal Marsden NHS Foundation Trust - ICR, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: [14C]Berzosertib|DRUG: Berzosertib|DRUG: Topotecan,ALL,"ADULT, OLDER_ADULT",PHASE1,6,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/15/22,6/28/23,"Magyar Honvédség Egészségügyi Központ, Podmaniczky utcai telephely, Onkológiai Osztály, Budapest, Hungary|PRA Magyarország Kft. Fázis I-es Klinikai Farmakológiai Vizsgálóhely, Budapest, Hungary",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastroenteropancreatic Neuroendocrine Tumor,DRUG: Lanreotide autogel,ALL,"ADULT, OLDER_ADULT",PHASE3,43,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/24/21,1/13/23,"Cancer Hospital Chinese Academy of Sciences, Beijing, Beijing Municipality, 100021, China|Beijing Cancer Hospital, Beijing, Beijing Municipality, 100142, China|Peking University Third Hospital, Beijing, Beijing Municipality, 100191, China|The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, 510080, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150081, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China|Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, 430030, China|Qilu Hospital Of Shandong University, Jinan, Shandong, 250012, China|Zhongshan Hospital Affiliated to Fudan University, Shanghai, Shanghai Municipality, 200032, China|Fudan University Shanghai Cancer Centre, Shanghai, Shanghai Municipality, 200433, China|The First Affiliated Hospital Of Xi'an Jiaotong University, Xi’an, Shanxi, 710061, China|West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, China|The second affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China|The First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310058, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cholangiocarcinoma|Urothelial Cancer|Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors|Primary CNS Tumors|Breast Cancer|Gastric Cancer,DRUG: Futibatinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,407,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/21/14,10/22/24,"Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Mayo Clinic (AZ), Scottsdale, Arizona, 85259, United States|The University of Arizona Cancer Center - North Campus, Tucson, Arizona, 85719, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|UCSF Helen Diller Family Comprehensive Cancer Center. Mission Bay, San Francisco, California, 94158, United States|Cancer Treatment Centers of America, Newnan, Georgia, 30265, United States|Cancer Treatment Centers of America Zion, IL, Zion, Illinois, 60099, United States|The University of Kansas Cancer Center, Fairway, Kansas, 66205, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institution, Boston, Massachusetts, 02215, United States|Wayne State Universtity (Karmanos Cancer Institute), Detroit, Michigan, 48201, United States|Mayo Clinic (MN), Rochester, Minnesota, 55905, United States|New Mexico Cancer Care Alliancer, Albuquerque, New Mexico, 87106, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Sidney Kimmel Cancer Center at Jefferson, Philadelphia, Pennsylvania, 19107, United States|University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Greenville Health System ITOR,Clinical Research Unit, Greenville, South Carolina, 29605, United States|Spartanburg Medical Center, Spartanburg, South Carolina, 29303, United States|Mary Crowley Cancer Research - Medical City, Dallas, Texas, 75230, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Utah, Huntsman Cancer Hospital, Salt Lake City, Utah, 84112, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22903, United States|Virginia Mason Cancer Center, Seattle, Washington, 98101, United States|University of Wisconsin Clinical Science Center, Madison, Wisconsin, 53792, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Royal Melbourne Hospital, Melbourne, Australia|Sunnybrook Research Institue, Toronto, M4N3M5, Canada|Centre Léon Bérard Bât, Lyon, Cedex, 69373, France|Institut Bergonie, Bordeaux, 33076, France|Hospices Civils de Lyon, Bron, 69677, France|Pitié-Salpêtrière Hospital, Paris, 75013, France|Rennes, Centre Eugène Marquis, Rennes, 35042, France|Institute Goustave-Roussy-DITEP, Villejuif, 94805, France|University Hospital Essen, West German Cancer Center, Department of Medical Oncology, Essen, 45147, Germany|The Chinese University of Hong Kong, Shatin, Hong Kong|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milan, 20133, Italy|UOC Oncologia Medica 1 I""V - Istituto Oncologico Veneto - IRCCS, Padua, 35128, Italy|Hokkaido University Hospital, Hokkaido, 060-8648, Japan|Kyoto University Hospital, Department of Clinical Pharmacology and Therapeutics, Kyoto, 606-8507, Japan|Tohoku University Hospital, Miyagi, 980-8574, Japan|Osaka International Cancer Institute, Osaka, 541-8567, Japan|National Cancer Center Hospital, Tokyo, 104-0045, Japan|University Hospital Jenna, Jenna, 07740, Netherlands|Yonsei University, Severance Hospital (Seoul), Seoul, 03722, South Korea|ASAN Medical Center (Seoul), Seoul, 05505, South Korea|Samsung Medical Center (Seoul), Seoul, 06351, South Korea|Seoul National University Hospital, Seoul, 110-744, South Korea|Val D'Hebron University Hospital, Barcelona, 08035, Spain|Hospital Clinic i Provincial de Barcelona,, Barcelona, 08036, Spain|University Hospital Ramón y Cajal, Madrid, 28034, Spain|Centro Integral Oncológico Clara Campal - Hospital Universitario Madrid Sanchinarro, Madrid, Spain|Cheng Kung University Hospital, Tainan, 704, Taiwan|National Taiwan University Hospital, Taipei, 10048, Taiwan|Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, United Kingdom|Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom|University College London Hospital, London, W1T 7HA, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Solid Tumor, Adult",DRUG: IMSA101|DRUG: Immune checkpoint inhibitor (ICI)|DRUG: Immuno-oncology (IO) therapy,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,40,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/23/19,9/15/23,"Honor Health, Scottsdale, Arizona, 85260, United States|UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States|Northwestern University, Chicago, Illinois, 60611, United States|Atlantic Health System/Morristown Medical Center, Morristown, New Jersey, 07962, United States|UT Southwestern, Dallas, Texas, 75390, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Adenocarcinoma, Gastric|Neoplasm, Breast",DRUG: DS-8201a,ALL,"ADULT, OLDER_ADULT",PHASE1,12,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/2/18,9/28/22,"National Taiwan University Hospital, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Taipei, 112, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: IMGC936,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,56,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/29/20,12/28/23,"UCSD, La Jolla, California, 92037, United States|Sarah Cannon Research Institute, Denver, Colorado, 80218, United States|Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Washington University, St Louis, Missouri, 63110, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Policlinico di Modena, Modena, 41124, Italy|IRCCS Humanitas, Rozzano, 20089, Italy|Azienda Ospedaliera Universitaria Senese, Siena, 53100, Italy|START Madrid-FJD Hospital Universitario Fundacion Jimenez Diaz, Madrid, 28040, Spain|START Madrid-HM CIOCC, Madrid, 28050, Spain|Hospital Universitario Quirónsalud Madrid, Madrid, 28223, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Relapsed or Refractory Solid Tumors,DRUG: Lenvatinib,ALL,"CHILD, ADULT",PHASE2,127,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/30/20,2/13/25,"Children's Hospital of Colorado ( Site 0110), Aurora, Colorado, 80045, United States|Cleveland Clinic ( Site 0119), Cleveland, Ohio, 44195, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt ( Site 0102), Nashville, Tennessee, 37232, United States|Mary Crowley Cancer Research Center ( Site 0107), Dallas, Texas, 75230, United States|Hospital Universitario Austral ( Site 0126), Pilar, Buenos Aires, B1629ODT, Argentina|Hospital de Niños Ricardo Gutiérrez ( Site 0125), Buenos Aires, Buenos Aires F.D., C1425EFD, Argentina|Sydney Children's Hospital ( Site 0801), Randwick, New South Wales, 2031, Australia|Queensland Children s Hospital ( Site 0804), Brisbane, Queensland, 4101, Australia|Royal Childrens Hospital Melbourne ( Site 0802), Parkville, Victoria, 3052, Australia|Perth Children s Hospital ( Site 0803), Nedlands, Western Australia, 6009, Australia|UZ Gent ( Site 0250), Ghent, Oost-Vlaanderen, 9000, Belgium|Klinicki bolnicki centar Rijeka ( Site 0726), Rijeka, Primorje-Gorski Kotar County, 51000, Croatia|Klinika za djecje bolesti Zagreb ( Site 0725), Zagreb, Zagreb County, 10000, Croatia|Fakultni Nemocnice Brno Bohunice ( Site 0651), Brno, Brno-mesto, 613 00, Czechia|Fakultni nemocnice v Motole ( Site 0650), Prague, 150 06, Czechia|Centre Leon-Berard ( Site 0326), Lyon, Auvergne, 69008, France|Hopital La Timone ( Site 0328), Marseille, Bouches-du-Rhone, 13005, France|Gustave Roussy ( Site 0327), Villejuif, Val-de-Marne, 94800, France|Institut Curie ( Site 0325), Paris, 75005, France|Unidad Nacional de Oncologia Pediatrica ( Site 0176), Guatemala City, 01011, Guatemala|Medi-K Cayala ( Site 0177), Guatemala City, 01016, Guatemala|Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi OktatoKorhaz ( Site 0678), Miskolc, Borsod-Abauj Zemplen county, 3526, Hungary|Semmelweis University ( Site 0675), Budapest, 1094, Hungary|Debreceni Egyetem Klinikai Kozpont ( Site 0677), Debrecen, 4032, Hungary|Chaim Sheba Medical Center ( Site 0500), Ramat Gan, 5265601, Israel|IRCCS Ospedale Pediatrico Bambino Gesu ( Site 0410), Rome, Roma, 00165, Italy|A.O.Universitaria Meyer-Oncology & Haematology Unit ( Site 0400), Florence, Tuscany, 50139, Italy|Istituto Giannina Gaslini ( Site 0411), Genova, 16147, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 0401), Milan, 20133, Italy|Ospedale Infantile Regina Margherita ( Site 0412), Torino, 10126, Italy|Starship Childrens Hospital ( Site 0826), Auckland, 1023, New Zealand|Clinica Anglo Americana ( Site 0203), San Isidro, Lima region, 15073, Peru|Dmitry Rogachev National Research Center ( Site 0550), Moscow, Moscow, 117198, Russia|St.Petersburg State Medical Univ. n.a. acad. I.P.Pavlov ( Site 0554), Saint Petersburg, Sankt-Peterburg, 197022, Russia|Clinical Research Center of specialized types medical care-Oncology ( Site 0553), Saint Petersburg, Sankt-Peterburg, 197758, Russia|Institute for Oncology and Radiology of Serbia ( Site 0780), Belgrade, Beograd, 11000, Serbia|Univerzitetska decja klinika ( Site 0782), Belgrade, Beograd, 11000, Serbia|Wits Clinical Research ( Site 0579), Soweto, Gauteng, 2013, South Africa|Cancercare Rondebosch Oncology ( Site 0575), Cape Town, Western Cape, 7700, South Africa|Tygerberg Hospital ( Site 0578), Parow, Western Cape, 7505, South Africa|Asan Medical Center ( Site 0876), Songpagu, Seoul, 05505, South Korea|Seoul National University Hospital ( Site 0875), Seoul, 03080, South Korea|Hospital Universitario Sant Joan de Deu ( Site 0476), Esplugues de Llobregat, Barcelona, 08950, Spain|Hospital Nino Jesus ( Site 0477), Madrid, 28009, Spain|Skanes Universitetssjukhus Lund. ( Site 0525), Lund, Skåne County, 221 85, Sweden|Hacettepe Universitesi Tip Fakultesi ( Site 0603), Ankara, 06100, Turkey (Türkiye)|Istanbul Universitesi Onkoloji Enstitusu ( Site 0600), Istanbul, 34093, Turkey (Türkiye)|Ege Universitesi Tip Fakultesi ( Site 0601), Izmir, 35040, Turkey (Türkiye)|Dokuz Eylul Universitesi Arastirma Uygulama Hastanesi ( Site 0602), Izmir, 35330, Turkey (Türkiye)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Metastatic dMMR Solid Cancer|Solid Tumor|Cancer|Metastatic Solid Tumor,DRUG: Sirolimus 2mg Tablet,ALL,"ADULT, OLDER_ADULT",PHASE2,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/16/20,5/16/23,"Montefiore Medical Center, The Bronx, New York, 10461, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors and Lymphomas,DRUG: Alobresib|DRUG: Exemestane|DRUG: Fulvestrant,ALL,"ADULT, OLDER_ADULT",PHASE1,33,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/16/15,10/11/17,"Scottsdale, Arizona, United States|Fort Wayne, Indiana, United States|Goshen, Indiana, United States|San Antonio, Texas, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Head and Neck Neoplasm,RADIATION: 50 Gy Radiation Therapy|RADIATION: 55 Gy Radiation Therapy|RADIATION: 60 Gy Radiation Therapy|DRUG: Concurrent Atezolizumab|DRUG: Adjuvant Atezolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,18,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/26/21,4/14/25,"Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,BIOLOGICAL: HS-110 (viagenpumatucel-L)|BIOLOGICAL: HS-130,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/18/19,4/1/22,"Providence Portland Medical Center, Portland, Oregon, 97213, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor|Lymphoma,DRUG: CX-072|DRUG: ipilimumab|DRUG: vemurafenib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,196,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/19/17,10/27/20,"PROCLAIM Investigative Site, Los Angeles, California, 90025, United States|PROCLAIM Investigative Site, Los Angeles, California, 90033, United States|PROCLAIM Investigative Site, New Haven, Connecticut, 06520, United States|PROCLAIM Investigative Site, Chicago, Illinois, 60612, United States|PROCLAIM Investigative Site, Indianapolis, Indiana, 46202, United States|PROCLAIM Investigative Site, Boston, Massachusetts, 02215, United States|PROCLAIM Investigative Site, Detroit, Michigan, 48201, United States|PROCLAIM Investigative Site, New York, New York, 10016, United States|PROCLAIM Investigative Site, New York, New York, 10032, United States|PROCLAIM Investigative Site, New York, New York, 10065, United States|PROCLAIM Investigative Site, Portland, Oregon, 97213, United States|PROCLAIM Investigative Site, Nashville, Tennessee, 37203, United States|PROCLAIM Investigative Site, Dallas, Texas, 75230, United States|PROCLAIM Investigative Site, Houston, Texas, 77030, United States|PROCLAIM Investigative Site, Fairfax, Virginia, 22031, United States|PROCLAIM Investigative Site, Madison, Wisconsin, 53579, United States|PROCLAIM Investigative Site, Amsterdam, 1007, Netherlands|PROCLAIM Investigative Site, Groningen, 9713 GZ, Netherlands|PROCLAIM Investigative Site, Rotterdam, 3000 CA, Netherlands|PROCLAIM Investigative Site, Katowice, 40-960, Poland|PROCLAIM Investigative Site, Pamplona, Navarre, 31008, Spain|PROCLAIM Investigative Site, Barcelona, 08908, Spain|PROCLAIM Investigative Site, Barcelona, 8036, Spain|PROCLAIM Investigative Site, Madrid, 28046, Spain|PROCLAIM Investigative Site, Madrid, 28050, Spain|PROCLAIM Investigative Ssite, Valencia, 46009, Spain|PROCLAIM Investigative Site, Dnipro, 49102, Ukraine|PROCLAIM Invetigative Site, Glasgow, G12 0YN, United Kingdom|PROCLAIM Investigative Site, London, W1G 6AD, United Kingdom|PROCLAIM Investigative Site, Manchester, M20 4BX, United Kingdom|PROCLAIM Investigative Site, Newcastle upon Tyne, NE7 7DN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Solid Tumor, Adult",DRUG: Pembrolizumab 200 mg Q3W,ALL,"ADULT, OLDER_ADULT",PHASE2,52,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/3/17,3/19/22,"Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, 33176, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Central Nervous System Tumors,DRUG: 25 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)|DRUG: 50 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)|DRUG: 100 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)|DRUG: 150 mg/m2 Lenalidomide (Revlimid®) and 180 mg/m2 Vorinostat (Zolinza®)|DRUG: 150 mg/m2 Lenalidomide (Revlimid®) and 230 mg/m2 Vorinostat (Zolinza®),ALL,"CHILD, ADULT",PHASE1,8,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/10/16,12/19/18,"Johns Hopkins All Childen's Hospital, St. Petersburg, Florida, 33701, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Biliary Tract Neoplasms,DRUG: Durvalumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,810,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",4/16/19,12/31/25,"Research Site, Los Angeles, California, 90027, United States|Research Site, Orange, California, 92868, United States|Research Site, Washington D.C., District of Columbia, 20007, United States|Research Site, Fort Myers, Florida, 33905, United States|Research Site, St. Petersburg, Florida, 33705, United States|Research Site, Westwood, Kansas, 66205, United States|Research Site, Louisville, Kentucky, 40202, United States|Research Site, Burlington, Massachusetts, 01805, United States|Research Site, St Louis, Missouri, 63110, United States|Research Site, Chapel Hill, North Carolina, 27514, United States|Research Site, Portland, Oregon, 97213, United States|Research Site, Philadelphia, Pennsylvania, 19111, United States|Research Site, Chattanooga, Tennessee, 37404, United States|Research Site, Nashville, Tennessee, 37203, United States|Research Site, Seattle, Washington, 98109, United States|Research Site, Buenos Aires, C1118AAT, Argentina|Research Site, Buenos Aires, C1426ANZ, Argentina|Research Site, CABA, C1012AAR, Argentina|Research Site, CABA, C1019ABS, Argentina|Research Site, Ciudad de Buenos Aires, 1280, Argentina|Research Site, Rosario, 2000, Argentina|Research Site, San Salvador de Jujuy, 4600, Argentina|Research Site, Burgas, 8000, Bulgaria|Research Site, Sofia, 1330, Bulgaria|Research Site, Sofia, 1407, Bulgaria|Research Site, Sofia, 1606, Bulgaria|Research Site, Varna, 9010, Bulgaria|Research Site, Santiago, 7630370, Chile|Research Site, Temuco, 4810218, Chile|Research Site, Baoding, 071000, China|Research Site, Beijing, 100021, China|Research Site, Beijing, 100142, China|Research Site, Bengbu, 233004, China|Research Site, Chongqing, 400038, China|Research Site, Foshan, 528000, China|Research Site, Guangzhou, 510062, China|Research Site, Hangzhou, 310003, China|Research Site, Hangzhou, 310009, China|Research Site, Harbin, 150081, China|Research Site, Hefei, 230001, China|Research Site, Hefei, 230601, China|Research Site, Jinan, 250014, China|Research Site, Nanchang, 330006, China|Research Site, Nanjing, 210002, China|Research Site, Shandong, China|Research Site, Shanghai, 200032, China|Research Site, Shenyang, 100003, China|Research Site, Suzhou, 215004, China|Research Site, Xi'an, 710061, China|Research Site, Zhengzhou, 450008, China|Research Site, Zhuhai, 519000, China|Research Site, Clichy, 92210, France|Research Site, Dijon, 21079, France|Research Site, Montpellier, 34295, France|Research Site, Nice, 6189, France|Research Site, Paris, 75571, France|Research Site, Pessac, 33604, France|Research Site, Poitiers, 86021, France|Research Site, Hong Kong, 00000, Hong Kong|Research Site, Hong Kong, 150001, Hong Kong|Research Site, Hong Kong, Hong Kong|Research Site, Kowloon, Hong Kong|Research Site, Gurgaon, 122001, India|Research Site, Kolkata, 700160, India|Research Site, Mumbai, 400012, India|Research Site, New Delhi, 110085, India|Research Site, Faenza, 48018, Italy|Research Site, Florence, 50134, Italy|Research Site, Milan, 20132, Italy|Research Site, Napoli, 80131, Italy|Research Site, Roma, 00168, Italy|Research Site, Verona, 37134, Italy|Research Site, Chūōku, 104-0045, Japan|Research Site, Kashiwa, 227-8577, Japan|Research Site, Kitaadachi-gun, 362-0806, Japan|Research Site, Mitaka-shi, 181-8611, Japan|Research Site, Osaka, 541-8567, Japan|Research Site, Suita-shi, 565-0871, Japan|Research Site, Wakayama, 641-8510, Japan|Research Site, Yokohama, 241-8515, Japan|Research Site, Gdansk, 80-952, Poland|Research Site, Lodz, 93-513, Poland|Research Site, Olsztyn, 10-228, Poland|Research Site, Poznan, 60-780, Poland|Research Site, Warsaw, 02-106, Poland|Research Site, Wroclaw, 50-556, Poland|Research Site, Barnaul, 656049, Russia|Research Site, Kostroma, 156005, Russia|Research Site, Moscow, 115478, Russia|Research Site, Moscow, 121467, Russia|Research Site, Moscow, 125284, Russia|Research Site, Omsk, 644033, Russia|Research Site, Saint Petersburg, 197022, Russia|Research Site, Saint Petersburg, 197758, Russia|Research Site, Seongnam-si, 13620, South Korea|Research Site, Seoul, 03080, South Korea|Research Site, Seoul, 03722, South Korea|Research Site, Seoul, 06351, South Korea|Research Site, Seoul, 06591, South Korea|Research Site, Seoul, 152-703, South Korea|Research Site, Chiayi City, 613, Taiwan|Research Site, Kaohsiung City, 82445, Taiwan|Research Site, Kaohsiung City, 83301, Taiwan|Research Site, Taichung, 40705, Taiwan|Research Site, Tainan, 704, Taiwan|Research Site, Taipei, 10050, Taiwan|Research Site, Taipei, 11217, Taiwan|Research Site, Taoyuan District, 333, Taiwan|Research Site, Bangkok, 10330, Thailand|Research Site, Bangkok, 10400, Thailand|Research Site, Hat Yai, 90110, Thailand|Research Site, Khon Kaen, 40002, Thailand|Research Site, Muang, 50200, Thailand|Research Site, Si Sa Ket, 33000, Thailand|Research Site, Ankara, 06100, Turkey (Türkiye)|Research Site, Istanbul, 34030, Turkey (Türkiye)|Research Site, Izmir, 35100, Turkey (Türkiye)|Research Site, Mersin, 33110, Turkey (Türkiye)|Research Site, Bristol, BS2 8ED, United Kingdom|Research Site, Cambridge, CB2 0QQ, United Kingdom|Research Site, London, NW3 2QG, United Kingdom|Research Site, London, W12 0NN, United Kingdom|Research Site, Manchester, M20 4BX, United Kingdom|Research Site, Oxford, OX3 7LE, United Kingdom|Research Site, Romford, RM7 0AG, United Kingdom|Research Site, Sheffield, S10 2SJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor,DRUG: 14 mg AFM24|DRUG: 40 mg AFM24|DRUG: 80 mg AFM24|DRUG: 160 mg AFM24|DRUG: 320 mg AFM24|DRUG: 480 mg AFM24|DRUG: 720 mg AFM24,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,85,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/7/20,6/24/24,"University of Southern California, Los Angeles, California, 90033, United States|Dana Faber Cancer Institute, Boston, Massachusetts, 02215, United States|Nordwest Hospital GmbH, Frankfurt am Main, Hesse, 60488, Germany|University Duisburg-Essen, University Hospital Essen, Essen, 45147, Germany|University Hospital Hamburg-Eppendorf, Hamburg, 20246, Germany|Seoul National University Bundang Hospital, Seongnam-si, 13620, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|The Catholic University of Korea St. Vincent's Hospital, Suwon, South Korea|Vall d'Hebron Institute of Oncology, Barcelona, 08035, Spain|University Hospital Foundation Jimenez Diaz, Madrid, 28040, Spain|University Hospital HM Sanchinarro, Madrid, 28050, Spain|Hospital Clinic Universitario Biomedical Research institute INCLIVA, Valencia, 46010, Spain|Institute of Cancer Research - Royal Marsden, London, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Recurrent and Refractory Solid Tumors,DRUG: Lenvatinib|DRUG: Everolimus,ALL,"CHILD, ADULT",PHASE1|PHASE2,64,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/16/17,9/30/22,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|Loma Linda University Medical Center, Loma Linda, California, 92350, United States|Miller Children's and Women's Hospital, Long Beach, California, 90806, United States|Children's Hospital of Los Angeles, Los Angeles, California, 90027, United States|Southern California Permanente Medical Group, Los Angeles, California, 90027, United States|Kaiser Permenente, Oakland, California, 94611, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center at Mission Bay - Pediatric Oncology, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Nemours/ Alfred I. duPont Hospital for Children, Wilmington, Delaware, 19803, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, 33908, United States|University of Florida, Gainesville, Florida, 32610, United States|Nicklaus Children's Hospital, Miami, Florida, 33155, United States|Kapi'olani Medical Center, Honolulu, Hawaii, 96826, United States|St Jude Midwest Affiliate, Peoria, Illinois, 61637, United States|Riley Hospital for Children - Indiana University, Indianapolis, Indiana, 46202, United States|University of Louisville and Norton Children's Hospital, Louisville, Kentucky, 40202, United States|Johns Hopkins, Baltimore, Maryland, 21287, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|CS Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Children's Mercy Hospital and Clinics, Kansas City, Missouri, 64108, United States|Alliance for Childhood Diseases, Las Vegas, Nevada, 89135, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Morristown Medical Center, Morristown, New Jersey, 07960, United States|Rutgers cancer Institute of NJ, New Brunswick, New Jersey, 08901, United States|Cohen Children's Medical Center, New Hyde Park, New York, 11040, United States|Columbia University/Herbert Irving Cancer Center, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|New York Medical College, Valhalla, New York, 10595, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37232, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, 78723, United States|The University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States|Texas Children's Hospital, Houston, Texas, 77030, United States|The Children's Hospital of San Antonio, San Antonio, Texas, 78207, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, 23507, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|IWK Health Centre, Halifax, Nova Scotia, B3K 6R8, Canada|Hospital for Sick Children, Toronto, Ontario, M5G 1X8, Canada|Montreal Children's Hospital, Montreal, Quebec, H4A3J1, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)|Acute Myeloid Leukemia (AML),DRUG: Tagraxofusp,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,138,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-09,3/12/20,"City of Hope National Medical Center, Duarte, California, 91010, United States|H. Lee Moffiitt Cancer Center & Research Institute, Tampa, Florida, 12902, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Columbia University Medical Center, New York, New York, 10032, United States|Duke University Medical Center, Durham, North Carolina, 27705, United States|Ohio State University, Columbus, Ohio, 43210, United States|University of Pittsburgh Medical Center Presbyterian Shady Side, Pittsburgh, Pennsylvania, 15213, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor,DRUG: SL-901,ALL,"ADULT, OLDER_ADULT",PHASE1,20,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/19/21,5/5/23,"Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, United Kingdom|Christie Hospital, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,KRAS Mutation-Related Tumors|Metastatic Solid Tumor|Advanced Solid Tumor,DRUG: TPX-0005|DRUG: Trametinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/23/21,3/1/23,"Local Institution - 2101, California City, California, 90033, United States|Local Institution - 2109, California City, California, 92663, United States|Local Institution - 2106, Denver, Colorado, 80218, United States|Local Institution - 2108, Nashville, Tennessee, 37203, United States|Local Institution - 2107, Houston, Texas, 77030, United States|Local Institution - 2102, Virginia Beach, Virginia, 22031, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Neoplasms|Neoplasm Metastasis|Triple Negative Breast Neoplasms|Head and Neck Neoplasms|Breast Neoplasms|Solid Tumor, Adult|Small Cell Lung Carcinoma",DRUG: LY3295668,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,13,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/29/17,4/20/20,"Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|McGill University, Montreal, Quebec, H4A 3J1, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Low-risk Papillary Thyroid Cancer|Endocrine Malignancy|Thyroid Cancer,PROCEDURE: Total Thyroidectomy (TT)|PROCEDURE: Prophylactic central neck lymph node dissection (pCND),ALL,"ADULT, OLDER_ADULT",PHASE2,14,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,4/15/15,5/7/19,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,MPN (Myeloproliferative Neoplasms),DRUG: Ruxolitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,66,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/15/11,12/19/18,"Birmingham, Alabama, United States|Beverly Hills, California, United States|Burbank, California, United States|La Jolla, California, United States|Los Angeles, California, United States|Pomona, California, United States|San Diego, California, United States|New Haven, Connecticut, United States|Fort Myers, Florida, United States|Jacksonville, Florida, United States|Orange City, Florida, United States|Atlanta, Georgia, United States|Augusta, Georgia, United States|Chicago, Illinois, United States|Iowa City, Iowa, United States|Louisville, Kentucky, United States|New Orleans, Louisiana, United States|Baltimore, Maryland, United States|Ann Arbor, Michigan, United States|Southfield, Michigan, United States|St Louis, Missouri, United States|Hackensack, New Jersey, United States|Morristown, New Jersey, United States|Somerville, New Jersey, United States|New York, New York, United States|Durham, North Carolina, United States|Hickory, North Carolina, United States|Canton, Ohio, United States|Cleveland, Ohio, United States|Portland, Oregon, United States|Danville, Pennsylvania, United States|Hershey, Pennsylvania, United States|Charleston, South Carolina, United States|Nashville, Tennessee, United States|Houston, Texas, United States|San Antonio, Texas, United States|Salt Lake City, Utah, United States|Burlington, Vermont, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor,DRUG: RP-6306 (oral PKMYT1 inhibitor),ALL,"ADULT, OLDER_ADULT",PHASE1,38,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,8/9/22,2/12/25,"#1019, UCLA, Westwood Cancer Center, Los Angeles, California, 90095, United States|#1022, Moffitt Cancer Center, Tampa, Florida, 33612, United States|#1008, Columbia University, New York, New York, 10032, United States|#1001, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|#1013, The University of Utah, Huntsman Cancer Center, Salt Lake City, Utah, 84112, United States|# 2001, Princess Margaret Cancer Centre, Toronto, Ontario, ON M5G 2M9, Canada|# 5002, South Texas Accelerated Research Therapeutics, Madrid, Spain|# 5003, Hospital Universitario HM Sanchinarro, Madrid, Spain|# 3003, Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neoplasms|Neoplasm Metastasis|Carcinoma, Non-Small-Cell Lung",DRUG: BI 891065|DRUG: BI 754091,ALL,"ADULT, OLDER_ADULT",PHASE1,62,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/8/17,10/28/20,"Florida Cancer Specialists, Sarasota, Florida, 34232, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Germ Cell Tumor,DRUG: Brentuximab Vedotin|DRUG: Bevacizumab,MALE,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/29/17,12/15/19,"University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Central Nervous System Neoplasm|Metastatic Malignant Neoplasm in the Central Nervous System,OTHER: Gadolinium|DRUG: Hyperpolarized Carbon C 13 Pyruvate|PROCEDURE: Magnetic Resonance Imaging|PROCEDURE: Magnetic Resonance Spectroscopic Imaging,ALL,"ADULT, OLDER_ADULT",PHASE1,9,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC,11/6/18,6/20/19,"Stanford University School of Medicine, Palo Alto, California, 94304, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Brain Tumor, Primary",DRUG: Perampanel,ALL,"ADULT, OLDER_ADULT",PHASE4,9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/7/15,4/10/17,"The Preston Robert Tisch Brain Tumor Center, Durham, North Carolina, 27710, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Adult Solid Tumor,DRUG: RP-6306 (oral PKMYT1 inhibitor),ALL,"ADULT, OLDER_ADULT",PHASE1,67,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/16/21,8/28/24,"# 1018, Mayo Clinic, Phoenix, Arizona, 85054, United States|# 1019, UCLA, Westwood Cancer Center, Los Angeles, California, 90095, United States|# 1017, Mayo Clinic, Jacksonville, Florida, 32224, United States|# 1022, Moffitt Cancer Center, Tampa, Florida, 33612, United States|# 1023, START Midwest, Grand Rapids, Michigan, 49546, United States|# 1016, Mayo Clinic, Rochester, Minnesota, 55902, United States|# 1008, Columbia University, New York, New York, 10032, United States|# 1004, Memorial Sloan Kettering Cancer Institute, New York, New York, 10065, United States|# 1010, University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|# 2001, Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2C1, Canada|# 3003, Sarah Cannon Research Institute, London, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Keratocystic Odontogenic Tumor,DRUG: vismodegib,ALL,"ADULT, OLDER_ADULT",PHASE2,2,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/27/15,2019-08,"NYU Bluestone Center For Cllinical Research, New York, New York, 10010, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neuroendocrine Tumor|Paraganglioma|Carcinoid Tumors|Neuroblastoma,PROCEDURE: Computed Tomography (CT)|DRUG: Gallium Ga 68-Edotreotide|PROCEDURE: Magnetic Resonance Imaging (MRI)|PROCEDURE: Positron Emission Tomography (PET),ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1|PHASE2,300,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,6/23/14,8/7/17,"University of California, San Francisco, San Francisco, California, 94143, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Myeloproliferative Diseases,DRUG: Pacritinib|DRUG: Busulfan|BEHAVIORAL: Questionnaires|BEHAVIORAL: Phone Calls|PROCEDURE: Allogeneic Stem Cell Transplantation|DRUG: Fludarabine,ALL,"ADULT, OLDER_ADULT",PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/15/15,1/20/17,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Ovarian Cancer|Ovarian Neoplasm,DRUG: Veliparib|DRUG: Paclitaxel|DRUG: Carboplatin|OTHER: Placebo to Veliparib,FEMALE,"ADULT, OLDER_ADULT",PHASE3,1140,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",7/14/15,10/5/23,"University of Alabama at Birmingham - Main /ID# 138087, Birmingham, Alabama, 35233, United States|Tennessee Valley Gyn-Onc /ID# 139548, Huntsville, Alabama, 35805, United States|University of South Alabama /ID# 138091, Mobile, Alabama, 36604-3302, United States|Alaska Womens Cancer Care /ID# 138231, Anchorage, Alaska, 99508-4684, United States|Arizona Oncology Associates, PC-HOPE /ID# 142002, Tucson, Arizona, 85711-2701, United States|Arizona Oncology Associates, PC-HOPE /ID# 143805, Tucson, Arizona, 85711-2701, United States|Arizona Oncology Associates, PC-HOPE /ID# 143806, Tucson, Arizona, 85711-2701, United States|Arizona Oncology Associates, PC-HOPE /ID# 143808, Tucson, Arizona, 85711-2701, United States|University of Arizona Cancer Center - North Campus /ID# 138084, Tucson, Arizona, 85719-1478, United States|University of Arizona Cancer Center - North Campus /ID# 139495, Tucson, Arizona, 85719-1478, United States|University of Arkansas for Medical Sciences /ID# 138253, Little Rock, Arkansas, 72205, United States|John Muir Medical Center /ID# 139618, Concord, California, 94520, United States|Ucsd /Id# 140323, La Jolla, California, 92093, United States|Long Beach Memorial Medical Ct /ID# 147526, Long Beach, California, 90806, United States|Kaiser Permanente /ID# 141305, Los Angeles, California, 90027, United States|University of California, Los Angeles /ID# 138179, Los Angeles, California, 90095, United States|Medical Oncology Care Assoc /ID# 139498, Orange, California, 92868-4304, United States|Univ CA, Irvine Med Ctr /ID# 139613, Orange, California, 92868, United States|UC Davis Comprehensive Cancer Center - Main /ID# 144439, Sacramento, California, 95817, United States|California Pacific Medical Ctr /ID# 138177, San Francisco, California, 94115, United States|Kaiser Permanente - San Francisco /ID# 142051, San Francisco, California, 94115, United States|Univ California, San Francisco /ID# 138178, San Francisco, California, 94143-2204, United States|Kaiser Permanente-Santa Clara /ID# 142053, Santa Clara, California, 95051-5173, United States|Stanford University School of Med /ID# 139450, Stanford, California, 94305-2200, United States|Palo Alto Medical Foundation /ID# 139452, Sunnyvale, California, 94086, United States|Kaiser Permanente Medical Ctr-Vallejo /ID# 139492, Vallejo, California, 94589-2441, United States|Kaiser Permanente- Walnut Creek /ID# 142052, Walnut Creek, California, 94596, United States|Kaiser Permanente, Waterpark III Institute for Health Research /ID# 139499, Aurora, Colorado, 80014, United States|Univ of Colorado Cancer Center /ID# 138016, Aurora, Colorado, 80045, United States|Hartford Healthcare /ID# 138184, New Britain, Connecticut, 6053, United States|Yale University /ID# 138056, New Haven, Connecticut, 06510, United States|University of Miami /ID# 139457, Miami, Florida, 33136, United States|Sarasota Memorial Health Care /ID# 138180, Sarasota, Florida, 34239, United States|Women's Cancer Associates /ID# 140321, St. Petersburg, Florida, 33701, United States|Moffitt Cancer Center /ID# 138061, Tampa, Florida, 33612-9416, United States|Georgia Regents University /ID# 138085, Augusta, Georgia, 30912, United States|IACT Health /ID# 138058, Columbus, Georgia, 31904-8946, United States|Memorial Health Univ Med Ctr /ID# 138019, Savannah, Georgia, 31404, United States|St. Joseph's/Candler /ID# 138090, Savannah, Georgia, 31405, United States|The Queens Medical Center /ID# 141709, Honolulu, Hawaii, 96813, United States|Kapiolani Medical Center /ID# 140319, Honolulu, Hawaii, 96826, United States|Rush University Medical Center /ID# 143491, Chicago, Illinois, 60612, United States|University of Chicago /ID# 139612, Chicago, Illinois, 60637-1443, United States|NorthShore University HealthSystem - Evanston Hospital /ID# 139451, Evanston, Illinois, 60201, United States|Sharma, Hinsdale, IL /ID# 140326, Hinsdale, Illinois, 60521, United States|Advocate Lutheran General Hosp /ID# 139489, Park Ridge, Illinois, 60068, United States|Indiana Univ School Medicine /ID# 139610, Indianapolis, Indiana, 46202, United States|Saint Vincent /ID# 139537, Indianapolis, Indiana, 46260, United States|McFarland Clinic, PC /ID# 139455, Ames, Iowa, 50010, United States|University of Iowa Hospitals and Clinics /ID# 138082, Iowa City, Iowa, 52242, United States|Univ Kansas Med Ctr /ID# 140322, Kansas City, Kansas, 66160, United States|Baptist Health Lexington /ID# 139542, Lexington, Kentucky, 40503, United States|University of Kentucky Chandler Medical Center /ID# 138060, Lexington, Kentucky, 40536, United States|Norton Cancer Institute /ID# 139567, Louisville, Kentucky, 40202-3700, United States|MMP Women's Health /ID# 139544, Portland, Maine, 04102, United States|Greater Baltimore Medical Ctr /ID# 138049, Baltimore, Maryland, 21204, United States|Sinai Hospital of Baltimore /ID# 141306, Baltimore, Maryland, 21215, United States|Weinberg Cancer Inst Franklin /ID# 138235, Rossville, Maryland, 21237, United States|Baystate Medical Center /ID# 139456, Springfield, Massachusetts, 01199, United States|UMass Memorial Medical Center /ID# 139458, Worcester, Massachusetts, 01655, United States|Wayne State University /ID# 139601, Detroit, Michigan, 48201-2013, United States|Henry Ford Health System /ID# 139536, Detroit, Michigan, 48202, United States|William Beaumont Hospital /ID# 139550, Royal Oak, Michigan, 48073-6710, United States|Mayo Clinic - Rochester /ID# 139565, Rochester, Minnesota, 55905-0001, United States|Mmcorc /Id# 139534, Saint Louis Park, Minnesota, 55416, United States|St. Dominic Hospital /ID# 138241, Jackson, Mississippi, 39216, United States|Ellis Fischel Cancer Center /ID# 139571, Columbia, Missouri, 65212-1000, United States|Cancer Research For the Ozarks /ID# 139538, Springfield, Missouri, 65804, United States|Ferrell-Duncan Clinic /ID# 143484, Springfield, Missouri, 65807, United States|Washington University-School of Medicine /ID# 138089, St Louis, Missouri, 63110, United States|Nebraska Methodist Hospital /ID# 139600, Omaha, Nebraska, 68114, United States|Womens Cancer Center of Nevada /ID# 138092, Las Vegas, Nevada, 89169, United States|Renown Regional Medical Center /ID# 138237, Reno, Nevada, 89502, United States|Dartmouth-Hitchcock Medical Center /ID# 139502, Lebanon, New Hampshire, 03756, United States|MD Anderson Cancer Ctr at Coop /ID# 139616, Camden, New Jersey, 08103, United States|Hackensack Univ Med Ctr /ID# 143776, Hackensack, New Jersey, 07601, United States|University of New Mexico /ID# 144220, Albuquerque, New Mexico, 87102, United States|SW Gynecologic Oncology Assoc /ID# 147097, Albuquerque, New Mexico, 87106, United States|Women's Cancer Care Associates /ID# 138234, Albany, New York, 12208, United States|SUNY Downstate Medical Center /ID# 139533, Brooklyn, New York, 11203, United States|Roswell Park Comprehensive Cancer Center /ID# 138052, Buffalo, New York, 14263, United States|Northwell Health /ID# 139572, Lake Success, New York, 11042, United States|Icahn School of Med Mt. Sinai /ID# 139617, New York, New York, 10029, United States|Columbia University Medical Center /ID# 138252, New York, New York, 10032-3729, United States|Memorial Sloan Kettering Cancer Center /ID# 138017, New York, New York, 10065-6007, United States|Memorial Sloan Kettering Cancer Center /ID# 154464, New York, New York, 10065-6007, United States|SUNY Upstate Medical University - Downtown /ID# 139513, Syracuse, New York, 13210, United States|Montefiore Medical Center /ID# 139585, The Bronx, New York, 10461, United States|Hope Womens Cancer Centers /ID# 139614, Asheville, North Carolina, 28816, United States|Univ NC Chapel Hill /ID# 138547, Chapel Hill, North Carolina, 27514-4220, United States|Atrium Health Carolinas Medical Center /ID# 139568, Charlotte, North Carolina, 28203, United States|Presbyterian Cancer Center /ID# 139590, Charlotte, North Carolina, 28204, United States|Duke University Medical Center /ID# 138048, Durham, North Carolina, 27710-3000, United States|Wake Forest Baptist Medical Center /ID# 139588, Winston-Salem, North Carolina, 27157-0001, United States|University of Cincinnati /ID# 139619, Cincinnati, Ohio, 45267-0585, United States|Univ Hosp Cleveland /ID# 139615, Cleveland, Ohio, 44106, United States|Fairview Hospital /ID# 144403, Cleveland, Ohio, 44111, United States|Cleveland Clinic Main Campus /ID# 139501, Cleveland, Ohio, 44195, United States|The Ohio State University - Columbus /ID# 138053, Columbus, Ohio, 43210, United States|Columbus NCORP /ID# 139587, Columbus, Ohio, 43215, United States|Womens Cancer Center /ID# 138062, Kettering, Ohio, 45429-1226, United States|Hillcrest Hospital /ID# 144404, Mayfield Heights, Ohio, 44124, United States|Univ Oklahoma HSC /ID# 138020, Oklahoma City, Oklahoma, 73104, United States|Oklahoma Cancer Specialists /ID# 138059, Tulsa, Oklahoma, 74146, United States|Willamette Valley Cancer Institute /ID# 140318, Eugene, Oregon, 97401-6043, United States|Kaiser Permanente, NW /ID# 138249, Portland, Oregon, 97227, United States|Abington Memorial Hospital /ID# 138086, Abington, Pennsylvania, 19001, United States|University of Pennsylvania /ID# 140079, Philadelphia, Pennsylvania, 19104-5502, United States|Thomas Jefferson University /ID# 138239, Philadelphia, Pennsylvania, 19107-4414, United States|Fox Chase Cancer Center /ID# 149479, Philadelphia, Pennsylvania, 19111, United States|University of Pittsburgh MC /ID# 138054, Pittsburgh, Pennsylvania, 15260, United States|Reading Hospital /ID# 138057, Reading, Pennsylvania, 19611, United States|Women and Infants Hospital /ID# 138083, Providence, Rhode Island, 02905, United States|Medical University of South Carolina /ID# 138181, Charleston, South Carolina, 29425, United States|Sanford Research/USD /ID# 139624, Sioux Falls, South Dakota, 57104-8805, United States|Chattanoogas Program in Womens /ID# 139545, Chattanooga, Tennessee, 37403, United States|Texas Oncology - Austin Central /ID# 143817, Austin, Texas, 78731, United States|Texas Oncology - South Austin /ID# 143818, Austin, Texas, 78745, United States|Texas Oncology - Bedford /ID# 143814, Bedford, Texas, 76022, United States|Texas Oncology - Medical City Dallas /ID# 143809, Dallas, Texas, 75230, United States|Texas Oncology - Medical City Dallas /ID# 143812, Dallas, Texas, 75230, United States|Texas Oncology - Forth Worth /ID# 143811, Fort Worth, Texas, 76104-2150, United States|Houston Methodist Hospital - Scurlock Tower /ID# 138232, Houston, Texas, 77030, United States|Memorial Hermann Hospital /ID# 138238, Houston, Texas, 77030, United States|Texas Oncology - The Woodlands /ID# 142003, The Woodlands, Texas, 77380, United States|Texas Oncology - Tyler /ID# 143810, Tyler, Texas, 75702, United States|University of Utah /ID# 138250, Salt Lake City, Utah, 84112-5500, United States|University of Vermont Medical Center /ID# 138251, Burlington, Vermont, 05401-1473, United States|University of Virginia /ID# 138088, Charlottesville, Virginia, 22908, United States|Carilion Roanoke Memorial Hosp /ID# 139602, Roanoke, Virginia, 24014, United States|Skagit Valley Medical Center /ID# 139586, Mount Vernon, Washington, 98273, United States|MultiCare Regional Cancer Ctr /ID# 149872, Puyallup, Washington, 93872, United States|Multicare Institute for Research and Innovation /ID# 143485, Tacoma, Washington, 98405, United States|HSHS St. Vincent Hospital /ID# 139453, Green Bay, Wisconsin, 54301, United States|Froedtert & the Medical College of Wisconsin /ID# 139449, Milwaukee, Wisconsin, 53226-3522, United States|Coffs Harbour Health Campus /ID# 145132, Coffs Harbour, New South Wales, 2450, Australia|Gosford Hospital /ID# 145299, Gosford, New South Wales, 2250, Australia|St George Hospital /ID# 145138, Kogarah, New South Wales, 2217, Australia|Newcastle Private Hospital /ID# 145834, Lambton Heights, New South Wales, 2305, Australia|The Prince of Wales Hospital /ID# 145134, Randwick, New South Wales, 2031, Australia|Northern Cancer Institute /ID# 145681, St Leonards, New South Wales, 2065, Australia|Calvary Mater Newcastle /ID# 145139, Waratah, New South Wales, 2298, Australia|Westmead Hospital /ID# 145137, Westmead, New South Wales, 2145, Australia|Southern Medical Day Care Ctr /ID# 145133, Wollongong, New South Wales, 2500, Australia|The Townsville Hospital /ID# 149163, Douglas, Queensland, 4814, Australia|Royal Brisbane and Women's Hospital /ID# 145135, Herston, Queensland, 4029, Australia|Icon Cancer Centre /ID# 148208, South Brisbane, Queensland, 4101, Australia|Mater Misericordiae Limited /ID# 145682, South Brisbane, Queensland, 4101, Australia|Royal Adelaide Hospital /ID# 150071, Adelaide, South Australia, 5000, Australia|Monash Health /ID# 145297, Clayton, Victoria, 3168, Australia|Cabrini Health /ID# 145142, Malvern, Victoria, 3144, Australia|Royal Womens Hospital /ID# 145136, Parkville, Victoria, 3052, Australia|Sir Charles Gairdner Hospital /ID# 145140, Nedlands, Western Australia, 6009, Australia|St. John of God Subiaco Hosp /ID# 147742, Subiaco, Western Australia, 6008, Australia|Hc Ufmg /Id# 137156, Belo Horizonte, Minas Gerais, 30130-100, Brazil|Hospital Sao Lucas da PUCRS /ID# 137157, Porto Alegre, Rio Grande do Sul, 90610-000, Brazil|Hospital de Cancer de Barretos /ID# 137121, Barretos, São Paulo, 14784-400, Brazil|Centro de Referencia da Saude da Mulher - Hospital Perola Byington /ID# 137120, São Paulo, São Paulo, 01317-000, Brazil|Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA) /ID# 137155, Rio de Janeiro, 20231-050, Brazil|Vejle Sygehus /ID# 137262, Vejle, Region Syddanmark, 7100, Denmark|Regionshospitalet Herning /ID# 137260, Herning, 7400, Denmark|Rambam Health Care Campus /ID# 137434, Haifa, 3109601, Israel|The Lady Davis Carmel MC /ID# 137537, Haifa, 3436212, Israel|Shaare Zedek Medical Center /ID# 137435, Jerusalem, 91031, Israel|Meir Medical Center /ID# 139397, Kfar Saba, 4428164, Israel|Sheba Medical Center /ID# 137436, Ramat Gan, 5262100, Israel|Kaplan Medical Center /ID# 137536, Rehovot, 76100, Israel|Aichi Cancer Center Hospital /ID# 148398, Nagoya, Aichi-ken, 464-8681, Japan|National Hospital Organization Kyushu Cancer Center /ID# 149133, Fukuoka, Fukuoka, 811-1395, Japan|Kurume University Hospital /ID# 148697, Kurume-shi, Fukuoka, 830-0011, Japan|Iwate Medical University Hospital /ID# 147721, Shiwa-gun, Iwate, 028-3695, Japan|Kumamoto University Hospital /ID# 154169, Kumamoto, Kumamoto, 860-8556, Japan|Mie University Hospital /ID# 149169, Tsu, Mie-ken, 514-8507, Japan|Tohoku University Hospital /ID# 149818, Sendai, Miyagi, 980-8574, Japan|Niigata University Medical & Dental Hospital /ID# 149488, Niigata, Niigata, 951-8520, Japan|Kindai University Hospital /ID# 154947, Ōsaka-sayama, Osaka, 5898511, Japan|Shizuoka Cancer Center /ID# 147723, Sunto-gun, Shizuoka, 411-8777, Japan|The Cancer Institute Hosp JFCR /ID# 148436, Koto-ku, Tokyo, 135-8550, Japan|Keio University Hospital /ID# 148326, Shinjuku-ku, Tokyo, 160-8582, Japan|Yamagata University Hospital /ID# 153646, Yamagata, Yamagata, 990-9585, Japan|Hyogo Cancer Center /ID# 148327, Akashi, 673-8558, Japan|Kansai Rosai Hospital /ID# 149237, Amagasaki, 660-8511, Japan|The Jikei Univ. Kashiwa Hosp. /ID# 149238, Kashiwa-shi, 277-0004, Japan|St. Marianna Univ Hospital /ID# 149327, Kawasaki, 216-8511, Japan|NHO Kure Medical Center and Ch /ID# 148569, Kure, 737-0023, Japan|Shikoku Cancer Center /ID# 148382, Matsuyama, 791-0280, Japan|Osaka International Cancer Institute /ID# 150778, Osaka, 541-8567, Japan|Hokkaido Cancer Center /ID# 148570, Sapporo, 003-0804, Japan|The Jikei University Hospital /ID# 148691, Tokyo, 105-8461, Japan|Auckland City Hospital /ID# 145123, Auckland, 1023, New Zealand|Uniwersyteckie C. Kliniczne /ID# 138021, Gdansk, 80-214, Poland|National Cancer Center /ID# 139404, Goyang, Gyeonggido, 10408, South Korea|Korea University Anam Hospital /ID# 136908, 성북구, Gyeonggido, 02841, South Korea|Gangnam Severance Hospital /ID# 136835, Seoul, Seoul Teugbyeolsi, 06273, South Korea|Samsung Medical Center /ID# 136834, Seoul, Seoul Teugbyeolsi, 06351, South Korea|Seoul National University Hospital /ID# 136909, Seoul, 03080, South Korea|Asan Medical Center /ID# 136836, Seoul, 05505, South Korea|Hospital Duran i Reynals /ID# 137298, L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Hospital Univ Vall d'Hebron /ID# 137297, Barcelona, 08035, Spain|Hospital Clinic de Barcelona /ID# 137300, Barcelona, 08036, Spain|Hospital Clin Univ San Carlos /ID# 137402, Madrid, 28040, Spain|Hosp Univ 12 de Octubre /ID# 137299, Madrid, 28041, Spain|Hosp Univ Madrid Sanchinarro /ID# 137414, Madrid, 28050, Spain|Fundacion Inst Valenciano Onc /ID# 137403, Valencia, 46009, Spain|Norfolk and Norwich Univ Hosp /ID# 137969, Norwich, Norfolk, NR4 7UY, United Kingdom|Beatson west of scotland cancer center /ID# 137965, Glasgow, Scotland, G12 0YN, United Kingdom|Ninewells Hospital /ID# 137967, Dundee, DD1 9SY, United Kingdom|James Paget University Hosp /ID# 137970, Great Yarmouth, NR31 6LA, United Kingdom|Imanova Limited, Hammersmith Hospital /ID# 137966, London, W12 0HS, United Kingdom|Oxford Univ Hosp NHS Trust /ID# 137973, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pituitary Tumor|Pain,DRUG: IV Caldolor|DRUG: IV Placebo,ALL,"ADULT, OLDER_ADULT",PHASE4,62,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2/1/15,4/1/16,"St. Joseph's Hospital and Medical Center, Phoenix, Arizona, 85013, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface|Malignant Peritoneal Mesothelioma|Peritoneal Carcinomatosis,BIOLOGICAL: DC vaccine|DRUG: Celecoxib|DRUG: Interferon Alfa-2b|BIOLOGICAL: rintatolimod,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,64,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-07,2/18/19,"UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: GFH018,ALL,"ADULT, OLDER_ADULT",PHASE1,50,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/30/19,8/11/22,"Shanghai East hospital, Shanghai, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Solid Tumor, Adult",BIOLOGICAL: GEN1053,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,31,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/4/22,5/24/24,"Yale University, New Haven, Connecticut, 06510, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Clinica Universidad de Navarra, Pamplona, Navarre, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Centro Integral Oncologico Clara Campal, Madrid, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignant Solid Neoplasm,DRUG: Adavosertib|DRUG: Carboplatin|DRUG: Everolimus|DRUG: Temozolomide|DRUG: Trametinib|DRUG: Veliparib,ALL,"ADULT, OLDER_ADULT",PHASE2,208,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/7/14,10/8/21,"University of Colorado Hospital, Aurora, Colorado, 80045, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, 30322, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, 40536, United States|National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, 20892, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, 15232, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor,DRUG: PTX-35,ALL,"ADULT, OLDER_ADULT",PHASE1,22,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/4/20,6/15/23,"Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, Oregon, 97213, United States|NEXT Oncology Austin, Austin, Texas, 78705, United States|Next Oncology, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: RP-3500 (camonsertib)|DRUG: Talazoparib|DRUG: Gemcitabine Injection,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,276,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/22/20,6/13/25,"#1014, Northwestern University, Chicago, Illinois, 60611, United States|#1006, Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|#1002, Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|#1004, Memorial Sloan Kettering Cancer Institute, New York, New York, 10065, United States|#1005, Duke Cancer Institute, Durham, North Carolina, 27710, United States|#1007, Rhode Island Hospital, Providence, Rhode Island, 02903, United States|#1003, Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|#1001, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|#2001, Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|#4001, Copenhagen University Hospital Rigshospitalet - Blegdamsvej, Copenhagen, DK, 2100 Ø, Denmark|#3003, Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom|#3001, The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|#3002, Freeman Hospital Newcastle, Newcastle upon Tyne, NE7 7DN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: Lurbinectedin|DRUG: Bosentan,ALL,"ADULT, OLDER_ADULT",PHASE1,11,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,1/14/21,1/18/22,"Fundación Jiménez Diaz, Madrid, 28040, Spain|Hospital de Sanchinarro, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Tenosynovial Giant Cell Tumor,DRUG: Pexidartinib,ALL,"ADULT, OLDER_ADULT",PHASE2,9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/15/21,5/31/26,"Nagoya University Hospital, Aichi, 466-8560, Japan|Kyushu University Hospital, Fukuoka, 812-8582, Japan|Kanazawa University Hospital, Ishikawa, 920-8641, Japan|National Hospital Organization Osaka National Hospital, Osaka, 540-0006, Japan|Osaka International Cancer Institute, Osaka, 541-8567, Japan|National Cancer Center Hospital, Tokyo, 104-0045, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Urinary Bladder Neoplasms,DRUG: Durvalumab|DRUG: Olaparib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,154,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",3/16/18,12/31/26,"Research Site, Birmingham, Alabama, 35294, United States|Research Site, Goodyear, Arizona, 85338, United States|Research Site, Fort Myers, Florida, 33901, United States|Research Site, St. Petersburg, Florida, 33705, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Louisville, Kentucky, 40202, United States|Research Site, New Hyde Park, New York, 11042, United States|Research Site, New York, New York, 10065, United States|Research Site, The Bronx, New York, 10461, United States|Research Site, Philadelphia, Pennsylvania, 19124, United States|Research Site, Nashville, Tennessee, 37232, United States|Research Site, Tacoma, Washington, 98405, United States|Research Site, Greater Sudbury, Ontario, P3E 5J1, Canada|Research Site, Hamilton, Ontario, L8V 5C2, Canada|Research Site, Newmarket, Ontario, L3Y 2P9, Canada|Research Site, Toronto, Ontario, M5G 2M9, Canada|Research Site, Montreal, Quebec, H3T 1E2, Canada|Research Site, Moscow, 105077, Russia|Research Site, Moscow, 125367, Russia|Research Site, Novosibirsk, 630108, Russia|Research Site, Omsk, 644013, Russia|Research Site, Saint Petersburg, 194354, Russia|Research Site, Saint Petersburg, 195271, Russia|Research Site, Saint Petersburg, 199178, Russia|Research Site, Incheon, 21565, South Korea|Research Site, Seoul, 02841, South Korea|Research Site, Seoul, 03722, South Korea|Research Site, Seoul, 05505, South Korea|Research Site, Seoul, 6351, South Korea|Research Site, Barcelona, 08036, Spain|Research Site, Madrid, 08035, Spain|Research Site, Madrid, 28041, Spain|Research Site, Málaga, 29010, Spain|Research Site, Santiago de Compostela, 15706, Spain|Research Site, Kaohsiung City, 807, Taiwan|Research Site, Kaohsiung City, Taiwan|Research Site, Taichung, 40705, Taiwan|Research Site, Tainan, 704, Taiwan|Research Site, Taipei, 10002, Taiwan|Research Site, Taipei, 104, Taiwan|Research Site, Taipei, 112, Taiwan|Research Site, Taoyuan, 333, Taiwan|Research Site, Hanoi, 100000, Vietnam|Research Site, Ho Chi Minh City, 700000, Vietnam",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor,BIOLOGICAL: MK-1248|BIOLOGICAL: pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,37,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/12/15,10/17/18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Uterine Cervical Neoplasms,DRUG: Bintrafusp alfa,FEMALE,"ADULT, OLDER_ADULT",PHASE2,146,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/30/20,12/14/22,"Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States|University of Arkansas Medical Sciences, Little Rock, Arkansas, 72202-3500, United States|Stanford University Hospital and Clinics - Stanford Cancer Center, Stanford, California, 94305, United States|The Stamford Hospital, Stamford, Connecticut, 06902, United States|Karmanos Cancer Institute, Farmington Hills, Michigan, 48334, United States|Washington University in St. Louis, St Louis, Missouri, 63110, United States|Comprehensive Cancer Centers of Nevada, Henderson, Nevada, 89074, United States|UC Health Clinical Trials Office, Cincinnati, Ohio, 45229, United States|Oregon Health &amp; Science University, Portland, Oregon, 97229, United States|The West Clinic, Germantown, Tennessee, 38138, United States|SCRI - Tennessee Oncology, Nashville, Tennessee, 37203, United States|Centro Oncologico Riojano Integral (CORI), La Rioja, Argentina|Sanatorio El Parque, Salta, Argentina|Centro Medico San Roque S.R.L., San Miguel de Tucumán, Argentina|Peter MacCallum Cancer Centre-East Melbourne, Melbourne, Australia|Linear Clinical Research Limited, Nedlands, Australia|Calvary Mater Newcastle, Waratah, Australia|Cliniques Universitaires Saint-Luc, Brussels, Belgium|Institut Jules Bordet, Brussels, Belgium|Universitair Ziekenhuis Gent - Pneumology, Ghent, Belgium|AZ Groeninge - Campus Kennedylaan - account 2, Kortrijk, Belgium|CHU de Liège - PARENT, Liège, Belgium|CHU Sart Tilman, Liège, Belgium|UZ Leuven, Pellenberg, Belgium|GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk, Belgium|HGB - Hospital Giovanni Battista - Mãe de Deus Center - Centro de Pesquisa Clínica - Instituto do Câncer, Porto Alegre, Brazil|Clínica de Pesquisas e Centro de Estudos em Oncologia Ginecológica e Mamária Ltda., São Paulo, Brazil|IBCC - Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil|Chongqing Cancer Hospital, Chongqing, China|Sun Yat-sen University, Cancer Center, Guangzhou, China|Zhejiang Cancer Hospital, Hangzhou, China|Anhui Provincial Hospital, Hefei, China|Shanghai Cancer Hospital, Fudan University, Shanghai, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, China|Henan Cancer Hospital, Zhengzhou, China|Institut Bergonié, Bordeaux, France|Centre Oscar lambret - Service d'Oncologie medicale, Lille, France|Centre Léon Bérard, Lyon, France|Centre Antoine Lacassagne, Nice, France|Hôpital Cochin - Hematologie et Oncologie Médicale, Paris, France|Centre Hospitalier Lyon Sud - service d'oncologie medicale, Pierre-Bénite, France|CARIO - Centre Armoricain de Radiothérapie, Imagerie médicale et Oncologie, Plérin, France|Institut Jean Godinot - Service d'hématologie et Oncologie Médicale, Reims, France|ICO - Site René Gauducheau, Saint-Herblain, France|Institut de Cancérologie de Strasbourg Europe - ICANS - Service d'oncologie médicale, Strasbourg, France|Orszagos Onkologiai Intezet - Nogyogyaszati Osztaly, Budapest, Hungary|SzSzB Megyei Korhazak es Egyetemi Oktatokorhaz - Onkoradiologia, Nyíregyháza, Hungary|National Cancer Center Hospital - Dept of Mammary Gland/Oncology, Chūōku, Japan|NHO Kyushu Cancer Center - Dept of Gynecology, Fukuoka, Japan|Saitama Medical University International Medical Center - Dept of Gynecology/Oncology, Hidaka-shi, Japan|Cancer Institute Hospital of JFCR - Dept of Gynecology, Kōtoku, Japan|Kurume University Hospital - Dept of Gynecology, Kurume-shi, Japan|Jikei University Hospital - Dept of Gynecology, Minatoku, Japan|University Hospital, University of the Ryukyus - Dept of Obstetrics/Gynecology, Nakagami-gun, Japan|Osaka International Cancer Institute - Dept of Gynecology, Osaka, Japan|NHO Hokkaido Cancer Center - Dept of Gynecology, Sapporo, Japan|Kanagawa Cancer Center - Dept of Gynecology, Yokohama, Japan|BHI of Omsk region ""Clinical Oncology Dispensary"", Omsk, Russia|LLC ""ClinicaUZI4D"", Pyatigorsk, Russia|National Cancer Center, Goyang-si, South Korea|Asan Medical Center, Seoul, South Korea|Samsung Medical Center, Seoul, South Korea|Seoul National University Hospital, Seoul, South Korea|Severance Hospital, Yonsei University Health System, Seoul, South Korea|Ajou University Hospital, Suwon, South Korea|Hospital Clinic i Provincial de Barcelona - Servicio de Oncologia, Barcelona, Spain|Hospital Universitari Vall d'Hebron - Dept of Oncology, Barcelona, Spain|ICO Girona - Hospital Doctor Josep Trueta - Servicio de Oncologia Medica, Girona, Spain|Clinica Universidad de Navarra (MAD) - Oncology Service, Madrid, Spain|Hospital Universitario 12 de Octubre - Servicio de Oncologia, Madrid, Spain|Hospital Universitario Ramon y Cajal - Servicio de Oncologia, Madrid, Spain|Hospital Regional Universitario de Malaga, Málaga, Spain|Hospital Clinico Universitario de Valencia - Servicio de Hematologia y Oncologia Medica, Valencia, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced/Metastatic Solid Tumors,DRUG: Selumetinib|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,32,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/18/19,6/28/22,"City of Hope National Medical Center ( Site 0004), Duarte, California, 91010, United States|START Midwest ( Site 0001), Grand Rapids, Michigan, 49546, United States|John Theurer Cancer Center ( Site 0002), Hackensack, New Jersey, 07601, United States|South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0003), San Antonio, Texas, 78229, United States|Princess Margaret Cancer Centre ( Site 0014), Toronto, Ontario, M5G 1Z5, Canada|CHU de Quebec Universite de Laval ( Site 0013), Québec, Quebec, G1R 2J6, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Solid Tumor,DRUG: Erdafitinib,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,316,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/20/19,12/31/26,"Arizona Oncology Associates, PC - HOPE, Tucson, Arizona, 85711, United States|Rocky Mountain Cancer Centers, Colorado Springs, Colorado, 80907, United States|Memorial Cancer Institute, Hollywood, Florida, 33021, United States|Cancer Specialists of North Florida, Jacksonville, Florida, 32256, United States|Emory University, Atlanta, Georgia, 30022, United States|Hawaii Cancer Care, ‘Aiea, Hawaii, 96701, United States|Maine Medical Center, Scarborough, Maine, 04074, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Mount Sinai, New York, New York, 10029, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10128, United States|Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina, 28204, United States|Oncology Hematology Care, Cincinnati, Ohio, 45242, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15232, United States|Tennessee Oncology, PLLC, Chattanooga, Tennessee, 37404, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|Texas Oncology Baylor Charles A Sammons Cancer Center, Dallas, Texas, 75246, United States|Texas Oncology-Fort Worth Cancer Center, Fort Worth, Texas, 76104, United States|MD Anderson, Houston, Texas, 77030, United States|Oncology Consultants Texas, Houston, Texas, 77030, United States|Texas Oncology Odessa-West Texas Cancer Center, Odessa, Texas, 79761, United States|Texas Oncology San Antonio Northeast, San Antonio, Texas, 78217, United States|NorthWest Medical Specialties, PLLC, Tacoma, Washington, 98405, United States|Aurora Research Institute, Wauwatosa, Wisconsin, 53226, United States|Instituto de Investigaciones Metabólicas, Buenos Aires, C1012AAR, Argentina|Hospital Aleman, Buenos Aires, C1118AAT, Argentina|Centro Oncológico Korben, Buenos Aires, C1426AGE, Argentina|Instituto Fleni, Buenos Aires, C1428AQK, Argentina|CEMIC Saavedra, Buenos Aires, C1431FWN, Argentina|Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica, Córdoba, 5000, Argentina|Hospital Italiano de La Plata, La Plata Lpl Lpl, 1900, Argentina|Instituto de Investigaciones Clinicas Mar del Plata, Mar del Plata, B7600FZN, Argentina|Hospital Privado de Comunidad, Mar del Plata, B7602CBM, Argentina|Hospital Universitario Austral, Pilar, 1629, Argentina|Sanatorio Britanico de Rosario, Rosario, 2000, Argentina|ARS Médica, San Salvador de Jujuy, Y4600AFW, Argentina|Flinders Centre for Innovation in Cancer, Adelaide, 5042, Australia|Chris O'Brien Lifehouse, Camperdown, 2050, Australia|St Vincent s Hospital Sydney, Darlinghurst, 2010, Australia|St Vincents Hospital Melbourne, Fitzroy, 3065, Australia|Fiona Stanley Hospital, Murdoch, 6150, Australia|Intergrated Clinical Oncology Network Pty Ltd (ICON), South Brisbane, 4101, Australia|AZ Klina, Brasschaat, 2930, Belgium|UCL Hopital Saint-Luc, Brussels, 1200, Belgium|Grand Hopital de Charleroi, site Notre Dame, Charleroi, 6000, Belgium|CHU UCL Namur - Site Dinant, Dinant, 5500, Belgium|UZA, Edegem, 2650, Belgium|AZ Maria Middelares, Ghent, 9000, Belgium|UZ Gent, Ghent, 9000, Belgium|Jolimont, Haine-Saint-Paul, 7100, Belgium|CHU UCL Namur - Site Sainte Elisabeth, Namur, 5000, Belgium|Cliniques St Pierre, Ottignies, 1340, Belgium|CHU UCL Namur - Site Godinne, Yvoir, 5530, Belgium|Fundacao Pio XII, Barretos, 14784-400, Brazil|Liga Paranaense de Combate ao Cancer, Curitiba, 81520 060, Brazil|Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge, Goiânia, 74605-070, Brazil|Associacao Hospital de Caridade Ijui, Ijuí, 98700-000, Brazil|Liga Norte Riograndense Contra O Cancer, Natal, 59075-740, Brazil|Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, 90050-170, Brazil|Instituto de Medicina Integral Professor Fernando Figueira, Recife, 50070-550, Brazil|Oncoclinicas Rio de Janeiro S A, Rio de Janeiro, 22250 905, Brazil|Instituto D Or de Pesquisa e Ensino IDOR, Rio de Janeiro, 22281 100, Brazil|Hospital Sao Rafael, Salvador, 41253 190, Brazil|Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo, São Paulo, 01246 000, Brazil|Sociedade Beneficente de Senhoras Hospital Sirio Libanes, São Paulo, 01308 901, Brazil|Real e Benemerita Associacao Portuguesa de Beneficencia, São Paulo, 01321-001, Brazil|Fundacao Antonio Prudente A C Camargo Cancer Center, São Paulo, 01509 900, Brazil|Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo, 05410-030, Brazil|GRAACC, São Paulo, 4039001, Brazil|Cancer Hospital Chinese Academy of Medical Sciences, Beijing, 100021, China|Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China|Peking University Third Hospital, Beijing, 100191, China|Chinese PLA General Hospital, Beijing, 100853, China|Beijing Luhe Hospital, Capital Medical University, Beijing, 101100, China|Jilin cancer hospital, Changchun, 130012, China|The First Hospital of Jilin University, Changchun, 130021, China|West China Hospital,Sichuan University, Chengdu, 610041, China|Chongqing Southwest Hospital, Chongqing, 400038, China|Third Military Medical University Daping Hospital Cancer Center, Chongqing, 400042, China|Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510289, China|First affiliated Hospital of Zhejiang University, Hangzhou, 310003, China|Zhejiang Cancer Hospital, Hangzhou, 310022, China|Eastern Theater General Hospital, Qinhuai District Medical Area, Nanjing, 210002, China|Ruijin Hospital Shanghai Jiao Tong University, Shanghai, 200025, China|Cancer Hospital, FuDan University, Shanghai, 200032, China|Shanghai Zhongshan Hospital, Shanghai, 200032, China|Huashan Hospital Fudan University, Shanghai, 200040, China|Hopital Saint André, Bordeaux, 33075, France|Centre Francois Baclesse, Caen, 14000, France|Centre Jean Perrin, Clermont-Ferrand, 63011, France|Centre Georges Francois Leclerc, Dijon, 21000, France|Centre Oscar Lambret, Lille, 59020, France|Centre Leon Berard, Lyon, 69008, France|Hopital de la Timone, Marseille, 130005, France|Institut Curie, Paris, 75005, France|CHU De Poitiers, Poitiers, 86021, France|Institut de Cancerologie de Lorraine, Vandœuvre-lès-Nancy, 54519, France|Institut Gustave Roussy, Villejuif, 94800, France|Charité, Berlin, 10115, Germany|Universitaetsklinikum Koeln, Cologne, 50937, Germany|Medizinische Fakultaet Carl Gustav Carus Technische Universitaet Dresden, Dresden, 01307, Germany|Universitaetsklinikum Essen, Essen, 45147, Germany|Universitaetsklinikum Frankfurt, Frankfurt, 60385, Germany|Asklepios Klinik Altona, Hamburg, 22763, Germany|Universitaetsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitaetsklinikum Leipzig, Leipzig, 04103, Germany|Universitatsmedizin der Johannes Gutenberg Universitat Mainz, Mainz, 55131, Germany|Klinikum rechts der Isar der TU Munchen, München, 81675, Germany|Universitatsklinikum Tubingen, Tübingen, 72076, Germany|Istituto Ortopedico Rizzoli, Bologna, 40136, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milan, 20162, Italy|ASST di Monza, Monza, 20900, Italy|Azienda Ospedaliera Univ.- Università Degli studi della Campania - Luigi Vanvitelli, Napoli, 80138, Italy|Fondazione G Pascale Istituto Nazionale Tumori IRCCS, Napoli, 80138, Italy|Ospedale S. Maria Della Misericordia, Perugia, 06132, Italy|Ospedale Santa Chiara AO Universitaria Pisana, Pisa, 56126, Italy|Azienda Ospedaliera S. Maria Terni, Terni, 5100, Italy|Ospedale Borgo Roma, Verona, 37134, Italy|National Cancer Center Hospital, Chūōku, 104 0045, Japan|Hiroshima University Hospital, Hiroshima, 734 8551, Japan|National Cancer Center Hospital East, Kashiwa, 277 8577, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, 791-0280, Japan|Fujita Health University Hospital, Toyoake, 470-1192, Japan|Centrum Onkologii im Prof F Lukaszczyka w Bydgoszczy, Bydgoszcz, 85 796, Poland|Przychodnia Lekarska KOMED Roman Karaszewski, Konin, 62-500, Poland|Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie, Krakow, 31 501, Poland|Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im M Kopernika w Lodzi, Lodz, 93 513, Poland|Centrum Medyczne Pratia Poznan, Skorzewo, 60 185, Poland|Instytut Matki i Dziecka, Warsaw, 01 211, Poland|Centralny Szpital Kliniczny MSWiA w Warszawie, Warsaw, 02-507, Poland|Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warsaw, 02-781, Poland|Severance Hospital Yonsei University Health System, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|The Catholic University of Korea Seoul St Marys Hospital, Seoul, 06591, South Korea|Seoul National University Hospital, Seoul, 3080, South Korea|Hosp. Univ. Quiron Dexeus, Barcelona, 08028, Spain|Hosp Univ Vall D Hebron, Barcelona, 08035, Spain|Hosp Clinic de Barcelona, Barcelona, 08036, Spain|Hosp. Sant Joan de Deu, Barcelona, 08950, Spain|Inst. Cat. Doncologia-H Duran I Reynals, L'Hospitalet de Llobregat, 08908, Spain|Hosp. Infantil Univ. Nino Jesus, Madrid, 28009, Spain|Clinica Univ. de Navarra, Madrid, 28027, Spain|Hosp. Univ. Ramon Y Cajal, Madrid, 28034, Spain|Hosp Univ Fund Jimenez Diaz, Madrid, 28040, Spain|Hosp. Univ. 12 de Octubre, Madrid, 28041, Spain|Hosp. Univ. La Paz, Madrid, 28046, Spain|Hosp. Virgen Del Rocio, Seville, 41013, Spain|Hosp. Clinico Univ. de Valencia, Valencia, 46010, Spain|Changhua Christian Hospital, Changhua, 50006, Taiwan|Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung City, 807, Taiwan|E-Da Cancer Hospital, Kaohsiung City, 82445, Taiwan|Chang Gung Medical Foundation, Kaohsiung City, 833, Taiwan|China Medical University Hospital, Taichung, 403, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|Chi Mei Medical Center Yong Kang, Tainan, 710, Taiwan|National Cheng Kung University Hospital, Tainan, 710, Taiwan|Chi Mei Medical Center Liu Ying, Tainan, 736, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Chang Gung Memorial Hospital Linkou Branch, Taoyuan, 333, Taiwan|Bristol Royal Hospital for Children, Bristol, BS2 8AE, United Kingdom|Bristol Haematology and Oncology Centre, Bristol, BS2 8ED, United Kingdom|The Christie Nhs Foundation Trust, Manchester, M20 4BX, United Kingdom|The Clatterbridge Cancer Centre, Metropolitan Borough of Wirral, CH63 4JY, United Kingdom|Freeman Hospital, Newcastle upon Tyne, NE7 7DN, United Kingdom|Derriford Hospital, Plymouth, PL6 8DH, United Kingdom|The Royal Marsden NHS Trust, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,CD20 Positive|Hematopoietic and Lymphoid Cell Neoplasm|Lymphocytic Neoplasm|Lymphoma,PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation|BIOLOGICAL: Anti-Thymocyte Globulin|DRUG: Bortezomib|DRUG: Carmustine|DRUG: Cytarabine|DRUG: Etoposide|BIOLOGICAL: Filgrastim|DRUG: Melphalan|DRUG: Methotrexate|BIOLOGICAL: Rituximab|DRUG: Tacrolimus,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,40,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/13/07,6/7/18,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasms|NUT Carcinoma,DRUG: BI 894999,ALL,"ADULT, OLDER_ADULT",PHASE1,174,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/8/15,11/23/21,"Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Brussels - HOSP Jules Bordet, Anderlecht, 1070, Belgium|Brussels - UNIV Saint-Luc, Brussels, 1200, Belgium|UNIV UZ Gent, Ghent, 9000, Belgium|UZ Leuven, Leuven, 3000, Belgium|HOP Timone, Marseille, 13385, France|HOP Hôtel-Dieu, Nantes, 44000, France|HOP Saint-Louis, Paris, 75475, France|INS Gustave Roussy, Villejuif, 94800, France|Universitätsklinikum Tübingen, Tübingen, 72076, Germany|Samsung Medical Center, Seoul, 06351, South Korea|Hospital Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: CPX-POM,ALL,"ADULT, OLDER_ADULT",PHASE1,9,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/19/19,4/30/23,"University of Kansas Medical Center, Kansas City, Kansas, 66160, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Select Advanced Solid Tumors,DRUG: IMCnyeso,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,29,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/15/18,5/10/21,"University of Colorado Hospital, Aurora, Colorado, 80045, United States|University of Iowa Hospital and Clinics, Iowa City, Iowa, 52242, United States|Washington University School of Medicine in St. Louis, St Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|UPMC - Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Tennessee Oncology NASH - SCRI, Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|Sarah Cannon Research Institute UK, London, W1G 6AD, United Kingdom|The Christie Hospital, Manchester, M20 4BX, United Kingdom|Royal Marsden Hospital, Sutton, SW3 6JJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Uterine Cervical Neoplasms,BIOLOGICAL: E7 T-Cell Receptor (TCR),FEMALE,"ADULT, OLDER_ADULT",EARLY_PHASE1,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/14/21,9/15/21,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm,DRUG: Palbociclib,ALL,"ADULT, OLDER_ADULT",PHASE2,40,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/31/16,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Neuroendocrine Neoplasm|Gastroenteropancreatic Neuroendocrine Tumor,DRUG: Nivolumab|DRUG: Carboplatin|DRUG: Etoposide,ALL,"ADULT, OLDER_ADULT",PHASE2,37,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/11/19,6/9/23,"Institut Català d'Oncologia Badalona, Badalona, Barcelona, Spain|Institut Català d'Oncologia l'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain|Vall d'Hebron University Hospital, Barcelona, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|MD Anderson Cancer Madrid, Madrid, Spain|Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Spain|Hospital Universitario Virgen del Rocío, Seville, Spain|Hospital Universitario Miguel Servet, Zaragoza, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Urinary Bladder Neoplasms,DRUG: Durvalumab|DRUG: Vicineum|DRUG: Acetaminophen|DRUG: Antihistamine|PROCEDURE: Bladder Biopsy|PROCEDURE: TURBT|PROCEDURE: Cystoscopy|DIAGNOSTIC_TEST: Urine cytology|DIAGNOSTIC_TEST: Electrocardiogram|DIAGNOSTIC_TEST: CT|DIAGNOSTIC_TEST: MRI,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/7/18,10/17/22,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors Harboring a BRAF V600 Mutation,DRUG: LGX818|DRUG: MEK162|DRUG: LEE011,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,189,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,5/28/12,3/9/23,"H. Lee Moffitt Cancer Center & Research Institute, Inc., Tampa, Florida, 33612, United States|Moffitt McKinley Outpatient Center, Tampa, Florida, 33612, United States|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21287, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Ophthalmic Consultants of Boston Inc (OCB), Boston, Massachusetts, 02114, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Chris O'Brien Lifehouse Hospital, Camperdown, New South Wales, 02050, Australia|Melanoma Institute Australia, North Sydney, New South Wales, 2060, Australia|Westmead Hospital-Redbank Rd, Northmead, New South Wales, 2152, Australia|Westmead Hospital-Redbank Rd, Westmead, New South Wales, 2145, Australia|Westmead Hospital, Westmead, New South Wales, 2145, Australia|Melanoma Institute Australia, North Sydney, 2065, Australia|UZ Leuven- Gasthuisberg Campus, Leuven, Vlaams Brabant, 3000, Belgium|Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|Hôpital Saint louis, Paris, 75010, France|Service de radiologie - Hopital Saint Louis, Paris, 75475, France|IRCCS Fondazione Pascale, Naples, Campania, 80131, Italy|Azienda Ospedaliera Monaldi, Napoli, Campania, 80131, Italy|Azienda Ospedaliera Universitaria Federico II, Napoli, Campania, 80131, Italy|ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda Ca' Granda, Milan, 20162, Italy|Istituto Nazionale per lo studio e la cura dei tumori Fondazione Giovanni Pascale, Napoli, 80131, Italy|National Cancer Centre Singapore, Singapore, 169610, Singapore|Hospital Universitario Vall d'Hebrón - PPDS, Barcelona, 08035, Spain|Hospital Universitario HM Sanchinarro ? CIOCC, Madrid, 28050, Spain|University Hospital Zürich, Dermatology, Zurich-Airport, Canton of Zurich, 8058, Switzerland|Kantonsspital St. Gallen, Sankt Gallen, 9007, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Urinary Bladder Neoplasms,DRUG: Mitomycin C|DRUG: Gemcitabine,ALL,"ADULT, OLDER_ADULT",PHASE3,101,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE,4/19/16,10/22/21,"Spectrum Health Medical Group-Division of Urology-LHCP, Grand Rapids, Michigan, 49503, United States|Spectrum Health Medical Group-Division of Urology, Grand Rapids, Michigan, 49503, United States|Urologic Consultants P.C., Grand Rapids, Michigan, 49503, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: LY3039478,ALL,"ADULT, OLDER_ADULT",PHASE1,11,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/9/16,5/30/23,"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Kashiwa, Chiba, 277 8577, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Cancer,DRUG: BMS-986242|BIOLOGICAL: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,7,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/27/17,8/28/18,"University Of Alabama At Birmingham, Birmingham, Alabama, 35294-3300, United States|Hoag Memorial Hospital Presbyterian, Los Angeles, California, 90033, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Local Institution, Baltimore, Maryland, 21287, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Urinary Bladder Neoplasms,DRUG: AGEN1884|DRUG: AGEN2034|DRUG: Cisplatin|DRUG: Gemcitabine,ALL,"ADULT, OLDER_ADULT",PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/14/20,3/14/22,"Mays Cancer Center, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Solid Tumor,DRUG: Ramucirumab,ALL,"ADULT, OLDER_ADULT",PHASE1,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/23/21,5/25/21,"Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States|Oncology Hematology West, Omaha, Nebraska, 68130, United States|Levine Cancer Institute- Carolinas Medical Center, Charlotte, North Carolina, 28204, United States|Tennessee Oncology PLLC, Nashville, Tennessee, 37203, United States|Kindai University Hospital, Osaka Sayama-shi, Osaka, 589 8511, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced/Metastatic Solid Tumors,DRUG: PF-05082566|DRUG: KW-0761,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INTERVENTIONAL,Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT,2015-05,2017-10,"UC San Diego Moores Cancer Center, La Jolla, California, 92037-0845, United States|UC San Diego Medical Center - La Jolla(Thornton Hospital), La Jolla, California, 92037, United States|University Of California / San Diego Moores Cancer Center, La Jolla, California, 92093, United States|University of California San Diego Moores Cancer Center, La Jolla, California, 92093, United States|UC San Diego Medical Center - Hillcrest, San Diego, California, 92103, United States|Georgetown University Medical Center, Washington D.C., District of Columbia, 20007, United States|Georgetown University, Washington D.C., District of Columbia, 20007, United States|Medstar Georgetown University Hospital, Washington D.C., District of Columbia, 20007, United States|Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States|Henry Ford Hospital Research Pharmacy, Detroit, Michigan, 48202, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|UNC Cancer Hospital Infusion Pharmacy, Chapel Hill, North Carolina, 27514, United States|UNC Hospitals, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 27599-7600, United States|Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, 44195, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Sanford Cancer Center, Sioux Falls, South Dakota, 57104, United States|Sanford Research, Sioux Falls, South Dakota, 57104, United States|Sanford USD Medical Center, Sioux Falls, South Dakota, 57105, United States|Tennessee Oncology, PLLC, Gallatin, Tennessee, 37066, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Blastic Plasmacytoid Dendritic Cell Neoplasm,BIOLOGICAL: Tagraxofusp-erzs,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/27/20,7/11/23,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gynecologic Neoplasms|Epithelial Ovarian Cancer|Uterine Endometrial Cancer|Fallopian Tube Cancer|Peritoneal Cancer,DRUG: Pembrolizumab,FEMALE,"ADULT, OLDER_ADULT",EARLY_PHASE1,39,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-06,1/31/22,"Duke Cancer Institute, Durham, North Carolina, 27710, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Locally Advanced Basal Cell Carcinoma|Skin Cancer|Cutaneous Malignancy,DRUG: Vismodegib|RADIATION: Radiation therapy,ALL,"ADULT, OLDER_ADULT",PHASE2,24,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-05,9/10/19,"University of California, San Francisco, San Francisco, California, 94115, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Tenosynovial Giant Cell Tumor,DRUG: Pexidartinib,ALL,"ADULT, OLDER_ADULT",PHASE4,32,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/20/20,7/7/23,"Honor Health, Scottsdale, Arizona, 85258, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Washington University, St Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Chris O'Brien Lifehouse, Camperdown, New South Wales, 2050, Australia|Peter MacCallum Cancer Centre, East Melbourne, Victoria, 3000, Australia|Magyar Honvedseg Egeszsegugyi Kozpont, Budapest, H-1062, Hungary|Rizzoli-Istituto Ortopedico Rizzoli, Bologna, 40136, Italy|Fondazione IRCC Istituto Nazionale dei Tumori, Milan, 20133, Italy|Leiden University Medical Center (LUMC), Leiden, 2333 ZA, Netherlands|Hospital Sant Pau, Barcelona, 08041, Spain|Hospital Virgen del Rocio, Seville, 41013, Spain|National Taiwan University Hospital, Taipei, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Malignant Solid Neoplasm|Metastatic Carcinoma in the Liver|Metastatic Carcinoma in the Lung|Metastatic Malignant Neoplasm in the Thoracic Cavity|Metastatic Malignant Solid Neoplasm,DRUG: Anti-GITR Agonistic Monoclonal Antibody BMS-986156|BIOLOGICAL: Ipilimumab|BIOLOGICAL: Nivolumab|RADIATION: Stereotactic Body Radiation Therapy,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,51,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/19/19,4/14/25,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Breast Cancer|Solid Tumors,DRUG: Alisertib|DRUG: MLN0128,ALL,"ADULT, OLDER_ADULT",PHASE1,47,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/13/16,3/18/20,"University of Colorado Cancer Center, Aurora, Colorado, 80045, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Urinary Bladder Neoplasms,DRUG: Erdafitinib|DRUG: Investigator Choice (Gemcitabine)|DRUG: Investigator Choice (Mitomycin C),ALL,"ADULT, OLDER_ADULT",PHASE2,107,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/28/20,2/27/25,"Urological Associates of Southern Arizona, P.C., Tucson, Arizona, 85741, United States|USC Institute of Urology, Los Angeles, California, 90033, United States|The Urology Center of Colorado, Denver, Colorado, 80211, United States|Urological Research Network, Hialeah, Florida, 33016, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Northwestern University, Chicago, Illinois, 60611, United States|Simmons Cancer Institute, Springfield, Illinois, 62702, United States|University of Kansas, Westwood, Kansas, 66205, United States|Albany Medical College, Albany, New York, 12208, United States|NYU Langone Health, New York, New York, 10016, United States|Great Lakes Physician PC d/b/a Western New York Urology Associates, Sanborn, New York, 14132, United States|Montefiore Medical Center, The Bronx, New York, 10461, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|The Urology Group, Cincinnati, Ohio, 45212, United States|The Ohio State University- James Cancer Hospital, Columbus, Ohio, 43221, United States|Oregon Health And Science University, Portland, Oregon, 97239, United States|MidLantic Urology, Bala-Cynwyd, Pennsylvania, 19004, United States|University of Pittsburgh Medical Center - Cancer Centers, Pittsburgh, Pennsylvania, 15232, United States|Urology Associates, Nashville, Tennessee, 37209, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|University of Washington, Seattle, Washington, 98008, United States|Medical College of Wisconsin Froedtert Hospital, Milwaukee, Wisconsin, 53226, United States|Sociedade Beneficente de Senhoras Hospital Sirio Libanes, Buenos Aires, C1419AHN, Argentina|CEMIC Saavedra, Buenos Aires, C1431FWN, Argentina|Hospital Britanico de Buenos Aires, Buenos Aires, Argentina|Hospital Italiano de Buenos Aires, Ciudad Autonoma de, C1199ABB, Argentina|Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica, Córdoba, 5000, Argentina|Centro Urologico Profesor Bengio, Córdoba, X5000KPH, Argentina|Hospital Privado de Cordoba, Córdoba, XX5016KEH, Argentina|Flinders Medical Centre, Bedford Park, 5042, Australia|St Vincent s Hospital Sydney, Darlinghurst, 2010, Australia|Macquarie University, Macquarie University, 2109, Australia|Peter MacCallum Cancer Centre, Melbourne, 3000, Australia|AZ Maria Middelares, Ghent, 9000, Belgium|UZ Leuven, Leuven, 3000, Belgium|CHU Sart-Tilman, Liège, 4000, Belgium|Algemeen Ziekenhuis Delta, Roeselare, 8800, Belgium|Liga Paranaense de Combate ao Cancer, Curitiba, 81520 060, Brazil|Oncocentro Ceará, Fortaleza, 60135-237, Brazil|Associacao de Combate ao Cancer em Goias - Hospital de Cancer Araujo Jorge, Goiânia, 74605-070, Brazil|Liga Norte Riograndense Contra O Cancer, Natal, 59075-740, Brazil|Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, 90050-170, Brazil|Hospital Nossa Senhora da Conceicao S A, Porto Alegre, 91350 200, Brazil|Instituto de Medicina Integral Professor Fernando Figueira, Recife, 50070-550, Brazil|Hospital Das Clinicas Da Faculdade De Medicina De RPUSP HCRP, Ribeirão Preto, 14048-900, Brazil|Oncoclinicas Rio de Janeiro S A, Rio de Janeiro, 22250 905, Brazil|Instituto de Educacao, Pesquisa e Gestao em Saude Instituto Americas (COI), Rio de Janeiro, 22775 001, Brazil|CEPHO Centro de Estudos e Pesquisa de Hematologia e Oncologia, Santo André, 09060-650, Brazil|Fundacao Faculdade de Medicina Instituto do Cancer do Estado de Sao Paulo, São Paulo, 01246 000, Brazil|Sociedade Beneficente de Senhoras Hospital Sirio Libanes, São Paulo, 01308 901, Brazil|Instituto de Assistencia Medica ao Servidor Publico Estadual IAMSPE, São Paulo, 04039-004, Brazil|Nanjing Drum Tower Hospital, Nanjing, 210008, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200240, China|Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, China|Fakultni nemocnice u sv. Anny v Brne, Brno, 656 91, Czechia|Krajská nemocnice Liberec, Liberec, 460 63, Czechia|Vseobecna fakultni nemocnice v Praze, Prague, 128 08, Czechia|Fakultni nemocnice v Motole, Prague, 150 06, Czechia|Hopital Pellegrin CHU Bordeaux, Bordeaux, 33076, France|CHU Gabriel-Montpied, Clermont-Ferrand, 63000, France|Hopital Huriez, Lille, 59037, France|Hôpital Edouard Herriot, Lyon, 69437, France|Institut Paoli Calmettes, Marseille, 13273, France|Hôpital Universitaire Pitié-Salpêtrière, Paris, 75013, France|Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, 75020, France|Hopital Bichat Claude Bernard, Paris, 75877, France|CHU De Poitiers, Poitiers, 86021, France|Chu Rennes Hopital Pontchaillou, Rennes, 35033, France|Hopital Charles Nicolle, Rouen, 76031, France|CHP Saint Gregoire, Saint-Grégoire, 35760, France|Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, 31000, France|Centre Hospitalier Universitaire de Nancy - Hôpital Central, Vandœuvre-lès-Nancy, 54519, France|Gustave Roussy, Villejuif, 94800, France|Urologicum Duisburg, Duisburg, 47169, Germany|Klinikum Herne - Urologie, Herne, 44625, Germany|Universitatsklinikum Schleswig Holstein Campus Lubeck, Lübeck, 23538, Germany|Praxisklinik Urologie Rhein/Ruhr - Germany, Mülheim, 45468, Germany|Klinikum rechts der Isar - III. Med. Klinik und Poliklinik, München, 81675, Germany|Universitaetsklinikum Muenster, Münster, 48149, Germany|MVZ Urologie 24 gGmbH, Nuremberg, 90491, Germany|Studienpraxis Urologie Drs. Feyerabend, Nürtingen, 72622, Germany|CUROS - Uberörtliche urologische Gemeinschaftspraxis, Wesseling, 50389, Germany|Health Care Global Enterprises pvt Ltd, Bangalore, 560027, India|Rajiv Gandhi Cancer Institute & Research Centre, Delhi, 110085, India|King Georges Medical University, Lucknow, 226003, India|Meenakshi Mission Hospital and Research Center, Madurai, 625107, India|Muljibhai Patel Urological Hospital, Nadiād, 387001, India|CIMET s Inamdar Multispeciality Hospital, Pune, 411040, India|Ente Ecclesiastico Ospedale Generale Regionale F. Miulli, Acquaviva delle Fonti, 70021, Italy|Ospedale Regionale Umberto Parini, Aosta, 11100, Italy|Fondazione Istituto G. Giglio, Cefalù, 90015, Italy|Ospedale Civile di Guastalla, Guastalla, 42016, Italy|Azienda Ospedaliera ''Vito Fazzi'', Lecce, 73100, Italy|UOC Oncologia Ospedale Provinciale di Macerata, Macerata, 62100, Italy|IRCCS Ospedale San Raffaele, Milan, 20132, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy|Fondazione G Pascale Istituto Nazionale Tumori IRCCS, Napoli, 80138, Italy|Azienda Ospedaliera Sant Andrea, Roma, 00189, Italy|Azienda Ospedaliera Universitaria Integrata Verona, Verona, 37126, Italy|Juntendo University Hospital, Bunkyō City, 113 8431, Japan|Tokyo Medical and Dental University Hospital, Bunkyō City, 113 8519, Japan|Asahi General Hospital, Chiba, 289-2511, Japan|Hakodate Goryoukaku Hospital, Hakodate, 040 8611, Japan|Saitama Medical University International Medical Center, Hidaka, 350-1298, Japan|Hitachi General Hospital, Hitachi, 317-0077, Japan|St Marianna University Hospital, Kanagawa, 216 8511, Japan|Nagoya University Hospital, Nagoya, 466 8560, Japan|JOHAS Osaka Rosai Hospital, Osaka, 591-8025, Japan|Gunma Prefectural Cancer Center, Ōta-ku, 373 8550, Japan|Osaka Medical and Pharmaceutical University Hospital, Takatsuki, 569-8686, Japan|Toranomon Hospital, Tokyo, 105-8470, Japan|The Cancer Institute Hospital of JFCR, Tokyo, 135 8550, Japan|Fujita Health University Hospital, Toyoake, 470-1192, Japan|University of Tsukuba Hospital, Tsukuba, 305 8576, Japan|Yokohama City University Medical Center, Yokohama, 232 0024, Japan|Uniwersyteckie Centrum Kliniczne, Gdansk, 80 214, Poland|Pratia MCM Krakow, Krakow, 30 727, Poland|Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie, Rzeszów, 35-055, Poland|Samodzielny Publiczny Szpital Kliniczny nr 2 PUM, Szczecin, 70-111, Poland|Medical Concierge Centrum Medyczne, Warsaw, 02 798, Poland|City Clinic Sp. z o.o., Warsaw, 02-473, Poland|Uniwersytecki Szpital Kliniczny, Wroclaw, 50-556, Poland|Pusan National University Hospital, Busan, 49241, South Korea|Chungbuk National University Hospital, Cheongju-si, 361-711, South Korea|Kyungpook National University Chilgok Hospital, Daegu, 41404, South Korea|National Cancer Center, Goyang-si, 10408, South Korea|Chonnam National University Hwasun Hospital, Jeollanam-do, 58128, South Korea|Korea University Anam Hospital, Seoul, 02841, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Kangbuk Samsung Hospital, Seoul, 03181, South Korea|Severance Hospital Yonsei University Health System, Seoul, 03722, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|Fund. Puigvert, Barcelona, 08025, Spain|Hosp Clinic de Barcelona, Barcelona, 8036, Spain|Hosp. Univ. Ramon Y Cajal, Madrid, 28034, Spain|Hosp. Univ. 12 de Octubre, Madrid, 28041, Spain|Hosp. Univ. La Paz, Madrid, 28046, Spain|Corporacio Sanitari Parc Tauli, Sabadell, 08208, Spain|Hosp. Univ. Marques de Valdecilla, Santander, 39008, Spain|Instituto Valenciano de Oncologia, Valencia, 46009, Spain|Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung City, 80756, Taiwan|China Medical University Hospital, Taichung, 40447, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Chang Gung Memorial Hospital- Linkou, Taoyuan, 33305, Taiwan|The Christie NHS Foundation Trust Christie Hospital, Manchester, M20 4BX, United Kingdom|Universirty of Sheffield Teaching Hospitals NHS Trust, Sheffield, S10 2JF, United Kingdom|Lister Hospital, Stevenage, SG1 4AB, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor|Colorectal Cancer,DRUG: Magrolimab|DRUG: Cetuximab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,78,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/2/16,2/10/20,"UCLA, Los Angeles, California, 90404, United States|Stanford University, Palo Alto, California, 94305-5757, United States|Wayne State University, Detroit, Michigan, 48201, United States|START Midwest, Grand Rapids, Michigan, 49503, United States|UPENN, Philadelphia, Pennsylvania, 19104, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Md Anderson, Houston, Texas, 77030, United States|START Center for Cancer Care, San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: paclitaxel|DRUG: TAK-228|DRUG: TAK-117,ALL,"ADULT, OLDER_ADULT",PHASE1,19,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/6/17,11/20/22,"Avera Cancer Institute, Sioux Falls, South Dakota, 57105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Tumor, Solid|Gastrointestinal Cancer",DRUG: Ulixertinib|DRUG: Hydroxychloroquine,ALL,"ADULT, OLDER_ADULT",PHASE2,47,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/26/22,7/14/24,"University of Arizona Cancer Center, Tucson, Arizona, 85719, United States|University of California San Francisco, San Francisco, California, 94143, United States|University of Kansas Cancer Center, Fairway, Kansas, 66205, United States|Rogel Cancer Center, University of Michigan Health, Ann Arbor, Michigan, 48109, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|Mount Sinai, New York, New York, 10029, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia, 23298, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Advanced/Metastatic Head and Neck, Oesophageal and Cervical Cancers","DRUG: simlukafusp alfa|DRUG: Atezolizumab (MPDL3280A), an Engineered Anti-PD-L1 Antibody|DRUG: Gemcitabine|DRUG: Vinorelbine",ALL,"ADULT, OLDER_ADULT",PHASE2,256,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/19/18,12/30/21,"University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94158, United States|Cancer Treatment Centers of America, Newnan, Georgia, 30265, United States|UZ Antwerpen, Edegem, 2650, Belgium|UZ Gent, Ghent, 9000, Belgium|UZ Leuven Gasthuisberg, Leuven, 3000, Belgium|Institut Bergonie, Bordeaux, 33076, France|Hopital Timone Adultes; Oncologie Medicale Et Usp, Marseille, 13385, France|ICM; Medecine B3, Montpellier, 34298, France|Gustave Roussy Cancer Campus, Villejuif, 94805, France|Universitätsklinikum Essen; Innere Klinik (Tumorforschung), Essen, 45147, Germany|Rambam Medical Center; Oncology, Haifa, 3109601, Israel|Auckland City Hospital; Clinical Oncology, Auckland, 1023, New Zealand|Uniwersyteckie Centrum Kliniczne; Osrodek Badan Wczesnych Faz, Gda?sk, 80-214, Poland|Narodowy Instytut Onkologii im. M. Sklodowskiej-Curie; Oddzial Badan Wczesnych Faz, Warsaw, 02-781, Poland|N.N.Burdenko Main Military Clinical Hospital; Oncology Dept, Moscow, 105229, Russia|S-Pb clinical scientific practical center of specialized kinds of medical care (oncological), Saint Petersburg, 197758, Russia|National University Hospital; National University Cancer Institute, Singapore (NCIS), Singapore, 119228, Singapore|National Cancer Centre; Medical Oncology, Singapore, 169610, Singapore|Seoul National University Bundang Hospital, Seongnam-si, 13620, South Korea|Severance Hospital, Yonsei University Health System, Seoul, 003-722, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 135-710, South Korea|Clinica Universitaria de Navarra, Pamplona, Navarre, 31008, Spain|Hospital del Mar; Servicio de Oncologia, Barcelona, 08003, Spain|Hospital Univ Vall d'Hebron; Servicio de Oncologia, Barcelona, 08035, Spain|Clinica Universidad de Navarra Madrid; Servicio de Oncología, Madrid, 28027, Spain|Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, 28034, Spain|START Madrid-FJD, Hospital Fundacion Jimenez Diaz, Madrid, 28040, Spain|START Madrid. Centro Integral Oncologico Clara Campal; CIOCC, Madrid, 28050, Spain|Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia, Valencia, 46010, Spain|Hôpitaux Universit. de Genève Médecine Oncologie; Oncologie, Geneva, 1211, Switzerland|National Cheng Kung Uni Hospital; Dept of Hematology and Oncology, Tainan, 704, Taiwan|National Taiwan Uni Hospital; Dept of Oncology, Taipei, 100, Taiwan|Adana Baskent University Hospital; Medical Oncology, Adana, 01120, Turkey (Türkiye)|Akdeniz University Medical Faculty; Medical Oncology Department, Antalya, 07070, Turkey (Türkiye)|Trakya Universitesi Tip Fakultesi, Medikal Onkoloji Bilim Dali, Balkan Yerleskesi, Edirne, 22030, Turkey (Türkiye)|Istanbul University Cerrahpa?a-Cerrahpa?a Medical Faculty; Medikal Onkoloji Departmani, Istanbul, 34098, Turkey (Türkiye)|?zmir Medical Park; Onkoloji, Izmir, Turkey (Türkiye)|Goztepe Prof.Dr. Suleyman Yalcin City Hospital; Clinical Oncology, Kadiköy, 34722, Turkey (Türkiye)|Barts, London, EC1M6BQ, United Kingdom|University College London Hospital, London, N7 9NH, United Kingdom|Christie Hospital Nhs Trust; Medical Oncology, Manchester, M2O 4BX, United Kingdom|Royal Marsden Hospital; Institute of Cancer Research, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Adenocarcinoma|Pancreatic Neoplasms,DRUG: X-82|DRUG: Everolimus,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,23,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,5/3/13,8/19/20,"Washington University School of Medicine, St Louis, Missouri, 63110, United States|Vanderbilt University, Nashville, Tennessee, 37232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pancreatic Neuroendocrine Tumor,DRUG: RAD001|DRUG: Temozolomide,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,43,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2008-05,3/29/19,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Lymphoma|Childhood Lymphoma|Solid Tumor|Childhood Solid Tumor|Neuroblastoma|Ewing Sarcoma|Hodgkin Lymphoma|Non-Hodgkin Lymphoma|Rhabdomyosarcoma|Soft Tissue Sarcoma|Medulloblastoma|Germ Cell Tumor|Wilms Tumor|Brain Neoplasms|Medulloblastoma, Childhood|Neuroectodermal Tumors, Primitive",DRUG: Genistein|DRUG: Placebo,ALL,"CHILD, ADULT",PHASE2,4,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",2016-08,2021-09,"University of Virginia, Charlottesville, Virginia, 22908, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Cancer|Solid Tumor|Lymphoma,DRUG: Sym023,ALL,"ADULT, OLDER_ADULT",PHASE1,24,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/24/18,6/3/20,"South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan, 49503, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|NEXT Oncology, San Antonio, Texas, 78240, United States|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Neoplasms, Advanced Solid",DRUG: TAK-931 PIC|DRUG: TAK-931 Tablet|DRUG: Esomeprazole,ALL,"ADULT, OLDER_ADULT",PHASE1,20,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER,3/28/19,12/3/19,"Radboud University Medical Center, Department of Medical Oncology, Nijmegen, Gelderland, 6525 GA, Netherlands|Netherlands Cancer Institute - Antoni van Leeuwenhoek, Department of Medical Oncology, Amsterdam, North Holland, 1066 CX, Netherlands|Leiden University Medical Center, Department of Clinical Oncology, Leiden, South Holland, 2333 ZA, Netherlands|Erasmus MC Cancer Institute, Department of Internal Oncology, Rotterdam, South Holland, 3015 GD, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor|Lymphoma,DRUG: MK-2118 (IT)|DRUG: MK-2118 (SC)|BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE1,140,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,9/20/17,2/22/23,"University of California San Diego Moores Cancer Center ( Site 0004), La Jolla, California, 92093, United States|UCLA ( Site 0003), Los Angeles, California, 90095, United States|University of Chicago ( Site 0002), Chicago, Illinois, 60637, United States|New York Presbyterian Hospital/Columbia University ( Site 0001), New York, New York, 10032, United States|UPMC Hillman Cancer Centers ( Site 0007), Pittsburgh, Pennsylvania, 15232, United States|Mary Crowley Cancer Research Center ( Site 0005), Dallas, Texas, 75230, United States|MD Anderson Cancer Centr. ( Site 0006), Houston, Texas, 77030, United States|Sheba Medical Center ( Site 0301), Ramat Gan, 5265601, Israel",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Urinary Bladder Neoplasms,BIOLOGICAL: Nivolumab|BIOLOGICAL: BCG|DRUG: BMS-986205,ALL,"ADULT, OLDER_ADULT",PHASE2,142,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/2/18,8/24/22,"Local Institution - 0044, Los Angeles, California, 90033, United States|Local Institution - 0081, Riverside, California, 92505, United States|Local Institution - 0087, San Francisco, California, 94158, United States|Local Institution - 0125, Tampa, Florida, 33612, United States|Local Institution - 0056, Hapeville, Georgia, 30354, United States|Local Institution - 0023, New Lenox, Illinois, 60451, United States|Wichita Urology Group, Wichita, Kansas, 67226, United States|Local Institution - 0001, Baltimore, Maryland, 21287, United States|Local Institution - 0077, Ann Arbor, Michigan, 48109, United States|Local Institution - 0032, Minneapolis, Minnesota, 55455, United States|Local Institution - 0040, Omaha, Nebraska, 68114, United States|Local Institution - 0144, New Brunswick, New Jersey, 08903, United States|Deleware Valley Urology, LLC, Voorhees Township, New Jersey, 08043, United States|Local Institution - 0051, New York, New York, 10016, United States|Local Institution - 0058, Columbus, Ohio, 43212, United States|Local Institution - 0036, Bala-Cynwyd, Pennsylvania, 19004, United States|Local Institution - 0049, Charleston, South Carolina, 29425, United States|Local Institution - 0002, Myrtle Beach, South Carolina, 29572, United States|Local Institution - 0057, Chattanooga, Tennessee, 37403, United States|Urology Clinics Of North Texas, Pa, Dallas, Texas, 75231, United States|Local Institution - 0048, Houston, Texas, 77030, United States|Local Institution - 0140, Houston, Texas, 77030, United States|Local Institution - 0047, Lubbock, Texas, 79415, United States|Urology San Antonio Research, Pa, San Antonio, Texas, 78229, United States|Local Institution - 0141, Seattle, Washington, 98195, United States|Local Institution - 0068, Capital Federal, Buenos Aires, 1426, Argentina|Local Institution - 0065, Capital Federal, Distrito Federal, C1280AEB, Argentina|Local Institution - 0089, Ciudad Autonoma Buenos Aires, Distrito Federal, 1118, Argentina|Local Institution, Viedma, Río Negro Province, 8500, Argentina|Instituto Oncologico De Cordoba, Córdoba, 5000, Argentina|Local Institution - 0137, Mendoza, 5500, Argentina|Local Institution - 0146, Camperdown, New South Wales, 2050, Australia|Local Institution - 0148, St Leonards, New South Wales, 2065, Australia|Local Institution - 0072, Fortaleza, Ceará, 60135-237, Brazil|Local Institution - 0151, Curitiba, Paraná, 80810050, Brazil|Local Institution - 0073, Porto Alegre, Rio Grande do Sul, 91350-200, Brazil|Local Institution, Itacorubi, Florianopolis, Santa Catarina, 88034, Brazil|Local Institution - 0078, Jaú, São Paulo, 17210-120, Brazil|Local Institution - 0150, Rio de Janeiro, 20230-130, Brazil|Local Institution - 0074, São Paulo, 01246-000, Brazil|Local Institution - 0143, North York, Ontario, M2K 1E1, Canada|Local Institution - 0086, Toronto, Ontario, M4N 3M5, Canada|Local Institution - 0084, Toronto, Ontario, M5G 2M9, Canada|Local Institution - 0046, Québec, Quebec, G1J 1Z4, Canada|Local Institution - 0154, Santiago, Santiago Metropolitan, 8420383, Chile|Local Institution - 0069, Santiago, Santiago Metropolitan, Chile|Local Institution - 0128, Beijing, Beijing Municipality, 100021, China|Local Institution - 0131, Beijing, Beijing Municipality, 100034, China|Local Institution - 0116, Beijing, Beijing Municipality, 100142, China|Local Institution - 0099, Beijing, Beijing Municipality, 100191, China|Local Institution - 0129, Chongqing, Chongqing Municipality, 400030, China|Local Institution - 0108, Fuzhou, Fujian, 350001, China|Local Institution - 0117, Guangzhou, Guangdong, 510000, China|Local Institution - 0102, Nanjing, Jiangsu, 210008, China|Local Institution - 0109, Nanchang, Jiangxi, 330000, China|Local Institution - 0112, Jinan, Shandong, 250012, China|Local Institution - 0111, Yantai, Shandong, 264000, China|Local Institution - 0098, Shanghai, Shanghai Municipality, 200025, China|Local Institution - 0094, Shanghai, Shanghai Municipality, 200032, China|Local Institution - 0097, Shanghai, Shanghai Municipality, 200040, China|Local Institution - 0120, Chengdu, Sichuan, 610041, China|Local Institution - 0133, Tianjin, Tianjin Municipality, 300211, China|Local Institution - 0126, Hangzhou, Zhejiang, 310003, China|Local Institution - 0027, Suresnes, Hauts-de-Seine, 92151, France|Local Institution - 0028, Angers, Maine-et-Loire, 49933, France|Local Institution - 0031, Bordeaux, 33076, France|Local Institution - 0088, Lille, 59037, France|Local Institution - 0091, Strasbourg, 67200, France|Local Institution - 0093, Hong Kong, Hong Kong|IRCCS Istituto Nazionale Tumori Milano, Milan, 20133, Italy|Instituto Nazionale Tumori Fondazione G. Pascale, Napoli, 80131, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, 56126, Italy|Local Institution - 0062, Tuxtla Gutiérrez, Chiapas, 290838, Mexico|Local Institution - 0055, Mexico City, Mexico City, 06100, Mexico|Local Institution - 0004, Amsterdam, 1066 CX, Netherlands|Local Institution - 0003, Nijmegen, 6525GA, Netherlands|Local Institution - 0005, Utrecht, 3584CX, Netherlands|Local Institution - 0070, Omsk, 644013, Russia|Local Institution - 0054, Saint Petersburg, 194044, Russia|Local Institution - 0153, Saint Petersburg, 199034, Russia|Local Institution, Madrid, 28041, Spain|Local Institution - 0033, Málaga, 29010, Spain|Local Institution - 0139, Santander, 39008, Spain|Local Institution - 0136, Valencia, 46010, Spain|Local Institution, Chelmsford, Essex, CM1 7ET, United Kingdom|Local Institution, London, Greater London, N18 1QX, United Kingdom|Local Institution - 0013, Southampton, Hampshire, SO16 6YD, United Kingdom|Local Institution - 0015, Lancaster, LA1 4RP, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,"Tenosynovial Giant Cell Tumor|Pigmented Villonodular Synovitis|Giant Cell Tumor of Tendon Sheath|Tenosynovial Giant Cell Tumor, Diffuse|Tenosynovial Giant Cell Tumor, Localized",DRUG: Vimseltinib|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,123,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",10/14/21,2026-07,"City of Hope, Duarte, California, 91010, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|University of Colorado, Aurora, Colorado, 80045, United States|University of Kansas, Kansas City, Kansas, 66160, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Mayo Clinic Rochester, Rochester, Minnesota, 55902, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10016, United States|Duke Sarcoma Research, Durham, North Carolina, 27710, United States|Ohio State University, Columbus, Ohio, 43210, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Chris O'Brien Lifehouse, Camperdown, Australia|McGill University, Montreal, Canada|Princess Margaret Hospital, Toronto, Canada|Institut Bergonié, Bordeaux, France|Centre Léon Bérard, Lyon, France|Institut Gustave Roussy, Villejuif, France|Helios Klinikum Berlin-Buch, Berlin, Germany|University Hospital Essen (Universitätsklinikum Essen), Essen, Germany|Prince of Wales Hospital, Hong Kong, Hong Kong|Istituto Ortopedico Rizzoli, Bologna, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy|Istituto Nazionale Tumori IRCCS ""Fondazione G. Pascale"", Naples, Italy|Istituto Oncologico Veneto, Padua, Italy|Istituto Nazionale Tumori Regina Elena, Rome, Italy|Leiden University Medical Center, Leiden, Netherlands|Oslo University Hospital, Oslo, Norway|Klinika Nowotworów Tkanek Miękkich, Kości i Czerniaków Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, Warsaw, Poland|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Fundacion Jimenez Diaz, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Universitäts-Kinderspital beider Basel (UKBB), Basel, Switzerland|Cancer & Haematology Centre, The Churchill Hospital - Oxford University Hospitals NHS Foundation Trust, London, United Kingdom|University College London Hospitals, London, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Melanoma|Carcinoma, Hepatocellular|Colorectal Neoplasms",DRUG: E7386|DRUG: Pembrolizumab|DRUG: Lenvatinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,89,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/27/21,10/15/24,"University of California, Los Angeles, Los Angeles, California, 90095, United States|University of California, Irvine Health, Orange, California, 92868, United States|Florida Cancer Specialists, Fort Myers, Florida, 33916, United States|SCRI Florida Cancer Specialists East, West Palm Beach, Florida, 33401, United States|Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Barbara Ann Karmanos Cancer Center, Detroit, Michigan, 48201, United States|Rutgers cancer Institute of NJ, New Brunswick, New Jersey, 08901, United States|Icahn School of Medicine at Mount Sinai, New York, New York, 10029, United States|Providence Medical Center Institute Franz Clinic, Portland, Oregon, 97213, United States|Tennessee Oncology PPLC, Nashville, Tennessee, 37203, United States|Chiba University Hospital, Chiba, Japan|National Cancer Center Hospital, Chūōku, Japan|Kurume University Hospital, Fukuoka, Japan|National Cancer Center Hospital East, Kashiwa, Japan|Osaka Metropolitan University Hospital, Osaka, Japan|Kindai University Hospital, Ōsaka-sayama, Japan|Sapporo-Kosei General Hospital, Sapporo, Japan|Shizuoka Cancer Center Hospital, Shizouka, Japan|Toranomon Hospital, Tokyo, Japan|Hospital Regional Universitario de Malaga, Málaga, Avenida Carolos Haya S/n, Spain|Hospital Clínico San Carlos, Madrid, Calle Profesor Martín Lagos, Spain|Clínica Universidad de Navarra, Pamplona, Navarre, Spain|Hospital Universitario de Badajoz, Badajoz, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario de la Paz, Madrid, Spain|Consorcio Hospital General Universitario de Valencia, Valencia, Spain|Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom|Imperial College London - Hammersmith Hospital, London, United Kingdom|Royal Free Hospital NHS Foundation Trust, London, United Kingdom|The Christie NHS Foundation Trust, Manchester, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced or Metastatic Solid Tumors,BIOLOGICAL: Nivolumab|BIOLOGICAL: Ipilimumab|DRUG: Cobimetinib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,1163,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/24/13,11/18/24,"Local Institution - 0047, Muscle Shoals, Alabama, 35661, United States|Local Institution - 0044, Aurora, Colorado, 80045, United States|Local Institution - 0015, New Haven, Connecticut, 06520, United States|Local Institution - 0046, Gainesville, Florida, 32610, United States|Local Institution - 0021, Tampa, Florida, 33612, United States|Local Institution - 0001, Atlanta, Georgia, 30322, United States|Local Institution - 0004, Baltimore, Maryland, 21287, United States|Local Institution - 0005, Boston, Massachusetts, 02215, United States|Local Institution - 0043, Boston, Massachusetts, 02215, United States|Local Institution - 0049, Omaha, Nebraska, 68130, United States|Local Institution - 0045, Mineola, New York, 11501, United States|Local Institution - 0006, New York, New York, 10065, United States|Local Institution - 0003, Charlotte, North Carolina, 28204, United States|Local Institution - 0008, Durham, North Carolina, 27710, United States|Local Institution - 0007, Portland, Oregon, 97239, United States|Local Institution - 0011, Franklin, Tennessee, 37067, United States|Local Institution - 0002, Nashville, Tennessee, 37232, United States|Local Institution - 0009, Houston, Texas, 77030, United States|Local Institution - 0042, Seattle, Washington, 98104, United States|Local Institution - 0038, Toronto, Ontario, M5G 2M9, Canada|Local Institution - 0039, Copenhagen, 2100, Denmark|Local Institution - 0014, Helsinki, Uusimaa, 00290, Finland|Local Institution - 0036, Tampere, 33521, Finland|Local Institution - 0048, Bonn, 53105, Germany|Local Institution - 0026, Frankfurt, 60488, Germany|Local Institution - 0016, Heidelberg, 69120, Germany|Local Institution - 0050, Kassel, 34125, Germany|Local Institution - 0024, Bologna, 40138, Italy|Local Institution - 0019, Milan, 20133, Italy|Local Institution - 0020, Napoli, 80131, Italy|Local Institution - 0032, Padua, 35128, Italy|Local Institution - 0037, Barcelona, 08036, Spain|Local Institution - 0023, Madrid, 28040, Spain|Local Institution - 0017, Madrid, 28041, Spain|Local Institution - 0010, Madrid, 28050, Spain|Local Institution - 0018, London, Greater London, SW3 6JJ, United Kingdom|Local Institution - 0012, Glasgow, Lanarkshire, G12 0YN, United Kingdom|Local Institution - 0013, Sutton, Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor|Kidney Cancer,DRUG: pazopanib|DRUG: everolimus,ALL,"ADULT, OLDER_ADULT",PHASE1,23,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2011-01,2017-03,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Gastro-enteropancreatic Neuroendocrine Tumor,DRUG: Lutathera|DRUG: 30 mg Octreotide long acting repeatable (LAR) (Sandostatin LAR Depot)|DRUG: 2.5% Lys-Arg sterile amino acid solution|DRUG: High dose 60 mg octreotide long-acting repeatable,ALL,"ADULT, OLDER_ADULT",PHASE3,226,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,1/8/20,10/29/27,"Yale Cancer Center, New Haven, Connecticut, 06520, United States|USF - H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States|University of Iowa Hospitals and Clinics - Oncology, Iowa City, Iowa, 52242, United States|University of Kentucky UK Markey Cancer Center, Lexington, Kentucky, 40536, United States|Mayo Clinic - Oncology, Rochester, Minnesota, 55905, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|London Health Sciences Centre, University of Western Ontario - Oncology, London, Canada|Centre Hospitalier Universitaire de Quebec, Québec, Canada|Sunnybrook Health Sciences Centre, Toronto, Canada|BC Cancer Agency, Vancouver, Canada|CHU Paris Nord-Val de Seine, Clichy, France|Hospices Civils de Lyon (HCL) - Hopital Edouard Herriot, Lyon, France|Institut du Cancer de Montpellier - Oncology, Montpellier, France|CHU-Hôtel Dieu Service de Médecine Nucléaire, Nantes, France|Institut Gustave Roussy, Villejuif, France|Universitätsklinikum Erlangen, Erlangen, Germany|Universitätsklinikum Essen - Klinik für Nuklearmedizin, Essen, Germany|A.O.di Bologna Policl.S.Orsola, Bologna, Italy|University of Genova - Oncology, Genova, Italy|Istituto Oncologico Romagnolo, Meldola, Italy|Fondazione Irccs Istituto Nazionale Tumori, Milan, Italy|Ieo, Irccs, Milan, Italy|IRCCS fondazione Pascale - Oncology, Napoli, Italy|Arcispedale Santa Maria Nuova, Reggio Emilia - Oncology, Reggio Emilia, Italy|Azienda Ospedaliera Sant'Andrea - Università La Sapienza U.O.C. Mal App. Digerente e - Oncology, Roma, Italy|Erasmus Medisch Centrum, Rotterdam, Netherlands|UMC Utrecht - Oncology, Utrecht, Netherlands|Seoul National University Bundang Hospital, Seongnam-si, South Korea|Asan Medical Center - Oncology, Seoul, South Korea|Seoul National University Hospital - Department of Internal Medicine, Seoul, South Korea|Severance Hospital, Yonsei University Health System - Medical Oncology, Seoul, South Korea|Hospital Universitario Vall d'Hebrón, Barcelona, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Spain|Bristol Haematology and Oncology Centre, Bristol, United Kingdom|Guys And St Thomas Hospital, London, United Kingdom|Kings College Hospital - Oncology, London, United Kingdom|Royal Free Hospital, London, London, United Kingdom|Weston Park Hospital, Sheffield, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Brain Tumor, Recurrent",DRUG: Photofrin photodynamic therapy.,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2015-06,12/19/17,"Medical College of Wisconsin/ Froedtert Hospital, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrointestinal Neoplasms|Adenocarcinoma,BIOLOGICAL: IMU-131|DRUG: Cisplatin and either Fluorouracil (5-FU) or Capecitabine or Oxaliplatin and capecitabine.,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,64,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,8/30/17,3/20/24,"ARENSIA Exploratory Medicine LLC, Tbilisi, 0112, Georgia|City Cancer Center, Vijayawada, Andhra Pradesh, 520002, India|North East Cancer Hospital and Research Institute, Guwahati, Assam, 781023, India|Shetty's Hospital, Bengaluru, Karnataka, 560068, India|Curie Manavata Cancer Centre, Nashik, Maharashtra, 422004, India|Deenanath Mangeshkar Hospital and Research Centre, Pune, Maharashtra, 411004, India|Victoria Hospital, Bangalore, 560002, India|MNJ Institute of Oncology and Regional Cancer Centre, Hyderabad, 500004, India|Tata Medical Centre, Kolkata, 700160, India|HCG NCHRI Cancer Centre, Nagpur, 440026, India|Regional Cancer Centre Indira Gandhi Institute of Medical Sciences, Patna, 800014, India|ARENSIA Exploratory Medicine IMSP Institutul Oncologic, Chisinau, 2025, Moldova|Oncology Institute of Vojvodina, Kamenitz, Južnobanatski Okrug, 21204, Serbia|Institute for Oncology and Radiology of Serbia - PPDS, Belgrade, 11000, Serbia|Military Medical Academy, Belgrade, 11000, Serbia|Clinical Hospital Center Bezanijska Kosa, Belgrade, 11070, Serbia|National Cheng-Kung University Hospital, Tainan, 70403, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Division of Medical Oncology, Department of Medicine, Prince of Songkla University, Songklanagarind Hospital, Hat Yai, Changwat Songkhla, 90110, Thailand|National Cancer Institute of Thailand, Bangkok, 10400, Thailand|Division of Oncology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand|ARENSIA Exploratory Medicine LLC, Kapitanivka, 8112, Ukraine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Broad Solid Tumor,DRUG: BMS-986207|BIOLOGICAL: Nivolumab|BIOLOGICAL: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,101,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/30/16,1/25/24,"Local Institution - 0001, Hackensack, New Jersey, 07601, United States|Local Institution - 0003, New York, New York, 10032, United States|Local Institution - 0012, Philadelphia, Pennsylvania, 19104, United States|Local Institution - 0002, Philadelphia, Pennsylvania, 19111, United States|Local Institution - 0009, Pittsburgh, Pennsylvania, 15213, United States|Local Institution - 0010, Salt Lake City, Utah, 84112, United States|Local Institution - 0023, CABA, Buenos Aires F.D., C1430EGF, Argentina|Local Institution - 0019, Córdoba, Córdoba Province, X5002HWE, Argentina|Local Institution - 0022, Buenos Aires, Distrito Federal, C1093AAS, Argentina|Local Institution - 0006, Nedlands, Western Australia, 6009, Australia|Local Institution - 0008, Ottawa, Ontario, K1H 8L6, Canada|Local Institution - 0007, Toronto, Ontario, M5G 2M9, Canada|Local Institution - 0021, Santiago, Santiago Metropolitan, 8420383, Chile|Local Institution - 0004, Kashiwa-shi, Chiba, 2778577, Japan|Local Institution - 0005, Chuo-ku, Tokyo, 1040045, Japan|Local Institution - 0017, Bucharest, 022328, Romania|Local Institution - 0016, Cluj-Napoca, 400015, Romania|Local Institution - 0018, Craiova, 200542, Romania|Local Institution - 0015, Florești, 407280, Romania|Local Institution - 0020, Singapore, 119074, Singapore",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Biphenotypic/Undifferentiated Leukemia|Chronic Myelogenous Leukemia|Myelodysplasia|Relapsed Large Cell Lymphoma|Mantle Cell Lymphoma|Hodgkin Lymphoma|Burkitt Lymphoma|Relapsed T-Cell Lymphoma|Lymphoplasmacytic Lymphoma,DRUG: Fludarabine (FLU)|DRUG: Cyclophosphamide (CY)|DRUG: Total Body Irradiation (TBI)|DRUG: Tacrolimus (Tac)|DRUG: Mycophenolate Mofetil (MMF)|DRUG: Granulocyte Colony-Stimulating Factor (G-CSF)|DRUG: Busulfan (BU)|DRUG: Melphalan|DRUG: MGTA 456 Infusion,ALL,"CHILD, ADULT",PHASE2,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/2/19,12/1/26,"Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, 55455, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Cancer|Solid Tumor|Lymphoma,DRUG: Sym022,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/8/18,1/6/20,"South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan, 49503, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Urinary Bladder Neoplasms,DRUG: nivolumab|OTHER: Placebo|BIOLOGICAL: Bacillus Calmette-Guérin (BCG),ALL,"ADULT, OLDER_ADULT",PHASE3,13,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",1/15/20,10/31/23,"The University Of Chicago, Chicago, Illinois, 60637, United States|Local Institution - 0084, The Bronx, New York, 10461, United States|Local Institution - 0009, Caba, Buenos Aires, 1426, Argentina|Local Institution - 0088, Capital Federal, Buenos Aires, 1419, Argentina|Local Institution - 0016, Ciudad Autonoma Beunos Aires, Buenos Aires, 1431, Argentina|Local Institution - 0081, Mar del Plata, Buenos Aires, 7600, Argentina|Local Institution - 0008, Viedma, Río Negro Province, 8500, Argentina|Local Institution - 0080, Buenos Aires, 1120, Argentina|Local Institution - 0107, Córdoba, 5000, Argentina|Local Institution - 0002, Sydney, New South Wales, 2050, Australia|Local Institution - 0001, Woolloongabba, Queensland, 4012, Australia|Local Institution - 0114, Bowral, 2576, Australia|Local Institution - 0097, Linz, 4010, Austria|Local Institution - 0104, Salzburger, 5020, Austria|Local Institution - 0099, Vienna, 1090, Austria|Local Institution - 0098, Wels, 4600, Austria|Local Institution - 0050, Uberlândia, Minas Gerais, 38408-150, Brazil|Local Institution - 0048, Porto Alegre, Rio Grande do Sul, 90035-001, Brazil|Local Institution - 0047, Itajaí, Santa Catarina, 88301-220, Brazil|Local Institution - 0049, Rio de Janeiro, 22793-080, Brazil|Local Institution - 0017, Toronto, Ontario, M5G 1Z5, Canada|Local Institution - 0038, Montreal, Quebec, H2X 0C2, Canada|Local Institution - 0037, Montreal, Quebec, H3T 1E2, Canada|Local Institution - 0012, Rimouski, Quebec, G5L 5T1, Canada|Local Institution - 0011, La Serena, Coquimbo Region, 1720430, Chile|Local Institution - 0072, Viña del Mar, Región de Valparaíso, 2520598, Chile|Local Institution - 0010, Recoleta, Santiago Metropolitan, 0, Chile|Local Institution - 0042, Angers, 49933, France|Local Institution - 0106, Dijon, 21079, France|Local Institution - 0045, Lille, 59000, France|Local Institution - 0108, Marseille, 13385, France|Local Institution - 0111, Paris, 75018, France|Local Institution - 0103, Paris, 75679, France|Local Institution - 0041, Strasbourg, FR-67091, France|Local Institution - 0040, Villejuif, 94800, France|Local Institution - 0105, Cologne, 50968, Germany|Local Institution - 0094, Herne, 44625, Germany|Local Institution - 0093, Jena, 07747, Germany|Local Institution - 0095, Trier, 54292, Germany|Local Institution - 0031, Haidari, 12462, Greece|Local Institution - 0032, Thessaloniki, 57001, Greece|Local Institution - 0075, Tel Aviv, Tel Aviv, 6423906, Israel|Local Institution - 0073, Jerusalem, 9103102, Israel|Local Institution - 0074, Ramat Gan, 52621, Israel|Local Institution - 0067, Torino, TO, 10126, Italy|Local Institution - 0062, Milan, 20133, Italy|Local Institution - 0063, Modena, 41124, Italy|Local Institution - 0064, Napoli, 80131, Italy|Local Institution - 0065, Reggio Emilia, 42100, Italy|Local Institution - 0066, Roma, 00168, Italy|Local Institution - 0054, Arnhem, 6815 AD, Netherlands|Local Institution, Rotterdam, 3015 GD, Netherlands|Local Institution - 0051, Moscow, 121309, Russia|Local Institution - 0052, Saint Petersburg, 199034, Russia|Local Institution - 0096, Pamplona, Navarre, 31008, Spain|Local Institution - 0061, Badajoz, 06006, Spain|Local Institution - 0060, Badalona-barcelona, 08916, Spain|Local Institution - 0055, Madrid, 28041, Spain|Local Institution - 0059, Sabadell, 08208, Spain|Local Institution - 0057, Santander, 39008, Spain|Local Institution - 0058, Valencia, 46010, Spain|Local Institution - 0087, Norrköping, 601 82, Sweden|Local Institution - 0083, Umeå, 901 85, Sweden",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors|Lymphoma,DRUG: epacadostat|DRUG: SD-101|RADIATION: Radiotherapy,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,20,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/17/18,4/8/20,"University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Glioblastoma|Brain Tumor|GBM,DRUG: Pembrolizumab|DRUG: Vorinostat|DRUG: Temozolomide|RADIATION: Radiotherapy,ALL,"ADULT, OLDER_ADULT",PHASE1,21,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/16/18,6/28/23,"H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Carcinoma|Carcinoma, Hepatocellular|Liver Neoplasm",DRUG: 99mTc-Macro Albumin Aggregate,ALL,"ADULT, OLDER_ADULT",PHASE4,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,4/25/23,7/5/23,"Inland Imaging, Spokane, Washington, 99208, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor|Unresectable Malignant Solid Neoplasm,PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|PROCEDURE: Magnetic Resonance Imaging|OTHER: Pharmacodynamic Study|PROCEDURE: Positron Emission Tomography|DRUG: Telaglenastat Hydrochloride,ALL,"ADULT, OLDER_ADULT",PHASE2,54,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/14/19,4/16/26,"University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, 35233, United States|UM Sylvester Comprehensive Cancer Center at Aventura, Aventura, Florida, 33180, United States|UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, 33146, United States|UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, 33442, United States|University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, 33136, United States|UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, 33176, United States|UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, 33324, United States|Moffitt Cancer Center-International Plaza, Tampa, Florida, 33607, United States|Moffitt Cancer Center - McKinley Campus, Tampa, Florida, 33612, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Northwestern University, Chicago, Illinois, 60611, United States|University of Kansas Clinical Research Center, Fairway, Kansas, 66205, United States|HaysMed, Hays, Kansas, 67601, United States|University of Kansas Cancer Center, Kansas City, Kansas, 66160, United States|The University of Kansas Cancer Center - Olathe, Olathe, Kansas, 66061, United States|Mercy Hospital Pittsburg, Pittsburg, Kansas, 66762, United States|Salina Regional Health Center, Salina, Kansas, 67401, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, 66606, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, 66205, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, 40536, United States|National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, 20892, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University Health Truman Medical Center, Kansas City, Missouri, 64108, United States|Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, 10016, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Wake Forest University at Clemmons, Clemmons, North Carolina, 27012, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, 15232, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Biliary Tract Neoplasms,DRUG: Gemcitabine|DRUG: Cisplatin|DRUG: Ipilimumab|DRUG: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE2,75,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/8/17,6/7/21,"Emory University, Atlanta, Georgia, 30322, United States|Northwestern University, Chicago, Illinois, 60611, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|University of Washington, Seattle, Washington, 98109, United States|University of Wisconsin, Madison, Wisconsin, 53705, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Blood Stem Cell Transplant Failure|Leukemia|Hematologic Malignancies,DRUG: Cyclophosphamide|DRUG: Fludarabine|DRUG: Melphalan|DRUG: Mesna|DRUG: Rituximab|PROCEDURE: Stem Cell Transplantation|DRUG: Thiotepa|DRUG: Tacrolimus|DRUG: Mycofenolate mofetil|DRUG: G-CSF,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,176,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/5/09,10/5/17,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Pancreatic Neoplasms|Digestive System Neoplasms|Neoplasms by Site|Neoplasms|Endocrine Gland Neoplasms|Pancreatic Diseases|Digestive System Diseases|Endocrine System Diseases|Gemcitabine|Antimetabolites, Antineoplastic",DRUG: nab-Paclitaxel|DRUG: Gemcitabine,ALL,"ADULT, OLDER_ADULT",PHASE3,866,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/28/14,6/30/22,"Local Institution - 043, Scottsdale, Arizona, 85259, United States|Mayo Clinic - Arizona, Scottsdale, Arizona, 85259, United States|UCSD Moores Cancer Center, La Jolla, California, 92093, United States|University of Southern California, Los Angeles, California, 90033, United States|Local Institution - 044, Sacramento, California, 95817, United States|UC Davis Cancer Center, Sacramento, California, 95817, United States|Local Institution - 001, San Francisco, California, 94110, United States|University of California, San Francisco Cutaneous Oncology and Melanoma Center, San Francisco, California, 9411, United States|University of California Los Angeles, Santa Monica, California, 90404, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Local Institution - 059, Denver, Colorado, 80218, United States|Rocky Mountain Cancer Centers, LLP [Denver-Midtown], Denver, Colorado, 80218, United States|Yale Cancer Center, New Haven, Connecticut, 06510, United States|Local Institution - 022, Boca Raton, Florida, 33486, United States|Lynn Cancer Institute, Boca Raton, Florida, 33486, United States|Florida Cancer Institute Cancer Spec, Fort Myers, Florida, 33916, United States|Local Institution - 031, Fort Myers, Florida, 33916, United States|Gainesville Heme Oncology Associates, Gainesville, Florida, 32605, United States|Local Institution - 011, Gainesville, Florida, 32610, United States|University of Florida, Gainesville, Florida, 32610, United States|University of Miami and Sylvester Cancer Center, Miami, Florida, 33136, United States|Florida Hospital Cancer Institute, Orlando, Florida, 32804, United States|Local Institution - 039, Orlando, Florida, 32804, United States|H Lee Moffitt Cancer Center, Tampa, Florida, 32207, United States|Georgia Cancer Specialist, Atlanta, Georgia, 30341, United States|University of Chicago Medical Center, Chicago, Illinois, 60637, United States|Northshore University Healthsystem Research Institute, Evanston, Illinois, 60201, United States|Illinois Cancer Specialists, Niles, Illinois, 60714, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, 70121-2483, United States|Ochsner Medical Center - Jefferson Highway, New Orleans, Louisiana, 70121-2483, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Beth Israel-Deaconess Medical Center, Boston, Massachusetts, 02115, United States|Local Institution - 040, Boston, Massachusetts, 02115, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Local Institution - 045, Boston, Massachusetts, 02215, United States|Local Institution - 036, Ann Arbor, Michigan, 48109, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Karmanos Cancer Center Wayne State University, Detroit, Michigan, 48201, United States|Local Institution - 021, Rochester, Minnesota, 55905, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Local Institution - 048, Omaha, Nebraska, 68114, United States|Nebraska Methodist Hospital, Omaha, Nebraska, 68114, United States|Local Institution - 064, Basking Ridge, New Jersey, 07920, United States|MSKCC Basking Ridge, Basking Ridge, New Jersey, 07920, United States|Saint Barnabas Medical Center, Livingston, New Jersey, 07039, United States|Local Institution - 025, Buffalo, New York, 14263, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Memorial Sloan-Kettering Cancer Center, Commack, New York, 11725, United States|Memorial Sloan Kettering Cancer Center West Harrison, Harrison, New York, 10604, United States|NYU Langone Medical Center, Lake Success, New York, 11042, United States|Local Institution - 008, New York, New York, 10021-6007, United States|Memorial Sloan-Kettering Cancer Center - NYC, New York, New York, 10021-6007, United States|Columbia University Medical Center, New York, New York, 10032, United States|Local Institution - 032, New York, New York, 10032, United States|Local Institution - 013, Rochester, New York, 14642, United States|University of Rochester Cancer Center, James P. Wilmot Cancer Center, Rochester, New York, 14642, United States|Local Institution - 066, Rockville Centre, New York, 11570, United States|MSKCC at Mercy Medical Center Mercy RockvilleCenter, Rockville Centre, New York, 11570, United States|MSKCC at Phelps Memorial Hospital Center. Phelps Sleepy Hollow, Sleepy Hollow, New York, 10591, United States|State University of New York Upstate Medical Center, Syracuse, New York, 13215, United States|Local Institution - 051, Winston-Salem, North Carolina, 27157-1082, United States|Wake Forest Univ. Health Sciences Outpatient Comprehensive Cancer Center, Winston-Salem, North Carolina, 27157-1082, United States|Local Institution - 030, Cincinnati, Ohio, 45242, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45242, United States|University of Cincinnati Medical CenterDivsion of Hematology OncologyThe Barrett Center, Cincinnati, Ohio, 45267-0501, United States|Case Western Reserve Center, Cleveland, Ohio, 44106, United States|Local Institution - 047, Cleveland, Ohio, 44106, United States|Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio, 44195, United States|Cleveland Clinic Foundation IRB, Cleveland, Ohio, 44195, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Local Institution - 020, Cleveland, Ohio, 44195, United States|Local Institution - 054, Cleveland, Ohio, 44195, United States|Local Institution - 005, Columbus, Ohio, 43210, United States|Ohio State University Medical Center, Columbus, Ohio, 43210, United States|Local Institution - 049, Oklahoma City, Oklahoma, 73104, United States|University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Local Institution - 019, Portland, Oregon, 97239, United States|Oregon Health and Science University OHSU, Portland, Oregon, 97239, United States|Local Institution - 016, Philadelphia, Pennsylvania, 19107, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Local Institution - 027, Pittsburgh, Pennsylvania, 15232, United States|UPMC Cancer Pavillion, Pittsburgh, Pennsylvania, 15232, United States|Chattanooga Oncology Hematology Care, Chattanooga, Tennessee, 37404, United States|Local Institution - 023, Chattanooga, Tennessee, 37404, United States|Local Institution - 004, Nashville, Tennessee, 37203, United States|Sarah Cannon Research Inst, Nashville, Tennessee, 37203, United States|Local Institution - 002, Nashville, Tennessee, 37232-6307, United States|Vanderbilt- Ingram Cancer Center, Nashville, Tennessee, 37232-6307, United States|Texas Oncology, Dallas, Texas, 75230, United States|Baylor Sammons Cancer Center, Dallas, Texas, 75246, United States|Local Institution - 062, Dallas, Texas, 75246, United States|Local Institution - 010, Dallas, Texas, 75390, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|Local Institution - 050, Fort Worth, Texas, 76104, United States|The Center for Cancer and Blood Disorders - Fort Worth, Fort Worth, Texas, 76104, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|Local Institution - 041, Houston, Texas, 77030, United States|Texas Oncology, P.A. - Tyler, Tyler, Texas, 75702, United States|Local Institution - 038, Charlottesville, Virginia, 22908, United States|University of Virginia, Charlottesville, Virginia, 22908, United States|Local Institution - 003, Seattle, Washington, 98109, United States|Seattle Cancer Care Alliance - Seattle, Seattle, Washington, 98109, United States|Virginia Mason Cancer Center, Seattle, Washington, 98111, United States|Local Institution - 014, Madison, Wisconsin, 53792, United States|University of Wisconsin - Madison Cancer Center, Madison, Wisconsin, 53792, United States|Canberra Hospital, Garran, Australian Capital Territory, 2605, Australia|Local Institution - 505, Garran, Australian Capital Territory, 2605, Australia|Local Institution - 501, Darlinghurst, New South Wales, 2010, Australia|Local Institution - 507, St Leonards, New South Wales, 2065, Australia|Northern Cancer Institute, St Leonards, New South Wales, 2065, Australia|Local Institution - 504, Herston, Queensland, 4029, Australia|ICON Cancer Center, Milton, Queensland, 4064, Australia|Local Institution - 502, Milton, Queensland, 4064, Australia|Local Institution - 506, Bentleigh East, Victoria, 3165, Australia|Local Institution - 508, Subiaco, Western Australia, 6008, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, 6008, Australia|Monash Medical Centre Moorabbin Campus, Bentleigh East, 3165, Australia|Saint Vincent's Hospital, Darlinghurst, 2010, Australia|Austin Hospital, Heidelberg, 3084, Australia|Local Institution - 509, Heidelberg, 3084, Australia|Royal Brisbane and Women's Hospital, Herston, 4029, Australia|Cabrini Hospital, Malvern, 3144, Australia|Local Institution - 503, Malvern, 3144, Australia|Local Institution - 500, Randwick, 2031, Australia|Prince of Wales Hospital, Randwick, 2031, Australia|The Queen Elizabeth Hospital, Woodville South, 5011, Australia|Local Institution - 205, Graz, 8036, Austria|Medical University of Graz, Graz, A-8036, Austria|Local Institution - 203, Innsbruck, 6020, Austria|Medical University Innsbruck, Innsbruck, 6020, Austria|Hospital of Elisabethinen Linz, Linz, 4010, Austria|Local Institution - 206, Linz, 4010, Austria|Local Institution - 204, Salzburg, 5020, Austria|Salzburger Landkliniken St. Johanns-Spital, Salzburg, 5020, Austria|Local Institution - 200, Vienna, 1090, Austria|Medizinische Universitat Wien, Vienna, 1090, Austria|Kaiser-Franz-Josef Spital, Vienna, 1100, Austria|Local Institution - 201, Vienna, 1100, Austria|Klinikum Wels-Grieskirchen GmbH, Wels, 4600, Austria|Local Institution - 0207, Wels, 4600, Austria|Hospital Wiener Neustadt, Wiener Neustadt, 2700, Austria|Local Institution - 202, Wiener Neustadt, 2700, Austria|Hopital Erasme, Brussels, 1070, Belgium|Local Institution - 211, Brussels, 1070, Belgium|UZ Antwerpen, Edegem, 2650, Belgium|Local Institution - 213, Ghent, 9000, Belgium|UZ Gent, Ghent, 9000, Belgium|Local Institution - 210, Leuven, 3000, Belgium|UZ Leuven, Leuven, 3000, Belgium|Local Institution - 102, Calgary, Alberta, T2N 4N2, Canada|Tom Baker Cancer Center, Calgary, Alberta, T2N 4N2, Canada|Local Institution - 101, Toronto, Ontario, M4N 3M5, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|Local Institution - 100, Toronto, Ontario, M5G 2M9, Canada|Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|Centre Hospitalier de L'Universite de Montreal St-Luc, Montreal, Quebec, H2X 3J4, Canada|Local Institution - 104, Montreal, Quebec, H2X 3J4, Canada|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|Local Institution - 103, Montreal, Quebec, H3T 1E2, Canada|Fakultni nemocnice Hradec Kralove, Hradec Králové, 500 05, Czechia|Local Institution - 220, Hradec Králové, 500 05, Czechia|Krajska nemocnice Liberec, a.s., Liberec, 460 63, Czechia|Krajska nemocnice T. Bati a.s., Zlín, 762 75, Czechia|Local Institution - 221, Zlín, 762 75, Czechia|Hæmatologisk afd. B Aalborg Sygehus Syd, Aalborg, 9000, Denmark|Local Institution - 231, Aalborg, 9000, Denmark|Herlev Hospital, Herlev, 2730, Denmark|Local Institution - 232, Herlev, 2730, Denmark|Local Institution - 230, Odense C, 5000, Denmark|Onk.Dep., Odense Universitets hospital, Odense C, 5000, Denmark|Local Institution - 240, Tampere, Oulun Lääni, FI-33520, Finland|Helsingin yliopistollinen keskussairaala, Helsinki, FI-00290, Finland|Local Institution - 241, Helsinki, FI-00290, Finland|Tampereen yliopistollinen sairaala, Tampere, 33521, Finland|Local Institution - 242, Turku, 20521, Finland|Turku University Hospital, Turku, 20521, Finland|Center Hospitalier Universitaire d' Angers, Angers, 49033, France|Local Institution - 253, Angers, 49033, France|Hopital Henri Mondor, Créteil, 94010, France|CHRU de Lille France, Lille, 59037, France|Local Institution - 257, Lille, 59037, France|Hopital prive Jean Mermoz, Lyon, 69008, France|Local Institution - 252, Lyon, 69008, France|Hopital Edouard Herriot - Hepato-gastroenterologie, Lyon, 69437, France|Local Institution - 258, Lyon, 69437, France|Hopital Europeen Georges Pompidou, Paris, 75015, France|Local Institution - 250, Paris, 75015, France|Hopital Saint Antoine, Paris, 75571, France|Hopital Pitie Salpetriere, Paris, 75651, France|Local Institution - 259, Paris, 75651, France|CHU La Miletrie, Poitiers, 86021, France|Local Institution - 251, Poitiers, 86021, France|Local Institution - 256, Toulose, 31059, France|Pole Des Specialites Medicales, Hopital Purpan, Toulose, 31059, France|Klinikum Weiden, Bayern, 92637, Germany|Local Institution - 280, Bayern, 92637, Germany|Charite - Universitätsmedizin Berlin, Berlin, 12203, Germany|Local Institution - 272, Berlin, 12203, Germany|Local Institution - 281, Cologne, 50674, Germany|Praxis Internistischer Onkologie und Hamatologie Koln, Cologne, 50674, Germany|Local Institution - 278, Dresden, D-01307, Germany|Universitatsklinikum Carl Gustav Carus an der TU Dresden, Dresden, D-01307, Germany|Kliniken Essen-Mitte, Essen, 45136, Germany|Local Institution - 277, Frankfurt, 60590, Germany|Universitatsklinkum Frankfurt, Frankfurt, 60590, Germany|Local Institution - 284, Frechen, 50226, Germany|Praxis Internistischer Onkologie und Hamatologie Frechen, Frechen, 50226, Germany|Local Institution - 275, Friedrichshafen, 88045, Germany|Praxis für Innere Medizin, Dr.Oettle Helmut, Friedrichshafen, 88045, Germany|Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, 17487, Germany|Local Institution - 279, Greifswald, 17487, Germany|Local Institution - 273, Hamburg, 20246, Germany|Universitaetsklinik Hamburg - Eppendorf, Hamburg, 20246, Germany|Local Institution - 274, Magdeburg, 39108, Germany|Universitatsklinik Magdeburg, Magdeburg, 39108, Germany|Klinikum der Johannes Gutenberg Uniervsitaet ,Haematologie, Mainz, 55131, Germany|Local Institution - 283, Mainz, 55131, Germany|Klinikum der Universitat Munchen-Grosshadern, München, 81377, Germany|Local Institution - 282, München, 81377, Germany|Klinikum Neuperlach, München, 81737, Germany|Local Institution - 276, München, 81737, Germany|Local Institution - 0271, Tübingen, 72076, Germany|University of Tubingen, Tübingen, 72076, Germany|Local Institution - 270, Würzburg, 97080, Germany|Universitatsklinikum Würzburg, Würzburg, 97080, Germany|Local Institution - 601, Hong Kong, 0, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Tuen Mun Hospital, Hong Kong, Hong Kong|Local Institution - 602, Shatin, 0, Hong Kong|Prince of Wales Hospital the Chinese University of Hong Kong, Shatin, Hong Kong|Fovarosi Szent Istvan es Szent Laszlo Korhaz es Rendelointezet, Budapest, 1097, Hungary|Local Institution - 293, Budapest, 1097, Hungary|Local Institution - 291, Budapest, 1145, Hungary|Uzsoki Utcai Korhaz, Budapest, 1145, Hungary|Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Debrecen, 4032, Hungary|Local Institution - 290, Debrecen, 4032, Hungary|Local Institution - 292, Győr, 9024, Hungary|Petz Aladar Megyei Oktato Korhaz,II. Belgyogyaszat, Győr, 9024, Hungary|Local Institution - 295, Szeged, 6720, Hungary|Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Szent-Gyorgyi Albert TE AOK Borgyogy, Szeged, 6720, Hungary|Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, 5004, Hungary|Local Institution - 311, Cork, T12 DFK4, Ireland|Cork University Hospital, Cork, Ireland|Local Institution - 310, Dublin, 4, Ireland|St Vincent's University Hospital, Dublin, 4, Ireland|Local Institution - 329, Terni, Umbria, 05100, Italy|Local Institution - 325, Ancona, 60020, Italy|Ospedali Riuniti Umberto I GM Lancisi, Ancona, 60020, Italy|Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, 40138, Italy|Local Institution - 330, Bologna, 40138, Italy|Azienda Ospedaliero-Universitaria Careggi, Florence, 50134, Italy|Local Institution - 328, Florence, 50134, Italy|Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori (I.R.S.T.), Meldola, 47014, Italy|Local Institution - 331, Meldola, 47014, Italy|Local Institution - 321, Milan, 20132, Italy|Ospedale San Raffaele S.r.l., Milan, 20132, Italy|Azienda Ospedaliera Niguarda Ca Granda, Milan, 20162, Italy|Local Institution - 322, Milan, 20162, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, 56126, Italy|Local Institution - 324, Pisa, 56126, Italy|Arcispedale Santa Maria Nuova, Reggio Emilia, 42100, Italy|Local Institution - 333, Reggio Emilia, 42100, Italy|Local Institution - 323, Roma, 00144, Italy|Local Institution - 327, Roma, 00168, Italy|Policlinico Universitario Agostino Gemelli, Roma, 00168, Italy|Istituto Nazionale Tumori Regina Elena, Roma, 144, Italy|Istituto Clinico Humanitas, Rozzano (MI), 20089, Italy|Local Institution - 326, Rozzano (MI), 20089, Italy|IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, 71013, Italy|Local Institution - 332, San Giovanni Rotondo, 71013, Italy|Azienda Ospedaliera S Maria di Terni, Terni, 05100, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, 37134, Italy|Local Institution - 320, Verona, 37134, Italy|Academisch Medisch Centrum Amsterdam, Amsterdam, 1105, Netherlands|Local Institution - 400, Amsterdam, 1105, Netherlands|Catharina Hospital, Eindhoven, 5632 EJ, Netherlands|Local Institution - 403, Eindhoven, 5632 EJ, Netherlands|Isala Klinieken, Zwolle, 8011, Netherlands|Local Institution - 402, Zwolle, 8011, Netherlands|Centro Hospitalar de Lisboa Central - Hospital de Santo António dos Capuchos, Lisbon, 1069-639, Portugal|Local Institution - 340, Lisbon, 1069-639, Portugal|Hospital Da Luz, Lisbon, 1500-650, Portugal|Local Institution - 341, Lisbon, 1500-650, Portugal|Hospital de Sao Joao, Porto, 4200, Portugal|Local Institution - 342, Porto, 4200, Portugal|Local Institution - 610, Singapore, 119074, Singapore|National University Hospital, Singapore, 119074, Singapore|Local Institution - 611, Singapore, 169-610, Singapore|National Cancer Center, Singapore, 169-610, Singapore|Local Institution - 641, Seoul, 03080, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Local Institution - 642, Seoul, 135-710, South Korea|Samsung Medical Center, Seoul, 135-710, South Korea|Asan Medical Center, Seoul, 138-736, South Korea|Local Institution - 640, Seoul, 138-736, South Korea|Local Institution - 371, Santander, Cantabria, 39008, Spain|Local Institution - 360, Barcelona, 08035, Spain|Clinic Barcelona Hospital Universitari, Barcelona, 08036, Spain|Local Institution - 363, Barcelona, 08036, Spain|Instituto Catalan de Oncologia-Hospital Duran, Barcelona, 08907, Spain|Local Institution - 370, Barcelona, 08907, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 8035, Spain|Hospital General Gregorio Maranon, Madrid, 28007, Spain|Local Institution - 367, Madrid, 28007, Spain|Local Institution - 362, Madrid, 28034, Spain|Ramon y Cajal Univeresity Hospital, Madrid, 28034, Spain|Hospital Clinico San Carlos, Madrid, 28040, Spain|Local Institution - 372, Madrid, 28040, Spain|Hospital 12 de Octubre, Madrid, 28041, Spain|Local Institution - 365, Madrid, 28041, Spain|Centro Integral, Madrid, 28050, Spain|Local Institution - 361, Madrid, 28050, Spain|Hospital General Carlos Haya, Málaga, 29010, Spain|Local Institution - 369, Málaga, 29010, Spain|Complejo Hospitalario de Navarra, Pamplona/ Navarra, 31008, Spain|Local Institution - 368, Pamplona/ Navarra, 31008, Spain|Hospital Universitario Marques de Valdecilla, Santander, 39008, Spain|Hospital Clinico Universitario De Santiago De Compostela, Santiago de Compostela, 15706, Spain|Local Institution - 366, Santiago de Compostela, 15706, Spain|Hospital Virgen del Rocio, Seville, 41013, Spain|Local Institution - 364, Seville, 41013, Spain|Local Institution - 620, Taichung, 40705, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|Local Institution - 625, Tainan, Taiana, 704, Taiwan|National Cheng Kung University Hospital, Tainan, Taiana, 704, Taiwan|Local Institution - 623, Taipei, 11217, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Tri-Service General Hospital, Taipei, 11490, Taiwan|Local Institution - 622, Taipei, 114, Taiwan|Chang Gung Medical Foundation-Linkou Branch, Taoyuan District, 333, Taiwan|Local Institution - 624, Taoyuan District, 333, Taiwan|Local Institution - 621, Tapei, 10002, Taiwan|National Taiwan University Hospital, Tapei, 10002, Taiwan|Addenbrookes Hospital, Cambridge, CB2 0QQ, United Kingdom|Local Institution - 382, Cambridge, CB2 0QQ, United Kingdom|Glasgow Royal Infirmary, Glasgow, G11 6NT, United Kingdom|Local Institution - 380, Glasgow, G11 6NT, United Kingdom|Local Institution - 381, Sheffield, S10 2SJ, United Kingdom|Weston Park Hospital, Sheffield South Yorkshire, S10 2SS, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Uveal Melanoma|Choroid Neoplasm,BIOLOGICAL: ICON-1,ALL,"ADULT, OLDER_ADULT",PHASE1,10,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2016-05,2017-09,"San Francisco, California, 94109, United States|Denver, Colorado, 80401, United States|Leawood, Kansas, 66211, United States|Boston, Massachusetts, 02114, United States|Grand Rapids, Michigan, 49546, United States|Royal Oak, Michigan, 48073, United States|Portland, Oregon, 97239, United States|Philadelphia, Pennsylvania, 19107, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Giant Cell Tumor of Bone,DRUG: Denosumab,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE4,85,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,11/13/17,7/27/23,"Sarcoma Oncology Research Center LLC, Santa Monica, California, 90403, United States|Washington Cancer Institute at MedStar Washington Hospital, Washington D.C., District of Columbia, 20010, United States|University of Minnesota Medical Center Fairview, Minneapolis, Minnesota, 55455, United States|Mount Sinai Beth Israel Downtown, New York, New York, 10003, United States|Abramson Cancer Center at Pennsylvania Hospital, Philadelphia, Pennsylvania, 19106, United States|Royal Prince Alfred Hospital, Camperdown, New South Wales, 2050, Australia|Centre Leon Berard, Lyon, 69373, France|Institut Gustave Roussy, Villejuif, 94805, France|Istituti Ortopedici Rizzoli, Bologna, 40136, Italy|Instytut Matki i Dziecka, Warsaw, 01-211, Poland|Narodowy Instytut Onkologii im Marii Sklodowskiej-Curie â€"" Panstwowy Instytut Badawczy, Warsaw, 02-781, Poland|Hospital Universitari Son Espases, Palma de Mallorca, Balearic Islands, 07010, Spain|Skane Universitetssjukhus, Lund, 221 85, Sweden|Royal Orthopaedic Hospital, Birmingham, B31 2AP, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Urinary Bladder Neoplasms,BIOLOGICAL: recMAGE-A3 + AS15 ASCI|BIOLOGICAL: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,83,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",2011-08,4/7/17,"Faculty teaching Hospital in Plzen, Pilsen, Czechia|Hospital Motol, Prague, Czechia|Thomayerova nemocnice, Prague, Czechia|Krajska zdravotni, a.s. - Masarykova nemocnice v Usti nad Labem, o.z., Ústí nad Labem, Czechia|Institut Bergonié, Bordeaux, France|Hôpital Huriez, Lille, France|Hôpital Edouard Herriot, Lyon, France|Institut Curie, Paris, France|Hôpital Rangueil, Toulouse, France|Universitätsklinikum Aachen, Aachen, Germany|Universitätsklinikum C.-G. Carus Dresden, Dresden, Germany|Heinrich-Heine University, Düsseldorf, Germany|Waldkrankenhaus St. Marien gGmbH, Erlangen, Germany|Universitätsklinikum Giessen, Giessen, Germany|Universitätsklinikum Jena, Jena, Germany|Universitätsmedizin, Mannheim, Germany|Universitätsklinikum Marburg, Marburg, Germany|Klinikum rechts der Isar der TU München, München, Germany|Universitätklinikum Rostock, Rostock, Germany|Universitätsklinikum Tübingen, Tübingen, Germany|Universitaria Policlinico Consorziale di Bari, Bari, Italy|Università Vita e Saluta, Milan, Italy|Ospedaliera di Perugia, Perugia, Italy|Universitaria Pisana, Pisa, Italy|Università di Roma, La Sapienza, Rome, Italy|NKI, Amsterdam, Netherlands|St Antoniusziekenhuis, Nieuwegein, Netherlands|RadboudUMC, Nijmegen, Netherlands|Kliniczny Dzial Urologii Swietokrzyskiego Centrum Onkologii, Kielce, Poland|Medical University of Warsaw, Warsaw, Poland|Oddzial Urologii Miedzyleski Szpital Specjalistyczny w Warszawie, Warsaw, Poland|Fundeni Clinical Institute, Bucharest, Romania|Clinical County Emergency Hospital Craiova, Craiova, Romania|Federal State Budget Institution ""Scientific Research Institute of Urology"" of the Ministry of Healthcare and Social Development of the Russian Federation, Moscow, Russia|Federal State Institution ""Moscow Research Oncology Institute named after P.A. Gertsen"" of the Ministry of Healthcare and Social Development of the Russian Federation, Moscow, Russia|Institution of the Russian Academy of Medical Science Russian Oncology Research Center named after N.N. Blokhin of RAMS, Moscow, Russia|Municipal Budget Institution of Health Care ""Clinical Diagnostic Center ""Zdorovie"" of Rostov-on-Don city"", Rostov-on-Don, Russia|Saint Petersburg State Institution of Health Care ""City Multi-Field Hospital #2"", Saint Petersburg, Russia|Hospital Universitario A Coruña, A Coruña, Spain|Hospital Universitario Principe de Asturias, Alcalá de Henares, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Spain|Fundación Puigvert, Barcelona, Spain|Hospital Clinic Barcelona, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitario Puerta del Mar, Cadiz, Spain|Hospital 12 de Octubre, Fundación de Investigación Biomédica, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Hospital Infanta Sofia, San Sebastián de los Reyes, Spain|Kyiv City Clinical Oncology Hospital, Kiev, Ukraine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor,DRUG: VX-984 120 mg + PLD 40 mg/m^2|DRUG: VX-984 240 mg + PLD 40 mg/m^2|DRUG: VX-984 480 mg + PLD 40 mg/m^2|DRUG: VX-984 720 mg + PLD 40 mg/m^2,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INTERVENTIONAL,Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2/29/16,10/19/17,"Scottsdale, Arizona, 85258, United States|Boston, Massachusetts, 02215, United States|Nashville, Tennessee, 37203, United States|Dallas, Texas, 75246, United States|Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced Malignant Solid Neoplasm,BIOLOGICAL: CD24 Extracellular Domain-IgG1 Fc Domain Recombinant Fusion Protein CD24Fc|DRUG: Placebo Administration,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,3,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",10/30/20,1/26/22,"University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Extensive Stage Lung Small Cell Carcinoma|Malignant Solid Neoplasm|Metastatic Malignant Neoplasm in the Brain,BIOLOGICAL: Atezolizumab|DRUG: Carboplatin|DRUG: Entinostat|DRUG: Etoposide,ALL,"ADULT, OLDER_ADULT",PHASE1,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/27/21,7/11/23,"Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, 15232, United States|Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, 84112, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22908, United States|University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, 53792, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Brain Stem Neoplasm|Pineal Region Neoplasm|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Primary Central Nervous System Neoplasm|Recurrent Visual Pathway Glioma|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm|Refractory Visual Pathway Glioma,DRUG: Entinostat|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study,ALL,"CHILD, ADULT",PHASE1,21,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/6/17,9/30/21,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, 30322, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Desmoid Tumor|Aggressive Fibromatosis,DRUG: Nirogacestat oral tablet|DRUG: Placebo Oral Tablet,ALL,"ADULT, OLDER_ADULT",PHASE3,142,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",4/17/19,10/17/24,"Arkansas Children's Hospital, Little Rock, Arkansas, 72202, United States|USC/Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Ronald Regan UCLA Medical Center, Los Angeles, California, 90095, United States|Stanford Cancer Center, Palo Alto, California, 94304, United States|UCSF Mission Bay, San Francisco, California, 94158, United States|Sarcoma Oncology Research Center, Santa Monica, California, 90403, United States|University of Colorado Hospital-Anschutz Cancer Pavilion (ACP), Aurora, Colorado, 80045, United States|Smilow Cancer Hospital at Yale-New Haven, New Haven, Connecticut, 06510, United States|Washington Cancer Institute at MedStar Washington Hospital Center, Washington D.C., District of Columbia, 20010, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States|Massachusetts General Hosptial (MGH), Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, 02215, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Northwell Health, Lake Success, New York, 11042, United States|Columbia University Medical Center, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|DUMC/Duke Cancer Center, Durham, North Carolina, 27710, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Oregon Health & Science University-Center for Health & Healing, Portland, Oregon, 97201, United States|Abramson Cancer Center at Pennsylvania Hospital, Philadelphia, Pennsylvania, 19106, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Henry-Joyce Cancer Clinic, Nashville, Tennessee, 37232, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|University of Wisconsin Clinical Science Center, Madison, Wisconsin, 53792, United States|Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Institut Jules Bordet-Medical Oncology, Brussels, 1000, Belgium|Cliniques Universitaires Saint-Luc, Institut Roi Albert II, Brussels, 1200, Belgium|UZ Gent, Ghent, 9000, Belgium|UZ Leuven, Leuven, 3000, Belgium|Princess Margaret Cancer Centre, Toronto, Ontario, M5G2M9, Canada|McGill University Health Centre, Montreal, Quebec, H4A3JI, Canada|Helios Klinikum Berlin-Buch, Berlin, 13125, Germany|Universitaetsklinikum Hamburg-Eppendorf, Hamburg, 20246, Germany|Universitätsmedizin Mannheim, Mannheim, D-68167, Germany|IRCCS Istituto Ortopedico Rizzoli, Bologna, 40136, Italy|Istituto di Candiolo IRCCS Oncologia Medica, Candiolo, 10060, Italy|Fondazione IRCCS Instituto Nazionale dei Tumori di Milano, Milan, 20133, Italy|Policlinico Unvrsitario Campus Bio-Medico, Roma, 00128, Italy|Radboud University Medical Centre, Nijmegen, Gelderland, 6525GA, Netherlands|The Netherlands Cancer Institute, Amsterdam, 1066, Netherlands|Leiden University Medical Center (LUMC), Leiden, 23333, Netherlands|Department of Oncology, University College of London Hospital, London, NW12PG, United Kingdom|The Royal Marsden NHS Foundation Trust, London, SW36JJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,COVID-19 Infection|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,OTHER: Questionnaire Administration|BIOLOGICAL: Sotrovimab|PROCEDURE: Biospecimen Collection,ALL,"ADULT, OLDER_ADULT",PHASE1,20,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION,1/25/22,1/10/23,"Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Tenosynovial Giant Cell Tumor,DRUG: Pexidartinib,ALL,"ADULT, OLDER_ADULT",PHASE3,40,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/25/20,2/28/26,"Beijing Ji Shui Tan Hospital, Beijing, China|Peking University Cancer Hospital, Beijing, China|The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China|The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China|Zhejiang Cancer Hospital, Hangzhou, China|Fudan University Shanghai Cancer Center, Shanghai, China|Shanghai General Hospital, Shanghai, China|National Taiwan University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Glioblastoma Multiforme|Brain Tumor,DRUG: Bevacizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,31,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-02,2021-10,"Lenox Hill Brain Tumor Center, New York, New York, 10065, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Uterine Cervical Neoplasms,DRUG: Tc99m tilmanocept,FEMALE,"ADULT, OLDER_ADULT",PHASE2,18,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2016-01,2017-07,"University of California, San Diego, La Jolla, California, 92093, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, 27157, United States|The University of Texas M.D. Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Gynecologic Cancer|Sexual Dysfunction,DRUG: Lidocaine Topical|DRUG: Placebo,FEMALE,"ADULT, OLDER_ADULT",PHASE4,4,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",6/6/19,11/3/21,"University of Iowa, Iowa City, Iowa, 52242, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms|Prostate Cancer,DRUG: [18F]CTT1057,MALE,"ADULT, OLDER_ADULT",PHASE2|PHASE3,195,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,9/7/21,11/24/23,"Explorer Molecular Imaging center, Sacramento, California, 95816, United States|Novartis Investigative Site, Marseille, 13273, France|Novartis Investigative Site, Nîmes, 30029, France|Novartis Investigative Site, Pierre-Bénite, 69495, France|Novartis Investigative Site, Toulouse, 31054, France|Novartis Investigative Site, Toulouse, 31059, France|Novartis Investigative Site, Bergamo, BG, 24127, Italy|Novartis Investigative Site, Milan, MI, 20132, Italy|Novartis Investigative Site, Milan, MI, 20141, Italy|Novartis Investigative Site, Milan, MI, 20162, Italy|Novartis Investigative Site, Rozzano, MI, 20089, Italy|Novartis Investigative Site, L'Hospitalet de Llobregat, Barcelona, 08907, Spain|Novartis Investigative Site, Barcelona, Catalonia, 08035, Spain|Novartis Investigative Site, Barcelona, 08036, Spain|Novartis Investigative Site, Bellinzona, 6500, Switzerland|Novartis Investigative Site, Geneva, 1211, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Malignant Solid Neoplasm|C-Reactive Protein Measurement|Cancer Fatigue|Metastatic Malignant Solid Neoplasm|Recurrent Malignant Solid Neoplasm|Weight Loss,DRUG: Anamorelin Hydrochloride|BEHAVIORAL: Exercise Intervention|OTHER: Laboratory Biomarker Analysis|OTHER: Nutritional Assessment|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,129,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,2/8/17,2/28/26,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Stage Solid Tumors,DRUG: Berzosertib,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/10/18,1/26/24,"Royal Marsden NHS Foundation Trust, Sutton, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Solid Tumor,DRUG: NKTR-102 145 mg/m2|DRUG: NKTR-102 120 mg/m2|DRUG: NKTR-102 95 mg/m2|DRUG: NKTR-102 50 mg/m2,ALL,"ADULT, OLDER_ADULT",PHASE2,27,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2011-10,2017-11,"Investigator Site - Los Angeles, Los Angeles, California, 90033, United States|Investigator Site - San Francisco, San Francisco, California, 94143, United States|Investigator Site - Whittier, Whittier, California, 90603, United States|Investigator Site - Minneapolis, Minneapolis, Minnesota, 55455, United States|Investigator Site - Cleveland, Cleveland, Ohio, 44106, United States|Investigator Site - Bruxelles, Brussels, Belgium|Investigator Site - Liege, Liège, 4000, Belgium",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors|Metastatic Melanoma,DRUG: losartan|DRUG: dextromethorphan|DRUG: caffeine|DRUG: omeprazole|DRUG: midazolam|DRUG: rosuvastatin|DRUG: bupropion immediate release (IR)|DRUG: encorafenib|DRUG: binimetinib|DRUG: modafinil,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, where kel is the apparent terminal elimination rate constant. AR00426032 was the metabolite of binimetinib., Predose, and 1,2, 6 and 8 hours postdose on Day 1 and Day 14|AUC%Extrap of Encorafenib on Day 1, AUC%extrap is the percentage of AUCinf obtained by forward extrapolation. It is calculated as (AUCinf minus AUClast)\*100/ AUCinf., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1|AUC%Extrap of LHY746 on Day 1, AUC%extrap is the percentage of AUCinf obtained by forward extrapolation. It is calculated as (AUCinf minus AUClast)\*100/ AUCinf. LHY746 was the metabolite of encorafenib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1|AUC%Extrap of Binimetinib on Day 1, AUC%extrap is the percentage of AUCinf obtained by forward extrapolation. It is calculated as (AUCinf minus AUClast)\*100/ AUCinf., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1|AUC%Extrap of AR00426032 on Day 1, AUC%extrap is the percentage of AUCinf obtained by forward extrapolation. It is calculated as (AUCinf minus AUClast)\*100/ AUCinf. AR00426032 was the metabolite of binimetinib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1|Kel of Encorafenib on Day 1, Kel is the apparent terminal elimination rate constant, which is estimated by linear regression of time versus loge concentration., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1|Kel of LHY746 on Day 1, Kel is the apparent terminal elimination rate constant, which is estimated by linear regression of time versus loge concentration. LHY746 was the metabolite of encorafenib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1|Kel of Binimetinib on Day 1, Kel is the apparent terminal elimination rate constant, which is estimated by linear regression of time versus loge concentration., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1|Kel of AR00426032 on Day 1, Kel is the apparent terminal elimination rate constant, which is estimated by linear regression of time versus loge concentration. AR00426032 was the metabolite of binimetinib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1|CL/F of Encorafenib on Day 1, CL/F is the apparent total body clearance of drug from the plasma (parent drugs only), which is estimated by Dose / AUCinf (Day -7) or Dose / AUClast (Day 1 and Day 14)., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1.|CL/F of Binimetinib on Day 1, CL/F is the apparent total body clearance of drug from the plasma (parent drugs only), which is estimated by Dose / AUCinf (Day -7) or Dose / AUClast (Day 1 and Day 14)., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1.|Vz/F of Encorafenib on Day 1, Vz/F is the apparent volume of distribution during the terminal phase (parent drugs only), which is calculated by CL/F/kel., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1.|Vz/F of Binimetinib on Day 1, Vz/F is the apparent volume of distribution during the terminal phase (parent drugs only), which is calculated by CL/F/kel., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 1.|Cmax of Binimetinib on Day 14 and Day 21, Cmax is the maximum plasma concentration which was observed directly from the concentration-time data., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|Cmax of AR00426032 on Day 14 and Day 21, Cmax is the maximum plasma concentration which was observed directly from the concentration-time data. AR00426032 was the metabolite of binimetinib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|AUClast of Binimetinib on Day 14 and Day 21, AUClast is AUC from time 0 to the time of the last quantifiable concentration. It was calculated using the linear trapezoidal/linear interpolation method., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|AUClast of AR00426032 on Day 14 and Day 21, AUClast is AUC from time 0 (pre-dose) to the time of the last quantifiable concentration. AR00426032 was the metabolite of binimetinib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|Tmax of Encorafenib on Day 14 and Day 21, Tmax is time to reach maximum observed plasma concentration. It was observed directly from the concentration-time data., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|Tmax of LHY746 on Day 14 and Day 21, Tmax is time to reach maximum observed plasma concentration. It was observed directly from the concentration-time data. LHY746 was the metabolite of encorafenib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|Tmax of Binimetinib on Day 14 and Day 21, Tmax is time to reach maximum observed plasma concentration. It was observed directly from the concentration-time data., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|Tmax of AR00426032 on Day 14 and Day 21, Tmax is time to reach maximum observed plasma concentration. It was observed directly from the concentration-time data. AR00426032 was the metabolite of binimetinib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|T1/2 of Encorafenib on Day 14 and Day 21, T1/2 is the terminal elimination half-life, which is estimated by Loge(2) / kel, where kel is the apparent terminal elimination rate constant., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|T1/2 of LHY746 on Day 14 and Day 21, T1/2 is the terminal elimination half-life, which is estimated by Loge(2) / kel, where kel is the apparent terminal elimination rate constant. LHY746 was the metabolite of encorafenib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|T1/2 of Binimetinib on Day 14 and Day 21, T1/2 is the terminal elimination half-life, which is estimated by Loge(2) / kel, where kel is the apparent terminal elimination rate constant., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|T1/2 of AR00426032 on Day 14 and Day 21, T1/2 is the terminal elimination half-life, which is estimated by Loge(2) / kel, where kel is the apparent terminal elimination rate constant. AR00426032 was the metabolite of binimetinib., Predose, and 1,2,3,4, 6 and 8 hours postdose on Day 14 and Day 21|Number of Participants With Treatment-Emergent Adverse Events (TEAEs) in the DDI Phase, An adverse event (AE) was any untoward medical occurrence in a participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. TEAEs were those with initial onset or increasing in severity between the first dose of encorafenib/binimetinib and up to 30 days after treatment discontinuation. A serious adverse event (SAE) was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. SAEs were adjudicated according to the investigator's assessment. Treatment-related AEs and SAEs were determined by the investigator., After 1st dose of encorafenib/binimetinib on Day 1 and up to Day 28 visit in the DDI Phase|Number of Participants With Laboratory Abnormalities in the DDI Phase, Laboratory parameters:hematology (hemoglobin,hematocrit,red blood cell \[RBC\],platelet,white blood cell count \[WBC\],neutrophils,eosinophils,monocytes, basophils, lymphocytes), chemistry (albumin, alkaline phosphatase, alanine aminotransferase, amylase, aspartate aminotransferase, bicarbonate, total bilirubin, blood urea nitrogen, calcium, chloride, creatine kinase, creatinine, glucose, lactate dehydrogenase, lipase, magnesium, inorganic phosphate, potassium, total protein, sodium, uric acid), urinalysis (appearance, color, specific gravity, pH, ketones, protein, glucose, blood, nitrates, leukocyte esterase, and urine microscopy results including WBC, RBC, bacteria, epithelial cells, and casts), coagulation (activated partial thromboplastin time, prothrombin time/international normalized ratio) and others. Clinically notable: worsening from baseline by at least 2 grades or to greater than or equal to (\>=) Grade 3, by Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03., After 1st dose of encorafenib/binimetinib on Day 1 and up to Day 28 visit in the DDI Phase|Number of Participants With Notable Abnormalities in Vital Signs in the DDI Phase, Vital signs (temperature, pulse rate \[PR\]), systolic blood pressure \[SBP\]), and diastolic blood pressure \[DBP\]) were obtained with participants following at least 5 minutes of supine rest. Categorical criteria were defined as DBP\>=100 millimeters of mercury (mm Hg)/less than or equal to (\<=) 50 mmHg with increase/decrease from baseline of \>=15 mmHg; SBP: \>=160 mmHg/\<=90 mmHg with increase/decrease from baseline of \>=20 mmHg; PR: \>=120 beats per minute (bpm)/\<=50 bpm with increase/decrease from baseline of \>=15 bpm; temperature for Arms 1 and 3: \>=37.5°C/\<=35°C; Arms 2: \>=37.5°C/\<=36°C., After 1st dose of encorafenib/binimetinib on Day 1 and up to Day 28 visit in the DDI Phase|Number of Participants With Notable Electrocardiogram (ECG) Findings in the DDI Phase, Triplicate 12-lead ECG were performed after the participant had rested quietly for at least 10 minutes in a supine position. ECG parameters included RR interval, PR interval, QRS complex, QT interval, corrected QT (QTc) interval, Bazett's correction QT (QTcB) interval, Heart Rate and Fridericia's correction (QTcF) interval. The criterion included: QTcF \>450 - \<=480 mesc, \>480 - \<=500 msec, \>500 msec, increase from baseline \>30 - \<=60 msec and increase from baseline \>60 msec. QT interval \>450 - \<=480 msec, \>480 - \<=500 msec, \>500 msec, increase from baseline \>30 - \<=60 msec and increase from baseline \>60 msec. Heart rate increase from baseline \>25% and value \>100 bpm and decrease from baseline \>25% and value \<60 bpm. PR interval increase from baseline \>25% and value \>200 msec. QRS interval increase from baseline \>25% and value \>110 msec. Any new post-baseline notable ECG findings in the DDI phase was collected and reported in this outcome measure., After 1st dose of encorafenib/binimetinib on Day 1 and up to Day 28 visit in the DDI Phase|Number of Participants With Left Ventricular Ejection Fraction (LVEF) Abnormalities in the DDI Phase, LVEF abnormalities are defined according to CTCAE grade version 4.03. Participants was considered as having a LVEF abnormality if the worst post-baseline value was Grade 2,3, or 4 according to the following classification: Grade 0: Non-missing value below Grade 2; Grade 2: LVEF between 40% and 50% or absolute change from baseline between -10% and \<-20%; Grade 3: LVEF between 20% and 39% or absolute change from baseline lower than or equal to -20%; Grade 4: LVEF lower than 20%., After 1st dose of encorafenib/binimetinib on Day 1 and up to Day 28 visit in the DDI Phase|Number of Participants With Treatment-Emergent Adverse Events (TEAEs) in the Post-DDI Phase, An AE was any untoward medical occurrence in a participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. TEAEs were those with initial onset or increasing in severity between the first dose of encorafenib/binimetinib and up to 30 days after treatment discontinuation. A SAE was an AE resulting in any of the following outcomes or deemed significant for any other reason: death; initial or prolonged inpatient hospitalization; life-threatening experience (immediate risk of dying); persistent or significant disability/incapacity; congenital anomaly. SAEs were adjudicated according to the investigator's assessment. Treatment-related AEs and SAEs were determined by the investigator. Any significant findings in the laboratory test, physical examinations, ophthalmic examinations, vital signs, ECG tests were captured as an AE.," After 1st dose of encorafenib/binimetinib on Day 1 up to 30 days after the post-DDI Phase""",ALL,"ADULT, OLDER_ADULT",PHASE1,56,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/2/18,5/29/23,"UC Irvine Health, Orange, California, 92868-3201, United States|University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora, Colorado, 80045, United States|University of Illinois at Chicago, Chicago, Illinois, 60612, United States|Hopkins Eye Clinic, Hopkins, Minnesota, 55343-8087, United States|Park Nicollet Eye Clinic, Maple Grove, Minnesota, 55369, United States|Regions Cancer Care Center, Saint Paul, Minnesota, 55101, United States|HealthPartners Specialty Center-Eye Care, Saint Paul, Minnesota, 55130, United States|Gabrail Cancer Center Research, Canton, Ohio, 44718, United States|University of TN Medical Center, Knoxville, Tennessee, 37920, United States|Mary Crowley Cancer Research - Medical City Hospital, Dallas, Texas, 75230, United States|Utah Cancer Specialists, West Valley City, Utah, 84119, United States|Universitair Ziekenhuis Antwerpen, Edegem, 2650, Belgium|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada|Jewish General Hospital, Montrea, Quebec, H3T 1E2, Canada|Het Nederlands Kanker Instituut Antoni Van Leeuwenhoek Ziekenhuis, Amsterdam, 1066 CX, Netherlands|Erasmus Medical Center, Rotterdam, 3000 CA, Netherlands|Hospital del Mar, Barcelona, 08003, Spain|Hospital Clinico Universitario Virgen de la Arrixaca, El Palmar, 30120, Spain|Hospital Universitari Arnau de Vilanova, Lleida, 25198, Spain|Hospital Beata Maria Ana, Madrid, 28007, Spain|Hospital General Universitario Gregorio Marañon, Madrid, 28007, Spain|Clinica Rementeria, Madrid, 28010, Spain|MD Anderson Cancer Center Madrid, Madrid, 28033, Spain|Hospital Universitario HM Sanchinarro - CIOCC, Madrid, 28050, Spain|CERCO, Seville, 41009, Spain|Hospital Universitario Virgen Macarena, Seville, 41009, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Primary Central Nervous System Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm,DRUG: Irinotecan|DRUG: Pevonedistat|DRUG: Temozolomide,ALL,"CHILD, ADULT",PHASE1,30,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/11/18,9/30/24,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, 30329, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Solid Tumor,BIOLOGICAL: BMS-986179|BIOLOGICAL: Nivolumab|BIOLOGICAL: rHuPH20,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,235,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/21/16,10/12/21,"Local Institution - 0028, Chicago, Illinois, 60611, United States|Local Institution - 0001, Baltimore, Maryland, 21287, United States|Local Institution - 0022, Boston, Massachusetts, 02215, United States|Local Institution - 0023, Buffalo, New York, 14263, United States|Local Institution - 0005, New York, New York, 10032, United States|Local Institution - 0020, Pittsburgh, Pennsylvania, 15232, United States|Local Institution - 0004, Nashville, Tennessee, 37203, United States|Local Institution - 0009, Dallas, Texas, 75230, United States|Local Institution - 0019, Randwick, New South Wales, 2031, Australia|Local Institution - 0017, Sydney, New South Wales, 2010, Australia|Local Institution - 0018, Melbourne, Victoria, 3004, Australia|Local Institution - 0003, Ottawa, Ontario, K1H 8L6, Canada|Local Institution - 0002, Toronto, Ontario, M5G 1Z5, Canada|Local Institution - 0024, Montreal, Quebec, H2X 3E4, Canada|Local Institution - 0014, Montreal, Quebec, H3T 1E2, Canada|Local Institution - 0033, Marseille, 13273, France|Local Institution - 0021, Marseille, 13385, France|Local Institution - 0008, Toulouse, 31059, France|Local Institution - 0007, Villejuif, 94805, France|Local Institution - 0016, Freiburg im Breisgau, 79106, Germany|Local Institution - 0015, Munich, 81675, Germany|Local Institution - 0012, Napoli, 80131, Italy|Local Institution - 0013, Padua, Padova, Italy|Local Institution - 0006, Amsterdam, 1066 CX, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Neuroendocrine Carcinoma|Neuroendocrine Cancer,DRUG: Pembrolizumab|DRUG: Lenvatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,20,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/15/17,5/13/24,"H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, 33612, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Cancer of Prostate|Cancer of the Prostate|Neoplasms, Prostate|Neoplasms, Prostatic|Prostate Cancer|Prostate Neoplasms|Prostatic Cancer",BIOLOGICAL: androgen ablation (AA)|BIOLOGICAL: DC1 vaccine,MALE,"ADULT, OLDER_ADULT",PHASE2,13,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,2009-09,10/5/19,"University of Pittsburgh Cancer institute, Pittsburgh, Pennsylvania, 15232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Thymoma|Thymus Neoplasms,DRUG: Sunitinib|DRUG: Sunitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,56,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/15/12,7/31/24,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Neuroendocrine Tumors|Carcinoma, Small Cell Lung|Neuroendocrine Carcinoma",DRUG: PEN-221|DRUG: PEN-221,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,89,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,12/8/16,2/25/21,"Florida Cancer Specialists South, Fort Myers, Florida, 33901, United States|Florida Cancer Specialists North, St. Petersburg, Florida, 33705, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Columbia University Medical Center/ NY Presbyterian, Manhattan, New York, 10032, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University College London, London, United Kingdom|The Christie NHS Trust, Manchester, United Kingdom|Southampton General Hospital, Southampton, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Hodgkin's Lymphoma|Lymphoid Leukemia|Lymphoma|Leukemia|Myeloma|Acute Lymphocytic Leukemia|Non Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Multiple Myeloma|Chronic Myelogenous Leukemia|Myelodysplastic Syndromes|Recurrent Acute Myeloid Leukemia, Adult|Recurrent Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia|Acute Myelogenous Leukemia",DRUG: mycophenolate mofetil|BIOLOGICAL: Sargramostim|BIOLOGICAL: Filgrastim,ALL,"ADULT, OLDER_ADULT",PHASE2,31,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/4/15,3/18/22,"Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, 23298, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Salivary Gland Neoplasms,DRUG: Apalutamide|DRUG: GnRH Agonist,ALL,"ADULT, OLDER_ADULT",PHASE2,31,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/7/20,12/31/27,"National Cancer Center Hospital, Chūōku, 104 0045, Japan|National Hospital Organization Kyushu Medical Center, Fukuoka, 810 8563, Japan|Kansai Medical University Hospital, Hirakata, 573 1191, Japan|National Hospital Organization Shikoku Cancer Center, Matsuyama, 791 0280, Japan|Aichi Cancer Center Hospital, Nagoya, 464 8681, Japan|Niigata University Medical And Dental Hospital, Niigata, 951 8520, Japan|Hokkaido University Hospital, Sapporo, 060-8648, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Neoplasms|Breast Cancer,DRUG: Paclitaxel|DRUG: Docetaxel|DRUG: Abraxane|DRUG: Ixabepilone,FEMALE,"ADULT, OLDER_ADULT",PHASE2,38,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2011-09,3/1/19,"Houston Methodist Hospital Cancer Center, Houston, Texas, 77030, United States|Houston Methodist Hospital Willowbrook, Houston, Texas, 77070, United States|Houston Methodist Hospital Sugar Land, Sugar Land, Texas, 77479, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Solid Tumor|Medullary Thyroid Cancer,DRUG: Selpercatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,77,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/16/20,2027-11,"Beijing Cancer Hospital, Beijing, Beijing Municipality, 100142, China|The First Affiated Hospital Of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China|Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, 510515, China|Hunan Cancer Hospital, Changsha, Hunan, 410013, China|Jilin Cancer Hospital, Changchun, Jilin, 130000, China|Jinan Central Hospital, Jinan, Shandong, 250013, China|Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, 200032, China|Shanghai East Hospital, Shanghai, Shanghai Municipality, 200120, China|Shanghai Chest Hospital, Shanghai, Shanghai/China, 200030, China|Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, 300060, China|The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,"Cancer of the Colon|Colon Cancer|Colon Neoplasms|Colonic Cancer|Neoplasms, Colonic",DRUG: Cetuximab|DRUG: Palbociclib,ALL,"ADULT, OLDER_ADULT",PHASE2,24,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/23/18,1/26/26,"Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, 27599-7295, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Colorectal Cancer|Colorectal Neoplasms|Colorectal Carcinoma|Colorectal Tumors|Neoplasms, Colorectal",DRUG: NUC-3373 + leucovorin|DRUG: NUC-3373|DRUG: NUFOX|DRUG: NUFOX + VEGF pathway inhibitor|DRUG: NUFOX + EGFR inhibitor|DRUG: NUFIRI|DRUG: NUFIRI + VEGF pathway inhibitor|DRUG: NUFIRI + EGFR inhibitor|DRUG: NUC-3373 + bevacizumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,111,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/5/18,3/21/24,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Vanderbilt University, Nashville, Tennessee, 37232, United States|Seattle Cancer Center, Seattle, Washington, 98109-1023, United States|Compass Oncology, Vancouver, Washington, 98684, United States|Hopital Franco-Britannique, Levallois-Perret, 92300, France|The Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|University College London Hospitals NHS Foundation Trust, London, W1T 7HA, United Kingdom|University of Oxford, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumors|Meningioma|Neuroblastoma|Medulloblastoma,RADIATION: 90Y-DOTA tyr3-Octreotide|DIAGNOSTIC_TEST: 68Ga-DOTATOC PET Positron Emission Tomography (PET) whole body scan|DRUG: Amino Acids,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,39,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/29/17,5/27/20,"University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Refractory or Relapsed Solid Tumors|Lymphoma,DRUG: Avelumab|DRUG: Avelumab,ALL,"CHILD, ADULT",PHASE1,21,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/7/18,7/27/21,"Children's Hospital Colorado, Aurora, Colorado, 80045, United States|The Children's Hospital at Montefiore (CHAM), The Bronx, New York, 10467, United States|Cliniques Universitaires Saint-Luc, Brussels, Belgium|UZ Leuven, Leuven, Belgium|Children's Hospital - London Health Sciences Centre, London, Canada|CHU Sainte-Justine, Montreal, Canada|The Hospital for Sick Children, Toronto, Canada|Rigshospitalet, Copenhagen, Denmark|Samsung Medical Center, Seoul, South Korea|Seoul National University Hospital, Seoul, South Korea|Severance Hospital, Yonsei University, Seoul, South Korea",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Symptomatic COVID-19 Infection Laboratory-Confirmed,OTHER: Best Practice|DRUG: Leflunomide|DRUG: Placebo Administration,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,2,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",1/7/21,10/27/21,"City of Hope Medical Center, Duarte, California, 91010, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor|Leiomyosarcoma|Osteosarcoma,DRUG: M6620,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/8/19,7/8/20,"Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02214, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Boston Children Hospital, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neuroendocrine Tumors|Neuroendocrine Carcinoma|Neuroendocrine Neoplasms|Carcinoma, Neuroendocrine|Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas",DRUG: Sunitinib|DRUG: Everolimus,ALL,"ADULT, OLDER_ADULT",PHASE2,16,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,4/8/15,5/22/19,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm,PROCEDURE: Biopsy Procedure|PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|PROCEDURE: Magnetic Resonance Imaging|DRUG: Palbociclib,ALL,"ADULT, OLDER_ADULT",PHASE2,43,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/22/17,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Locally Advanced or Metastatic Solid Tumors,DRUG: Pamiparib|DRUG: Temozolomide,ALL,"ADULT, OLDER_ADULT",PHASE1,139,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/28/17,5/4/23,"Start Midwest, Grand Rapids, Michigan, 49503, United States|Washington University in St Louis, St Louis, Missouri, 63110, United States|Mount Sinai Prime, New York, New York, 10029, United States|Montefiore Medical Park At Eastchester Einstein Campus, The Bronx, New York, 10467, United States|Sarah Cannon Cancer Center, Nashville, Tennessee, 37203, United States|Texas Oncology (Loop) Usor, Dallas, Texas, 75230, United States|The University of Texas Md Anderson Cancer Center, Houston, Texas, 77030-4009, United States|Chris Obrien Lifehouse, Camperdown, New South Wales, 2050, Australia|Saint Vincents Hospital Sydney, Darlinghurst, New South Wales, 2010, Australia|Icon Cancer Centre South Brisbane, South Brisbane, Queensland, 4101, Australia|Peter Maccallum Cancer Centre, Melbourne, Victoria, 3000, Australia|Hospital Universitario Vall Dhebron, Barcelona, 08035, Spain|Ico H Duran I Reynals, Barcelona, 08907, Spain|Hospital Universitario Ramon Y Cajal, Madrid, 28034, Spain|Start Madrid Fundacion Jimenez Diaz, Madrid, 28040, Spain|Centro Integral Oncologico Clara Campal, Madrid, 28050, Spain|Hospital Universitario Virgen de La Macarena, Seville, 41009, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|Northern Centre For Cancer Care, High Heaton, NE7 7DN, United Kingdom|University College Hospital, London, NW1 2PG, United Kingdom|Sarah Cannon Research Institute Uk, London, W1G 6AD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cancer Pain,OTHER: ELEQUIL,ALL,"ADULT, OLDER_ADULT",PHASE2,70,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,5/18/22,1/16/24,"MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Gynecologic Cancer,DRUG: PSMA-based 18F-DCFPyL PET tracer,FEMALE,"ADULT, OLDER_ADULT",PHASE2,15,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC,11/15/17,1/20/20,"University of Wisconsin, Madison, Madison, Wisconsin, 53705, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Select Advanced Malignancies|Kidney Cancer|Clear Cell Renal Cell Carcinoma,BIOLOGICAL: MEDI0680|BIOLOGICAL: Durvalumab|BIOLOGICAL: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,97,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/19/14,3/17/20,"Research Site, Los Angeles, California, 90025, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Overland Park, Kansas, 66209, United States|Research Site, Louisville, Kentucky, 40202, United States|Research Site, Rochester, Minnesota, 55905, United States|Research Site, Hackensack, New Jersey, 07601, United States|Research Site, New York, New York, 10065, United States|Research Site, Cleveland, Ohio, 44195, United States|Research Site, Oklahoma City, Oklahoma, 73104, United States|Research Site, Portland, Oregon, 97213, United States|Research Site, Hershey, Pennsylvania, 17033-0850, United States|Research Site, Nashville, Tennessee, 37203, United States|Research Site, Seattle, Washington, 98109, United States|Research Site, East Bentleigh, 3165, Australia|Research Site, Frankston, 3199, Australia|Research Site, Toronto, Ontario, M5G 2M9, Canada|Research Site, Montreal, Quebec, H3T 1E2, Canada|Research Site, Bordeaux, 33075, France|Research Site, Dijon, 21079, France|Research Site, Marseille, 13009, France|Research Site, Paris, 75908, France|Research Site, Villejuif, 94805, France|Research Site, Amsterdam, 1066 CX, Netherlands|Research Site, Groningen, 9713 GZ, Netherlands|Research Site, Cambridge, CB2 0QQ, United Kingdom|Research Site, Cardiff, CF14 2TL, United Kingdom|Research Site, Southampton, SO16 6YD, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ectropion|Skin Neoplasms,DRUG: 5-Fluorouracil|OTHER: Normal saline,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",8/25/16,1/25/19,"Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, 02114, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor|Metastatic Bladder Cancer,DRUG: RX-3117,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,127,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2013-12,2019-12,"Rexahn Site, Birmingham, Alabama, 35294, United States|Rexahn Site, Tucson, Arizona, 85724, United States|Rexahn Site, Duarte, California, 91010, United States|Rexahn Site, Miami, Florida, 33136, United States|Rexahn Site, Miami Lakes, Florida, 33014, United States|Rexahn Site, Skokie, Illinois, 60077, United States|Rexahn Site, St Louis, Missouri, 63110, United States|Rexahn Site, Las Vegas, Nevada, 89119, United States|Rexahn Site, New York, New York, 10021, United States|Rexahn Site, San Antonio, Texas, 78229, United States|Rexahn Site, Salt Lake City, Utah, 84112, United States|Rexahn Site, Fairfax, Virginia, 22031, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastric Cancer|Gastric Neoplasms,DEVICE: Endoscope+Cellvizio(R) 100 microscope,ALL,"ADULT, OLDER_ADULT",PHASE2,37,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2/11/19,5/5/20,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Gynecologic Neoplasms|Epithelial Ovarian Cancer,DRUG: PLX2853|DRUG: Carboplatin,FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,37,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/11/20,4/25/22,"The University of Chicago Medical Center, Chicago, Illinois, 05841, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University of Oklahoma - Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Tennessee Oncology / Sarah Cannon, Nashville, Tennessee, 37203, United States|University of Virginia Health Systems, Charlottesville, Virginia, 22908, United States|Virginia Cancer Specialists, PC, Fairfax, Virginia, 22031, United States|University of Washington / Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Princess Margaret Cancer Centre, Toronto, Ontario, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,UNKNOWN,YES,"Ovarian Granulosa Cell Tumor|Ovarian Gynandroblastoma|Ovarian Sertoli-Leydig Cell Tumor|Ovarian Sex Cord Tumor With Annular Tubules|Ovarian Sex Cord-Stromal Tumor|Ovarian Sex Cord-Stromal Tumor, Not Otherwise Specified|Ovarian Steroid Cell Tumor",BIOLOGICAL: Bleomycin Sulfate|DRUG: Carboplatin|DRUG: Cisplatin|DRUG: Etoposide Phosphate|OTHER: Laboratory Biomarker Analysis|DRUG: Paclitaxel,FEMALE,"ADULT, OLDER_ADULT",PHASE2,63,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/8/10,11/2/22,"Alaska Breast Care and Surgery LLC, Anchorage, Alaska, 99508, United States|Alaska Women's Cancer Care, Anchorage, Alaska, 99508, United States|Anchorage Oncology Centre, Anchorage, Alaska, 99508, United States|Katmai Oncology Group, Anchorage, Alaska, 99508, United States|Providence Alaska Medical Center, Anchorage, Alaska, 99508, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, 91505, United States|Olive View-University of California Los Angeles Medical Center, Sylmar, California, 91342, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|Hartford Hospital, Hartford, Connecticut, 06102, United States|The Hospital of Central Connecticut, New Britain, Connecticut, 06050, United States|Sibley Memorial Hospital, Washington D.C., District of Columbia, 20016, United States|Northside Hospital, Atlanta, Georgia, 30342, United States|Augusta University Medical Center, Augusta, Georgia, 30912, United States|Northside Hospital-Forsyth, Cumming, Georgia, 30041, United States|Central Georgia Gynecologic Oncology, Macon, Georgia, 31201, United States|Memorial Health University Medical Center, Savannah, Georgia, 31404, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, 31405, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, 83814, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, 83854, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, 83864, United States|Saint Joseph Medical Center, Bloomington, Illinois, 61701, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, 61704, United States|Illinois CancerCare-Canton, Canton, Illinois, 61520, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, 62902, United States|SIH Cancer Institute, Carterville, Illinois, 62918, United States|Illinois CancerCare-Carthage, Carthage, Illinois, 62321, United States|Centralia Oncology Clinic, Centralia, Illinois, 62801, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, 62526, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Crossroads Cancer Center, Effingham, Illinois, 62401, United States|Illinois CancerCare-Eureka, Eureka, Illinois, 61530, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, 60201, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, 61401, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, 61401, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, 60026, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, 60035, United States|Sudarshan K Sharma MD Limited-Gynecologic Oncology, Hinsdale, Illinois, 60521, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, 61443, United States|Illinois CancerCare-Macomb, Macomb, Illinois, 61455, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, 62864, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, 60451, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, 62269, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, 61350, United States|Radiation Oncology of Northern Illinois, Ottawa, Illinois, 61350, United States|Illinois CancerCare-Pekin, Pekin, Illinois, 61554, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, 61554, United States|Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, 61615, United States|Methodist Medical Center of Illinois, Peoria, Illinois, 61636, United States|OSF Saint Francis Medical Center, Peoria, Illinois, 61637, United States|Illinois CancerCare-Peru, Peru, Illinois, 61354, United States|Valley Radiation Oncology, Peru, Illinois, 61354, United States|Illinois CancerCare-Princeton, Princeton, Illinois, 61356, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, 62702, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Springfield Clinic, Springfield, Illinois, 62702, United States|Memorial Medical Center, Springfield, Illinois, 62781, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, 62226, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, 46260, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|Coffeyville Regional Medical Center, Coffeyville, Kansas, 67337, United States|University of Kansas Clinical Research Center, Fairway, Kansas, 66205, United States|HaysMed University of Kansas Health System, Hays, Kansas, 67601, United States|University of Kansas Cancer Center, Kansas City, Kansas, 66160, United States|Olathe Health Cancer Center, Olathe, Kansas, 66061, United States|Ascension Via Christi - Pittsburg, Pittsburg, Kansas, 66762, United States|Salina Regional Health Center, Salina, Kansas, 67401, United States|University of Kansas Health System Saint Francis Campus, Topeka, Kansas, 66606, United States|University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas, 66205, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, 40536, United States|University Medical Center New Orleans, New Orleans, Louisiana, 70112, United States|Sinai Hospital of Baltimore, Baltimore, Maryland, 21215, United States|MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore, Maryland, 21237, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, 21287, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Green Bay Oncology - Escanaba, Escanaba, Michigan, 49829, United States|Green Bay Oncology - Iron Mountain, Iron Mountain, Michigan, 49801, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Borgess Medical Center, Kalamazoo, Michigan, 49048, United States|William Beaumont Hospital-Royal Oak, Royal Oak, Michigan, 48073, United States|William Beaumont Hospital - Troy, Troy, Michigan, 48085, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, 65613, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, 63628, United States|Cox Cancer Center Branson, Branson, Missouri, 65616, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|Southeast Cancer Center, Cape Girardeau, Missouri, 63703, United States|Capital Region Southwest Campus, Jefferson City, Missouri, 65109, United States|Freeman Health System, Joplin, Missouri, 64804, United States|Mercy Hospital Joplin, Joplin, Missouri, 64804, United States|Truman Medical Centers, Kansas City, Missouri, 64108, United States|University of Kansas Cancer Center - North, Kansas City, Missouri, 64154, United States|University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri, 64116, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, 65401, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, 63670, United States|Mercy Hospital Springfield, Springfield, Missouri, 65804, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Saint Louis Cancer and Breast Institute-South City, St Louis, Missouri, 63109, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, 63080, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, 63127, United States|Community Hospital of Anaconda, Anaconda, Montana, 59711, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Saint Vincent Healthcare, Billings, Montana, 59101, United States|Bozeman Deaconess Hospital, Bozeman, Montana, 59715, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, 59701, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Great Falls Clinic, Great Falls, Montana, 59405, United States|Saint Peter's Community Hospital, Helena, Montana, 59601, United States|Kalispell Regional Medical Center, Kalispell, Montana, 59901, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, 59802, United States|Community Medical Hospital, Missoula, Montana, 59804, United States|Nebraska Methodist Hospital, Omaha, Nebraska, 68114, United States|Women's Cancer Center of Nevada, Las Vegas, Nevada, 89169, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, 07920, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87102, United States|Southwest Gynecologic Oncology Associates Inc, Albuquerque, New Mexico, 87106, United States|Memorial Sloan Kettering Commack, Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Sleepy Hollow, Sleepy Hollow, New York, 10591, United States|Stony Brook University Medical Center, Stony Brook, New York, 11794, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, 11553, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, 28203, United States|Atrium Health Cabarrus/LCI-Concord, Concord, North Carolina, 28025, United States|Duke University Medical Center, Durham, North Carolina, 27710, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Summa Health System - Akron Campus, Akron, Ohio, 44304, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, 45714, United States|Adena Regional Medical Center, Chillicothe, Ohio, 45601, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|MetroHealth Medical Center, Cleveland, Ohio, 44109, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, 44111, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Mount Carmel East Hospital, Columbus, Ohio, 43213, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, 43214, United States|Riverside Methodist Hospital, Columbus, Ohio, 43214, United States|Grant Medical Center, Columbus, Ohio, 43215, United States|The Mark H Zangmeister Center, Columbus, Ohio, 43219, United States|Mount Carmel Health Center West, Columbus, Ohio, 43222, United States|Doctors Hospital, Columbus, Ohio, 43228, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, 43015, United States|Delaware Radiation Oncology, Delaware, Ohio, 43015, United States|Grady Memorial Hospital, Delaware, Ohio, 43015, United States|Dublin Methodist Hospital, Dublin, Ohio, 43016, United States|Central Ohio Breast and Endocrine Surgery, Gahanna, Ohio, 43230, United States|Mount Carmel Grove City Hospital, Grove City, Ohio, 43123, United States|Fairfield Medical Center, Lancaster, Ohio, 43130, United States|Lancaster Radiation Oncology, Lancaster, Ohio, 43130, United States|OhioHealth Mansfield Hospital, Mansfield, Ohio, 44903, United States|Marietta Memorial Hospital, Marietta, Ohio, 45750, United States|OhioHealth Marion General Hospital, Marion, Ohio, 43302, United States|Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, 44124, United States|UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, 44060, United States|Knox Community Hospital, Mount Vernon, Ohio, 43050, United States|Licking Memorial Hospital, Newark, Ohio, 43055, United States|Newark Radiation Oncology, Newark, Ohio, 43055, United States|Southern Ohio Medical Center, Portsmouth, Ohio, 45662, United States|Springfield Regional Medical Center, Springfield, Ohio, 45505, United States|Saint Ann's Hospital, Westerville, Ohio, 43081, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, 43701, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, 74146, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, 97015, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, 97015, United States|Providence Newberg Medical Center, Newberg, Oregon, 97132, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, 97045, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Providence Saint Vincent Medical Center, Portland, Oregon, 97225, United States|Jefferson Abington Hospital, Abington, Pennsylvania, 19001, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, 18103, United States|Geisinger Medical Center, Danville, Pennsylvania, 17822, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, 18201, United States|Jefferson Hospital, Jefferson Hills, Pennsylvania, 15025, United States|Geisinger Medical Oncology-Lewisburg, Lewisburg, Pennsylvania, 17837, United States|Lewistown Hospital, Lewistown, Pennsylvania, 17044, United States|Forbes Hospital, Monroeville, Pennsylvania, 15146, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Temple University Hospital, Philadelphia, Pennsylvania, 19140, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, 15212, United States|West Penn Hospital, Pittsburgh, Pennsylvania, 15224, United States|Geisinger Cancer Services-Pottsville, Pottsville, Pennsylvania, 17901, United States|Community Medical Center, Scranton, Pennsylvania, 18510, United States|Geisinger Medical Oncology-Selinsgrove, Selinsgrove, Pennsylvania, 17870, United States|Geisinger Medical Group, State College, Pennsylvania, 16801, United States|Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, 15090, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, 18711, United States|Women and Infants Hospital, Providence, Rhode Island, 02905, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, 57104, United States|Avera Cancer Institute, Sioux Falls, South Dakota, 57105, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, 57117-5134, United States|Parkland Memorial Hospital, Dallas, Texas, 75235, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, 75390, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States|PeaceHealth Saint John Medical Center, Longview, Washington, 98632, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, 98664, United States|Green Bay Oncology at Saint Vincent Hospital, Green Bay, Wisconsin, 54301-3526, United States|Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, 54301, United States|Green Bay Oncology Limited at Saint Mary's Hospital, Green Bay, Wisconsin, 54303, United States|Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, 54303, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, 54311, United States|Holy Family Memorial Hospital, Manitowoc, Wisconsin, 54221, United States|Bay Area Medical Center, Marinette, Wisconsin, 54143, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, 53215, United States|Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, 54154, United States|Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, 54235-1495, United States|Green Bay Oncology - Sturgeon Bay, Sturgeon Bay, Wisconsin, 54235, United States|Aurora West Allis Medical Center, West Allis, Wisconsin, 53227, United States|Big Horn Basin Cancer Center, Cody, Wyoming, 82414, United States|Billings Clinic-Cody, Cody, Wyoming, 82414, United States|Welch Cancer Center, Sheridan, Wyoming, 82801, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Esophagogastric Tumors|Gastric Cancer|Gastric Tumor|Esophageal Cancer|Esophageal Neoplasms|Esophageal Tumor|GastroEsophageal Cancer|Gastroesophageal Junction Adenocarcinoma|Gastroesophageal Junction Tumor|Gastroesophageal Junction Cancer,DRUG: Trastuzumab|DRUG: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/10/20,12/30/22,"Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, 10065, United States|Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, 11553, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphatic System Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,PROCEDURE: Biopsy Procedure|PROCEDURE: Computed Tomography|DRUG: Copanlisib Hydrochloride|PROCEDURE: Magnetic Resonance Imaging,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/20/18,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neuroendocrine Tumor|Anaplastic Thyroid Cancer|Adenocarcinoma|Pheochromocytoma|Paraganglioma,DRUG: Cabozantinib 40 mg,ALL,"ADULT, OLDER_ADULT",PHASE2,93,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/7/20,12/15/23,"Hospital Germans Trias i Pujol - ICO Badalona, Badalona, Barcelona, 08916, Spain|Hospital Duran i Reynals - ICO L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Hospital General Universitario Elche, Alicante, 03010, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|MD Anderson Cancer Center, Madrid, 28033, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Universitario Virgen de la Victoria, Málaga, 29010, Spain|Hospital General Universitario Morales Meseguer, Murcia, 30008, Spain|Hospital Universitario Central de Asturias, Oviedo, 33011, Spain|Hospital Universitario de Canarias, Santa Cruz de Tenerife, 38320, Spain|Hospital Universitario Marqués de Valdecilla, Santander, 39008, Spain|Hospital Universitario Virgen del Rocío, Seville, 41013, Spain|Hospital Universitario Miguel Servet, Zaragoza, 50009, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Breast Cancer|Breast Neoplasms,DRUG: Pembrolizumab|DRUG: IRX 2,ALL,"ADULT, OLDER_ADULT",PHASE2,12,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/30/20,2025-12,"Providence Portland Medical Center, Portland, Oregon, 97213, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms|Prostatic Cancer,BIOLOGICAL: ETBX-071; adenoviral PSA vaccine|BIOLOGICAL: ETBX-061; adenoviral MUC1 vaccine|BIOLOGICAL: ETBX-051; adenoviral brachyury vaccine,MALE,"ADULT, OLDER_ADULT",PHASE1,18,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/24/18,3/9/21,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor|Colorectal Cancer,DRUG: PF-02341066|DRUG: PD-0325901|DRUG: Binimetinib,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE1,82,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2014-11,12/3/18,"Oxford University Hospital NHS Trust, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostate Cancer|Prostatic Neoplasms,DEVICE: Visualase Thermal Therapy System,MALE,"ADULT, OLDER_ADULT",PHASE2,15,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/12/11,7/31/18,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Multiple Myeloma|Solid Tumors,DRUG: Carfilzomib,ALL,"ADULT, OLDER_ADULT",PHASE2,101,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/9/09,5/17/17,"Pinnacle Oncology Hematology, Scottsdale, Arizona, 85258, United States|Tower Cancer Research Foundation, Beverly Hills, California, 90211, United States|City of Hope National Medial Center, Duarte, California, 91010, United States|University of California Medical Center, San Francisco, California, 94143, United States|Colorado Blood Cancer Institute, Denver, Colorado, 80218, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Winship Cancer Institute - Emory University, Atlanta, Georgia, 30322, United States|Northwestern University, Chicago, Illinois, 60611, United States|University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|Washington University School of Medicine, St Louis, Missouri, 63110-1093, United States|John Theurer Cancer Center at Hackensack UMC, Hackensack, New Jersey, 07601, United States|Weill Cornell Medical College, New York, New York, 10021, United States|Mount Sinai School of Medicine, New York, New York, 10029, United States|Gabrail Cancer Center Research, Canton, Ohio, 44718, United States|The Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203-1632, United States|Texas Oncology Cancer Center, Austin, Texas, 78731, United States|The University of Texas, MD Anderson Cancer Center, Houston, Texas, 77030, United States|Northwest Cancer Center, Houston, Texas, 77090, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States|University of Toronto, Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|Jewish General Hospital, Montreal, Quebec, H3t 1E2, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Endometrial Cancer,DRUG: Carboplatin AUC|DRUG: Abraxane,FEMALE,"ADULT, OLDER_ADULT",PHASE2,23,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-07,3/1/20,"NYU Perlmutter Cancer Center, New York, New York, 10016, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"RET-altered Non Small Cell Lung Cancer|Medullary Thyroid Cancer|RET-altered Papillary Thyroid Cancer|RET-altered Colon Cancer|RET-altered Solid Tumors|Lung Neoplasm|Carcinoma, Non-Small-Cell Lung|Thyroid Diseases|Thyroid Neoplasm|Thyroid Cancer, Papillary|Carcinoma, Neuroendocrine|Respiratory Tract Neoplasms|Thoracic Neoplasms|Neoplasms by Site|Neoplasms|Lung Diseases|Respiratory Tract Disease|Carcinoma, Bronchogenic|Bronchial Neoplasms|Endocrine System Diseases|Endocrine Gland Neoplasm|Head and Neck Neoplasms|Adenocarcinoma, Papillary|Adenocarcinoma|Carcinoma|Neoplasms, Glandular and Epithelial|Neoplasms by Histologic Type|Neuroendocrine Tumors|Neuroectodermal Tumors|Neoplasms, Germ Cell and Embryonal|Neoplasms, Nerve Tissue|Colonic Neoplasms|Colorectal Neoplasms|Intestinal Neoplasms|Gastrointestinal Neoplasms|Digestive System Neoplasm|Digestive System Disease|Gastrointestinal Disease|Colonic Diseases|Intestinal Disease",DRUG: pralsetinib (BLU-667),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,590,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,3/17/17,3/21/24,"Mayo Clinic Hospital, Phoenix, Arizona, 85054, United States|UC Irvine Medical Center, Orange, California, 92868, United States|University of Colorado Anschutz Medical Campus, Aurora, Colorado, 80045, United States|Georgetown University Medical Center, Washington D.C., District of Columbia, 20007, United States|Mayo Clinic-Jacksonville, Jacksonville, Florida, 32224, United States|Sylvester Comprehensive Cancer Center, Miami, Florida, 33136-1002, United States|Maryland Oncology Hematology, P.A., Columbia, Maryland, 21044-3257, United States|Massachusetts General Hospital., Boston, Massachusetts, 02114-2696, United States|University of Michigan, Ann Arbor, Michigan, 48109-0934, United States|Mayo Clinic Rochester, Rochester, Minnesota, 55902-3003, United States|Washington University School of Medicine in St. Louis, St Louis, Missouri, 63110-1010, United States|Albany Medical Center, Albany, New York, 12208-3412, United States|Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York, 10021, United States|Oregon Health & Science University, Portland, Oregon, 97239, United States|Texas Oncology-Austin Midtown, Austin, Texas, 78705-1165, United States|Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas, 75246, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030-4000, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Antwerp University Hospital, Edegem, 2650, Belgium|Beijing Cancer Hospital, Beijing, 100036, China|Beijing Cancer Hospital, Beijing, 100142, China|The affiliated Cancer Hospital, School of Medicine, UESTC, Chengdu, 610041, China|West China Hospital, Sichuan University, Chengdu, 610041, China|Chongqing Cancer Hospital, Chongqing, 400030, China|Fujian Provincial Cancer Hospital, Fuzhou, 350014, China|First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China|Sun Yet-sen University Cancer Center, Guangzhou, 510060, China|Guangdong General Hospital, Guangzhou, 510080, China|Zhejiang Cancer Hospital, Hangzhou, 310022, China|Jinan Central Hospital, Jinan, 250013, China|Gansu Cancer Hospital, Lanzhou, 730050, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|Fudan University Shanghai Cancer Center, Shanghai, 200120, China|Tianjin Medical University Cancer Institute & Hospital, Tianjing, 300060, China|Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan, 430023, China|Henan Cancer Hospital, Zhengzhou, 450008, China|Institut Bergonie, Bordeaux, 33000, France|Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez, Lille, 59037, France|Centre Léon Bérard, Lyon, 69008, France|Centre Antoine Lacassagne, Nice, 6100, France|Institut Curie, Paris, 75248, France|CHU de Rennes - Hopital de Pontchaillo, Rennes, 35033, France|Hôpital Larrey, Toulouse, 31059, France|Gustave Roussy, Villejuif, 94800, France|Helios Klinikum Emil von Behring GmbH, Berlin, 14165, Germany|Universitätsklinikum Essen, Essen, 45122, Germany|Thoraxklinik Heidelberg gGmbH, Heidelberg, 69126, Germany|Klinikum der Universität München, München, 81377, Germany|Pius-Hospital, Oldenburg, 26121, Germany|The Chinese University of Hong Kong, Shatin, 123456, Hong Kong|Ospedale Santa Maria Delle Croci, Ravenna, Emilia-Romagna, 48100, Italy|Istituto Nazionale Tumori Regina Elena, Rome, Lazio, 00144, Italy|IEO, Milan, Lombardy, 20141, Italy|Asst Grande Ospedale Metropolitano Niguarda, Milan, Lombardy, 20162, Italy|Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, 1066 CX, Netherlands|Universitair Medisch Centrum Groningen, Groningen, 9713 GZ, Netherlands|National Cancer Centre, Singapore, 169610, Singapore|Seoul National University Hospital, Seoul, 03080, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|Severance Hospital, Yonsei University Health System, Seoul, 120-752, South Korea|Institut Catala d Oncologia Hospitalet, L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, 08035, Spain|Hospital Clinic de Barcelona, Barcelona, 08036, Spain|Hospital Ramon y Cajal, Madrid, 28034, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|National Taiwan University Hospital, Taipei, 10002, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Guys and St Thomas NHS Foundation Trust, Guys Hospital, London, SE1 9RT, United Kingdom|University College London Hospitals NHS Foundation Trust, London, W1T 7HA, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,PROCEDURE: Biopsy Procedure|PROCEDURE: Biospecimen Collection|PROCEDURE: Echocardiography Test|PROCEDURE: Multigated Acquisition Scan|DRUG: Osimertinib|PROCEDURE: Radiologic Examination,ALL,"ADULT, OLDER_ADULT",PHASE2,19,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/8/16,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Anal Intraepithelial Neoplasia|High-grade Squamous Intraepithelial Lesion|HIV Infection,DRUG: imiquimod|DRUG: fluorouracil|OTHER: questionnaire administration|OTHER: laboratory biomarker analysis,ALL,"ADULT, OLDER_ADULT",PHASE3,91,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT,12/28/15,5/2/24,"UCLA CARE Center, Los Angeles, California, 90035, United States|UCSF-Mount Zion, San Francisco, California, 94115, United States|University of California, San Francisco, San Francisco, California, 94143, United States|Emory University, Atlanta, Georgia, 30303, United States|Louisiana State University Health Sciences Center - New Orleans, New Orleans, Louisiana, 70112, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|Laser Surgery Care, New York, New York, 10011, United States|Cornell Clinical Trials Unit, New York Presbyterian Hospital, New York, New York, 10065, United States|Weill Medical College of Cornell University, New York, New York, 10065, United States|Montefiore Medical Center, The Bronx, New York, 10461, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Benaroya Research Institute at Virginia Mason Medical Center, Seattle, Washington, 98101, United States|University of Puerto Rico, San Juan, 00936-3027, Puerto Rico",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Myelodysplastic Syndromes|Myeloproliferative Neoplasm,DRUG: Azacitidine Subcutaneous Injection or Intravenous Infusion|DRUG: Pevonedistat Infusion|PROCEDURE: Bone Marrow Biopsy & Aspirate,ALL,"ADULT, OLDER_ADULT",PHASE2,71,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/7/17,11/27/23,"University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|University of Kansas Cancer Center, Westwood, Kansas, 66205, United States|Memorial Sloan-Kettering, New York, New York, 10065, United States|University of Rochester Medical Center, Rochester, New York, 14642, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Taselisib,ALL,"ADULT, OLDER_ADULT",PHASE2,70,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/25/16,3/19/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Carcinoma, Squamous Cell|Head and Neck Neoplasms|Oropharyngeal Neoplasms",RADIATION: Intensity Modulated Radiotherapy (IMRT)|DRUG: Cisplatin (or alternative)|PROCEDURE: Assessment for surgical evaluation,ALL,"ADULT, OLDER_ADULT",PHASE2,195,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-12,12/14/22,"University of Florida, Gainesville, Florida, 32610, United States|University of Florida Proton Therapy Institute, Jacksonville, Florida, 32206, United States|University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, 27599, United States|Rex Healthcare, Raleigh, North Carolina, 27607, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematopoietic and Lymphoid Cell Neoplasm,PROCEDURE: Allogeneic Bone Marrow Transplantation|PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation|BIOLOGICAL: Anti-Thymocyte Globulin|DRUG: Bendamustine Hydrochloride|DRUG: Fludarabine Phosphate|BIOLOGICAL: Inotuzumab Ozogamicin|DRUG: Methotrexate|PROCEDURE: Peripheral Blood Stem Cell Transplantation|BIOLOGICAL: Rituximab|DRUG: Tacrolimus,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,27,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/29/12,6/28/23,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Adenocarcinoma|Pancreatic Neoplasms|Neoplasm, Glandular|Neoplasms|Neoplasms Pancreatic|Digestive System Neoplasm|Endocrine Gland Neoplasms|Digestive System Disease|Pancreatic Diseases|Endocrine System Diseases",DRUG: Nab-paclitaxel|DRUG: Gemcitabine|DRUG: Capecitabine|DRUG: Cisplatin|DRUG: Irinotecan|DRUG: Nab-paclitaxel|DRUG: Gemcitabine|DRUG: Capecitabine|DRUG: Cisplatin|DRUG: Irinotecan,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,48,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,6/21/18,10/3/22,"Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21231, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Female Reproductive System Neoplasm,DRUG: Hydromorphone|PROCEDURE: Laparotomy|DRUG: Liposomal Bupivacaine|OTHER: Questionnaire Administration,FEMALE,"ADULT, OLDER_ADULT",PHASE4,105,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE,7/9/20,8/8/23,"Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hepatitis B Infection|Malignant Solid Neoplasm,OTHER: Best Practice|DRUG: Entecavir|DRUG: Tenofovir Alafenamide|DRUG: Tenofovir Disoproxil Fumarate,ALL,"ADULT, OLDER_ADULT",PHASE3,4,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION,1/17/20,12/20/22,"Mercy Hospital Fort Smith, Fort Smith, Arkansas, 72903, United States|Kaiser Permanente-Anaheim, Anaheim, California, 92806, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, 94531, United States|Kaiser Permanente-Baldwin Park, Baldwin Park, California, 91706, United States|Kaiser Permanente-Bellflower, Bellflower, California, 90706, United States|Epic Care-Dublin, Dublin, California, 94568, United States|Kaiser Permanente Dublin, Dublin, California, 94568, United States|Bay Area Breast Surgeons Inc, Emeryville, California, 94608, United States|Epic Care Partners in Cancer Care, Emeryville, California, 94608, United States|Kaiser Permanente-Fontana, Fontana, California, 92335, United States|Kaiser Permanente-Fremont, Fremont, California, 94538, United States|Fresno Cancer Center, Fresno, California, 93720, United States|Kaiser Permanente-Fresno, Fresno, California, 93720, United States|Kaiser Permanente - Harbor City, Harbor City, California, 90710, United States|Kaiser Permanente-Irvine, Irvine, California, 92618, United States|Tibor Rubin VA Medical Center, Long Beach, California, 90822, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, 90027, United States|Los Angeles County-USC Medical Center, Los Angeles, California, 90033, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Kaiser Permanente West Los Angeles, Los Angeles, California, 90034, United States|Contra Costa Regional Medical Center, Martinez, California, 94553-3156, United States|Kaiser Permanente-Modesto, Modesto, California, 95356, United States|USC Norris Oncology/Hematology-Newport Beach, Newport Beach, California, 92663, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, 94609, United States|Bay Area Tumor Institute, Oakland, California, 94609, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, 94611, United States|Kaiser Permanente-Oakland, Oakland, California, 94611, United States|Kaiser Permanente-Ontario, Ontario, California, 91761, United States|Kaiser Permanente - Panorama City, Panorama City, California, 91402, United States|Keck Medical Center of USC Pasadena, Pasadena, California, 91105, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, 95670, United States|Kaiser Permanente-Redwood City, Redwood City, California, 94063, United States|Kaiser Permanente-Richmond, Richmond, California, 94801, United States|Kaiser Permanente-Riverside, Riverside, California, 92505, United States|Rohnert Park Cancer Center, Rohnert Park, California, 94928, United States|Kaiser Permanente-Roseville, Roseville, California, 95661, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, 95678, United States|Kaiser Permanente Downtown Commons, Sacramento, California, 95814, United States|Kaiser Permanente-South Sacramento, Sacramento, California, 95823, United States|South Sacramento Cancer Center, Sacramento, California, 95823, United States|Kaiser Permanente - Sacramento, Sacramento, California, 95825, United States|Kaiser Permanente-San Diego Zion, San Diego, California, 92120, United States|Kaiser Permanente-San Francisco, San Francisco, California, 94115, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, 95119, United States|Kaiser Permanente San Leandro, San Leandro, California, 94577, United States|Kaiser Permanente-San Marcos, San Marcos, California, 92078, United States|Kaiser Permanente-San Rafael, San Rafael, California, 94903, United States|Kaiser San Rafael-Gallinas, San Rafael, California, 94903, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, 95051, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, 95403, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, 94080, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, 94080, United States|Kaiser Permanente-Stockton, Stockton, California, 95210, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, 95688, United States|Kaiser Permanente-Vallejo, Vallejo, California, 94589, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, 94596, United States|Epic Care Cyberknife Center, Walnut Creek, California, 94597, United States|Kaiser Permanente-Woodland Hills, Woodland Hills, California, 91367, United States|Broward Health North, Deerfield Beach, Florida, 33064, United States|Broward Health Medical Center, Fort Lauderdale, Florida, 33316, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, 31405, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, 96813, United States|Island Urology, Honolulu, Hawaii, 96813, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, 96813, United States|Queen's Medical Center, Honolulu, Hawaii, 96813, United States|Straub Clinic and Hospital, Honolulu, Hawaii, 96813, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, 96813, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, 96817, United States|Hawaii Diagnostic Radiology Services LLC, Honolulu, Hawaii, 96817, United States|Kuakini Medical Center, Honolulu, Hawaii, 96817, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, 96817, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, 96817, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, 96819, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States|Castle Medical Center, Kailua, Hawaii, 96734, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, 96766, United States|Hawaii Cancer Care - Savio, ‘Aiea, Hawaii, 96701, United States|Pali Momi Medical Center, ‘Aiea, Hawaii, 96701, United States|Queen's Cancer Center - Pearlridge, ‘Aiea, Hawaii, 96701, United States|The Cancer Center of Hawaii-Pali Momi, ‘Aiea, Hawaii, 96701, United States|The Queen's Medical Center - West Oahu, ‘Ewa Beach, Hawaii, 96706, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, 83706, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, 83605, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, 83814, United States|Walter Knox Memorial Hospital, Emmett, Idaho, 83617, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, 83642, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, 83686, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, 83854, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, 83864, United States|Saint Anthony's Health, Alton, Illinois, 62002, United States|Rush - Copley Medical Center, Aurora, Illinois, 60504, United States|Northwestern University, Chicago, Illinois, 60611, United States|Carle on Vermilion, Danville, Illinois, 61832, United States|Carle Physician Group-Effingham, Effingham, Illinois, 62401, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, 61938, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, 62864, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|The Carle Foundation Hospital, Urbana, Illinois, 61801, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, 60560, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, 66720, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, 67801, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, 67042, United States|Central Care Cancer Center - Garden City, Garden City, Kansas, 67846, United States|Central Care Cancer Center - Great Bend, Great Bend, Kansas, 67530, United States|Cancer Center of Kansas-Independence, Independence, Kansas, 67301, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, 67068, United States|Lawrence Memorial Hospital, Lawrence, Kansas, 66044, United States|Kansas Institute of Medicine Cancer and Blood Center, Lenexa, Kansas, 66219, United States|Minimally Invasive Surgery Hospital, Lenexa, Kansas, 66219, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, 67905, United States|Cancer Center of Kansas-Manhattan, Manhattan, Kansas, 66502, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, 67460, United States|Cancer Center of Kansas - Newton, Newton, Kansas, 67114, United States|Menorah Medical Center, Overland Park, Kansas, 66209, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, 67357, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, 67124, United States|Cancer Center of Kansas - Salina, Salina, Kansas, 67401, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, 67152, United States|Associates In Womens Health, Wichita, Kansas, 67208, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, 67208, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, 67214, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, 67156, United States|Ochsner LSU Health Monroe Medical Center, Monroe, Louisiana, 71202, United States|LSU Health Sciences Center at Shreveport, Shreveport, Louisiana, 71103, United States|Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, 55337, United States|Cambridge Medical Center, Cambridge, Minnesota, 55008, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Fairview Southdale Hospital, Edina, Minnesota, 55435, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, 55369, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, 55109, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, 55109, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States|Health Partners Inc, Minneapolis, Minnesota, 55454, United States|Monticello Cancer Center, Monticello, Minnesota, 55362, United States|New Ulm Medical Center, New Ulm, Minnesota, 56073, United States|Fairview Northland Medical Center, Princeton, Minnesota, 55371, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, 55422, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|United Hospital, Saint Paul, Minnesota, 55102, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States|Lakeview Hospital, Stillwater, Minnesota, 55082, United States|Ridgeview Medical Center, Waconia, Minnesota, 55387, United States|Rice Memorial Hospital, Willmar, Minnesota, 56201, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, 55125, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, 55092, United States|University of Mississippi Medical Center, Jackson, Mississippi, 39216, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, 63011, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, 65613, United States|Cox Cancer Center Branson, Branson, Missouri, 65616, United States|Centerpoint Medical Center LLC, Independence, Missouri, 64057, United States|Freeman Health System, Joplin, Missouri, 64804, United States|Mercy Hospital Joplin, Joplin, Missouri, 64804, United States|Research Medical Center, Kansas City, Missouri, 64132, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, 65401, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, 64506, United States|Mercy Hospital Springfield, Springfield, Missouri, 65804, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Saint Louis Cancer and Breast Institute-South City, St Louis, Missouri, 63109, United States|Mercy Hospital South, St Louis, Missouri, 63128, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Mercy Hospital Washington, Washington, Missouri, 63090, United States|Community Hospital of Anaconda, Anaconda, Montana, 59711, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Bozeman Deaconess Hospital, Bozeman, Montana, 59715, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Great Falls Clinic, Great Falls, Montana, 59405, United States|Saint Peter's Community Hospital, Helena, Montana, 59601, United States|Kalispell Regional Medical Center, Kalispell, Montana, 59901, United States|Community Medical Hospital, Missoula, Montana, 59804, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, 73120, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, 97814, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, 97914, United States|Kaiser Permanente Northwest, Portland, Oregon, 97227, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, 29316, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, 29640, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, 29605, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, 29605, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, 29605, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, 29615, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, 29650, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, 29672, United States|M D Anderson Cancer Center, Houston, Texas, 77030, United States|Kaiser Permanente Washington, Seattle, Washington, 98112, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, 54017, United States|Billings Clinic-Cody, Cody, Wyoming, 82414, United States|Welch Cancer Center, Sheridan, Wyoming, 82801, United States|FHP Health Center-Guam, Tamuning, 96913, Guam",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Relapsed / Recurrent Germ Cell Tumors,DRUG: Erlotinib|DRUG: Sirolimus,ALL,"CHILD, ADULT",PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/8/14,1/27/18,"Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|UT Southwestern Medical Center/Children's Medical Center, Dallas, Texas, 75390, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Locally Advanced Malignant Solid Neoplasm,BIOLOGICAL: Pembrolizumab,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/31/19,11/8/24,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL),DRUG: SRA737,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,107,INTERVENTIONAL,Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2016-07,10/28/19,"Royal Marsden Hospital, Sutton, London, SM2 5PT, United Kingdom|Belfast City Hospital, Belfast, Northern Ireland, BT9 7AB, United Kingdom|Oxford University Hospitals, Headington, Oxford, OX3 7LE, United Kingdom|Velindre Cancer Centre - Cardiff, Cardiff, Whitchurch, CF14 2TL, United Kingdom|The Clatterbridge Cancer Centre, Bebington, Wirral, CH63 4JY, United Kingdom|Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|The Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|The Leeds Teaching Hospitals of St James University Hospital, Leeds, LS9 7TF, United Kingdom|University Hospitals of Leicester, Leicester, LE1 5WW, United Kingdom|Guy's and St. Thomas, London, SE1 9RT, United Kingdom|Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom|University College London Hospitals, London, W1T 7HA, United Kingdom|The Christie, Manchester, M20 4BX, United Kingdom|Freeman Hospital, Newcastle upon Tyne, NE7 7DN, United Kingdom|Sheffield Teaching Hospitals, Sheffield, S10 2SJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Advanced Solid Tumor, Adult",DRUG: RP-3500 (camonsertib),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,156,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/21/21,11/13/24,"Participating Site #1018, Phoenix, Arizona, 97401, United States|Participating Site #1025, San Francisco, California, 94158, United States|Participating Site #1028, Aurora, Colorado, 80012, United States|Participating Site #1012, New Haven, Connecticut, 06511, United States|Participating Site #1017, Jacksonville, Florida, 32224, United States|Participating Site #1009, Baltimore, Maryland, 21205, United States|Participating Site #1015, Ann Arbor, Michigan, 48109, United States|Participating Site # 1016, Rochester, Minnesota, 55905, United States|Participating Site #1026, New York, New York, 10029, United States|Participating Site # 1008, New York, New York, 10032, United States|Participating Site #1029, Eugene, Oregon, 97401, United States|Participating Site # 1001, Houston, Texas, 77030, United States|Participating Site # 1013, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Gastrinoma|Glucagonoma|Insulinoma|Metastatic Gastrointestinal Carcinoid Tumor|Pancreatic Polypeptide Tumor|Pulmonary Carcinoid Tumor|Recurrent Gastrointestinal Carcinoid Tumor|Recurrent Islet Cell Carcinoma|Somatostatinoma,DRUG: regorafenib|OTHER: laboratory biomarker analysis,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/16/16,8/20/20,"Mayo Clinic in Arizona, Scottsdale, Arizona, 85259, United States|USC Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, 92663, United States|USC Norris Oncology Hematology-Newport Beach, Newport Beach, California, 92663, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Cancer|Ovarian Neoplasms,DRUG: Atezolizumab|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Bevacizumab,FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,18,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/19/18,7/20/20,"Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, 21287, United States|Duke Cancer Institute, Durham, North Carolina, 27710, United States|University of Virginia, Charlottesville, Virginia, 22908, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Prostatic Neoplasms|Prostate Cancer,DRUG: 18F DCFBC|DRUG: Sodium (Na)18F positron emission tomography (PET)/computed tomography (CT),MALE,"ADULT, OLDER_ADULT",EARLY_PHASE1,116,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC,7/12/14,1/11/18,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Neoplasms|Triple-Negative Breast Cancer,DRUG: PF-06647263|DRUG: PF-06647263,ALL,"ADULT, OLDER_ADULT",PHASE1,60,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/9/14,5/10/17,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Brigham & Women's Hospital (BWH), Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Comprehensive Cancer Centers Of Nevada, Las Vegas, Nevada, 89169, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Tennessee Oncology, PLLC, Nashville, Tennessee, 37203, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Huntsman Cancer Hospital / University of Utah, Salt Lake City, Utah, 84112, United States|Huntsman Cancer Institute-University of Utah, Salt Lake City, Utah, 84112, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Glioblastoma|Glioblastoma Multiforme|Gliosarcoma|Brain Neoplasms|Central Nervous System Neoplasms,DRUG: topotecan|DRUG: pazopanib,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/10/15,9/12/19,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Prostatic Neoplasms|Prostate Cancer,BIOLOGICAL: Autologus elutriated monocyte placebo vaccine|BIOLOGICAL: Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine,MALE,"ADULT, OLDER_ADULT",PHASE2,7,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT,7/10/15,2/13/20,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Non-small Cell Lung Cancer|Lung Cancer|Advanced Malignancies|Carcinoma,DRUG: Brigatinib|DRUG: Crizotinib,ALL,"ADULT, OLDER_ADULT",PHASE3,275,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,5/26/16,1/29/21,"USOR - Arizona Oncology Associates - Sedona, Sedona, Arizona, 86336, United States|Kaiser Permanente Bellflower Medical Offices, Bellflower, California, 90706, United States|University of Colorado Cancer Center, Aurora, Colorado, 80045, United States|Rocky Mountain Cancer Centers - Boulder, Boulder, Colorado, 80303-1385, United States|Sylvester Comprehensive Cancer Center, Deerfield Beach, Florida, 33442, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Minnesota Oncology, Coon Rapids, Minnesota, 55433, United States|Montefiore Medical Center, The Bronx, New York, 10461, United States|Oncology Hematology Care - Blue Ash, Cincinnati, Ohio, 45242-5665, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Virginia Cancer Specialists - Fairfax Office, Fairfax, Virginia, 22031, United States|Saint George Hospital, Kogarah, New South Wales, 2217, Australia|Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia|Monash Medical Centre, Bentleigh East, Victoria, 3165, Australia|Saint Vincent's Hospital Melbourne, Fitzroy, Victoria, 3065, Australia|Universitatsklinium St. Polten, Sankt Pölten, Lower Austria, 3100, Austria|Otto-Wagner-Spital Baumgartner Hohe, Vienna, 1140, Austria|Princess Margaret Cancer Centre, Toronto, Ontario, M5G 2M9, Canada|Odense University Hospital, Odense C, 5000, Denmark|Hopital Albert Michallon, Grenoble, Auvergne-Rhône-Alpes, 38043, France|Centre Leon Berard, Lyon, Auvergne-Rhône-Alpes, 69008, France|Centre de Lutte Contre le Cancer Francois Baclesse, Caen, Basse-normandie, 14076, France|Hopital Charles Nicolle, Rouen, Haute-normandie, 76041, France|Centre Hospitalier Universitaire Hopital Nord, Marseille, Provence-Alpes-Côte d'Azur Region, 13915, France|Centre Hospitalier Intercommunal de Creteil, Créteil, Île-de-France Region, 94010, France|Hopital Tenon, Paris, Île-de-France Region, 75020, France|Universitatsklinik Freiburg, Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany|Thoraxklinik Heidelberg gGmbH, Heidelberg, Baden-Wurttemberg, 69126, Germany|Pius Hospital Oldenburg, Oldenburg, Lower Saxony, 26121, Germany|Kliniken der Stadt Koeln gGmbH - Krankenhaus Merheim, Cologne, North Rhine-Westphalia, 51109, Germany|Evangelische Lungenklinik Berlin, Berlin, 13125, Germany|Studiengesellschaft Haemato-Onkologie Hamburg Prof. Laack und Partner, Hamburg, 20251, Germany|Tuen Mun Hospital, Tuenmen, New Territories, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Queen Elizabeth Hospital, Kowloon, 150001, Hong Kong|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Forli-cesena, 47014, Italy|Azienda Ospedaliera San Gerardo di Monza, Monza, Monza E Brianza, 20052, Italy|Centro di Riferimento Oncologico di Aviano, Aviano, Pordenone, 33081, Italy|Azienda Ospedaliera San Giuseppe Moscati, Avellino, 83100, Italy|Istituto Oncologico di Bari Giovanni Paolo II, Bari, 70124, Italy|Azienda Ospedaliero Universitaria di Bologna Policlinico Sant'Orsola-Malpighi, Bologna, 40138, Italy|Istituto Scientifico Universitario San Raffaele, Milan, 20132, Italy|Istituto Europeo di Oncologia, Milan, 20141, Italy|Istituto Tumori Napoli Fondazione G. Pascale, Napoli, 80131, Italy|Azienda Ospedaliero Universitaria Maggiore della Carita, Novara, 28100, Italy|Azienda Ospedaliera di Perugia - Ospedale S. Maria della Misericordia, Perugia, 06132, Italy|Azienda Unita Sanitaria Locale di Ravenna, Ravenna, 48121, Italy|Policlinico Universitario Campus Bio-Medico, Roma, 00128, Italy|Centre Hospitalier de Luxembourg - Hopital Municipal, Luxembourg, 1210, Luxembourg|Amphia Ziekenhuis - Locatie Langendijk Breda, Breda, North Brabant, 4818 CK, Netherlands|Antoni van Leeuwenhoekziekenhuis, Amsterdam, North Holland, 1066 CX, Netherlands|Isala Klinieken, Zwolle, Overijssel, 8025 AB, Netherlands|Universitair Medisch Centrum Groningen, Groningen, 9713 GZ, Netherlands|Radiumhospitalet, Oslo, 0379, Norway|National University Hospital, Singapore, 119228, Singapore|National Cancer Centre Singapore, Singapore, 169610, Singapore|OncoCare Cancer Centre, Singapore, 258499, Singapore|National Cancer Center, Goyang-si, Gyeonggi-do, 10408, South Korea|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, 13620, South Korea|Chungbuk National University Hospital, Cheongju-si, North Chungcheong, 28644, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|The Catholic University of Korea, Seoul, 06591, South Korea|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Universitario Puerta de Hierro - Majadahonda, Majadahonda, Madrid, 28222, Spain|Hospital Universitario Central de Asturias, Oviedo, Principality of Asturias, 33011, Spain|Hospital Teresa Herrera - Materno Infantil, A Coruña, 15006, Spain|Hospital General Universitario de Alicante, Alicante, 03010, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Ramon Y Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Regional Universitario Carlos Haya Malaga Instituto de Neurociencias Clinicas, Málaga, 29010, Spain|Hospital Universitario Marques de Valdecilla, Santander, 39008, Spain|Hospital Universitario Virgen del Rocio, Seville, 41013, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Karolinska Universitetssjukhuset, Stockholm, 171 76, Sweden|University Hospital Zurich, Zurich, 8091, Switzerland|National Cheng Kung University, Tainan, Taipei, 70403, Taiwan|China Medical University Hospital, Taichung, 404, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|Leicester Royal Infirmary, Leicester, England, LE1 5WW, United Kingdom|University College London, London, England, NW1 2PG, United Kingdom|Guy's and Saint Thomas' NHS Foundation Trust, London, England, SE1 9RT, United Kingdom|Royal Marsden NHS Trust, London, England, SW3 6JJ, United Kingdom|Maidstone Hospital, Maidstone, England, ME16 9QQ, United Kingdom|The Christie NHS Foundation Trust, Manchester, England, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Prostatic Neoplasms, Castration-Resistant",BIOLOGICAL: BMS-986218|DRUG: Docetaxel|BIOLOGICAL: Nivolumab,MALE,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2/14/22,12/6/23,"Arizona Oncology - Tucson - Wilmot Road Location, Tucson, Arizona, 85711-2701, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, 90027-5969, United States|Rocky Mountain Cancer Centers - Littleton, Littleton, Colorado, 80120-4413, United States|Yale School Of Medicine, New Haven, Connecticut, 06510-3206, United States|Medical Oncology Hematology Consultants - Newark, Newark, Delaware, 19713-2055, United States|The Winship Cancer Institute of Emory University, Atlanta, Georgia, 30322-1013, United States|Local Institution - 0004, Marietta, Georgia, 30060, United States|The University of Chicago Medical Center - Duchossois Center for Advanced Medicine, Chicago, Illinois, 60637-1426, United States|University Of Iowa Hospitals And Clinics, Iowa City, Iowa, 52242, United States|The Johns Hopkins Hospital, Baltimore, Maryland, 21287, United States|Washington University School of Medicine in St. Louis, St Louis, Missouri, 63110-1010, United States|Local Institution - 0006, New York, New York, 10032-3729, United States|Duke Cancer Institute, Durham, North Carolina, 27710, United States|Oncology Hematology Care, Inc. - Eastgate, Cincinnati, Ohio, 45245-1995, United States|Willamette Valley Cancer Institute, Eugene, Oregon, 97477, United States|Texas Oncology-Beaumont Mamie McFaddin Ward Cancer Center, Beaumont, Texas, 77702, United States|Texas Oncology, Bedford, Texas, 76022-6920, United States|Texas Oncology - Denton North, Denton, Texas, 76201-4315, United States|Texas Oncology, Flower Mound, Texas, 75028, United States|Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas, 76104-2150, United States|The University of Texas - MD Anderson Cancer Center - Genitourinary (GU) Cancer Center, Houston, Texas, 77030-4004, United States|Texas Oncology - McKinney, McKinney, Texas, 75071-8106, United States|Texas Oncology- Tyler, Tyler, Texas, 75702-8363, United States|Local Institution - 0056, Hampton, Virginia, 23666-5963, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Local Institution - 0003, Toulouse, 31100, France|Local Institution - 0037, Milan, MI, 20162, Italy|Local Institution - 0021, Rozzano, MI, 20089, Italy|Local Institution - 0071, Meldola, 47014, Italy|Local Institution - 0016, Modena, 41124, Italy|Local Institution - 0029, Pozzuoli, 80078, Italy",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Malignant Glioma|Recurrent Brain Neoplasm|Recurrent Childhood Central Nervous System Neoplasm|Recurrent Childhood Glioblastoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm|WHO Grade 3 Glioma,OTHER: Pharmacological Study|DRUG: Selinexor,ALL,"CHILD, ADULT",PHASE1,59,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/30/15,12/31/24,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, 30329, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States|Children's Hospital of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Steroid-Refractory Pneumonitis,BIOLOGICAL: Infliximab|BIOLOGICAL: Intravenous Immunoglobulin Therapy|DRUG: Prednisone|DRUG: Methylprednisolone,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/7/21,12/21/23,"Northwestern University, Chicago, Illinois, 60611, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, 21287, United States|Bronson Battle Creek, Battle Creek, Michigan, 49017, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, 49503, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, 49503, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Mercy Health Mercy Campus, Muskegon, Michigan, 49444, United States|Lakeland Hospital Niles, Niles, Michigan, 49120, United States|Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, 49444, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, 49677, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, 49085, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, 49085, United States|Munson Medical Center, Traverse City, Michigan, 49684, United States|Metro Health Hospital, Wyoming, Michigan, 49519, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|VCU Massey Cancer Center at Stony Point, Richmond, Virginia, 23235, United States|Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia, 23298, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Prostate Cancer|Prostatic Neoplasm|Prostatic Neoplasms, Castration-Resistant|Prostatic Neoplasm of Uncertain Behavior",DRUG: Ga-68 PSMA-HBED-CC PET,MALE,"ADULT, OLDER_ADULT",PHASE2|PHASE3,22,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,2/16/18,7/22/21,"University of Iowa Hospitals and Clinics, Iowa City, Iowa, 52242, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Capivasertib,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/31/16,3/19/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Lung Neoplasms|Lung Cancer,DRUG: OTL38 for Injection|DEVICE: Near infrared camera imaging system,ALL,"ADULT, OLDER_ADULT",PHASE3,112,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC,3/26/20,11/1/21,"Stamford, Stamford, Connecticut, 06904, United States|University of Iowa, Iowa City, Iowa, 55242, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, 15212, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15232, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|University of Virginia, Charlottesville, Virginia, 22908, United States|Swedish Hospital, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pediatric Patients With Solid Tumors,PROCEDURE: Sentinel Lymph Node Biopsy|DRUG: indocyanine green (ICG),ALL,"CHILD, ADULT",PHASE2|PHASE3,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,9/13/16,9/2/22,"Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|St. Jude's Children's Research Hospital, Memphis, Tennessee, 38105, United States|Texas Children's Hospital, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Ovarian Neoplasms|Ovarian Cancer,DRUG: Niraparib,FEMALE,"ADULT, OLDER_ADULT",PHASE2,463,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/23/15,8/23/21,"GSK Investigational Site, Chandler, Arizona, 85224, United States|GSK Investigational Site, Phoenix, Arizona, 85016, United States|GSK Investigational Site, Tucson, Arizona, 85710, United States|GSK Investigational Site, Burbank, California, 91505, United States|GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Los Angeles, California, 90027, United States|GSK Investigational Site, Los Angeles, California, 90048, United States|GSK Investigational Site, San Francisco, California, 94118, United States|GSK Investigational Site, Santa Barbara, California, 93105, United States|GSK Investigational Site, Stanford, California, 94305-5317, United States|GSK Investigational Site, New Haven, Connecticut, 06510, United States|GSK Investigational Site, Tampa, Florida, 33612, United States|GSK Investigational Site, West Palm Beach, Florida, 33401, United States|GSK Investigational Site, Atlanta, Georgia, 30342, United States|GSK Investigational Site, Chicago, Illinois, 60611, United States|GSK Investigational Site, Chicago, Illinois, 60637, United States|GSK Investigational Site, Indianapolis, Indiana, 46260, United States|GSK Investigational Site, Indianapolis, Indiana, 54244, United States|GSK Investigational Site, Covington, Louisiana, 70433, United States|GSK Investigational Site, New Orleans, Louisiana, 70121, United States|GSK Investigational Site, Baltimore, Maryland, 21202, United States|GSK Investigational Site, Boston, Massachusetts, 02115, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Burlington, Massachusetts, 01805, United States|GSK Investigational Site, Ann Arbor, Michigan, 48109, United States|GSK Investigational Site, Minneapolis, Minnesota, 55455, United States|GSK Investigational Site, Rochester, Minnesota, 55905, United States|GSK Investigational Site, Springfield, Missouri, 65804, United States|GSK Investigational Site, Hackensack, New Jersey, 07601, United States|GSK Investigational Site, Morristown, New Jersey, 07962-1956, United States|GSK Investigational Site, East Setauket, New York, 11733, United States|GSK Investigational Site, Jamaica, New York, 11432, United States|GSK Investigational Site, Lake Success, New York, 11042, United States|GSK Investigational Site, New York, New York, 10065, United States|GSK Investigational Site, Durham, North Carolina, 27710, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73104, United States|GSK Investigational Site, Medford, Oregon, 97504-8342, United States|GSK Investigational Site, Wynnewood, Pennsylvania, 19096, United States|GSK Investigational Site, Providence, Rhode Island, 02905, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Austin, Texas, 78731, United States|GSK Investigational Site, Dallas, Texas, 75390, United States|GSK Investigational Site, Fort Worth, Texas, 76104, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, The Woodlands, Texas, 77380, United States|GSK Investigational Site, Tyler, Texas, 75702, United States|GSK Investigational Site, Spokane, Washington, 99202, United States|GSK Investigational Site, Tacoma, Washington, 98405, United States|GSK Investigational Site, Calgary, Alberta, T2N 4N2, Canada|GSK Investigational Site, Toronto, Ontario, M5G 2M9, Canada|GSK Investigational Site, Montreal, Quebec, H1T 2M4, Canada|GSK Investigational Site, Montreal, Quebec, H2L 4M1, Canada|GSK Investigational Site, Montreal, Quebec, H3T 1E2, Canada|GSK Investigational Site, Montreal, Quebec, H4A 3J1, Canada|GSK Investigational Site, Sherbrooke, Quebec, J1H 5N4, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Crizotinib,ALL,"ADULT, OLDER_ADULT",PHASE2,5,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/12/15,3/17/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Recurrent Malignant Solid Neoplasm|Recurrent Osteosarcoma|Refractory Malignant Solid Neoplasm|Refractory Osteosarcoma,OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Pepinemab|OTHER: Pharmacological Study,ALL,"CHILD, ADULT",PHASE1|PHASE2,26,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,1/31/18,6/30/24,"Children's Hospital of Alabama, Birmingham, Alabama, 35233, United States|Children's Hospital Los Angeles, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Yale University, New Haven, Connecticut, 06520, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, 30322, United States|Lurie Children's Hospital-Chicago, Chicago, Illinois, 60611, United States|Riley Hospital for Children, Indianapolis, Indiana, 46202, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, 21287, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|C S Mott Children's Hospital, Ann Arbor, Michigan, 48109, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, 10032, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, 15224, United States|Saint Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, 77030, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|Children's Hospital of The King's Daughters, Norfolk, Virginia, 23507, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neoplasms|Neoplasm Metastasis|Melanoma|Carcinoma, Non-Small-Cell Lung|Colorectal Neoplasms",DRUG: LY3009120 capsule,ALL,"ADULT, OLDER_ADULT",PHASE1,51,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/26/13,10/5/18,"Pinnacle Oncology Hematology, Scottsdale, Arizona, 85258, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Nedlands, 6009, Australia|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Villejuif, 94805, France|For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Barcelona, 08035, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Defactinib Hydrochloride,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/19/15,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Trametinib Dimethyl Sulfoxide,ALL,"ADULT, OLDER_ADULT",PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/25/16,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Binimetinib,ALL,"ADULT, OLDER_ADULT",PHASE2,53,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/31/16,3/19/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Trametinib Dimethyl Sulfoxide,ALL,"ADULT, OLDER_ADULT",PHASE2,50,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/25/16,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Afatinib Dimaleate,ALL,"ADULT, OLDER_ADULT",PHASE2,40,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/12/15,3/17/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: PI3K-beta Inhibitor GSK2636771,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/21/16,12/31/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Acute Myeloid Leukemia,DRUG: Cladribine|DRUG: Cytarabine|DRUG: Gemtuzumab Ozogamicin|BIOLOGICAL: Recombinant Granulocyte Colony-Stimulating Factor|OTHER: Laboratory Biomarker Analysis|DRUG: Mitoxantrone Hydrochloride,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,66,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/14/18,11/1/21,"Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Breast Neoplasm Female|Breast Cancer,DRUG: Aminolevulinic Acid Hydrochloride|DEVICE: Eagle V1.2 Imaging System|DRUG: Placebo,FEMALE,"ADULT, OLDER_ADULT",PHASE3,57,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",4/27/21,12/20/24,"Stamford Hospital, Stamford, Connecticut, 06902, United States|BayCare Morton Plant Hospital, Clearwater, Florida, 33756, United States|University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, 33136, United States|Orlando Health, Inc., Orlando, Florida, 32806, United States|BayCare St. Joseph's Hospital, Tampa, Florida, 33607, United States|Montefiore Medical Center, The Bronx, New York, 10467, United States|Aurora St. Luke's Medical Centre, Milwaukee, Wisconsin, 53215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Papillomavirus Infections|Oropharyngeal Neoplasms,BIOLOGICAL: E7 T-Cell Receptor (TCR),ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,7/6/20,7/15/20,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: PI3K-beta Inhibitor GSK2636771,ALL,"ADULT, OLDER_ADULT",PHASE2,24,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/5/16,12/31/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Suspected Central Nervous System Tumors,DRUG: Indocyanine Green (ICG)|RADIATION: Intraoperative near-infrared (NIR),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,336,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,6/10/15,4/2/20,"Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Triple Negative Breast Neoplasms,DRUG: Docetaxel|DRUG: Carboplatin|PROCEDURE: FDG-PET/MR,FEMALE,"ADULT, OLDER_ADULT",PHASE2,148,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/7/14,12/31/21,"Washington University School of Medicine, St Louis, Missouri, 63110, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Esophageal Cancer,DRUG: Docetaxel|DRUG: 5-FU|RADIATION: Radiotherapy|PROCEDURE: Esophagectomy|DRUG: Dexamethasone,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2010-10,6/14/20,"University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified|Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified",PROCEDURE: Biospecimen Collection|PROCEDURE: Bone Marrow Aspiration|PROCEDURE: Bone Marrow Biopsy|DRUG: Hydroxyurea|BIOLOGICAL: Luspatercept|OTHER: Questionnaire Administration,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2/20/23,6/17/23,"Mayo Clinic Hospital in Arizona, Phoenix, Arizona, 85054, United States|Mayo Clinic in Florida, Jacksonville, Florida, 32224-9980, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Triple Negative Breast Neoplasms,DRUG: Bintrafusp alfa,ALL,"ADULT, OLDER_ADULT",PHASE2,11,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/12/20,7/8/22,"Medical Oncology Hematology Consultants, PA, Helen F. Graham Cancer Center, Suite 3400, Newark, Delaware, 19713-2055, United States|Mayo Clinic-Jacksonville, Jacksonville, Florida, 32224, United States|Maryland Oncology Hematology, P.A., Silver Spring, Maryland, 20904, United States|New York Oncology Hematology, P.C. - Albany, Albany, New York, 12206, United States|TheOhio State University, Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio, 43212, United States|UPMC Hillman Cancer Center - Hillman Cancer Center, Monroeville, Pennsylvania, 15146, United States|Charleston Hematology Oncology Associates, PA, Charleston, South Carolina, 29414, United States|The West Clinic, Germantown, Tennessee, 38138, United States|Texas Oncology, P.A. - Austin - Austin Central Cancer Center, Austin, Texas, 78731, United States|Texas Oncology, P.A. - Medical City Dallas - Pediatric Hematology/Oncology, Dallas, Texas, 75230, United States|Texas Oncology, P.A. - Plano, Plano, Texas, 75075, United States|Texas Oncology-San Antonio Stone Oak, San Antonio, Texas, 78240, United States|Texas Oncology, P.A. - Tyler, Tyler, Texas, 75702, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|Virginia Oncology Associates - Hampton, Norfolk, Virginia, 23502, United States|Universitair Ziekenhuis Brussel - Geriatrie, Brussels, Belgium|UZ Leuven, Leuven, Belgium|AZ Sint-Maarten - PARENT, Mechelen, Belgium|Centre François Baclesse - Pathologies Gynecologiques, Caen, France|Centre Léon Bérard, Lyon, France|Hôpital Privé du Confluent SAS, Nantes, France|Groupe Hospitalier Diaconesses - Hôpital De La Croix Saint Simon - service d'oncologie medicale, Paris, France|CARIO - Centre Armoricain de Radiothérapie, Imagerie médicale et Oncologie, Plérin, France|Institut Curie - Centre René Huguenin - Service d'Oncologie Médicale, Saint-Cloud, France|IEO Istituto Europeo di Oncologia, Milan, Italy|Ospedale San Raffaele, Milan, Italy|Istituto Nazionale Tumori Fondazione G. Pascale - Dipartimento di Senologia, Napoli, Italy|IOV - Istituto Oncologico Veneto IRCCS - Oncologia Medica 2, Padua, Italy|Azienda Ospedaliero Universitaria Pisana - U.O. Oncologia II, Pisa, Italy|Policlinico Universitario Agostino Gemelli - UOC Oncologia Medica, Roma, Italy|Istituto Clinico Humanitas, Rozzano, Italy|SBIH of Arkhangelsk region ""Arkhangelsk Clinical Oncological Dispensary"" - Chemotherapy, Arkhangelsk, Russia|SBIH "" Clinical Oncological Dispensary # 1"" - Location, Krasnodar, Russia|SBIH "" Clinical Oncological Dispensary 1"" - Location, Krasnodar, Russia|FSBSI ""Russian Oncological Scientific Center n.a. N.N. Blokhin"" - Moscow Cancer Research Centre, Moscow, Russia|BHI of Omsk region ""Clinical Oncology Dispensary"", Omsk, Russia|LLC ""ClinicaUZI4D"", Pyatigorsk, Russia|FSBI ""Clinical Research and Practical Center for specialized medical care (oncology)"", Saint Petersburg, Russia|Tomsk Research Instutite of Oncology - Chemotherapy, Tomsk, Russia|SBIH Republican Clinical Oncological Dispensary of the MoH of Republic Bashkortostan, Ufa, Russia|Hospital Universitario Reina Sofia - Dept of Oncology, Córdoba, Spain|Hospital General Universitario Gregorio Marañon - Servicio de Oncologia Medica, Madrid, Spain|Hospital Ruber Internacional - Servicio de Oncologia, Madrid, Spain|Hospital Universitario Ramon y Cajal - Servicio de Oncologia, Madrid, Spain|Hospital Universitario Virgen del Rocio - Servicio de Oncologia, Seville, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,BIOLOGICAL: Trastuzumab Emtansine,ALL,"ADULT, OLDER_ADULT",PHASE2,38,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/12/15,3/19/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hormone-Resistant Prostate Cancer|Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Soft Tissues|Metastatic Prostate Carcinoma|Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer,BIOLOGICAL: Pembrolizumab|BIOLOGICAL: pTVG-HP Plasmid DNA Vaccine,MALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,66,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/1/15,7/27/23,"University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, 53792, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors (Phase 1)|Relapsed/Recurrent GBM (Phase 2),DRUG: USL311|DRUG: USL311|DRUG: USL311|DRUG: Lomustine,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,26,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2016-04,7/1/20,"Washington University, St Louis, Missouri, 63110, United States|University of Oklahoma Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|University of Texas/MD Anderson Cancer Center, Houston, Texas, 77030, United States|South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, 78229, United States|UT Health San Antonio Cancer Center, San Antonio, Texas, 78229, United States|South Texas Accelerated Research Therapeutics (START) - FJD, Madrid, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumor Spine Metastases,"RADIATION: Post-operative, Stereotactic Body Radiation Therapy (SBRT)",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/20/13,7/27/18,"The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, 21287, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Solid Tumors|Relapsed/Refractory Sarcomas,DRUG: Vorinostat and Etoposide,ALL,"CHILD, ADULT",PHASE1|PHASE2,27,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/9/11,12/8/20,"Phoenix Children'S Hospital, Phoenix, Arizona, 85016, United States|Children's Hospital Colorado, Aurora, Colorado, 80045, United States|Arnold Palmer Hospital for Children/MD Anderson Cancer Center Orlando, Orlando, Florida, 32806, United States|All Children's Hospital, St. Petersburg, Florida, 33701, United States|John Hopkins Medical Center, Baltimore, Maryland, 21287, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Children's Mercy Hospital & Clinics, Kansas City, Missouri, 64108, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Pennsylvania State University College of Medicine, Hershey, Pennsylvania, 17110, United States|Md Anderson Cancer Center, Houston, Texas, 77030, United States|Alberta Children'S Hospital, Calgary, Alberta, T2N 1N4, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Human Papilloma Virus|Cervical Cancer|Oropharyngeal Cancer|Anal Cancer|Vaginal or Penile Cancer,DRUG: M7824,ALL,"ADULT, OLDER_ADULT",PHASE2,57,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/27/18,12/31/22,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Crizotinib,ALL,"ADULT, OLDER_ADULT",PHASE2,4,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/12/15,3/17/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Cancer|Breast Neoplasms,BIOLOGICAL: P10s-PADRE/ MONTANIDE™ ISA 51 VG|DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: Docetaxel,FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,58,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/14/15,1/3/23,"Highlands Oncology Group, Fayetteville, Arkansas, 72703, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Locally Advanced Solid Tumor,DRUG: OBI-999|DRUG: OBI-999,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,44,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/25/19,10/27/23,"Scripps MD Anderson Cancer Center, La Jolla, California, 92037, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|West Cancer Center, Germantown, Tennessee, 38138, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Solid Tumor|Lymphoma,DRUG: Milademetan|DRUG: Milademetan,ALL,"ADULT, OLDER_ADULT",PHASE1,107,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/11/13,12/3/20,"Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Columbia University College of Physicians and Surgeons, New York, New York, 10032, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|UT MD Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Melanoma|Metastatic Melanoma|Solid Tumor|Neoplasm,DRUG: MLN2480,ALL,"ADULT, OLDER_ADULT",PHASE1,149,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/15/11,10/16/18,"San Francisco, California, United States|Denver, Colorado, United States|Augusta, Georgia, United States|Indianapolis, Indiana, United States|New York, New York, United States|Easton, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|San Antonio, Texas, United States|Lakewood, Washington, United States|Bristol, Avon, United Kingdom|Cambridge, Cambridgeshire, United Kingdom|Chelmsford, Essex, United Kingdom|London, Greater London, United Kingdom|Manchester, Greater Manchester, United Kingdom|Oxford, Oxfordshire, United Kingdom|Newcastle upon Tyne, Tyne & Wear, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Advanced Solid Tumors, Neoplasms, Advanced Solid",DRUG: Pevonedistat|DRUG: [14C]-Pevonedistat|DRUG: Docetaxel|DRUG: Carboplatin|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1,8,INTERVENTIONAL,Allocation: |Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER,5/11/17,11/5/18,"Magyar Honvédség Egészségügyi Központ Onkológiai osztály, Budapest, 1062, Hungary|PRA Magyarország Kft. Fázis I-es Klinikai Farmakológiai Vizsgálóhely, Budapest, 1076, Hungary",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Advanced or Metastatic Solid Tumors|FGFR Mutations|FGFR Translocations,DRUG: Pemigatinib,ALL,"ADULT, OLDER_ADULT",PHASE2,1,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/31/19,6/12/20,"Compassionate Cancer Care Medical Group, Fountain Valley, California, 92708, United States|Ocala Oncology Center, Ocala, Florida, 34474, United States|Hawaii Cancer Care, Honolulu, Hawaii, 96813, United States|Illinois Cancer Care, Peoria, Illinois, 61615, United States|FMH James M Stockman Cancer Institute, Frederick, Maryland, 21702, United States|New Jersey Cancer Care and Blood Disorders, Belleville, New Jersey, 07109, United States|TriHealth, Cincinnati, Ohio, 45220, United States|Sanford Cancer Center, Sioux Falls, South Dakota, 51704, United States|Mary Crowley Cancer Center, Dallas, Texas, 75230, United States|Oncology Consultants, Houston, Texas, 77030, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Choriocarcinoma|FIGO Stage I Gestational Trophoblastic Tumor|FIGO Stage II Gestational Trophoblastic Tumor|FIGO Stage III Gestational Trophoblastic Tumor|Hydatidiform Mole,BIOLOGICAL: Dactinomycin|DRUG: Leucovorin Calcium|DRUG: Methotrexate|OTHER: Quality-of-Life Assessment,FEMALE,"ADULT, OLDER_ADULT",PHASE3,57,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/18/12,7/17/20,"Anchorage Associates in Radiation Medicine, Anchorage, Alaska, 98508, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, 99504, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, 99508, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, 99508, United States|Alaska Regional Hospital, Anchorage, Alaska, 99508, United States|Alaska Women's Cancer Care, Anchorage, Alaska, 99508, United States|Anchorage Oncology Centre, Anchorage, Alaska, 99508, United States|Katmai Oncology Group, Anchorage, Alaska, 99508, United States|Providence Alaska Medical Center, Anchorage, Alaska, 99508, United States|Cancer Center at Saint Joseph's, Phoenix, Arizona, 85004, United States|Saint Joseph's Hospital and Medical Center, Phoenix, Arizona, 85013, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, 91505, United States|UC San Diego Moores Cancer Center, La Jolla, California, 92093, United States|Loma Linda University Medical Center, Loma Linda, California, 92354, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, 90027, United States|Hartford Hospital, Hartford, Connecticut, 06102, United States|The Hospital of Central Connecticut, New Britain, Connecticut, 06050, United States|Northside Hospital, Atlanta, Georgia, 30342, United States|Augusta University Medical Center, Augusta, Georgia, 30912, United States|Northside Hospital-Forsyth, Cumming, Georgia, 30041, United States|Dekalb Medical Center, Decatur, Georgia, 30033, United States|Northeast Georgia Medical Center-Gainesville, Gainesville, Georgia, 30501, United States|Low Country Cancer Care, Savannah, Georgia, 31404, United States|Memorial Health University Medical Center, Savannah, Georgia, 31404, United States|Summit Cancer Care-Memorial, Savannah, Georgia, 31404, United States|Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, 31405, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, 83712, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, 83814, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, 83619, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, 83642, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, 83686, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, 83854, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, 83864, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, 83301, United States|Rush - Copley Medical Center, Aurora, Illinois, 60504, United States|Northwestern University, Chicago, Illinois, 60611, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Carle on Vermilion, Danville, Illinois, 61832, United States|Carle Physician Group-Effingham, Effingham, Illinois, 62401, United States|NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, 60201, United States|NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, 60026, United States|NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, 60035, United States|Sudarshan K Sharma MD Limited-Gynecologic Oncology, Hinsdale, Illinois, 60521, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, 61938, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, 62864, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, 60451, United States|North Shore Medical Center, Skokie, Illinois, 60076, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|The Carle Foundation Hospital, Urbana, Illinois, 61801, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, 60560, United States|Elkhart Clinic, Elkhart, Indiana, 46514-2098, United States|Michiana Hematology Oncology PC-Elkhart, Elkhart, Indiana, 46514, United States|Elkhart General Hospital, Elkhart, Indiana, 46515, United States|Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, 46260, United States|Community Howard Regional Health, Kokomo, Indiana, 46904, United States|IU Health La Porte Hospital, La Porte, Indiana, 46350, United States|Franciscan Saint Anthony Health-Michigan City, Michigan City, Indiana, 46360, United States|Woodland Cancer Care Center, Michigan City, Indiana, 46360, United States|Cancer Care Partners LLC, Mishawaka, Indiana, 46545, United States|Memorial Regional Cancer Center Day Road, Mishawaka, Indiana, 46545, United States|Michiana Hematology Oncology PC-Mishawaka, Mishawaka, Indiana, 46545, United States|Saint Joseph Regional Medical Center-Mishawaka, Mishawaka, Indiana, 46545, United States|Michiana Hematology Oncology PC-Plymouth, Plymouth, Indiana, 46563, United States|Memorial Hospital of South Bend, South Bend, Indiana, 46601, United States|Michiana Hematology Oncology PC-South Bend, South Bend, Indiana, 46601, United States|South Bend Clinic, South Bend, Indiana, 46617, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, 46628, United States|Michiana Hematology Oncology PC-Westville, Westville, Indiana, 46391, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, 51101, United States|Mercy Medical Center-Sioux City, Sioux City, Iowa, 51102, United States|Saint Luke's Regional Medical Center, Sioux City, Iowa, 51104, United States|Saint Elizabeth Healthcare Edgewood, Edgewood, Kentucky, 41017, United States|Maine Medical Center-Bramhall Campus, Portland, Maine, 04102, United States|Maine Medical Center- Scarborough Campus, Scarborough, Maine, 04074, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, 20889-5600, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Bronson Battle Creek, Battle Creek, Michigan, 49017, United States|Cancer Research Consortium of West Michigan NCORP, Grand Rapids, Michigan, 49503, United States|Mercy Health Saint Mary's, Grand Rapids, Michigan, 49503, United States|Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, 49503, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Borgess Medical Center, Kalamazoo, Michigan, 49048, United States|Monroe Cancer Center, Monroe, Michigan, 48162, United States|Mercy Health Mercy Campus, Muskegon, Michigan, 49444, United States|Lakeland Hospital Niles, Niles, Michigan, 49120, United States|Spectrum Health Reed City Hospital, Reed City, Michigan, 49677, United States|Lakeland Medical Center Saint Joseph, Saint Joseph, Michigan, 49085, United States|Marie Yeager Cancer Center, Saint Joseph, Michigan, 49085, United States|Munson Medical Center, Traverse City, Michigan, 49684, United States|Metro Health Hospital, Wyoming, Michigan, 49519, United States|Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Fairview Southdale Hospital, Edina, Minnesota, 55435, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Hutchinson Area Health Care, Hutchinson, Minnesota, 55350, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, 55109, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, 55109, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States|Health Partners Inc, Minneapolis, Minnesota, 55454, United States|New Ulm Medical Center, New Ulm, Minnesota, 56073, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, 55422, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, 55416, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|United Hospital, Saint Paul, Minnesota, 55102, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States|Lakeview Hospital, Stillwater, Minnesota, 55082, United States|Ridgeview Medical Center, Waconia, Minnesota, 55387, United States|Rice Memorial Hospital, Willmar, Minnesota, 56201, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, 55125, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, 65613, United States|Cox Cancer Center Branson, Branson, Missouri, 65616, United States|Freeman Health System, Joplin, Missouri, 64804, United States|Mercy Hospital Joplin, Joplin, Missouri, 64804, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, 65401, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States|Cancer Research for the Ozarks NCORP, Springfield, Missouri, 65804, United States|Mercy Hospital Springfield, Springfield, Missouri, 65804, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Saint Louis Cancer and Breast Institute-South City, St Louis, Missouri, 63109, United States|Barnes-Jewish Hospital, St Louis, Missouri, 63110, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Community Hospital of Anaconda, Anaconda, Montana, 59711, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Saint Vincent Healthcare, Billings, Montana, 59101, United States|Montana Cancer Consortium NCORP, Billings, Montana, 59102, United States|Bozeman Deaconess Hospital, Bozeman, Montana, 59715, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, 59701, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Great Falls Clinic, Great Falls, Montana, 59405, United States|Saint Peter's Community Hospital, Helena, Montana, 59601, United States|Kalispell Regional Medical Center, Kalispell, Montana, 59901, United States|Montana Cancer Specialists, Missoula, Montana, 59802, United States|Saint Patrick Hospital - Community Hospital, Missoula, Montana, 59802, United States|Community Medical Hospital, Missoula, Montana, 59804, United States|Women's Cancer Center of Nevada, Las Vegas, Nevada, 89106, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87102, United States|Southwest Gynecologic Oncology Associates Inc, Albuquerque, New Mexico, 87106, United States|State University of New York Downstate Medical Center, Brooklyn, New York, 11203, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, 28203, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, 27157, United States|Summa Health System - Akron Campus, Akron, Ohio, 44304, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, 45714, United States|Adena Regional Medical Center, Chillicothe, Ohio, 45601, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, 45220, United States|Bethesda North Hospital, Cincinnati, Ohio, 45242, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland, Ohio, 44111, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, 43214, United States|Riverside Methodist Hospital, Columbus, Ohio, 43214, United States|Columbus NCI Community Oncology Research Program, Columbus, Ohio, 43215, United States|Grant Medical Center, Columbus, Ohio, 43215, United States|The Mark H Zangmeister Center, Columbus, Ohio, 43219, United States|Mount Carmel Health Center West, Columbus, Ohio, 43222, United States|Doctors Hospital, Columbus, Ohio, 43228, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, 43015, United States|Delaware Radiation Oncology, Delaware, Ohio, 43015, United States|Grady Memorial Hospital, Delaware, Ohio, 43015, United States|Fairfield Medical Center, Lancaster, Ohio, 43130, United States|Lancaster Radiation Oncology, Lancaster, Ohio, 43130, United States|Marietta Memorial Hospital, Marietta, Ohio, 45750, United States|Hillcrest Hospital Cancer Center, Mayfield Heights, Ohio, 44124, United States|UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, 44060, United States|Knox Community Hospital, Mount Vernon, Ohio, 43050, United States|Licking Memorial Hospital, Newark, Ohio, 43055, United States|Newark Radiation Oncology, Newark, Ohio, 43055, United States|Southern Ohio Medical Center, Portsmouth, Ohio, 45662, United States|Springfield Regional Medical Center, Springfield, Ohio, 45505, United States|ProMedica Flower Hospital, Sylvania, Ohio, 43560, United States|Saint Ann's Hospital, Westerville, Ohio, 43081, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, 43701, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, 74146, United States|Saint Charles Health System, Bend, Oregon, 97701, United States|Clackamas Radiation Oncology Center, Clackamas, Oregon, 97015, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, 97015, United States|Bay Area Hospital, Coos Bay, Oregon, 97420, United States|Providence Newberg Medical Center, Newberg, Oregon, 97132, United States|Providence Willamette Falls Medical Center, Oregon City, Oregon, 97045, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Providence Saint Vincent Medical Center, Portland, Oregon, 97225, United States|Jefferson Abington Hospital, Abington, Pennsylvania, 19001, United States|UPMC-Heritage Valley Health System Beaver, Beaver, Pennsylvania, 15009, United States|Geisinger Medical Center, Danville, Pennsylvania, 17822, United States|UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, 15601, United States|Geisinger Medical Center-Cancer Center Hazleton, Hazleton, Pennsylvania, 18201, United States|UPMC-Johnstown/John P. Murtha Regional Cancer Center, Johnstown, Pennsylvania, 15901, United States|UPMC Cancer Center at UPMC McKeesport, McKeesport, Pennsylvania, 15132, United States|UPMC-Coraopolis/Heritage Valley Radiation Oncology, Moon Township, Pennsylvania, 15108, United States|Temple University Hospital, Philadelphia, Pennsylvania, 19140, United States|UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania, 15213, United States|UPMC-Presbyterian Hospital, Pittsburgh, Pennsylvania, 15213, United States|UPMC-Saint Margaret, Pittsburgh, Pennsylvania, 15215, United States|University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, 15232, United States|UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, 15232, United States|UPMC Jefferson Regional Radiation Oncology, Pittsburgh, Pennsylvania, 15236, United States|UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, 15237, United States|UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, 15243, United States|UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, 16346, United States|Geisinger Medical Group, State College, Pennsylvania, 16801, United States|UPMC Uniontown Hospital Radiation Oncology, Uniontown, Pennsylvania, 15401, United States|UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, 15301, United States|Reading Hospital, West Reading, Pennsylvania, 19611, United States|Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre, Pennsylvania, 18711, United States|Women and Infants Hospital, Providence, Rhode Island, 02905, United States|Saint Francis Hospital, Greenville, South Carolina, 29601, United States|Saint Francis Cancer Center, Greenville, South Carolina, 29607, United States|University of Tennessee - Knoxville, Knoxville, Tennessee, 37920, United States|Dell Seton Medical Center at The University of Texas, Austin, Texas, 78701, United States|Parkland Memorial Hospital, Dallas, Texas, 75235, United States|UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, 75390, United States|Providence Regional Cancer System-Aberdeen, Aberdeen, Washington, 98520, United States|Cancer Care Center at Island Hospital, Anacortes, Washington, 98221, United States|Swedish Cancer Institute-Eastside Oncology Hematology, Bellevue, Washington, 98005, United States|PeaceHealth Saint Joseph Medical Center, Bellingham, Washington, 98225, United States|Providence Regional Cancer System-Centralia, Centralia, Washington, 98531, United States|Swedish Cancer Institute-Edmonds, Edmonds, Washington, 98026, United States|Providence Regional Cancer Partnership, Everett, Washington, 98201, United States|Swedish Cancer Institute-Issaquah, Issaquah, Washington, 98029, United States|Providence Regional Cancer System-Lacey, Lacey, Washington, 98503, United States|PeaceHealth Saint John Medical Center, Longview, Washington, 98632, United States|Minor and James Medical PLLC, Seattle, Washington, 98104, United States|Pacific Gynecology Specialists, Seattle, Washington, 98104, United States|Swedish Medical Center-Ballard Campus, Seattle, Washington, 98107, United States|Kaiser Permanente Washington, Seattle, Washington, 98112, United States|Swedish Medical Center-First Hill, Seattle, Washington, 98122-4307, United States|Providence Regional Cancer System-Shelton, Shelton, Washington, 98584, United States|MultiCare Deaconess Cancer and Blood Specialty Center - Downtown, Spokane, Washington, 99204, United States|MultiCare Deaconess Cancer and Blood Specialty Center - North, Spokane, Washington, 99218, United States|MultiCare Deaconess Cancer and Blood Specialty Center - Valley, Spokane Valley, Washington, 99216, United States|PeaceHealth Southwest Medical Center, Vancouver, Washington, 98664, United States|Providence Saint Mary Regional Cancer Center, Walla Walla, Washington, 99362, United States|North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington, 98902, United States|Providence Regional Cancer System-Yelm, Yelm, Washington, 98597, United States|Monongalia Hospital, Morgantown, West Virginia, 26505, United States|Aurora Cancer Care-Southern Lakes VLCC, Burlington, Wisconsin, 53105, United States|Aurora Health Center-Fond du Lac, Fond du Lac, Wisconsin, 54937, United States|Aurora Health Care Germantown Health Center, Germantown, Wisconsin, 53022, United States|Aurora Cancer Care-Grafton, Grafton, Wisconsin, 53024, United States|Aurora BayCare Medical Center, Green Bay, Wisconsin, 54311, United States|Aurora Cancer Care-Kenosha South, Kenosha, Wisconsin, 53142, United States|Aurora Bay Area Medical Group-Marinette, Marinette, Wisconsin, 54143, United States|Bay Area Medical Center, Marinette, Wisconsin, 54143, United States|Aurora Cancer Care-Milwaukee, Milwaukee, Wisconsin, 53209, United States|Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin, 53215, United States|Aurora Sinai Medical Center, Milwaukee, Wisconsin, 53233, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, 54017, United States|Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh, Wisconsin, 54904, United States|Aurora Cancer Care-Racine, Racine, Wisconsin, 53406, United States|Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan, Wisconsin, 53081, United States|Aurora Medical Center in Summit, Summit, Wisconsin, 53066, United States|Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers, Wisconsin, 54241, United States|Aurora Cancer Care-Waukesha, Waukesha, Wisconsin, 53188, United States|Aurora Cancer Care-Milwaukee West, Wauwatosa, Wisconsin, 53226, United States|Aurora West Allis Medical Center, West Allis, Wisconsin, 53227, United States|Rocky Mountain Oncology, Casper, Wyoming, 82609, United States|Big Horn Basin Cancer Center, Cody, Wyoming, 82414, United States|Billings Clinic-Cody, Cody, Wyoming, 82414, United States|Welch Cancer Center, Sheridan, Wyoming, 82801, United States|Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|CHUM - Hopital Notre-Dame, Montreal, Quebec, H2L 4M1, Canada|Tohoku University School of Medicine, Sendai, Aoba-ku, 980-8574, Japan|Kure National Hospital, Kure, Hiroshima, 737, Japan|Hokkaido University Hospital, Sapporo, Hokkaido, 060-8648, Japan|Iwate Medical University Hospital, Shiwa-gun, Iwate, 028-3695, Japan|Kagoshima City Hospital, Kagoshima, Kagoshima-ken, 890-8760, Japan|Niigata University Medical and Dental Hospital, Niigata, Niigata, 951-8520, Japan|University of the Ryukyus Hospital-Col Health Scnc, Nakagami-gun, Okinawa, 903-0215, Japan|Hiroshima University Hospital, Hiroshima, 734-8551, Japan|Kindai University, Osaka, 589 8511, Japan|Saitama Medical University International Medical Center, Saitama, 350-1298, Japan|Tottori University, Tottori, 680-8550, Japan|Samsung Medical Center, Seoul, Korea, 135-710, South Korea|Catholic University of Korea-Seoul Saint Mary's Hospital, Seoul, Korea, 137-040, South Korea|Seoul National University Bundang Hospital, Seongnam, Kyeonggi-do, 463-707, South Korea|Gachon University Gil Hospital, Incheon, 405-760, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Gangnam Severance Hospital, Seoul, 06273, South Korea|Seoul National University Hospital, Seoul, 110-744, South Korea|Korea Cancer Center Hospital, Seoul, 139-706, South Korea|Weston Park Hospital, Sheffield, England, S10 2SJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Upper Extremity Deep Vein Thrombosis|Central Venous Catheter Thrombosis|Cancer,DRUG: Rivaroxaban 10 MG,ALL,"ADULT, OLDER_ADULT",PHASE3,105,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION,3/15/19,6/14/20,"The Ottawa Hospital General Campus, Ottawa, Ontario, K1H 8L6, Canada",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cushing's Disease|Acromegaly|Neuroendocrine Tumors|Pituitary Tumors|Ectopic ACTH Secreting (EAS) Tumors|Dumping Syndrome|Prostate Cancer|Melanoma Negative for bRAF|Melanoma Negative for nRAS,DRUG: Pasireotide|DRUG: Cabergoline|DRUG: Pasireotide LAR,ALL,"ADULT, OLDER_ADULT",PHASE4,337,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,6/10/13,7/25/23,"Ximed Research SC - SOM230B2412, La Jolla, California, 92037, United States|Cedars Sinai Medical Center Cedars Sinai 4, Los Angeles, California, 90048, United States|Stanford Universtiy Medical Center Stanford Hospital & Clinics, Stanford, California, 94304, United States|University of Michigan Comprehensive Cancer Center SC-2, Ann Arbor, Michigan, 48109, United States|Memorial Sloan-Kettering Cancer Center SC, New York, New York, 10065, United States|Virginia Endocrinology Research SC, Chesapeake, Virginia, 23321, United States|Swedish Cancer Institute Swedish Cancer Institute (SC), Seattle, Washington, 98104, United States|Recordati Investigative Site, CABA, Buenos Aires, C1405BCH, Argentina|Recordati Investigative Site, Mar del Plata, Buenos Aires, B7602CBM, Argentina|Recordati Investigative Site, Edegem, Antwerpen, 2650, Belgium|Recordati Investigative Site, Bruges, 8310, Belgium|Recordati Investigative Site, Brussels, 1090, Belgium|Recordati Investigative Site, Brussels, 1200, Belgium|Recordati Investigative Site, Ghent, 9000, Belgium|Recordati Investigative Site, Leuven, 3000, Belgium|Recordati Investigative Site, Liège, 4000, Belgium|Recordati Investigative Site, Wilrijk, 2610, Belgium|Recordati Investigative Site, Fortaleza, Ceará, 60430 370, Brazil|Recordati Investigative Site, Curitiba, Paraná, 80030-110, Brazil|Recordati Investigative Site, Rio de Janeiro, Rio de Janeiro, 21941-913, Brazil|Recordati Investigative Site, Porto Alegre, Rio Grande do Sul, 90560 030, Brazil|Recordati Investigative Site, Joinville, Santa Catarina, 89201260, Brazil|Recordati Investigative Site, Botucatu, São Paulo, 18618-970, Brazil|Recordati Investigative Site, São Paulo, São Paulo, 05403 000, Brazil|Recordati Investigative Site, Sofia, 1431, Bulgaria|Recordati Investigative Site, Halifax, Nova Scotia, B3H 1V7, Canada|Recordati Investigative Site, London, Ontario, N6A 4L6, Canada|Recordati Investigative Site, Montreal, Quebec, H2L 4M1, Canada|Recordati Investigative Site, Montreal, Quebec, H2W 1T8, Canada|Recordati Investigative Site, Toulouse, Cedex 9, 31000, France|Recordati Investigative Site, Angers, 49933, France|Recordati Investigative Site, Bron, 69677, France|Recordati Investigative Site, Le Kremlin-Bicêtre, 94275, France|Recordati Investigative Site, Lille, 59037, France|Recordati Investigative Site, Marseille, 13385, France|Recordati Investigative Site, Pessac, 33604, France|Recordati Investigative Site, Pierre-Bénite, 69495, France|Recordati Investigative Site, Berlin, 13353, Germany|Recordati Investigative Site, Hamburg, 20246, Germany|Recordati Investigative Site, München, 81377, Germany|Recordati Investigative Site, München, 81667, Germany|Recordati Investigative Site, Tübingen, 72076, Germany|Recordati Investigative Site, Ulm, 89081, Germany|Recordati Investigative Site, Würzburg, 97080, Germany|Recordati Investigative Site, Athens, GR, 115 27, Greece|Recordati Investigative Site, Budapest, 1085, Hungary|Recordati Investigative Site, Bangalore, Karnataka, 560054, India|Recordati Investigative Site, Vellore, Tamil Nadu, 632004, India|Recordati Investigative Site, Petah Tikva, 49100, Israel|Recordati Investigative Site, Ancona, AN, 60126, Italy|Recordati Investigative Site, Genova, GE, 16132, Italy|Milano Investigative Site, Milan, MI, 20149, Italy|Recordati Investigative Site, Padua, PD, 35128, Italy|Recordati Investigative Site, Roma, RM, 00168, Italy|Recordati Investigative Site, Nagoya, Aichi-ken, 460-0001, Japan|Recordati Investigative Site, Maebashi, Gunma, 371 8511, Japan|Recordati Investigative Site, Kobe, Hyōgo, 650-0017, Japan|Recordati Investigative Site, Nankoku, Kochi, 783 8505, Japan|Recordati Investigative Site, Kyoto, Kyoto, 612-8555, Japan|Recordati Investigative Site, Suita, Osaka, 565 0871, Japan|Recordati Investigative Site, Kuala Lumpur, 62502, Malaysia|Recordati Investigative Site, Pulau Pinang, 10990, Malaysia|Recordati Investigative Site, Guadalajara, Jalisco, 44130, Mexico|Recordati Investigative Site, Mexico City, Mexico City, 14269, Mexico|Recordati Investigative Site, Durango, 34270, Mexico|Recordati Investigative Site, Mexico City, 07760, Mexico|Recordati Investigative Site, Groningen, 9713 GZ, Netherlands|Recordati Investigative Site, San Isidro, Lima region, 27, Peru|Recordati Investigative Site, Gdansk, 80 952, Poland|Recordati Investigative Site, Poznan, 60-355, Poland|Recordati Investigative Site, Warsaw, 04141, Poland|Recordati Investigative Site, Wroclaw, 50 367, Poland|Recordati Investigative Site, Porto, 4200-319, Portugal|Recordati Investigative Site, Bucharest, 011863, Romania|Recordati Investigative Site, Barnaul, 656024, Russia|Recordati Investigative Site, Moscow, 123317, Russia|Recordati Investigative Site, Saint Petersburg, 197341, Russia|Recordati Investigative Site, Tyumen, 625023, Russia|Recordati Investigative Site, Seoul, 03722, South Korea|Recordati Investigative Site, Seoul, 06351, South Korea|Recordati Investigative Site, Alicante, Valencia, 03010, Spain|Recordati Investigative Site, Barcelona, 08041, Spain|Recordati Investigative Site, Lausanne, 1011, Switzerland|Recordati Investigative Site, Zurich, 8091, Switzerland|Recordati Investigative Site, Taichung, 40705, Taiwan|Recordati Investigative Site, Bangkok, 10400, Thailand|Recordati Investigative Site, Bangkok, 10700, Thailand|Recordati Investigative Site, Songkhla, 90110, Thailand|Recordati Investigative Site, Istanbul, TUR, 34098, Turkey (Türkiye)|Recordati Investigative Site, Ankara, 06500, Turkey (Türkiye)|Recordati Investigative Site, Antalya, 07070, Turkey (Türkiye)|Recordati Investigative Site, Istanbul, 34890, Turkey (Türkiye)|Recordati Investigative Site, Izmir, 35340, Turkey (Türkiye)|Recordati Investigative Site, Kocaeli, 41380, Turkey (Türkiye)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colon Cancer|Pancreatic Cancer|Cholangiocarcinoma|Metastatic Colon Carcinoma|Liver Metastasis,DRUG: MVT-5873|PROCEDURE: pancreatectomy or hepatectomy,ALL,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,11/13/19,5/27/22,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Lung Cancer, Non-Small Cell|Neoplasms",PROCEDURE: Tumor biopsy,ALL,"ADULT, OLDER_ADULT",PHASE2,6,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,5/25/21,11/15/22,"GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Madrid, 28050, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Gastrointestinal Stromal Tumor (GIST),DRUG: BGJ398|DRUG: Imatinib Mesylate,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,16,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,10/2/14,3/25/19,"Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States|Md Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Functioning Pancreatic Neuroendocrine Tumor|Intermediate Grade Lung Neuroendocrine Neoplasm|Locally Advanced Digestive System Neuroendocrine Neoplasm|Locally Advanced Digestive System Neuroendocrine Tumor G1|Locally Advanced Lung Neuroendocrine Neoplasm|Locally Advanced Pancreatic Neuroendocrine Tumor|Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm|Low Grade Lung Neuroendocrine Neoplasm|Lung Neuroendocrine Tumor|Lung Neuroendocrine Tumor G2|Metastatic Digestive System Neuroendocrine Neoplasm|Metastatic Digestive System Neuroendocrine Tumor G1|Metastatic Lung Neuroendocrine Neoplasm|Metastatic Lung Neuroendocrine Tumor|Metastatic Pancreatic Neuroendocrine Neoplasm|Metastatic Pancreatic Neuroendocrine Tumor|Metastatic Thymus Neuroendocrine Neoplasm|Neuroendocrine Neoplasm|Neuroendocrine Tumor|Neuroendocrine Tumor G2|Non-Functioning Pancreatic Neuroendocrine Tumor|Pancreatic Serotonin-Producing Neuroendocrine Tumor|Thymus Neuroendocrine Tumor|Unresectable Digestive System Neuroendocrine Neoplasm|Unresectable Digestive System Neuroendocrine Tumor G1|Unresectable Lung Neuroendocrine Neoplasm|Unresectable Pancreatic Neuroendocrine Neoplasm|Unresectable Thymus Neuroendocrine Neoplasm,PROCEDURE: Biospecimen Collection|DRUG: Cabozantinib S-malate|PROCEDURE: Computed Tomography|PROCEDURE: Magnetic Resonance Imaging|OTHER: Placebo Administration|OTHER: Quality-of-Life Assessment|PROCEDURE: X-Ray Imaging,ALL,"ADULT, OLDER_ADULT",PHASE3,298,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",10/26/18,8/19/26,"Katmai Oncology Group, Anchorage, Alaska, 99508, United States|Kingman Regional Medical Center, Kingman, Arizona, 86401, United States|Mayo Clinic Hospital in Arizona, Phoenix, Arizona, 85054, United States|Banner University Medical Center - Tucson, Tucson, Arizona, 85719, United States|University of Arizona Cancer Center-North Campus, Tucson, Arizona, 85719, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, 94531, United States|PCR Oncology, Arroyo Grande, California, 93420, United States|Sutter Auburn Faith Hospital, Auburn, California, 95602, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, 94704, United States|Mills-Peninsula Medical Center, Burlingame, California, 94010, United States|City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States|Epic Care-Dublin, Dublin, California, 94568, United States|Epic Care Partners in Cancer Care, Emeryville, California, 94608, United States|Kaiser Permanente-Fremont, Fremont, California, 94538, United States|Palo Alto Medical Foundation-Fremont, Fremont, California, 94538, United States|Kaiser Permanente-Fresno, Fresno, California, 93720, United States|Contra Costa Regional Medical Center, Martinez, California, 94553-3156, United States|Fremont - Rideout Cancer Center, Marysville, California, 95901, United States|Memorial Medical Center, Modesto, California, 95355, United States|Kaiser Permanente-Modesto, Modesto, California, 95356, United States|Palo Alto Medical Foundation-Camino Division, Mountain View, California, 94040, United States|Alta Bates Summit Medical Center - Summit Campus, Oakland, California, 94609, United States|Kaiser Permanente-Oakland, Oakland, California, 94611, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, 94301, United States|Stanford Cancer Institute Palo Alto, Palo Alto, California, 94304, United States|Kaiser Permanente-Redwood City, Redwood City, California, 94063, United States|Kaiser Permanente-Richmond, Richmond, California, 94801, United States|Kaiser Permanente-Roseville, Roseville, California, 95661, United States|Sutter Roseville Medical Center, Roseville, California, 95661, United States|Kaiser Permanente Downtown Commons, Sacramento, California, 95814, United States|Sutter Medical Center Sacramento, Sacramento, California, 95816, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|Kaiser Permanente-South Sacramento, Sacramento, California, 95823, United States|Salinas Valley Memorial, Salinas, California, 93901, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, 94115, United States|Kaiser Permanente-San Francisco, San Francisco, California, 94115, United States|UCSF Medical Center-Mission Bay, San Francisco, California, 94158, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, 95119, United States|Kaiser Permanente San Leandro, San Leandro, California, 94577, United States|Mills Health Center, San Mateo, California, 94401, United States|Kaiser Permanente-San Rafael, San Rafael, California, 94903, United States|Kaiser San Rafael-Gallinas, San Rafael, California, 94903, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, 95051, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, 95065, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, 95403, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, 94080, United States|Kaiser Permanente-Stockton, Stockton, California, 95210, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, 94086, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, 95688, United States|Kaiser Permanente-Vallejo, Vallejo, California, 94589, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, 94589, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, 94596, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, 80012, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, 80304, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, 80907, United States|National Jewish Health-Main Campus, Denver, Colorado, 80206, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, 80218, United States|Saint Joseph Hospital - Cancer Centers of Colorado, Denver, Colorado, 80218, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, 80220, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, 80113, United States|Swedish Medical Center, Englewood, Colorado, 80113, United States|National Jewish Health-Western Hematology Oncology, Golden, Colorado, 80401, United States|Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, 81501, United States|Banner North Colorado Medical Center, Greeley, Colorado, 80631, United States|Good Samaritan Hospital - Cancer Centers of Colorado, Lafayette, Colorado, 80026, United States|Rocky Mountain Cancer Centers-Littleton, Littleton, Colorado, 80120, United States|Rocky Mountain Cancer Centers-Sky Ridge, Lone Tree, Colorado, 80124, United States|Banner North Colorado Medical Center - Loveland Campus, Loveland, Colorado, 80539, United States|National Jewish Health-Northern Hematology Oncology, Thornton, Colorado, 80260, United States|Intermountain Health Lutheran Hospital, Wheat Ridge, Colorado, 80401, United States|Danbury Hospital, Danbury, Connecticut, 06810, United States|Norwalk Hospital, Norwalk, Connecticut, 06856, United States|MedStar Georgetown University Hospital, Washington D.C., District of Columbia, 20007, United States|GenesisCare USA - Aventura FP, Aventura, Florida, 33180, United States|GenesisCare USA - Aventura, Aventura, Florida, 33180, United States|GenesisCare USA - Boca Ration FP06, Boca Raton, Florida, 33431, United States|Regional Cancer Center-Lee Memorial Health System, Fort Myers, Florida, 33905, United States|Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, 33021, United States|Mayo Clinic in Florida, Jacksonville, Florida, 32224-9980, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Emory University Hospital Midtown, Atlanta, Georgia, 30308, United States|Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, 30322, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia, 30342, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, 96813, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, 96813, United States|Queen's Medical Center, Honolulu, Hawaii, 96813, United States|Straub Clinic and Hospital, Honolulu, Hawaii, 96813, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, 96817, United States|Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii, 96819, United States|Hawaii Cancer Care - Westridge, ‘Aiea, Hawaii, 96701, United States|Pali Momi Medical Center, ‘Aiea, Hawaii, 96701, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, 83706, United States|Saint Luke's Cancer Institute - Boise, Boise, Idaho, 83712, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, 83605, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, 83814, United States|Walter Knox Memorial Hospital, Emmett, Idaho, 83617, United States|Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, 83619, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, 83642, United States|Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, 83642, United States|Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, 83687, United States|Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, 83687, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, 83854, United States|Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, 83864, United States|Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, 83301, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, 61704, United States|Illinois CancerCare-Canton, Canton, Illinois, 61520, United States|Illinois CancerCare-Carthage, Carthage, Illinois, 62321, United States|University of Illinois, Chicago, Illinois, 60612, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Carle at The Riverfront, Danville, Illinois, 61832, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, 62526, United States|Illinois CancerCare-Dixon, Dixon, Illinois, 61021, United States|Carle Physician Group-Effingham, Effingham, Illinois, 62401, United States|Crossroads Cancer Center, Effingham, Illinois, 62401, United States|Illinois CancerCare-Eureka, Eureka, Illinois, 61530, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, 61401, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, 61443, United States|Illinois CancerCare-Macomb, Macomb, Illinois, 61455, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, 61938, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, 60451, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, 62269, United States|University of Chicago Medicine-Orland Park, Orland Park, Illinois, 60462, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, 61350, United States|Illinois CancerCare-Pekin, Pekin, Illinois, 61554, United States|Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States|Illinois CancerCare-Peru, Peru, Illinois, 61354, United States|Illinois CancerCare-Princeton, Princeton, Illinois, 61356, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Springfield Clinic, Springfield, Illinois, 62702, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|Illinois CancerCare - Washington, Washington, Illinois, 61571, United States|Memorial Hospital of South Bend, South Bend, Indiana, 46601, United States|University of Iowa Healthcare Cancer Services Quad Cities, Bettendorf, Iowa, 52722, United States|Mercy Hospital, Cedar Rapids, Iowa, 52403, United States|Oncology Associates at Mercy Medical Center, Cedar Rapids, Iowa, 52403, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, 50325, United States|UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, 50325, United States|Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, 51503, United States|Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa, 51503, United States|Greater Regional Medical Center, Creston, Iowa, 50801, United States|Iowa Methodist Medical Center, Des Moines, Iowa, 50309, United States|UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, 50309, United States|Broadlawns Medical Center, Des Moines, Iowa, 50314, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, 50314, United States|UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, 50314, United States|UI Healthcare Mission Cancer and Blood - Fort Dodge, Fort Dodge, Iowa, 50501, United States|University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, 50266, United States|University of Kentucky/Markey Cancer Center, Lexington, Kentucky, 40536, United States|LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, 70805, United States|Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, 70808, United States|Our Lady of The Lake, Baton Rouge, Louisiana, 70808, United States|Louisiana Hematology Oncology Associates LLC, Baton Rouge, Louisiana, 70809, United States|Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, 70809, United States|Northshore Oncology Associates-Covington, Covington, Louisiana, 70433, United States|Oncology Center of The South Incorporated, Houma, Louisiana, 70360, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02115, United States|Boston Medical Center, Boston, Massachusetts, 02118, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, 01805, United States|Hickman Cancer Center, Adrian, Michigan, 49221, United States|Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan, 48106, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Bronson Battle Creek, Battle Creek, Michigan, 49017, United States|Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, 48114, United States|Trinity Health Medical Center - Brighton, Brighton, Michigan, 48114, United States|Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, 48188, United States|Trinity Health Medical Center - Canton, Canton, Michigan, 48188, United States|Caro Cancer Center, Caro, Michigan, 48723, United States|Chelsea Hospital, Chelsea, Michigan, 48118, United States|Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, 48118, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, 48346, United States|McLaren Cancer Institute-Clarkston, Clarkston, Michigan, 48346, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, 48346, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Henry Ford Health Saint John Hospital, Detroit, Michigan, 48236, United States|Henry Ford River District Hospital, East China Township, Michigan, 48054, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|Cancer Hematology Centers - Flint, Flint, Michigan, 48503, United States|Genesee Hematology Oncology PC, Flint, Michigan, 48503, United States|Genesys Hurley Cancer Institute, Flint, Michigan, 48503, United States|Hurley Medical Center, Flint, Michigan, 48503, United States|McLaren Cancer Institute-Flint, Flint, Michigan, 48532, United States|Singh and Arora Hematology Oncology PC, Flint, Michigan, 48532, United States|Henry Ford Saint John Hospital - Academic, Grosse Pointe Woods, Michigan, 48236, United States|Henry Ford Saint John Hospital - Breast, Grosse Pointe Woods, Michigan, 48236, United States|Henry Ford Saint John Hospital - Van Elslander, Grosse Pointe Woods, Michigan, 48236, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, 49007, United States|West Michigan Cancer Center, Kalamazoo, Michigan, 49007, United States|Beacon Kalamazoo Cancer Center, Kalamazoo, Michigan, 49009, United States|Karmanos Cancer Institute at McLaren Greater Lansing, Lansing, Michigan, 48910, United States|University of Michigan Health - Sparrow Lansing, Lansing, Michigan, 48912, United States|Hope Cancer Clinic, Livonia, Michigan, 48154, United States|Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, 48154, United States|Henry Ford Saint John Hospital - Macomb Medical, Macomb, Michigan, 48044, United States|Henry Ford Warren Hospital - Breast Macomb, Macomb, Michigan, 48044, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, 48453, United States|Toledo Clinic Cancer Centers-Monroe, Monroe, Michigan, 48162, United States|McLaren Cancer Institute-Macomb, Mount Clemens, Michigan, 48043, United States|McLaren Cancer Institute-Central Michigan, Mount Pleasant, Michigan, 48858, United States|McLaren Cancer Institute-Northern Michigan, Petoskey, Michigan, 49770, United States|Hope Cancer Center, Pontiac, Michigan, 48341, United States|Michigan Healthcare Professionals Pontiac, Pontiac, Michigan, 48341, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, 48341, United States|Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, 48341, United States|Huron Medical Center PC, Port Huron, Michigan, 48060, United States|Lake Huron Medical Center, Port Huron, Michigan, 48060, United States|McLaren-Port Huron, Port Huron, Michigan, 48060, United States|Henry Ford Rochester Hospital, Rochester Hills, Michigan, 48309, United States|MyMichigan Medical Center Saginaw, Saginaw, Michigan, 48601, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, 48604, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, 48312, United States|MyMichigan Medical Center Tawas, Tawas City, Michigan, 48764, United States|Advanced Breast Care Center PLLC, Warren, Michigan, 48088, United States|Henry Ford Health Warren Hospital, Warren, Michigan, 48093, United States|Henry Ford Madison Heights Hospital - Breast, Warren, Michigan, 48093, United States|Henry Ford Warren Hospital - GLCMS, Warren, Michigan, 48093, United States|Macomb Hematology Oncology PC, Warren, Michigan, 48093, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, 48661, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, 48106, United States|Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, 48197, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, 56601, United States|Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States|Minnesota Oncology - Burnsville, Burnsville, Minnesota, 55337, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Essentia Health - Deer River Clinic, Deer River, Minnesota, 56636, United States|Essentia Health Cancer Center, Duluth, Minnesota, 55805, United States|Fairview Southdale Hospital, Edina, Minnesota, 55435, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Essentia Health Hibbing Clinic, Hibbing, Minnesota, 55746, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, 55369, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, 55109, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, 55109, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States|Health Partners Inc, Minneapolis, Minnesota, 55454, United States|New Ulm Medical Center, New Ulm, Minnesota, 56073, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, 55422, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|United Hospital, Saint Paul, Minnesota, 55102, United States|Essentia Health Sandstone, Sandstone, Minnesota, 55072, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States|Lakeview Hospital, Stillwater, Minnesota, 55082, United States|Essentia Health Virginia Clinic, Virginia, Minnesota, 55792, United States|Ridgeview Medical Center, Waconia, Minnesota, 55387, United States|Rice Memorial Hospital, Willmar, Minnesota, 56201, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, 55125, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, 55092, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, 63628, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters, Missouri, 63376, United States|Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, 63141, United States|Parkland Health Center - Farmington, Farmington, Missouri, 63640, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, 63670, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Siteman Cancer Center-South County, St Louis, Missouri, 63129, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Siteman Cancer Center at Christian Hospital, St Louis, Missouri, 63136, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, 63080, United States|BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, 63127, United States|Community Hospital of Anaconda, Anaconda, Montana, 59711, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Saint Vincent Frontier Cancer Center, Billings, Montana, 59102, United States|Bozeman Health Deaconess Hospital, Bozeman, Montana, 59715, United States|Saint James Community Hospital and Cancer Treatment Center, Butte, Montana, 59701, United States|Benefis Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Great Falls Clinic, Great Falls, Montana, 59405, United States|Saint Peter's Community Hospital, Helena, Montana, 59601, United States|Logan Health Medical Center, Kalispell, Montana, 59901, United States|Community Medical Center, Missoula, Montana, 59804, United States|Nebraska Cancer Specialists/Oncology Hematology West PC, Grand Island, Nebraska, 68803, United States|Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, 68114, United States|Nebraska Methodist Hospital, Omaha, Nebraska, 68114, United States|Oncology Associates PC, Omaha, Nebraska, 68114, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, 89703, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, 89052, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, 89052, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, 89074, United States|Oncology Las Vegas - Henderson, Henderson, Nevada, 89074, United States|Desert West Surgery, Las Vegas, Nevada, 89102, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, 89102, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Hope Cancer Care of Nevada, Las Vegas, Nevada, 89103, United States|Cancer and Blood Specialists-Shadow, Las Vegas, Nevada, 89106, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, 89106, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, 89113, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, 89119, United States|Cancer Therapy and Integrative Medicine, Las Vegas, Nevada, 89121, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, 89128, United States|Cancer and Blood Specialists-Tenaya, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, 89128, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, 89128, United States|Oncology Las Vegas - Tenaya, Las Vegas, Nevada, 89128, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, 89144, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, 89144, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, 89148-2405, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, 89148, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, 89149, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, 89169, United States|University Cancer Center, Las Vegas, Nevada, 89169, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, 89048, United States|Renown Regional Medical Center, Reno, Nevada, 89502, United States|Saint Mary's Regional Medical Center, Reno, Nevada, 89503, United States|Radiation Oncology Associates, Reno, Nevada, 89509, United States|Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire, 03756, United States|Dartmouth Cancer Center - Nashua, Nashua, New Hampshire, 03063, United States|Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, 07920, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, 07631, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, 07645, United States|The Valley Hospital - Luckow Pavilion, Paramus, New Jersey, 07652, United States|Valley Health System Ridgewood Campus, Ridgewood, New Jersey, 07450, United States|Valley Medical Group - Wayne Multispecialty Practice, Wayne, New Jersey, 07470, United States|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87106, United States|New Mexico Oncology Hematology Consultants, Albuquerque, New Mexico, 87109, United States|Presbyterian Kaseman Hospital, Albuquerque, New Mexico, 87110, United States|Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho, New Mexico, 87124, United States|Hematology Oncology Associates of Central New York-Auburn, Auburn, New York, 13021, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|Hematology Oncology Associates of CNY at Camillus, Camillus, New York, 13031, United States|Memorial Sloan Kettering Commack, Commack, New York, 11725, United States|Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse, New York, 13057, United States|Memorial Sloan Kettering Westchester, Harrison, New York, 10604, United States|Mount Sinai Hospital, New York, New York, 10029, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|University of Rochester, Rochester, New York, 14642, United States|Memorial Sloan Kettering Nassau, Uniondale, New York, 11553, United States|Wilmot Cancer Institute at Webster, Webster, New York, 14580, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States|Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, 28328, United States|Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, 27534, United States|Margaret R Pardee Memorial Hospital, Hendersonville, North Carolina, 28791, United States|Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, 28546, United States|ECU Health Oncology Kinston, Kinston, North Carolina, 28501, United States|Marion L Shepard Cancer Center - ECU Health Beaufort Hospital, Washington, North Carolina, 27889, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, 58501, United States|Sanford Broadway Medical Center, Fargo, North Dakota, 58122, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, 58122, United States|UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, 44122, United States|Strecker Cancer Center-Belpre, Belpre, Ohio, 45714, United States|Miami Valley Hospital South, Centerville, Ohio, 45459, United States|Adena Regional Medical Center, Chillicothe, Ohio, 45601, United States|Case Western Reserve University, Cleveland, Ohio, 44106, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, 43214, United States|Grant Medical Center, Columbus, Ohio, 43215, United States|The Mark H Zangmeister Center, Columbus, Ohio, 43219, United States|Doctors Hospital, Columbus, Ohio, 43228, United States|Miami Valley Hospital, Dayton, Ohio, 45409, United States|Premier Blood and Cancer Center, Dayton, Ohio, 45409, United States|Miami Valley Hospital North, Dayton, Ohio, 45415, United States|Delaware Health Center-Grady Cancer Center, Delaware, Ohio, 43015, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, 45005-1066, United States|OhioHealth Mansfield Hospital, Mansfield, Ohio, 44903, United States|Marietta Memorial Hospital, Marietta, Ohio, 45750, United States|OhioHealth Marion General Hospital, Marion, Ohio, 43302, United States|Toledo Clinic Cancer Centers-Maumee, Maumee, Ohio, 43537, United States|Toledo Radiation Oncology at Northwest Ohio Onocolgy Center, Maumee, Ohio, 43537, United States|UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, 44060, United States|UH Seidman Cancer Center at Southwest General Hospital, Middleburg Heights, Ohio, 44130, United States|Licking Memorial Hospital, Newark, Ohio, 43055, United States|University Hospitals Parma Medical Center, Parma, Ohio, 44129, United States|Mercy Health - Perrysburg Hospital, Perrysburg, Ohio, 43551, United States|Southern Ohio Medical Center, Portsmouth, Ohio, 45662, United States|Mercy Health - Saint Anne Hospital, Toledo, Ohio, 43623, United States|Toledo Clinic Cancer Centers-Toledo, Toledo, Ohio, 43623, United States|Upper Valley Medical Center, Troy, Ohio, 45373, United States|University Hospitals Sharon Health Center, Wadsworth, Ohio, 44281, United States|UH Seidman Cancer Center at Saint John Medical Center, Westlake, Ohio, 44145, United States|Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, 43701, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, 74146, United States|Saint Alphonsus Cancer Care Center-Baker City, Baker City, Oregon, 97814, United States|Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, 97015, United States|Providence Newberg Medical Center, Newberg, Oregon, 97132, United States|Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, 97914, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Providence Saint Vincent Medical Center, Portland, Oregon, 97225, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, 18103, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, 18017, United States|Pocono Medical Center, East Stroudsburg, Pennsylvania, 18301, United States|Saint Vincent Hospital, Erie, Pennsylvania, 16544, United States|Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, 18201, United States|Jefferson Hospital, Jefferson Hills, Pennsylvania, 15025, United States|Forbes Hospital, Monroeville, Pennsylvania, 15146, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Temple University Hospital, Philadelphia, Pennsylvania, 19140, United States|Allegheny General Hospital, Pittsburgh, Pennsylvania, 15212, United States|West Penn Hospital, Pittsburgh, Pennsylvania, 15224, United States|Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, 15090, United States|Prisma Health Cancer Institute - Spartanburg, Boiling Springs, South Carolina, 29316, United States|Prisma Health Cancer Institute - Easley, Easley, South Carolina, 29640, United States|Prisma Health Cancer Institute - Butternut, Greenville, South Carolina, 29605, United States|Prisma Health Cancer Institute - Faris, Greenville, South Carolina, 29605, United States|Prisma Health Cancer Institute - Eastside, Greenville, South Carolina, 29615, United States|Prisma Health Cancer Institute - Greer, Greer, South Carolina, 29650, United States|Prisma Health Cancer Institute - Seneca, Seneca, South Carolina, 29672, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, 57104, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, 57117-5134, United States|Farmington Health Center, Farmington, Utah, 84025, United States|University of Ut",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Salt Lake City, Utah,84106, United States|Huntsman Cancer Institute/University of Utah,84112, United States|Virginia Mason Medical Center, Seattle, Washington,98101, United States|Edwards Comprehensive Cancer Center, Huntington, West Virginia,25701, United States|West Virginia University Healthcare, Morgantown, West Virginia,26506, United States|ThedaCare Regional Cancer Center, Appleton, Wisconsin,54911, United States|Duluth Clinic Ashland, Ashland, Wisconsin,54806, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin,54701, United States|University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin,53792, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin,54449, United States|Marshfield Medical Center - Minocqua, Minocqua, Wisconsin,54548, United States|ProHealth D N Greenwald Center, Mukwonago, Wisconsin,53149, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin,54017, United States|ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin,53066, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin,54868, United States|Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin,54482, United States|ProHealth Waukesha Memorial Hospital, Waukesha, Wisconsin,53188, United States|UW Cancer Center at ProHealth Care, Waukesha, Wisconsin,53188, United States|Marshfield Medical Center - Weston, Weston, Wisconsin,54476, United States|Billings Clinic-Cody, Cody, Wyoming,82414, United States|Welch Cancer Center, Sheridan, Wyoming,82801," United States""",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Ewing Sarcoma|Ewing Family of Tumors|Ewing's Tumor Metastatic|Ewing's Sarcoma Metastatic|Ewing's Tumor Recurrent|Rare Diseases|Sarcoma|Neoplasms, Connective and Soft Tissue|Neoplasms by Histologic Type|Neoplasms, Bone Tissue|Neoplasms, Connective Tissue|Sarcoma, Ewing|Neoplasms",BIOLOGICAL: Vigil|DRUG: Irinotecan|DRUG: Temozolomide,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,32,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/21/18,1/20/22,"Arkansas Children's Hospital, Little Rock, Arkansas, 72202, United States|Southern California Permanente Medical Group, Los Angeles, California, 90027, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|Nicklaus Children's Hospital, Miami, Florida, 33155, United States|Dana-Farber/Boston Children's Cancer and Blood Disorders, Boston, Massachusetts, 02215, United States|Washington University Siteman Cancer Center, St Louis, Missouri, 63110, United States|Nebraska Methodist Hospital, Omaha, Nebraska, 68114, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Duke Children's Hospital and Health Center; Duke Cancer Institute, Durham, North Carolina, 27710, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Texas Oncology - Pediatrics, Dallas, Texas, 75230, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pancreatic Neuroendocrine Tumor G1|Pancreatic Neuroendocrine Tumor G2|Refractory Pancreatic Neuroendocrine Carcinoma,DRUG: Sapanisertib,ALL,"ADULT, OLDER_ADULT",PHASE2,13,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/28/17,12/21/22,"Mayo Clinic Hospital in Arizona, Phoenix, Arizona, 85054, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, 85259, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, 71913, United States|PCR Oncology, Arroyo Grande, California, 93420, United States|Sutter Auburn Faith Hospital, Auburn, California, 95602, United States|Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, 95603, United States|Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, 94704, United States|Mills-Peninsula Medical Center, Burlingame, California, 94010, United States|Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, 95682, United States|Eden Hospital Medical Center, Castro Valley, California, 94546, United States|Sutter Davis Hospital, Davis, California, 95616, United States|Palo Alto Medical Foundation-Fremont, Fremont, California, 94538, United States|Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|Memorial Medical Center, Modesto, California, 95355, United States|Palo Alto Medical Foundation-Camino Division, Mountain View, California, 94040, United States|Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, 94040, United States|Sutter Cancer Research Consortium, Novato, California, 94945, United States|Palo Alto Medical Foundation Health Care, Palo Alto, California, 94301, United States|Stanford Cancer Institute Palo Alto, Palo Alto, California, 94304, United States|Sutter Cancer Centers Radiation Oncology Services-Roseville, Roseville, California, 95661, United States|Sutter Roseville Medical Center, Roseville, California, 95661, United States|Sutter Medical Center Sacramento, Sacramento, California, 95816, United States|California Pacific Medical Center-Pacific Campus, San Francisco, California, 94115, United States|Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, 95065, United States|Sutter Pacific Medical Foundation, Santa Rosa, California, 95403, United States|Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, 94086, United States|Sutter Cancer Centers Radiation Oncology Services-Vacaville, Vacaville, California, 95687, United States|Sutter Solano Medical Center/Cancer Center, Vallejo, California, 94589, United States|University of Colorado Hospital, Aurora, Colorado, 80045, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, 80907, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, 80907, United States|UCHealth Memorial Hospital Central, Colorado Springs, Colorado, 80909, United States|Porter Adventist Hospital, Denver, Colorado, 80210, United States|Mercy Medical Center, Durango, Colorado, 81301, United States|Southwest Oncology PC, Durango, Colorado, 81301, United States|Poudre Valley Hospital, Fort Collins, Colorado, 80524, United States|Mountain Blue Cancer Care Center, Golden, Colorado, 80401, United States|Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, 80228, United States|Saint Anthony Hospital, Lakewood, Colorado, 80228, United States|Littleton Adventist Hospital, Littleton, Colorado, 80122, United States|Longmont United Hospital, Longmont, Colorado, 80501, United States|Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, 80501, United States|Parker Adventist Hospital, Parker, Colorado, 80138, United States|Rocky Mountain Cancer Centers-Parker, Parker, Colorado, 80138, United States|Saint Mary Corwin Medical Center, Pueblo, Colorado, 81004, United States|Rocky Mountain Cancer Centers - Pueblo, Pueblo, Colorado, 81008, United States|Rocky Mountain Cancer Centers-Thornton, Thornton, Colorado, 80260, United States|Middlesex Hospital, Middletown, Connecticut, 06457, United States|Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, 96813, United States|Island Urology, Honolulu, Hawaii, 96813, United States|Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, 96813, United States|Queen's Medical Center, Honolulu, Hawaii, 96813, United States|Straub Clinic and Hospital, Honolulu, Hawaii, 96813, United States|University of Hawaii Cancer Center, Honolulu, Hawaii, 96813, United States|Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, 96817, United States|Kuakini Medical Center, Honolulu, Hawaii, 96817, United States|Queen's Cancer Center - Kuakini, Honolulu, Hawaii, 96817, United States|The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, 96817, United States|Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States|Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, 96766, United States|Pali Momi Medical Center, ‘Aiea, Hawaii, 96701, United States|Queen's Cancer Center - Pearlridge, ‘Aiea, Hawaii, 96701, United States|The Cancer Center of Hawaii-Pali Momi, ‘Aiea, Hawaii, 96701, United States|Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, 83706, United States|Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, 83605, United States|Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, 83814, United States|Walter Knox Memorial Hospital, Emmett, Idaho, 83617, United States|Idaho Urologic Institute-Meridian, Meridian, Idaho, 83642, United States|Saint Alphonsus Medical Center-Nampa, Nampa, Idaho, 83686, United States|Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, 83854, United States|Kootenai Cancer Clinic, Sandpoint, Idaho, 83864, United States|Rush - Copley Medical Center, Aurora, Illinois, 60504, United States|Saint Joseph Medical Center, Bloomington, Illinois, 61701, United States|Illinois CancerCare-Bloomington, Bloomington, Illinois, 61704, United States|Illinois CancerCare-Canton, Canton, Illinois, 61520, United States|Memorial Hospital of Carbondale, Carbondale, Illinois, 62902, United States|SIH Cancer Institute, Carterville, Illinois, 62918, United States|Illinois CancerCare-Carthage, Carthage, Illinois, 62321, United States|Centralia Oncology Clinic, Centralia, Illinois, 62801, United States|Northwestern University, Chicago, Illinois, 60611, United States|Carle on Vermilion, Danville, Illinois, 61832, United States|Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, 62526, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Carle Physician Group-Effingham, Effingham, Illinois, 62401, United States|Crossroads Cancer Center, Effingham, Illinois, 62401, United States|Illinois CancerCare-Eureka, Eureka, Illinois, 61530, United States|Illinois CancerCare-Galesburg, Galesburg, Illinois, 61401, United States|Western Illinois Cancer Treatment Center, Galesburg, Illinois, 61401, United States|Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, 60134, United States|Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, 61443, United States|Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, 60045, United States|Illinois CancerCare-Macomb, Macomb, Illinois, 61455, United States|Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, 61938, United States|Good Samaritan Regional Health Center, Mount Vernon, Illinois, 62864, United States|Cancer Care Center of O'Fallon, O'Fallon, Illinois, 62269, United States|Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, 61350, United States|Illinois CancerCare-Pekin, Pekin, Illinois, 61554, United States|OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center, Pekin, Illinois, 61554, United States|Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States|OSF Saint Francis Radiation Oncology at Peoria Cancer Center, Peoria, Illinois, 61615, United States|Methodist Medical Center of Illinois, Peoria, Illinois, 61636, United States|OSF Saint Francis Medical Center, Peoria, Illinois, 61637, United States|Illinois CancerCare-Peru, Peru, Illinois, 61354, United States|Valley Radiation Oncology, Peru, Illinois, 61354, United States|Illinois CancerCare-Princeton, Princeton, Illinois, 61356, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Springfield Clinic, Springfield, Illinois, 62702, United States|Memorial Medical Center, Springfield, Illinois, 62781, United States|Southwest Illinois Health Services LLP, Swansea, Illinois, 62226, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|The Carle Foundation Hospital, Urbana, Illinois, 61801, United States|Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, 60555, United States|Rush-Copley Healthcare Center, Yorkville, Illinois, 60560, United States|Deaconess Clinic Downtown, Evansville, Indiana, 47713, United States|Chancellor Center for Oncology, Newburgh, Indiana, 47630, United States|Reid Health, Richmond, Indiana, 47374, United States|Medical Oncology and Hematology Associates-West Des Moines, Clive, Iowa, 50325, United States|Mercy Cancer Center-West Lakes, Clive, Iowa, 50325, United States|Alegent Health Mercy Hospital, Council Bluffs, Iowa, 51503, United States|Greater Regional Medical Center, Creston, Iowa, 50801, United States|Mercy Medical Center - Des Moines, Des Moines, Iowa, 50314, United States|Mission Cancer and Blood - Laurel, Des Moines, Iowa, 50314, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, 51101, United States|Mercy Medical Center-West Lakes, West Des Moines, Iowa, 50266, United States|Cancer Center of Kansas - Chanute, Chanute, Kansas, 66720, United States|Cancer Center of Kansas - Dodge City, Dodge City, Kansas, 67801, United States|Cancer Center of Kansas - El Dorado, El Dorado, Kansas, 67042, United States|Cancer Center of Kansas - Fort Scott, Fort Scott, Kansas, 66701, United States|Cancer Center of Kansas-Independence, Independence, Kansas, 67301, United States|Cancer Center of Kansas-Kingman, Kingman, Kansas, 67068, United States|Lawrence Memorial Hospital, Lawrence, Kansas, 66044, United States|Cancer Center of Kansas-Liberal, Liberal, Kansas, 67905, United States|Cancer Center of Kansas-Manhattan, Manhattan, Kansas, 66502, United States|Cancer Center of Kansas - McPherson, McPherson, Kansas, 67460, United States|Cancer Center of Kansas - Newton, Newton, Kansas, 67114, United States|Cancer Center of Kansas - Parsons, Parsons, Kansas, 67357, United States|Cancer Center of Kansas - Pratt, Pratt, Kansas, 67124, United States|Cancer Center of Kansas - Salina, Salina, Kansas, 67401, United States|Cancer Center of Kansas - Wellington, Wellington, Kansas, 67152, United States|Cancer Center of Kansas-Wichita Medical Arts Tower, Wichita, Kansas, 67208, United States|Ascension Via Christi Hospitals Wichita, Wichita, Kansas, 67214, United States|Cancer Center of Kansas - Wichita, Wichita, Kansas, 67214, United States|Cancer Center of Kansas - Winfield, Winfield, Kansas, 67156, United States|Flaget Memorial Hospital, Bardstown, Kentucky, 40004, United States|Commonwealth Cancer Center-Corbin, Corbin, Kentucky, 40701, United States|Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, 40504, United States|Saint Joseph Hospital East, Lexington, Kentucky, 40509, United States|Saint Joseph London, London, Kentucky, 40741, United States|Jewish Hospital, Louisville, Kentucky, 40202, United States|Saints Mary and Elizabeth Hospital, Louisville, Kentucky, 40215, United States|UofL Health Medical Center Northeast, Louisville, Kentucky, 40245, United States|Jewish Hospital Medical Center South, Shepherdsville, Kentucky, 40165, United States|Mercy Medical Center, Springfield, Massachusetts, 01104, United States|Saint Joseph Mercy Hospital, Ann Arbor, Michigan, 48106, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Saint Joseph Mercy Brighton, Brighton, Michigan, 48114, United States|Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, 48114, United States|Saint Joseph Mercy Canton, Canton, Michigan, 48188, United States|Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, 48188, United States|Caro Cancer Center, Caro, Michigan, 48723, United States|Saint Joseph Mercy Chelsea, Chelsea, Michigan, 48118, United States|Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, 48118, United States|Hematology Oncology Consultants-Clarkston, Clarkston, Michigan, 48346, United States|Newland Medical Associates-Clarkston, Clarkston, Michigan, 48346, United States|Beaumont Hospital - Dearborn, Dearborn, Michigan, 48124, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|Ascension Saint John Hospital, Detroit, Michigan, 48236, United States|Great Lakes Cancer Management Specialists-Doctors Park, East China Township, Michigan, 48054, United States|Weisberg Cancer Treatment Center, Farmington Hills, Michigan, 48334, United States|Genesee Cancer and Blood Disease Treatment Center, Flint, Michigan, 48503, United States|Genesee Hematology Oncology PC, Flint, Michigan, 48503, United States|Genesys Hurley Cancer Institute, Flint, Michigan, 48503, United States|Hurley Medical Center, Flint, Michigan, 48503, United States|Academic Hematology Oncology Specialists, Grosse Pointe Woods, Michigan, 48236, United States|Great Lakes Cancer Management Specialists-Van Elslander Cancer Center, Grosse Pointe Woods, Michigan, 48236, United States|Michigan Breast Specialists-Grosse Pointe Woods, Grosse Pointe Woods, Michigan, 48236, United States|Allegiance Health, Jackson, Michigan, 49201, United States|Sparrow Hospital, Lansing, Michigan, 48912, United States|Hope Cancer Clinic, Livonia, Michigan, 48154, United States|Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, 48154, United States|Great Lakes Cancer Management Specialists-Macomb Medical Campus, Macomb, Michigan, 48044, United States|Michigan Breast Specialists-Macomb Township, Macomb, Michigan, 48044, United States|Saint Mary's Oncology/Hematology Associates of Marlette, Marlette, Michigan, 48453, United States|Monroe Cancer Center, Monroe, Michigan, 48162, United States|21st Century Oncology-Pontiac, Pontiac, Michigan, 48341, United States|Hope Cancer Center, Pontiac, Michigan, 48341, United States|Newland Medical Associates-Pontiac, Pontiac, Michigan, 48341, United States|Saint Joseph Mercy Oakland, Pontiac, Michigan, 48341, United States|Huron Medical Center PC, Port Huron, Michigan, 48060, United States|Lake Huron Medical Center, Port Huron, Michigan, 48060, United States|Great Lakes Cancer Management Specialists-Rochester Hills, Rochester Hills, Michigan, 48309, United States|Ascension Saint Mary's Hospital, Saginaw, Michigan, 48601, United States|Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, 48604, United States|Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, 48312, United States|Ascension Saint Joseph Hospital, Tawas City, Michigan, 48764, United States|Advanced Breast Care Center PLLC, Warren, Michigan, 48088, United States|Great Lakes Cancer Management Specialists-Macomb Professional Building, Warren, Michigan, 48093, United States|Macomb Hematology Oncology PC, Warren, Michigan, 48093, United States|Michigan Breast Specialists-Warren, Warren, Michigan, 48093, United States|Saint John Macomb-Oakland Hospital, Warren, Michigan, 48093, United States|Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, 48661, United States|Huron Gastroenterology PC, Ypsilanti, Michigan, 48106, United States|Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, 48197, United States|Sanford Joe Lueken Cancer Center, Bemidji, Minnesota, 56601, United States|Essentia Health Saint Joseph's Medical Center, Brainerd, Minnesota, 56401, United States|Fairview Ridges Hospital, Burnsville, Minnesota, 55337, United States|Mercy Hospital, Coon Rapids, Minnesota, 55433, United States|Essentia Health - Deer River Clinic, Deer River, Minnesota, 56636, United States|Essentia Health Saint Mary's - Detroit Lakes Clinic, Detroit Lakes, Minnesota, 56501, United States|Essentia Health Cancer Center, Duluth, Minnesota, 55805, United States|Essentia Health Saint Mary's Medical Center, Duluth, Minnesota, 55805, United States|Miller-Dwan Hospital, Duluth, Minnesota, 55805, United States|Fairview Southdale Hospital, Edina, Minnesota, 55435, United States|Lake Region Healthcare Corporation-Cancer Care, Fergus Falls, Minnesota, 56537, United States|Essentia Health - Fosston, Fosston, Minnesota, 56542, United States|Unity Hospital, Fridley, Minnesota, 55432, United States|Essentia Health Hibbing Clinic, Hibbing, Minnesota, 55746, United States|Fairview Clinics and Surgery Center Maple Grove, Maple Grove, Minnesota, 55369, United States|Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, 55109, United States|Saint John's Hospital - Healtheast, Maplewood, Minnesota, 55109, United States|Abbott-Northwestern Hospital, Minneapolis, Minnesota, 55407, United States|Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States|Health Partners Inc, Minneapolis, Minnesota, 55454, United States|Monticello Cancer Center, Monticello, Minnesota, 55362, United States|New Ulm Medical Center, New Ulm, Minnesota, 56073, United States|Essentia Health - Park Rapids, Park Rapids, Minnesota, 56470, United States|North Memorial Medical Health Center, Robbinsdale, Minnesota, 55422, United States|Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States|Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, 55416, United States|Regions Hospital, Saint Paul, Minnesota, 55101, United States|United Hospital, Saint Paul, Minnesota, 55102, United States|Essentia Health Sandstone, Sandstone, Minnesota, 55072, United States|Saint Francis Regional Medical Center, Shakopee, Minnesota, 55379, United States|Lakeview Hospital, Stillwater, Minnesota, 55082, United States|Sanford Thief River Falls Medical Center, Thief River Falls, Minnesota, 56701, United States|Essentia Health Virginia Clinic, Virginia, Minnesota, 55792, United States|Ridgeview Medical Center, Waconia, Minnesota, 55387, United States|Rice Memorial Hospital, Willmar, Minnesota, 56201, United States|Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, 55125, United States|Sanford Cancer Center Worthington, Worthington, Minnesota, 56187, United States|Fairview Lakes Medical Center, Wyoming, Minnesota, 55092, United States|Saint Louis Cancer and Breast Institute-Ballwin, Ballwin, Missouri, 63011, United States|Central Care Cancer Center - Bolivar, Bolivar, Missouri, 65613, United States|Parkland Health Center-Bonne Terre, Bonne Terre, Missouri, 63628, United States|Cox Cancer Center Branson, Branson, Missouri, 65616, United States|Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States|Southeast Cancer Center, Cape Girardeau, Missouri, 63703, United States|Capital Region Southwest Campus, Jefferson City, Missouri, 65109, United States|Freeman Health System, Joplin, Missouri, 64804, United States|Mercy Hospital Joplin, Joplin, Missouri, 64804, United States|Delbert Day Cancer Institute at PCRMC, Rolla, Missouri, 65401, United States|Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, 64506, United States|Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, 63670, United States|Mercy Hospital Springfield, Springfield, Missouri, 65804, United States|CoxHealth South Hospital, Springfield, Missouri, 65807, United States|Saint Louis Cancer and Breast Institute-South City, St Louis, Missouri, 63109, United States|Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Missouri Baptist Sullivan Hospital, Sullivan, Missouri, 63080, United States|Missouri Baptist Outpatient Center-Sunset Hills, Sunset Hills, Missouri, 63127, United States|Mercy Hospital Washington, Washington, Missouri, 63090, United States|Community Hospital of Anaconda, Anaconda, Montana, 59711, United States|Billings Clinic Cancer Center, Billings, Montana, 59101, United States|Bozeman Deaconess Hospital, Bozeman, Montana, 59715, United States|Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, 59405, United States|Great Falls Clinic, Great Falls, Montana, 59405, United States|Saint Peter's Community Hospital, Helena, Montana, 59601, United States|Kalispell Regional Medical Center, Kalispell, Montana, 59901, United States|Community Medical Hospital, Missoula, Montana, 59804, United States|CHI Health Saint Francis, Grand Island, Nebraska, 68803, United States|Heartland Hematology and Oncology, Kearney, Nebraska, 68845, United States|CHI Health Good Samaritan, Kearney, Nebraska, 68847, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, 68510, United States|Alegent Health Immanuel Medical Center, Omaha, Nebraska, 68122, United States|Hematology and Oncology Consultants PC, Omaha, Nebraska, 68122, United States|Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, 68124, United States|Alegent Health Lakeside Hospital, Omaha, Nebraska, 68130, United States|Creighton University Medical Center, Omaha, Nebraska, 68131, United States|Midlands Community Hospital, Papillion, Nebraska, 68046, United States|Carson Tahoe Regional Medical Center, Carson City, Nevada, 89703, United States|Cancer and Blood Specialists-Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada, 89052, United States|Las Vegas Cancer Center-Henderson, Henderson, Nevada, 89052, United States|OptumCare Cancer Care at Seven Hills, Henderson, Nevada, 89052, United States|Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada, 89074, United States|GenesisCare USA - Henderson, Henderson, Nevada, 89074, United States|Desert West Surgery, Las Vegas, Nevada, 89102, United States|OptumCare Cancer Care at Charleston, Las Vegas, Nevada, 89102, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, 89102, United States|Cancer and Blood Specialists-Shadow, Las Vegas, Nevada, 89106, United States|Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada, 89106, United States|GenesisCare USA - Las Vegas, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway, Las Vegas, Nevada, 89109, United States|HealthCare Partners Medical Group Oncology/Hematology-San Martin, Las Vegas, Nevada, 89113, United States|Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada, 89119, United States|Cancer Therapy and Integrative Medicine, Las Vegas, Nevada, 89121, United States|Ann M Wierman MD LTD, Las Vegas, Nevada, 89128, United States|Cancer and Blood Specialists-Tenaya, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada, 89128, United States|GenesisCare USA - Vegas Tenaya, Las Vegas, Nevada, 89128, United States|HealthCare Partners Medical Group Oncology/Hematology-Tenaya, Las Vegas, Nevada, 89128, United States|OptumCare Cancer Care at MountainView, Las Vegas, Nevada, 89128, United States|Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada, 89144, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, 89144, United States|Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada, 89148-2405, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89148, United States|GenesisCare USA - Fort Apache, Las Vegas, Nevada, 89148, United States|OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, 89148, United States|HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills, Las Vegas, Nevada, 89149, United States|Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada, 89169, United States|University Cancer Center, Las Vegas, Nevada, 89169, United States|Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada, 89048, United States|Renown Regional Medical Center, Reno, Nevada, 89502, United States|Saint Mary's Regional Medical Center, Reno, Nevada, 89503, United States|Radiation Oncology Associates, Reno, Nevada, 89509, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08903, United States|Mount Sinai Hospital, New York, New York, 10029, United States|University of Rochester, Rochester, New York, 14642, United States|Montefiore Medical Center-Einstein Campus, The Bronx, New York, 10461, United States|Montefiore Medical Center-Weiler Hospital, The Bronx, New York, 10461, United States|Montefiore Medical Center - Moses Campus, The Bronx, New York, 10467, United States|Southeastern Medical Oncology Center-Clinton, Clinton, North Carolina, 28328, United States|Southeastern Medical Oncology Center-Goldsboro, Goldsboro, North Carolina, 27534, United States|Wayne Memorial Hospital, Goldsboro, North Carolina, 27534, United States|Onslow Memorial Hospital, Jacksonville, North Carolina, 28546, United States|Southeastern Medical Oncology Center-Jacksonville, Jacksonville, North Carolina, 28546, United States|Sanford Bismarck Medical Center, Bismarck, North Dakota, 58501, United States|Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota, 58103, United States|Sanford South University Medical Center, Fargo, North Dakota, 58103, United States|Sanford Broadway Medical Center, Fargo, North Dakota, 58122, United States|Sanford Roger Maris Cancer Center, Fargo, North Dakota, 58122, United States|Essentia Health - Jamestown Clinic, Jamestown, North Dakota, 58401, United States|Indu and Raj Soin Medical Center, Beavercreek, Ohio, 45431, United States|Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, 45459, United States|Miami Valley Hospital South, Centerville, Ohio, 45459, United States|Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, 45220, United States|Oncology Hematology Care Inc-Kenwood, Cincinnati, Ohio, 45236, United States|Bethesda North Hospital, Cincinnati, Ohio, 45242, United States|TriHealth Cancer Institute-Westside, Cincinnati, Ohio, 45247, United States|TriHealth Cancer Institute-Anderson, Cincinnati, Ohio, 45255, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|Good Samaritan Hospital - Dayton, Dayton, Ohio, 45406, United States|Miami Valley Hospital, Dayton, Ohio, 45409, United States|Dayton Physician LLC-Miami Valley Hospital North, Dayton, Ohio, 45415, United States|Miami Valley Hospital North, Dayton, Ohio, 45415, United States|Armes Family Cancer Center, Findlay, Ohio, 45840, United States|Blanchard Valley Hospital, Findlay, Ohio, 45840, United States|Orion Cancer Care, Findlay, Ohio, 45840, United States|Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, 45005-1066, United States|Dayton Physicians LLC-Atrium, Franklin, Ohio, 45005, United States|Dayton Physicians LLC-Wayne, Greenville, Ohio, 45331, United States|Wayne Hospital, Greenville, Ohio, 45331, United States|Greater Dayton Cancer Center, Kettering, Ohio, 45409, United States|First Dayton Cancer Care, Kettering, Ohio, 45420, United States|Kettering Medical Center, Kettering, Ohio, 45429, United States|Dayton Physicians LLC-Signal Point, Middletown, Ohio, 45042, United States|Dayton Physicians LLC-Wilson, Sidney, Ohio, 45365, United States|Springfield Regional Cancer Center, Springfield, Ohio, 45504, United States|Springfield Regional Medical Center, Springfield, Ohio, 45505, United States|ProMedica Flower Hospital, Sylvania, Ohio, 43560, United States|Dayton Physicians LLC-Upper Valley, Troy, Ohio, 45373, United States|Upper Valley Medical Center, Troy, Ohio, 45373, United States|Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, 73120, United States|Saint Alphonsus Medical Center-Baker City, Baker City, Oregon, 97814, United States|Saint Alphonsus Medical Center-Ontario, Ontario, Oregon, 97914, United States|Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, 18103, United States|Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, 18017, United States|Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, 57104, United States|Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, 57117-5134, United States|Memorial Hospital, Chattanooga, Tennessee, 37404, United States|Pulmonary Medicine Center of Chattanooga-Hixson, Hixson, Tennessee, 37343, United States|Memorial GYN Plus, Ooltewah, Tennessee, 37363, United States|Saint Joseph Regional Cancer Center, Bryan, Texas, 77802, United States|Sovah Health Martinsville, Martinsville, Virginia, 24115, United States|Harrison HealthPartners Hematology and Oncology-Bremerton, Bremerton, Washington, 98310, United States|Harrison Medical Center, Bremerton, Washington, 98310, United States|Highline Medical Center-Main Campus, Burien, Washington, 98166, United States|Saint Elizabeth Hospital, Enumclaw, Washington, 98022, United States|Saint Francis Hospital, Federal Way, Washington, 98003, United States|Saint Clare Hospital, Lakewood, Washington, 98499, United States|Harrison HealthPartners Hematology and Oncology-Poulsbo, Poulsbo, Washington, 98370, United States|Franciscan Research Center-Northwest Medical Plaza, Tacoma, Washington, 98405, United States|Northwest Medical Specialties PLLC, Tacoma, Washington, 98405, United States|United Hospital Center, Bridgeport, West Virginia, 26330, United States|WVUH-Berkely Medical Center, Martinsburg, West Virginia, 25401, United States|West Virginia University Healthcare, Morgantown, West Virginia, 26506, United States|Camden Clark Medical Center, Parkersburg, West Virginia, 26101, United States|Duluth Clinic Ashland, Ashland, Wisconsin, 54806, United States|Northwest Wisconsin Cancer Center, Ashland, Wisconsin, 54806, United States|Marshfield Clinic-Chippewa Center, Chippewa Falls, Wisconsin, 54729, United States|Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, 54701, United States|Marshfield Clinic - Ladysmith Center, Ladysmith, Wisconsin, 54848, United States|Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, 54449, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin, 54548, United States|Cancer Center of Western Wisconsin, New Richmond, Wisconsin, 54017, United States|Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, 54868, United States|Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, 54482, United States|Marshfield Clinic-Wausau Center, Wausau, Wisconsin, 54401, United States|Marshfield Medical Center - Weston, Weston, Wisconsin, 54476, United States|Marshfield Clinic - Wisconsin Rapids Center, Wisconsin Rapids, Wisconsin, 54494, United States|Billings Clinic-Cody, Cody, Wyoming, 82414, United States|Welch Cancer Center, Sheridan, Wyoming, 82801, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Plasma Cell Myeloma,DRUG: FGFR Inhibitor AZD4547,ALL,"ADULT, OLDER_ADULT",PHASE2,52,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/31/16,6/30/20,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,"Prostatic Neoplasms, Castration-Resistant",DRUG: Niraparib 200 mg|DRUG: Cetrelimab 240 mg|DRUG: Cetrelimab 480 mg|DRUG: Abiraterone acetate 1000 mg|DRUG: Prednisone 5 mg,MALE,"ADULT, OLDER_ADULT",PHASE2,136,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,3/2/18,12/31/25,"Urological Associates of Southern Arizona, P.C., Tucson, Arizona, 85741, United States|The Urology Center of Colorado, Denver, Colorado, 80211, United States|Mayo Clinic - Division Of Hematology/oncology, Jacksonville, Florida, 32224, United States|First Urology, PSC, Jeffersonville, Indiana, 47130, United States|Chesapeake Urology Research Associates, Towson, Maryland, 21204, United States|Michigan Institute of Urology, Troy, Michigan, 48084, United States|New York Oncology Hematology, Albany, New York, 12208, United States|Memorial Sloan Kettering Cancer Center, Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, 15232, United States|MUSC-Hollings Cancer Center, Charleston, South Carolina, 29425, United States|Carolina Urologic Research Center, Myrtle Beach, South Carolina, 29572, United States|Urology Associates, Nashville, Tennessee, 37209, United States|Houston Metro Urology, Houston, Texas, 77027, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|Urology of Virginia, PLCC, Virginia Beach, Virginia, 23462, United States|University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, 5379200, United States|OLV Ziekenhuis Aalst, Aalst, 9300, Belgium|ZNA Middelheim, Antwerp, 2020, Belgium|ULB Hôpital Erasme, Brussels, 1070, Belgium|Universitair Ziekenhuis Gent, Ghent, 9000, Belgium|Az Groeninge, Kortrijk, 8500, Belgium|Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman, Liège, B-4000, Belgium|Southern Alberta Institute of Urology / Prostate Cancer Centre, Calgary, Alberta, T2V 1P9, Canada|British Columbia Cancer Agency, Vancouver, British Columbia, V5Z4E6, Canada|Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, M5G2M9, Canada|Centre de Recherche du CHUM, Montreal, Quebec, H2X 0A9, Canada|Asaf Harofe Medical Center, Beer Yaakov, 60930, Israel|Soroka Hospital, Beersheba, 85101, Israel|Rambam Medical Center, Haifa, 31096, Israel|Rabin Medical Center, Petah Tikva, 49100, Israel|Sheba Medical Center Tel Hashomer, Ramat Gan, 52621, Israel|Azienda Ospedaliera Universitaria Careggi di Firenze, Florence, 50134, Italy|Azienda Ospedaliera ''Vito Fazzi'', Lecce, 73100, Italy|UOC Oncologia Ospedale Provinciale di Macerata, Macerata, 62100, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milan, 20162, Italy|IRCCS-Fondazione Pascale, Napoli, 80131, Italy|Hosp. de La Santa Creu I Sant Pau, Barcelona, 08025, Spain|Hospital Vall D'Hebron, Barcelona, 8035, Spain|Hosp. Univ. de La Princesa, Madrid, 28006, Spain|Hosp Univ Fund Jimenez Diaz, Madrid, 28040, Spain|Hosp Univ Hm Sanchinarro, Madrid, 28050, Spain|Hosp Virgen de La Victoria, Málaga, 29010, Spain|Royal United Hospital, Bath, BA1 3NG, United Kingdom|University College London Hospitals, London, WC1E 6BT, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|The Royal Marsden NHS Trust Sutton, Sutton, SM2 5PT, United Kingdom|Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital, Truro, TR1 3LJ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Head and Neck Neoplasms,DRUG: Patritumab|DRUG: Cetuximab|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE2,87,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",12/22/15,2/21/18,"Institut Jules Bordet, Brussels, 1000, Belgium|Univeristair Ziekenhuis Antwerpen, Edegem, 2650, Belgium|UZ Leuven, Leuven, 3000, Belgium|Institut Curie, Paris, Cedex, 75248, France|Institut de Cancerologie de l'Ouest, Angers, 49055, France|Centre Hospitalier de Bordeaux - Hôpital Saint André, Bordeaux, 33075, France|Hopital Croix-Rousse, Lyon, 69004, France|Centre Leon Berard, Lyon, 69373, France|CHU Hopital de la Timone, Marseille, 13005, France|Hopital Saint Joseph, Marseille, 13008, France|Centre de Cancerologie du Grand Montpellier, Montpellier, 34070, France|Institut de Cancerologie de l'Ouest, Saint-Herblain, 44805, France|Gustave Roussy, Villejuif, 94805, France|Charite Universitatsmedizin Berlin, Berlin, 12200/12203, Germany|Medizinische Hochschule Hannover, Hanover, 30625, Germany|Klinikum der Universitat Munchen, München, 81377, Germany|Orszagos Onkologiai Intezet, Budapest, 1122, Hungary|Debreceni Egyetem Orvos-es Egeszsegtudomanyi Centrum, Debrecen, 4032, Hungary|Bacs-Kiskun Megyei Korhaz, Kecskemét, 6000, Hungary|Borsod Abauj Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz, Miskolc, 3526, Hungary|Josa Andras Oktatokorhaz, Nyíregyháza, 4400, Hungary|Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy, Bydgoszcz, 85-796, Poland|Przychodnia Lekarska ""KOMED"", Konin, 62-500, Poland|Regionalny Osrodek Onkologiczny Szpital im. M. Kopernika w Lodzi, Lodz, 93-513, Poland|Medisprof SRL, Cluj-Napoca, 400058, Romania|Centrul de Oncologie Sfantul Nectarie, Craiova, 200347, Romania|Institutul Regional de Oncologie Iasi, Iași, 700483, Romania|University College London Hospitals NHS Foundation Trust - University College Hospital, London, NW1 2PG, United Kingdom|Guy's and St Thomas' NHS Foundation Trust - St Thomas' Hospital, London, SE1 7EH, United Kingdom|The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom|Weston Park Hospital, Sheffield, S10 2SJ, United Kingdom|The Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, SY3 8XQ, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|The Royal Marsden NHS Foundation Trust, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Prostatic Neoplasms|Pelvic Nodal,DRUG: Enzalutamide|DRUG: Leuprolide|RADIATION: Intensity-Modulated Radiation Therapy,MALE,"ADULT, OLDER_ADULT",PHASE2,11,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/22/15,8/31/20,"University of California San Francisco, San Francisco, California, 94158, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,"Carcinoma|Carcinoma, Renal Cell|Kidney Neoplasms|Urologic Neoplasms|Kidney Diseases|Neoplasms by Site|Enzyme Inhibitors|Protein Kinase Inhibitors",DRUG: Savolitinib|DRUG: Sunitinib,ALL,"ADULT, OLDER_ADULT",PHASE3,60,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,7/25/17,12/31/25,"Research Site, La Jolla, California, 92093, United States|Research Site, Atlanta, Georgia, 30322, United States|Research Site, Chicago, Illinois, 60637, United States|Research Site, Iowa City, Iowa, 52242, United States|Research Site, Boston, Massachusetts, 02215, United States|Research Site, Kansas City, Missouri, 64132, United States|Research Site, New York, New York, 10021, United States|Research Site, Nashville, Tennessee, 37203, United States|Research Site, Barretos, 14784-400, Brazil|Research Site, Curitiba, 81520-060, Brazil|Research Site, Passo Fundo, 99010-080, Brazil|Research Site, Pelotas, 096015-280, Brazil|Research Site, Porto Alegre, 90050-170, Brazil|Research Site, Porto Alegre, 90610-000, Brazil|Research Site, Porto Alegre, 91350-200, Brazil|Research Site, Rio de Janeiro, 22793-080, Brazil|Research Site, São José do Rio Preto, 15090-000, Brazil|Research Site, São Paulo, 01246-000, Brazil|Research Site, São Paulo, 01323-903, Brazil|Research Site, Bordeaux, 33000, France|Research Site, Vandœuvre-lès-Nancy, 54519, France|Research Site, Villejuif, 94805, France|Research Site, Arezzo, 52100, Italy|Research Site, Meldola, 47014, Italy|Research Site, Milan, 20133, Italy|Research Site, Modena, 41100, Italy|Research Site, Orbassano, 10043, Italy|Research Site, Pavia, 27100, Italy|Research Site, Roma, 00152, Italy|Research Site, Krasnoyarsk, 660133, Russia|Research Site, Moscow, 105077, Russia|Research Site, Moscow, 115478, Russia|Research Site, Moscow, 115522, Russia|Research Site, Moscow, RU-121356, Russia|Research Site, Murmansk, 183047, Russia|Research Site, Nizhny Novgorod, 603109, Russia|Research Site, Obninsk, 249036, Russia|Research Site, Omsk, 644013, Russia|Research Site, Saint Petersburg, 194017, Russia|Research Site, Saint Petersburg, 195271, Russia|Research Site, Saint Petersburg, 196603, Russia|Research Site, Volgograd, 400138, Russia|Research Site, Daejeon, 35015, South Korea|Research Site, Goyang-si, 10408, South Korea|Research Site, Hwasun-gun, 58128, South Korea|Research Site, Incheon, 21565, South Korea|Research Site, Seoul, 03080, South Korea|Research Site, Seoul, 05505, South Korea|Research Site, Seoul, 06273, South Korea|Research Site, Seoul, 120-752, South Korea|Research Site, Seoul, 6351, South Korea|Research Site, Dnipro, 49005, Ukraine|Research Site, Dnipro, 49102, Ukraine|Research Site, Ivano-Frankivsk, 76018, Ukraine|Research Site, Kharkiv Region, 61070, Ukraine|Research Site, Kyiv, 03022, Ukraine|Research Site, Kyiv, 03115, Ukraine|Research Site, Odesa, 65055, Ukraine|Research Site, Sumy, 40022, Ukraine",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Cancer Of Prostate|Prostate Neoplasms|Prostate Cancer|Neoplasms of Prostate|Prostatic Cancer,RADIATION: Prostate bed with integrated boost|RADIATION: Prostate bed irradiation only|DIAGNOSTIC_TEST: Whole Body Bone Scan|DIAGNOSTIC_TEST: 18F-NaF PET Imaging|DIAGNOSTIC_TEST: CT|DIAGNOSTIC_TEST: mpMRI|DRUG: ADT,MALE,"ADULT, OLDER_ADULT",PHASE1,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/17/18,12/8/25,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations,DRUG: Neratinib|DRUG: Fulvestrant|DRUG: Trastuzumab|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE2,582,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/30/13,1/2/23,"University of Alabama at Birmingham, Birmingham, Alabama, 35249, United States|Mayo Clinic Arizona, Phoenix, Arizona, 85054, United States|City of Hope, Duarte, California, 91010, United States|University of California, San Diego, La Jolla, California, 92093, United States|University of Southern California, Los Angeles, California, 90089, United States|University of California, Los Angeles, Los Angeles, California, 90095, United States|Stanford Cancer Center, Palo Alto, California, 94304, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94115, United States|Kaiser Permanente NoCal (STRATA), Vallejo, California, 94589, United States|Mayo Clinic Florida, Jacksonville, Florida, 32224, United States|University of Miami, Miami, Florida, 33136, United States|Winship Cancer Institute, Emory University, Atlanta, Georgia, 30322, United States|Northwestern University, Chicago, Illinois, 60611, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, 70121, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Metro Minnesota Community Oncology Research Consortium, Saint Louis Park, Minnesota, 55416, United States|Washington University, St Louis, Missouri, 63110, United States|Roswell Park Comprehensive Cancer Center, Buffalo, New York, 14263, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|UPMC Magee-Woman's Hospital, Women's Cancer Center, Pittsburgh, Pennsylvania, 15213, United States|Saint Francis Cancer Center-Bon Secours, Greenville, South Carolina, 29607, United States|The West Clinic, Germantown, Tennessee, 38138, United States|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, 37232, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Gundersen Center for Cancer and Blood Disorders, La Crosse, Wisconsin, 54601, United States|University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, 53792, United States|Peter MacCallum Cancer Centre, East Melbourne, Victoria, 8006, Australia|UZ Leuven, Leuven, 3000, Belgium|British Columbia Cancer Center, Vancouver, British Columbia, V5Z 4E6, Canada|University Hospital, Rigshospitalet, Copenhagen, DK-2100, Denmark|Institut Gustave Roussy, Villejuif, Paris, 94800, France|Institut Bergonié, Bordeaux, 33076, France|Centre Leon Berard, Lyon, 69393, France|Institut Curie - Hopital Rene Huguenin, Saint-Cloud, Île-de-France Region, 92210, France|St. Vincent's University Hospital, Dublin, Leinster, D04 T6F4, Ireland|Hadassah Medical Center, Jerusalem, 9112001, Israel|Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, 4941494, Israel|Sheba Medical Center, Ramat Gan, 5262000, Israel|Kaplan Medical Center, Rehovot, 7661041, Israel|Sourasky Medical Center, Tel Aviv, 6423906, Israel|Azienda Socio Sanitaria Territoriale di Cremona, Cremona, 26100, Italy|Istituto Europeo di Oncologia (IEO) I.R.C.C.S., Milan, 20141, Italy|Fondazione Policlinico Universitario Gemelli I.R.C.C.S., Roma, 00168, Italy|AOU Citta della Salute e della Scienza di Torino, Torino, 10126, Italy|Institute for Oncology and Radiology of Serbia, Belgrade, 11000, Serbia|Yonsei University Health System, Serverance Hospital, Seodaemun-Gu, Seoul, 120-752, South Korea|Hospital Universitario Quiron Dexeus, Barcelona, 08028, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08035, Spain|Hospital Universitari Clinic Barcelona, Barcelona, 08036, Spain|Hospital Clinico Universitario San Carlos, Madrid, 28040, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, 28040, Spain|Hospital Universitario Madrid Sanchinarro (START Madrid), Madrid, 28050, Spain|Hospital Universitario Quiron Madrid, Madrid, 28223, Spain|Instituto Valenciano de Oncologia, Valencia, 46009, Spain|Hospital Clinico Universitario de Valencia, Valencia, 46010, Spain|Royal Free Hospital, London, NW3 2QG, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,DRUG: Trametinib Dimethyl Sulfoxide,ALL,"ADULT, OLDER_ADULT",PHASE2,35,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/12/15,3/19/26,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Thrombocythemia, Essential|Primary Myelofibrosis",DRUG: Bomedemstat,ALL,"ADULT, OLDER_ADULT",PHASE2,81,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/15/21,8/22/24,"University of Miami Leonard M. Miller, Miami, Florida, 33136, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|UMPC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Fred Hutchinson Cancer Center, Seattle, Washington, 98109, United States|Royal Prince Alfred Hospital, Camperdown, New South Wales, 2050, Australia|Royal North Shore Hospital, Saint Leonards, New South Wales, 2065, Australia|Gold Coast Hospital and Health Service, Southport, Queensland, 4215, Australia|Royal Adelaide Hospital, Adelaide, South Australia, 5000, Australia|Universittsklinikum Essen, Essen, 45147, Germany|Queen Mary Hospital, Hong Kong, Hong Kong|Ospedale di Circolo-a Fondazione Macchi, Varese, VA, 2100, Italy|Azienda Ospedaliera SS. Antonio, Alessandria, 15121, Italy|Azienda Ospedaliero-Universitaria Careggi - S.O.D. Ematologia (CRIMM), Florence, 50134, Italy|Azienda Ospedaliero Universitaria di Bologna, Pavia, 27100, Italy|Middlemore Clinical Trials, Papatoetoe, Aukland, 2025, New Zealand|Waitemata District Health Board, Takapuna, Aukland, 0622, New Zealand|University College London Hospitals NHS Foundation Trust, London, NW1 12G, United Kingdom|Guy's and Saint Thomas' NHS Foundation Trus, London, SE1 9RT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Relapsed Solid Tumor|Refractory Solid Tumor|Relapsed Central Nervous System Tumor|Refractory Central Nervous System Tumor|Diffuse Intrinsic Pontine Glioma|High Grade Glioma,DRUG: cemiplimab (monotherapy)|DRUG: cemiplimab (maintenance)|RADIATION: Conventional or hypofractionated|RADIATION: Re-irradiation,ALL,"CHILD, ADULT",PHASE1|PHASE2,57,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,9/24/18,5/10/23,"Children's Hospital Los Angeles (CHLA), Los Angeles, California, 90054, United States|Rady Children's Hospital, San Diego, California, 92123, United States|UCSF Benioff Children's Hospital, San Francisco, California, 94158, United States|Children's National Health System (Children's National Medical Center), Washington D.C., District of Columbia, 20010, United States|University of Florida- Neurosurgery, Gainesville, Florida, 32610, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, 60611, United States|Johns Hopkins - Pediatric Oncology, Baltimore, Maryland, 21287, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana Farber Cancer Institute/ Boston Children's Hospital, Boston, Massachusetts, 02215, United States|C. S. Mott/University of Michigan, Ann Arbor, Michigan, 48109, United States|Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota, 55404, United States|University of Minnesota / Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Nationwide Children's Hospital, Columbus, Ohio, 43205, United States|Oregon Health & Science University (OHSU) - Doernbecher Children's Hospital, Portland, Oregon, 97239, United States|The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Texas Children's Cancer & Hematology Centers Baylor College of Medicine, Houston, Texas, 77030, United States|University of Utah, Salt Lake City, Utah, 84113, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Endometrial Cancer|Carcinosarcoma,DRUG: ZW25,FEMALE,"ADULT, OLDER_ADULT",PHASE2,16,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT,8/12/20,3/8/24,"Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison, New York, 10604, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, 11570, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Locally Advanced or Metastatic Solid Tumor,DRUG: Rebastinib|DRUG: Paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,177,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,10/25/18,5/23/22,"University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, 35233, United States|University of Colorado Denver- Anschutz Medical Center, Aurora, Colorado, 80045, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States|The University of Kansas Clinical Research Center, Kansas City, Kansas, 66160, United States|Dana-Farber, Boston, Massachusetts, 02215, United States|Northwell Health/Monter Cancer Center, Lake Success, New York, 11042, United States|Montefiore Medical Center, The Bronx, New York, 10467, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, 43210, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, 19111, United States|Women & Infants Hospital, Providence, Rhode Island, 02905, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Oncology Consultants- Texas Medical Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Cervical Cancer|Oropharyngeal Cancer|Vaginal Cancer|Anal Cancer|Penile Cancer,DRUG: Fludarabine|DRUG: Cyclophosphamide|BIOLOGICAL: Young TIL|DRUG: Aldesleukin,ALL,"ADULT, OLDER_ADULT",PHASE2,29,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/13/12,8/1/16,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Hematopoietic and Lymphoid Cell Neoplasm,"OTHER: Best Practice and Internet site with links to existing resources|OTHER: Internet, Mobile app and Telehealth Intervention|OTHER: Survey Administration",ALL,"ADULT, OLDER_ADULT",PHASE3,546,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE,10/29/20,12/31/23,"Moffitt Cancer Center, Tampa, Florida, 33612, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|University of Kansas Cancer Center, Kansas City, Kansas, 66160, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02114, United States|Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|National Marrow Donor Program, Minneapolis, Minnesota, 55401, United States|Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, 55413-5000, United States|University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, 55455, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, 27599, United States|Cleveland Clinic Foundation, Cleveland, Ohio, 44195, United States|University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, 19104, United States|Texas Oncology at Baylor Charles A Sammons Cancer Center, Dallas, Texas, 75246, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, 98109, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Hematopoietic and Lymphoid Cell Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Plasma Cell Myeloma,BIOLOGICAL: Nivolumab,ALL,"ADULT, OLDER_ADULT",PHASE2,47,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/31/16,5/17/20,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Breast Cancer|Colorectal Cancer|Adenoid Cystic Carcinoma|Non-hodgkin Lymphoma|Glomus Tumor, Malignant|Hepatocellular Carcinoma|Osteosarcoma|T-ALL",DRUG: CB-103,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,79,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,12/5/17,11/11/22,"Sarcoma Oncology Research Center, Santa Monica, California, 90403, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|MD Anderson, Houston, Texas, 77030, United States|Centre Hospitalier Lyon-Sud, Lyon, France|Hôpital Saint-Louis, Paris, 75475, France|Charite- Universitaetsmedizin Berlin- Campus Benjamin Franklin, Berlin, 10117, Germany|Universitätsklinikum Frankfurt, Frankfurt, 60590, Germany|Nationales Centrum für Tumorerkrankungen Heidelberg, Heidelberg, 69120, Germany|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital - Yonsei Cancer Center, Seoul, 03722, South Korea|Seoul National University Hospital, Seoul, 06351, South Korea|Hospital Quirón Barcelona, Barcelona, 08023, Spain|Vall d'Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain|Catalan Institute of Oncology, Barcelona, 08916, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Oncology Institute of Southern Switzerland, Bellinzona, 6500, Switzerland|Kantonsspital St.Gallen, Sankt Gallen, 9007, Switzerland",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Liver Cancer|Liver Neoplasm|Hepatocellular Carcinoma|HCC,DRUG: [18F] FMISO,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,6/12/15,3/7/18,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Blasts More Than 20 Percent of Bone Marrow Nucleated Cells|Blasts More Than 20 Percent of Peripheral Blood White Cells|Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia,DRUG: Decitabine|OTHER: Laboratory Biomarker Analysis|DRUG: Ruxolitinib Phosphate,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,30,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2/12/15,3/19/21,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Carcinoma, Squamous Cell|Head and Neck Neoplasms|Oropharyngeal Neoplasms",RADIATION: Intensity Modulated Radiotherapy (IMRT)|DRUG: Cisplatin (or alternative)|PROCEDURE: Assessment for surgical evaluation,ALL,"ADULT, OLDER_ADULT",PHASE2,115,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-08,11/24/24,"University of Florida, Gainesville, Florida, 32610, United States|University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, 27599, United States|Pardee Memorial Hospital, Hendersonville, North Carolina, 28791, United States|High Point Regional Health, High Point, North Carolina, 27262, United States|Rex Healthcare, Raleigh, North Carolina, 27607, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Chemotherapy-Induced Peripheral Neuropathy|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,DRUG: Palmidrol|DRUG: Placebo Administration|OTHER: Quality-of-Life Assessment,ALL,"ADULT, OLDER_ADULT",PHASE2,88,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE",5/16/22,2/28/26,"Middlesex Hospital, Middletown, Connecticut, 06457, United States|Carle Cancer Center NCI Community Oncology Research Program, Urbana, Illinois, 61801, United States|Siouxland Regional Cancer Center, Sioux City, Iowa, 51101, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Cone Health Cancer Center, Greensboro, North Carolina, 27403, United States|Geisinger Medical Center, Danville, Pennsylvania, 17822, United States|Rapid City Regional Hospital, Rapid City, South Dakota, 57701, United States|Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, 37232, United States|Mayo Clinic Health System Eau Claire Hospital-Luther Campus, Eau Claire, Wisconsin, 54703, United States|Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, 54601, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Lung Neoplasms|Lung Cancer,DRUG: OTL38 for Injection|DEVICE: Near infrared camera imaging system|PROCEDURE: Endoscopic or Thoracic Surgery,ALL,"ADULT, OLDER_ADULT",PHASE2,100,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC,5/4/17,11/30/18,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, 15232, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Leiden University Medical Center, Leiden, 2333 ZA, Netherlands",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Triple Negative Breast Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Olaparib|DRUG: Carboplatin|DRUG: Gemcitabine,ALL,"ADULT, OLDER_ADULT",PHASE2,462,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/19/19,11/26/25,"Pacific Cancer Care ( Site 0142), Monterey, California, 93940, United States|UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0138), San Francisco, California, 94158, United States|John Wayne Cancer Institute ( Site 0111), Santa Monica, California, 90404, United States|St. Joseph Heritage Healthcare ( Site 0104), Santa Rosa, California, 95403, United States|University of Miami Sylvester CC ( Site 0146), Miami, Florida, 33136, United States|Georgia Cancer Center at Augusta University ( Site 0129), Augusta, Georgia, 30912, United States|University of Chicago ( Site 0159), Chicago, Illinois, 60637, United States|Massachusetts General Hospital ( Site 0155), Boston, Massachusetts, 02114, United States|Henry Ford Health System ( Site 0103), Detroit, Michigan, 48202, United States|Virginia Piper Cancer Institute ( Site 0157), Minneapolis, Minnesota, 55407, United States|Memorial Sloan Kettering Cancer Center- Monmouth ( Site 0161), Middletown, New Jersey, 07748, United States|MSKCC-Bergen ( Site 0162), Montvale, New Jersey, 07645, United States|Memorial Sloan-Kettering Cancer Center at Commack ( Site 0160), Commack, New York, 11725, United States|Memorial Sloan-Kettering Cancer Center ( Site 0156), New York, New York, 10065, United States|Mercy Clinic Oncology and Hematology ( Site 0110), Oklahoma City, Oklahoma, 73120, United States|The Center For Cancer And Blood Disorders ( Site 0151), Fort Worth, Texas, 76104, United States|Texas Oncology-New Braunfels ( Site 0168), New Braunfels, Texas, 78130, United States|Texas Oncology-San Antonio Northeast ( Site 0165), San Antonio, Texas, 78217, United States|Texas Oncology-San Antonio Medical Center ( Site 0158), San Antonio, Texas, 78240, United States|Texas Oncology - San Antonio Stone Oak ( Site 0166), San Antonio, Texas, 78258, United States|Renovatio Clinical ( Site 0117), The Woodlands, Texas, 77380, United States|Virginia Oncology Associates ( Site 0163), Newport News, Virginia, 23606, United States|Virginia Oncology Associates ( Site 0153), Norfolk, Virginia, 23502, United States|Virginia Oncology Associates ( Site 0164), Virginia Beach, Virginia, 23456, United States|YVMH dba Virginia Mason Memorial/North Star Lodge Cancer Center ( Site 0128), Yakima, Washington, 98902, United States|Princess Margaret Cancer Centre ( Site 0005), Toronto, Ontario, M5G 2M9, Canada|CSSS de Laval- Hopital de la Cite de la Sante ( Site 0011), Laval, Quebec, H7M 3L9, Canada|Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0003), Montreal, Quebec, H2X 3E4, Canada|Jewish General Hospital ( Site 0010), Montreal, Quebec, H3T 1E2, Canada|McGill University Health Centre ( Site 0002), Montreal, Quebec, H4A 3J1, Canada|IC La Serena Research ( Site 0511), La Serena, Coquimbo Region, 1720430, Chile|Fundacion Arturo Lopez Perez ( Site 0500), Santiago, Region M. de Santiago, 7500921, Chile|Pontificia Universidad Catolica de Chile ( Site 0501), Santiago, Region M. de Santiago, 8330032, Chile|Centro Investigación del Cáncer James Lind ( Site 0510), Temuco, Región de la Araucanía, 4780000, Chile|Oncocentro ( Site 0502), Viña del Mar, Región de Valparaíso, 2520598, Chile|Fundacion Colombiana de Cancerologia Clinica Vida ( Site 0601), Medellín, Antioquia, 050030, Colombia|Clinica de la Costa Ltda. ( Site 0600), Barranquilla, Atlántico, 080020, Colombia|Organizacion Clinica Bonnadona-Prevenir S.A.S. ( Site 0609), Barranquilla, Atlántico, 080020, Colombia|Oncomedica S.A. ( Site 0606), Montería, Departamento de Córdoba, 230002, Colombia|Fundacion Valle del Lili ( Site 0602), Cali, Valle del Cauca Department, 760032, Colombia|Hemato Oncologos S.A. ( Site 0603), Cali, Valle del Cauca Department, 760042, Colombia|Centre Francois Baclesse ( Site 1012), Caen, Calvados, 14076, France|CHU-Jean Minjoz ( Site 1013), Besançon, Doubs, 25030, France|Institut Claudius Regaud IUCT Oncopole ( Site 1001), Toulouse, Haute-Garonne, 31059, France|Centre de Cancerologie du Grand Montpellier ( Site 1009), Montpellier, Languedoc-Roussillon, 34070, France|CHR-METZ-THIONVILLE - Hopital de Mercy ( Site 1007), Metz, Moselle, 57085, France|Centre Jean Perrin ( Site 1003), Clermont-Ferrand, Puy-de-Dome, 63001, France|Centre Leon Berard ( Site 1018), Lyon, Rhone, 69373, France|Centre Henri Becquerel ( Site 1020), Rouen, Seine-Maritime, 76038, France|CHU Amiens Hopital Sud ( Site 1023), Amiens, Somme, 80000, France|Institut Gustave Roussy ( Site 1010), Villejuif, Val-de-Marne, 94805, France|Institut Sainte Catherine ( Site 1026), Avignon, Vaucluse, 84918, France|Hôpital Saint-Louis ( Site 1025), Paris, 75010, France|Universitaetsklinikum Mannheim GmbH ( Site 1213), Mannheim, Baden-Wurttemberg, 68167, Germany|Universitaetsklinikum Erlangen ( Site 1201), Erlangen, Bavaria, 91054, Germany|Klinik und Poliklinik fuer Frauenheilkunde und Geburtshilfe ( Site 1200), Munich, Bavaria, 80337, Germany|Hochwaldkrankenhaus Bad Nauheim ( Site 1211), Bad Nauheim, Hesse, 61231, Germany|Sana Klinikum Offenbach Klinik fuer Gynakologie und Geburtshilfe ( Site 1206), Offenbach, Hesse, 63069, Germany|Gynaekologisch-onkologische Praxis Hannover ( Site 1207), Hanover, Lower Saxony, 30177, Germany|Gynaekologisches Zentrum-Schwerpunkt Gyn. Onkologie ( Site 1205), Bonn, North Rhine-Westphalia, 53111, Germany|Universitaetsklinikum AoeR Duesseldorf ( Site 1210), Düsseldorf, North Rhine-Westphalia, 40225, Germany|Kliniken Essen-Mitte ( Site 1215), Essen, North Rhine-Westphalia, 45136, Germany|Frauenklinik St. Louise ( Site 1216), Paderborn, North Rhine-Westphalia, 33098, Germany|Universitaetsklinikum Carl Gustav Carus ( Site 1203), Dresden, Saxony, 01307, Germany|Pecsi Tudomanyegyetem Klinikai Kozpont ( Site 1607), Pécs, Baranya, 7624, Hungary|Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1608), Kecskemét, Bács-Kiskun county, 6000, Hungary|Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 1601), Szolnok, Jász-Nagykun-Szolnok, 5000, Hungary|Zala Megyei Szent Rafael Korhaz ( Site 1605), Zalaegerszeg, Zala County, 8900, Hungary|Orszagos Onkologiai Intezet ( Site 1602), Budapest, 1122, Hungary|Debreceni Egyetem Klinikai Kozpont ( Site 1600), Debrecen, 4032, Hungary|Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 1604), Kaposvár, 7400, Hungary|Cork University Hospital ( Site 0902), Cork, T12 DC4A, Ireland|St Vincents University Hospital ( Site 0900), Dublin, D04 YN63, Ireland|Aichi Cancer Center Hospital ( Site 2202), Nagoya, Aichi-ken, 464-8681, Japan|Hyogo College of Medicine Hospital ( Site 2203), Nishinomiya, Hyōgo, 663-8501, Japan|Fukushima Medical University Hospital ( Site 2201), Fukushima, 960-1295, Japan|Hiroshima City Hiroshima Citizens Hospital ( Site 2204), Hiroshima, 730-8518, Japan|National Hospital Organization - Osaka National Hospital - Institute For Clinical Research (Site 2200), Osaka, 540-0006, Japan|Pleszewskie Centrum Medyczne w Pleszewie Sp. z o.o. ( Site 1909), Pleszew, Greater Poland Voivodeship, 65-300, Poland|Pratia MCM Krakow ( Site 1919), Krakow, Lesser Poland Voivodeship, 30-510, Poland|Regionalny Szpital Specjalistyczny Latawiec ( Site 1917), Swidnica, Lower Silesian Voivodeship, 58-100, Poland|Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (Site 1908), Warsaw, Masovian Voivodeship, 02-781, Poland|Szpital Morski im. PCK. Szpitale Pomorskie Sp. Z o.o ( Site 1913), Gdynia, Pomeranian Voivodeship, 81-519, Poland|Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1912), Gliwice, Silesian Voivodeship, 44-102, Poland|National Cancer Center ( Site 2406), Goyang-si, Kyonggi-do, 10408, South Korea|Seoul National University Bundang Hospital ( Site 2409), Seongnam-si, Kyonggi-do, 13605, South Korea|Ajou University Hospital ( Site 2407), Suwon, Kyonggi-do, 16499, South Korea|Kyungpook National University Chilgok Hospital ( Site 2402), Daegu, Taegu-Kwangyokshi, 41404, South Korea|Gachon University Gil Medical Center ( Site 2408), Incheon, 21565, South Korea|Seoul National University Hospital ( Site 2403), Seoul, 03080, South Korea|Severance Hospital Yonsei University Health System ( Site 2401), Seoul, 03722, South Korea|Asan Medical Center ( Site 2404), Seoul, 05505, South Korea|Samsung Medical Center ( Site 2405), Seoul, 06351, South Korea|Hospital Universitario Reina Sofia ( Site 0705), Córdoba, Andalusia, 14004, Spain|Hospital General Arnau de Vilanova de Valencia ( Site 0706), Valencia, Valenciana, Comunitat, 46015, Spain|Instituto Oncologico Baselga.Hospital Quiron. ( Site 0707), Barcelona, 08023, Spain|Hospital Universitari Vall d Hebron ( Site 0701), Barcelona, 08035, Spain|Hospital Clinic I Provincial de Barcelona ( Site 0702), Barcelona, 08036, Spain|Clinica Universitaria Navarra - Madrid ( Site 0700), Madrid, 28027, Spain|Kaohsiung Chang Gung Memorial Hospital ( Site 2304), Kaohsiung City, 83301, Taiwan|National Cheng Kung University Hospital ( Site 2303), Tainan, 704, Taiwan|MacKay Memorial Hospital ( Site 2301), Taipei, 10449, Taiwan|Koo Foundation Sun Yat-Sen Cancer Center ( Site 2300), Taipei, 112, Taiwan|China Medical University Hospital ( Site 2302), Taipei, 40447, Taiwan|Chernihiv Medical Center of Modern Oncology ( Site 1520), Chernihiv, Chernihiv Oblast, 14029, Ukraine|Dnipropetrovsk City Multidiscipline Clinical Hosp. 4 of DRC ( Site 1502), Dnipro, Dnipropetrovsk Oblast, 49102, Ukraine|CI Krivorizhskiy oncology dispensery ( Site 1504), Kryviy Rih, Dnipropetrovsk Oblast, 50048, Ukraine|MI Precarpathian Clinical Oncology Center ( Site 1506), Ivano-Frankivsk, Ivano-Frankivsk Oblast, 76018, Ukraine|Grigoriev Institute for medical Radiology NAMS of Ukraine ( Site 1508), Kharkiv, Kharkivs’ka Oblast’, 61024, Ukraine|Communal non profit enterprise Regional Clinical Oncology Center ( Site 1512), Kharkiv, Kharkivs’ka Oblast’, 61070, Ukraine|SI-Zaytsev institute of general and urgent surgery-NAMS ( Site 1518), Kharkiv, Kharkivs’ka Oblast’, 61103, Ukraine|Medical Centre Consilium Medical ( Site 1514), Kyiv, Kyivska Oblast, 04050, Ukraine|Medical center of the Limited Liability Company Yulis ( Site 1517), Zaporizhzhia, Zaporizhzhia Oblast, 69035, Ukraine|Medical Centre LLC Oncolife ( Site 1510), Zaporizhzhya, Zaporizhzhia Oblast, 69104, Ukraine|Zhytomyr Regional Oncology Center ( Site 1515), Zhytomyr, Zhytomyr Oblast, 10002, Ukraine|Medical Center Verum ( Site 1501), Kyiv, 03039, Ukraine|Raigmore Hospital ( Site 0915), Inverness, Highland, IV2 3UJ, United Kingdom|Blackpool Victoria Hospital ( Site 0921), Blackpool, Lancashire, FY3 8NR, United Kingdom|Barts Health NHS Trust ( Site 0912), London, London, City of, EC1M 6BQ, United Kingdom|North West Cancer Centre ( Site 0922), Londonderry, London, City of, BT47 6SB, United Kingdom|Musgrove Park Hospital ( Site 0918), Taunton, Somerset, TA1 5DA, United Kingdom|The Christie NHS Foundation Trust ( Site 0914), Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Triple Negative Breast Neoplasms,DRUG: Atezolizumab|DRUG: Placebo|DRUG: Gemcitabine|DRUG: Capecitabine|DRUG: Carboplatin,ALL,"ADULT, OLDER_ADULT",PHASE3,595,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",1/11/18,10/23/24,"Florida Cancer Specialists - Fort Myers (Broadway), Fort Myers, Florida, 33916, United States|Florida Cancer Specialists & Research Institute, St. Petersburg, Florida, 33705, United States|The Valley Hospital, Paramus, New Jersey, 07652, United States|Magee-Woman's Hospital, Pittsburgh, Pennsylvania, 15213, United States|SCRI Oncology Partners, Nashville, Tennessee, 37203, United States|Inova Schar Cancer Institute, Fairfax, Virginia, 22031, United States|Hospital Provincial del Centenario, Rosario, 2000, Argentina|Instituto de Oncología de Rosario, Rosario, S2000KZE, Argentina|Clinical center University of Sarajevo, Sarajevo, 71000, Bosnia and Herzegovina|Oncocentro Serviços Medicos E Hospitalares Ltda, Fortaleza, Ceará, 60130-241, Brazil|Hospital Araujo Jorge, Goiânia, Goiás, 74605-070, Brazil|Hospital do Cancer de Pernambuco - HCP, Recife, Pernambuco, 50040-000, Brazil|Hospital Sao Vicente de Paulo, Passo Fundo, Rio Grande do Sul, 99010-090, Brazil|Hospital Nossa Senhora da Conceicao, Porto Alegre, Rio Grande do Sul, 91350-200, Brazil|Centro de Oncologia de Santa Catarina LTDA, Chapecó, Santa Catarina, 89812-211, Brazil|Instituto de Pesquisa Grupo NotreDame Intermedica, São Paulo, São Paulo, 01229-010, Brazil|Hospital Perola Byington, São Paulo, São Paulo, 01317-000, Brazil|Núcleo de Pesquisa São Camilo, São Paulo, São Paulo, 03102-002, Brazil|Bradford Hill Centro de Investigaciones Clinicas, Recoleta, 8420383, Chile|Clinica Vespucio, Santiago, 8241479, Chile|the First Affiliated Hospital of Bengbu Medical College, Anhui, DUMMY_VALUE, China|Cancer Hospital , Chinese Academy of Medical, Beijing, 100021, China|Peking University People's Hospital, Beijing, 100044, China|Beijing Cancer Hospital, Beijing, 100142, China|Jilin Cancer Hospital, Changchun, 132013, China|The First Affiliated Hospital, Chongqing Medical University, Chongqing, 400016, China|Fujian Medical University Union Hospital, Fujian, 350001, China|Sun Yat-sen Memorial Hospital, Guangzhou, 510000, China|Sir Run Run Shaw Hospital Zhejiang University, Hangzhou, 310016, China|Zhejiang Cancer Hospital, Hangzhou, 310022, China|Harbin Medical University Cancer Hospital, Harbin, 150081, China|The First Affiliated Hospital Of Jinzhou Medical University, Jinzhou, 121001, China|Jiangsu Province Hospital, Nanjing, 210036, China|The Affiliated Hospital of Medical College Qingdao University, Qingdao, 266003, China|Fudan University Shanghai Cancer Center, Shanghai, 200032, China|Shanxi Province Cancer Hospital, Taiyuan, DUMMY_VALUE, China|Tianjin Cancer Hospital, Tianjin, 300060, China|The First Affiliated Hospital of The Fourth Military Medical University (Xijing Hospital), Xi'an, 710032, China|Hospital Hermanos Ameijeiras, La Habana, 10300, Cuba|Instituto Nacional de Oncología y Radiología (INOR), La Habana, 10400, Cuba|Helsinki University Central Hospital, Helsinki, 00029, Finland|Tampere University Hospital, Tampere, 33520, Finland|Centre Georges-François Lecler, Dijon, 21034, France|Centre Leon Berard, Lyon, 69373, France|Institut Paoli-Calmettes, Marseille, 13009, France|Centre Régional de Lutte Contre Le Cancer Val D'aurelle Paul Lamarque, Montpellier, 34298, France|Centre Eugene Marquis, Rennes, 35042, France|Centre Alexis Vautrin, Vandœuvre-lès-Nancy, 54511, France|IGR, Villejuif, 94800, France|Universitätsklinikum ""Carl Gustav Carus"", Dresden, 01307, Germany|Klinikum Essen-Mitte Ev. Huyssens-Stiftung / Knappschafts GmbH, Essen, 45136, Germany|Varisano Klinikum Frankfurt Höchst GmbH, Frankfurt, 65929, Germany|Universitätsklinikum Halle (Saale), Halle, 06120, Germany|Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe, Hanover, 30625, Germany|Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, 69120, Germany|Medizinisches Zentrum für Hämatologie und Onkologie, München, 80639, Germany|Szent Margit Hospital, Budapest, 1032, Hungary|Orszagos Onkologiai Intezet, Budapest, 1122, Hungary|Budapesti Uzsoki Utcai Kórház, Budapest, 1145, Hungary|Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz, Miskolc, 3526, Hungary|Pécsi Tudományegyetem, Pécs, 7623, Hungary|Ospedale Antonio Perrino, Brindisi, Apulia, 72100, Italy|Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Napoli, Campania, 80131, Italy|Azienda Ospedaliero Universitaria San Martino, Genoa, Liguria, 16132, Italy|Ospedale San Raffaele S.r.l., Milan, Lombardy, 20132, Italy|Irccs Istituto Europeo Di Oncologia (IEO), Milan, Lombardy, 20141, Italy|Ospedale San Gerardo, Monza, Lombardy, 20900, Italy|Fondazione Del Piemonte Per L'oncologia Ircc Di Candiolo, Candiolo, Piedmont, 10060, Italy|Azienda Ospedaliero-Universitaria Careggi, Florence, Tuscany, 50134, Italy|IRCCS Istituto Oncologico Veneto (IOV), Padua, Veneto, 35128, Italy|Kazakh Scientific Research Institution Of Oncology and Radiology, Almaty, 050022, Kazakhstan|Centro Medico Dalinde, Mexico City, Mexico CITY (federal District), 06760, Mexico|Instituto Nacional de Cancerologia, Distrito Federal, 14080, Mexico|CENEIT Oncologicos, Mexico City, 03100, Mexico|Clinical Center of Montenegro, Podgorica, 81000, Montenegro|Centre Hospitalier Universitaire Hassan II, Fes, 30000, Morocco|Centre Hospitalier Universitaire Mohamed VI, Marrakesh, 40000, Morocco|Clinique specialise Menara, Marrakesh, 40000, Morocco|The Panama Clinic, Panama City, 32400, Panama|Instituto Nacional de Enfermedades Neoplasicas, Lima, Lima 34, Peru|?wi?tokrzyskie Centrum Onkologii, Kielce, 25-734, Poland|Narodowy Inst.Onkologii im.Sklodowskiej-Curie Panstw.Inst.Bad, Warsaw, 02-781, Poland|Hospital de Santa Maria, Lisbon, 1649-035, Portugal|Centro Hospitalar do Porto ? Hospital de Santo António, Porto, 4099-001, Portugal|Moscow City Oncology Hospital #62, Moscovskaya Oblast, Moscow Oblast, 143423, Russia|Moscow Clinical Scientific Center, Moscow, Moscow Oblast, 111123, Russia|FSBI ""National Medical Research Center of Oncology N.N. Blokhin?, Moscow, Moscow Oblast, 115478, Russia|Private Healthcare Institution Clinical Hospital RZhD Medicine, Saint Petersburg, Sankt-Peterburg, 195271, Russia|City Clinical Oncology Dispensary, SPb SBIH CCOD, Saint Petersburg, Sankt-Peterburg, 198255, Russia|FBI ""Scientific Research Institute of Oncology n. a. N. N. Petrov"", Saint Petersburg, Sankt-Peterburg, DUMMY_VALUE, Russia|Institute of Oncology and Radiology of Serbia, Belgrade, 11000, Serbia|University Hospital Medical Center Bezanijska kosa, Belgrade, 11080, Serbia|Oncology Institute of Vojvodina, Kamenitz, 21204, Serbia|Clinical Centre Nis, Clinic for Oncology, Niš, 18000, Serbia|National Cancer Centre, Singapore, 168583, Singapore|Wits Clinical Research, Johannesburg, 2193, South Africa|Medical Oncology Centre of Rosebank, Johannesburg, 2196, South Africa|Private Oncology Centre, Pretoria, 0081, South Africa|Seoul National University Bundang Hospital, Gyeonggi-do, 13620, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Severance Hospital, Yonsei University Health System, Seoul, 03722, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|Hospital de Cruces, Bilbao, Vizcaya, 48903, Spain|Hospital Universitari Vall d'Hebron, Barcelona, 08035, Spain|Hospital General Universitario Gregorio Marañon, Madrid, 28007, Spain|Hospital Ramon y Cajal, Madrid, 28034, Spain|Hospital Clinico Universitario Virgen de la Victoria, Málaga, 29010, Spain|Hospital Clínico Universitario de Valencia, Valencia, 46010, Spain|Ankara Oncology Hospital, Ankara, 06200, Turkey (Türkiye)|Ege University Medical Faculty, Bornova, ?zm?r, 35100, Turkey (Türkiye)|Trakya Universitesi Tip Fakultesi, Medikal Onkoloji Bilim Dali, Balkan Yerleskesi, Edirne, 22030, Turkey (Türkiye)|Medipol University Medical Faculty, Istanbul, 34214, Turkey (Türkiye)|Marmara University Pendik Training and Research Hospital, Istanbul, 34890, Turkey (Türkiye)|Necmettin Erbakan University Meram Medical Faculty, Konya, 42080, Turkey (Türkiye)|Velindre Cancer Centre, Cardiff, CF14 2TL, United Kingdom|University Hospital Coventry, Coventry, CV2 2DX, United Kingdom|Western General Hospital, Edinburgh, EH4 2XU, United Kingdom|Royal Lancaster Infirmary, Morecambe Bay Hospitals Nhs Trust, Lancaster, LA1 4RP, United Kingdom|Barts, London, EC1M6BQ, United Kingdom|Guys and St Thomas NHS Foundation Trust, Guys Hospital, London, SE1 9RT, United Kingdom|Christie Hospital NHS Trust, Manchester, M20 4BX, United Kingdom|Mount Vernon Cancer Centre, Northwood, HA6 2RN, United Kingdom|Royal Stoke University Hospital, Stoke-on-Trent, ST4 6QG, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Advanced Digestive System Neuroendocrine Neoplasm|Duodenal Neuroendocrine Tumor G1|Functional Pancreatic Neuroendocrine Tumor|Gastric Neuroendocrine Tumor|Intermediate Grade Lung Neuroendocrine Neoplasm|Low Grade Lung Neuroendocrine Neoplasm|Nonfunctional Pancreatic Neuroendocrine Tumor|Thymus Neoplasm,OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|DRUG: Ribociclib,ALL,"ADULT, OLDER_ADULT",PHASE2,21,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,8/25/15,6/5/19,"M D Anderson Cancer Center, Houston, Texas, 77030, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Lung Adenocarcinoma|Lung Neoplasms,DRUG: osimertinib|OTHER: Local Ablative Therapy (LAT),ALL,"ADULT, OLDER_ADULT",PHASE2,37,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/13/16,9/20/22,"National Institutes of Health Clinical Center, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Neoplasm Metastasis / Bone and Bones,OTHER: Data Collection,ALL,"ADULT, OLDER_ADULT",PHASE4,255,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER,12/18/14,1/31/24,"Anchorage, Alaska, 99503, United States|Tucson, Arizona, 85704, United States|Plantation, Florida, 33324, United States|Indianapolis, Indiana, 46202, United States|Ashland, Kentucky, 41101, United States|New Orleans, Louisiana, 70112, United States|Shreveport, Louisiana, 71103, United States|Baltimore, Maryland, 21201, United States|Boston, Massachusetts, 02114, United States|Detroit, Michigan, 48201, United States|Omaha, Nebraska, 68130, United States|Syracuse, New York, 13210, United States|Pittsburgh, Pennsylvania, 15215, United States|Watertown, South Dakota, 57201, United States|Seattle, Washington, 98109, United States|Darlinghurst, New South Wales, 2010, Australia|Westmead, New South Wales, 2145, Australia|Fitzroy, Victoria, 3065, Australia|Heidelberg, Victoria, 3084, Australia|Kortrijk, 8500, Belgium|Leuven, 3000, Belgium|Porto Alegre, Rio Grande do Sul, 90020-090, Brazil|Barretos/SP, São Paulo, 14784-400, Brazil|São Paulo, São Paulo, 01246-000, Brazil|Toronto, Ontario, M4N 3M5, Canada|Montreal, Quebec, H2X 0A9, Canada|Prague, 128 08, Czechia|Helsinki, 00290, Finland|Tampere, FIN-33520, Finland|Bordeaux, 33076, France|Nantes, 44805, France|Nîmes, 30029, France|Saint-Cloud, 92210, France|Tours, 37044, France|Villejuif, 94805, France|Ulm, Baden-Wurttemberg, 89091, Germany|Erlangen, Bavaria, 91054, Germany|München, Bavaria, 81377, Germany|Rostock, Mecklenburg-Vorpommern, 18107, Germany|Aachen, North Rhine-Westphalia, 52074, Germany|Mainz, Rhineland-Palatinate, 55131, Germany|Dresden, Saxony, 01307, Germany|Magdeburg, Saxony-Anhalt, 39120, Germany|Jena, Thuringia, 07747, Germany|Berlin, 10719, Germany|Berlin, 12203, Germany|Bremen, 28277, Germany|Chai Wan, 0, Hong Kong|Afula, 1834111, Israel|Haifa, 3109601, Israel|Jerusalem, 9112001, Israel|Petah Tikva, 4941492, Israel|Ramat Gan, 5262000, Israel|Tel Aviv, 6423906, Israel|Zrifin, 7030000, Israel|Forlì Cesena, Emilia-Romagna, 47014, Italy|Modena, Emilia-Romagna, 41124, Italy|Rome, Lazio, 00161, Italy|Rome, Lazio, 00189, Italy|Milan, Lombardy, 20133, Italy|Trento, Trentino-Alto Adige, 38100, Italy|Matsuyama, Ehime, 791-0280, Japan|Sapporo, Hokkaido, 003-0804, Japan|Sapporo, Hokkaido, 060-8648, Japan|Kanazawa, Ishikawa-ken, 920-8641, Japan|Yokohama, Kanagawa, 236-0004, Japan|Yokohama, Kanagawa, 241-8515, Japan|Kurashiki, Okayama-ken, 701-0192, Japan|Sayama, Osaka, 589-8511, Japan|Hidaka, Saitama, 350-1298, Japan|Kita-Adachigun, Saitama, 362-0806, Japan|Koto-ku, Tokyo, 135-8550, Japan|Fukuoka, 811-1395, Japan|Kumamoto, 860-0008, Japan|Miyazaki, 889-1692, Japan|Osaka, 540-0006, Japan|Bodø, 8092, Norway|Oslo, 0424, Norway|Bialystok, 15-027, Poland|Gliwice, 44-101, Poland|Warsaw, 02-781, Poland|Obninsk, 249036, Russia|Singapore, 119074, Singapore|Singapore, 168583, Singapore|Seoul, Seoul Teugbyeolsi, 3080, South Korea|Seoul, Seoul Teugbyeolsi, 6273, South Korea|Daegu, 42601, South Korea|Incheon, South Korea|Seoul, 138-736, South Korea|Seoul, 3722, South Korea|Badalona (Barcelona), Barcelona, 08916, Spain|Palma de Mallorca, Illes Baleares, 7120, Spain|A Coruña, 15009, Spain|Barcelona, 08035, Spain|Barcelona, 08036, Spain|Barcelona, 08041, Spain|Madrid, 28007, Spain|Madrid, 28040, Spain|Madrid, 28050, Spain|Málaga, 29010, Spain|Pamplona, 31008, Spain|Seville, 41013, Spain|Seville, 41071, Spain|Umeå, 901 85, Sweden|Kaohsiung City, 81362, Taiwan|Taichung, 40705, Taiwan|Taipei, 11217, Taiwan|Taipei, Taiwan|Taoyuan District, 33305, Taiwan|Truro, Cornwall, TR1 3LJ, United Kingdom|Plymouth, Devon, PL6 8DH, United Kingdom|Sheffield, South Yorkshire, S10 2SJ, United Kingdom|Guildford, Surrey, GU2 7XX, United Kingdom|Sutton, Surrey, SM2 5PT, United Kingdom|Coventry, Warwickshire, CV2 2DX, United Kingdom|Bristol, BS2 8ED, United Kingdom|Cottingham, HU16 5JQ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Triple Negative Breast Neoplasms,BIOLOGICAL: Pembrolizumab|DRUG: Nab-paclitaxel|DRUG: Anthracycline (doxorubicin)|DRUG: Cyclophosphamide|DRUG: Carboplatin|DRUG: Paclitaxel,FEMALE,"ADULT, OLDER_ADULT",PHASE1,60,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/27/16,11/18/19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Thyroid Carcinoma|Thyroid Cancer|Thyroid Cancer, Follicular|Thyroid Cancer (Follicular Cell)|Thyroid Cancer, Papillary|BRAF V600E Mutation Positive",DIAGNOSTIC_TEST: I-124 PET/CT lesion dosimetry|DRUG: Vemurafenib|DRUG: Copanlisib,ALL,"ADULT, OLDER_ADULT",PHASE1,8,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,6/26/20,9/29/23,"Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, 07920, United States|Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, 07748, United States|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, 07645, United States|Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities), Commack, New York, 11725, United States|Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison, New York, 10604, United States|Memorial Sloan-Kettering Cancer Center (All protocol activities), New York, New York, 10065, United States|Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York, 11553, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Prostatic Neoplasms, Castration-Resistant",DRUG: BI 836845|DRUG: Enzalutamide|DRUG: Enzalutamide,MALE,"ADULT, OLDER_ADULT",PHASE1,120,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/11/14,6/1/23,"Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|NewYork-Presbyterian/Weill Cornell Medical Center, New York, New York, 10065, United States|Oregon Health and Sciences University, Portland, Oregon, 97239, United States|Prince of Wales Hospital, Hong Kong, 999077, Hong Kong|Queen Mary Hospital, Hong Kong, 999077, Hong Kong|Erasmus MC - Daniel den Hoed, Rotterdam, 3075 EA, Netherlands|Tweesteden Ziekenhuis, locatie Tilburg, Tilburg, 5042 AD, Netherlands|National Cancer Centre Singapore, Singapore, 169610, Singapore|OncoCare Cancer Centre, Singapore, 258499, Singapore|Tan Tock Seng Hospital, Singapore, 308433, Singapore|Samsung Medical Center, Seoul, 135-710, South Korea|Asan Medical Center, Seoul, 138-736, South Korea|Hospital Vall d'Hebron, Barcelona, 08035, Spain|Hospital Clínic de Barcelona, Barcelona, 08036, Spain|Hospital Santa Creu i Sant Pau, Barcelona, 08041, Spain|Hospital Duran i Reynals, L'Hospitalet de Llobregat, 08908, Spain|Hospital General Universitario Gregorio Marañón, Madrid, 28007, Spain|Hospital Ramón y Cajal, Madrid, 28034, Spain|Instituto Valenciano de Oncología, Valencia, 46009, Spain|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|National Taiwan University Hospital, Taipei, 100, Taiwan|Taipei Veterans General Hospital, Taipei, 11217, Taiwan|The Clatterbridge Cancer Centre, Bebington, Wirral, CH63 4JY, United Kingdom|Velindre Cancer Centre, Cardiff, CF14 2TL, United Kingdom|The Christie Hospital, Manchester, M20 4BX, United Kingdom|Churchill Hospital, Oxford, OX3 7LE, United Kingdom|The Royal Marsden Hospital, Sutton, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Locally Advanced or Metastatic Solid Tumor,DRUG: Rebastinib|DRUG: Carboplatin,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,70,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,1/2/19,11/1/22,"University of California San Francisco (UCSF), San Francisco, California, 94115, United States|UCLA Medical Center, Santa Monica, California, 90404, United States|University of Chicago, Chicago, Illinois, 60637, United States|University of Kansas Medical Center, Kansas City, Kansas, 66160, United States|Levine Cancer Institute, Charlotte, North Carolina, 28204, United States|The Ohio State University, Columbus, Ohio, 43210, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|NEXT Oncology, San Antonio, Texas, 78240, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Triple Negative Breast Neoplasms,DRUG: alpelisib|DRUG: placebo|DRUG: nab-paclitaxel,ALL,"ADULT, OLDER_ADULT",PHASE3,137,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",6/8/20,1/13/26,"University of California LA, Los Angeles, California, 90095, United States|Hematology and Oncology Clinic, Baton Rouge, Louisiana, 70809, United States|Mayo Clinic Rochester, Rochester, Minnesota, 55905, United States|Park Nicollet Institute, Saint Louis Park, Minnesota, 55416, United States|SCRI Oncology Partners, Nashville, Tennessee, 37203, United States|Novartis Investigative Site, Rosario, Santa Fe Province, S2000KZE, Argentina|Novartis Investigative Site, CABA, C1113AAE, Argentina|Novartis Investigative Site, Melbourne, Victoria, 3000, Australia|Novartis Investigative Site, Nedlands, Western Australia, 6009, Australia|Novartis Investigative Site, Innsbruck, Tyrol, 6020, Austria|Novartis Investigative Site, Leoben, A 8700, Austria|Novartis Investigative Site, Barretos, São Paulo, 14784 400, Brazil|Novartis Investigative Site, São Paulo, São Paulo, 01317-002, Brazil|Novartis Investigative Site, São Paulo, São Paulo, 04014-002, Brazil|Novartis Investigative Site, Plovdiv, 4004, Bulgaria|Novartis Investigative Site, Hefei, Anhui, 230001, China|Novartis Investigative Site, Shijiazhuang, Hebei, 050011, China|Novartis Investigative Site, Changsha, Hunan, 410013, China|Novartis Investigative Site, Nanjing, Jiangsu, 210029, China|Novartis Investigative Site, Nanchang, Jiangxi, 330009, China|Novartis Investigative Site, Changchun, Jilin, 130021, China|Novartis Investigative Site, Shengyang, Liaoning, 110042, China|Novartis Investigative Site, Shenyang, Liaoning, 110011, China|Novartis Investigative Site, Chengdu, Sichuan, 610041, China|Novartis Investigative Site, Hangzhou, Zhejiang, 310016, China|Novartis Investigative Site, Dalian, 116000, China|Novartis Investigative Site, Shanghai, 200025, China|Novartis Investigative Site, Tianjin, 300480, China|Novartis Investigative Site, Bogotá, 110221, Colombia|Novartis Investigative Site, Zagreb, 10000, Croatia|Novartis Investigative Site, Saint-Cloud, Hauts De Seine, 92210, France|Novartis Investigative Site, Angers, 49055, France|Novartis Investigative Site, Saint-Herblain, 44805, France|Novartis Investigative Site, Villejuif, 94800, France|Novartis Investigative Site, Dresden, Saxony, 01307, Germany|Novartis Investigative Site, Leipzig, Saxony, 04103, Germany|Novartis Investigative Site, Essen, 45136, Germany|Novartis Investigative Site, Budapest, 1134, Hungary|Novartis Investigative Site, Faridabad, Haryana, 121 001, India|Novartis Investigative Site, Mumbai, Maharashtra, 400056, India|Novartis Investigative Site, Vellore, Tamil Nadu, 632 004, India|Novartis Investigative Site, Hyderabad, Telangana, 500034, India|Novartis Investigative Site, Tel Aviv, 6423906, Israel|Novartis Investigative Site, Meldola, FC, 47014, Italy|Novartis Investigative Site, Roma, RM, 00128, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Petaling Jaya, Selangor, 46050, Malaysia|Novartis Investigative Site, Kuala Lumpur, 59100, Malaysia|Novartis Investigative Site, Monterrey, Nuevo León, 64460, Mexico|Novartis Investigative Site, Oslo, NO-0407, Norway|Novartis Investigative Site, Trujillo, La Libertad, 13011, Peru|Novartis Investigative Site, Gdynia, 81 519, Poland|Novartis Investigative Site, Opole, 45-061, Poland|Novartis Investigative Site, Poznan, 61 485, Poland|Novartis Investigative Site, Arkhangelsk, 163045, Russia|Novartis Investigative Site, Chelyabinsk, 454048, Russia|Novartis Investigative Site, Moscow, 117997, Russia|Novartis Investigative Site, Moscow, 123056, Russia|Novartis Investigative Site, Saint Petersburg, 196603, Russia|Novartis Investigative Site, Bratislava, 812 50, Slovakia|Novartis Investigative Site, Bratislava, 83310, Slovakia|Novartis Investigative Site, Košice, 041 91, Slovakia|Novartis Investigative Site, Ljubljana, 1000, Slovenia|Novartis Investigative Site, Port Elizabeth, Western Cape, 6045, South Africa|Novartis Investigative Site, Johannesburg, 2196, South Africa|Novartis Investigative Site, Seoul, 03080, South Korea|Novartis Investigative Site, Seoul, 05505, South Korea|Novartis Investigative Site, Seoul, 06351, South Korea|Novartis Investigative Site, Palma, Balearic Islands, 07120, Spain|Novartis Investigative Site, Badajoz, Extremadura, 06080, Spain|Novartis Investigative Site, Alicante, 03010, Spain|Novartis Investigative Site, Lausanne, 1011, Switzerland|Novartis Investigative Site, Taipei, 10002, Taiwan|Novartis Investigative Site, Taipei, 10449, Taiwan|Novartis Investigative Site, Istanbul, Fatih, 34098, Turkey (Türkiye)|Novartis Investigative Site, Istanbul, Kadikoy, 34722, Turkey (Türkiye)|Novartis Investigative Site, Nottingham, NG5 1PB, United Kingdom|Novartis Investigative Site, Oxford, OX3 7LE, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Cancer|Breast Tumors|Metastatic Cancer,DRUG: AMG 479|DRUG: Placebo,FEMALE,"ADULT, OLDER_ADULT",PHASE2,156,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",3/27/08,9/23/11,"Research Site, Chandler, Arizona, 85224, United States|Research Site, Anaheim, California, 92801, United States|Research Site, Beverly Hills, California, 90211, United States|Research Site, Concord, California, 94520, United States|Research Site, Duarte, California, 91010, United States|Research Site, Montebello, California, 90640, United States|Research Site, San Francisco, California, 94115, United States|Research Site, Sylmar, California, 91342, United States|Research Site, Stamford, Connecticut, 06902, United States|Research Site, Boca Raton, Florida, 33428, United States|Research Site, Boynton Beach, Florida, 33435, United States|Research Site, Coral Springs, Florida, 33065, United States|Research Site, Gainesville, Florida, 32605, United States|Research Site, Lake Worth, Florida, 33467, United States|Research Site, Atlanta, Georgia, 30309, United States|Research Site, Marietta, Georgia, 30060, United States|Research Site, Chicago, Illinois, 60637, United States|Research Site, Lebanon, New Hampshire, 03756, United States|Research Site, Denville, New Jersey, 07834, United States|Research Site, High Point, North Carolina, 27262, United States|Research Site, Hershey, Pennsylvania, 17033, United States|Research Site, Pittsburgh, Pennsylvania, 15213, United States|Research Site, Memphis, Tennessee, 38120, United States|Research Site, American Fork, Utah, 84003, United States|Research Site, Tacoma, Washington, 98405, United States|Research Site, Waratah, New South Wales, 2298, Australia|Research Site, Woodville South, South Australia, 5011, Australia|Research Site, Footscray, Victoria, 3011, Australia|Research Site, Geelong, Victoria, 3220, Australia|Research Site, Malvern, Victoria, 3144, Australia|Research Site, Vancouver, British Columbia, V5Z 4E6, Canada|Research Site, Ottawa, Ontario, K1H 8L6, Canada|Research Site, Sault Ste. Marie, Ontario, P6B 0A8, Canada|Research Site, Toronto, Ontario, M5G 2M9, Canada|Research Site, Montreal, Quebec, H1T 2M4, Canada|Research Site, Dijon, 21079, France|Research Site, Le Mans, 72000, France|Research Site, Lyon, 69008, France|Research Site, Montpellier, 34298, France|Research Site, Nice, 06182, France|Research Site, Paris, 75248, France|Research Site, Reims, 51056, France|Research Site, Saint-Herblain, 44800, France|Research Site, Frankfurt, 60590, Germany|Research Site, Frankfurt, 65929, Germany|Research Site, Hanover, 30177, Germany|Research Site, Munich, 80637, Germany|Research Site, Dublin, 4, Ireland|Research Site, Dublin, 8, Ireland|Research Site, Barcelona, CataluÃ±a, 08003, Spain|Research Site, L'Hospitalet de Llobregat, CataluÃ±a, 08907, Spain|Research Site, Sabadell, CataluÃ±a, 08208, Spain|Research Site, Madrid, 28040, Spain|Research Site, Chur, 7000, Switzerland|Research Site, Lucerne, 6000, Switzerland|Research Site, Zurich, 8032, Switzerland|Research Site, Derby, DE22 3DT, United Kingdom|Research Site, London, W6 8RF, United Kingdom|Research Site, Manchester, M20 4BX, United Kingdom|Research Site, Peterborough, PE3 9GZ, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Brain and Central Nervous System Tumors,DRUG: Induction Chemotherapy|DRUG: Low-Risk Therapy|DRUG: High-Risk Therapy|DRUG: Intermediate-Risk Therapy,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, particularly in the context of diffusion tensor imaging (DTI) used in MRI scans. FA values range from 0 to 1, From baseline (month 0) to 60 months (therapy duration lasted approximately 48 weeks or 11 months)|Change in Neurostructure, Especially White Matter Volume and Integrity, Quantitative MRI measures Fractional Anisotropy (FA) change per month in left occipital lobe over time in each risk group will be assessed using a random effects model incorporating various covariates. Covariates to be considered include age at diagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, particularly in the context of diffusion tensor imaging (DTI) used in MRI scans. FA values range from 0 to 1, From baseline (month 0) to 60 months (therapy duration lasted approximately 48 weeks or 11 months)|Change in Neurostructure, Especially White Matter Volume and Integrity, Quantitative MRI measures Fractional Anisotropy (FA) change per month in right temporal lobe over time in each risk group will be assessed using a random effects model incorporating various covariates. Covariates to be considered include age at diagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, particularly in the context of diffusion tensor imaging (DTI) used in MRI scans. FA values range from 0 to 1, From baseline (month 0) to 60 months (therapy duration lasted approximately 48 weeks or 11 months)|Change in Neurostructure, Especially White Matter Volume and Integrity, Quantitative MRI measures Fractional Anisotropy (FA) change per month in left temporal lobe over time in each risk group will be assessed using a random effects model incorporating various covariates. Covariates to be considered include age at diagnosis,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, particularly in the context of diffusion tensor imaging (DTI) used in MRI scans. FA values range from 0 to 1, From baseline (month 0) to 60 months (therapy duration lasted approximately 48 weeks or 11 months)|Change in Quantitative Magnetic Resonance (MR) Measures in the Frontal Lobe, Quantitative MRI measures Fractional Anisotropy (FA) change per month in frontal lobe over time in each risk group will be assessed using a random effects model incorporating various covariates. Covariates to be considered include age at diagnosis, time since diagnosis and risk-arm. Differences in quantitative MRI measures of neurostructure volume and integrity between patient groups will be evaluated as a metric of structural neurotoxicity of therapy.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, particularly in the context of diffusion tensor imaging (DTI) used in MRI scans. FA values range from 0 to 1, From baseline (month 0) to 60 months (therapy duration lasted approximately 48 weeks or 11 months)|Change in Quantitative MR Measures in the Right Frontal-parietal Regions, Quantitative MRI measures Fractional Anisotropy (FA) change per month in right frontal-parietal region over time in each risk group will be assessed using a random effects model incorporating various covariates. Covariates to be considered include age at diagnosis, time since diagnosis and risk-arm. Differences in quantitative MRI measures of neurostructure volume and integrity between patient groups will be evaluated as a metric of structural neurotoxicity of therapy.,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, particularly in the context of diffusion tensor imaging (DTI) used in MRI scans. FA values range from 0 to 1," From baseline (month 0) to 60 months (therapy duration lasted approximately 48 weeks or 11 months)""",ALL,CHILD,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,12/17/07,2026-04,"Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California, 94304, United States|Rady Children's Hospital, San Diego, California, 92123, United States|Children's Hospitals and Clinics of Minnesota - St. Paul, Saint Paul, Minnesota, 55102, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, 75390, United States|Lady Cilento Children's Hospital, Brisbane, Brisbane, Queensland, 4029, Australia",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Head and Neck Neoplasms,DRUG: SCB01A,ALL,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,4/30/17,11/20/18,"National Cheng Kung University Hospital, Tainan, Taiwan|Suang Ho Hospital, Taipei, Taiwan|Taipei Medical University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,MSI Positive Colorectal Cancer|MSI Negative Colorectal Cancer|MSI Positive Non-Colorectal Cancers,DRUG: MK-3475,ALL,"ADULT, OLDER_ADULT",PHASE2,113,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2013-09,2019-08,"Stanford University, Stanford, California, 94305, United States|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, 21231, United States|Investigator Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, NIH, Bethesda, Maryland, 20892, United States|Ohio State University, Columbus, Ohio, 43210, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|University of Pennsylvania, Abramson Cancer Center, Philadelphia, Pennsylvania, 19104, United States|University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15232, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Warts, Genital|Neoplasms, Anal",BIOLOGICAL: V503|OTHER: Placebo,MALE,"CHILD, ADULT",PHASE3,1059,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION",11/30/20,7/23/25,"Umeyama Clinic ( Site 6406), Takasaki, Gunma, 370-0826, Japan|Association of Healthcare Corporation Koukankai Koukan Clinic ( Site 6424), Kawasaki, Kanagawa, 210-0852, Japan|Ocean Clinic ( Site 6407), Yokohama, Kanagawa, 231-8331, Japan|Kanno Clinic ( Site 6402), Sakai, Osaka, 590-0024, Japan|P-One Clinic, Keikokai Medical Corp. ( Site 6419), Hachiōji, Tokyo, 192-0071, Japan|Iwasa Clinic ( Site 6411), Osaka, 542-0073, Japan|Nomura Clinic Namba ( Site 6405), Osaka, 542-0076, Japan|Medical Corporation Seiwakai Hayakawa Clinic ( Site 6409), Osaka, 542-0086, Japan|Yamanaka Clinic ( Site 6410), Osaka, 553-0001, Japan|Doujin Memorial Medical Foundation, Meiwa Hospital ( Site 6404), Tokyo, 101-0041, Japan|Yuge Clinic ( Site 6421), Tokyo, 103-0014, Japan|Taisei Clinic ( Site 6403), Tokyo, 107-0052, Japan|Mildix Skin Clinic ( Site 6423), Tokyo, 120-0034, Japan|Sugisawa Dermatology Clinic ( Site 6422), Tokyo, 125-0041, Japan|Medical Corporation Sanshikai Toru Clinic ( Site 6401), Tokyo, 132-0011, Japan|Medical Corporation Mori to Umi Tokyo Tokyo Kamata Hospital ( Site 6418), Tokyo, 144-0051, Japan|Seiyukai Medical Corporation Itoh Skin Clinic ( Site 6416), Tokyo, 154-0024, Japan|Naoko Dermatology Clinic ( Site 6417), Tokyo, 158-0097, Japan|Medical Corporation Iseikai My City Clinic ( Site 6414), Tokyo, 160-0022, Japan|Shinjuku Higashiguchi Clinic ( Site 6415), Tokyo, 160-0022, Japan|Ogikuboekimae Clinic ( Site 6413), Tokyo, 167-0051, Japan|Kusunoki Clinic ( Site 6412), Tokyo, 175-0092, Japan",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Small Cell Lung Carcinoma|Non Small Cell Lung Carcinoma|Irinotecan Sensitive Cancers,DRUG: Carfilzomib|DRUG: Irinotecan,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,78,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,2013-11,7/1/19,"Cancer Treatment Centers of America, Western Regional Medical Center, Goodyear, Arizona, 85338, United States|University of Kentucky Markey Cancer Center, Lexington, Kentucky, 40536, United States|Norton Cancer Institute, Louisville, Kentucky, 40202, United States|Washington University School of Medicine, St Louis, Missouri, 63110, United States|Providence Portland Medical Center | Earle A. Chiles Research Institute, Portland, Oregon, 97213, United States|University of Texas Medical Branch at Galveston, Galveston, Texas, 77555, United States|Virginia Mason Cancer Institute, Seattle, Washington, 98111, United States|Aurora Research Institute | Aurora Cancer Care, Wauwatosa, Wisconsin, 53226, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Triple Negative Breast Neoplasms,DRUG: 350 mg leronlimab|DRUG: 525 mg leronlimab|DRUG: 700 mg leronlimab|DRUG: AUC 5 Carboplatin|DRUG: Maximum Tolerated Dose (MTD) of leronlimab,FEMALE,"ADULT, OLDER_ADULT",PHASE1|PHASE2,10,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,4/22/19,9/16/22,"Quest Clinical Research, San Francisco, California, 94115, United States|CD07 Investigational Site, Chicago, Illinois, 60611, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Prostatic Neoplasms, Castration-Resistant",DRUG: Atezolizumab|DRUG: Enzalutamide,MALE,"ADULT, OLDER_ADULT",PHASE3,759,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/10/17,12/20/22,"City of Hope Medical Grp Inc., Duarte, California, 91010, United States|University of California San Diego, La Jolla, California, 92037-1337, United States|Kaiser Permanente San Diego - Los Angeles, Los Angeles, California, 90027, United States|UC Irvine Medical Center, Orange, California, 92868, United States|Pacific Hematology Oncology Associates, San Francisco, California, 94115, United States|University of Colorado; Division of Medical Oncology, Aurora, Colorado, 80021, United States|Yale School of Medicine, New Haven, Connecticut, 06510-3206, United States|Stamford Hospital; BCC, MOHR, Stamford, Connecticut, 06904, United States|Lynn Cancer Institute/Boca Raton Regional Hospital, Boca Raton, Florida, 33486, United States|SCRI Florida Cancer Specialists South, Fort Myers, Florida, 33916, United States|Miami Cancer Institute of Baptist Health, Inc., Miami, Florida, 33176, United States|Florida Cancer Specialist, North Region, St. Petersburg, Florida, 33705, United States|Investigative Clin Rsch of IN, Indianapolis, Indiana, 46260, United States|Associates in Oncology/Hematology P.C., Rockville, Maryland, 20850, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute.., Detroit, Michigan, 48201, United States|Nebraska Cancer Specialists; Oncology Hematology West, PC, Omaha, Nebraska, 68130, United States|Urology Cancer Center & GU Research Network, Omaha, Nebraska, 68130, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89128, United States|MSKCC at Basking Ridge, Basking Ridge, New Jersey, 07920, United States|New York Oncology Hematology, P.C., Albany, New York, 12208, United States|Columbia University Medical Center, New York, New York, 10032, United States|Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, United States|Oncology Hematology Care, Inc., Cincinnati, Ohio, 45230, United States|James Cancer Hospital;Solove Research Institute, Columbus, Ohio, 43210, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|Allegheny Cancer Center, Pittsburgh, Pennsylvania, 15212, United States|University of Pittsburgh Cancer Institute; Division of Medical Oncology, Pittsburgh, Pennsylvania, 15232, United States|Miriam Hospital, Providence, Rhode Island, 02906, United States|Charleston Oncology, P .A, Charleston, South Carolina, 29414, United States|Carolina Urologic Research Center, Myrtle Beach, South Carolina, 29572, United States|Sarah Cannon Research Institute / Tennessee Oncology, Chattanooga, Tennessee, 37404, United States|Texas Oncology Cancer Center, Austin, Texas, 78731, United States|Texas Oncology - Methodist Dallas Cancer Center, Dallas, Texas, 75203, United States|Texas Oncology, P.A. - Fort Worth, Fort Worth, Texas, 76104, United States|Texas Oncology - Memorial City, Houston, Texas, 77024, United States|Texas Oncology-Tyler, Irving, Texas, 75063, United States|Virginia Cancer Specialists - Alexandria, Alexandria, Virginia, 22304, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|Eastern Health; Cancer Services, Box Hill, New South Wales, 3128, Australia|Concord Repatriation General Hospital; Concord Cancer Centre, Concord, New South Wales, 2139, Australia|Macquarie University Hospital, Macquarie Park, New South Wales, 2113, Australia|Royal Brisbane & Women's Hosp; Cancer Care Serv, Herston, Queensland, 4029, Australia|Adelaide Cancer Centre, Kurralta Park, South Australia, 5037, Australia|Monash Medical Centre; Oncology, Clayton, Victoria, 3168, Australia|LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie, Graz, 8036, Austria|Ordensklinikum Linz Elisabethinen; Abteilung für Urologie und Andrologie, Linz, 4020, Austria|Medizinische Universität Wien; Universitätsklinik für Urologie, Vienna, 1090, Austria|Onze Lieve Vrouwziekenhuis Aalst, Aalst, 9300, Belgium|UZ Gent, Ghent, 9000, Belgium|CHU Sart-Tilman, Liège, 4000, Belgium|Tom Baker Cancer Centre-Calgary, Calgary, Alberta, T2N 4N2, Canada|Kingston General Hospital, Kingston, Ontario, K7L 2V7, Canada|Lakeridge Health Oshawa; Oncology, Oshawa, Ontario, L1G 2B9, Canada|Princess Margaret Cancer Center, Toronto, Ontario, M5G 1Z5, Canada|Hopital Charles Lemoyne; Centre Integre de Lutte Contre Le Cancer de La Monteregie, Greenfield Park, Quebec, J4V 2H1, Canada|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada|Centre Hospitalier Universitaire de Sherbrooke - Hopital Fleurimont, Sherbrooke, Quebec, J1H 5N4, Canada|CHU de Québec - Université Laval - Hôtel-Dieu de Québec, Québec, G1J 1Z4, Canada|Friendship Hospital, Capital Medical University, Beijing, 100050, China|Jiangsu Cancer Hospital, Nanjing, 211100, China|Zhongshan Hospital Fudan University, Shanghai, 200032, China|Fudan University Shanghai Cancer Center, Shanghai, 200120, China|Masarykuv onkologicky ustav, Brno, 656 53, Czechia|Fakultni nemocnice u sv. Anny v Brne, Brno, 656 91, Czechia|Thomayerova nemocnice, Praha 4 - Krc, 140 59, Czechia|Aalborg Universitetshospital; Onkologisk Afdeling, Aalborg, 9000, Denmark|Herlev Hospital; Afdeling for Kræftbehandling, Herlev, 2730, Denmark|Odense Universitetshospital, Onkologisk Afdeling R, Odense C, 5000, Denmark|Institut Sainte-Catherine; Oncologie, Avignon, 84082, France|Centre Francois Baclesse; Oncologie, Caen, 14076, France|Hopital Louis Pasteur; Medecine B, Colmar, 68024, France|Centre Oscar Lambret; Chir Cancerologie General, Lille, 59000, France|Clinique Chenieux; Oncology, Limoges, 87039, France|Hopital Saint Louis, Service D Oncologie Medicale, Paris, 75475, France|Hopital d'Instruction des Armees de Begin, Saint-Mandé, 94160, France|Institut Claudius Regaud; Departement Oncologie Medicale, Toulouse, 31059, France|Institut Gustave Roussy, Villejuif, 94805, France|Universitätsklinikum Freiburg; Chirurgische Klinik; Abteilung Urologie, Freiburg im Breisgau, 79106, Germany|Medizinische Hochschule Hannover; Klinik für Urologie und Onkologische Urologie, Hanover, 30625, Germany|Universitätsklinikum Münster, Klinik für Urologie und Kinderurologie, Münster, 48149, Germany|Universitätsklinikum Tübingen; Klinik für Urologie, Tübingen, 72076, Germany|Urologisches Zentrum Euregio; Würselen, Urologische Praxis am Wasserturm, Würselen, 52146, Germany|Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine, Athens, 115 22, Greece|Alexandras Hospital; Dept. of Clin. Therapeutics, Athens Uni School of Medicine, Athens, 115 28, Greece|Athens Medical Center; Dept. of Oncology, Athens, 151 25, Greece|IASO General Hospital of Athens, Athens, 155 62, Greece|Agioi Anargyroi Cancer Hospital; 2Nd Oncology Dept., Kifissia, 145 64, Greece|University Hospital of Patras Medical Oncology, Pátrai, 265 04, Greece|Papageorgiou General Hospital; Medical Oncology, Thessaloniki, 564 29, Greece|Semmelwies University of Medicine; Urology Dept., Budapest, 1082, Hungary|Orszagos Onkologiai Intezet; ""C"" Belgyógyászati-Onkológiai és Klinikai Farmakológiai Osztály, Budapest, 1122, Hungary|Debreceni Egyetem Klinikai Kozpont ; Department of Oncology, Debrecen, 4032, Hungary|Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica, Bari, Apulia, 70124, Italy|IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia, San Giovanni Rotondo, Apulia, 71013, Italy|ISTITUTO NAZIONALE TUMORI IRCCS FONDAZIONE G. PASCALE; Dipartimento Uro-Ginecologico, Napoli, Campania, 80131, Italy|A.O. Universitaria Policlinico Di Modena; Oncologia, Modena, Emilia-Romagna, 41124, Italy|Azienda Ospedaliera San Camillo Forlanini; Oncologia Medica, Rome, Lazio, 00152, Italy|IRCCS AOU San Martino - IST; Oncologia Medica 1, Genoa, Liguria, 16132, Italy|A.O. Istituti Ospitalieri - Cremona; S.C. Oncologia, Cremona, Lombardy, 26100, Italy|Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2, Milan, Lombardy, 20133, Italy|Irccs Istituto Europeo Di Oncologia (IEO); Cure Mediche, Milan, Lombardy, 20141, Italy|Ospedale Area Aretina Nord; U.O.C. Oncologia, Arezzo, Tuscany, 52100, Italy|IRCCS Istituto Oncologico Veneto (IOV); Oncologia Medica Prima, Padua, Veneto, 35128, Italy|Nagoya City University Hospital, Aichi, 467-8602, Japan|National Cancer Center East, Chiba, 277-8577, Japan|Toho University Sakura Medical Center, Chiba, 285-8741, Japan|Kyushu University Hospital, Fukuoka, 812-8582, Japan|National Hospital Organization Hokkaido Cancer Center, Hokkaido, 003-0804, Japan|Yokohama City University Medical Center, Kanagawa, 232-0024, Japan|Kitasato University Hospital, Kanagawa, 252-0375, Japan|University Hospital Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan|Nara Medical University Hospital, Nara, 634-8522, Japan|Niigata University Medical & Dental Hospital, Niigata, 951-8520, Japan|Kansai Medical University Hospital, Osaka, 573-1191, Japan|Toranomon Hospital, Tokyo, 105-8470, Japan|The Jikei University Hospital, Tokyo, 105-8471, Japan|Nippon Medical School Hospital, Tokyo, 113-8603, Japan|Woj. Wielospec. Centrum Onkologii i Traumatologii, ?ód?, 93-513, Poland|Medical University of Bialystok; Oncology clinic, Bialystok, 15-027, Poland|Przychodnia Lekarska KOMED, Roman Karaszewski, Konin, 62-500, Poland|Szpital Uniwersytecki w Krakowie, Oddzia? Kliniczny Kliniki Onkologii, Krakow, 30-688, Poland|SPZOZ Opolskie Centrum Onkologii im. Prof. Tadeusza Koszarawskiego, Opole, 45-061, Poland|Europejskie Centrum Zdrowia Otwock Szpital im. Fryderyka Chopina, Klinika Onkologii, Otwock, 05-400, Poland|Szpital Sw. Elzbiety - Mokotowskie Centrum Medyczne Sp. z o.o., Warsaw, 02-616, Poland|Wojewodzki Szpital; Specjalistyczny ul., Wroclaw, 51-124, Poland|Russian Scientific Center of Roentgenoradiology, Moscow, Moscow Oblast, 117997, Russia|P.A. Herzen Oncological Inst. ; Oncology, Moscow, Moscow Oblast, 125248, Russia|SBEI HPE ""The First St.Petersburg State Medical University n.a. acad. I.P.Pavlova""of MoH of RF, Saint Petersburg, Sankt-Peterburg, 197022, Russia|National Cancer Center, Goyang-si, 10408, South Korea|Seoul National University Hospital, Seoul, 03080, South Korea|Asan Medical Center, Seoul, 05505, South Korea|Samsung Medical Center, Seoul, 06351, South Korea|Institut Catala d?Oncologia Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Insititut Catala D'Oncologia, L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Corporacio Sanitaria Parc Tauli; Servicio de Oncologia, Sabadell, Barcelona, 8208, Spain|Hospital Universitario Reina Sofia; Servicio de Oncologia, Córdoba, Cordoba, 14004, Spain|Clinica Universitaria de Navarra; Servicio de Oncologia, Pamplona, Navarre, 31008, Spain|Hospital Universitari Vall d'Hebron; Oncology, Barcelona, 08035, Spain|Hospital Clínic i Provincial; Servicio de Oncología, Barcelona, 08036, Spain|Hospital de la Santa Creu i Sant Pau; Servicio de Oncologia, Barcelona, 08041, Spain|Hospital Ramon y Cajal; Servicio de Oncologia, Madrid, 28034, Spain|Hospital Clinico San Carlos; Servicio de Oncologia, Madrid, 28040, Spain|Hospital Universitario 12 de Octubre; Servicio de Oncologia, Madrid, 28041, Spain|Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia, Málaga, 29010, Spain|Hospital Universitario Virgen del Rocio; Servicio de Oncologia, Seville, 41013, Spain|Inselspital Bern; Universitätsklinik für Medizinische Onkologie, Klinische Forschungseinheit, Bern, 3010, Switzerland|Kantonsspital St. Gallen; Onkologie/Hämatologie, Sankt Gallen, 9007, Switzerland|Taichung Veterans General Hospital; Division of Urology, Taichung, 407, Taiwan|National Taiwan University Hospital, Department of Urology, Taipei, 10048, Taiwan|TAIPEI VETERANS GENERAL HOSPITAL, Urology, Taipei, 11217, Taiwan|Chang Gung Memorial Hospital-LinKou; Urology, Taoyuan District, 333, Taiwan|Royal Blackburn Hospital, Blackburn, BB2 3HH, United Kingdom|Leicester Royal Infirmary, Leicester, LE1 5WW, United Kingdom|Barts and the London NHS Trust., London, EC1A 7BE, United Kingdom|Sarah Cannon Research Institute, London, W1G 6AD, United Kingdom|The Christie NHS Foundation Trust, Manchester, M20 4BX, United Kingdom|Royal Marsden Hospital; Institute of Cancer Research, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Hepatoma|Liver Neoplasms|Adenoma, Liver Cell|Carcinoma, Hepatocellular|Liver Neoplasms, Experimental",DRUG: TRC 105|DRUG: Sorafenib,ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,27,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2/11/11,6/9/17,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Pediatric Central Nervous System Tumor,DRUG: tozuleristide|DEVICE: Canvas System,ALL,"CHILD, ADULT",PHASE2|PHASE3,118,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER,11/26/18,6/13/22,"Chlidren's Hospital Los Angeles, Los Angeles, California, 90027, United States|University of California, San Francisco, San Francisco, California, 94158, United States|University of Florida Shands Hospital, Gainesville, Florida, 32608, United States|Johns Hopkins University, Baltimore, Maryland, 21287, United States|Children's Hospital of Michigan, Detroit, Michigan, 48201, United States|Children's Minnesota, Saint Paul, Minnesota, 55102, United States|Washington University St. Louis Children's Hospital, St Louis, Missouri, 63110, United States|St. Jude Children's Research Hospital, Memphis, Tennessee, 38105, United States|Seattle Children's Hospital, Seattle, Washington, 98105, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,High Grade Anal Canal Intraepithelial Neoplasia|High Grade Vulvar Squamous Intraepithelial Lesion,OTHER: Laboratory Biomarker Analysis|OTHER: Placebo Administration|OTHER: Questionnaire Administration|BIOLOGICAL: Recombinant Human Papillomavirus Nonavalent Vaccine,ALL,"ADULT, OLDER_ADULT",PHASE4,188,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT",8/1/17,12/31/22,"University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, 35233, United States|Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, 98109, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Central Nervous System Neoplasms|Medulloblastoma,DRUG: Pomalidomide|DRUG: Pomalidomide,ALL,"CHILD, ADULT",PHASE2,53,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,9/18/17,9/14/23,"Stanford University Cancer Center, Stanford, California, 94305-5750, United States|University Of Florida, Gainesville, Florida, 32611, United States|Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois, 60611, United States|Local Institution - 506, Bethesda, Maryland, 20892, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Texas Children's Hospital, Houston, Texas, 77030, United States|Local Institution - 104, Lille, Nord, 59020, France|Local Institution - 102, Lyon, 69008, France|Local Institution - 103, Marseille, 13005, France|Local Institution - 100, Paris, 75005, France|Local Institution - 106, Toulouse, 31059, France|Local Institution - 105, Vandœuvre-lès-Nancy, 54511, France|Local Institution - 101, Villejuif, 94805, France|Local Institution - 201, Genova, 0, Italy|Local Institution - 200, Milan, 20133, Italy|Local Institution - 202, Roma, 00165, Italy|Local Institution - 302, Barcelona, 8035, Spain|Local Institution - 300, Madrid, 28009, Spain|Local Institution - 301, Valencia, 46026, Spain|Local Institution - 400, Leeds, LS7 4SA, United Kingdom|Local Institution - 403, London, WC1N 3JH, United Kingdom|Local Institution - 401, Sutton-Surrey, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Desmoplastic Small Round Cell Tumor,DRUG: Ramucirumab|DRUG: Cyclophosphamide|DRUG: Vinorelbine,ALL,"CHILD, ADULT",PHASE1|PHASE2,30,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,1/22/20,2026-10,"Phoenix Children's Hospital, Phoenix, Arizona, 85016, United States|Children's Hospital of Los Angeles, Los Angeles, California, 90027, United States|Children's National Medical Center, Washington D.C., District of Columbia, 20010, United States|Washington University, St Louis, Missouri, 63110, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, 19104, United States|Royal Children's Hospital, Parkville, Victoria, 3052, Australia|Universitaetsklinikum Freiburg, Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany|Universitaetsklinikum Essen, Essen, North Rhine-Westphalia, 45122, Germany|Universitaetsklinikum Hamburg-Eppendorf, Hamburg, 20251, Germany|Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardy, 20133, Italy|Humanitas, Rozzano, Milano, 20089, Italy|Ospedale Pediatrico Bambino Gesù, Rome, Roma, 165, Italy|Azienda Ospedaliera di Padova, Padua, Veneto, 35128, Italy|National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan|Kyushu University Hospital, Fukuoka, 812-8582, Japan|Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], 08035, Spain|Hospital Universitario Virgen Del Rocio, Seville, 41013, Spain|University College London Hospital, London, London, City of, NW1 2PG, United Kingdom|Royal Marsden Hospital (Sutton), London, Sutton, SM2 5PT, United Kingdom|Royal Manchester Children's Hospital, Manchester, M13 9WL, United Kingdom|The Christie, Manchester, M20 4BX, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,HER-2 Positive Breast Cancer|Metastatic Neoplasm,BIOLOGICAL: Margetuximab|BIOLOGICAL: Trastuzumab|DRUG: Physician's choice of chemotherapy.,ALL,"ADULT, OLDER_ADULT",PHASE3,624,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/24/15,6/14/22,"Ironwood Cancer & Research Center, Chandler, Arizona, 85224, United States|Banner MD Anderson Cancer Center, Gilbert, Arizona, 85234, United States|Western Regional Medical Center, Inc., Goodyear, Arizona, 85338, United States|East Valley Hematology And Oncology, Burbank, California, 91505, United States|UCLA Hematology Oncology Santa Monica, Los Angeles, California, 90095, United States|UC Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|Sharp Memorial Hospital, San Diego, California, 92123, United States|University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94115, United States|Kaiser Permenente Medical Center, Vallejo, California, 94589, United States|Poudre Valley Health Care, Inc., Fort Collins, Colorado, 80528, United States|MedStar Washington Hospital Center, Washington D.C., District of Columbia, 20010, United States|Florida Cancer Specialists, Fort Myers, Florida, 33916, United States|Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, 33021, United States|Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, 33140, United States|Florida Cancer Specialists, New Port Richey, Florida, 34655, United States|Orlndo Health Cancer Center, Orlando, Florida, 32806, United States|Hem-Onc Associates, Port Saint Lucie, Florida, 34952, United States|Palm Beach Cancer Center, West Palm Beach, Florida, 33401, United States|Piedmont Cancer Institute, P.C., Atlanta, Georgia, 30318, United States|Northwest Georgia Oncology Centers, PC, Marietta, Georgia, 30060, United States|CTCA - Southeastern Regional Medical Center, Newnan, Georgia, 30265, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, 96819, United States|Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611, United States|Rush University Medical Center, Chicago, Illinois, 60612, United States|Carle Cancer Center, Urbana, Illinois, 61801, United States|CTCA - Midwestern Regional Medical Center, Zion, Illinois, 60099, United States|Indiana University Health Goshen Center for Cancer Care, Goshen, Indiana, 46526, United States|ARH Cancer Clinic, Hazard, Kentucky, 41701, United States|St. Joseph's Hospital, Lexington, Kentucky, 40504, United States|Touro Infirmary Hospital, New Orleans, Louisiana, 70115, United States|New England Cancer Specialists, Scarborough, Maine, 04074, United States|Mercy Medical Center, Baltimore, Maryland, 21202, United States|Tufts-NEMC Cancer Center, Boston, Massachusetts, 02111, United States|Forrest General Hospital, Hattiesburg, Mississippi, 39401, United States|Saint Luke's Cancer Specialists, Kansas City, Missouri, 64111, United States|Mercy Hospital Saint Louis, St Louis, Missouri, 63141, United States|Dartmouth-Hitchcock - Norris C, Lebanon, New Hampshire, 03756, United States|New Jersey Hematology Oncology Associates, Brick, New Jersey, 08724, United States|Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|Saint Barnabas Medical Center - The Cancer Center, Livingston, New Jersey, 07039, United States|New Mexico Cancer Care Alliance (NMCCA), Albuquerque, New Mexico, 87106, United States|Queens Hospital Center, Jamaica, New York, 11432, United States|ProHEALTH CARE Associates, LLP, Lake Success, New York, 11042, United States|New York University Clinical Cancer Center, New York, New York, 10016, United States|Wake Forest University Baptist Medical Center (WFUBMC), Winston-Salem, North Carolina, 27157, United States|Mercy Physicians Of Oklahoma, Oklahoma City, Oklahoma, 73120, United States|Pinnacle Health Cancer Institute, Harrisburg, Pennsylvania, 17109, United States|Monongahela Valley Hospital, Monongahela, Pennsylvania, 15063, United States|CTCA - Eastern Regional Medical Center, Inc., Philadelphia, Pennsylvania, 19124, United States|Guthrie Medical Group, PC, Sayre, Pennsylvania, 18840, United States|Tennessee Oncology, PLLC, Chattanooga, Tennessee, 37404, United States|The Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Austin Cancer Center, Austin, Texas, 78758, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|The Center for Cancer and Blood Disorders, Fort Worth, Texas, 76104, United States|Utah Cancer Specialists, Salt Lake City, Utah, 84106, United States|University of Virginia Cancer Center, Charlottesville, Virginia, 22908, United States|Inova Schar Cancer Institute, Fairfax, Virginia, 22031, United States|Fort Belvoir Community Hospital, Fort Belvoir, Virginia, 22060, United States|Swedish Cancer Institute/ Swedish Health Services, Seattle, Washington, 98104, United States|University of Washington/ Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Cancer Care Northwest, PS, Spokane, Washington, 99202, United States|Medizinische Universität Innsbruck, Innsbruck, Tyrol, 6020, Austria|UZ Antwerpen, Edegem, Antwerpen, 2650, Belgium|GZA Ziekenhuizen - Campus Sint-Augustinus, Wilrijk, Antwerpen, 2610, Belgium|Clinique Saint-Pierre Ottignies, Ottignies, Brabant Wallon, 1340, Belgium|UZ Brussel - Campus Jette, Brussels, Brussels Capital, 1090, Belgium|Cliniques universitaires Saint-Luc, Brussels, Brussels Capital, 1200, Belgium|Jessa Ziekenhuis - Campus Virga Jesse, Hasselt, Limburg, 3500, Belgium|AZ Nikolaas - Campus Sint-Niklaas Moerland, Sint-Niklaas, Oost-Vlaanderen, 9100, Belgium|AZ Sint-Jan Brugge - Oostende - Campus Sint-Jan, Bruges, West-Vlaanderen, 8000, Belgium|AZ Groeninge - Campus Loofstraat, Kortrijk, West-Vlaanderen, 8500, Belgium|AZ Damiaan, Ostend, West-Vlaanderen, 8400, Belgium|Chc - Clinique Saint-Joseph, Liège, 4000, Belgium|Clinique Sainte Elisabeth, Namur, 5000, Belgium|Dr. Leon Richard Oncology Centre, Moncton, New Brunswick, E1C 8X3, Canada|Lakeridge Health Oshawa, Oshawa, Ontario, L1G 2B9, Canada|Masarykuv onkologicky ustav, Brno, Brno-město, 656 53, Czechia|Fakultni nemocnice Olomouc, Olomouc, 779 00, Czechia|Fakultni nemocnice v Motole, Prague, 150 06, Czechia|Aarhus Universitetshospital, Aarhus C, Central Jutland, 8000, Denmark|Regionshospitalet Herning (Herning Centralsygehus), Herning, Central Jutland, 7400, Denmark|Vejle Sygehus, Vejle, Region Syddanmark, 7100, Denmark|Næstved Sygehus, Aarhus N, Zeeland, 4700, Denmark|Tampere University Hospital, Tampere, Etelä-Suomen Lääni, 33521, Finland|Helsinki University Central Hospital (HUCH) - Meilahden Sair, Helsinki, Länsi-Suomen Lääni, 00029, Finland|Center de Lutte Contre le Cancer (CLCC), Nice, Alpes-Martitimes, 06189, France|Centre Léon Bérard, Lyon, Auvergne-Rhône-Alpes, 69373, France|Center de Lutte Contre le Cancer (CLCC), Caen, Calvados, 14076, France|Centre Georges-François Lecler, Dijon, Côte-d'Or, 21079, France|Centre de Lutte Contre le Cancer (CLCC) - Institut de Cancer, Saint-Herblain, Loire-Atlantique, 44805, France|Centre Jean Perrin, Clermont-Ferrand, Puy-de-Dôme, 63011, France|Institut Curie, Paris, Île-de-France Region, 75005, France|Institut Curie - Hôpital René Huguenin, Saint-Cloud, Île-de-France Region, 92210, France|Universitaetsklinikum Tuebingen, Tübingen, Baden-Wurttemberg, 72076, Germany|Universitätsklinikum Erlangen, Erlangen, Bavaria, 91054, Germany|Praxis für Frauenheilkunde Anita, München, Bavaria, 81925, Germany|Marien Hospital Düsseldorf, Düsseldorf, Nordhein-Westfalen, 40479, Germany|Universitaetsklinikum Essen - Klinik fuer Frauenheilkunde, Essen, North Rhine-Westphalia, 45122, Germany|Marien Hospital, Witten, North Rhine-Westphalia, 58452, Germany|Medizinische Fakultät Carl Gustav Carus, Dresden, Saxony, 01307, Germany|Universtatsklinikum Heidelberg Nationales, Heidelberg, Germany|Meir Medical Center, Kfar Saba, Central District, 44281, Israel|Rabin Medical Center - Beilinson Hospital, Petah Tikva, Central District, 49100, Israel|The Chaim Sheba Medical Center - Insititute of Oncology, Ramat Gan, Central District, 52621, Israel|Kaplan Medical Center, Rehovot, Central District, 761001, Israel|Hadassah Medical Organisation, Hadassah Medical Center, Ein-Karem, Jerusalem, Jerusalem, 91120, Israel|Soroka Medical Center [Oncology], Beersheba, Southern District, 84802, Israel|Clalit Health Services - Lin Medical Center, Haifa, 35152, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel|PO Garibaldi-Nesima, ARNAS Garibaldi, Catania, Cantania, 95122, Italy|Irccs Irst, Meldola, Forli, 47014, Italy|Istituto di Candiolo, IRCCS, Candiolo, Torino, 10060, Italy|Azienda Ospedaliero Universitaria Senese Universita degli St, Siena, Tuscany, 53100, Italy|Ospedale Umberto I, AOU Ospedali Riuniti Umberto I - GM.Lanc, Ancona, 60126, Italy|AO G.Rummo, Benevento, 82100, Italy|ASST Papa Giovanni XXIII - Oncologia-Bergamo, Bergamo, 24127, Italy|PO di Cremona, ASST di Cremona - Patologia Mammaria e Breast Unit - Cremona, Cremona, 26100, Italy|Arcispedale S.Anna, AOU di Ferrara, Ferrara, 44124, Italy|E.O. Ospedali Galliera, Genova, 16128, Italy|PO A.Manzoni di Lecco, ASST Lecco - Oncologia Medica - Lecco, Lecco, 23900, Italy|Azienda Ospedaliera Fatebenefratelli e Oftalmico, Milan, 20121, Italy|Istituto Europeo di Oncologia Via Ripamonti, Milan, 20141, Italy|AOU Policlinico di Modena, Modena, 41122, Italy|Fondazione Pascale, IRCCS Istituto Nazionale dei Tumori, Napoli, 80131, Italy|AOU di Parma, Parma, 43126, Italy|IRCCS Policlinico San Matteo, Pavia, 27100, Italy|IRCSS Fodazione Salvatore Maugeri, Pavia, 27100, Italy|SO S.Chiara, AOU Pisana, Pisa, 56126, Italy|Nuovo ospedale di Prato, Prato, 59100, Italy|PU Campus Bio-medico di Roma, Roma, 00128, Italy|AO S.Andrea, Università degli Studi di Roma La Sapienza, Roma, 00189, Italy|Ospedale Belcolle Viterbo, Viterbo, 01100, Italy|Maastricht University Medical Centre, Maastricht, Limburg, 6229 HX, Netherlands|Haga Ziekenhuis, loc. Leyenburg, The Hague, South Holland, 2545 CH, Netherlands|MAGODENT Sp. z o.o., Warsaw, Masovian Voivodeship, 04-125, Poland|Mazowiecki Szpital Onkologiczny, Wieliszew, Masovian Voivodeship, 05-135, Poland|Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Lublin, 20-090, Poland|Centro Clínico Champalimaud/Fundação Champalimaud, Lisbon, Lisbon District, 1400-038, Portugal|H. Santa Maria - Centro Hospitalar Lisboa Norte, Lisbon, 1649-035, Portugal|Instituto Português Oncologia Francisco Gentil do Porto, Porto, 4200-072, Portugal|Fundacion de Investigacion de Diego, San Juan, 927, Puerto Rico|Seoul National University Hospital, Seoul, Seoul Teugbyeolsi, 03080, South Korea|Severance Hospital, Yonsei University Health System, Seoul, Seoul Teugbyeolsi, 03722, South Korea|Asan Medical Center, Seoul, Seoul Teugbyeolsi, 05505, South Korea|Samsung Medical Center, Seoul, Seoul Teugbyeolsi, 06351, South Korea|H.U.V. del Rocío, Seville, Andalusia, 41013, Spain|Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Badalona, Barcelona, 08916, Spain|Hospital Universitari Parc Taulí, Sabadell, Barcelona, 08208, Spain|Hospital del Mar, Barcelona, Catalonia, 08003, Spain|H.C.U. Valencia, Valencia, Comunidad, 46010, Spain|Hospital de Navarra, Pamplona, Navarre, 31008, Spain|H.U. Sant Joan de Reus, Reus, Tarragona, 43204, Spain|Hospital Ntra. Sra. de Sonsoles, Ávila, 5004, Spain|Hospital Universitario Vall d'Hebron, Barcelona, 08023, Spain|H. San Pedro de Alcántara, Cáceres, 10003, Spain|H.U. Arnau de Vilanova, Lleida, 25198, Spain|M.D. Anderson Cancer Center Madrid, Madrid, 28033, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital Universitario Clínico San Carlos, Madrid, 28040, Spain|Fundación Instituto Valenciano de Oncología, Valencia, 46009, Spain|Hospital Universitari I Politecnic La Fe, Valencia, 46026, Spain|Guys and St Thomas Hospital, London, City of London, SE1 9RT, United Kingdom|Castle Hill Hospital (Hull), Hull, East Riding Of Yorkshire, HU16 5JQ, United Kingdom|Kent Oncology Centre, Maidstone Hospital, Maidstone, Kent, ME16 9QQ, United Kingdom|Royal Preston Hospital, Fulwood, Lancashire, PR2 9HT, United Kingdom|South Tees Hospitals NHS Foundation Trust, Middlesbrough, TS4 3BW, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Carcinoma, Non-Small -Cell Lung|Ovarian Neoplasms|Small Cell Lung Carcinoma|Uterine Cervical Neoplasms|Carcinoma, Neuroendocrine|Extrapulmonary Small Cell Cancer",DRUG: Topotecan|DRUG: VX-970 (M6620),ALL,"ADULT, OLDER_ADULT",PHASE1|PHASE2,62,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT,7/30/15,12/26/24,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Solid Tumor|Unresectable or Metastatic Melanoma,DRUG: CX-072|DRUG: Ipilimumab,ALL,"ADULT, OLDER_ADULT",PHASE2,3,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,11/20/19,5/21/20,"City of Hope National Medical Center, Duarte, California, 91010, United States|The Angeles Clinic and Research Institute, Los Angeles, California, 90025, United States|Beacon Cancer Care, Coeur d'Alene, Idaho, 83814, United States|University of Chicago, Chicago, Illinois, 60637, United States|Norton Cancer Institute, Louisville, Kentucky, 40202, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|NYC Cancer Institute, New York, New York, 10016, United States|Columbia Medical Center, New York, New York, 10032, United States|Oregon Health & Science Center, Portland, Oregon, 97210, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|Inova Dwight and March Schar Cancer Institute, Fairfax, Virginia, 22031, United States|Virginia Cancer Specialists, Fairfax, Virginia, 22031, United States|Multicare Institute for Research and Innovation, Spokane, Washington, 99204, United States|Sunshine Coast University Private Hospital, Sunshine Coast, Queensland, Australia|Ballarat Oncology and Haematology Services, Wendouree, Victoria, Australia|The Netherlands Cancer Institute, Amsterdam, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Asan Medical Center, Seoul, South Korea|Samsung Medical Center, Seoul, South Korea|Seoul National University Hospital, Seoul, South Korea|Severance Hospital Yonsei University Health System, Seoul, South Korea|ICO Hospitalet, Hospital Duran I Reynals, Barcelona, 08908, Spain|Hospital Clinic de Barcelona. Servicio Oncologia Medica, Barcelona, Spain|Hospital Universitario La Paz, Madrid, Spain|START- Madrid, Madrid, Spain|Clinica Universitaria de Navarra, Pamplona, Spain",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Colorectal Neoplasms|Melanoma|Prostatic Neoplasms|Renal Cell Carcinoma|Neoplasms|Patients Who Have/Have Had Melanoma and Other Tumors,"DRUG: CP-675,206 (Tremelimumab)",ALL,"ADULT, OLDER_ADULT",PHASE2,37,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,3/5/07,10/27/23,"Research Site, Los Angeles, California, 90024, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Ann Arbor, Michigan, 48109, United States|Research Site, New York, New York, 10016, United States|Research Site, Houston, Texas, 77030, United States|Research Site, Newecastle Upon Tyne, NE7 7DN, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Metastatic Malignant Neoplasm in the Liver|Metastatic Uveal Melanoma|Stage IV Uveal Melanoma AJCC v7,BIOLOGICAL: Ipilimumab|BIOLOGICAL: Nivolumab|DRUG: Embolization Therapy,ALL,"ADULT, OLDER_ADULT",PHASE2,14,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,5/2/18,12/31/24,"Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, 19107, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,"Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases|Nonmalignant Neoplasm|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific",BIOLOGICAL: anti-thymocyte globulin|DRUG: busulfan|DRUG: carboplatin|DRUG: cyclophosphamide|DRUG: etoposide|DRUG: fludarabine phosphate|DRUG: melphalan|DRUG: thiotepa|RADIATION: total-body irradiation,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE2|PHASE3,361,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/19/98,7/12/19,"Roswell Park Cancer Institute, Buffalo, New York, 14263-0001, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ACTIVE_NOT_RECRUITING,YES,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma,PROCEDURE: Biopsy Procedure|PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|PROCEDURE: Echocardiography Test|PROCEDURE: Magnetic Resonance Imaging|PROCEDURE: Radionuclide Imaging|DRUG: Sunitinib,ALL,"ADULT, OLDER_ADULT",PHASE2,10,INTERVENTIONAL,Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,11/1/16,12/31/25,"ECOG-ACRIN Cancer Research Group, Philadelphia, Pennsylvania, 19103, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,"Neoplasms, Head and Neck",DRUG: feladilimab|DRUG: Pembrolizumab|DRUG: Placebo,ALL,"ADULT, OLDER_ADULT",PHASE3,315,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",11/21/19,6/20/23,"GSK Investigational Site, Duarte, California, 91010, United States|GSK Investigational Site, Washington D.C., District of Columbia, 20010, United States|GSK Investigational Site, St. Petersburg, Florida, 33705, United States|GSK Investigational Site, Indianapolis, Indiana, 46202, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Charlotte, North Carolina, 28204, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19111, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15232, United States|GSK Investigational Site, Charleston, South Carolina, 29425, United States|GSK Investigational Site, Greenville, South Carolina, 29607, United States|GSK Investigational Site, Chattanooga, Tennessee, 37404, United States|GSK Investigational Site, Nashville, Tennessee, 37203, United States|GSK Investigational Site, Seattle, Washington, 98108, United States|GSK Investigational Site, Ciudad Autónoma de Buenos Aires, Buenos Aires, C1125ABD, Argentina|GSK Investigational Site, La Plata, Buenos Aires, 1900, Argentina|GSK Investigational Site, Buenos Aires, C1426ABP, Argentina|GSK Investigational Site, San Juan, J5402DIL, Argentina|GSK Investigational Site, Blacktown, New South Wales, 2148, Australia|GSK Investigational Site, St Leonards, New South Wales, 2065, Australia|GSK Investigational Site, Herston, Queensland, 4029, Australia|GSK Investigational Site, Heidelberg, Victoria, 3084, Australia|GSK Investigational Site, Melbourne, Victoria, 3000, Australia|GSK Investigational Site, Nedlands, Western Australia, 6009, Australia|GSK Investigational Site, Darlinghurst, 2010, Australia|GSK Investigational Site, Vitória, Espírito Santo, 29043-260, Brazil|GSK Investigational Site, Florianópolis, Santa Catarina, 88034-000, Brazil|GSK Investigational Site, Barretos, São Paulo, 14784-400, Brazil|GSK Investigational Site, São José do Rio Preto, São Paulo, 15090-000, Brazil|GSK Investigational Site, Belo Horizonte, Minas Gerais, 30150-221, Brazil|GSK Investigational Site, São Paulo, 01246-000, Brazil|GSK Investigational Site, São Paulo, 04014-002, Brazil|GSK Investigational Site, Calgary, Alberta, T2N 4N2, Canada|GSK Investigational Site, Edmonton, Alberta, T6G 1Z2, Canada|GSK Investigational Site, Vancouver, British Columbia, V5Z 4E6, Canada|GSK Investigational Site, Hamilton, Ontario, L8V 5C2, Canada|GSK Investigational Site, Toronto, Ontario, M5G 1Z5, Canada|GSK Investigational Site, Montreal, Quebec, H2X 3E4, Canada|GSK Investigational Site, Montreal, Quebec, H3T 1E2, Canada|GSK Investigational Site, Québec, Quebec, G1J 1Z4, Canada|GSK Investigational Site, Rimouski, Quebec, G5L 5T1, Canada|GSK Investigational Site, Guangzhou, Guangdong, 510060, China|GSK Investigational Site, Guangzhou, Guangdong, 510503, China|GSK Investigational Site, Nanning, Guangxi, 530021, China|GSK Investigational Site, Guiyang, Guizhou, 550000, China|GSK Investigational Site, Wuhan, Hubei, 430022, China|GSK Investigational Site, Nanchang, Jiangxi, 330029, China|GSK Investigational Site, Chengdu, Sichuan, 610000, China|GSK Investigational Site, Chengdu, Sichuan, 610041, China|GSK Investigational Site, Bengbu, 233000, China|GSK Investigational Site, Harbin, 150000, China|GSK Investigational Site, Hefei, 230001, China|GSK Investigational Site, Shnghai, 200126, China|GSK Investigational Site, Copenhagen, DK-2100, Denmark|GSK Investigational Site, Bordeaux, 33000, France|GSK Investigational Site, Epagny Metz-Tessy, 74370, France|GSK Investigational Site, Le Mans, 72000, France|GSK Investigational Site, Lille, 59000, France|GSK Investigational Site, Lyon, 69373, France|GSK Investigational Site, Paris, 75005, France|GSK Investigational Site, Saint-Herblain, 44805, France|GSK Investigational Site, Strasbourg, 67200, France|GSK Investigational Site, Toulouse, 31059, France|GSK Investigational Site, Valenciennes, 59322, France|GSK Investigational Site, Ulm, Baden-Wurttemberg, 89075, Germany|GSK Investigational Site, Aachen, North Rhine-Westphalia, 52074, Germany|GSK Investigational Site, Leipzig, Saxony, 04103, Germany|GSK Investigational Site, Berlin, 12200, Germany|GSK Investigational Site, Hamburg, 20246, Germany|GSK Investigational Site, Hamburg, 22087, Germany|GSK Investigational Site, Heraklion,Crete, 71110, Greece|GSK Investigational Site, Thessaloniki, 54622, Greece|GSK Investigational Site, Thessaloniki, 54645, Greece|GSK Investigational Site, Dublin, 8, Ireland|GSK Investigational Site, Dublin, D09 V2N0, Ireland|GSK Investigational Site, Jerusalem, 91120, Israel|GSK Investigational Site, Petah Tikva, 49100, Israel|GSK Investigational Site, Ramat Gan, 52621, Israel|GSK Investigational Site, Meldola (FC), Emilia-Romagna, 47014, Italy|GSK Investigational Site, Brescia, Lombardy, 25123, Italy|GSK Investigational Site, Milan, Lombardy, 20133, Italy|GSK Investigational Site, Milan, Lombardy, 20141, Italy|GSK Investigational Site, Candiolo, Piedmont, 10060, Italy|GSK Investigational Site, Legnago (VR), Veneto, 37045, Italy|GSK Investigational Site, Chiba, 260-8717, Japan|GSK Investigational Site, Chiba, 277-8577, Japan|GSK Investigational Site, Ehime, 791-0280, Japan|GSK Investigational Site, Fukuoka, 812-8582, Japan|GSK Investigational Site, Hokkaido, 060-8648, Japan|GSK Investigational Site, Hyōgo, 673-8558, Japan|GSK Investigational Site, Ibaraki, 305-8576, Japan|GSK Investigational Site, Kagawa, 761-0793, Japan|GSK Investigational Site, Kanagawa, 259-1143, Japan|GSK Investigational Site, Miyagi, 981-1293, Japan|GSK Investigational Site, Niigata, 951-8520, Japan|GSK Investigational Site, Numakunai, 028-3695, Japan|GSK Investigational Site, Osaka, 534-0021, Japan|GSK Investigational Site, Saitama, 362-0806, Japan|GSK Investigational Site, Shizuoka, 411-8777, Japan|GSK Investigational Site, Tokyo, 113-8431, Japan|GSK Investigational Site, Tokyo, 113-8519, Japan|GSK Investigational Site, Saltillo, Coahuila, 25279, Mexico|GSK Investigational Site, Guadalajara, Jalisco, 44680, Mexico|GSK Investigational Site, Maastricht, 6229 HX, Netherlands|GSK Investigational Site, Rotterdam, 3015 GD, Netherlands|GSK Investigational Site, Bergen, 5021, Norway|GSK Investigational Site, Oslo, 0379, Norway|GSK Investigational Site, Bydgoszcz, 85-796, Poland|GSK Investigational Site, Gdynia, 81-519, Poland|GSK Investigational Site, Gliwice, 44-101, Poland|GSK Investigational Site, Krakow, 31-826, Poland|GSK Investigational Site, Olsztyn, 10-228, Poland|GSK Investigational Site, Tomaszów Mazowiecki, 97-200, Poland|GSK Investigational Site, Warsaw, 02-781, Poland|GSK Investigational Site, Coimbra, 3000-075, Portugal|GSK Investigational Site, Lisbon, 1649-035, Portugal|GSK Investigational Site, Matosinhos Municipality, 4454-509, Portugal|GSK Investigational Site, Porto, 4200-072, Portugal|GSK Investigational Site, Porto, 4200-319, Portugal|GSK Investigational Site, Brasov, 500283, Romania|GSK Investigational Site, Bucharest, 021389, Romania|GSK Investigational Site, Cluj-Napoca, 400015, Romania|GSK Investigational Site, Constanța, 900591, Romania|GSK Investigational Site, Craiova, 200347, Romania|GSK Investigational Site, Floreşti, 407280, Romania|GSK Investigational Site, Iași, 700106, Romania|GSK Investigational Site, Oradea, 410469, Romania|GSK Investigational Site, Otopeni, 075100, Romania|GSK Investigational Site, Satu Mare, 440055, Romania|GSK Investigational Site, Suceava, 720284, Romania|GSK Investigational Site, Moscow, 111123, Russia|GSK Investigational Site, Poselok Kuzmolovsky, 188663, Russia|GSK Investigational Site, Pushkin, 196603, Russia|GSK Investigational Site, Saint Petersburg, 197022, Russia|GSK Investigational Site, Saint Petersburg, 198255, Russia|GSK Investigational Site, Yaroslavl, 150054, Russia|GSK Investigational Site, Busan, 49241, South Korea|GSK Investigational Site, Hwasun,Jeollanam-do, 58128, South Korea|GSK Investigational Site, Incheon, 21565, South Korea|GSK Investigational Site, Seongnam-si, Gyeonggi-do, 13620, South Korea|GSK Investigational Site, Seoul, 02841, South Korea|GSK Investigational Site, Seoul, 03080, South Korea|GSK Investigational Site, Seoul, 05505, South Korea|GSK Investigational Site, Seoul, 120-752, South Korea|GSK Investigational Site, Barcelona, 08035, Spain|GSK Investigational Site, Barcelona, 08908, Spain|GSK Investigational Site, Madrid, 28046, Spain|GSK Investigational Site, Málaga, 29010, Spain|GSK Investigational Site, Pozuelo de Alarcón/Madrid, 28223, Spain|GSK Investigational Site, Santiago de Compostela, 15706, Spain|GSK Investigational Site, Valencia, 46009, Spain|GSK Investigational Site, Zaragoza, 50009, Spain|GSK Investigational Site, Sankt Gallen, 9007, Switzerland|GSK Investigational Site, Zurich, 8091, Switzerland|GSK Investigational Site, Changhua, 50006, Taiwan|GSK Investigational Site, Kaohsiung City, 833, Taiwan|GSK Investigational Site, Taipei, 10002, Taiwan|GSK Investigational Site, Taipei, 112, Taiwan|GSK Investigational Site, Taipei, 11490, Taiwan|GSK Investigational Site, Taoyuan, 333, Taiwan|GSK Investigational Site, Manchester, Lancashire, M20 4BX, United Kingdom|GSK Investigational Site, London, SW3 6JJ, United Kingdom|GSK Investigational Site, Nottingham, NG5 1PB, United Kingdom|GSK Investigational Site, Sutton, SM2 5PT, United Kingdom",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Breast Cancer|Brain Tumor - Metastatic,DRUG: Cabozantinib|DRUG: Trastuzumab,ALL,"ADULT, OLDER_ADULT",PHASE2,36,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT,2014-11,3/17/20,"Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TERMINATED,YES,Metastatic or Locally Advanced Unresectable Solid Tumors,DRUG: M4112,ALL,"ADULT, OLDER_ADULT",PHASE1,15,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,10/3/17,1/14/19,"Yale Cancer Center, New Haven, Connecticut, 06510, United States|University of TX M.D. Anderson Cancer Center-Investigational Cancer Therapeutics Partner, Houston, Texas, 77030, United States|South Texas Accelerated Research Therapeutics (START), San Antonio, Texas, 78229, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,COMPLETED,YES,Mesothelioma|Uveal Melanoma|Renal Cell Carcinoma|Cholangiocarcinoma,DRUG: Niraparib,ALL,"ADULT, OLDER_ADULT",PHASE2,37,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,8/13/18,8/30/22,"University of Florida, Gainesville, Florida, 32610, United States|University of Miami, Miami, Florida, 33136, United States|Orlando Health UF Health Cancer Center, Orlando, Florida, 32806, United States",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,